Citrus Sinensis ID: 002289
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 941 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGD7 | 953 | Probable LRR receptor-lik | yes | no | 0.963 | 0.951 | 0.7 | 0.0 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.954 | 0.936 | 0.520 | 0.0 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.936 | 0.940 | 0.525 | 0.0 | |
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.871 | 0.866 | 0.348 | 1e-119 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.811 | 0.655 | 0.296 | 1e-83 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.328 | 0.363 | 0.461 | 2e-70 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.297 | 0.327 | 0.474 | 3e-68 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.309 | 0.353 | 0.447 | 7e-68 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.295 | 0.316 | 0.493 | 1e-67 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.295 | 0.426 | 0.455 | 3e-67 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 1318 bits (3410), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 651/930 (70%), Positives = 770/930 (82%), Gaps = 23/930 (2%)
Query: 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQ 88
D IT+P+EV ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYLH+ ELQ
Sbjct: 30 DDITNPVEVRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYLHVSELQ 89
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
L ++NLSGNLSPE+GRLS LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPE
Sbjct: 90 LFSMNLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPE 149
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
ELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPEL LPS+VH+L
Sbjct: 150 ELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPELGSLPSIVHIL 209
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNNNL+GYLPPELS +P+LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+P
Sbjct: 210 LDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVP 269
Query: 269 DLSRIPNLGYL---------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 313
DLS IPNLGYL LS +ITTI LSNN LTGTIP+NFSGLPRLQ+L +
Sbjct: 270 DLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSLTGTIPTNFSGLPRLQKLSL 329
Query: 314 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 373
ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GNP C +
Sbjct: 330 ANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSDG 389
Query: 374 NAEQFCGSHSDDD-NEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKS 432
N + CG +++D N+ ++N+T+ CP YE+SP RCFCAAPLLVGYRLKS
Sbjct: 390 NLLRLCGPITEEDINQGSTNSNTTI---CSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKS 446
Query: 433 PGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYV 492
PG S F Y++ FE+Y+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++
Sbjct: 447 PGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFI 506
Query: 493 FNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIIL 552
FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+S A+AGI+L
Sbjct: 507 FNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVL 566
Query: 553 GAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFN 612
G++A AVT++AI++L+I+R M+ Y A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFN
Sbjct: 567 GSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKIEGVKSFTYAELALATDNFN 626
Query: 613 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
SSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G
Sbjct: 627 SSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLG 686
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHTEA+PP+F
Sbjct: 687 FCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIF 746
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH
Sbjct: 747 HRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTH 806
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
+LTDKSDVYSLGVV LEL TGMQPI+HGKNIVRE+NIAY+S + S +D M S P EC+
Sbjct: 807 QLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYESGSILSTVDKRMSSVPDECL 866
Query: 853 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD-TKTPEFINSEHTSKEETPPS 911
EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES KT + T + S
Sbjct: 867 EKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHVAKTADL---SETMTHPSSSS 923
Query: 912 SSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941
+SS++KH Y S DVSGS+LVSGV P++ PR
Sbjct: 924 NSSIMKHHYTSMDVSGSDLVSGVAPSVAPR 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 935 bits (2416), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/954 (52%), Positives = 655/954 (68%), Gaps = 56/954 (5%)
Query: 27 DDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRE 86
D IT P +VSAL+ + + L D + L +W + DPC SNWTGV+C DG+LH++E
Sbjct: 23 DAQEITHPTDVSALQYVHRKLKDPLNHLQDWKKTDPCASNWTGVICIPDP-SDGFLHVKE 81
Query: 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
L+LLN+NL+G L+PE+G LS LTIL+FMWN ++G IP E+GN+ L LLL+GN+LTGSL
Sbjct: 82 LRLLNMNLTGQLAPELGLLSNLTILNFMWNDLTGQIPPELGNLTHLIFLLLSGNQLTGSL 141
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
P+ELG L L +QID N ISG LP S ANL K +HFHMNNNSI+GQIPPE S L +++H
Sbjct: 142 PQELGSLSNLLILQIDYNEISGKLPTSLANLKKLKHFHMNNNSITGQIPPEYSTLTNVLH 201
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266
L+DNN LTG LPPEL+++P L ILQLD +NF+GT IP+SY ++ L+KLSLRNC+L+GP
Sbjct: 202 FLMDNNKLTGNLPPELAQMPSLRILQLDGSNFDGTEIPSSYGSIPNLVKLSLRNCNLEGP 261
Query: 267 MPDLSRIPNLGYL---------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 311
+PDLS+ L YL S NITTI L NN L+G+IPSNFSGLPRLQRL
Sbjct: 262 IPDLSKSLVLYYLDISSNKLTGEIPKNKFSANITTINLYNNLLSGSIPSNFSGLPRLQRL 321
Query: 312 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-FNIPPNVTVRLRGNPFC 370
+ NN+LSG IP IW++R L A E ILD +NN +N+S N P NVTV+L GNP C
Sbjct: 322 QVQNNNLSGEIP-VIWENRILKAEEKLILDLRNNMFSNVSSVLLNPPSNVTVKLYGNPVC 380
Query: 371 LNTNAEQ---FCG--SHSDDDNEIDRSTNSTLDCRAQSCPT--DYEYSPTSPIRCFCAAP 423
N NA + CG + + T ST DC+ QSCP +Y+Y SP+ CFCAAP
Sbjct: 381 ANVNAGKLADLCGISTLEVESPATSSETISTGDCKRQSCPVSENYDYVIGSPVACFCAAP 440
Query: 424 LLVGYRLKSPGLSYFPAYK--NLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFP 481
L + RL+SP S F YK + + L +N YQ+ ID+F W+ GPRL M +K+FP
Sbjct: 441 LGIDLRLRSPSFSDFRPYKVSYMLDVASPKNLGINPYQISIDTFAWQSGPRLFMNMKIFP 500
Query: 482 VYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDV---FPPSR 538
Y S NS FN++EV RI F + + D GPYE+I+ G Y+DV FP +
Sbjct: 501 EY--SELNSK-FNSTEVQRIVDFFATFTLNTDDSLGPYEIISIN-TGAYKDVTIIFP--K 554
Query: 539 NSGISKAALAGIILGAIAGAVTISAIVSLLIV----------RAHMKNYHAISRRRHSSK 588
SG+S GII+GAIA + +S++ + + M+ H + K
Sbjct: 555 KSGMSIGVSVGIIIGAIAFFLVLSSLALVFFIKRSKRKRKTREVDMEQEHPL------PK 608
Query: 589 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 648
+ ++ V+ + + E+ AT++F+ +QIG+GGYGKVYKG LP G VVAVKRA++GSLQG
Sbjct: 609 PPMNMESVKGYNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQGSLQG 668
Query: 649 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 708
+KEF TEI+ LSRLHHRNLVSL+GYCD++GEQMLVYE+M NG+L+D LSA+ ++PL A+
Sbjct: 669 QKEFFTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQPLSLAL 728
Query: 709 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768
RL IALGS+RGILYLHTEADPP+ HRDIK SNILLD K KVADFG+S+L + D G+
Sbjct: 729 RLRIALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLIAL-DGGGV 787
Query: 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828
HV+T+VKGTPGY+DPEY+L+H+LT+KSDVYSLG+VFLE+LTGM+PISHG+NIVREVN
Sbjct: 788 QRDHVTTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGRNIVREVN 847
Query: 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888
A + MM SVID +MG Y ECV++F++LA++CCQD +ARP M E++RELE+I+ ++P
Sbjct: 848 EACDAGMMMSVIDRSMGQYSEECVKRFMELAIRCCQDNPEARPWMLEIVRELENIYGLIP 907
Query: 889 ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS-SDVSGSNLVSGVIPTITPR 941
+ + P S +S + + + Y + S+ + + LVSGVIP+I PR
Sbjct: 908 KEE--KPYSSPSVQSSASGMSGFAVASPRSSYTTFSEFTANQLVSGVIPSIAPR 959
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 904 bits (2336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/928 (52%), Positives = 614/928 (66%), Gaps = 47/928 (5%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG 96
V+ALR IK+SL+D LSNW +GDPC SNWTG++CF + +DG+ H+RELQL+ LNLSG
Sbjct: 34 VNALREIKRSLIDPMRNLSNWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSG 93
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
L+PE+G+L YL ILD MWN ++G IP EIG I SL+LLLLNGN+ TGSLP ELG L L
Sbjct: 94 ELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNL 153
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
+R+Q+D+N I+GS+P SF NL +H H+NNN+ISG+IP ELS+LP LVHM+LDNNNLTG
Sbjct: 154 NRLQVDENNITGSVPFSFGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTG 213
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
LP EL++LP L ILQLDNNNFEG+TIP +Y + S+L+KLSLRNC LQG +PDLSRI NL
Sbjct: 214 TLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENL 273
Query: 277 GYL---------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321
YL LS N+TTI+LS N LTG+IP +FS L LQ L + NNSLSGS
Sbjct: 274 SYLDLSWNHLTGTIPESKLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGS 333
Query: 322 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNA------ 375
+P+ IWQ ++ + + D NNN ++ +G+ P NVT+ LRGNP C +T+
Sbjct: 334 VPTEIWQDKSFENNKLQVYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQF 392
Query: 376 -EQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPG 434
E CG STNS C SCP +E SP C C APL + YRLKSP
Sbjct: 393 FEYICGEKKQT------STNSNTPCSNVSCP--FENVKVSPGICLCTAPLSIDYRLKSPS 444
Query: 435 LSYFPAY-KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVF 493
+F Y + F EY+TS L+L +QL ID E R +MYLKL P F
Sbjct: 445 FFFFTPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRMYLKLVP------KGRITF 498
Query: 494 NASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILG 553
N SEV RIR F W+ +D FGPYEL++F LQGPY D+ ++ SGI I+ G
Sbjct: 499 NKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAG 556
Query: 554 AIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNS 613
++ A +S +LL VR +N H ++++R S +I GV+ F++ E++ ATN F+S
Sbjct: 557 SVVAATVLSVTATLLYVRKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDS 616
Query: 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
ST IG+G YGKVYKGIL + T VA+KR +E SLQ EKEFL EI LSRLHHRNLVSL+GY
Sbjct: 617 STLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGY 676
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+ GEQMLVYE+M NG +RD LSA + + L F+MR +ALGS++GILYLHTEA+PPV H
Sbjct: 677 SSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIH 736
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
RDIK SNILLD + AKVADFGLSRLAP PAHVSTVV+GTPGYLDPEYF+T +
Sbjct: 737 RDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTVVRGTPGYLDPEYFMTQQ 796
Query: 794 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 853
LT +SDVYS GVV LELLTGM P G +I+REV A + + SV D MG + V+
Sbjct: 797 LTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTANECGTVLSVADSRMGQCSPDKVK 856
Query: 854 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 913
K +LAL CC+D + RP MS+V++ELE I + E PE + T+K +S
Sbjct: 857 KLAELALWCCEDRPETRPPMSKVVKELEGICQSVRE-----PEMFS--ETTKLLCSKTSP 909
Query: 914 SMLKHPYVSSDVSGSNLVSGVIPTITPR 941
S P S + GSNL SG + PR
Sbjct: 910 SSSSVPSPLSLLPGSNLDSGFFHAVKPR 937
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1103), Expect = e-119, Method: Compositional matrix adjust.
Identities = 330/946 (34%), Positives = 487/946 (51%), Gaps = 126/946 (13%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ TD + +AL+++K D SK +W DPC + W G+ C N + + L
Sbjct: 25 AFTDGSDFTALQALKNEW-DTLSK--SWKSSDPCGTEWVGITCNNDN------RVVSISL 75
Query: 90 LNLNLSGNLSPEIGRLSYLTILDFMWN-KISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
N NL G L EI LS L LD N ++SG +P IGN++ L L L G G +P+
Sbjct: 76 TNRNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPD 135
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNK----------------------------- 179
+G L +L R+ ++ N SG++P S L+K
Sbjct: 136 SIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDML 195
Query: 180 --TRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
T HFH NN +SG+IP +L S +L+H+L D N TG +P L + L +L+LD N
Sbjct: 196 LQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRN 255
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT- 295
G IP+S +N++ L +L L + G +P+L+ + +L T+ +SNN L
Sbjct: 256 RLSGD-IPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSL--------YTLDVSNNPLAL 306
Query: 296 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW---QSRTLNATETFI------------- 339
+PS L L L + + L G +P+S++ Q +T++ I
Sbjct: 307 SPVPSWIPFLNSLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQ 366
Query: 340 ---LDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEID-RSTNS 395
+D ++N +T N P V V L N C + A Q G N + ST S
Sbjct: 367 LDFVDLRDNFITGYKSPANNP--VNVMLADNQVCQDP-ANQLSGYC----NAVQPNSTFS 419
Query: 396 TLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--FEEYMTSGL 453
TL C E + C C PL + L+SP S F N F E + +
Sbjct: 420 TLTKCGNHCGKGKEPNQG----CHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFF 475
Query: 454 KLNLYQLDIDSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWN 509
K Y +D + R + P L + L +FP SG FN +E+ I S FT +
Sbjct: 476 KNGKYPVDSVAMRNISENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSINSAFTIQD 529
Query: 510 IPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLI 569
FGPY + Y+ F +S + ++ + + + A+ +
Sbjct: 530 YKPPPRFGPYIFV----ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYA 584
Query: 570 VRAHMKNYHAISRRRHSSK--------TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGG 621
+R + A + +K + ++ G ++FT+ E++ TNNF+ + +G GG
Sbjct: 585 LRQKKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGG 644
Query: 622 YGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681
YG+VYKG LP+G V+A+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+C ++ EQM
Sbjct: 645 YGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQM 704
Query: 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741
LVYE++ NG+LRD LS K+ L + RL IALGS +G+ YLH ADPP+ HRD+K++NI
Sbjct: 705 LVYEYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNI 764
Query: 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVY 801
LLD TAKVADFGLS+L P+ AHV+T VKGT GYLDPEY++T++LT+KSDVY
Sbjct: 765 LLDEHLTAKVADFGLSKLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVY 819
Query: 802 SLGVVFLELLTGMQPISHGKNIVREV--------NIAYQSSMMFSVIDGNMGSYPSECVE 853
GVV LELLTG PI G +V+EV N+ ++ + I N G+ + E
Sbjct: 820 GFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQNSGNL--KGFE 877
Query: 854 KFIKLALKCCQDETDARPSMSEVMRELESIWNMM---PESDTKTPE 896
K++ +AL+C + E RP+MSEV++ELESI ++ P +D+ T E
Sbjct: 878 KYVDVALQCVEPEGVNRPTMSEVVQELESILRLVGLNPNADSATYE 923
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 270/911 (29%), Positives = 422/911 (46%), Gaps = 147/911 (16%)
Query: 84 LRELQLLNLNLSGN-LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+ L L N LSG+ L+ + +++ +T L +N ISGS+P + N +L +L L+ N
Sbjct: 328 LQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGF 387
Query: 143 TGSLPEELGYL---PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
TG++P L P L++I I NY+SG++P + ++ N ++G IP E+
Sbjct: 388 TGNVPSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIW 447
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259
LP+L +++ NNLTG +P EG + L L L
Sbjct: 448 MLPNLSDLVMWANNLTGTIP-------------------EGVCVKGG-----NLETLILN 483
Query: 260 NCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318
N L G +P+ +SR N+ + I LS+N+LTG IPS L +L L + NNSL
Sbjct: 484 NNLLTGSIPESISRCTNMIW--------ISLSSNRLTGKIPSGIGNLSKLAILQLGNNSL 535
Query: 319 SGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSFNIPPNV----TVRLRGNPFCLNT 373
SG++P + ++L LD +NNLT ++ G + +V + F N
Sbjct: 536 SGNVPRQLGNCKSL-----IWLDLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNE 590
Query: 374 NAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSP 433
G+ + E R+ SCP YS + + F A ++ + +
Sbjct: 591 GGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGMT-MYTFSANGSMIYFDISYN 649
Query: 434 GLSYF--PAYKNLFEEYMTSGLKLNLYQLDI-----DSFRWEKGPRLKMYLKLFPVYDNS 486
+S F P Y N+ Y+ LNL I DSF LK V D S
Sbjct: 650 AVSGFIPPGYGNM--GYLQV---LNLGHNRITGTIPDSFGG---------LKAIGVLDLS 695
Query: 487 SGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSR---NSGI- 542
N + +G + S + ++ ++++ GP G FP SR NSG+
Sbjct: 696 HNNLQGYLPGSLGSL-SFLSDLDVSNNNLTGPIPF------GGQLTTFPVSRYANNSGLC 748
Query: 543 ---------------------SKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAIS 581
K +A ++ IA + ++ + + R
Sbjct: 749 GVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQK 808
Query: 582 RRRH------SSKTSIKIDGV---------------RSFTYGEMALATNNFNSSTQIGQG 620
R ++ S S K+ V R T+ + ATN F++ T +G G
Sbjct: 809 REKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSG 868
Query: 621 GYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680
G+G+VYK L DG+VVA+K+ + QG++EF+ E++ + ++ HRNLV L+GYC E+
Sbjct: 869 GFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEER 928
Query: 681 MLVYEFMSNGTLRDQLSAKSKEP----LGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 736
+LVYE+M G+L L KS + L +A R IA+G++RG+ +LH P + HRD+
Sbjct: 929 LLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDM 988
Query: 737 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGYLDPEYFLTHKLT 795
K+SN+LLD F A+V+DFG++RL D H+S + + GTPGY+ PEY+ + + T
Sbjct: 989 KSSNVLLDEDFEARVSDFGMARLVSALD------THLSVSTLAGTPGYVPPEYYQSFRCT 1042
Query: 796 DKSDVYSLGVVFLELLTGMQPISHGK-----NIVREVNIAYQSSMMFSVIDGNMGSYPSE 850
K DVYS GV+ LELL+G +PI G+ N+V Y+ ++D + + S
Sbjct: 1043 AKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSG 1102
Query: 851 CVEKF--IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 908
VE F +K+A +C D RP+M ++M M E T E + + S +ET
Sbjct: 1103 DVELFHYLKIASQCLDDRPFKRPTMIQLMA-------MFKEMKADTEEDESLDEFSLKET 1155
Query: 909 PPSSSSMLKHP 919
P S K P
Sbjct: 1156 PLVEESRDKEP 1166
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 149/323 (46%), Positives = 200/323 (61%), Gaps = 14/323 (4%)
Query: 597 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 656
R FT E+ AT NF+ IG GG+GKVY+G L DGT++A+KRA S QG EF TEI
Sbjct: 506 RKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEI 565
Query: 657 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 716
LSRL HR+LVSL+G+CDE E +LVYE+M+NGTLR L + PL + RL +GS
Sbjct: 566 VMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGS 625
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 776
+RG+ YLHT ++ + HRD+K +NILLD F AK++DFGLS+ P D HVST
Sbjct: 626 ARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMD-----HTHVSTA 680
Query: 777 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS----HGKNIVREVNIAYQ 832
VKG+ GYLDPEYF +LT+KSDVYS GVV E + I+ + + E +++Q
Sbjct: 681 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQ 740
Query: 833 SSM-MFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 890
+ S+ID N+ G+Y E +EK+ ++A KC DE RP M EV+ LE + + E+
Sbjct: 741 KQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIH-EA 799
Query: 891 DTKTPEFINSEHTSK--EETPPS 911
+ NS +S+ EE P S
Sbjct: 800 WLRKQNGENSFSSSQAVEEAPES 822
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (666), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 138/291 (47%), Positives = 184/291 (63%), Gaps = 11/291 (3%)
Query: 597 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 656
R F + E+ ATN F+ S+ +G GG+G+VYKG L DGT VAVKR S QG EF TEI
Sbjct: 496 RCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEI 555
Query: 657 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 716
+ LS+L HR+LVSL+GYCDE E +LVYE+M+NG LR L PL + RL I +G+
Sbjct: 556 EMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGA 615
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 776
+RG+ YLHT A + HRD+K +NILLD AKVADFGLS+ P D HVST
Sbjct: 616 ARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLD-----QTHVSTA 670
Query: 777 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT---GMQPISHGKNI-VREVNIAYQ 832
VKG+ GYLDPEYF +LT+KSDVYS GVV +E+L + P+ + + + E +A+Q
Sbjct: 671 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQ 730
Query: 833 SS-MMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
++ ++D N+ G ++KF + A KC + RPSM +V+ LE
Sbjct: 731 KKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLE 781
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 136/304 (44%), Positives = 186/304 (61%), Gaps = 13/304 (4%)
Query: 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFL 659
++ E+ TNNF+ S IG GG+G V++G L D T VAVKR GS QG EFL+EI L
Sbjct: 478 SFAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITIL 537
Query: 660 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 719
S++ HR+LVSLVGYC+E+ E +LVYE+M G L+ L + PL + RL + +G++RG
Sbjct: 538 SKIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARG 597
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+ YLHT + + HRDIK++NILLD+ + AKVADFGLSR P D HVST VKG
Sbjct: 598 LHYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCID-----ETHVSTGVKG 652
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------YQS 833
+ GYLDPEYF +LTDKSDVYS GVV E+L +P + +VN+A +
Sbjct: 653 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RPAVDPLLVREQVNLAEWAIEWQRK 711
Query: 834 SMMFSVIDGNMGSYPSEC-VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 892
M+ ++D N+ C ++KF + A KCC D RP++ +V+ LE + +
Sbjct: 712 GMLDQIVDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPL 771
Query: 893 KTPE 896
PE
Sbjct: 772 NIPE 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 144/292 (49%), Positives = 184/292 (63%), Gaps = 14/292 (4%)
Query: 597 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 656
R F+ E+ AT NF +S IG GG+G VY G L DGT VAVKR S QG EF TEI
Sbjct: 512 RYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEI 571
Query: 657 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 716
Q LS+L HR+LVSL+GYCDE E +LVYEFMSNG RD L K+ PL + RL I +GS
Sbjct: 572 QMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGS 631
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 776
+RG+ YLHT + HRD+K++NILLD AKVADFGLS+ D+ HVST
Sbjct: 632 ARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-----DV-AFGQNHVSTA 685
Query: 777 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------ 830
VKG+ GYLDPEYF +LTDKSDVYS GVV LE L +P + + +VN+A
Sbjct: 686 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCA-RPAINPQLPREQVNLAEWAMQW 744
Query: 831 YQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
+ ++ +ID ++ G+ E ++KF + A KC +D RP+M +V+ LE
Sbjct: 745 KRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLE 796
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (656), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 134/294 (45%), Positives = 188/294 (63%), Gaps = 16/294 (5%)
Query: 598 SFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 657
+FTY E++ ATN F+ + +GQGG+G V+KGILP G VAVK+ + GS QGE+EF E++
Sbjct: 267 TFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVE 326
Query: 658 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 717
+SR+HHR+LVSL+GYC +++LVYEF+ N L L K + + ++ RL IALGS+
Sbjct: 327 IISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSA 386
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
+G+ YLH + +P + HRDIKASNIL+D KF AKVADFGL+++A + HVST V
Sbjct: 387 KGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTN------THVSTRV 440
Query: 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE---------VN 828
GT GYL PEY + KLT+KSDV+S GVV LEL+TG +P+ V + +N
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 829 IAYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
A + + D MG+ Y E + + + A C + RP MS+++R LE
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 941 | ||||||
| 225434309 | 959 | PREDICTED: probable LRR receptor-like se | 0.980 | 0.962 | 0.742 | 0.0 | |
| 297745743 | 960 | unnamed protein product [Vitis vinifera] | 0.981 | 0.962 | 0.731 | 0.0 | |
| 357460549 | 955 | hypothetical protein MTR_3g062590 [Medic | 0.987 | 0.972 | 0.685 | 0.0 | |
| 334182352 | 953 | putative leucine-rich repeat transmembra | 0.963 | 0.951 | 0.7 | 0.0 | |
| 224124832 | 926 | predicted protein [Populus trichocarpa] | 0.958 | 0.974 | 0.704 | 0.0 | |
| 297848960 | 941 | predicted protein [Arabidopsis lyrata su | 0.971 | 0.971 | 0.696 | 0.0 | |
| 356569432 | 953 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.970 | 0.674 | 0.0 | |
| 356537716 | 954 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.969 | 0.669 | 0.0 | |
| 449439195 | 952 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.957 | 0.680 | 0.0 | |
| 224146594 | 865 | predicted protein [Populus trichocarpa] | 0.902 | 0.981 | 0.677 | 0.0 |
| >gi|225434309|ref|XP_002276020.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1413 bits (3658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 703/947 (74%), Positives = 796/947 (84%), Gaps = 24/947 (2%)
Query: 11 LFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGV 70
L + LCWSSS I A ++TDP+EV+ALR+IK+SL D + L+NWNRGDPCTS WTGV
Sbjct: 21 LLVWLCWSSSFIGAKA---TVTDPVEVTALRAIKESLEDPMNNLTNWNRGDPCTSEWTGV 77
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK 130
LCFNTTM+D YLH++ELQLLN++LSG LSPE+GRLSY+ ILDFMWN I+GSIPKEIGNI
Sbjct: 78 LCFNTTMNDSYLHVKELQLLNMHLSGTLSPELGRLSYMQILDFMWNNITGSIPKEIGNIT 137
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+LELLLLNGN+LTGSLPEELG LP LDRIQIDQN ISGS+P+SFANLNKT+HFHMNNNSI
Sbjct: 138 TLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRSFANLNKTKHFHMNNNSI 197
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250
SGQIP ELSRLP LVH LLDNNNL+GYLPPE SE+PKLLI+QLDNN+F G+ IPASYSNM
Sbjct: 198 SGQIPSELSRLPELVHFLLDNNNLSGYLPPEFSEMPKLLIVQLDNNHFNGS-IPASYSNM 256
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIPNLGYL---------------LSLNITTIKLSNNKLT 295
SKLLKLSLRNCSLQG +P+LS+IP LGYL S NITTI LSNN LT
Sbjct: 257 SKLLKLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPGRFSENITTIDLSNNNLT 316
Query: 296 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 355
GTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+++DFQNN+L+NISG+ +
Sbjct: 317 GTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETYVVDFQNNDLSNISGTLD 376
Query: 356 IPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSP 415
+P NVTVRL GNP C N + QFCGS S+++N+ NST+DC A CP YE SP S
Sbjct: 377 LPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVDCTAVRCPLYYEISPASL 436
Query: 416 IRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKM 475
C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL QL IDS WEKGPRLKM
Sbjct: 437 EICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLDQLKIDSVEWEKGPRLKM 496
Query: 476 YLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFP 535
Y KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGPYELINFTL Y+DV
Sbjct: 497 YFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGPYELINFTLTDIYKDVIG 553
Query: 536 PSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDG 595
S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH ISRRR S++ SIKIDG
Sbjct: 554 SSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYHTISRRRKSTRISIKIDG 613
Query: 596 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 655
V+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+KRAQEGSLQG+KEF TE
Sbjct: 614 VKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAIKRAQEGSLQGQKEFFTE 673
Query: 656 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIAL 714
I+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LSA KSKEPL FAMRLSIAL
Sbjct: 674 IELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSAAKSKEPLSFAMRLSIAL 733
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
GSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLSRLAPVPDIEG PAHVS
Sbjct: 734 GSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLSRLAPVPDIEGSTPAHVS 793
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834
TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN++YQS
Sbjct: 794 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVNVSYQSG 853
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 894
M+FSVID MGSYPSECVEKF+KLALKCCQ++TDARPSM++V+RELE+IW MMPESDTKT
Sbjct: 854 MIFSVIDNRMGSYPSECVEKFVKLALKCCQEDTDARPSMAQVVRELENIWLMMPESDTKT 913
Query: 895 PEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941
E + +E K +PPSSS+ K+PYVSSD+SGS LVSGV+PTI PR
Sbjct: 914 TESLITE-PGKLISPPSSSTPTKNPYVSSDISGSELVSGVVPTIAPR 959
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745743|emb|CBI15799.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1395 bits (3610), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 693/947 (73%), Positives = 787/947 (83%), Gaps = 23/947 (2%)
Query: 11 LFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGV 70
L + LCWSSS I A ++TDP+EV+ALR+IK+SL D + L+NWNRGDPCTS WTGV
Sbjct: 21 LLVWLCWSSSFIGAKA---TVTDPVEVTALRAIKESLEDPMNNLTNWNRGDPCTSEWTGV 77
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK 130
LCFNTTM+D YLH++ELQLLN++LSG LSPE+GRLSY+ ILDFMWN I+GSIPKEIGNI
Sbjct: 78 LCFNTTMNDSYLHVKELQLLNMHLSGTLSPELGRLSYMQILDFMWNNITGSIPKEIGNIT 137
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+LELLLLNGN+LTGSLPEELG LP LDRIQIDQN ISGS+P+SFANLNKT+HFHMNNNSI
Sbjct: 138 TLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRSFANLNKTKHFHMNNNSI 197
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 250
SGQIP ELSRLP LVH LLDNNNL+GYLPPE SE+PKLLI+QLDNN+F GT +
Sbjct: 198 SGQIPSELSRLPELVHFLLDNNNLSGYLPPEFSEMPKLLIVQLDNNHFNGTFFLPKLQSR 257
Query: 251 SKLLKLSLRNCSLQGPMPDLSRIPNLGYL---------------LSLNITTIKLSNNKLT 295
S L+ LSLRNCSLQG +P+LS+IP LGYL S NITTI LSNN LT
Sbjct: 258 SMLMNLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPGRFSENITTIDLSNNNLT 317
Query: 296 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 355
GTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+++DFQNN+L+NISG+ +
Sbjct: 318 GTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETYVVDFQNNDLSNISGTLD 377
Query: 356 IPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSP 415
+P NVTVRL GNP C N + QFCGS S+++N+ NST+DC A CP YE SP S
Sbjct: 378 LPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVDCTAVRCPLYYEISPASL 437
Query: 416 IRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKM 475
C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL QL IDS WEKGPRLKM
Sbjct: 438 EICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLDQLKIDSVEWEKGPRLKM 497
Query: 476 YLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFP 535
Y KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGPYELINFTL Y+DV
Sbjct: 498 YFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGPYELINFTLTDIYKDVIG 554
Query: 536 PSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDG 595
S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH ISRRR S++ SIKIDG
Sbjct: 555 SSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYHTISRRRKSTRISIKIDG 614
Query: 596 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 655
V+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+KRAQEGSLQG+KEF TE
Sbjct: 615 VKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAIKRAQEGSLQGQKEFFTE 674
Query: 656 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIAL 714
I+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LS AKSKEPL FAMRLSIAL
Sbjct: 675 IELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSAAKSKEPLSFAMRLSIAL 734
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
GSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLSRLAPVPDIEG PAHVS
Sbjct: 735 GSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLSRLAPVPDIEGSTPAHVS 794
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834
TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN++YQS
Sbjct: 795 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVNVSYQSG 854
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 894
M+FSVID MGSYPSECVEKF+KLALKCCQ++TDARPSM++V+RELE+IW MMPESDTKT
Sbjct: 855 MIFSVIDNRMGSYPSECVEKFVKLALKCCQEDTDARPSMAQVVRELENIWLMMPESDTKT 914
Query: 895 PEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941
E + +E K +PPSSS+ K+PYVSSD+SGS LVSGV+PTI PR
Sbjct: 915 TESLITE-PGKLISPPSSSTPTKNPYVSSDISGSELVSGVVPTIAPR 960
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357460549|ref|XP_003600556.1| hypothetical protein MTR_3g062590 [Medicago truncatula] gi|355489604|gb|AES70807.1| hypothetical protein MTR_3g062590 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1339 bits (3465), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 659/962 (68%), Positives = 783/962 (81%), Gaps = 33/962 (3%)
Query: 1 MFSSRG---AVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNW 57
MF S+G V+F+ C+ +++ A ++IT+P EV AL++IKK L+D LSNW
Sbjct: 6 MFFSKGYKHEVVFILWFCCY----VLLVAAQENITNPTEVEALKAIKKRLIDPNRNLSNW 61
Query: 58 NRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK 117
NRGDPCTS+WTGVLCFN T+ DGYLH++ELQL+NL+LSGNL+PEIG L Y+ L+FMWNK
Sbjct: 62 NRGDPCTSHWTGVLCFNETLVDGYLHVQELQLMNLSLSGNLAPEIGSLVYMERLNFMWNK 121
Query: 118 ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL 177
I+GSIPKEIGNIKSL LLLLNGN+LTGSLPEELG+LPKLDRIQIDQN ISG LPKSFANL
Sbjct: 122 ITGSIPKEIGNIKSLFLLLLNGNQLTGSLPEELGFLPKLDRIQIDQNNISGPLPKSFANL 181
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
NKT+HFHMNNNSISGQIPPEL+RLPSLVH LLDNNNL+GYLPP+LS+LP LLILQLDNNN
Sbjct: 182 NKTKHFHMNNNSISGQIPPELARLPSLVHFLLDNNNLSGYLPPQLSQLPNLLILQLDNNN 241
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL--------------LSLN 283
FEG +IP +YS+MSKLLKLSL+NC+LQGP+PDLSRIP+L YL L+ N
Sbjct: 242 FEGNSIPDTYSDMSKLLKLSLKNCNLQGPIPDLSRIPHLLYLDLSSNQLNESLPSKLAEN 301
Query: 284 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 343
ITTI LSNN+LTG IPS+FS L +LQRL +ANNSL+GS+PS+IWQ + LN +E FIL+ +
Sbjct: 302 ITTIDLSNNQLTGNIPSSFSSLSKLQRLSLANNSLNGSVPSTIWQDKKLNGSERFILELE 361
Query: 344 NNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQS 403
NN T +SGS ++P VTV LRGNP C N Q C S ++ ++ TN+ C QS
Sbjct: 362 NNQFTTVSGSTDLPSKVTVLLRGNPLCSNNTLSQLCSSEGVNNTDVLVPTNNNGSCLVQS 421
Query: 404 CPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDID 463
CP YE+S + CFCAAPLLVGYRLKSPG S F +KN FEEY+T+GL +N+ QL+
Sbjct: 422 CPPPYEFS----LDCFCAAPLLVGYRLKSPGFSDFLPFKNEFEEYLTTGLSINISQLNF- 476
Query: 464 SFRWEKGPRLKMYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELI 522
+FRW GPRL+M LK FP+Y D++S S+ FN +EV RIRSMFTGWNIPDSD+FGPYELI
Sbjct: 477 TFRWVAGPRLRMDLKFFPLYVDHNS--SHTFNETEVQRIRSMFTGWNIPDSDLFGPYELI 534
Query: 523 NFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISR 582
NF + G Y++ S SGIS A+ GI+LGAIA AVT+SAIV+LLI+R +K+YHA+S+
Sbjct: 535 NFNM-GLYQNATSTSSKSGISTGAIVGIVLGAIACAVTLSAIVTLLILRTKLKDYHAVSK 593
Query: 583 RRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQ 642
RRH SK IK+DGVRSFTY E++ ATNNF+SS Q+GQGGYGKVYKG++ GT VA+KRAQ
Sbjct: 594 RRHVSKIKIKMDGVRSFTYEELSSATNNFSSSAQVGQGGYGKVYKGVISGGTAVAIKRAQ 653
Query: 643 EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE 702
EGSLQGEKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYE+M NGTLRD LS +KE
Sbjct: 654 EGSLQGEKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEYMPNGTLRDHLSVSAKE 713
Query: 703 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762
PL F MRL IALGS++G++YLH EADPP+FHRD+KASNILLD K +AKVADFGLSRLAPV
Sbjct: 714 PLTFIMRLKIALGSAKGLMYLHNEADPPIFHRDVKASNILLDSKLSAKVADFGLSRLAPV 773
Query: 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
PD+EGIVP HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE+LTGM PISHGKN
Sbjct: 774 PDMEGIVPGHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEILTGMHPISHGKN 833
Query: 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
IVREVN++YQS ++FS+ID MGSYPSE VEKF+ LALKC DE D RP+M+EV+RELE+
Sbjct: 834 IVREVNLSYQSGVIFSIIDERMGSYPSEHVEKFLTLALKCVNDEPDNRPTMAEVVRELEN 893
Query: 883 IWNMMPESDTKTPEFINS---EHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTIT 939
IWN+MPESDT+ E I S +SK + PSSSS ++ +VS DVSGS+LVSGVIP+I
Sbjct: 894 IWNVMPESDTRRAESITSGSVSDSSKAMSTPSSSSAIRTAFVSGDVSGSDLVSGVIPSIK 953
Query: 940 PR 941
PR
Sbjct: 954 PR 955
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182352|ref|NP_172169.2| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|264664524|sp|C0LGD7.2|Y1684_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g06840; Flags: Precursor gi|332189923|gb|AEE28044.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1318 bits (3410), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 651/930 (70%), Positives = 770/930 (82%), Gaps = 23/930 (2%)
Query: 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQ 88
D IT+P+EV ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYLH+ ELQ
Sbjct: 30 DDITNPVEVRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYLHVSELQ 89
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
L ++NLSGNLSPE+GRLS LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPE
Sbjct: 90 LFSMNLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPE 149
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
ELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPEL LPS+VH+L
Sbjct: 150 ELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPELGSLPSIVHIL 209
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNNNL+GYLPPELS +P+LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+P
Sbjct: 210 LDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVP 269
Query: 269 DLSRIPNLGYL---------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 313
DLS IPNLGYL LS +ITTI LSNN LTGTIP+NFSGLPRLQ+L +
Sbjct: 270 DLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSLTGTIPTNFSGLPRLQKLSL 329
Query: 314 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT 373
ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GNP C +
Sbjct: 330 ANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSDG 389
Query: 374 NAEQFCGSHSDDD-NEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKS 432
N + CG +++D N+ ++N+T+ CP YE+SP RCFCAAPLLVGYRLKS
Sbjct: 390 NLLRLCGPITEEDINQGSTNSNTTI---CSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKS 446
Query: 433 PGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYV 492
PG S F Y++ FE+Y+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++
Sbjct: 447 PGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFI 506
Query: 493 FNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIIL 552
FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+S A+AGI+L
Sbjct: 507 FNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVL 566
Query: 553 GAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFN 612
G++A AVT++AI++L+I+R M+ Y A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFN
Sbjct: 567 GSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKIEGVKSFTYAELALATDNFN 626
Query: 613 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
SSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G
Sbjct: 627 SSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLG 686
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHTEA+PP+F
Sbjct: 687 FCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIF 746
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH
Sbjct: 747 HRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTH 806
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
+LTDKSDVYSLGVV LEL TGMQPI+HGKNIVRE+NIAY+S + S +D M S P EC+
Sbjct: 807 QLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYESGSILSTVDKRMSSVPDECL 866
Query: 853 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD-TKTPEFINSEHTSKEETPPS 911
EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES KT + T + S
Sbjct: 867 EKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHVAKTADL---SETMTHPSSSS 923
Query: 912 SSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941
+SS++KH Y S DVSGS+LVSGV P++ PR
Sbjct: 924 NSSIMKHHYTSMDVSGSDLVSGVAPSVAPR 953
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124832|ref|XP_002319433.1| predicted protein [Populus trichocarpa] gi|222857809|gb|EEE95356.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1315 bits (3402), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 649/921 (70%), Positives = 755/921 (81%), Gaps = 19/921 (2%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG 96
V AL+ I+ SL+D LSNW RGDPCTSNWTGVLCFNTT +D YLH+RELQLLN+NLSG
Sbjct: 9 VKALQDIRNSLIDINKNLSNWRRGDPCTSNWTGVLCFNTTKEDAYLHVRELQLLNMNLSG 68
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
LSP +G LSY+ ILDFMWN I+GSIP EIGNIKSLELLLLNGN+LTG LPEELG LPKL
Sbjct: 69 TLSPSLGLLSYMEILDFMWNSITGSIPPEIGNIKSLELLLLNGNQLTGPLPEELGNLPKL 128
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
DRIQIDQN+ISG +PKSFA LN T+HFHMNNNSISGQIP ELSRLP+LVH LLDNNNL+G
Sbjct: 129 DRIQIDQNHISGPIPKSFAYLNSTKHFHMNNNSISGQIPAELSRLPNLVHFLLDNNNLSG 188
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
LPP+L +LPKLLILQLDNN F+G+TIP SY NM++LLKLSLRNCSL+G MPDLS IPNL
Sbjct: 189 TLPPDLYKLPKLLILQLDNNQFDGSTIPPSYGNMTQLLKLSLRNCSLRGLMPDLSGIPNL 248
Query: 277 GYL---------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321
GYL L NITTI LSNN L GTIP+ FS LPRLQ L IANNSLSGS
Sbjct: 249 GYLDLSFNQLAGPIPPNKLFENITTINLSNNTLNGTIPAYFSDLPRLQLLSIANNSLSGS 308
Query: 322 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGS 381
+PS+IWQ+RT N E L F+NN L+NISGS ++P NVT+ L+GNP C N+N +FCGS
Sbjct: 309 VPSTIWQTRT-NGNEGLDLHFENNRLSNISGSTSLPQNVTLWLQGNPACSNSNIVKFCGS 367
Query: 382 HSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAY 441
+ D N+ + ++ C QSCP YEY T I C CAAPL+ YRLKSPG S F Y
Sbjct: 368 QNGDMNDQSTTESNVTTCSVQSCPPPYEYFQTPTISCVCAAPLIFEYRLKSPGFSKFIPY 427
Query: 442 KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRI 501
+ F++Y+TSGL+L+LYQLD+ S WEKGPRLKM LKLFPVY N + +S+ FN SEV RI
Sbjct: 428 RVAFQDYLTSGLELHLYQLDLSSAIWEKGPRLKMQLKLFPVYVNEN-SSHKFNDSEVRRI 486
Query: 502 RSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPS-RNSGISKAALAGIILGAIAGAVT 560
SMFTGWNIPDS +FGPYEL+ L GPY +V + + S +S AL GI+LGAIAGAV
Sbjct: 487 ISMFTGWNIPDSQLFGPYELLYINLLGPYINVLSVTPQKSKLSTGALVGIVLGAIAGAVA 546
Query: 561 ISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQG 620
+SA+VSLLI+R +N+ AIS+RR SK S+KI+GV+ F+Y EMALATNNFNSS+Q+GQG
Sbjct: 547 LSAVVSLLILRKRSRNHGAISKRRRVSKASLKIEGVKYFSYAEMALATNNFNSSSQVGQG 606
Query: 621 GYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680
GYGKVYKG L DG VA+KRA+E S QGE+EFLTEI+ LSR+HHRNLVSL+G+CDE GEQ
Sbjct: 607 GYGKVYKGYLADGRTVAIKRAEEASFQGEREFLTEIELLSRVHHRNLVSLIGFCDEGGEQ 666
Query: 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 740
MLVYEFMSNGTLRD LSAK+KEPL FA RL IAL S++GILYLHTEADPP+FHRD+KASN
Sbjct: 667 MLVYEFMSNGTLRDHLSAKAKEPLSFATRLGIALASAKGILYLHTEADPPIFHRDVKASN 726
Query: 741 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 800
ILLD ++ AKVADFGLS+LAPVPDIEG VP H+STVVKGTPGYLDPEYFLTHKLTDKSDV
Sbjct: 727 ILLDSRYNAKVADFGLSKLAPVPDIEGDVPGHISTVVKGTPGYLDPEYFLTHKLTDKSDV 786
Query: 801 YSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLAL 860
YSLGVVFLELLTGMQPISHGKNIVREVNIAYQ+ M+FS++DG MGSYPS+CV+KF+ LA+
Sbjct: 787 YSLGVVFLELLTGMQPISHGKNIVREVNIAYQTGMIFSIVDGRMGSYPSDCVDKFLTLAM 846
Query: 861 KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920
KCC DETD RPSM +V+RELE++W+MMPESDTKT + +N++ T E T PSS S+LK+PY
Sbjct: 847 KCCNDETDERPSMIDVVRELENMWHMMPESDTKTTDTMNTD-TGMEMTSPSSCSLLKNPY 905
Query: 921 VSSDVSGSNLVSGVIPTITPR 941
VSS+VS S+LVSGV PTITPR
Sbjct: 906 VSSEVSSSDLVSGVAPTITPR 926
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297848960|ref|XP_002892361.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297338203|gb|EFH68620.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1304 bits (3375), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 653/937 (69%), Positives = 772/937 (82%), Gaps = 23/937 (2%)
Query: 23 VVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYL 82
V+AA + + ALR IK+SL D +L NW GDPC SNWTGV+CFN+T+DDGYL
Sbjct: 10 VMAAAKRKLLLTFLLRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYL 69
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
H+ ELQL ++NLSGNLSP++GRL+ LTIL FMWNKI+GSIPKEIGNIKSLELLLLNGN L
Sbjct: 70 HVSELQLFSMNLSGNLSPDLGRLTRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLL 129
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
G+LPEELG+LP LDRIQID+N ISG LPKSFANLNKT+HFHMNNNSISGQIPPE+ LP
Sbjct: 130 IGNLPEELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPEIGSLP 189
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
S+VH+LLDNNNL+GYLPPELS +P LLILQLDNN+F+GTTIP SY NMSKLLK+SLRNCS
Sbjct: 190 SIVHILLDNNNLSGYLPPELSNMPHLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCS 249
Query: 263 LQGPMPDLSRIPNLGYL---------------LSLNITTIKLSNNKLTGTIPSNFSGLPR 307
LQGP+PDLS IPNLGYL LS NITTI LS+N LTGTIP+NFSGLPR
Sbjct: 250 LQGPVPDLSSIPNLGYLDLSQNQLNGSIPTGKLSDNITTIDLSSNSLTGTIPTNFSGLPR 309
Query: 308 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 367
LQ+L +ANN+LSGSIPS IWQ R LN+TE+ I+D +NN +NISG ++ PNVTV L+GN
Sbjct: 310 LQKLSLANNALSGSIPSRIWQERELNSTESIIVDLRNNRFSNISGRSDLRPNVTVWLQGN 369
Query: 368 PFCLNTNAEQFCGSHSDDD-NEIDRSTNS-TLDCRAQSCPTDYEYSPTSPIRCFCAAPLL 425
P C + N + CG +++D N+ STNS T C CP YE+SP RCFCAAPLL
Sbjct: 370 PLCSDGNLLRLCGPITEEDINQGQGSTNSYTTTC--SDCPPPYEFSPEPLRRCFCAAPLL 427
Query: 426 VGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDN 485
VGYRLKSPG S F Y++ FEEY+TSGL LNLYQL +DSF+W+KGPRL+MYLK FPV+ +
Sbjct: 428 VGYRLKSPGFSDFVPYRSEFEEYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGS 487
Query: 486 SSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKA 545
++ NS++FN SEV RIR MFTGWNI D D+FGPYEL+NFTL YRDVFP + SG+SK
Sbjct: 488 NANNSFIFNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSKG 547
Query: 546 ALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMA 605
A+AGI+LG++A AVT++AI++L+I+R M+ Y+A++RR+ SSK S+KI+GV+SFTY E+A
Sbjct: 548 AVAGIVLGSVAAAVTLTAIIALIIMRKRMRGYNAVARRKRSSKASLKIEGVKSFTYAELA 607
Query: 606 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR 665
LAT+NFNSSTQIGQGGYGKVYKG L GTVVA+KRAQEGSLQGEKEFLTEI+ LSRLHHR
Sbjct: 608 LATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHR 667
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
NLVSL+G+CDEEGEQMLVYE+M NGTLRD +S K KEPL FAMRL IALGS++GILYLHT
Sbjct: 668 NLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHT 727
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
EA+PP+FHRDIKASNILLD +FTAKVADFGLSRLAPVPD+EGI P HVSTVVKGTPGYLD
Sbjct: 728 EANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPHHVSTVVKGTPGYLD 787
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
PEYFLTH+LTDKSDVYSLGVVFLELLTGMQPI+HGKNIVRE+NIAY+S + S +D M
Sbjct: 788 PEYFLTHQLTDKSDVYSLGVVFLELLTGMQPITHGKNIVREINIAYESGSILSAVDKRMS 847
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD-TKTPEFINSEHTS 904
S P EC+EKF LAL+CC++ETDARPSM+EV+RELE IW +MPES KT + T
Sbjct: 848 SVPDECLEKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHVAKTADL---SETM 904
Query: 905 KEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941
+ S+SS++KHPY S DVSGS+LVSG+ P++ PR
Sbjct: 905 THPSSSSNSSIMKHPYTSMDVSGSDLVSGIAPSVAPR 941
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569432|ref|XP_003552905.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1294 bits (3348), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 646/958 (67%), Positives = 778/958 (81%), Gaps = 33/958 (3%)
Query: 5 RGAVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT 64
+ V+F+ C+ ++ AA ++ITDP+EV ALR+IK L+D LSNWN GDPCT
Sbjct: 8 KHEVVFILWFCCY----LLHAAGQNNITDPVEVDALRAIKSRLIDPNGNLSNWNDGDPCT 63
Query: 65 SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK 124
S W GVLCFN T +DG+LH+ ELQLL LNL G L+P++G+L+Y+ L+FMWN ISGSIP
Sbjct: 64 SRWKGVLCFNETKEDGHLHVEELQLLRLNLLGTLAPDLGKLTYMKRLNFMWNNISGSIPN 123
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+GNI SLELLLLNGN+LTGSLPEE+GYLP LDRIQIDQN ISG +P SFANLNKT+HFH
Sbjct: 124 EVGNITSLELLLLNGNKLTGSLPEEIGYLPNLDRIQIDQNQISGPIPTSFANLNKTKHFH 183
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
MNNNS+SGQIPPELSRLP+LVH+LLDNNNL+GYLP EL+++P LLI+QLDNNNFEG +IP
Sbjct: 184 MNNNSLSGQIPPELSRLPNLVHLLLDNNNLSGYLPRELADMPSLLIIQLDNNNFEGNSIP 243
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL-LSLN--------------ITTIKL 289
+Y+NMSKLLK+SLRNCSLQGP+PDLSRIP+L YL LSLN ITTI L
Sbjct: 244 DTYANMSKLLKMSLRNCSLQGPIPDLSRIPHLLYLDLSLNQLNESIPPNKLSEHITTIDL 303
Query: 290 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 349
S+N+LTG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++T N T+TF+L+ +NNNLT
Sbjct: 304 SSNRLTGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTSNGTKTFLLELENNNLTT 363
Query: 350 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE 409
ISGS ++PPNVTV L GNP C N QFCGS + + +TNS+ C Q+CP YE
Sbjct: 364 ISGSIDLPPNVTVGLNGNPLCSNVTLTQFCGSEGANVTDGSFTTNSS-SCPPQACPPPYE 422
Query: 410 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEK 469
YS + CFC PL+V YRLKSPG S F Y N FE YM SG+K++ QL D F W+
Sbjct: 423 YS----VNCFCGLPLIVDYRLKSPGFSNFLPYLNDFEVYMASGVKISTNQLQYD-FYWQV 477
Query: 470 GPRLKMYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQG 528
GPRL+M LK FP Y DNSS S+ FN SE+ R+ SMFTGW IPDSD+FGPYEL+ F L G
Sbjct: 478 GPRLRMNLKFFPAYVDNSS--SHTFNRSELLRLTSMFTGWLIPDSDLFGPYELMGFNLLG 535
Query: 529 PYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSK 588
PY+D S SGIS AL GI++GAIA AVT+SAIV++LI+R +++YHA+SRRRH+SK
Sbjct: 536 PYQDEIGRSSKSGISTGALVGIVIGAIAFAVTLSAIVTILILRIRLRDYHAVSRRRHASK 595
Query: 589 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 648
SIKIDGVR+F+YGE++ ATNNF++S Q+GQGGYGKVYKG+L DGT+VA+KRAQEGSLQG
Sbjct: 596 ISIKIDGVRAFSYGELSSATNNFSTSAQVGQGGYGKVYKGVLSDGTIVAIKRAQEGSLQG 655
Query: 649 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 708
EKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS +K+PL FAM
Sbjct: 656 EKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLSVTAKDPLTFAM 715
Query: 709 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768
RL +ALG+++G+LYLH+EADPP+FHRD+KASNILLD KF+AKVADFGLSRLAPVPD+EG+
Sbjct: 716 RLKMALGAAKGLLYLHSEADPPIFHRDVKASNILLDSKFSAKVADFGLSRLAPVPDMEGV 775
Query: 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828
VP HVSTVVKGTPGYLDPEYFLT KLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN
Sbjct: 776 VPGHVSTVVKGTPGYLDPEYFLTRKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVN 835
Query: 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888
+AYQS ++FS+IDG MGSYPSE VEKF+ LA+KCC+DE +ARP M+EV+RELE+IW+ MP
Sbjct: 836 VAYQSGVIFSIIDGRMGSYPSEHVEKFLTLAMKCCEDEPEARPRMAEVVRELENIWSTMP 895
Query: 889 ESDTKTPEFINSEHTSKE-----ETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941
ESDTK EF++S+ + + +S+S++K P+VS DVSGS+LVSGVIP+I PR
Sbjct: 896 ESDTKRAEFMSSDSGKADSHSTPSSSSASASIMKTPFVSGDVSGSDLVSGVIPSIKPR 953
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537716|ref|XP_003537371.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1280 bits (3313), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 641/958 (66%), Positives = 769/958 (80%), Gaps = 33/958 (3%)
Query: 5 RGAVLFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT 64
G V L+ C C+ ++ AA ++ITDP+EV ALR+IK+ L+D LSNW DPCT
Sbjct: 9 HGVVFLLWFC-CY----LLHAAGQNNITDPVEVDALRAIKRRLIDPNGNLSNWEDRDPCT 63
Query: 65 SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK 124
S W GVLCFN T +DGYLH+ ELQLL LNL G L+P++G+L+Y+ L+FMWN ISGSIPK
Sbjct: 64 SRWKGVLCFNETKEDGYLHVEELQLLRLNLFGTLAPDLGKLTYMKRLNFMWNNISGSIPK 123
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+GNI SLELLLLNGN LTGSLPEE+GYLP LDRIQIDQN ISG +P SFANLNKT+HFH
Sbjct: 124 EVGNITSLELLLLNGNNLTGSLPEEIGYLPNLDRIQIDQNQISGPIPTSFANLNKTKHFH 183
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
MNNNS+SGQIPPELSRLP LVH+LLDNNNL+GYLP EL+++P LLI+QLDNNNFEG +IP
Sbjct: 184 MNNNSLSGQIPPELSRLPKLVHLLLDNNNLSGYLPRELADMPSLLIIQLDNNNFEGNSIP 243
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL---------------LSLNITTIKL 289
+Y+NMSKLLK+SLRNC+L+GP+PDL RIP+L YL LS NITTI L
Sbjct: 244 DTYANMSKLLKMSLRNCNLRGPLPDLRRIPHLLYLDLSFNQLNGSIPPNKLSENITTIDL 303
Query: 290 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 349
SNN LTG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++TLN TE F L+ +NNNLT
Sbjct: 304 SNNLLTGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTLNGTEKFFLELENNNLTT 363
Query: 350 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE 409
ISGS ++PPNVTV L GNP C N QFCGS + +TN + C Q CP +E
Sbjct: 364 ISGSIDLPPNVTVGLNGNPLCSNITLIQFCGSEAATVTNGSLTTNFS-SCPPQGCPPPFE 422
Query: 410 YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEK 469
Y+ + CFCA PL+V YRLKSPG + F Y N F++YMT GL+++ QL+ D F W+
Sbjct: 423 YT----VDCFCALPLIVFYRLKSPGFTNFLPYLNGFKDYMTHGLEISFDQLEYD-FYWQV 477
Query: 470 GPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGP 529
GPRLKM LK FP Y N++ N + FN SE+ RI+S FTGW IPD+D FGPYELI F L G
Sbjct: 478 GPRLKMDLKFFPPYLNNTSN-HTFNESELLRIKSKFTGWLIPDNDTFGPYELIGFNLLGS 536
Query: 530 YRDVFPP-SRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSK 588
Y+DV P S + I L GI++GAIA AVT+SAIV++LI+R +++YHA+S++RH+SK
Sbjct: 537 YQDVIPTRSESQNIRTGVLVGIVIGAIACAVTLSAIVTILILRIKLRDYHAVSKQRHASK 596
Query: 589 TSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG 648
SIKIDGVR+FTYGE++ ATNNF+ S Q+GQGGYGKVYKG+L DGTVVA+KRAQEGSLQG
Sbjct: 597 ISIKIDGVRAFTYGELSFATNNFSISAQVGQGGYGKVYKGVLSDGTVVAIKRAQEGSLQG 656
Query: 649 EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 708
EKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS +K+PL FAM
Sbjct: 657 EKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLSVTAKDPLTFAM 716
Query: 709 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768
RL IALG+++G++YLHTEADPP+FHRD+KASNILLD KF+AKVADFGLSRLAPVPD+EG+
Sbjct: 717 RLKIALGAAKGLMYLHTEADPPIFHRDVKASNILLDSKFSAKVADFGLSRLAPVPDMEGV 776
Query: 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828
VP HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PISHGKNIVREVN
Sbjct: 777 VPGHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPISHGKNIVREVN 836
Query: 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888
+AYQS ++FS+IDG MGSYPSE VEKF+ LA+KCC+DE +ARPSM+EV+RELE+IW+ MP
Sbjct: 837 VAYQSGVIFSIIDGRMGSYPSEHVEKFLTLAMKCCEDEPEARPSMTEVVRELENIWSTMP 896
Query: 889 ESDTKTPEFINSEHTSKE-----ETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941
ESDTK EFI+S+ + + +S+S++K P+VS DVSGS+LVSGVIP+I PR
Sbjct: 897 ESDTKRAEFISSDSGKADSHSTPSSSSASASVMKTPFVSGDVSGSDLVSGVIPSIKPR 954
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439195|ref|XP_004137372.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1246 bits (3224), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 638/937 (68%), Positives = 741/937 (79%), Gaps = 25/937 (2%)
Query: 22 IVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGY 81
+VVAA+ T P EV AL IK SL D LSNWN+GDPC SNWTGVLC+NTT DD Y
Sbjct: 24 VVVAAEMG--THPSEVDALLLIKSSLFDPNGNLSNWNKGDPCNSNWTGVLCYNTTFDDNY 81
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
LH+ ELQLLN++LSG LSP +GRLSYL +LDFMWNKISG IP+EIGN+ SLELLLLNGN+
Sbjct: 82 LHVAELQLLNMSLSGKLSPALGRLSYLRVLDFMWNKISGEIPREIGNLTSLELLLLNGNQ 141
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L+GSLPE+LG L LDRIQIDQN+ISG +PKSFANL T+HFHMNNNSISG+IP ELS L
Sbjct: 142 LSGSLPEDLGNLLHLDRIQIDQNHISGLIPKSFANLKATKHFHMNNNSISGEIPSELSGL 201
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
P+LVH LLDNNNL+G LPPEL +LP L ILQLDNNNF G TIP SY M+KLLKLSLRNC
Sbjct: 202 PNLVHFLLDNNNLSGKLPPELFQLPNLEILQLDNNNFSGATIPDSYGKMTKLLKLSLRNC 261
Query: 262 SLQGPMPDLSRIPNLGYL---------------LSLNITTIKLSNNKLTGTIPSNFSGLP 306
+LQG +PDLSRI NLGYL LS NITTI LS+N+LTGTIPS+ GLP
Sbjct: 262 TLQGSIPDLSRIKNLGYLDLSSNQLSGLIPRGKLSENITTIILSDNRLTGTIPSSLLGLP 321
Query: 307 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRG 366
LQ+L +ANNSL+GS+PS+IWQSR LN+ ++ ++ QNNN ++I GS ++P NV+VRL+G
Sbjct: 322 HLQKLSVANNSLNGSVPSTIWQSRMLNSLDSLTVELQNNNFSDILGSIHLPLNVSVRLQG 381
Query: 367 NPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYE-YSPTSPIRCFCAAPLL 425
NP C N + FCGS S+D ID TN+ L C CP YE YS P C C+APLL
Sbjct: 382 NPACANNSLLDFCGSESEDI--IDIPTNNPLGCSGPICPPSYECYSAKCPSSCLCSAPLL 439
Query: 426 VGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDN 485
+GYRLKSPG S F Y+++FEEY+TSGLK++L QLDI S WEKGPRL+M LK+FP+Y
Sbjct: 440 IGYRLKSPGFSRFSPYQHMFEEYLTSGLKVHLEQLDIGSAVWEKGPRLRMSLKVFPLYVA 499
Query: 486 SSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVF-PPSRNSGISK 544
S +S++FN SEV RI FT W I DSDIFGPYEL++ T+ Y+ VF PS +S +SK
Sbjct: 500 DSNSSHMFNDSEVLRIVYKFTNWKIQDSDIFGPYELLSLTISDVYKKVFFTPSSDSTMSK 559
Query: 545 AALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEM 604
ALAGIILGAIAG +SAIV + I+R+ ++ +H ISRRRH SKTSIKI GV+ F Y EM
Sbjct: 560 GALAGIILGAIAGGAMLSAIVFIFIIRSRVRGHH-ISRRRHLSKTSIKIKGVKEFGYREM 618
Query: 605 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 664
ALATNNF+ S +GQGGYGKVYKGIL D VA+KRAQEGSLQGEKEFLTEIQ LSRLHH
Sbjct: 619 ALATNNFHCSMVVGQGGYGKVYKGILADSMAVAIKRAQEGSLQGEKEFLTEIQLLSRLHH 678
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
RNLV+L+GYCDEEGEQML YEFMSNGTLRD LS S EPL FA RL ALG+++GILYLH
Sbjct: 679 RNLVALIGYCDEEGEQMLAYEFMSNGTLRDHLSVNSAEPLSFATRLKAALGAAKGILYLH 738
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
TEADPP+FHRDIK+SNILLD K+ AKVADFGLSRLAP+P+ EG VPAHVSTVVKGTPGYL
Sbjct: 739 TEADPPIFHRDIKSSNILLDSKYVAKVADFGLSRLAPLPNAEGDVPAHVSTVVKGTPGYL 798
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
DPEYFLTHKLTDKSDVYSLGVVFLELLTG PISHGKNIVREVN AYQS +FS+IDG +
Sbjct: 799 DPEYFLTHKLTDKSDVYSLGVVFLELLTGRHPISHGKNIVREVNSAYQSGKIFSIIDGRL 858
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 904
GSYP+ECVEKF+ LALKCCQD+TDARPSM EV+R LE+IW M+PESD+K E + ++
Sbjct: 859 GSYPAECVEKFVTLALKCCQDDTDARPSMVEVVRTLENIWLMLPESDSKISEPLINDVIK 918
Query: 905 KEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941
P SSS+M Y S+VSGS+LVSGV PTI PR
Sbjct: 919 VTSPPSSSSNM---NYYISEVSGSDLVSGVTPTIMPR 952
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146594|ref|XP_002326064.1| predicted protein [Populus trichocarpa] gi|222862939|gb|EEF00446.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1231 bits (3185), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/919 (67%), Positives = 715/919 (77%), Gaps = 70/919 (7%)
Query: 39 ALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNL 98
ALR IK SL+D + LSNW RGDPCTSNWTGVLCFN T +DGY H+REL
Sbjct: 1 ALRDIKNSLIDINNNLSNWRRGDPCTSNWTGVLCFNKTEEDGYQHVREL----------- 49
Query: 99 SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158
LLNGN+LTG LP+ELGYLP L+R
Sbjct: 50 -------------------------------------LLNGNQLTGPLPDELGYLPNLER 72
Query: 159 IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218
IQIDQN ISG +PKSFANLNKT+HFHMNNNSISG IP ELSRLPSL+H LLDNNNL+G L
Sbjct: 73 IQIDQNNISGPIPKSFANLNKTQHFHMNNNSISGNIPAELSRLPSLLHFLLDNNNLSGTL 132
Query: 219 PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGY 278
PPELS P LLILQLDNNNF+G+TIPASY NM+KLLKLSLRNCSLQGPMPDLS IPNLGY
Sbjct: 133 PPELSNFPNLLILQLDNNNFDGSTIPASYGNMTKLLKLSLRNCSLQGPMPDLSGIPNLGY 192
Query: 279 L---------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 323
L LS NITTI LS N L GTIP+NFS LP LQ+L IANNSLSGS+P
Sbjct: 193 LDLSFNQLAGPIPTNKLSKNITTIDLSYNNLNGTIPANFSELPLLQQLSIANNSLSGSVP 252
Query: 324 SSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 383
+ WQ+R N TE LDF+NN L+NISGS ++P NVT+RL+GNP C N++ QFC S +
Sbjct: 253 FTTWQTRA-NGTEGLDLDFENNTLSNISGSISLPQNVTLRLKGNPVCSNSSIFQFCESQN 311
Query: 384 DDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKN 443
+D N ST S C QSCP+ YEYSPTSP CFCAAPL+ GYRLKSPG S F Y+
Sbjct: 312 NDMNN-QSSTESNATCFTQSCPSPYEYSPTSPTSCFCAAPLIFGYRLKSPGFSKFVPYRI 370
Query: 444 LFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRS 503
FE Y+TSGLKL+L+QLD+ S WE GPRLKM+LKLFPVY N + FN SE RI S
Sbjct: 371 RFENYLTSGLKLSLFQLDLASVVWESGPRLKMHLKLFPVYVNGTN---TFNTSEARRIIS 427
Query: 504 MFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSG-ISKAALAGIILGAIAGAVTIS 562
MFTGW IPDS+IFGPYEL+ TL PYRDV S+ S IS AL GI+LGAIAGAVT+S
Sbjct: 428 MFTGWKIPDSEIFGPYELLYITLLDPYRDVIVTSQKSNKISTGALVGIVLGAIAGAVTLS 487
Query: 563 AIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGY 622
A+VSLLI+R +++Y AIS+RR SK S+KI+GV+ F+Y EMA+ATNNFNSS+Q+GQGGY
Sbjct: 488 AVVSLLILRRRLRDYTAISKRRRQSKASLKIEGVKDFSYAEMAMATNNFNSSSQVGQGGY 547
Query: 623 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682
GKVYKGIL DG VA+KR +EGSLQGEKEFLTEI+ LSRLHHRNLVSL+GYCDE+GEQML
Sbjct: 548 GKVYKGILADGRTVAIKRTEEGSLQGEKEFLTEIELLSRLHHRNLVSLLGYCDEQGEQML 607
Query: 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 742
VYEFM NGTLRD LS K KEPL FA RL IA+ S++GILYLHTEA+PP+FHRDIKASNIL
Sbjct: 608 VYEFMPNGTLRDHLSVKGKEPLSFATRLKIAMTSAKGILYLHTEANPPIFHRDIKASNIL 667
Query: 743 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYS 802
+D ++ AKVADFGLSRLAPVPDIEG VP H+STVVKGTPGYLDPEYFLTHKLTDKSDVYS
Sbjct: 668 VDSRYDAKVADFGLSRLAPVPDIEGSVPDHISTVVKGTPGYLDPEYFLTHKLTDKSDVYS 727
Query: 803 LGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKC 862
LGVVFLELLTG QPISHGKNIVREV IAYQS M+FS+ID MGSYPS+C++KF+ LA+KC
Sbjct: 728 LGVVFLELLTGKQPISHGKNIVREVKIAYQSGMIFSIIDERMGSYPSDCIDKFLTLAMKC 787
Query: 863 CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922
C +ETDARPSM++V+RELE IW+MM ESDT T + I++++ KE TPPSSSSM+ +P VS
Sbjct: 788 CNEETDARPSMADVVRELEGIWHMMSESDTATTDTISTDN-RKEMTPPSSSSMMMNPCVS 846
Query: 923 SDVSGSNLVSGVIPTITPR 941
S+VSGS+LVSG +PTITPR
Sbjct: 847 SEVSGSDLVSGAVPTITPR 865
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 941 | ||||||
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.875 | 0.866 | 0.511 | 1.2e-216 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.939 | 0.943 | 0.482 | 1.2e-214 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.793 | 0.769 | 0.367 | 1.3e-114 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.808 | 0.798 | 0.359 | 1.4e-112 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.806 | 0.802 | 0.355 | 1.3e-107 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.792 | 0.870 | 0.328 | 1.6e-95 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.330 | 0.326 | 0.404 | 1.4e-76 | |
| TAIR|locus:2128625 | 898 | AT4G20450 [Arabidopsis thalian | 0.342 | 0.358 | 0.424 | 4.7e-74 | |
| TAIR|locus:2148151 | 866 | AT5G16900 [Arabidopsis thalian | 0.329 | 0.357 | 0.446 | 7.6e-74 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.317 | 0.468 | 0.396 | 9.3e-74 |
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2093 (741.8 bits), Expect = 1.2e-216, P = 1.2e-216
Identities = 434/848 (51%), Positives = 549/848 (64%)
Query: 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRIQ 160
EIG++S L +L NK+SG++P E+G + P+ L K+ +
Sbjct: 121 EIGQISSLVLLLLNGNKLSGTLPSELGYLSNLNRFQIDENNITGPIPKSFSNLKKVKHLH 180
Query: 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYXXX 220
+ N ++G +P +NL H ++NN +SG +PP+LS LP+L + LDNNN +G
Sbjct: 181 FNNNSLTGQIPVELSNLTNIFHVLLDNNKLSGNLPPQLSALPNLQILQLDNNNFSGSDIP 240
Query: 221 XXXXXXXXXXXXXDNN-NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL 279
N + +G +P +S + L L L L GP+P +
Sbjct: 241 ASYGNFSNILKLSLRNCSLKGA-LP-DFSKIRHLKYLDLSWNELTGPIPSSN-------- 290
Query: 280 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 339
S ++TTI LSNN L G+IP +FS LP LQ L + NN LSGS+P S+W++ + +
Sbjct: 291 FSKDVTTINLSNNILNGSIPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKNISFPKKARLL 350
Query: 340 LDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN---TNAEQFCGSHSDDDNEI-DRSTNS 395
LD +NN+L+ + G P NVT+RL GN C N +NA FC S + + + STNS
Sbjct: 351 LDLRNNSLSRVQGDLTPPQNVTLRLDGNLICTNGSISNANLFCESKGKEWISLPNNSTNS 410
Query: 396 TLDCRAQSCPTD--YEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGL 453
LDC +CPT YEYSP SP+RCFCAAPL +GYRLKSP SYFP Y + F EY+T L
Sbjct: 411 ALDCPPLACPTPDFYEYSPASPLRCFCAAPLRIGYRLKSPSFSYFPPYIDQFGEYVTDFL 470
Query: 454 KLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDS 513
++ YQL IDS++WEKGPRL+MYLKLFP + + + FN SEV RIR +F W P S
Sbjct: 471 QMEPYQLWIDSYQWEKGPRLRMYLKLFPKVNETYTRT--FNESEVLRIRGIFASWRFPGS 528
Query: 514 DIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAH 573
D+FGPYEL+NFTLQGPY V S G+S V ISA+V+ L++R +
Sbjct: 529 DLFGPYELLNFTLQGPYSYVNFNSERKGVSWRRLAAITAGAVVTAVAISAVVAALLLRRY 588
Query: 574 MKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDG 633
K+ ISRRR SSK S+ G+R F++ E+A AT++F+SST +G+GGYGKVY+G+L D
Sbjct: 589 SKHEREISRRRSSSKASLLNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDN 648
Query: 634 TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 693
TV A+KRA EGSLQGEKEFL EI+ LSRLHHRNLVSL+GYCDEE EQMLVYEFMSNGTLR
Sbjct: 649 TVAAIKRADEGSLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLR 708
Query: 694 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753
D LSAK KE L F MR+ +ALG+++GILYLHTEA+PPVFHRDIKASNILLD F AKVAD
Sbjct: 709 DWLSAKGKESLSFGMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVAD 768
Query: 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 813
FGLSRLAPV + E VP HVSTVV+GTPGYLDPEYFLTHKLTDKSDVYS+GVVFLELLTG
Sbjct: 769 FGLSRLAPVLEDEEDVPKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTG 828
Query: 814 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSM 873
M ISHGKNIVREV A Q MM S+ID M + E VEKF LAL+C D + RP M
Sbjct: 829 MHAISHGKNIVREVKTAEQRDMMVSLIDKRMEPWSMESVEKFAALALRCSHDSPEMRPGM 888
Query: 874 SEVMRELESIWNMMPESDTKTPEFINXXXXXXXXXXXXXXXMLKHPYVSSDVSGSNLVSG 933
+EV++ELES+ P+ +T+ E + + Y SS + GS+L SG
Sbjct: 889 AEVVKELESLLQASPDRETRV-ELASSSSVLSTSSSNVTRDL----YESSSLLGSDLSSG 943
Query: 934 VIPTITPR 941
+P+I PR
Sbjct: 944 FVPSIAPR 951
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2074 (735.1 bits), Expect = 1.2e-214, P = 1.2e-214
Identities = 446/925 (48%), Positives = 566/925 (61%)
Query: 37 VSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYXXXXXXXXXXXXXXX 96
V+ALR IK+SL+D LSNW +GDPC SNWTG++CF + +DG+
Sbjct: 34 VNALREIKRSLIDPMRNLSNWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSG 93
Query: 97 XXSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKL 156
+PE+G+L YL ILD MWN ++G IP EIG I P ELG L L
Sbjct: 94 ELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNL 153
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
+R+Q+D+N I+GS+P SF NL +H H+NNN+ISG+IP ELS+LP LVHM+LDNNNLTG
Sbjct: 154 NRLQVDENNITGSVPFSFGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTG 213
Query: 217 YXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
DNNNFEG+TIP +Y + S+L+KLSLRNC LQG +PDLSRI NL
Sbjct: 214 TLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENL 273
Query: 277 GYL---------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321
YL LS N+TTI+LS N LTG+IP +FS L LQ L + NNSLSGS
Sbjct: 274 SYLDLSWNHLTGTIPESKLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGS 333
Query: 322 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN---AEQF 378
+P+ IWQ ++ + + D NNN ++ +G+ P NVT+ LRGNP C +T+ QF
Sbjct: 334 VPTEIWQDKSFENNKLQVYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQF 392
Query: 379 CGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYF 438
+ + STNS C SCP +E SP C C APL + YRLKSP +F
Sbjct: 393 FEYICGEKKQT--STNSNTPCSNVSCP--FENVKVSPGICLCTAPLSIDYRLKSPSFFFF 448
Query: 439 PAY-KNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASE 497
Y + F EY+TS L+L +QL ID E R +MYLKL P G FN SE
Sbjct: 449 TPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRMYLKLVP-----KGR-ITFNKSE 502
Query: 498 VGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXX 557
V RIR F W+ +D FGPYEL++F LQGPY D+ ++ SGI
Sbjct: 503 VIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAGSVVA 560
Query: 558 XVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQI 617
+S +LL VR +N H ++++R S +I GV+ F++ E++ ATN F+SST I
Sbjct: 561 ATVLSVTATLLYVRKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDSSTLI 620
Query: 618 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 677
G+G YGKVYKGIL + T VA+KR +E SLQ EKEFL EI LSRLHHRNLVSL+GY +
Sbjct: 621 GRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGYSSDI 680
Query: 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 737
GEQMLVYE+M NG +RD LSA + + L F+MR +ALGS++GILYLHTEA+PPV HRDIK
Sbjct: 681 GEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIK 740
Query: 738 ASNILLDHKFTAKVADFGLSRLAPV-PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 796
SNILLD + AKVADFGLSRLAP + +G PAHVSTVV+GTPGYLDPEYF+T +LT
Sbjct: 741 TSNILLDCQLHAKVADFGLSRLAPAFGEGDG-EPAHVSTVVRGTPGYLDPEYFMTQQLTV 799
Query: 797 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 856
+SDVYS GVV LELLTGM P G +I+REV A + + SV D MG + V+K
Sbjct: 800 RSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTANECGTVLSVADSRMGQCSPDKVKKLA 859
Query: 857 KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINXXXXXXXXXXXXXXXML 916
+LAL CC+D + RP MS+V++ELE I + E PE + +
Sbjct: 860 ELALWCCEDRPETRPPMSKVVKELEGICQSVRE-----PEMFSETTKLLCSKTSPSSSSV 914
Query: 917 KHPYVSSDVSGSNLVSGVIPTITPR 941
P S + GSNL SG + PR
Sbjct: 915 PSPL--SLLPGSNLDSGFFHAVKPR 937
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1130 (402.8 bits), Expect = 1.3e-114, P = 1.3e-114
Identities = 305/829 (36%), Positives = 437/829 (52%)
Query: 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRIQI 161
+G L L IL +G+IP E+G +K P LG L K+ + +
Sbjct: 118 LGDLQKLNILILAGCGFTGTIPNELGYLKDLSFLALNSNNFTGKIPASLGNLTKVYWLDL 177
Query: 162 DQNYISGSLPKSFAN------LNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNL 214
N ++G +P S + L K +HFH N N +SG IPP+L S L+H+L D N
Sbjct: 178 ADNQLTGPIPISSGSSPGLDLLLKAKHFHFNKNQLSGTIPPKLFSSEMILIHVLFDGNRF 237
Query: 215 TGYXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 274
TG D N G +P + SN++ +++L+L + L G +PDLS +
Sbjct: 238 TGSIPSTLGLIQTLEVLRLDRNTLTGK-VPENLSNLTNIIELNLAHNKLVGSLPDLSDMK 296
Query: 275 NLGYL-LSLN----------------ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 317
++ Y+ LS N +TT+ + L G +P+ G P+LQ++ + N+
Sbjct: 297 SMNYVDLSNNSFDPSESPLWFSTLPSLTTLVMEYGSLQGPLPNKLFGFPQLQQVRLKKNA 356
Query: 318 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE- 376
+G++ S+ T+ E ++D Q+N++++++ S N T+ L GNP C +
Sbjct: 357 FNGTL--SLGD--TVGP-ELQLVDLQDNDISSVTLSSGYT-N-TLILEGNPVCTTALSNT 409
Query: 377 QFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSP--- 433
+C I ST S +C +SCP D + SP S C CA P + P
Sbjct: 410 NYCQIQQQQVKRI-YST-SLANCGGKSCPLDQKVSPQS---CECAYPYEGTLYFRGPMFR 464
Query: 434 GLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVF 493
LS Y +L E + L L + + + + L++ L LFP Y F
Sbjct: 465 DLSNVNTYHSL-EMSLWVKLGLTPGSVSLQNPFFNNDDYLQIQLALFPPM-----GKY-F 517
Query: 494 NASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXX 553
N +EV RI + +FGPY + + PY FP N G S
Sbjct: 518 NRTEVQRIGFDLSNQTYKPPPLFGPY----YFIASPY--TFPADGN-GHSLSSRMVTGII 570
Query: 554 XXXXXVTISAIVSLLIVRAHMKNY--HAISRRR------HSSKTS---IKIDGVRSFTYG 602
+ + +V+L I K AI R S K S ++ G R F+Y
Sbjct: 571 TGCSALVL-CLVALGIYAMWQKRRAEQAIGLSRPFVSWASSGKDSGGAPQLKGARWFSYE 629
Query: 603 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL 662
E+ TNNF+ S+++G GGYGKVYKG+L DG +VA+KRAQ+GS QG EF TEI+ LSR+
Sbjct: 630 ELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEIELLSRV 689
Query: 663 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 722
HH+NLV LVG+C E+GEQ+LVYE+MSNG+L+D L+ +S L + RL +ALGS+RG+ Y
Sbjct: 690 HHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGITLDWKRRLRVALGSARGLAY 749
Query: 723 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 782
LH ADPP+ HRD+K++NILLD TAKVADFGLS+L V D HVST VKGT G
Sbjct: 750 LHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKL--VSDC---TKGHVSTQVKGTLG 804
Query: 783 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM--MFSVI 840
YLDPEY+ T KLT+KSDVYS GVV +EL+T QPI GK IVRE+ + S + +
Sbjct: 805 YLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVMNKSDDDFYGLR 864
Query: 841 DG------NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
D ++G+ P + ++++LALKC + D RP+MSEV++E+E I
Sbjct: 865 DKMDRSLRDVGTLPE--LGRYMELALKCVDETADERPTMSEVVKEIEII 911
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1111 (396.2 bits), Expect = 1.4e-112, P = 1.4e-112
Identities = 304/845 (35%), Positives = 432/845 (51%)
Query: 100 PEIGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRI 159
P IG L L L + SG IP+ IG +K P +G L KL
Sbjct: 108 PNIGNLGKLRNLILVGCSFSGQIPESIGTLKELIYLSLNLNKFSGTIPPSIGLLSKLYWF 167
Query: 160 QIDQNYISGSLPKSFAN-------LNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDN 211
I N I G LP S L +T+HFH N +SG IP EL S SL+H+L D
Sbjct: 168 DIADNQIEGELPVSNGTSAPGLDMLLQTKHFHFGKNKLSGNIPKELFSSNMSLIHVLFDG 227
Query: 212 NNLTGYXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLS 271
N TG D N G IP+ +N++ L +L L N G +P+L+
Sbjct: 228 NQFTGEIPETLSLVKTLTVLRLDRNKLIGD-IPSYLNNLTNLNELYLANNRFTGTLPNLT 286
Query: 272 RIPNL----------------GYLLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 314
+ +L ++ SL +++T+++ +L G IP +F P+LQ + +
Sbjct: 287 SLTSLYTLDVSNNTLDFSPIPSWISSLPSLSTLRMEGIQLNGPIPISFFSPPQLQTVILK 346
Query: 315 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT- 373
NS+ S+ S L F+ D Q N +T+ S N + V L NP CL
Sbjct: 347 RNSIVESLDFGTDVSSQLE----FV-DLQYNEITDYKPSAN--KVLQVILANNPVCLEAG 399
Query: 374 NAEQFCGSHSDDDNEIDRSTN-STLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKS 432
N +C + I +T+ STL C E SPT C CA P + +S
Sbjct: 400 NGPSYCSA-------IQHNTSFSTLPTNCSPCEPGMEASPT----CRCAYPFMGTLYFRS 448
Query: 433 PGLS-YFPAYK-NLFEEYMTSGLKLNLYQLDIDSFR-WEKGP---RLKMYLKLFPVYDNS 486
P S F + ++ ++ + K Y +D R + P +L + L +FP+ S
Sbjct: 449 PSFSGLFNSTNFSILQKAIADFFKKFNYPVDSVGVRNIRENPTDHQLLIDLLVFPLGRES 508
Query: 487 SGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXX 546
FN + + + F+ IFGPY + L + DV S++S S
Sbjct: 509 ------FNQTGMSLVGFAFSNQTYKPPPIFGPY-IFKADLYKQFSDVEVSSKSSNKSILI 561
Query: 547 XXXXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRR-----HSSKTSI---KIDGVRS 598
+TI+ I +L R + A + +SK+SI ++ G ++
Sbjct: 562 GAVVGVVVLLLLLTIAGIYAL---RQKKRAERATGQNNPFAKWDTSKSSIDAPQLMGAKA 618
Query: 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF 658
FT+ E+ T+NF+ + +G GGYGKVY+GILP+G ++A+KRAQ+GSLQG EF TEI+
Sbjct: 619 FTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIEL 678
Query: 659 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR 718
LSR+HH+N+V L+G+C + EQMLVYE++SNG+L+D LS KS L + RL IALGS +
Sbjct: 679 LSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIRLDWTRRLKIALGSGK 738
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
G+ YLH ADPP+ HRDIK++NILLD TAKVADFGLS+L P+ HV+T VK
Sbjct: 739 GLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPE-----KTHVTTQVK 793
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF- 837
GT GYLDPEY++T++LT+KSDVY GVV LELLTG PI GK +VREV S
Sbjct: 794 GTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVKTKMNKSRSLY 853
Query: 838 ---SVIDGNM--GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM---PE 889
++D + S + EK++ LAL+C ++E RPSM EV++E+E+I + P
Sbjct: 854 DLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIENIMQLAGLNPN 913
Query: 890 SDTKT 894
SD+ T
Sbjct: 914 SDSAT 918
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 301/847 (35%), Positives = 435/847 (51%)
Query: 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRIQI 161
IG L LT L M +G IP IGN++ P +G L KL I
Sbjct: 113 IGNLRKLTFLSLMGCAFNGPIPDSIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDI 172
Query: 162 DQNYISGSLP----KSFANLN---KTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNN 213
N + G LP S L+ +T HFH NN +SG+IP +L S +L+H+L D N
Sbjct: 173 ADNQLEGKLPVSDGASLPGLDMLLQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQ 232
Query: 214 LTGYXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRI 273
TG D N G IP+S +N++ L +L L + G +P+L+ +
Sbjct: 233 FTGSIPESLGLVQNLTVLRLDRNRLSGD-IPSSLNNLTNLQELHLSDNKFTGSLPNLTSL 291
Query: 274 PNLGYL--------LS--------LN-ITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 315
+L L LS LN ++T++L + +L G +P++ FS L +LQ + + +
Sbjct: 292 TSLYTLDVSNNPLALSPVPSWIPFLNSLSTLRLEDIQLDGPVPTSLFSPL-QLQTVSLKH 350
Query: 316 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNA 375
N ++ ++ S+ L+ F+ D ++N +T N P NV L N C + A
Sbjct: 351 NLINTTLDLGTNYSKQLD----FV-DLRDNFITGYKSPANNPVNVM--LADNQVCQDP-A 402
Query: 376 EQFCGSHSDDDNEID-RSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPG 434
Q G N + ST STL C E P C C PL + L+SP
Sbjct: 403 NQLSGYC----NAVQPNSTFSTLTKCGNHCGKGKE--PNQG--CHCVYPLTGVFTLRSPS 454
Query: 435 LSYFPAYKNL--FEEYMTSGLKLNLYQLDIDSFR-WEKGP---RLKMYLKLFPVYDNSSG 488
S F N F E + + K Y +D + R + P L + L +FP SG
Sbjct: 455 FSGFSNNSNFLKFGESLMTFFKNGKYPVDSVAMRNISENPTDYHLLINLLIFP-----SG 509
Query: 489 NSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXX 548
FN +E+ I S FT + FGPY + Y+ F +S
Sbjct: 510 RDR-FNQTEMDSINSAFTIQDYKPPPRFGPYIFV----ADQYK-TFSDLEDSKTVSMKVI 563
Query: 549 XXXXXXXXXXVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSI---KID-----GVRSFT 600
+ + A+ + +R + A + +K ++D G ++FT
Sbjct: 564 IGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFT 623
Query: 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLS 660
+ E++ TNNF+ + +G GGYG+VYKG LP+G V+A+KRAQ+GS+QG EF TEI+ LS
Sbjct: 624 FEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLS 683
Query: 661 RLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
R+HH+N+V L+G+C ++ EQMLVYE++ NG+LRD LS K+ L + RL IALGS +G+
Sbjct: 684 RVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGL 743
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
YLH ADPP+ HRD+K++NILLD TAKVADFGLS+L P+ AHV+T VKGT
Sbjct: 744 AYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPE-----KAHVTTQVKGT 798
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV--------NIAYQ 832
GYLDPEY++T++LT+KSDVY GVV LELLTG PI G +V+EV N+
Sbjct: 799 MGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKSRNLYDL 858
Query: 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM---PE 889
++ + I N G+ EK++ +AL+C + E RP+MSEV++ELESI ++ P
Sbjct: 859 QELLDTTIIQNSGNLKG--FEKYVDVALQCVEPEGVNRPTMSEVVQELESILRLVGLNPN 916
Query: 890 SDTKTPE 896
+D+ T E
Sbjct: 917 ADSATYE 923
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 950 (339.5 bits), Expect = 1.6e-95, P = 1.6e-95
Identities = 275/837 (32%), Positives = 425/837 (50%)
Query: 100 PE-IGRLSYLTILDFMWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGY-LPKLD 157
PE IG L L L NK +G+IP IG + P G LP LD
Sbjct: 10 PESIGSLEQLVTLSLNSNKFNGTIPASIGLLSKLYWFDIADNQIEGKLPVSDGASLPGLD 69
Query: 158 RI------QIDQNYISGSLPKSFANLNKT-RHFHMNNNSISGQIPPELSRLPSLVHMLLD 210
+ +N +SG +P+ + N T +H + N ++G+IP LS + +L + LD
Sbjct: 70 MLLQTKHFHFGKNKLSGDIPEKLFSANMTLKHLLFDGNLLTGEIPQSLSLVKTLTVLRLD 129
Query: 211 NNNLTGYXXXXXXXXXXXXXXXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL 270
N L+G +N F G+ +P S ++++ L L++ N L
Sbjct: 130 RNRLSGEIPPSLNNLTNLQELYLSDNKFTGS-LP-SLTSLTSLSTLAVSNNRLTS----- 182
Query: 271 SRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 330
S+I + LL ++ T++++ +L G IP++ LP LQ + + N L+ ++ +S+
Sbjct: 183 SQISSWISLLPTSLATLRMAGLQLQGPIPTSLFSLPELQTVILKRNWLNETLDFGTNKSQ 242
Query: 331 TLNATETFILDFQNNNLTN-ISGSFNIPPNVTVRLRGNPFC--LNTNAEQFCGSHSDDDN 387
L+ F+ D Q N++T I N + V L NP C + ++C + ++
Sbjct: 243 NLD----FV-DLQYNDITEYIKQPANKGSSRIVILANNPVCPEVGNPPNEYC-IEVEHNS 296
Query: 388 EIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEE 447
N+ C + D E PT+ C C P+ +SP S + + + FE
Sbjct: 297 SYSSPKNTCGRCSGE----DREPIPTT---CRCVYPITGTLTFRSPSFSGY-SNNDTFEN 348
Query: 448 Y---MTSGLKLNLYQLD---IDSFRWEKGPR-LKMYLKLFPVYDNSSGNSYVFNASEVGR 500
+T + Y +D I + R ++ L + L LFP Y FN + +
Sbjct: 349 LRLNLTGFFENRNYTVDSVAIRNIREDEDDHYLLIDLSLFP-YKQDR-----FNETGMDS 402
Query: 501 IRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVT 560
+ S F+ + FGPY + + P+ S S +
Sbjct: 403 VISRFSTQTYKPPNTFGPY-IFKANKYNKF-----PAGGSNSSHIIGAVVGSTVFLLILM 456
Query: 561 ISAIVSLLIVR-AHMKN-----------------------YHAISRRRHSSKTSI---KI 593
I+ I +L R A N + ++ + +++ S+ ++
Sbjct: 457 IAGIYALKQKRRAEKANDQINPFGKDVLLSGKTDKILIAFFLYVTAKWDANQNSVDAPQL 516
Query: 594 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL 653
G ++FT+ EM NNF+ + +G GGYG+VYKGILP G ++A+KRAQ GSLQG EF
Sbjct: 517 MGTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFK 576
Query: 654 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 713
TEI+ LSR+HH+N+V L+G+C + GEQMLVYE++ NG+LRD LS KS L + RL IA
Sbjct: 577 TEIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGIRLDWTRRLRIA 636
Query: 714 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773
LGS +G+ YLH ADPP+ HRD+K+SN+LLD TAKVADFGLS+L V D E A+V
Sbjct: 637 LGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQL--VEDAE---KANV 691
Query: 774 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 833
+ VKGT GYLDPEY++T++LT+KSDVY GV+ LELLTG PI +GK +V+E+ +
Sbjct: 692 TAQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKMNK 751
Query: 834 SM-MFSV---IDGNMGSYPSECV---EKFIKLALKCCQDETDARPSMSEVMRELESI 883
S ++ + +D + + + + EK++ +AL+C E RPSM+EV++E+E+I
Sbjct: 752 SKNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENI 808
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
Identities = 132/326 (40%), Positives = 192/326 (58%)
Query: 564 IVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYG 623
IV L+ K Y + S+++ + SF+ ++ +ATNNF+S+ +IG+GG+G
Sbjct: 578 IVFLVFGTLWKKGYLRSKSQMEKDFKSLELM-IASFSLRQIKIATNNFDSANRIGEGGFG 636
Query: 624 KVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683
VYKG L DGT++AVK+ GS QG +EFL EI +S LHH NLV L G C E G+ +LV
Sbjct: 637 PVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLV 696
Query: 684 YEFMSNGTLRDQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741
YEF+ N +L L + L + R I +G +RG+ YLH E+ + HRDIKA+N+
Sbjct: 697 YEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNV 756
Query: 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVY 801
LLD + K++DFGL++L D E H+ST + GT GY+ PEY + LTDK+DVY
Sbjct: 757 LLDKQLNPKISDFGLAKL----DEED--STHISTRIAGTFGYMAPEYAMRGHLTDKADVY 810
Query: 802 SLGVVFLELLTGMQ-PISHGKN----IVREVNIAYQSSMMFSVIDGNMGS-YPSECVEKF 855
S G+V LE++ G I KN ++ V + + + + ++D +GS Y E
Sbjct: 811 SFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTM 870
Query: 856 IKLALKCCQDETDARPSMSEVMRELE 881
I++A+ C E RPSMSEV++ LE
Sbjct: 871 IQIAIMCTSSEPCERPSMSEVVKMLE 896
|
|
| TAIR|locus:2128625 AT4G20450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 4.7e-74, Sum P(2) = 4.7e-74
Identities = 144/339 (42%), Positives = 208/339 (61%)
Query: 562 SAIVSLLIVRAHMKNYHAISRRRHSSKT-SIKIDGVRSFTYGEMALATNNFNSSTQIGQG 620
+A V ++I + N + +++ S + S + RS+TY E+A+ TNNF +G+G
Sbjct: 543 AASVGIIIAVLLLVNILLLRKKKPSKASRSSMVANKRSYTYEEVAVITNNFERP--LGEG 600
Query: 621 GYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680
G+G VY G + D VAVK E S QG K+F E+ L R+HH NLV+LVGYCDE
Sbjct: 601 GFGVVYHGNVNDNEQVAVKVLSESSAQGYKQFKAEVDLLLRVHHINLVTLVGYCDEGQHL 660
Query: 681 MLVYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 739
+L+YE+MSNG L+ LS + S+ PL + RL IA +++G+ YLH PP+ HRDIK+
Sbjct: 661 VLIYEYMSNGNLKQHLSGENSRSPLSWENRLRIAAETAQGLEYLHIGCKPPMIHRDIKSM 720
Query: 740 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 799
NILLD+ F AK+ DFGLSR PV HVST V G+PGYLDPEY+ T+ LT+KSD
Sbjct: 721 NILLDNNFQAKLGDFGLSRSFPVGS-----ETHVSTNVAGSPGYLDPEYYRTNWLTEKSD 775
Query: 800 VYSLGVVFLELLTGMQPI---SHGKNIVRE-VNIAYQSSMMFSVIDGNM-GSYPSECVEK 854
V+S GVV LE++T QP+ + K+ + E V + + +++D +M G Y S + K
Sbjct: 776 VFSFGVVLLEIITS-QPVIDQTREKSHIGEWVGFKLTNGDIKNIVDPSMNGDYDSSSLWK 834
Query: 855 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 893
++LA+ C + RP+MS+V EL+ ++ E+ K
Sbjct: 835 ALELAMSCVSPSSSGRPNMSQVANELQEC--LLTENSRK 871
|
|
| TAIR|locus:2148151 AT5G16900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 7.6e-74, Sum P(2) = 7.6e-74
Identities = 145/325 (44%), Positives = 200/325 (61%)
Query: 564 IVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGV-RSFTYGEMALATNNFNSSTQIGQGGY 622
I L+++ +K + R H S+ ++ ++ R TY E+ L TNNF IG+GG+
Sbjct: 527 IAVLVLIIVFIKKRPSSIRALHPSRANLSLENKKRRITYSEILLMTNNFERV--IGEGGF 584
Query: 623 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682
G VY G L D VAVK S QG KEF E++ L R+HH NLVSLVGYCDE+ L
Sbjct: 585 GVVYHGYLNDSEQVAVKVLSPSSSQGYKEFKAEVELLLRVHHINLVSLVGYCDEQAHLAL 644
Query: 683 VYEFMSNGTLRDQLSAKSKE-PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741
+YE+M+NG L+ LS K + L + RLSIA+ ++ G+ YLH+ P + HRD+K+ NI
Sbjct: 645 IYEYMANGDLKSHLSGKHGDCVLKWENRLSIAVETALGLEYLHSGCKPLMVHRDVKSMNI 704
Query: 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVY 801
LLD F AK+ADFGLSR V + +HVST V GTPGYLDPEY+ T++LT+KSDVY
Sbjct: 705 LLDEHFQAKLADFGLSRSFSVGE-----ESHVSTGVVGTPGYLDPEYYRTYRLTEKSDVY 759
Query: 802 SLGVVFLELLTGMQPI----SHGKNIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFI 856
S G+V LE++T QP+ + ++I V S + +++D N+ G Y S V K +
Sbjct: 760 SFGIVLLEIITN-QPVLEQANENRHIAERVRTMLTRSDISTIVDPNLIGEYDSGSVRKAL 818
Query: 857 KLALKCCQDETDARPSMSEVMRELE 881
KLA+ C ARP MS V++EL+
Sbjct: 819 KLAMSCVDPSPVARPDMSHVVQELK 843
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 9.3e-74, Sum P(2) = 9.3e-74
Identities = 127/320 (39%), Positives = 200/320 (62%)
Query: 573 HMKN-YHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP 631
H +N + + H + S+ +R F + E+ +ATNNF+S +G+GGYG VYKGIL
Sbjct: 275 HNQNTFFDVKDGNHHEEVSL--GNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILG 332
Query: 632 DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690
D TVVAVKR ++G +L GE +F TE++ +S HRNL+ L G+C + E++LVY +MSNG
Sbjct: 333 DSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNG 392
Query: 691 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 750
++ ++ K+K L +++R IA+G++RG++YLH + DP + HRD+KA+NILLD A
Sbjct: 393 SVASRM--KAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAV 450
Query: 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 810
V DFGL++L D +HV+T V+GT G++ PEY T + ++K+DV+ G++ LEL
Sbjct: 451 VGDFGLAKLLDHQD------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 504
Query: 811 LTGMQPISHGK-----NIVRE-VNIAYQSSMMFSVIDGNM---GSYPSECVEKFIKLALK 861
+TG + GK ++ + V +Q + ++D + SY +++ +++AL
Sbjct: 505 VTGQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALL 564
Query: 862 CCQDETDARPSMSEVMRELE 881
C Q RP MSEV+R LE
Sbjct: 565 CTQYLPGHRPKMSEVVRMLE 584
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGD7 | Y1684_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7 | 0.9638 | 0.9517 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00023921001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (903 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 941 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-29 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 3e-54
Identities = 90/275 (32%), Positives = 133/275 (48%), Gaps = 33/275 (12%)
Query: 616 QIGQGGYGKVYKGIL--PDGTV---VAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 669
++G+G +G+VYKG L G VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
L+G C EE +V E+M G L L K++ L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG---YLDP 786
HRD+ A N L+ K++DFGLSR + +G ++ P
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRD---------LYDDDYYRKRGGKLPIRWMAP 172
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
E K T KSDV+S GV+ E+ T G QP N EV + Y + +G
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--EV-LEY-------LKNGYRL 222
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
P C + L L+C ++ + RP+ SE++ L
Sbjct: 223 PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 1e-53
Identities = 91/276 (32%), Positives = 135/276 (48%), Gaps = 34/276 (12%)
Query: 616 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 669
++G+G +G+VYKG L VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
L+G C EE M+V E+M G L D L + L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----EGIVPAHVSTVVKGTPGYLD 785
HRD+ A N L+ K++DFGLSR D G +P ++ ++
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP------IR----WMA 172
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE K T KSDV+S GV+ E+ T G +P + EV + Y + G
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEV-LEY-------LKKGYR 222
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
P C + KL L+C ++ + RP+ SE++ L
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 91/287 (31%), Positives = 130/287 (45%), Gaps = 47/287 (16%)
Query: 616 QIGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 670
++G+G +G+VYKG L T VAVK +E S + K+FL E + + +L H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYL 723
+G C EE LV E+M G L D L K L LS A+ ++G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVK 778
HRD+ A N L+ K++DFGLSR D G +P ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP------IR 172
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREVNIAYQSS 834
PE T KSDV+S GV+ E+ T G P +S EV + Y
Sbjct: 173 WMA----PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEV-LEY--- 219
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
+ G P C ++ +L L C Q + + RP+ SE++ LE
Sbjct: 220 ----LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 6e-47
Identities = 74/268 (27%), Positives = 116/268 (43%), Gaps = 28/268 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 673
++G+G +GKVY G +VA+K ++ ++ ++E L EI+ L +L H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
++E + LV E+ G L D L + + A + YLH + H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLH---SKGIVH 120
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
RD+K NILLD K+ADFGL+R + ++T V GTP Y+ PE L
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE-------KLTTFV-GTPEYMAPEVLLGKG 172
Query: 794 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI---DGNMGSYPSE 850
D++SLGV+ ELLTG P + +F I +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQL----------LELFKKIGKPKPPFPPPEWD 222
Query: 851 CVEKFIKLALKCCQDETDARPSMSEVMR 878
+ L K + + R + E ++
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 88/277 (31%), Positives = 130/277 (46%), Gaps = 36/277 (12%)
Query: 616 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 669
++G+G +G+VYKG L T VAVK +EG+ + E+ EFL E + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
L+G C + +V E+M G L D L E L L +AL ++G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVKGTPGYL 784
HRD+ A N L+ K++DFGLSR D G +P +K
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP------IKWMA--- 172
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
PE K T KSDV+S GV+ E+ T G QP N ++ + DG
Sbjct: 173 -PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN----------EEVLELLEDGY 221
Query: 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
P C ++ +L L+C + + RP+ SE++ +L
Sbjct: 222 RLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 78/268 (29%), Positives = 111/268 (41%), Gaps = 57/268 (21%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 674
+G+GG+G VY G VA+K ++ E L EI+ L +L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
++E LV E+ G+L+D L L L I L G+ YLH+ + HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 735 DIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 792
D+K NILLD K+ADFGLS+L + GTP Y+ PE L
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-------LKTIVGTPAYMAPEVLLGKG 169
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
++KSD++SLGV+ EL
Sbjct: 170 YYSEKSDIWSLGVILYEL------------------------------------------ 187
Query: 853 EKFIKLALKCCQDETDARPSMSEVMREL 880
+ L K Q + + RPS E++ L
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 86/269 (31%), Positives = 126/269 (46%), Gaps = 26/269 (9%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
++G G +G VYK G +VAVK + + + ++ EI+ L RL H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+++ LV E+ G L D LS PL IAL RG+ YLH+ +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K NILLD K+ADFGL++ + + T GTP Y+ PE L
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 793 KL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG-NMGSYPSE 850
K DV+SLGV+ ELLTG +P G+NI+ Q ++ ++ P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTG-KPPFSGENILD------QLQLIRRILGPPLEFDEPKW 226
Query: 851 C--VEKFIKLALKCCQDETDARPSMSEVM 877
E+ L KC + RP+ E++
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 76/270 (28%), Positives = 121/270 (44%), Gaps = 33/270 (12%)
Query: 616 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 672
+G+G +G VY + D G ++AVK + E + EI+ LS L H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 673 -YCDEEGEQMLVY-EFMSNGTLRDQLSAKSK--EPLGFAMRL---SIALGSSRGILYLHT 725
DEE + ++ E++S G+L L K EP+ +R I G+ YLH+
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLHS 119
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ HRDIK +NIL+D K+ADFG ++ + I + V+GTP ++
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKR-----LGDIETGEGTGSVRGTPYWMA 171
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
PE + +D++SLG +E+ TG P S N + +++ G
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--------AALYKIGSSGEPP 223
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSE 875
P E+ KC + + RP+ E
Sbjct: 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 3e-38
Identities = 117/361 (32%), Positives = 168/361 (46%), Gaps = 69/361 (19%)
Query: 36 EVSALRSIKKSLVDDYSKLSNWN-RGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNL 94
E+ L S K S+ D LSNWN D C W G+ C N++ + + L N+
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNSS------RVVSIDLSGKNI 81
Query: 95 SGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-----------------------GNIKS 131
SG +S I RL Y+ ++ N++SG IP +I G+I +
Sbjct: 82 SGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN 141
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
LE L L+ N L+G +P ++G L + + N + G +P S NL + +N +
Sbjct: 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLV 201
Query: 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMS 251
GQIP EL ++ SL + L NNL+G +P E+ L L L L NN G IP+S N+
Sbjct: 202 GQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG-PIPSSLGNLK 260
Query: 252 KLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIP------------ 299
L L L L GP+P I +L L+SL+ LS+N L+G IP
Sbjct: 261 NLQYLFLYQNKLSGPIP--PSIFSLQKLISLD-----LSDNSLSGEIPELVIQLQNLEIL 313
Query: 300 ----SNFSG--------LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 347
+NF+G LPRLQ L + +N SG IP ++ + L +LD NNL
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT-----VLDLSTNNL 368
Query: 348 T 348
T
Sbjct: 369 T 369
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-34
Identities = 92/280 (32%), Positives = 145/280 (51%), Gaps = 20/280 (7%)
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
++ L+ + L NLSG + EIG L+ L LD ++N ++G IP +GN+K+L+ L L N
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+L+G +P + L KL + + N +SG +P+ L H+ +N+ +G+IP L+
Sbjct: 271 KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
LP L + L +N +G +P L + L +L L NN G IP + L KL L +
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG-EIPEGLCSSGNLFKLILFS 389
Query: 261 CSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320
SL+G +P +LG SL ++L +N +G +PS F+ LP + L I+NN+L G
Sbjct: 390 NSLEGEIP-----KSLGACRSLR--RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442
Query: 321 SIPSSIWQSRTLNATETFILDFQNNN----LTNISGSFNI 356
I S W +L +L N L + GS +
Sbjct: 443 RINSRKWDMPSLQ-----MLSLARNKFFGGLPDSFGSKRL 477
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 31/269 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IG+GG+G+VYK G VA+K + S + +++ + EIQ L + H N+V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
++ E +V EF S G+L+D L + + L + + +G+ YLH+ + HR
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHR 122
Query: 735 DIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
DIKA+NILL K+ DFGLS +L+ +V GTP ++ PE
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---------GTPYWMAPEVINGKP 173
Query: 794 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG----SYPS 849
K+D++SLG+ +EL G P S + ++ +G G S
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYS---------ELPPMKALFKIATNGPPGLRNPEKWS 224
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + F+K KC Q + RP+ ++++
Sbjct: 225 DEFKDFLK---KCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 30/282 (10%)
Query: 605 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 664
A+ + IG+G +G V G G VAVK ++ S + FL E ++ L H
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
NLV L+G + +V E+M+ G+L D L ++ + + A +L AL G+ YL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ HRD+ A N+L+ AKV+DFGL++ A G +P VK T
Sbjct: 120 EKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------VKWTA--- 167
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG--KNIVREVNIAYQSSMMFSVID 841
PE K + KSDV+S G++ E+ + G P K++V V Y+
Sbjct: 168 -PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--------- 217
Query: 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
M + P C + K+ C + + RP+ ++ +L I
Sbjct: 218 --MEA-PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 23/283 (8%)
Query: 616 QIGQGGYGKVYKG---ILPDGT--VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVS 669
Q+G+G +GKV L D T VAVK G Q +F EI+ L L H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 670 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
G C++ G + L+ E++ +G+LRD L + ++ + L + +G+ YL ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-YLDP 786
HRD+ A NIL++ + K++DFGL+++ P + +P + P
Sbjct: 130 ---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK-----DYYYVKEPGESPIFWYAP 181
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG-KNIVREVNIAYQSSMMFSVI----D 841
E T K + SDV+S GV EL T P +R + IA ++ ++ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884
G P C ++ L C + E RPS ++++ ++ +
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 85/281 (30%), Positives = 124/281 (44%), Gaps = 47/281 (16%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676
+G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEADPPVF 732
E +V E+MS G+L D L K G +RL +A + G+ YL +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTV--VKGTPGYLDPEYF 789
HRD+ A NIL+ K+ADFGL+RL IE A +K T PE
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL-----IEDDEYTAREGAKFPIKWTA----PEAA 176
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-------GMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
+ T KSDV+S G++ E++T GM + ++ +V Y+
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVERGYRMPR------- 225
Query: 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P C E+ L L+C + + RP+ + LE
Sbjct: 226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 31/272 (11%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G+V++G+ + T VAVK + G++ K+FL E Q + +L H L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
E +V E M G+L + L + L + +A + G+ YL + HRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEYFLTHK 793
+ A N+L+ KVADFGL+R+ E I A +K T PE L ++
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTA----PEAALYNR 180
Query: 794 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PS 849
+ KSDV+S G++ E++T +G+ + Y V+ Y P
Sbjct: 181 FSIKSDVWSFGILLTEIVT------YGR-------MPYPGMTNAEVLQQVDQGYRMPCPP 227
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
C ++ + L C +++ D RP+ + +LE
Sbjct: 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 87/281 (30%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 617 IGQGGYGKVYKGILPDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV 671
IG+G +G VY G L D AVK L+ ++FL E + H N++SL+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 672 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHT 725
G C EG ++V +M +G LR+ + +++ P +GF ++++ +G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA------KGMEYL-- 114
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
A HRD+ A N +LD FT KVADFGL+R + D E H T K ++
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSV-HNHTGAKLPVKWMA 170
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
E T K T KSDV+S GV+ EL+T G P V +I ++ G
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VDSFDITVY------LLQGRR 220
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885
P C + ++ L C + + RP+ SE++ +E I++
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G V+ G VA+K +EG++ E +F+ E + + +L H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
++ +V E+M+NG L + L + K LG L + + YL + HRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 795
+ A N L+ KV+DFGL+R V D + VK P PE F + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP----PEVFDYSRFS 179
Query: 796 DKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
KSDV+S GV+ E+ + G P N +V V+ Y+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR------------PKLAP 227
Query: 853 EKFIKLALKCCQDETDARPSMSEVMREL 880
+ + C ++ + RP+ +++ +L
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 86/310 (27%), Positives = 138/310 (44%), Gaps = 60/310 (19%)
Query: 610 NFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL 662
N +G+G +GKV K T VAVK +E + E ++ L+E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 663 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--------------------- 701
+H +++ L G C ++G +L+ E+ G+LR L K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 702 -EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-- 758
L +S A SRG+ YL A+ + HRD+ A N+L+ K++DFGLSR
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 759 ---LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 814
+ V +G +P VK ++ E H T +SDV+S GV+ E++T G
Sbjct: 178 YEEDSYVKRSKGRIP------VK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 815 QPISHGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSM 873
P IA + +F+++ G P C E+ L L C + E D RP+
Sbjct: 228 NPYP---------GIAPER--LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276
Query: 874 SEVMRELESI 883
+++ +ELE +
Sbjct: 277 ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 83/271 (30%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 616 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
++G G YG+VY+G+ VAVK +E +++ E EFL E + + H NLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
D+ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182
Query: 795 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECV 852
+ KSDV++ GV+ E+ T GM P S ++ +++ G P C
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYP-----------GIDLSQVYELLEKGYRMERPEGCP 231
Query: 853 EKFIKLALKCCQDETDARPSMSEVMRELESI 883
K +L C Q RPS +E+ + E++
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-29
Identities = 88/272 (32%), Positives = 140/272 (51%), Gaps = 36/272 (13%)
Query: 82 LHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ L+ L++L+L N +G + + L L +L NK SG IPK +G +L +L L+
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N LTG +PE L L ++ + N + G +PKS R + +NS SG++P E
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 199 SRLPSLVHML-LDNNNLTGYLPPELSELPKLLILQLDNNNFEGT---------------- 241
++LP LV+ L + NNNL G + ++P L +L L N F G
Sbjct: 425 TKLP-LVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLS 483
Query: 242 ------TIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKL 294
+P ++S+L++L L L G +PD LS L +SL++ S+N+L
Sbjct: 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL---VSLDL-----SHNQL 535
Query: 295 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 326
+G IP++FS +P L +L ++ N LSG IP ++
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 71/213 (33%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRN 666
N+ IG+G +G VYKG+ L G VA+K+ ++ E K + EI L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 724
+V +G + ++ E+ NG+LR + E L A+ + L +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQVL---QGLAYLH 116
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGY 783
+ V HRDIKA+NIL K+ADFG++ +L V + V GTP +
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--------SKDDASVVGTPYW 165
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ PE + SD++SLG +ELLTG P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 83/272 (30%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
IG G +GKVY + L G ++AVK R Q+ + KE E++ L L H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 674 CDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ E++ ++ E+ S GTL + L ++ L G+ YLH+ +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHG---IV 121
Query: 733 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 791
HRDIK +NI LDH K+ DFG + +L G ++ GTP Y+ PE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA----GTPAYMAPEVITG 177
Query: 792 HKLTDK---SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
K +D++SLG V LE+ TG +P S N + +MF V G+ P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---------EFQIMFHVGAGHKPPIP 228
Query: 849 -----SECVEKFIKLALKCCQDETDARPSMSE 875
S + F+ C + + RP+ SE
Sbjct: 229 DSLQLSPEGKDFLDR---CLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G+V++G+ + VA+K + L +++F E+Q L RL H++L+SL C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
++ E M G+L L + + L A + +A + G+ YL + HRD
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYFLTHKL 794
+ A NIL+ KVADFGL+RL E + + + K T PE
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIK----EDVYLSSDKKIPYKWTA----PEAASHGTF 181
Query: 795 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSE 850
+ KSDV+S G++ E+ T +G+ + Y V D Y P++
Sbjct: 182 STKSDVWSFGILLYEMFT------YGQ-------VPYPGMNNHEVYDQITAGYRMPCPAK 228
Query: 851 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
C ++ K+ L+C E + RPS + EL++I
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 77/267 (28%), Positives = 122/267 (45%), Gaps = 21/267 (7%)
Query: 615 TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+GQG G VYK P G + A+K+ + K+ L E++ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+EGE +V E+M G+L D L K P ++ + +G+ YLHT+ +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI--LKGLDYLHTKRH--II 122
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRDIK SN+L++ K K+ADFG+S+ +E + + V GT Y+ PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISK-----VLENTLDQCNTFV--GTVTYMSPERIQGE 175
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
+ +D++SLG+ LE G P +M ++ DG S P+E
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPS-------FFELMQAICDGPPPSLPAEEF 228
Query: 853 -EKFIKLALKCCQDETDARPSMSEVMR 878
+F C Q + RPS +E+++
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 84/274 (30%), Positives = 129/274 (47%), Gaps = 34/274 (12%)
Query: 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
+IG G +G V+ G + VA+K +EG++ E++F+ E Q + +L H LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADP 729
C E LV+EFM +G L D L A+ S+E L L + L G+ YL +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN-- 120
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
V HRD+ A N L+ KV+DFG++R V D + ST K + PE F
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQ----YTSSTGTKFPVKWSSPEVF 173
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGS 846
K + KSDV+S GV+ E+ + G P + N +V +N ++
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----------- 222
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
P + +L C ++ + RPS S ++ +L
Sbjct: 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 25/271 (9%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 674
+IG+G +G VYKG+L T VAVK + K FL E + L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
++ +V E + G+L L K K L L ++L ++ G+ YL ++ HR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHK 793
D+ A N L+ K++DFG+SR + EG + VS +K P + PE +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----EEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171
Query: 794 LTDKSDVYSLGVVFLELLT-GMQPISHGKNI-VREVNIAYQSSMMFSVIDGNMGSYPSEC 851
T +SDV+S G++ E + G P N RE + G P C
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-----------RIESGYRMPAPQLC 220
Query: 852 VEKFIKLALKCCQDETDARPSMSEVMRELES 882
E+ +L L+C + + RPS SE+ EL+
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 88/310 (28%), Positives = 135/310 (43%), Gaps = 64/310 (20%)
Query: 609 NNFNSSTQIGQGGYGKVYK----GILP--DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSR 661
NN IGQG +G+V++ G+LP T+VAVK +E S + +F E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------------K 701
H N+V L+G C L++E+M+ G L + L +S
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 702 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761
PL +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR--- 178
Query: 762 VPDIEGIVPAHVSTVVKGTPG------YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 814
+I + + K + ++ PE ++ T +SDV++ GVV E+ + GM
Sbjct: 179 --NI------YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 815 QP---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 871
QP ++H E I Y V DGN+ S P C + L C RP
Sbjct: 231 QPYYGMAH------EEVIYY-------VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
Query: 872 SMSEVMRELE 881
S + + R L+
Sbjct: 278 SFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 616 QIGQGGYGKVYKG----ILPDG--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLV 668
++G+G +GKV+ G + P+ +VAVK +E + K+F E + L+ H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGS 716
G C E ++V+E+M +G L L + L + L IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHV 773
+ G++YL A HRD+ N L+ + K+ DFG+SR D + G H
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG----HT 184
Query: 774 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP-ISHGKNIVREVNIAY 831
++ P PE + K T +SDV+S GVV E+ T G QP V E
Sbjct: 185 MLPIRWMP----PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---- 236
Query: 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
+ G + P C + + L C + + R ++ ++ L+
Sbjct: 237 -------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 4e-27
Identities = 95/336 (28%), Positives = 146/336 (43%), Gaps = 21/336 (6%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHR 665
++ ++G+G +G+VY D +VA+K E + + FL EIQ L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLH 724
N+V L + +EG LV E++ G+L D L K PL + L I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 725 TEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
++ + HRDIK NILLD K+ DFGL++L P P +PA ST V GTPGY
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 784 LDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQP---ISHGKNIVREVNIAYQSSMMF 837
+ PE L + SD++SLG+ ELLTG+ P + + + I +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM-RELESIWNMMPESDTKTPE 896
+ S P + L K + R S S + +L + + ESD
Sbjct: 235 LASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK-LKESDLSDLL 292
Query: 897 FINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 932
+ + PPS +++ + +
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 87/267 (32%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
EE +V E+MS G+L D L + + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 795
++A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 796 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 854
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPES 231
Query: 855 FIKLALKCCQDETDARPSMSEVMRELE 881
L +C + E + RP+ + LE
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 78/273 (28%), Positives = 124/273 (45%), Gaps = 35/273 (12%)
Query: 616 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEF-LTEIQFLSRLHHRNLVSLVG 672
QIG+G +GKVY DG + +K + E+E L E++ L +L+H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 673 YCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHT 725
Y + E+G+ +V E+ G L ++ + KE F + + L + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL--ALKYLHS 121
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ HRDIK NI L K+ DFG+S++ + V TVV GTP YL
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSSTVD-LAKTVV-GTPYYLS 171
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
PE KSD++SLG V EL T P G+N + ++ G
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGEN---------LLELALKILKGQYP 221
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
PS+ + L Q + + RPS++++++
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 62/298 (20%)
Query: 615 TQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNL 667
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRG 719
V L+G ++V E M+ G L+ L ++ E P + +A + G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIV 769
+ YL A HRD+ A N ++ T K+ DFG++R DI +G++
Sbjct: 132 MAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYRKGGKGLL 183
Query: 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 828
P ++ PE T KSDV+S GVV E+ T QP
Sbjct: 184 PVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP------------ 221
Query: 829 IAYQ----SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
YQ ++ VIDG P C +K ++L C Q RP+ E++ L+
Sbjct: 222 --YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 32/272 (11%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G V G VA+K +EGS+ E EF+ E + + +L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
++ +V E+MSNG L + L K + L + G+ YL ++ HRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLESKQ---FIHRD 125
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLDPEYFL 790
+ A N L+D + KV+DFGLSR V D E + S+V V+ +P PE L
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRY--VLDDE-----YTSSVGSKFPVRWSP----PEVLL 174
Query: 791 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
K + KSDV++ GV+ E+ + G P N S + V G P
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----------SETVEKVSQGLRLYRPH 224
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
EK + C ++ + RP+ +++ +E
Sbjct: 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCD 675
+G+G +G+V+KG L D T VAVK +E Q K +FL+E + L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
+ +V E + G L K K+ L + AL ++ G+ YL ++ HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHKL 794
+ A N L+ K++DFG+SR + +GI + S+ +K P + PE +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----QEDDGI---YSSSGLKQIPIKWTAPEALNYGRY 171
Query: 795 TDKSDVYSLGVVFLELLT-GMQPISHGKN-IVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
+ +SDV+S G++ E + G+ P N RE V G S P +C
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----------QVEKGYRMSCPQKCP 220
Query: 853 EKFIKLALKCCQDETDARPSMSEVMRELES 882
+ K+ +C + + RP SE+ +EL +
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 666
+ + +IG+G G+VYK G VA+K+ + Q ++ + EI + H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEP-LGFAMRLSIALGSSRGILY 722
+V E +V E+M G+L D Q + EP + + R + +G+ Y
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLEY 131
Query: 723 LHTEADPPVFHRDIKASNILLDHKFTAKVADFG----LSRLAPVPDIEGIVPAHVSTVVK 778
LH++ V HRDIK+ NILL + K+ADFG L++ ++VV
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----------KRNSVV- 177
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
GTP ++ PE K D++SLG++ +E+ G P
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-----EIQFLSRLHHRNLVSL 670
+G+G YG VYK G +VA+K+ + L E+E + EI L L H N+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR---LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEAD 728
+ E + LV+E+ L+ L K P + L SI RG+ Y H+
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
+ HRD+K NIL++ K+ADFGL+R +P + + VV T Y PE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-----LRTYTHEVV--TLWYRAPEI 169
Query: 789 FLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
L K + D++S+G +F E++TG +P+ G +
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 46/227 (20%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 669
QIG+G YG+VYK G +VA+K+ ++ EKE + EI+ L +L H N+V
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 670 LVGYCDEE--GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS---------- 717
L + G +V+E+M + D L+ G + S
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH----D-LT-------GLLDSPEVKFTESQIKCYMKQLL 110
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTV 776
G+ YLH+ + HRDIK SNIL+++ K+ADFGL+R + + V
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-----ADYTNRV 162
Query: 777 VKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
+ T Y PE L + + D++S+G + EL G +PI G
Sbjct: 163 I--TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 90/294 (30%), Positives = 128/294 (43%), Gaps = 57/294 (19%)
Query: 617 IGQGGYGKVYKG----ILPDGT---VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 668
+G G +G+VY+G IL G+ VAVK ++G+ EK EFL E +S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 669 SLVGYCDEEGEQMLVYEFMSNGT----LRDQLSAKSKEP-LGFAMRLSIALGSSRGILYL 723
L+G C Q ++ E M G LRD + P L L I L ++G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 724 HTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDI----------EGI 768
HRD+ A N L+ K K+ DFGL+R DI EG+
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEGEGL 174
Query: 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 827
+P ++ PE L K T +SDV+S GV+ E+LT G QP N EV
Sbjct: 175 LPVR----------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EV 222
Query: 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
+ + V G P C +K +L C + RP+ + L+
Sbjct: 223 -LQH-------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 82/274 (29%), Positives = 119/274 (43%), Gaps = 29/274 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY 673
IG G VY I LP+ VA+KR Q E E+Q +S+ +H N+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPP 730
E LV ++S G+L D + KS P G IA +G+ YLH+
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
HRDIKA NILL + K+ADFG+S A + D G V GTP ++ PE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVS--ASLAD-GGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 791 THK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
K+D++S G+ +EL TG P S + + M+ + + S +
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLML--TLQNDPPSLET 229
Query: 850 ECVEK-----FIKLALKCCQDETDARPSMSEVMR 878
K F K+ C Q + RP+ E+++
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 80/275 (29%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 616 QIGQGGYGKVYKGI--LPDGTV--VAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
++G G +G V KG+ + G VAVK QE G+KEFL E +++L H +V L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C E MLV E G L L + + P+ + +A + G+ YL E+
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYL--ESKHF 116
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG------YL 784
V HRD+ A N+LL ++ AK++DFG+SR A S + T +
Sbjct: 117 V-HRDLAARNVLLVNRHQAKISDFGMSR-ALGAG---------SDYYRATTAGRWPLKWY 165
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
PE K + KSDV+S GV E + G +P K + + ++++
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------AEVIAMLESG 214
Query: 844 --MGSYPSECVEKFIKLALKCCQDETDARPSMSEV 876
+ P EC ++ + L C + + RP+ SE+
Sbjct: 215 ERLPR-PEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 83/282 (29%), Positives = 120/282 (42%), Gaps = 55/282 (19%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 670
+G G +G VY+G+ L DG AVK A +G E K+ EI LS+L H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
+G EE + E + G+L L EP+ I LG + YLH D
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH---D 120
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGY 783
HRDIK +NIL+D K+ADFG+++ V KG+P +
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-------------QVVEFSFAKSFKGSPYW 167
Query: 784 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
+ PE +D++SLG LE+ TG P S + +F + G
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ----------LEGVAAVFKI--G 215
Query: 843 NMGSYP------SECVEKFIKLALKCCQDETDARPSMSEVMR 878
P S+ + FI LKC Q + RP+ +E++
Sbjct: 216 RSKELPPIPDHLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 76/261 (29%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+G+G YG VYK I G VVA+K E LQ E + EI L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
+ + +V E+ G++ D + +K L +I + +G+ YLH HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
DIKA NILL+ + AK+ADFG+S A +TV+ GTP ++ PE
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176
Query: 795 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 854
+K+D++SLG+ +E+ G P S + I + S P + +
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD--------PEKWSPE 228
Query: 855 FIKLALKCCQDETDARPSMSE 875
F KC + + RPS +
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 617 IGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
IG G +G+V +G L P VA+K + GS ++ +FLTE + + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G + M++ E+M NG+L D+ ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLDP 786
HRD+ A NIL++ KV+DFGLSR + G +P + P
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----------WTAP 177
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
E K T SDV+S G+V E+++ G +P N ++V + +V DG
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDV--------IKAVEDGYRL 227
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
P +C +L L C Q + + RP+ S+++ L+
Sbjct: 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 85/267 (31%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
EE +V EFM G+L D L + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 795
++A+NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 796 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 854
KSDV+S G++ EL+T G P N REV + V G P C E
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVN--REV--------LEQVERGYRMPCPQGCPES 231
Query: 855 FIKLALKCCQDETDARPSMSEVMRELE 881
+L C + + D RP+ + LE
Sbjct: 232 LHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 79/266 (29%), Positives = 123/266 (46%), Gaps = 22/266 (8%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G V+ G VA+K EG++ E++F+ E + + +L H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
++ +V EFM NG L + L + + L M LS+ G+ YL + HRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 795
+ A N L+ KV+DFG++R V D E + VK +P PE F K +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSP----PEVFNFSKYS 179
Query: 796 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 854
KSDV+S GV+ E+ T G P N Y+ M S G P
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMIS--RGFRLYRPKLASMT 229
Query: 855 FIKLALKCCQDETDARPSMSEVMREL 880
++ C ++ + RP+ +E++R +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 83/267 (31%), Positives = 124/267 (46%), Gaps = 22/267 (8%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
EE +V E+MS G+L D L L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 795
++++NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 796 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 854
KSDV+S G++ EL+T G P N REV + V G P +C
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNN--REV--------LEQVERGYRMPCPQDCPIS 231
Query: 855 FIKLALKCCQDETDARPSMSEVMRELE 881
+L L+C + + + RP+ + LE
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 79/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 617 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
IG G +G+V++GIL VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G + M++ E+M NG L L E + + + + G + G+ YL +D
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDMNY 128
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 791
HRD+ A NIL++ KV+DFGLSR+ D EG + ++ K + PE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEG---TYTTSGGKIPIRWTAPEAIAY 184
Query: 792 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 850
K T SDV+S G+V E+++ G +P N EV M ++ DG P +
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEV--------MKAINDGFRLPAPMD 234
Query: 851 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
C +L L+C Q + RP +++ L+ +
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 39/294 (13%)
Query: 616 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G+G +GKV+ + P D +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSA--------------KSKEPLGFAMRLSIALG 715
G C + ++V+E+M +G L L A ++K LG + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 775
+ G++YL A HRD+ N L+ K+ DFG+SR D V H
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-VGGHTML 187
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 834
++ P PE + K T +SDV+S GV+ E+ T G QP N +
Sbjct: 188 PIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----------TE 233
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888
++ + G + P C ++ + L C Q E R ++ E+ + L ++ P
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 82/285 (28%), Positives = 122/285 (42%), Gaps = 29/285 (10%)
Query: 617 IGQGGYGKVYKGIL------PDGT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNL 667
+G+G +GKV L DGT +VAVK + Q + EI L L+H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 668 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
V G C E+G + L+ E++ G+LRD L K L A L A G+ YLH+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ HRD+ A N+LLD+ K+ DFGL++ P EG V +
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWYA 178
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVID--- 841
E +K + SDV+S GV ELLT S K + + +I+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 842 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885
G P C ++ L C + E RP+ ++ L+ + +
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 46/292 (15%)
Query: 616 QIGQGGYGKVYKGIL--PDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 668
++G+G +GKVYKG L P+ T VA+K +E + ++EF E + +S L H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----------------SAKSKEPLGFAMRLS 711
L+G C +E +++E++++G L + L S + F L
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LH 128
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771
IA+ + G+ YL + HRD+ A N L+ T K++DFGLSR D +
Sbjct: 129 IAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 830
+ V ++ PE L K T +SD++S GVV E+ + G+QP N +EV
Sbjct: 186 SLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEV--- 235
Query: 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
+ + + P +C + L ++C + RP ++ L S
Sbjct: 236 -----IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 82/291 (28%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 616 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G+G +GKV+ + P D +VAVK ++ S K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA-----------MRLSIALGSSR 718
G C E ++V+E+M +G L L A + + A L IA +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
G++YL A HRD+ N L+ K+ DFG+SR D V H ++
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIR 187
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 837
P PE + K T +SDV+SLGVV E+ T G QP N + ++
Sbjct: 188 WMP----PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----------NEVIE 233
Query: 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888
+ G + P C ++ L L C Q E R ++ E+ L+++ P
Sbjct: 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 82/268 (30%), Positives = 124/268 (46%), Gaps = 30/268 (11%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
IG+G +G V +G G VAVK + + + Q FL E +++LHH+NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
G +V E MS G L + L + + + L +L + G+ YL ++ + HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
D+ A NIL+ AKV+DFGL+R+ + +P VK T PE K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTA----PEALKHKKF 174
Query: 795 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 853
+ KSDV+S GV+ E+ + G P + K ++EV + G P C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP--YPKMSLKEVKECVEK--------GYRMEPPEGCPA 224
Query: 854 KFIKLALKCCQDETDARPSMSEVMRELE 881
L C + E RPS ++ +LE
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 38/287 (13%)
Query: 616 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G+G +GKV+ +LP D +VAVK +E S ++F E + L+ L H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-------------PLGFAMRLSIALGS 716
G C E ++V+E+M +G L L + + L L+IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 776
+ G++YL A HRD+ N L+ K+ DFG+SR DI V
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGGR 183
Query: 777 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 835
++ PE L K T +SD++S GVV E+ T G QP N +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----------TEA 233
Query: 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
+ + G P C + + C Q E R + ++ L++
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 68/225 (30%), Positives = 96/225 (42%), Gaps = 37/225 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFLT-EIQFLSRLHHRNLVSLVGY 673
IG+G +G V K DG ++ K G++ + EK+ L E+ L L H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 674 CDEE--GEQMLVY---EFMSNGTLRDQLSAKSKEP---------LGFAMRLSIALGSSRG 719
D +Y E+ G L QL K K+ +L +AL
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALY---- 119
Query: 720 ILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
H +DP V HRD+K +NI LD K+ DFGL+++ A T V
Sbjct: 120 --ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG----HDSSFAK--TYV 171
Query: 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
GTP Y+ PE +KSD++SLG + EL P +N
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 79/283 (27%), Positives = 124/283 (43%), Gaps = 38/283 (13%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-----KEFLTEIQFLSRL 662
N+ +GQG +G+VY D G +AVK+ E EIQ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 663 HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 718
H +V G C + E + ++ E+M G+++DQL A A+ ++ +R
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQIL 114
Query: 719 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPV-PDIEGIVPAHVST 775
G+ YLH+ + HRDIK +NIL D K+ DFG S RL + G+
Sbjct: 115 EGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS----- 166
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835
V GTP ++ PE K+DV+S+G +E+LT P + + + IA Q +
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT- 224
Query: 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + S+ S F++ + RPS E++R
Sbjct: 225 -----NPQLPSHVSPDARNFLRRTFV---ENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 84/296 (28%), Positives = 132/296 (44%), Gaps = 49/296 (16%)
Query: 616 QIGQGGYGKVYK---GILPDGT--VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
Q+G+G +G V L D T VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 671 VGYCDEEG--EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
G C G LV E++ G+LRD L K +E L L A +G+ YL ++
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----Y 783
HRD+ NIL++ + K+ DFGL+++ P D E V+ PG +
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKE-------YYKVR-EPGESPIFW 177
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTG-----------MQPISHGKNIVREVNIAYQ 832
PE K + SDV+S GVV EL T M+ + + K
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ-------- 229
Query: 833 SSMMFSVIDGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884
+++ +I+ + P C + + +C ++ RPS SE+ ++E+I
Sbjct: 230 -MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 616 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
++G G G V K P G ++AVK + E + +K+ L E+ L + + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGSSRGILYLHTEADP 729
G+ + E+M G+L L LG IA+ +G+ YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE--KH 120
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDP 786
+ HRD+K SNIL++ + K+ DFG+S V+++ K GT Y+ P
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------------VNSLAKTFVGTSSYMAP 168
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
E + + KSD++SLG+ +EL TG P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 67/256 (26%), Positives = 110/256 (42%), Gaps = 36/256 (14%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-V 671
IG+G +GKV D + A+K + + + L E + L L+H LV+L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIA-LGSSRGILYLHTEA 727
+ DEE ++V + + G LR LS K K F+ ++ I + + YLH++
Sbjct: 68 SFQDEENMYLVV-DLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVL--ALEYLHSKG 120
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HRDIK NILLD + + DF ++ P ++T GTPGY+ PE
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNIATKVT--------PDTLTTSTSGTPGYMAPE 169
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE--VNIAYQSSMMFSVIDGNMG 845
+ D +SLGV E L G +P +R+ + +++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW---- 225
Query: 846 SYPSECVEKFIKLALK 861
+E ++ I L+
Sbjct: 226 --STEAID-AINKLLE 238
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 54/291 (18%)
Query: 617 IGQGGYGKVYKGI---LPDGTV---VAVK-RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
+G G +G+VY+G+ V VAVK + S Q E +FL E +S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLS---AKSKEPLGFAMR--LSIALGSSRGILYLH 724
L+G E + ++ E M+ G L+ L + + P M+ L A ++G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 725 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG----------IVPA 771
HRDI A N LL K AK+ADFG++R DI ++P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLP- 184
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 830
+K P PE FL T K+DV+S GV+ E+ + G P N +EV
Sbjct: 185 -----IKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEV--- 230
Query: 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
M F G + P C ++ C Q + RP+ + ++ ++
Sbjct: 231 ----MEFVTGGGRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 29/269 (10%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G+V+ G T VA+K ++GS+ E FL E + +L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVT 71
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
+E ++ E+M NG+L D L L + +A + G+ ++ + HRD
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 795
++A+NIL+ K+ADFGL+RL + D E +K T PE T
Sbjct: 128 LRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTA----PEAINYGTFT 181
Query: 796 DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSEC 851
KSDV+S G++ E++T +G+ I Y VI Y P C
Sbjct: 182 IKSDVWSFGILLTEIVT------YGR-------IPYPGMTNPEVIQNLERGYRMPRPDNC 228
Query: 852 VEKFIKLALKCCQDETDARPSMSEVMREL 880
E+ +L C +++ + RP+ E +R +
Sbjct: 229 PEELYELMRLCWKEKPEERPTF-EYLRSV 256
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-22
Identities = 80/290 (27%), Positives = 119/290 (41%), Gaps = 81/290 (27%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISG----------------------- 120
L+ LQL + SG + +G+ + LT+LD N ++G
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 121 -SIPKEIGNIKSLELLLLNGNELTGSLPEELGYL------------------------PK 155
IPK +G +SL + L N +G LP E L P
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
L + + +N G LP SF + + + ++ N SG +P +L L L+ + L N L+
Sbjct: 454 LQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN 275
G +P ELS KL+ L L +N G IPAS+S M P
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQ-IPASFSEM-----------------------PV 548
Query: 276 LGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 325
L L LS N+L+G IP N + L ++ I++N L GS+PS+
Sbjct: 549 LSQL--------DLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-CD 675
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
E+G +V E+M+ G+L D L ++ + LG L +L + YL EA+ V HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANNFV-HRD 127
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 795
+ A N+L+ AKV+DFGL++ A G +P VK T PE K +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFS 177
Query: 796 DKSDVYSLGVVFLELLT-GMQPISH--GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
KSDV+S G++ E+ + G P K++V V Y+ M + P C
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------MDA-PDGCP 225
Query: 853 EKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ +C + RPS ++ +LE I
Sbjct: 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 617 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 670
+G G +G VYKG+ +P+G VA+K +E + + KE L E ++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 671 VGYCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
+G C Q L+ + M G L D + K+ +G L+ + ++G+ YL +
Sbjct: 75 LGIC--LSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYL 784
+ HRD+ A N+L+ K+ DFGL++L V + E G VP +K ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP------IK----WM 178
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
E L T KSDV+S GV EL+T G +P G E+ + + G
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP-AVEI-----PDL---LEKGE 228
Query: 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
P C + +KC + ++RP+ E++ E
Sbjct: 229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 617 IGQGGYGK--VYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+G +G+ +Y+ D ++V K L + ++ L EI LS L H N+++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ ++ ++ E+ + GTL D++ + + M L + Y+H +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRDIK NI L K+ DFG+S+ I G + TVV GTP Y+ PE
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK------ILGSEYSMAETVV-GTPYYMSPELCQGV 176
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
K KSD+++LG V ELLT + R + +++ ++ GN S
Sbjct: 177 KYNFKSDIWALGCVLYELLT----------LKRTFDATNPLNLVVKIVQGNYTPVVSVYS 226
Query: 853 EKFIKLALKCCQDETDARPSMSEVM 877
+ I L Q + + RP+ EV+
Sbjct: 227 SELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 23/272 (8%)
Query: 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRN 666
+F +IG+G +G V+K + D V A+K+ + + + +E + E + L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
++ ++G+ +V E+ NG L L + PL + G+ +LH++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRDIK+ N+ LD K+ D G+++L +T+V GTP YL P
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIV-GTPYYLSP 170
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846
E +KSDV++LGVV E TG P + Q +++ +I G
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPF----------DANNQGALILKIIRGVFPP 220
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
++ +L +C + RP +++R
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 70/274 (25%), Positives = 110/274 (40%), Gaps = 29/274 (10%)
Query: 616 QIGQGGYGKVYKG--ILPDGTV--VAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSL 670
++G G +G V +G G V VAVK + L +FL E + L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
G M+V E G+L D+L + + A+ + G+ YL ++
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYF 789
HRD+ A NILL K+ DFGL R P + +V P + PE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNE-----DHYVMEEHLKVPFAWCAPESL 172
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQPISH--GKNIVREVNIAYQSSMMFSVIDGNMGS 846
T + SDV+ GV E+ T G +P + G I+++++ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----------E 221
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
P C + + L+C RP+ + + L
Sbjct: 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 672
+IG+G YG VYK G +VA+K+ + K L EI+ L L+H N++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+G+ LV+EFM +L + L ++ S +G+ + H+ +
Sbjct: 66 VFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K N+L++ + K+ADFGL+R P V + VV T Y PE L
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSP-----VRPYTHYVV--TRWYRAPELLLGD 173
Query: 793 KLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVN 828
K D++S+G +F ELL+ +P+ GK+ + ++
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 86/281 (30%), Positives = 125/281 (44%), Gaps = 35/281 (12%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 663
N+ +GQG +G+VY D G +A K+ Q S + KE EIQ L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 664 HRNLVSLVGYCDEEGEQMLV--YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 721
H +V G + E+ L E+M G+++DQL A A+ S+ +R IL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQIL 116
Query: 722 ----YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT--- 170
Query: 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837
GTP ++ PE K+DV+SLG +E+LT P + + + IA Q +
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--- 226
Query: 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + S+ SE F L C E RPS E++R
Sbjct: 227 ---NPQLPSHISEHARDF----LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 86/275 (31%), Positives = 124/275 (45%), Gaps = 32/275 (11%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 666
F +IG G +G VY + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
HRDIKA NILL T K+ADFG + L PA+ S V GTP ++ P
Sbjct: 135 E---RIHRDIKAGNILLTEPGTVKLADFGSASLVS--------PAN-SFV--GTPYWMAP 180
Query: 787 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
E L + K DV+SLG+ +EL P+ + + +IA S S D
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW- 239
Query: 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
S+ F+ C Q RPS E+++
Sbjct: 240 -----SDYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 607 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLS 660
++ ++G+G +G+VYK + G VVA+K+ + EK+ L EI+ L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILK 62
Query: 661 RLHHRNLVSL----VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMR 709
+L H N+V L V D+ + +V +M +G L + S K E
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYM 121
Query: 710 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL----APVPDI 765
L + GI YLH + + HRDIKA+NIL+D++ K+ADFGL+R P P
Sbjct: 122 LQLL----EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 821
G T + T Y PE L + T D++ +G VF E+ T +PI GK
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 21/258 (8%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G+V+ G + T VAVK + G++ + FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
+E ++ E+M+ G+L D L + + + + + G+ Y+ + HRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRD 128
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 795
++A+N+L+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 129 LRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFT 182
Query: 796 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 854
KSDV+S G++ E++T G P N S +M ++ G C ++
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSN----------SDVMSALQRGYRMPRMENCPDE 232
Query: 855 FIKLALKCCQDETDARPS 872
+ C +++ + RP+
Sbjct: 233 LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 669
+IG+G YG VYK G +VA+K+ + L+ E E + EI L L+H N+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
L+ E + LV+EF+ + L+ + + L + S +GI Y H+
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
V HRD+K N+L+D + K+ADFGL+R VP V + VV T Y PE
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGVP-----VRTYTHEVV--TLWYRAPEIL 171
Query: 790 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 820
L + + + D++S+G +F E++ +P+ G
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNR-RPLFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQ---EGSLQGEKEFLT---EIQFLSRLHHRNLVSL 670
+G+G YG VY G+ G ++AVK+ + L EKE+ E+ L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C ++ + EF+ G++ L+ P + + + G+ YLH +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH---NNC 122
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
V HRDIK +N++L K+ DFG +R + G +++ + GTP ++ PE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG-THSNMLKSMHGTPYWMAPEVIN 181
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYP 848
KSD++S+G E+ TG P++ + + MF + M P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AAMFYIGAHRGLMPRLP 231
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMR 878
I C + RPS +++R
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 669
+IG+G YG VYKG G +VA+K+ + L+ E+E + EI L L H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
L +E L++EF+S + S + + + S +GIL+ H+
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
V HRD+K N+L+D+K K+ADFGL+R +P V + VV T Y PE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-----VRVYTHEVV--TLWYRAPEVL 173
Query: 790 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 820
L + + + D++S+G +F E+ T +P+ HG
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 674
IG+G +G+VYK I VVA+K + E E + EIQFLS+ + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 675 DEEGEQM-LVYEFMSNGTLRDQL-SAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPV 731
+G ++ ++ E+ G+ D L K E + F +R + G+ YLH E
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHEEG---K 119
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----GTPGYLD 785
HRDIKA+NILL + K+ADFG V ++ T+ K GTP ++
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFG-------------VSGQLTSTMSKRNTFVGTPFWMA 166
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819
PE +K+D++SLG+ +EL G P+S
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 37/279 (13%)
Query: 617 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 670
+G G +G VYKGI +PDG VA+K +E S + KE L E ++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C Q LV + M G L D + ++K+ +G L+ + ++G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 785
+ HRD+ A N+L+ K+ DFGL+RL + + E G VP ++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----------WMA 179
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
E L + T +SDV+S GV EL+T G +P RE+ + G
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEK--------GER 229
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P C + +KC +++ RP E++ E +
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 617 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
IG G +G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G + M+V E+M NG+L D K + + G + G+ YL +D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGY 127
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
HRD+ A NIL++ KV+DFGLSR L P+ A+ + K + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIA 182
Query: 791 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
K T SDV+S G+V E+++ G +P N ++ ++ +G P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----------QDVIKAIEEGYRLPAPM 232
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+C +L L C Q + + RP +++ L+ +
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 9e-20
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVSL 670
+G+G Y VYK G +VA+K+ + G + K+ L EI+ L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+ + LV+EFM L + KS L A S L + RG+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSI-VLTPADIKSYMLMTLRGLEYLH---SNW 122
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ HRD+K +N+L+ K+ADFGL+R P+ + VV T Y PE
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-----MTHQVV--TRWYRAPELLF 175
Query: 791 THKL-TDKSDVYSLGVVFLELL 811
+ D++S+G +F ELL
Sbjct: 176 GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 53/270 (19%)
Query: 634 TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692
+VAVK + + + +FL E++ LSRL N+ L+G C + ++ E+M NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 693 ---------RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 743
A + + L F+ L +A + G+ YL HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 744 DHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 800
+T K+ADFG+SR D ++G P + ++ E L K T KSDV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKSDV 215
Query: 801 YSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG------------S 846
++ GV E+LT QP H + VI+ N G
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTD--------------QQVIE-NAGHFFRDDGRQIYLP 260
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEV 876
P C + +L L+C + + + RP+ E+
Sbjct: 261 RPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 617 IGQGGYGKVYKGIL-PDG---TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 671
IG G +G+V +G L G VA+K + G + + ++FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G + M++ EFM NG L D ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFL 790
HRD+ A NIL++ KV+DFGLSR + + P + S++ P + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 791 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY-- 847
K T SDV+S G+V E+++ G +P Y VI+ Y
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP--------------YWDMSNQDVINAIEQDYRL 230
Query: 848 --PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P +C +L L C Q + +ARP +++ L+ +
Sbjct: 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 41/287 (14%)
Query: 617 IGQGGYGKVYKGIL--PDGTV--VAVKRAQ-EGSLQGE-KEFLTEIQFLSRLHHRNLVSL 670
+G+G +G V +G L DG+ VAVK + + E +EFL+E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 671 VGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 720
+G C E M++ FM +G L L E L L + + G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVSTV-V 777
YL HRD+ A N +L T VADFGLS+ D +G ++ + V
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG----RIAKMPV 179
Query: 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 836
K ++ E T KSDV++ GV E+ T G P +N +
Sbjct: 180 K----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----------HEIY 225
Query: 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ GN P +C+++ L C + + RP+ +++ LE+I
Sbjct: 226 DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 87/313 (27%), Positives = 135/313 (43%), Gaps = 54/313 (17%)
Query: 605 ALATNNFNSSTQIGQGGYGKVYKG-ILPDGTVV--AVKRAQE-GSLQGEKEFLTEIQFLS 660
L N+ IG+G +G+V K I DG + A+KR +E S ++F E++ L
Sbjct: 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62
Query: 661 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLG 705
+L HH N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 706 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765
L A +RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--- 176
Query: 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISH 819
VK T G L + L T SDV+S GV+ E+++ G P
Sbjct: 177 ----------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC- 225
Query: 820 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879
G + + + G P C ++ L +C +++ RPS +++
Sbjct: 226 GMTC---------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI--- 273
Query: 880 LESIWNMMPESDT 892
L S+ M+ E T
Sbjct: 274 LVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-19
Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 37/266 (13%)
Query: 633 GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV--GYCDEEGEQMLVYEFM 687
G VA+K + + + E + F E +RL+H N+V+L+ G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 688 SNGTLRDQLSAKSKEPLGFAMRL------SIALGSSRGILYLHTEADPPVFHRDIKASNI 741
TLR+ L+A P G RL ++A ++GI+ HRD+K NI
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIV-----------HRDLKPQNI 110
Query: 742 LL---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVS--TVVKGTPGYLDPEYFLTHKLTD 796
++ + AKV DFG+ L +P + A ++ T V GTP Y PE +T
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTL--LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 797 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 856
SD+Y+ G++FLE LTG Q + G + V E+ S + S + + +P + + +
Sbjct: 169 NSDLYAWGLIFLECLTG-QRVVQGAS-VAEILYQQLSPVDVS-LPPWIAGHP---LGQVL 222
Query: 857 KLAL-KCCQDETDARPSMSEVMRELE 881
+ AL K + + P+++E R LE
Sbjct: 223 RKALNKDPRQRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 44/297 (14%)
Query: 606 LATNNFNSSTQIGQGGYGKVY----KGILPDG--TVVAVKRAQEGSLQGEK-EFLTEIQF 658
+A S ++GQG +G VY KG++ D T VA+K E + E+ EFL E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 659 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRL 710
+ + ++V L+G + +++ E M+ G L+ L + + P +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 711 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----- 765
+A + G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 123 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 824
+G++P ++ PE T SDV+S GVV E+ T QP N
Sbjct: 180 KGLLPVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-- 227
Query: 825 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
++ V++G + P C + +L C Q RPS E++ ++
Sbjct: 228 --------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 74/272 (27%), Positives = 130/272 (47%), Gaps = 26/272 (9%)
Query: 616 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 672
+IG+G +G+V+ G L D T VAVK +E +L + +FL E + L + H N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
C ++ +V E + G L + L + + ++ G+ YL ++
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLT 791
HRD+ A N L+ K K++DFG+SR + +G+ + + +K P + PE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYAS--TGGMKQIPVKWTAPEALNY 170
Query: 792 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 850
+ + +SDV+S G++ E + G P + N++ Q + + G P
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYA---------NLSNQQTREA-IEQGVRLPCPEL 220
Query: 851 CVEKFIKLALKCCQDETDARPSMSEVMRELES 882
C + +L +C + + RPS S V +EL+S
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 35/281 (12%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 663
N+ +GQG +G+VY D G +AVK+ Q S + KE EIQ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 664 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 718
H +V G + E+ L E M G+++DQL + A+ ++ +R
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQIL 116
Query: 719 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
G+ YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT--- 170
Query: 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837
GTP ++ PE K+D++S+G +E+LT P + + + IA Q +
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--- 226
Query: 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + + S+ F+K E RPS E++R
Sbjct: 227 ---NPVLPPHVSDHCRDFLKRIFV----EAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-- 672
IG+G YGKVYK G +VA+K + E+E E L + +H N+ + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 673 ----YCDEEGEQMLVYEFMSNGT-------LRDQLSAKSKEPLGFAMRLSIALGSSRGIL 721
+ + LV E G+ LR + +E + + +R ++ RG+
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL-----RGLA 127
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVK-- 778
YLH + V HRDIK NILL K+ DFG+S A + ST+ +
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS-------------AQLDSTLGRRN 171
Query: 779 ---GTPGYLDPE-----YFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
GTP ++ PE +SDV+SLG+ +EL G P+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 40/289 (13%)
Query: 616 QIGQGGYGKVYKG--ILP---DGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G+ +GK+YKG LP +VA+K ++ + Q EF E ++ LHH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIAL 714
L+G +E +++E+++ G L + L +S K L L IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
+ G+ YL + H+D+ A NIL+ + K++D GLSR D + P +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 833
+ ++ PE + K + SD++S GVV E+ + G+QP N
Sbjct: 189 PI-----RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----------Q 233
Query: 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
++ V + +C + L +C Q+ RP ++ L S
Sbjct: 234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 669
+IG+G YG V+K +VA+KR + L + E L EI L L H+N+V
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 670 LVGYCDEEGEQMLVYEFMS----------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 719
L + + LV+E+ NG + D KS F +L +G
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKS-----FMFQLL------KG 111
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+ + H+ V HRD+K N+L++ K+ADFGL+R +P V + + VV
Sbjct: 112 LAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP-----VRCYSAEVV-- 161
Query: 780 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI 823
T Y P+ KL S D++S G +F EL +P+ G ++
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 78/296 (26%), Positives = 136/296 (45%), Gaps = 53/296 (17%)
Query: 617 IGQGGYGKVYKGIL-----PDGTV-VAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 668
+G+G +G+V K P+ T VAVK ++ + + + + ++E++ + + H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIAL 714
+L+G C +EG +V E+ ++G LRD L A+ +E L +S A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
+RG+ +L A HRD+ A N+L+ K+ADFGL+R DI H+
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIH-----HID 186
Query: 775 TVVKGTPGYLD-----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 828
K T G L PE T +SDV+S GV+ E+ T G P
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP---------G 237
Query: 829 IAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
I + +F ++ +G P C ++ L C + RP+ +++ +L+ +
Sbjct: 238 IPVEE--LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 75/267 (28%), Positives = 117/267 (43%), Gaps = 49/267 (18%)
Query: 611 FNSSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGEKEFLT--------EIQFL 659
+ IG+G YG+VYK DG A+K+ +G+KE T EI L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-----FKGDKEQYTGISQSACREIALL 56
Query: 660 SRLHHRNLVSLVGYC--DEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIAL 714
L H N+VSLV + L++++ + ++ AK + +M S+
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV-SIPPSMVKSLLW 115
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL---APVPDIEG 767
G+ YLH+ V HRD+K +NIL+ + K+ D GL+RL P
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP---- 168
Query: 768 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 826
A + VV T Y PE L T D++++G +F ELLT ++PI G+ +
Sbjct: 169 --LADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIK 224
Query: 827 VNIAYQSSMM---FSVIDGNMGSYPSE 850
+ +Q + F V +G P+E
Sbjct: 225 KSNPFQRDQLERIFEV----LG-TPTE 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 663
NF +IG+G YG VYK G VVA+K+ + L E E + EI L L+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELN 57
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
H N+V L+ E + LV+EF+ + L+ + A + + S +G+ +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H+ V HRD+K N+L++ + K+ADFGL+R VP V + VV T Y
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-----VRTYTHEVV--TLWY 166
Query: 784 LDPEYFLTHKL-TDKSDVYSLGVVFLELLT 812
PE L K + D++SLG +F E++T
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 8e-19
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 617 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 672
+G+G +GKV G + A+K ++ + KE LTE LSR++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEAD 728
E + LV E+ G L LS + + +A + +AL YLH+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE------YLHSLG- 113
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
+ +RD+K NILLD K+ DFGL++ + +T GTP YL PE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTNTFC-GTPEYLAPEV 164
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQP 816
L D +SLGV+ E+LTG P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 83/314 (26%), Positives = 145/314 (46%), Gaps = 61/314 (19%)
Query: 617 IGQGGYGKVYK----GI---LPDGTV-VAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 666
+G+G +G+V + GI PD TV VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 712
+++L+G C +EG ++ E+ + G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------ 766
A +RG+ YL + HRD+ A N+L+ K+ADFGL+R V DI+
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194
Query: 767 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 824
G +P VK ++ PE T +SDV+S G++ E+ T G P
Sbjct: 195 NGRLP------VK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP------ 238
Query: 825 REVNIAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
I + +F ++ +G+ PS C + L +C RP+ +++ L+ +
Sbjct: 239 ---GIPVEE--LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
Query: 884 WNMMPES--DTKTP 895
+ E D P
Sbjct: 294 LAAVSEEYLDLSMP 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 616 QIGQGGYGKVYKGILPD------GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 668
++GQG +G VY+G D T VAVK E SL+ EFL E + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSA---KSKEPLG-----FAMRLSIALGSSRGI 720
L+G + ++V E M++G L+ L + +++ G + +A + G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVST 775
YL+ + HRD+ A N ++ H FT K+ DFG++R D +G++P
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 834
++ PE T SD++S GVV E+ + QP N +
Sbjct: 187 -------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------EQV 230
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
+ F V+DG P C E+ L C Q RP+ E++ L+
Sbjct: 231 LKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 73/284 (25%), Positives = 130/284 (45%), Gaps = 46/284 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRA--------QEGSLQGE--KEFLTEIQFLSRLHHR 665
IG+G YG+VY + + G ++AVK+ + S Q + K +EI+ L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYL 723
N+V +G+ E + E++ G++ L + +E + G+ YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ----LVRFFTEQVLEGLAYL 124
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H++ + HRD+KA N+L+D K++DFG+S+ + + I + ++G+ +
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKS-----DDIYDNDQNMSMQGSVFW 176
Query: 784 LDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841
+ PE ++ + K D++SLG V LE+ G +P S + I + MF +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------AAMFKL-- 224
Query: 842 GNMGS---YPSECVEKFIKLALK----CCQDETDARPSMSEVMR 878
GN S P + +AL C D RP+ E+++
Sbjct: 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-18
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 34 PIEVSALRSIKK----------SLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLH 83
P + A RS+++ L +++KL D +N G ++
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG------RINSRKWD 450
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
+ LQ+L+L G L P+ L LD N+ SG++P+++G++ L L L+ N
Sbjct: 451 MPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+L+G +P+EL KL + + N +SG +P SF+ + ++ N +SG+IP L
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569
Query: 201 LPSLVHMLLDNNNLTGYLPP 220
+ SLV + + +N+L G LP
Sbjct: 570 VESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 33/273 (12%)
Query: 616 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
++G G +GKVYK + G A K Q S + ++F+ EI LS H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 675 DEEGEQMLVYEFMSNGTLR---DQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPP 730
E + ++ EF G L +L EP + + R + + +LH+
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSHK--- 123
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
V HRD+KA NILL K+ADFG+S T + GTP ++ PE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL------QKRDTFI-GTPYWMAPEVVA 176
Query: 791 THKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
D K+D++SLG+ +E L M+P H N +R V + S +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE-LAQMEPPHHELNPMR-VLLKILKS------EPPTL 228
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
PS+ F C + D RP+ +E+++
Sbjct: 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 33/225 (14%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---F----LTEIQFLSRLHHRNLV 668
I +G YG VY+ G +VA+K+ L+ EKE F L EI L +L H N+V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKK-----LKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 669 SL----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
++ VG + +V E++ + L+ + K+P + + L G+ +LH
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
D + HRD+K SN+LL+++ K+ DFGL+R P + + VV T Y
Sbjct: 124 ---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-----LKPYTQLVV--TLWYR 173
Query: 785 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828
PE L + + D++S+G +F ELLT +P+ GK+ + ++N
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 71/296 (23%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 617 IGQGGYGKVYK----GILPD----GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 666
+G+G +G+V GI D VAVK ++ + + + + ++E++ + + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 712
+++L+G C ++G ++ E+ S G LR+ L A+ E + F +S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDYYK 194
Query: 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 831
+T + ++ PE T +SDV+S GV+ E+ T G P
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-----------GI 243
Query: 832 QSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886
+F ++ +G+ P+ C + + C RP+ +++ +L+ I +
Sbjct: 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGY 673
+G G G V K +P GTV+A K G+ K+ L E+Q + +VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
E + EFM G+L D++ K P+ + IA+ G+ YL+ + H
Sbjct: 72 FLNENNICMCMEFMDCGSL-DRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
RDIK SNIL++ + K+ DFG+S G + ++ GT Y+ PE K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQGGK 178
Query: 794 LTDKSDVYSLGVVFLELLTGMQPIS 818
T KSDV+SLG+ +EL G P +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
+G+G YG V K G +VA+K + E +K L E++ L +L H N+V+L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYLHTEADPP 730
+G LV+E++ TL + L A P G A+R I + I Y H+
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEAS---PGGLPPDAVRSYI-WQLLQAIAYCHSHN--- 120
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ HRDIK NIL+ K+ DFG +R PA T T Y PE +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRAR------PASPLTDYVATRWYRAPELLV 174
Query: 791 THKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
K DV+++G + ELL G +P+ G +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 59/234 (25%), Positives = 90/234 (38%), Gaps = 28/234 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRL-H 663
++F IG+G + V A+K + L EK E + L+RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
H ++ L +E V E+ NG L + L A + YL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYL 118
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP------------- 770
H++ + HRD+K NILLD K+ DFG +++
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 771 -AHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKN 822
++ V GT Y+ PE L K K SD+++LG + ++LTG P G N
Sbjct: 176 RRRFASFV-GTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKE-------FLTEIQFLSRLHHRN 666
IG G +G VY G+ G ++AVK+ + S + EI L L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
+V +G + + E++ G L + A +E L I +G+ YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQIL----KGLNYL 122
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H + HRDIK +NIL+D+K K++DFG+S+ + + ++G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
+ PE T K+D++SLG + +E+LTG P Q +F + +
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD----------CTQLQAIFKIGENA 228
Query: 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
PS + I K + + + RP+ +E+++
Sbjct: 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 617 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGY 673
IG+G +G V+K G VA+K+ L+G + L EI+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+LV E+M L + L + PL A S +G+ Y+H + H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANG---IMH 122
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 792
RD+K +N+L+ K+ADFGL+RL E + V T Y PE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFS----EEEPRLYSHQV--ATRWYRAPELLYGAR 176
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
K D++++G +F ELL G P+ G+N
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG-SPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-18
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 27/274 (9%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
+G G +G VYKGI +P+G V + A + + EF+ E ++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C Q LV + M +G L D + + K+ +G + L+ + ++G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ HRD+ A N+L+ K+ DFGL+RL +EG + + K ++ E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARL-----LEGDEKEYNADGGKMPIKWMALECIH 184
Query: 791 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
K T +SDV+S GV EL+T G +P + RE+ + G P
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP--YDGIPTREIPDLLEK--------GERLPQPP 234
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
C + +KC + D+RP E+ E +
Sbjct: 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-18
Identities = 83/280 (29%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLV 671
+IG G +G VY VVAVK+ + G EK + + E++FL +L H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G +E LV E+ G+ D L K+PL +I G+ +G+ YLH+ +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 791
HRDIKA NILL K+ADFG + + PA+ S V GTP ++ PE L
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSS--------PAN-SFV--GTPYWMAPEVILA 191
Query: 792 H---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
+ K DV+SLG+ +EL P+ + + +IA S
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ---------S 242
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888
+E + F C Q RP+ +E++R + + P
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH-DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 39/232 (16%)
Query: 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE-----FLT 654
+G+ + + F+ QIG+G YG+VYK D G +VA+K+ + L EKE +
Sbjct: 1 WGKRCV--DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIR 55
Query: 655 EIQFLSRLHHRNLVSL----------VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSK 701
EI+ L +L+HRN+V+L + + ++G LV+E+M + G L L S+
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 702 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761
+ + M+ + G+ Y H HRDIK SNILL++K K+ADFGL+RL
Sbjct: 116 DHIKSFMKQLL-----EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLT 812
+ + + V+ T Y PE L + DV+S G + EL T
Sbjct: 168 SEESR----PYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 30/271 (11%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G+V+ T VAVK + GS+ E FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+E ++ EFM+ G+L D L + SK+PL + S + + G+ ++ H
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRN---YIH 125
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
RD++A+NIL+ K+ADFGL+R+ + D E +K T PE
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGS 179
Query: 794 LTDKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGSYPSE 850
T KSDV+S G++ +E++T G P N ++R + Y+ +
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN------------ 227
Query: 851 CVEKFIKLALKCCQDETDARPSMSEVMRELE 881
C E+ + ++C ++ + RP+ + L+
Sbjct: 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 61/306 (19%)
Query: 605 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQ 657
A +N T +G+G +G+V+ T+V VK Q+ + + EF E+
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 658 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKE------PLGFAMRL 710
+L H+N+V L+G C E ++ E+ G L+ L A KSK+ PL ++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 711 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR------------ 758
++ + G+ +L HRD+ A N L+ + KV+ LS+
Sbjct: 121 ALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 759 -LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 816
L P+ +L PE + KSDV+S GV+ E+ T G P
Sbjct: 178 ALIPLR-------------------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
Query: 817 ISHGKNIVREVNIAYQS-SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 875
EV Q+ + V P C + KL +C RPS SE
Sbjct: 219 --FYGLSDEEVLNRLQAGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSE 268
Query: 876 VMRELE 881
++ L
Sbjct: 269 LVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 80/328 (24%), Positives = 150/328 (45%), Gaps = 53/328 (16%)
Query: 617 IGQGGYGKVYK----GILPD----GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 666
+G+G +G+V GI D VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 712
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDYYK 191
Query: 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832
+T + ++ PE T +SDV+S GV+ E+ T + + V E
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYPGIPVEE------ 244
Query: 833 SSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 891
+F ++ +G+ P+ C + + +C RP+ +++ +L+ + +
Sbjct: 245 ---LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV----- 296
Query: 892 TKTPEFINSEHTSKEETP-----PSSSS 914
T T E+++ ++ +P PSS S
Sbjct: 297 TSTDEYLDLSVPFEQYSPGCPDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 617 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLV 671
IG+G +G VY+G+ + VAVK + + +E FL E + + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G E +V E G LR L +K L A + + S + YL ++
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----YLDP 786
HRDI A N+L+ K+ DFGLSR + K + G ++ P
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRY-----------LEDESYYKASKGKLPIKWMAP 177
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
E + T SDV+ GV E+L G++P KN + ++ + +G
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----------NDVIGRIENGERL 227
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886
P C L KC + RP +E+ +L I
Sbjct: 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-17
Identities = 54/146 (36%), Positives = 80/146 (54%), Gaps = 9/146 (6%)
Query: 32 TDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSN---WTGVLC-FNTTMDDGYLHLREL 87
T EVSAL+++K SL + WN GDPC W+G C F++T G + L
Sbjct: 369 TLLEEVSALQTLKSSL-GLPLRFG-WN-GDPCVPQQHPWSGADCQFDSTK--GKWFIDGL 423
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L N L G + +I +L +L ++ N I G+IP +G+I SLE+L L+ N GS+P
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKS 173
E LG L L + ++ N +SG +P +
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 53/243 (21%)
Query: 610 NFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 663
F +IG+G YG VY+ G +VA+K+ + + E++ L EI L L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLREITLLLNLR 64
Query: 664 HRNLVSL---------------VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 708
H N+V L + YC EQ L +L D + P +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYC----EQDL-------ASLLDNMPT----PFSESQ 109
Query: 709 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768
+ L RG+ YLH + HRD+K SN+LL K K+ADFGL+R G+
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY------GL 160
Query: 769 VPAHVS-TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVRE 826
++ VV T Y PE L + D++++G + ELL +P+ GK+ + +
Sbjct: 161 PAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQ 217
Query: 827 VNI 829
+++
Sbjct: 218 LDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 33/276 (11%)
Query: 610 NFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSL-QGEKE-FLTEIQFLSRLHHRN 666
+F ++G+G YG VYK L D A+K GS+ Q E+E + EI+ L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 667 LVSLVGYCDE--EGEQM-LVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGIL 721
++S Y + +G ++ +V E+ G L +S K ++ + I + RG+
Sbjct: 61 IIS---YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
LH + + HRD+K++NILL K+ D G+S++ +++ GTP
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---------KNMAKTQIGTP 165
Query: 782 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841
Y+ PE + + KSD++SLG + E+ T P +++ + + V
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSM---------QDLRYKVQR 215
Query: 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 877
G P + Q + RP+ +++
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 55/301 (18%)
Query: 617 IGQGGYGKVYK----GILPDG----TVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 666
+G+G +G+V G+ + T VAVK + + + + + ++E++ + + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 712
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R DI H
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIH-----H 192
Query: 773 VSTVVKGTPG-----YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 826
+ K T G ++ PE T +SDV+S GV+ E+ T G P
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------- 244
Query: 827 VNIAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885
+F ++ +G+ PS C + + C RP+ +++ +L+ I
Sbjct: 245 ---GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
Query: 886 M 886
+
Sbjct: 302 L 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 79/295 (26%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 666
+ +G+G YG VY V +A+K E + + EI S L HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-----SKEP-LGFAMRLSIALGSSRGI 720
+V +G E G + E + G+L L +K E + F + + G+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGL 121
Query: 721 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK 778
YLH D + HRDIK N+L++ + K++DFG S RLA GI P +
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA------GINP--CTETFT 170
Query: 779 GTPGYLDPEYFLTHKLTDK--------SDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830
GT Y+ PE + DK +D++SLG +E+ TG P + +
Sbjct: 171 GTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---------IELG 215
Query: 831 YQSSMMFSVIDGNMGSYP------SECVEKFIKLALKCCQDETDARPSMSEVMRE 879
+ MF V G +P S + FI L+C + + D R S +++++
Sbjct: 216 EPQAAMFKV--GMFKIHPEIPESLSAEAKNFI---LRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 27/222 (12%)
Query: 609 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 661
NN + +G G +GKV + G+ V VAVK + + E+E L +E++ +S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 662 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
L +H N+V+L+G C G +++ E+ G L + L K + L LS + ++G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKG 779
+L A HRD+ A N+LL H K+ DFGL+R DI + S VVKG
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DI-----MNDSNYVVKG 201
Query: 780 TP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 816
++ PE T +SDV+S G++ E+ + G P
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 70/268 (26%), Positives = 118/268 (44%), Gaps = 28/268 (10%)
Query: 616 QIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G G +G V KG+ D + +K E S++ E + E + + +L + +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVR 59
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
++G C+ E MLV E S G L LS K K+ + + + + S G+ YL +
Sbjct: 60 MIGVCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
HRD+ A N+LL ++ AK++DFGLS+ D + K + PE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----YKARSAGKWPLKWYAPECI 170
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
K + +SDV+S G+ E + G +P K +M + G P
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----------PEVMSFIEQGKRLDCP 220
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEV 876
+EC + L C + + RP+ ++V
Sbjct: 221 AECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 37/271 (13%)
Query: 617 IGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 673
+G+G +G V+ + V+ + E + E+ E Q L L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYLHTEA 727
E+ M+V E+ GTL + + + L F +++ +AL ++HT+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH------HVHTKL 121
Query: 728 DPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRD+K NILLD HK K+ DFG+S++ + TVV GTP Y+ P
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVV-GTPCYISP 170
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846
E KSD+++LG V EL + + R A +++ ++ G
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFAP 220
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEVM 877
+L L + RP +S++M
Sbjct: 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY- 673
IG+G YG VY+G +P G VVA+K + + + E+ LS+L ++ Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 674 -CDEEGEQM-LVYEFMSNGTLRDQLSA-KSKEP-LGFAMR-LSIALGSSRGILYLHTEAD 728
+G ++ ++ E+ G++R + A E + +R + +AL Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK------YIHKV-- 120
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
V HRDIKA+NIL+ + K+ DFG++ L + ST V GTP ++ PE
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALL------NQNSSKRSTFV-GTPYWMAPEV 172
Query: 789 FLTHKLTD-KSDVYSLGVVFLELLTGMQPIS 818
K D K+D++SLG+ E+ TG P S
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 617 IGQGGYGKVYKGILP--DGTV--VAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
+G+G +G V + L DG+ VAVK +A S +EFL E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 671 VGYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMR--LSIALGSSRGI 720
+G + M++ FM +G L L S +EP ++ + + + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
YL ++ HRD+ A N +L+ T VADFGLS+ D K
Sbjct: 127 EYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-----YRQGCASKLP 178
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839
+L E + T SDV++ GV E++T G P + +N S + +
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----------SEIYNYL 228
Query: 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884
I GN P +C+E +L +C E RPS + +LE IW
Sbjct: 229 IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 617 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 671
IG+G +G+V + ++ DG + A+K +E S ++F E++ L +L HH N+++L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLS---------AKSKE-----PLGFAMRLSIALGSS 717
G C+ G + E+ G L D L A +KE L L A +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
G+ YL ++ HRD+ A N+L+ +K+ADFGLSR V V
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-------------YV 173
Query: 778 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 831
K T G L + L T KSDV+S GV+ E+++ G P G
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKLP 232
Query: 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
Q M P C ++ +L +C +D RP +++ +L
Sbjct: 233 QGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLH 663
NF +IG+G + VYK I L DG VVA+K+ Q + K + L EI L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPL------GFAMRLSIALG 715
H N++ + E E +V E G L + K K + + ++L AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 775
++H++ + HRDIK +N+ + K+ D GL R AH S
Sbjct: 121 ------HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AH-SL 166
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 810
V GTP Y+ PE + KSD++SLG + E+
Sbjct: 167 V--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 8e-17
Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 611 FNSSTQIGQGGYGKVY-KGILPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 666
F +IG G +G VY + VVA+K+ + G EK + + E++FL R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRDIKA NILL K+ADFG + +A PA+ GTP ++ P
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASIAS--------PANSFV---GTPYWMAP 190
Query: 787 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
E L + K DV+SLG+ +EL P+ + + +IA S
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----- 245
Query: 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
+E + F C Q RP+ E+++ +
Sbjct: 246 ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 8e-17
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF--------LTEIQFLSRL-HHR 665
Q+G G +G VY G +VA+K+ + K+F L E++ L +L H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
N+V L E E V+E+M G L + + +P ++ SI +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP--AHVSTVVKGTPGY 783
FHRD+K N+L+ K+ADFGL+R +I P +VS T Y
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVS-----TRWY 164
Query: 784 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
PE L D+++LG + EL T ++P+ G +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSS 203
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 673
+G+G YG V K + G +VA+K+ E K + EI+ L +L H NLV+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+ LV+EF+ + T+ D L K L + RGI + H+ + H
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 734 RDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
RDIK NIL+ K+ DFG +R LA P V T T Y PE +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLA--------APGEVYTDYVATRWYRAPELLVGD 175
Query: 793 -KLTDKSDVYSLGVVFLELLTG 813
K D++++G + E+LTG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 74/266 (27%), Positives = 118/266 (44%), Gaps = 39/266 (14%)
Query: 635 VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 693
+VAVK +E + + + +FL EI+ +SRL N++ L+ C ++ E+M NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 694 DQLSA-KSKEPLGFAMRLSIALGS--------SRGILYLHTEADPPVFHRDIKASNILLD 744
LS + +E A ++I+ + + G+ YL + HRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164
Query: 745 HKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 799
+T K+ADFG+SR D I+G ++P ++ E L K T SD
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMSWESILLGKFTTASD 214
Query: 800 VYSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY---PSECVEK 854
V++ GV E+LT QP S + + + + F D Y P+ C +
Sbjct: 215 VWAFGVTLWEILTLCKEQPYSQ----LSDEQVIENTGEFFR--DQGRQVYLPKPALCPDS 268
Query: 855 FIKLALKCCQDETDARPSMSEVMREL 880
KL L C + RPS E+ L
Sbjct: 269 LYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRA--QEGSLQGEKE---FLTEIQFLSRLH 663
N+ +G+G +G+VY D G +AVK+ S + KE EIQ L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 664 HRNLVSLVGYC--DEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
H +V G C D E +++ ++ E+M G+++DQL A R + + +G+
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGV 119
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+ GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GT 172
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834
P ++ PE K+DV+S+ +E+LT P + + + IA Q +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 617 IGQGGYGKV----YKGILPDG----TVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNL 667
+G+G +GKV Y P+G VAVK + S L EI+ L L+H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 668 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
V G C E+G L+ EF+ +G+L++ L ++K + +L A+ +G+ YL +
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
HRD+ A N+L++ + K+ DFGL++ V + + V +
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYA 180
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT----GMQPIS---------HGK-NIVREVNIAY 831
PE + K SDV+S GV ELLT P++ HG+ + R V +
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-- 238
Query: 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ +G P C E+ +L KC + + R + ++ E+I
Sbjct: 239 -------LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 617 IGQGGYGKVY---KGILPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSL 670
I +G YG+V+ K G + A+K ++ + + + LTE LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 671 VGYCDEEGEQML--VYEFMSNGTLR---------DQLSAK--SKEPLGFAMRLSIALGSS 717
Y +G++ L V E++ G L D+ A+ E I L
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE---------IVLA-- 105
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVST 775
+ YLH+ + HRD+K NIL+D K+ DFGLS++ V
Sbjct: 106 --LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
+V GTP Y+ PE L + D +SLG + E L G+ P
Sbjct: 161 IV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
+G G G VYK L ++AVK + +++ +K+ ++E++ L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
E + EFM G+L D + LG IA+ +G+ YL + + H
Sbjct: 68 FFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---ILH 118
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
RD+K SN+L++ + K+ DFG+S +V + T V GT Y+ PE +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST--------QLVNSIAKTYV-GTNAYMAPERISGEQ 169
Query: 794 LTDKSDVYSLGVVFLELLTGMQPISH-GKNIVREVNIAYQSSMM-----FSVIDGNMGSY 847
SDV+SLG+ F+EL G P KN Q S+M ++D +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPPVL 220
Query: 848 P-SECVEKFIKLALKCCQDETDARPSMSEVM 877
P + EKF+ +C + + RP+ +M
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 83/334 (24%), Positives = 144/334 (43%), Gaps = 90/334 (26%)
Query: 616 QIGQGGYGKVYK------GILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G G +GKVYK G L V+ K +E ++++ EI+ L+ +H +V
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYMVEIEILATCNHPYIVK 73
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
L+G +G+ ++ EF G + +L EP +++ I + YLH+
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHSM 129
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTP 781
+ HRD+KA N+LL K+ADFG+S +V T+ + GTP
Sbjct: 130 K---IIHRDLKAGNVLLTLDGDIKLADFGVS------------AKNVKTLQRRDSFIGTP 174
Query: 782 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836
++ PE + + D K+D++SLG+ +E + ++P H N +R
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIE-MAQIEPPHHELNPMR----------- 222
Query: 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 896
+ LK + E P++S+ S W+M + +
Sbjct: 223 ---------------------VLLKIAKSEP---PTLSQ-----PSKWSM------EFRD 247
Query: 897 FINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 930
F+ + ET PS++ +L+HP+VSS S L
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 611 FNSSTQIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRN 666
F +IG+G +G+V+KGI D VVA+K + E E + EI LS+
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+ G + + ++ E++ G+ D L A + A L L +G+ YLH+E
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE 120
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
HRDIKA+N+LL + K+ADFG++ I+ +T V GTP ++ P
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR------NTFV-GTPFWMAP 170
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846
E K+D++SLG+ +EL G P S + ++F + N +
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSD----------MHPMRVLFLIPKNNPPT 220
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
E + F + C + RP+ E+++
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR----AQEGSLQGEKEFLTEIQFLSRLHH 664
NF ++G+G Y VYKG G +VA+K A+EG+ + EI + L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT---PSTAIREISLMKELKH 57
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
N+V L E + MLV+E+M + + + L S +GI + H
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ V HRD+K N+L++ + K+ADFGL+R +P V + VV T Y
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-----VNTFSNEVV--TLWYR 167
Query: 785 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
P+ L + S D++S+G + E++TG +P+ G N
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSLV- 671
IG G YG V + G VA+K+ L K L EI+ L L H N++ L+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 672 ----GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT 725
++ + +V E M D L KS +PL RG+ YLH+
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKGTPGYL 784
A+ V HRD+K SNIL++ K+ DFGL+R D + ++ VV T Y
Sbjct: 122 -AN--VIHRDLKPSNILVNSNCDLKICDFGLARGV---DPDEDEKGFLTEYVV--TRWYR 173
Query: 785 DPEYFLT-HKLTDKSDVYSLGVVFLELLTG 813
PE L+ + T D++S+G +F ELLT
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+G G V K L + G + A+K LQ K+ L E++ +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66
Query: 673 YCDEEGEQML--VYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGILY 722
+E + E+ G+L D + K K+ LG IA +G+ Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSY 120
Query: 723 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 782
LH+ + HRDIK SNILL K K+ DFG+S V + T GT
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFT-GTSF 168
Query: 783 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 817
Y+ PE + SDV+SLG+ LE+ P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 664
+F TQ+GQGGYG+V+ D G +VA+KR ++ L E LTE L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 665 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGI 720
LV L+ Y ++ E + L E++ G R L+ S++ F M +
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
LH HRD+K N L+D K+ DFGLS+ + A+ S V G+
Sbjct: 117 --LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYAN-SVV--GS 161
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
P Y+ PE D +SLG + E L G P S
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-16
Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 59/282 (20%)
Query: 635 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 693
+VAVK + + + +FL E++ LSRL N++ L+G C +E ++ E+M NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 694 DQLSAKSKE-----------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 736
LS+ + + ++ L +AL + G+ YL + HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164
Query: 737 KASNILLDHKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLT 791
N L+ T K+ADFG+SR D I+G ++P ++ E L
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----------WMAWECILM 214
Query: 792 HKLTDKSDVYSLGVVFLEL-----------LTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
K T SDV++ GV E+ LT Q I + R+ Q ++
Sbjct: 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRD-----QGRQVYL-- 267
Query: 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
P C + +L L+C + RPS S++ L
Sbjct: 268 -----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 32/271 (11%)
Query: 617 IGQGGYGKV----YKGILPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
+G+G YG+V ++ DG +K+ + S + K E Q LS+L H N+V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 671 V-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
+ E+G +V F G L +L + + L + + + + YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
+ HRD+K N+ L KV D G++R L D+ ST++ GTP Y+ PE
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-------ASTLI-GTPYYMSPEL 173
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
F KSDV++LG E+ T + H N +++N S+++ +I+G + P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT----LKHAFN-AKDMN-----SLVYRIIEGKLPPMP 223
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRE 879
+ + +L + RPS+ ++R+
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 674
++G G +GKVYK + V+A + + + E E ++ EI L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E ++ EF + G + D + + + PL + + + YLH + + HR
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTPGYLDPEYF 789
D+KA NIL K+ADFG+S + T+ + GTP ++ PE
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS------------AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 790 LTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
+ D K+DV+SLG+ +E + ++P H N +R + + + +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIE-MAQIEPPHHELNPMRVL-------LKIAKSEPPT 227
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ PS +F KC + DAR + +++++
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 617 IGQGGYGKVYKGI-LPDGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 670
+G G +G V+KGI +P+G VA+K Q+ S Q +E + + L H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C Q LV + G+L D + + ++ L L+ + ++G+ YL
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ HR++ A NILL ++ADFG++ L PD + + T +K ++ E L
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSEHKTPIK----WMALESIL 184
Query: 791 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID----GNMG 845
+ T +SDV+S GV E+++ G +P Y V D G
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEP--------------YAGMRPHEVPDLLEKGERL 230
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
+ P C + +KC + + RP+ E+ E
Sbjct: 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 51/289 (17%)
Query: 617 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 671
IG+G +G+V K + DG + A+KR +E S ++F E++ L +L HH N+++L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSS 717
G C+ G L E+ +G L D L + L L A +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V V
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------------YV 166
Query: 778 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 831
K T G L + L T SDV+S GV+ E+++ G P G
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTC-------- 217
Query: 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
+ + + G P C ++ L +C +++ RPS ++++ L
Sbjct: 218 -AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-16
Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 39/288 (13%)
Query: 606 LATNNFNSSTQIGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFL 659
L F +G G +G VYKG+ +P+G VA+K +E S + KE L E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 660 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 719
+ + + ++ L+G C Q L+ + M G L D + + K+ +G L+ + ++G
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKG 121
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVS 774
+ YL + + HRD+ A N+L+ K+ DFGL++L + E G VP
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-- 176
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 833
++ E L T +SDV+S GV EL+T G +P +
Sbjct: 177 --------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----------GIPA 217
Query: 834 SMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
S + S+++ G P C + +KC + D+RP E++ E
Sbjct: 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 54/284 (19%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLV 671
++G+G YG V K +P GT++AVKR A S Q +K L ++ R + V+
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP--------LGFAMRLSIALGSSRGILYL 723
G EG+ + E M T D+ K + LG IA+ + + YL
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYL 119
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVKGTPG 782
H++ V HRD+K SN+L++ K+ DFG+S G +V + T+ G
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS---------GYLVDSVAKTIDAGCKP 168
Query: 783 YLDPEYF---LTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838
Y+ PE L K D KSDV+SLG+ +EL TG P K +++
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK---------Q 219
Query: 839 VIDGN-----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 877
V++ + E + F+ KC + RP+ E++
Sbjct: 220 VVEEPSPQLPAEKFSPEFQD-FVN---KCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 74/277 (26%), Positives = 116/277 (41%), Gaps = 28/277 (10%)
Query: 609 NNFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHH-R 665
N+ + +IG G G+VYK G V+AVK+ + G+ + K L ++ + + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
+V GY + + + E MS T D+L + + P+ + + + + + YL
Sbjct: 75 YIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ V HRD+K SNILLD K+ DFG+S RL V + T G Y+
Sbjct: 133 KHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL---------VDSKAKTRSAGCAAYM 181
Query: 785 DPEYFLTHKLTDK----SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
PE K +DV+SLG+ +EL TG P + K + Q +
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--PSL 239
Query: 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 877
N G P F C + RP E++
Sbjct: 240 PPNEGFSP-----DFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 610 NFNSSTQIGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKEF-LTEIQFLSRLHHRN 666
+ +IG+G +GK+Y K V + EKE E+ L+++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+V+ E G +V E+ G L +++ + LS + S G+ ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-- 118
Query: 727 ADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
D + HRDIK+ NI L AK+ DFG++R + D ++ GTP YL
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LND-----SMELAYTCVGTPYYLS 170
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE +K+D++SLG V EL T P
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 65/279 (23%), Positives = 125/279 (44%), Gaps = 26/279 (9%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA---QEGSLQGEK---EFLTEIQFLSRL 662
+ Q+G G + Y+ + GT++AVK+ + S + E+ EI+ ++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 663 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 722
+H +++ ++G E+ L E+M+ G++ LS A+ ++ RG+ Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSY 118
Query: 723 LHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGT 780
LH + + HRD+K +N+L+D ++ADFG + RLA G + GT
Sbjct: 119 LH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA--AKGTG--AGEFQGQLLGT 171
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
++ PE + DV+S+G V +E+ T P + + +++F +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-------AEKHSNHLALIFKIA 224
Query: 841 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
S P + L+C + + + RP E+++
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 40/267 (14%)
Query: 635 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 693
+VAVK + + + +FL EI+ +SRL + N++ L+G C + ++ E+M NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 694 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDH 745
LS + E F +I S +LY+ + A HRD+ N L+ +
Sbjct: 106 QFLSQREIES-TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 746 KFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 800
+T K+ADFG+SR D I+G ++P ++ E L K T SDV
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMAWESILLGKFTTASDV 214
Query: 801 YSLGVVFLEL--LTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-----SYPSECVE 853
++ GV E+ L QP S ++ + + + F N G S C
Sbjct: 215 WAFGVTLWEMFTLCKEQPYS----LLSDEQVIENTGEFFR----NQGRQIYLSQTPLCPS 266
Query: 854 KFIKLALKCCQDETDARPSMSEVMREL 880
KL ++C + RP+ +++ L
Sbjct: 267 PVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-15
Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 30/240 (12%)
Query: 653 LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 712
+EI + +L H N+V L+G C E L++E++ L + L S E R I
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWE-----RRRKI 785
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772
A+G ++ + +LH P V ++ I++D K + RL+ P
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSL--------PGL 831
Query: 773 VSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN--IVRE 826
+ T K + Y+ PE T +T+KSD+Y G++ +ELLTG P G + IV
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
Query: 827 VNIAYQSSMMFSVID----GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
Y + ID G++ +E VE + LAL C + ARP ++V++ LES
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 666
F+ +IG G +G VY + + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+ G E LV E+ G+ D L K+PL ++ G+ +G+ YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRD+KA NILL K+ DFG + + + PA+ GTP ++ P
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASI--------MAPANXFV---GTPYWMAP 180
Query: 787 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPI 817
E L + K DV+SLG+ +EL P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 83/274 (30%), Positives = 121/274 (44%), Gaps = 38/274 (13%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 671
+IG G G VYK I P G + A+K E +++ ++ EI+ L ++H N+V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPNVVKCH 138
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-LSIALGSSRGILYLHTEADPP 730
D GE ++ EFM G+L A + A + LS GI YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLHRRH--- 188
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
+ HRDIK SN+L++ K+ADFG+SR LA D P + S GT Y+ PE
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----PCNSSV---GTIAYMSPERI 240
Query: 790 ---LTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
L H D D++SLGV LE G P G+ +S+M ++
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWASLMCAICMSQP 293
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
P+ +F C Q E R S ++++
Sbjct: 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-15
Identities = 79/231 (34%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS-LELLLLNGNELTGSLP 147
LNLN + E+ L+ LT LD N I+ IP IG +KS L+ L L+ N++ SLP
Sbjct: 99 DLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP 156
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207
L LP L + + N +S LPK +NL+ + ++ N IS +PPE+ L +L +
Sbjct: 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214
Query: 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267
L NN++ L LS L L L+L NN + +P S N+S L L L N
Sbjct: 215 DLSNNSIIE-LLSSLSNLKNLSGLELSNN--KLEDLPESIGNLSNLETLDLSNNQ----- 266
Query: 268 PDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318
+S I +LG L +L + LS N L+ +P L L+ L +L
Sbjct: 267 --ISSISSLGSLTNL--RELDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313
|
Length = 394 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 83/320 (25%), Positives = 132/320 (41%), Gaps = 41/320 (12%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 664
TN + +G G +G V G VA+K+ + + K E++ L L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 665 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
N++SL E + V E + L L+++ E L L RG+ Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL---RGLKYV 124
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H+ V HRD+K SNIL++ K+ DFGL+R+ P + G V T Y
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYV---------STRYY 171
Query: 784 LDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
PE LT K + D++S G +F E+L G +P+ GK+ V + FS+I
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQ----------FSIITD 220
Query: 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 902
+G+ P + + C + T R S RE +D + +
Sbjct: 221 LLGTPPDDVINTI-------CSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272
Query: 903 TSKEETPPSSSSMLKHPYVS 922
+ S++ L HPY++
Sbjct: 273 VFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 616 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNL 667
+IG+G YG VYK D +A+K+ + L+ E E + EI L + H N+
Sbjct: 9 KIGEGTYGVVYKA--RDRVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLH 724
V L E LV+E++ + L+ + + +K P L L RGI Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH 119
Query: 725 TEADPPVFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
+ V HRD+K N+L+D + A K+ADFGL+R +P V VV T Y
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-----VRTFTHEVV--TLWY 169
Query: 784 LDPEYFL-THKLTDKSDVYSLGVVFLELLT 812
PE L + + D++S+G +F E++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHR 665
NF +IG+G + +VY+ L DG VA+K+ Q L K + + EI L +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 721
N++ E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
++H+ V HRDIK +N+ + K+ D GL R AH + GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHS---LVGTP 170
Query: 782 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
Y+ PE + KSD++SLG + E+ P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 611 FNSSTQIGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 668
F +IG+G +G+VYKGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
G + + ++ E++ G+ D L E A L L +G+ YLH+E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSERK 122
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
HRDIKA+N+LL + K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
K+D++SLG+ +EL G P S
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+GG+G+V + G + A K+ + L +GE+ L E + L ++ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ + + LV M+ G L+ + + A + A G+ +LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
+RD+K N+LLD +++D GL+ +++G GTPGY+ PE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRA---GTPGYMAPEVLQGE 169
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPI-SHGKNIVRE 826
D ++LG E++ G P + + +E
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 668
F +IG+G +G+V+KGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
G ++ + ++ E++ G+ D L + A L L +G+ YLH+E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 122
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
HRDIKA+N+LL K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN----M 844
K+D++SLG+ +EL G P S + ++F + N
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSE----------LHPMKVLFLIPKNNPPTLE 222
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
G+Y S+ +++F++ C E RP+ E+++
Sbjct: 223 GNY-SKPLKEFVE---ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 45/222 (20%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEG----SLQGEKEFLTEIQFLSRLHHRNLV 668
+IG G YG VYK + G +VA+K + + G +Q E I L H N+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE------ISMLKECRHPNIV 63
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHT 725
+ G + +V E+ G+L+D ++ PL L IA + +G+ YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----G 779
HRDIK +NILL K+ADFG+S A ++ T+ K G
Sbjct: 120 TG---KIHRDIKGANILLTEDGDVKLADFGVS-------------AQLTATIAKRKSFIG 163
Query: 780 TPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPIS 818
TP ++ PE + K D+++LG+ +EL P+
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEF------------LTEIQFLSR 661
+G+G YGKV K G +VA+K+ + E S K+ L E++ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALG 715
+ H N++ LV E LV + M+ L+ + K +RL+ I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--------IRLTESQVKCILLQ 127
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH--- 772
G+ LH HRD+ +NI ++ K K+ADFGL+R P +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 773 ------VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 825
S VV T Y PE + K D++S+G +F ELLTG +P+ G+N +
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEID 241
Query: 826 E 826
+
Sbjct: 242 Q 242
|
Length = 335 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 674
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 675 DEEG-----EQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
++ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 131
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 132 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 182
Query: 789 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 817
+ D KSD++SLG+ +E+ G P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSL--- 670
IG+G YG V P G VA+K+ E ++ L EI+ L R H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDI 71
Query: 671 --VGYCDEEGEQMLVYEFMSNG---TLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLH 724
+ + +V E M ++ Q LS + + + RG+ Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL--------RGLKYIH 123
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGY 783
+ A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 124 S-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-----TRWY 175
Query: 784 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 821
PE L K K+ D++S+G + E+L+ +P+ GK
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 617 IGQGGYGKVYKGIL-PDGTVVAVKR---------AQEGSLQGEKEFLTEI--QFLSRLHH 664
+G GG+G+V + A+K Q+ + EKE L E F+ +L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF---AMRLSIALGSSR 718
+ D++ ML+ E+ G L L + + F + L+ +R
Sbjct: 61 T-------FKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
GI+Y RD+K N+LLD K+ DFG ++ ++ T
Sbjct: 113 GIIY-----------RDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTW--TFC- 153
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
GTP Y+ PE L D +SLG++ ELLTG P
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 617 IGQGGYGKVYKGIL-PDGTV--VAVKRAQEG-SLQGEKE-FLTEIQFLSRLHHRNLVSLV 671
+G+G +G V +G L D ++ VAVK + + E E FL+E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 672 GYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSIALGS--SRGIL 721
G C + E +++ FM +G L L S P ++ + + + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
YL +++ HRD+ A N +L+ VADFGLS+ D + K
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-----YRQGRIAKMPV 178
Query: 782 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840
++ E T KSDV+S GV E+ T G P +N S + +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----------SEIYDYLR 228
Query: 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
GN P +C++ L C RPS + ELE
Sbjct: 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 619 QGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVG 672
+G +G+++ GIL D V VK ++ + + + L E L L H+N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 673 YCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGILYLHT 725
C E+GE ++Y +M+ G L+ L LS +A+ + G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAP-----VPDIEGIVPAHVSTVVKG 779
V H+DI A N ++D + K+ D LSR L P + D E + VK
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE-------NRPVK- 184
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 816
++ E + + + SDV+S GV+ EL+T G P
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 29/278 (10%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHR 665
NF +IG+G + +VY+ L D VA+K+ Q + + ++ + EI L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 721
N++ + E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
++H+ V HRDIK +N+ + K+ D GL R AH S V GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAH-SLV--GTP 170
Query: 782 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841
Y+ PE + KSD++SLG + E+ P K +N+ S+ +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLF---SLCQKIEQ 222
Query: 842 GNMGSYPSE-CVEKFIKLALKCCQDETDARPSMSEVMR 878
+ P+E EK +L C + D RP + V +
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 615 TQIGQGGYGKVYKGILPD-GTVVAVKR--AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 671
++IG+G YG V+K + G +VA+K+ E +K L EI+ L +L H NLV+L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 727
+ + LV+E+ + T+ ++L K P G + + I++ +A
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELE---KNPRG------VPEHLIKKIIWQTLQAVNFC 116
Query: 728 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
HRD+K NIL+ + K+ DFG +R+ P + T T Y P
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-------YTDYVATRWYRAP 169
Query: 787 EYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 821
E + + DV+++G VF ELLTG QP+ GK
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 47/285 (16%)
Query: 614 STQIGQGGYGKV-YKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH- 663
S +G G G V + DG AVK A + Q E L F S +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 664 HRNLVSLVGYCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIAL 714
H + D + LV ++ + G LR ++ +++K F A L I +
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL--APVPDIEGIVPAH 772
+L +H + HRDIK++NILL K+ DFG S++ A V D
Sbjct: 153 -----LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD-------D 200
Query: 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832
V GTP Y+ PE + + K+D++SLGV+ ELLT +P G+N+ EV
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-GENM-EEV----- 253
Query: 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 877
M + G P + ++ + RPS S+++
Sbjct: 254 ---MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 36/271 (13%)
Query: 617 IGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 671
+G G +G++ +G L VA+ + G S + + FL E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G M+V E+MSNG L D K + L + + G + G+ YL ++
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYF 789
H+ + A +L++ K++ F RL E I T + G L PE
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RL-QEDKSEAIY-----TTMSGKSPVLWAAPEAI 180
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
H + SDV+S G+V E+++ G +P +S ++ +V DG
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------------QDVIKAVEDGFRL 227
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEV 876
P C +L L C Q E RP S++
Sbjct: 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY- 673
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 674 -----CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
+ + LV EF G++ D + L I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK- 141
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 142 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 192
Query: 789 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 817
+ D +SD++SLG+ +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 655 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 714
E L+++ H N+V+ + +G +V E+ G L ++ + + L +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
G+ ++H + V HRDIK+ NI L K+ DFG +RL P A+
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP------GAYAC 158
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIVREV 827
T V GTP Y+ PE + +KSD++SLG + EL T P KN++ +V
Sbjct: 159 TYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 603 EMALATNNFNSSTQIGQGGYGKVYKGIL-------PDGTVV--AVKRAQEGSLQGEKEFL 653
E+ L+T F ++G+ +GKVYKG L V +K EG L+ +EF
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFK 56
Query: 654 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------- 700
E SRL H N+V L+G +E +++ + S+ L + L +S
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 701 -KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759
K L A + I + G+ +L + V H+D+ N+L+ K K++D GL R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 818
D ++ + + ++ PE + K + SD++S GVV E+ + G+QP
Sbjct: 174 VYAADYYKLMGNSLLPI-----RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 819 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
N ++V ++ + P +C L L+C + RP ++
Sbjct: 229 GYSN--QDVIEMIRNRQVLPC--------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278
Query: 879 ELES 882
L +
Sbjct: 279 RLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 672
+G+G +GKV L G + AVK ++ + + + +TE + LS + ++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 673 YCDEEGEQML-VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALGSSRGILYLHTEA 727
C + +++ V EF++ G L Q S + E +A ++ AL ++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL------MFLH--- 113
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
D + +RD+K N+LLDH+ K+ADFG+ + EGI ++ GTP Y+ PE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTPDYIAPE 166
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
D +++GV+ E+L G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 617 IGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSL 670
+GQG +GKV+ K PD G + A+K ++ +L+ T E L+ ++H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM-RLSIALGS--SRGILYLH 724
EG+ L+ +F+ G L +LS + ++E + F + L++AL S GI+Y
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY-- 121
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
RD+K NILLD + K+ DFGLS+ E I + GT Y+
Sbjct: 122 ---------RDLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYSFCGTVEYM 165
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
PE T +D +S GV+ E+LTG P GK+
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 616 QIGQGGYGKVYKGILPDGTVVA---VKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
+IG G +GKV G G A VK + + E+ FL E+Q L+H N++ +
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIALGSSRGILYLHTEAD 728
G C E +LV EF G L++ L + A + +A + G+L+LH +AD
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP-- 786
H D+ N L + K+ D+GL+ D H + P ++
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 818
+ L T KS+++SLGV EL T QP
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 64/208 (30%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 616 QIGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---HRNLVS 669
+IG G YG VYK P G VA+K R Q + E+ L RL H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 670 LVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
L+ C D E + LV+E + LR L L + RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGY 783
+ HRD+K NIL+ K+ADFGL+R I ++ T V T Y
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTPVVVTLWY 173
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELL 811
PE L D++S+G +F E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 666
++ +IG+G G V I D G VAVK+ Q + E+ + H N
Sbjct: 20 YLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGI 720
+V + E +V EF+ G L D ++ R++ + L + +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKAL 128
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
+LH + V HRDIK+ +ILL K++DFG + VP S V GT
Sbjct: 129 SFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GT 178
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
P ++ PE + D++SLG++ +E++ G P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 71/224 (31%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 616 QIGQGGYGKVYKGILPDG---TVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLV 671
+IG G +GKV G + G V VK + S+Q + +FL E Q L H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFA-MRLSIALGSSRGILYLH 724
G C E +LV EF G L+ L + K +P M IAL G+L+LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL----GLLHLH 117
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GY 783
H D+ N LL T K+ D+GLS D +V+ P +
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY------YVTPDQLWVPLRW 168
Query: 784 LDPEY-------FLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 819
+ PE L T +S+V+SLGV EL G QP H
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 606 LATNNFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 663
L ++F +++G G G V K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
+V G +GE + E M G+L L + P ++SIA+ RG+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYL 119
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 817
+ PE + +SD++S+G+ +EL G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 616 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IG+G G V G VAVK+ Q + E+ + HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E +V EF+ G L D ++ A ++ L R + YLH + V HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLHNQG---VIHR 142
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
DIK+ +ILL K++DFG + VP S V GTP ++ PE
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGF-----CAQVSKEVPKRKSLV--GTPYWMAPEVISRLPY 195
Query: 795 TDKSDVYSLGVVFLELLTGMQP 816
+ D++SLG++ +E++ G P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 614 STQIGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRL---HH 664
+IG+G YG VYK L G VA+K+ ++EG L EI L +L H
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEH 60
Query: 665 RNLVSLVGYC-----DEEGEQMLVYEFMSN--GTLRDQLSAK--SKEPLGFAMRLSIALG 715
N+V L+ C D E + LV+E + T + E + MR +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL--- 117
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 775
RG+ +LH+ + HRD+K NIL+ K+ADFGL+R I A S
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTSV 166
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 810
VV T Y PE L D++S+G +F EL
Sbjct: 167 VV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 45/238 (18%)
Query: 609 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSR 661
+ + +IGQG +G+V+K +VA+K+ ++ EKE F L EI+ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKT-KQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 662 LHHRNLVSLVGYCDEEGEQ--------MLVYEF--------MSNGTLRDQLSAKSKEPLG 705
L H N+V+L+ C + LV+EF +SN ++ LS K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--- 124
Query: 706 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765
M L+ G+ Y+H + HRD+KA+NIL+ K+ADFGL+R A
Sbjct: 125 MKMLLN-------GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR-AFSLSK 173
Query: 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKN 822
+ + VV T Y PE L + D++ G + E+ T PI G
Sbjct: 174 NSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 71/277 (25%)
Query: 610 NFNSSTQIGQGGYGKVY----KG--------------ILPDGTVVAV---KRAQEGSLQG 648
+FN +G+G +GKV KG I+ D V KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL--ALPG 58
Query: 649 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL--RDQLSAKSKE 702
+ FLT++ Q + RL+ V E+++ G L Q K KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYHIQQVGKFKE 100
Query: 703 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---- 149
Query: 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK- 821
E I + GTP Y+ PE D ++ GV+ E+L G QP G+
Sbjct: 150 ---ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG-QPPFDGED 205
Query: 822 -----NIVREVNIAYQSSM---MFSVIDGNMGSYPSE 850
+ E N++Y S+ S+ G + +P++
Sbjct: 206 EDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAK 242
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 616 QIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVS 669
+IG+G +GK IL DG +K + ++ E E+ LS + H N+V
Sbjct: 7 KIGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYL 723
+E G +V ++ G L +++A+ + L + +++ +AL ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HV 117
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H D + HRDIK+ NI L T K+ DFG++R+ + V ++ GTP Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV-----LNSTV--ELARTCIGTPYY 167
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIV 824
L PE +KSD+++LG V E+ T G KN+V
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 606 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 663
L ++F +++G G G V+K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
+V G +GE + E M G+L L + P ++SIA+ +G+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYL 119
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 817
+ PE + +SD++S+G+ +E+ G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-13
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 28/283 (9%)
Query: 654 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 713
+E+ L+ H +V + + +L+ E+ S G L Q+ + KE L F +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEVG 172
Query: 714 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773
L + +L L + HRD+K++NI L K+ DFG S+ V V
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-----QYSDSVSLDV 227
Query: 774 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 833
++ GTP YL PE + + + K+D++SLGV+ ELLT +P Q
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----------QR 277
Query: 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIWNMMPE-- 889
+M V+ G +P L RP+ +++ L+ + N+ +
Sbjct: 278 EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIV 337
Query: 890 --SDTKTP----EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926
S+T +P E + S E PP SS +++ V+SDV+
Sbjct: 338 RHSETISPHDREEILRQLQESGERAPPPSS--IRYGVVTSDVT 378
|
Length = 478 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNLVSLVGY 673
+IGQG G VY I + G VA+K+ Q +KE + EI + H N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 674 CDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRGILYL 723
E +V E+++ G+L D Q++A +E L + + +L
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------------QALEFL 131
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPG 782
H+ V HRDIK+ NILL + K+ DFG +++ P + ST+V GTP
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPY 180
Query: 783 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
++ PE K D++SLG++ +E++ G P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 616 QIGQGGYGKV-YKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IG+G G V + G +VAVK+ Q + E+ + H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E +V EF+ G L D ++ A ++ L + + LH + V HR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---AVCLAVLKALSVLHAQG---VIHR 140
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
DIK+ +ILL H K++DFG + VP S V GTP ++ PE
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GTPYWMAPELISRLPY 193
Query: 795 TDKSDVYSLGVVFLELLTGMQP 816
+ D++SLG++ +E++ G P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRN--- 666
+IG+G YGKVYK G +VA+K+ + L+ ++E L EI L L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTR---LEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 667 -LVSLVGYCDEEGEQM--LVYEFMSNGTLR--DQLSAKSKEPLGFAMRLSIALGSSRGIL 721
L+ + ++ G+ LV+E++ + + D PL S +G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 722 YLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
+ H V HRD+K N+L+D K K+AD GL R +P V ++ +V T
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP-----VKSYTHEIV--T 174
Query: 781 PGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPI 817
Y PE L TH T D++S+G +F E+ QP+
Sbjct: 175 LWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 671
IG+G +GKV DG AVK Q+ ++ +KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 672 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTE 726
Y + +++ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG------YLHSL 115
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ +RD+K NILLD + + DFGL + EGI + ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTSTFCGTPEYLAP 165
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
E D + LG V E+L G+ P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 611 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 666
F +G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+VSL + + LV M+ G L+ + + + A G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGY 783
+ +RD+K NILLD +++D GL+ VP+ I+G V GT GY
Sbjct: 122 R---IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV---------GTVGY 167
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-GKNIVRE 826
+ PE + T D ++LG + E++ G P K I RE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 74/280 (26%), Positives = 111/280 (39%), Gaps = 34/280 (12%)
Query: 615 TQIGQGGYGKVYKGIL---PDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G G +G V KG+ VAVK + + E L E + +L + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHT 725
++G C+ E MLV E G L L K ++S+ G+ YL
Sbjct: 61 MIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLE- 112
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ HRD+ A N+LL + AK++DFGLS+ + H VK +
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYA 166
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE +K + KSDV+S GV+ E + G +P K EV +S G
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIES--------GER 216
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884
P C + L C D RP + V L + +
Sbjct: 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 64/246 (26%), Positives = 100/246 (40%), Gaps = 56/246 (22%)
Query: 617 IGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKEFLTEIQFLSRLH 663
+G+G +GKV KG + AVK ++ EK L L+
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLA----LAG-K 54
Query: 664 HRNLVSLVGYCDEEGEQML--VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALG-- 715
H L L + + + L V E+++ G L Q S + EP +A + + L
Sbjct: 55 HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 775
RGI+Y RD+K N+LLD + K+ADFG+ + EGI+ ++
Sbjct: 113 HERGIIY-----------RDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTS 154
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNI 829
GTP Y+ PE D ++LGV+ E+L G P G + + E +
Sbjct: 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEV 213
Query: 830 AYQSSM 835
Y +
Sbjct: 214 RYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 671
IG+G +GKV DG+ AVK Q+ ++ +KE + E L L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 672 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTE 726
Y + E++ V ++++ G L L + EP +A ++ A+G YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG------YLHSL 115
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ +RD+K NILLD + + DFGL + EG+ P ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGVEPEETTSTFCGTPEYLAP 165
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
E D + LG V E+L G+ P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 84/338 (24%), Positives = 128/338 (37%), Gaps = 96/338 (28%)
Query: 617 IGQGGYGKVYK----GI--LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 668
+G+G +GKV + GI VAVK +EG+ E K +TE++ L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 669 SLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRL- 710
+L+G C + G M++ E+ G L + L +K K+ G RL
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 711 ------------------------------------------SIALGSSRGILYLHTEAD 728
S + +RG+ +L A
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTP----GY 783
HRD+ A NILL K+ DFGL+R + PD V KG +
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------VRKGDARLPLKW 241
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
+ PE T +SDV+S GV+ E+ + G P G I E + +G
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQIDEEFCRRLK--------EG 292
Query: 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
P + + L C + + RP+ SE++ L
Sbjct: 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 37/98 (37%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
G+ LH + HRDIK N+L+D K+ DFGLSR G+
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-------GLENKKFV---- 154
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
GTP YL PE L SD +SLG V E L G P
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 70/289 (24%), Positives = 113/289 (39%), Gaps = 63/289 (21%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHH-RNLVSLVGY 673
IG+G +G V K + GT++AVKR + + E K L ++ + R +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 674 CDEEGEQMLVYEFMS--------------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 719
EG+ + E M + +++ K IA+ + +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------------IAVATVKA 119
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVK 778
+ YL E + HRD+K SNILLD K+ DFG+S G +V + T
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---------GQLVDSIAKTRDA 168
Query: 779 GTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835
G Y+ PE +SDV+SLG+ E+ TG P ++ ++
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT------- 221
Query: 836 MFSVIDGN---MGSYP----SECVEKFIKLALKCCQDETDARPSMSEVM 877
V+ G+ + + S FI L C + RP E++
Sbjct: 222 --QVVKGDPPILSNSEEREFSPSFVNFINL---CLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-12
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 54/224 (24%)
Query: 616 QIGQGGYGKVYKGILPD---GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHRNLV 668
++G+G YG V+K I D VVA+K+ A + ++ F EI FL L H N+V
Sbjct: 14 KLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 669 SLVGYCDEEGEQ--MLVYEFMSN--------GTLRD--------QLSAKSKEPLGFAMRL 710
L+ E ++ LV+E+M L D QL
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL------------- 117
Query: 711 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 770
+ + Y+H+ V HRD+K SNILL+ K+ADFGL+R + ++E
Sbjct: 118 -------KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS--LSELEENPE 165
Query: 771 AHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTG 813
V T T Y PE L + + T D++S+G + E+L G
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 59/265 (22%), Positives = 114/265 (43%), Gaps = 31/265 (11%)
Query: 625 VYKGILPDGTVV--AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY----CDEEG 678
+YKGI + V+ K+ +G EI+ L R+ N++ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 738
L+ E+ + G LR+ L K K+ L F +L +A+ +G+ L+ + P ++++ +
Sbjct: 96 RLSLILEYCTRGYLREVLD-KEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 739 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTD 796
+ L+ + K+ GL ++ P + +V+ +V Y + + T
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFK-----NVNFMV-----YFSYKMLNDIFSEYTI 201
Query: 797 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 856
K D+YSLGVV E+ TG P N+ + + N P +C +
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFE---------NLTTKEIYDLIINKNNSLKLPLDCPLEIK 252
Query: 857 KLALKCCQDETDARPSMSEVMRELE 881
+ C ++ RP++ E++ L
Sbjct: 253 CIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 33/229 (14%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS---- 669
IG+G YG V I G VA+K+ + + L EI+ L L H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 670 -LVGYCDEEGEQMLVYEFMSNG-----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
L E + +V+E M + D L+ + + + + R + Y+
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------RALKYI 119
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
HT VFHRD+K NIL + K+ DFGL+R+A A T T Y
Sbjct: 120 HTAN---VFHRDLKPKNILANADCKLKICDFGLARVA----FNDTPTAIFWTDYVATRWY 172
Query: 784 LDPEY---FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 829
PE F + K T D++S+G +F E+LTG +P+ GKN+V ++++
Sbjct: 173 RAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDL 219
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IGQG G V+ I + G VA+K+ ++ + EI + L + N+V+ +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E +V E+++ G+L D ++ + A ++ + + +LH V HR
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA---AVCRECLQALEFLHANQ---VIHR 139
Query: 735 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
DIK+ N+LL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 794 LTDKSDVYSLGVVFLELLTGMQP 816
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 81/322 (25%), Positives = 124/322 (38%), Gaps = 57/322 (17%)
Query: 616 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH---HR 665
+IG+G YGKV+K + G VA+KR + +Q +E + E+ L L H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 666 NLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
N+V L C D E + LV+E + L L + + + RG+
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
+LH+ V HRD+K NIL+ K+ADFGL+R+ T V T
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------QMALTSVVVT 172
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
Y PE L D++S+G +F E+ +P+ G + V Q + VI
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVD------QLGKILDVI 225
Query: 841 DGNMGSYPSECVEKFIKLALKCCQD--ETDARPSMSEVMRELESIWNMMPESDTKTPEFI 898
P E +D A P + + + I + + D + +
Sbjct: 226 -----GLPGE-------------EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 267
Query: 899 NSEHTSKEETPPSSSSMLKHPY 920
T S+ S L HPY
Sbjct: 268 LKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 617 IGQGGYGKVYKGILPDGT--VVAVKRAQEGSLQGEKEF---LTEIQFLS-RLHHRNLVSL 670
+G+G +GKV L GT V A+K ++ + + + +TE + L+ H L +L
Sbjct: 3 LGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLG--FAMRLSIALGSSRGILYLHTE 726
+ V E+++ G L Q+ S K EP +A +++AL ++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLHRH 115
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
V +RD+K NILLD + K+ADFG+ + EGI+ +T GTP Y+ P
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYIAP 165
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
E + D ++LGV+ E++ G P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 609 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSR 661
++F +G G +G+V +K G A+K A+ L+ + L E + L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS--IALGSSRG 719
+ H LV+L G ++ LV E++ G L L + P A + + L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA---- 113
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+ YLH+ + +RD+K N+LLD K+ DFG ++ V T+ G
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK---------RVKGRTYTLC-G 160
Query: 780 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
TP YL PE L K K+ D ++LG++ E+L G P
Sbjct: 161 TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 17/220 (7%)
Query: 611 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 666
F +G+GG+G+V + G + A KR ++ ++ GE L E Q L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+V+L + + LV M+ G L+ + L A G+ LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLD 785
+RD+K NILLD +++D GL+ P + I G V GT GY+
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMA 169
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 825
PE + T D + LG + E++ G P K V+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 63/246 (25%), Positives = 94/246 (38%), Gaps = 51/246 (20%)
Query: 609 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRA---------QEGSLQGEKEFLTE 655
++F IG+G +G+V+ L G V A+K Q ++ E++ L +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 656 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 715
+V L +E LV E+M G L + L K P A R IA
Sbjct: 58 A------DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIA-- 108
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS--------------RLAP 761
+L L + HRDIK NIL+D K+ADFGL
Sbjct: 109 --ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 762 VPDIEGIVPA---------HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 812
+ + ++ ++ V GTP Y+ PE + D +SLGV+ E+L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 813 GMQPIS 818
G P
Sbjct: 226 GFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 671
IG+G +GKV DG AVK Q+ + KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 672 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
Y + E++ V +F++ G L L + P A + + S+ G YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHSIN--- 116
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ +RD+K NILLD + + DFGL + EGI + +T GTP YL PE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQP 816
+ D + LG V E+L G+ P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 617 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 672
+G+GG+G+V + G + A K+ + L+ K + + E + L+++H R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEADPP 730
+ + LV M+ G LR + +E GF + + G+ +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ +RD+K N+LLD+ +++D GL+ +E + GTPG++ PE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-------VELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQP 816
+ D ++LGV E++ P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IGQG G VY I + G VA+K+ ++ + EI + + N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALDFLHSNQ---VIHR 139
Query: 735 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
DIK+ NILL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 794 LTDKSDVYSLGVVFLELLTGMQP 816
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 671
IG+G Y KV L + + + L + E + +Q F +H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
E V E+++ G L + + K P A S + S + YLH +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYLHERG---I 117
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 791
+RD+K N+LLD + K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 792 HKLTDKSDVYSLGVVFLELLTGMQP 816
D ++LGV+ E++ G P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 41/288 (14%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSR 661
T+ + IG+G YGKVYK DG++ AVK + ++ E L Q L
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNIL---QSLP- 76
Query: 662 LHHRNLVSLVG--YCDEE---GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIAL 714
+H N+V G Y ++ G+ LV E + G++ + + + L AM I
Sbjct: 77 -NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
G+ G+ +LH + HRD+K +NILL + K+ DFG+S + +
Sbjct: 136 GALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR------N 186
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPISHGKNIVREVNI 829
T V GTP ++ PE + D S DV+SLG+ +EL G P+ + I
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
Query: 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 877
+P + F +C + +ARPS++ ++
Sbjct: 246 PRNPPPTL--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 39/277 (14%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRN---LVSL 670
++G+G YG VYK + P G +A+K E L+ E +F I L LH +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMK---EIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEAD 728
G EG + E+M G+L D+L A G + I +G+ +L E +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
+ HRD+K +N+L++ K+ DFG+S G + A ++ G Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS---------GNLVASLAKTNIGCQSYMAPER 172
Query: 789 FLTHKLTD------KSDVYSLGVVFLELLTGMQPISHGKNIVREV--NIAYQSSMMFSVI 840
+ +SDV+SLG+ LE+ G P E NI Q S +++
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP------PETYANIFAQLS---AIV 223
Query: 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 877
DG+ + PS + KC + RP+ ++++
Sbjct: 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVG 672
IG+GG G+VY P VA+K+ +E + K FL E + + L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 673 YCDEEGEQMLVY---EFMSNGTLR---------DQLSAKSKEPLGFAMRLSIALGSSRGI 720
C + G+ VY ++ TL+ + LS + E LSI I
Sbjct: 70 ICSD-GD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL------------APVPDI--- 765
Y+H++ V HRD+K NILL + D+G + +I
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 812
+P + GTP Y+ PE L ++ +D+Y+LGV+ ++LT
Sbjct: 184 SMTIPGKIV----GTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 57/285 (20%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEG-SLQGEKEFLT-------------EIQFLSR 661
++G+G +G VY +V K+A L+ KE E Q LS+
Sbjct: 7 RLGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK 58
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALG 715
L H +V E ++ E+ L +L E + + LG
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 775
+ Y+H + HRD+KA NI L + K+ DFG+SRL + ++T
Sbjct: 119 ----VHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-------MGSCDLAT 163
Query: 776 VVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834
GTP Y+ PE L H+ D KSD++SLG + E+ + G+N + S
Sbjct: 164 TFTGTPYYMSPEA-LKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFL---------S 212
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA-RPSMSEVMR 878
++ +++G S P E + + ++ ++ + RPS +E++R
Sbjct: 213 VVLRIVEGPTPSLP-ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 68/222 (30%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 616 QIGQGGYGKVYKGILP-DGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
++G+G Y VYKGI +G +VA+K + +EG + E L L H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV---PFTAIREASLLKGLKHANIVLL 68
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG---FAMRLSIALGSSRGILYLHTEA 727
+ V+E+M D + P G + +RL RG+ Y+H +
Sbjct: 69 HDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQH 123
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HRD+K N+L+ + K+ADFGL+R +P + S VV T Y P+
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-----QTYSSEVV--TLWYRPPD 173
Query: 788 YFLTHKLTDKS---DVYSLGVVFLELLTGMQPISHGKNIVRE 826
L TD S D++ G +F+E+L G QP G + V E
Sbjct: 174 VLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 71/277 (25%)
Query: 610 NFNSSTQIGQGGYGKVY----KG--------ILPDGTVV---------AVKRAQEGSLQG 648
+FN +G+G +GKV KG IL V+ KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVL--ALSG 58
Query: 649 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKE 702
+ FLT++ Q + RL+ V E+++ G L Q+ + KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYQIQQVGRFKE 100
Query: 703 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---- 149
Query: 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
E + + GTP Y+ PE D ++ GV+ E+L G P G++
Sbjct: 150 ---ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-GED 205
Query: 823 ------IVREVNIAYQSSM---MFSVIDGNMGSYPSE 850
+ E N+AY SM ++ G M +P +
Sbjct: 206 EDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 656 IQFLSRLHHRNLVSLVGYCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 712
I+ L LH N +VG+ +GE + E M G+L L + P ++SI
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI 106
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772
A+ RG+ YL + + HRD+K SNIL++ + K+ DFG+S G +
Sbjct: 107 AV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDS 153
Query: 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 817
++ GT Y+ PE T +SD++SLG+ +E+ G PI
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 44/225 (19%)
Query: 611 FNSSTQIGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKE-FLTEI 656
F +G+G +GKV YK G + A+K ++G SL EK F T
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFET-- 55
Query: 657 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLS 711
+ H LV+L E V E+ + G L D S EP
Sbjct: 56 --ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAAC 109
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771
+ LG + YLH + + +RD+K N+LLD + K+ADFGL + EG+
Sbjct: 110 VVLG----LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-------EGMGFG 155
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
++ GTP +L PE T D + LGV+ E+L G P
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 617 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+GG+G+V + G + A K+ ++ ++ GE L E + L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 673 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--GILYLHTEADP 729
Y E + + LV M+ G L+ + GF + +I + G+ L E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDLQRER-- 122
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLDPEY 788
+ +RD+K NILLD + +++D GL+ P + + G V GT GY+ PE
Sbjct: 123 -IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---------GTVGYMAPEV 172
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 825
K T D + LG + E++ G P K V+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ---VIHR 140
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGYLDPEYFLTHK 793
DIK+ NILL + K+ DFG I P + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC--------AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 794 LTDKSDVYSLGVVFLELLTGMQP 816
K D++SLG++ +E++ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 617 IGQGGYGKV----YKGILPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVS 669
+GQG YG V + VA+K+ K L E++ L H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 670 LVG----YCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 723
L + E L E M L +S +PL A S G+ Y+
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEA-----DLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPG 782
H+ A+ V HRD+K N+L++ K+ DFGL+R + P G ++ V T
Sbjct: 122 HS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP---GENAGFMTEYV-ATRW 174
Query: 783 YLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVN 828
Y PE L+ + K+ DV+S+G + ELL G +P+ GK+ V ++N
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 36/205 (17%)
Query: 658 FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTL--RDQLSAKSKEPLGFAMRLSIAL 714
FL++LH C + +++ V E+++ G L Q K KEP I++
Sbjct: 62 FLTQLHS---------CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV 112
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
G + +LH + +RD+K N++LD + K+ADFG+ + E +V +
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTT 158
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVN 828
GTP Y+ PE D ++ GV+ E+L G QP G++ + E N
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG-QPPFDGEDEDELFQSIMEHN 217
Query: 829 IAYQSSM---MFSVIDGNMGSYPSE 850
++Y S+ S+ G M +PS+
Sbjct: 218 VSYPKSLSKEAVSICKGLMTKHPSK 242
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL- 670
+IG+G + +V K G A+K SL+ + L EIQ L RL H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLI 64
Query: 671 -VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
V + + G LV+E M + L + L K PL S + + ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
+FHRDIK NIL+ K+ADFG R GI T T Y PE
Sbjct: 121 -IFHRDIKPENILIK-DDILKLADFGSCR--------GIYSKPPYTEYISTRWYRAPECL 170
Query: 790 LTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828
LT K D++++G VF E+L+ + P+ G N + ++
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIA 209
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 616 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 672
++G+G Y VYKG L D +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
E LV+E++ + L+ L ++L + RG+ Y H V
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRRK---VL 126
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-T 791
HRD+K N+L++ + K+ADFGL+R +P + + VV T Y P+ L +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYSNEVV--TLWYRPPDILLGS 179
Query: 792 HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832
+ + D++ +G +F E+ TG +P+ G + +++ ++
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 617 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 672
IG+G +GKV + D + A+K ++ + E L E L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ LV F++ G L L + + L A + L + L V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL-----LCALENLHKFNVI 115
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
+RD+K NILLD++ + DFGL +L + + GTP YL PE L H
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL-------NMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 793 KLTDKSDVYSLGVVFLELLTGMQP 816
T D ++LGV+ E+LTG+ P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 25/258 (9%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT---EIQFLSRLHHR 665
+F +IG G YG VYK + G + A+K + L+ ++F EI + H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
N+V+ G + + EF G+L+D PL + ++ + +G+ YLH+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS 124
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ HRDIK +NILL K+ADFG+S I + S + GTP ++
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFI--GTPYWMA 174
Query: 786 PEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
PE + D++++G+ +E L +QP + +R + + +S+ +
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIE-LAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233
Query: 843 NMGSYPSECVEKFIKLAL 860
M S F+K+AL
Sbjct: 234 KMKW--SNSFHHFVKMAL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK----EFLTEIQFLSRLHHRNLVSLV 671
+G+G Y VYKG G +VA+K E L+ E+ + E L L H N+V+L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK---EIRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGILYLHTE 726
+ LV+E++ D G +M L L RG+ Y H
Sbjct: 70 DIIHTKKTLTLVFEYLD----TDLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCH-- 120
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
V HRD+K N+L+ + K+ADFGL+R VP + + VV T Y P
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-----SKTYSNEVV--TLWYRPP 172
Query: 787 EYFLTHKLTDKS---DVYSLGVVFLELLTGM 814
+ L T+ S D++ +G +F E+ TG
Sbjct: 173 DVLLGS--TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 671
IG+G Y KV L + + + L + E + +Q F + +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALG--SSRGILYLHT 725
E V EF+S G L + + K P ++ +S+AL RGI+Y
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY--- 119
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
RD+K N+LLD + K+ D+G+ + EGI P ++ GTP Y+
Sbjct: 120 --------RDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCGTPNYIA 164
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE D ++LGV+ E++ G P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 44/250 (17%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
IG G YG V I G VA+K+ K L E++ L H N++++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 674 CDEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGILYL 723
G +V + M + S +PL F +L RG+ Y+
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHH---IIHSDQPLTEEHIRYFLYQLL------RGLKYI 123
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--GIVPAHVSTVVKGTP 781
H+ A+ V HRD+K SN+L++ ++ DFG++R E + +V+T
Sbjct: 124 HS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR----- 175
Query: 782 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
Y PE L+ + T D++S+G +F E+L G + + GKN V +Q ++ SV
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV------HQLKLILSV- 227
Query: 841 DGNMGSYPSE 850
+GS E
Sbjct: 228 ---LGSPSEE 234
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 617 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 673 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI--ALGSSRGILYLHTEADP 729
Y E + + LV M+ G L+ + + GF ++ A + G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLHRER-- 122
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDP 786
+ +RD+K NILLD +++D GL+ +P+ I G V GT GY+ P
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV---------GTVGYMAP 170
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 825
E + T D + LG + E++ G P K V+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 671
IG+G Y KV L + + + L + E + +Q F + LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEA 727
LV E+++ G L + + K P +A + IAL +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------FLHERG 116
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ +RD+K N+LLD K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPGDTTSTFCGTPNYIAPE 166
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ D ++LGV+ E++ G P
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 616 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 672
++G+G Y V+KG L + +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEAD 728
+ LV+E++ D+ + + G M + RG+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
V HRD+K N+L++ + K+ADFGL+R VP + + VV T Y P+
Sbjct: 125 --VLHRDLKPQNLLINERGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYRPPDV 175
Query: 789 FL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832
L + + + + D++ +G +F E+ +G +P+ G + E+++ ++
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
G+ +LH++ + +RD+K NILLD K+ADFG+ + E ++ +
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK-------ENMLGDAKTCTFC 157
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
GTP Y+ PE L K D +S GV+ E+L G P HG +
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF-HGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---------QGEKEFLT---EIQFLSRLH 663
+G+G +GKV L G AVK ++ + EK L E FL+ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 664 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 721
YC + ++ L V EF++ G L + K + L A + + G+
Sbjct: 62 ---------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQ 110
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
+LH++ + +RD+K N++LD K+ADFG+ + E + + ++ GTP
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCGTP 160
Query: 782 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
Y+ PE K T D +S GV+ E+L G P HG +
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 617 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+GG+G+V + G + A K+ + L+ GEK L E + L +++ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ + LV M+ G L+ + + L + + + GIL+LH+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IV 117
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
+RD+K N+LLD + +++D GL+ + D + I T GT GY+ PE
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI------TQRAGTNGYMAPEILKEE 169
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 824
+ D +++G E++ G P K V
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 5e-10
Identities = 73/254 (28%), Positives = 104/254 (40%), Gaps = 58/254 (22%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG------SLQGEKE-----FLTEIQ 657
N + +IG G +G+V+ +V KR QE S +G KE + E+
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 658 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 715
+ L H+N+V + + Q L + EF G L + K + G +I +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAI-VD 122
Query: 716 SSRGIL----YLHTEADPP----VFHRDIKASNILLDH------KFTA-----------K 750
+R +L Y H D P V HRD+K NI L K TA K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFL 808
+ DFGLS+ + + AH GTP Y PE L T DKSD+++LG +
Sbjct: 183 IGDFGLSKNIGIESM-----AHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 809 ELLTGMQPISHGKN 822
EL +G P N
Sbjct: 235 ELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 13/184 (7%)
Query: 633 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692
G VAVK Q + E+ + H+N+V + E ++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 752
D +S A L + + YLH++ V HRDIK+ +ILL K++
Sbjct: 106 TDIVSQTRLNEEQIATVCESVL---QALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159
Query: 753 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 812
DFG I VP S V GTP ++ PE + D++SLG++ +E++
Sbjct: 160 DFGF-----CAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212
Query: 813 GMQP 816
G P
Sbjct: 213 GEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 36/225 (16%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLT-----EIQFLSRLHHRNLVS 669
++G+G YG VYK DG K +E +L Q E ++ EI L L H N+++
Sbjct: 8 KVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62
Query: 670 L--VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGIL 721
L V + + L++++ + + S +K+P+ +M S+ GI
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 722 YLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVST 775
YLH V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 776 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 819
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 30/211 (14%)
Query: 617 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 669
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF-AMRLSIALGSSRGILYLHT 725
L V E+ + G L LS + S++ F + ALG YLH+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHS 113
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 114 CD---VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYLA 163
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE + D + LGVV E++ G P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 664
+++ ++G G YG VYK L G + AVK + L+ +F EI + H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKH 65
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
N+V+ G + + E+ G+L+D PL + + +G+ YLH
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH 123
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
++ HRDIK +NILL K+ADFG++ I + S + GTP ++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVA-----AKITATIAKRKSFI--GTPYWM 173
Query: 785 DPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 816
PE K D++++G+ +E L +QP
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 616 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-- 670
++G+G YG VYK DG A+K+ + + EI L L H N++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 671 VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGILYLH 724
V + + L++++ + + S +K+P+ M S+ GI YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 725 TEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVSTVVK 778
V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----- 177
Query: 779 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 819
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPDGTV--VAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 664
+FN +G G +G+V + VA+KR ++ + +K+ +E + L+ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
V+L G +E LV EF+ G L + P +++ +L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIFE 145
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ +RD+K N+LLD K+ DFG ++ +V T+ GTP Y+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---------VVDTRTYTLC-GTPEYI 195
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE L +D ++LG+ E+L G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRN 666
+++ ++G+G Y VYKG +G +VA+K + +G + E L L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYL 723
+V L + LV+E++ D K P G ++L + RG+ Y+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYI 119
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H + HRD+K N+L+ K+ADFGL+R VP+H + T Y
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS-------VPSHTYSNEVVTLWY 169
Query: 784 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 823
P+ L + + + D++ +G +F+E++ G+ K+I
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 617 IGQGGYGKVYKGILPDGT----VVAVKRAQEGSL-QGEKEFL---TEIQFLSRLHHRNLV 668
+G+GGYGKV++ G + A+K ++ ++ + +K+ E L + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR---------LSIALGSSRG 719
L+ G+ L+ E++S G L L E G M +S+AL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALE---- 114
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+LH + + +RD+K NILLD + K+ DFGL + E I V+ G
Sbjct: 115 --HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVTHTFCG 162
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
T Y+ PE + D +SLG + ++LTG P +
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 616 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGY 673
++G+G Y V+KG +VA+K + +G + E+ L L H N+V+L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 674 CDEEGEQMLVYEFMSN---------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
E LV+E++ + G L + K F +L RG+ Y H
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-----FMFQL------LRGLSYCH 120
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ HRD+K N+L++ K K+ADFGL+R VP + + VV T Y
Sbjct: 121 KRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYR 170
Query: 785 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832
P+ L + + + D++ +G + E+ TG +P+ G + E+++ ++
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 37/229 (16%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
IG+G YG V + VA+K+ A + + K L EI+ L L H N++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA-KRTLREIKLLRHLDHENVIAIKD 71
Query: 673 YCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGIL 721
+ +VYE M T Q+ +S + L F +L RG+
Sbjct: 72 IMPPPHREAFNDVYIVYELMD--TDLHQI-IRSSQTLSDDHCQYFLYQLL------RGLK 122
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
Y+H+ A+ V HRD+K SN+LL+ K+ DFGL+R + + +V T
Sbjct: 123 YIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVV-----TR 172
Query: 782 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 829
Y PE L + T DV+S+G +F ELL G +P+ GK+ V ++ +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKL 220
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 611 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 667
+ + + +G G YG+V G VA+K+ S K E++ L + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 668 VSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 717
+ L V E LV M N ++ Q LS + L + +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL-------- 128
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
RG+ Y+H+ A + HRD+K SNI ++ K+ DFGL+R ++ G V
Sbjct: 129 RGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDD-EMTGYV-------- 176
Query: 778 KGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTG 813
T Y PE L H D++S+G + ELLTG
Sbjct: 177 -ATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDN L G++P ++S+L L + L N+ G IP S +++ L L L S G +P
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN-IPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 269 DLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLP 306
+ +LG L SL I + L+ N L+G +P+ G
Sbjct: 484 E-----SLGQLTSLRI--LNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
G+ +LH + + +RD+K N+LLD K+ADFG+ + E + ++
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK-------ENMNGEGKASTFC 157
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
GTP Y+ PE K + D +S GV+ E+L G P HG++
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-HGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLV 671
IG+G +GKV + AVK Q+ ++ + EK ++E L + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTEA 727
+ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG------YLHSLN 116
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ +RD+K NILLD + + DFGL + E I ++ GTP YL PE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTSTFCGTPEYLAPE 166
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
D + LG V E+L G+ P
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 77/339 (22%), Positives = 127/339 (37%), Gaps = 80/339 (23%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+G G G V+ + D VAVK+ Q K L EI+ + RL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSS-------- 717
VYE + S +E + + + G
Sbjct: 67 -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 718 -----RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPA 771
RG+ Y+H+ V HRD+K +N+ ++ K+ DFGL+R IV
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR---------IVDP 167
Query: 772 HVSTVVKG-------TPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 823
H S KG T Y P L+ + T D+++ G +F E+LTG +P+ G +
Sbjct: 168 HYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHE 224
Query: 824 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ ++ + +S + D N E + + R E R L
Sbjct: 225 LEQMQLILESVPVVREEDRN------ELL----------NVIPSFVRNDGGEPRRPLR-- 266
Query: 884 WNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922
+++P + + +F+ T ++ L HPY+S
Sbjct: 267 -DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 617 IGQGGYGKV----YKGILPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 669
+G G +G+V +KG G A+K + +E ++ + E L L H +V+
Sbjct: 26 LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 670 LV-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL---YLHT 725
++ + DE + EF+ G L L + P A L +L YLH+
Sbjct: 83 MMCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL-----VLAFEYLHS 136
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ + +RD+K N+LLD+K KV DFG ++ VP T+ GTP YL
Sbjct: 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK---------VPDRTFTLC-GTPEYLA 183
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE + D +++GV+ E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 8e-09
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 617 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 669
+G+G +GKV IL G A+K ++ + + E LTE + L H L S
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEA 727
L + V E+++ G L LS + F+ + G+ + YLH+
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSGK 115
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ +RD+K N++LD K+ DFGL + EGI A GTP YL PE
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCK-------EGITDAATMKTFCGTPEYLAPE 165
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ D + LGVV E++ G P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 73/300 (24%), Positives = 112/300 (37%), Gaps = 57/300 (19%)
Query: 618 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCD 675
+ K P T+VAVK+ S E K EI +L H N++ V
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPPVF 732
+ E +V M+ G+ D L K+ P G L+IA + Y+H++
Sbjct: 70 VDSELYVVSPLMAYGSCEDLL--KTHFPEGLP-ELAIAFILKDVLNALDYIHSKG---FI 123
Query: 733 HRDIKASNILLDHKFTAKVADFGLS--------RLAPVPDIEGIVPAHVSTVVKGTPGYL 784
HR +KAS+ILL ++ S R V D P + +L
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF----PKSSVKNLP----WL 175
Query: 785 DPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISH---GKNIVREVN---------- 828
PE L L +KSD+YS+G+ EL G P + ++ +V
Sbjct: 176 SPE-VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 829 --IAYQSSMMFSVIDGNMGSYPSECV---------EKFIKLALKCCQDETDARPSMSEVM 877
Y+ SM S N + V E F + C Q + ++RPS S+++
Sbjct: 235 TYPLYEDSMSQSR-SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 54/282 (19%)
Query: 610 NFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGS-LQGEK---EFLTEIQFLSR 661
NF +G G YGKV+ G G + A+K ++ + +Q K TE Q L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 662 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGS 716
+ LV+L + + L+ ++++ G L L + E + + +AL
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 717 --SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR--LAPVPD-------- 764
GI+Y RDIK NILLD + + DFGLS+ LA +
Sbjct: 121 LHQLGIIY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN 822
IE + P + G+ G+ D +SLGV+ ELLTG P + +N
Sbjct: 170 IEYMAPEVIRG---GSGGH-----------DKAVDWWSLGVLTFELLTGASPFTVDGEQN 215
Query: 823 IVREVN--IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKC 862
E++ I + + + +EK K L
Sbjct: 216 SQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 31/245 (12%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL 662
+F+ + +G+G +G+V ++ + G + A+K ++ L ++ F E LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 663 HHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAM-RLSIALGSSRGI 720
+ + L Y ++ + + LV E+ G L L+ + ++ M + +A +
Sbjct: 59 NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLA----ELV 112
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKG 779
L +H+ HRDIK N+L+D K+ADFG + RL +V S + G
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL----TANKMV---NSKLPVG 165
Query: 780 TPGYLDPEYFLTHKLTDKS------DVYSLGVVFLELLTGMQPISHGKNIVREVNI-AYQ 832
TP Y+ PE T K D +SLGV+ E++ G P G + NI +Q
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225
Query: 833 SSMMF 837
+ F
Sbjct: 226 RFLKF 230
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 49/226 (21%), Positives = 77/226 (34%), Gaps = 35/226 (15%)
Query: 122 IPKEIGNIKSLELLLLNGNEL------TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 175
+ + SL+ L L+ NE SL + L L + + N +
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 176 NLNKT---RHFHMNNNSISGQIPPEL-----SRLPSLVHMLLDNNNLTGY----LPPELS 223
+L ++ + +NNN + + L P+L ++L N L G L L
Sbjct: 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162
Query: 224 ELPKLLILQLDNNNFEGTTIPA---SYSNMSKLLKLSLRNCSL--QGPMPDLSRIPNLGY 278
L L L NN I A L L L N L +G L+
Sbjct: 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG-ASALA-----ET 216
Query: 279 LLSL-NITTIKLSNNKLTGTI-----PSNFSGLPRLQRLFIANNSL 318
L SL ++ + L +N LT + S L L ++ N +
Sbjct: 217 LASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVG-Y 673
IG+G YGKV+K + +G+ AVK + ++E E L L H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 674 CDEE---GEQM-LVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYL 723
++ G+Q+ LV E + G++ D + + +EP+ A L AL G+ +L
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-IAYILHEAL---MGLQHL 140
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H HRD+K +NILL + K+ DFG+S A + GTP +
Sbjct: 141 HVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTR-----LRRNTSVGTPFW 190
Query: 784 LDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPIS 818
+ PE + D + DV+SLG+ +EL G P++
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 617 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 669
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 670 LVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
L V E+ + G L R+++ ++ + + + AL YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALD------YLH 112
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+E + V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 113 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYL 163
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE + D + LGVV E++ G P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 616 QIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV- 671
IG G +G V+ P DG VA+K+ +L K E++ L H N++S +
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 672 ----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
+ D E +V E M + + +S + + L L RG+ YLH+
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSAG 123
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HRDIK N+L++ K+ DFGL+R+ PD + V T Y PE
Sbjct: 124 ---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE-PDESKHMTQEVVTQY-----YRAPE 174
Query: 788 YFL-THKLTDKSDVYSLGVVFLELLTG 813
+ + T D++S+G +F ELL
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 670
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 671 VGYCDEEGEQM-LVYEFMSNGTLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHT 725
+ Y +++ + + M+ G L LS KE +A + + G+ ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHN 115
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
V +RD+K +NILLD +++D GL+ D P H S GT GY+
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMA 163
Query: 786 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 821
PE D S D +SLG + +LL G P K
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 68/257 (26%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 658
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 659 LSRLHHRNLVSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSI- 712
+ +V L Y + E L+ E++ G + L K ++E F + +I
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS---RLAPVPDIEGIV 769
A+ S + Y+H RDIK N+LLD K K++DFGL + + + I+
Sbjct: 113 AIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 770 PAHV------------------------------STVVKGTPGYLDPEYFLTHKLTDKSD 799
+ STV GTP Y+ PE FL + D
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECD 221
Query: 800 VYSLGVVFLELLTGMQP 816
+SLGV+ E+L G P
Sbjct: 222 WWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 34/95 (35%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
YLH+ V +RDIK N++LD K+ DFGL + EGI GTP
Sbjct: 110 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTP 159
Query: 782 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
YL PE + D + LGVV E++ G P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQE----GSLQGEKEFLTEIQFLSRLHHRNLVSLV 671
+IG G +GKV + T VA +E S + + EFL + L H N++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLS-IALGSSRGILYLHTEADP 729
G C E +LV+E+ G L+ LS + + L +A + G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGL--SRLAP---VPDIEGIVPAHVSTVVKGTPGYL 784
H D+ N L T KV D+G+ SR + + VP +L
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----------WL 168
Query: 785 DPEY-------FLTHKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREV 827
PE +T + T S+V++LGV EL QP SH + REV
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REV 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLV 671
Q+G G YG V + G VA+K+ Q E K E++ L + H N++ L+
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 672 GY------CDEEGEQMLVYEFMSN--GTL--RDQLSAKSKEPLGFAMRLSIALGSSRGIL 721
D + LV FM G L ++LS + L + M +G+
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML--------KGLK 132
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
Y+H + HRD+K N+ ++ K+ DFGL+R ++ G V T
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVV---------TR 179
Query: 782 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
Y PE L T D++S+G + E+LTG +P+ G +
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 39/125 (31%), Positives = 63/125 (50%), Gaps = 9/125 (7%)
Query: 73 FNTTMDDGYLHLRELQLLNLN---LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F+ + L EL L L+ LSG + E+ L LD N++SG IP +
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
L L L+ N+L+G +P+ LG + L ++ I N++ GSLP + A L +N ++
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA------INASA 600
Query: 190 ISGQI 194
++G I
Sbjct: 601 VAGNI 605
|
Length = 968 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 620 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678
G G+V+ P V +K Q+G+ L E L ++H +++ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRM-------- 122
Query: 679 EQMLVYEFMS-------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
+ LV ++ + L L+ +S+ PL L I G+ YLH + +
Sbjct: 123 KDTLVSGAITCMVLPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---I 178
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPV--PDIEGIVPAHVSTVVKGTPGYLDPEYF 789
HRD+K NI ++ + D G ++ PV P G + GT PE
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG---------LAGTVETNAPEVL 228
Query: 790 LTHKLTDKSDVYSLGVVFLELL 811
K K+D++S G+V E+L
Sbjct: 229 ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 59/250 (23%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQFL 659
+F S IG+G +G+V D G V A+K + Q G ++ E++ L E L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 660 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGS 716
+V + ++ L+ EF+ G + L K ++E F +
Sbjct: 62 W------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYI-------- 107
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-------RLAPVPDIEGIV 769
+ +L + + HRDIK N+LLD K K++DFGL R ++ +
Sbjct: 108 AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 770 PAH-----------------------VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 806
P+ STV GTP Y+ PE F+ D +SLGV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 807 FLELLTGMQP 816
E+L G P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 64/250 (25%), Positives = 109/250 (43%), Gaps = 25/250 (10%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHR 665
N F +G+G YG V K + +VA+K+ + E + + ++ L E++ L L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
N+V L G+ LV+E++ ++ L + P G + + I +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVE----KNMLELLEEMPNG-VPPEKVRSYIYQLIKAIHW 115
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ HRDIK N+L+ H K+ DFG +R EG + V T Y
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS----EGSNANYTEYV--ATRWYRS 169
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
PE L D++S+G + EL G QP+ G++ + + +F+ I +G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQ---------LFT-IQKVLG 218
Query: 846 SYPSECVEKF 855
P+E ++ F
Sbjct: 219 PLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 59/281 (20%), Positives = 114/281 (40%), Gaps = 44/281 (15%)
Query: 616 QIGQGGYGKVYKGILPDG--TVVAVKRA-----QEGSLQGEKE-----FLTEIQFL-SRL 662
+G G +G VYK + ++A+K G + E++ ++E+ + +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 663 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSK-----EPLGFAMRLSIALGS 716
H N+V E +V + + L + ++ K K E + + + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 776
+ YLH E + HRD+ +NI+L + DFGL++ P T
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ--------PESKLTS 172
Query: 777 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836
V GT Y PE +K+DV++ G + ++ T +QP + N++ S+
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNML---------SLA 222
Query: 837 FSVIDGNMGSYPSECVEKFIKLALK-CCQDETDARPSMSEV 876
+++ P + + + C + +ARP + +V
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 12/89 (13%)
Query: 733 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 791
HRD+K N+LLD K+ADFG ++ D G+V T V GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM----DANGMV--RCDTAV-GTPDYISPEVLKS 217
Query: 792 HKLTD----KSDVYSLGVVFLELLTGMQP 816
+ D +S+GV E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 1/91 (1%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+D + +D + G +P + L + +++ NSI G IPP L + SL + L N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
G +P L +L L IL L+ N+ G +PA+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSG-RVPAA 509
|
Length = 623 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 45/224 (20%)
Query: 610 NFNSSTQIGQGGYGKVYKG------------ILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 657
+ +G G +G+V+ ++ V+ +K QE + EK L E+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK--QEQHVHNEKRVLKEVS 59
Query: 658 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 715
H ++ L + E ++ L + E++ G L L + F+ +
Sbjct: 60 ------HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYA 107
Query: 716 SS--RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773
S + YLH++ + +RD+K NILLD + K+ DFG ++ + D
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRD--------R 154
Query: 774 STVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
+ + GTP YL PE + K +K+ D ++LG++ E+L G P
Sbjct: 155 TWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 58/187 (31%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 638 VKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 695
+KRA+ + E+ L + Q+++ LH+ +E LV ++ G L
Sbjct: 40 LKRAETACFREERNVLVNGDCQWITTLHYA--------FQDENYLYLVMDYYVGGDLLTL 91
Query: 696 LSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 754
LS + + P A R IA +L +H+ HRDIK N+LLD ++ADF
Sbjct: 92 LSKFEDRLPEDMA-RFYIA----EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF 146
Query: 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLE 809
G S L D G V S+V GTP Y+ PE K + D +SLGV E
Sbjct: 147 G-SCLKMNQD--GTVQ---SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 810 LLTGMQP 816
+L G P
Sbjct: 201 MLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 743
Y+ ++ +++ LS E L LS +RG+ +L A HRD+ A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 744 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV-KGTP----GYLDPEYFLTHKLTDKS 798
K+ DFGL+R DI H S V KG+ ++ PE + T S
Sbjct: 271 AQGKIVKICDFGLAR-----DI-----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS 320
Query: 799 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKL 858
DV+S G++ E+ + + + IV S+ + G + P ++ +
Sbjct: 321 DVWSYGILLWEIFS-LGGTPYPGMIV-------DSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 859 ALKCCQDETDARPSMSEVMRELESI 883
+KC E + RPS + +ES+
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 672
IG+G +G+VY+ D + A+K + + +KE + E L R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 673 Y---CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
+ + LV ++MS G L L + + A + IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIA----ELVLALEHLHKY 115
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
+ +RD+K NILLD + DFGLS+ ++ + GT YL PE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK----ANLTD---NKTTNTFCGTTEYLAPEVL 168
Query: 790 LTHK-LTDKSDVYSLGVVFLELLTGMQP 816
L K T D +SLGV+ E+ G P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 41/126 (32%), Positives = 59/126 (46%), Gaps = 19/126 (15%)
Query: 256 LSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 315
L L N L+G +P+ I L +L S+N LS N + G IP + + L+ L ++
Sbjct: 423 LGLDNQGLRGFIPN--DISKLRHLQSIN-----LSGNSIRGNIPPSLGSITSLEVLDLSY 475
Query: 316 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR-LRGNPFCLNTN 374
NS +GSIP S+ Q +L IL+ N+L S +P + R L F N
Sbjct: 476 NSFNGSIPESLGQLTSLR-----ILNLNGNSL-----SGRVPAALGGRLLHRASFNFTDN 525
Query: 375 AEQFCG 380
A CG
Sbjct: 526 A-GLCG 530
|
Length = 623 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 670
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 671 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
+ Y +++ + + M+ G L LS G + ++ IL L +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
V +RD+K +NILLD +++D GL+ D P H S GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMAPEVL 167
Query: 790 LTHKLTDKS-DVYSLGVVFLELLTGMQP 816
D S D +SLG + +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 701 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 759
K PL + + +RG+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 760 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 814
PD V KG+ ++ PE T +SDV+S GV+ E+ + G
Sbjct: 225 YKDPDY----------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274
Query: 815 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 874
P G I E + DG P + ++ L C Q + RP+ S
Sbjct: 275 SPYP-GVQINEEFCQRLK--------DGTRMRAPENATPEIYRIMLACWQGDPKERPTFS 325
Query: 875 EVMREL 880
++ L
Sbjct: 326 ALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 666
+ S Q+G G YG V I G VA+K+ Q E K E+ L + H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 667 LVSLVGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
++ L+ DE + LV +M + S++ + + + + G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML-----CGL 130
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
Y+H+ + HRD+K N+ ++ K+ DFGL+R A ++ G V T
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVV---------T 177
Query: 781 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 813
Y PE L +++ D++S+G + E+LTG
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 35/89 (39%), Positives = 44/89 (49%), Gaps = 11/89 (12%)
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-- 790
HRDIK N+LLD ++ADFG S L + D G V S V GTP Y+ PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG-SCLRLLAD--GTV---QSNVAVGTPDYISPEILQAM 178
Query: 791 ---THKLTDKSDVYSLGVVFLELLTGMQP 816
+ + D +SLGV E+L G P
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 67/266 (25%), Positives = 96/266 (36%), Gaps = 89/266 (33%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQ- 657
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 658 ------FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM 708
F S RNL L+ EF+ G + L K S+E F +
Sbjct: 61 AWVVKMFYSFQDKRNL-------------YLIMEFLPGGDMMTLLMKKDTLSEEATQFYI 107
Query: 709 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768
+ +L + HRDIK N+LLD K K++DFGL G+
Sbjct: 108 --------AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC--------TGL 151
Query: 769 VPAH--------------------------------------VSTVVKGTPGYLDPEYFL 790
AH STV GTP Y+ PE F+
Sbjct: 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV--GTPDYIAPEVFM 209
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQP 816
D +SLGV+ E+L G P
Sbjct: 210 QTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 179
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 813
T Y PE L + D++S+G + E++ G
Sbjct: 180 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-06
Identities = 19/40 (47%), Positives = 23/40 (57%), Gaps = 5/40 (12%)
Query: 36 EVSALRSIKKSLVDDYS-KLSNWNR--GDPCTSNWTGVLC 72
+ AL + K SL D S LS+WN DPC +WTGV C
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 617 IGQGGYGKV---YKGILPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
IG G G V + +L G VAVK R + ++ + E+ L ++H+N++SL
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 671 VGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
+ +E + LV E M + E + + + + GI +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ + HRD+K SNI++ T K+ DFGL+R A + + P V T Y
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVV------TRYYR 189
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTG 813
PE L + D++S+G + EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 11/103 (10%)
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK--- 778
YLH + HRD+K N+L+ K+ DFGLS++ + + H+ +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 779 -----GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
GTP Y+ PE L D +++G++ E L G P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 28/186 (15%)
Query: 701 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 759
K+ L + + ++G+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 760 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 814
PD V KG ++ PE T +SDV+S GV+ E+ + G
Sbjct: 230 YKDPDY----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 279
Query: 815 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 874
P G I E + +G P + + L C E RP+ S
Sbjct: 280 SPYP-GVKIDEE--------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 330
Query: 875 EVMREL 880
E++ L
Sbjct: 331 ELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 617 IGQGGYGKVYKGILPDGTVV----------AVKRAQEGSLQGEKEFLT--EIQFLSRLHH 664
IG+G +G+V L + V +KRA+ + E++ L + Q+++ LH+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLG--FAMRLSIALGSSRG 719
+E LV ++ G TL + + E + + + IA+ S
Sbjct: 69 A--------FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+ Y+H RDIK NIL+D ++ADFG S L + D G V S+V G
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMED--GTVQ---SSVAVG 165
Query: 780 TPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQP 816
TP Y+ PE K + D +SLGV E+L G P
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 610 NFNSSTQIGQGGYGKVY---------------KGILPDGTVVAVKRAQEGSLQGEKEFLT 654
NF +G G YGKV+ +L T+V + E + + E++ L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 655 EIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 711
I+ FL LH+ + + L+ ++++ G L LS + + F +
Sbjct: 60 HIRQSPFLVTLHYA--------FQTDTKLHLILDYINGGELFTHLSQRER----FKEQ-E 106
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771
+ + S +L L + +RDIK NILLD + DFGLS+ ++E
Sbjct: 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER---- 162
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLT-DKS-DVYSLGVVFLELLTGMQPIS 818
+ GT Y+ P+ DK+ D +S+GV+ ELLTG P +
Sbjct: 163 --AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 55/202 (27%), Positives = 80/202 (39%), Gaps = 54/202 (26%)
Query: 703 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762
PL L + ++G+ +L A HRD+ A N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---- 260
Query: 763 PDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
DI + VVKG ++ PE T +SDV+S G++ E+ S
Sbjct: 261 -DIMN----DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------S 309
Query: 819 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE-KFIKLALKCCQ-DETD-ARPSMSE 875
GK+ YP V KF K+ + Q D A P +
Sbjct: 310 LGKS-----------------------PYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS 346
Query: 876 VMRELESIWNMMPESDTKTPEF 897
+M+ WN+ P T+ P F
Sbjct: 347 IMK---MCWNLEP---TERPTF 362
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 610 NFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSL-QGEK---EFLTEIQFLSR 661
NF +G G YGKV+ K D G + A+K Q+ +L Q K TE L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 662 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTL------RDQLSAKSKEPLGFAMRLSIAL 714
+ LV+L E + L+ +++S G + RD S + L++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
GI+Y RDIK NILLD + + DFGLS+ + E +
Sbjct: 121 LHKLGIVY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER------T 163
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPIS 818
GT Y+ PE K+ D +SLG++ ELLTG P +
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 667
+ + + +G G YG V G VAVK+ S+ K E++ L + H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 668 VSLVGY------CDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 717
+ L+ +E + LV M N ++ Q L+ + L + +
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL-------- 130
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
RG+ Y+H+ AD + HRD+K SN+ ++ K+ DFGL+R H +
Sbjct: 131 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEM 174
Query: 778 KG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 813
G T Y PE L +++ D++S+G + ELLTG
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 62/267 (23%), Positives = 103/267 (38%), Gaps = 38/267 (14%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L L+LS N L + L L LD +N +S +PK + N+ +L L L+GN+++
Sbjct: 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
LP L+ ++NNSI ++ LS L +
Sbjct: 200 -------------------------DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN 233
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L NN L LP + L L L L NN + +S +++ L +L L SL
Sbjct: 234 LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ---ISSISSLGSLTNLRELDLSGNSL 289
Query: 264 QGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 323
+P ++ + L LL + T+K KL + +N +
Sbjct: 290 SNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNN--ILSNGETSSPEALSILESL 347
Query: 324 SSIWQSRTLNATETFILDFQNNNLTNI 350
+++W E+ + + N I
Sbjct: 348 NNLWTLDNA-LDESNLNRYIVKNPNAI 373
|
Length = 394 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 26/143 (18%)
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+Q + E + D+L+ +++ L F+ +++ +G+ +L A H
Sbjct: 191 SGSYIDQDVTSEILEE----DELALDTEDLLSFSYQVA------KGMSFL---ASKNCIH 237
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP----GYLDPEYF 789
RD+ A NILL H K+ DFGL+R DI + VVKG ++ PE
Sbjct: 238 RDLAARNILLTHGRITKICDFGLAR-----DIRN----DSNYVVKGNARLPVKWMAPESI 288
Query: 790 LTHKLTDKSDVYSLGVVFLELLT 812
T +SDV+S G++ E+ +
Sbjct: 289 FNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 32/124 (25%), Positives = 46/124 (37%), Gaps = 40/124 (32%)
Query: 733 HRDIKASNILLDHKFTAKVADFGLS-------------RL-------APVPDIEGIVPAH 772
HRDIK NIL+D K++DFGLS +L + + +
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 773 VSTVVK--------------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 812
++ + GTP Y+ PE FL + D +SLG + E L
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 813 GMQP 816
G P
Sbjct: 244 GWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 8/126 (6%)
Query: 609 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 661
+N +G G +GKV + G+ + V VAVK + + E+E L +E++ LS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 662 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
L H+N+V+L+G C G +++ E+ G L + L K++ L F M L +S
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 721 LYLHTE 726
+ E
Sbjct: 158 KNITLE 163
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 615 TQIGQGGYGKVYKGILPDGTV---VAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS 669
T +G G YG V D + VAVK+ SL + E++ L + H N++
Sbjct: 21 TPVGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 670 LVGY------CDEEGEQMLVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
L+ + E LV M N ++ Q S E + F + + RG+
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLL-----RGL 131
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
Y+H+ + HRD+K SN+ ++ ++ DFGL+R A ++ G V T
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYV---------AT 178
Query: 781 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 813
Y PE L +++ D++S+G + ELL G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 5/65 (7%)
Query: 283 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 342
N+ ++ LSNN+LT F GLP L+ L ++ N+L+ P + +L LD
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSL-----RSLDL 55
Query: 343 QNNNL 347
NNL
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 71/284 (25%), Positives = 111/284 (39%), Gaps = 48/284 (16%)
Query: 617 IGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLHHRN 666
+GQG + +YKG+L + V QE S+ F +S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
LV L G C + M V E++ G L D + K + +L +A + + YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGT 780
D + H ++ NIL VA +GL VP I+ I V+
Sbjct: 119 -DKKLVHGNVCGKNIL--------VARYGL-NEGYVPFIKLSDPGIPITVLSREERVERI 168
Query: 781 PGYLDPEYF--LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS-MM 836
P ++ PE LT +D +S G LE+ + G +P+S SS
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS-----------TLSSSEKE 216
Query: 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
D + P +C E L +C + RPS ++R+L
Sbjct: 217 RFYQDQHRLPMP-DCAELA-NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 32/90 (35%), Positives = 43/90 (47%), Gaps = 10/90 (11%)
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ HRD+K N+LLD K+ADFG D G+V T V GTP Y+ PE
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMV--RCDTAV-GTPDYISPEVLK 216
Query: 791 THK----LTDKSDVYSLGVVFLELLTGMQP 816
+ + D +S+GV E+L G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 33/120 (27%), Positives = 46/120 (38%), Gaps = 36/120 (30%)
Query: 733 HRDIKASNILLDHKFTAKVADFGL---------SR------------LAPVPDIEGIVPA 771
HRDIK NIL+D K+ DFGL S+ + P + I
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 772 HVSTVVK---------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ + + GTP Y+ PE L T D +S+GV+ E+L G P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 617 IGQGGYGKVYKGI---LPDG-----TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
+GQG + K++KGI + D T V +K + + F +S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
G C E ++V E++ G+L D K+K + + +L +A + + +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLE---D 118
Query: 729 PPVFHRDIKASNILL 743
+ H ++ A N+LL
Sbjct: 119 KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 617 IGQGGYGKV---YKGILPDGTVVA-VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
IG G G V Y +L + + R + ++ + E+ + ++H+N++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 83
Query: 673 Y------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+E + LV E M + E + + + + GI +LH+
Sbjct: 84 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA 138
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--------SFMMTPYVVTRYYRAP 187
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELL 811
E L + D++S+G + E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 46/312 (14%)
Query: 631 PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688
P GT+V V+ + E K E+ H N+++ ++ FM+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748
G+ L E + A+ +I G+ RG+ YLH HR+IKAS+IL
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL------ 133
Query: 749 AKVADFGLSRLAPVPDIEGIVP-AHVSTVVKGTPGY-------LDPEYFLT--HKLTDKS 798
++ GL L+ + + +V + VV P + L PE + KS
Sbjct: 134 --ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 799 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG------NMGSYP-SEC 851
D+YS+G+ EL TG P ++ M+ + G ++ ++P E
Sbjct: 192 DIYSVGITACELATGRVPFQD----------MLRTQMLLQKLKGPPYSPLDITTFPCEES 241
Query: 852 VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP-- 909
K + + E+ M++ M E + P S T +P F N ++ P
Sbjct: 242 RMKNSQSGVDSGIGESVVAAGMTQTMTS-ERLRT--PSSKTFSPAFQNLVELCLQQDPEK 298
Query: 910 -PSSSSMLKHPY 920
PS+SS+L H +
Sbjct: 299 RPSASSLLSHAF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 617 IGQGGYGKVYK----GILPDGT--VVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 668
+G+G +G+V + GI T VAVK +EG+ E + ++E++ L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 669 SLVGYCDEE-GEQMLVYEFMSNGTLRDQLSAKSKE 702
+L+G C + G M++ EF G L + L +K E
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGE 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 187
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 813
T Y PE L + D++S+G + E++ G
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 25/154 (16%)
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGIL 721
N+V L Y E LV + G L +S P +A + +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFG-LSRLAPVPDIEGIVPAHVSTVVKGT 780
LH E + RD+ +NILLD + ++ F S + D E +
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-----------E 145
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM 814
Y PE + T+ D +SLG + ELLTG
Sbjct: 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 15/60 (25%), Positives = 27/60 (45%)
Query: 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 214
L + + N ++ +F L + ++ N+++ P S LPSL + L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 617 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-- 673
IG G +G VY+ I D + VA+K+ LQ + E+ + L+H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 674 --CDEEGEQML----VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS---SRGILYLH 724
C ++ E+ + V EF+ T+ + ++ + L + L S R + Y+H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAYIH 187
Query: 725 TEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
++ + HRD+K N+L+D + T K+ DFG ++ ++ S + Y
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLAGQRSVSYICSRFY 236
Query: 784 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 827
PE L T D++SLG + E++ G PI G++ V ++
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 48/248 (19%)
Query: 611 FNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLH 663
F +G+G G+V+ KG G + A+K + + + LTE + L+ L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSS 717
H L +L E LV ++ G L L + + L +A + +AL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE-- 117
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD--IEGIVPAHVS- 774
YLH + +RD+K NILL ++DF LS+ + V + +
Sbjct: 118 ----YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 775 ---------TVVK----------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 815
T + GT Y+ PE D ++LG++ E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 816 PISHGKNI 823
P G N
Sbjct: 231 PFK-GSNR 237
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K N+LLD K+ADFG + EG+V + GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTAV---GTPDYISPEVLKSQ 218
Query: 793 K----LTDKSDVYSLGVVFLELLTGMQP 816
+ D +S+GV E+L G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 49/178 (27%), Positives = 69/178 (38%), Gaps = 18/178 (10%)
Query: 636 VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 695
V +K Q G TE L ++H +++ L G L+ L
Sbjct: 120 VVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCY 172
Query: 696 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755
L+AK + L+I R I YLH + HRDIKA NI ++H + DFG
Sbjct: 173 LAAKRNIAI--CDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG 227
Query: 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 813
+ PV DI A+ GT PE D++S G+V E+ T
Sbjct: 228 -AACFPV-DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 8e-04
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 281 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 340
S + +I LS ++G I S LP +Q + ++NN LSG IP I+ + ++ L
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT----SSSLRYL 123
Query: 341 DFQNNNLTNISGSFNIPPNVTVRLRGNPF 369
+ NNN T +IP T+ L N
Sbjct: 124 NLSNNNFTGSIPRGSIPNLETLDLSNNML 152
|
Length = 968 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-04
Identities = 43/187 (22%), Positives = 66/187 (35%), Gaps = 44/187 (23%)
Query: 169 SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
S +L+ +++ S E + L N N EL EL L
Sbjct: 64 SSLSRLLSLDLLSPSGISSLDGS-----ENLLNLLPLPSLDLNLNRLRSNISELLELTNL 118
Query: 229 LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIK 288
L LDNNN ++ IP L LL N+ +
Sbjct: 119 TSLDLDNNN--------------------------------ITDIPPLIGLLKSNLKELD 146
Query: 289 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 348
LS+NK+ ++PS LP L+ L ++ N LS +P + LN LD N ++
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN-----NLDLSGNKIS 199
Query: 349 NISGSFN 355
++
Sbjct: 200 DLPPEIE 206
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 16/61 (26%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 131 SLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
+L+ L L+ N LT +P+ LP L + + N ++ P++F+ L R ++ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 190 I 190
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 655 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIA 713
E + L RL H +++L+ G LV ++ S+ L L A+ + PLG A ++A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARLR-PLGLAQVTAVA 266
Query: 714 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL------SRLAPVP-DIE 766
I Y+H E + HRDIK N+L++ + DFG S P I
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 809
G V + V+ G P T D++S G+V E
Sbjct: 324 GTVDTNAPEVLAGDP------------YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 54/201 (26%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 631 PDGTVVAVKRAQEGSLQGEK-EFL-TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688
P G V V+R + E FL E+ +H N+V + E +V FM+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748
G+ +D + + + I G + + Y+H HR +KAS+IL+
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILI--SVD 137
Query: 749 AKVADFGL----------SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT--- 795
KV GL RL V D P + V+ +L PE L L
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDF----PKYSVKVLP----WLSPE-VLQQNLQGYD 188
Query: 796 DKSDVYSLGVVFLELLTGMQP 816
KSD+YS+G+ EL G P
Sbjct: 189 AKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.003
Identities = 26/85 (30%), Positives = 35/85 (41%), Gaps = 12/85 (14%)
Query: 733 HRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 791
H DIK N+L D K + D+GL + + GT Y PE
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK-----------IIGTPSCYDGTLDYFSPEKIKG 180
Query: 792 HKLTDKSDVYSLGVVFLELLTGMQP 816
H D +++GV+ ELLTG P
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 941 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.93 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.46 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.43 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-73 Score=723.11 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=208.3
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
...|...+.||+|+||.||+|+. .+++.||||+++.... ...+|++.+++++||||++++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577888999999999999997 4789999999875332 223568899999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|+|.++++. ++|..+.+|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||.+.....
T Consensus 765 ~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 765 IEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 999999999952 7899999999999999999997655669999999999999999988875 665543211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC----chhHHHHHHHHhhccchhhhcC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG----KNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.....+|..|+|||++.+..++.++|||||||++|||+||+.||... ....+|.+..+........+++
T Consensus 835 -------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 -------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred -------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 11235788999999999999999999999999999999999998532 2344555443333333333343
Q ss_pred CCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 843 NMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 843 ~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
... ..+.+...++.+++.+||+.+|++||+|.++++.|+++.+..
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 321 244566778899999999999999999999999999876543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=438.19 Aligned_cols=284 Identities=52% Similarity=0.884 Sum_probs=248.0
Q ss_pred CccccchHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecc
Q 002289 595 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674 (941)
Q Consensus 595 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 674 (941)
....|+|.++..+|++|...+.||+|+||.||+|..++|+.||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443145699999999999999999999999
Q ss_pred ccCC-cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 675 DEEG-EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 675 ~~~~-~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
.+.+ +.+||||||++|||.++|+.....+++|..|++||.++|+||+|||+...++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 599999999999999999875543789999999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC-----chhHHHHH
Q 002289 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG-----KNIVREVN 828 (941)
Q Consensus 754 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~-----~~~~~~~~ 828 (941)
||+|+..+... .+......||.+|+|||++..+..+.|+||||||++++|++||+.+.+.. .++.+|..
T Consensus 221 FGLa~~~~~~~------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 221 FGLAKLGPEGD------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred ccCcccCCccc------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99997543200 11111117999999999999999999999999999999999999888742 34788887
Q ss_pred HHHhhccchhhhcCCCC--CCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 829 IAYQSSMMFSVIDGNMG--SYPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 829 ~~~~~~~~~~~~~~~~~--~~~~-~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
.......+.+++|+.+. .++. +....+..++..|++.+|..||+|.+|+++|+.+.
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 77777788899998874 4554 68888999999999999999999999999986654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=397.98 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=208.4
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchh-------hHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG-------EKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++...... ...+.+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346678899999999999999995 479999999987532211 234579999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---CcEEEeeec
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFG 755 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DFG 755 (941)
..|+|||||+||+|.+.+-.++ .+.+...+.++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999986654 3777788899999999999999999 9999999999999766 789999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCC---CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
+|+.... ...+...+||+.|.|||++.+.. +..++|+||+||+||-+++|..||.......
T Consensus 325 lAK~~g~--------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------- 388 (475)
T KOG0615|consen 325 LAKVSGE--------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------- 388 (475)
T ss_pred hhhcccc--------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------
Confidence 9997642 34567789999999999998754 3347899999999999999999997543211
Q ss_pred hccch-hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC
Q 002289 833 SSMMF-SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 911 (941)
Q Consensus 833 ~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 911 (941)
.+. ++..+.....|. .+. +.+.++.+||++||++||++|+|
T Consensus 389 --sl~eQI~~G~y~f~p~-~w~-----------------------------------~Iseea~dlI~~mL~VdP~~R~s 430 (475)
T KOG0615|consen 389 --SLKEQILKGRYAFGPL-QWD-----------------------------------RISEEALDLINWMLVVDPENRPS 430 (475)
T ss_pred --cHHHHHhcCcccccCh-hhh-----------------------------------hhhHHHHHHHHHhhEeCcccCcC
Confidence 011 112222211111 111 12234458999999999999999
Q ss_pred CccCCCCCCCCCCC
Q 002289 912 SSSMLKHPYVSSDV 925 (941)
Q Consensus 912 a~e~L~Hpwf~~~~ 925 (941)
+.|||+||||....
T Consensus 431 ~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 431 ADEALNHPWFKDAP 444 (475)
T ss_pred HHHHhcChhhhccc
Confidence 99999999998543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=389.13 Aligned_cols=195 Identities=31% Similarity=0.454 Sum_probs=174.3
Q ss_pred CccceeeccCcEEEEEEEeC-CCcEEEEEEeccC-CchhhHhHHHHHHHHHhcCCCceeeeeeccccCC-cEEEEEecCC
Q 002289 612 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFMS 688 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~LV~e~~~ 688 (941)
+..+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++.+||+||++||.|..++ +..++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34678999999999999976 6899999999543 3334678999999999999999999999999888 5999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
+|||++++... +.+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|+|||+|||.+..+...
T Consensus 162 gGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999999765 348999999999999999999996 66 999999999999999999999999999876432
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
......||..|||||.+.+..|+.++||||||++++|+.+|+.||...
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 335567999999999999999999999999999999999999999754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=371.67 Aligned_cols=280 Identities=26% Similarity=0.461 Sum_probs=222.1
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|...++||+|.||.||+|++ ++|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999995 479999999998654332 3568999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
||+ -+|+..++.+ ...++...++.++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+..++
T Consensus 82 fm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred ecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 996 5999999654 456899999999999999999999999 9999999999999999999999999999886543
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
+..+..+-|.+|+|||.+.| ..|+..+|+||.||++.||+-| .||..+.+..+++...+.. +
T Consensus 156 ------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~~----------L 218 (318)
T KOG0659|consen 156 ------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRA----------L 218 (318)
T ss_pred ------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHH----------c
Confidence 22333367889999999987 5699999999999999999988 5666666656655544421 2
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH-HhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE-SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~-~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
+...++.+.++..+ |++.++.+.-. .....++....++.||+.+|+++||.+|+||+|+|+||||++
T Consensus 219 GTP~~~~WP~~~~l------------pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSL------------PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred CCCCcccCcccccc------------ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 22222222222221 22222211000 011145666677799999999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=401.08 Aligned_cols=260 Identities=38% Similarity=0.584 Sum_probs=221.4
Q ss_pred CccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccCC-cEEEEEecCC
Q 002289 612 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFMS 688 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~LV~e~~~ 688 (941)
...+.||+|+||+||+|.++....||||++....... .+.|.+|+.+|++++|||||+|+|+|.+.. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3455699999999999999655559999998654333 458999999999999999999999998887 7999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeeccccccCCCCCCC
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 767 (941)
+|+|.++++......+++..++.++.|||+||+|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc---
Confidence 9999999987555679999999999999999999999874 99999999999999998 99999999998654321
Q ss_pred ccccccccccccCCCcccccccc--cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .+.... -+..+.++
T Consensus 199 ----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~--------v~~~~~Rp 265 (362)
T KOG0192|consen 199 ----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASA--------VVVGGLRP 265 (362)
T ss_pred ----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHH--------HHhcCCCC
Confidence 2233467999999999999 56999999999999999999999999987665 221111 12345566
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
.+|..++..+..++..||+.+|..||++.+++..|+.+......
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 77888999999999999999999999999999999988775554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=406.57 Aligned_cols=252 Identities=25% Similarity=0.443 Sum_probs=214.0
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.+|...+.||+|||+.||.+++ ++|..||+|++..... ...+.+.+||++.++++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999997 7899999999876433 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|+|++++|.+++++ +.++++.+++.+..||+.||.|||+++ |+|||||..|+++++++++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 99999999999963 456999999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......+||+.|.|||++....++..+||||+||++|.|+.|++||+...- .+
T Consensus 172 ------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-ke------------------- 225 (592)
T KOG0575|consen 172 ------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-KE------------------- 225 (592)
T ss_pred ------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-HH-------------------
Confidence 2345678899999999999999999999999999999999999999964321 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
.+. |+...--.+|+ ....++.|||++||+.||.+|||++++|.|+||+
T Consensus 226 ----------ty~----~Ik~~~Y~~P~----------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 226 ----------TYN----KIKLNEYSMPS----------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred ----------HHH----HHHhcCccccc----------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 111 11111111222 2345567899999999999999999999999993
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=394.65 Aligned_cols=287 Identities=22% Similarity=0.345 Sum_probs=230.1
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchh-hHhHHHHHHHHHhcC-CCceeeeeeccccCC-cEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG-EQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~L 682 (941)
..++|...++||.|.||.||+|+. .+|..||||+++..-... +-.-++|++.|++++ ||||+++.+.+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 457889999999999999999995 478999999988643333 233479999999998 999999999998887 9999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||| ..+|+++++++ ...|++..++.|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+||....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99999 56999999877 678999999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
....+..+.|.+|+|||++.. +-|+.+.|+||+|||++|+.+-+..|.+ .+..+++.... ++
T Consensus 163 --------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG-~sE~Dqi~KIc------~V-- 225 (538)
T KOG0661|consen 163 --------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG-ASEIDQIYKIC------EV-- 225 (538)
T ss_pred --------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC-CcHHHHHHHHH------HH--
Confidence 234567788999999999865 7799999999999999999998766654 44444433322 11
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
++....+.+.+-.+++..+--.-|..-|+- +...++....++.++|.+|+.|||++||||+|+|+||||
T Consensus 226 --LGtP~~~~~~eg~~La~~mnf~~P~~~~~~---------l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 226 --LGTPDKDSWPEGYNLASAMNFRFPQVKPSP---------LKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF 294 (538)
T ss_pred --hCCCccccchhHHHHHHHhccCCCcCCCCC---------hHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence 222223333333566666554555544432 223345577788899999999999999999999999999
Q ss_pred CCCCC
Q 002289 922 SSDVS 926 (941)
Q Consensus 922 ~~~~~ 926 (941)
+....
T Consensus 295 q~~~~ 299 (538)
T KOG0661|consen 295 QVGRA 299 (538)
T ss_pred ccccc
Confidence 77655
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=382.45 Aligned_cols=272 Identities=23% Similarity=0.367 Sum_probs=225.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
..++|++.++||+|+||.||.++.+ +++.+|+|++++.... ..+...+|..+|.+++||.||+++..|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4567999999999999999999965 6899999999865433 24567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|+||+.||.|..+|++++. +++..++.++..|+.||.|||+.+ ||||||||+|||+|.+|+++|+|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999976654 899999999999999999999999 99999999999999999999999999985432
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. ...+...+||+.|||||++.+..|+..+|+||+|+++|||++|..||..... .+..+
T Consensus 178 ~-------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-~~~~~-------------- 235 (357)
T KOG0598|consen 178 D-------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-KKMYD-------------- 235 (357)
T ss_pred C-------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-HHHHH--------------
Confidence 2 2234457899999999999999999999999999999999999999975432 11111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCcccccccCCCCCCCCC----CCccCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPP----SSSSMLK 917 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~----sa~e~L~ 917 (941)
-+..+ .+ ...+. .+..+.|+++++|+.||++|. .++++-.
T Consensus 236 ---------------~I~~~------k~--------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 236 ---------------KILKG------KL--------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ---------------HHhcC------cC--------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 00000 00 11122 455667899999999999995 6888999
Q ss_pred CCCCCCCCCCCccccccccccCC
Q 002289 918 HPYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 918 Hpwf~~~~~~~~~~~~~~~~~~~ 940 (941)
||||....+..-+...+.|++.|
T Consensus 281 HpfF~~inW~~l~~k~l~PpF~P 303 (357)
T KOG0598|consen 281 HPFFKGINWEKLLAKKLSPPFKP 303 (357)
T ss_pred CcccccCCHHHHHhcCCCCCeec
Confidence 99999988877777777777776
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=399.98 Aligned_cols=264 Identities=30% Similarity=0.500 Sum_probs=224.3
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
+.++...+.+...+.||+|.||.||.|.++....||+|.++..... .+.|.+|+++|++++|+|||+++|+|..++.++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 3444445555667899999999999999988889999999876433 458999999999999999999999999988999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
||||||+.|+|.++|+...+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence 9999999999999998866778999999999999999999999999 9999999999999999999999999999543
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
..... ......-...|.|||++..+.++.|||||||||+||||+| |+.||....+.. .+..+-
T Consensus 355 d~~Y~------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------v~~~le 418 (468)
T KOG0197|consen 355 DDEYT------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------VLELLE 418 (468)
T ss_pred CCcee------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------HHHHHh
Confidence 33221 1122223568999999999999999999999999999999 888887554321 122334
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+.+.+-|+.|+..++++|..||+.+|++|||+..+...++++..
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 456667889999999999999999999999999999988887754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=377.78 Aligned_cols=270 Identities=24% Similarity=0.399 Sum_probs=213.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|...+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+++|+.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888889999999999999975 6899999998765 3444567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC------CcEEEeeecccc
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK------FTAKVADFGLSR 758 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~------~~~kl~DFGla~ 758 (941)
|||.||+|.+++++++ .+++..++.++.|+|.||++||+++ ||||||||+|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999998765 4899999999999999999999999 9999999999999764 569999999999
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
.+.. .......+|++.|||||++..++|+.|+|+||+|+++|++++|+.||...... +... .++.
T Consensus 164 ~L~~--------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-eL~~-~~~k----- 228 (429)
T KOG0595|consen 164 FLQP--------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-ELLL-YIKK----- 228 (429)
T ss_pred hCCc--------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-HHHH-HHhc-----
Confidence 8763 23345678999999999999999999999999999999999999999754321 1111 0000
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
-....+.++........++...-+..++.+|-.+.+ .|...++.-+|.+|+.+.++=.+
T Consensus 229 -~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~--------------------~~~~~~l~~~p~~~~~~~~~~~~ 287 (429)
T KOG0595|consen 229 -GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFED--------------------FFDHPFLAANPQDRADAFELESR 287 (429)
T ss_pred -cccccCchhhhccCchhhhhhHHHhcCccccCchHH--------------------hhhhhhcccCcccccCccccccc
Confidence 001112234444445556666666667766665543 34555666667666666554433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=369.83 Aligned_cols=281 Identities=24% Similarity=0.349 Sum_probs=217.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|+...++|+|+||+|||++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999976 699999999976432 224567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
||+. ++.+-+++.. ..++...+.+++.|+++|+.|+|+++ +|||||||+|||++.++.+||+|||.|+.+..+
T Consensus 82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 9976 5555555443 34888999999999999999999999 999999999999999999999999999987532
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
....+..+.|.+|+|||.+.+ .+|+.++||||+||++.||++|...|....+..+...+.. .+
T Consensus 155 -----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k-----------tL 218 (396)
T KOG0593|consen 155 -----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK-----------TL 218 (396)
T ss_pred -----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH-----------HH
Confidence 344566778999999999998 7899999999999999999999877766555443322211 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCC----CCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDA----RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~----RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
+...+. -+++. ..+|-- -|.. +..+.+...++.......||+..+|..||++|++.+|+|.|||
T Consensus 219 G~L~pr----hq~iF----~~N~~F~Gv~lP~~----~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y 286 (396)
T KOG0593|consen 219 GNLIPR----HQSIF----SSNPFFHGVRLPEP----EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY 286 (396)
T ss_pred cccCHH----HHHHh----ccCCceeeeecCCC----CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence 111111 11111 111110 0111 1122333455666667789999999999999999999999999
Q ss_pred CCCC
Q 002289 921 VSSD 924 (941)
Q Consensus 921 f~~~ 924 (941)
|++-
T Consensus 287 Fd~~ 290 (396)
T KOG0593|consen 287 FDGF 290 (396)
T ss_pred HHHH
Confidence 9553
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=390.36 Aligned_cols=285 Identities=25% Similarity=0.371 Sum_probs=219.7
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~L 682 (941)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++..+.. .......+||.+|++++||||+++.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34567788999999999999995 5799999999876543 3345678999999999999999999998665 68999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|+|||++ +|.-++.. ..-.|++.+++.++.|++.||+|||+++ |+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999975 88888854 3446999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. ....+..+-|.+|+|||++.| ..|+.++|+||.||||.||++|+..|... ..++++...+.
T Consensus 271 ~~------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-tEveQl~kIfk--------- 334 (560)
T KOG0600|consen 271 SG------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-TEVEQLHKIFK--------- 334 (560)
T ss_pred CC------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-cHHHHHHHHHH---------
Confidence 33 233566778999999999998 57999999999999999999998777544 44444444332
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
..+...++++. ..++- .+...-| ..++.. .+.+ .+...++.+.+|+..||.+||.+|.||.++|+|+||
T Consensus 335 -lcGSP~e~~W~-~~kLP-~~~~~kp--~~~y~r---~l~E---~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 335 -LCGSPTEDYWP-VSKLP-HATIFKP--QQPYKR---RLRE---TFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred -HhCCCChhccc-cccCC-cccccCC--CCcccc---hHHH---HhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 12333444443 22221 1111111 111111 1111 234456677899999999999999999999999999
Q ss_pred CCC
Q 002289 922 SSD 924 (941)
Q Consensus 922 ~~~ 924 (941)
+.+
T Consensus 404 ~t~ 406 (560)
T KOG0600|consen 404 TTE 406 (560)
T ss_pred ccC
Confidence 543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=358.82 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=214.0
Q ss_pred cCCCccceeeccCcEEEEEEE-eCCCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeee-ccccCCc-EEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVG-YCDEEGE-QMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~LV 683 (941)
.+|++.++||+|.||+||++. ..+|..||.|.++-+... ..++...|+.+|++++|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457778899999999999999 468999999998854443 3467899999999999999999999 4555554 8999
Q ss_pred EecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 684 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEAD-PPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
||||.+|+|..+++. +.+..+++..+|+++.|++.||.++|+.-. ..|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999974 455679999999999999999999998321 23899999999999999999999999999987
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... .......+||+.||+||.+.+.+|+.+|||||+||++|||+.-+.||... ++..... ++.
T Consensus 179 ~s~-------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~---------KI~ 241 (375)
T KOG0591|consen 179 SSK-------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCK---------KIE 241 (375)
T ss_pred cch-------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHH---------HHH
Confidence 543 23456678999999999999999999999999999999999999999865 3332221 233
Q ss_pred cCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 841 DGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 841 ~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
.+..++.| +.++..+.+++..|+..||+.||+.-.+++.+..
T Consensus 242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 44556666 7889999999999999999999996555555443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=368.13 Aligned_cols=286 Identities=23% Similarity=0.366 Sum_probs=225.1
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEecc--CCchhhHhHHHHHHHHHhcCCCceeeeeecccc-----CC
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EG 678 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~ 678 (941)
...+|...+.||+|+||.|+.|... +|+.||||++.. ......++..+|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456666789999999999999965 789999999873 344456788999999999999999999999855 35
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..|+|+|+| +-+|...++.+ +.++...+..+..|+++||.|+|+.+ |+||||||+|++++.+..+||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 789999999 67999999654 34899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
..... ......+....|.+|+|||.+.. ..|+.+.||||.||++.||++|+..|.+.+ ...++...
T Consensus 174 ~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-~v~Ql~lI------- 240 (359)
T KOG0660|consen 174 YLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-YVHQLQLI------- 240 (359)
T ss_pred ecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-hHHHHHHH-------
Confidence 77532 11344577788999999999865 789999999999999999999987775444 34433322
Q ss_pred hhhcCCCCCCChHHHHHHH-HHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 838 SVIDGNMGSYPSECVEKFI-KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~-~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
-...+..+++....+. +-+..-++..|...+. .+.+.++..++.+.||+.+||++||.+|+||+|||
T Consensus 241 ---~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~---------~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 241 ---LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQ---------PFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred ---HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCC---------CHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 1223444444444332 1122233333332221 23345688899999999999999999999999999
Q ss_pred CCCCCCC
Q 002289 917 KHPYVSS 923 (941)
Q Consensus 917 ~Hpwf~~ 923 (941)
+||||..
T Consensus 309 ~hPYl~~ 315 (359)
T KOG0660|consen 309 AHPYLAP 315 (359)
T ss_pred cChhhhh
Confidence 9999965
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=358.98 Aligned_cols=283 Identities=24% Similarity=0.340 Sum_probs=213.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccc--cCCcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~LV 683 (941)
+.|+.+++|++|.||.||+|+++ +++.||+|+++...... .-..++||.+|.+++|||||.+..+.. .-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777899999999999999975 68999999998643211 234689999999999999999988864 34679999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||||+. +|..+++.-. +++...+++.++.|+++|++|||.+. |+|||||++|+|+++.|.+||+|||+|+.+..+
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999965 9999997654 67999999999999999999999999 999999999999999999999999999988654
Q ss_pred CCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
....+..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||++++..|.... ..+++...+..
T Consensus 231 -------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~l--------- 293 (419)
T KOG0663|consen 231 -------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFKL--------- 293 (419)
T ss_pred -------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHHH---------
Confidence 234566778999999999998 469999999999999999999977665444 44444443321
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC--CCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE--SDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~--~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
++...+..++.+..+-. ++ -..+|... ...|+ ..++. ......+|++.+|++||++|+||+|+|+|+|
T Consensus 294 -lGtPte~iwpg~~~lp~--~k--~~~f~~~p--yn~lr---~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 294 -LGTPSEAIWPGYSELPA--VK--KMTFSEHP--YNNLR---KKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred -hCCCccccCCCccccch--hh--ccccCCCC--chhhh---hhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 11111111111111100 00 00111110 11122 22333 2366789999999999999999999999999
Q ss_pred CCC
Q 002289 921 VSS 923 (941)
Q Consensus 921 f~~ 923 (941)
|..
T Consensus 364 F~e 366 (419)
T KOG0663|consen 364 FRE 366 (419)
T ss_pred ccc
Confidence 987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=377.83 Aligned_cols=266 Identities=22% Similarity=0.318 Sum_probs=217.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 682 (941)
..+|...+.||.|+|++|++|+.. +++.||||++.+.-... .+.+..|-.+|.+| .||.|++|+..|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 456778899999999999999964 68999999987643322 35678899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|+||+++|+|.++|++.+ .|++...+.++.+|+.||+|||++| ||||||||+|||+|++|++||+|||.|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999998765 4999999999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCC------ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 763 PDIEG------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 763 ~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
..... ..........+||..|.+||++.....+..+|+|+|||++|+|+.|+.||....+..-
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----------- 295 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----------- 295 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-----------
Confidence 43220 0111112557899999999999999999999999999999999999999976543211
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
+.+++..-.. ..+.-.+.+.||++++|..||.+|+|++|+.
T Consensus 296 ------------------FqkI~~l~y~---------------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 296 ------------------FQKIQALDYE---------------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred ------------------HHHHHHhccc---------------------CCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 1111111111 1112223445788889999999999999999
Q ss_pred CCCCCCCCCCCC
Q 002289 917 KHPYVSSDVSGS 928 (941)
Q Consensus 917 ~Hpwf~~~~~~~ 928 (941)
+||||.+..+..
T Consensus 337 ~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 337 AHPFFEGVDWEN 348 (604)
T ss_pred hCcccccCChhh
Confidence 999999988765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=351.59 Aligned_cols=268 Identities=22% Similarity=0.347 Sum_probs=219.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhh---HhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
-++|+..+.||.|+||+|.+++.+ +|..+|+|+++....-.. +...+|..+|+.+.||+++++++.|.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356778899999999999999965 689999999987554433 4567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||++||-|..++++.+ .+++..++.+|.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+...
T Consensus 123 meyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred EeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 99999999999997654 4999999999999999999999999 9999999999999999999999999998763
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
..+...+||+.|+|||.+....+..++|.|||||++|||+.|..||...... +... .++.+
T Consensus 196 --------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~iY~---------KI~~~- 256 (355)
T KOG0616|consen 196 --------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-QIYE---------KILEG- 256 (355)
T ss_pred --------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-HHHH---------HHHhC-
Confidence 2356789999999999999999999999999999999999999999765431 1111 11111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC-----CCccCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKH 918 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~H 918 (941)
...+| +--++++.||+.++|+.|-.+|. -..++..|
T Consensus 257 ~v~fP---------------------------------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 257 KVKFP---------------------------------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred cccCC---------------------------------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence 11122 22334445677777777777773 56789999
Q ss_pred CCCCCCCCCCccccccccccCC
Q 002289 919 PYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 919 pwf~~~~~~~~~~~~~~~~~~~ 940 (941)
|||.+..+..-+...+.+|+-|
T Consensus 298 ~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 298 PWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred cccccccHHHHhhccccCCCCC
Confidence 9999888866666666666544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=398.15 Aligned_cols=264 Identities=30% Similarity=0.501 Sum_probs=223.9
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
....+....+.||+|+||.||+|+.. +...||||.+++.... ..++|++|++++..++|||||+|+|.|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34455566789999999999999853 3568999999987666 5789999999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcC------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 746 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 746 (941)
.+++|+|||..|||.++|.... +.+++..+.+.||.|||.||+||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 9999999999999999997421 234899999999999999999999999 9999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHH
Q 002289 747 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 825 (941)
Q Consensus 747 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~ 825 (941)
..|||+|||+++..-..+++.. .....-.++|||||.|..++++.+||||||||+|||+++ |+.||..-.+..
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~-----~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E- 713 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKV-----RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE- 713 (774)
T ss_pred eEEEecccccchhhhhhhhhcc-----cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-
Confidence 9999999999997655554321 112223579999999999999999999999999999999 999998655421
Q ss_pred HHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
.+..+-.+..-+-|+.|+.+++++|..||+..|++||++.||-..|+.+....
T Consensus 714 ---------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 ---------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 12233345556679999999999999999999999999999999999886543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=376.92 Aligned_cols=265 Identities=25% Similarity=0.397 Sum_probs=218.6
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
...|....+||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 35677778999999999999984 57899999999876666667789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
|+||+|.|.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-- 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-- 423 (550)
T ss_pred cCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc--
Confidence 9999999998543 3899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......||+.|||||++....|++++||||||++++||+-|..||..+..+...+. +.....
T Consensus 424 -----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL----------Ia~ng~-- 486 (550)
T KOG0578|consen 424 -----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----------IATNGT-- 486 (550)
T ss_pred -----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH----------HhhcCC--
Confidence 245667899999999999999999999999999999999999999986544322111 111111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
|... ......+.+.|||++||+.|+++|++|+|+|+||||.....
T Consensus 487 ------------------------P~lk-----------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 487 ------------------------PKLK-----------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred ------------------------CCcC-----------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 1100 11122344558999999999999999999999999966555
Q ss_pred CCcccc
Q 002289 927 GSNLVS 932 (941)
Q Consensus 927 ~~~~~~ 932 (941)
.+.+.+
T Consensus 532 ~ssL~p 537 (550)
T KOG0578|consen 532 ESSLNP 537 (550)
T ss_pred HHHhHH
Confidence 555443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=360.99 Aligned_cols=274 Identities=26% Similarity=0.331 Sum_probs=217.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchh-hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
..+.|++.+.||.|..++||+|+. +.+..||||++..+.... .+.+.+|+..|+.++||||++++..|..+...|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346788999999999999999994 578999999998655444 478899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
.||.+||+.+++...-...+++..+..|.+++++||.|||++| .||||||+.|||++++|.|||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999998877777999999999999999999999999 9999999999999999999999999986654322
Q ss_pred CCCccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
...........||+.|||||+++. ..|+.|+||||||++..|+.+|+.||..-....-
T Consensus 181 ---~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv----------------- 240 (516)
T KOG0582|consen 181 ---DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV----------------- 240 (516)
T ss_pred ---ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----------------
Confidence 111112256789999999999654 5799999999999999999999999964332110
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETD----ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~----~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
...-++-+|- .....++. ......+.+++..||+.||++||||+++|+|
T Consensus 241 ----------------Ll~tLqn~pp~~~t~~~~~d~~-----------k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 241 ----------------LLLTLQNDPPTLLTSGLDKDED-----------KKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ----------------HHHHhcCCCCCcccccCChHHh-----------hhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0011111110 00011110 0111244578888999999999999999999
Q ss_pred CCCCCCCCCCcc
Q 002289 919 PYVSSDVSGSNL 930 (941)
Q Consensus 919 pwf~~~~~~~~~ 930 (941)
+||+......-+
T Consensus 294 ~FFk~~k~~~~~ 305 (516)
T KOG0582|consen 294 AFFKKAKSKEYL 305 (516)
T ss_pred HHHhhccchhhc
Confidence 999887664333
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.69 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=213.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+... ...+.+.+|++++++++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999965 689999998865322 224568999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+.| +|..++...+ .++++.+..|+.+++.||.|||+.+ |+|||+||.|||++..+.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--- 152 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc---
Confidence 9965 9999997654 4899999999999999999999999 99999999999999999999999999997643
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.....+.+.||+.|||||+..+++|+..+|.||+||++||+++|++||..
T Consensus 153 ----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------------------------- 202 (808)
T KOG0597|consen 153 ----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------------------------- 202 (808)
T ss_pred ----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------------------------
Confidence 24556778899999999999999999999999999999999999999952
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
..+.++++.... ||-.-|+ .....+..|+..+|..||..|+|=.+++.|||..+..
T Consensus 203 -------~si~~Lv~~I~~-d~v~~p~----------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 203 -------RSITQLVKSILK-DPVKPPS----------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred -------HHHHHHHHHHhc-CCCCCcc----------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 223333333322 2222222 1223344678888899999999999999999987766
Q ss_pred CC
Q 002289 926 SG 927 (941)
Q Consensus 926 ~~ 927 (941)
.+
T Consensus 259 ~~ 260 (808)
T KOG0597|consen 259 NI 260 (808)
T ss_pred hh
Confidence 64
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.18 Aligned_cols=203 Identities=31% Similarity=0.498 Sum_probs=173.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC--cEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~LV~e 685 (941)
.++...+.||+|+||+||++... +|...|||.....+....+.+.+|+.+|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45666889999999999999975 49999999887653333556899999999999999999999854444 6899999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeeccccccCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGla~~~~~~~ 764 (941)
|+++|+|.+++.+.+. .+++..++.++.||++||+|||+++ ||||||||+|||++. ++.+||+|||++.......
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988776 7999999999999999999999999 999999999999999 7999999999998664310
Q ss_pred CCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
..........||+.|||||++..+ ....++||||+||++.||+||+.||..
T Consensus 173 ----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 ----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 112334457799999999999963 334599999999999999999999964
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=368.70 Aligned_cols=267 Identities=25% Similarity=0.463 Sum_probs=220.5
Q ss_pred chHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccC
Q 002289 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEE 677 (941)
Q Consensus 600 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 677 (941)
+.++|++..+.+.+.+.||+|.||+||+|.|.. .||||+++...... .+.|+.|+.++++-+|.||+-|+|||...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 346777777788889999999999999999964 69999998655443 57899999999999999999999999988
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
.. .||+.+|+|-+|+.++|-.. ..|+..+.+.||.||++||.|||.++ |||||||..||++.++++|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 77 99999999999999998654 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
..-..- ..........|...|||||+++. .+|++.+|||||||++|||+||..||. ..+.. .
T Consensus 536 tvk~~w-----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~d---------q 600 (678)
T KOG0193|consen 536 TVKTRW-----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRD---------Q 600 (678)
T ss_pred eeeeee-----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChh---------h
Confidence 753221 11223334457889999999975 468999999999999999999999997 33211 1
Q ss_pred cchhhhcCCC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 835 MMFSVIDGNM----GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 835 ~~~~~~~~~~----~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
.++.+-.+.. -.....++.++.+++..||..++++||.+.+++..|+.+....|
T Consensus 601 IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 601 IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 2222222211 12446788899999999999999999999999998888766444
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=363.68 Aligned_cols=269 Identities=22% Similarity=0.304 Sum_probs=214.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
..++|+++..||+|+||.||+|+-+ +|..+|+|++++..... .+.++.|-.+|....+|.||+++-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4678999999999999999999965 69999999998765443 3457889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||++||++..+|.+. ..+++..++.++.+++.|++-+|+.| +|||||||+|+|||..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999654 45899999999999999999999999 99999999999999999999999999853321
Q ss_pred CCC---------------C---Cccc-----c-----------------ccccccccCCCcccccccccCCCCchhHhHH
Q 002289 763 PDI---------------E---GIVP-----A-----------------HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYS 802 (941)
Q Consensus 763 ~~~---------------~---~~~~-----~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS 802 (941)
... + ...+ . ......+|||.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 0 0000 0 0012357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 803 LGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 803 lG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
+|||+|||+.|.+||........+.++... ..||..-.+.+.+
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nw---------------------------r~~l~fP~~~~~s---------- 416 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNW---------------------------RETLKFPEEVDLS---------- 416 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHH---------------------------hhhccCCCcCccc----------
Confidence 999999999999999765432222111100 1233322222222
Q ss_pred hHhhCCCCCCCCcccccccCCCCCCCCCC---CccCCCCCCCCCCCCC
Q 002289 883 IWNMMPESDTKTPEFINSEHTSKEETPPS---SSSMLKHPYVSSDVSG 927 (941)
Q Consensus 883 ~~~~~~~~~~~~~dll~~~L~~dP~~R~s---a~e~L~Hpwf~~~~~~ 927 (941)
+++.|||.++|. ||++|+- ++|+.+||||++..+.
T Consensus 417 ---------~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 417 ---------DEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred ---------HHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 456689999999 9999984 8999999999997774
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=379.55 Aligned_cols=291 Identities=23% Similarity=0.353 Sum_probs=219.7
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CC-----ceeeeeeccccCCcEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCDEEGEQML 682 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~~L 682 (941)
+|.+.+.||+|.||.|-+|.+. +++.||||+++... ....+...|+.+|..++ |. |+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999965 69999999998643 33446678999999997 43 89999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--CCcEEEeeecccccc
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLA 760 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFGla~~~ 760 (941)
|+|.+ .-+|+++++.+....++...++.|+.||+.||.+||+.+ |||+||||+|||+.+ ...+||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 679999999988888999999999999999999999999 999999999999964 348999999999875
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... ......+..|+|||++.|.+|+.+.||||||||+.||++| .|+..+.+..+++....+.
T Consensus 342 ~q~----------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~------- 403 (586)
T KOG0667|consen 342 SQR----------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEV------- 403 (586)
T ss_pred CCc----------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHH-------
Confidence 321 1255678899999999999999999999999999999999 5655666666665543321
Q ss_pred cCCCCCCChHHHHHHH---HH-------HHHhcccCCCCCCCHHHHHHHHHHhHh-------------hCC-CCCCCCcc
Q 002289 841 DGNMGSYPSECVEKFI---KL-------ALKCCQDETDARPSMSEVMRELESIWN-------------MMP-ESDTKTPE 896 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~---~l-------~~~c~~~~p~~RPs~~~v~~~L~~~~~-------------~~~-~~~~~~~d 896 (941)
.+..|....+... +. ...|...+-.+-+...++...+..... ..+ ..+..+.|
T Consensus 404 ---lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d 480 (586)
T KOG0667|consen 404 ---LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID 480 (586)
T ss_pred ---hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence 1222222221111 11 111222221111112222222221111 111 23334578
Q ss_pred cccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 897 FINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 897 ll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
||.+||.|||.+|+|+.|+|+||||++...
T Consensus 481 flk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 481 FLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 999999999999999999999999996544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=379.42 Aligned_cols=273 Identities=27% Similarity=0.467 Sum_probs=229.8
Q ss_pred ccccchHHHHHHhcCC---------CccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCchh-hHhHHHHHHHHHh
Q 002289 596 VRSFTYGEMALATNNF---------NSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSR 661 (941)
Q Consensus 596 ~~~~~~~~~~~~~~~y---------~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~ 661 (941)
+..++|+|...+...| .+.++||.|.||.||+|+++ ....||||.++....+. +.+|+.|..||.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 3456777666655444 45789999999999999975 24579999999866554 5689999999999
Q ss_pred cCCCceeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 002289 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741 (941)
Q Consensus 662 l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 741 (941)
+.||||++|.|+....+..++|+|||++|+|+.+|+.+..+ |++.+...+.++||.||.||-+++ +|||||.++||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNI 762 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNI 762 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhhe
Confidence 99999999999999999999999999999999999876654 999999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCC
Q 002289 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 820 (941)
Q Consensus 742 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~ 820 (941)
|++.+..+||+|||+++.++++... ...+..-.-..+|.|||.+...+++.+|||||||++|||.++ |.+||.+.
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~----~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEA----AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred eeccceEEEeccccceeecccCCCc----cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 9999999999999999987544311 111122223468999999999999999999999999999888 99999766
Q ss_pred chhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.+. +.+..+-++.+.+.|.+|+..+.++|..||++|-.+||++.+++..|.++...
T Consensus 839 SNQ----------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 839 SNQ----------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred chH----------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 542 12234445566778999999999999999999999999999999999987654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.50 Aligned_cols=293 Identities=25% Similarity=0.380 Sum_probs=221.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCc-eeeeeeccccCC-----
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEG----- 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~----- 678 (941)
...|...++||+|+||+||+|+.. +|+.||+|++.....+ ......+|+.++++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666788999999999999964 7899999998765432 2456789999999999999 999999997766
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCC--CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 679 -EQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 679 -~~~LV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
..++||||+ .-+|.+++..... ..++...++.++.||++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 788999999 5699999976553 35777889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
+|+....+ ....+...+|..|+|||++.+. .|+...||||+||+++||++++..|....+ .++....+.
T Consensus 166 lAra~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~-- 235 (323)
T KOG0594|consen 166 LARAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFR-- 235 (323)
T ss_pred hHHHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHH--
Confidence 99965432 3445667789999999999986 799999999999999999998777765554 333333322
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
++ +...++.++.+..+.. ++....+++....+. ...+..++...|++.+||+++|++|.||+.
T Consensus 236 ----~l----GtP~e~~Wp~v~~~~~--~k~~f~~~~~~~~l~-------~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 236 ----LL----GTPNEKDWPGVSSLPD--YKAPFPKWPGPKDLS-------SILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred ----Hc----CCCCccCCCCcccccc--ccccCcCCCCccchH-------HhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 11 1111111111111110 000111222222222 233455578889999999999999999999
Q ss_pred CCCCCCCCCCCCCCccc
Q 002289 915 MLKHPYVSSDVSGSNLV 931 (941)
Q Consensus 915 ~L~Hpwf~~~~~~~~~~ 931 (941)
+|.||||.........+
T Consensus 299 al~h~yf~~~~~~~~~~ 315 (323)
T KOG0594|consen 299 ALTHPYFSELPEKSSQL 315 (323)
T ss_pred HhcChhhcccccchhhh
Confidence 99999998865544433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=369.67 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=207.9
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC----Cc-hhhHhHHHHHHHHHhcC-CCceeeeeeccccCC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG----SL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG 678 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 678 (941)
...++|.+.+.||+|+||+|+.|... +++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34678999999999999999999854 7899999977653 11 23456778999999998 999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeeccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 757 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFGla 757 (941)
..++||||+.||+|.+++... .++.+..+..++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999999773 45888999999999999999999999 9999999999999999 99999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCC-CC-chhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+..... ...
T Consensus 169 ~~~~~-------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-l~~------- 233 (370)
T KOG0583|consen 169 AISPG-------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-LYR------- 233 (370)
T ss_pred cccCC-------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-HHH-------
Confidence 87631 123456678999999999999977 86 67999999999999999999997633211 000
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
.+......+|... . .+++.+|+.+||..||.+|+|+.|+
T Consensus 234 ---ki~~~~~~~p~~~------------------------------------~--S~~~~~Li~~mL~~~P~~R~t~~~i 272 (370)
T KOG0583|consen 234 ---KIRKGEFKIPSYL------------------------------------L--SPEARSLIEKMLVPDPSTRITLLEI 272 (370)
T ss_pred ---HHhcCCccCCCCc------------------------------------C--CHHHHHHHHHHcCCCcccCCCHHHH
Confidence 0110000111100 0 4445678888899999999999999
Q ss_pred CCCCCCCC
Q 002289 916 LKHPYVSS 923 (941)
Q Consensus 916 L~Hpwf~~ 923 (941)
+.||||+.
T Consensus 273 ~~h~w~~~ 280 (370)
T KOG0583|consen 273 LEHPWFQK 280 (370)
T ss_pred hhChhhcc
Confidence 99999987
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=361.46 Aligned_cols=201 Identities=27% Similarity=0.421 Sum_probs=174.9
Q ss_pred CCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 610 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.|+..+.||+|+||+||+|.. .+|+.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999996 4789999998865332 223467899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999998886655556899999999999999999999999 9999999999999999999999999997643211
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 1223468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=360.94 Aligned_cols=281 Identities=23% Similarity=0.345 Sum_probs=208.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.++||+|+||+||+|..+ +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999965 689999999875332 2244678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ |+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 96 59999886543 35788999999999999999999999 9999999999999999999999999987543221
Q ss_pred CccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... +....... ..+
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~----------~~~ 221 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFR----------LLG 221 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH----------HhC
Confidence 11223457899999999876 56899999999999999999999999754321 11111110 011
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
..+.+.+..+.......-...|..|+.. .....+..+.+..|||.+||++||.+|+||+|+|+||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQP---------LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCc---------hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1112211111100000000011111111 112223455667899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=335.67 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=209.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++.|++.+.||+|.|+.||++.. .+|+.+|+|++.... ..+.+++.+|+++-+.++||||+++.+.+.+.+..++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999885 479999999876432 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecccccc
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLA 760 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGla~~~ 760 (941)
+|+|+|++|..-+-.+ ..+++..+-.++.||+++|.|+|.++ |||||+||+|+++.+ ..-+||+|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997765443 45788899999999999999999999 999999999999954 346999999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.. ....-...||++|||||++...+|+..+|||+.||+||-++.|+.||.+.... + +
T Consensus 164 ~~--------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-r----------l---- 220 (355)
T KOG0033|consen 164 ND--------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-R----------L---- 220 (355)
T ss_pred CC--------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-H----------H----
Confidence 52 22334567999999999999999999999999999999999999999764321 0 0
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
+.+++..-...++.+ ++...+++.+|+++||+.||.+|+||.|+|+|||
T Consensus 221 --------------ye~I~~g~yd~~~~~-----------------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 221 --------------YEQIKAGAYDYPSPE-----------------WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred --------------HHHHhccccCCCCcc-----------------cCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 111111112222222 2334456678999999999999999999999999
Q ss_pred CCCC
Q 002289 921 VSSD 924 (941)
Q Consensus 921 f~~~ 924 (941)
+...
T Consensus 270 i~~r 273 (355)
T KOG0033|consen 270 ICNR 273 (355)
T ss_pred hcch
Confidence 9763
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=373.57 Aligned_cols=281 Identities=20% Similarity=0.257 Sum_probs=214.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..+|++.+.||+|+||.||+|.+. +++.||+|.... +.+.+|++++++++||||+++++++...+..++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 457999999999999999999964 689999997542 3567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+ +++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 165 ~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 165 Y-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred C-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 9 579998886543 4788999999999999999999998 9999999999999999999999999997532211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchh------HHHHHHHHhhccchhhh
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI------VREVNIAYQSSMMFSVI 840 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~------~~~~~~~~~~~~~~~~~ 840 (941)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ ...
T Consensus 237 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~------~~~ 306 (391)
T PHA03212 237 ----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII------RRS 306 (391)
T ss_pred ----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH------HHh
Confidence 11223457999999999999999999999999999999999999888643221 11111110 111
Q ss_pred cCCCCCCChH---HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 841 DGNMGSYPSE---CVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 841 ~~~~~~~~~~---~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
......++.. .......-...+....|..||....+... ..+..++|.+||.+||++||||+|+|+
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL-----------PIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhh-----------hhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1000111111 11222222234455667778776554321 223457999999999999999999999
Q ss_pred CCCCCC
Q 002289 918 HPYVSS 923 (941)
Q Consensus 918 Hpwf~~ 923 (941)
||||..
T Consensus 376 hp~f~~ 381 (391)
T PHA03212 376 FAAFQD 381 (391)
T ss_pred Chhhcc
Confidence 999976
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=350.69 Aligned_cols=275 Identities=22% Similarity=0.330 Sum_probs=203.1
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC-----cEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQMLV 683 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~LV 683 (941)
.|...+++|.|+||.||+|+.. +++.||||+.-.+.. .-.+|+++|+.+.|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4556789999999999999964 579999998764322 2347999999999999999998884322 34689
Q ss_pred EecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeecccccc
Q 002289 684 YEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLA 760 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFGla~~~ 760 (941)
|||||. +|.+.++.. .+..++...++-++.||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999964 999998742 3455778888899999999999999998 9999999999999976 99999999999987
Q ss_pred CCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
... ........|..|+|||.+.+ ..|+.+.||||.||++.||+-|+..|.+... .+++..... +
T Consensus 177 ~~~--------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik------~ 241 (364)
T KOG0658|consen 177 VKG--------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIK------V 241 (364)
T ss_pred ccC--------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHH------H
Confidence 543 23356678899999999988 5799999999999999999999877765433 333322111 1
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDE--TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~--p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
++....+... |+..+ -.+-|.+.... ..+ -.....++++.||+.++|+++|.+|.+|.|+|.
T Consensus 242 ----lG~Pt~e~I~--------~mn~~y~~~~~p~ik~~~--~~~--~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 242 ----LGTPTREDIK--------SMNPNYTEFKFPQIKAHP--WHK--VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ----hCCCCHHHHh--------hcCcccccccCccccccc--cee--ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111111 11111 01111111100 000 123456677889999999999999999999999
Q ss_pred CCCCCC
Q 002289 918 HPYVSS 923 (941)
Q Consensus 918 Hpwf~~ 923 (941)
||||+.
T Consensus 306 h~fFde 311 (364)
T KOG0658|consen 306 HPFFDE 311 (364)
T ss_pred chhhHH
Confidence 999965
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=360.56 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=204.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999975 68999999986432 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999996543 4888999999999999999999999 999999999999999999999999998764321
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +..+ .
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~---------i~~~-~ 214 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEK---------ILAG-K 214 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH---------HHhC-C
Confidence 123458999999999999999999999999999999999999996543211 0000 0000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC-----CccCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKHP 919 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-----a~e~L~Hp 919 (941)
..++ ...+....++|.+||..||++|++ ++|+++||
T Consensus 215 ~~~~---------------------------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 LEFP---------------------------------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred cCCC---------------------------------------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 0000 011223457888889999999995 99999999
Q ss_pred CCCCCCC
Q 002289 920 YVSSDVS 926 (941)
Q Consensus 920 wf~~~~~ 926 (941)
||....+
T Consensus 256 ~~~~~~~ 262 (291)
T cd05612 256 WFKSVDW 262 (291)
T ss_pred cccCCCH
Confidence 9976443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=364.98 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=212.4
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
+-|+..+.||+|+-|.|-.|+. .+|+.+|||++...... ....+.+|+-+|+-+.||||+++++.+++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4466788999999999999995 58999999998765221 1346789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|-|.+++-+++ ++.+.++.++++||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|.....
T Consensus 92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-- 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-- 164 (786)
T ss_pred EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence 9999999999997765 4888999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccccccccCCCcccccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......+|++.|.|||+++|.+|. .++||||.|||||.|+||+.||+++. ....+.. +.
T Consensus 165 ------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-ir~LLlK---------V~--- 225 (786)
T KOG0588|consen 165 ------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-IRVLLLK---------VQ--- 225 (786)
T ss_pred ------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-HHHHHHH---------HH---
Confidence 3344566899999999999999885 57999999999999999999998433 1111110 00
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
...+.+.....+++-|||++||.+||++|+|.+|+++|||+..
T Consensus 226 -------------------------------------~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 226 -------------------------------------RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred -------------------------------------cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 0112223334455668999999999999999999999999977
Q ss_pred CCCC
Q 002289 924 DVSG 927 (941)
Q Consensus 924 ~~~~ 927 (941)
-..-
T Consensus 269 ~~~~ 272 (786)
T KOG0588|consen 269 YTSL 272 (786)
T ss_pred CCCC
Confidence 6553
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=343.73 Aligned_cols=281 Identities=23% Similarity=0.327 Sum_probs=227.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC-CcEEEEEEeccCCchhh---HhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
-+.|+..+.||+|.-|+||++..++ +..+|+|++.+.....+ .+...|-+||+.++||.++.+|+.|+.++..|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3456667899999999999999764 68999999987655443 4677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||||+||+|..+.+++....+++..++.++..++-||+|||-.| ||.|||||+||||.++|++-|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999997543210
Q ss_pred -CC-----------------------------C-C------------------ccccccccccccCCCcccccccccCCC
Q 002289 764 -DI-----------------------------E-G------------------IVPAHVSTVVKGTPGYLDPEYFLTHKL 794 (941)
Q Consensus 764 -~~-----------------------------~-~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~ 794 (941)
.. . . ......+...+||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 0 0 000122345679999999999999999
Q ss_pred CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 002289 795 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 874 (941)
Q Consensus 795 ~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~ 874 (941)
+.++|+|+|||++|||+.|+.||....+... +..++.... .+|.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------l~NIv~~~l-~Fp~------------------------- 356 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------LRNIVGQPL-KFPE------------------------- 356 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------HHHHhcCCC-cCCC-------------------------
Confidence 9999999999999999999999976554221 111211111 1110
Q ss_pred HHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC----CccCCCCCCCCCCCCCCccccccccccCCC
Q 002289 875 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS----SSSMLKHPYVSSDVSGSNLVSGVIPTITPR 941 (941)
Q Consensus 875 ~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s----a~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~ 941 (941)
.+.....+.|||+++|..||.+|+- |.|+-+||||++..+. ++...+||.-|+
T Consensus 357 ------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa--Lir~~~PP~iP~ 413 (459)
T KOG0610|consen 357 ------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA--LIRCARPPEIPK 413 (459)
T ss_pred ------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh--heeccCCCcCCC
Confidence 0112244568999999999999999 9999999999998887 777777776553
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=365.43 Aligned_cols=199 Identities=26% Similarity=0.397 Sum_probs=173.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC--CcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||.||+|.+++ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4568889999999999999998643 4689999886422 2224567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999997653 4889999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 1 123468999999999999889999999999999999999999997543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=361.39 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=209.4
Q ss_pred HHhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeeccccC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 677 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 677 (941)
...++|++.++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++.+ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4567899999999999999999974 2357899999875432 2345789999999999 899999999988654
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 002289 678 -GEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 700 (941)
Q Consensus 678 -~~~~LV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 700 (941)
+..++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46899999999999999986432
Q ss_pred ----CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccc
Q 002289 701 ----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 776 (941)
Q Consensus 701 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~ 776 (941)
..++++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... ......
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~ 235 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGS 235 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc-----hhcccC
Confidence 134788889999999999999999999 99999999999999999999999999986532211 011122
Q ss_pred cccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHH
Q 002289 777 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 855 (941)
Q Consensus 777 ~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 855 (941)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........... .+..+.....+..++..+
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l 306 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---------RLKDGTRMRAPENATPEI 306 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---------HHhcCCCCCCCCCCCHHH
Confidence 345678999999999999999999999999999997 9999975432111111 112222233455667789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 856 IKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 856 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+++.+||+.+|++||++.++++.|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=354.18 Aligned_cols=284 Identities=22% Similarity=0.284 Sum_probs=209.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|+||+||+|+.+ +++.||+|+++.... ...+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999975 688999999875322 224568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|++++.+..+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 9988777655432 235888999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
........|+..|+|||++.+..++.++||||+||++|||++|+.||............ ....+
T Consensus 155 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~-----------~~~~~ 218 (287)
T cd07848 155 -----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI-----------QKVLG 218 (287)
T ss_pred -----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------HHhhC
Confidence 11122346889999999999989999999999999999999999999765432211111 01112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
..+.+....+.. .........|........ + .......+..+.+|+.+||+.||++|+|++|+|+||||
T Consensus 219 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~-~--~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 219 PLPAEQMKLFYS----NPRFHGLRFPAVNHPQSL-E--RRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CCCHHHHHhhhc----cchhcccccCcccCcccH-H--HhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 223222221110 000000011111000000 0 01112234557799999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.77 Aligned_cols=286 Identities=21% Similarity=0.324 Sum_probs=209.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||+||+|+.. +++.||||+++..... ....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 6899999998754322 23467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 68888886543 45788899999999999999999999 9999999999999999999999999987543211
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....+........... .
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------~---- 221 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV------L---- 221 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH------h----
Confidence 11233457899999999876 458889999999999999999999997655433332221110 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETD--ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~--~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
+......+..... +-...|+ ...+...+.+... . ......+.+|+.+||+.||++|+|++|+|+||||+
T Consensus 222 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 222 GTPNEDTWPGVHS----LPHFKPERFTLYSPKNLRQAWN----K-LSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred CCCChhhccchhh----ccccccccccccCCccHHHHhh----c-cCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 0000000000000 0000010 0001111111111 1 11234567899999999999999999999999998
Q ss_pred CC
Q 002289 923 SD 924 (941)
Q Consensus 923 ~~ 924 (941)
..
T Consensus 293 ~~ 294 (303)
T cd07869 293 DL 294 (303)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.57 Aligned_cols=278 Identities=24% Similarity=0.359 Sum_probs=206.7
Q ss_pred cCCCccceeeccCcEEEEEEEeC--CCcEEEEEEeccCCch--hhHhHHHHHHHHHhc---CCCceeeeeeccc-----c
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCD-----E 676 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~ 676 (941)
++|++.+.||+|+||+||+|+.. +++.||+|+++..... ....+.+|+++++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 4788999988753222 234566787777665 6999999999874 3
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
....++||||++ ++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 69999997766566899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||....+.... ..
T Consensus 157 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~------- 220 (290)
T cd07862 157 ARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GK------- 220 (290)
T ss_pred eEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HH-------
Confidence 9765321 1223456899999999999889999999999999999999999999765442211 11
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
+++......+.+++... .+...++...+. .... ...+..+....+++.+||+.||++|||+.|+|
T Consensus 221 --i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 221 --ILDVIGLPGEEDWPRDV-ALPRQAFHSKSA--QPIE----------KFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred --HHHHhCCCChhhchhhh-cccchhccCCCC--CCHH----------HHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 11110011111211111 111222222211 1111 12234455667899999999999999999999
Q ss_pred CCCCC
Q 002289 917 KHPYV 921 (941)
Q Consensus 917 ~Hpwf 921 (941)
+||||
T Consensus 286 ~hp~f 290 (290)
T cd07862 286 SHPYF 290 (290)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.21 Aligned_cols=264 Identities=28% Similarity=0.392 Sum_probs=206.7
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--------------hhHhHHHHHHHHHhcCCCceeeee
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------GEKEFLTEIQFLSRLHHRNLVSLV 671 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~nIv~l~ 671 (941)
..++|++...||+|.||.|-+|+.. +++.||||++.+.... ..+.+.+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999965 7999999998753211 124788999999999999999999
Q ss_pred ecccc--CCcEEEEEecCCCCCHHHHHhhcCCCC-ccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 002289 672 GYCDE--EGEQMLVYEFMSNGTLRDQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748 (941)
Q Consensus 672 ~~~~~--~~~~~LV~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 748 (941)
.+..+ .+.+|||+|||..|.+... ....+ +++.++++++++++.||+|||.++ ||||||||+|+|++++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 99865 4689999999988877543 23334 899999999999999999999999 999999999999999999
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCC----CCchhHhHHHHHHHHHHHhCCCCCCCCchhH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGKNIV 824 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~ 824 (941)
+||+|||.+.........+. ........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+...+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred EEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999987654432221 22233478999999999998733 3567999999999999999999997544321
Q ss_pred HHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCC
Q 002289 825 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 904 (941)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~ 904 (941)
-.- +++ .+|-.=|... +..+.+.|+|.+||..
T Consensus 327 l~~----------KIv------------------------n~pL~fP~~p--------------e~~e~~kDli~~lL~K 358 (576)
T KOG0585|consen 327 LFD----------KIV------------------------NDPLEFPENP--------------EINEDLKDLIKRLLEK 358 (576)
T ss_pred HHH----------HHh------------------------cCcccCCCcc--------------cccHHHHHHHHHHhhc
Confidence 110 111 1222223322 2234445889999999
Q ss_pred CCCCCCCCccCCCCCCCCCCCC
Q 002289 905 KEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 905 dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
||++|++..++..|||.+.+..
T Consensus 359 dP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 359 DPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred ChhheeehhhheecceeccCCC
Confidence 9999999999999999987644
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.44 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=214.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|.||.||.|+.+ ++..||+|++...... -+.++.+|+++-+.++||||+++++||.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467889999999999999999954 6889999998654332 256899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
+||.++|++...|.......+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++..||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998777777999999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......+||..|.+||...+..++..+|+|++|++.||++.|..||.....
T Consensus 176 -------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------------------- 227 (281)
T KOG0580|consen 176 -------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------------------- 227 (281)
T ss_pred -------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------------
Confidence 2345667899999999999999999999999999999999999999964321
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.+.++-+.++--..| ......+.|+|.++|..+|.+|.+-.|++.|||+..
T Consensus 228 ---------~etYkrI~k~~~~~p--------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 228 ---------SETYKRIRKVDLKFP--------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ---------HHHHHHHHHccccCC--------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 111111222211111 123345568889999999999999999999999865
Q ss_pred C
Q 002289 924 D 924 (941)
Q Consensus 924 ~ 924 (941)
.
T Consensus 279 ~ 279 (281)
T KOG0580|consen 279 N 279 (281)
T ss_pred c
Confidence 3
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=360.66 Aligned_cols=273 Identities=24% Similarity=0.382 Sum_probs=217.3
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHHHHhc-CCCceeeeeeccccCCcE
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 680 (941)
...++|....+||+|.||+|+++..+ +++.+|||++++...-. .+..+.|-+++... +||.++.++.+|+.+++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578889999999999999999976 68899999999865433 34567788888777 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
|+||||+.||++..+. ....+++..+..++..|+.||+|||+++ ||+||||.+|||+|.+|.+||+|||+++..
T Consensus 445 ~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999944333 3346999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.. ....+...+||+.|||||++.+..|+.++|+|||||+||||+.|..||..++.. .+++.|
T Consensus 519 m~-------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------e~FdsI 580 (694)
T KOG0694|consen 519 MG-------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------EVFDSI 580 (694)
T ss_pred CC-------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHH
Confidence 21 234567789999999999999999999999999999999999999999755431 112222
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC-----CccC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSM 915 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-----a~e~ 915 (941)
-.....+|..++.+.. ++++++|+.+|++|+- |.++
T Consensus 581 ~~d~~~yP~~ls~ea~---------------------------------------~il~~ll~k~p~kRLG~~e~d~~~i 621 (694)
T KOG0694|consen 581 VNDEVRYPRFLSKEAI---------------------------------------AIMRRLLRKNPEKRLGSGERDAEDI 621 (694)
T ss_pred hcCCCCCCCcccHHHH---------------------------------------HHHHHHhccCcccccCCCCCCchhh
Confidence 2222334444444433 3455566677777764 5788
Q ss_pred CCCCCCCCCCCCCccccccccccCCC
Q 002289 916 LKHPYVSSDVSGSNLVSGVIPTITPR 941 (941)
Q Consensus 916 L~Hpwf~~~~~~~~~~~~~~~~~~~~ 941 (941)
.+||||++-.+..-....+-||+.|+
T Consensus 622 ~~hpFFr~i~w~~L~~r~i~PPf~P~ 647 (694)
T KOG0694|consen 622 KKHPFFRSIDWDDLLNRRIKPPFVPT 647 (694)
T ss_pred hhCCccccCCHHHHhhccCCCCCCcc
Confidence 89999999777655556666766653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=362.23 Aligned_cols=198 Identities=25% Similarity=0.424 Sum_probs=174.5
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 689999999875321 22356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999997643 4788889999999999999999999 999999999999999999999999999765321
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 172 ---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred ---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 123468999999999999999999999999999999999999996543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=359.42 Aligned_cols=194 Identities=26% Similarity=0.342 Sum_probs=168.7
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 689999999875321 22346788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccc
Q 002289 691 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 770 (941)
Q Consensus 691 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 770 (941)
+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------- 148 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------- 148 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-------
Confidence 9999986543 5889999999999999999999999 999999999999999999999999998753211
Q ss_pred cccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 771 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 11223456999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.79 Aligned_cols=297 Identities=22% Similarity=0.363 Sum_probs=223.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
..++|++.++||+|+||.||+|.+. ++..+|+|.+..... ...+.+.+|++++++++|+||++++++|.+.++.++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999976 688999998875432 23457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999996543 478899999999999999999974 5 999999999999999999999999998754321
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ........ ...+.
T Consensus 158 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~-----~~~~~ 221 (333)
T cd06650 158 ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGC-----PVEGD 221 (333)
T ss_pred ---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcC-----cccCC
Confidence 112345889999999999989999999999999999999999999754321 11111100 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC------CCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE------SDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~------~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
... .............|....|..||++.. .+....+....+. .+.+..+|+.+||+.||++|||++|+++
T Consensus 222 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 222 PAE--SETSPRPRPPGRPLSSYGPDSRPPMAI-FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccc--cccCcccCCccchhhhhcccccccccH-HHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000 000011112223455567888887642 2233322222111 1233468999999999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 918 HPYVSSDVSG 927 (941)
Q Consensus 918 Hpwf~~~~~~ 927 (941)
||||+....+
T Consensus 299 h~~~~~~~~~ 308 (333)
T cd06650 299 HAFIKRSEAE 308 (333)
T ss_pred CHHHhcCccc
Confidence 9999876443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.92 Aligned_cols=294 Identities=24% Similarity=0.355 Sum_probs=214.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC---C--CcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeecccc-CC
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP---D--GTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 678 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~ 678 (941)
....|+....||+|.||.||+|.-. + .+.+|+|.++..... -.....+|+.+++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3457888999999999999999643 2 237999998864221 13467899999999999999999999866 77
Q ss_pred cEEEEEecCCCCCHHHHHhhc---CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC----CcEEE
Q 002289 679 EQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKV 751 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~~kl 751 (941)
..++++||.+. +|.+.++-+ ....++...++.|..||+.|+.|||++- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999975 999988643 2246888999999999999999999999 9999999999999877 89999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~ 830 (941)
+|||+|+.+..+-. +-.....++-|..|+|||.+.|. .|+.+.||||.||++.||+|-.+.|...+...+. .
T Consensus 178 aDlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~-~-- 250 (438)
T KOG0666|consen 178 ADLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT-K-- 250 (438)
T ss_pred ecccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc-C--
Confidence 99999998865421 12233456678999999999984 6899999999999999999987777543221100 0
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcc---cCCCCCCCHHHHHHHH----------HHhHhhCCCCCCCCccc
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQ---DETDARPSMSEVMREL----------ESIWNMMPESDTKTPEF 897 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~---~~p~~RPs~~~v~~~L----------~~~~~~~~~~~~~~~dl 897 (941)
.++..+-..++.+++-.-.+ ++-+.-|.....+... -.+.......++.+.+|
T Consensus 251 --------------~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~L 316 (438)
T KOG0666|consen 251 --------------NPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDL 316 (438)
T ss_pred --------------CCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHH
Confidence 01111222222222110000 0001112222222222 23333444566778999
Q ss_pred ccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 898 INSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 898 l~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
+.+||++||.+|+||++||+|+||+.+.
T Consensus 317 L~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 317 LQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred HHHHhccCchhhccHHHHhcccccccCC
Confidence 9999999999999999999999998863
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=358.01 Aligned_cols=298 Identities=23% Similarity=0.374 Sum_probs=214.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||.||+++.. +|..||+|.+..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999975 688999999875432 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+. |+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999996543 47889999999999999999998532 999999999999999999999999998754321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... + ........ ..+....
T Consensus 158 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~-~~~~~~~~----~~~~~~~ 224 (331)
T cd06649 158 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-E-LEAIFGRP----VVDGEEG 224 (331)
T ss_pred -------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-H-HHHHhccc----ccccccC
Confidence 122346899999999999999999999999999999999999999654321 1 11111000 0000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC------CCCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP------ESDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~------~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
. +.............+....+..+|.+. +.+.+..+..... ...++..+|+.+||++||++|||++|+++||
T Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 E-PHSISPRPRPPGRPVSGHGMDSRPAMA-IFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred C-ccccCcccccccccccccccccccchh-HHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 000000000000001111222333332 1122222211111 1123456899999999999999999999999
Q ss_pred CCCCCCC
Q 002289 920 YVSSDVS 926 (941)
Q Consensus 920 wf~~~~~ 926 (941)
||.....
T Consensus 303 ~~~~~~~ 309 (331)
T cd06649 303 FIKRSEV 309 (331)
T ss_pred HHhhccc
Confidence 9976544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.48 Aligned_cols=240 Identities=29% Similarity=0.513 Sum_probs=205.9
Q ss_pred ccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 613 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 613 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
.++-||.|+-|.||+|+++ ++.||||+++.- -..+|+-|++++|+||+.|.|+|...-.+|||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3567999999999999985 588999987641 23578899999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.++|+.. .++.......+..+||.||.|||.+. |||||||+-||||+.+..|||+|||-++..... .
T Consensus 200 ~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--------S 266 (904)
T KOG4721|consen 200 YEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--------S 266 (904)
T ss_pred HHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--------h
Confidence 9999654 45788888899999999999999999 999999999999999999999999999865431 2
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC-CCCChHH
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-GSYPSEC 851 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 851 (941)
.....+||..|||||+++..++++|+|||||||+||||+||..||.+... ...++-+-...+ ...|..|
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----------sAIIwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----------SAIIWGVGSNSLHLPVPSTC 336 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----------heeEEeccCCcccccCcccC
Confidence 23567899999999999999999999999999999999999999975432 122223322222 3578999
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 852 VEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 852 ~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
++.+.-+++.||+..|..||++.+++.+|+-.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 99999999999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=380.35 Aligned_cols=262 Identities=32% Similarity=0.534 Sum_probs=219.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC--Cc----EEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD--GT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
..+.+..+.||+|+||.||.|...+ |. .||||.++... .+...+|.+|..+|+.++|||||+++|.|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4455667899999999999999643 43 48999988654 44467899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhc-----CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 681 MLVYEFMSNGTLRDQLSAK-----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
++++|||++|+|..+|++. ....++..+.+.++.|||+|+.||++++ +|||||.++|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999764 1346889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
+|+.....+++... ....-...|||||.+..+.++.|+|||||||++||++| |..||....+..
T Consensus 848 lArDiy~~~yyr~~-----~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---------- 912 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKH-----GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---------- 912 (1025)
T ss_pred hhHhhhhchheecc-----CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----------
Confidence 99955443332111 11123468999999999999999999999999999999 899998766522
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
.+..+..+.+.+.|..|++.++++|..||+.+|++||++..+++.+..+.+..
T Consensus 913 v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 913 VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 12224445577789999999999999999999999999999999888876644
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=326.52 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=206.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh--------hHhHHHHHHHHHhc-CCCceeeeeeccccC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--------EKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 677 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 677 (941)
-++|...+.||+|..++|-++..+ +|..+|+|++....... .+.-.+|+.+|+++ .||+|+++.++|..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777889999999999998865 68899999876422111 23456899999998 699999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
...++|+|.|+.|.|.|++... -.+++...++|++|+..|++|||.+. ||||||||+|||+|++.++||+|||.|
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999654 45899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc------CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~ 831 (941)
+.+.. +......+||++|+|||.+.. ..|+..+|+||.||++|.++.|..||.+...+.-
T Consensus 171 ~~l~~--------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM------ 236 (411)
T KOG0599|consen 171 CQLEP--------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM------ 236 (411)
T ss_pred eccCC--------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH------
Confidence 97754 345677899999999999863 3578899999999999999999999965433210
Q ss_pred hhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC
Q 002289 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 911 (941)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 911 (941)
+..+..+.. .+.. |. +.+.....+|||.++|+.||.+|+|
T Consensus 237 ----LR~ImeGky-qF~s---------------------pe--------------Wadis~~~KdLIsrlLqVdp~~Rit 276 (411)
T KOG0599|consen 237 ----LRMIMEGKY-QFRS---------------------PE--------------WADISATVKDLISRLLQVDPTKRIT 276 (411)
T ss_pred ----HHHHHhccc-ccCC---------------------cc--------------hhhccccHHHHHHHHHeeCchhccc
Confidence 001111111 1111 11 1122345578999999999999999
Q ss_pred CccCCCCCCCCC
Q 002289 912 SSSMLKHPYVSS 923 (941)
Q Consensus 912 a~e~L~Hpwf~~ 923 (941)
|+|+|.||||.+
T Consensus 277 ake~LaHpff~q 288 (411)
T KOG0599|consen 277 AKEALAHPFFIQ 288 (411)
T ss_pred HHHHhcChHHHH
Confidence 999999999944
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=354.89 Aligned_cols=192 Identities=29% Similarity=0.408 Sum_probs=167.5
Q ss_pred eeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 58899999986432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-------~ 148 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-------D 148 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------C
Confidence 99996543 4889999999999999999999999 9999999999999999999999999987532211 1
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=360.48 Aligned_cols=285 Identities=24% Similarity=0.368 Sum_probs=215.3
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccCC-----cEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 681 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 681 (941)
+|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 7899999988643 2233467889999999999999999999997766 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||++ ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 6888887543 35889999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... ........++..|+|||++.+. .++.++||||+||++|||++|+.||....... ......
T Consensus 155 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~--------- 218 (372)
T cd07853 155 PDE------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLIT--------- 218 (372)
T ss_pred cCc------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHH---------
Confidence 221 1112334578899999999874 57899999999999999999999997654322 111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
...+..+.+.......-....+...+...|....+. ......++.+.+||.+||..||++|||++|+|+|||
T Consensus 219 -~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 219 -DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY-------TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred -HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc-------ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 111222222222222223333334455555433221 122334566788999999999999999999999999
Q ss_pred CCCC
Q 002289 921 VSSD 924 (941)
Q Consensus 921 f~~~ 924 (941)
|...
T Consensus 291 ~~~~ 294 (372)
T cd07853 291 LDEG 294 (372)
T ss_pred hCCC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.00 Aligned_cols=234 Identities=24% Similarity=0.288 Sum_probs=184.4
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
+.||+|+||.||++... +|+.||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 689999999875322 22346778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccc
Q 002289 691 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 770 (941)
Q Consensus 691 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 770 (941)
+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~------ 149 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC------
Confidence 9999886543 5889999999999999999999999 9999999999999999999999999987532111
Q ss_pred cccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChH
Q 002289 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 850 (941)
Q Consensus 771 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... +......+|..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~----------~~~~~~~~p~~ 217 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FEL----------ILMEEIRFPRT 217 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHH----------HhcCCCCCCCC
Confidence 112335689999999999999999999999999999999999999975432111 110 00111123334
Q ss_pred HHHHHHHHHHHhcccCCCCCC
Q 002289 851 CVEKFIKLALKCCQDETDARP 871 (941)
Q Consensus 851 ~~~~l~~l~~~c~~~~p~~RP 871 (941)
.+..+.+++..|++.+|++|+
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhC
Confidence 445555666666666666665
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=373.40 Aligned_cols=297 Identities=22% Similarity=0.306 Sum_probs=208.7
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC------Cceeeeeecc
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH------RNLVSLVGYC 674 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~ 674 (941)
+++....++|++.++||+|+||+||+|... +++.||||+++... .....+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456789999999999999999999964 68899999986432 223455667777777654 4588999988
Q ss_pred ccC-CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCC-----
Q 002289 675 DEE-GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKF----- 747 (941)
Q Consensus 675 ~~~-~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~----- 747 (941)
... ++.++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+ .+ ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 654 5789999998 78999988654 358899999999999999999997 47 99999999999998765
Q ss_pred -----------cEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCC
Q 002289 748 -----------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816 (941)
Q Consensus 748 -----------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~P 816 (941)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 49999999876421 122345789999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCH--HHHHHHHHHhHhhCCCCCCC
Q 002289 817 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSM--SEVMRELESIWNMMPESDTK 893 (941)
Q Consensus 817 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~--~~v~~~L~~~~~~~~~~~~~ 893 (941)
|....+... ... +....+.+|.++.... ......++......+|.. ..+.+............++.
T Consensus 345 f~~~~~~~~-~~~----------i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (467)
T PTZ00284 345 YDTHDNLEH-LHL----------MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL 413 (467)
T ss_pred CCCCChHHH-HHH----------HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHH
Confidence 976543221 111 1111233333332210 000111111111111111 11111110000000112355
Q ss_pred CcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 894 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 894 ~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
+.|||.+||++||++|+||+|+|+||||...-.
T Consensus 414 ~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 414 LCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 679999999999999999999999999987444
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=346.89 Aligned_cols=200 Identities=27% Similarity=0.417 Sum_probs=174.5
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
+|++.+.||+|+||+||++... +++.||+|++...... ....+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 6899999998653322 23457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999999887655556899999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 112345889999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=354.53 Aligned_cols=287 Identities=24% Similarity=0.369 Sum_probs=208.6
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccC-----CcEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQM 681 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 681 (941)
+|++.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 6899999998742 222345688999999999999999999987433 3579
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+ +++|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 579999886543 4889999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCCCccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...... ..
T Consensus 155 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~------~~- 222 (338)
T cd07859 155 NDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLI------TD- 222 (338)
T ss_pred cccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHH------HH-
Confidence 22110 111234568999999999876 67899999999999999999999999654432 111110 01
Q ss_pred hcCCCCCCChHHHHHHHHH-HHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 840 IDGNMGSYPSECVEKFIKL-ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l-~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
..+..+.+....+... ....+.......|.. ....++..++...+++.+||..||++|||++|+|+|
T Consensus 223 ---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 223 ---LLGTPSPETISRVRNEKARRYLSSMRKKQPVP---------FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred ---HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCc---------hHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1111222222221110 000000000111110 011233445566789999999999999999999999
Q ss_pred CCCCCCCC
Q 002289 919 PYVSSDVS 926 (941)
Q Consensus 919 pwf~~~~~ 926 (941)
|||.+...
T Consensus 291 p~f~~~~~ 298 (338)
T cd07859 291 PYFKGLAK 298 (338)
T ss_pred chhhhcCc
Confidence 99977554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.04 Aligned_cols=194 Identities=25% Similarity=0.404 Sum_probs=167.3
Q ss_pred eeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
||+|+||+||++... +++.||+|.+...... ..+.+..|+++++.++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 6899999998653322 224577899999999999999999999999999999999999999
Q ss_pred HHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccc
Q 002289 693 RDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 770 (941)
Q Consensus 693 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 770 (941)
.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------ 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ------ 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC------
Confidence 9887542 3346899999999999999999999999 9999999999999999999999999987653321
Q ss_pred cccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 771 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1123346899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.83 Aligned_cols=269 Identities=31% Similarity=0.484 Sum_probs=221.8
Q ss_pred chHHHHHHhcCCCccceeeccCcEEEEEEEeC--CC--cE-EEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeee
Q 002289 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP--DG--TV-VAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLV 671 (941)
Q Consensus 600 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~--~~--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~ 671 (941)
.-+.|+...++....++||+|+||.||+|.+. ++ .. ||||..+... ....++|.+|.++|++++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 33456666666677799999999999999964 22 23 8999988522 34457899999999999999999999
Q ss_pred eccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 002289 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 751 (941)
Q Consensus 672 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 751 (941)
|++..+..+++|||+|+||+|.++|++.+. .++..++..++.++|+||+|||+++ +|||||.++|+|++.++.+||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999999987654 6899999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~ 830 (941)
+|||+++...... .......-...|+|||.+..+.|+.++|||||||++||+++ |..||.......-.
T Consensus 304 SDFGLs~~~~~~~-------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---- 372 (474)
T KOG0194|consen 304 SDFGLSRAGSQYV-------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---- 372 (474)
T ss_pred CccccccCCccee-------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH----
Confidence 9999987543111 00111134578999999999999999999999999999999 88899866543211
Q ss_pred Hhhccchhh-hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 831 YQSSMMFSV-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 831 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
..+ ..+.+...|...+..+..++..||..+|+.||+|.++.+.++.+......
T Consensus 373 ------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 373 ------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 122 23444566778888999999999999999999999999999998776543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.03 Aligned_cols=194 Identities=27% Similarity=0.351 Sum_probs=168.5
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 68999999987532 223356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccc
Q 002289 691 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 770 (941)
Q Consensus 691 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 770 (941)
+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------- 148 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------- 148 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-------
Confidence 9999886543 5889999999999999999999999 999999999999999999999999998753211
Q ss_pred cccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 771 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 11123356899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.01 Aligned_cols=195 Identities=27% Similarity=0.420 Sum_probs=166.8
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||+||+|+.+ +++.||||+++... ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68999999987532 12234567888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------ 149 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------ 149 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------
Confidence 99999986543 4889999999999999999999999 999999999999999999999999998753211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=351.66 Aligned_cols=290 Identities=25% Similarity=0.355 Sum_probs=197.2
Q ss_pred cceeeccCcEEEEEEEeC---CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc--CCcEEEEEecCC
Q 002289 614 STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVYEFMS 688 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~LV~e~~~ 688 (941)
.++||+|+||+||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 468999999999999864 468899999875322 3457889999999999999999998843 45689999999
Q ss_pred CCCHHHHHhhc-------CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEeeeccc
Q 002289 689 NGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLS 757 (941)
Q Consensus 689 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DFGla 757 (941)
+++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 46898887532 1235889999999999999999999999 9999999999999 45679999999999
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
+....... +........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........... .+....+
T Consensus 160 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~-~~~~~~~ 234 (317)
T cd07868 160 RLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN-PYHHDQL 234 (317)
T ss_pred eccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccc-cccHHHH
Confidence 86543211 1112234568999999999987 4589999999999999999999999964322100000 0000000
Q ss_pred hhhhcCCCCCCChHHHHHHHHHH-----HHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLA-----LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 911 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~-----~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 911 (941)
..++ ...+......++.+.++. ...+........ .+...++ ......+..+.|||.+||++||++|+|
T Consensus 235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~dli~~mL~~dP~~R~t 307 (317)
T cd07868 235 DRIF-NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC---SLIKYME---KHKVKPDSKAFHLLQKLLTMDPIKRIT 307 (317)
T ss_pred HHHH-HhcCCCChHHhHHHhhccchhhhhhhhhccccCcc---cccchHH---hcCCCCChHHHHHHHHHhccCcccCCC
Confidence 0000 001111111111111100 000000000000 0111111 111233455778999999999999999
Q ss_pred CccCCCCCCC
Q 002289 912 SSSMLKHPYV 921 (941)
Q Consensus 912 a~e~L~Hpwf 921 (941)
|+|+|+||||
T Consensus 308 ~~e~l~hp~f 317 (317)
T cd07868 308 SEQAMQDPYF 317 (317)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.81 Aligned_cols=197 Identities=30% Similarity=0.443 Sum_probs=174.5
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 589999999875322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999996543 4888999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 123456899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=354.26 Aligned_cols=199 Identities=27% Similarity=0.342 Sum_probs=169.6
Q ss_pred CCCccceeeccCcEEEEEEEe----CCCcEEEEEEeccCC----chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcE
Q 002289 610 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 680 (941)
+|++.+.||+|+||+||+++. .+++.||+|++.... ....+.+.+|+++++.+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999885 358899999986422 12234678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999986543 4889999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
.... ........||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 156 LSEE------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccC------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 3221 1112345689999999999875 478899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=352.58 Aligned_cols=195 Identities=27% Similarity=0.414 Sum_probs=167.6
Q ss_pred ceeeccCcEEEEEEEe----CCCcEEEEEEeccCCc----hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 615 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+.||+|+||.||+++. .+++.||+|+++.... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 3578999999875321 2234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|+|.+++.... .+.+..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999996543 4778888899999999999999999 9999999999999999999999999987432211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 11233568999999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=347.81 Aligned_cols=285 Identities=22% Similarity=0.350 Sum_probs=210.4
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|.+.+.||+|+||+||+|+.+ +++.||+|.++..... ....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57889999999999999999975 6889999998754322 234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ ++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 96 58988886543 34788899999999999999999999 9999999999999999999999999987543221
Q ss_pred CccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||.+.+ ..++.++||||+||++|||+||+.||...... +...... .. .+
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~------~~----~~ 222 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIF------RL----LG 222 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH------HH----hC
Confidence 11223457889999999875 56889999999999999999999999754331 1111110 00 11
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
..+.+.+..+.......-...|..+|.. .....+..+.+..+||.+||..||++|+|++|+|+||||+.-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQP---------LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCCc---------hhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 1111111111111000001112111111 1122234456677999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.28 Aligned_cols=261 Identities=20% Similarity=0.336 Sum_probs=208.7
Q ss_pred CccccchHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh---hHhHHHHHHHHHhcCCCceeeee
Q 002289 595 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLV 671 (941)
Q Consensus 595 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~ 671 (941)
++..++.+++.. .....||+|++|.||+|.+ +|+.||||+++...... .+.+.+|++++++++||||++++
T Consensus 11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 344455555522 2236799999999999998 68999999987643322 35678999999999999999999
Q ss_pred ecccc----CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCC
Q 002289 672 GYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHK 746 (941)
Q Consensus 672 ~~~~~----~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~ 746 (941)
|++.+ ....++||||+++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+||+++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 99866 34689999999999999999754 3588999999999999999999984 6 7899999999999999
Q ss_pred CcEEEeeeccccccCCCCCCCccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhH
Q 002289 747 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 824 (941)
Q Consensus 747 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~ 824 (941)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 160 ~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~ 228 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-K 228 (283)
T ss_pred CcEEEcccchHhhhcccc----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-H
Confidence 999999999987653211 12357889999999976 6899999999999999999999999975432 1
Q ss_pred HHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 825 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+....... .......+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 229 ~~~~~i~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 229 EIYDLIIN--------KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHh--------cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11111100 112233455678889999999999999999999999999987653
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=361.73 Aligned_cols=286 Identities=22% Similarity=0.255 Sum_probs=206.7
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
...+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3557999999999999999999975 578999996432 246789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
++ .++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 241 ~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99 579999886543 36899999999999999999999999 99999999999999999999999999986532211
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch------hHHHHHHHHhhccchhh
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNIAYQSSMMFSV 839 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~------~~~~~~~~~~~~~~~~~ 839 (941)
........||..|+|||++.+..++.++|||||||++|||++|..|+..... ....+.........
T Consensus 316 -----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~--- 387 (461)
T PHA03211 316 -----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV--- 387 (461)
T ss_pred -----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc---
Confidence 1112345699999999999999999999999999999999998877643221 01111111100000
Q ss_pred hcCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 840 IDGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 840 ~~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
......... ......+.... ......+..++... .+...+....+||.+||++||++||||.|+|+|
T Consensus 388 ~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~-----------~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 388 HVDEFPQHAGSRLVSQYRHRA-ARNRRPAYTRPAWT-----------RYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccCCCCcchHHHHHHHhhh-hcccCCccCCcchh-----------hhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000011111 11111111100 01111111111111 112234566789999999999999999999999
Q ss_pred CCCCC
Q 002289 919 PYVSS 923 (941)
Q Consensus 919 pwf~~ 923 (941)
|||++
T Consensus 456 p~f~~ 460 (461)
T PHA03211 456 PLFQS 460 (461)
T ss_pred cccCC
Confidence 99976
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=352.63 Aligned_cols=192 Identities=26% Similarity=0.389 Sum_probs=166.1
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999987532 22334677888888776 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~------ 149 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------ 149 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC------
Confidence 99999886543 5889999999999999999999999 999999999999999999999999998753221
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~ 818 (941)
........||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 112234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=347.31 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=215.4
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHHHHhcC-CCceeeeeeccccCCcEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 681 (941)
....|++.+.||+|.||.||+++.+ +|+.+|+|++....... ...+.+|+++|+++. ||||+.+++.|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3567888899999999999999976 59999999998655443 358899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC----CcEEEeeeccc
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLS 757 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~~kl~DFGla 757 (941)
+|||++.||.|.+.+.+. .+++..+..++.|++.|+.|||+.+ |+||||||+|+|+... +.+|++|||+|
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999766 3999999999999999999999999 9999999999999643 57999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||..........
T Consensus 187 ~~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------- 248 (382)
T KOG0032|consen 187 KFIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------- 248 (382)
T ss_pred eEccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------
Confidence 87643 234567789999999999999999999999999999999999999997655322111
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
.+..+. +.. .++ .++.....+.+|++.||..||.+|+||.++|+
T Consensus 249 ~i~~~~-------------------~~f---~~~--------------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 249 AILRGD-------------------FDF---TSE--------------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHcCC-------------------CCC---CCC--------------CccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111111 000 111 12223445568999999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 918 HPYVSSDVS 926 (941)
Q Consensus 918 Hpwf~~~~~ 926 (941)
|||+++...
T Consensus 293 HpWi~~~~~ 301 (382)
T KOG0032|consen 293 HPWIKSIGE 301 (382)
T ss_pred CccccCCcc
Confidence 999988643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.95 Aligned_cols=270 Identities=26% Similarity=0.390 Sum_probs=205.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHh--cCCCceeeeeeccccCC----cEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEEG----EQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~ 681 (941)
....+..+.||+|.||.||||.++ ++.||||++.. +..+.|..|-++.+. ++|+||++|+++-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 344556788999999999999984 49999999975 344578888887776 58999999999875544 899
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC------CCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE------ADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
||+||.+.|||.++|..+ .++|....+|+..+++||+|||+. .+|+|+|||||++||||.+|+++.|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999765 489999999999999999999974 36789999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCC-CC-----chhHhHHHHHHHHHHHhCCCCCCCC--ch----h
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-----DKSDVYSLGVVFLELLTGMQPISHG--KN----I 823 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDVwSlG~ll~elltG~~Pf~~~--~~----~ 823 (941)
+|..+..... .......+||.+|||||++.+.. +. .+.||||+|.++|||+++..-++.+ .+ +
T Consensus 362 LAl~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9998864332 22234478999999999997743 22 3689999999999999986655321 11 0
Q ss_pred HHHHHHHHhhccchhh--hcCCCCCCChHH-----HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 824 VREVNIAYQSSMMFSV--IDGNMGSYPSEC-----VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 824 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-----~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
...+......+.+.+. .+..++.+|+.+ ...+.+.+..||+.|++.|-|+.=+.+.+..+....+.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 0011000011122222 223445555543 45688999999999999999999998888877554443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=358.40 Aligned_cols=208 Identities=26% Similarity=0.377 Sum_probs=175.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 68999999987532 122346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999996543 4899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCccc-------------------------------cccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhC
Q 002289 765 IEGIVP-------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 813 (941)
Q Consensus 765 ~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG 813 (941)
...... ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000000 0011124699999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 002289 814 MQPISHGK 821 (941)
Q Consensus 814 ~~Pf~~~~ 821 (941)
+.||....
T Consensus 236 ~~Pf~~~~ 243 (364)
T cd05599 236 YPPFCSDN 243 (364)
T ss_pred CCCCCCCC
Confidence 99997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=351.93 Aligned_cols=195 Identities=26% Similarity=0.344 Sum_probs=167.6
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
+.||+|+||.||++... +|+.||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 689999999875321 22346778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 691 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 691 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
+|.+++.... .+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 150 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----- 150 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-----
Confidence 9999886543 58899999999999999999997 67 9999999999999999999999999987532111
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 11233468999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=354.48 Aligned_cols=208 Identities=26% Similarity=0.365 Sum_probs=175.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 689999999875322 22346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997543 5889999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCc----------------------------cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCC
Q 002289 765 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816 (941)
Q Consensus 765 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~P 816 (941)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0000 000011245799999999999999999999999999999999999999
Q ss_pred CCCCc
Q 002289 817 ISHGK 821 (941)
Q Consensus 817 f~~~~ 821 (941)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=357.77 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=202.1
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999975 68999999986422 1223457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998653 3778888899999999999999999 99999999999999999999999999976532
Q ss_pred CCCCCccccccccccccCCCcccccccccC----CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .. .
T Consensus 195 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~---------~ 258 (370)
T cd05596 195 NG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YS---------K 258 (370)
T ss_pred CC------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-HH---------H
Confidence 21 1112345689999999998753 478899999999999999999999975432111 00 0
Q ss_pred hhcCC-CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCC--CCCCccC
Q 002289 839 VIDGN-MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET--PPSSSSM 915 (941)
Q Consensus 839 ~~~~~-~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~--R~sa~e~ 915 (941)
+.... ...++. .......+.+||.+||+.+|++ |+|++|+
T Consensus 259 i~~~~~~~~~~~-------------------------------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 259 IMDHKNSLTFPD-------------------------------------DIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred HHcCCCcCCCCC-------------------------------------cCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 00000 000000 0011233456788888878877 8899999
Q ss_pred CCCCCCCCCCC
Q 002289 916 LKHPYVSSDVS 926 (941)
Q Consensus 916 L~Hpwf~~~~~ 926 (941)
++||||++..+
T Consensus 302 l~h~~~~~~~~ 312 (370)
T cd05596 302 KSHPFFKNDQW 312 (370)
T ss_pred hcCcccCCCCh
Confidence 99999887554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=355.17 Aligned_cols=205 Identities=22% Similarity=0.317 Sum_probs=174.6
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
....++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999975 58899999986422 12234678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999643 3788889999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCC----CCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||....
T Consensus 193 ~~~~------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 193 DETG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccCC------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 3221 11123456999999999997643 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=351.44 Aligned_cols=290 Identities=23% Similarity=0.313 Sum_probs=211.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCC-----
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 678 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 678 (941)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999964 68999999986432 233457889999999999999999999885443
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 679 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 679 -~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
..++||||++ ++|.+.++. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 4799999996 567776642 3778889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
+..... .......||..|+|||++.+..++.++||||+||++|||++|+.||........+...
T Consensus 171 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-------- 234 (359)
T cd07876 171 RTACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV-------- 234 (359)
T ss_pred cccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------
Confidence 754221 1123346889999999999999999999999999999999999999765443222111
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHH--HhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELE--SIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~--~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
+ ...+..+.+....+...........|... .+..+...... .........++...+||.+||..||++|+|++|
T Consensus 235 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 235 --I-EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred --H-HhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 0 11122233333333333333333333222 12222111000 000000112345678999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 915 MLKHPYVSS 923 (941)
Q Consensus 915 ~L~Hpwf~~ 923 (941)
+|+||||..
T Consensus 312 ~l~hp~~~~ 320 (359)
T cd07876 312 ALRHPYITV 320 (359)
T ss_pred HhcCchhhh
Confidence 999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=352.81 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=196.7
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
+|+..++||+|+||+||+|++. +++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3455788999999999999965 689999999865432 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++|+|.+.. ...+..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 222 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--- 222 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence 999986532 2456778889999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccccccCCCccccccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..... ..+
T Consensus 223 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~---------------- 281 (353)
T PLN00034 223 ----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDW---------------- 281 (353)
T ss_pred ----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccH----------------
Confidence 11233468999999998743 2345689999999999999999999963221 000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
..++.......+...+ ........+||.+||..||++|+|++|+|+||||.
T Consensus 282 -------------~~~~~~~~~~~~~~~~----------------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~ 332 (353)
T PLN00034 282 -------------ASLMCAICMSQPPEAP----------------ATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332 (353)
T ss_pred -------------HHHHHHHhccCCCCCC----------------CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 0000000000110111 11122345788889999999999999999999998
Q ss_pred CCCCCCc
Q 002289 923 SDVSGSN 929 (941)
Q Consensus 923 ~~~~~~~ 929 (941)
......+
T Consensus 333 ~~~~~~~ 339 (353)
T PLN00034 333 RAQPGQG 339 (353)
T ss_pred cCCcccc
Confidence 8765433
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=349.69 Aligned_cols=238 Identities=24% Similarity=0.394 Sum_probs=186.7
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHH---HhcCCCceeeeeeccccCCcEEEE
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFL---SRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
|++.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999965 689999999875321 1234566666654 566899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|..+++. ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 35899999999999999999999999 999999999999999999999999998743211
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +.... +.. .
T Consensus 155 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~---------i~~-~ 216 (324)
T cd05589 155 -------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDS---------IVN-D 216 (324)
T ss_pred -------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHH---------HHh-C
Confidence 11223456899999999999999999999999999999999999999754321 11110 111 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPS 872 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs 872 (941)
...+|...+..+.+++.+|++.+|.+||+
T Consensus 217 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 217 EVRYPRFLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCC
Confidence 12234444556666777777777777764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=350.06 Aligned_cols=192 Identities=26% Similarity=0.394 Sum_probs=166.8
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 689999999975322 2234578899999988 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------ 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------ 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC------
Confidence 9999988654 35899999999999999999999999 999999999999999999999999998742211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~ 818 (941)
........||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 112234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.23 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=213.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh-hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
...|+..+.||+|.||.||+|.+. .++.||+|++..+.... .+++.+|+.++.+++++||.++|+.|..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 446777899999999999999964 68999999998654443 4678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
||.||++.+.++... .+.+.....|.++++.|+.|||+++ .+|||||+.|||+..+|.+|++|||.+.......
T Consensus 92 y~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred HhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 999999999996443 3477778889999999999999999 9999999999999999999999999997664322
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......||+.|||||++.+..|+.|+||||||++.+||.+|..|+..... +..++.+-....+
T Consensus 166 ------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 166 ------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------MRVLFLIPKSAPP 229 (467)
T ss_pred ------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------ceEEEeccCCCCC
Confidence 222567899999999999998999999999999999999999999975443 2233444444445
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
.+...+...+.+++..|+.++|+.||++.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 5666788889999999999999999999999864
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=356.22 Aligned_cols=207 Identities=22% Similarity=0.317 Sum_probs=173.6
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.|+..+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999964 689999999875332 224568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999996543 4788899999999999999999999 99999999999999999999999999864321100
Q ss_pred CCc----------------------------------------cccccccccccCCCcccccccccCCCCchhHhHHHHH
Q 002289 766 EGI----------------------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 805 (941)
Q Consensus 766 ~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ 805 (941)
... ..........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000112356999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCc
Q 002289 806 VFLELLTGMQPISHGK 821 (941)
Q Consensus 806 ll~elltG~~Pf~~~~ 821 (941)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (381)
T cd05626 237 ILFEMLVGQPPFLAPT 252 (381)
T ss_pred HHHHHHhCCCCCcCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.35 Aligned_cols=200 Identities=23% Similarity=0.367 Sum_probs=170.5
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCC-CceeeeeeccccCCcEEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~LV~ 684 (941)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.++++.++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999975 57899999987532 1233567889999999976 56889999999899999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 9999999999986543 4788999999999999999999999 999999999999999999999999998643211
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
........||..|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 ------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred ------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=358.35 Aligned_cols=208 Identities=25% Similarity=0.338 Sum_probs=173.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999864 78999999886432 122356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999654 35888899999999999999999999 9999999999999999999999999996432110
Q ss_pred CCC----------ccc------------------------------cccccccccCCCcccccccccCCCCchhHhHHHH
Q 002289 765 IEG----------IVP------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLG 804 (941)
Q Consensus 765 ~~~----------~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG 804 (941)
... ... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 0000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCc
Q 002289 805 VVFLELLTGMQPISHGK 821 (941)
Q Consensus 805 ~ll~elltG~~Pf~~~~ 821 (941)
|++|||++|+.||....
T Consensus 236 vil~elltG~~Pf~~~~ 252 (377)
T cd05629 236 AIMFECLIGWPPFCSEN 252 (377)
T ss_pred hhhhhhhcCCCCCCCCC
Confidence 99999999999996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.09 Aligned_cols=200 Identities=29% Similarity=0.465 Sum_probs=180.4
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhH---hHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++.....+++ .+.+|+++|+.++||||+.++.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45677888999999999999996 57999999999876665554 468999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||..+|.|+|++.+.+ .+++.+.+.+++||..|+.|+|+++ ++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 99999999999997654 4899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCccccccccccccCCCcccccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......+|++-|.+||.+.|.+|. +.+|-||+||+||.++.|..||+..
T Consensus 206 -------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 206 -------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred -------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 3445678899999999999998885 5799999999999999999999753
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=355.96 Aligned_cols=208 Identities=26% Similarity=0.342 Sum_probs=177.7
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|+.. +++.||+|+++.... .....+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999975 689999999875321 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 45889999999999999999999998 9999999999999999999999999997654322
Q ss_pred CC----------------------CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IE----------------------GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.. ............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 00 0000112234568999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=333.17 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=208.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||.||+|.++ .+..||+|+++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999853 357899999886433 234578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997543 35889999999999999999999999 99999999999999999999999998764321
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. ........++..|+|||++.+..++.++|||||||++||+++ |+.||...... +... .+.+
T Consensus 160 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~---------~~~~ 223 (266)
T cd05064 160 EA------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIK---------AVED 223 (266)
T ss_pred cc------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHH---------HHHC
Confidence 11 011112335678999999999999999999999999999875 99999754321 1111 1122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
+.....+..++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 223344566778899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=341.12 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=218.7
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCc-EEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE-QMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~LV~ 684 (941)
++|...+++|+|+||.++..+.+ +++.+|+|.+...... .+....+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998865 6789999988754433 23468899999999999999999999999988 99999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
+|++||++.+.+.++....+++..+..++.|++.|+.|||++. |+|||||+.||+++.+..|||+|||+|+.+...+
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998877778999999999999999999999888 9999999999999999999999999999876532
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.....+.||+.||.||.+.+.+|..|+||||+||++|||++-+.+|...+- ...+ .++.....
T Consensus 161 -------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-~~Li---------~ki~~~~~ 223 (426)
T KOG0589|consen 161 -------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-SELI---------LKINRGLY 223 (426)
T ss_pred -------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-HHHH---------HHHhhccC
Confidence 234567899999999999999999999999999999999999999965432 2222 23333445
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
.+.|..+..++..++..|++.+|+.||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 67788999999999999999999999999999876
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=349.64 Aligned_cols=290 Identities=20% Similarity=0.295 Sum_probs=212.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccC------
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 677 (941)
..++|++.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999965 68899999987532 23345788999999999999999999987543
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
...++||||++ ++|.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999995 578877743 3778889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+...
T Consensus 174 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~-------- 237 (364)
T cd07875 174 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV-------- 237 (364)
T ss_pred cccCCC--------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------
Confidence 764321 1123346889999999999999999999999999999999999999765543322111
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHH-HHh-HhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMREL-ESI-WNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L-~~~-~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
+. ..+....+....+...+.......|... ..+.++.... ... ..........+.+||.+||+.||++|||++|
T Consensus 238 --~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 238 --IE-QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred --HH-hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 11 1122233444444333333333222211 1122111100 000 0001112345578999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 915 MLKHPYVSS 923 (941)
Q Consensus 915 ~L~Hpwf~~ 923 (941)
+|+||||..
T Consensus 315 ~L~hp~~~~ 323 (364)
T cd07875 315 ALQHPYINV 323 (364)
T ss_pred HhcCccccc
Confidence 999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.82 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=213.7
Q ss_pred HhcCCCccceeeccCcEEEEEEE-eCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccC-----CcE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 680 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 680 (941)
..++|++.+.||+|||+-||.++ ..+++.+|+|++.....++.+..++|++..++++||||++++++...+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 46789999999999999999999 568899999999987777888999999999999999999999998443 358
Q ss_pred EEEEecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 681 MLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
||+++|+..|||.+.++.. .+..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999998753 3446999999999999999999999986 689999999999999999999999999987
Q ss_pred ccCCCCCCCc--cccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhh
Q 002289 759 LAPVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 833 (941)
Q Consensus 759 ~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~ 833 (941)
...-.-.+.. ..-+.......|..|+|||.+.- ...++++|||||||++|+|+.|..||+.... +.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------~G 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------QG 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------cC
Confidence 6542211100 00112244568999999999863 5678999999999999999999999963211 11
Q ss_pred ccc-hhhhcCCCC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 834 SMM-FSVIDGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 834 ~~~-~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
+.+ ..+..+... +-...+++.+.++++.|++.||.+||+..+++..++..
T Consensus 249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111 111221111 11123788999999999999999999999999887754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=337.60 Aligned_cols=261 Identities=27% Similarity=0.431 Sum_probs=203.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC-----------------CcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceee
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVS 669 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~ 669 (941)
.++|.+.++||+|+||.||+|.+++ +..||+|.+...... ..+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678889999999999999998532 347999998764322 3567999999999999999999
Q ss_pred eeeccccCCcEEEEEecCCCCCHHHHHhhcC-----------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 002289 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732 (941)
Q Consensus 670 l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 732 (941)
+++++.+.+..++||||+++|+|.+++.... ...+++..+++++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986432 124678889999999999999999999 99
Q ss_pred eccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh
Q 002289 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 812 (941)
Q Consensus 733 H~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt 812 (941)
||||||+|||++.++.+||+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999976533221 111223345788999999998899999999999999999997
Q ss_pred --CCCCCCCCchh--HHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 813 --GMQPISHGKNI--VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 813 --G~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
+..||...... .......+.. .........+..++..+.+++.+||+.+|++||++.++.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRD-----QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhh-----ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 55677543321 1111111100 0001111234456678999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=323.62 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=203.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc--CCCceeeeeeccccC----CcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE----GEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~----~~~~ 681 (941)
..+..+.+.||+|.||.||+|.| .|..||||++.. .+++.+.+|.++++.. +|+||+.|++.-..+ .+.+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45677789999999999999999 578999999974 3456788899988874 999999999987443 3789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-----CCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-----EADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
||++|.+.|||+|+|.+ ..++....++++..+|.||+|||. +|+|.|.|||||+.||||..++.+.|+|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999965 458999999999999999999994 6888999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCC----C--CchhHhHHHHHHHHHHHhC----------CCCCCCC
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----L--TDKSDVYSLGVVFLELLTG----------MQPISHG 820 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDVwSlG~ll~elltG----------~~Pf~~~ 820 (941)
|......... . .-.....+||.+|||||++...- + -..+||||||.++||+..+ +.||.+.
T Consensus 363 Av~h~~~t~~--i-di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 363 AVRHDSDTDT--I-DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred eEEecccCCc--c-cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9876543211 1 22334567999999999986431 1 2369999999999999874 4566432
Q ss_pred ---chhHHHHHHHHhhccchhhhcCCCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 821 ---KNIVREVNIAYQSSMMFSVIDGNMGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 821 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+...+..+..+- ++..++.+ ..++...+.++|+.||..+|..|-++-.+.+.+.++.+
T Consensus 440 Vp~DPs~eeMrkVVC-------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVC-------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhccee-------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 111222211111 11222222 35677889999999999999999999999888887754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=331.88 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=210.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3567889999999999999999988888999998875332 346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.++++......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 99999999997765567889999999999999999999998 99999999999999999999999999986533211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ..... .....
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~-~~~~~--------~~~~~ 223 (261)
T cd05072 159 -----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-V-MSALQ--------RGYRM 223 (261)
T ss_pred -----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-H-HHHHH--------cCCCC
Confidence 11122345678999999998889999999999999999998 999996543211 1 11111 11111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
+....++..+.+++.+|+..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2233456778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=351.67 Aligned_cols=289 Identities=20% Similarity=0.295 Sum_probs=202.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4467999999999999999999975 5789999975432 34568999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+ .++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 138 HY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred cc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 99 578998886543 45899999999999999999999999 999999999999999999999999998743211
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC---
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG--- 842 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 842 (941)
.......||..|+|||++.+..++.++|||||||++|||+++..|+..................+..++..
T Consensus 211 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~ 284 (357)
T PHA03209 211 ------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284 (357)
T ss_pred ------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence 11233568999999999999999999999999999999999766654322111000000000011111100
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
....++.+.... +....+......|..... ...++. ........+||.+||++||++||||+|+|+||||+
T Consensus 285 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 285 HPEEFPRDPGSR---LVRGFIEYASLERQPYTR-YPCFQR-----VNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred ChhhcCCCCccH---HHHHHHhhcccCCCcccc-cHHHhc-----cCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 000011000000 111111111111111100 000110 12334556799999999999999999999999997
Q ss_pred C
Q 002289 923 S 923 (941)
Q Consensus 923 ~ 923 (941)
+
T Consensus 356 ~ 356 (357)
T PHA03209 356 Q 356 (357)
T ss_pred c
Confidence 5
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.44 Aligned_cols=279 Identities=23% Similarity=0.342 Sum_probs=204.9
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|+.. +++.||||+++.... ...+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 578999999875321 2234566778887764 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 150 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-----
Confidence 9999999654 34788899999999999999999999 9999999999999999999999999987432211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
.......||..|+|||++.+..++.++||||+||++|||++|+.||...... +.... +......++.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~----------i~~~~~~~~~ 217 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQS----------IRMDNPCYPR 217 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHHH----------HHhCCCCCCc
Confidence 1123456899999999999999999999999999999999999999754321 11111 1111122334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMS-EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~-~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
.....+.+++.+|++.+|++||++. ++.++ .+ +...+ ...+. -..++|.-++...+...+.||....
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h--~~---~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQH--PF---FREID---WSALE-EREIEPPFKPKVKSANDCSNFDKEF 285 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHcC--cc---cCCCC---HHHHH-hCCCCCCcCCCCCCccchhhcChhh
Confidence 4455667777788888888887775 33211 01 11100 00111 1234566677777777777775543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=358.21 Aligned_cols=279 Identities=22% Similarity=0.337 Sum_probs=200.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccC--------C
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--------G 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~ 678 (941)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999964 68999999885422 2345799999999999999998876321 2
Q ss_pred cEEEEEecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeec
Q 002289 679 EQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFG 755 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFG 755 (941)
..++||||++ ++|.+++.. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999996 588777753 23456899999999999999999999999 99999999999999665 79999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
+|+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||............ .
T Consensus 217 la~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i-~--- 284 (440)
T PTZ00036 217 SAKNLLAG--------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI-I--- 284 (440)
T ss_pred cchhccCC--------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-H---
Confidence 99865321 112334688999999998764 6899999999999999999999999765432211111 0
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC-CCCCCCcccccccCCCCCCCCCCCc
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP-ESDTKTPEFINSEHTSKEETPPSSS 913 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~-~~~~~~~dll~~~L~~dP~~R~sa~ 913 (941)
.. .+..+.+....+..-. .-. .-|...+ .++ ...++ ...+++.+||.+||++||++|+||.
T Consensus 285 ---~~----~~~p~~~~~~~~~~~~-~~~-~~~~~~~--~~l-------~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~ 346 (440)
T PTZ00036 285 ---QV----LGTPTEDQLKEMNPNY-ADI-KFPDVKP--KDL-------KKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346 (440)
T ss_pred ---HH----hCCCCHHHHHHhchhh-hcc-cCCccCc--hhH-------HHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 00 0111111111000000 000 0010000 111 11122 2345678999999999999999999
Q ss_pred cCCCCCCCCCC
Q 002289 914 SMLKHPYVSSD 924 (941)
Q Consensus 914 e~L~Hpwf~~~ 924 (941)
|+|+||||..-
T Consensus 347 e~l~hp~f~~~ 357 (440)
T PTZ00036 347 EALADPFFDDL 357 (440)
T ss_pred HHhCChhHHhh
Confidence 99999999753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=347.80 Aligned_cols=194 Identities=28% Similarity=0.421 Sum_probs=164.6
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHH-HHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||+||+|+.. +|+.||+|++..... ...+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 689999999874322 12234555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------ 149 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC------
Confidence 99999986543 5888999999999999999999999 999999999999999999999999998743211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=338.62 Aligned_cols=262 Identities=30% Similarity=0.432 Sum_probs=217.0
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh-hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
......+.++||+|-||.|..+....+..||||+++...... +++|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 445667789999999999999999888999999999766554 5899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
||++|+|.+++.++............|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+-..+.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999998775444566667789999999999999999 99999999999999999999999999996654443
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh--CCCCCCCCchhHHHHHHHHhhccchhhhcC-
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDG- 842 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~- 842 (941)
+ +......-.++|||+|.+.-++++.++|||+||+++||+++ ...||....+..- ++ ....+++.
T Consensus 693 y-----~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-ve------n~~~~~~~~ 760 (807)
T KOG1094|consen 693 Y-----RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-VE------NAGEFFRDQ 760 (807)
T ss_pred e-----eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-HH------hhhhhcCCC
Confidence 2 22223344579999999999999999999999999999887 6788865433111 00 11111221
Q ss_pred C---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 843 N---MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 843 ~---~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
. ....|.-|+..+++++..||..+.++||+++++...|++.
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 2345778999999999999999999999999999888753
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.33 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=204.4
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.|+..+.||+|+||+||++... +++.||+|.+...... ..+.+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999975 6899999988653222 23457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999999987655566899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
......|+..|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~------------------- 210 (285)
T cd05630 157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------------- 210 (285)
T ss_pred -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-------------------
Confidence 112346899999999999999999999999999999999999999643221100
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC-----CccCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKHPY 920 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-----a~e~L~Hpw 920 (941)
+. ...+... .+. .......+...+|+++||+.||++|+| ++|+++|||
T Consensus 211 ----~~---~~~~~~~----~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 211 ----EE---VERLVKE----VQE----------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ----HH---HHhhhhh----hhh----------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 00 0000000 000 000112233457888999999999999 899999999
Q ss_pred CCCC
Q 002289 921 VSSD 924 (941)
Q Consensus 921 f~~~ 924 (941)
|..-
T Consensus 264 ~~~~ 267 (285)
T cd05630 264 FKQI 267 (285)
T ss_pred hhcc
Confidence 9764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=356.82 Aligned_cols=207 Identities=22% Similarity=0.309 Sum_probs=173.3
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
+|++.++||+|+||+||+|+.. +++.||+|++..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 688999999875322 223568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999996543 4788889999999999999999999 99999999999999999999999999853321000
Q ss_pred CC----------------------------------------ccccccccccccCCCcccccccccCCCCchhHhHHHHH
Q 002289 766 EG----------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 805 (941)
Q Consensus 766 ~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ 805 (941)
.. ...........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00 00000112346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCc
Q 002289 806 VFLELLTGMQPISHGK 821 (941)
Q Consensus 806 ll~elltG~~Pf~~~~ 821 (941)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.71 Aligned_cols=265 Identities=29% Similarity=0.478 Sum_probs=227.2
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeCC-CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
+++|+....+....++||-|-||.||.|.|+. .-.||||.++.+.++ .++|+.|..+|+.++|||+|+++|+|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 46777777778889999999999999999974 678999999986554 4589999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
+|||+|||..|+|.++|++..+..++....+.++.||+.||+||..++ +|||||.++|+|+.++..+||+|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999888888888899999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
+..+.+++. ....-.+-|.|||-+....++.|+|||+|||+|||+.| |..||...+- . ..+.
T Consensus 415 MtgDTYTAH------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-S----------qVY~ 477 (1157)
T KOG4278|consen 415 MTGDTYTAH------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-S----------QVYG 477 (1157)
T ss_pred hcCCceecc------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-H----------HHHH
Confidence 865543321 11123467999999999999999999999999999999 8888865331 1 1122
Q ss_pred hh-cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 839 VI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 839 ~~-~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
++ .+.+..-|+.|++.++++|..||+..|.+||++.|+-+.++.++..
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 22 2344567899999999999999999999999999999999877653
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.38 Aligned_cols=250 Identities=37% Similarity=0.596 Sum_probs=199.9
Q ss_pred ccceeeccCcEEEEEEEeC-----CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 613 SSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 613 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+.+.||.|.||.||+|.+. .+..|+||.++..... ..+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 2578999999764333 367899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|+|.++++......+++..++.|+.||++||+|||+++ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 99999999998875667999999999999999999999998 99999999999999999999999999986522111
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
............|+|||.+.+..++.++||||||+++|||++ |+.||..... .+... .+.++...
T Consensus 159 ----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~---------~~~~~~~~ 224 (259)
T PF07714_consen 159 ----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIE---------KLKQGQRL 224 (259)
T ss_dssp ----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHH---------HHHTTEET
T ss_pred ----ccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc---------cccccccc
Confidence 122233446678999999999999999999999999999999 7788865532 22111 12222333
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
..+..++..+.+++..||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 45566788899999999999999999999998865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.82 Aligned_cols=277 Identities=25% Similarity=0.375 Sum_probs=201.4
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhc---CCCceeeeeecccc-----CC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDE-----EG 678 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 678 (941)
+|++.+.||+|+||+||+|... +++.||+|.++..... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999965 6899999988753222 123566777777665 69999999998754 34
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||++ ++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999996 59999987665556899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
...... ......||..|+|||++.+..++.++||||+||++|||++|+.||........ ......
T Consensus 157 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~------ 221 (288)
T cd07863 157 IYSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFD------ 221 (288)
T ss_pred cccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHH------
Confidence 653211 12234578899999999999999999999999999999999999865443211 111100
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
.+.. .....+... ....... ..+..... +....+..+....+++.+||..||++|+|++|++.|
T Consensus 222 ~~~~---~~~~~~~~~-~~~~~~~--~~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 222 LIGL---PPEDDWPRD-VTLPRGA--FSPRGPRP----------VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HhCC---CChhhCccc-ccccccc--cCCCCCCc----------hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000000000 0000000 00101111 111223344455789999999999999999999999
Q ss_pred CCC
Q 002289 919 PYV 921 (941)
Q Consensus 919 pwf 921 (941)
|||
T Consensus 286 p~f 288 (288)
T cd07863 286 PFF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=356.03 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=217.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCC-cEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeec-ccc------C
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY-CDE------E 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~-~~~------~ 677 (941)
...++++.+.|.+|||+.||.|.+..+ ..||+|++-..+....+.+.+|+++|+.|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345667789999999999999998765 999999988777777788999999999996 9999999993 211 2
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
-+.+|.||||+||+|-|++..+-...|++.++++|+.|+++|+++||... +||||||||-+|||++.++..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 37789999999999999998765556999999999999999999999874 88999999999999999999999999998
Q ss_pred cccCCCC--CCCccccccccccccCCCccccccc---ccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 758 RLAPVPD--IEGIVPAHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 758 ~~~~~~~--~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
....... ..+...-........|+.|+|||.+ .+..+++|+|||||||+||-|+..+.||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 7432211 0010001112234578999999987 467899999999999999999999999986532
Q ss_pred hccchhhhcCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 833 SSMMFSVIDGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 833 ~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
..++.+.....+ +.++..+..+|..|++.+|.+||++.+|+..+.++....
T Consensus 264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 234555443322 589999999999999999999999999999998876643
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.74 Aligned_cols=194 Identities=26% Similarity=0.411 Sum_probs=165.5
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|+.. +|+.||+|+++.... ...+.+..|.+++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 689999999875321 2234566788877754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 149 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------ 149 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC------
Confidence 99999986543 4788899999999999999999999 999999999999999999999999998743211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
........||..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=293.50 Aligned_cols=283 Identities=25% Similarity=0.399 Sum_probs=219.7
Q ss_pred CCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|...++||+|.||+||+|+. ++++.||+|++..+.. .-.....+|+-+++.++|.|||++++....++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999995 4689999998875332 2246789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
| ..+|..+...-. ..++.+.++.++.|+++||.|+|+++ +.|||+||.|.|++.+|+.|++|||+|+-+..+
T Consensus 83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 9 568988886543 35889999999999999999999999 999999999999999999999999999876432
Q ss_pred CccccccccccccCCCcccccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.+......-|..|++|.++.+.+ |+...|+||-||++.|+.....|.+++.+..++....+..- +
T Consensus 155 ----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l----------g 220 (292)
T KOG0662|consen 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL----------G 220 (292)
T ss_pred ----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh----------C
Confidence 34455567889999999998854 88999999999999999997778777877777766554321 1
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
...++.++.+.++ .|..--|.+... ..+.+..|.......|+++++|.-+|..|++|+++|+||||+..
T Consensus 221 ~p~ed~wps~t~l------pdyk~yp~ypat----tswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 221 TPTEDQWPSMTKL------PDYKPYPIYPAT----TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCccccCCccccC------CCCcccCCcccc----chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1111112211111 111111222111 12233345555666799999999999999999999999999764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=347.53 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=206.6
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeecccc
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 676 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 676 (941)
....++|++.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456788899999999999999973 246689999987533 23346788999999999 89999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 700 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 700 (941)
.+..++||||+++|+|.++++...
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999986432
Q ss_pred -----------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 701 -----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 701 -----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788899999999999999999998 999999999999999999999999999765332
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.. ........++..|+|||++.+..++.++|||||||++|||++ |..||............ . ..+
T Consensus 268 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~-~--------~~~ 333 (375)
T cd05104 268 SN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-I--------KEG 333 (375)
T ss_pred cc-----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH-H--------HhC
Confidence 11 011122335678999999999999999999999999999998 88888654322111111 1 111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
.....+...+.++.+++..||+.+|++||++.++++.|++
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112233345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=347.85 Aligned_cols=265 Identities=25% Similarity=0.391 Sum_probs=208.7
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeecc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYC 674 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 674 (941)
.+....++|++.+.||+|+||.||+|++. ++..||||+++.... .....+.+|+++++.+ +|+||++++++|
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 33445678999999999999999999842 345899999975432 2345688999999999 899999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcC------------------------------------------------------
Q 002289 675 DEEGEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------ 700 (941)
Q Consensus 675 ~~~~~~~LV~e~~~~gsL~~~l~~~~------------------------------------------------------ 700 (941)
...+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999985421
Q ss_pred --------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 701 --------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 701 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
..++++..+++++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~- 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN- 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-
Confidence 124788889999999999999999998 99999999999999999999999999976532211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
........++..|+|||++.+..++.++|||||||++|||++ |+.||............. ..+...
T Consensus 268 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---------~~~~~~ 334 (374)
T cd05106 268 ----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---------KRGYQM 334 (374)
T ss_pred ----eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---------HcccCc
Confidence 111122335678999999999999999999999999999997 999996543211111110 011111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
..+...+.++.+++.+||+.+|++||++.++++.|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 223334578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=332.99 Aligned_cols=256 Identities=30% Similarity=0.525 Sum_probs=209.7
Q ss_pred cCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
++|++.+.||+|+||.||+|.... ...||+|.++.... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998642 25799999875433 23457899999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhhcCC--------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC
Q 002289 682 LVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 747 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 747 (941)
++|||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975421 45788999999999999999999999 99999999999999999
Q ss_pred cEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHH
Q 002289 748 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 826 (941)
Q Consensus 748 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~ 826 (941)
.+||+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEV 235 (283)
T ss_pred cEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999975432221 111223346788999999998899999999999999999998 9999975432 111
Q ss_pred HHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
. ..+..+.....+..++.++.+++.+||+.+|.+||++.++.+.|++
T Consensus 236 ~---------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 I---------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H---------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 1122233344567788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=356.65 Aligned_cols=208 Identities=23% Similarity=0.317 Sum_probs=173.7
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.+|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999964 689999999864321 22356789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999996543 4788889999999999999999999 9999999999999999999999999985332100
Q ss_pred CCC------------------------------------ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHH
Q 002289 765 IEG------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 808 (941)
Q Consensus 765 ~~~------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ 808 (941)
... ...........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 00000112356999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCc
Q 002289 809 ELLTGMQPISHGK 821 (941)
Q Consensus 809 elltG~~Pf~~~~ 821 (941)
||++|+.||....
T Consensus 236 ell~G~~Pf~~~~ 248 (376)
T cd05598 236 EMLVGQPPFLADT 248 (376)
T ss_pred ehhhCCCCCCCCC
Confidence 9999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.77 Aligned_cols=280 Identities=20% Similarity=0.302 Sum_probs=209.1
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|+.. +++.||+|+++.... ...+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 588999999875321 2233456677776654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 99999986543 4888999999999999999999999 9999999999999999999999999997542211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +... .+......++.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-~~~~----------~i~~~~~~~~~ 217 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-ELFD----------SILNDRPHFPR 217 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-HHHH----------HHHcCCCCCCC
Confidence 1223456899999999999999999999999999999999999999754431 1111 11122333455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMS-EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~-~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
.+..++.+++..|++.+|.+||++. +++++ . + +...+ .+.+.+ -+..|.-++.......++||.....
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h-~-~---~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQH-P-F---FRGID---WERLEK-REIPPPFKPKVKSPSDASNFDREFT 286 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHcC-c-c---cCCCC---HHHHHh-CCCCCCcCCCCCCcchhhhcCcccc
Confidence 5667788899999999999999875 33321 0 0 00000 011111 1334555667777777888865444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=331.85 Aligned_cols=257 Identities=29% Similarity=0.497 Sum_probs=216.0
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
....+|++.++||+|+||.||+|...+++.+|+|.+..........+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567889999999999999999988899999999987665556678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 999999999998766667899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... +... .+.....
T Consensus 159 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~---------~~~~~~~ 222 (261)
T cd05148 159 ------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYD---------QITAGYR 222 (261)
T ss_pred ------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHH---------HHHhCCc
Confidence 11123335678999999998899999999999999999998 89999654321 1111 1112222
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
...+..+++.+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 33455677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.78 Aligned_cols=241 Identities=20% Similarity=0.324 Sum_probs=189.2
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
+|++.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999975 578999999875322 1234566788888777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999986543 4888999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +. ...
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~---------i~-~~~ 217 (323)
T cd05616 156 -------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQS---------IM-EHN 217 (323)
T ss_pred -------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-HHHH---------HH-hCC
Confidence 12234568999999999999999999999999999999999999997544311 1110 11 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSM 873 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~ 873 (941)
..+|...+.++.+++.+|++.+|.+|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 22344445556666666666666666664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.41 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=205.3
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
++|++.+.||+|+||.||+|.++++..+|+|.+..... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45788899999999999999988888999998875432 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce---
Confidence 999999987543 35889999999999999999999999 99999999999999999999999999876532211
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... +.... +..+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~~~---------i~~~~~~~~ 222 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEM---------ISRGFRLYR 222 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH---------HHCCCCCCC
Confidence 11122335568999999998889999999999999999999 89999754432 11111 111112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 344556789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=344.50 Aligned_cols=193 Identities=24% Similarity=0.376 Sum_probs=166.9
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||+||+|... +++.||+|+++.... ...+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 678999999975432 2234578899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 149 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------ 149 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC------
Confidence 99999886543 4899999999999999999999999 999999999999999999999999998743211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 150 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred -CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 1122345689999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.37 Aligned_cols=203 Identities=26% Similarity=0.347 Sum_probs=174.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|... +|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999965 689999999875322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997642 35899999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCCccccccccccccCCCcccccccc------cCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
........||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 157 ------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 11123346899999999987 4567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.26 Aligned_cols=195 Identities=26% Similarity=0.412 Sum_probs=167.0
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|+.. +++.||+|+++.... ...+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 588999999875321 2234567888888866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 150 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----- 150 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-----
Confidence 99999986543 4888999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=347.35 Aligned_cols=291 Identities=20% Similarity=0.276 Sum_probs=210.1
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccC------
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 677 (941)
..++|++.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 68999999987532 22345778899999999999999999987543
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
...++||||++ +++.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 35799999995 577777643 3788889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+....
T Consensus 167 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~------- 231 (355)
T cd07874 167 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI------- 231 (355)
T ss_pred ccCCCc--------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------
Confidence 754321 11233468899999999999999999999999999999999999997654332221111
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCC-CCCHHHHH-HHHHHh-HhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDA-RPSMSEVM-RELESI-WNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~-~~L~~~-~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
. ..+....++...+......+....|.. +..+.... ..+... ..........+.+||.+||+.||++|||+.|
T Consensus 232 ---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~e 307 (355)
T cd07874 232 ---E-QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307 (355)
T ss_pred ---H-HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHH
Confidence 1 111122333333333333333222211 00111000 000000 0000112234578999999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 915 MLKHPYVSSD 924 (941)
Q Consensus 915 ~L~Hpwf~~~ 924 (941)
+|+||||..-
T Consensus 308 ll~hp~~~~~ 317 (355)
T cd07874 308 ALQHPYINVW 317 (355)
T ss_pred HhcCcchhcc
Confidence 9999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=351.94 Aligned_cols=286 Identities=20% Similarity=0.239 Sum_probs=207.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC---CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
..+|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999987642 24568999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|++ +++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999 47899988433 45899999999999999999999999 9999999999999999999999999997654322
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHHhhccchhhhcC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 842 (941)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..... .+..
T Consensus 240 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~------~~~~ 308 (392)
T PHA03207 240 D-----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR------CMQV 308 (392)
T ss_pred c-----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH------Hhcc
Confidence 1 11223456899999999999999999999999999999999999999754321 111111100 0000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
....++......+.+.. -+.....||...- -..+.. ...+....+||.+||++||++||||.|+|.||||.
T Consensus 309 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~ 379 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHF---KQYAIVLRPPYTI-PPVIRK-----YGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT 379 (392)
T ss_pred CccccCCccchhHHHHH---HhhcccccCCccc-cchhhc-----cCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence 01111211111111111 1112222332210 000000 11234456799999999999999999999999997
Q ss_pred CC
Q 002289 923 SD 924 (941)
Q Consensus 923 ~~ 924 (941)
..
T Consensus 380 ~~ 381 (392)
T PHA03207 380 KE 381 (392)
T ss_pred cc
Confidence 63
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.56 Aligned_cols=194 Identities=29% Similarity=0.415 Sum_probs=164.8
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHH-HHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986432 122345556655 56779999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------ 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------ 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC------
Confidence 9999988654 35889999999999999999999999 999999999999999999999999998743211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
........||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.96 Aligned_cols=256 Identities=29% Similarity=0.489 Sum_probs=210.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..++|++.+.||+|+||.||+|.+.+++.||+|.++.... ..+++.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4567889999999999999999987788999999876432 356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997655556899999999999999999999999 99999999999999999999999999986642211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
........+..|+|||++.+..++.++||||||+++|||++ |+.||......... . .+......
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~---------~~~~~~~~ 223 (261)
T cd05068 159 -----EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-Q---------QVDQGYRM 223 (261)
T ss_pred -----cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-H---------HHHcCCCC
Confidence 11111223458999999999999999999999999999999 99998654321111 1 01111112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
..+..++..+.+++.+|++.+|.+||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 2345566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=340.03 Aligned_cols=195 Identities=25% Similarity=0.391 Sum_probs=167.1
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||+||+|... +++.||||+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 58899999987532 12234567888888887 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 150 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----- 150 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-----
Confidence 99999886543 5889999999999999999999999 9999999999999999999999999986432111
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 11233468999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.49 Aligned_cols=256 Identities=31% Similarity=0.478 Sum_probs=210.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..+|++.+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345778899999999999999975 58899999987543 3346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.......+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 99999999997766667899999999999999999999998 99999999999999999999999999976543211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+..... ......
T Consensus 160 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~---------~~~~~~ 224 (263)
T cd05052 160 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELL---------EKGYRM 224 (263)
T ss_pred -----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH---------HCCCCC
Confidence 11112234568999999999999999999999999999998 8889865432 2211111 111122
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
..+..++..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 34555678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.83 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=198.2
Q ss_pred eeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
||+|+||.||++..+ +|+.||+|.+..... ..++.+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 689999999864322 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--------
Confidence 99987666667899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHH
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (941)
......|+..|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-------------------------- 203 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-------------------------- 203 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--------------------------
Confidence 122345889999999999988999999999999999999999999643221100
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC----ccCCCCCCCCCCCC
Q 002289 853 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS----SSMLKHPYVSSDVS 926 (941)
Q Consensus 853 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa----~e~L~Hpwf~~~~~ 926 (941)
. ++....+....... ....+.+..+++.+||..||++|+++ ++++.||||..-.+
T Consensus 204 ~---~~~~~~~~~~~~~~----------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 204 E---ELKRRTLEDEVKFE----------------HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred H---HHHHHhhccccccc----------------cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 0 00001111110000 00112334578888999999999999 56779999987443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=343.00 Aligned_cols=282 Identities=23% Similarity=0.358 Sum_probs=206.9
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccC-----
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 677 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 677 (941)
...++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34678999999999999999999964 688999999875322 2345678899999999999999999987533
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 678 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 678 -~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999998 8899988753 34889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
++..... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||....... .+.....
T Consensus 165 ~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~--- 230 (343)
T cd07878 165 ARQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIME--- 230 (343)
T ss_pred ceecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHH---
Confidence 9864321 223468899999999877 568899999999999999999999996543321 1111100
Q ss_pred chhhhcCCCCCCChHHHHHHHH-HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 836 MFSVIDGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~-l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
. .+..+.+....+.. ........-|. .|. . .....+...++...+|+.+||..||++|+|++|
T Consensus 231 ---~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~-------~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 231 ---V----VGTPSPEVLKKISSEHARKYIQSLPH-MPQ-Q-------DLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred ---H----hCCCCHHHHHhcchhhHHHHhhcccc-ccc-h-------hHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 0 01111111111100 00111111111 110 0 011122234455678999999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 915 MLKHPYVSSD 924 (941)
Q Consensus 915 ~L~Hpwf~~~ 924 (941)
+|+||||...
T Consensus 295 ll~hp~~~~~ 304 (343)
T cd07878 295 ALAHPYFSQY 304 (343)
T ss_pred HhcCcchhcc
Confidence 9999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=342.82 Aligned_cols=200 Identities=24% Similarity=0.376 Sum_probs=170.0
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~ 684 (941)
+|+..+.||+|+||+||+|... +|+.||+|++..... ...+.+..|.++++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999965 689999999875321 22345778888888885 577888999999989999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999986543 4889999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 156 -------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred -------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 11233468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=346.84 Aligned_cols=238 Identities=24% Similarity=0.307 Sum_probs=186.7
Q ss_pred ceeeccCcEEEEEEEe----CCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 615 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3589999999875322 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+|+|.+++.+. ..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----
Confidence 99999999654 35899999999999999999999999 9999999999999999999999999987543221
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (941)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .... +. .....+|
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~---------i~-~~~~~~p 218 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-TMTM---------IL-KAKLGMP 218 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-HHHH---------HH-cCCCCCC
Confidence 12234568999999999999889999999999999999999999997543211 1110 01 1111233
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002289 849 SECVEKFIKLALKCCQDETDARPSMSE 875 (941)
Q Consensus 849 ~~~~~~l~~l~~~c~~~~p~~RPs~~~ 875 (941)
...+..+.+++..|++.+|++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 334445555666666666666666554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=346.63 Aligned_cols=208 Identities=22% Similarity=0.303 Sum_probs=176.6
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccC
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 677 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 677 (941)
.++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 345556789999999999999999999975 68899999986422 12234578899999999999999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999998643 3788888999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccC----CCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
+...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 190 ~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 190 MKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eEcCcCC------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 8653221 1112345699999999998754 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.03 Aligned_cols=289 Identities=25% Similarity=0.344 Sum_probs=195.4
Q ss_pred cceeeccCcEEEEEEEeC---CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccc--cCCcEEEEEecCC
Q 002289 614 STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQMLVYEFMS 688 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~LV~e~~~ 688 (941)
..+||+|+||+||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++. .....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 357899998875332 345788999999999999999999884 3557899999995
Q ss_pred CCCHHHHHhhc-------CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEeeeccc
Q 002289 689 NGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLS 757 (941)
Q Consensus 689 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DFGla 757 (941)
++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5888877532 2235888999999999999999999999 9999999999999 56679999999999
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
+....... .........||..|+|||++.+ ..++.++|||||||++|||+||+.||........... .+....+
T Consensus 160 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~-~~~~~~~ 234 (317)
T cd07867 160 RLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN-PFHHDQL 234 (317)
T ss_pred eccCCCcc----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccc-cccHHHH
Confidence 86543221 1112234568899999999876 4588999999999999999999999964332110000 0000000
Q ss_pred hhhhcCCCCCCChHHHHHHHHH------HHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKL------ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l------~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 910 (941)
...+. ..+....+.+..+.+. .... .......++ +...+ .......+....+++.+||+.||++||
T Consensus 235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~---~~~~~~~~~~~~~ll~~~l~~dP~~R~ 306 (317)
T cd07867 235 DRIFS-VMGFPADKDWEDIRKMPEYPTLQKDF-RRTTYANSS---LIKYM---EKHKVKPDSKVFLLLQKLLTMDPTKRI 306 (317)
T ss_pred HHHHH-hcCCCChhhhhhhhhcccchhhhhhh-cccccCCch---hhhhh---hcccCCCChHHHHHHHHHhccCccccc
Confidence 00000 0011111111111100 0000 000000011 11111 111122344567799999999999999
Q ss_pred CCccCCCCCCC
Q 002289 911 SSSSMLKHPYV 921 (941)
Q Consensus 911 sa~e~L~Hpwf 921 (941)
||+|+|+||||
T Consensus 307 t~~e~l~hp~f 317 (317)
T cd07867 307 TSEQALQDPYF 317 (317)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=333.62 Aligned_cols=200 Identities=28% Similarity=0.411 Sum_probs=174.0
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
|+..+.||+|+||+||+|.+. +++.||+|.+...... ....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999964 6899999998654322 234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999987655557999999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
......|+..|+|||++.+..++.++|+||+||++|||++|+.||....
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=350.00 Aligned_cols=208 Identities=25% Similarity=0.370 Sum_probs=174.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|+..+.||+|+||+||+|... +++.||+|+++... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 68999999987432 122356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999996543 4889999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCc----------------------------cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCC
Q 002289 765 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816 (941)
Q Consensus 765 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~P 816 (941)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011234699999999999999999999999999999999999999
Q ss_pred CCCCc
Q 002289 817 ISHGK 821 (941)
Q Consensus 817 f~~~~ 821 (941)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 96543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=341.96 Aligned_cols=202 Identities=28% Similarity=0.344 Sum_probs=172.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999965 68999999986421 122356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999653 235889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCccccccccccccCCCccccccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
........||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 ------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 111223458999999999873 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.45 Aligned_cols=256 Identities=28% Similarity=0.503 Sum_probs=209.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|+++++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568888999999999999998632 478999998765444 456899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 002289 681 MLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 748 (941)
++||||+++++|.++++..+ ...+++..+..++.|++.|++|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997542 235788999999999999999999999 999999999999999999
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 827 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~ 827 (941)
+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 161 ~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VI 234 (280)
T ss_pred EEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HH
Confidence 99999999875432211 011122345678999999999999999999999999999998 999987544321 11
Q ss_pred HHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
. .+..+.....+..++..+.+++.+||..+|++||++.++++.|+
T Consensus 235 ~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 E---------CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 11122233345566788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=336.74 Aligned_cols=283 Identities=23% Similarity=0.375 Sum_probs=207.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|.+.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 688999999874332 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 96 69999886543 35788999999999999999999999 9999999999999999999999999987543221
Q ss_pred CccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +...... .. .+
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~------~~----~~ 222 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIF------RI----LG 222 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH------HH----cC
Confidence 11123346889999999876 45788999999999999999999999754332 1111110 00 01
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
......+..+......+....|..++.. + ....+..++...++|.+||+.||++|+|++|+|+||||..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPKYRADC------L---HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred CCChhhchhhhccccccccccCcccccc------H---HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1111111111110000000011111100 0 0112233455678999999999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=343.96 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=210.0
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcC-CCceeeeeeccc
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLH-HRNLVSLVGYCD 675 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 675 (941)
+....++|.+.++||+|+||.||+|++. .+..||||+++..... ..+.+.+|+++++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3445678899999999999999999852 1347999999754332 3457899999999996 999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC-------------------------------------------------------
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------- 700 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~------------------------------------------------------- 700 (941)
..+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999999886421
Q ss_pred ---------------------------------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 002289 701 ---------------------------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741 (941)
Q Consensus 701 ---------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 741 (941)
...+++..+..++.|+++||+|||+.+ |+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 124778888999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCC
Q 002289 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 820 (941)
Q Consensus 742 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~ 820 (941)
|++.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999999986532211 111122346778999999999999999999999999999997 98998653
Q ss_pred chhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
........ .+..+.....+..++..+.+++.+||+.+|++||++.++.+.|+++.
T Consensus 344 ~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 344 IVDSTFYN---------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred chhHHHHH---------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 22111111 11111222345566788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=352.95 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=207.3
Q ss_pred CCCccceeeccCcEEEEEEEeC-C-CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999854 3 6788999876555444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 688 SNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 688 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
++|+|.++++.. ...++++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 3446889999999999999999999998 99999999999999999999999999986543211
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +. +..+..+...
T Consensus 225 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~---------~~~~~~~~~~ 289 (478)
T PTZ00267 225 -----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-EI---------MQQVLYGKYD 289 (478)
T ss_pred -----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HH---------HHHHHhCCCC
Confidence 11233456899999999999999999999999999999999999999754321 11 1122223333
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
..+..++..+.+++..|+..+|+.||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 445556678999999999999999999998864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=325.49 Aligned_cols=256 Identities=31% Similarity=0.478 Sum_probs=208.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.++|++.++||+|+||+||+|.+.+...||+|+++.... ..+.+.+|++++++++|+||+++++++.. +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 467999999999999999999987777899999875332 34578999999999999999999998754 5679999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++|+|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-- 157 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence 9999999997654456889999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......++..|+|||+..+..++.++|||||||++|||++ |+.||........ .. .+.......
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~---------~~~~~~~~~ 223 (262)
T cd05071 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LD---------QVERGYRMP 223 (262)
T ss_pred ----ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HH---------HHhcCCCCC
Confidence 11122346678999999998899999999999999999999 8888865432111 11 111111122
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
.+.+++..+.+++.+|++.+|++||++.++.+.|+...
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 34566788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.72 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=208.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..++|++.++||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3467889999999999999999988888899999876433 3457899999999999999999999885 4568999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.++++......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 99999999997655556899999999999999999999999 99999999999999999999999999976533211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... +... .+......
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~---------~~~~~~~~ 222 (260)
T cd05070 158 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLE---------QVERGYRM 222 (260)
T ss_pred -----ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHH---------HHHcCCCC
Confidence 11112235668999999988899999999999999999999 88888654321 1111 11112222
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
..+...+..+.+++.+|+..+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3455667789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.05 Aligned_cols=277 Identities=22% Similarity=0.318 Sum_probs=219.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
..+.|+.-++||+|+||.||-++.+ +|+.+|.|.+..... .++...+.|-.++.+++.+.||.+--.|...+..|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3466788899999999999999865 699999998765433 345667899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|+..|.||+|.-+|...+...++++.++.++.+|+.||++||++. ||.||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998887778999999999999999999999999 99999999999999999999999999997754
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.. .....+||.+|||||++.++.|+...|.||+||++|||+.|+.||.....-+++-. +...+..
T Consensus 340 g~--------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE-------vdrr~~~ 404 (591)
T KOG0986|consen 340 GK--------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE-------VDRRTLE 404 (591)
T ss_pred CC--------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH-------HHHHHhc
Confidence 32 23445799999999999999999999999999999999999999964333222110 0000101
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC-----CCccCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLK 917 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~ 917 (941)
....+++.+ ++++.++.+.+|+.||++|+ .|+++-+
T Consensus 405 ~~~ey~~kF---------------------------------------S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 405 DPEEYSDKF---------------------------------------SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred chhhccccc---------------------------------------CHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 111122222 23344566666777777775 6789999
Q ss_pred CCCCCCCCCCCccccccccccCC
Q 002289 918 HPYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 918 Hpwf~~~~~~~~~~~~~~~~~~~ 940 (941)
||||..--+..--.++..||+-|
T Consensus 446 HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 446 HPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred CcccccCCHhHHhccCCCCCCCC
Confidence 99999977765555556666554
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=329.27 Aligned_cols=260 Identities=29% Similarity=0.512 Sum_probs=212.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999842 356799999887666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 002289 683 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 748 (941)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 234789999999999999999999999 999999999999999999
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 827 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~ 827 (941)
++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+| |+.||....... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VI 235 (291)
T ss_pred EEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999975433211 111223446788999999999999999999999999999999 999986544321 11
Q ss_pred HHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
. ....+.....+..++..+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 236 ~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 E---------CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H---------HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 1111222223444567889999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=324.26 Aligned_cols=251 Identities=30% Similarity=0.476 Sum_probs=205.5
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
++|++.+.||+|+||+||+|.+.++..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 45778899999999999999987777899998875433 34678999999999999999999999998889999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--- 155 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce---
Confidence 9999999975433 5899999999999999999999999 99999999999999999999999999876532211
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+..+.....
T Consensus 156 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-~~---------~~~~~~~~~~ 222 (256)
T cd05113 156 ---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET-VE---------KVSQGLRLYR 222 (256)
T ss_pred ---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-HH---------HHhcCCCCCC
Confidence 11122335678999999998889999999999999999999 9999865443111 11 1112222223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
+...+..+.+++.+||+.+|.+||++.++++.+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 344567889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.07 Aligned_cols=280 Identities=24% Similarity=0.394 Sum_probs=207.8
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|+||.||+|+.. +|+.||+|+++..... ....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5788899999999999999975 6899999998653222 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ ++|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 96 68888876533 35899999999999999999999999 9999999999999999999999999987553221
Q ss_pred CccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||++.+. .++.++|||||||++|||+||..|+....+..+........ .+
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~ 218 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL----------LG 218 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHH----------hC
Confidence 112234578899999998774 47899999999999999999999986655443332221110 11
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
..+......+.++... ...+...... .+....+.....+.+++.+||..||++|||++|++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 219 TPTEESWPGVSKLPDY------KPYPMYPATT----SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCChHHhHHhhhcccc------cccCCCCCcc----hhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1111111111111100 0111111000 1112223445566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=333.23 Aligned_cols=284 Identities=22% Similarity=0.348 Sum_probs=208.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|+||.||++... ++..+|+|.++.... ....++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 688899998875422 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
+++++|.++++.. ..+++..+..++.|+++||+|||+ .+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999755 358889999999999999999997 46 999999999999999999999999998754221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+... .........
T Consensus 154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~-~~~~~~~~~- 222 (308)
T cd06615 154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KE-LEAMFGRP-VSEGEAKES- 222 (308)
T ss_pred -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hh-HHHhhcCc-cccccccCC-
Confidence 11234678899999999888899999999999999999999999964432 11 11111100 000000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC------CCCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP------ESDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~------~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
. ......+...+....+.+.++.+....+ ..+....+|+.+||..||++|||++|+++||
T Consensus 223 --~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 223 --H------------RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred --c------------ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 0000001111111111111111111100 0123356899999999999999999999999
Q ss_pred CCCCC
Q 002289 920 YVSSD 924 (941)
Q Consensus 920 wf~~~ 924 (941)
||...
T Consensus 289 ~~~~~ 293 (308)
T cd06615 289 FIKRA 293 (308)
T ss_pred hhhhc
Confidence 99763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.48 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=207.1
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
...++|++.+.||+|+||.||+|.+. .+..||+|+++... .....++.+|+.+++.++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999753 25679999886533 233457889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcC--------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 750 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 750 (941)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999986532 124678889999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002289 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 829 (941)
Q Consensus 751 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~ 829 (941)
|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 160 l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~- 232 (277)
T cd05062 160 IGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLR- 232 (277)
T ss_pred ECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH-
Confidence 9999998755332210 11112345678999999999899999999999999999999 6888864432 11111
Q ss_pred HHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
.+........+..++..+.+++.+|++.+|++||++.++++.++
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 --------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11222233345556678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=328.27 Aligned_cols=261 Identities=30% Similarity=0.494 Sum_probs=211.3
Q ss_pred hcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.++|.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45788899999999999999984 234679999987655555678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC-----------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 002289 682 LVYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 750 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 750 (941)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999996432 235899999999999999999999999 99999999999999999999
Q ss_pred EeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002289 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 829 (941)
Q Consensus 751 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~ 829 (941)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 161 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~~~- 233 (288)
T cd05093 161 IGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIE- 233 (288)
T ss_pred eccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH-
Confidence 999999975532211 111122335678999999999999999999999999999998 88898654321 1111
Q ss_pred HHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.+..+.....+..++..+.+++.+||+.+|.+||++.++.+.|+++...
T Consensus 234 --------~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 --------CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --------HHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111122223334556799999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.49 Aligned_cols=260 Identities=29% Similarity=0.479 Sum_probs=222.3
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEeCC---C--cEEEEEEeccC-CchhhHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGILPD---G--TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
....+.....++||.|-||.||+|.+.+ | -.||||..+.+ .....+.|+.|..+|+.++||||++++|.|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3444555567899999999999999632 3 35899999874 34456789999999999999999999999976 4
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..|+|||.++-|.|..+++.+ +..++......++.||+.||+|||+.. +|||||..+|||+.+...+|++|||+++
T Consensus 464 P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 789999999999999999765 456888999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
..+...++.. ....-.+-|||||.+.-.+++.++|||-|||++||++. |..||..-.+ .+.+.
T Consensus 540 ~~ed~~yYka------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------sDVI~ 603 (974)
T KOG4257|consen 540 YLEDDAYYKA------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------SDVIG 603 (974)
T ss_pred hccccchhhc------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------cceEE
Confidence 8876654322 12233568999999999999999999999999999998 9999986554 23444
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+-.+.+.+.|+.|+..++.++.+||..+|.+||.+.++...|.++..
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 556678888999999999999999999999999999999999988765
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.84 Aligned_cols=206 Identities=21% Similarity=0.236 Sum_probs=168.1
Q ss_pred ccceeecc--CcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 613 SSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 613 ~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
+.++||+| +|++||++..+ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999864 789999999875432 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997655556899999999999999999999999 9999999999999999999999998754332111000
Q ss_pred ccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
...........++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 000011122346778999999976 468899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.84 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=209.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC----CcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||+||+|.+.. ...||||.++..... ....+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4678899999999999999999742 457999998754333 34578999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||++++++.++|+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999997643 36899999999999999999999998 99999999999999999999999999987642
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... ........++..|+|||.+.+..++.++||||||+++|||++ |..||........ .. .+..
T Consensus 159 ~~~-----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--~~--------~~~~ 223 (266)
T cd05033 159 SEA-----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IK--------AVED 223 (266)
T ss_pred ccc-----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--HH--------HHHc
Confidence 111 111112335678999999999999999999999999999998 9999965433211 11 1111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
......+..++..+.+++..|++.+|++||++.++++.|+++
T Consensus 224 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222233455677899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=339.95 Aligned_cols=239 Identities=23% Similarity=0.308 Sum_probs=183.2
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHH-HHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 578999999874321 12234444544 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+.+..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~------ 149 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH------ 149 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC------
Confidence 99999996543 4778888899999999999999999 999999999999999999999999998753221
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..... .. .....+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i---------~~-~~~~~~~ 217 (325)
T cd05602 150 -NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNI---------LN-KPLQLKP 217 (325)
T ss_pred -CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-HHHHH---------Hh-CCcCCCC
Confidence 112234568999999999999999999999999999999999999997544321 11110 00 1111222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHH
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMSEV 876 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~~v 876 (941)
..+..+.+++.+|++.+|.+|++..+.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 344555666666666666666666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=323.14 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=209.3
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4567889999999999999999988899999999876443 3457899999999999999999999874 4578999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 99999999997666667899999999999999999999998 99999999999999999999999999976542211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||...... +.... +......
T Consensus 158 -----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~---------~~~~~~~ 222 (260)
T cd05067 158 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQN---------LERGYRM 222 (260)
T ss_pred -----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHH---------HHcCCCC
Confidence 11123345678999999998889999999999999999999 99999654321 11111 1111112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
..+...+.++.+++.+|+..+|++||+++++...|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2344456789999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.57 Aligned_cols=263 Identities=27% Similarity=0.454 Sum_probs=207.5
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeeeeecccc-
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 676 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~- 676 (941)
...++|++.+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|+++++++ +|+||++++++|..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34568999999999999999999742 3578999998754322 345678899999999 89999999998854
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 700 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 700 (941)
....++||||+++++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 457889999999999999986422
Q ss_pred ---CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcccccccccc
Q 002289 701 ---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777 (941)
Q Consensus 701 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 777 (941)
..++++..+.+++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++.+..... .......
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-----~~~~~~~ 235 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGDA 235 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----hhhccCC
Confidence 126889999999999999999999998 99999999999999999999999999986532211 1112233
Q ss_pred ccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHH
Q 002289 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 856 (941)
Q Consensus 778 ~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 856 (941)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........ ..... ..+.....+.....++.
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRL--------KEGTRMRAPEYATPEIY 306 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHH--------hccCCCCCCccCCHHHH
Confidence 45678999999999999999999999999999998 9999964322111 11111 11112223445567889
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 857 KLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 857 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+++.+||+.+|++||++.+++++|+++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=326.43 Aligned_cols=256 Identities=28% Similarity=0.491 Sum_probs=205.8
Q ss_pred cCCCccceeeccCcEEEEEEEe-----CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++|++.+.||+|+||+||+|.. .++..||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 2467899999875332 334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC---------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC
Q 002289 683 VYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 747 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 747 (941)
||||+++++|.+++.... ...+++...+.++.|++.||+|||+++ |+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985332 234788899999999999999999999 99999999999999999
Q ss_pred cEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHH
Q 002289 748 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 826 (941)
Q Consensus 748 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~ 826 (941)
.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEV 235 (283)
T ss_pred cEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999976533221 111223345678999999998889999999999999999998 9889865332 111
Q ss_pred HHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
... +........+..++..+.+++.+|++.+|++||++.++.+.+..
T Consensus 236 ~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEM---------VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHH---------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 11112223445566789999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=328.31 Aligned_cols=282 Identities=23% Similarity=0.351 Sum_probs=206.5
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999975 6899999998653322 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ ++|.+++..... .+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 97 599998865443 6889999999999999999999999 9999999999999999999999999987542211
Q ss_pred CccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.......+.....+. .+.
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----------~~~ 222 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR----------VLG 222 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH----------hcC
Confidence 11122346788999999876 45889999999999999999999999755433222221111 011
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCC--CCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD--TKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~--~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
....+................+...+ ..+ ....+... ....+++.+||..+|++|||++|++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 223 TPTEETWPGVSSNPEFKPYSFPFYPP--RPL-------INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CCChhhhhhhhhccccccccccccCC--hhH-------HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11111111111110000000011111 111 11112222 455689999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.11 Aligned_cols=279 Identities=27% Similarity=0.399 Sum_probs=207.8
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|+..+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999975 6899999988753322 235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ ++|.+++.......+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 95 68999987665667899999999999999999999998 9999999999999999999999999987553221
Q ss_pred CccccccccccccCCCcccccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||++.+.. ++.++||||||+++|||+||+.||..........+ .... .+
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~----------~~ 218 (284)
T cd07860 155 -----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRT----------LG 218 (284)
T ss_pred -----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHH----------hC
Confidence 1112234678999999987644 68899999999999999999999975543222111 1100 01
Q ss_pred CCChHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
..+......+..+...+. ..|.. +....++ .+..++...++|.+|+..||++|||++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKP-SFPKWARQDFSKV----------VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCChhhhhhhhHHHHHHh-hcccccccCHHHH----------cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111111112222111111 11111 1111111 12233445689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=326.38 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=207.6
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
...++|++.++||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45788999999999999999999753 245899998865432 23456788999999999999999999999989
Q ss_pred cEEEEEecCCCCCHHHHHhhcC--------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 750 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 750 (941)
..++||||+++|+|.+++.... ....++..+..++.|++.||.|||+++ |+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532 234567788899999999999999999 99999999999999999999
Q ss_pred EeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002289 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 829 (941)
Q Consensus 751 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~ 829 (941)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 160 L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~~~~- 232 (288)
T cd05061 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLK- 232 (288)
T ss_pred ECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH-
Confidence 999999876533221 111122235678999999999899999999999999999999 7888864332 11111
Q ss_pred HHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
.+.++.....+..++..+.+++..|++.+|++||++.++++.+++.
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 --------FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1222333334555667899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=328.60 Aligned_cols=282 Identities=24% Similarity=0.380 Sum_probs=209.6
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5788999999999999999975 689999999876442 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+ +++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999986544 56899999999999999999999999 99999999999999999999999999886543221
Q ss_pred CccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|+|||.+.+. .++.++||||+||+++||++|+.||....+... ...... ...
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~----------~~~ 218 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-LAIVFR----------TLG 218 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-HHHHHH----------HcC
Confidence 112234588899999998754 468899999999999999999777754433221 111100 001
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
......+..+.++....-...+..++.. +....+..+....+++.+||..||++|||++++|.||||.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIP---------LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcch---------HHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1111111111111000000011111111 1122344456667899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=326.50 Aligned_cols=279 Identities=27% Similarity=0.404 Sum_probs=205.0
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|++|.||+|+.. +++.||+|+++..... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 6899999998653222 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
++ ++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 68998886543 256899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......++..|+|||++.+ ..++.++|||||||++|||+||+.||............ .. ..
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~------~~---- 218 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FR------IL---- 218 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HH------Hh----
Confidence 11223356789999998875 45788999999999999999999999765433221111 00 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC-CCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~-~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
+......+.....+... -...+. ..+. +.......+++..++|++||..||++|||+.|++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 219 GTPTEDVWPGVTSLPDY-KNTFPKWKKGS----------LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCCChhhhhcchhhHHH-HhhccccCcch----------hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01111111111100000 000000 0000 011122344556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.45 Aligned_cols=282 Identities=20% Similarity=0.320 Sum_probs=215.6
Q ss_pred chHHHHHHhcCCCccceeeccCcEEEEEEE-eCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccC
Q 002289 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 677 (941)
Q Consensus 600 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 677 (941)
+++|+...+ .+.||+|+|++|-.++ +.+|..+|||++.+.....++++.+|++++.+. .|+||+.++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 467777777 4689999999999988 678999999999887667788999999999998 599999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEeee
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADF 754 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DF 754 (941)
+.+|||||.|.||+|..+++++. .+++.++.+++++|+.||.|||.+| |.||||||+|||..+.. -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999997654 5899999999999999999999999 99999999999997654 4899999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCCch-hHHHHH
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKN-IVREVN 828 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~-~~~~~~ 828 (941)
.++.-......-...........+|+..|||||+.. ...|+.+.|.||+||++|-|+.|..||...-. .-.|.+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 887654322221122233345667999999999874 24588899999999999999999999964211 000000
Q ss_pred H---HHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCC
Q 002289 829 I---AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 905 (941)
Q Consensus 829 ~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~d 905 (941)
. ..-...+++.|......+|+..+..+ ..+++|++..+|..|
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahI-----------------------------------S~eakdlisnLlvrd 348 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHI-----------------------------------SSEAKDLISNLLVRD 348 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCChhhhHHh-----------------------------------hHHHHHHHHHHHhcc
Confidence 0 00001122223333333444333322 123457888899999
Q ss_pred CCCCCCCccCCCCCCCCCCCC
Q 002289 906 EETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 906 P~~R~sa~e~L~Hpwf~~~~~ 926 (941)
+..|.+|.+.++|||+..-.-
T Consensus 349 a~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 349 AKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHhhhhhhhccCCccccccch
Confidence 999999999999999976443
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=320.84 Aligned_cols=251 Identities=27% Similarity=0.453 Sum_probs=204.2
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
.+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999987778899999865332 34568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 9999999975433 5899999999999999999999999 99999999999999999999999999876532110
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... .. +........
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~---------~~~~~~~~~ 222 (256)
T cd05059 156 ---TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ES---------VSAGYRLYR 222 (256)
T ss_pred ---cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-HH---------HHcCCcCCC
Confidence 11111223457999999999999999999999999999999 88898654332111 11 111111223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
+..++..+.+++.+||..+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 445677899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=331.07 Aligned_cols=258 Identities=26% Similarity=0.442 Sum_probs=205.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCc----EEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
..+|++.+.||+|+||.||+|++. ++. .||+|+++... ....+++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356889999999999999999864 333 48999987543 23456789999999999999999999999764 577
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+|+||+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999997643 34788999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +. .....
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~-~~~~~-------- 225 (316)
T cd05108 161 ADEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EI-SSILE-------- 225 (316)
T ss_pred CCCc-----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HH-HHHHh--------
Confidence 3221 011112234678999999999999999999999999999998 99998654321 11 11111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+.....+..+...+.+++..||..+|.+||++.+++..+..+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111223344566788999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.05 Aligned_cols=203 Identities=28% Similarity=0.329 Sum_probs=171.8
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.++||+|+||+||+++.+ +++.||+|++..... .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999975 578999999864221 12345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.+.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997532 35888999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 157 ------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 11123356899999999986 3467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.39 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=206.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.++|.+.+.||+|+||.||+|.++++..||+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 356888999999999999999987777899998765332 3457889999999999999999999875 45688999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++|+|.++++......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc--
Confidence 9999999997665556899999999999999999999998 99999999999999999999999999976532211
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||......... . .........
T Consensus 158 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~---------~~~~~~~~~ 223 (260)
T cd05069 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-E---------QVERGYRMP 223 (260)
T ss_pred ----cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H---------HHHcCCCCC
Confidence 11112335678999999998899999999999999999999 89998754432111 1 011111223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
.+...+..+.+++.+|+..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 345567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=320.97 Aligned_cols=257 Identities=30% Similarity=0.500 Sum_probs=211.6
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
...++|++.++||+|+||.||+|..++++.||||.+..... ..+++.+|++++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 35678999999999999999999988888999999875433 34678999999999999999999999998889999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++.......+++..+..++.|++.|++|||+++ ++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997765567899999999999999999999998 99999999999999999999999999876542110
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... ..... +.....
T Consensus 159 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~---------~~~~~~ 222 (261)
T cd05034 159 ------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQ---------VERGYR 222 (261)
T ss_pred ------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH---------HHcCCC
Confidence 11112234568999999999899999999999999999999 99999654321 11111 111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
...+...+..+.+++.+|+..+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 22344456789999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=335.24 Aligned_cols=237 Identities=25% Similarity=0.345 Sum_probs=185.8
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHH-HHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 689999999875322 12334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 150 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE----- 150 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-----
Confidence 9999988654 34788888999999999999999999 9999999999999999999999999987432211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +.......+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~----------i~~~~~~~~~ 217 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-SQMYDN----------ILHKPLQLPG 217 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-HHHHHH----------HhcCCCCCCC
Confidence 122345689999999999999999999999999999999999999975432 111111 1111223344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMS 874 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~ 874 (941)
.....+.+++..|++.+|.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 4556677777778877777777653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=348.17 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=207.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCC-----
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 678 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 678 (941)
..++|++.+.||+|+||+||+|... +|+.||||++..... .....+.+|+.++..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4579999999999999999999854 789999999865432 23456889999999999999999988764332
Q ss_pred ---cEEEEEecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 679 ---EQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 679 ---~~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999998653 2346899999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhh
Q 002289 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 833 (941)
Q Consensus 754 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~ 833 (941)
||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...
T Consensus 187 FGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-~~~~~----- 255 (496)
T PTZ00283 187 FGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-EEVMH----- 255 (496)
T ss_pred cccCeecccccc-----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHH-----
Confidence 999986543211 1122345689999999999999999999999999999999999999975432 11111
Q ss_pred ccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
....+.....+..++..+.+++..||+.+|.+||++.+++++
T Consensus 256 ----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 ----KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 122233334556677889999999999999999999998764
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=326.66 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=207.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCchh-hHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.+|++.+.||+|+||.||+|... +++.||+|+++...... .+.+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34667889999999999999853 25789999997543322 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--------------CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC
Q 002289 682 LVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 747 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 747 (941)
+++||+++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998532 1234788889999999999999999999 99999999999999999
Q ss_pred cEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHH
Q 002289 748 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 826 (941)
Q Consensus 748 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~ 826 (941)
.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDV 235 (283)
T ss_pred ceEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999876532211 111223345778999999998889999999999999999998 8888865432 111
Q ss_pred HHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
. ..+........+.+++..+.+++..||+.+|++||++.++++.|+.
T Consensus 236 ~---------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I---------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H---------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1222333344566788889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.18 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=199.3
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|+||.||+|... +++.|++|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999975 6899999988643 233456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.++++......+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 99999999998765567899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......|+..|+|||+..+..++.++|||||||++|||++|+.||...... .... .+..+....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~~~ 220 (256)
T cd08529 156 -----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-ALIL---------KIIRGVFPP 220 (256)
T ss_pred -----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHH---------HHHcCCCCC
Confidence 1122345788999999999999999999999999999999999999754421 1111 112222233
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
.+..+...+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 33345556666677776666666666666553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.68 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=208.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999965 78999999876422 233456889999999999999999999999889999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 685 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 685 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||+++|+|.+++... ....+++..++.++.|+++||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988642 2345788999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||............. +...
T Consensus 159 ~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--------~~~~ 223 (267)
T cd08228 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK--------IEQC 223 (267)
T ss_pred hh-------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH--------HhcC
Confidence 21 11123457889999999998889999999999999999999999996543211111111 1111
Q ss_pred CCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 843 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 843 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
..+. .+...+..+.+++.+||..+|++||++.++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1222 2345667899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.85 Aligned_cols=283 Identities=23% Similarity=0.375 Sum_probs=205.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh-hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++++|.+.+.||+|+||.||+|... +|+.||+|++....... ...+.+|+++++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 68999999987543222 346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||++ +++.+++.... ..+.+..+..++.|++.||+|||+.+ |+|+||||+||+++.++++||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 78877765433 34778888899999999999999998 9999999999999999999999999987543221
Q ss_pred CCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||.......+.....+..
T Consensus 158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~---------- 220 (291)
T cd07870 158 -------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV---------- 220 (291)
T ss_pred -------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH----------
Confidence 111233468899999998764 57889999999999999999999997654432222211110
Q ss_pred CCCCChHHHHHHHHHHH---HhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 844 MGSYPSECVEKFIKLAL---KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~---~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
.+.........+..+-. ...... .++... .+..... ......+++.+|+..||++|||++|++.|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~-~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEWFLPC--KPQQLR-------VVWKRLS-RPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred cCCCChhhhhhhhhcccccchhcccc--CCcchh-------hhccccC-CChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 00011111111110000 000000 011111 1111111 2345568999999999999999999999999
Q ss_pred C
Q 002289 921 V 921 (941)
Q Consensus 921 f 921 (941)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=325.24 Aligned_cols=260 Identities=24% Similarity=0.406 Sum_probs=202.8
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999996 478999999986542 33346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997552 3678888999999999999999999 999999999999999999999999998754321
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-------------------~ 203 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-------------------L 203 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-------------------c
Confidence 122346889999999999999999999999999999999999999642110000 0
Q ss_pred CChHHHHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCC-QDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~-~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
.+ ... ..|+ ..++...|. ...++...+++.+|+..+|++||+++|+++||||....
T Consensus 204 ~~----~~~----~~~~~~~~~~~~~~---------------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 204 MP----LQL----LQCIVDEDPPVLPV---------------GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred ch----HHH----HHHHhccCCCCCCC---------------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 00 000 0111 111111110 11122345788899999999999999999999998765
Q ss_pred CCC
Q 002289 926 SGS 928 (941)
Q Consensus 926 ~~~ 928 (941)
.++
T Consensus 261 ~~~ 263 (279)
T cd06619 261 DGN 263 (279)
T ss_pred Ccc
Confidence 543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.41 Aligned_cols=281 Identities=24% Similarity=0.447 Sum_probs=219.5
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC--------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeeccc
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 675 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 675 (941)
...++|.+.+.||+|+||.||+|... ....||+|.++.... .....+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34568889999999999999999742 245799998875332 2345788999999999 6999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 741 (941)
..+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 8899999999999999999996532 235888999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCC
Q 002289 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 820 (941)
Q Consensus 742 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~ 820 (941)
++++++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred EEcCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999865322111 11112224467999999999899999999999999999999 88888643
Q ss_pred chhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccc
Q 002289 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINS 900 (941)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~ 900 (941)
.. .+.... +..+.....+..++.++.+++.+|+..+|++||++.++++.|+++.....+ ...++...
T Consensus 241 ~~-~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~---~~~~~~~~ 307 (314)
T cd05099 241 PV-EELFKL---------LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE---EYLDLSMP 307 (314)
T ss_pred CH-HHHHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC---CceeeEEe
Confidence 32 111111 111122234455667888999999999999999999999999988765433 33456667
Q ss_pred cCCCCCC
Q 002289 901 EHTSKEE 907 (941)
Q Consensus 901 ~L~~dP~ 907 (941)
+.+++|+
T Consensus 308 ~~~~~~~ 314 (314)
T cd05099 308 FEQYSPS 314 (314)
T ss_pred hhhcCCC
Confidence 7777663
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=337.19 Aligned_cols=203 Identities=27% Similarity=0.318 Sum_probs=173.0
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 68899999986422 122345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997532 35888999999999999999999999 9999999999999999999999999997653221
Q ss_pred CCCccccccccccccCCCccccccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
........||+.|+|||++.+ +.++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 ------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 111223468999999999875 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.81 Aligned_cols=264 Identities=27% Similarity=0.496 Sum_probs=211.8
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeecc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYC 674 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 674 (941)
++....++|++.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+++++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34456678899999999999999999864 236899999875432 2345688999999999 899999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhc--------------CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 002289 675 DEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 740 (941)
Q Consensus 675 ~~~~~~~LV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 740 (941)
...+..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 9999999999999999999999642 2346889999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCC
Q 002289 741 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 819 (941)
Q Consensus 741 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~ 819 (941)
|++++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred EEEcCCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 99999999999999999865432211 11122235678999999998899999999999999999998 9899865
Q ss_pred CchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 820 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
.... +.... +..+.....+..+...+.+++.+|++.+|++||++.++++.|+++.
T Consensus 238 ~~~~-~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 238 IPVE-ELFKL---------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCHH-HHHHH---------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 4321 11111 1112222344556778999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=315.60 Aligned_cols=250 Identities=29% Similarity=0.473 Sum_probs=208.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.++|++.+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999874 78999999986544 4568899999999999999999999999899999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999997766557899999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.....+..|+|||++.+..++.++||||||+++||+++ |+.||...... ...... .......
T Consensus 157 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~--------~~~~~~~ 219 (256)
T cd05039 157 -------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHV--------EKGYRME 219 (256)
T ss_pred -------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH--------hcCCCCC
Confidence 12234568999999998889999999999999999997 99998654321 111111 1111222
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
.+..+++.+.+++.+|+..+|++||++.+++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 344566788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.54 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=207.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.+|...++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 356899999886655556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCC-------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 002289 683 VYEFMSNGTLRDQLSAKSK-------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 749 (941)
||||+++++|.+++..... ..+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999975432 34789999999999999999999999 9999999999999999999
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 828 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~ 828 (941)
||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||........ ..
T Consensus 162 kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IE 235 (280)
T ss_pred EECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-HH
Confidence 9999999875432211 111122335678999999999999999999999999999998 8999865433211 11
Q ss_pred HHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
....+.....+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 ---------CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11122222334456678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.10 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=200.0
Q ss_pred eeeccCcEEEEEEEeC---CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCC
Q 002289 616 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 691 (941)
.||+|+||.||+|.+. ++..||+|++...... ..+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 3567999998765332 2457899999999999999999999885 457899999999999
Q ss_pred HHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcccc
Q 002289 692 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771 (941)
Q Consensus 692 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 771 (941)
|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++........ .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc----e
Confidence 99998643 345899999999999999999999998 999999999999999999999999999755332210 1
Q ss_pred ccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChH
Q 002289 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 850 (941)
Q Consensus 772 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (941)
.......++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ... .+..+.....+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---------~~~~~~~~~~~~~ 222 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMS---------FIEQGKRLDCPAE 222 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHH---------HHHCCCCCCCCCC
Confidence 11122234578999999988889999999999999999996 999997543311 111 1122233345566
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 851 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 851 ~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
++.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 778899999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=334.20 Aligned_cols=264 Identities=22% Similarity=0.391 Sum_probs=210.3
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCchh-hHhHHHHHHHHHhcC-CCceeeeeecc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLH-HRNLVSLVGYC 674 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~ 674 (941)
++....++|.+.+.||+|+||.||+|+++ .++.||+|+++...... .+.+.+|++++.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 45556677888999999999999999853 34689999998643322 346889999999997 99999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcCC-----------------------------------------------------
Q 002289 675 DEEGEQMLVYEFMSNGTLRDQLSAKSK----------------------------------------------------- 701 (941)
Q Consensus 675 ~~~~~~~LV~e~~~~gsL~~~l~~~~~----------------------------------------------------- 701 (941)
...+..++||||+++|+|.+++++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999965321
Q ss_pred -------------------------------------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 002289 702 -------------------------------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 738 (941)
Q Consensus 702 -------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 738 (941)
..+++..++.++.|++.||+|||+.+ |+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 23677788999999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCC
Q 002289 739 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPI 817 (941)
Q Consensus 739 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf 817 (941)
+|||+++++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999976432211 011122346788999999998889999999999999999998 88898
Q ss_pred CCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 818 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
............ +..+.....+..++..+.+++.+||..+|.+||++.++++.|+.+
T Consensus 343 ~~~~~~~~~~~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 343 PELPMNEQFYNA---------IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCCchHHHHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 643321111111 111112234555678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.63 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=204.4
Q ss_pred CCccceeeccCcEEEEEEEeC-C---CcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCc-----
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 679 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 679 (941)
|++.+.||+|+||.||+|... + +..||+|+++.... .....+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2 37899999875432 234578999999999999999999998865443
Q ss_pred -EEEEEecCCCCCHHHHHhhc----CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 002289 680 -QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 754 (941)
Q Consensus 680 -~~LV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 754 (941)
.++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999988542 2346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhh
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 833 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~ 833 (941)
|+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....+. +..
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~~~------ 225 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIY------ 225 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHH------
Confidence 999865432211 11112234678999999988899999999999999999999 88888654431 111
Q ss_pred ccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
..+..+.....+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 ---DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---HHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11222333345566778899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.43 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=205.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
..++|.+.+.||+|+||.||+|.+.+ +..||+|....... ..+..+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678899999999999999999743 57899998875432 334578999999999999999999999988889
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-----CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEE
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKV 751 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl 751 (941)
.++||||+++++|.++++.... ..+++..+++++.||+.||+|||+++ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 35899999999999999999999999 99999999999998754 6999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~ 830 (941)
+|||+++....... .........+..|+|||++.+..++.++|||||||++|||++ |+.||...... +....
T Consensus 161 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~- 233 (277)
T cd05036 161 ADFGMARDIYRASY-----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEF- 233 (277)
T ss_pred ccCccccccCCccc-----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH-
Confidence 99999986532111 001112223568999999999999999999999999999997 99999754331 11111
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
+........+..++..+.+++.+|++.+|++||++.+++++|+
T Consensus 234 --------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 --------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111222345556678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.74 Aligned_cols=284 Identities=24% Similarity=0.329 Sum_probs=204.9
Q ss_pred CCCccceeeccCcEEEEEEEeC---CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQM 681 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 681 (941)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999974 47899999988633 22235678899999999999999999999887 7899
Q ss_pred EEEecCCCCCHHHHHhhc---CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC----CCcEEEeee
Q 002289 682 LVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH----KFTAKVADF 754 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~----~~~~kl~DF 754 (941)
+||||++ +++.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 5787776532 2236889999999999999999999999 999999999999999 999999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhh
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 833 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~ 833 (941)
|+++........ ........++..|+|||++.+. .++.++|||||||+++||++|+.||......... ...
T Consensus 157 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-~~~--- 228 (316)
T cd07842 157 GLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK-SNP--- 228 (316)
T ss_pred ccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc-cch---
Confidence 999865432210 1112334578899999988764 5789999999999999999999999643321100 000
Q ss_pred ccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH----------------HHHHHhHhhCCCCCCCCccc
Q 002289 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM----------------RELESIWNMMPESDTKTPEF 897 (941)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~----------------~~L~~~~~~~~~~~~~~~dl 897 (941)
.....+.+++..+-...+..++.+.+.. ..+..........+....++
T Consensus 229 ----------------~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (316)
T cd07842 229 ----------------FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292 (316)
T ss_pred ----------------hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence 0001111111111111111111111100 00111111112445567789
Q ss_pred ccccCCCCCCCCCCCccCCCCCCC
Q 002289 898 INSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 898 l~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
+.+||+.||++|||++|+++||||
T Consensus 293 i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 293 LRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhcCCcccCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.29 Aligned_cols=268 Identities=23% Similarity=0.366 Sum_probs=210.6
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.+|++.+.||.|+||+||+|.. .+++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999986 478999999987655555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++++|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999998543 4889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||............ ... . ......
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-~~~-~------~~~~~~ 237 (296)
T cd06655 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATN-G------TPELQN 237 (296)
T ss_pred ----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hhc-C------CcccCC
Confidence 1122345788999999999888999999999999999999999999754432111000 000 0 000000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCCC
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 927 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~~ 927 (941)
+. ...+...+++.+|+..||++||++.+++.||||......
T Consensus 238 ~~---------------------------------------~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~ 278 (296)
T cd06655 238 PE---------------------------------------KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278 (296)
T ss_pred cc---------------------------------------cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccc
Confidence 00 011223357777888888888999999999999877766
Q ss_pred Ccccccccc
Q 002289 928 SNLVSGVIP 936 (941)
Q Consensus 928 ~~~~~~~~~ 936 (941)
+.+..+..|
T Consensus 279 ~~~~~~~~~ 287 (296)
T cd06655 279 SSLTPLILA 287 (296)
T ss_pred ccCCccccc
Confidence 665555433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.64 Aligned_cols=258 Identities=27% Similarity=0.459 Sum_probs=206.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CC--cEEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DG--TVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 683 (941)
++|++.+.||+|+||.||+|... ++ ..+++|.++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999875 33 357888887432 23346789999999999 799999999999998999999
Q ss_pred EecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 002289 684 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 749 (941)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 134888999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 828 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~ 828 (941)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... +...
T Consensus 159 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-ELYE 229 (297)
T ss_pred EECCcCCCccccce--------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Confidence 99999998643211 00111123457999999998899999999999999999997 99999754321 1111
Q ss_pred HHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
.+..+.....+..++..+.+++.+|++.+|.+||++.++++.|+.+....
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 ---------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11112222344556678899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.05 Aligned_cols=289 Identities=21% Similarity=0.301 Sum_probs=218.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-C-C----ceeeeeeccccCCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-H-R----NLVSLVGYCDEEGE 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----nIv~l~~~~~~~~~ 679 (941)
.+++|.+...+|+|.||.|-.+.++ .+..||||+++... ...+..+-|+++++++. + | -++.+.+||...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3789999999999999999999865 47899999998533 23446678999999994 2 2 37889999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--------------
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------- 745 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-------------- 745 (941)
.|+|+|.+ |.|+.+++..++-.+++...++.|+.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999 779999999888889999999999999999999999999 999999999999932
Q ss_pred ------CCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 746 ------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 746 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
+..++|+|||.|+.... ....++.|..|+|||++.+-.++.++||||+||||+|+.||...|..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e----------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHE----------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eeccCCCcceEEEecCCcceecc----------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 34699999999986432 22556788999999999999999999999999999999999999976
Q ss_pred CchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHH-----HHHHHHhcc--cCCCCCCCHHHHHHHHHHhHhhC---CC
Q 002289 820 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF-----IKLALKCCQ--DETDARPSMSEVMRELESIWNMM---PE 889 (941)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-----~~l~~~c~~--~~p~~RPs~~~v~~~L~~~~~~~---~~ 889 (941)
-++..... +.+.+ ++++|.....+- ..-. +++ .....| .+..+.+........+ ..
T Consensus 312 Hen~EHLa--------MMerI---lGp~P~~mi~r~~~~Kyf~~~--rldw~e~~~~~-~~k~v~~~ckpl~~~~~~~d~ 377 (415)
T KOG0671|consen 312 HENLEHLA--------MMERI---LGPIPSRMIKKTRKEKYFRRG--RLDWPEVSSKG-KSKYVFEPCKPLKKYMLQDDL 377 (415)
T ss_pred CCcHHHHH--------HHHHh---hCCCcHHHhhhhhhHhhhhcc--cccCccccccc-cchhhhcCCccHHHHhccCcH
Confidence 55433221 11112 234444433322 1111 222 111111 1222222222222222 22
Q ss_pred CCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 890 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 890 ~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
+..++.|||++||.+||.+|+|+.|||.||||..-
T Consensus 378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 378 EHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 33446789999999999999999999999999863
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=314.72 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=211.0
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 78999999886422 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 685 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 685 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 3356899999999999999999999999 99999999999999999999999999876533
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-IVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~ 841 (941)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||..... ..+... ....
T Consensus 159 ~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~ 222 (267)
T cd08224 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------KIEK 222 (267)
T ss_pred CC-------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh---------hhhc
Confidence 21 111234578899999999998899999999999999999999999965432 111111 1111
Q ss_pred CCCCCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 842 GNMGSYPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 842 ~~~~~~~~-~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
+.....+. .+...+.+++.+|+..+|++||++.++++.++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 22333333 5667899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.02 Aligned_cols=266 Identities=27% Similarity=0.429 Sum_probs=205.0
Q ss_pred cCC-CccceeeccCcEEEEEEEe-----CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccC--Cc
Q 002289 609 NNF-NSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GE 679 (941)
Q Consensus 609 ~~y-~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 679 (941)
++| +..+.||+|+||+||++.. .+++.||+|.++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 7889999999999988653 3578999999876432 3356788999999999999999999987553 46
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+++++|.+++... .+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 78999999999999999653 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHH-HHHHH---hhcc
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE-VNIAY---QSSM 835 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~-~~~~~---~~~~ 835 (941)
....... ........++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ....
T Consensus 157 ~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 5432110 01112223566799999999888999999999999999999999998643321110 00000 0001
Q ss_pred chhhhc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 836 MFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 836 ~~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
....++ ......+..++..+.+++..||+.+|++||++.++++.++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111 1122335566788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.98 Aligned_cols=248 Identities=27% Similarity=0.414 Sum_probs=199.6
Q ss_pred eeeccCcEEEEEEEeC---CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCC
Q 002289 616 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
.||+|+||.||+|.++ ++..||+|+++.... ...+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578999999875432 23567899999999999999999999885 45678999999999
Q ss_pred CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccc
Q 002289 691 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 770 (941)
Q Consensus 691 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 770 (941)
+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---- 151 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---- 151 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe----
Confidence 9999996543 5889999999999999999999999 999999999999999999999999999865432210
Q ss_pred cccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 771 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
........++..|+|||.+....++.++|||||||++|||++ |+.||..... .+.... +..+.....|.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~---------i~~~~~~~~~~ 221 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQM---------IESGERMECPQ 221 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH---------HHCCCCCCCCC
Confidence 011122234578999999988889999999999999999998 9999975432 111111 11122334556
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
.++.++.+++..||+.+|++||++.+|.+.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 6778899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=314.60 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=199.7
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999975 78999999876433 23346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~ 151 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-----AS 151 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-----cc
Confidence 99996543 35889999999999999999999999 99999999999999999999999999875432110 00
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHH
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 851 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (941)
......++..|+|||.+.++.++.++|||||||++|||++ |..||....... ... .+........+..+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~--------~~~~~~~~~~~~~~ 221 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TRE--------AIEQGVRLPCPELC 221 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHH--------HHHcCCCCCCcccC
Confidence 0111123457999999999899999999999999999998 888886443211 111 11111222345566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 852 VEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 852 ~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
+..+.+++.+|++.+|++||++.++.+.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.36 Aligned_cols=250 Identities=25% Similarity=0.445 Sum_probs=198.3
Q ss_pred cceeeccCcEEEEEEEeC-CCcEEEEEEecc----CCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC--cEEEEEec
Q 002289 614 STQIGQGGYGKVYKGILP-DGTVVAVKRAQE----GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYEF 686 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~LV~e~ 686 (941)
..+||+|+|-+||+|.+. +|..||--.++. ......++|..|+++|+.|+|+||+++++++.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999975 577776432221 12333478999999999999999999999986654 47899999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGla~~~~~~~~ 765 (941)
|..|+|..|+.+..+ .+....+.|++||++||.|||++. |||||||||.+||+|+. .|.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 999999999977654 778899999999999999999975 89999999999999975 589999999999876432
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
....+.|||.|||||... ..|++.+||||||++++||+|+.+||....+..+.++.. +.+..+
T Consensus 200 -------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV---------~SGiKP 262 (632)
T KOG0584|consen 200 -------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV---------TSGIKP 262 (632)
T ss_pred -------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH---------HcCCCH
Confidence 234478999999999987 789999999999999999999999998777655444332 222111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
. .+ ....+++..+||.+||.. .++|+||.|+|.||||+.+
T Consensus 263 ----~---sl-------------------------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 263 ----A---AL-------------------------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----H---Hh-------------------------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 0 00 011244555677777777 8889999999999999875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=335.29 Aligned_cols=290 Identities=22% Similarity=0.320 Sum_probs=213.3
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccC------
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 677 (941)
..++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999965 7899999998643 223345678899999999999999999987543
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
...++||||++ ++|.+.+... +++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 6898887543 788899999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
+...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........+...
T Consensus 166 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-------- 229 (353)
T cd07850 166 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI-------- 229 (353)
T ss_pred eeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------
Confidence 8653211 122345788999999999999999999999999999999999999765443222111
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhh---CCCCCCCCcccccccCCCCCCCCCCCc
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNM---MPESDTKTPEFINSEHTSKEETPPSSS 913 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~~---~~~~~~~~~dll~~~L~~dP~~R~sa~ 913 (941)
+ ...+..+.++...+...........+..++ .+.++.......... .......+.++|.+||++||++|||+.
T Consensus 230 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 230 --I-EQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred --H-HhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 1 112333444444444333333333332221 222221110000000 001223456899999999999999999
Q ss_pred cCCCCCCCCC
Q 002289 914 SMLKHPYVSS 923 (941)
Q Consensus 914 e~L~Hpwf~~ 923 (941)
|+|.||||..
T Consensus 307 eiL~~~~~~~ 316 (353)
T cd07850 307 DALQHPYINV 316 (353)
T ss_pred HHhcChhHhh
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=318.77 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=203.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCc----EEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++|++.+.||+|+||+||+|.+. +++ .|++|.+...... ...++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56788899999999999999964 444 4777877543222 23567788889999999999999998864 45789
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 35899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... ........++..|+|||++.++.++.++|||||||++||+++ |+.||....... ...... .
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~--------~ 226 (279)
T cd05111 162 DDK-----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLE--------K 226 (279)
T ss_pred CCc-----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--------C
Confidence 211 111233456778999999999999999999999999999998 999996543211 111111 1
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
+.....+..+...+..++.+||..+|.+||++.++++.+..+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 112222334556788899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.21 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=209.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCC-----CcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeecccc-CCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGE 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 679 (941)
..++|++.+.||+|+||.||+|.+.+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46788999999999999999999765 6889999887543 2335678899999999999999999998765 567
Q ss_pred EEEEEecCCCCCHHHHHhhcCC------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
.++++||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999865322 46899999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHh
Q 002289 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 754 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~ 832 (941)
||+++.+...+. ........++..|+|||++.+..++.++|||||||++||+++ |+.||..... .+....
T Consensus 161 ~g~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~--- 231 (280)
T cd05043 161 NALSRDLFPMDY-----HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAY--- 231 (280)
T ss_pred CCCcccccCCce-----EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHH---
Confidence 999986533221 011122345678999999998889999999999999999999 9999975432 111111
Q ss_pred hccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+..+.....+..++..+.+++.+||..+|++||++.++++.|+.+..
T Consensus 232 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 ------LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ------HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111122334456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=324.30 Aligned_cols=262 Identities=26% Similarity=0.480 Sum_probs=209.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC--------CCcEEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeecccc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 676 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 676 (941)
..++|.+.+.||+|+||.||+|... ++..+|+|.++... ......+.+|+++++.+ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467999999999999999999752 23579999987543 23345688899999999 79999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCC--------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 742 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 742 (941)
.+..++||||+++|+|.+++..+.. ..+++..++.++.|++.||+|||+++ ++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 9999999999999999999975421 35888999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCc
Q 002289 743 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 821 (941)
Q Consensus 743 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~ 821 (941)
++.++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred EcCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999998765322110 11112224568999999999889999999999999999998 888885432
Q ss_pred hhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
..+.... . ........+..++..+.+++.+|+..+|++||++.++++.|+++...
T Consensus 248 -~~~~~~~-~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 -VEELFKL-L--------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -HHHHHHH-H--------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 1 11112234556678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=315.70 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=207.5
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
+|++.+.||+|+||.||++... +++.||+|.++... ....+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788899999999999999965 68999999886432 333467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++|+|.+++.......+++..++.++.|++.||.|||+++ |+|+||||+||++++++.++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--- 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc---
Confidence 9999999987655566899999999999999999999999 9999999999999999999999999987653221
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .... .+..+.....
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~~~~ 220 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-NLIL---------KVCQGSYKPL 220 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-HHHH---------HHhcCCCCCC
Confidence 1122345888999999999988999999999999999999999999754321 1111 1122233344
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
+..++..+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 55667788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.44 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=208.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
..++|++.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45688899999999999999998642 36899999875432 334578899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 002289 680 QMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 751 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 751 (941)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999996532 224688899999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~ 830 (941)
+|||+++.....+. ........++..|+|||.+.+..++.++|||||||++||+++ |+.||...... +...
T Consensus 161 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~-- 232 (277)
T cd05032 161 GDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-EVLK-- 232 (277)
T ss_pred CCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-HHHH--
Confidence 99999876533221 111223346788999999998889999999999999999998 88898643321 1111
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
.+..+.....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 233 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 -------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11222333455666788999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=325.62 Aligned_cols=279 Identities=24% Similarity=0.359 Sum_probs=207.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ...+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47888999999999999999976 689999998864322 224567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|..++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888877543 34899999999999999999999998 99999999999999999999999999986543211
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||................ ..++.
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~--- 222 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL---GDLIP--- 222 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh---CCCCh---
Confidence 1223357789999999876 557889999999999999999999997554322111110000 00000
Q ss_pred CCCChHHHHHHHH---HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 845 GSYPSECVEKFIK---LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 845 ~~~~~~~~~~l~~---l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
. ...+.. .........+..+++... ..+..+....+|+.+|+..||++||++.|++.||||
T Consensus 223 -----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 223 -----R-HQQIFSTNQFFKGLSIPEPETREPLES----------KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred -----H-HhhhcccccccccccCCCcccccCHHH----------HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 000000 000001112222222211 122335566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.37 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=208.4
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
...++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3457889999999999999999998778889999887533 234578899999999999999999999877 78899999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999997765566889999999999999999999998 99999999999999999999999999976532211
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......++..|+|||++.+..++.++|+|||||++||+++ |+.||......... . .. ..+..
T Consensus 158 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-~-~~--------~~~~~ 221 (260)
T cd05073 158 ------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-R-AL--------ERGYR 221 (260)
T ss_pred ------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-H-HH--------hCCCC
Confidence 11112335678999999998889999999999999999999 89998654331111 1 10 11111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
...+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22334556778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=323.51 Aligned_cols=198 Identities=36% Similarity=0.588 Sum_probs=172.1
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhH--hHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
|++.+.||+|+||+||+++.. +++.||+|++......... ...+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999976 5779999999876544432 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++++|.+++... ..+++..++.++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---- 151 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST----
T ss_pred cccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc----
Confidence 999999999733 34899999999999999999999999 999999999999999999999999998753111
Q ss_pred ccccccccccccCCCcccccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
........++..|+|||++. +..++.++||||+|+++|+|++|..||...
T Consensus 152 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 ---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp ---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22334456888999999998 788999999999999999999999999754
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.89 Aligned_cols=267 Identities=28% Similarity=0.434 Sum_probs=205.2
Q ss_pred cCCCccceeeccCcEEEEEEEe-----CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc--CCcEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQM 681 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 681 (941)
.+|++.+.||+|+||+||+|.. .+++.||+|.++.......+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788899999999999999974 2578999999887655556788999999999999999999998643 34689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999996543 35899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHh----hccc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI-VREVNIAYQ----SSMM 836 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~-~~~~~~~~~----~~~~ 836 (941)
..... ........++..|+|||++.+..++.++|||||||++|||++|..++...... .+....... ...+
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 32210 00111122345699999999889999999999999999999988776432211 000000000 0000
Q ss_pred hhhhc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 837 FSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 837 ~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
.+.+. ......+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111 112233455667899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.72 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=203.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecc-ccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~LV~e~ 686 (941)
..+|++.+.||+|+||.||+|... |..||+|..+... ..+.+.+|+.++++++|+|++++++++ ...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357888999999999999999864 7889999886532 245789999999999999999999976 455678999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999997766566899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..... ..+...
T Consensus 157 --------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~---------~~~~~~ 218 (256)
T cd05082 157 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRV---------EKGYKM 218 (256)
T ss_pred --------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH---------hcCCCC
Confidence 12234568999999998899999999999999999998 9999864321 1111110 111112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
..++.++..+.+++.+|++.+|++||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 3345567789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=323.01 Aligned_cols=288 Identities=26% Similarity=0.407 Sum_probs=225.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCc----EEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.++|+..+.||+|+||.||+|.+. +|. .||+|.+...... ...++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999864 443 5788988754332 234688999999999999999999998654 567
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999986543 35788999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||..... +.......
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~-------- 225 (303)
T cd05110 161 GDEK-----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE-------- 225 (303)
T ss_pred Cccc-----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH--------
Confidence 2211 111122345678999999999999999999999999999998 8899865321 11111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
.+.....+..+...+.+++..||..+|++||++.++++.++.+... -.+.+.+.++.|+.+...-.|||
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 294 (303)
T cd05110 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD-----------PQRYLVIQGDDRMKLPSPNDSKF 294 (303)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc-----------hhhheeeccCCcCCCCCCchhhH
Confidence 1111223344567789999999999999999999999998876432 12347788999999999999999
Q ss_pred CCCCCC
Q 002289 921 VSSDVS 926 (941)
Q Consensus 921 f~~~~~ 926 (941)
|..-+.
T Consensus 295 ~~~~~~ 300 (303)
T cd05110 295 FQNLLD 300 (303)
T ss_pred Hhcccc
Confidence 987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.46 Aligned_cols=281 Identities=25% Similarity=0.360 Sum_probs=206.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccC--CcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV 683 (941)
++|++.+.||+|+||.||+|.++ +++.||+|.++...... ...+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999976 58999999987543222 34567899999999999999999998766 899999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 59999886543 36899999999999999999999999 999999999999999999999999998865432
Q ss_pred CCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. .......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||........ ..... .
T Consensus 160 ~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~----------~ 221 (293)
T cd07843 160 L-------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIF----------K 221 (293)
T ss_pred c-------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH----------H
Confidence 1 111234467899999998764 468899999999999999999999975443211 11110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC--CCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES--DTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~--~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
..+......+..+..+...- .....++....+ ...++.. .+...++|++||+.||++|||++|+|.|||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAK--KKTFTKYPYNQL-------RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred HhCCCchHHHHHhhccchhc--ccccccccchhh-------hccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 11111111122211111000 000011111111 1222322 555678999999999999999999999999
Q ss_pred C
Q 002289 921 V 921 (941)
Q Consensus 921 f 921 (941)
|
T Consensus 293 f 293 (293)
T cd07843 293 F 293 (293)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=323.54 Aligned_cols=263 Identities=25% Similarity=0.488 Sum_probs=210.7
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC--------CCcEEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeeccc
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 675 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 675 (941)
...++|.+.+.||+|+||.||+|+.. ++..||+|...... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45678889999999999999999741 24579999887533 23346789999999999 8999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 741 (941)
..+..++||||+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997532 235788899999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCC
Q 002289 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 820 (941)
Q Consensus 742 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~ 820 (941)
++++++.+||+|||.++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999865432211 11222345678999999999889999999999999999998 77887543
Q ss_pred chhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
. ..+..... ..+.....+..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 244 ~-~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 P-VEELFKLL---------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred C-HHHHHHHH---------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2 22221111 11112233456678899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=335.62 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=212.9
Q ss_pred CccceeeccCcEEEEEEEe-CCC----cEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 612 NSSTQIGQGGYGKVYKGIL-PDG----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
...++||+|+||+||+|.| ..| -+||+|++.... .+..+++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467999999999999996 344 468999887543 334678999999999999999999999998765 889999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
||+.|+|.|+++.+ +..+..+..+.|..|||+||.|||.+. +|||||.++||||.+-..+||.|||+|+.+..++.
T Consensus 778 ~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999764 456888999999999999999999988 99999999999999999999999999998865543
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
+- ......-.+.|||-|.+....|+.++|||||||++||++| |..|++.... +.+. ..+-++.+
T Consensus 854 ey-----~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--~eI~--------dlle~geR 918 (1177)
T KOG1025|consen 854 EY-----SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--EEIP--------DLLEKGER 918 (1177)
T ss_pred cc-----cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--HHhh--------HHHhcccc
Confidence 21 1122234568999999999999999999999999999999 9999975432 1111 11233555
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
.+.|+.|..+++.++.+||..|+..||+++++...+.++.+..
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 6788999999999999999999999999999999888775543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.83 Aligned_cols=258 Identities=30% Similarity=0.486 Sum_probs=206.3
Q ss_pred CCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
+|++.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+++++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235789998875433 234578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC----------------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 002289 683 VYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 740 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 740 (941)
|+||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 235788999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCC
Q 002289 741 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 819 (941)
Q Consensus 741 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~ 819 (941)
|++++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999765322110 11122345678999999988899999999999999999999 9989864
Q ss_pred CchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 820 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
... .+.... . ........+..++..+.+++..|++.+|++||++.++++.|+++..
T Consensus 233 ~~~-~~~~~~-~--------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 233 IAP-ERLFNL-L--------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCH-HHHHHH-H--------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 332 111111 1 0111222345566789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.58 Aligned_cols=201 Identities=25% Similarity=0.387 Sum_probs=172.9
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|+||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45789999999999999999996 46899999998765444455688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.++++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 99999999986543 5889999999999999999999998 9999999999999999999999999997653211
Q ss_pred CccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 161 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 161 -----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1112345788999999984 345788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=327.49 Aligned_cols=280 Identities=26% Similarity=0.384 Sum_probs=207.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 589999998764322 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.++.... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998877543 24899999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..
T Consensus 155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-------~~---- 217 (286)
T cd07846 155 ------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK-------CL---- 217 (286)
T ss_pred ------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH-------Hh----
Confidence 11223457889999999875 4578899999999999999999988865543222111110 00
Q ss_pred CCCChHHHHHHH--HHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 845 GSYPSECVEKFI--KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 845 ~~~~~~~~~~l~--~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
..........+. .+..... .|. ..+. .......+.......+|+.+|+..+|++||+++++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMR--LPE----VKEI----EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCCchhhHHHhccchHhhccc--ccc----ccCc----chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000000000000 0000011 111 0000 01111234455667789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.43 Aligned_cols=281 Identities=27% Similarity=0.401 Sum_probs=207.3
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-----hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-----GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
+|++.+.||+|+||.||+|... +++.||||.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999975 6899999998764432 234677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+ +|+|.+++.... ..+++..++.++.||++||+|||+++ |+|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997544 36899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. .......++..|+|||.+.+ ..++.++|||||||++|||++|..||....+.. ....... .
T Consensus 156 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~------~--- 218 (298)
T cd07841 156 N-------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFE------A--- 218 (298)
T ss_pred C-------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHH------H---
Confidence 1 11122346778999999865 467889999999999999999977775443321 1111110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
..............+...+... ..+... ....+........+++.+||..||++|||++|++.||||+
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 219 -LGTPTEENWPGVTSLPDYVEFK---PFPPTP--------LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred -cCCCchhhhhhccccccccccc---ccCCcc--------hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 0111111111111111111100 011100 0111223344567899999999999999999999999998
Q ss_pred CC
Q 002289 923 SD 924 (941)
Q Consensus 923 ~~ 924 (941)
+.
T Consensus 287 ~~ 288 (298)
T cd07841 287 ND 288 (298)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=335.10 Aligned_cols=193 Identities=26% Similarity=0.358 Sum_probs=161.4
Q ss_pred eeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHHHHhc---CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
||+|+||+||+|+.. +++.||||++....... ...+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 68999999986432221 22345566766655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 150 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN----- 150 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-----
Confidence 99999986543 4889999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||..|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 112345689999999998764 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=352.18 Aligned_cols=292 Identities=20% Similarity=0.244 Sum_probs=200.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCC--CcEEEEE------------------EeccCCchhhHhHHHHHHHHHhcCCCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVK------------------RAQEGSLQGEKEFLTEIQFLSRLHHRN 666 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 666 (941)
..++|++.++||+|+||+||++..+. +..+++| .+.. .......+.+|++++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987532 2222222 1111 1122356789999999999999
Q ss_pred eeeeeeccccCCcEEEEEecCCCCCHHHHHhhcC---CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 002289 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 743 (941)
Q Consensus 667 Iv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 743 (941)
|+++++++...+..++|+|++ +++|.+++.... ........++.++.|++.||+|||+++ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 568888775432 122345667789999999999999999 9999999999999
Q ss_pred cCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCC-CCc-
Q 002289 744 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS-HGK- 821 (941)
Q Consensus 744 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~-~~~- 821 (941)
+.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|..++. ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred CCCCCEEEEeCCCceecCccc------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 999999999999998654321 111233568999999999999999999999999999999999876443 221
Q ss_pred hhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhhCCCCCCCCcccccc
Q 002289 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPESDTKTPEFINS 900 (941)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~~~~~~~~~~~dll~~ 900 (941)
............ ....... +++. ...+.+.+.. ......+ ....++..+ .......++|.+
T Consensus 375 ~~~~~~~~~~~~---~~~~~~~---~p~~-~~~~~~~i~~---~~~~~~~~~~~~~~~~~--------~~~~~~~~li~k 436 (501)
T PHA03210 375 KPGKQLLKIIDS---LSVCDEE---FPDP-PCKLFDYIDS---AEIDHAGHSVPPLIRNL--------GLPADFEYPLVK 436 (501)
T ss_pred CHHHHHHHHHHh---cccChhh---cCCc-HHHHHHHhhh---hhcccCccchhhHHHhc--------CCChHHHHHHHH
Confidence 211211111110 0001111 1111 1112222211 1111111 222222111 123455678999
Q ss_pred cCCCCCCCCCCCccCCCCCCCCCCCCC
Q 002289 901 EHTSKEETPPSSSSMLKHPYVSSDVSG 927 (941)
Q Consensus 901 ~L~~dP~~R~sa~e~L~Hpwf~~~~~~ 927 (941)
||++||++||||+|+|.||||+.....
T Consensus 437 mL~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 437 MLTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred HhccCcccCcCHHHHhhChhhhcCCch
Confidence 999999999999999999999875543
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=315.58 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=206.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CC---cEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|+..+.||+|+||.||+|... ++ ..+|+|.++... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457788899999999999999964 33 379999887543 2334678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++++|.+++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999996543 45889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.... .........+..|+|||++.+..++.++|||||||++|||++ |+.||...... +.... +..
T Consensus 160 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-~~~~~---------i~~ 225 (268)
T cd05063 160 DPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKA---------IND 225 (268)
T ss_pred cccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHH---------Hhc
Confidence 2110 111112223457999999998889999999999999999998 99999654321 11111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
....+.+.+++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 122233445667889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.26 Aligned_cols=198 Identities=26% Similarity=0.438 Sum_probs=174.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||++.+. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999975 689999999865322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999665 35889999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223457889999999988888999999999999999999999996544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=311.38 Aligned_cols=247 Identities=30% Similarity=0.483 Sum_probs=200.7
Q ss_pred ceeeccCcEEEEEEEeCCCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCHH
Q 002289 615 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 693 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~ 693 (941)
+.||+|+||.||+|...+++.||+|.++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999998764332 2456889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcccccc
Q 002289 694 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773 (941)
Q Consensus 694 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 773 (941)
+++.... ..+++..++.++.|++.||.|+|+++ ++||||||+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------~~ 150 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------SS 150 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc------cc
Confidence 9986543 35789999999999999999999999 99999999999999999999999999875322110 11
Q ss_pred ccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHH
Q 002289 774 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852 (941)
Q Consensus 774 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (941)
.....++..|+|||++.+..++.++||||||+++||+++ |..||........ .. .+........+..++
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~--------~~~~~~~~~~~~~~~ 220 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--RE--------QVEKGYRMSCPQKCP 220 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HH--------HHHcCCCCCCCCCCC
Confidence 112234568999999998899999999999999999998 9999965432211 11 111112223345567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 853 EKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 853 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
..+.+++.+|+..+|++||++.++.+.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.65 Aligned_cols=204 Identities=29% Similarity=0.437 Sum_probs=173.8
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-----hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-----GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++|++.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999964 6899999988643221 23468889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|+||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999986543 4788999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.... ........++..|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 157 ICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred cccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 2110 111123457789999999999889999999999999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.09 Aligned_cols=267 Identities=23% Similarity=0.319 Sum_probs=207.8
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|+..+.||+|+||+||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999975 5899999998764333 3456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999997665567899999999999999999999999 9999999999999999999999999987553221
Q ss_pred CCCcc----------------------ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch
Q 002289 765 IEGIV----------------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822 (941)
Q Consensus 765 ~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~ 822 (941)
..... .........|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10000 00111234678899999999998899999999999999999999999964432
Q ss_pred hHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccC
Q 002289 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 902 (941)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L 902 (941)
...... +.. ..+ ..|.. ........+++.+|+
T Consensus 238 ~~~~~~----------~~~-----------------------~~~-~~~~~--------------~~~~~~~~~li~~~l 269 (316)
T cd05574 238 DETFSN----------ILK-----------------------KEV-TFPGS--------------PPVSSSARDLIRKLL 269 (316)
T ss_pred HHHHHH----------Hhc-----------------------CCc-cCCCc--------------cccCHHHHHHHHHHc
Confidence 111100 000 000 00000 001223346778888
Q ss_pred CCCCCCCCC----CccCCCCCCCCCCCC
Q 002289 903 TSKEETPPS----SSSMLKHPYVSSDVS 926 (941)
Q Consensus 903 ~~dP~~R~s----a~e~L~Hpwf~~~~~ 926 (941)
..||++|+| ++|+|.||||.+..+
T Consensus 270 ~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 270 VKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred cCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 889999999 999999999987544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=315.54 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=200.0
Q ss_pred CCccceeeccCcEEEEEEEeCC-Cc--EEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccC------Cc
Q 002289 611 FNSSTQIGQGGYGKVYKGILPD-GT--VVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GE 679 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 679 (941)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++... ....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999754 33 68999887532 23346788999999999999999999986322 25
Q ss_pred EEEEEecCCCCCHHHHHhhc----CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 680 QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 2345889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
+++....... ........++..|+|||+..+..++.++|||||||++|||++ |+.||...... +...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~------ 225 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIYD------ 225 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH------
Confidence 9986543221 011122345678999999999999999999999999999999 78888654321 1111
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
.+..+.....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 ---YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112222233445667889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.59 Aligned_cols=285 Identities=25% Similarity=0.352 Sum_probs=206.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccC--CcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~L 682 (941)
.++|++.+.||+|+||.||+|... +|+.||+|+++...... ...+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999975 68999999987533222 23567899999999999999999998654 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.+.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999995 58988886533 46899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ......
T Consensus 161 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~--------- 223 (309)
T cd07845 161 PA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQ--------- 223 (309)
T ss_pred cc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH---------
Confidence 21 11122335778999999876 5578999999999999999999999975443221 111110
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
..+......+..+..+........+... .. .+...++...+...+||.+||.+||++|||++|++.||||
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 224 -LLGTPNESIWPGFSDLPLVGKFTLPKQP--YN-------NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred -hcCCCChhhchhhhcccccccccccCCC--CC-------chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 0011111111111111100000000000 00 1111222335566789999999999999999999999999
Q ss_pred CCC
Q 002289 922 SSD 924 (941)
Q Consensus 922 ~~~ 924 (941)
...
T Consensus 294 ~~~ 296 (309)
T cd07845 294 KEK 296 (309)
T ss_pred ccC
Confidence 753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=348.65 Aligned_cols=270 Identities=25% Similarity=0.349 Sum_probs=208.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.++||+|+||.||+|.+. +|+.||+|++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999975 589999999875322 22457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcC---------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 685 EFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
||++||+|.+++.... ....++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 123567788899999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCC-c----------cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhH
Q 002289 756 LSRLAPVPDIEG-I----------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 824 (941)
Q Consensus 756 la~~~~~~~~~~-~----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~ 824 (941)
+++......... . ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652211000 0 00011123469999999999999999999999999999999999999996533211
Q ss_pred HHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhhCCC
Q 002289 825 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPE 889 (941)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~~~~~ 889 (941)
.... . ....+.......+.+..+.+++.+|++.+|++|| +++++.+.|+.+....++
T Consensus 239 i~~~-----~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 ISYR-----D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred hhhh-----h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 0000 0 0001000011124456788999999999999996 567777888877654443
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=320.76 Aligned_cols=260 Identities=24% Similarity=0.393 Sum_probs=208.4
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeeccccC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 677 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 677 (941)
...++|.+.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34567899999999999999999741 345799998875432 2345788999999999 799999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
+..++||||+++|+|.++++......+++.+++.++.|++.||+|||+++ |+|+||||+||+++.++.++++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997655445899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
+....... ........++..|+|||.+.+..++.++||||+||++|||++ |+.||...........
T Consensus 189 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-------- 255 (302)
T cd05055 189 RDIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-------- 255 (302)
T ss_pred ccccCCCc-----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH--------
Confidence 76533210 011122345678999999999999999999999999999998 9999865432111111
Q ss_pred hhhhcC-CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 837 FSVIDG-NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 837 ~~~~~~-~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
.+.. .....+...+..+.+++.+|+..+|++||++.++++.|++.
T Consensus 256 --~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 --LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111 11122334456889999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=310.63 Aligned_cols=271 Identities=23% Similarity=0.325 Sum_probs=218.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHh---HHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|..+++||+|.||.|-+++-+ +++.+|+|++++.-....++ -..|-++|+..+||.+..+.-.|+..++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 456778899999999999999965 79999999998765444333 35688899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||..||.|.-++.+. ..+++...+.+-..|+.||.|||+++ ||.||||.+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--- 318 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc---
Confidence 9999999999888653 45889999999999999999999999 999999999999999999999999999743
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
+.........+||+.|+|||++....|+.++|.|.+||++|||++|+.||...+.
T Consensus 319 ----I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------------------- 373 (516)
T KOG0690|consen 319 ----IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------------------- 373 (516)
T ss_pred ----ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---------------------
Confidence 2224456778999999999999999999999999999999999999999975432
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC-----CCccCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKH 918 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~H 918 (941)
+.+.+++..|--+-| ....+++..|+..+|..||.+|+ .|+|+.+|
T Consensus 374 ---------~kLFeLIl~ed~kFP--------------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 374 ---------EKLFELILMEDLKFP--------------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---------hHHHHHHHhhhccCC--------------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 223344433321111 12334455677777888888886 46888999
Q ss_pred CCCCCCCCCCccccccccccCC
Q 002289 919 PYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 919 pwf~~~~~~~~~~~~~~~~~~~ 940 (941)
+||.+..+.-..--.+.||++|
T Consensus 425 ~FF~~v~W~~~~~Kki~PPfKP 446 (516)
T KOG0690|consen 425 RFFASVDWEATYRKKIEPPFKP 446 (516)
T ss_pred hhhccCCHHHHHHhccCCCCCC
Confidence 9998877765555556666665
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=314.51 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=208.7
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||+|.. .+++.||||.+.... ....+++.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999996 478999999876432 223457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 685 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 685 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||+++++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998642 2346899999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.. .......++..|+|||++.+..++.++||||||+++|||++|..||............ .+...
T Consensus 159 ~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 223 (267)
T cd08229 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------KIEQC 223 (267)
T ss_pred CC-------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--------hhhcC
Confidence 21 1112345788999999999888999999999999999999999999644321111110 11111
Q ss_pred CCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 843 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 843 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
..+. .+...+..+.+++.+||..+|++||++.++++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1222 2345677899999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=315.39 Aligned_cols=258 Identities=28% Similarity=0.463 Sum_probs=206.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-C---CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||.||+|.+. + +..+|+|.++.... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999863 2 34799998875432 234678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999997653 35889999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.... ........++..|+|||++.+..++.++|||||||++||+++ |+.||....... ... .+.+
T Consensus 159 ~~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-~~~---------~~~~ 224 (267)
T cd05066 159 DPEA----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-VIK---------AIEE 224 (267)
T ss_pred ccce----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-HHH---------HHhC
Confidence 2110 111112223568999999999899999999999999999887 999996543211 111 1111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
....+.+..++..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111223344567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=328.74 Aligned_cols=262 Identities=26% Similarity=0.433 Sum_probs=204.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeeeeeccccC-
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE- 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~- 677 (941)
..++|++.+.||+|+||.||+|.+ .+++.||||+++..... ....+.+|++++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456899999999999999999974 34789999999754322 345688999999999 689999999988554
Q ss_pred CcEEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKS--------------------------------------------------------- 700 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 700 (941)
...++||||+++|+|.++++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999986431
Q ss_pred --------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 701 --------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 701 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
...+++..+..++.|+++||+|||+++ |+||||||+||++++++++||+|||++........ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~ 236 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YV 236 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc-----hh
Confidence 123678888999999999999999999 99999999999999999999999999876432110 01
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHH
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 851 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (941)
......++..|+|||++.+..++.++||||||+++|||++ |..||......... ... +..+.....+...
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~--------~~~~~~~~~~~~~ 307 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CRR--------LKEGTRMRAPDYT 307 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-HHH--------HhccCCCCCCCCC
Confidence 1112335678999999999999999999999999999997 99998653321111 111 1111222233334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 852 VEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 852 ~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
...+.+++..||+.+|++||++.+++++|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=306.90 Aligned_cols=294 Identities=23% Similarity=0.322 Sum_probs=213.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeecccc--------C
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------E 677 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~ 677 (941)
..|+...+||+|.||.||+|+.+ +|+.||+|+.--+. ........+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34566788999999999999965 57889998653211 1223467899999999999999999998843 2
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
..+++||++|+. +|.-++.. ....++..++.+++.++..||.|+|... |+|||+|+.|+|++.++.+||+|||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 358999999965 88888854 3356889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
+.+...+... ....+..+-|.+|++||.+.| ..|+++.|||+-||++.||+||.+.+....+.. ++.
T Consensus 172 r~fs~~~n~~---kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq-ql~-------- 239 (376)
T KOG0669|consen 172 RAFSTSKNVV---KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ-QLH-------- 239 (376)
T ss_pred cceecccccC---CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH-HHH--------
Confidence 8776544321 223455667999999999987 569999999999999999999977776544422 211
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHH-HhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLAL-KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~-~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
.+..-.+.+..+.++.+.++-. .-++..|--.-+.+ .++...+.+ ..++.+.|++.+||++||.+|+.|+++
T Consensus 240 --~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~r----kv~n~~kp~-~kd~~a~dLle~ll~~DP~kR~~ad~a 312 (376)
T KOG0669|consen 240 --LISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKR----KVKNRLKPY-VKDDEALDLLEKLLKLDPTKRIDADQA 312 (376)
T ss_pred --HHHHHhccCCcccCCCcccchHHHhccCCCCCcchhh----hhhhhcccc-cCChhHHHHHHHHhccCcccCcchHhh
Confidence 1222223333333322221110 01111221111222 222322222 346788999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 002289 916 LKHPYVSSDVS 926 (941)
Q Consensus 916 L~Hpwf~~~~~ 926 (941)
|.|.||..+-.
T Consensus 313 lnh~~F~kdp~ 323 (376)
T KOG0669|consen 313 LNHDFFWKDPM 323 (376)
T ss_pred hchhhhhcCCc
Confidence 99999966544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=329.52 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=211.8
Q ss_pred CCCccceeeccCcEEEEEEEeC--CCc--EEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.....++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|-+++|+|++++||...+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445678999999999999986 344 5899999876554 45789999999999999999999999987 6788999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|.++.|||.+.|++.....|-......++.|||.||.||.+++ +|||||..+|+|+-..-.|||+|||+.+-+...+
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999998866678899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
... .......-...|.|||.+....++.++|||+|||++|||+| |..||....... .+..+-+++
T Consensus 267 d~Y----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------IL~~iD~~e 332 (1039)
T KOG0199|consen 267 DMY----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------ILKNIDAGE 332 (1039)
T ss_pred cce----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------HHHhccccc
Confidence 211 11112234568999999999999999999999999999999 888997544311 111222455
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
+..-|..|+++++++++.||...|++||++.++.+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 6667899999999999999999999999999997444
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.65 Aligned_cols=200 Identities=25% Similarity=0.422 Sum_probs=175.4
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888999999999999999964 68999999987655555667899999999999999999999999899999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 999999998543 4788899999999999999999999 9999999999999999999999999987543211
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......+++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 171 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred ----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223458889999999998889999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=319.40 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=210.3
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
+-|...+.||+|.|..|-+|++ -+|..||||++.+..... ...+.+|+++|+.++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577778999999999999985 389999999998755443 4578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE-cCCCcEEEeeeccccccCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~~~~~~kl~DFGla~~~~~~~ 764 (941)
.-++|+|+|++-++. ..+.+....+++.||+.|+.|+|+.+ +|||||||+||.+ ..-|-+||+|||.+..+.
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 999999999996654 35899999999999999999999999 9999999999877 567899999999987553
Q ss_pred CCCccccccccccccCCCcccccccccCCCCc-hhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
+.......+|+..|-|||.+.|..|+. ++||||+|||||-+++|+.||....+..
T Consensus 171 -----PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------------------- 226 (864)
T KOG4717|consen 171 -----PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------------------- 226 (864)
T ss_pred -----CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------------
Confidence 345566778999999999999999875 6899999999999999999997554321
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
-...|+.|----| . ....+..|||.+||+-||.+|.|.+|+..|+|++.
T Consensus 227 -----------TLTmImDCKYtvP-------s-------------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 227 -----------TLTMIMDCKYTVP-------S-------------HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred -----------hhhhhhcccccCc-------h-------------hhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 1122333422111 1 11223457889999999999999999999999976
Q ss_pred CCC
Q 002289 924 DVS 926 (941)
Q Consensus 924 ~~~ 926 (941)
...
T Consensus 276 ~D~ 278 (864)
T KOG4717|consen 276 GDR 278 (864)
T ss_pred CCC
Confidence 444
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=322.36 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=203.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCc--EEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++... ....+.+.+|++++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356788899999999999999964 454 46777776432 23345788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 002289 683 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 748 (941)
||||+++|+|.++++... ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 135789999999999999999999999 999999999999999999
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 827 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~ 827 (941)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||...... +..
T Consensus 163 ~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELY 233 (303)
T ss_pred EEeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHH
Confidence 999999998632110 01111224567999999988889999999999999999998 99999644321 111
Q ss_pred HHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.. .........+...+..+.+++.+|++.+|++||++.++++.++.+..
T Consensus 234 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EK---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HH---------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 11111122333455678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=319.71 Aligned_cols=257 Identities=32% Similarity=0.504 Sum_probs=206.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
..++|++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567899999999999999999853 467899999875433 334678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--------------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 002289 680 QMLVYEFMSNGTLRDQLSAKS--------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 739 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~ 739 (941)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996432 124788889999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCC
Q 002289 740 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 818 (941)
Q Consensus 740 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~ 818 (941)
||++++++.++|+|||.++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred heEecCCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999998754322110 11112234567999999998999999999999999999998 888886
Q ss_pred CCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 819 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
.... .+... .+.++.....+..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus 235 ~~~~-~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAH-EEVIY---------YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCH-HHHHH---------HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 4432 11111 11222222334556678999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=326.21 Aligned_cols=243 Identities=30% Similarity=0.486 Sum_probs=204.5
Q ss_pred CCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchh---hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 611 FNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
|.-++.||.|+||.||-|++ .+..+||||++.....+. =.++..|++.|++++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44467899999999999996 478999999987544333 24689999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
| -||-.|++.-. +.++.+..+..|+.+.++||+|||+.+ .||||||+.|||+++.|.|||+|||.|.....
T Consensus 108 C-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred H-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 9 67999988643 356889999999999999999999999 99999999999999999999999999986532
Q ss_pred CccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
....+||+.|||||++.. +.|+-++||||+|++..|+.-+++|++........ +.+-...
T Consensus 179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL----------YHIAQNe 241 (948)
T KOG0577|consen 179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------YHIAQNE 241 (948)
T ss_pred -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH----------HHHHhcC
Confidence 345679999999999864 68999999999999999999999998865543322 2222222
Q ss_pred CCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 844 MGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 844 ~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
-+. ...+++..+..++..|+++-|.+|||..+++++
T Consensus 242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 233 346788999999999999999999999988764
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=323.32 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=201.8
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334567999999999999964 6899999998765555566789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||++++++.++|+|||++.......
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 9999988542 4788999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
.......|+..|+|||...+..++.++||||||+++|||++|+.||........ .
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~---------------------- 227 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-M---------------------- 227 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H----------------------
Confidence 112234588899999999988899999999999999999999999964332110 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCCCC
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGS 928 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~~~ 928 (941)
..+............ .......+++.+|+..||++|||++|+++||||......+
T Consensus 228 -------~~~~~~~~~~~~~~~-----------------~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 228 -------RRIRDNLPPRVKDSH-----------------KVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred -------HHHHhcCCCcccccc-----------------ccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 001111100000000 0111223577788899999999999999999998755544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=316.10 Aligned_cols=203 Identities=31% Similarity=0.465 Sum_probs=172.7
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccC------C
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE------G 678 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~ 678 (941)
+++.|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5678889999999999999999965 68899999987543 3345788999999998 799999999998542 4
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||+++++|.+++.......+++..+..++.|++.||+|||+++ |+||||||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 6899999999999999997655567899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
...... .......|+..|+|||++. +..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 160 QLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred eccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 543211 1223456889999999986 345788999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.42 Aligned_cols=265 Identities=25% Similarity=0.479 Sum_probs=210.3
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeC--------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeec
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGY 673 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 673 (941)
++....+|++.+.||+|+||.||+|... .+..||+|.++.... ...+.+.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445567899999999999999999742 123689998875332 2346789999999999 79999999999
Q ss_pred cccCCcEEEEEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 002289 674 CDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 739 (941)
Q Consensus 674 ~~~~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~ 739 (941)
|...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999997532 234788999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCC
Q 002289 740 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 818 (941)
Q Consensus 740 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~ 818 (941)
||+++.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999976532211 011122234567999999999999999999999999999998 888886
Q ss_pred CCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 819 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.... .+.... +..+.....+..++..+.+++.+|++.+|.+||++.++++.|+.+...
T Consensus 239 ~~~~-~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 239 GIPV-EELFKL---------LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred CCCH-HHHHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 5432 221111 111122234455667899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.02 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=205.4
Q ss_pred hcCCCcc-ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHh-cCCCceeeeeecccc----CCcE
Q 002289 608 TNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE----EGEQ 680 (941)
Q Consensus 608 ~~~y~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~ 680 (941)
+++|++. ++||-|-.|.|-.+..+ +|+.+|+|++.+. ....+|++.-=. -.|||||.++++|.. .+.+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4555553 57899999999999865 7899999998752 345678876433 379999999999843 4577
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeeccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLS 757 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGla 757 (941)
.+|||.|+||.|...++.++...+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||.|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999999999999999999999999999999999999 999999999999964 568999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
+.... .......+-|+.|.|||++...+|+...|+||+||++|-|++|..||....... . ...+.
T Consensus 212 K~t~~--------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------i-spgMk 276 (400)
T KOG0604|consen 212 KETQE--------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------I-SPGMK 276 (400)
T ss_pred cccCC--------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc------C-ChhHH
Confidence 86432 123345668999999999999999999999999999999999999997543210 0 01111
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
..+...-..||.+.+..+.+ .++|+|+.+|+.+|++|+|.+|.+.
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe-----------------------------------~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSE-----------------------------------AAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCccCCChhHhHHHH-----------------------------------HHHHHHHHHhcCCchhheeHHHhhc
Confidence 22222223455544443322 2347899999999999999999999
Q ss_pred CCCCCCCC
Q 002289 918 HPYVSSDV 925 (941)
Q Consensus 918 Hpwf~~~~ 925 (941)
|||+.+..
T Consensus 322 hpwi~~~~ 329 (400)
T KOG0604|consen 322 HPWINQYE 329 (400)
T ss_pred Cchhcccc
Confidence 99998843
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=320.18 Aligned_cols=281 Identities=24% Similarity=0.367 Sum_probs=204.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcC-CCceeeeeeccccCCc-----
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGE----- 679 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~----- 679 (941)
++|++.+.||+|+||.||+|.+. +++.||+|........ ....+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47889999999999999999975 6899999987653222 2356888999999995 6999999999876655
Q ss_pred EEEEEecCCCCCHHHHHhhcC---CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeec
Q 002289 680 QMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFG 755 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFG 755 (941)
.++||||+++ +|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8988886532 246899999999999999999999999 999999999999998 8999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||............ ..
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~-~~-- 226 (295)
T cd07837 157 LGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI-FK-- 226 (295)
T ss_pred cceecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HH--
Confidence 987553221 11122346788999998865 45789999999999999999999999765443322211 10
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
.+ ...+.........+.... ..|..+|. ......+..+....+||.+||..||++||+++|
T Consensus 227 ----~~----~~~~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 227 ----LL----GTPTEQVWPGVSKLRDWH--EFPQWKPQ---------DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred ----Hh----CCCChhhCcchhhccchh--hcCcccch---------hHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 00 000111111111100000 01111111 011222344556678999999999999999999
Q ss_pred CCCCCCCC
Q 002289 915 MLKHPYVS 922 (941)
Q Consensus 915 ~L~Hpwf~ 922 (941)
++.||||+
T Consensus 288 il~~~~~~ 295 (295)
T cd07837 288 ALTHPYFD 295 (295)
T ss_pred HhcCCCcC
Confidence 99999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.52 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=207.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC----CcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|.+.+.||+|+||.||+|.+.+ ...||||...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568888999999999999998643 3478999887644 3345678999999999999999999999875 45789
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999996543 35899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... .......++..|+|||.+....++.++||||||+++||+++ |+.||........... +..
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----------~~~ 223 (270)
T cd05056 160 ESY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----------IEN 223 (270)
T ss_pred ccc------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----------HHc
Confidence 211 11112234568999999988889999999999999999996 9999976543211111 111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+.....+..++..+.+++.+|+..+|.+||++.+++..|+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 22223455667789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.30 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=202.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC---------------CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeee
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD---------------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLV 671 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~ 671 (941)
.++|++.+.||+|+||.||++...+ ...||+|.++.... .....+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4688999999999999999987532 23589999875432 2345789999999999999999999
Q ss_pred eccccCCcEEEEEecCCCCCHHHHHhhcC----------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 002289 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741 (941)
Q Consensus 672 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 741 (941)
+++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986432 124688899999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh--CCCCCCC
Q 002289 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISH 819 (941)
Q Consensus 742 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt--G~~Pf~~ 819 (941)
++++++.+||+|||++........ ........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999876532211 111222345678999999999899999999999999999998 5667764
Q ss_pred Cch--hHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 820 GKN--IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 820 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
... ........+.. .........+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRN-----QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhh-----ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 322 11111110100 0000111223345578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.13 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=172.6
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeecccc-CCcEEEEEe
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 685 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~LV~e 685 (941)
+|++.+.||+|++|.||++..+ +++.||+|.+..... ...+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999965 578999999865332 234568899999999999999999998764 446789999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++.......+++.+++.++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999997655566899999999999999999999999 9999999999999999999999999987653221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......+++.|+|||++.+..++.++||||+|++++||++|+.||...
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1123345788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.53 Aligned_cols=201 Identities=26% Similarity=0.419 Sum_probs=175.1
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|+||.||++... +|+.||+|.+.... ....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999964 68999999986432 23345789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.......+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999997655556889999999999999999999998 9999999999999999999999999997653221
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......|+..|+|||+..+..++.++|||||||+++||++|+.||...
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 1122345788999999999988999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.70 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=204.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCc----EEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.++|++.++||+|+||+||+|.+. +++ .||+|+++.... ...+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457888999999999999999853 444 489999875433 335678899999999999999999999875 4578
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+++||+++|+|.++++... ..+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999996543 35889999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... ........++..|+|||...+..++.++|||||||++|||++ |..||....... ..... .
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~--------~ 225 (279)
T cd05109 161 IDET-----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLL--------E 225 (279)
T ss_pred cccc-----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH--------H
Confidence 3211 011112234678999999999999999999999999999998 889986543211 11111 1
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.......+..++..+.+++.+||+.+|++||++.++++.++.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111223344566788999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=316.02 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=195.0
Q ss_pred HHHHHhcCCCcccee--eccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCC
Q 002289 603 EMALATNNFNSSTQI--GQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 678 (941)
Q Consensus 603 ~~~~~~~~y~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 678 (941)
+.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +|+||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344445677777776 99999999999964 68899999987532221 122222222 7999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeeccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLS 757 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla 757 (941)
..++||||+++++|.+++.... .+++..++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997653 6899999999999999999999999 99999999999999998 9999999998
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
+..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||.......-
T Consensus 158 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~------------ 214 (267)
T PHA03390 158 KIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL------------ 214 (267)
T ss_pred eecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh------------
Confidence 754321 123578899999999998999999999999999999999999963321000
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC-ccCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-SSML 916 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa-~e~L 916 (941)
....+. ...... + ...+..++.+.+||.+||+.+|++|+++ +|+|
T Consensus 215 -------------~~~~~~----~~~~~~----~-------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 215 -------------DLESLL----KRQQKK----L-------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred -------------hHHHHH----Hhhccc----C-------------CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 000000 000000 0 0011233445689999999999999975 9999
Q ss_pred CCCCCCC
Q 002289 917 KHPYVSS 923 (941)
Q Consensus 917 ~Hpwf~~ 923 (941)
+||||.+
T Consensus 261 ~h~~~~~ 267 (267)
T PHA03390 261 KHPFLKI 267 (267)
T ss_pred cCCcccC
Confidence 9999974
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.14 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=202.9
Q ss_pred ceeeccCcEEEEEEEeCC--C--cEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILPD--G--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3699999987665 456789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999997654356899999999999999999999998 999999999999999999999999999876432211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (941)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....... .......+
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~--------~~~~~~~~ 223 (257)
T cd05040 154 -YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDK--------EGERLERP 223 (257)
T ss_pred -eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh--------cCCcCCCC
Confidence 111123456789999999999899999999999999999999 999996543321 1111110 11112234
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 849 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 455678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.80 Aligned_cols=259 Identities=28% Similarity=0.466 Sum_probs=204.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CC---cEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
..|++.+.||+|+||.||+|... ++ ..||||.++... ....++|..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34778899999999999999964 33 369999987542 23346799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999986543 35889999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
..... .........+..|+|||++.+..++.++|||||||++||+++ |..||...... +.... . ...
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~-i--------~~~ 227 (269)
T cd05065 160 TSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINA-I--------EQD 227 (269)
T ss_pred ccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHH-H--------HcC
Confidence 21100 000011112457999999999999999999999999999887 99999754321 11111 0 111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
...+.+.+++..+.+++..||+.+|.+||++.+++..|+++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11223455677889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.33 Aligned_cols=278 Identities=26% Similarity=0.402 Sum_probs=206.0
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
|++.+.||.|++|.||+|... +|+.||+|++...... ..+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999965 7999999998754322 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
+++|.+++.......+++..++.++.|+++||+|||+++ ++||||+|+||+++.++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---
Confidence 479999997665556899999999999999999999998 9999999999999999999999999997543221
Q ss_pred ccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||............ . .. ...
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~---------~~-~~~ 218 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI-F---------RT-LGT 218 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H---------HH-hCC
Confidence 111223467899999988764 5788999999999999999999999765443221111 0 00 011
Q ss_pred CChHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
...........+.... ..-+.. .+... ...+.......+++.+|+..||++|||++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 219 PDEDVWPGVTSLPDYK-PTFPKWARQDLS----------KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CChHHhhhhhhchhhh-hhcccccccchh----------hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1111111111110000 000100 11111 1122333456689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.29 Aligned_cols=249 Identities=29% Similarity=0.482 Sum_probs=200.0
Q ss_pred ceeeccCcEEEEEEEeC--C--CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP--D--GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
++||+|+||.||+|++. + +..||+|.+..... ...+++.+|+++++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 36899999886544 24567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc---
Confidence 99999997654 5889999999999999999999998 999999999999999999999999999865332110
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (941)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +.... . ........+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~-~--------~~~~~~~~~ 220 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAM-L--------ESGERLPRP 220 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHH-H--------HcCCcCCCC
Confidence 111112224568999999999999999999999999999998 99999754431 11111 1 111122345
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 849 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
..++..+.+++.+|+..+|++||++.++.+.|+++
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 55667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.02 Aligned_cols=254 Identities=31% Similarity=0.498 Sum_probs=196.6
Q ss_pred ceeeccCcEEEEEEEeC----CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccc-cCCcEEEEEecCC
Q 002289 615 TQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLVYEFMS 688 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~LV~e~~~ 688 (941)
+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 24679999886432 333567889999999999999999999775 4556899999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+|+|.+++.... ....+..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~- 155 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS- 155 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee-
Confidence 999999997543 23677788899999999999999998 9999999999999999999999999997543221100
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCC-CCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM-QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
........++..|+|||++.+..++.++|||||||++|||++|. .||.... ....... +..+.....
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~---------~~~~~~~~~ 223 (262)
T cd05058 156 --VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-SFDITVY---------LLQGRRLLQ 223 (262)
T ss_pred --ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH---------HhcCCCCCC
Confidence 11112334567899999999889999999999999999999954 4554332 2221111 112222233
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+...+..+.+++..||+.+|++||++.++++.++++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 44456788999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.72 Aligned_cols=206 Identities=28% Similarity=0.506 Sum_probs=174.3
Q ss_pred CCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc------hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
+|++.+.||+|+||+||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998864321 1124688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999996543 4788999999999999999999998 999999999999999999999999998765321
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
..... .........|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 156 GLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 11100 0112233468899999999999889999999999999999999999996543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=318.86 Aligned_cols=193 Identities=26% Similarity=0.417 Sum_probs=167.6
Q ss_pred eeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
||+|+||+||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 689999998865322 2244667899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.+++.......+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+...... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--------~ 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--------K 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--------C
Confidence 99997766557899999999999999999999999 999999999999999999999999998754321 1
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
......++..|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 112345778999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.27 Aligned_cols=206 Identities=27% Similarity=0.485 Sum_probs=173.2
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---------hHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---------EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
+|.+...||+|+||.||+|... +++.||+|.+....... .+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4777889999999999999864 68899999886532211 2467889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 35788899999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
......... .........|+..|+|||.+.+..++.++||||+||++|||++|+.||....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 643211100 0111223457889999999999889999999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=310.83 Aligned_cols=205 Identities=27% Similarity=0.400 Sum_probs=173.4
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++.+++++.....||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445666777789999999999999964 678999999887665666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCc--cHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeeccccc
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRL 759 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGla~~ 759 (941)
|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+++ |+||||||+||+++. ++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999997542 224 78888999999999999999998 999999999999976 67999999999875
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCC--CCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
..... .......|+..|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 159 LAGIN-------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred cccCC-------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 53211 1112235788999999987643 78899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.52 Aligned_cols=262 Identities=29% Similarity=0.445 Sum_probs=205.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC-----------------CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceee
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVS 669 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~ 669 (941)
.++|++.+.||+|+||.||+|...+ +..||+|.+..... ...+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999988542 24689999875433 34567899999999999999999
Q ss_pred eeeccccCCcEEEEEecCCCCCHHHHHhhcC---------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 002289 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 740 (941)
Q Consensus 670 l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 740 (941)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999899999999999999999997543 125899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh--CCCCCC
Q 002289 741 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 818 (941)
Q Consensus 741 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt--G~~Pf~ 818 (941)
|+++.++.++|+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999876533221 111223446778999999998889999999999999999998 677876
Q ss_pred CCchhHHHHHHHHhhccchhhhc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 819 HGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
....... ...... ...... ......+..++.++.+++..|++.+|.+||++.++++.|+
T Consensus 236 ~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQV-IENAGH---FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHHH-HHHHHh---ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 4332111 111100 000000 0011223345578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.24 Aligned_cols=267 Identities=25% Similarity=0.422 Sum_probs=205.1
Q ss_pred cCCCccceeeccCcEEEEEEEe-----CCCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 680 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 680 (941)
..|++.+.||+|+||.||++.. .++..||+|.++... ....+.+.+|++++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 357899999987543 23346789999999999999999999998765 568
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999996543 35899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhH-HHHH---HHHh-hcc
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REVN---IAYQ-SSM 835 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~-~~~~---~~~~-~~~ 835 (941)
...... ........++..|+|||++.+..++.++|||||||++|||++++.|........ +... .... ...
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 432210 111223446778999999998889999999999999999999877653221100 0000 0000 000
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
......+...+.+..++..+.+++.+|++.+|++||++.++++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001111222233455678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.86 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=197.5
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|+..+.||+|+||.||.++.. +++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999854 68999999876532 33356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999997765566899999999999999999999998 99999999999999999999999999976533221
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
......++..|+|||++.+..++.++||||||+++|||++|..||..... .+... .+..+....
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~---------~~~~~~~~~ 220 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVV---------KIVQGNYTP 220 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHH---------HHHcCCCCC
Confidence 12334588999999999988889999999999999999999999965332 11111 111222222
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
.+..++..+.+++..|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 33344455666666666666666666665554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.83 Aligned_cols=247 Identities=26% Similarity=0.436 Sum_probs=208.9
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
-|.++++||+|+||+||+|.++ .|++||+|.+..+ .+.+++..|+.+|++.+.+++|++||.|.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4667889999999999999975 6999999988743 345688999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
-||+.|.++.+ +.++.++++..+.++.++||+|||... -||||||+.|||++-+|.+||+|||.|..+...
T Consensus 112 AGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT----- 182 (502)
T KOG0574|consen 112 AGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT----- 182 (502)
T ss_pred CCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-----
Confidence 99999999754 457999999999999999999999888 799999999999999999999999999765321
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC--
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS-- 846 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 846 (941)
......+.||+-|||||++..-.|+.++||||+|++..||..|+.||.+.... ..++-+-....+.
T Consensus 183 --MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------RAIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 183 --MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------RAIFMIPTKPPPTFK 250 (502)
T ss_pred --HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------ceeEeccCCCCCCCC
Confidence 22345678999999999999999999999999999999999999999765431 1111111111122
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
-|+.++.++.++++.|+-+.|++|-++.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 468888999999999999999999988877654
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.18 Aligned_cols=244 Identities=26% Similarity=0.399 Sum_probs=205.5
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCHH
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 693 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~ 693 (941)
-+||+|.||+||.|++. +...+|||-+.....+..+-+.+|+.+-++++|.|||+++|.+.+.+++-+.||.++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999975 45679999988766666677889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCc--cHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEeeeccccccCCCCCCCccc
Q 002289 694 DQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVP 770 (941)
Q Consensus 694 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 770 (941)
++++.+ ..++ .+.++-.+.+||++||.|||++. |||||||-+|||++ -.|.+||+|||-++++..-
T Consensus 661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi------- 729 (1226)
T KOG4279|consen 661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI------- 729 (1226)
T ss_pred HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-------
Confidence 999753 2345 78889999999999999999999 99999999999996 5799999999999876431
Q ss_pred cccccccccCCCcccccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh-hcCCCCCC
Q 002289 771 AHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV-IDGNMGSY 847 (941)
Q Consensus 771 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 847 (941)
...+...-||..|||||++..+ .|+.++|||||||++.||.||++||..-.+... .++++ +-...+++
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------AMFkVGmyKvHP~i 800 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------AMFKVGMYKVHPPI 800 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------hhhhhcceecCCCC
Confidence 1233456699999999999764 588999999999999999999999975444221 11121 11234678
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
|++.+.+....+.+|+.++|..||++.++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 9999999999999999999999999999874
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.37 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=203.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-----------------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceee
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-----------------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVS 669 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~ 669 (941)
.++|++.++||+|+||.||++... ++..||+|++..... ...+.+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999998532 245799999875432 33567899999999999999999
Q ss_pred eeeccccCCcEEEEEecCCCCCHHHHHhhcCC---------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCc
Q 002289 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK---------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 740 (941)
Q Consensus 670 l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 740 (941)
+++++...+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999875421 24678889999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh--CCCCCC
Q 002289 741 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 818 (941)
Q Consensus 741 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt--G~~Pf~ 818 (941)
|++++++.++|+|||+++....... ........++..|+|||+..++.++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999876532211 011122234678999999988899999999999999999998 677886
Q ss_pred CCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 819 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
..... +....... .............+..++..+.+++..||+.+|.+||++.++.+.|+
T Consensus 236 ~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 236 QLSDE-QVIENTGE--FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccChH-HHHHHHHH--HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 43321 11111000 00000001111223446678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.76 Aligned_cols=251 Identities=31% Similarity=0.520 Sum_probs=203.4
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999987788999998875433 34578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+++|.+++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.++......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc----
Confidence 999999986543 35789999999999999999999999 9999999999999999999999999987543221
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
........++.+|+|||++.+..++.++||||||+++|||++ |+.||..... ...... +..+.....
T Consensus 155 --~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~---------~~~~~~~~~ 222 (256)
T cd05112 155 --YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVET---------INAGFRLYK 222 (256)
T ss_pred --ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHH---------HhCCCCCCC
Confidence 011122234578999999998899999999999999999998 9999865432 111111 011111112
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 333457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=315.49 Aligned_cols=263 Identities=26% Similarity=0.360 Sum_probs=204.7
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999964 68899999987533 22456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCC-CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
+++++|.++++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433 56899999999999999999999999 99999999999999999999999999876644321
Q ss_pred CCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.. ........|+..|+|||++... .++.++|+|||||++|||++|+.||........... ..
T Consensus 158 ~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~----------~~---- 220 (267)
T cd06610 158 RT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML----------TL---- 220 (267)
T ss_pred cc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH----------Hh----
Confidence 10 1122344588899999998876 789999999999999999999999964332111000 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
...+..-+...+ .........+++.+|+..||++||+++|+++||||
T Consensus 221 -------------------~~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 221 -------------------QNDPPSLETGAD-----------YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -------------------cCCCCCcCCccc-----------cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000000000000 01111223478888999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.76 Aligned_cols=249 Identities=30% Similarity=0.489 Sum_probs=197.5
Q ss_pred ceeeccCcEEEEEEEeC-CCc--EEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|.+. ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 343 57888887533 33446788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 690 GTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 690 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999996532 124789999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... .+....
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~----- 223 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEK----- 223 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHH-----
Confidence 98632110 00111223567999999988889999999999999999997 9999964332 111111
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
+..+.....+..+...+.+++.+||..+|.+||++.+++..|+++.
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 ----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111122233445667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=320.85 Aligned_cols=276 Identities=26% Similarity=0.338 Sum_probs=207.0
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCC----
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG---- 678 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 678 (941)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 589999999875432 22346788999999999999999999986544
Q ss_pred ------cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 002289 679 ------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 752 (941)
Q Consensus 679 ------~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 752 (941)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 787777544 346899999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 002289 753 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831 (941)
Q Consensus 753 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~ 831 (941)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 159 dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~------- 225 (302)
T cd07864 159 DFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA------- 225 (302)
T ss_pred cccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-------
Confidence 9999986543221 11122345778999998865 457889999999999999999999996443211
Q ss_pred hhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH---------HHHhHhhCCCCCCCCcccccccC
Q 002289 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE---------LESIWNMMPESDTKTPEFINSEH 902 (941)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~---------L~~~~~~~~~~~~~~~dll~~~L 902 (941)
.+..+...|....|..+|.+.+.... ...+............+++.+||
T Consensus 226 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 283 (302)
T cd07864 226 ----------------------QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHML 283 (302)
T ss_pred ----------------------HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHc
Confidence 11122222333333333322211100 00111122223455678999999
Q ss_pred CCCCCCCCCCccCCCCCCC
Q 002289 903 TSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 903 ~~dP~~R~sa~e~L~Hpwf 921 (941)
..||.+||++++++.||||
T Consensus 284 ~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 284 TLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cCChhhCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.11 Aligned_cols=248 Identities=35% Similarity=0.545 Sum_probs=205.9
Q ss_pred ceeeccCcEEEEEEEeCC----CcEEEEEEeccCCchh-hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|.... +..||+|.++...... .+.+.+|++.++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 7899999998654433 56889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 690 GTLRDQLSAKS-------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 690 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
++|.+++.... ...+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 356899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... ........++..|+|||.+.+..++.++||||+|+++|||++ |..||...... +... .+..
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~---------~~~~ 222 (262)
T cd00192 158 DDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLE---------YLRK 222 (262)
T ss_pred ccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-HHHH---------HHHc
Confidence 221 112233457789999999998889999999999999999999 69999765321 1111 1122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
+.....+..++.++.+++.+|++.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 333345666678899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.86 Aligned_cols=239 Identities=21% Similarity=0.373 Sum_probs=188.7
Q ss_pred ceeeccCcEEEEEEEeCC-------------CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 615 TQIGQGGYGKVYKGILPD-------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
+.||+|+||.||+|+..+ ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999877654444567889999999999999999999999988999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-------EEEeee
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-------AKVADF 754 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-------~kl~DF 754 (941)
+||||+++|+|..+++.+. ..+++..++.++.||++||+|||+++ |+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999886543 35899999999999999999999998 999999999999987664 899999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccc-cCCCCchhHhHHHHHHHHHHH-hCCCCCCCCchhHHHHHHHHh
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlG~ll~ell-tG~~Pf~~~~~~~~~~~~~~~ 832 (941)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.||..... .+... ..
T Consensus 157 g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~-~~- 222 (262)
T cd05077 157 GIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKER-FY- 222 (262)
T ss_pred CCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-hHHHH-HH-
Confidence 998654211 2234778999999987 467899999999999999998 58878754321 11111 00
Q ss_pred hccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
.... .........+.+++.+||+.+|.+||++.++++.+
T Consensus 223 --------~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 --------EGQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------hcCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0011 11122346788999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.65 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=171.4
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
-|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3667889999999999999976 578899999876555556678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+++|.+++.+. ..++++..+..++.|+++||+|||+.+ |+||||||+||+++.++++||+|||++.......
T Consensus 86 ~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 86 GGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99999988653 346899999999999999999999999 9999999999999999999999999987543211
Q ss_pred cccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 1122345888999999984 455788999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.58 Aligned_cols=252 Identities=26% Similarity=0.349 Sum_probs=202.2
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999975 589999999875332 335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++... .++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999665 46889999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||........
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------------------- 207 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-------------------- 207 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH--------------------
Confidence 12334578899999999988899999999999999999999999975432100
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC--ccCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS--SSMLKHPYV 921 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa--~e~L~Hpwf 921 (941)
..+.+.........|.. ......++|.+|+..||.+|+++ +|++.||||
T Consensus 208 -------~~~~~~~~~~~~~~~~~--------------------~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 208 -------DQIRAKQETADVLYPAT--------------------WSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------HHHHHHhccccccCccc--------------------CcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00001100000011111 11233467888899999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.69 Aligned_cols=260 Identities=24% Similarity=0.404 Sum_probs=200.4
Q ss_pred CCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc------hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
+|+..+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999996 5789999999864321 124578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeeccccccC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAP 761 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~~ 761 (941)
||||+++++|.+++.... ++++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999996543 5889999999999999999999999 99999999999998776 69999999987664
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
..... .........++..|+|||.+.+..++.++||||+|++++||++|+.||........ ...
T Consensus 156 ~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~------------ 219 (268)
T cd06630 156 AKGTG---AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LAL------------ 219 (268)
T ss_pred ccccc---CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHH------------
Confidence 32110 01112234578899999999888899999999999999999999999863321100 000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
+.+.. .... .|... +..++...+++.+|+..+|++||++.|+++||||
T Consensus 220 -------------~~~~~---~~~~---~~~~~-------------~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 220 -------------IFKIA---SATT---APSIP-------------EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred -------------HHHHh---ccCC---CCCCc-------------hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 00000 0000 01000 0112233468888899999999999999999998
Q ss_pred C
Q 002289 922 S 922 (941)
Q Consensus 922 ~ 922 (941)
.
T Consensus 268 ~ 268 (268)
T cd06630 268 R 268 (268)
T ss_pred C
Confidence 5
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.78 Aligned_cols=289 Identities=24% Similarity=0.372 Sum_probs=207.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccC-----CcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 680 (941)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999964 68999999986422 22345678899999999999999999886543 357
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++|+||++ ++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 588887743 35899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
...... ........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........ .... ...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~------~~~ 225 (336)
T cd07849 157 DPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLI------LGV 225 (336)
T ss_pred cccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH------HHH
Confidence 332111 111233568899999998765 5688999999999999999999999965432211 1100 000
Q ss_pred hcCCCCCCChHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
.+..+.+....+.... ...+...|.. +... +....+..++...+++.+||..||++|||+.|+++|
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 ----LGTPSQEDLNCIISLRARNYIKSLPFK-PKVP--------WNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred ----cCCCCHHHHHHhhchhhhhHHhhcCcC-Cccc--------HHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111111110 1111111111 1110 001123345667799999999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 919 PYVSSDVSG 927 (941)
Q Consensus 919 pwf~~~~~~ 927 (941)
|||..-.+.
T Consensus 293 p~~~~~~~~ 301 (336)
T cd07849 293 PYLEQYHDP 301 (336)
T ss_pred ccccccCCC
Confidence 999765543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=317.87 Aligned_cols=280 Identities=25% Similarity=0.365 Sum_probs=204.7
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcEEEEEe
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVYE 685 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV~e 685 (941)
|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999976 58999999998653 22345688999999999999999999999877 89999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 58998886543 46899999999999999999999998 99999999999999999999999999986643321
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........ ..
T Consensus 156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~----------~~ 218 (287)
T cd07840 156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFE----------LC 218 (287)
T ss_pred ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH----------Hh
Confidence 11223346788999998765 45789999999999999999999999754432 11111110 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
.......+..+.++ +.......++.....+ .. .+.. ......+++++|+..+|++||+++++++||||
T Consensus 219 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 219 GSPTDENWPGVSKL---PWFENLKPKKPYKRRL---RE---FFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred CCCchhhccccccc---hhhhhccccccchhHH---HH---HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00111111111111 1111111111111111 11 1111 24556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.10 Aligned_cols=280 Identities=25% Similarity=0.396 Sum_probs=207.4
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
+|++.++||+|++|.||+|+.. +|+.||||+++..... ..+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 6899999998764332 2456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 688 SNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 688 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+ ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 7 58988886543 346899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......++..|++||++.+ ..++.++|||||||++|||++|+.||....... ........ ..
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~----------~~ 218 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRI----------MG 218 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHH----------hC
Confidence 11223446789999999866 457889999999999999999999997554321 11111100 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
.........+... ...-...| +...... ....+..+....+++.+|++.||++|++++|+++||||
T Consensus 219 ~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 219 TPTESTWPGISQL-PEYKPTFP--RYPPQDL-------QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChhhHHHHhcC-chhccccc--CCChHHH-------HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1111111111100 00001111 1111111 11223345667899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=319.57 Aligned_cols=258 Identities=22% Similarity=0.335 Sum_probs=201.3
Q ss_pred cceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 614 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999964 6899999998765444556788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-------~ 172 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------P 172 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-------c
Confidence 998754 34789999999999999999999999 9999999999999999999999999987543211 1
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHH
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (941)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~----------------------- 228 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKR----------------------- 228 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-----------------------
Confidence 12335588999999999988999999999999999999999999964332111 000
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCCCCccc
Q 002289 853 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLV 931 (941)
Q Consensus 853 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~~~~~~ 931 (941)
+.......... .........+++++|++.+|++||+++|+++||||...-..+-++
T Consensus 229 ------~~~~~~~~~~~-----------------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~ 284 (297)
T cd06659 229 ------LRDSPPPKLKN-----------------AHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284 (297)
T ss_pred ------HhccCCCCccc-----------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccccc
Confidence 00000000000 001122234678888899999999999999999987654444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=309.36 Aligned_cols=253 Identities=27% Similarity=0.343 Sum_probs=191.9
Q ss_pred ceeeccCcEEEEEEEeCC---CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCC
Q 002289 615 TQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 46799998875432 33457889999999999999999999999889999999999999
Q ss_pred CHHHHHhhcC---CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 691 TLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 691 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
+|.++++... ....++..+..++.|++.|++|||+.+ ++||||||+||+++.++++||+|||.++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 9999997532 234667788899999999999999999 99999999999999999999999999875432211
Q ss_pred ccccccccccccCCCcccccccccC-------CCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTH-------KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
........++..|+|||++.+. .++.++||||||+++|||++ |+.||........... .... .....
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~-~~~~~ 230 (269)
T cd05087 156 ---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TVRE-QQLKL 230 (269)
T ss_pred ---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-Hhhc-ccCCC
Confidence 0111234567889999998642 35789999999999999996 9999965443221111 1110 00011
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
. .+.........+.+++..|| .+|++||++.++++.|+
T Consensus 231 ~---~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 P---KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C---CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 11122234556788999999 57999999999997764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=318.83 Aligned_cols=279 Identities=26% Similarity=0.380 Sum_probs=206.5
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|+||.||+|..+ +++.||+|+++... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999975 58899999886532 2234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|++++.+..+.... ..+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99887666655432 34889999999999999999999998 99999999999999999999999999886543221
Q ss_pred CCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||............. .. .
T Consensus 156 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~~----~ 218 (288)
T cd07833 156 ------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ-------KC----L 218 (288)
T ss_pred ------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------HH----h
Confidence 122334578899999999887 88999999999999999999999986543321111100 00 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHhHhhCCC-CCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETD----ARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~----~RPs~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
+..+......+ ..++. +.+...+. ..+...++. ......+|+++||..+|++|||++++++||
T Consensus 219 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 286 (288)
T cd07833 219 GPLPPSHQELF--------SSNPRFAGVAFPEPSQP----ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286 (288)
T ss_pred CCCCHHHhhhc--------ccCccccccccCCCCCc----HHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence 01111000000 00000 01111110 011111222 256678999999999999999999999999
Q ss_pred CC
Q 002289 920 YV 921 (941)
Q Consensus 920 wf 921 (941)
||
T Consensus 287 ~f 288 (288)
T cd07833 287 YF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=317.64 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=196.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHH-HHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|+||.||+|+.. +|+.||+|+++.... ..+..+..|+.. ++..+|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 699999999875432 234556667665 666799999999999999999999999
Q ss_pred cCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 686 FMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 686 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|++ |+|.+++... ....+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 7898887642 234689999999999999999999987 7 99999999999999999999999999876432
Q ss_pred CCCCCccccccccccccCCCccccccccc----CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
. .......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.......+....
T Consensus 157 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------- 219 (283)
T cd06617 157 S--------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ--------- 219 (283)
T ss_pred c--------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH---------
Confidence 1 11122457889999998865 45688999999999999999999999643221111110
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
...+.....+. .+ ......+|+.+||..+|++||++++++.|
T Consensus 220 ~~~~~~~~~~~-------------------~~-------------------~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 VVEEPSPQLPA-------------------EK-------------------FSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhcCCCCCCc-------------------cc-------------------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00 01123457778888889999999999999
Q ss_pred CCCCCCCC
Q 002289 919 PYVSSDVS 926 (941)
Q Consensus 919 pwf~~~~~ 926 (941)
|||.....
T Consensus 262 ~~~~~~~~ 269 (283)
T cd06617 262 PFFELHLS 269 (283)
T ss_pred chhhhccc
Confidence 99987653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=316.46 Aligned_cols=207 Identities=24% Similarity=0.389 Sum_probs=172.7
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999975 578999998875432 22356789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999996543 5889999999999999999999998 9999999999999999999999999987421111
Q ss_pred CCCc--------cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 765 IEGI--------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 765 ~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.... ..........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0000 0001112245788999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.62 Aligned_cols=200 Identities=25% Similarity=0.415 Sum_probs=170.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999976 789999998875322 2245788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999886532 2368999999999999999999996 46 999999999999999999999999998754321
Q ss_pred CCCccccccccccccCCCcccccccccCC------CCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 --------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred --------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 112334778999999986543 478999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.82 Aligned_cols=199 Identities=31% Similarity=0.429 Sum_probs=174.8
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999965 68999999987543 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++... .+++..++.++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999654 6899999999999999999999998 9999999999999999999999999998764321
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 1123345788999999999988999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.50 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=191.5
Q ss_pred eeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHH---hcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 616 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLS---RLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
.||+|+||.||++... +++.||+|.+...... ....+.+|..+++ ..+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999974 6899999988653221 1233445544443 3479999999999998899999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+|+|.+++..+. .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999986543 4899999999999999999999999 9999999999999999999999999987543211
Q ss_pred cccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHhhccchhhhcCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI-VREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ....... .......
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------~~~~~~~ 217 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------TLTVNVE 217 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---------hhcCCcC
Confidence 122358899999999864 56889999999999999999999999643210 0000000 0000000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC-----CCccCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKHPYV 921 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~Hpwf 921 (941)
.+. .......++|.+||..||++|+ |++|+++||||
T Consensus 218 ~~~---------------------------------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 218 LPD---------------------------------------SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred Ccc---------------------------------------ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 111 1122334677788888888888 69999999999
Q ss_pred CCCCCCCccccc
Q 002289 922 SSDVSGSNLVSG 933 (941)
Q Consensus 922 ~~~~~~~~~~~~ 933 (941)
..-.+.......
T Consensus 259 ~~~~~~~~~~~~ 270 (279)
T cd05633 259 KGIDWQQVYLQK 270 (279)
T ss_pred cCCCHhHHhcCC
Confidence 886665544333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=310.36 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=207.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCc----EEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
..+|++.+.||+|+||.||+|.++ +|+ .||+|....... .....+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356788899999999999999864 333 689998876543 234678899999999999999999999987 7899
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||.++...
T Consensus 85 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999997643 34899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... ........++..|+|||.+....++.++||||||+++||+++ |+.||..... .+... .+.
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~---------~~~ 225 (279)
T cd05057 161 VDEK-----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPD---------LLE 225 (279)
T ss_pred Cccc-----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHHHH---------HHh
Confidence 2211 011112224568999999988889999999999999999999 9999975432 11111 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+.....+..+...+..++.+||..+|.+||++.++++.++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 226 KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122223344566778899999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.51 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=173.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 356778889999999999999964 6899999998765444445688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++...+ .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999999986543 5889999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......|+..|+|||++. ...++.++||||+||++|||++|+.||...
T Consensus 161 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 161 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 1123346889999999974 456888999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.67 Aligned_cols=283 Identities=22% Similarity=0.343 Sum_probs=206.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|++|+||+|... +|+.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999975 689999998865332 223568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeeccccccCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGla~~~~~~~ 764 (941)
|++ ++|.+++.......+++..++.++.||+.||+|||+++ ++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 68888886655555788889999999999999999998 999999999999985 5679999999997543211
Q ss_pred CCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......++..|+|||++.+ ..++.++||||+||++|||+||+.||............ + ....
T Consensus 158 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~-~------~~~~-- 221 (294)
T PLN00009 158 -------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI-F------RILG-- 221 (294)
T ss_pred -------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H------HHhC--
Confidence 11123356789999999876 45788999999999999999999999765432211111 0 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
......+.....+-.. ....|..++.. .....+..++.+.+++.+||..+|++||++.++++||||+.
T Consensus 222 --~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 222 --TPNEETWPGVTSLPDY-KSAFPKWPPKD---------LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred --CCChhhccccccchhh-hhhcccCCCCC---------HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 0000000000000000 00011111110 01112344556778999999999999999999999999976
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=314.79 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=206.7
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788999999999999999996 47899999998765555566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-- 169 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc--
Confidence 9999999998543 4788899999999999999999998 9999999999999999999999999987543221
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......+++.|+|||.+.+..++.++|||||||++|++++|+.||........ ...........
T Consensus 170 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----------~~~~~~~~~~~ 234 (297)
T cd06656 170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----------LYLIATNGTPE 234 (297)
T ss_pred -----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----------eeeeccCCCCC
Confidence 112234578899999999998899999999999999999999999965332110 00000000000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
. ..| ........+|+.+|+..+|++||+++++++||||.....
T Consensus 235 ~---------------------~~~----------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 235 L---------------------QNP----------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred C---------------------CCc----------------cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 0 000 001112236777888999999999999999999976555
Q ss_pred CCc
Q 002289 927 GSN 929 (941)
Q Consensus 927 ~~~ 929 (941)
-..
T Consensus 278 ~~~ 280 (297)
T cd06656 278 LSS 280 (297)
T ss_pred ccc
Confidence 443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=311.64 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=173.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.++||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467889999999999999999975 5899999999876655567789999999999999999999999989999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|..++.+.. ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999998875433 35899999999999999999999998 999999999999999999999999998653221
Q ss_pred CccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
........++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 164 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 164 ----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 11122345788999999985 345678999999999999999999998643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.08 Aligned_cols=248 Identities=30% Similarity=0.487 Sum_probs=201.2
Q ss_pred ceeeccCcEEEEEEEeCCCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCHH
Q 002289 615 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 693 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~ 693 (941)
++||+|+||.||+|.+.+++.||+|.+...... ..+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999988765443 4567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcccccc
Q 002289 694 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773 (941)
Q Consensus 694 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 773 (941)
+++.... ..+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||.++....... ...
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-----~~~ 151 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-----TVS 151 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-----eec
Confidence 9996543 35789999999999999999999999 99999999999999999999999999875432110 001
Q ss_pred ccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHH
Q 002289 774 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852 (941)
Q Consensus 774 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (941)
......+..|+|||.+.++.++.++|||||||++|||++ |..||........ .. . +........+...+
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-~~-~--------~~~~~~~~~~~~~~ 221 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-RE-R--------IESGYRMPAPQLCP 221 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-HH-H--------HhcCCCCCCCccCC
Confidence 111223567999999998899999999999999999999 8888865432111 11 0 01111223455667
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 853 EKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 853 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
..+.+++.+|+..+|++||++.++++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 78999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.18 Aligned_cols=288 Identities=23% Similarity=0.322 Sum_probs=202.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCC------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 678 (941)
.++|++.+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457899999999999999999975 6899999988643222 2345678999999999999999999875543
Q ss_pred --cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 679 --EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 679 --~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999995 58888886543 35899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
+.......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ....
T Consensus 166 ~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~~~~----- 236 (310)
T cd07865 166 ARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-LTLI----- 236 (310)
T ss_pred cccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-----
Confidence 98664332111 1112234577899999988764 478899999999999999999999875443211 1100
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
..+ .+..+.+.......+ .++............+...+. ....+....++|.+||..||++|||++|+
T Consensus 237 -~~~----~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~-----~~~~~~~~~dli~~~l~~~P~~R~t~~e~ 304 (310)
T cd07865 237 -SQL----CGSITPEVWPGVDKL--ELFKKMELPQGQKRKVKERLK-----PYVKDPHALDLIDKLLVLDPAKRIDADTA 304 (310)
T ss_pred -HHH----hCCCChhhcccccch--hhhhhccCCCccchhhHHhcc-----cccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 000 111111111110000 000000000000000101110 01123455789999999999999999999
Q ss_pred CCCCCC
Q 002289 916 LKHPYV 921 (941)
Q Consensus 916 L~Hpwf 921 (941)
|+||||
T Consensus 305 l~h~~f 310 (310)
T cd07865 305 LNHDFF 310 (310)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.39 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=201.0
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
++|++.+.||+|+||.||++.. +++.||+|..+... ..+.+.+|+.++++++|+||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 67889999986532 235788999999999999999999998654 5799999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999997766556899999999999999999999998 999999999999999999999999998753211
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||...... +.... . ..+.....
T Consensus 154 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~-~--------~~~~~~~~ 218 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKEC-V--------EKGYRMEP 218 (254)
T ss_pred -----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHH-H--------hCCCCCCC
Confidence 111223567999999998899999999999999999998 99998654321 11111 1 11112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
+..++..+.+++.+||+.+|++||++.++++.++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 4456678899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=306.18 Aligned_cols=203 Identities=28% Similarity=0.419 Sum_probs=176.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999975 5789999998865555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999998654 245889999999999999999999998 9999999999999999999999999987643211
Q ss_pred CccccccccccccCCCcccccccccC---CCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 156 -----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 156 -----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112234578899999999876 88999999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.61 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=202.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV~ 684 (941)
++|+..+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||++++++|... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999975 689999999875332 3456789999999999999999999988543 4689999
Q ss_pred ecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 685 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 685 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998754 23345888999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.. .....++..|+|||.+.+..++.++||||+||++|||++|+.||.......
T Consensus 158 ~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------------------ 210 (287)
T cd06621 158 SL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP------------------ 210 (287)
T ss_pred cc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC------------------
Confidence 11 123346789999999999999999999999999999999999996432100
Q ss_pred CCCCCChHHHHHHHHHHHHh----cccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKC----CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c----~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
..+.+ +.+.+..+ +...+..+-. .++...+|+.+|+..+|++|||+.|+++|
T Consensus 211 ---~~~~~----~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 211 ---LGPIE----LLSYIVNMPNPELKDEPGNGIK-----------------WSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ---CChHH----HHHHHhcCCchhhccCCCCCCc-----------------hHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00000 00111100 0000100000 01123478899999999999999999999
Q ss_pred CCCCCCCC
Q 002289 919 PYVSSDVS 926 (941)
Q Consensus 919 pwf~~~~~ 926 (941)
|||.....
T Consensus 267 ~~~~~~~~ 274 (287)
T cd06621 267 PWIKAQMK 274 (287)
T ss_pred cccccccc
Confidence 99966544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.48 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=206.3
Q ss_pred cCCCccceeeccCcEEEEEEEeCC-CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
+-|.++..||.|+||.||+|..++ +-..|-|++...+.+..++|.-|+++|....||+||++++.|..++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345567789999999999999764 4556778887666666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
.||-++..+-.-+ ..+.+.++..+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+.....
T Consensus 112 ~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~----- 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS----- 182 (1187)
T ss_pred CCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-----
Confidence 9999998876544 35899999999999999999999999 99999999999999999999999999753211
Q ss_pred ccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.........||++|||||+.. ..+|+.++||||||++|.||..+.+|...-.. ++.
T Consensus 183 --t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-MRV---------------- 243 (1187)
T KOG0579|consen 183 --TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRV---------------- 243 (1187)
T ss_pred --HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-HHH----------------
Confidence 123445678999999999985 46899999999999999999999888643221 111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
+.+++ ..+| ||.. ....+...+.||+.++|..||+.||+|.++|+||||+
T Consensus 244 ------------llKia----KSeP---PTLl-----------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 244 ------------LLKIA----KSEP---PTLL-----------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred ------------HHHHh----hcCC---Cccc-----------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 11111 1111 2221 1223444556788888888899999999999999998
Q ss_pred CCCC
Q 002289 923 SDVS 926 (941)
Q Consensus 923 ~~~~ 926 (941)
+..+
T Consensus 294 ~~~S 297 (1187)
T KOG0579|consen 294 NAPS 297 (1187)
T ss_pred cCCc
Confidence 6444
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=308.02 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=190.4
Q ss_pred eeeccCcEEEEEEEeCC---CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCC
Q 002289 616 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 691 (941)
.||+|+||.||+|...+ ...+|+|.+..... .....+.+|++.++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 45788887764332 234568899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCC---CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 692 LRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 692 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
|.+++..... ...++...+.++.|++.||+|||+++ |+||||||+||++++++++||+|||+++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999976432 23467788899999999999999999 99999999999999999999999999865422111
Q ss_pred cccccccccccCCCccccccccc-------CCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
........++..|+|||++.. ..++.++|||||||++|||++ |..||....+... ........ ..
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~----~~ 228 (269)
T cd05042 156 --YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQ----DI 228 (269)
T ss_pred --eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhcc----Cc
Confidence 001122345678999998743 456789999999999999999 7788865443221 11111110 00
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
....+..+..++..+.+++..|| .+|++||++.++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11112234456677788899998 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.73 Aligned_cols=238 Identities=24% Similarity=0.370 Sum_probs=187.3
Q ss_pred eeeccCcEEEEEEEeCC-------------------------CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeee
Q 002289 616 QIGQGGYGKVYKGILPD-------------------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 670 (941)
.||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589998876444445678889999999999999999
Q ss_pred eeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---
Q 002289 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF--- 747 (941)
Q Consensus 671 ~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~--- 747 (941)
++++......++||||+++|+|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998653 335788999999999999999999998 99999999999997643
Q ss_pred ----cEEEeeeccccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHH-hCCCCCCCCc
Q 002289 748 ----TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELL-TGMQPISHGK 821 (941)
Q Consensus 748 ----~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~ell-tG~~Pf~~~~ 821 (941)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999987643211 12246788999998876 56899999999999999995 6899986543
Q ss_pred hhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
.... ...+. . ....+......+.+++.+||+.+|++||++.++++.|
T Consensus 227 ~~~~--~~~~~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PSEK--ERFYE---------K-KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hHHH--HHHHH---------h-ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2111 00110 0 1112222345688999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.84 Aligned_cols=200 Identities=31% Similarity=0.475 Sum_probs=175.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC-CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||.||+|...+ ++.||+|.+..... .+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999999764 88999999875422 56899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 99999999986533 46899999999999999999999998 9999999999999999999999999988654321
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 154 -----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1122344788999999999999999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=345.34 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=202.6
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeecccc--
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-- 676 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 676 (941)
.+.....++|.+.+.||+|+||+||+|... ++..||+|.+..... .....+..|+.++++++||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 344445678999999999999999999975 578899998875322 234678899999999999999999998854
Q ss_pred CCcEEEEEecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCC----CCeEeccCCCCcEEEcC-----
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEAD----PPVFHRDIKASNILLDH----- 745 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~DLkp~NILl~~----- 745 (941)
....++||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 45689999999999999999753 23468999999999999999999998542 34999999999999964
Q ss_pred ------------CCcEEEeeeccccccCCCCCCCccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHH
Q 002289 746 ------------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELL 811 (941)
Q Consensus 746 ------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~ell 811 (941)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 3359999999997653211 1234468999999999864 45889999999999999999
Q ss_pred hCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 812 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 812 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
+|+.||.............. ..........+..+.+++..||..+|.+||++.+++.
T Consensus 238 TGk~PF~~~~~~~qli~~lk----------~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 238 SGKTPFHKANNFSQLISELK----------RGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HCCCCCCcCCcHHHHHHHHh----------cCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999976554333222111 1111111234567889999999999999999999984
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.35 Aligned_cols=202 Identities=29% Similarity=0.392 Sum_probs=175.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467889999999999999999975 6899999998866555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 99999999986543 35899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......++..|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 1123345888999999975 345778999999999999999999999643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.40 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=173.5
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 68899999987543 22346788999999999999999999999988999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 765 (941)
+++++|.+++.......+++..++.++.|+++||+|||+++ ++|+||||+||+++++ +.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998765566899999999999999999999998 9999999999999855 468999999998654321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 112345788999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.32 Aligned_cols=266 Identities=26% Similarity=0.363 Sum_probs=203.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356788899999999999999965 68999999876543 2335688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|+++++|.+++... ..+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999998654 358899999999999999999997 46 999999999999999999999999998654211
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
......|+..|+|||++.+..++.++|||||||++||+++|+.||.......+
T Consensus 158 --------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------------------- 210 (284)
T cd06620 158 --------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------------------- 210 (284)
T ss_pred --------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh-------------------
Confidence 11234588999999999888999999999999999999999999974332110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
.......+.+.....+...+..-++. + ......+|+.+|+..||++|||++|+++||||...
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------------~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 211 ---GQDDPMGILDLLQQIVQEPPPRLPSS-D--------------FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ---hhhhhhHHHHHHHHHhhccCCCCCch-h--------------cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00111112222222222222111111 0 11123467777888888888888888888888553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=310.12 Aligned_cols=249 Identities=32% Similarity=0.509 Sum_probs=199.7
Q ss_pred ceeeccCcEEEEEEEeCC-------CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 615 TQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+.||+|+||.||+|+..+ ++.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 25799998765432 3356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-----CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-----cEEEeeecc
Q 002289 687 MSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-----TAKVADFGL 756 (941)
Q Consensus 687 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-----~~kl~DFGl 756 (941)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234788999999999999999999998 99999999999999887 899999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhcc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||....+... ...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~-~~~------ 225 (269)
T cd05044 158 ARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-LQH------ 225 (269)
T ss_pred cccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH-HHH------
Confidence 8765332211 11122345678999999999999999999999999999998 9999965443211 110
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
+..+.....+...+..+.+++.+||..+|.+||++.++.+.|+
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 ---VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111222344556788899999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.32 Aligned_cols=203 Identities=31% Similarity=0.449 Sum_probs=170.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-----hhhHhHHHHHHHHHhcCCCceeeeeecccc--CCcE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 680 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 680 (941)
.+|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++|+||+++++++.. .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 689999998764321 223468889999999999999999998865 3567
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++|+||+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999996543 4788999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
...... ........++..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 157 QTICMS----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccc----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 321110 11112345788999999999988999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.77 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=196.6
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999865 57899999887543 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++++|.+++.. ..+++..++.++.|+++|+.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999998854 35789999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
.......++..|+|||++.+..++.++|||||||++|||++|+.||........ . ..+........
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~---------~~~~~~~~~~~ 221 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-L---------FLIPKNSPPTL 221 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-H---------hhhhcCCCCCC
Confidence 111234578899999999998999999999999999999999999864322110 0 01111112223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
+..++..+.+++.+|++.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 34455667777778888888888877777753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.79 Aligned_cols=239 Identities=23% Similarity=0.408 Sum_probs=191.0
Q ss_pred ceeeccCcEEEEEEEeCC--------CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 615 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888887654444456788999999999999999999999988999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--------EEEeeecccc
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKVADFGLSR 758 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--------~kl~DFGla~ 758 (941)
+++|+|.++++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976443 5889999999999999999999999 999999999999987765 6999999886
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCC-CCCCCCchhHHHHHHHHhhccc
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGM-QPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~-~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|. .||..... ......
T Consensus 157 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~------- 217 (258)
T cd05078 157 TVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQF------- 217 (258)
T ss_pred ccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHH-------
Confidence 4321 122357789999999987 45789999999999999999995 45443222 111110
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
. .....+|...+.++.+++.+||+.+|++||+++++++.|
T Consensus 218 ---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 218 ---Y-EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---H-HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 112234444557789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=308.93 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=204.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
++|++...||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67888999999999999999964 2467999988754433 3467899999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhhcCC-------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 002289 682 LVYEFMSNGTLRDQLSAKSK-------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 754 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 754 (941)
+||||+++|+|.++++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975441 25899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhh
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 833 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~ 833 (941)
|++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+...
T Consensus 162 ~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-~~~~~--- 231 (275)
T cd05046 162 SLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRL--- 231 (275)
T ss_pred ccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-HHHHH---
Confidence 99875432211 11122345678999999988888999999999999999999 788886433211 11110
Q ss_pred ccchhhhcCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 834 SMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 834 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
..+.. ...+..++..+.+++.+|++.+|.+||++.++++.+.
T Consensus 232 ------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 ------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00111 1123455678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=308.47 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=193.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..|+..+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999975 58899999987543 23356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|+|.+++... ++++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 9999999998642 4788889999999999999999998 9999999999999999999999999997653321
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......++..|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.......
T Consensus 156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~---------~~~~~~~~~~ 220 (277)
T cd06640 156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-L---------FLIPKNNPPT 220 (277)
T ss_pred -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-h---------hhhhcCCCCC
Confidence 112234578899999999988899999999999999999999999965432110 0 0001111222
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
.+..++..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 34445555666666666655555555555543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.47 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=212.1
Q ss_pred cceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCC
Q 002289 614 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
.+.||+|-||+||-|+.+ +|+.||||++.+... ..+.++.+|+.+|+.++||.||.+.-.|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 578999999999999964 799999999876432 34578999999999999999999999999999999999999 67
Q ss_pred CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---CcEEEeeeccccccCCCCCCC
Q 002289 691 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 691 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DFGla~~~~~~~~~~ 767 (941)
+..+++-......+++...+.++.||+.||.|||.++ |+|+||||+|||+.+. .++||+|||.|+....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE----- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE----- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch-----
Confidence 8878776666677999999999999999999999999 9999999999999643 4899999999998754
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
......+.||+.|+|||+++.+.|...-|+||.||++|--++|..||..+++..++++.+. . -+
T Consensus 720 ---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------F-My 783 (888)
T KOG4236|consen 720 ---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------F-MY 783 (888)
T ss_pred ---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc------------c-cc
Confidence 3445678899999999999999999999999999999999999999987776555443210 0 01
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
|.+ | +.+..+.+.|||+.+|++.-++|.|.+..|.|||++.-+
T Consensus 784 Pp~----------------P-------------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 784 PPN----------------P-------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred CCC----------------c-------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 111 1 123345667999999999999999999999999998744
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=311.41 Aligned_cols=255 Identities=22% Similarity=0.379 Sum_probs=201.9
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
|...+.||+|++|.||+|... +++.||+|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444679999999999999964 6899999998765545556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||.+.......
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~----- 169 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV----- 169 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC-----
Confidence 999999865 34888999999999999999999999 9999999999999999999999999886543211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-~~~~-------------------- 226 (285)
T cd06648 170 --PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-AMKR-------------------- 226 (285)
T ss_pred --cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-HHHH--------------------
Confidence 11123458889999999998889999999999999999999999986433211 0000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
+.... .|...+ .........+|+++|+..+|++||++.|+++||||+..-
T Consensus 227 ---------~~~~~------~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 227 ---------IRDNL------PPKLKN-----------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ---------HHhcC------CCCCcc-----------cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 00000 000000 001122345788889999999999999999999997633
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=311.66 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=175.6
Q ss_pred cchHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccc-
Q 002289 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD- 675 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~- 675 (941)
+.++.+..+.++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344566668899999999999999999999965 68899999876432 2245688899999999 6999999999873
Q ss_pred ----cCCcEEEEEecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 002289 676 ----EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749 (941)
Q Consensus 676 ----~~~~~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 749 (941)
..+..++||||+++++|.++++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999988642 2346889999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCccccccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
||+|||+++...... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 164 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEccCCceeecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999987653221 11223458899999999853 457889999999999999999999996543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=310.30 Aligned_cols=210 Identities=29% Similarity=0.452 Sum_probs=176.0
Q ss_pred chHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeecccc-
Q 002289 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 676 (941)
Q Consensus 600 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~- 676 (941)
++.++....+.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555667789999999999999999999974 68999999986533 2335688899999998 79999999999843
Q ss_pred -----CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 002289 677 -----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 751 (941)
Q Consensus 677 -----~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 751 (941)
.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999997655566888899999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
+|||++....... .......|+..|+|||.+. +..++.++|||||||++|||++|+.||...
T Consensus 163 ~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 163 VDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred eeCcchhhhhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999987543211 1122345888999999986 346788999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.55 Aligned_cols=288 Identities=26% Similarity=0.368 Sum_probs=204.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccC-------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEE------- 677 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 677 (941)
.++|++.++||+|+||.||+|... +++.||+|++....... ...+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 68999999886533222 34578899999999999999999987443
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 678 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 678 -~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
...++|+||++ +++.+.+... ...+++..++.++.|+++||+|||+++ |+||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999995 5787777543 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcc----ccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 002289 757 SRLAPVPDIEGIV----PAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831 (941)
Q Consensus 757 a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~ 831 (941)
++........... .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 9765432211110 1112234567889999998865 45789999999999999999999998654432 2111111
Q ss_pred hhccchhhhcCCCCCCChHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC
Q 002289 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c-~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 910 (941)
. .. ...++........+.... +...+...+...+ .+........+|+.+||..||++||
T Consensus 241 ~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 241 K------LC----GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE----------RFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred H------Hh----CCCChhhchhhhhcccccccccCCCCCccHHH----------HcccCChhHHHHHHHHcccCcccCc
Confidence 0 00 000111111110000000 0001111111111 1223345567899999999999999
Q ss_pred CCccCCCCCCC
Q 002289 911 SSSSMLKHPYV 921 (941)
Q Consensus 911 sa~e~L~Hpwf 921 (941)
|+.|++.||||
T Consensus 301 t~~ell~~~~f 311 (311)
T cd07866 301 TASDALEHPYF 311 (311)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.81 Aligned_cols=267 Identities=27% Similarity=0.446 Sum_probs=207.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-----CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeecccc--CCcE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 680 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 680 (941)
+.|+..+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999853 3689999999865443 45689999999999999999999999876 5578
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 25899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHH-HHHH---Hhhccc
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE-VNIA---YQSSMM 836 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~-~~~~---~~~~~~ 836 (941)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .... .....+
T Consensus 160 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 422110 01111233456799999999889999999999999999999999998643211100 0000 000001
Q ss_pred hhhhc-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 837 FSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 837 ~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
...+. ......+..++.++.+++.+|++.+|++||++.+++++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 112223455668899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=322.26 Aligned_cols=284 Identities=23% Similarity=0.358 Sum_probs=207.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccC---------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--------- 677 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------- 677 (941)
..+|.+.+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999964 6899999998766555567788999999999999999999876543
Q ss_pred -----CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEE
Q 002289 678 -----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKV 751 (941)
Q Consensus 678 -----~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl 751 (941)
...++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++ +++.+|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 699888853 24889999999999999999999999 99999999999997 4567999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~ 830 (941)
+|||.++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........
T Consensus 157 ~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~-- 230 (342)
T cd07854 157 GDFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL-- 230 (342)
T ss_pred CCcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence 999999765322110 111122357889999998754 5678899999999999999999999976554322111
Q ss_pred HhhccchhhhcCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCC
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 909 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 909 (941)
.++. .+....+....+ ..+...+.......+.+..+ ..+..+....+|+++||+.||++|
T Consensus 231 --------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~R 291 (342)
T cd07854 231 --------ILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD----------LLPGVNPEALDFLEQILTFNPMDR 291 (342)
T ss_pred --------HHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHH----------HccCCCHHHHHHHHHHhCCCchhc
Confidence 1111 111111111111 11222222111112222221 123344556789999999999999
Q ss_pred CCCccCCCCCCCCC
Q 002289 910 PSSSSMLKHPYVSS 923 (941)
Q Consensus 910 ~sa~e~L~Hpwf~~ 923 (941)
||++|++.||||+.
T Consensus 292 ~t~~ell~h~~~~~ 305 (342)
T cd07854 292 LTAEEALMHPYMSC 305 (342)
T ss_pred cCHHHHhCCCcccc
Confidence 99999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=315.69 Aligned_cols=291 Identities=21% Similarity=0.218 Sum_probs=198.6
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCC
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 691 (941)
.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33444555555555544 6899999998754 23344678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcccc
Q 002289 692 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771 (941)
Q Consensus 692 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 771 (941)
|.+++.......+++.....++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+..............
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999998765556889999999999999999999999 99999999999999999999999999875532221111111
Q ss_pred ccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 772 HVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 772 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||.............. ......++... .+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~ 238 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLLDKST--YPL 238 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccccccCc--hhh
Confidence 12233457789999999876 4588899999999999999999999976543222111100 00001111000 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMSE-VMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~~-v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
.. ..... .+ .+..-+.... .-.... ........+|+.+||.+||++|||++|+|+||||....
T Consensus 239 ~~-~~~~~---~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 239 YE-DSMSQ---SR---SSNEHPNNRDSVDHPYT------RTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hc-CCcCc---cc---ccccccchhhhhhcchh------hHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00 00000 00 0000000000 000000 00112345789999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=310.46 Aligned_cols=132 Identities=21% Similarity=0.352 Sum_probs=115.7
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-----C---Cceeeeeecccc--
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----H---RNLVSLVGYCDE-- 676 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~-- 676 (941)
..+|.+.++||.|.|++||+|.+ .+.+.||+|+.+.. ....+....||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 47899999999999999999996 46789999999863 344567889999999984 2 379999999954
Q ss_pred --CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 002289 677 --EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 743 (941)
Q Consensus 677 --~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 743 (941)
..+.|+|+|++ |.+|..+|....-+.++...+++|++||+.||.|||+++. |||.||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 45899999999 8899999988777779999999999999999999998774 9999999999999
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.81 Aligned_cols=250 Identities=34% Similarity=0.548 Sum_probs=203.6
Q ss_pred CCccceeeccCcEEEEEEEeCC-----CcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 611 FNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
+++.+.||+|+||.||++.+.+ +..||+|+++..... ..+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 388999999765443 4568999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654433899999999999999999999998 9999999999999999999999999998664332
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.. ......++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ..... .+....
T Consensus 158 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~---------~~~~~~ 221 (258)
T smart00219 158 YY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLE---------YLKKGY 221 (258)
T ss_pred cc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH---------HHhcCC
Confidence 11 0112236789999999988889999999999999999998 7788764322 11111 111122
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
....+...+.++.+++.+|+..+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 233444567789999999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.19 Aligned_cols=203 Identities=29% Similarity=0.433 Sum_probs=170.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-----chhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 680 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 680 (941)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999965 58999999875321 12235678899999999999999999988653 467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++++|.+++.... .+++...++++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986543 4788889999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 322110 11122345888999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.41 Aligned_cols=204 Identities=24% Similarity=0.304 Sum_probs=164.8
Q ss_pred ceeecc--CcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
..||+| +||+||+|.+. +|+.||+|+...... ...+.+.+|+.+++.++||||++++++|...+..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999974 799999999875332 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999997765556899999999999999999999998 999999999999999999999999865433211110000
Q ss_pred ccccccccccCCCcccccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.........++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 00001112345679999999763 47889999999999999999999997554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.94 Aligned_cols=203 Identities=25% Similarity=0.353 Sum_probs=170.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccC--CchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
...|++.++||+||.+.||++...+.+.+|+|++... +.....-|..|+..|.++ .|.+|+++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3468889999999999999999888888999876642 333356799999999999 4999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||= ..+|..+|.........| .++.+..|++.|+.++|+++ |||.||||.|+|+-. |.+||+|||+|.....+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 987 679999998776655556 77889999999999999999 999999999999864 799999999998765432
Q ss_pred CCCccccccccccccCCCcccccccccCC-----------CCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----------LTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
+ .-.....+||+.||+||.+.... ++.++||||+||+||+|+.|+.||..-.
T Consensus 514 -T----sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 514 -T----SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred -c----ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 1 22334567999999999986432 5678999999999999999999996543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=320.80 Aligned_cols=290 Identities=22% Similarity=0.351 Sum_probs=211.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeecccc----CCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 680 (941)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999965 689999999875322 234567889999999999999999998753 3468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+. ++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 69999886543 4899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
...... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~--------- 224 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLI--------- 224 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHH---------
Confidence 332211 1112233468889999999865 568899999999999999999999996543321 11110
Q ss_pred hcCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 840 IDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
....+..+.+..... .+.+..+++..+...+..- ....+.......++|.+||+.||++||++++++.|
T Consensus 225 -~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 225 -LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW---------SKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred -HHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCH---------HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001111121111111 1122233333332222111 01123345566789999999999999999999999
Q ss_pred CCCCCCCC
Q 002289 919 PYVSSDVS 926 (941)
Q Consensus 919 pwf~~~~~ 926 (941)
|||..-..
T Consensus 295 ~~~~~~~~ 302 (334)
T cd07855 295 PFLAQYHD 302 (334)
T ss_pred hhhhhccC
Confidence 99975443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=320.23 Aligned_cols=283 Identities=21% Similarity=0.327 Sum_probs=208.0
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccC-
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE- 677 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 677 (941)
.++....++|++.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45566789999999999999999999985 478999999987532 22345678899999999999999999987532
Q ss_pred -----CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 002289 678 -----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 752 (941)
Q Consensus 678 -----~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 752 (941)
...++|++++ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3468888887 88999888543 4889999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 002289 753 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831 (941)
Q Consensus 753 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~ 831 (941)
|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .....
T Consensus 163 dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~ 231 (345)
T cd07877 163 DFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLIL 231 (345)
T ss_pred cccccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 9999875321 1223457889999999876 5688899999999999999999999965433211 11100
Q ss_pred hhccchhhhcCCCCCCChHHHHH----HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCC
Q 002289 832 QSSMMFSVIDGNMGSYPSECVEK----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 907 (941)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~----l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~ 907 (941)
... ...+...... .......+....|..+. . ......++...+||.+||..||+
T Consensus 232 ---------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----------~~~~~~~~~~~~li~~~L~~dp~ 289 (345)
T cd07877 232 ---------RLV-GTPGAELLKKISSESARNYIQSLTQMPKMNF--A----------NVFIGANPLAVDLLEKMLVLDSD 289 (345)
T ss_pred ---------HHh-CCCCHHHHhhcccHhHHHHHHHhcccCCcch--h----------hhcCCCCHHHHHHHHHHcCCChh
Confidence 000 0011111110 01111112222221111 0 01112345567899999999999
Q ss_pred CCCCCccCCCCCCCCCC
Q 002289 908 TPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 908 ~R~sa~e~L~Hpwf~~~ 924 (941)
+|+++.|++.||||..-
T Consensus 290 ~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 290 KRITAAQALAHAYFAQY 306 (345)
T ss_pred hcCCHHHHhcChhhhhc
Confidence 99999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=321.70 Aligned_cols=281 Identities=23% Similarity=0.361 Sum_probs=202.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccC------C
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 678 (941)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|+++++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999964 689999999865321 1234678999999999999999999988644 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++|+||+. .+|.++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4699999995 57777652 24888999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +....
T Consensus 166 ~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~------ 228 (342)
T cd07879 166 HADA----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQIL------ 228 (342)
T ss_pred CCCC----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH------
Confidence 5421 1123356789999999876 4688999999999999999999999975443221 11111
Q ss_pred hhhcCCCCCCChHHHHHHHHHHH-HhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLAL-KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~-~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
.. .+...+.....+..... ......|. .|. ..+...++..+....+||.+||+.||++||+++|++
T Consensus 229 ---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 229 ---KV-TGVPGPEFVQKLEDKAAKSYIKSLPK-YPR--------KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred ---Hh-cCCCCHHHHHHhcccchHHHHhhcCC-ccc--------chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00 01111111111110000 00000000 000 011112234455667999999999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 917 KHPYVSSDVS 926 (941)
Q Consensus 917 ~Hpwf~~~~~ 926 (941)
.||||..-..
T Consensus 296 ~h~~f~~~~~ 305 (342)
T cd07879 296 EHPYFDSFRD 305 (342)
T ss_pred cCcchhhccc
Confidence 9999977543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=341.47 Aligned_cols=268 Identities=24% Similarity=0.295 Sum_probs=212.8
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeecccc
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 676 (941)
..++....++|.++++||+|+||.|..++.+ ++++||+|+++...+- ...-|..|-.+|..-+.+=|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3466667789999999999999999999975 6899999999863322 23467888899999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
+.+.|+|||||+||+|-.++.+.. .+++..++.++..|+-||.-+|+.| +|||||||+|||+|..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999997665 6899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCccccccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~ 831 (941)
+-.+.... .-.+...+|||.|.+||++.. +.|+..+|+||+||++|||+.|..||..+. +++-+....
T Consensus 222 Clkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-lveTY~KIm 294 (1317)
T KOG0612|consen 222 CLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-LVETYGKIM 294 (1317)
T ss_pred HHhcCCCC------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-HHHHHHHHh
Confidence 87654322 233455679999999999862 568999999999999999999999996432 222111111
Q ss_pred hhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC
Q 002289 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 911 (941)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 911 (941)
.. ...-.+|++ .+...++.+||+++++ +|+.|+.
T Consensus 295 ~h--------k~~l~FP~~-------------------------------------~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 295 NH--------KESLSFPDE-------------------------------------TDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred ch--------hhhcCCCcc-------------------------------------cccCHHHHHHHHHHhc-Chhhhcc
Confidence 00 000111100 1123344567776554 5889988
Q ss_pred ---CccCCCCCCCCCCCC
Q 002289 912 ---SSSMLKHPYVSSDVS 926 (941)
Q Consensus 912 ---a~e~L~Hpwf~~~~~ 926 (941)
++++-.||||.+..|
T Consensus 329 rngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 329 RNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred cccHHHHHhCccccCCCh
Confidence 999999999999999
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.01 Aligned_cols=199 Identities=30% Similarity=0.480 Sum_probs=172.6
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-----chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+++++.++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78999999876533 12346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999996543 4789999999999999999999999 999999999999999999999999998765322
Q ss_pred CCCCccccccccccccCCCcccccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
. ......++..|+|||.+.... ++.++|+||||+++|||++|+.||....
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 1 123345788999999988766 8999999999999999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=310.67 Aligned_cols=276 Identities=24% Similarity=0.351 Sum_probs=198.9
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcC-CCceeeeeeccccC--CcEEEEEe
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLVYE 685 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~LV~e 685 (941)
|++.+.||+|+||.||+|... +++.||+|+++.... .......+|+.+++++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999965 689999999875322 22234567899999885 99999999999877 88999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|++ |+|.+.+.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 68888886543 45899999999999999999999999 999999999999999 999999999997653221
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
......++..|+|||++.. ..++.++||||+||++|||++|+.||....... .+.... . ..
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~------~----~~ 215 (282)
T cd07831 154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIH------D----VL 215 (282)
T ss_pred -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHH------H----Hc
Confidence 1122357889999998654 557889999999999999999999996544321 111110 0 01
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
+..+......+..- ...-...|..-+. .+....+.......+++.+||..+|++||+++|+++||||
T Consensus 216 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 216 GTPDAEVLKKFRKS-RHMNYNFPSKKGT---------GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CCCCHHHHHhhccc-ccccccCcccccc---------cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11112111110000 0000000100000 0111122335666789999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=307.62 Aligned_cols=192 Identities=24% Similarity=0.384 Sum_probs=167.6
Q ss_pred eeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++.+....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 489999999875332 2346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.+++.+.. .+++..+..++.|+++||+|||+++ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--------
Confidence 99996543 4889999999999999999999998 9999999999999999999999999998654321
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1223457889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.64 Aligned_cols=264 Identities=27% Similarity=0.393 Sum_probs=201.2
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccC-
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE- 677 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~- 677 (941)
..++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3455556889999999999999999999974 68999999986532 2245678899999998 899999999998543
Q ss_pred ----CcEEEEEecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 002289 678 ----GEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 751 (941)
Q Consensus 678 ----~~~~LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 751 (941)
+..++||||+++++|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 3589999999999999988642 3346899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccC-----CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 826 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~ 826 (941)
+|||++....... .......|+..|+|||++... .++.++|||||||++|||++|+.||.........
T Consensus 170 ~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 170 VDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred eecccchhccccc-------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 9999987653221 111234578899999997643 3678999999999999999999999654321110
Q ss_pred HHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCC
Q 002289 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 906 (941)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP 906 (941)
.. +........ .+| ........+++.+|+..+|
T Consensus 243 ~~----------~~~~~~~~~-----------------~~~--------------------~~~~~~l~~li~~~l~~~p 275 (291)
T cd06639 243 FK----------IPRNPPPTL-----------------LHP--------------------EKWCRSFNHFISQCLIKDF 275 (291)
T ss_pred HH----------HhcCCCCCC-----------------Ccc--------------------cccCHHHHHHHHHHhhcCh
Confidence 00 000000000 000 0111123467888889999
Q ss_pred CCCCCCccCCCCCCCC
Q 002289 907 ETPPSSSSMLKHPYVS 922 (941)
Q Consensus 907 ~~R~sa~e~L~Hpwf~ 922 (941)
++||++.|+++||||.
T Consensus 276 ~~Rps~~~il~~~~~~ 291 (291)
T cd06639 276 EARPSVTHLLEHPFIK 291 (291)
T ss_pred hhCcCHHHHhcCcccC
Confidence 9999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.85 Aligned_cols=199 Identities=28% Similarity=0.442 Sum_probs=174.0
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|+..+.||+|+||.||++..+ +++.||+|.+..... ...+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999976 689999998876432 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 99999999997543 568899999999999999999999 88 9999999999999999999999999986542211
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11156788999999999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.40 Aligned_cols=203 Identities=32% Similarity=0.467 Sum_probs=174.5
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 6899999998765443 456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999996543 4788899999999999999999999 999999999999999999999999998876433211
Q ss_pred CccccccccccccCCCcccccccccCC---CCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
. ........++..|+|||++.+.. ++.++||||||+++||+++|+.||...
T Consensus 156 ~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 156 M---GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred c---cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 0 11012345788999999998766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.71 Aligned_cols=293 Identities=24% Similarity=0.320 Sum_probs=207.9
Q ss_pred hcCCCc-cceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh--------------hHhHHHHHHHHHhcCCCceeeee
Q 002289 608 TNNFNS-STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--------------EKEFLTEIQFLSRLHHRNLVSLV 671 (941)
Q Consensus 608 ~~~y~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~ 671 (941)
.++|.. .+.||+|+||+||+|... +++.||||.++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 467999999999999965 68999999886532221 12477899999999999999999
Q ss_pred eccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 002289 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 751 (941)
Q Consensus 672 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 751 (941)
+++...+..++||||++ |+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 99999999999999996 6999998653 34888999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCCCCCc-------cccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchh
Q 002289 752 ADFGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNI 823 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~ 823 (941)
+|||+++.......... ..........++..|+|||.+.+. .++.++||||+||++|||++|+.||....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999976542211000 001111233467889999998764 4688999999999999999999999765442
Q ss_pred HHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCC
Q 002289 824 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHT 903 (941)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~ 903 (941)
... .... .... ..+...+.....+... ....+...+.. ....+.......+++.+||.
T Consensus 241 ~~~-~~i~------~~~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~ 298 (335)
T PTZ00024 241 DQL-GRIF------ELLG----TPNEDNWPQAKKLPLY-TEFTPRKPKDL----------KTIFPNASDDAIDLLQSLLK 298 (335)
T ss_pred HHH-HHHH------HHhC----CCchhhCcchhhcccc-cccCcCCcccH----------HHhCcCCChHHHHHHHHHcC
Confidence 211 1110 0000 0000000000000000 00001111111 11223344566789999999
Q ss_pred CCCCCCCCCccCCCCCCCCCCCCCC
Q 002289 904 SKEETPPSSSSMLKHPYVSSDVSGS 928 (941)
Q Consensus 904 ~dP~~R~sa~e~L~Hpwf~~~~~~~ 928 (941)
.+|++|+|++|+|.||||++.....
T Consensus 299 ~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 299 LNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred CCchhccCHHHHhcCcccCCCCCCC
Confidence 9999999999999999998875543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=319.09 Aligned_cols=289 Identities=25% Similarity=0.370 Sum_probs=212.1
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCC-----cEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 681 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 681 (941)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 58999999987643 334567899999999999999999999987765 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||++ ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 58999886543 6899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
..... ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ..... .
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i---------~ 220 (330)
T cd07834 155 PDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLI---------V 220 (330)
T ss_pred ccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHH---------H
Confidence 33210 0112334578899999999887 78999999999999999999999997554321 11111 0
Q ss_pred cCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 841 DGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
...+..+.+..... ...+.......+..++ . .+....+.......+++.+||..+|++|||++++++||
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 221 -EVLGTPSEEDLKFITSEKARNYLKSLPKKPK-K--------PLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred -HhcCCCChhHhhhccccchhhHHhhcccCCc-c--------hhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 00111111111100 0000000000000000 0 01112233455667899999999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 920 YVSSDVSGS 928 (941)
Q Consensus 920 wf~~~~~~~ 928 (941)
||++-...+
T Consensus 291 ~~~~~~~~~ 299 (330)
T cd07834 291 YLAQLHDPE 299 (330)
T ss_pred cHHhhcccc
Confidence 997755543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.07 Aligned_cols=202 Identities=25% Similarity=0.423 Sum_probs=171.3
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeecccc--CCcEEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVY 684 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~LV~ 684 (941)
+|++.+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++++++|+||+++++++.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 68899999987533 2334578899999999999999999998753 45679999
Q ss_pred ecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhh-----cCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 685 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLH-----TEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 685 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
||+++++|.+++... ...++++..++.++.|++.||+||| +.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 2456899999999999999999999 666 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
....... .......++..|+|||++.+..++.++||||||+++++|++|+.||....
T Consensus 158 ~~~~~~~-------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDS-------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCc-------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 8654321 11223458889999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.33 Aligned_cols=251 Identities=20% Similarity=0.361 Sum_probs=201.0
Q ss_pred CCCccceeeccCcEEEEEEEeCC--CcEEEEEEeccCC----------chhhHhHHHHHHHHHh-cCCCceeeeeecccc
Q 002289 610 NFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS----------LQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE 676 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 676 (941)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 6889999875321 1123456788888765 799999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
.+..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998854 234468999999999999999999996 56 99999999999999999999999
Q ss_pred eccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhh
Q 002289 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 833 (941)
Q Consensus 754 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~ 833 (941)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~---- 224 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATK---- 224 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHH----
Confidence 99997643221 223445888999999999988999999999999999999999999654321 11111
Q ss_pred ccchhhhcCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 834 SMMFSVIDGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 834 ~~~~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
+......+.+ ..++..+.+++.+||+.+|++||++.++..+++
T Consensus 225 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 -----IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111212 245578899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.71 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=199.5
Q ss_pred CCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCC------
Q 002289 611 FNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 678 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 678 (941)
|.+.+.||+|+||+||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36889999987542 223457889999999999999999999875432
Q ss_pred cEEEEEecCCCCCHHHHHhhc----CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 002289 679 EQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 754 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 754 (941)
..++++||+++|+|.+++... ....+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887532 2235788999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhh
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 833 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~ 833 (941)
|.++....... ........++..|++||.+.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-~~~~~---- 227 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-EIYNY---- 227 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-HHHHH----
Confidence 99986532211 011112235578999999998889999999999999999999 88888644321 11111
Q ss_pred ccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
+........+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 -----LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111112223345567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=309.28 Aligned_cols=278 Identities=26% Similarity=0.395 Sum_probs=209.1
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
|++.+.||+|++|.||+|... +++.+++|.+...... ....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999975 6899999998754332 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
+ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 6 58988886643 46899999999999999999999999 9999999999999999999999999987654321
Q ss_pred ccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......... ..... ..+.
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~-~~~~~----------~~~~ 217 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL-FKIFR----------TLGT 217 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH----------HcCC
Confidence 111234577899999998876 7899999999999999999999999765543221 11110 0111
Q ss_pred CChHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
...+....+.+.+..+....|.. .....++. +..+....+||.+|+..||.+||+++|++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF----------PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CchHhcccchhhhhhhhhhhccccccCHHHhh----------hhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11122222222222221111211 11222111 2234556789999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=302.50 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=188.5
Q ss_pred eeeccCcEEEEEEEeCCC---cEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCC
Q 002289 616 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 691 (941)
.||+|+||+||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985433 356677766433 2345689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcC--CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 692 LRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 692 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|.+++++.. ....++..++.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999997542 234677778899999999999999998 99999999999999999999999999864321110
Q ss_pred ccccccccccCCCccccccccc-------CCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
........++..|+|||++.. ..++.++|||||||++|||++ |..||...... +........ ......+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKD-QQVKLFK 231 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhh-cccccCC
Confidence 011123457889999999753 245779999999999999997 56677544332 211111111 1111111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
+..+..+...+.+++..|| .+|++||++.++++.|
T Consensus 232 ---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 ---PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ---CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 2223345567888999999 6799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.97 Aligned_cols=237 Identities=24% Similarity=0.410 Sum_probs=189.1
Q ss_pred ceeeccCcEEEEEEEeCC-C----------cEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 615 TQIGQGGYGKVYKGILPD-G----------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
+.||+|+||.||+|.+.+ + ..|++|.+...... ...+.+|+.+++.++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999754 3 25788877654333 5688999999999999999999999987 788999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-------cEEEeeecc
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-------TAKVADFGL 756 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-------~~kl~DFGl 756 (941)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976443 5889999999999999999999998 99999999999999888 799999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccC--CCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhh
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 833 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~ 833 (941)
+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||..... ..+.. .+.
T Consensus 155 a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~-~~~- 220 (259)
T cd05037 155 PITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKER-FYQ- 220 (259)
T ss_pred cccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHH-HHh-
Confidence 875432 1123456789999999876 78999999999999999999 5777754432 11111 111
Q ss_pred ccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
.......+ ....+.+++.+||..+|.+||++.++++.|
T Consensus 221 -------~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -------DQHRLPMP--DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------cCCCCCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111111 127888999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=306.43 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=197.7
Q ss_pred eeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875443 3346788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC-cccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPA 771 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 771 (941)
.+++.+.. .+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997654 5899999999999999999999999 9999999999999999999999999987543221100 0001
Q ss_pred ccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHH
Q 002289 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 851 (941)
Q Consensus 772 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (941)
.......++..|+|||...+..++.++||||||+++||+++|+.||...... ....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~----------------------- 211 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIFQ----------------------- 211 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHH-----------------------
Confidence 1223445788999999999888999999999999999999999999643321 0000
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC---ccCCCCCCCCC
Q 002289 852 VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS---SSMLKHPYVSS 923 (941)
Q Consensus 852 ~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa---~e~L~Hpwf~~ 923 (941)
.+. . ....+|... .......+|+.+|+..+|++|||+ .|+|+||||+.
T Consensus 212 -----~~~----~-~~~~~~~~~--------------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 212 -----NIL----N-GKIEWPEDV--------------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred -----HHh----c-CCcCCCccc--------------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 000 0 000011100 012233468888899999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.80 Aligned_cols=203 Identities=32% Similarity=0.452 Sum_probs=172.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCC------
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG------ 678 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------ 678 (941)
.+++|++.+.||+|+||.||+|... +++.+++|++..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4689999999999999999999975 678999999876433 346789999999999 7999999999986544
Q ss_pred cEEEEEecCCCCCHHHHHhhcC--CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999986533 456899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCccccccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 160 SAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ceecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 87543211 11233458889999998754 34678899999999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.81 Aligned_cols=200 Identities=28% Similarity=0.467 Sum_probs=173.0
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|+||.||+|..+ +|..||+|.+..... ...+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999975 588999999865322 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 765 (941)
+++++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997765556899999999999999999999999 99999999999999885 56999999987653221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
.......|+..|+|||+..+..++.++||||||++++||++|+.||..
T Consensus 157 ------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 157 ------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred ------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 112234588899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.60 Aligned_cols=199 Identities=27% Similarity=0.359 Sum_probs=168.6
Q ss_pred CCCccceeeccCcEEEEEEEe----CCCcEEEEEEeccCCc----hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcE
Q 002289 610 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 680 (941)
+|++.+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3689999999875322 2235678899999999 599999999999988899
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999996543 4788899999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCCCccccccccccccCCCcccccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
..... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 156 HEDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 32211 112234578899999998753 467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=309.13 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=203.4
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV 683 (941)
++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888999999999999999975 78999999987532 223457889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.+.. .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997653 5899999999999999999999999 999999999999999999999999999866433
Q ss_pred CCCCcc-------------ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002289 764 DIEGIV-------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830 (941)
Q Consensus 764 ~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~ 830 (941)
...... .........++..|+|||...+..++.++||||||++++++++|+.||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----- 230 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT----- 230 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-----
Confidence 211000 01122334578899999999888899999999999999999999999964432110
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 910 (941)
+..+....+ ......++...+|+.+||..+|.+||
T Consensus 231 ------------------------~~~~~~~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~R~ 265 (280)
T cd05581 231 ------------------------FQKILKLEY---------------------SFPPNFPPDAKDLIEKLLVLDPQDRL 265 (280)
T ss_pred ------------------------HHHHHhcCC---------------------CCCCccCHHHHHHHHHHhcCCHhhCC
Confidence 000000000 00011123345688888999999999
Q ss_pred CC----ccCCCCCCC
Q 002289 911 SS----SSMLKHPYV 921 (941)
Q Consensus 911 sa----~e~L~Hpwf 921 (941)
++ +|+++||||
T Consensus 266 ~~~~~~~~ll~~~~~ 280 (280)
T cd05581 266 GVNEGYDELKAHPFF 280 (280)
T ss_pred CcccCHHHHhcCCCC
Confidence 99 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.54 Aligned_cols=201 Identities=30% Similarity=0.429 Sum_probs=176.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++.+++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999976 589999999876544 3456899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
+++++|.+++... ..+++..++.++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999754 458999999999999999999999 88 99999999999999999999999999876543221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 156 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 156 -------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred -------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1123457889999999999999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=302.02 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=170.1
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch----------hhHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ----------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
+|.+.+.||+|+||.||+|... +|+.||+|.++..... ..+.+.+|+++++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777889999999999999864 6899999987532111 1235788999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 35888999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCC--CCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
....... ........|+..|+|||.+.... ++.++||||||+++||+++|..||....
T Consensus 157 ~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 157 KSDDIYD-----NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred ccccccc-----ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 5432110 11123345788999999987654 7889999999999999999999996443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=317.93 Aligned_cols=283 Identities=24% Similarity=0.375 Sum_probs=207.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccC-----Cc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 679 (941)
.++|.+.+.||+|+||+||+|+.. +++.||||.+... .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999964 6899999988753 222345678899999999999999999988543 35
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7999988654 35899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
..... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....... .
T Consensus 158 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~------~ 223 (337)
T cd07858 158 TSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLIT------E 223 (337)
T ss_pred cCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHH------H
Confidence 53221 11233457889999998865 46889999999999999999999999654321 1111110 0
Q ss_pred hhcCCCCCCChHHHH-----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCc
Q 002289 839 VIDGNMGSYPSECVE-----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 913 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~-----~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 913 (941)
.. +..+.+... ...+.+. ......++... ...+...+...+++++||+.||++|||++
T Consensus 224 ~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 224 LL----GSPSEEDLGFIRNEKARRYIR---SLPYTPRQSFA----------RLFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred Hh----CCCChHHhhhcCchhhhHHHH---hcCcccccCHH----------HHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 00 100110000 0000000 00011112221 11233455667899999999999999999
Q ss_pred cCCCCCCCCCCCCC
Q 002289 914 SMLKHPYVSSDVSG 927 (941)
Q Consensus 914 e~L~Hpwf~~~~~~ 927 (941)
|+++||||......
T Consensus 287 ell~h~~~~~~~~~ 300 (337)
T cd07858 287 EALAHPYLASLHDP 300 (337)
T ss_pred HHHcCcchhhhcCc
Confidence 99999999765443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=305.76 Aligned_cols=200 Identities=26% Similarity=0.432 Sum_probs=174.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68889999999999999999864 68899999987554455567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 999999998643 3788899999999999999999999 9999999999999999999999999887543221
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......+++.|+|||.+.+..++.++||||||+++||+++|+.||....
T Consensus 170 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223458889999999988889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=344.35 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=208.0
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
+-+++....||.|.||.||.|.. ++|...|+|-++.... ...+.+.+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 46677789999999999999994 5799999997764332 22456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|||++|+|.++++... ..++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|.......
T Consensus 1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999996433 3677778889999999999999999 9999999999999999999999999998775431
Q ss_pred CCCccccccccccccCCCcccccccccC---CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... ........||+.|||||++.+. ....+.||||+|||+.||+||+.||..-++ ....|+.+-.
T Consensus 1389 --~~~-~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1389 --QTM-PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVAA 1456 (1509)
T ss_pred --hcC-CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHhc
Confidence 111 1233467899999999999863 356689999999999999999999965433 1234566667
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
+..+++|+..+.+=.+.+..|+..||++|.++.|+++
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 7777888887777778888888888888866665554
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=303.97 Aligned_cols=276 Identities=26% Similarity=0.380 Sum_probs=200.1
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhc---CCCceeeeeeccccCCc-----
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGE----- 679 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~----- 679 (941)
|++.+.||+|+||.||+|+.+ +++.||+|+++..... ....+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 4899999998743222 134566788777666 59999999999987766
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||++ ++|.+++.......+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58999987655556899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||..... .+...........
T Consensus 157 ~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~--- 224 (287)
T cd07838 157 YSFEM--------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGL--- 224 (287)
T ss_pred ccCCc--------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCC---
Confidence 53321 11223467899999999999999999999999999999999888865433 2222211110000
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
......+.. ......+....+ .+.+.++. +...+...+++.+||..||++||+++|++.||
T Consensus 225 --~~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 225 --PSEEEWPRN-----VSLPRSSFPSYT--PRSFKSFV----------PEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred --CChHhcCCC-----cccchhhccccc--ccchhhhh----------hhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 000000000 000000010000 01111111 12234456899999999999999999999999
Q ss_pred CC
Q 002289 920 YV 921 (941)
Q Consensus 920 wf 921 (941)
||
T Consensus 286 ~~ 287 (287)
T cd07838 286 YF 287 (287)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.29 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=189.4
Q ss_pred eeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHH---HHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 616 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
.||+|+||.||+|... +++.||+|.+...... ....+..|.. .++...|++|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 6899999988653322 1223444443 4445579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-----
Confidence 99999988654 35899999999999999999999998 999999999999999999999999998754321
Q ss_pred cccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
......|+..|+|||++.++ .++.++||||+||++|||++|+.||........
T Consensus 151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~---------------------- 204 (278)
T cd05606 151 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---------------------- 204 (278)
T ss_pred ----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----------------------
Confidence 11233588999999999754 688999999999999999999999964321000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC-----CCccCCCCCCCC
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKHPYVS 922 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~Hpwf~ 922 (941)
....+... ..++.. .........+++.+||..+|++|+ ++.|+++||||.
T Consensus 205 -----~~~~~~~~-------~~~~~~-------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~ 259 (278)
T cd05606 205 -----HEIDRMTL-------TMAVEL-------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259 (278)
T ss_pred -----HHHHHHhh-------ccCCCC-------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence 00000000 000000 011123345677788888888888 999999999998
Q ss_pred CCCCC
Q 002289 923 SDVSG 927 (941)
Q Consensus 923 ~~~~~ 927 (941)
...+.
T Consensus 260 ~~~~~ 264 (278)
T cd05606 260 SLDWQ 264 (278)
T ss_pred CCCch
Confidence 76543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=301.46 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=191.2
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
-|+..+.||+|+||.||+|... +++.||+|....... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667889999999999999864 689999998764332 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch---
Confidence 999999998542 4789999999999999999999999 9999999999999999999999999987653221
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
.......++..|+|||.+.+..++.++|||||||++|||++|..||...... ..... +........
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~---------~~~~~~~~~ 221 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVLFL---------IPKNNPPTL 221 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHHHH---------HhcCCCCCC
Confidence 1122345788999999999888999999999999999999999999643221 11110 111111222
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
+..++..+.+++.+|++.+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 3334455555666666666666666555554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=310.19 Aligned_cols=278 Identities=28% Similarity=0.423 Sum_probs=205.6
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|++++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999975 58999999988643 222456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
+ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||.++......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 152 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--- 152 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc---
Confidence 7 69999997653 35899999999999999999999999 9999999999999999999999999987653321
Q ss_pred ccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ...... ....
T Consensus 153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~----------~~~~ 217 (282)
T cd07829 153 ----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQ----------ILGT 217 (282)
T ss_pred ----cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHH----------HhCC
Confidence 112223456789999998776 789999999999999999999999865443211 111100 0011
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
..+..+..+.++. -+.......+. . .....++..+....+++++||..||++||++++++.||||
T Consensus 218 ~~~~~~~~~~~~~--~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 218 PTEESWPGVTKLP--DYKPTFPKFPP-K-------DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CcHHHHHhhcccc--cccccccccCc-c-------chHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111111111110 00000000000 0 0011223335567889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=314.53 Aligned_cols=281 Identities=22% Similarity=0.357 Sum_probs=206.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCC-----
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 678 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 678 (941)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999854 78999999986432 222456889999999999999999999886543
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 679 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 679 -~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7899988853 35889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
...... .....++..|+|||.+.+ ..++.++||||+||++|++++|+.||........... .
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~-~------ 228 (343)
T cd07880 166 RQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME-I------ 228 (343)
T ss_pred cccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-H------
Confidence 754321 122356889999999876 4588899999999999999999999975543221111 1
Q ss_pred hhhhcCCCCCCChHHHHHHHHH-HHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKL-ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l-~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
+.. ....+.++...+..- ...-...-|..++. + +....+...+...++|.+||..||++|+|+.++
T Consensus 229 ---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 229 ---MKV-TGTPSKEFVQKLQSEDAKNYVKKLPRFRKK--D-------FRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred ---HHh-cCCCCHHHHHhhcchhHHHHHHhccccCcc--h-------HHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 000 011122222221100 00000111111111 0 111223445567789999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 916 LKHPYVSSD 924 (941)
Q Consensus 916 L~Hpwf~~~ 924 (941)
+.||||+..
T Consensus 296 l~~~~~~~~ 304 (343)
T cd07880 296 LAHPYFEEF 304 (343)
T ss_pred hcCccHhhh
Confidence 999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=305.04 Aligned_cols=279 Identities=26% Similarity=0.381 Sum_probs=204.6
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEEecC
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
|++.+.||+|+||+||+|+.. +++.||||++..... ..+....+|+..+++++ |+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 578999999875432 22334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
+|+|.+++.......+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 889999987765456899999999999999999999998 9999999999999999999999999987553211
Q ss_pred ccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
......++..|+|||++.+ ..++.++|+||||++++||++|+.||........ ..... .. .+.
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~------~~----~~~ 217 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKIC------SV----LGT 217 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHH------Hh----cCC
Confidence 1123457889999998854 5578999999999999999999999865433211 11100 00 111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
...+.+..-..+.. .+...-..++.. . + ....+.......+|+++|++.||++|||++|++.||||
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~-~----~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 218 PTKQDWPEGYKLAS-KLGFRFPQFAPT-S----L---HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred CChhhhhhHhhhhc-cccccccccccc-c----H---HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11111111111110 111000000000 0 0 11222334556789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=283.80 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=198.3
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecC
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.+.+..||.|..|.||+++.+ +|..+|||.+.... .+..++++..+.++..- .+|+||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344667999999999999975 68999999987643 34457788888876665 4999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
.-.++.++. .-..++++...-++...+.+||.||.+++. |+|||+||+|||+|+.|++|++|||++-++...
T Consensus 174 -s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---- 245 (391)
T KOG0983|consen 174 -STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---- 245 (391)
T ss_pred -HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecc----
Confidence 445555554 345569999999999999999999998764 999999999999999999999999999776432
Q ss_pred ccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
...+...|.+.|||||.+.- ..|+-++||||||++++|+.||+.||.......+.+. .+.+...
T Consensus 246 ----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt---------kvln~eP 312 (391)
T KOG0983|consen 246 ----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT---------KVLNEEP 312 (391)
T ss_pred ----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH---------HHHhcCC
Confidence 23345568899999999864 4688999999999999999999999986554333222 2333222
Q ss_pred CCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 845 GSY--PSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 845 ~~~--~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
+.. ...++..+.+++..|+.+|+.+||.+.+++++
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222 23477889999999999999999999988754
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=301.61 Aligned_cols=198 Identities=29% Similarity=0.473 Sum_probs=170.5
Q ss_pred CCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcC---CCceeeeeeccccCCcEEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.|+..+.||+|+||.||+|.+ .+++.||+|.+..... ...+++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 4789999999875432 33457889999999996 999999999999989999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998543 5889999999999999999999999 9999999999999999999999999998664322
Q ss_pred CCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223458889999999875 45688999999999999999999999643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.88 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=197.7
Q ss_pred cceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 614 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
..+||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999874 7899999998654445566789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.+++... .+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+....... .
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------~ 171 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------P 171 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-------c
Confidence 9987432 4788999999999999999999998 9999999999999999999999999987543211 1
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHH
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (941)
......|+..|+|||.+.+..++.++||||+|+++|||++|+.||...... +...
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~------------------------ 226 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMK------------------------ 226 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH------------------------
Confidence 123345788999999998888999999999999999999999998643321 1000
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 853 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 853 ~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
.+..++.... + .....+....+++.+||..||.+|+++.+++.||||.....
T Consensus 227 -----~~~~~~~~~~---~--------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 227 -----MIRDNLPPKL---K--------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred -----HHHhhCCccc---C--------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 0000100000 0 00111222335777888888999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.87 Aligned_cols=281 Identities=22% Similarity=0.351 Sum_probs=208.0
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCc----
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE---- 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 679 (941)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999975 68899999886432 2234567889999999999999999998866554
Q ss_pred --EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 680 --QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 680 --~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6799999864 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
...... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||...... ..+....
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~----- 229 (343)
T cd07851 166 RHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIM----- 229 (343)
T ss_pred cccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH-----
Confidence 754321 223357788999999865 46788999999999999999999999755432 2111111
Q ss_pred hhhhcCCCCCCChHHHHHHHHHH--HHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLA--LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~--~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
+. .+..++.....+..-. ..+.......++...++ +...+..+.+|+++||..||++|||+.|
T Consensus 230 ----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 230 ----NL-VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV----------FSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred ----Hh-cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHH----------hccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 00 1111222211111000 00000111112222221 1233556779999999999999999999
Q ss_pred CCCCCCCCCCC
Q 002289 915 MLKHPYVSSDV 925 (941)
Q Consensus 915 ~L~Hpwf~~~~ 925 (941)
+++||||..-.
T Consensus 295 ll~h~~~~~~~ 305 (343)
T cd07851 295 ALAHPYLAEYH 305 (343)
T ss_pred HhcCCCccccC
Confidence 99999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.46 Aligned_cols=199 Identities=28% Similarity=0.351 Sum_probs=168.0
Q ss_pred CCCccceeeccCcEEEEEEEe----CCCcEEEEEEeccCCc----hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcE
Q 002289 610 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 680 (941)
+|++.+.||+|+||.||+++. .+++.||||+++.... ...+.+.+|+++++++ +|+||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999984 3578899999874322 2235678999999999 599999999999988999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998654 35888999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCC--CCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
.... ........|+..|+|||.+.+.. .+.++||||||+++|||++|..||..
T Consensus 156 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 156 LAEE------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccc------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 3321 11112345788999999987655 78899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=313.63 Aligned_cols=288 Identities=26% Similarity=0.400 Sum_probs=208.4
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhc-CCCceeeeeeccccC--CcE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE--GEQ 680 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~ 680 (941)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999975 6889999987542 223345677899999999 999999999998543 367
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||++ ++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 6999988653 5788999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
....... .........|+..|+|||++.+ ..++.++||||||+++|||++|+.||........ .....
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~-------- 226 (337)
T cd07852 158 SELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKII-------- 226 (337)
T ss_pred ccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH--------
Confidence 4322110 0112233468899999998865 5578899999999999999999999965443221 11110
Q ss_pred hcCCCCCCChHHHHHHH-HHHHHhcccCC-CCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 840 IDGNMGSYPSECVEKFI-KLALKCCQDET-DARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~-~l~~~c~~~~p-~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
. ..+..+.+....+. .....++...+ ..++.+.+ ..+.......+++.+|++.||++|||+.++++
T Consensus 227 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 227 -E-VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE----------LLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred -H-HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhh----------hccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0 01111222222111 11111121111 11122211 12234455678999999999999999999999
Q ss_pred CCCCCCC
Q 002289 918 HPYVSSD 924 (941)
Q Consensus 918 Hpwf~~~ 924 (941)
||||..-
T Consensus 295 ~~~~~~~ 301 (337)
T cd07852 295 HPYVAQF 301 (337)
T ss_pred Chhhhhh
Confidence 9999664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=299.63 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=190.0
Q ss_pred ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHH-HHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||.||+|... +++.||+|++....... ...+..|..+ ....+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999974 68999999987543222 2234455544 3455899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 99999996543 4788899999999999999999998 99999999999999999999999999875321
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
.....++..|+|||.+.+..++.++||||||+++|||++|..||....... ...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~--------------------- 203 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFD--------------------- 203 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHH---------------------
Confidence 122357789999999998889999999999999999999999996433211 000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC---ccCCCCCCCCCC
Q 002289 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS---SSMLKHPYVSSD 924 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa---~e~L~Hpwf~~~ 924 (941)
.+....... .+. ..+.......+++.+||..+|++|++| +|+|.||||..-
T Consensus 204 -------~~~~~~~~~----~~~-------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 204 -------NILSRRINW----PEE-------------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -------HHHhcccCC----CCc-------------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 000000000 000 001123344578888999999999977 599999999763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.56 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=177.4
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
..+.|+..+.||+|+||.||+|.++ +++.|++|++..... ..+.+.+|+++++.++|+||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 689999999876544 45678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999997654 36899999999999999999999998 9999999999999999999999999986543221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 171 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 171 ------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 11223457889999999998889999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=303.28 Aligned_cols=245 Identities=29% Similarity=0.465 Sum_probs=187.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
..+|+..+.||+|+||+||+|... +++.||+|.+..... ...+++.+|+++++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999965 689999998864322 2235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99996 68888775433 35899999999999999999999999 999999999999999999999999998754221
Q ss_pred CCCCccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
....++..|+|||++. ...++.++||||||+++|||++|+.||........... +.
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----------~~ 227 (307)
T cd06607 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----------IA 227 (307)
T ss_pred -----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----------Hh
Confidence 1235778999999984 35688899999999999999999999975443221111 11
Q ss_pred cCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 841 DGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 841 ~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
...... .+..++..+.+++.+||..+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 228 QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111111 12234445555555555555555555555543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.24 Aligned_cols=264 Identities=14% Similarity=0.158 Sum_probs=188.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC----CcEEEEEEeccCCchh--h---------HhHHHHHHHHHhcCCCceeeeee
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQG--E---------KEFLTEIQFLSRLHHRNLVSLVG 672 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~nIv~l~~ 672 (941)
.++|++.++||+|+||+||+|...+ +..+|+|+........ + .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999653 4567777643222111 1 11223344556678999999998
Q ss_pred ccccCC----cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 002289 673 YCDEEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748 (941)
Q Consensus 673 ~~~~~~----~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 748 (941)
++.... ..++++|++ ..++.+.+.... ..++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 765443 447888887 457777775432 3567888999999999999999998 999999999999999999
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~ 828 (941)
++|+|||+|+....................||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986643211111111122334699999999999999999999999999999999999999975432111111
Q ss_pred HHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
... .+....+..+.. ....++..+.+++..|+..+|++||++.++.+.+
T Consensus 245 ~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAK-CDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhH-HHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 100 000111111111 1223457789999999999999999999998765
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=309.88 Aligned_cols=286 Identities=24% Similarity=0.365 Sum_probs=207.7
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeecccc-CC
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 678 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~ 678 (941)
++...+++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44557889999999999999999999965 78999999875422 2234578899999999999999999998865 56
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++|+||+ +++|.+++... .+++.....++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||.+.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999999 67999888532 4778888899999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 157 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~-------- 218 (328)
T cd07856 157 IQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII-------- 218 (328)
T ss_pred ccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------
Confidence 43211 122356788999999866 56899999999999999999999999654331111000
Q ss_pred hhhcCCCCCCChHHHHHHHH-HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 838 SVIDGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~-l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
....+..+++....+.. -....+...+...+.. .....+..+....+++.+||+.+|++|||++|++
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 219 ---TDLLGTPPDDVINTICSENTLRFVQSLPKREPVP---------FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred ---HHHhCCCCHHHHHhccchhhHHHHhhccccCCCc---------HHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00111122222111100 0000011111111100 0112233445667899999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 917 KHPYVSSDV 925 (941)
Q Consensus 917 ~Hpwf~~~~ 925 (941)
.||||....
T Consensus 287 ~~~~~~~~~ 295 (328)
T cd07856 287 AHPYLAPYH 295 (328)
T ss_pred cCCcccccc
Confidence 999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=295.49 Aligned_cols=277 Identities=21% Similarity=0.353 Sum_probs=209.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHh---HHHHHHHHHhc-CCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 682 (941)
..+|..+.+||+|+||.|.+|..+ +.+.+|||+++.+-....++ -..|-++|... +-|.++.++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 456888999999999999999865 46789999998754333222 24566666655 57899999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+.||+|-..++.-++ +.+..+..+|..||-||-+||+++ ||.||||.+||++|.+|.+||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-- 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-- 500 (683)
T ss_pred EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc--
Confidence 9999999999998876554 778888999999999999999999 999999999999999999999999998742
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
......+...+||+.|+|||.+..++|+..+|+|||||+||||+.|+.||+..+.. .++..+..
T Consensus 501 -----i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-----------elF~aI~e 564 (683)
T KOG0696|consen 501 -----IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----------ELFQAIME 564 (683)
T ss_pred -----ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHH
Confidence 23344556788999999999999999999999999999999999999999865431 12222222
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
....+|...+.+...+....+.+.|..|--. -|+ ...++-.||||+
T Consensus 565 hnvsyPKslSkEAv~ickg~ltK~P~kRLGc-------------------------------g~~---ge~di~~H~FFR 610 (683)
T KOG0696|consen 565 HNVSYPKSLSKEAVAICKGLLTKHPGKRLGC-------------------------------GPE---GERDIREHPFFR 610 (683)
T ss_pred ccCcCcccccHHHHHHHHHHhhcCCccccCC-------------------------------CCc---cccchhhCcchh
Confidence 3334555555555555444444444444211 111 125677788888
Q ss_pred CCCCCCccccccccccCCC
Q 002289 923 SDVSGSNLVSGVIPTITPR 941 (941)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~ 941 (941)
.-.+..-=-.+.-||+.|+
T Consensus 611 ~iDWek~E~~eiqPPfkPk 629 (683)
T KOG0696|consen 611 RIDWEKLERREIQPPFKPK 629 (683)
T ss_pred hccHHHHhhccCCCCCCCc
Confidence 8666544445566777764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=302.96 Aligned_cols=199 Identities=29% Similarity=0.410 Sum_probs=165.0
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|...+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. |+||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999965 689999999875332 33567889999999996 99999999999988999999999
Q ss_pred CCCCCHHHHH---hhcCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 687 MSNGTLRDQL---SAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 687 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
++ +++.++. .......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 5666543 233345689999999999999999999975 6 99999999999999999999999999975532
Q ss_pred CCCCCccccccccccccCCCcccccccccC---CCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.. ......|+..|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 161 SI--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CC--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 21 11233578899999998876 6889999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=291.46 Aligned_cols=283 Identities=24% Similarity=0.355 Sum_probs=215.4
Q ss_pred ccceeeccCcEEEEEEEeC-CCcEEEEEEecc--CCchhhHhHHHHHHHHHhcCCCceeeeeeccccC-----CcEEEEE
Q 002289 613 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQMLVY 684 (941)
Q Consensus 613 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~LV~ 684 (941)
-.+.||.|+||.||...+. +|+.||.|++.. .+....+.+.+|++++..++|.|++..++..... .+.|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3578999999999999975 799999998764 2334567899999999999999999998876543 3678899
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|.|. .+|...+- ..+.++.+.++-+..||++||.|||+.+ |.||||||.|.|++++..+||+|||+|+..+..+
T Consensus 137 ELmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 9994 58877773 4567888899999999999999999999 9999999999999999999999999999765443
Q ss_pred CCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
...++...-|..|+|||.++| ..|+.+.||||.||++.|++.++..|..... .+++. ++..-
T Consensus 211 ------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~----------lItdL 273 (449)
T KOG0664|consen 211 ------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQ----------MIIDL 273 (449)
T ss_pred ------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHH----------HHHHH
Confidence 344555667889999999998 4699999999999999999988877765433 22222 22222
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
++....+.+..-.+-++.-+-.-+.+-|+..-+.. |. .......+..+++..||.+||++|++..+++.|+|...
T Consensus 274 LGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYt-ls----S~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 274 LGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYK-IA----SPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hCCCcHHHHHHHhhhhHHHhhccCCCCCCccceee-ec----CCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 34444454444444444444344445565543321 11 11123345577899999999999999999999999754
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=291.88 Aligned_cols=199 Identities=34% Similarity=0.515 Sum_probs=176.2
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
.|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999975 689999999987555456789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999986643 46899999999999999999999988 99999999999999999999999999876543210
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||...
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23445788999999999888999999999999999999999999754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.99 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=176.1
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|+||.||++.+. +++.||+|++..... ...+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999975 689999999876443 3456788999999999999999999999888999999999
Q ss_pred CCCCCHHHHHhhcC--CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 356899999999999999999999998 9999999999999999999999999997654321
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||...
T Consensus 158 -------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1122345788999999999888999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=291.66 Aligned_cols=202 Identities=29% Similarity=0.449 Sum_probs=176.2
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcEEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 684 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV~ 684 (941)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 689999999876543 3456789999999999999999999999887 8899999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 6899999999999999999999998 9999999999999999999999999988664332
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.. .......++..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10 01233457889999999998889999999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.07 Aligned_cols=281 Identities=24% Similarity=0.334 Sum_probs=200.8
Q ss_pred CCCccceeeccCcEEEEEEEeC-C--CcEEEEEEeccCC--chhhHhHHHHHHHHHhc-CCCceeeeeecccc----CCc
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-D--GTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGE 679 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~ 679 (941)
+|++.+.||+|+||.||++... + +..||+|++.... ....+.+.+|+++++++ +|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999964 4 7899999886422 22245678899999999 59999999987532 246
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++++||+. ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999985 7999988543 35889999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
....... .........|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...... ........
T Consensus 155 ~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~------ 224 (332)
T cd07857 155 FSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ------ 224 (332)
T ss_pred ccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH------
Confidence 5432211 1111233568899999998866 56899999999999999999999998654421 11111000
Q ss_pred hhcCCCCCCChHHHHHHHH----HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 839 VIDGNMGSYPSECVEKFIK----LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~----l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
..+..+.+....+.. ....-.... .++.+. ...+..+....+|+.+||+.||++|||++|
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 288 (332)
T cd07857 225 ----VLGTPDEETLSRIGSPKAQNYIRSLPNI--PKKPFE----------SIFPNANPLALDLLEKLLAFDPTKRISVEE 288 (332)
T ss_pred ----HhCCCCHHHHHhhhhhhHHHHHHhcccc--CCcchH----------hhCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 011111111111100 000000000 011111 112333455678999999999999999999
Q ss_pred CCCCCCCC
Q 002289 915 MLKHPYVS 922 (941)
Q Consensus 915 ~L~Hpwf~ 922 (941)
++.||||.
T Consensus 289 ll~~~~~~ 296 (332)
T cd07857 289 ALEHPYLA 296 (332)
T ss_pred HhcChhhh
Confidence 99999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=294.09 Aligned_cols=203 Identities=29% Similarity=0.430 Sum_probs=170.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC-----CchhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 680 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 680 (941)
.+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999964 6899999987532 122335788999999999999999999998654 457
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++|+||+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999986543 3788889999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 157 QTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 321110 11112345888999999999988999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=292.95 Aligned_cols=246 Identities=25% Similarity=0.418 Sum_probs=194.3
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|+||.||+++.. +++.+|+|.+..... ....++.+|+++++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788999999999999999865 688999999875332 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
+++++|.+++.+. ....+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998652 2346899999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... + ... .+.....
T Consensus 157 --------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~-~~~--------~~~~~~~ 218 (256)
T cd08530 157 --------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-D-LRY--------KVQRGKY 218 (256)
T ss_pred --------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H-HHH--------HHhcCCC
Confidence 112234788999999999999999999999999999999999999654321 1 110 1111222
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVM 877 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~ 877 (941)
+..+..+...+.+++.+|+..+|++||++.+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 333444555566666666666666666665554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=286.14 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=199.0
Q ss_pred cceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHH-HHhcCCCceeeeeeccccCCcEEEEEecCCCC
Q 002289 614 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
...||.|+||+|+|-.++ .|+..|||++..... ...++++.|.+. ++.-++||||+++|.+..++..|+.||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 457999999999998865 799999999987655 446788999885 55568999999999999999999999999 56
Q ss_pred CHHHHHh---hcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 691 TLRDQLS---AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 691 sL~~~l~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
||+.+.. ......+++...-+|+...++||.||.+..+ |||||+||+|||++..|.+||+|||++-.+..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~----- 220 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD----- 220 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH-----
Confidence 8766543 3344568888899999999999999997654 99999999999999999999999999875532
Q ss_pred ccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
+-..+.-.|...|||||.+.. ..|+-+|||||+|++|||+.||+.|+....+..+++.... .+..+
T Consensus 221 ---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv---------~gdpp 288 (361)
T KOG1006|consen 221 ---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV---------IGDPP 288 (361)
T ss_pred ---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH---------cCCCC
Confidence 223345568889999999964 4589999999999999999999999987777665554432 22222
Q ss_pred --CCChH---HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 846 --SYPSE---CVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 846 --~~~~~---~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
..+.+ +...+...+..|+.++-..||++.++.++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 23333 66788899999999999999999988754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.24 Aligned_cols=276 Identities=24% Similarity=0.376 Sum_probs=212.7
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccC-Cchh------hHhHHHHHHHHHhcCCCceeeeeecc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQG------EKEFLTEIQFLSRLHHRNLVSLVGYC 674 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~ 674 (941)
|-....++|-.++.||+|||+.||+|.+ ...+.||||+-... +... .+...+|.++-+.+.||.||++|+||
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3344567888899999999999999995 46789999975432 1222 24567899999999999999999999
Q ss_pred c-cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEE
Q 002289 675 D-EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAK 750 (941)
Q Consensus 675 ~-~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~k 750 (941)
. +.+.+|-|+|||+|.+|+-+|+.+. .+++.+++.|+.||+.||.||.+. ++||||-||||.|||+. .-|.+|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 5 5578899999999999999996543 489999999999999999999987 48899999999999995 357899
Q ss_pred EeeeccccccCCCCCCCccccccccccccCCCcccccccccC----CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002289 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 826 (941)
Q Consensus 751 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~ 826 (941)
|+|||+++.+.............+....||.+|++||.+.-+ +.+.|+||||+||++|..+.|+.||.+.....+.
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 999999998876654433334455567899999999998643 5788999999999999999999999765442221
Q ss_pred HHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCC
Q 002289 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 906 (941)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP 906 (941)
+.. .. ++...-..| ..-|....++.+||++||.+.-
T Consensus 694 Lqe----NT---IlkAtEVqF-------------------------------------P~KPvVsseAkaFIRRCLaYRK 729 (775)
T KOG1151|consen 694 LQE----NT---ILKATEVQF-------------------------------------PPKPVVSSEAKAFIRRCLAYRK 729 (775)
T ss_pred Hhh----hc---hhcceeccC-------------------------------------CCCCccCHHHHHHHHHHHHhhh
Confidence 111 00 111000011 1112334556689999999999
Q ss_pred CCCCCCccCCCCCCCCCCC
Q 002289 907 ETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 907 ~~R~sa~e~L~Hpwf~~~~ 925 (941)
++|+.+.++-.||||.--+
T Consensus 730 eDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 730 EDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hhhhhHHHHccCccccchh
Confidence 9999999999999985433
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=290.96 Aligned_cols=200 Identities=32% Similarity=0.521 Sum_probs=175.2
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|++.+.||+|++|.||+|+.. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788899999999999999865 678999999886544 3446789999999999999999999999988999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999999665 45899999999999999999999999 99999999999999999999999999986643221
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
......++..|+|||...+..++.++||||+|+++|+|++|+.||....
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1233457889999999988888999999999999999999999996543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=309.61 Aligned_cols=262 Identities=24% Similarity=0.358 Sum_probs=209.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
...|.+...||+|.|+.|..|+.. ++..||+|.+.+.... ....+.+|+++|+.++|||||+++.+...+...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888999999999999999964 6999999999865433 2345889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+.+|.+.+++.++++ ..+..+..++.|+.+|++|||+++ |||||||++|||++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 99999999999987765 445788889999999999999999 99999999999999999999999999987753
Q ss_pred CCCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......+|++.|.|||++.+.+| ++.+|+||+|+++|.|+.|..||+...-. . .-..++.+.
T Consensus 208 ------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-~---------Lr~rvl~gk 271 (596)
T KOG0586|consen 208 ------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-E---------LRPRVLRGK 271 (596)
T ss_pred ------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-c---------ccchheeee
Confidence 234556789999999999999776 46899999999999999999999753210 0 000000000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
+ ...--...+..++|+++|..+|.+|++.+++++|+|...
T Consensus 272 ~----------------------------------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 272 Y----------------------------------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred e----------------------------------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 0 000111233446888888999999999999999999866
Q ss_pred CCCCCcccc
Q 002289 924 DVSGSNLVS 932 (941)
Q Consensus 924 ~~~~~~~~~ 932 (941)
.-....+.+
T Consensus 312 ~~~~~~l~p 320 (596)
T KOG0586|consen 312 LLEARLLAP 320 (596)
T ss_pred hhhhhhhhc
Confidence 544433333
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=299.03 Aligned_cols=245 Identities=29% Similarity=0.469 Sum_probs=192.8
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
|+..+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999964 689999999864322 2235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ |+|.+.+... ..++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 5888877543 345899999999999999999999999 99999999999999999999999999865322
Q ss_pred CccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||.......... .+....
T Consensus 178 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~----------~~~~~~ 240 (317)
T cd06635 178 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----------HIAQNE 240 (317)
T ss_pred -------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH----------HHHhcc
Confidence 12235788999999974 4568889999999999999999999987543221111 111111
Q ss_pred CC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 844 MG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 844 ~~-~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
.. .....++..+.+++.+|++.+|.+||++.+++++.-
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 11 122345566777888888888888888877776543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=298.50 Aligned_cols=199 Identities=29% Similarity=0.457 Sum_probs=165.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC-CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++.+.||+|+||.||+|.+++ ++.||||.++.... .....+.+|+.++.+.. |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4668889999999999999999864 89999999875432 23456777887776664 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||+ ++++.+++.... ..+++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++......
T Consensus 94 e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 998 458887775533 368999999999999999999997 46 999999999999999999999999998765321
Q ss_pred CCCCccccccccccccCCCcccccccccCC----CCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 169 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 169 K--------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred C--------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 1 112234778999999987654 78899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=325.62 Aligned_cols=264 Identities=28% Similarity=0.486 Sum_probs=217.7
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC----C----CcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeeeee
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP----D----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVG 672 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~ 672 (941)
.++...++..+.+.||+|.||.||+|... . ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45666667777789999999999999842 1 457999999865443 356899999999998 6999999999
Q ss_pred ccccCCcEEEEEecCCCCCHHHHHhhcC------------C--CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 002289 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKS------------K--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 738 (941)
Q Consensus 673 ~~~~~~~~~LV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 738 (941)
+|...+..++|+||++.|+|.++++... . ..+.....+.++.|||.|++||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997654 0 23888999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEeeeccccccCCCCCCCcccccccccccc--CCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCC
Q 002289 739 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 815 (941)
Q Consensus 739 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~ 815 (941)
+|||+.++..+||+|||+|+.....+.+. .....| ...|||||.+....|+.++||||||++||||+| |..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYR------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceE------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 99999999999999999998654433221 011112 345999999999999999999999999999999 888
Q ss_pred CCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 816 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 816 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
||.......+ .+..+.++.+...|..|..+++.+|+.||+.+|++||++.++.+.++...
T Consensus 521 PYp~~~~~~~---------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 521 PYPGIPPTEE---------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCCCCcHHH---------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 9875221111 11134556667789999999999999999999999999999999998854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=274.02 Aligned_cols=280 Identities=16% Similarity=0.330 Sum_probs=209.3
Q ss_pred HhcCCCccceeeccCcEEEEEEE-eCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeeccccC--CcEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~L 682 (941)
..++|++.+++|+|.|+.||.|. ..+.+.++||+++.. ..+.+.+|+++|+.+. ||||+++++...+. ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35789999999999999999998 457889999999853 3457899999999996 99999999998654 46689
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeeccccccC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAP 761 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFGla~~~~ 761 (941)
|+||+.+.+...+.. .++...+..++.+++.||.|+|++| |+|||+||.|+++|.. -.++|+|+|+|.++.
T Consensus 113 iFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred HhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999999988877652 3667778899999999999999999 9999999999999965 479999999999875
Q ss_pred CCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... .......+..|.-||.+.. ..|+..-|+|||||++.+|+..+.||+.+.+-.+++-..... +
T Consensus 185 p~~--------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV------L 250 (338)
T KOG0668|consen 185 PGK--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV------L 250 (338)
T ss_pred CCc--------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH------h
Confidence 432 2223345667889999876 568899999999999999999999999877655444322111 0
Q ss_pred cCCCCCCChHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHH-H-hHhhCCC-----CCCCCcccccccCCCCCCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELE-S-IWNMMPE-----SDTKTPEFINSEHTSKEETPPSS 912 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~-~~c~~~~p~~RPs~~~v~~~L~-~-~~~~~~~-----~~~~~~dll~~~L~~dP~~R~sa 912 (941)
+ .+ ++..-+ +.-+..+ |.+.+++..-. . +...... ..+++.||+.++|++|-.+|+||
T Consensus 251 ----G--t~----el~~Yl~KY~i~Ld----p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa 316 (338)
T KOG0668|consen 251 ----G--TD----ELYAYLNKYQIDLD----PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA 316 (338)
T ss_pred ----C--hH----HHHHHHHHHccCCC----hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch
Confidence 0 00 111111 1111111 33344332211 1 1111111 23677899999999999999999
Q ss_pred ccCCCCCCCCCCC
Q 002289 913 SSMLKHPYVSSDV 925 (941)
Q Consensus 913 ~e~L~Hpwf~~~~ 925 (941)
+||+.||||....
T Consensus 317 kEam~HpyF~~~~ 329 (338)
T KOG0668|consen 317 KEAMAHPYFAPVR 329 (338)
T ss_pred HHHhcCchHHHHH
Confidence 9999999997543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=330.90 Aligned_cols=145 Identities=25% Similarity=0.373 Sum_probs=130.7
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|.+.++||+|+||+||+|.+. +++.||||+++..... ....+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999976 6899999998754322 2357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
||+++++|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999996543 4788899999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.80 Aligned_cols=282 Identities=23% Similarity=0.321 Sum_probs=217.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccC------C
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 678 (941)
..+|.-...+|.|.- .|..|.+. .++.||+|+.... .....++..+|..++..++|+||++++.+|... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788899987 66666654 5899999987543 233456788999999999999999999998543 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
+.|+||||| .++|...++ ..++-.+...|..|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|+
T Consensus 95 e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 679999999 679999886 23677888999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
.... .-..+....|..|+|||++.+..+.+.+||||+||++.||++|+..|.+.....+|.+..
T Consensus 167 ~e~~--------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~-------- 230 (369)
T KOG0665|consen 167 TEDT--------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKII-------- 230 (369)
T ss_pred ccCc--------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHH--------
Confidence 5432 224556778899999999999889999999999999999999999998666665555432
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh-hC-------CCCCCCCcccccccCCCCCCCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN-MM-------PESDTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~-~~-------~~~~~~~~dll~~~L~~dP~~R~ 910 (941)
..++...+.+..++...+..-.. .||.... ...-+.+-+ .+ +.....+.|++.+||..||++|.
T Consensus 231 ---~~lgtpd~~F~~qL~~~~r~yv~----~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri 302 (369)
T KOG0665|consen 231 ---EQLGTPDPSFMKQLQPTVRNYVE----NRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI 302 (369)
T ss_pred ---HHhcCCCHHHHHHhhHHHHHHhh----cChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc
Confidence 22344556677777666655544 3333322 111111100 00 11223457799999999999999
Q ss_pred CCccCCCCCCCC
Q 002289 911 SSSSMLKHPYVS 922 (941)
Q Consensus 911 sa~e~L~Hpwf~ 922 (941)
|++++|.|||++
T Consensus 303 sv~daL~HPY~~ 314 (369)
T KOG0665|consen 303 SVDDALRHPYIK 314 (369)
T ss_pred cHHHHhcCCeee
Confidence 999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=315.26 Aligned_cols=271 Identities=20% Similarity=0.311 Sum_probs=186.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-----------------CCCcEEEEEEeccCCchhhHh--------------HHHH
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-----------------PDGTVVAVKRAQEGSLQGEKE--------------FLTE 655 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 655 (941)
..++|++.++||+|+||+||+|.. .+++.||||+++.......++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999987543222222 3446
Q ss_pred HHHHHhcCCCce-----eeeeecccc--------CCcEEEEEecCCCCCHHHHHhhcC----------------------
Q 002289 656 IQFLSRLHHRNL-----VSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKS---------------------- 700 (941)
Q Consensus 656 ~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~LV~e~~~~gsL~~~l~~~~---------------------- 700 (941)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677887743 357899999999999999987421
Q ss_pred CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccC
Q 002289 701 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780 (941)
Q Consensus 701 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt 780 (941)
...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ........+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~------~~~~~~g~~t 373 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI------NFNPLYGMLD 373 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC------ccCccccCCC
Confidence 113467788899999999999999998 9999999999999999999999999997543211 0111122347
Q ss_pred CCcccccccccCCC----------------------CchhHhHHHHHHHHHHHhCCC-CCCCCchhHHHHHHHHhhccch
Q 002289 781 PGYLDPEYFLTHKL----------------------TDKSDVYSLGVVFLELLTGMQ-PISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 781 ~~y~aPE~~~~~~~----------------------~~~sDVwSlG~ll~elltG~~-Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
+.|+|||.+..... ..+.||||+||+++||++|.. ||............
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-------- 445 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-------- 445 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh--------
Confidence 89999998764321 124799999999999999875 66432111110000
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCC---CCCCCCcc
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE---ETPPSSSS 914 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP---~~R~sa~e 914 (941)
. ...... |......+..+. .+...++...||+.+||..+| .+|+||+|
T Consensus 446 ---------~-~~~~~~--------~r~~~~~~~~~~-----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 446 ---------Y-DNDLNR--------WRMYKGQKYDFS-----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred ---------c-cchHHH--------HHhhcccCCCcc-----------cccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 0 000000 111111111111 122334566789999999766 68999999
Q ss_pred CCCCCCCCC
Q 002289 915 MLKHPYVSS 923 (941)
Q Consensus 915 ~L~Hpwf~~ 923 (941)
+|+||||..
T Consensus 497 aL~Hp~f~~ 505 (507)
T PLN03224 497 ALSHRFFLP 505 (507)
T ss_pred HhCCCCcCC
Confidence 999999964
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=310.35 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=197.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++.|.....+|.|+|+.|-.+... +++..+||++... ..+..+|+.++... +||||+++++.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 456777778999999999998854 6889999998764 22345677665555 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE-cCCCcEEEeeeccccccCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~~~~~~kl~DFGla~~~~~~~ 764 (941)
.+.++-+.+.+..... +. ..+..|+.+|+.|+.|||++| ||||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988887754432 23 677789999999999999999 9999999999999 68999999999999865432
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
....+-|..|.|||+.....|++++|+||||++||+|++|+.||....+-.
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-------------------- 520 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-------------------- 520 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--------------------
Confidence 223345779999999999999999999999999999999999996433210
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC-CC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV-SS 923 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf-~~ 923 (941)
-+..|+ .+|++. ......++|||++||++||++|+++.|++.|||| +.
T Consensus 521 -------------ei~~~i-----~~~~~s-------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 521 -------------EIHTRI-----QMPKFS-------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred -------------HHHHhh-----cCCccc-------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 011111 123332 2234566799999999999999999999999999 44
Q ss_pred CC
Q 002289 924 DV 925 (941)
Q Consensus 924 ~~ 925 (941)
+.
T Consensus 570 ~t 571 (612)
T KOG0603|consen 570 PT 571 (612)
T ss_pred CC
Confidence 44
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.24 Aligned_cols=192 Identities=31% Similarity=0.429 Sum_probs=167.5
Q ss_pred eeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 617 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
||+|+||.||++... +++.||+|++...... ....+..|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 5899999998754332 345788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 772 (941)
.+++.... .+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~ 148 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------S 148 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-------C
Confidence 99996553 4889999999999999999999988 9999999999999999999999999987653321 1
Q ss_pred cccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 773 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
......++..|+|||...+..++.++|+||||+++||+++|+.||...
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 123445788999999999888899999999999999999999999644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=284.16 Aligned_cols=268 Identities=24% Similarity=0.336 Sum_probs=223.3
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeec
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGY 673 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~ 673 (941)
..++....++++....+-+|.||.||.|.|.+ .+.|.||.++....+ ....+..|.-.+..+.|||+..+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45777788899999999999999999997643 356778887764433 34578889999999999999999999
Q ss_pred ccc-CCcEEEEEecCCCCCHHHHHhh------cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC
Q 002289 674 CDE-EGEQMLVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 746 (941)
Q Consensus 674 ~~~-~~~~~LV~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 746 (941)
+.+ .+..+++|.++.-|+|..++.. ...+.++..+...++.|++.|++|||+++ |||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 854 4577899999999999999971 33456788888999999999999999999 9999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHH
Q 002289 747 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 825 (941)
Q Consensus 747 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~ 825 (941)
.++||+|=.+++.+-..++. ...........||+||.+....|+.++||||||+++|||+| |+.|+...+...
T Consensus 433 LqVkltDsaLSRDLFP~DYh-----cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYH-----CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred eeEEeccchhccccCccccc-----ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 99999999999987655532 11223345678999999999999999999999999999999 999997544321
Q ss_pred HHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
....+.|+.+...|-.|+++++.+|.-||...|++||++++++.-|.++..+
T Consensus 507 ---------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 ---------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ---------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 1223567777788999999999999999999999999999999999887654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=290.06 Aligned_cols=199 Identities=26% Similarity=0.366 Sum_probs=165.4
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-----chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
+|.+.+.||+|+||.||++.+. .+..+++|+++... ......+..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999865 34556666655321 12234577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 684 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
|||+++++|.+++.. .....+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 23356899999999999999999999999 999999999999975 569999999987653
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
... .......|+..|+|||...+..++.++|+||||+++|+|++|..||..
T Consensus 157 ~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSC-------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCc-------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 221 112234578899999999888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=288.47 Aligned_cols=179 Identities=23% Similarity=0.214 Sum_probs=152.8
Q ss_pred cCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCHHHHHhh
Q 002289 620 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 698 (941)
Q Consensus 620 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~ 698 (941)
|.||.||++.+. +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999975 68999999987532 234455555566799999999999999999999999999999999865
Q ss_pred cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccc
Q 002289 699 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778 (941)
Q Consensus 699 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 778 (941)
.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------~~~~~ 143 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------CDGEA 143 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----------cccCC
Confidence 43 4889999999999999999999998 999999999999999999999999987654321 11233
Q ss_pred cCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCC
Q 002289 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818 (941)
Q Consensus 779 gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~ 818 (941)
++..|+|||.+.+..++.++||||+|+++|||++|+.|+.
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 5668999999988889999999999999999999987764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=322.35 Aligned_cols=277 Identities=23% Similarity=0.315 Sum_probs=178.3
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-C----CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeec------cc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-D----GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY------CD 675 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~ 675 (941)
..++|++.+.||+|+||.||+|++. + +..||||++...... +....| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999975 4 689999987642211 111111 1222222333322222 24
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCC------------------CccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKSKE------------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 737 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 737 (941)
.....++||||+++++|.++++..... ......+..++.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556899999999999999998653211 1123445679999999999999998 9999999
Q ss_pred CCcEEEcC-CCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccC----------------------CC
Q 002289 738 ASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----------------------KL 794 (941)
Q Consensus 738 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 794 (941)
|+|||++. ++.+||+|||+|+...... ........+++.|+|||.+... .+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999986 5799999999997653221 1122345688999999965422 23
Q ss_pred CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 002289 795 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 874 (941)
Q Consensus 795 ~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~ 874 (941)
+.++|||||||++|||+++..++.. +.... ...... ..... ..+.... .+..++...
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~--~~~~~-~~~l~~-----------~~~~~---~~~~~~~------~~~~~~~~~ 413 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDS--NLIQF-NRQLKR-----------NDYDL---VAWRKLV------EPRASPDLR 413 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCch--HHHHH-HHHHHh-----------cCCcH---HHHHHhh------ccccchhhh
Confidence 4567999999999999987655432 11111 110000 00010 1111110 111122211
Q ss_pred HHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 875 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 875 ~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
+.. ...........|||.+||+.||++|||++|+|+||||+....
T Consensus 414 ~~~-------~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 414 RGF-------EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhh-------hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 111 111122233458999999999999999999999999987544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=319.54 Aligned_cols=206 Identities=29% Similarity=0.404 Sum_probs=163.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeecccc--------
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 676 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 676 (941)
-..+|+..+.||+||||.||+++.+ ||+.||||++.... ...-..+.+|+..+++++|||||+++....+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4456778889999999999999976 89999999987653 1223568899999999999999999721100
Q ss_pred --------------------------------------------------------------------------------
Q 002289 677 -------------------------------------------------------------------------------- 676 (941)
Q Consensus 677 -------------------------------------------------------------------------------- 676 (941)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc
Q 002289 677 -----------------------E--------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725 (941)
Q Consensus 677 -----------------------~--------~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 725 (941)
+ ...||-||||+..+++++++++.... .....++++++|++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 0 13578899999888888887654321 467789999999999999999
Q ss_pred CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC----CC-------CCCCccccccccccccCCCcccccccccC--
Q 002289 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP----VP-------DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-- 792 (941)
Q Consensus 726 ~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~----~~-------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 792 (941)
+| ||||||||.||++|+++.|||+|||+|+... .. ...........+..+||.-|+|||++.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99 9999999999999999999999999998722 00 00111122245677899999999999764
Q ss_pred -CCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 793 -KLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 793 -~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
.|+.|+|+||+|++++||+ +||..
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~---yPF~T 817 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEML---YPFGT 817 (1351)
T ss_pred ccccchhhhHHHHHHHHHHh---ccCCc
Confidence 4999999999999999999 56753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=304.23 Aligned_cols=200 Identities=31% Similarity=0.462 Sum_probs=171.4
Q ss_pred CCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeecccc------CCcEEE
Q 002289 611 FNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQML 682 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~L 682 (941)
+...+.||+|+||.||+|+. .+|+.||||.++... ....+...+|+++|++++|+|||++++.-.+ .+...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999995 579999999998643 3345678899999999999999999988543 346799
Q ss_pred EEecCCCCCHHHHHhhc-CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc--CCC--cEEEeeeccc
Q 002289 683 VYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKF--TAKVADFGLS 757 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~--~~kl~DFGla 757 (941)
|||||.+|||+..+.+. +...+++.+.+.+..+++.||.|||+++ ||||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999753 3356999999999999999999999999 99999999999983 333 5899999999
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
+.++.. ...+...||..|.+||.... +.|+..+|.|||||++||++||..||.+..
T Consensus 172 rel~d~--------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDN--------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCC--------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 977542 34577889999999999984 889999999999999999999999997543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=292.35 Aligned_cols=195 Identities=33% Similarity=0.517 Sum_probs=165.4
Q ss_pred CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 611 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
|...+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 689999999864322 2235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+. |++.+++.... .++++..++.++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 68888875433 45899999999999999999999999 99999999999999999999999998864211
Q ss_pred CccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12345788999999984 4568889999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=293.97 Aligned_cols=196 Identities=31% Similarity=0.506 Sum_probs=165.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|+++++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999965 68899999886422 223356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+. |++.+++.... .++++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9995 68888775433 45889999999999999999999998 999999999999999999999999998754321
Q ss_pred CCCccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
....++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2234788999999975 356788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=307.23 Aligned_cols=286 Identities=25% Similarity=0.390 Sum_probs=217.4
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccc---
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD--- 675 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~--- 675 (941)
++.+...++.|++.+.||+|.+|.||+++. ++++.+|+|+..... ..++++..|.++++.. .|||++.++|+|.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344445677889999999999999999994 579999999987643 3445788899999888 6999999999983
Q ss_pred --cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 676 --EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 676 --~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
.++++|||||||.+||..|+++.-....+.|..+..|++.++.|+.+||... ++|||||-.|||++.++.||+.|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 3578999999999999999998766778999999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCCCCccccccccccccCCCcccccccccC-----CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002289 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828 (941)
Q Consensus 754 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~ 828 (941)
||.+..+... ........||+.|||||++... .|+.++|+||+|++..||--|..|+.+....
T Consensus 167 FGvSaQldsT-------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----- 234 (953)
T KOG0587|consen 167 FGVSAQLDST-------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----- 234 (953)
T ss_pred eeeeeeeecc-------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----
Confidence 9998765432 2344566799999999999643 4777999999999999999999999765431
Q ss_pred HHHhhccchhhhcCCCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCC
Q 002289 829 IAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 906 (941)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP 906 (941)
..++.+.....+. -|..+.+++-+.+..|+.+|.++||++.+++++-- ....+ ...+....|..+...++
T Consensus 235 -----raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF--i~e~~-~e~qir~~ik~~~~~~r 306 (953)
T KOG0587|consen 235 -----RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF--ITEQP-NERQVRIQIKDHIDRSR 306 (953)
T ss_pred -----hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc--ccccc-cHHHHHHHHHHHHhhcc
Confidence 1122222211111 35667777777777777777777777776664311 00000 11222335556666666
Q ss_pred CCCC
Q 002289 907 ETPP 910 (941)
Q Consensus 907 ~~R~ 910 (941)
.+|-
T Consensus 307 ~~k~ 310 (953)
T KOG0587|consen 307 KKRG 310 (953)
T ss_pred chhh
Confidence 4443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-33 Score=295.77 Aligned_cols=202 Identities=22% Similarity=0.342 Sum_probs=177.7
Q ss_pred cCCCccceeeccCcEEEEEEEeCCC-cEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.+++++..||-|+||.|-++..+.. ..+|+|++++.. ...++.+..|-++|...+.|.||++|..|.+++..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4455677899999999999887543 348888887543 333456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|-|-||.|+..++.++ .|+..+.+.++..+++|++|||+++ ||.|||||+|.+++.+|-+||.|||.|+....
T Consensus 500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-- 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-- 572 (732)
T ss_pred HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence 9999999999997654 5899999999999999999999999 99999999999999999999999999997754
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchh
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 823 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~ 823 (941)
...+...+||+.|.|||.+.+...+.++|.||+|+++|||++|.+||...+..
T Consensus 573 ------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 573 ------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred ------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 34567789999999999999999999999999999999999999999865543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=273.33 Aligned_cols=202 Identities=24% Similarity=0.389 Sum_probs=176.8
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhc-CCCceeeeeeccccCCc
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 679 (941)
....++|...++||+|+|..|-.+++. +.+.+|+|++++.... ....+..|-.+..+. +||.+|-++.+|..+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 345678999999999999999999964 6789999999864332 234567787777776 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++|.||++||+|--+++++. .+++..++.+...|.-||.|||++| ||.||||.+|||+|..|.+|++|+|+++.
T Consensus 326 lffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 999999999999987776554 4889999999999999999999999 99999999999999999999999999874
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCC
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~ 818 (941)
- ..+...+...+||+.|.|||.+++..|...+|+|++||+++||+.|+.||+
T Consensus 401 ~-------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 G-------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred C-------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 2 233455667899999999999999999999999999999999999999996
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=293.37 Aligned_cols=301 Identities=21% Similarity=0.291 Sum_probs=216.8
Q ss_pred ccccchHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC------CCcee
Q 002289 596 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH------HRNLV 668 (941)
Q Consensus 596 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv 668 (941)
-..|.+.-.+....+|.+....|+|-|++|.+|.+. .|..||||++...... .+.=+.|+++|++|+ --|++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 345666666677899999999999999999999975 4789999999864332 245578999999996 34899
Q ss_pred eeeeccccCCcEEEEEecCCCCCHHHHHhhcCC-CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-
Q 002289 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK- 746 (941)
Q Consensus 669 ~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~- 746 (941)
+++..|....++|||||-+ .-+|.++|.+.+. ..+....+..++.|+.-||..|...+ |+|.||||+||||++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 9999999999999999998 5799999987543 35888899999999999999999999 9999999999999865
Q ss_pred CcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002289 747 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 826 (941)
Q Consensus 747 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~ 826 (941)
..+||||||.|......+. +.+.-+..|+|||.+.|.+|+...|+||+||+|||+.||+..|.+..+-.
T Consensus 574 ~iLKLCDfGSA~~~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~-- 642 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ-- 642 (752)
T ss_pred ceeeeccCccccccccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--
Confidence 5799999999987654332 22334557999999999999999999999999999999999997654411
Q ss_pred HHHHHhhccchhhhcCCCCCCChHHHHHHH----HHHHHh----cccCC-----------CCCCCHHHHHHHHHHhHhhC
Q 002289 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFI----KLALKC----CQDET-----------DARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~----~l~~~c----~~~~p-----------~~RPs~~~v~~~L~~~~~~~ 887 (941)
|..+...-.+.+|..+...-+ .+-..| ...|+ .-.|| .++...|..... +
T Consensus 643 ---------MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt-kdl~s~l~~~q~-~ 711 (752)
T KOG0670|consen 643 ---------MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT-KDLGSELIAVQR-L 711 (752)
T ss_pred ---------HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcc-hhHHHHHhccCC-C
Confidence 001111111222221111000 000000 00011 01121 223333322111 1
Q ss_pred CCCC----CCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 888 PESD----TKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 888 ~~~~----~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
++.. .++.+||.+||..||++|+|..|||+||||+.
T Consensus 712 ~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 712 PDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred CchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 2222 23468999999999999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=282.47 Aligned_cols=296 Identities=22% Similarity=0.339 Sum_probs=214.9
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccC
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 677 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 677 (941)
++....+.|...++||+|.|++||+|.+. ..+.||+|.+...+. ..++.+|+++|..+ .+.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455678899999999999999999853 468899998875433 35689999999998 599999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGL 756 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGl 756 (941)
+..++|+||+++..-.++... ++...+..+.+.+..||+++|++| ||||||||+|+|.+. .+.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999999998843 567888899999999999999999 999999999999974 56789999999
Q ss_pred ccccCCCC------C-------------------CC------------ccccccccccccCCCccccccccc-CCCCchh
Q 002289 757 SRLAPVPD------I-------------------EG------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKS 798 (941)
Q Consensus 757 a~~~~~~~------~-------------------~~------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~s 798 (941)
|....... . .+ ...........||++|+|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221100 0 00 000111234579999999999875 5678899
Q ss_pred HhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 002289 799 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALK--CCQDETDARPSMSEV 876 (941)
Q Consensus 799 DVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~~p~~RPs~~~v 876 (941)
||||.|++++-+++++.||....+.......... + +....+.+...+-.+ .|++ ..+|+..++
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~t------i-------fG~~~mrk~A~l~g~~~l~~k--sn~~~~~e~ 324 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIAT------I-------FGSAEMRKCAALPGRILLWQK--SNIPTIPEL 324 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHH------H-------hChHHHHHHhhcCCceeeecc--ccccccHHH
Confidence 9999999999999999999865442221111000 0 001111111111111 1222 346666666
Q ss_pred HHHHHHhH-hhCCC--------------CCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 877 MRELESIW-NMMPE--------------SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 877 ~~~L~~~~-~~~~~--------------~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
....+... ..... .+..+.||++++|..||.+|+||+|+|+||||..
T Consensus 325 ~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 325 RVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred HhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 65555441 21111 1124578999999999999999999999999974
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=250.60 Aligned_cols=215 Identities=26% Similarity=0.382 Sum_probs=175.0
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccC-CchhhHhHHHHHHH-HHhcCCCceeeeeeccccCCcE
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
++...+.......||+|++|.|-+-++ .+|+..|+|++... ..+..++..+|+.+ ++...+|.+|.|+|.+..++..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444555555678899999999988875 58999999998753 23445678888886 4556899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 681 MLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
++.||.| .-||..+-.+ .....+++...-+|+..+.+||.|||++-+ +||||+||+|||++.+|++|++|||++-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 4588776543 244568899999999999999999999764 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc----CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 829 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~ 829 (941)
.+... -..+...|...|||||.+.. ..|+-++||||+|+++.||.+++.||.......++++.
T Consensus 198 ~L~dS--------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 198 YLVDS--------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred eehhh--------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 66431 22233457889999999864 36889999999999999999999999877765555443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=303.79 Aligned_cols=255 Identities=28% Similarity=0.414 Sum_probs=195.1
Q ss_pred CCccceeeccCcEE-EEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecCC
Q 002289 611 FNSSTQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 611 y~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
|...+.+|.|+-|+ ||+|.. +|+.||||++-... .+-..+|+..++.- +|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44456789999985 799998 67899999876432 34567899999887 6999999999999999999999999
Q ss_pred CCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---C--CcEEEeeeccccccC
Q 002289 689 NGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---K--FTAKVADFGLSRLAP 761 (941)
Q Consensus 689 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~--~~~kl~DFGla~~~~ 761 (941)
..+|.++++.. ..........+.+..|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999999763 1111121445778899999999999998 999999999999975 3 479999999999876
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhC-CCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... .-.......||.+|+|||++....-+.++||||+||++|+.++| ..||.+.. .++..+ +
T Consensus 663 ~~~s----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NI----------l 726 (903)
T KOG1027|consen 663 GGKS----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANI----------L 726 (903)
T ss_pred CCcc----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--Hhhhhh----------h
Confidence 4331 12224567799999999999998888899999999999999995 89996432 222221 1
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
.+... ..+++ +..+.++.|||.+|+..||..||+|.++|.||+
T Consensus 727 ~~~~~--------------L~~L~-----------------------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 727 TGNYT--------------LVHLE-----------------------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPL 769 (903)
T ss_pred cCccc--------------eeeec-----------------------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence 11100 00111 111115568999999999999999999999999
Q ss_pred CCCCCC
Q 002289 921 VSSDVS 926 (941)
Q Consensus 921 f~~~~~ 926 (941)
|.....
T Consensus 770 FW~~ek 775 (903)
T KOG1027|consen 770 FWDSEK 775 (903)
T ss_pred cCChHH
Confidence 977554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=282.32 Aligned_cols=209 Identities=22% Similarity=0.309 Sum_probs=173.1
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhh---HhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.-|..++.||-|+||.|.++.. ++...+|.|.+.+.+.-.+ ..+..|-.||.....+-||+||-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4466678899999999999984 4577899998876544332 34678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC--
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV-- 762 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~-- 762 (941)
||++||++-.+|-+.+ .|.+..++.++..+..|+++.|..| +|||||||+|||||.+|.+||+|||++.-+.-
T Consensus 709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999986654 4889999999999999999999999 99999999999999999999999999753221
Q ss_pred -CCCCC------------------cc-----------c---cccccccccCCCcccccccccCCCCchhHhHHHHHHHHH
Q 002289 763 -PDIEG------------------IV-----------P---AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 809 (941)
Q Consensus 763 -~~~~~------------------~~-----------~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~e 809 (941)
..++. .. . .......+||..|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00000 00 0 001124579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCch
Q 002289 810 LLTGMQPISHGKN 822 (941)
Q Consensus 810 lltG~~Pf~~~~~ 822 (941)
|+.|+.||.....
T Consensus 864 m~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 864 MLVGQPPFLADTP 876 (1034)
T ss_pred HhhCCCCccCCCC
Confidence 9999999976543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=321.97 Aligned_cols=324 Identities=30% Similarity=0.528 Sum_probs=233.4
Q ss_pred CCHHHHHHHHHHHHhCcCCCCCCCCCCCCCCCCCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEE
Q 002289 32 TDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTIL 111 (941)
Q Consensus 32 ~~~~d~~aL~~~k~~~~~~~~~~~~w~~~~~c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L 111 (941)
.+++|..||++||+++.++...+.+|+..++|| .|.||+|.+. .+|+.|+|++++++|.+++.|..+++|+.|
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~~------~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L 98 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNNS------SRVVSIDLSGKNISGKISSAIFRLPYIQTI 98 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCCC------CcEEEEEecCCCccccCChHHhCCCCCCEE
Confidence 467899999999999987766788998777775 7999999642 268899999988888888888888899999
Q ss_pred EcccCCCCCCCCCccC-CccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccc
Q 002289 112 DFMWNKISGSIPKEIG-NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190 (941)
Q Consensus 112 ~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 190 (941)
+|++|++.+.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+
T Consensus 99 ~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l 176 (968)
T PLN00113 99 NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176 (968)
T ss_pred ECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcc
Confidence 9998888888886654 788888888888888776664 3466777777777777777777777777777777777777
Q ss_pred cccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCC-
Q 002289 191 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD- 269 (941)
Q Consensus 191 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~- 269 (941)
.+.+|..++++++|++|+|++|++++.+|..++++++|+.|+|++|++++ .+|..++++++|++|+|++|++++.+|.
T Consensus 177 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 255 (968)
T PLN00113 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG-EIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255 (968)
T ss_pred cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC-cCChhHhcCCCCCEEECcCceeccccChh
Confidence 76777777777777777777777776677777777777777777777766 5666677777777777777776665543
Q ss_pred CCCCCcccc----------------cccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccC
Q 002289 270 LSRIPNLGY----------------LLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 333 (941)
Q Consensus 270 ~~~l~~l~~----------------l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~ 333 (941)
+..++++.. ..+.+|++|+|++|.+.+.+|..+.++++|+.|++++|.+++.+|..+..+
T Consensus 256 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l---- 331 (968)
T PLN00113 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL---- 331 (968)
T ss_pred HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcC----
Confidence 222222211 112356677777777777777777777777777777777776666666543
Q ss_pred ccccceEEccCCCCCCC-CCCC-CCCCCcEEEecCCCCc
Q 002289 334 ATETFILDFQNNNLTNI-SGSF-NIPPNVTVRLRGNPFC 370 (941)
Q Consensus 334 ~~~L~~L~Ls~N~l~~~-~~~~-~~~~~~~l~l~~Np~~ 370 (941)
++|+.|+|++|+++.. +..+ .++.++.|++++|.+.
T Consensus 332 -~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~ 369 (968)
T PLN00113 332 -PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369 (968)
T ss_pred -CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeE
Confidence 3456788888887743 4333 5667788888888764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-31 Score=289.95 Aligned_cols=292 Identities=22% Similarity=0.211 Sum_probs=177.7
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
..|++.|+|.+|-|+..-.+++.-++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+..--..|.++.+|..|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 45678888888777766566666667677777777666643334555555666666666666655555566666666666
Q ss_pred cccccccccCCcccccccccceEeccccccc------------------------ccCchhccCCCccceeeccCCcCCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSIS------------------------GQIPPELSRLPSLVHMLLDNNNLTG 216 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------------~~~p~~~~~l~~L~~L~L~~N~l~~ 216 (941)
|+.|+++...+..|.+|++|+.|+|..|+|. ..-.+.|..+.++++|+|+.|+++.
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~ 283 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA 283 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh
Confidence 6666666444455555555555555555544 3334455666666777777777766
Q ss_pred CCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCC
Q 002289 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTG 296 (941)
Q Consensus 217 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~ 296 (941)
.-..++.+|++|+.|+||.|.|.. +-++.++...+|++|+|++|+|+...++ .+..+..|++|+|++|.|..
T Consensus 284 vn~g~lfgLt~L~~L~lS~NaI~r-ih~d~WsftqkL~~LdLs~N~i~~l~~~-------sf~~L~~Le~LnLs~Nsi~~ 355 (873)
T KOG4194|consen 284 VNEGWLFGLTSLEQLDLSYNAIQR-IHIDSWSFTQKLKELDLSSNRITRLDEG-------SFRVLSQLEELNLSHNSIDH 355 (873)
T ss_pred hhcccccccchhhhhccchhhhhe-eecchhhhcccceeEeccccccccCChh-------HHHHHHHhhhhcccccchHH
Confidence 555667777777777777777776 4667777778888888888888754442 23333344555555555555
Q ss_pred CcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCC-------
Q 002289 297 TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGN------- 367 (941)
Q Consensus 297 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~N------- 367 (941)
....+|..+++|+.|||++|.|++.|-+.-.-.. .++.|+.|+|.||+|+.|+-.. .++.+++|+|.+|
T Consensus 356 l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~--gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~ 433 (873)
T KOG4194|consen 356 LAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN--GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQP 433 (873)
T ss_pred HHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc--cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecc
Confidence 5555555555566666666655555444222111 1334555556666655554322 4455555555555
Q ss_pred ----------------CCccCCCcccccCCC
Q 002289 368 ----------------PFCLNTNAEQFCGSH 382 (941)
Q Consensus 368 ----------------p~~c~c~~~~~~~~~ 382 (941)
.|.|||++.++-...
T Consensus 434 nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl 464 (873)
T KOG4194|consen 434 NAFEPMELKELVMNSSSFLCDCQLKWLAQWL 464 (873)
T ss_pred cccccchhhhhhhcccceEEeccHHHHHHHH
Confidence 467999998876644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=261.49 Aligned_cols=186 Identities=35% Similarity=0.550 Sum_probs=164.6
Q ss_pred CcEEEEEEEeC-CCcEEEEEEeccCCchh-hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCHHHHHhh
Q 002289 621 GYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 698 (941)
Q Consensus 621 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~ 698 (941)
+||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999998655444 57899999999999999999999999998999999999999999999865
Q ss_pred cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccc
Q 002289 699 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778 (941)
Q Consensus 699 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 778 (941)
... +++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--------cccccc
Confidence 443 788999999999999999999998 9999999999999999999999999998654321 223445
Q ss_pred cCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 779 gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
++..|++||...+..++.++||||+|++++++++|..||..
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 78899999999988899999999999999999999999965
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=265.08 Aligned_cols=295 Identities=21% Similarity=0.242 Sum_probs=186.6
Q ss_pred CCCCCCCCCceEecCCCCCC---------CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcc
Q 002289 60 GDPCTSNWTGVLCFNTTMDD---------GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK 130 (941)
Q Consensus 60 ~~~c~~~w~gv~C~~~~~~~---------~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 130 (941)
+.+|.|.-.-..|+...+.. -+...+.|++++|.|+..-+..|-+|++|++++|.+|.++ .+|...+...
T Consensus 47 pa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sg 125 (873)
T KOG4194|consen 47 PATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESG 125 (873)
T ss_pred CCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccccccc
Confidence 34566666666776544321 2456788999999998777777888888888888888888 7776555555
Q ss_pred ccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeecc
Q 002289 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (941)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 210 (941)
+|+.|+|.+|.|+..-.+.+..++.|+.||||.|.|+.+.-.+|..-.+|++|+|++|+|+..-.+.|.++.+|..|.|+
T Consensus 126 hl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLs 205 (873)
T KOG4194|consen 126 HLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLS 205 (873)
T ss_pred ceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecc
Confidence 57777777777776666667777777777777777775555566666677777777777776666667777777777777
Q ss_pred CCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEcc
Q 002289 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLS 290 (941)
Q Consensus 211 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls 290 (941)
+|+++...+..|.+|++|+.|+|..|+|.- .....|.++++|+.|.|..|.|. .+....|..+.++++|+|+
T Consensus 206 rNrittLp~r~Fk~L~~L~~LdLnrN~iri-ve~ltFqgL~Sl~nlklqrN~I~-------kL~DG~Fy~l~kme~l~L~ 277 (873)
T KOG4194|consen 206 RNRITTLPQRSFKRLPKLESLDLNRNRIRI-VEGLTFQGLPSLQNLKLQRNDIS-------KLDDGAFYGLEKMEHLNLE 277 (873)
T ss_pred cCcccccCHHHhhhcchhhhhhccccceee-ehhhhhcCchhhhhhhhhhcCcc-------cccCcceeeecccceeecc
Confidence 777775555666777777777777777653 22455666666666666666665 3444445555555555555
Q ss_pred CCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCC
Q 002289 291 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNP 368 (941)
Q Consensus 291 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np 368 (941)
.|++...-..++-+|++|+.|+||+|.|+-.-++++... +.|+.|||++|+|+.+++.- .+..+++|.|+.|.
T Consensus 278 ~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft-----qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns 352 (873)
T KOG4194|consen 278 TNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT-----QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS 352 (873)
T ss_pred cchhhhhhcccccccchhhhhccchhhhheeecchhhhc-----ccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence 555555555555555555555555555553334433222 22345555555555553222 23334444444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=262.77 Aligned_cols=196 Identities=25% Similarity=0.371 Sum_probs=169.0
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh--------hHhHHHHHHHHHhcC---CCceeeeeecccc
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--------EKEFLTEIQFLSRLH---HRNLVSLVGYCDE 676 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 676 (941)
..|.....+|.|+||.|+.|+++ +...|+||.+.+...-. ...+-.|+++|..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999976 46789999887643211 123567999999997 9999999999999
Q ss_pred CCcEEEEEecC-CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 677 EGEQMLVYEFM-SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 677 ~~~~~LV~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
++.+||+||-. ++.+|.+++..+.+ +++.++..|++||+.|+++||+++ |||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 99999999975 56799999976554 889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCCCC-chhHhHHHHHHHHHHHhCCCCCC
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPIS 818 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlG~ll~elltG~~Pf~ 818 (941)
.|..... ......+||..|.|||++.|.+|- ..-|||++|++||.++....||.
T Consensus 716 saa~~ks---------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKS---------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcC---------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9876532 234456799999999999998875 45899999999999999888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=272.67 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=195.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|+...++|.|.||.||||++. .++..|+|+++......-+-..+|+-+++..+|+||+.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888999999999999999964 6899999999876655556778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
|.+|+|.+.-+. -.++++.++-..++..++|++|||+.+ =+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita---- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA---- 164 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh----
Confidence 999999998754 346899999999999999999999999 79999999999999999999999999865432
Q ss_pred CccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
. -.......||+.|||||+.. .+.|...+|||+.|+...|+---+.|.++-..... . +.+ .....+..
T Consensus 165 -t--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-l---~Lm--TkS~~qpp 235 (829)
T KOG0576|consen 165 -T--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-L---FLM--TKSGFQPP 235 (829)
T ss_pred -h--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-H---HHh--hccCCCCC
Confidence 1 22345678999999999874 46789999999999999999887777654332111 0 000 00111111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
...-+..+.+.+.++++.|+.++|++||+++.+++
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11123344555556666666666666666655443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=232.51 Aligned_cols=210 Identities=37% Similarity=0.605 Sum_probs=181.6
Q ss_pred eeccCcEEEEEEEeCC-CcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCHHH
Q 002289 617 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD 694 (941)
Q Consensus 617 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~ 694 (941)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++|+||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999865443 34678999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeeccccccCCCCCCCcccccc
Q 002289 695 QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHV 773 (941)
Q Consensus 695 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 773 (941)
++.... ..+++..++.++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------h
Confidence 996542 35889999999999999999999998 999999999999999 89999999999976543210 1
Q ss_pred ccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHH
Q 002289 774 STVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852 (941)
Q Consensus 774 ~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (941)
.....+...|++||..... .++.++|+|++|++++++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2334567899999999887 888999999999999998
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 853 EKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 853 ~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
..+.+++..|+..+|.+||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 456788999999999999999988754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=234.92 Aligned_cols=199 Identities=36% Similarity=0.527 Sum_probs=172.6
Q ss_pred CCccceeeccCcEEEEEEEeCC-CcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 611 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 899999999875544 56788999999999999999999999998899999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+++|.+++...... +++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~---- 152 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL---- 152 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc----
Confidence 99999999764432 788999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccCCCccccccc-ccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 --AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0122334577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-28 Score=264.83 Aligned_cols=276 Identities=25% Similarity=0.343 Sum_probs=218.8
Q ss_pred cceeeEEEecCCCCCcc-CCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCcccee
Q 002289 81 YLHLRELQLLNLNLSGN-LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (941)
++.++.+++.+|+|... +|+.+.+|..|+.||||+|++. ..|..+..-+++-.|+||+|+|..+.-..|.+|+.|-.|
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFL 155 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhh
Confidence 45688889999998653 8899999999999999999999 889999999999999999999994444557899999999
Q ss_pred ecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCC-CCCCccCCCCCCCCEEeccCCcC
Q 002289 160 QIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT-GYLPPELSELPKLLILQLDNNNF 238 (941)
Q Consensus 160 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l 238 (941)
|||+|++. .+|..+..|..|++|.|++|.+.-.--..+-.+++|+.|.+++.+=+ ..+|.++..+.+|..+|||+|++
T Consensus 156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L 234 (1255)
T KOG0444|consen 156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL 234 (1255)
T ss_pred ccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC
Confidence 99999998 78888999999999999999887443344556677888888876643 35788888888888888888888
Q ss_pred CCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccC
Q 002289 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318 (941)
Q Consensus 239 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 318 (941)
. ..|+.+-++.+|+.|+||+|+|+..-... -...+|++|+||+|+++ .+|.++..|++|+.|.+.+|+|
T Consensus 235 p--~vPecly~l~~LrrLNLS~N~iteL~~~~--------~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL 303 (1255)
T KOG0444|consen 235 P--IVPECLYKLRNLRRLNLSGNKITELNMTE--------GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKL 303 (1255)
T ss_pred C--cchHHHhhhhhhheeccCcCceeeeeccH--------HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcc
Confidence 7 57888888888888888888887432211 12345678888888887 7788888888888888888877
Q ss_pred ccC-CCcccccccccC------------------ccccceEEccCCCCCCCCCCC-CCCCCcEEEecCCCC
Q 002289 319 SGS-IPSSIWQSRTLN------------------ATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPF 369 (941)
Q Consensus 319 ~~~-~p~~~~~l~~l~------------------~~~L~~L~Ls~N~l~~~~~~~-~~~~~~~l~l~~Np~ 369 (941)
+-. ||..++.+..|. ...|+.|.|++|.|.++|..+ .++.+..|+|+.||=
T Consensus 304 ~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 304 TFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred cccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcC
Confidence 633 666666655442 124678999999999999998 567788999999983
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=225.36 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=186.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeec-cccCCcEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY-CDEEGEQMLV 683 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~LV 683 (941)
..+.|.+.+.+|+|.||.+-++.++ ..+.+|+|.+.... ...++|.+|...--.+ .|.||+.-|+. |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467889999999999999999976 57889999887633 3356899998764445 58999987765 6778889999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE-c-CCCcEEEeeeccccccC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-D-HKFTAKVADFGLSRLAP 761 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~-~~~~~kl~DFGla~~~~ 761 (941)
+||+|.|+|.+-+... .+.+...++++.|++.|+.|+|+++ +||||||.+|||+ + +..++||+|||+.+...
T Consensus 101 qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999999887543 4788889999999999999999999 9999999999999 3 33489999999987542
Q ss_pred CCCCCCccccccccccccCCCcccccccccC-----CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHH--HHHHHHhhc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR--EVNIAYQSS 834 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~--~~~~~~~~~ 834 (941)
.. .....-+-.|.+||..... ...+.+|||.||++++.++||+.||.......+ |-...|+.
T Consensus 175 ~t----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~- 243 (378)
T KOG1345|consen 175 TT----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK- 243 (378)
T ss_pred ce----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc-
Confidence 11 1112234579999987532 356789999999999999999999974322111 11111221
Q ss_pred cchhhhcCCCCCCCh---HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 835 MMFSVIDGNMGSYPS---ECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~---~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
+.....|. ...+...++.++-+..++++|-...++.++...
T Consensus 244 -------rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 244 -------RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred -------ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 12222222 345677778888889999999666666555443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-27 Score=243.38 Aligned_cols=309 Identities=21% Similarity=0.231 Sum_probs=235.8
Q ss_pred CCCCCCCC---CceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcccc
Q 002289 60 GDPCTSNW---TGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSL 132 (941)
Q Consensus 60 ~~~c~~~w---~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 132 (941)
+.+|.|+- .-|.|....+. +-+...++|+|..|+|+...+.+|+.+++|+.||||+|+|+.+-|++|.++.+|
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 45787765 44889775542 345678999999999997777799999999999999999999999999999999
Q ss_pred ceecccC-ccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccC
Q 002289 133 ELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (941)
Q Consensus 133 ~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 211 (941)
..|-+.+ |+|+......|++|.+|+.|.+.-|++.-+..+.|..|++|..|.|.+|.+...--..|..+.+++++.+..
T Consensus 118 ~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~ 197 (498)
T KOG4237|consen 118 LSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQ 197 (498)
T ss_pred hHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhc
Confidence 8887766 999977778899999999999999999988899999999999999999999944344888999999999999
Q ss_pred CcCC------------CCCCccCCCCCCCCEEeccCCcCCCCCcchhc-cCCCCCcEEEccCCCCcCCCCCCCCCCcccc
Q 002289 212 NNLT------------GYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGY 278 (941)
Q Consensus 212 N~l~------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~ 278 (941)
|.+- ...|.+++......-..|.++++... -+..| ..++++..=..+.+..-+. .|...|
T Consensus 198 np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~-~a~kf~c~~esl~s~~~~~d~~d~~------cP~~cf 270 (498)
T KOG4237|consen 198 NPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQE-DARKFLCSLESLPSRLSSEDFPDSI------CPAKCF 270 (498)
T ss_pred CccccccccchhhhHHhhchhhcccceecchHHHHHHHhccc-chhhhhhhHHhHHHhhccccCcCCc------ChHHHH
Confidence 9832 23445555555555556666665531 22222 2222222212222222222 223335
Q ss_pred cccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCC-CCC-CC
Q 002289 279 LLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSF-NI 356 (941)
Q Consensus 279 l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~-~~~-~~ 356 (941)
-.+.+|+.|+|++|+|+++-+.+|.++..|++|.|..|+|...--..| ..+..|+.|+|.+|+|+.+. ..+ ..
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f-----~~ls~L~tL~L~~N~it~~~~~aF~~~ 345 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMF-----QGLSGLKTLSLYDNQITTVAPGAFQTL 345 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhh-----hccccceeeeecCCeeEEEeccccccc
Confidence 556778999999999999999999999999999999999983333333 34556778999999999984 444 56
Q ss_pred CCCcEEEecCCCCccCCCcccccC
Q 002289 357 PPNVTVRLRGNPFCLNTNAEQFCG 380 (941)
Q Consensus 357 ~~~~~l~l~~Np~~c~c~~~~~~~ 380 (941)
..+.+|.|-+|||+|||.+.++-+
T Consensus 346 ~~l~~l~l~~Np~~CnC~l~wl~~ 369 (498)
T KOG4237|consen 346 FSLSTLNLLSNPFNCNCRLAWLGE 369 (498)
T ss_pred ceeeeeehccCcccCccchHHHHH
Confidence 678899999999999999987755
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-26 Score=243.01 Aligned_cols=278 Identities=32% Similarity=0.465 Sum_probs=222.5
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
...+..++..+|+++ .+|+.++++.+|..|++.+|++.. .|...-+++.|++||..+|.++ .+|+.++.+.+|..||
T Consensus 136 ~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~Ly 212 (565)
T KOG0472|consen 136 LLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLY 212 (565)
T ss_pred Hhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHH
Confidence 345777888888888 578899999999999999999994 4445555999999999999998 8899999999999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhcc-CCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS-RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 239 (941)
|..|+|. .+| .|.++..|++|+++.|+|+ .+|...+ ++++|..|||.+|++. ..|+.+..+.+|++||+|+|.|+
T Consensus 213 L~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is 288 (565)
T KOG0472|consen 213 LRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS 288 (565)
T ss_pred hhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc
Confidence 9999998 677 8999999999999999999 6676654 8999999999999999 78999999999999999999999
Q ss_pred CCCcchhccCCCCCcEEEccCCCCcCCCCC---------------------C----------------------------
Q 002289 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPD---------------------L---------------------------- 270 (941)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---------------------~---------------------------- 270 (941)
+ +|..++++ .|+.|-+.+|.+...-.+ +
T Consensus 289 ~--Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tk 365 (565)
T KOG0472|consen 289 S--LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTK 365 (565)
T ss_pred c--CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhh
Confidence 5 88999999 899998888877321000 0
Q ss_pred ---------CCCCc-------------------------------------------------ccccccCCcCEEEccCC
Q 002289 271 ---------SRIPN-------------------------------------------------LGYLLSLNITTIKLSNN 292 (941)
Q Consensus 271 ---------~~l~~-------------------------------------------------l~~l~~~~L~~L~Ls~N 292 (941)
+.+|. .......+|..|+|++|
T Consensus 366 iL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN 445 (565)
T KOG0472|consen 366 ILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNN 445 (565)
T ss_pred hhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccc
Confidence 00000 00001234788888888
Q ss_pred cCCCCcchhhcCCcccceeecccccCccCCCcccccccc-------------------cCccccceEEccCCCCCCCCCC
Q 002289 293 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT-------------------LNATETFILDFQNNNLTNISGS 353 (941)
Q Consensus 293 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-------------------l~~~~L~~L~Ls~N~l~~~~~~ 353 (941)
.+. .+|..++.+..|+.||++.|++. .+|..+..+.. ....+|..|||.+|.|..+|+.
T Consensus 446 ~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~ 523 (565)
T KOG0472|consen 446 LLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPI 523 (565)
T ss_pred hhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChh
Confidence 888 78888888888999999998887 56644332211 1345788999999999999887
Q ss_pred C-CCCCCcEEEecCCCCc
Q 002289 354 F-NIPPNVTVRLRGNPFC 370 (941)
Q Consensus 354 ~-~~~~~~~l~l~~Np~~ 370 (941)
. +...+++|.+.||||.
T Consensus 524 LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 524 LGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hccccceeEEEecCCccC
Confidence 7 7888999999999986
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-26 Score=253.05 Aligned_cols=278 Identities=22% Similarity=0.377 Sum_probs=197.6
Q ss_pred ceeeEEEecCCCCCc-cCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 82 LHLRELQLLNLNLSG-NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
+-|+.+|+++|.++| ..|.....+++++.|.|...++. .+|++++.+.+|++|.+++|++. .+-..+..|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 456777777777774 56777777777777777777776 67777777777777777777777 5566677777777777
Q ss_pred cccccccc-cCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCC
Q 002289 161 IDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 161 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 239 (941)
+..|++.. -+|..+..|..|+.|+|++|++. ..|..+...+++-.|+||+|+|..+.-.-|.+++.|-+||||+|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 77777653 35666777777777777777777 66666777777777777777777333334667777777777777776
Q ss_pred CCCcchhccCCCCCcEEEccCCCCcC----CCCCCCCCCccc--------------ccccCCcCEEEccCCcCCCCcchh
Q 002289 240 GTTIPASYSNMSKLLKLSLRNCSLQG----PMPDLSRIPNLG--------------YLLSLNITTIKLSNNKLTGTIPSN 301 (941)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~l~~l~--------------~l~~~~L~~L~Ls~N~l~~~~p~~ 301 (941)
.+|.-...+..|+.|+|++|.|.- ..|.+..+.-+. .-.+.||..+|||.|.+. .+|++
T Consensus 164 --~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec 240 (1255)
T KOG0444|consen 164 --MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC 240 (1255)
T ss_pred --hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence 466667777777777777776642 122211111000 001246788999999998 89999
Q ss_pred hcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC-CCCCCcEEEecCCCCcc
Q 002289 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 371 (941)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~-~~~~~~~l~l~~Np~~c 371 (941)
+-++++|+.|+||+|+|+ .+...... ..+|+.|+||.|+|+.+|..+ .+++++.|++.+|.+.-
T Consensus 241 ly~l~~LrrLNLS~N~it-eL~~~~~~-----W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~F 305 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKIT-ELNMTEGE-----WENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTF 305 (1255)
T ss_pred HhhhhhhheeccCcCcee-eeeccHHH-----HhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccc
Confidence 999999999999999998 44433333 346778999999999998777 88889999999988644
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-27 Score=246.47 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=234.1
Q ss_pred eeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
+..+.+++|++. .+.+.+.+|..|++|++++|++. ..|.+++.+..++.|+.++|+++ .+|..++++.+|..|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 678899999998 46678999999999999999999 78889999999999999999999 8999999999999999999
Q ss_pred ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCc
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 243 (941)
|.+. .+|++++.+-.|+.|+..+|+++ ..|+.++.+.+|..|++.+|++... |+..-+++.|+.||.-+|-++ .+
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~--tl 198 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE--TL 198 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh--cC
Confidence 9998 88889999999999999999999 7788899999999999999999955 444445999999999999998 69
Q ss_pred chhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhc-CCcccceeecccccCccCC
Q 002289 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFS-GLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~ 322 (941)
|..++.+.+|..|||.+|+|...+ +|.+. ..|++|+++.|+|+ .+|.+.. .+++|..|||++|+|+ ++
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~~lP-ef~gc--------s~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIRFLP-EFPGC--------SLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred ChhhcchhhhHHHHhhhcccccCC-CCCcc--------HHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 999999999999999999998543 44433 34589999999999 6666655 8999999999999999 99
Q ss_pred CcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCc
Q 002289 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 370 (941)
Q Consensus 323 p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~ 370 (941)
|..++.+++|+ .||||+|.|+.+|.+..--.+..|-+.|||+.
T Consensus 268 Pde~clLrsL~-----rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 268 PDEICLLRSLE-----RLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred chHHHHhhhhh-----hhcccCCccccCCcccccceeeehhhcCCchH
Confidence 99998876654 89999999999998884348899999999974
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=270.06 Aligned_cols=153 Identities=18% Similarity=0.177 Sum_probs=114.0
Q ss_pred hcCC-Cceeeeeecc-------ccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 002289 661 RLHH-RNLVSLVGYC-------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732 (941)
Q Consensus 661 ~l~h-~nIv~l~~~~-------~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 732 (941)
.++| +||++++++| ...+..+.++||+ +++|.+++... ...+++..++.++.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 5888888887 2234677889988 67999999643 345899999999999999999999999 99
Q ss_pred eccCCCCcEEEcCCCc-------------------EEEeeeccccccCCCCC---CC------ccccccccccccCCCcc
Q 002289 733 HRDIKASNILLDHKFT-------------------AKVADFGLSRLAPVPDI---EG------IVPAHVSTVVKGTPGYL 784 (941)
Q Consensus 733 H~DLkp~NILl~~~~~-------------------~kl~DFGla~~~~~~~~---~~------~~~~~~~~~~~gt~~y~ 784 (941)
||||||+|||++..+. +|++|||+++....... .. ...........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999965444 45555555543211000 00 00000112245889999
Q ss_pred cccccccCCCCchhHhHHHHHHHHHHHhCCCCCC
Q 002289 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818 (941)
Q Consensus 785 aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~ 818 (941)
|||++.+..++.++|||||||++|||++|..|+.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 9999999999999999999999999999988764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=224.59 Aligned_cols=267 Identities=21% Similarity=0.267 Sum_probs=201.0
Q ss_pred CCCccceeeccCcEEEEEEEeCCC--cEEEEEEeccCCchhhHhHHHHHHHHHhcCC----Cceeeeeecc-ccCCcEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILPDG--TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH----RNLVSLVGYC-DEEGEQML 682 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~L 682 (941)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ...+..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997543 5789998776433333367889998888863 6899999998 57788999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-----CcEEEeeeccc
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLS 757 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-----~~~kl~DFGla 757 (941)
||+.+ |.+|.++........++..+...|+.|++.+|+++|+.| ++||||||+|+++... ..+.|.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 899999887666677999999999999999999999999 9999999999999754 46999999999
Q ss_pred cccC--CCCCCCcccccc-ccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhc
Q 002289 758 RLAP--VPDIEGIVPAHV-STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 758 ~~~~--~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
+... ........+.+. .....||..|.++.++.+.+.+.+.|+||++.++.|++.|..||........... +...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~--~~~~ 252 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK--FEKD 252 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH--HHHH
Confidence 9433 222111111222 3456699999999999999999999999999999999999999965443211111 0000
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
........ .....+..+.++...+-..+..++|.+..+...++.....
T Consensus 253 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 PRKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00000100 1222334555566666668999999999999988776554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-24 Score=210.77 Aligned_cols=247 Identities=18% Similarity=0.355 Sum_probs=196.2
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCC
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gs 691 (941)
..+|.+...|..|+|+|+ |..+++|+++-... ...++|..|.-.++-+.||||++++|.|.......++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 447888999999999995 45566677654322 234679999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcccc
Q 002289 692 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771 (941)
Q Consensus 692 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 771 (941)
|+.++++......+..++.+++.++|+|++|||+.. +-|----|.+..|++|++.+++|+= +-+++ +
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf-----------s 340 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----------S 340 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----------e
Confidence 999999988777888999999999999999999975 2233456899999999999888751 11111 1
Q ss_pred ccccccccCCCcccccccccCCCC---chhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC
Q 002289 772 HVSTVVKGTPGYLDPEYFLTHKLT---DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848 (941)
Q Consensus 772 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (941)
-......-.+.||+||.+...+-+ .++|+|||++++||+.|+..||.+-....-- +.-.+.+-+..+|
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------mkialeglrv~ip 411 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------MKIALEGLRVHIP 411 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------hhhhhccccccCC
Confidence 111223346799999999876533 4699999999999999999999865543222 2223445566688
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 849 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
+.....+.+++.-|+..||.+||.+..++..|++.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 88899999999999999999999999999888865
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=206.36 Aligned_cols=268 Identities=19% Similarity=0.288 Sum_probs=210.3
Q ss_pred cCCCccceeeccCcEEEEEEE-eCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
-.|++.++||+|.||..+.|+ +-+++.||||.-...+ ...++..|.+..+.+ ..+.|..++-+-.+..+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368889999999999999999 4578999999865432 234678899988888 578999988888888889999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-----CCcEEEeeeccccccC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLAP 761 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DFGla~~~~ 761 (941)
+ |.||.|++.- ....|+..++..+|.|++.-++|+|++. .|.|||||+|.||.. ...+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9 8999998854 3456999999999999999999999999 999999999999963 3469999999999998
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHhhccchhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK--NIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~ 839 (941)
.++.....+-+......||.+||+--...|.+.+.+.|.-|+|-++.+.+.|..||..-. +..+.++. +
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK---------I 251 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK---------I 251 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH---------h
Confidence 887776677777788899999999999999999999999999999999999999997532 11111111 1
Q ss_pred hcCCCCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCC
Q 002289 840 IDGNMGS----YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 892 (941)
Q Consensus 840 ~~~~~~~----~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~ 892 (941)
-+..... .-+..+.++..-+...-..+-++-|.++-+...+.+.++..-..++
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 1111111 1123344555555555566778889998888777777665544443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=198.85 Aligned_cols=271 Identities=20% Similarity=0.270 Sum_probs=209.0
Q ss_pred HhcCCCccceeeccCcEEEEEEE-eCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC-CceeeeeeccccCCcEEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~LV~ 684 (941)
..++|.++++||.|+||.+|.|. ..+|..||||+-..... ..++..|.++.+.+++ ..|..+..|..+.+.-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35689999999999999999999 56899999998765332 2467889999999975 56777788888888999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeeccccccC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAP 761 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGla~~~~ 761 (941)
|.+ |.||.+++.-. ...++..+++-++-|++.-++|+|.++ +|||||||+|.|..- ...+.++|||+|+.+.
T Consensus 91 dLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999 89999988543 345899999999999999999999999 999999999999953 4579999999999886
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHH-HHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE-VNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~ 840 (941)
........+.+......||.+|.+--...+.+.+.+.|+-|+|.+|..+-.|..||..-....+. ......+..+...+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 65544445566667788999999999988888899999999999999999999999864322111 11111111111111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
.. .-..++.++.-.+..|-..--++.|...-+.+....++....
T Consensus 246 e~----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 246 EV----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred HH----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 11 122344567777888888888899998877777766655443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=204.89 Aligned_cols=168 Identities=21% Similarity=0.288 Sum_probs=124.4
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|||.++++.+ ...+++..++.++.|+++||+|||+++ ||+|||++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 7899999754 346999999999999999999999876 999999999999999 9998764321
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
...||+.|+|||++.+..++.++|||||||++|||+||+.||................. .. ........+.
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~ 133 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM--PA-DDPRDRSNLE 133 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh--cc-CCccccccHH
Confidence 12578999999999999999999999999999999999999965433222222111100 00 0000011222
Q ss_pred HHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 850 ECVE--KFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 850 ~~~~--~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
.... .+.+++..|+..+|++||++.++++++....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 3333 5788888888888888888888887776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=224.01 Aligned_cols=171 Identities=19% Similarity=0.203 Sum_probs=131.6
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC--CCcEEEEEEeccCC-----chhhHhHHHHHHHHHhcCCCceee-eeeccccC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVS-LVGYCDEE 677 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~ 677 (941)
...++|.+.+.||+|+||+||+|+++ +++.||||+..... ....+.+.+|++++++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 35678999999999999999999864 57888999865321 123456899999999999999985 5442
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC-CCCcEEEcCCCcEEEeeecc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL-kp~NILl~~~~~~kl~DFGl 756 (941)
+..++||||++|++|.. +... . ...++.++++||+|||+++ |+|||| ||+|||++.++.+||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARPH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCcc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 45799999999999973 2111 1 1457889999999999999 999999 99999999999999999999
Q ss_pred ccccCCCCCCCcccc-ccccccccCCCcccccccccC
Q 002289 757 SRLAPVPDIEGIVPA-HVSTVVKGTPGYLDPEYFLTH 792 (941)
Q Consensus 757 a~~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 792 (941)
|+........+.... .......++..|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 997754332211111 112456788899999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-23 Score=242.80 Aligned_cols=262 Identities=20% Similarity=0.248 Sum_probs=188.7
Q ss_pred ccceeeccCcEEEEEEEeC-CCcEEEEEEec----cCCc-h-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 613 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQ----EGSL-Q-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 613 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~----~~~~-~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
..+.+|.|++|.|+..... ....++.|.+. .... . ....+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3678999999988877643 33444444332 1111 1 11225667778888999999988888877777666799
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
||++ +|..++... ..+....+..+..|+..|++|+|+.| |.|||+|++|++++.+|.+||+|||.+.....+..
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999998654 24777888899999999999999999 99999999999999999999999999976654321
Q ss_pred CCccccccccccccCCCcccccccccCCCCch-hHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
. .........|+..|+|||++.+.+|.++ .||||.|+++..|.+|+.||........... .......
T Consensus 476 ~---~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------~~~~~~~ 543 (601)
T KOG0590|consen 476 K---NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------TNNYSDQ 543 (601)
T ss_pred h---hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------hhccccc
Confidence 1 1245567889999999999999999875 8999999999999999999964332111000 0000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
.... -....++..| + ......|.+||++||++|+|++++++++||+..
T Consensus 544 ~~~~----------------------~~~~~~~~~l-------p---~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 544 RNIF----------------------EGPNRLLSLL-------P---RETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred cccc----------------------cChHHHHHhc-------h---hhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 0000 0111122111 1 122357889999999999999999999999873
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=226.02 Aligned_cols=237 Identities=28% Similarity=0.381 Sum_probs=153.7
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
+++.|++.+|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ .+|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 45666666666663 332 2456666666666666 34432 345666666666666 344322 456666677
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
+|+|+ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++
T Consensus 291 ~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-- 356 (788)
T PRK15387 291 GNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-- 356 (788)
T ss_pred CCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC--
Confidence 77666 33432 3567777777777763 3432 2356666777777763 4431 1467777777777774
Q ss_pred cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCC
Q 002289 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 322 (941)
+|.. ..+|+.|++++|+|++. |.+ ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+
T Consensus 357 LP~l---p~~L~~L~Ls~N~L~~L-P~l----------~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sI 417 (788)
T PRK15387 357 LPTL---PSELYKLWAYNNRLTSL-PAL----------PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SL 417 (788)
T ss_pred CCCC---CcccceehhhccccccC-ccc----------ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CC
Confidence 4443 24566777777777742 221 1357899999999995 5543 357999999999998 57
Q ss_pred CcccccccccCccccceEEccCCCCCCCCCCC-CCCCCcEEEecCCCCccC
Q 002289 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 372 (941)
Q Consensus 323 p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~-~~~~~~~l~l~~Np~~c~ 372 (941)
|... .+|+.|+|++|+|+.+|..+ .++.+..|+|++|||.+.
T Consensus 418 P~l~--------~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 418 PMLP--------SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred Ccch--------hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCch
Confidence 7542 34678999999999998777 688899999999998753
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=229.80 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=198.7
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
+.+.|++++++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 46789999999884 666553 58999999999999 6776554 58999999999999 6676554 479999999
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
+|+++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|+|++|+|+.
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-- 318 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-- 318 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc--
Confidence 99998 6677664 58999999999999 5777654 589999999999994 565443 579999999999985
Q ss_pred cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCC
Q 002289 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 322 (941)
+|..+. ++|+.|++++|.|++.+..+ ..+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~LP~~l----------~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~L 382 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTSLPASL----------PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NL 382 (754)
T ss_pred CCcccc--ccceeccccCCccccCChhh----------cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CC
Confidence 555443 68999999999998644322 246899999999998 5676663 68999999999999 67
Q ss_pred CcccccccccCccccceEEccCCCCCCCCCCC-----CCCCCcEEEecCCCCcc
Q 002289 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSF-----NIPPNVTVRLRGNPFCL 371 (941)
Q Consensus 323 p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~-----~~~~~~~l~l~~Np~~c 371 (941)
|..+. ..|+.|++++|+|+.+|..+ ..+.+..|+|.+||+..
T Consensus 383 P~~l~-------~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 383 PENLP-------AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred CHhHH-------HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 77653 25789999999999998665 34677899999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-19 Score=199.31 Aligned_cols=258 Identities=31% Similarity=0.484 Sum_probs=196.6
Q ss_pred CCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCC-ceeeeeeccccCCcEEEEEec
Q 002289 611 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHR-NLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~LV~e~ 686 (941)
|.+...||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999986 78999988754332 356799999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhcCC-CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~~~~~ 764 (941)
+.++++.+++..... ..+.......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977754432 25888999999999999999999999 99999999999999988 79999999998554322
Q ss_pred CCCccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCch---hHHHHHHHHhhccchh
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREVNIAYQSSMMFS 838 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~ 838 (941)
..... ........|+..|+|||.+.+ ..+....|+||+|++++++++|..||..... ..+........ ...
T Consensus 157 ~~~~~-~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~- 233 (384)
T COG0515 157 STSSI-PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-PTP- 233 (384)
T ss_pred ccccc-cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc-CCc-
Confidence 11000 013456779999999999988 5788899999999999999999999765543 11111111110 000
Q ss_pred hhcCCCCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 839 VIDGNMGSYP----SECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 839 ~~~~~~~~~~----~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
....... ......+.+++..|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0001111 1223567888899999999999988876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-20 Score=185.63 Aligned_cols=139 Identities=19% Similarity=0.150 Sum_probs=108.3
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh---------h-----------------HhHHHHHHHHHhcCCCce
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG---------E-----------------KEFLTEIQFLSRLHHRNL 667 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------~-----------------~~~~~E~~~l~~l~h~nI 667 (941)
...||+|+||.||+|...+|+.||||+++...... . .....|++.++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999987542110 1 122359999999988776
Q ss_pred eeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccCCCCcEEEcCC
Q 002289 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDIKASNILLDHK 746 (941)
Q Consensus 668 v~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DLkp~NILl~~~ 746 (941)
.....+.. ...++||||++++++....... ..++......++.|++.+|.|+ |+.+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 43333222 2348999999888776543222 3588899999999999999999 6888 99999999999998 4
Q ss_pred CcEEEeeecccccc
Q 002289 747 FTAKVADFGLSRLA 760 (941)
Q Consensus 747 ~~~kl~DFGla~~~ 760 (941)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-20 Score=189.34 Aligned_cols=171 Identities=15% Similarity=0.104 Sum_probs=133.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHh---------HHHHHHHHHhcCCCceeeeeeccccC
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE---------FLTEIQFLSRLHHRNLVSLVGYCDEE 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~ 677 (941)
..++|+..+.+|.|+||.||.+.. ++..+|||.+.......++. +.+|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 478999999999999999999766 57789999997544333222 67899999999999999998886432
Q ss_pred --------CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 002289 678 --------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749 (941)
Q Consensus 678 --------~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 749 (941)
+..++||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||++++++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35899999999999988741 222 24558899999999999 99999999999999988 9
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHH
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL 811 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ell 811 (941)
+|+|||..+....... ...+.....+..++|+|+||+++.-..
T Consensus 174 ~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999998865422110 011334455667899999999877654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-21 Score=221.31 Aligned_cols=264 Identities=27% Similarity=0.320 Sum_probs=188.8
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
+++.|+..+|-+.... .-..-.+|+.+|+++|+++ .+|+.++.+.+|+.|+..+|+|+ .+|..+...++|+.|++.
T Consensus 220 ~l~~L~a~~n~l~~~~--~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLD--VHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred chheeeeccCcceeec--cccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 4555555555555211 1123456777777777777 55677777777777777777775 677777777777777777
Q ss_pred cccccccCCcccccccccceEecccccccccCchh-ccCCC-ccceeeccCCcCCCCCCc-cCCCCCCCCEEeccCCcCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLP-SLVHMLLDNNNLTGYLPP-ELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~ 239 (941)
.|.++ .+|.....++.|++|+|..|+|. ..|+. |.-+. +|..|+.+.|++.. .|. .=..++.|+.|++.+|.|+
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~-lp~~~e~~~~~Lq~LylanN~Lt 372 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLST-LPSYEENNHAALQELYLANNHLT 372 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccc-cccccchhhHHHHHHHHhcCccc
Confidence 77777 66777777777888888888777 34443 33333 36777777777763 331 1223567888899999988
Q ss_pred CCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCc
Q 002289 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
. ..-..+.+++.|+.|+|++|+|...+ .-.+..+..|++|+||+|+|+ .+|.++.+++.|+.|...+|+|.
T Consensus 373 d-~c~p~l~~~~hLKVLhLsyNrL~~fp-------as~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 373 D-SCFPVLVNFKHLKVLHLSYNRLNSFP-------ASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred c-cchhhhccccceeeeeecccccccCC-------HHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence 7 45566788889999999999887333 233334455688899999998 78899999999999999999998
Q ss_pred cCCCcccccccccCccccceEEccCCCCCCC--CCCCCCCCCcEEEecCCCC
Q 002289 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNI--SGSFNIPPNVTVRLRGNPF 369 (941)
Q Consensus 320 ~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~--~~~~~~~~~~~l~l~~Np~ 369 (941)
..| .+.+ .+.|+++|||.|+|+.+ +.....|.++.|+|+||+|
T Consensus 444 -~fP-e~~~-----l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 444 -SFP-ELAQ-----LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred -ech-hhhh-----cCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 677 5544 45567999999999987 4444668899999999996
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=222.59 Aligned_cols=276 Identities=19% Similarity=0.260 Sum_probs=185.5
Q ss_pred CcceeeEEEecCCC------CCccCCccccCCC-CCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCC
Q 002289 80 GYLHLRELQLLNLN------LSGNLSPEIGRLS-YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGY 152 (941)
Q Consensus 80 ~~~~l~~L~L~~~~------l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 152 (941)
...+++.|.+.++. +...+|..|..++ +|+.|++.+|.+. .+|..| .+.+|+.|+|++|++. .++..+..
T Consensus 556 ~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~ 632 (1153)
T PLN03210 556 GMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHS 632 (1153)
T ss_pred cCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccccc
Confidence 35567777775542 3334666666654 4788888887776 667666 4677888888888877 56777777
Q ss_pred cCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEe
Q 002289 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232 (941)
Q Consensus 153 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 232 (941)
+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+..+++|+.|++++|...+.+|..+ ++++|+.|+
T Consensus 633 l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~ 710 (1153)
T PLN03210 633 LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLN 710 (1153)
T ss_pred CCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEe
Confidence 88888888877654445553 6777888888888776666777777788888888887765444666554 677788888
Q ss_pred ccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCccc-----------------------ccccCCcCEEEc
Q 002289 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG-----------------------YLLSLNITTIKL 289 (941)
Q Consensus 233 Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~-----------------------~l~~~~L~~L~L 289 (941)
|++|...+ .+|.. ..+|+.|+|++|.++..+..+ .++++. +....+|+.|+|
T Consensus 711 Lsgc~~L~-~~p~~---~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~L 785 (1153)
T PLN03210 711 LSGCSRLK-SFPDI---STNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFL 785 (1153)
T ss_pred CCCCCCcc-ccccc---cCCcCeeecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeC
Confidence 87775443 34432 356777777777776443321 222222 122357899999
Q ss_pred cCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccc---cC-------------ccccceEEccCCCCCCCCCC
Q 002289 290 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT---LN-------------ATETFILDFQNNNLTNISGS 353 (941)
Q Consensus 290 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---l~-------------~~~L~~L~Ls~N~l~~~~~~ 353 (941)
++|...+.+|..++++++|+.|+|++|...+.+|..+ .+.. |. ..+|+.|+|++|.|+.+|..
T Consensus 786 s~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i~~iP~s 864 (1153)
T PLN03210 786 SDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEEVPWW 864 (1153)
T ss_pred CCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCCCCCccChHH
Confidence 9999888999999999999999999986555777654 1111 10 13456666666777666655
Q ss_pred C-CCCCCcEEEecC
Q 002289 354 F-NIPPNVTVRLRG 366 (941)
Q Consensus 354 ~-~~~~~~~l~l~~ 366 (941)
+ .++.+..|+|.+
T Consensus 865 i~~l~~L~~L~L~~ 878 (1153)
T PLN03210 865 IEKFSNLSFLDMNG 878 (1153)
T ss_pred HhcCCCCCEEECCC
Confidence 5 566666777665
|
syringae 6; Provisional |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.2e-19 Score=176.61 Aligned_cols=191 Identities=14% Similarity=0.074 Sum_probs=140.4
Q ss_pred CccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh----hHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEEec
Q 002289 612 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.+...|++|+||+||.+.. .+..++.+.+....... ...+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 67888878776543321 125789999999995 5889999886 457999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC-CCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
++|.+|.+.+.. ....++.|++++|+++|+++ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998764421 11346788999999999999 999999 79999999999999999999985432210
Q ss_pred C-Cccc----cc-cccccccCCCcccccccccC-CCC-chhHhHHHHHHHHHHHhCCCCCCC
Q 002289 766 E-GIVP----AH-VSTVVKGTPGYLDPEYFLTH-KLT-DKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 766 ~-~~~~----~~-~~~~~~gt~~y~aPE~~~~~-~~~-~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
. .... .+ .......++.|++|+...-. ..+ .+.+.++.|+.+|.++||..+...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0000 00 01123367788888865432 333 568999999999999999888753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-20 Score=208.56 Aligned_cols=222 Identities=27% Similarity=0.295 Sum_probs=170.9
Q ss_pred eeccCcEEEEEEE----eCCCcEEEEEEeccCCchh--hHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEEecCCC
Q 002289 617 IGQGGYGKVYKGI----LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 617 lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+|+|.||.|+.+. .+.|..+|.|+.+...... ......|..++...+ ||.+++++-.+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6999999999765 2347889999887643322 124456778888886 99999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|.|...+... ..+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-..+
T Consensus 82 g~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 82 GDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred chhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 9998887543 34677777778888999999999999 9999999999999999999999999998653221
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCCh
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (941)
..+||..|||||++. ....++|.||||++++||+||..||.. +.. ..+-..-..+|.
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~-------------~~Il~~~~~~p~ 208 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTM-------------KRILKAELEMPR 208 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHH-------------HHHhhhccCCch
Confidence 117899999999998 557789999999999999999999964 111 111111233555
Q ss_pred HHHHHHHHHHHHhcccCCCCCC
Q 002289 850 ECVEKFIKLALKCCQDETDARP 871 (941)
Q Consensus 850 ~~~~~l~~l~~~c~~~~p~~RP 871 (941)
+.+.....++......+|..|-
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHh
Confidence 5666666666666656665553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=178.38 Aligned_cols=140 Identities=19% Similarity=0.122 Sum_probs=110.2
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh--------------------------hHhHHHHHHHHHhcCCCce
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--------------------------EKEFLTEIQFLSRLHHRNL 667 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~nI 667 (941)
...||+|+||.||+|...+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987542110 1123578999999999987
Q ss_pred eeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCC
Q 002289 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHK 746 (941)
Q Consensus 668 v~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~ 746 (941)
.....+... ..++||||++++++....... ..++......++.|++.++.++|+ .+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 544433322 248999999888654432222 246778889999999999999999 88 99999999999999 8
Q ss_pred CcEEEeeeccccccC
Q 002289 747 FTAKVADFGLSRLAP 761 (941)
Q Consensus 747 ~~~kl~DFGla~~~~ 761 (941)
+.++|+|||+|+...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=207.32 Aligned_cols=224 Identities=24% Similarity=0.301 Sum_probs=176.2
Q ss_pred CCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCcc
Q 002289 77 MDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156 (941)
Q Consensus 77 ~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 156 (941)
++....+|+.|+|++|+|+. +|.. .++|+.|+|++|.|+ .+|.. +.+|+.|+|++|+++ .+|.. +++|
T Consensus 237 LP~lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L 304 (788)
T PRK15387 237 LPALPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGL 304 (788)
T ss_pred CCCCCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhc---hhhcCEEECcCCccc-ccccc---cccc
Confidence 34456789999999999995 5542 468999999999998 56643 367889999999999 56653 4789
Q ss_pred ceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCC
Q 002289 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236 (941)
Q Consensus 157 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 236 (941)
+.|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|
T Consensus 305 ~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N 372 (788)
T PRK15387 305 QELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNN 372 (788)
T ss_pred ceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcc
Confidence 999999999995 45433 467889999999984 5642 2589999999999994 5653 357889999999
Q ss_pred cCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccc
Q 002289 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 316 (941)
Q Consensus 237 ~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 316 (941)
+|++ +|.. ..+|+.|+|++|+|++.++. ..+|+.|+|++|+|++ +|..+ .+|+.|++++|
T Consensus 373 ~L~~--LP~l---~~~L~~LdLs~N~Lt~LP~l-----------~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~N 432 (788)
T PRK15387 373 RLTS--LPAL---PSGLKELIVSGNRLTSLPVL-----------PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRN 432 (788)
T ss_pred cccc--Cccc---ccccceEEecCCcccCCCCc-----------ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccC
Confidence 9985 5654 35799999999999864331 1357999999999995 66543 46889999999
Q ss_pred cCccCCCcccccccccCccccceEEccCCCCCCC
Q 002289 317 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350 (941)
Q Consensus 317 ~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~ 350 (941)
+|+ .+|..++.+. +|+.|+|++|+|+..
T Consensus 433 qLt-~LP~sl~~L~-----~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 433 QLT-RLPESLIHLS-----SETTVNLEGNPLSER 460 (788)
T ss_pred ccc-ccChHHhhcc-----CCCeEECCCCCCCch
Confidence 998 8999887654 556999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-19 Score=210.03 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=180.5
Q ss_pred CCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCC-chhhHhHHHHHHH--HHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 610 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS-LQGEKEFLTEIQF--LSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+|...+.||++.|=+|.+|++++|. |+||++-... .-....|.++++- ...++|||.+++.-+-...+..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667889999999999999998887 8899876543 2223344443332 5556899999999888888888999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
.. -+|+|.+..+. .+...+.++|+.|++.||.-+|+.+ |+|||||.+|||+++-.-+.|+||..-+..-.+..+
T Consensus 103 vk-hnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 95 59999996543 4788889999999999999999999 999999999999999999999999876533222211
Q ss_pred CccccccccccccCCCcccccccccC----------C-CCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHH-HHhh
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTH----------K-LTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI-AYQS 833 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~-~~~~ 833 (941)
................|.|||.+... . .+++-||||+||++.|+++ |++||.- ..+..+-.. .+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-SQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-SQLLAYRSGNADDP 255 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-HHHHhHhccCccCH
Confidence 11111112222344589999987541 1 5678999999999999999 6777741 111110000 0000
Q ss_pred ccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
+...+. +++ ..+++++..|++.||.+|-+++++++.-
T Consensus 256 e~~Le~-------Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 256 EQLLEK-------IED---VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HHHHHh-------CcC---ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 000000 111 2578899999999999999999998773
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.6e-19 Score=209.89 Aligned_cols=232 Identities=27% Similarity=0.399 Sum_probs=185.7
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
..+++.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|+.|+
T Consensus 198 p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~ 268 (754)
T PRK15370 198 PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLD 268 (754)
T ss_pred ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence 346899999999999 4666554 58999999999999 5676554 47999999999999 7787664 5899999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.|++
T Consensus 269 Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 269 LFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS 339 (754)
T ss_pred CcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc
Confidence 9999999 5677664 589999999999994 565543 579999999999994 565443 689999999999985
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCcc
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 320 (941)
+|..+. ++|+.|+|++|+|+..+..+ ..+|+.|+|++|+|+ .+|..+. .+|+.|++++|+|+
T Consensus 340 --LP~~l~--~sL~~L~Ls~N~L~~LP~~l----------p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~- 401 (754)
T PRK15370 340 --LPASLP--PELQVLDVSKNQITVLPETL----------PPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV- 401 (754)
T ss_pred --CChhhc--CcccEEECCCCCCCcCChhh----------cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-
Confidence 666654 79999999999998533211 246899999999999 4566554 37999999999998
Q ss_pred CCCcccccccccCccccceEEccCCCCCC
Q 002289 321 SIPSSIWQSRTLNATETFILDFQNNNLTN 349 (941)
Q Consensus 321 ~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~ 349 (941)
.+|..+..+... .+.+..|+|.+|.|+.
T Consensus 402 ~LP~sl~~~~~~-~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 402 RLPESLPHFRGE-GPQPTRIIVEYNPFSE 429 (754)
T ss_pred cCchhHHHHhhc-CCCccEEEeeCCCccH
Confidence 788877655432 3567899999999873
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=205.28 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=186.8
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC---CCceeeeeeccccCCc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGE 679 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~ 679 (941)
+.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+...... |.-=.+++.+|+ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 5556778899999999999999999998889999999988755442 222234445554 2345555666666778
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-------CCCcEEEe
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-------HKFTAKVA 752 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-------~~~~~kl~ 752 (941)
-+||+||.+.|||.+++. ....++|..++.++.|+++.+++||..+ |||+||||+|.|+. +...++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 899999999999999996 4456899999999999999999999999 99999999999993 24469999
Q ss_pred eeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 753 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 753 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
|||.+-.+..-. ........++|-.+-.+|...|..++...|.|.++.+++-|+.|+..= ..
T Consensus 844 DfG~siDm~lfp-----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------~~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFP-----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------VK 905 (974)
T ss_pred ecccceeeeEcC-----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------hc
Confidence 999986543221 123456677899999999999999999999999999999999985421 01
Q ss_pred hccchhhhcCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 833 SSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 833 ~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+..+. +...+.. ...+.+.++..++ +..+...-|...++...++.++.
T Consensus 906 ~g~~~~-~~~~~~Ry~~~~~W~~~F~~l---LN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 NGSSWM-VKTNFPRYWKRDMWNKFFDLL---LNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CCccee-ccccchhhhhHHHHHHHHHHH---hCcCcccchhHHHHHHHHHHHHH
Confidence 111111 1111122 2234455555444 44666667888888877777654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-21 Score=177.05 Aligned_cols=167 Identities=28% Similarity=0.508 Sum_probs=104.9
Q ss_pred cCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccc
Q 002289 126 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205 (941)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 205 (941)
+.++.+.+.|.||+|+++ .+|+.++.|.+|+.|++++|+|+ .+|..++.+++|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-------------------------~lp~~issl~klr 82 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-------------------------ELPTSISSLPKLR 82 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-------------------------hcChhhhhchhhh
Confidence 334555566666666666 45555555555555555555555 4455555555555
Q ss_pred eeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcC
Q 002289 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNIT 285 (941)
Q Consensus 206 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~ 285 (941)
.|+++-|++. ..|..|+.++.|+.|||..|++....+|..|..++.|+.|+|++|.++-.+|++..+.++ +
T Consensus 83 ~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~l--------q 153 (264)
T KOG0617|consen 83 ILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNL--------Q 153 (264)
T ss_pred heecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcce--------e
Confidence 5555555555 556666666666666666666665566666666666666666666666555554444332 5
Q ss_pred EEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccc
Q 002289 286 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 329 (941)
Q Consensus 286 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (941)
.|.+..|.+- .+|..++.+.+|++|++.+|+++ .+|..++++
T Consensus 154 il~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 154 ILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred EEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 5666666655 67888888888888888888888 777776543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=180.58 Aligned_cols=201 Identities=22% Similarity=0.287 Sum_probs=144.9
Q ss_pred CCCceeeeeecccc---------------------------CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHH
Q 002289 663 HHRNLVSLVGYCDE---------------------------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 715 (941)
Q Consensus 663 ~h~nIv~l~~~~~~---------------------------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 715 (941)
+|||||++.++|.+ ....|+||.-+ ..+|.+++-.+. .+.-...-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999987743 23579999988 469999996543 445556678899
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCcEEE--cCCC--cEEEeeeccccccCCCCCCCccc-cccccccccCCCcccccccc
Q 002289 716 SSRGILYLHTEADPPVFHRDIKASNILL--DHKF--TAKVADFGLSRLAPVPDIEGIVP-AHVSTVVKGTPGYLDPEYFL 790 (941)
Q Consensus 716 ia~gL~yLH~~~~~~ivH~DLkp~NILl--~~~~--~~kl~DFGla~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~ 790 (941)
+++|+.|||+++ |.|||+|++|||+ |+|+ ...|+|||++--...... ..+ .......-|...-||||+..
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGl--qlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGL--QLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeecccccc--ccccccccccCCCcceecchhhhh
Confidence 999999999999 9999999999999 3443 678899998642211000 000 11122344677899999986
Q ss_pred cCC------CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcc
Q 002289 791 THK------LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQ 864 (941)
Q Consensus 791 ~~~------~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~ 864 (941)
..+ --.|+|.|+.|.+.||+++...||.......-..+ .++ ...++..|+.++....+++...++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-~Yq--------e~qLPalp~~vpp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-TYQ--------ESQLPALPSRVPPVARQLVFDLLK 495 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-hhh--------hhhCCCCcccCChHHHHHHHHHhc
Confidence 532 12489999999999999999999976332111111 122 234567788899999999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 002289 865 DETDARPSMSEVMRELE 881 (941)
Q Consensus 865 ~~p~~RPs~~~v~~~L~ 881 (941)
.+|.+|++..-....++
T Consensus 496 r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVLN 512 (598)
T ss_pred CCccccCCccHHHhHHH
Confidence 99999998875555443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-20 Score=176.86 Aligned_cols=166 Identities=26% Similarity=0.531 Sum_probs=132.7
Q ss_pred ccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccc
Q 002289 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (941)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (941)
+.++.+++.|.||+|+++ .+|..+..+.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. +.|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445667777778888887 56667778888888888888887 77777888888888888888777 7788888888888
Q ss_pred eEeccccccc-ccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccC
Q 002289 182 HFHMNNNSIS-GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260 (941)
Q Consensus 182 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~ 260 (941)
.|+|..|+++ ..+|..|..+..|+-|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|.+.+
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll--~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL--SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh--hCcHHHHHHHHHHHHhccc
Confidence 8888888775 356888888888888888888888 78888888999999999888886 5888888888888888888
Q ss_pred CCCcCCCCCCCCC
Q 002289 261 CSLQGPMPDLSRI 273 (941)
Q Consensus 261 N~l~~~~~~~~~l 273 (941)
|+++-.+|++..+
T Consensus 183 nrl~vlppel~~l 195 (264)
T KOG0617|consen 183 NRLTVLPPELANL 195 (264)
T ss_pred ceeeecChhhhhh
Confidence 8888777765443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=195.14 Aligned_cols=216 Identities=26% Similarity=0.424 Sum_probs=161.8
Q ss_pred HHhcCCCceeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCe-EeccCC
Q 002289 659 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV-FHRDIK 737 (941)
Q Consensus 659 l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~DLk 737 (941)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.....++++|+.||+|+|+.. | .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeec
Confidence 4578999999999999999999999999999999999965 4456999999999999999999999765 5 899999
Q ss_pred CCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCC-------CCchhHhHHHHHHHHHH
Q 002289 738 ASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-------LTDKSDVYSLGVVFLEL 810 (941)
Q Consensus 738 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDVwSlG~ll~el 810 (941)
++|+++|....+|++|||+......... ........-..-|.|||.+.+.. .+.+.||||||++++|+
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred cccceeeeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999876642100 00111112335799999997631 46679999999999999
Q ss_pred HhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC-h-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 811 LTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP-S-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 811 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
++.+.||.......+.......... .-....++... . +..+.+..++..||..+|.+||++.++...++.+..
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HhccCccccccccCChHHHHHHHHh--cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999999754332221111111000 00001112211 1 444578899999999999999999999888876654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-17 Score=211.98 Aligned_cols=262 Identities=23% Similarity=0.270 Sum_probs=175.0
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+++.|+|.++.+. .++..+..+++|+.|+|++|...+.+| .++.+++|++|+|++|.....+|..+.++++|+.|+|
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 45666677666665 355566667777777777665444555 3666777777777776655567777777777777777
Q ss_pred ccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccC-------------------
Q 002289 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL------------------- 222 (941)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~------------------- 222 (941)
++|..-+.+|..+ ++++|+.|+|++|...+.+|.. ..+|++|+|++|.+. .+|..+
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~ 763 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLW 763 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhcc
Confidence 7654434555544 5667777777766544444432 346667777777765 334321
Q ss_pred -----------CCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccC
Q 002289 223 -----------SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSN 291 (941)
Q Consensus 223 -----------~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~ 291 (941)
...++|+.|+|++|...+ .+|..++++++|+.|+|++|..-+.+|... .+.+|+.|+|++
T Consensus 764 ~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~-~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~--------~L~sL~~L~Ls~ 834 (1153)
T PLN03210 764 ERVQPLTPLMTMLSPSLTRLFLSDIPSLV-ELPSSIQNLHKLEHLEIENCINLETLPTGI--------NLESLESLDLSG 834 (1153)
T ss_pred ccccccchhhhhccccchheeCCCCCCcc-ccChhhhCCCCCCEEECCCCCCcCeeCCCC--------CccccCEEECCC
Confidence 112467788888887665 588889999999999998875433344321 235678999998
Q ss_pred CcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccC-CCCCCCCCCC-CCCCCcEEEecCCC
Q 002289 292 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN-NNLTNISGSF-NIPPNVTVRLRGNP 368 (941)
Q Consensus 292 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~-N~l~~~~~~~-~~~~~~~l~l~~Np 368 (941)
|..-..+|.. .++|+.|+|++|.|+ .+|.++..+ ++|+.|+|++ |+|+.++... .++.+..+++++++
T Consensus 835 c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l-----~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 835 CSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKF-----SNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCcccccccc---ccccCEeECCCCCCc-cChHHHhcC-----CCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 8655455543 357899999999998 788877654 4567999988 8888887665 56777788877553
|
syringae 6; Provisional |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=169.16 Aligned_cols=136 Identities=17% Similarity=0.202 Sum_probs=106.0
Q ss_pred CccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-----CCCceeeeeeccccCC---c-EEE
Q 002289 612 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-----HHRNLVSLVGYCDEEG---E-QML 682 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~-~~L 682 (941)
...+.||+|+||.||. .-+++.. +||+.........+.+.+|+++++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3467899999999996 2224444 69988765444567899999999999 5799999999997763 3 337
Q ss_pred EEec--CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHH-HHhhcCCCCCeEeccCCCCcEEEcC----CCcEEEeeec
Q 002289 683 VYEF--MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI-LYLHTEADPPVFHRDIKASNILLDH----KFTAKVADFG 755 (941)
Q Consensus 683 V~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~DLkp~NILl~~----~~~~kl~DFG 755 (941)
|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5579999999553 25554 34577888777 9999999 999999999999974 3489999955
Q ss_pred cc
Q 002289 756 LS 757 (941)
Q Consensus 756 la 757 (941)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.6e-20 Score=209.49 Aligned_cols=252 Identities=25% Similarity=0.313 Sum_probs=205.9
Q ss_pred CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCcccee
Q 002289 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (941)
Q Consensus 80 ~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (941)
.+.+++.++++.|++++ +|..++.+.+|+.|+..+|+|. .+|..+...++|+.|++..|.+. -+|.....+++|++|
T Consensus 239 ~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tL 315 (1081)
T KOG0618|consen 239 VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTL 315 (1081)
T ss_pred ccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeee
Confidence 45679999999999995 5699999999999999999996 89999999999999999999999 888899999999999
Q ss_pred ecccccccccCCcccccccc-cceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcC
Q 002289 160 QIDQNYISGSLPKSFANLNK-TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238 (941)
Q Consensus 160 ~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 238 (941)
+|..|+|....+..|.-+.. |..|+.+.|.++...--.=..++.|+.|++.+|.|+...-+.+.+..+|+.|+|++|+|
T Consensus 316 dL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL 395 (1081)
T KOG0618|consen 316 DLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL 395 (1081)
T ss_pred eehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence 99999999444434444444 78888899998833311123467899999999999988888899999999999999999
Q ss_pred CCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccC
Q 002289 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318 (941)
Q Consensus 239 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 318 (941)
.. .....+.++..|++|+||+|+|+..+..+.. ...|++|...+|+|. ..| .+..+++|+.+|++.|+|
T Consensus 396 ~~-fpas~~~kle~LeeL~LSGNkL~~Lp~tva~--------~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L 464 (1081)
T KOG0618|consen 396 NS-FPASKLRKLEELEELNLSGNKLTTLPDTVAN--------LGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNL 464 (1081)
T ss_pred cc-CCHHHHhchHHhHHHhcccchhhhhhHHHHh--------hhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchh
Confidence 85 3445689999999999999999854433322 344689999999998 667 899999999999999999
Q ss_pred ccC-CCcccccccccCccccceEEccCCCCCCCC
Q 002289 319 SGS-IPSSIWQSRTLNATETFILDFQNNNLTNIS 351 (941)
Q Consensus 319 ~~~-~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~ 351 (941)
+.. +|.. +..++|++|||+||.-..++
T Consensus 465 ~~~~l~~~------~p~p~LkyLdlSGN~~l~~d 492 (1081)
T KOG0618|consen 465 SEVTLPEA------LPSPNLKYLDLSGNTRLVFD 492 (1081)
T ss_pred hhhhhhhh------CCCcccceeeccCCcccccc
Confidence 832 2332 23378999999999854443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=173.28 Aligned_cols=230 Identities=21% Similarity=0.253 Sum_probs=144.2
Q ss_pred CccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHHHHhcCC----------Cceeeeeecc---
Q 002289 612 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHH----------RNLVSLVGYC--- 674 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h----------~nIv~l~~~~--- 674 (941)
...+.||.|+++.||.+++. +|+.+|||++....... -+++.+|.-....+.+ -.++..++..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34678999999999999976 58999999876433222 2455566544444322 1122111111
Q ss_pred ------ccC---C-----cEEEEEecCCCCCHHHHHhh---c--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 002289 675 ------DEE---G-----EQMLVYEFMSNGTLRDQLSA---K--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735 (941)
Q Consensus 675 ------~~~---~-----~~~LV~e~~~~gsL~~~l~~---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 735 (941)
... . ..+++|+-+ -++|.+++.. . ....+....++.+..|+++.+++||+.| ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 111 1 236788888 5799887642 2 2234566777888999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCccccccccc--------CCCCchhHhHHHHHHH
Q 002289 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--------HKLTDKSDVYSLGVVF 807 (941)
Q Consensus 736 Lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwSlG~ll 807 (941)
|||+|++++.+|.++|+||+....... .......+..|.+||.... ..++.+.|.|++|+++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~----------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT----------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE----------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc----------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999998765421 1111334578999997744 2478899999999999
Q ss_pred HHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCC
Q 002289 808 LELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR 870 (941)
Q Consensus 808 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R 870 (941)
|.|.+|..||........ ... ....-. +.++.+..++...++.+|.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~-------~~~-------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEAD-------PEW-------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGST-------SGG-------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCcccc-------ccc-------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999975432110 000 111112 566777778888887777766
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-19 Score=201.55 Aligned_cols=279 Identities=19% Similarity=0.224 Sum_probs=170.5
Q ss_pred EEEecCCCCCc-cCCccccCCCCCCEEEcccCCCCC----CCCCccCCccccceecccCccccC------CCCcccCCcC
Q 002289 86 ELQLLNLNLSG-NLSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTG------SLPEELGYLP 154 (941)
Q Consensus 86 ~L~L~~~~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 154 (941)
.|+|.++++++ .....+..+.+|+.|++++|.++. .++..+...++|++|++++|.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 35666666663 344455666777777777777743 244455566677777777777662 2334566677
Q ss_pred ccceeecccccccccCCcccccccc---cceEecccccccc----cCchhccCC-CccceeeccCCcCCCC----CCccC
Q 002289 155 KLDRIQIDQNYISGSLPKSFANLNK---TRHFHMNNNSISG----QIPPELSRL-PSLVHMLLDNNNLTGY----LPPEL 222 (941)
Q Consensus 155 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~ 222 (941)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 7888888887777656666655555 8888888887763 223344555 7778888888887732 23345
Q ss_pred CCCCCCCEEeccCCcCCCCC---cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcc
Q 002289 223 SELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIP 299 (941)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p 299 (941)
..+++|+.|+|++|.+++.. ++..+..+++|++|+|++|.+++.... .+.. .+....+|++|++++|.+++...
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--~l~~-~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--ALAE-TLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--HHHH-HhcccCCCCEEecCCCcCchHHH
Confidence 66677888888888776422 233455556788888888877532111 0000 01122456888888888776444
Q ss_pred hhhcC-----CcccceeecccccCccCCCccccc-ccccCccccceEEccCCCCCCCCCC-----C--CCCCCcEEEecC
Q 002289 300 SNFSG-----LPRLQRLFIANNSLSGSIPSSIWQ-SRTLNATETFILDFQNNNLTNISGS-----F--NIPPNVTVRLRG 366 (941)
Q Consensus 300 ~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~~~-l~~l~~~~L~~L~Ls~N~l~~~~~~-----~--~~~~~~~l~l~~ 366 (941)
..+.. .++|+.|++++|.++......+.. +.. .++|+.+|+++|.++.-+.. . ..+.+..+++.+
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~--~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAE--KESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD 316 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhc--CCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence 33332 367888888888876222222211 111 25677888888888754211 1 225678888888
Q ss_pred CCC
Q 002289 367 NPF 369 (941)
Q Consensus 367 Np~ 369 (941)
|||
T Consensus 317 ~~~ 319 (319)
T cd00116 317 DSF 319 (319)
T ss_pred CCC
Confidence 887
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-19 Score=187.93 Aligned_cols=286 Identities=18% Similarity=0.169 Sum_probs=213.2
Q ss_pred CCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCC
Q 002289 67 WTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146 (941)
Q Consensus 67 w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 146 (941)
..+-+|.+.. =..++-++-+|+ .+|..+ -..-+.++|..|+|+.+.|.+|+.+++|+.||||+|.|+.+-
T Consensus 38 P~pC~Cs~~~-------g~~VdCr~~GL~-eVP~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~ 107 (498)
T KOG4237|consen 38 PAPCTCSDVE-------GGIVDCRGKGLT-EVPANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIA 107 (498)
T ss_pred CCCcccCCCC-------CceEEccCCCcc-cCcccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcC
Confidence 3466665432 134666676776 355443 245688999999999888899999999999999999999999
Q ss_pred CcccCCcCccceeeccc-ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCC
Q 002289 147 PEELGYLPKLDRIQIDQ-NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSEL 225 (941)
Q Consensus 147 p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 225 (941)
|++|.++++|..|-+.+ |+|+....+.|.+|..|+.|.+.-|++.-...+.|..+++|..|.+-+|.+...-...|..+
T Consensus 108 p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l 187 (498)
T KOG4237|consen 108 PDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGL 187 (498)
T ss_pred hHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccch
Confidence 99999999998887776 99997777889999999999999999998888899999999999999999995444589999
Q ss_pred CCCCEEeccCCcCCCC-----------CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCccccccc-CCc-CEEEccCC
Q 002289 226 PKLLILQLDNNNFEGT-----------TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLS-LNI-TTIKLSNN 292 (941)
Q Consensus 226 ~~L~~L~Ls~N~l~~~-----------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~-~~L-~~L~Ls~N 292 (941)
.+++.+.+..|.+... ..|-.++...-..-..|.++++....+ -.|... ..+ ..+....+
T Consensus 188 ~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a-------~kf~c~~esl~s~~~~~d~ 260 (498)
T KOG4237|consen 188 AAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDA-------RKFLCSLESLPSRLSSEDF 260 (498)
T ss_pred hccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccch-------hhhhhhHHhHHHhhccccC
Confidence 9999999999985320 112223333333333333333332211 111111 011 22233344
Q ss_pred cCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCc
Q 002289 293 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFC 370 (941)
Q Consensus 293 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~ 370 (941)
...--....|..|++|+.|+|++|+|++.-+.+|..+.. ++.|.|..|+|..+...+ .+..+.+|+|.||.+.
T Consensus 261 ~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~-----l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it 335 (498)
T KOG4237|consen 261 PDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAE-----LQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQIT 335 (498)
T ss_pred cCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhh-----hhhhhcCcchHHHHHHHhhhccccceeeeecCCeeE
Confidence 444344567999999999999999999888888877544 568999999999997666 6788999999999998
Q ss_pred cCCC
Q 002289 371 LNTN 374 (941)
Q Consensus 371 c~c~ 374 (941)
|-..
T Consensus 336 ~~~~ 339 (498)
T KOG4237|consen 336 TVAP 339 (498)
T ss_pred EEec
Confidence 8654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-18 Score=200.46 Aligned_cols=172 Identities=28% Similarity=0.450 Sum_probs=122.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..+|+.++.|-.|+||.||..+++ ..+.+|.|+-+. .. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch-----hhhc--cccccCCccee------------------
Confidence 457788899999999999999876 467788854332 11 1110 22222333333
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC---
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP--- 763 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~--- 763 (941)
|+-.+.+..-+..+.+ . +.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+++.--..
T Consensus 136 ---gDc~tllk~~g~lPvd--m--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPVD--M--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCCCcch--h--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4555555433333322 2 67899999999 999999999999999999999999998642111
Q ss_pred -----CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 -----DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 -----~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.++.....-....++||+.|+|||++..+.|...+|+|++|+++||.+-|+.||+.+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 1111111112234689999999999999999999999999999999999999998653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.9e-19 Score=196.93 Aligned_cols=263 Identities=19% Similarity=0.208 Sum_probs=196.8
Q ss_pred eeeEEEecCCCCCcc----CCccccCCCCCCEEEcccCCCCC------CCCCccCCccccceecccCccccCCCCcccCC
Q 002289 83 HLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISG------SIPKEIGNIKSLELLLLNGNELTGSLPEELGY 152 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 152 (941)
+++.|++.++.++.. ++..+...+.|++|+++++.+.+ .++..+..+++|++|+|++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 489999999998653 56677788899999999998873 23456777889999999999998777766666
Q ss_pred cCc---cceeecccccccc----cCCcccccc-cccceEeccccccccc----CchhccCCCccceeeccCCcCCCC---
Q 002289 153 LPK---LDRIQIDQNYISG----SLPKSFANL-NKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLTGY--- 217 (941)
Q Consensus 153 l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~--- 217 (941)
+.+ |++|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 665 9999999999883 334456677 8999999999999843 344566778999999999999843
Q ss_pred -CCccCCCCCCCCEEeccCCcCCCC---CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCc
Q 002289 218 -LPPELSELPKLLILQLDNNNFEGT---TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNK 293 (941)
Q Consensus 218 -~p~~~~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~ 293 (941)
++..+..+++|+.|+|++|.+++. .+...+..+++|++|++++|.+++.... .+..........|++|++++|.
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~--~l~~~~~~~~~~L~~L~l~~n~ 261 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA--ALASALLSPNISLLTLSLSCND 261 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH--HHHHHHhccCCCceEEEccCCC
Confidence 344566678999999999998752 1345677889999999999998741110 0100000123578999999999
Q ss_pred CC----CCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCC
Q 002289 294 LT----GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 347 (941)
Q Consensus 294 l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l 347 (941)
++ ..+...+..+++|++|++++|.++..-...+.....-...+|+.||+.+|.+
T Consensus 262 i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 262 ITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 97 2345667778899999999999985544444443333336788999998864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=164.60 Aligned_cols=134 Identities=20% Similarity=0.330 Sum_probs=113.3
Q ss_pred ceeeccCcEEEEEEEeCCCcEEEEEEeccCCch--------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 615 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
+.||+|++|.||+|.+ +|..|++|+....... ....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986543221 123578899999999999988777777777788999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
++|++|.+++.... . .+..++.+++.+|.++|+.+ ++|||++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985432 1 77889999999999999999 99999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-16 Score=161.12 Aligned_cols=143 Identities=19% Similarity=0.183 Sum_probs=111.7
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch----------------------hhHhHHHHHHHHH
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----------------------GEKEFLTEIQFLS 660 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 660 (941)
++......|.+.+.||+|+||.||+|..++|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333333447888999999999999999888999999987642210 0123577899999
Q ss_pred hcCCC--ceeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 002289 661 RLHHR--NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 738 (941)
Q Consensus 661 ~l~h~--nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 738 (941)
.+.|+ .+.+.++. ...++||||+++++|.++... .....++.+++.++.++|+.+ |+||||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 99877 44444442 355899999999999776421 234568899999999999998 99999999
Q ss_pred CcEEEcCCCcEEEeeecccccc
Q 002289 739 SNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 739 ~NILl~~~~~~kl~DFGla~~~ 760 (941)
+||+++++++++|+|||.+...
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred ccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-16 Score=165.45 Aligned_cols=142 Identities=20% Similarity=0.159 Sum_probs=110.3
Q ss_pred CCCccceeeccCcEEEEEEE--eCCCcEEEEEEeccCCch------------------------hhHhHHHHHHHHHhcC
Q 002289 610 NFNSSTQIGQGGYGKVYKGI--LPDGTVVAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 663 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 663 (941)
-|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36778899999999999998 468999999998753210 0123568999999997
Q ss_pred CC--ceeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 002289 664 HR--NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741 (941)
Q Consensus 664 h~--nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 741 (941)
+. .+.+++++ ...++||||+++++|....... ..........++.|++.++++||+.+. |+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhE
Confidence 53 34444443 2358999999998887654222 235566678899999999999998763 99999999999
Q ss_pred EEcCCCcEEEeeecccccc
Q 002289 742 LLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 742 Ll~~~~~~kl~DFGla~~~ 760 (941)
+++ +++++|+|||.|...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=4e-16 Score=160.92 Aligned_cols=130 Identities=22% Similarity=0.337 Sum_probs=106.4
Q ss_pred eeeccCcEEEEEEEeCCCcEEEEEEeccCCch--------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.||+|+||.||+|.+ +|..|++|+....... ...++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999995 6788999986542211 1246778999999999887665555555666779999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
+|++|.+++..... .++.+++++|.+||+.+ ++|||++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998754211 78999999999999999 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.7e-16 Score=187.16 Aligned_cols=144 Identities=37% Similarity=0.589 Sum_probs=104.4
Q ss_pred CCCCCHHHHHHHHHHHHhCcCCCCCCCCCCCCCCCC---CCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCC
Q 002289 29 DSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT---SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRL 105 (941)
Q Consensus 29 ~~~~~~~d~~aL~~~k~~~~~~~~~~~~w~~~~~c~---~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l 105 (941)
...+.+.|..||+.+|+++.++. ..+|+ +++|+ +.|.||.|..... .....++.|+|++|++.|.+|+.|+.|
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~--~~~W~-g~~C~p~~~~w~Gv~C~~~~~-~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPL--RFGWN-GDPCVPQQHPWSGADCQFDST-KGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcc--cCCCC-CCCCCCcccccccceeeccCC-CCceEEEEEECCCCCccccCCHHHhCC
Confidence 34567889999999999997543 24796 57774 4799999953211 112357788888888888887777777
Q ss_pred CCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCccccc
Q 002289 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN 176 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 176 (941)
++|+.|+|++|+|.|.+|..++.+++|+.|+|++|+++|.+|..+++|++|+.|+|++|+++|.+|..+..
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 77888887777777777777777777777777777777777777777777777777777666666665543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=6e-16 Score=183.58 Aligned_cols=143 Identities=20% Similarity=0.264 Sum_probs=114.0
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEE-eccC-Cc------hhhHhHHHHHHHHHhcCCCceeeeeec
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKR-AQEG-SL------QGEKEFLTEIQFLSRLHHRNLVSLVGY 673 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~-~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 673 (941)
.........|...+.||+|+||+||+|.+.+.. +++|+ .... .. ...+.+.+|+++++.++|++++....+
T Consensus 326 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 326 IKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred ccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 333334455677899999999999999875443 33333 2211 11 113468899999999999999988877
Q ss_pred cccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 674 ~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
+......++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+||++ +++.++|+|
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEe
Confidence 777778899999999999999884 35678999999999999999 9999999999999 678999999
Q ss_pred eccccc
Q 002289 754 FGLSRL 759 (941)
Q Consensus 754 FGla~~ 759 (941)
||+++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-16 Score=174.84 Aligned_cols=128 Identities=27% Similarity=0.401 Sum_probs=108.5
Q ss_pred CcEEEEEecCCCCCHHHHHhh-cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
...++.|++|.-.+|.+|+.+ ......++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 357899999999999999974 344567888899999999999999 67 89999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 812 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt 812 (941)
........ +...+....+...||..||+||.+.+..|+.++||||||++++|++.
T Consensus 403 ~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87654432 11112334566789999999999999999999999999999999996
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=142.52 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=114.1
Q ss_pred ccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC--CceeeeeeccccCCcEEEEEecCCCC
Q 002289 613 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 613 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899998865433 4578899999999976 58999999988888999999999887
Q ss_pred CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 691 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 691 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.+..+ +......++.+++++++++|......++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4456677899999999999986444599999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=148.06 Aligned_cols=136 Identities=23% Similarity=0.212 Sum_probs=98.1
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh--hHh----------------------HHHHHHHHHhcCCCc--e
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKE----------------------FLTEIQFLSRLHHRN--L 667 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--I 667 (941)
.+.||+|+||+||+|...+++.||||++....... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999887532211 111 134566666664432 4
Q ss_pred eeeeeccccCCcEEEEEecCCCCCHHH-HHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcC
Q 002289 668 VSLVGYCDEEGEQMLVYEFMSNGTLRD-QLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 745 (941)
Q Consensus 668 v~l~~~~~~~~~~~LV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~ 745 (941)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 24589999999854322 111111 11 5577899999999999999 88 99999999999999
Q ss_pred CCcEEEeeeccccccC
Q 002289 746 KFTAKVADFGLSRLAP 761 (941)
Q Consensus 746 ~~~~kl~DFGla~~~~ 761 (941)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.4e-15 Score=179.49 Aligned_cols=263 Identities=21% Similarity=0.237 Sum_probs=193.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC--CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~L 682 (941)
...|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-+.+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345677788999999999887753 34567777665432 222334455777777776 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhh-cCCCCCeEeccCCCCcEEEcCCC-cEEEeeecccccc
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLA 760 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~ 760 (941)
+++|..++++.+-+........+....-.+..|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999999883222223455556678999999999999 888 99999999999999999 9999999999877
Q ss_pred CC-CCCCCcccccccccccc-CCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 761 PV-PDIEGIVPAHVSTVVKG-TPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 761 ~~-~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
.. ... ........| ++.|+|||...+. -.....|+||.|+++.-+++|..|+........ ..
T Consensus 176 ~~~~g~-----~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---------~~- 240 (601)
T KOG0590|consen 176 RNKNGA-----ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---------RY- 240 (601)
T ss_pred cccCCc-----ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---------cc-
Confidence 54 221 223344567 9999999999884 445679999999999999999999864332110 00
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
...+..| .|.+ ...+........+++.+++..+|..|.+.+++-.
T Consensus 241 ------------------~~~~~~~------~~~~-----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 241 ------------------SSWKSNK------GRFT-----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------------------eeecccc------cccc-----------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000000 0000 0112233455668899999999999999999999
Q ss_pred CCCCCC
Q 002289 918 HPYVSS 923 (941)
Q Consensus 918 Hpwf~~ 923 (941)
|||+..
T Consensus 286 d~~~~~ 291 (601)
T KOG0590|consen 286 DNWLSS 291 (601)
T ss_pred cccccc
Confidence 999988
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=146.36 Aligned_cols=135 Identities=23% Similarity=0.294 Sum_probs=104.9
Q ss_pred cceee-ccCcEEEEEEEeCCCcEEEEEEeccCCc-------------hhhHhHHHHHHHHHhcCCCce--eeeeeccccC
Q 002289 614 STQIG-QGGYGKVYKGILPDGTVVAVKRAQEGSL-------------QGEKEFLTEIQFLSRLHHRNL--VSLVGYCDEE 677 (941)
Q Consensus 614 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 677 (941)
...|| .|+.|+||.+... +..+|||++..... .....+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999874 67889998753211 123467889999999998875 6677764332
Q ss_pred -C---cEEEEEecCCC-CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 002289 678 -G---EQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 752 (941)
Q Consensus 678 -~---~~~LV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 752 (941)
. ..++||||++| .+|.+++... .++.. .+.+++.++.+||+.| |+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6999988542 24433 3568899999999999 9999999999999999999999
Q ss_pred eeccccc
Q 002289 753 DFGLSRL 759 (941)
Q Consensus 753 DFGla~~ 759 (941)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998864
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-15 Score=166.47 Aligned_cols=184 Identities=28% Similarity=0.503 Sum_probs=136.4
Q ss_pred CccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCcccee
Q 002289 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207 (941)
Q Consensus 128 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 207 (941)
.++.-...||+.|++. ++|..+..+..|+.|.|+.|.+. .+|..+.++..|++|+|+.|+++ .+|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3455566667777766 66666666666777777777766 66677777777777777777777 5666666663 7777
Q ss_pred eccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEE
Q 002289 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTI 287 (941)
Q Consensus 208 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L 287 (941)
-+++|+++ .+|+.++.+..|..||.+.|++. .+|.-++++.+|+.|.+..|++...++++..+ .|..|
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~--slpsql~~l~slr~l~vrRn~l~~lp~El~~L---------pLi~l 216 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ--SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL---------PLIRL 216 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh--hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC---------ceeee
Confidence 77777777 66777777777777788877776 47777777888888888888877666654322 36788
Q ss_pred EccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccc
Q 002289 288 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 329 (941)
Q Consensus 288 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (941)
|+|+|++. .+|..|.+|+.|++|-|.+|.|+ ..|..++..
T Consensus 217 DfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k 256 (722)
T KOG0532|consen 217 DFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK 256 (722)
T ss_pred ecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence 99999998 89999999999999999999998 778777654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.7e-14 Score=157.03 Aligned_cols=194 Identities=25% Similarity=0.414 Sum_probs=100.2
Q ss_pred CCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEe
Q 002289 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (941)
Q Consensus 105 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (941)
|..-...||+.|++. .+|..+..+..|+.|.|++|.+. .+|..+.++..|++|||+.|+++ .+|..++.|+ |+.|.
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 333445555555555 55555555555555555555555 55555555555555555555555 4455444443 55555
Q ss_pred cccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCc
Q 002289 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (941)
Q Consensus 185 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (941)
+++|+++ .+|..++.+..|..|+.+.|++. .+|..++++.+|+.|.+..|++. .+|..+..| .|..||+|+|++.
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~--~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE--DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh--hCCHHHhCC-ceeeeecccCcee
Confidence 5555555 45555555555555555555555 44555555555555555555554 244444422 4555555555555
Q ss_pred CCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcC---Ccccceeecccc
Q 002289 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSG---LPRLQRLFIANN 316 (941)
Q Consensus 265 ~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~---l~~L~~L~Ls~N 316 (941)
..+-++ ..+..|++|-|.+|.|. ..|..+.- ..=.++|+..-+
T Consensus 225 ~iPv~f--------r~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 225 YLPVDF--------RKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred ecchhh--------hhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 333322 22233455555555555 33443332 222345555544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-12 Score=148.39 Aligned_cols=140 Identities=22% Similarity=0.256 Sum_probs=100.3
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh----------------------------------------hHhHH
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----------------------------------------EKEFL 653 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 653 (941)
.+.||.|++|.||+|++++|+.||||+.+...... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986532110 01244
Q ss_pred HHHHHHHhcC-----CCceeeeeec-cccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHH-HHHHhhcC
Q 002289 654 TEIQFLSRLH-----HRNLVSLVGY-CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR-GILYLHTE 726 (941)
Q Consensus 654 ~E~~~l~~l~-----h~nIv~l~~~-~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 726 (941)
+|.+.+.+++ ++++. +-.. ....+..+|||||++|++|.++...... .. .+..++.++++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5665555552 33332 2222 2234567999999999999987643211 12 23456666666 47889998
Q ss_pred CCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 727 ~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+ ++|+|+||.||+++++++++++|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.1e-12 Score=132.34 Aligned_cols=154 Identities=25% Similarity=0.397 Sum_probs=114.2
Q ss_pred HHHhcCCCceeeeeeccccCC-----cEEEEEecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCC
Q 002289 658 FLSRLHHRNLVSLVGYCDEEG-----EQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730 (941)
Q Consensus 658 ~l~~l~h~nIv~l~~~~~~~~-----~~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 730 (941)
-+-++.|.|||+++.|+.+.+ +..+++|||..|++..+|++ +....+....-.+++-||..||.|||+. .|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344567999999999985543 57899999999999999975 2334567777788999999999999987 588
Q ss_pred eEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHH
Q 002289 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 810 (941)
Q Consensus 731 ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~el 810 (941)
|+|+++..+-|++..++-+|++----.. . .+..... .........+-++|.|||+-.....+.++|||+||....||
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s-~-h~s~~~~-~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-T-HPSVNST-REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc-c-chhhhhh-hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999999988875311110 0 0000000 01111223456899999988777778899999999999999
Q ss_pred HhCCC
Q 002289 811 LTGMQ 815 (941)
Q Consensus 811 ltG~~ 815 (941)
.-+..
T Consensus 276 ailEi 280 (458)
T KOG1266|consen 276 AILEI 280 (458)
T ss_pred HHhee
Confidence 87643
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.4e-12 Score=147.57 Aligned_cols=200 Identities=31% Similarity=0.480 Sum_probs=109.9
Q ss_pred EEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcC-ccceeecccccccccCCcccccccccceEecccc
Q 002289 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP-KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (941)
Q Consensus 110 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (941)
.|+++.|.+... ...+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 455555555321 223344455666666666665 4455455443 5666666666655 44455555666666666666
Q ss_pred cccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCC
Q 002289 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (941)
Q Consensus 189 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (941)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+.+++++..|.+.+|++...+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~--~~~~~~~~~~~l~~l~l~~n~~~~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--ELLSSLSNLKNLSGLELSNNKLEDLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce--ecchhhhhcccccccccCCceeeeccc
Confidence 665 44444445556666666666665 44444444445666666666432 345555666666666666666553221
Q ss_pred CCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCccc
Q 002289 269 DLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 326 (941)
Q Consensus 269 ~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 326 (941)
.+..+ .+++.|++++|+++...+ ++.+.+|+.|++++|.+....|...
T Consensus 250 ~~~~l--------~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 250 SIGNL--------SNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hhccc--------cccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 11111 224666777777663333 6777777777777777775555443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-12 Score=148.36 Aligned_cols=200 Identities=36% Similarity=0.498 Sum_probs=107.1
Q ss_pred EEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcc-ccceecccCccccCCCCcccCCcCccceeeccccc
Q 002289 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIK-SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165 (941)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 165 (941)
+++..+.+...+ ..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 98 l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 98 LDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 444444443221 23344455666666666666 4444445553 6666666666666 444555666666666666666
Q ss_pred ccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcch
Q 002289 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245 (941)
Q Consensus 166 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~ 245 (941)
++ .+|.....+++|+.|++++|++. .+|........|++|.+++|++. ..+..+.+++++..|.+++|++.. ++.
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~--~~~ 249 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED--LPE 249 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee--ccc
Confidence 65 44444445566666666666666 44444444445666666666433 344455566666666666666542 345
Q ss_pred hccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhc
Q 002289 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFS 303 (941)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~ 303 (941)
.++.+++|+.|++++|.++.... +. ...+++.|++++|.+....|....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~-~~--------~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS-LG--------SLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hhccccccceecccccccccccc-cc--------ccCccCEEeccCccccccchhhhc
Confidence 55566666666666666653222 11 112346666666666655444433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.1e-11 Score=146.38 Aligned_cols=93 Identities=32% Similarity=0.535 Sum_probs=81.0
Q ss_pred CCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCC-CCCCCcccccccCCcCEEEccCCcCCCCcchhhcCC
Q 002289 227 KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL 305 (941)
Q Consensus 227 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l 305 (941)
.++.|+|++|.+.| .+|..+..+++|+.|+|++|+|+|.+|. +..+ .+|+.|+|++|+|+|.+|..++++
T Consensus 419 ~v~~L~L~~n~L~g-~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l--------~~L~~LdLs~N~lsg~iP~~l~~L 489 (623)
T PLN03150 419 FIDGLGLDNQGLRG-FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI--------TSLEVLDLSYNSFNGSIPESLGQL 489 (623)
T ss_pred EEEEEECCCCCccc-cCCHHHhCCCCCCEEECCCCcccCcCChHHhCC--------CCCCEEECCCCCCCCCCchHHhcC
Confidence 47889999999998 7889999999999999999999987774 3333 456899999999999999999999
Q ss_pred cccceeecccccCccCCCccccc
Q 002289 306 PRLQRLFIANNSLSGSIPSSIWQ 328 (941)
Q Consensus 306 ~~L~~L~Ls~N~l~~~~p~~~~~ 328 (941)
++|+.|+|++|+++|.+|..+..
T Consensus 490 ~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 490 TSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CCCCEEECcCCcccccCChHHhh
Confidence 99999999999999999998754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-11 Score=141.65 Aligned_cols=143 Identities=21% Similarity=0.207 Sum_probs=94.4
Q ss_pred cCCCccceeeccCcEEEEEEEeCC-CcEEEEEEeccCCch----------------------------------hhH---
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ----------------------------------GEK--- 650 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--- 650 (941)
..|+. +.||+|++|.||+|+.++ |+.||||+.+..... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34666 789999999999999887 999999998753110 011
Q ss_pred ---hHHHHHHHHHhcC----CCceeeeeeccc-cCCcEEEEEecCCCCCHHHH--HhhcCC--CCccHHHHHHHHHHHHH
Q 002289 651 ---EFLTEIQFLSRLH----HRNLVSLVGYCD-EEGEQMLVYEFMSNGTLRDQ--LSAKSK--EPLGFAMRLSIALGSSR 718 (941)
Q Consensus 651 ---~~~~E~~~l~~l~----h~nIv~l~~~~~-~~~~~~LV~e~~~~gsL~~~--l~~~~~--~~l~~~~~~~i~~~ia~ 718 (941)
++.+|...+.+++ +.+.+.+-..+. -....+|||||++|+.+.++ +...+. ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2344444444432 333333323332 24567899999999999875 322221 123333333444443
Q ss_pred HHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeeccccccCC
Q 002289 719 GILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGLSRLAPV 762 (941)
Q Consensus 719 gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFGla~~~~~ 762 (941)
+..| ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3467 99999999999999888 999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2e-11 Score=137.77 Aligned_cols=251 Identities=22% Similarity=0.219 Sum_probs=179.6
Q ss_pred cCCCccceeec--cCcEEEEEEEe---CCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcE
Q 002289 609 NNFNSSTQIGQ--GGYGKVYKGIL---PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 609 ~~y~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 680 (941)
..|.+...+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+.....+ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999986 3688999997443222 2223445677766666 499999988889999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHH----HHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeec
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFG 755 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFG 755 (941)
++-+|++ +.+|.++.+.... .++....+.+..+..+ |+.++|+.. ++|-|+||.||+...+ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999999 6788888765432 3667777888888888 999999999 9999999999999999 899999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
+............ ........|...|++||...+ -++..+|+|++|.+..|..++..+...+.+.. |. +...
T Consensus 269 ~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~----~~r~ 340 (524)
T KOG0601|consen 269 LVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WS----QLRQ 340 (524)
T ss_pred eeEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-cc----cccc
Confidence 9987765543221 111223357788999998755 45789999999999999999877765442210 00 0000
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 877 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~ 877 (941)
.+ +. ..+-+.-..++......+++.++..|++.+.+.
T Consensus 341 ~~--ip---~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 341 GY--IP---LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc--Cc---hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 00 00 001111223455577788888888888777665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.8e-11 Score=119.52 Aligned_cols=130 Identities=16% Similarity=0.108 Sum_probs=96.8
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCcee-eeeeccccCCcEEEEEecCCCCCH
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV-SLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
.+.|+.|.++.||++... +..|++|+...... ....+.+|+++++.+.+.+++ +++.+.. +..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 457899999999999874 77899998765322 223567899999988655544 4554433 345899999999887
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
.+.. . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6430 1 11235678999999999887 22359999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-10 Score=129.14 Aligned_cols=166 Identities=19% Similarity=0.196 Sum_probs=126.4
Q ss_pred eCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHH
Q 002289 630 LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 709 (941)
Q Consensus 630 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~ 709 (941)
..++.+|.|...+...........+-++.|+.++||||+++++.+..++..|||+|-+. .|..++.+.+ ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence 34678888888776544334557788899999999999999999999999999999983 6777776543 5566
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCccccccc
Q 002289 710 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789 (941)
Q Consensus 710 ~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 789 (941)
...+.||++||.|||..++ ++|++|.-+-|+|+..|+.||++|.++........ ......--..|..|+.+
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------ccccchhhhcccChhhc
Confidence 7788999999999997664 99999999999999999999999998864432110 00111111246667655
Q ss_pred ccCCCCchhHhHHHHHHHHHHHhC
Q 002289 790 LTHKLTDKSDVYSLGVVFLELLTG 813 (941)
Q Consensus 790 ~~~~~~~~sDVwSlG~ll~elltG 813 (941)
.... -..|.|.|||+++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 4333 246999999999999998
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-11 Score=125.81 Aligned_cols=221 Identities=20% Similarity=0.267 Sum_probs=108.1
Q ss_pred ceeeEEEecCC-------C-CCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCc
Q 002289 82 LHLRELQLLNL-------N-LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYL 153 (941)
Q Consensus 82 ~~l~~L~L~~~-------~-l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 153 (941)
.++..|..+.. | +...+|-.+.-+++|+.+.+|.+.-.. +-+--..-+.|+++...+.-++. .|. +-..
T Consensus 182 ~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe 258 (490)
T KOG1259|consen 182 TQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQD-VPS-LLPE 258 (490)
T ss_pred hheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccc-ccc-ccch
Confidence 45677766542 1 222344455567777777777765431 11112223556777666555441 111 1111
Q ss_pred Cccceeecccc-cccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEe
Q 002289 154 PKLDRIQIDQN-YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232 (941)
Q Consensus 154 ~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 232 (941)
..+..+.-+.- -.+|..-..+...+.|++|+|++|.|+ .+..+..-+|.++.|++|+|.|. .+. .+..+++|+.||
T Consensus 259 ~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LD 335 (490)
T KOG1259|consen 259 TILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLD 335 (490)
T ss_pred hhhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEee
Confidence 12221111111 112222333444456666666666666 45555555666666666666665 222 255566666666
Q ss_pred ccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCc-chhhcCCccccee
Q 002289 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTI-PSNFSGLPRLQRL 311 (941)
Q Consensus 233 Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L 311 (941)
||+|.++. +..+-..+-+++.|.|++|.|+ .+..+..+ -+|..||+++|+|.... -..+++||-|+.|
T Consensus 336 LS~N~Ls~--~~Gwh~KLGNIKtL~La~N~iE-------~LSGL~KL--YSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l 404 (490)
T KOG1259|consen 336 LSGNLLAE--CVGWHLKLGNIKTLKLAQNKIE-------TLSGLRKL--YSLVNLDLSSNQIEELDEVNHIGNLPCLETL 404 (490)
T ss_pred cccchhHh--hhhhHhhhcCEeeeehhhhhHh-------hhhhhHhh--hhheeccccccchhhHHHhcccccccHHHHH
Confidence 66666653 3344445555566666666554 11122111 13455555555554221 2334556666666
Q ss_pred ecccccCc
Q 002289 312 FIANNSLS 319 (941)
Q Consensus 312 ~Ls~N~l~ 319 (941)
.|.+|.|.
T Consensus 405 ~L~~NPl~ 412 (490)
T KOG1259|consen 405 RLTGNPLA 412 (490)
T ss_pred hhcCCCcc
Confidence 66666655
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.8e-10 Score=113.16 Aligned_cols=137 Identities=17% Similarity=0.085 Sum_probs=98.5
Q ss_pred cceeeccCcEEEEEEEeCC-------CcEEEEEEeccCCc----------------------hhhHh----HHHHHHHHH
Q 002289 614 STQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGSL----------------------QGEKE----FLTEIQFLS 660 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~----~~~E~~~l~ 660 (941)
...||.|--+.||.|...+ +..+|||+.+.... ...+. ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 47999997652110 00112 248999999
Q ss_pred hcCC--CceeeeeeccccCCcEEEEEecCCCCCHHH-HHhhcCCCCccHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccC
Q 002289 661 RLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTLRD-QLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDI 736 (941)
Q Consensus 661 ~l~h--~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DL 736 (941)
++.. -++.+++++ ...++||||+.+..+.. .+.. ..++......+..+++.+|.++ |+.+ +|||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9853 456666654 56789999996643422 2221 1244455667889999999999 7888 999999
Q ss_pred CCCcEEEcCCCcEEEeeeccccccC
Q 002289 737 KASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 737 kp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
++.||+++ ++.++|+|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.8e-11 Score=144.26 Aligned_cols=270 Identities=19% Similarity=0.229 Sum_probs=181.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
..+.+.+.+-+-+|.++.++.+.-. .|...+.|+......-. -+....+-.++-..+||-+++..-.+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4566777778889999999877632 34444444433211111 1122223233333456777766555666678899
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|++|..+++|...++..+ ..+....+.....+.++++|||... +.|+|++|.|.+...++..+++|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999997654 3444455556667788999999987 89999999999999999999999984432211
Q ss_pred C----CC-----------------C---CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCC
Q 002289 763 P----DI-----------------E---GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818 (941)
Q Consensus 763 ~----~~-----------------~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~ 818 (941)
. +. . ............||+.|.+||...+......+|+|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 0 0001122345679999999999999999999999999999999999999996
Q ss_pred CCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccc
Q 002289 819 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFI 898 (941)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll 898 (941)
...... ....+...... +-....+..+.+.+++
T Consensus 1037 a~tpq~----------~f~ni~~~~~~-------------------------------------~p~g~~~~s~~aq~~~ 1069 (1205)
T KOG0606|consen 1037 AETPQQ----------IFENILNRDIP-------------------------------------WPEGPEEGSYEAQDLI 1069 (1205)
T ss_pred Ccchhh----------hhhccccCCCC-------------------------------------CCCCccccChhhhhhh
Confidence 543210 00011111000 0011123345566788
Q ss_pred cccCCCCCCCCCCCc---cCCCCCCCCCCCCCC
Q 002289 899 NSEHTSKEETPPSSS---SMLKHPYVSSDVSGS 928 (941)
Q Consensus 899 ~~~L~~dP~~R~sa~---e~L~Hpwf~~~~~~~ 928 (941)
...|+.+|.+|..|. +.-.||+|+...++.
T Consensus 1070 ~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1070 NRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hhhhccCchhccCcccccccccCCccCCCCccc
Confidence 889999999999888 888999998877653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-11 Score=125.85 Aligned_cols=128 Identities=24% Similarity=0.323 Sum_probs=71.8
Q ss_pred CCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccc
Q 002289 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLL 280 (941)
Q Consensus 201 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~ 280 (941)
+..|++||||+|.|+ .+.+++.-++.++.|++|+|.|.. + ..+..+++|+.||||+|.++
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~--v-~nLa~L~~L~~LDLS~N~Ls---------------- 342 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT--V-QNLAELPQLQLLDLSGNLLA---------------- 342 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceee--e-hhhhhcccceEeecccchhH----------------
Confidence 445566666666665 445555555666666666666542 1 23555555555555555544
Q ss_pred cCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCC--CC-CCC
Q 002289 281 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG--SF-NIP 357 (941)
Q Consensus 281 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~--~~-~~~ 357 (941)
.+..+-..|-+++.|.|++|.|. ++..+.+|. +|..||+++|+|..++. .+ .+|
T Consensus 343 ----------------~~~Gwh~KLGNIKtL~La~N~iE-----~LSGL~KLY--SLvnLDl~~N~Ie~ldeV~~IG~LP 399 (490)
T KOG1259|consen 343 ----------------ECVGWHLKLGNIKTLKLAQNKIE-----TLSGLRKLY--SLVNLDLSSNQIEELDEVNHIGNLP 399 (490)
T ss_pred ----------------hhhhhHhhhcCEeeeehhhhhHh-----hhhhhHhhh--hheeccccccchhhHHHhccccccc
Confidence 23333334445555555555554 233333332 45567777777766642 22 678
Q ss_pred CCcEEEecCCCCcc
Q 002289 358 PNVTVRLRGNPFCL 371 (941)
Q Consensus 358 ~~~~l~l~~Np~~c 371 (941)
-+.++.|.+||+.-
T Consensus 400 CLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 400 CLETLRLTGNPLAG 413 (490)
T ss_pred HHHHHhhcCCCccc
Confidence 88999999999743
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.8e-12 Score=134.21 Aligned_cols=232 Identities=19% Similarity=0.267 Sum_probs=157.2
Q ss_pred eeeEEEecCCCCCcc----CCccccCCCCCCEEEcccC---CCCCCCCCc-------cCCccccceecccCccccCCCCc
Q 002289 83 HLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWN---KISGSIPKE-------IGNIKSLELLLLNGNELTGSLPE 148 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N---~l~~~~p~~-------~~~l~~L~~L~Ls~N~l~~~~p~ 148 (941)
.++.|+|++|.+... +.+.+.+.++|+..++|+= ++...+|.. +...++|++||||+|.|.-.-+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 579999999988643 5566788899999999863 223344443 34557999999999999855444
Q ss_pred c----cCCcCccceeecccccccccCCc-------------ccccccccceEecccccccccC----chhccCCCcccee
Q 002289 149 E----LGYLPKLDRIQIDQNYISGSLPK-------------SFANLNKTRHFHMNNNSISGQI----PPELSRLPSLVHM 207 (941)
Q Consensus 149 ~----~~~l~~L~~L~Ls~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L 207 (941)
. +.++..|++|+|.+|.+...--. -...-++|+.+...+|++.... ...|...+.|+.+
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leev 190 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEV 190 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceE
Confidence 3 45678899999999998622111 1234478899999999887432 2345667889999
Q ss_pred eccCCcCCCC----CCccCCCCCCCCEEeccCCcCCC---CCcchhccCCCCCcEEEccCCCCcCCCCC--CCCCCcccc
Q 002289 208 LLDNNNLTGY----LPPELSELPKLLILQLDNNNFEG---TTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGY 278 (941)
Q Consensus 208 ~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~l~~l~~ 278 (941)
.++.|.|... +...|..+++|+.|||..|-|+. ..+...+..++.|++|++++|.++..-.. +..+..
T Consensus 191 r~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~--- 267 (382)
T KOG1909|consen 191 RLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKE--- 267 (382)
T ss_pred EEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhc---
Confidence 9999988632 22457788999999999998863 23455677888888888888888632111 101110
Q ss_pred cccCCcCEEEccCCcCCC----CcchhhcCCcccceeecccccC
Q 002289 279 LLSLNITTIKLSNNKLTG----TIPSNFSGLPRLQRLFIANNSL 318 (941)
Q Consensus 279 l~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 318 (941)
..++|++|+|.+|.|+. .+-.+....+.|..|+|++|.+
T Consensus 268 -~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 268 -SAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred -cCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 13456777777777763 2333444566677777777766
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.6e-11 Score=118.19 Aligned_cols=125 Identities=29% Similarity=0.418 Sum_probs=30.5
Q ss_pred ccccceecccCccccCCCCcccC-CcCccceeecccccccccCCcccccccccceEecccccccccCchhc-cCCCccce
Q 002289 129 IKSLELLLLNGNELTGSLPEELG-YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVH 206 (941)
Q Consensus 129 l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~ 206 (941)
..++++|+|++|+|+ .+. .++ .+.+|+.|+|++|.|+.. +.+..+++|++|++++|+|+. +...+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred ccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCE
Confidence 334455555555554 222 222 344455555555554422 124444555555555555552 22222 23455555
Q ss_pred eeccCCcCCCCCC-ccCCCCCCCCEEeccCCcCCCCC--cchhccCCCCCcEEEc
Q 002289 207 MLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTT--IPASYSNMSKLLKLSL 258 (941)
Q Consensus 207 L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~--~p~~~~~l~~L~~L~L 258 (941)
|+|++|+|...-. ..+..+++|+.|+|.+|.+.... -...+..+++|+.||-
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 5555555542211 23444555666666666554310 0113445555655544
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.8e-12 Score=134.25 Aligned_cols=256 Identities=18% Similarity=0.252 Sum_probs=154.1
Q ss_pred ccccCCCCCCEEEcccCCCCC----CCCCccCCccccceecccCcccc---CCCCcc-------cCCcCccceeeccccc
Q 002289 100 PEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELT---GSLPEE-------LGYLPKLDRIQIDQNY 165 (941)
Q Consensus 100 ~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~-------~~~l~~L~~L~Ls~N~ 165 (941)
+.+..+..++.|+||+|.|.. .+-..+.+.++|+.-++++-.-. ..+|.. +...++|++||||+|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 345567778888888888763 23344556677777777653221 123322 2334455555555555
Q ss_pred ccccCCcc----cccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCC
Q 002289 166 ISGSLPKS----FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (941)
Q Consensus 166 l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 241 (941)
|....+.. +.++..|++|+|.+|.+.-.--..++ ..|..|. .|+ -...-++|+++..++|++...
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNK-------KAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHh-------ccCCCcceEEEEeeccccccc
Confidence 54332222 23344444444444444311000111 0111111 111 122346788888888888632
Q ss_pred ---CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCC----cchhhcCCcccceeecc
Q 002289 242 ---TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIA 314 (941)
Q Consensus 242 ---~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls 314 (941)
.+...|...+.|+.+.++.|.|.. +.+ .+-...+-++++|+.|||.+|-++.. +..++..+++|+.|+++
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~--eG~-~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~ 249 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRP--EGV-TALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG 249 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccC--chh-HHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence 123457777888888888888752 211 12223445567789999999988743 46677789999999999
Q ss_pred cccCccCCCcccccccccCccccceEEccCCCCCCC-----CCCC-CCCCCcEEEecCCCC
Q 002289 315 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-----SGSF-NIPPNVTVRLRGNPF 369 (941)
Q Consensus 315 ~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~-----~~~~-~~~~~~~l~l~~Np~ 369 (941)
+|.++..--..+..--.-..+.|++|+|.+|.|+.= ...+ ..|.+..|.|+||.+
T Consensus 250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 999987766666554333467899999999999762 1111 477889999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-10 Score=132.15 Aligned_cols=246 Identities=20% Similarity=0.227 Sum_probs=173.7
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeC--CCcEEEEEEeccCCchhh--HhHHHHHHHHHhc-CCCceeeeeeccccCC
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 678 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 678 (941)
......+|..+..||.|.|+.|++...+ ++..+++|.......... ..-..|+.+...+ .|.+++.....+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445678888999999999999988743 678999998776443322 2234566666665 5888888777777777
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeeccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 757 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFGla 757 (941)
..++=-||++++++...+ .-...+++..++.+..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+
T Consensus 340 ~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 778999999999987766 23345778889999999999999999988 9999999999999886 88999999998
Q ss_pred cccCCCCCCCccccccccccccCCCcc--cccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
..+... ........++. +++......+..+.|++|||..+.|.++|..--.... .
T Consensus 415 t~~~~~----------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------~ 471 (524)
T KOG0601|consen 415 TRLAFS----------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------Q 471 (524)
T ss_pred ccccee----------cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------------c
Confidence 643211 11112223444 5555666788899999999999999999854322211 1
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
...+..+.....+... ..++.+.+.+...++..||.+.+...
T Consensus 472 ~~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 472 SLTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ceeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcc
Confidence 1222333333333333 56666666677777777777665543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-11 Score=142.70 Aligned_cols=242 Identities=26% Similarity=0.302 Sum_probs=140.4
Q ss_pred cCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccce
Q 002289 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (941)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (941)
..+..++.+++..|.|.. +-..+..+++|..|+|.+|+|. .+...+..+++|++|+|++|.|+.+. .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhh
Confidence 345666666677777762 3334666777777777777777 44444666777777777777777542 3445555777
Q ss_pred EecccccccccCchhccCCCccceeeccCCcCCCCCC-ccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCC
Q 002289 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (941)
Q Consensus 183 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (941)
|++++|.|+. + ..+..+++|+.+++++|++....+ . ...+.+|+.+++++|.+.. ...+..+..+..+++..|
T Consensus 145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~---i~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE---IEGLDLLKKLVLLSLLDN 218 (414)
T ss_pred heeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc---ccchHHHHHHHHhhcccc
Confidence 7777777762 2 234456777777777777774433 1 4666777777777777653 234444555555577777
Q ss_pred CCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEE
Q 002289 262 SLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 341 (941)
Q Consensus 262 ~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~ 341 (941)
.++- +..+.......|+.+++++|++. .++..+..+..+..|++.+|++...-... ....+..+.
T Consensus 219 ~i~~-------~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~~~-------~~~~~~~~~ 283 (414)
T KOG0531|consen 219 KISK-------LEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEGLE-------RLPKLSELW 283 (414)
T ss_pred ccee-------ccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccccc-------ccchHHHhc
Confidence 6652 11111111112567777777776 33355666777777777777776221111 122344555
Q ss_pred ccCCCCCCCC----C--CCCCCCCcEEEecCCCC
Q 002289 342 FQNNNLTNIS----G--SFNIPPNVTVRLRGNPF 369 (941)
Q Consensus 342 Ls~N~l~~~~----~--~~~~~~~~~l~l~~Np~ 369 (941)
++.|.+.... . ....+.+..+.+.+||.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (414)
T KOG0531|consen 284 LNDNKLALSEAISQEYITSAAPTLVTLTLELNPI 317 (414)
T ss_pred cCcchhcchhhhhccccccccccccccccccCcc
Confidence 6666655321 1 22344455566666654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.7e-11 Score=131.65 Aligned_cols=215 Identities=19% Similarity=0.197 Sum_probs=143.3
Q ss_pred ccCCCCCCEEEcccCCCCCCCC--CccCCccccceecccCccccCCCC--cccCCcCccceeecccccccccCCcc-ccc
Q 002289 102 IGRLSYLTILDFMWNKISGSIP--KEIGNIKSLELLLLNGNELTGSLP--EELGYLPKLDRIQIDQNYISGSLPKS-FAN 176 (941)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~ 176 (941)
=.++.+|++..|.+..+. ..+ .....+++++.||||+|-|....+ .....||+|+.|+|+.|++....... -..
T Consensus 117 Qsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 346778888888887776 333 355678888888888888874322 33567888888888888877443322 224
Q ss_pred ccccceEecccccccccC-chhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcE
Q 002289 177 LNKTRHFHMNNNSISGQI-PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255 (941)
Q Consensus 177 l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 255 (941)
++.|+.|.|+.+.|+..- -..+..+|+|+.|+|..|...+.-......+..|+.|||++|++-....-...+.++.|+.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence 678888888888887321 2234567888888888885333444455567788888888888864333356778888888
Q ss_pred EEccCCCCcCC-CCCCCCCCcccccccCCcCEEEccCCcCCCC-cchhhcCCcccceeecccccCc
Q 002289 256 LSLRNCSLQGP-MPDLSRIPNLGYLLSLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 256 L~Ls~N~l~~~-~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
|.++.+.+... .|+...+... -....|+.|+++.|+|... --..+..+++|+.|.+..|.|.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt--~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKT--HTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hhccccCcchhcCCCccchhhh--cccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 88888887653 2322111111 1124578889999988521 1233556778888888899886
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-11 Score=130.85 Aligned_cols=210 Identities=21% Similarity=0.253 Sum_probs=142.5
Q ss_pred CCccccceecccCccccCCCC--cccCCcCccceeecccccccccCC--cccccccccceEecccccccccCchhc-cCC
Q 002289 127 GNIKSLELLLLNGNELTGSLP--EELGYLPKLDRIQIDQNYISGSLP--KSFANLNKTRHFHMNNNSISGQIPPEL-SRL 201 (941)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l 201 (941)
.++.+|+...|.+..+. ..+ .....|++++.||||.|-+....+ .....|++|+.|+|+.|++.....+.. ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46788999999888877 333 356778999999999998874433 345678999999999999874443322 246
Q ss_pred CccceeeccCCcCCCC-CCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCC--CCCCCCCcccc
Q 002289 202 PSLVHMLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM--PDLSRIPNLGY 278 (941)
Q Consensus 202 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~l~~ 278 (941)
+.|+.|.|+.|.|+.. +...+..+++|+.|+|..|.... .......-+..|++|||++|++-... +....
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~-~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~------ 269 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIIL-IKATSTKILQTLQELDLSNNNLIDFDQGYKVGT------ 269 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccc-eecchhhhhhHHhhccccCCccccccccccccc------
Confidence 7889999999998832 22334567899999999995332 33345566778999999999886322 11222
Q ss_pred cccCCcCEEEccCCcCCCCc-chh-----hcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCC
Q 002289 279 LLSLNITTIKLSNNKLTGTI-PSN-----FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350 (941)
Q Consensus 279 l~~~~L~~L~Ls~N~l~~~~-p~~-----~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~ 350 (941)
+++|..|+++.+.|..+- |+. ...+++|++|+++.|++.. . .++.++.. ..+|+.|....|.|+.-
T Consensus 270 --l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w-~sl~~l~~--l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 270 --LPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-W-RSLNHLRT--LENLKHLRITLNYLNKE 341 (505)
T ss_pred --ccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccc-c-cccchhhc--cchhhhhhccccccccc
Confidence 245577788888887543 333 3467889999999998851 1 12222222 23667777788888764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-09 Score=104.20 Aligned_cols=143 Identities=22% Similarity=0.240 Sum_probs=104.3
Q ss_pred ccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch--------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 613 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 613 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
....+-||+-+.|+++.+ .|+...||.-...... ..++..+|.+.+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999998 5677777743221111 1356788999998886444443334555556667999
Q ss_pred ecCCC-CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEeeeccccc
Q 002289 685 EFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRL 759 (941)
Q Consensus 685 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DFGla~~ 759 (941)
||++| .++.+++...............++..|-+.+.-||..+ |||+||..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99965 47888876554433333444678888899999999999 99999999999997655 468999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-09 Score=114.04 Aligned_cols=142 Identities=23% Similarity=0.349 Sum_probs=110.1
Q ss_pred ceeeccCcEEEEEEEeCCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCC--ceeeeeeccccC---CcEEEEEecCC
Q 002289 615 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHR--NLVSLVGYCDEE---GEQMLVYEFMS 688 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~---~~~~LV~e~~~ 688 (941)
+.|+.|.++.||++...+|+.+++|....... .....+.+|+++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998765332 1345788999999999763 456777777654 36689999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA----------------------------------------- 727 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 727 (941)
|.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888775531 24667777788888888888888521
Q ss_pred ------------CCCeEeccCCCCcEEEcC--CCcEEEeeeccccc
Q 002289 728 ------------DPPVFHRDIKASNILLDH--KFTAKVADFGLSRL 759 (941)
Q Consensus 728 ------------~~~ivH~DLkp~NILl~~--~~~~kl~DFGla~~ 759 (941)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1e-10 Score=115.74 Aligned_cols=126 Identities=30% Similarity=0.399 Sum_probs=42.7
Q ss_pred ccCCCCCCEEEcccCCCCCCCCCccC-CccccceecccCccccCCCCcccCCcCccceeecccccccccCCccc-ccccc
Q 002289 102 IGRLSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF-ANLNK 179 (941)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 179 (941)
+.+..++++|+|++|+|+. +. .++ .+.+|+.|||++|.|+ .++ .+..+++|+.|+|++|.|+.. .+.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCcc-ccchHHhCCc
Confidence 3444557777777777773 32 354 4677777777777777 333 466677777777777777743 3333 35777
Q ss_pred cceEecccccccccC-chhccCCCccceeeccCCcCCCCCCc----cCCCCCCCCEEec
Q 002289 180 TRHFHMNNNSISGQI-PPELSRLPSLVHMLLDNNNLTGYLPP----ELSELPKLLILQL 233 (941)
Q Consensus 180 L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L 233 (941)
|++|+|++|+|...- -..+..+++|+.|+|.+|.++.. +. .+..+|+|+.||-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 777777777776322 13456677888888888887633 21 2455778887764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-09 Score=103.97 Aligned_cols=131 Identities=22% Similarity=0.304 Sum_probs=98.1
Q ss_pred ceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh--------hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 615 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--------EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..+++|+-+.+|.+.+. |..+++|.-....... ..+-.+|.+++.+++--.|...+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 4446777533222111 23567899999988755555555566667778899999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888554 2345566666677899999 99999999999998765 99999999874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.2e-11 Score=134.89 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=167.6
Q ss_pred CCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEec
Q 002289 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (941)
+.++.++...+.+.+.--. ...+..++.+++..|.+. .+-..+..+.+|+.|+|.+|+|.++ ...+..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheec
Confidence 3455556655554421111 156788889999999998 4556688899999999999999944 333788999999999
Q ss_pred ccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchh-ccCCCCCcEEEccCCCCc
Q 002289 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQ 264 (941)
Q Consensus 186 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~-~~~l~~L~~L~Ls~N~l~ 264 (941)
++|+|+...+ +..++.|+.|++++|.|+.. ..+..+++|+.+++++|++.. +... ...+.+|+.+++.+|.+.
T Consensus 126 s~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~--ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 126 SFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVD--IENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred cccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhh--hhhhhhhhccchHHHhccCCchh
Confidence 9999995543 56777899999999999843 356668999999999999985 2222 578899999999999887
Q ss_pred CCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccC
Q 002289 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 344 (941)
Q Consensus 265 ~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~ 344 (941)
.. ..+... ..+..+++..|.++..-+........|+.+++++|++. .++..+. ....+..||+.+
T Consensus 200 ~i-------~~~~~~--~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~-----~~~~l~~l~~~~ 264 (414)
T KOG0531|consen 200 EI-------EGLDLL--KKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS-RSPEGLE-----NLKNLPVLDLSS 264 (414)
T ss_pred cc-------cchHHH--HHHHHhhcccccceeccCcccchhHHHHHHhcccCccc-ccccccc-----ccccccccchhh
Confidence 21 111111 23355588889887443322111113889999999988 4432222 234566899999
Q ss_pred CCCCCCCCCCCCCCCcEEEecCCCC
Q 002289 345 NNLTNISGSFNIPPNVTVRLRGNPF 369 (941)
Q Consensus 345 N~l~~~~~~~~~~~~~~l~l~~Np~ 369 (941)
|++..+...-..+....+.+..|+.
T Consensus 265 n~~~~~~~~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 265 NRISNLEGLERLPKLSELWLNDNKL 289 (414)
T ss_pred ccccccccccccchHHHhccCcchh
Confidence 9998876544555555566666654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.9e-08 Score=106.23 Aligned_cols=167 Identities=19% Similarity=0.256 Sum_probs=127.7
Q ss_pred cEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccc----cCCcEEEEEecCCC-CCHHHH
Q 002289 622 YGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----EEGEQMLVYEFMSN-GTLRDQ 695 (941)
Q Consensus 622 fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~LV~e~~~~-gsL~~~ 695 (941)
-.+.||+... ||..|++|+++............-+++++++.|.|||+|.++|. .+...++||+|+|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999854 89999999996544443333455688999999999999999885 33478999999875 577775
Q ss_pred Hhhc-------------CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 696 LSAK-------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 696 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
-... .....++...|.++.|+..||.++|+.| ..-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4321 1224678899999999999999999999 99999999999999999999988887665432
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 815 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~ 815 (941)
++. |-+.+ -.+-|.-.||.+++.|.||..
T Consensus 446 d~~---------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT---------------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC---------------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 210 11111 235789999999999999954
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.6e-11 Score=132.74 Aligned_cols=181 Identities=24% Similarity=0.326 Sum_probs=112.0
Q ss_pred CcccCCcCccceeecccccccccCCcccccc-cccceEecccccccccCchh-------ccC---CCccceeeccCCcCC
Q 002289 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANL-NKTRHFHMNNNSISGQIPPE-------LSR---LPSLVHMLLDNNNLT 215 (941)
Q Consensus 147 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~-------~~~---l~~L~~L~L~~N~l~ 215 (941)
|-.+..+.+|+.|.|.++.|.. -..+..+ ..|+.|.. +|.+. .+... +++ ...|...+.+.|.|.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~-Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLD-ALRHVFASCGGDISNSPVWNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHH-HHHHHHHHhccccccchhhhhHhhhhcchhhHH
Confidence 5567777888999888888763 1112111 23444432 33322 11111 111 236788888999988
Q ss_pred CCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCC
Q 002289 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT 295 (941)
Q Consensus 216 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~ 295 (941)
.+..++.-++.|+.|+|++|+++.. +.+..+++|++|||++|.|+ .++.+..... .|+.|.|.+|.++
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v---~~Lr~l~~LkhLDlsyN~L~-------~vp~l~~~gc-~L~~L~lrnN~l~ 245 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKV---DNLRRLPKLKHLDLSYNCLR-------HVPQLSMVGC-KLQLLNLRNNALT 245 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhh---HHHHhcccccccccccchhc-------cccccchhhh-hheeeeecccHHH
Confidence 6677888888999999999998753 47788888888888888887 2222322222 2566777777665
Q ss_pred CCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC---CCCCCcEEEecCCCCccC
Q 002289 296 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLN 372 (941)
Q Consensus 296 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~---~~~~~~~l~l~~Np~~c~ 372 (941)
... .+.+|.+|+.||+++|-|. ..+.-. .+..+..|+|.|||++|.
T Consensus 246 tL~--gie~LksL~~LDlsyNll~-----------------------------~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 246 TLR--GIENLKSLYGLDLSYNLLS-----------------------------EHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhh--hHHhhhhhhccchhHhhhh-----------------------------cchhhhHHHHHHHHHHHhhcCCccccC
Confidence 221 2345556666666666554 332111 234567789999999998
Q ss_pred CC
Q 002289 373 TN 374 (941)
Q Consensus 373 c~ 374 (941)
..
T Consensus 295 p~ 296 (1096)
T KOG1859|consen 295 PW 296 (1096)
T ss_pred HH
Confidence 74
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=6e-08 Score=103.68 Aligned_cols=140 Identities=14% Similarity=0.144 Sum_probs=100.2
Q ss_pred eeeccCcEEEEEEEeCCCcEEEEEEeccCCchh-h----------HhHHHHHHHHHhcCCCce--eeeeecccc-----C
Q 002289 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-E----------KEFLTEIQFLSRLHHRNL--VSLVGYCDE-----E 677 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~nI--v~l~~~~~~-----~ 677 (941)
.+-.-....|++..+ +|+.|.||......... . ..+.+|.+.+.++...+| .+.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 343333345667666 67889999775433111 1 147889998888854333 344455432 2
Q ss_pred CcEEEEEecCCCC-CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-------CCcE
Q 002289 678 GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------KFTA 749 (941)
Q Consensus 678 ~~~~LV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-------~~~~ 749 (941)
..-+||||++++. +|.+++......+.+...+..++.+++..+.-||..| |+|+|++++|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999875 8999985432334566777889999999999999999 999999999999975 4689
Q ss_pred EEeeeccccc
Q 002289 750 KVADFGLSRL 759 (941)
Q Consensus 750 kl~DFGla~~ 759 (941)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.3e-08 Score=99.60 Aligned_cols=125 Identities=26% Similarity=0.312 Sum_probs=82.1
Q ss_pred EEEEEEeCCCcEEEEEEeccCCc-------------h-------------hhHhHHHHHHHHHhcCCC--ceeeeeeccc
Q 002289 624 KVYKGILPDGTVVAVKRAQEGSL-------------Q-------------GEKEFLTEIQFLSRLHHR--NLVSLVGYCD 675 (941)
Q Consensus 624 ~Vy~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--nIv~l~~~~~ 675 (941)
.||.|...+|..+|||+.+.... . ......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999998653110 0 013457899999999765 456666553
Q ss_pred cCCcEEEEEecCC--CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHH-hhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 002289 676 EEGEQMLVYEFMS--NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY-LHTEADPPVFHRDIKASNILLDHKFTAKVA 752 (941)
Q Consensus 676 ~~~~~~LV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 752 (941)
..+|||||++ |..+..+.... ++......+..+++..+.. +|..+ |+|+||.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4579999998 55555444222 1123345567777775555 57888 9999999999999988 99999
Q ss_pred eecccccc
Q 002289 753 DFGLSRLA 760 (941)
Q Consensus 753 DFGla~~~ 760 (941)
|||.|...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-08 Score=124.09 Aligned_cols=178 Identities=23% Similarity=0.337 Sum_probs=92.1
Q ss_pred eeeEEEecCCC--CCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 83 HLRELQLLNLN--LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 83 ~l~~L~L~~~~--l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
.+++|-+..|. +.......|..++.|++|||++|.=-+.+|..+++|.+|++|+|++..++ .+|..+++|.+|.+||
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 45555555554 22222223555666666666666544566666666666666666666666 6666666666666666
Q ss_pred cccccccccCCcccccccccceEecccccc--cccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCC----EEecc
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSI--SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL----ILQLD 234 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l--~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls 234 (941)
+..+.-...+|.....|.+|++|.+..-.. ....-..+..+.+|+.+....... .+-..+..+.+|. .+.+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence 666654444455555566666666654431 111122223333444333322221 0011112222222 22222
Q ss_pred CCcCCCCCcchhccCCCCCcEEEccCCCCcC
Q 002289 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 235 ~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
.+... ..+..+..+.+|+.|.+.++.+..
T Consensus 703 ~~~~~--~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 703 GCSKR--TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred ccccc--eeecccccccCcceEEEEcCCCch
Confidence 22222 355677788888888888887753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.4e-09 Score=85.07 Aligned_cols=59 Identities=32% Similarity=0.567 Sum_probs=26.2
Q ss_pred ccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEeccccc
Q 002289 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189 (941)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 189 (941)
+|++|+|++|+++...+..|.++++|++|+|++|.++...|+.|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333344444444444444444444444444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-08 Score=83.22 Aligned_cols=61 Identities=33% Similarity=0.579 Sum_probs=35.2
Q ss_pred CccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcC
Q 002289 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 214 (941)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 214 (941)
|+|++|+|++|+|+...++.|.++++|++|+|++|+++...+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3556666666666655555556666666666666666554455555555555555555543
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.4e-07 Score=94.48 Aligned_cols=136 Identities=22% Similarity=0.202 Sum_probs=95.2
Q ss_pred CCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc----------------------hhhHhHHHHHHHHHhcCCC--c
Q 002289 611 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------------------QGEKEFLTEIQFLSRLHHR--N 666 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 666 (941)
+.+.+.||-|--+.||.|..++|..+|||.=+.... .......+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999995321110 0123457899999998654 5
Q ss_pred eeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC
Q 002289 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 746 (941)
Q Consensus 667 Iv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 746 (941)
|.+.+++ +..++||||++|--|...- ++....-.+...|++-+.-+-..| |||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 6655544 4678999999886554432 111222233444444444444677 9999999999999999
Q ss_pred CcEEEeeecccccc
Q 002289 747 FTAKVADFGLSRLA 760 (941)
Q Consensus 747 ~~~kl~DFGla~~~ 760 (941)
|.+.++||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.4e-06 Score=92.28 Aligned_cols=260 Identities=15% Similarity=0.162 Sum_probs=159.8
Q ss_pred ccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeec------ccc-CCcEEEEE
Q 002289 613 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY------CDE-EGEQMLVY 684 (941)
Q Consensus 613 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~------~~~-~~~~~LV~ 684 (941)
..+.||+|+-+.+|-.- .-...+-|+..........+ .+..|... .||-+-.=+.+ -.+ .....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35789999999998532 11223456666433332222 22233332 45543321111 112 22367788
Q ss_pred ecCCCC-CHHHHHh----hcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 685 EFMSNG-TLRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 685 e~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
..+.+. -..+++. ++.-...+|+..++.++.++.+.+-||..| .+-+|+.++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 877654 2222222 233345899999999999999999999999 89999999999999999999987543221
Q ss_pred cCCCCCCCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhC-CCCCCCCch---hHHHHHHH
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTG-MQPISHGKN---IVREVNIA 830 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG-~~Pf~~~~~---~~~~~~~~ 830 (941)
-. .........|...|.+||... +..-+...|-|.+|+++++++.| +.||..... .....+..
T Consensus 167 ~~--------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 167 NA--------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cc--------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 11 123344567888999999865 34456679999999999999996 999964211 00000001
Q ss_pred HhhccchhhhcCCCC------CCC-hHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhHhhCC
Q 002289 831 YQSSMMFSVIDGNMG------SYP-SECVEKFIKLALKCCQDE--TDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~------~~~-~~~~~~l~~l~~~c~~~~--p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
.....+...-+...+ ..| .-.+..+..+...|+... +.-||+.+.++..|......+.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 111111111111111 122 223457788888888664 5689999999998887765443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.6e-08 Score=112.17 Aligned_cols=184 Identities=19% Similarity=0.320 Sum_probs=120.9
Q ss_pred HHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc--cccccccccccCCCcccccccccC
Q 002289 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLTH 792 (941)
Q Consensus 715 ~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~ 792 (941)
+++.|+.|+|... .+||++|.|++|.++..+..||+.|+.+.....+..... ..............|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999999755 499999999999999999999999998765443211000 001112223345689999999998
Q ss_pred CCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCC
Q 002289 793 KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 871 (941)
Q Consensus 793 ~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP 871 (941)
..+.++|+||+|+++|.+.. |+.-+........+ .... ...+...-.+..+.+.++.+-+.+.+..++.-||
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~------~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSR------NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhh------cccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 88999999999999999995 54444333221111 1000 0111111123455667777888888999999999
Q ss_pred CHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC
Q 002289 872 SMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 912 (941)
Q Consensus 872 s~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa 912 (941)
++..+... ..+.+....+..|+..+.++||.+--+.
T Consensus 258 ~~~~l~~~-----~ff~D~~~~aLrfLD~l~~kdn~qKs~F 293 (700)
T KOG2137|consen 258 TLDLLLSI-----PFFSDPGLKALRFLDDLPQKDNSQKSSF 293 (700)
T ss_pred chhhhhcc-----cccCCchhhhhhhcccccccCcHHHHHH
Confidence 77655432 2344455566778888888888655443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.1e-09 Score=118.13 Aligned_cols=126 Identities=25% Similarity=0.307 Sum_probs=75.9
Q ss_pred ccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCc-cCCCCCCCCEEec
Q 002289 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP-ELSELPKLLILQL 233 (941)
Q Consensus 155 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L 233 (941)
.|...+.+.|.+. ....++.-++.|+.|+|++|++... +.+..++.|++|||++|.|+ .+|. ...++. |..|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4666677777766 5566666667777777777777633 25666777777777777776 3332 233333 777777
Q ss_pred cCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCccccc-ccCCcCEEEccCCcCC
Q 002289 234 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL-LSLNITTIKLSNNKLT 295 (941)
Q Consensus 234 s~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l-~~~~L~~L~Ls~N~l~ 295 (941)
++|-++.. ..+.++++|+.|||++|-|.+. ..+.++ .+..|+.|+|.+|.+.
T Consensus 240 rnN~l~tL---~gie~LksL~~LDlsyNll~~h-------seL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL---RGIENLKSLYGLDLSYNLLSEH-------SELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh---hhHHhhhhhhccchhHhhhhcc-------hhhhHHHHHHHHHHHhhcCCccc
Confidence 77776531 3456677777777777766531 111111 1234566777777665
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.9e-08 Score=118.21 Aligned_cols=104 Identities=26% Similarity=0.293 Sum_probs=56.7
Q ss_pred CCCEEEcccCC--CCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEe
Q 002289 107 YLTILDFMWNK--ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (941)
Q Consensus 107 ~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (941)
+|++|-+..|. +..+.++.|..++.|++|||++|.=.+.+|..+++|-+|++|+|++..++ .+|..+.+|++|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 45555555554 33222333555566666666655544455666666666666666666555 5555555555666665
Q ss_pred cccccccccCchhccCCCccceeeccC
Q 002289 185 MNNNSISGQIPPELSRLPSLVHMLLDN 211 (941)
Q Consensus 185 L~~N~l~~~~p~~~~~l~~L~~L~L~~ 211 (941)
+..+.-...+|.....+.+|++|.+..
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccccccccccchhhhcccccEEEeec
Confidence 555554444444444555555555543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=2e-06 Score=87.11 Aligned_cols=137 Identities=19% Similarity=0.185 Sum_probs=103.8
Q ss_pred eccCcEEEEEEEeCCCcEEEEEEeccC---C---chhhHhHHHHHHHHHhcCCCc--eeeeeeccc-c----CCcEEEEE
Q 002289 618 GQGGYGKVYKGILPDGTVVAVKRAQEG---S---LQGEKEFLTEIQFLSRLHHRN--LVSLVGYCD-E----EGEQMLVY 684 (941)
Q Consensus 618 G~G~fg~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~-~----~~~~~LV~ 684 (941)
|+||.+.|++-... |+.+-+|.-... + .-++..|.+|+..++++...+ +.+.. ++. . .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888889987764 447888876521 1 235678999999999985332 44444 332 1 12468999
Q ss_pred ecCCC-CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--EEEeeeccccc
Q 002289 685 EFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 759 (941)
Q Consensus 685 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DFGla~~ 759 (941)
|-++| .+|.+++......+.+...+..+..++++.+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97743 68999987655556778888899999999999999999 999999999999986666 99999987653
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.6e-08 Score=102.49 Aligned_cols=172 Identities=17% Similarity=0.237 Sum_probs=105.8
Q ss_pred ccccccceEecccccccccCch----hccCCCccceeeccCCcCCCCC----Ccc---------CCCCCCCCEEeccCCc
Q 002289 175 ANLNKTRHFHMNNNSISGQIPP----ELSRLPSLVHMLLDNNNLTGYL----PPE---------LSELPKLLILQLDNNN 237 (941)
Q Consensus 175 ~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~----p~~---------~~~l~~L~~L~Ls~N~ 237 (941)
..|++|+.++||+|-|....|. .+++-+.|++|.|++|.+.-.- ..+ ..+-+.|+......|+
T Consensus 89 lkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNR 168 (388)
T COG5238 89 LKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNR 168 (388)
T ss_pred hcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccch
Confidence 3344444444444444433332 2334455666666666554111 111 1234788899999998
Q ss_pred CCCCCc---chhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCC----cchhhcCCcccce
Q 002289 238 FEGTTI---PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGT----IPSNFSGLPRLQR 310 (941)
Q Consensus 238 l~~~~~---p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~ 310 (941)
+..... ...|..-.+|+.+.+.+|.|. +..+..+--++..+..+|+.|||.+|-++-. +..++..++.|+.
T Consensus 169 lengs~~~~a~~l~sh~~lk~vki~qNgIr--pegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE 246 (388)
T COG5238 169 LENGSKELSAALLESHENLKEVKIQQNGIR--PEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE 246 (388)
T ss_pred hccCcHHHHHHHHHhhcCceeEEeeecCcC--cchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence 874211 123444468999999999886 2223334444455667899999999998743 4556677888999
Q ss_pred eecccccCccCCCccccc-ccccCccccceEEccCCCCC
Q 002289 311 LFIANNSLSGSIPSSIWQ-SRTLNATETFILDFQNNNLT 348 (941)
Q Consensus 311 L~Ls~N~l~~~~p~~~~~-l~~l~~~~L~~L~Ls~N~l~ 348 (941)
|.+.+|-++...-.++.. ......++|+.|.+.+|.+.
T Consensus 247 L~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 247 LRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred ccccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 999999998666555433 34455667777777777664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.6e-06 Score=89.74 Aligned_cols=106 Identities=25% Similarity=0.304 Sum_probs=83.2
Q ss_pred hHhHHHHHHHHHhcCCCc--eeeeeeccccC----CcEEEEEecCCCC-CHHHHHhhcCCCCccHHHHHHHHHHHHHHHH
Q 002289 649 EKEFLTEIQFLSRLHHRN--LVSLVGYCDEE----GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 721 (941)
Q Consensus 649 ~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~----~~~~LV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 721 (941)
.....+|.+.+..+.... +.+.+++.... ...++|+|++++. +|.+++..... .+......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346788888888775333 44556655432 2458999999874 89999865333 556677889999999999
Q ss_pred HhhcCCCCCeEeccCCCCcEEEcCCC---cEEEeeeccccc
Q 002289 722 YLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRL 759 (941)
Q Consensus 722 yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DFGla~~ 759 (941)
-||..| |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.9e-08 Score=89.34 Aligned_cols=133 Identities=23% Similarity=0.228 Sum_probs=87.6
Q ss_pred eeEEEecCCCCCcc--CCccccCCCCCCEEEcccCCCCCCCCCccC-CccccceecccCccccCCCCcccCCcCccceee
Q 002289 84 LRELQLLNLNLSGN--LSPEIGRLSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 84 l~~L~L~~~~l~~~--~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
+-.++|+++.|... .+..+....+|+..+|++|.+. ..|..|. ..+.++.|+|++|.|+ .+|..+..++.|+.|+
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34456666665421 2234556667777788888887 4555554 3457888888888888 6777788888888888
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCc
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 220 (941)
++.|.|. ..|..+..|.+|..|+..+|.+. .+|-.+..-...-...+.++.+.+.-+.
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 8888887 56666777888888888888777 4554433333344445566666655443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.4e-06 Score=97.65 Aligned_cols=141 Identities=22% Similarity=0.276 Sum_probs=93.2
Q ss_pred ceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh----------------------------------------hHhHHH
Q 002289 615 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----------------------------------------EKEFLT 654 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 654 (941)
+.|+.++-|.||+|++++|+.||||+.+..-... +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999876421100 012344
Q ss_pred HHHHHHhcC-----CCceeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHH-HHHhhcCCC
Q 002289 655 EIQFLSRLH-----HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG-ILYLHTEAD 728 (941)
Q Consensus 655 E~~~l~~l~-----h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~ 728 (941)
|..-+.+++ .+++.--.=|..-.+...|+|||++|-.+.+...-+. ..++ +..++..++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhcC-
Confidence 555444442 3333222222233567899999999999988742221 2233 22333333332 33333456
Q ss_pred CCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 729 ~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
+.|.|..|.||+++.+|++.+.|||+...+..
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 941 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-26 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-153
Identities = 122/314 (38%), Positives = 174/314 (55%), Gaps = 17/314 (5%)
Query: 581 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKR 640
SS + + ++ ATNNF+ IG G +GKVYKG+L DG VA+KR
Sbjct: 12 INDALSSSYLVPFES-YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 641 AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SA 698
S QG +EF TEI+ LS H +LVSL+G+CDE E +L+Y++M NG L+ L S
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 699 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758
+ + RL I +G++RG+ YLHT + HRD+K+ NILLD F K+ DFG+S+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
D H+STVVKGT GY+DPEYF+ +LT+KSDVYS GVV E+L I
Sbjct: 188 KGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 819 HGK-----NIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPS 872
N+ ++ + + ++D N+ E + KF A+KC ++ RPS
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 873 MSEVMRELESIWNM 886
M +V+ +LE +
Sbjct: 303 MGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-126
Identities = 123/298 (41%), Positives = 184/298 (61%), Gaps = 17/298 (5%)
Query: 596 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLT 654
++ F+ E+ +A++NF++ +G+GG+GKVYKG L DGT+VAVKR +E QG E +F T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 655 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSI 712
E++ +S HRNL+ L G+C E++LVY +M+NG++ L +S+ PL + R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772
ALGS+RG+ YLH DP + HRD+KA+NILLD +F A V DFGL++L D H
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD------TH 190
Query: 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI-------SHGKNIVR 825
V+T V+GT G++ PEY T K ++K+DV+ GV+ LEL+TG + ++
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 826 EVNIAYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
V + + +++D ++ Y E VE+ I++AL C Q RP MSEV+R LE
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-124
Identities = 100/304 (32%), Positives = 164/304 (53%), Gaps = 25/304 (8%)
Query: 595 GVRSFTYGEMALATNNFNSSTQ------IGQGGYGKVYKGILPDGTVVAVKR----AQEG 644
SF++ E+ TNNF+ +G+GG+G VYKG + + T VAVK+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 645 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL-SAKSKEP 703
+ + +++F EI+ +++ H NLV L+G+ + + LVY +M NG+L D+L P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 704 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763
L + MR IA G++ GI +LH + HRDIK++NILLD FTAK++DFGL+R +
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 823
+++ + GT Y+ PE L ++T KSD+YS GVV LE++TG+ + +
Sbjct: 187 AQT-----VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 824 VREVNIAY----QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879
++I + + ID M S VE +A +C ++ + RP + +V +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 880 LESI 883
L+ +
Sbjct: 301 LQEM 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 9e-79
Identities = 87/321 (27%), Positives = 131/321 (40%), Gaps = 25/321 (7%)
Query: 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ +P + AL IKK L + + LS+W D C W GVLC T + L L
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDL 57
Query: 90 LNLNLSG--NLSPEIGRLSYLTILDFM-WNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
LNL + + L YL L N + G IP I + L L + ++G++
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
P+ L + L + N +SG+LP S ++L + N ISG IP L
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 207 ML-LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ + N LTG +PP + L L + L N EG + + K+ L SL
Sbjct: 178 SMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235
Query: 266 PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 325
+ + NL L L NN++ GT+P + L L L ++ N+L G IP
Sbjct: 236 DLGKVGLSKNLNGL--------DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 326 IWQSRTLNATETFILDFQNNN 346
+ + + NN
Sbjct: 288 -GNLQRFDV-----SAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 3e-19
Identities = 25/119 (21%), Positives = 47/119 (39%), Gaps = 4/119 (3%)
Query: 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
L+L + L L G+ S G + N ++ + ++G K+L L L
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRN 253
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPP 196
N + G+LP+ L L L + + N + G +P+ + + + N +P
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS-AYANNKCLCGSPLPA 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-76
Identities = 64/316 (20%), Positives = 109/316 (34%), Gaps = 44/316 (13%)
Query: 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF 658
+ + +G +G V+K VAVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 659 LSRLHHRNLVSLVGYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 714
L + H N++ +G + + L+ F G+L D L + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAE 128
Query: 715 GSSRGILYLHTEAD-------PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767
+RG+ YLH + P + HRDIK+ N+LL + TA +ADFGL+ G
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 768 IVPAHVSTVVKGTPGYLDPEYF-----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
+ GT Y+ PE + D+Y++G+V EL +
Sbjct: 189 -----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG--- 240
Query: 823 IVREVNIAYQS---------SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDET 867
V E + ++ M V+ + + +C +
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 868 DARPSMSEVMRELESI 883
+AR S V + +
Sbjct: 301 EARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-70
Identities = 78/334 (23%), Positives = 129/334 (38%), Gaps = 45/334 (13%)
Query: 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--I 656
E +L +N IG+G YG VYKG L D VAVK S + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 657 QFLSRLHHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 711
+ + H N+ + D E +LV E+ NG+L LS +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 712 IALGSSRGILYLHTEAD------PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPD 764
+A +RG+ YLHTE P + HRD+ + N+L+ + T ++DFGLS L
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 765 IEGIVPAHVSTVVKGTPGYLDPEYF-------LTHKLTDKSDVYSLGVVFLELLTGMQPI 817
+ + + GT Y+ PE + D+Y+LG+++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 818 SHGKNIVREVNIAYQS---------SMMFSVIDGNM-------GSYPSECVEKFIKLALK 861
G++ V E +A+Q+ M V S V +
Sbjct: 236 FPGES-VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 862 CCQDETDARPSMSEVMRELESIWNMMPESDTKTP 895
C + +AR + + + + + + +P
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 8e-70
Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 25/303 (8%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+G+G +G V K VA+K+ + S K F+ E++ LSR++H N+V L G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 676 EEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
LV E+ G+L + L A+ A +S L S+G+ YLH+ + HR
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 735 DIKASNILLDHKFT-AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
D+K N+LL T K+ DFG + T KG+ ++ PE F
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI----------QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 794 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 853
++K DV+S G++ E++T +P + M++V +G +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--------MWAVHNGTRPPLIKNLPK 231
Query: 854 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 913
L +C + RPSM E+++ + + P +D E+
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 291
Query: 914 SML 916
Sbjct: 292 VDF 294
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-68
Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 23/272 (8%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
+IG G +G V++ G+ VAVK Q+ + EFL E+ + RL H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 674 CDEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ +V E++S G+L L + ++E L RLS+A ++G+ YLH +PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HR++K+ N+L+D K+T KV DFGLSRL + S GTP ++ PE
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-------SKSAAGTPEWMAPEVLRDE 214
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-SYPSEC 851
+KSDVYS GV+ EL T QP + ++ +V P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPA----------QVVAAVGFKCKRLEIPRNL 264
Query: 852 VEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ + C +E RPS + +M L +
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-66
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-------KEFLTEIQFLSRLHHRNL 667
QIG+GG+G V+KG + D +VVA+K G +GE +EF E+ +S L+H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
V L G +V EF+ G L +L P+ ++++L + L + GI Y+ +
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 728 DPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 782
+PP+ HRD+++ NI L AKVADFGLS+ + H + + G
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----------VHSVSGLLGNFQ 191
Query: 783 YLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
++ PE + T+K+D YS ++ +LTG P + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--------KIKFINMIR 243
Query: 841 DGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ + + P +C + + C + RP S +++EL +
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 5e-65
Identities = 83/281 (29%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----GEKEFLTEIQFLSRLHHRNLVSLV 671
IG GG+GKVY+ G VAVK A+ + + E + + L H N+++L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G C +E LV EF G L L S + + + ++ A+ +RG+ YLH EA P+
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 732 FHRDIKASNILLDHKF--------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
HRD+K+SNIL+ K K+ DFGL+R G +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---------EWHRTTKMSAAGAYAW 180
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
+ PE + SDV+S GV+ ELLTG P + ++ + V
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----------AVAYGVAMNK 230
Query: 844 M-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ PS C E F KL C + +RPS + ++ +L +I
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-64
Identities = 65/306 (21%), Positives = 119/306 (38%), Gaps = 20/306 (6%)
Query: 616 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+G+G +G+ K G V+ +K + ++ FL E++ + L H N++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
++ + E++ GTLR + ++ R+S A + G+ YLH+ + HR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 735 DIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGYLDPE 787
D+ + N L+ VADFGL+RL V G P ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847
+K DV+S G+V E++ + + +V
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY--------LPRTMDFGLNVRGFLDRYC 244
Query: 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 907
P C F + ++CC + + RPS ++ LE++ + P+ + E
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWET 304
Query: 908 TPPSSS 913
S
Sbjct: 305 YRRGES 310
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-63
Identities = 83/295 (28%), Positives = 125/295 (42%), Gaps = 22/295 (7%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
L+ L++ N S + P +G S L LD NK+SG + I L+LL ++
Sbjct: 198 RCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA-NLNKTRHFHMNNNSISGQIPPEL 198
N+ G +P L L + + +N +G +P + + ++ N G +PP
Sbjct: 257 NQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 199 SRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMS-KLLKL 256
L + L +NN +G LP + L ++ L +L L N F G +P S +N+S LL L
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE-LPESLTNLSASLLTL 373
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 316
L + + GP+ PNL + + L NN TG IP S L L ++ N
Sbjct: 374 DLSSNNFSGPIL-----PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN 428
Query: 317 SLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSFNIPPN-VTVRLRGNPF 369
LSG+IPSS+ L L N L I T+ L N
Sbjct: 429 YLSGTIPSSLGSLSKLR-----DLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 7e-59
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 29/298 (9%)
Query: 80 GYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136
LQ L L +G + P + S L L +N +SG+IP +G++ L L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 196
L N L G +P+EL Y+ L+ + +D N ++G +P +N ++NN ++G+IP
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 197 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 256
+ RL +L + L NN+ +G +P EL + L+ L L+ N F G TIPA+ S +
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG-TIPAAMFKQSGKIAA 567
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLLSLN---------------ITTIKLSNNKLTGTIPSN 301
+ + + +L +++ G
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPN 359
F + L ++ N LSG IP I L IL+ +N++ SGS IP
Sbjct: 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF-----ILNLGHNDI---SGS--IPDE 675
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 9e-55
Identities = 63/271 (23%), Positives = 120/271 (44%), Gaps = 22/271 (8%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+++ L+ L L +L+G + + + L + N+++G IPK IG +++L +L L+
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
N +G++P ELG L + ++ N +G++P + + + N I+G+ +
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIK 579
Query: 200 RLPSLVHMLLDNN--NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
N G +L+ L + + + G ++ N ++ L
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH-TSPTFDNNGSMMFLD 638
Query: 258 LRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 317
+ L G +P I ++ YL LN L +N ++G+IP L L L +++N
Sbjct: 639 MSYNMLSGYIP--KEIGSMPYLFILN-----LGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 318 LSGSIPSSIWQSRTLNATETFILDFQNNNLT 348
L G IP ++ L +D NNNL+
Sbjct: 692 LDGRIPQAMSALTMLT-----EIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-54
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 25/279 (8%)
Query: 84 LRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
L +L+ L L L G + E+ + L L +N ++G IP + N +L + L+ N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
LTG +P+ +G L L +++ N SG++P + +N N +G IP + +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLR 259
+ N + G + N E + +S ++
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
+ G N G ++ L+ +S N L+G IP +P L L + +N +S
Sbjct: 617 SRVYGGHTSPT--FDNNGSMMFLD-----MSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPP 358
GSIP + R LN ILD +N L G IP
Sbjct: 670 GSIPDEVGDLRGLN-----ILDLSSNKL---DGR--IPQ 698
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-53
Identities = 63/337 (18%), Positives = 118/337 (35%), Gaps = 62/337 (18%)
Query: 36 EVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNL 94
E+ L S K L D + L +W+ +PC + GV C + + + L + L
Sbjct: 13 EIHQLISFKDVLPDK-NLLPDWSSNKNPC--TFDGVTCRDD-------KVTSIDLSSKPL 62
Query: 95 SGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP 154
+ ++ + ++ LE L L+ + + GS+
Sbjct: 63 NVGF---------------------SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSA 100
Query: 155 KLDRIQIDQNYISGSLP--KSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDN 211
L + + +N +SG + S + + + ++++N++ +L SL + L
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160
Query: 212 NNLTGYLPPEL---SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
N+++G +L L + N G + S L L + + + +P
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISG-DVD--VSRCVNLEFLDVSSNNFSTGIP 217
Query: 269 DLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 328
L L + +S NKL+G S L+ L I++N G IP +
Sbjct: 218 FLGDCSAL--------QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK 269
Query: 329 SRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLR 365
S L N T G IP ++
Sbjct: 270 SLQ-------YLSLAENKFT---GE--IPDFLSGACD 294
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-28
Identities = 34/158 (21%), Positives = 60/158 (37%), Gaps = 3/158 (1%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWN--KISGSIPKEIGNIKSLELLLLNGNELTGSL 146
+ ++G I N + G +++ + + + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
+ + + N +SG +PK ++ ++ +N ISG IP E+ L L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
+ L +N L G +P +S L L + L NNN G IP
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG-PIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-26
Identities = 41/142 (28%), Positives = 66/142 (46%)
Query: 78 DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
+DG L G S ++ RLS + G N S+ L +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE 197
+ N L+G +P+E+G +P L + + N ISGS+P +L +++N + G+IP
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699
Query: 198 LSRLPSLVHMLLDNNNLTGYLP 219
+S L L + L NNNL+G +P
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIP 721
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 54/278 (19%), Positives = 111/278 (39%), Gaps = 34/278 (12%)
Query: 615 TQIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
T++ + G+++KG G + VK + ++ S + ++F E L H N++ ++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 673 YCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
C L+ +M G+L + L + + + + AL +RG+ +LHT +P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ + + ++++D TA+++ + S P ++ PE L
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS------------FQSPGRMYAPAWVAPE-AL 180
Query: 791 THK----LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG- 845
K +D++S V+ EL+T P + N+ + V +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----------EIGMKVALEGLRP 230
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ P KL C ++ RP ++ LE +
Sbjct: 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-60
Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 673
+IG G +G VYKG G V AVK + + + F E+ L + H N++ +GY
Sbjct: 31 RIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+ +V ++ +L L S+ + IA ++RG+ YLH + H
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---YFL 790
RD+K++NI L T K+ DFGL+ +H + G+ ++ PE
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM----GS 846
++ + +SDVY+ G+V EL+TG P S+ N ++ V G++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---------DQIIEMVGRGSLSPDLSK 249
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
S C ++ +L +C + + D RPS ++ E+E +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-59
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 31/280 (11%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 673
IG+G +G+VY G G V A++ + K F E+ + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
C ++ TL + +K L IA +G+ YLH + H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
+D+K+ N+ D+ + DFGL ++ V + G +L PE
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLS 210
Query: 794 L---------TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
+ SDV++LG ++ EL P ++++ + G
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----------EAIIWQMGTGMK 260
Query: 845 GSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ ++ + L C E + RP+ +++M LE +
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-57
Identities = 66/300 (22%), Positives = 108/300 (36%), Gaps = 46/300 (15%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 673
+G+G YG+V++G G VAVK S + EK + TE+ L H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 674 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 728
+ L+ + G+L D L L L I L + G+ +LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 729 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
P + HRD+K+ NIL+ +AD GL+ + + V + GT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG---NNPRVGTKRYM 184
Query: 785 DPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ------ 832
PE + D+++ G+V E+ M IV + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG----IVEDYKPPFYDVVPND 240
Query: 833 ---SSMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
M V + + KL +C AR + + + L I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-55
Identities = 74/304 (24%), Positives = 113/304 (37%), Gaps = 46/304 (15%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 673
QIG+G YG+V+ G G VAVK E + TEI + H N++ +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 674 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 728
+ L+ ++ NG+L D L L L +A S G+ +LHTE
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 729 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
P + HRD+K+ NIL+ T +AD GL+ E +P GT Y+
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP---PNTRVGTKRYM 213
Query: 785 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS----- 833
PE H + +D+YS G++ E+ IV E + Y
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG----IVEEYQLPYHDLVPSD 269
Query: 834 ----SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
M V + EC+ + KL +C +R + V + L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 884 WNMM 887
Sbjct: 330 SESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-53
Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 46/300 (15%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--IQFLSRLHHRNLVSLVGY 673
IG+G +G+V++G G VAVK S + E+ + E I L H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 674 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 728
+ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 729 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
P + HRD+K+ NIL+ T +AD GL+ D GT Y+
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYM 218
Query: 785 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS----- 833
PE + H + ++D+Y++G+VF E+ + + Y
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI----HEDYQLPYYDLVPSD 274
Query: 834 ----SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
M V + + E + K+ +C AR + + + L +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-47
Identities = 62/367 (16%), Positives = 113/367 (30%), Gaps = 66/367 (17%)
Query: 28 DDSITDPIEVSALRSIKKSLVDDYSKLSNWNR------------GDPCTSNWT------- 68
D+++TD V S + DY L G +NW
Sbjct: 9 DNALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDM 68
Query: 69 -----GVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISG--- 120
GV + + L L SG + IG+L+ L +L +
Sbjct: 69 WGAQPGVSLNSNG------RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 121 -SIPKEIGNIKSLELLLLNGNELTGSLPEELGYL--PKLDRIQIDQNYISGSLPKSFANL 177
PK I S E + + L + I+ + S+ KS
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
K +N+I+ + + RL L + N+ E E Q
Sbjct: 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ---- 237
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLT- 295
T + N+ L + + NC +P L +P + I ++ N+
Sbjct: 238 --YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM--------QLINVACNRGIS 287
Query: 296 -------GTIPSNFSGLPRLQRLFIANNSL-SGSIPSSIWQSRTLNATETFILDFQNNNL 347
++ ++Q ++I N+L + + +S+ + + L +L+ N L
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG-----MLECLYNQL 342
Query: 348 TNISGSF 354
+F
Sbjct: 343 EGKLPAF 349
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-45
Identities = 50/305 (16%), Positives = 98/305 (32%), Gaps = 54/305 (17%)
Query: 87 LQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISG-------------------SIP 123
L+ + N +S + RL+ L + +
Sbjct: 183 LKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 124 KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI--------SGSLPKSFA 175
+ N+K L + + LP L LP++ I + N
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 176 NLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
K + ++ N++ + + L ++ L + N L G P KL L L
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLA 361
Query: 235 NNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNK 293
N T IPA+ ++ LS + L+ +P++ ++ + +++ S N+
Sbjct: 362 YNQI--TEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAID-----FSYNE 413
Query: 294 LTGTIPSNFSGLP-------RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 346
+ NF L + + ++NN +S L+ ++ N
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS-----SINLMGNM 468
Query: 347 LTNIS 351
LT I
Sbjct: 469 LTEIP 473
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-41
Identities = 52/293 (17%), Positives = 92/293 (31%), Gaps = 35/293 (11%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+++L +L L G P G L L+ +N+I+ G + +E L
Sbjct: 328 KMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH 386
Query: 140 NELTGSLPE--ELGYLPKLDRIQIDQNYISG-------SLPKSFANLNKTRHFHMNNNSI 190
N+L +P + + + I N I L + +++NN I
Sbjct: 387 NKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445
Query: 191 SGQIPPELSRLPSLVHMLLDNNNLTG-------YLPPELSELPKLLILQLDNNNFEGTTI 243
S S L + L N LT L + L N T +
Sbjct: 446 SKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL--TKL 503
Query: 244 PAS--YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN 301
+ + L+ + L S L N N+ P
Sbjct: 504 SDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRN--QRDAQGNRTLREWPEG 561
Query: 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 354
+ P L +L I +N + + I + ++ +LD ++N +I S+
Sbjct: 562 ITLCPSLTQLQIGSNDIR-KVNEKITPN--IS-----VLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 36/259 (13%), Positives = 84/259 (32%), Gaps = 39/259 (15%)
Query: 88 QLLNLNLSGNL------SPEIGRLSYLTILDFMWNKISG-------SIPKEIGNIKSLEL 134
Q+ NL+ + N + +S ++ +DF +N+I + ++
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 135 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG-------SLPKSFANLNKTRHFHMNN 187
+ L+ N+++ E L I + N ++ ++F N +
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497
Query: 188 NSISGQIPPEL--SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN-----NFEG 240
N ++ + + + LP LV + L N+ + P + L + N N
Sbjct: 498 NKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPS 300
P + L +L + + D+ ++ + NI+ + + +N S
Sbjct: 556 REWPEGITLCPSLTQLQIGSN-------DIRKVNEK--ITP-NISVLDIKDNPNISIDLS 605
Query: 301 NFSGLPRLQRLFIANNSLS 319
+ +
Sbjct: 606 YVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-28
Identities = 37/249 (14%), Positives = 70/249 (28%), Gaps = 38/249 (15%)
Query: 84 LRELQLLNL----------NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLE 133
+ + ++ L P + ++ ++ N+IS + L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 134 LLLLNGNELTG-------SLPEELGYLPKLDRIQIDQNYISGSLPKSFA--NLNKTRHFH 184
+ L GN LT E L I + N ++ L F L
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGID 519
Query: 185 MNNNSISGQIPPELSRLPSLVHM------LLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
++ NS S P + +L N P ++ P L LQ+ +N+
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTI 298
+ + L +++ DLS + L +K
Sbjct: 579 --RKVNE--KITPNISVLDIKDNPNIS--IDLSYVCPYIEAGMYM-----LFYDKTQDIR 627
Query: 299 PSNFSGLPR 307
+ + R
Sbjct: 628 GCDALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-24
Identities = 35/202 (17%), Positives = 70/202 (34%), Gaps = 24/202 (11%)
Query: 75 TTMDDGYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISG-------SIPK 124
+D + +NL +S S L+ ++ M N ++ +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGY--LPKLDRIQIDQNYISGSLPKSFANLNKTRH 182
N L + L N+LT L ++ LP L I + N S P N + +
Sbjct: 483 NFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
Query: 183 FHMNN------NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
F + N N + P ++ PSL + + +N++ + ++ P + +L + +N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDN 597
Query: 237 NFEGTTIPASYSNMSKLLKLSL 258
+ + L
Sbjct: 598 PNIS-IDLSYVCPYIEAGMYML 618
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 15/131 (11%), Positives = 35/131 (26%), Gaps = 19/131 (14%)
Query: 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTG----TIPSNFS 303
++ ++ LSL G +P +G L L + L ++ P S
Sbjct: 78 NSNGRVTGLSLEGFGASGRVP-----DAIGQLTEL--EVLALGSHGEKVNERLFGPKGIS 130
Query: 304 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 363
++ + D + + + +I + +
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYD--------PREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 364 LRGNPFCLNTN 374
L+ +N
Sbjct: 183 LKDTQIGQLSN 193
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-46
Identities = 81/314 (25%), Positives = 138/314 (43%), Gaps = 30/314 (9%)
Query: 576 NYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGT 634
++ +++ + K+ + + R+ + L + QIG+G +G+V+ G L D T
Sbjct: 83 DHLLSTQQPLTKKSGVVL--HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNT 140
Query: 635 VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 693
+VAVK +E + +FL E + L + H N+V L+G C ++ +V E + G
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 694 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753
L L L + ++ G+ YL ++ HRD+ A N L+ K K++D
Sbjct: 201 TFLR-TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISD 256
Query: 754 FGLSRLAPVPDIEGIVPAHVSTV---VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 810
FG+SR +G+ A VK T PE + + +SDV+S G++ E
Sbjct: 257 FGMSREEA----DGVYAASGGLRQVPVKWTA----PEALNYGRYSSESDVWSFGILLWET 308
Query: 811 LT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA 869
+ G P + N ++ V G P C + +L +C E
Sbjct: 309 FSLGASPYPNLSN--QQT--------REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQ 358
Query: 870 RPSMSEVMRELESI 883
RPS S + +EL+SI
Sbjct: 359 RPSFSTIYQELQSI 372
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-44
Identities = 67/308 (21%), Positives = 116/308 (37%), Gaps = 18/308 (5%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
++ L L + L + R S LT LD +N IS P+ + L++L L NEL
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ + + L + + N I F +++N +S +L
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 203 SLVHMLLDNNNLTGYLPPELS--ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+L +LL NN + EL L L+L +N + P + + +L L L N
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNN 204
Query: 261 CSLQGPMPDLSRIPNLGYLLSL-NITTIKLSNNKLTGTIPSNFSGL--PRLQRLFIANNS 317
L + L L+ +I + LSN++L+ T + F GL L L ++ N+
Sbjct: 205 VQLGPSLT-----EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
Query: 318 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPFCLNTNA 375
L+ S L + NN+ ++ S S + NV L+ + + +
Sbjct: 260 LNVVGNDSFAWLPQLE-----YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 376 EQFCGSHS 383
Sbjct: 315 ASLPKIDD 322
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-37
Identities = 61/301 (20%), Positives = 107/301 (35%), Gaps = 20/301 (6%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIG----NIKSLELL 135
L+ L+ LN+ ++ G S L L L + S L +L
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386
Query: 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQI 194
L N+++ + +L L+ + + N I L + L +++ N
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446
Query: 195 PPELSRLPSLVHMLLDNNNLTG--YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ +PSL ++L L P L L IL L NNN + K
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI-NDDMLEGLEK 505
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRL 311
L L L++ +L + + +L L ++ + L +N F L L+ +
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565
Query: 312 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTV-RLRGNP 368
+ N+L+ S +L L+ Q N +T++ N+T +R NP
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLK-----SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620
Query: 369 F 369
F
Sbjct: 621 F 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-37
Identities = 52/309 (16%), Positives = 104/309 (33%), Gaps = 27/309 (8%)
Query: 80 GYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIG---NIKSLE 133
L+ L L + + L L ++ S+ +++ S+
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 134 LLLLNGNELTGSLPEELGYL--PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
L L+ ++L+ + L L + + N ++ SFA L + +F + N+I
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 192 GQIPPELSRLPSLVHMLLDNN---------NLTGYLPPELSELPKLLILQLDNNNFEGTT 242
L L ++ ++ L + +L L L L +++N+ G
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI- 344
Query: 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNF 302
++ + L LSL N +L + + L+ NK++ F
Sbjct: 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA---HSPLHILNLTKNKISKIESDAF 401
Query: 303 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVT 361
S L L+ L + N + + W+ F + N + SF + P++
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWR----GLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 362 V-RLRGNPF 369
LR
Sbjct: 458 RLMLRRVAL 466
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-22
Identities = 37/237 (15%), Positives = 67/237 (28%), Gaps = 16/237 (6%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISG--SIPKEIGNIKSLELLLL 137
L + + L + L L + S P +++L +L L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYIS--------GSLPKSFANLNKTRHFHMNNNS 189
+ N + + L L KL+ + + N ++ G L+ ++ +N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 190 ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSN 249
L L + L NNL + L L L N
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
Query: 250 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLP 306
L +L +R I ++ T I ++ P ++ G P
Sbjct: 608 FRNLTELDMRFNPFDC---TCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP 661
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 26/311 (8%)
Query: 616 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
Q+G+G +G V G +VAVK+ Q +++F EIQ L LH +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 671 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
G G Q LV E++ +G LRD L + + L + L + +G+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR- 147
Query: 729 PPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
HRD+ A NIL++ + K+ADFGL++L P+ +V + + PE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA----PE 200
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846
+ + +SDV+S GVV EL T + S +R + + +++
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 847 Y----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 902
P C + +L C RPS S + +L+ +W+ +T F + H
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG--SRGCETHAF--TAH 316
Query: 903 TSKEETPPSSS 913
+ S S
Sbjct: 317 PEGKHHSLSFS 327
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 79/307 (25%), Positives = 132/307 (42%), Gaps = 65/307 (21%)
Query: 616 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G+G +GKV+ + +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALG 715
G C + ++V+E+M +G L L A K LG + L IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--------- 766
+ G++YL A HRD+ N L+ K+ DFG+SR D+
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGG 193
Query: 767 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGK 821
++P ++ P PE + K T +SDV+S GV+ E+ T G QP +S+
Sbjct: 194 HTMLP------IRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-- 241
Query: 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
EV + + G + P C ++ + L C Q E R ++ E+ + L
Sbjct: 242 ---TEV--------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 882 SIWNMMP 888
++ P
Sbjct: 291 ALGKATP 297
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 36/274 (13%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC- 674
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
+E+G +V E+M+ G+L D L ++ + LG L +L + YL HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
D+ A N+L+ AKV+DFGL++ A G +P VK T PE K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKF 191
Query: 795 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PS 849
+ KSDV+S G++ E+ + G P ++V + V G Y P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL--KDV--------VPRVEKG----YKMDAPD 237
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
C ++ C + RPS ++ +LE I
Sbjct: 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-42
Identities = 79/320 (24%), Positives = 128/320 (40%), Gaps = 58/320 (18%)
Query: 616 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 668
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGI 720
L+G + +++ E M+ G L+ L + P + + +A + G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIVP 770
YL HRD+ A N ++ FT K+ DFG++R DI +G++P
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLP 203
Query: 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 829
V+ PE T SDV+S GVV E+ T QP N +V
Sbjct: 204 ------VRWMS----PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQV-- 249
Query: 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889
+ V++G + P C + +L C Q RPS E++ ++ E
Sbjct: 250 ------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE----EME 299
Query: 890 SDTKTPEFINSEHTSKEETP 909
+ F SE E
Sbjct: 300 PGFREVSFYYSEENKLPEPE 319
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-42
Identities = 83/321 (25%), Positives = 128/321 (39%), Gaps = 37/321 (11%)
Query: 570 VRAHMKNYHAISRR-RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKG 628
V + + + R + F AL IG+G +G V G
Sbjct: 153 VEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG 212
Query: 629 ILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFM 687
G VAVK + + + FL E +++L H NLV L+G +E+G +V E+M
Sbjct: 213 DY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 747
+ G+L D L ++ + LG L +L + YL HRD+ A N+L+
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 326
Query: 748 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVF 807
AKV+DFGL++ A G +P VK T PE K + KSDV+S G++
Sbjct: 327 VAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFSTKSDVWSFGILL 376
Query: 808 LELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSECVEKFIKLALKC 862
E+ + G P Y + V+ Y P C + C
Sbjct: 377 WEIYSFGRVP--------------YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC 422
Query: 863 CQDETDARPSMSEVMRELESI 883
+ RP+ ++ +LE I
Sbjct: 423 WHLDAATRPTFLQLREQLEHI 443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 25/283 (8%)
Query: 616 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 669
+G+G +GKV G VAVK + S + EI+ L L+H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 670 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
G C E+G L+ EF+ +G+L++ L K+K + +L A+ +G+ YL +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLD 785
HRD+ A N+L++ + K+ DFGL++ + + V
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKA--IETDKEYYTVKDDRDSPVFWYA---- 197
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID--- 841
PE + K SDV+S GV ELLT S ++ + + + +++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 842 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
G P C ++ +L KC + + R S ++ E++
Sbjct: 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 79/302 (26%), Positives = 127/302 (42%), Gaps = 54/302 (17%)
Query: 616 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
++G+G +GKV+ + +VAVK +E S ++F E + L+ L H+++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQL-------------SAKSKEPLGFAMRLSIALGS 716
G C E ++V+E+M +G L L + PLG L++A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPA 771
+ G++YL A HRD+ N L+ K+ DFG+SR D ++P
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 223
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREV 827
++ P PE L K T +SDV+S GVV E+ T G QP +S+ E
Sbjct: 224 -----IRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEA 269
Query: 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887
+ + G P C + + C Q E R S+ +V L+++
Sbjct: 270 --------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
Query: 888 PE 889
P
Sbjct: 322 PV 323
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-41
Identities = 87/282 (30%), Positives = 126/282 (44%), Gaps = 22/282 (7%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 736
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 251 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 737 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 796
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 307 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 360
Query: 797 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 855
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPESL 410
Query: 856 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 897
L +C + E + RP+ + LE +
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-41
Identities = 84/284 (29%), Positives = 128/284 (45%), Gaps = 22/284 (7%)
Query: 616 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
++G G YG+VY+G+ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 342
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
++ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 396
Query: 795 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 853
+ KSDV++ GV+ E+ T GM P +V + P C E
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV--------YELLEKDYRMERPEGCPE 446
Query: 854 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 897
K +L C Q RPS +E+ + E+++ SD E
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 38/289 (13%)
Query: 617 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
IG+G +G VY G D A+K + + FL E + L+H N+++L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 672 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
G EG ++ +M +G L + + +S L +RG+ YL A+
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL---AEQK 144
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGY 783
HRD+ A N +LD FT KVADFGL+R + +P VK T
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP------VKWTA-- 196
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
E T++ T KSDV+S GV+ ELLT G P H ++ + G
Sbjct: 197 --LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDL--------THFLAQG 244
Query: 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 891
P C + ++ +C + + RP+ ++ E+E I + +
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 86/294 (29%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 617 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
IG+G +G VY G L D AVK + GE +FLTE + H N++SL+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 672 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
G C EG ++V +M +G LR+ + + L ++G+ YL A
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------------GIVPAHVSTVVK 778
HRD+ A N +LD KFT KVADFGL+R D+ +P VK
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKLP------VK 197
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 837
E T K T KSDV+S GV+ EL+T G P ++
Sbjct: 198 WMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI--------TV 243
Query: 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 891
++ G P C + ++ LKC + + RPS SE++ + +I++
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+IG G +G V+ G + VA+K +EG++ E++F+ E + + +L H LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
E+ LV EFM +G L D L + L + L G+ YL + V HRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 789
+ A N L+ KV+DFG++R V D + P VK PE F
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFP------VKWAS----PEVF 177
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
+ + KSDV+S GV+ E+ + G P + N EV + + G P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEV--------VEDISTGFRLYKP 227
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
++ C ++ + RP+ S ++R+L I
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 80/314 (25%), Positives = 125/314 (39%), Gaps = 56/314 (17%)
Query: 616 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 669
+G+G +G V + L VAVK + + +EFL E + H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 670 LVGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRG 719
LVG + M++ FM +G L L ++ L + + + G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIV 769
+ YL + HRD+ A N +L T VADFGLSR I +
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKL 201
Query: 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 828
P VK E + T SDV++ GV E++T G P + +N E+
Sbjct: 202 P------VKWLA----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEI- 248
Query: 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW-NMM 887
+I GN P EC+E+ L +C + RPS + + ELE+I ++
Sbjct: 249 -------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 888 PESDTKTPEFINSE 901
S ++ P +IN E
Sbjct: 302 VLSTSQDPLYINIE 315
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-41
Identities = 53/307 (17%), Positives = 104/307 (33%), Gaps = 53/307 (17%)
Query: 82 LHLRELQLLNL-NLSGNLSPEIGRLSYLTILDFMWNKISG-------------------S 121
+ L++ Q+ NL N +S I RL+ L I+ F + + +
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482
Query: 122 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG---------SLPK 172
N+K L + L LP+ L LP+L + I N L
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 173 SFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 230
K + F+M N++ P L ++ L + +N + KL
Sbjct: 543 DEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTD 599
Query: 231 LQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKL 289
L+LD N IP + + ++ L + L+ +P++ ++ + S++
Sbjct: 600 LKLDYNQI--EEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVD-----F 651
Query: 290 SNNKLTGTIPSNFSGLP-----RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 344
S NK+ + + + ++ N + ++ + N
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS-----TIILSN 706
Query: 345 NNLTNIS 351
N +T+I
Sbjct: 707 NLMTSIP 713
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-34
Identities = 46/309 (14%), Positives = 93/309 (30%), Gaps = 40/309 (12%)
Query: 83 HLRELQLLNLNLSGN-LS--PEIGRLSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLN 138
+ +L LL+ N + G LT L +N+I IP++ +E L +
Sbjct: 571 KMVKLGLLDC--VHNKVRHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFS 627
Query: 139 GNELTGSLPE--ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR-----HFHMNNNSIS 191
N+L +P + + + N I +++ + ++ N I
Sbjct: 628 HNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686
Query: 192 GQIPPELSRLPSLVHMLLDNNNLT-------GYLPPELSELPKLLILQLDNNNFEGTTIP 244
+ + ++L NN +T L + L N T++
Sbjct: 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL--TSLS 744
Query: 245 AS--YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL-LSLNITTIKLSNNKLTGTIPSN 301
+ + L + + L + N++ P+
Sbjct: 745 DDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRD---AEGNRILRQWPTG 801
Query: 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP--PN 359
+ P L +L I +N + + + L ILD +N +I + P
Sbjct: 802 ITTCPSLIQLQIGSNDIR-KVDEKLTPQ--LY-----ILDIADNPNISIDVTSVCPYIEA 853
Query: 360 VTVRLRGNP 368
L +
Sbjct: 854 GMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-31
Identities = 52/328 (15%), Positives = 91/328 (27%), Gaps = 58/328 (17%)
Query: 42 SIKKSLVDDYSKLSNWNRGDPCTS--NWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLS 99
+++ NWN + GV N + L L G +
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG------RVTGLSLAGFGAKGRVP 340
Query: 100 PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEE-LGYLPKLDR 158
IG+L+ L +L F + + S + ++ + + + L Y +L+
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400
Query: 159 IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218
+ Q+ I N N I + + N +T +
Sbjct: 401 SDLLQDAI-------------------NRNPEMKPIKKDSRISLKDTQIGNLTNRITF-I 440
Query: 219 PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLG 277
+ L KL I+ N+ F T + + S + +L
Sbjct: 441 SKAIQRLTKLQIIYFANSPF--TYDNIA----VDWEDANSDYAKQYENEELSWSNLKDL- 493
Query: 278 YLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG---------SIPSSIWQ 328
T ++L N +P LP LQ L IA N +
Sbjct: 494 -------TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
Query: 329 SRTLNATETFILDFQNNNLTNISGSFNI 356
+ I NNL S ++
Sbjct: 547 GPKIQ-----IFYMGYNNLEEFPASASL 569
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 4e-17
Identities = 24/174 (13%), Positives = 51/174 (29%), Gaps = 24/174 (13%)
Query: 83 HLRELQLLNL----------NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI--GNIK 130
+ + L N LT +D +NK++ S+ + +
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ------NYISGSLPKSFANLNKTRHFH 184
L + ++ N + S P + +L I N I P
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLT-GYLPPELSELPKLLILQLDNNN 237
+ +N I + +L P L + + +N + + + + L +
Sbjct: 813 IGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 24/211 (11%), Positives = 52/211 (24%), Gaps = 47/211 (22%)
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK-----------LSLR 259
+ + E + +DN + +P ++ +K L +
Sbjct: 225 SQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK 284
Query: 260 NCSLQGPMPD----------------LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFS 303
N + P + + +T + L+ G +P
Sbjct: 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 304 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI--------------------LDFQ 343
L L+ L +S + S + T + +E D
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 344 NNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 374
+ + I + + L+ TN
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 12/104 (11%), Positives = 28/104 (26%), Gaps = 11/104 (10%)
Query: 83 HLRELQLL-NLNLSGN-----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136
L+ + + GN I L L N I + +++ L +L
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILD 833
Query: 137 LNGNELT-GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
+ N + Y+ + + + + +
Sbjct: 834 IADNPNISIDVTSVCPYI-EAGMYVLLYDKTQDIRGCDALGIER 876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 616 QIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
++G G YG+VY+G+ ++ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E ++ EFM+ G L D L +++ + + L +A S + YL HR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAP----VPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
D+ A N L+ KVADFGLSRL P +K T PE
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTA----PESLA 185
Query: 791 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
+K + KSDV++ GV+ E+ T GM P +V + P
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV--------YELLEKDYRMERPE 235
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 897
C EK +L C Q RPS +E+ + E+++ SD E
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 25/285 (8%)
Query: 616 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 671 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 134
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 786
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPGESPIFWYA----P 186
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS-VIDGNM 844
E K + SDV+S GVV EL T + S +R + Q M+ +I+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 845 GSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885
+ P C ++ + +C + + RPS ++ ++ I +
Sbjct: 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 35/288 (12%)
Query: 616 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 669
+G+G +GKV G +VAVK + + + EI L L+H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 670 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
G C++ G LV E++ G+LRD L + +G A L A G+ YLH +
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 728 DPPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL-- 784
+ HRD+ A N+LLD+ K+ DFGL++ VP G
Sbjct: 155 ----YIHRDLAARNVLLDNDRLVKIGDFGLAKA---------VPEGHEYYRVREDGDSPV 201
Query: 785 ---DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840
PE +K SDV+S GV ELLT S + + IA + +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 841 DGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884
+ P +C + L C + E RP+ ++ L+++
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 616 QIGQGGYGKVYKGILPDG----TVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
+G+G +G V +G L VAVK + S + +EFL+E + H N++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 670 LVGYCDEEGEQ-----MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 720
L+G C E Q M++ FM G L L + + L + + G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIVP 770
YL ++ HRD+ A N +L T VADFGLS+ I +P
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMP 212
Query: 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 829
VK E T KSDV++ GV E+ T GM P +N E+
Sbjct: 213 ------VKWIA----IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEM-- 258
Query: 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889
++ G+ P +C+++ ++ C + + RP+ S + +LE + +P+
Sbjct: 259 ------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 34/275 (12%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G+V+ G T VAVK ++GS+ FL E + +L H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
+E ++ E+M NG+L D L S L L +A + G+ ++ + HRD
Sbjct: 79 QEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 789
++A+NIL+ + K+ADFGL+RL + D E P +K T PE
Sbjct: 135 LRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFP------IKWTA----PEAI 182
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
T KSDV+S G++ E++T G P N EV + ++ G P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV--------IQNLERGYRMVRP 232
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
C E+ +L C ++ + RP+ + LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 25/287 (8%)
Query: 616 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 671 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 165
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 786
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 166 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEYYKVKEPGESPIFWYA----P 217
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM-----MFSVI 840
E K + SDV+S GVV EL T + S +R + Q M + +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887
+ P C ++ + +C + + RPS ++ ++ I + M
Sbjct: 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-40
Identities = 87/282 (30%), Positives = 126/282 (44%), Gaps = 22/282 (7%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 736
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 334 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 737 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 796
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 390 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 443
Query: 797 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 855
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPESL 493
Query: 856 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 897
L +C + E + RP+ + LE +
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 34/275 (12%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G V G VAVK +EGS+ E EF E Q + +L H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
+E +V E++SNG L + L + K L + L + G+ +L HRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 789
+ A N L+D KV+DFG++R V D + P VK + PE F
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP------VKWSA----PEVF 177
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
K + KSDV++ G++ E+ + G P N EV + V G+ P
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEV--------VLKVSQGHRLYRP 227
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ ++ C + + RP+ +++ +E +
Sbjct: 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-40
Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 30/272 (11%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676
+G G +G+V+ T VAVK + GS+ + FL E + L H LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 736
E ++ EFM+ G+L D L + + + + G+ ++ HRD+
Sbjct: 255 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDL 310
Query: 737 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 796
+A+NIL+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 311 RAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFTI 364
Query: 797 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSEC 851
KSDV+S G++ +E++T G P N EV + ++ G Y P C
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSN--PEV--------IRALERG----YRMPRPENC 410
Query: 852 VEKFIKLALKCCQDETDARPSMSEVMRELESI 883
E+ + ++C ++ + RP+ + L+
Sbjct: 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
++G G +G V G VA+K +EGS+ E EF+ E + + L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
++ ++ E+M+NG L + L + + L + + YL HRD
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 789
+ A N L++ + KV+DFGLSR V D E P V+ +P PE
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP------VRWSP----PEVL 193
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
+ K + KSD+++ GV+ E+ + G P N E + G P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SET--------AEHIAQGLRLYRP 243
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886
EK + C ++ D RP+ ++ + + +
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 44/313 (14%)
Query: 616 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 668
+G G +G+VY+G + P VAVK E + ++ +FL E +S+ +H+N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 723
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 724 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI-----EGIVPAHVST 775
+ HRDI A N LL AK+ DFG++R ++P
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP----- 208
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 834
VK P PE F+ T K+D +S GV+ E+ + G P N +EV
Sbjct: 209 -VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV------- 254
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 894
+ V G P C ++ +C Q + + RP+ + ++ +E +T
Sbjct: 255 -LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 895 PEFINSEHTSKEE 907
P +E+
Sbjct: 314 PIEYGPLVEEEEK 326
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-40
Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 26/283 (9%)
Query: 617 IGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 671
IG+G +G VY G L D AVK + +FLTE + H N++SL+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 672 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
G C EG ++V +M +G LR+ + + L ++G+ +L A
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYF 789
HRD+ A N +LD KFT KVADFGL+R + + + + + VK E
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LESL 268
Query: 790 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
T K T KSDV+S GV+ EL+T G P ++ ++ G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI--------TVYLLQGRRLLQP 318
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 891
C + ++ LKC + + RPS SE++ + +I++
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 66/305 (21%), Positives = 124/305 (40%), Gaps = 66/305 (21%)
Query: 616 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 668
++G+ +GKVYKG L VA+K ++ +EF E +RL H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIAL 714
L+G ++ +++ + S+G L + L +S K L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------- 766
+ G+ YL + V H+D+ N+L+ K K++D GL R ++
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLL 187
Query: 767 --GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHG 820
++P ++ PE + K + SD++S GVV E+ + G+QP S+
Sbjct: 188 GNSLLP------IRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 236
Query: 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
++V + + + + P +C L ++C + RP ++ L
Sbjct: 237 ----QDV--------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 881 ESIWN 885
+ N
Sbjct: 285 RAWGN 289
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 74/331 (22%), Positives = 136/331 (41%), Gaps = 62/331 (18%)
Query: 616 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 665
+G+G +G+V T VAVK + + + + + ++E++ + + H+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 711
N+++L+G C ++G ++ E+ S G LR+ L S +E L +S
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 766
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 822
G +P VK PE T +SDV+S GV+ E+ T G P +
Sbjct: 253 GRLP------VKWMA----PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299
Query: 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
E+ + +G+ PS C + + C RP+ +++ +L+
Sbjct: 300 --EEL--------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD- 348
Query: 883 IWNMMPESDTKTPEFINSEHTSKEETPPSSS 913
++ + + + + H + P + +
Sbjct: 349 --RIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 67/294 (22%), Positives = 112/294 (38%), Gaps = 33/294 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
++G+GG+ V L DG A+KR Q +E E +H N++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 675 DEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEAD 728
E L+ F GTL +++ + L + LG RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLA--PVPDIEGIVPAHVSTVVKGTPGYLDP 786
HRD+K +NILL + + D G A V + + T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 787 EYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
E F + +++DV+SLG V ++ G P ++ +Q ++ N
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY----------DMVFQKGDSVALAVQN 262
Query: 844 MGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 892
S P S + + + + RP + ++ +LE++ P T
Sbjct: 263 QLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-39
Identities = 80/318 (25%), Positives = 127/318 (39%), Gaps = 54/318 (16%)
Query: 616 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 668
+G G +G+VY+G + VAVK E S Q E +FL E +S+ +H+N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 723
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 724 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI----------EGIVP 770
+ HRDI A N LL AK+ DFG++R DI ++P
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLP 249
Query: 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 829
VK P PE F+ T K+D +S GV+ E+ + G P N +EV
Sbjct: 250 ------VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV-- 295
Query: 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889
+ V G P C ++ +C Q + + RP+ + ++ +E
Sbjct: 296 ------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
Query: 890 SDTKTPEFINSEHTSKEE 907
+T P +E+
Sbjct: 350 INTALPIEYGPLVEEEEK 367
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 6e-39
Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 617 IGQGGYGKVYKGIL-PDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 670
+G G +G VYKG+ P+G VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 785
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
E L T +SDV+S GV EL+T G +P E+ + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI--------SSILEKGER 237
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P C + KC + D+RP E++ E +
Sbjct: 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-39
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 59/301 (19%)
Query: 616 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 665
+G+G +G+V + VAVK ++ + + + + ++E++ + + H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 711
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 766
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 822
G +P VK PE T +SDV+S GV+ E+ T G P I
Sbjct: 265 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311
Query: 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
E+ + +G+ P+ C + + C RP+ +++ +L+
Sbjct: 312 --EEL--------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 883 I 883
I
Sbjct: 362 I 362
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 617 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
+G+G +G+VY+G+ + VAVK ++ K +F++E + L H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G +EE ++ E G L L ++K L + +L + + YL E+ V
Sbjct: 80 GIIEEE-PTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL--ESINCV 135
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE---------GIVPAHVSTVVKGTPG 782
HRDI NIL+ K+ DFGLSR IE +P +K
Sbjct: 136 -HRDIAVRNILVASPECVKLGDFGLSR-----YIEDEDYYKASVTRLP------IKWMS- 182
Query: 783 YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841
PE + T SDV+ V E+L+ G QP +N ++V + +
Sbjct: 183 ---PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDV--------IGVLEK 229
Query: 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886
G+ P C L +C + RP +E++ L ++ M
Sbjct: 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-39
Identities = 49/313 (15%), Positives = 106/313 (33%), Gaps = 37/313 (11%)
Query: 81 YLHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
L + E +L L+ + ++ L+ ++ + I + L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN 313
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPE 197
+ +L L +L G S +L ++ N +S G
Sbjct: 314 CKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
SL ++ L N + + L +L L ++N + + + + ++ L+ L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 258 LRNCSLQGPMPD-LSRIPNLGYL-LSLN----------------ITTIKLSNNKLTGTIP 299
+ + + + + +L L ++ N +T + LS +L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 300 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS--FNIP 357
+ F+ L LQ L +++N+ +L +LD+ N++ + P
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ-----VLDYSLNHIMTSKKQELQHFP 542
Query: 358 PN-VTVRLRGNPF 369
+ + L N F
Sbjct: 543 SSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 54/283 (19%), Positives = 95/283 (33%), Gaps = 20/283 (7%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
ELQ+L+L + LS+L+ L N I + SL+ L+
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYI-SGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
L +G+L L + + N I S LP+ F+NL H +++N I +L
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 199 SRLPSL----VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL- 253
L + + + L N + + P + +L L L NN + ++ L
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 228
Query: 254 -LKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKL-TGTIPSNFSGLPRLQRL 311
+L L +G + L L +L I +L+ I F+ L +
Sbjct: 229 VHRLVLGEFRNEGNLEKFD-KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 312 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 354
+ + ++ S L+ N
Sbjct: 288 SLVSVTIERVKDFS-------YNFGWQHLELVNCKFGQFPTLK 323
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-35
Identities = 47/246 (19%), Positives = 84/246 (34%), Gaps = 12/246 (4%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
IP + S + L L+ N L P+L + + + I ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ N I S L SL ++ NL + L L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLLSLNITTIKLSNNKLTGTIP 299
+P +SN++ L L L + +Q DL + + L ++ LS N + P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN----LSLDLSLNPMNFIQP 194
Query: 300 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPN 359
F + RL +L + NN S ++ + Q + N +
Sbjct: 195 GAFKEI-RLHKLTLRNNFDSLNVMKTCIQ----GLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 360 VTVRLR 365
L
Sbjct: 250 ALEGLC 255
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 40/281 (14%), Positives = 85/281 (30%), Gaps = 20/281 (7%)
Query: 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
Q + LN + + LD +N + + L++L L+ E+
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L L + + N I +F+ L+ + +++ + L +L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 206 HMLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL----LKLSLRN 260
+ + +N + + LP S L L L L +N + + ++ L L L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSL 186
Query: 261 CSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLS 319
+ P + + + L NN + + GL L+ +
Sbjct: 187 NPMNFIQPGA--------FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNV 360
+ L L + L + + ++
Sbjct: 239 NEGNLEKFDKSALEGLCN--LTIEEFRLAYLDYYLDDIIDL 277
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-33
Identities = 45/253 (17%), Positives = 82/253 (32%), Gaps = 17/253 (6%)
Query: 82 LHLRELQLLNL-----NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136
+ L L+ L+L + G S + L LD +N + + ++ LE L
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 402
Query: 137 LNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 195
+ L L L + I + + F L+ M NS
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 196 PE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254
P+ + L +L + L L P + L L +L + +NNF Y ++ L
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQ 521
Query: 255 KLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN--FSGLPRLQRLF 312
L + L + S ++ + L+ N T + ++L
Sbjct: 522 VLDYSLNHIMTSKKQE-----LQHFPS-SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLL 575
Query: 313 IANNSLSGSIPSS 325
+ + + PS
Sbjct: 576 VEVERMECATPSD 588
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-28
Identities = 38/225 (16%), Positives = 73/225 (32%), Gaps = 11/225 (4%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNEL 142
L L+LS N +S L L LDF + + + ++++L L ++
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
+ L L+ +++ N + P F L ++ + P + L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
SL + + +NN L L +L N+ + S L L+L
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 262 SLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLP 306
L ++ + ++ PS+ G+P
Sbjct: 554 DFAC---TCEHQSFLQWIKDQRQLL--VEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-18
Identities = 26/151 (17%), Positives = 55/151 (36%), Gaps = 7/151 (4%)
Query: 83 HLRELQLLNL---NLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
L L++L + + N P+I L LT LD ++ P ++ SL++L ++
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT-RHFHMNNNSISGQIPPE 197
N L L + N+I S + + + ++ N + +
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
Query: 198 --LSRLPSLVHMLLDNNNLTGYLPPELSELP 226
L + +L++ + P + +P
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 32/306 (10%)
Query: 616 QIGQGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 669
IG G +G+VYKG+L + VA+K + G + ++ +FL E + + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
L G + M++ E+M NG L L + + + G + G+ YL A+
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEY 788
HRD+ A NIL++ KV+DFGLSR+ D E + ++ T PE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEATYTTSGGKIPIRWTA----PEA 221
Query: 789 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847
K T SDV+S G+V E++T G +P N EV M ++ DG
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV--------MKAINDGFRLPT 271
Query: 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 907
P +C +L ++C Q E RP ++++ L+ + P+S +F
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-APDSLKTLADFDPRVSIR--- 327
Query: 908 TPPSSS 913
PS+S
Sbjct: 328 -LPSTS 332
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 41/274 (14%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 672
+IG+G + VYKG+ VA Q+ L + F E + L L H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 673 YC-DEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTE 726
+ + E M++GTL+ L K +++ S +G+ +LHT
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 727 ADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
PP+ HRD+K NI + + K+ D GL+ + A + V GTP ++
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---------LKRASFAKAVIGTPEFMA 198
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
PE + K + DVY+ G+ LE+ T P S +N + + V G
Sbjct: 199 PEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKP 248
Query: 846 SYP----SECVEKFIKLALKCCQDETDARPSMSE 875
+ V++ I+ C + D R S+ +
Sbjct: 249 ASFDKVAIPEVKEIIE---GCIRQNKDERYSIKD 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 72/320 (22%), Positives = 132/320 (41%), Gaps = 64/320 (20%)
Query: 616 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 665
+G+G +G+V VAVK ++ + + + + ++E++ + + H+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 711
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 766
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 822
G +P VK PE T +SDV+S GV+ E+ T G P I
Sbjct: 219 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265
Query: 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882
E+ + +G+ P+ C + + C RP+ +++ +L+
Sbjct: 266 --EEL--------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 883 IWNMMPESDTKTPEFINSEH 902
I + T E+++
Sbjct: 316 IL-----TLTTNEEYLDLSQ 330
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 74/297 (24%), Positives = 118/297 (39%), Gaps = 51/297 (17%)
Query: 616 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 667
+G+G +G+V + VAVK +EG+ E ++E++ L + HH N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 668 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSI 712
V+L+G C G M++ EF G L L K+ L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EG 767
+ ++G+ +L A HRD+ A NILL K K+ DFGL+R +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 826
+P +K PE T +SDV+S GV+ E+ + G P G I E
Sbjct: 211 RLP------LKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEE 259
Query: 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ +G P + + L C E RP+ SE++ L ++
Sbjct: 260 F--------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 24/280 (8%)
Query: 615 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 670
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C E MLV E G L L +E + + + S G+ YL +
Sbjct: 76 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
HRD+ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186
Query: 791 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
K + +SDV+S GV E L+ G +P K EV M + G P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV--------MAFIEQGKRMECPP 236
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889
EC + L C + + RP V + + + + +
Sbjct: 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-38
Identities = 57/293 (19%), Positives = 99/293 (33%), Gaps = 23/293 (7%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L L+L+ L + LS L L NK N SL L + GN
Sbjct: 279 GLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338
Query: 144 GSLPEE-LGYLPKLDRIQIDQNYI--SGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
L L L L + + + I S NL+ + +++ N
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE 398
Query: 201 LPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259
P L + L L L L +L L ++ + + + + L L+L+
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS-SEQLFDGLPALQHLNLQ 457
Query: 260 NCSLQGPMPDLSR-IPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318
+ + LG L L LS L+ F+ L + + +++N L
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILV-----LSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 319 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPN-VTVRLRGNPF 369
+ S ++ + + L+ +N+++ I I T+ LR NP
Sbjct: 513 TSSSIEALSHLKGI------YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-38
Identities = 65/298 (21%), Positives = 113/298 (37%), Gaps = 22/298 (7%)
Query: 83 HLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGN--IKSLELLL 136
L++ L+LNL+GN + P + L+F + I K + N I+SL L
Sbjct: 175 SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 137 LNGNELTGSLPEELGYLPKLDRIQID--QNYISGSLPKSFANLNKTRHFHMNNNSISGQI 194
+ P L ++ I+ ++Y +F + + + +S ++
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293
Query: 195 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254
P L L +L ++L N S P L L + N N+ L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 255 KLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 314
+L L + ++ ++ NL +L SLN LS N+ F P+L+ L +A
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLN-----LSYNEPLSLKTEAFKECPQLELLDLA 408
Query: 315 NNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 369
L S +Q+ L +L+ ++ L S F+ P + L+GN F
Sbjct: 409 FTRLKVKDAQSPFQNLHLLK-----VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 58/324 (17%), Positives = 97/324 (29%), Gaps = 29/324 (8%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+ L + RL LT LD +I + L+ L+L N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
L L + Q IS N ++ +N IS P+
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L + NN + ++S L + L L+ N + I + + L+
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
Query: 263 LQGPMP---DLSRIPNLGYL------------------LSLNITTIKLSNNKLTGTIPSN 301
+ S I +L +++ +I L + +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNV 360
F LQ L + LS +PS + TL L N N+ S + P++
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLK-----KLVLSANKFENLCQISASNFPSL 327
Query: 361 TV-RLRGNPFCLNTNAEQFCGSHS 383
T ++GN L +
Sbjct: 328 THLSIKGNTKRLELGTGCLENLEN 351
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-35
Identities = 57/305 (18%), Positives = 97/305 (31%), Gaps = 19/305 (6%)
Query: 71 LCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSYLTILDFMWNKISGSIPKEIGN 128
+ F + L +++ E + ++ +
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 129 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
L+ L L L+ LP L L L ++ + N S +N H + N
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 189 SISGQIPPE-LSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLDNNNFEGTTIPA 245
+ ++ L L +L + L ++++ +L L L L L N ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP--LSLKT 393
Query: 246 SY-SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSG 304
+L L L L+ S NL L LN LS++ L + F G
Sbjct: 394 EAFKECPQLELLDLAFTRLKV-KDAQSPFQNLHLLKVLN-----LSHSLLDISSEQLFDG 447
Query: 305 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV- 362
LP LQ L + N +TL E L +L++I +F +
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI--LVLSFCDLSSIDQHAFTSLKMMNHV 505
Query: 363 RLRGN 367
L N
Sbjct: 506 DLSHN 510
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-32
Identities = 51/295 (17%), Positives = 102/295 (34%), Gaps = 26/295 (8%)
Query: 75 TTMDDGYLHLRELQLLNLN---LSGNLSPEIGRLSYLTILDFMWNKISGSIPKE-IGNIK 130
+ + G + L L+ L L+ LT L N + + N++
Sbjct: 291 SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 131 SLELLLLNGNELTGS--LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
+L L L+ +++ S +L L L + + N ++F + +
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410
Query: 189 SISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI--PA 245
+ + L L + L ++ L LP L L L N+F I
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYL-LSLN-ITTIK-------------L 289
S + +L L L C L + + + ++ LS N +T+ L
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNL 530
Query: 290 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 344
++N ++ +PS L + + + + N L + S+I+ + D ++
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDCT-CSNIYFLEWYKENMQKLEDTED 584
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 74/311 (23%)
Query: 616 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 668
+G+G +GKV K T VAVK +E + E + L+E L +++H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------------SAKSKEPLGF 706
L G C ++G +L+ E+ G+LR L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 707 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 765
+S A S+G+ YL A+ + HRD+ A NIL+ K++DFGLSR D+
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVY 201
Query: 766 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 815
+G +P VK E H T +SDV+S GV+ E++T G
Sbjct: 202 EEDSYVKRSQGRIP------VKWMA----IESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 816 P---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 872
P I + + G+ P C E+ +L L+C + E D RP
Sbjct: 252 PYPGIPP-----ERL--------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 873 MSEVMRELESI 883
+++ ++LE +
Sbjct: 299 FADISKDLEKM 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 61/298 (20%)
Query: 616 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNLVSL 670
IG+G +G+V K + A+KR +E + + + +F E++ L +L HH N+++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSIALGS 716
+G C+ G L E+ +G L D L + + L L A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------GIV 769
+RG+ YL + HRD+ A NIL+ + AK+ADFGLSR E G +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 203
Query: 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVR 825
P V+ E T SDV+S GV+ E+++ G P ++
Sbjct: 204 P------VRWMA----IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 248
Query: 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
E+ + G P C ++ L +C +++ RPS ++++ L +
Sbjct: 249 EL--------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-38
Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 616 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 670
IG G G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
G M+V E+M NG+L L + + G G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG--- 171
Query: 731 VF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEY 788
+ HRD+ A N+L+D KV+DFGLSR+ D + + ++ T PE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTA----PEA 225
Query: 789 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847
+ SDV+S GVV E+L G +P + N R+V + SV +G
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDV--------ISSVEEGYRLPA 275
Query: 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P C +L L C + RP S+++ L+++
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-38
Identities = 65/336 (19%), Positives = 123/336 (36%), Gaps = 30/336 (8%)
Query: 585 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE 643
H +S G + + M + +IG+G +GK DG +K
Sbjct: 4 HHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI 59
Query: 644 GSL-QGEKEF-LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 701
+ E+E E+ L+ + H N+V +E G +V ++ G L +++A+
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 702 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761
L + + ++H D + HRDIK+ NI L T ++ DFG++R+
Sbjct: 120 VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821
+ GTP YL PE +KSD+++LG V EL T
Sbjct: 177 STV------ELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAG 228
Query: 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE-- 879
++ +++ +I G+ L + + RPS++ ++ +
Sbjct: 229 SM---------KNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279
Query: 880 -LESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914
+ I + + + + P+
Sbjct: 280 IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 74/276 (26%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 616 QIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSL 670
++G G +G V KG VAVK + + + E L E + +L + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C+ E MLV E G L L + + + + S G+ YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EESNF 138
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEY 788
V HRD+ A N+LL + AK++DFGLS+ + E A VK PE
Sbjct: 139 V-HRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKWYA----PEC 191
Query: 789 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847
+K + KSDV+S GV+ E + G +P K EV + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEV--------TAMLEKGERMGC 241
Query: 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P+ C + L C + + RP + V L +
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 68/304 (22%)
Query: 616 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 667
+G G +GKV + VAVK + + EK ++E++ +S L H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------SAKSKEPLGFAMRLSIALG 715
V+L+G C G +++ E+ G L + L A + L +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI---------- 765
++G+ +L A HRD+ A N+LL + AK+ DFGL+R DI
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKG 224
Query: 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 824
+P VK PE T +SDV+S G++ E+ + G+ P
Sbjct: 225 NARLP------VKWMA----PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-------- 266
Query: 825 REVNIAYQSSM-----MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879
Y + V DG + P+ + + C E RP+ ++
Sbjct: 267 ------YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
Query: 880 LESI 883
L+
Sbjct: 321 LQEQ 324
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 9e-38
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 617 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL--ESKRFV 138
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 785
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 139 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 185
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE + T SDV+ GV E+L G++P KN +V + + +G
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--------IGRIENGER 235
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P C L KC + RP +E+ +L +I
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 83/311 (26%), Positives = 131/311 (42%), Gaps = 74/311 (23%)
Query: 616 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 668
IG+G +G+V++ P T+VAVK +E S + +F E ++ + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----------------------PLGF 706
L+G C L++E+M+ G L + L + S PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 707 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 765
A +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR +I
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIY 225
Query: 766 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 815
+P ++ P PE ++ T +SDV++ GVV E+ + G+Q
Sbjct: 226 SADYYKADGNDAIP------IRWMP----PESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 816 P---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 872
P ++H EV I Y V DGN+ + P C + L C RPS
Sbjct: 276 PYYGMAH-----EEV-IYY-------VRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322
Query: 873 MSEVMRELESI 883
+ R L+ +
Sbjct: 323 FCSIHRILQRM 333
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 66/310 (21%), Positives = 116/310 (37%), Gaps = 54/310 (17%)
Query: 616 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 667
+GQG + K++KG+ T V +K + + F +S+L H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
V G C E +LV EF+ G+L L K+K + +L +A + + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 728 DPPVFHRDIKASNILLDHKFT--------AKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+ + H ++ A NILL + K++D G+S +P +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQER------IPW 183
Query: 780 TPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 837
P PE K +D +S G E+ + G +P+S + + +
Sbjct: 184 VP----PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRK--------LQ 229
Query: 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 897
D + P + L C E D RPS ++R+L S++ TP+
Sbjct: 230 FYEDRHQLPAPKAA--ELANLINNCMDYEPDHRPSFRAIIRDLNSLF---------TPDL 278
Query: 898 INSEHTSKEE 907
+
Sbjct: 279 VPRGSHHHHH 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 48/304 (15%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 667
+F IG GG+G+V+K DG +KR + ++ E++ L++L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 668 VSLVGYCDEEGEQM----------------LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 711
V G D + EF GTL + + E L + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771
+ ++G+ Y+H + +RD+K SNI L K+ DFGL +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--------LKND 175
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831
T KGT Y+ PE + + D+Y+LG++ ELL ++
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL---- 231
Query: 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 891
G +K L K + + RP+ SE++R L +W PE +
Sbjct: 232 -----------RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT-VWKKSPEKN 279
Query: 892 TKTP 895
+
Sbjct: 280 ERHT 283
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 53/273 (19%), Positives = 96/273 (35%), Gaps = 40/273 (14%)
Query: 84 LRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+ + L L + RLS+L + + +P + LE L L
Sbjct: 78 ATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
N L +LP + L +L + I LP+ A+ E
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST---------------DASGEHQ 180
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259
L +L + L+ + LP ++ L L L++ N+ + + + ++ KL +L LR
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL--SALGPAIHHLPKLEELDLR 237
Query: 260 NCSLQGPMPDLSRIPN-LGYLLSLNITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNS 317
C+ L P G L + L + + L T+P + L +L++L +
Sbjct: 238 GCTA------LRNYPPIFGGRAPL--KRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 318 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350
+PS I Q I+ + +
Sbjct: 289 NLSRLPSLIAQLPANC-----IILVPPHLQAQL 316
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 40/263 (15%), Positives = 84/263 (31%), Gaps = 26/263 (9%)
Query: 75 TTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134
+ + H + L S L P LS N + ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW-HSAWRQANSNNPQI 60
Query: 135 LLLNGNELTGSLPEELGYL--PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
G L + + L P +++ + P L+ +H ++ +
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN--------FEGTTIP 244
++P + + L + L N L LP ++ L +L L + T
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN-LGYLLSLNITTIKLSNNKLTGTIPSNFS 303
+ + L L L ++ +P + L +L ++K+ N+ L+ +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-------SLPASIANLQNL--KSLKIRNSPLS-ALGPAIH 226
Query: 304 GLPRLQRLFIANNSLSGSIPSSI 326
LP+L+ L + + + P
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 50/279 (17%), Positives = 89/279 (31%), Gaps = 32/279 (11%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL--LLLNGNE 141
+ + N + + I + + + + L L
Sbjct: 35 WQRHYNADRNRWHSAW-RQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVP 92
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L P++ L L + ID + LP + + N + +P ++ L
Sbjct: 93 LP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
Query: 202 PSLVHMLLDNNNLTGYLPPEL---------SELPKLLILQLDNNNFEGTTIPASYSNMSK 252
L + + LP L L L L+L+ ++PAS +N+
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI--RSLPASIANLQN 207
Query: 253 LLKLSLRNCSLQGPMPDLSRIPN-LGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 311
L L +RN LS + + +L L + L P F G L+RL
Sbjct: 208 LKSLKIRNSP-------LSALGPAIHHLPKL--EELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 312 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350
+ + S ++P I + L E L NL+ +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQL---EKLDLR-GCVNLSRL 293
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 49/267 (18%), Positives = 91/267 (34%), Gaps = 27/267 (10%)
Query: 96 GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPK 155
G+ S L F + + + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRN-------RWHSAWRQAN 54
Query: 156 LDRIQIDQNYISG--SLPKSFANLNKT--RHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211
+ QI+ + + + + + + Q P + RL L HM +D
Sbjct: 55 SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 212 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-- 269
L LP + + L L L N +PAS +++++L +LS+R C +P+
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPL--RALPASIASLNRLRELSIRACPELTELPEPL 170
Query: 270 --LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 327
L++L +++L + ++P++ + L L+ L I N+ LS ++ +I
Sbjct: 171 ASTDASGEHQGLVNL--QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226
Query: 328 QSRTLNATETFILDFQNNNLTNISGSF 354
L E L L N F
Sbjct: 227 HLPKL---EELDLR-GCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 30/147 (20%), Positives = 55/147 (37%), Gaps = 10/147 (6%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L +L L L I L L L + +S ++ I ++ LE L L G
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 144 GSLPEELGYLPKLDRIQI-DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ P G L R+ + D + + +LP L + + ++P +++LP
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 203 SLVHMLLDNN---NLTGYLPPELSELP 226
+ +L+ + L + P P
Sbjct: 302 ANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 2/90 (2%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNE 141
L EL L N P G + L L + + ++P +I + LE L L G
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLP 171
LP + LP I + + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 14/74 (18%), Positives = 26/74 (35%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+ L L + + L +I RL+ L LD +P I + + ++L+ +
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
Query: 143 TGSLPEELGYLPKL 156
P
Sbjct: 314 AQLDQHRPVARPAE 327
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 72/311 (23%), Positives = 124/311 (39%), Gaps = 42/311 (13%)
Query: 617 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 670
+G G +G V+KG+ V +K ++ S Q + + + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C LV +++ G+L D + + + LG + L+ + ++G+ YL +
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL---EEHG 135
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 785
+ HR++ A N+LL +VADFG++ L P D + P +K
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------IKWMA---- 185
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
E K T +SDV+S GV EL+T G +P + + EV + G
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEV--------PDLLEKGER 235
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 904
+ P C + +KC + + RP+ E+ E + P I E
Sbjct: 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLV-----IKRESGP 290
Query: 905 KEETPPSSSSM 915
P +
Sbjct: 291 GIAPGPEPHGL 301
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 45/310 (14%)
Query: 617 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 670
+G G +G VYKG+ VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 785
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
E L T +SDV+S GV EL+T G +P E+ + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI--------SSILEKGER 237
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 904
P C + +KC + D+RP E++ E + + P+
Sbjct: 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--------ARDPQRYLVIQGD 289
Query: 905 KEETPPSSSS 914
+ PS +
Sbjct: 290 ERMHLPSPTD 299
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 68/298 (22%), Positives = 114/298 (38%), Gaps = 52/298 (17%)
Query: 616 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 667
+G G +GKV + VAVK + + E+ ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------SAKSKEPLGFAMRLS 711
V+L+G C G +++ E+ G L + L + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 766
+ ++G+ +L A HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 825
+P VK PE T +SDV+S G+ EL + G P G +
Sbjct: 207 ARLP------VKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-GMPVDS 255
Query: 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ + +G P + + C + RP+ ++++ +E
Sbjct: 256 KF--------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 76/311 (24%), Positives = 132/311 (42%), Gaps = 34/311 (10%)
Query: 616 QIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 670
+G G +G+V G L VA+K + G + ++ +FL E + + H N++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
G + M+V E+M NG+L L K + + G + G+ YL +D
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLD 785
HRD+ A NIL++ KV+DFGL R +E A +T ++ T
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKIPIRWTS---- 218
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE K T SDV+S G+V E+++ G +P N ++V + +V +G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDV--------IKAVDEGYR 268
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 904
P +C +L L C Q + + RP +++ L+ + T +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLL 328
Query: 905 KEETPPSSSSM 915
+++ ++
Sbjct: 329 LDQSNVDITTF 339
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 26/284 (9%)
Query: 616 QIGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLV 668
++G G +G V +G P G VAVK + L + +F+ E+ + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
L G +V E G+L D+L K + A+ + G+ YL E+
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL--ESK 140
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
+ HRD+ A N+LL + K+ DFGL R P D ++ H PE
Sbjct: 141 RFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PES 195
Query: 789 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847
T + SD + GV E+ T G +P ++ + +G
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQI-------LHKIDKEGERLPR 246
Query: 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 891
P +C + + ++C + + RP+ + L ++
Sbjct: 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAE 290
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 70/308 (22%), Positives = 114/308 (37%), Gaps = 67/308 (21%)
Query: 616 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 667
+G G +GKV VAVK +E + E+ ++E++ +++L H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL---------------------SAKSKEPLGF 706
V+L+G C G L++E+ G L + L + L F
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 707 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 765
L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R DI
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIM 223
Query: 766 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 815
+P VK PE T KSDV+S G++ E+ + G+
Sbjct: 224 SDSNYVVRGNARLP------VKWMA----PESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 816 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 875
P G + + +G P E+ + C ++ RPS
Sbjct: 274 P-YPGIPVDANF--------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324
Query: 876 VMRELESI 883
+ L
Sbjct: 325 LTSFLGCQ 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 30/289 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV 671
+IG+G + +VY+ L DG VA+K+ Q L K + EI L +L+H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEADP 729
E+ E +V E G L + K+ + + ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
V HRDIK +N+ + K+ D GL R ++V GTP Y+ PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------TAAHSLV-GTPYYMSPERI 208
Query: 790 LTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
+ KSD++SLG + E+ P N+ S+ + + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---------SLCKKIEQCDYPPLP 259
Query: 849 SECV-EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 896
S+ E+ +L C + + RP ++ V + M + +
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYV---YDVAKRMHACTASSLEH 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 26/284 (9%)
Query: 604 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFL-TEIQFLS 660
M ++ IG G YG+ K DG ++ K GS+ + EK+ L +E+ L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 661 RLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGS 716
L H N+V + L V E+ G L ++ +KE L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 717 SRGILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
+ + H +D V HRD+K +N+ LD K K+ DFGL+R+ +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------SFAK 174
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834
T V GTP Y+ PE +KSD++SLG + EL M P +
Sbjct: 175 TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQ---------KE 223
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + +G P ++ ++ + + RPS+ E++
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-36
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 24/281 (8%)
Query: 615 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 670
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C E MLV E G L L +E + + + S G+ YL E
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL--EEKNF 457
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
V HR++ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 458 V-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 512
Query: 791 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
K + +SDV+S GV E L+ G +P K EV M + G P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV--------MAFIEQGKRMECPP 562
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 890
EC + L C + + RP V + + + + +
Sbjct: 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 617 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 671
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYL--ESKRFV 513
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 785
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 514 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 560
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE + T SDV+ GV E+L G++P KN +V + + +G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--------IGRIENGER 610
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P C L KC + RP +E+ +L +I
Sbjct: 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 31/284 (10%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+L NL + N + L+ L L + IS P + N+ + L L N
Sbjct: 89 KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL- 145
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
S L + L+ + + ++ + P ANL +N N I P L+ L SL
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ N +T ++ + +L L++ NN T + +N+S+L L + +
Sbjct: 202 HYFTAYVNQITD--ITPVANMTRLNSLKIGNNKI--TDLSP-LANLSQLTWLEIGTNQI- 255
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 324
S I + L L + + +N+++ S + L +L LF+ NN L
Sbjct: 256 ------SDINAVKDLTKL--KMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 325 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 368
I L L N++T+I ++ +
Sbjct: 306 VIGGLTNLT-----TLFLSQNHITDIRPLASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 50/269 (18%), Positives = 105/269 (39%), Gaps = 32/269 (11%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
L L ++ + P L+ ++ + ++S+ L++ G ++
Sbjct: 2 AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ + YL L+ + ++ N I+ P +NL K + ++ N I+ L L +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L+ +N++ L+ L K+ L L N+ + + SNM+ L L++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHN--LSDLSPLSNMTGLNYLTVTESK- 166
Query: 264 QGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 323
+ + + L L ++ L+ N++ S + L L N ++ P
Sbjct: 167 ------VKDVTPIANLTDL--YSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP 216
Query: 324 SSIWQSRTLNATETFILDFQNNNLTNISG 352
+ LN L NN +T++S
Sbjct: 217 --VANMTRLN-----SLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 53/268 (19%), Positives = 106/268 (39%), Gaps = 33/268 (12%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ L ++G I L+ L L+ N+I+ P + N+ L L + N++T
Sbjct: 45 SITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD 102
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L L + ++++ IS ANL K ++ N LS + L
Sbjct: 103 --ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGL 157
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
++ + + + ++ L L L L+ N I ++++ L +
Sbjct: 158 NYLTVTESKVKD--VTPIANLTDLYSLSLNYNQI--EDISPL-ASLTSLHYFTAYVNQ-- 210
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 324
++ I + + L ++K+ NNK+T P + L +L L I N +S +
Sbjct: 211 -----ITDITPVANMTRL--NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--IN 259
Query: 325 SIWQSRTLNATETFILDFQNNNLTNISG 352
++ L +L+ +N +++IS
Sbjct: 260 AVKDLTKLK-----MLNVGSNQISDISV 282
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 5/83 (6%)
Query: 88 QLLNLNLSGN-LS--PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+L LN+ N +S + LS L L N++ + IG + +L L L+ N +T
Sbjct: 266 KLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 145 SLPEELGYLPKLDRIQIDQNYIS 167
L L K+D I
Sbjct: 326 I--RPLASLSKMDSADFANQVIK 346
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 57/282 (20%), Positives = 104/282 (36%), Gaps = 43/282 (15%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 671
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
Y + +V E N L L K + + +H +
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 148
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 787
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 788 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 253
Query: 841 DGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
D N P + ++ +K C + + R S+ E++
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 40/295 (13%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 666
++F +GQG +G+V K D A+K+ + + L+E+ L+ L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 667 LVSLVG-YCDEEGEQM------------LVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSI 712
+V + + + E+ NGTL D + S + RL
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDI 765
+ + Y+H++ + HRD+K NI +D K+ DFGL++ + +
Sbjct: 124 QILE--ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 823
+ T GT Y+ E L K D+YSLG++F E++ P S G
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234
Query: 824 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
V + S+ F + + +K I+ + + RP ++
Sbjct: 235 VNILKKLRSVSIEF---PPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 47/273 (17%), Positives = 91/273 (33%), Gaps = 29/273 (10%)
Query: 82 LHLRELQLLNL--NLSGNLSPEIGR-LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ ++ + + + + + LD N +S ++ LELL L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N L +L L L + ++ NY+ H NN+IS ++
Sbjct: 67 SNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
++ L NN +T + ++ L L N + ++ L L+L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 259 RNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318
+ + + L T+ LS+NKL + F + + + NN L
Sbjct: 177 QYNF-------IYDVKGQVVFAKL--KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 319 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 351
I ++ S+ L D + N +
Sbjct: 227 V-LIEKALRFSQNLE-----HFDLRGNGFHCGT 253
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 49/268 (18%), Positives = 92/268 (34%), Gaps = 38/268 (14%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+I + N ++ + + L +L + + + N +S A K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++++N + +L L +L + L+NN + EL P + L NNN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-- 111
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYL-LSLN-ITTI---------- 287
+ + S + L N + D + YL L LN I T+
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 288 -----KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 342
L N + + +L+ L +++N L+ + + + +
Sbjct: 170 TLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WISL 221
Query: 343 QNNNLTNISGSFNIPPNVTV-RLRGNPF 369
+NN L I + N+ LRGN F
Sbjct: 222 RNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 49/260 (18%), Positives = 88/260 (33%), Gaps = 27/260 (10%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+L LNLS N+ + ++ LS L LD N + E+ S+E L N ++
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPS 203
+ I + N I+ ++ ++ + N I + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L H+ L N + + ++ KL L L +N + + + + + +SLRN L
Sbjct: 171 LEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL--AFMGPEFQSAAGVTWISLRNNKL 226
Query: 264 QGPMPDLSRIPN-LGYLLSLNITTIKLSNNKLT-GTIPSNFSGLPRLQRLFIANNSLSGS 321
I L + +L L N GT+ FS R+Q +
Sbjct: 227 -------VLIEKALRFSQNL--EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 322 IPSSIWQSRTLNATETFILD 341
TL + +
Sbjct: 278 QNEEECTVPTLGHYGAYCCE 297
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 35/195 (17%), Positives = 61/195 (31%), Gaps = 11/195 (5%)
Query: 89 LLNLNLSGN----LSP-EIGRLSYLTILDFMWNKISG-SIPKEIGNIKSLELLLLNGNEL 142
N+ L+ N L + G S + LD N+I + + + +LE L L N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ ++ KL + + N ++ + F + + NN + I L
Sbjct: 182 Y-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
+L H L N + + + T L C
Sbjct: 238 NLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 263 LQGPMPDLSRIPNLG 277
P P R+ LG
Sbjct: 297 EDLPAPFADRLIALG 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 70/275 (25%), Positives = 111/275 (40%), Gaps = 39/275 (14%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+G+G YG VY G L + +A+K E + + EI L H+N+V +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SF 88
Query: 676 EEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPVF 732
E + ++ E + G+L L +K PL + G+ YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 733 HRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 791
HRDIK N+L++ K++DFG S+ + GI P + GT Y+ PE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 792 HKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP- 848
+D++SLG +E+ TG P MF V G +P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------AMFKV--GMFKVHPE 246
Query: 849 -----SECVEKFIKLALKCCQDETDARPSMSEVMR 878
S + FI KC + + D R ++++
Sbjct: 247 IPESMSAEAKAFIL---KCFEPDPDKRACANDLLV 278
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 37/279 (13%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRL--HHRNLVSLV 671
QIG GG KV++ + + A+K + + EI +L++L H ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
Y + +V E N L L K + + +H +
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 129
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 787
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 788 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 234
Query: 841 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
D N +P + + C + + R S+ E++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 61/292 (20%), Positives = 106/292 (36%), Gaps = 39/292 (13%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRN 666
+F +G+GG+G V++ D A+KR + + + +E + E++ L++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 667 LVSLVGYCDEEGEQM------------LVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIA 713
+V E+ + + L+D ++ + E ++ L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 714 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDIE 766
L + + +LH + HRD+K SNI KV DFGL V
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 826
H V GT Y+ PE + + K D++SLG++ ELL P S VR
Sbjct: 182 PAYARHTGQV--GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236
Query: 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ V + ++ + RP ++
Sbjct: 237 LTD---------VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 58/307 (18%)
Query: 602 GEMALATN---NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTE 655
G M + + F+ +IG G +G V+K + DG + A+KR E+ L E
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 656 IQFLSRL-HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGF--AMRLS 711
+ + L H ++V E + ML+ E+ + G+L D +S + F A
Sbjct: 61 VYAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------------KFTAKVA 752
+ L RG+ Y+H+ + + H DIK SNI + K K+
Sbjct: 120 LLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 753 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELL 811
D G P V +G +L E + K+D+++L + +
Sbjct: 177 DLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225
Query: 812 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 871
+G + G + P ++F +L + + RP
Sbjct: 226 GAEPLPRNG-------------DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP 272
Query: 872 SMSEVMR 878
S +++
Sbjct: 273 SAMALVK 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 64/340 (18%), Positives = 119/340 (35%), Gaps = 47/340 (13%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 671
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
Y + +V E N L L K + + +H +
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 176
Query: 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 787
H D+K +N L+ K+ DFG++ ++ + V G Y+ PE
Sbjct: 177 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 788 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 281
Query: 841 DGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIWNMMPESDTKT 894
D N P + ++ +K C + + R S+ E++ ++ + + + T
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 338
Query: 895 PEFINS--EHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 932
E + +P S K Y S+ S
Sbjct: 339 TEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSS 378
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 58/270 (21%), Positives = 103/270 (38%), Gaps = 36/270 (13%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL-HHRNLVSL 670
++G G YG+V+K DG + AVKR+ +G K+ L E+ ++ H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 671 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
EEG + L E +L+ L A + + +LH++
Sbjct: 123 EQ-AWEEGGILYLQTEL-CGPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
+ H D+K +NI L + K+ DFGL + A V +G P Y+ PE
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVE--------LGTAGAGEVQEGDPRYMAPE-L 227
Query: 790 LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-GSYP 848
L +DV+SLG+ LE+ M+ + + G + +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL-------------PHGGEGWQQLRQGYLPPEFT 274
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + + + + + R + ++
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-33
Identities = 55/292 (18%), Positives = 107/292 (36%), Gaps = 25/292 (8%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
++ + L +++ ++ + L + ++ P ++ L+ L L N+
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKG 340
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT--RHFHMNNNSISGQIPPELSR 200
S+ + LP L + + +N +S S S+++L RH ++ N +
Sbjct: 341 --SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG 397
Query: 201 LPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259
L L H+ ++ L L KLL L + N + + ++ L L +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK-IDFDGIFLGLTSLNTLKMA 456
Query: 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
S + N+ + N+T + LS +L F L RLQ L +++N+L
Sbjct: 457 GNSFKDNTL-----SNVFANTT-NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510
Query: 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPN-VTVRLRGNPF 369
S Q +L+ LD N + + P + L N
Sbjct: 511 FLDSSHYNQLYSLS-----TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 51/267 (19%), Positives = 97/267 (36%), Gaps = 20/267 (7%)
Query: 87 LQLLNLNLSGNLSPEI--GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ +L++ + L +L L NK S I + + SL L L+ N L+
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364
Query: 145 SLPE--ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRL 201
S L + + N + +F L + +H ++++ L
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L+++ + N L L L++ N+F+ T+ ++N + L L L C
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 262 SLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321
L+ + L L LN +S+N L S+++ L L L + N + S
Sbjct: 484 QLEQISWGV--FDTLHRLQLLN-----MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536
Query: 322 IPSSIWQSRTLNATETFILDFQNNNLT 348
++L + NN++
Sbjct: 537 KGILQHFPKSLA-----FFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-32
Identities = 53/335 (15%), Positives = 95/335 (28%), Gaps = 54/335 (16%)
Query: 61 DPCTSNWTGVLCFNTTMDDGYLHLREL------QLLNLNLSGN----LSPE-IGRLSYLT 109
+PC N T L ++ N++LS N L S L
Sbjct: 5 NPCIEV-----VPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
LD +I K + L L+L GN + P L L+ + + ++
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 170 LPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTG------------ 216
L + ++ +N I ++P S L +LVH+ L N +
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 217 ---------------YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
++ + + KL L L N + N++ L L
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239
Query: 262 SLQGPMPDLSRIPN--LGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
+ +L + L + I +L+ F L + + +A S+
Sbjct: 240 EFKD-ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
Query: 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 354
+ + L L
Sbjct: 299 -YLEDVPKHFKWQ------SLSIIRCQLKQFPTLD 326
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-30
Identities = 52/271 (19%), Positives = 102/271 (37%), Gaps = 14/271 (5%)
Query: 96 GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPK 155
G+L+P I + +T M K+S +P +I + S + + L+ N L +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
L + + + I K++ L+ + + N I P S L SL +++ L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIP 274
+ +L L L + +N +PA +SN++ L+ + L +Q + DL +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 275 NLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 334
+ ++ +S N + F G+ +L L + N S +I + Q N
Sbjct: 178 ENPQVN----LSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQ----NL 228
Query: 335 TETFILDFQNNNLTNISGSFNIPPNVTVRLR 365
+ + P++ L
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-14
Identities = 24/137 (17%), Positives = 42/137 (30%), Gaps = 4/137 (2%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLN 138
L +L L++ N + L+ L L N + + N +L L L+
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
+L L +L + + N + + L + N I
Sbjct: 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 199 SRLPSLVHMLLDNNNLT 215
SL L NN++
Sbjct: 542 HFPKSLAFFNLTNNSVA 558
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 65/321 (20%), Positives = 120/321 (37%), Gaps = 41/321 (12%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 673
+ +GG+ VY+ + G A+KR + + + E+ F+ +L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 674 C-------DEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHT 725
D + L+ + G L + L +S+ PL L I + R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGT 780
PP+ HRD+K N+LL ++ T K+ DFG + + V T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 781 PGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837
P Y PE + + +K D+++LG + L P ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--------------FEDGAKL 259
Query: 838 SVIDGN--MGSYP--SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 893
+++G + + I+ Q + R S++EV+ +L+ I + K
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEI-AAARNVNPK 315
Query: 894 TPEFINSEHTSKEETPPSSSS 914
+P E + S
Sbjct: 316 SPITELLEQNGGYGSATLSRG 336
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 49/273 (17%), Positives = 92/273 (33%), Gaps = 29/273 (10%)
Query: 82 LHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
+ ++ + +L L+ + LD N +S ++ LELL L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N L +L L L + ++ NY+ H NN+IS ++
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
++ L NN +T + ++ L L N + ++ L L+L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 259 RNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318
+ + + L T+ LS+NKL + F + + + NN L
Sbjct: 177 QYNF-------IYDVKGQVVFAKL--KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 319 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 351
I ++ S+ L D + N +
Sbjct: 227 V-LIEKALRFSQNLE-----HFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 49/268 (18%), Positives = 92/268 (34%), Gaps = 38/268 (14%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+I + N ++ + + L +L + + + N +S A K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++++N + +L L +L + L+NN + EL P + L NNN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-- 111
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYL-LSLN-ITTIK--------- 288
+ + S + L N + D + YL L LN I T+
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 289 ------LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 342
L N + + +L+ L +++N L+ + + + +
Sbjct: 170 TLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WISL 221
Query: 343 QNNNLTNISGSFNIPPNVTV-RLRGNPF 369
+NN L I + N+ LRGN F
Sbjct: 222 RNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 42/294 (14%), Positives = 85/294 (28%), Gaps = 35/294 (11%)
Query: 89 LLNLNLSGN----LSP-EIGRLSYLTILDFMWNKISG-SIPKEIGNIKSLELLLLNGNEL 142
N+ L+ N L + G S + LD N+I + + + +LE L L N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ ++ KL + + N ++ + F + + NN + I L
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 203 SLVHMLLDNNNL-TGYLPPELSELPKLLIL--------------------QLDNNNFEGT 241
+L H L N G L S+ ++ + +
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
Query: 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN 301
+PA + +L+ L + +L + I + I
Sbjct: 298 DLPAPF--ADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQV 355
Query: 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 355
L +L + + L+ T + L + + +
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV--GQIELQHATEEQS 407
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 27/276 (9%), Positives = 57/276 (20%), Gaps = 39/276 (14%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEI----------------- 126
+ ++L N + + L D N ++
Sbjct: 215 GVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
Query: 127 ------GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS----LPKSFAN 176
L L L R + GS L N
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 177 LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236
+ R I R + + + L + +L
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
Query: 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTG 296
+ +LL+ ++ + + I + +K T
Sbjct: 395 GQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQ--------NNAIRDWDMYQHKETQ 446
Query: 297 TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 332
N +A S + ++ + + + L
Sbjct: 447 LAEENARLKKLNGEADLALASANATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 18/188 (9%), Positives = 45/188 (23%), Gaps = 6/188 (3%)
Query: 75 TTMDDGYLHLRELQLLNLNLSGNLSPEIGR-LSYLTILDFMWNKISGSIPKEIGNIKSLE 133
T+ D + + +Q + L+ + + T+ + + +L+
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311
Query: 134 LLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
GS L E + I + + + +
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371
Query: 190 ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP-KLLILQLDNNNFEGTTIPASYS 248
+ Q+ L L + P +LL + + +
Sbjct: 372 LDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQN 431
Query: 249 NMSKLLKL 256
N + +
Sbjct: 432 NAIRDWDM 439
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 66/313 (21%), Positives = 123/313 (39%), Gaps = 33/313 (10%)
Query: 617 IGQGGYGKVYKGIL-PDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+G G G V+K P G V+A K E + + E+Q L + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
+GE + E M G+L L K + + +++ +G+ YL + + HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHR 156
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
D+K SNIL++ + K+ DFG+S ++ + ++ V GT Y+ PE
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 795 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 854
+ +SD++S+G+ +E+ G PI + + + + +E +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIP-----------PPDAKELELMFGCQVEGDAAETPPR 256
Query: 855 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTP------EFINSEHTSKEET 908
+ D+RP M+ + L+ I N P +F+N
Sbjct: 257 PRTPGRPLNKFGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 909 PPSSSSMLKHPYV 921
++ H ++
Sbjct: 316 RADLKQLMVHAFI 328
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 616 QIGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRN 666
++G GG VY IL VA+K + ++E L E+ S+L H+N
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIP---PREKEETLKRFEREVHNSSQLSHQN 72
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+VS++ +E+ LV E++ TL + + +S PL ++ GI + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRDIK NIL+D T K+ DFG+++ + + V+ GT Y P
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNHVL-GTVQYFSP 181
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846
E + +D+YS+G+V E+L G P + G+ V+IA + I ++ +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFN-GET---AVSIAIKH------IQDSVPN 231
Query: 847 YPSECV----EKFIKLALKCCQDETDARP-SMSEVMRELESI 883
++ + + L+ + + R ++ E+ +L S+
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-32
Identities = 75/347 (21%), Positives = 126/347 (36%), Gaps = 63/347 (18%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTIL 111
C++ VLC + + L+L N + +L L
Sbjct: 9 CSAQDRAVLC-------HRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 112 DFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGS 169
+ N +S ++ N+ +L L L N L +P L L ++ I +N I
Sbjct: 62 ELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVIL 119
Query: 170 LPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPK 227
L F +L + + +N + I S L SL + L+ NLT +P E LS L
Sbjct: 120 LDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG 177
Query: 228 LLILQLDNNNFEGTTIPA-SYSNMSKLLKLSL-RNCSLQGPMPDLSRIPNLGYLLSLNIT 285
L++L+L + N I S+ + +L L + L P+ NL L
Sbjct: 178 LIVLRLRHLNI--NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL------ 229
Query: 286 TIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLN------- 333
+++ LT +P L L+ L ++ N +S +I S+ + +
Sbjct: 230 --SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285
Query: 334 --ATETF-------ILDFQNNNLTNIS-GSFNIPPN-VTVRLRGNPF 369
F +L+ N LT + F+ N T+ L NP
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-29
Identities = 66/354 (18%), Positives = 122/354 (34%), Gaps = 55/354 (15%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
L L L N + + LS LT LD NKI + + ++ +L+ L + N+
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND 139
Query: 142 LTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LS 199
L + L L+++ +++ ++ ++ ++L+ + + +I+ I
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSL 258
RL L + + + + P L L + + N T +P + ++ L L+L
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL--TAVPYLAVRHLVYLRFLNL 255
Query: 259 RNCSLQGPMPDLSRIPN--LGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 315
+S I L LL L I+L +L + F GL L+ L ++
Sbjct: 256 SYNP-------ISTIEGSMLHELLRL--QEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSG 305
Query: 316 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLT----------NISGSFNIPPNVT---- 361
N L+ ++ S++ S + ET L +N L T
Sbjct: 306 NQLT-TLEESVFHS--VGNLET--LILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360
Query: 362 VRLRGNPFC---LNTNAEQFC------GSHSDDDNEIDRSTNSTLDCRAQSCPT 406
++G F F +D CRA P
Sbjct: 361 EFVQGKEFKDFPDVLLPNYFTCRRARIRDRKAQQVFVDEGHTVQFVCRADGDPP 414
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 76/315 (24%), Positives = 131/315 (41%), Gaps = 41/315 (13%)
Query: 617 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 667
+G GG +V+ VAVK RA L + F E Q + L+H +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRAD---LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 668 VSL--VGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
V++ G + + +V E++ TLRD + ++ P+ + + + + + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFS 132
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H + + HRD+K +NI++ KV DFG++R + + V GT Y
Sbjct: 133 H-QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIGTAQY 185
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ--SSMMFSVID 841
L PE + +SDVYSLG V E+LTG P + G + V++AYQ
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDS---PVSVAYQHVREDPIPPSA 241
Query: 842 GNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPESDTKTPEFINS 900
+ G ++ + LK + R + +E+ +L + N P K ++
Sbjct: 242 RHEGLSAD--LDAVV---LKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT--DA 294
Query: 901 EHTSKEETPPSSSSM 915
E TS + + S
Sbjct: 295 ERTSLLSSAAGNLSG 309
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 73/321 (22%), Positives = 124/321 (38%), Gaps = 47/321 (14%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTILDFMWNKISG 120
C + L L ++ L+L N EI L L L + NKIS
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89
Query: 121 SIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
I + LE L L+ N+L LPE++ L +++ +N I+ F LN+
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 180 TRHFHMNNNSI-SGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
+ N + S I + L ++ + + N+T +P L P L L LD N
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 203
Query: 238 FEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTG 296
T + A+ ++ L KL L S+ + N +L L+ L+NNKL
Sbjct: 204 I--TKVDAASLKGLNNLAKLGLSFNSISAVDNGS--LANTPHLRELH-----LNNNKLV- 253
Query: 297 TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI--LDFQNNNLTNISGSF 354
+P + +Q +++ NN++S +I S+ + N + + +N +
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE--- 309
Query: 355 NIPPNV--------TVRLRGN 367
I P+ V+L
Sbjct: 310 -IQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 53/253 (20%), Positives = 106/253 (41%), Gaps = 26/253 (10%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+PK++ LL L N++T + L L + + N IS P +FA L K
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFE 239
+++ N + ++P ++ +L + + N +T + + L ++++++L N +
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 240 GTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTI 298
+ I ++ M KL + + + + ++ IP L ++T + L NK+T +
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTN-------ITTIPQ--GLPP-SLTELHLDGNKIT-KV 207
Query: 299 PSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 357
+ GL L +L ++ NS+S ++ + N L NN L + G
Sbjct: 208 DAASLKGLNNLAKLGLSFNSIS-AVDNGSLA----NTPHLRELHLNNNKLVKVPGGLADH 262
Query: 358 PN-VTVRLRGNPF 369
V L N
Sbjct: 263 KYIQVVYLHNNNI 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 55/265 (20%), Positives = 96/265 (36%), Gaps = 30/265 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+G+G +G+V++ G AVK+ + + E E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 676 EEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
E + E + G+L + E L AL G+ YLHT + H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-ALYYLGQAL---EGLEYLHTRR---ILH 173
Query: 734 RDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
D+KA N+LL A + DFG + + + + GT ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVVMGK 231
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYPSE 850
K D++S + L +L G P + ++ + + + P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQ----------YFRGPLCLKIASEPPPIREIPPS 281
Query: 851 CVEKFIKLALKCCQDETDARPSMSE 875
C + + + E R S E
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAME 306
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 617 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 667
+G+GG G VY+ + +VA+K L + F T E + RL ++
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMSET---LSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
V + + + +G+ + ++ L L + + PL ++I + H A
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH-AA 153
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
HRD+K NIL+ A + DFG++ + + V GT Y+ PE
Sbjct: 154 G--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNTV-GTLYYMAPE 205
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
F T ++D+Y+L V E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 66/330 (20%), Positives = 111/330 (33%), Gaps = 66/330 (20%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISG----------------SIPKEIG 127
+L L +SGN L L L+I + S+P
Sbjct: 82 ELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPP 141
Query: 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187
++ L + + N+L SLP L KL N ++ SLP + L + +++
Sbjct: 142 GLQELSV---SDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGL---QELSVSD 190
Query: 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 247
N ++ +P S L L NN LT LP S L +L + N T++P
Sbjct: 191 NQLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGLKEL---IVSGNRL--TSLPVL- 239
Query: 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPN-LGYLLSLNITTIKLSNNKLTGTIPSNFSGLP 306
S+L +L + L +P LLSL+ + N+LT +P + L
Sbjct: 240 --PSELKELMVSGNRLT-------SLPMLPSGLLSLS-----VYRNQLT-RLPESLIHLS 284
Query: 307 RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRG 366
+ + N LS + T + + + P T L
Sbjct: 285 SETTVNLEGNPLS-ERTLQALREITS-------APGYSGPIIRFDMAGASAPRETRALHL 336
Query: 367 NPFCLNTNAEQFCGSHSDDDNEIDRSTNST 396
A + + +D + + N+
Sbjct: 337 AAADWLVPAREGEPAPADRWHMFGQEDNAD 366
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 54/288 (18%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
H+ L + + NL+ +L L L+ N+++ S+P + L + L
Sbjct: 62 HITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL 116
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+LP L L I N ++ SLP L + +++N ++ +P S L
Sbjct: 117 P-ALPSGLCKL------WIFGNQLT-SLPVLPPGL---QELSVSDNQLA-SLPALPSELC 164
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L NN LT LP S L L + +N ++P S+L KL N
Sbjct: 165 KL---WAYNNQLT-SLPMLPS---GLQELSVSDNQL--ASLPTL---PSELYKLWAYNNR 212
Query: 263 LQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322
L+ +P L S + + +S N+LT ++P L+ L ++ N L+ S+
Sbjct: 213 -------LTSLPA---LPS-GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SL 256
Query: 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 369
P + L N LT + S + T L GNP
Sbjct: 257 PMLPSGLLS--------LSVYRNQLTRLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 44/257 (17%), Positives = 80/257 (31%), Gaps = 38/257 (14%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L+EL + + L+ +L L L + N+++ S+P ++ L + + N+L
Sbjct: 142 GLQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQELSV---SDNQL 193
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL- 201
SLP L KL N ++ SLP + L + ++ N ++ +P S L
Sbjct: 194 A-SLPTLPSELYKLW---AYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSELK 244
Query: 202 ----------------PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245
L+ + + N LT LP L L + L+ N +
Sbjct: 245 ELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL--SERTL 301
Query: 246 SYSNMSKLLKL-SLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSG 304
S R +L + + F
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQ 361
Query: 305 LPRLQRLFIANNSLSGS 321
+ + LS +
Sbjct: 362 EDNADAFSLFLDRLSET 378
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 63/310 (20%), Positives = 109/310 (35%), Gaps = 48/310 (15%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGNLSPEI-----GRLSYLTILDFMWNKISG 120
C + L L+ + L+L N E+ L +L L + NKIS
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91
Query: 121 SIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
I ++ ++ L+ L ++ N L +P L L ++I N I F+ L
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 180 TRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
M N + + P L ++ + LT +P +L L L LD+N
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI 205
Query: 239 EGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDLSRIP-----NLGYLLSLNITTIKLSNN 292
I SKL +L L + + I L L L+ L NN
Sbjct: 206 --QAIELEDLLRYSKLYRLGLGHNQI-------RMIENGSLSFLPTLRELH-----LDNN 251
Query: 293 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI--LDFQNNNLTNI 350
KL+ +P+ L LQ +++ N+++ + + + + + NN +
Sbjct: 252 KLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309
Query: 351 SGSFNIPPNV 360
+ P
Sbjct: 310 E----VQPAT 315
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 65/274 (23%), Positives = 109/274 (39%), Gaps = 41/274 (14%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
++PKEI LL L N+++ ++ L L + + N IS K+F+ L K
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFE 239
+ +++ N + +IPP L SLV + + +N + +P S L + +++ N E
Sbjct: 105 QKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL-LSLN-ITTI---------- 287
+ + KL L + L G DL L L L N I I
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQAIELEDLLRYSK 218
Query: 288 ----KLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 342
L +N++ I + S LP L+ L + NN LS +P+ + + L ++
Sbjct: 219 LYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ-----VVYL 271
Query: 343 QNNNLTNIS-GSF-------NIPPNVTVRLRGNP 368
NN+T + F + L NP
Sbjct: 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 52/237 (21%), Positives = 89/237 (37%), Gaps = 17/237 (7%)
Query: 88 QLLNLNLSGNLSPEI--GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELT- 143
+L L +S N EI S L L N+I +PK + ++++ + + GN L
Sbjct: 103 KLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLEN 161
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLP 202
KL+ ++I + ++G L H+++N I I E L R
Sbjct: 162 SGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL---NELHLDHNKIQ-AIELEDLLRYS 217
Query: 203 SLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
L + L +N + + LS LP L L LDNN + +PA ++ L + L
Sbjct: 218 KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL--SRVPAGLPDLKLLQVVYLHTN 274
Query: 262 SLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT-GTIPSN-FSGLPRLQRLFIANN 316
++ + P + I L NN + + F + + N
Sbjct: 275 NITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 29/111 (26%), Positives = 45/111 (40%), Gaps = 19/111 (17%)
Query: 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 318
CS G L +P +S + T + L NN ++ + + F GL L L + NN +
Sbjct: 39 QCSDLG----LKAVPKE---ISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 319 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 367
S I + R L L N+L I N+P ++ R+ N
Sbjct: 91 S-KIHEKAFSPLRKLQ-----KLYISKNHLVEIPP--NLPSSLVELRIHDN 133
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 54/300 (18%), Positives = 102/300 (34%), Gaps = 29/300 (9%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
++ + E L+ I+ F + + +P + + + +ELL LN
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79
Query: 141 ELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL- 198
++ + Y + ++ + N I P F N+ + N +S +P +
Sbjct: 80 QIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 137
Query: 199 SRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
P L + + NNNL + + L LQL +N T + S + L +
Sbjct: 138 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDL--SLIPSLFHAN 192
Query: 258 LRNCSLQ--GPMPDLS-------RIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRL 308
+ L + I + +++ +T +KL +N LT P L
Sbjct: 193 VSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGL 250
Query: 309 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 367
+ ++ N L I + L NN L ++ P + V L N
Sbjct: 251 VEVDLSYNELE-KIMYHPFV----KMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 58/310 (18%), Positives = 119/310 (38%), Gaps = 43/310 (13%)
Query: 82 LHLRELQLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELL 135
+ L + + + L + + +L+ +I I +++ L
Sbjct: 42 ITLNNQK--IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKL 98
Query: 136 LLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 194
+ N + LP +P L + +++N +S F N K M+NN++ +I
Sbjct: 99 YMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RI 156
Query: 195 PPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253
+ SL ++ L +N LT ++ L +P L + N +T+ + +
Sbjct: 157 EDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLL--STLAIPIA----V 207
Query: 254 LKLSLRNCSLQ----GPMPDLS-------RIPNLGYLLSL-NITTIKLSNNKLTGTIPSN 301
+L + S+ +L+ + + +LL+ + + LS N+L I +
Sbjct: 208 EELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYH 266
Query: 302 -FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPN 359
F + RL+RL+I+NN L ++ TL +LD +N+L ++
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-----VLDLSHNHLLHVERNQPQFDRL 320
Query: 360 VTVRLRGNPF 369
+ L N
Sbjct: 321 ENLYLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 59/271 (21%), Positives = 97/271 (35%), Gaps = 40/271 (14%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
L L L N L I LT L N + I + SL+ L L+ N
Sbjct: 118 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
LT + L +P L + N +S + A ++NSI+ + +
Sbjct: 177 LT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--N 225
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRN 260
L + L +NNLT L P L+ + L N I + M +L +L + N
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL--EKIMYHPFVKMQRLERLYISN 281
Query: 261 CSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320
L + G + + + LS+N L + N RL+ L++ +NS+
Sbjct: 282 NRL-------VALNLYGQPIP-TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV- 331
Query: 321 SIPSSIWQSRTLNATETFILDFQNNNLTNIS 351
++ S + L +N+ S
Sbjct: 332 TLKLSTHHTLK-------NLTLSHNDWDCNS 355
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 50/264 (18%), Positives = 97/264 (36%), Gaps = 34/264 (12%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
I + + ++ E L + + + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
++N+ I +I + ++ + + N + YLPP +P L +L L+ N+
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 239 EGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYL-LSLN-ITTI------- 287
+++P + N KL LS+ N +L+ +L L LS N +T +
Sbjct: 130 --SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 187
Query: 288 ----KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 343
+S N L+ + ++ L ++NS++ + + T IL Q
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELT-------ILKLQ 234
Query: 344 NNNLTNISGSFNIPPNVTVRLRGN 367
+NNLT+ + N P V V L N
Sbjct: 235 HNNLTDTAWLLNYPGLVEVDLSYN 258
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 71/314 (22%), Positives = 118/314 (37%), Gaps = 53/314 (16%)
Query: 586 SSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-E 643
S +KI + + + +IG+G YG V K + P G ++AVKR +
Sbjct: 4 ESSGKLKISPEQHWD-----FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 644 GSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE 702
+ +K+ L ++ + R +V G EG+ + E MS + S
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 703 PLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RL 759
+ I L + + + +L + HRDIK SNILLD K+ DFG+S +L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 760 APVPDIEGIVPAHVSTVVK----GTPGYLDPEYFLTHKLTD----KSDVYSLGVVFLELL 811
V ++ K G Y+ PE +SDV+SLG+ EL
Sbjct: 177 -------------VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 812 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK-------FIKLALKCCQ 864
TG P ++ + V+ G+ + + F+ C
Sbjct: 224 TGRFPYPKWNSVFD---------QLTQVVKGDPPQLSNSEEREFSPSFINFVN---LCLT 271
Query: 865 DETDARPSMSEVMR 878
+ RP E+++
Sbjct: 272 KDESKRPKYKELLK 285
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-30
Identities = 43/210 (20%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 617 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL- 670
I GG G +Y + +G V +K G + + + E QFL+ + H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 671 -VGYCDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+ + Y E++ +L+ + L A ++ L + YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ + D+K NI+L + K+ D G + GTPG+ P
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----------NSFGYLY-GTPGFQAP 246
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
E + T +D+Y++G L +
Sbjct: 247 EI-VRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-30
Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 43/283 (15%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L +N S N + L+ L + N+I+ P + N+ +L L L N++T
Sbjct: 69 NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
+ L L L+R+++ N IS + + L + N L+ L +L
Sbjct: 127 --IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTL 179
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ + +N ++ L++L L L NN + I ++ L +LSL L+
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQI--SDITPL-GILTNLDELSLNGNQLK 234
Query: 265 GPMP---------------DLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 309
+S + L L L T +KL N+++ P +GL L
Sbjct: 235 DIGTLASLTNLTDLDLANNQISNLAPLSGLTKL--TELKLGANQISNISP--LAGLTALT 290
Query: 310 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 352
L + N L P I + L L NN+++IS
Sbjct: 291 NLELNENQLEDISP--ISNLKNLT-----YLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 34/270 (12%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ LQ L + ++ + L+ LT ++F N+++ P + N+ L +L+N N++
Sbjct: 47 QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
L L L + + N I+ NL +++N+IS LS L
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLT 156
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
SL + N L+ L L L + +N + + + ++ L L N
Sbjct: 157 SLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV---SDISVLAKLTNLESLIATNNQ 210
Query: 263 LQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322
+ I LG L +L + L+ N+L + L L L +ANN +S
Sbjct: 211 ISD-------ITPLGILTNL--DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 259
Query: 323 PSSIWQSRTLNATETFILDFQNNNLTNISG 352
P + L L N ++NIS
Sbjct: 260 P--LSGLTKLT-----ELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 62/273 (22%), Positives = 103/273 (37%), Gaps = 31/273 (11%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
L LQ L+ + L+ L LD NK+S + + +LE L+ N++
Sbjct: 154 GLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI 211
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
+ LG L LD + ++ N + + A+L + NN IS LS L
Sbjct: 212 SDI--TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLT 265
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
L + L N ++ L+ L L L+L+ N I SN+ L L+L +
Sbjct: 266 KLTELKLGANQISN--ISPLAGLTALTNLELNENQL--EDISPI-SNLKNLTYLTLYFNN 320
Query: 263 LQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322
+ I + L L + NNK++ S+ + L + L +N +S
Sbjct: 321 ISD-------ISPVSSLTKL--QRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLT 369
Query: 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSFN 355
P + N T L + TN ++
Sbjct: 370 PLA-------NLTRITQLGLNDQAWTNAPVNYK 395
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 58/285 (20%), Positives = 102/285 (35%), Gaps = 35/285 (12%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + L + L +T L I + + +L + + N+LT
Sbjct: 25 EKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTD 82
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L KL I ++ N I+ ANL + NN I+ L L +L
Sbjct: 83 I--TPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNL 136
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L +N ++ LS L L L N T +N++ L +L + +
Sbjct: 137 NRLELSSNTISD--ISALSGLTSLQQLSFGNQV----TDLKPLANLTTLERLDISSNK-- 188
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 324
+S I L L +L ++ +NN+++ P L L L + N L
Sbjct: 189 -----VSDISVLAKLTNL--ESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IG 237
Query: 325 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 369
++ L LD NN ++N++ + ++L N
Sbjct: 238 TLASLTNLT-----DLDLANNQISNLAPLSGLTKLTELKLGANQI 277
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 56/286 (19%), Positives = 107/286 (37%), Gaps = 33/286 (11%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L +L + N +G L+ L L N++ + ++ +L L L N+++
Sbjct: 200 NLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L KL +++ N IS P A L + +N N + +S L +L
Sbjct: 258 L--APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNL 311
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
++ L NN++ +S L KL L NN + +S +N++ + LS +
Sbjct: 312 TYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKV---SDVSSLANLTNINWLSAGHN--- 363
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 324
+S + L L + T + L++ T + + + + +L P+
Sbjct: 364 ----QISDLTPLANLTRI--TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPA 415
Query: 325 SIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTVRLRGNPF 369
+I + D N + + S+ VT+ F
Sbjct: 416 TISDGGSYTE-----PDITWNLPSYTNEVSYTFSQPVTIGKGTTTF 456
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-14
Identities = 33/167 (19%), Positives = 64/167 (38%), Gaps = 25/167 (14%)
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245
+ I+ QI + L + +L N+T ++L ++ LQ D
Sbjct: 10 QDTPIN-QIFT-DTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI---KSID 62
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL 305
++ L +++ N L+ I L L L I ++NN++ + + L
Sbjct: 63 GVEYLNNLTQINFSNNQ-------LTDITPLKNLTKL--VDILMNNNQIAD--ITPLANL 111
Query: 306 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 352
L L + NN ++ P + LN L+ +N +++IS
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLN-----RLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-13
Identities = 36/195 (18%), Positives = 69/195 (35%), Gaps = 34/195 (17%)
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232
+ L + + +++ + + L + + D + + L L +
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74
Query: 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP---------------DLSRIPNLG 277
NN T I N++KL+ + + N + P ++ I L
Sbjct: 75 FSNNQL--TDITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 131
Query: 278 YLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 337
L +L ++LS+N ++ S SGL LQ+L N + TL
Sbjct: 132 NLTNL--NRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLE---- 180
Query: 338 FILDFQNNNLTNISG 352
LD +N +++IS
Sbjct: 181 -RLDISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-13
Identities = 26/159 (16%), Positives = 54/159 (33%), Gaps = 10/159 (6%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L L L N + L+ L L F NK+S + N+ ++ L N+++
Sbjct: 310 NLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD 367
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L ++ ++ ++ + + AN++ ++ P +S S
Sbjct: 368 --LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSY 423
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243
+ N + Y + + + F GT
Sbjct: 424 TEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ ++ +V E +L + + A + G YLH V
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 137
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 189
Query: 793 KLTD-KSDVYSLGVVFLELLTGMQP 816
K + DV+S+G + LL G P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ ++ +V E +L + + A + G YLH V
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 163
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 215
Query: 793 KLTD-KSDVYSLGVVFLELLTGMQP 816
K + DV+S+G + LL G P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 24/254 (9%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+P I + LL L+ N++ +L L+ +Q+ +N+I +F L
Sbjct: 57 EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 238
+ +N ++ IP L L + L NN + +P + +P L L L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK- 171
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGT 297
+ I ++ +S L L+L C+ L IPNL L+ L + LS N L+
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCN-------LREIPNLTPLIKL--DELDLSGNHLSAI 222
Query: 298 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNI 356
P +F GL LQ+L++ + + I + + + L + ++ +NNLT + F
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN--LQSLVE--INLAHNNLTLLPHDLFTP 277
Query: 357 PPN-VTVRLRGNPF 369
+ + L NP+
Sbjct: 278 LHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 35/153 (22%), Positives = 51/153 (33%), Gaps = 49/153 (32%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L LNL+ EI L+ L L+ L L+GN L+ ++
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLI---------------------KLDELDLSGNHLS-AIR 223
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVH 206
SF L + M + I I L SLV
Sbjct: 224 PG-----------------------SFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVE 259
Query: 207 MLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+ L +NNLT LP + + L L + L +N +
Sbjct: 260 INLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 37/232 (15%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVK-----------------RAQEGSLQGEKEFLTEIQFL 659
+ QG + K+ D A+K + +F E+Q +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 660 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS-- 717
+ + + ++ G E ++YE+M N ++ + + I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 718 ----RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773
Y+H E + + HRD+K SNIL+D K++DFG S +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--------DKKI 207
Query: 774 STVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 823
GT ++ PE+F + K D++SLG+ + + P S ++
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 674
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 675 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 728
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 729 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 785 DPEYFLTHKLTD--------KSDVYSLGVVFLELLTGMQP 816
P+ + L D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 48/281 (17%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQF-LSRLHHRNLVSLVGY 673
+G+G YG V K +P G ++AVKR + Q +K L ++ + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPV 731
EG+ + E M + +L + + IA+ + + +LH++ V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 732 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDP 786
HRD+K SN+L++ K+ DFG+S L V V K G Y+ P
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL-------------VDDVAKDIDAGCKPYMAP 178
Query: 787 EYFLTHKLTD----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
E KSD++SLG+ +EL P + + V++
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------QLKQVVEE 229
Query: 843 NM-----GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ +E V+ F +C + + RP+ E+M+
Sbjct: 230 PSPQLPADKFSAEFVD-FTS---QCLKKNSKERPTYPELMQ 266
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-29
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 29/239 (12%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLV--- 671
+G GG+G V + I G VA+K+ ++ +E EIQ + +L+H N+VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 672 ---GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLH 724
+L E+ G LR L+ G L + S + YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISS--ALRYLH 138
Query: 725 TEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
+ HRD+K NI+L + K+ D G ++ + + T GT
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--------LDQGELCTEFVGTL 187
Query: 782 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
YL PE K T D +S G + E +TG +P V+ + S V+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 56/255 (21%), Positives = 105/255 (41%), Gaps = 26/255 (10%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+P+ I + L L N + + +L L+ +Q+ +N I +F L
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+ +N ++ IP L L + L NN + +P + +P L+ L L
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK- 182
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGT 297
+ I ++ + L L+L C+ + +PNL L+ L +++S N
Sbjct: 183 KLEYISEGAFEGLFNLKYLNLGMCN-------IKDMPNLTPLVGL--EELEMSGNHFP-E 232
Query: 298 IPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFN 355
I F GL L++L++ N+ +S I + + L + L+ +NNL+++ F
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDG--LASLVE--LNLAHNNLSSLPHDLFT 287
Query: 356 IPPN-VTVRLRGNPF 369
V + L NP+
Sbjct: 288 PLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 49/153 (32%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
L LNL ++ L+ L LE L ++GN +
Sbjct: 197 NLKYLNLGMCNIKDMPNLTPLV---------------------GLEELEMSGNHFP-EIR 234
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVH 206
SF L+ + + N+ +S I L SLV
Sbjct: 235 PG-----------------------SFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 207 MLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+ L +NNL+ LP + + L L+ L L +N +
Sbjct: 271 LNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 41/277 (14%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY 673
+G G G+V+K G V+AVK+ + G+ + K L ++ + + H +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+ + E M GT ++L + + P+ + + + + + YL + V H
Sbjct: 93 FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIH 148
Query: 734 RDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDPEY 788
RD+K SNILLD + K+ DFG+S RL V K G Y+ PE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL-------------VDDKAKDRSAGCAAYMAPER 195
Query: 789 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
T ++DV+SLG+ +EL TG P + K ++ V+
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---------VLTKVLQEE 246
Query: 844 MGSYPSECV--EKFIKLALKCCQDETDARPSMSEVMR 878
P F C + RP ++++
Sbjct: 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
IG G V P VA+KR E E L EIQ +S+ HH N+VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS---IAL---GSSRGILYLHTEAD 728
+ E LV + +S G++ D + + + L IA G+ YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
HRD+KA NILL + ++ADFG+S LA DI T V GTP ++ PE
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK--TFV-GTPCWMAPE 196
Query: 788 YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISH 819
+ D K+D++S G+ +EL TG P
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 68/323 (21%), Positives = 110/323 (34%), Gaps = 70/323 (21%)
Query: 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGN----------- 128
L+E + NL+ + E + T W++ + P G
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 129 --IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186
+ L LN L+ SLPE +L L N ++ LP+ +L + N
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 187 NNSISGQIP---------------PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 231
++S P PEL L + +DNN+L LP P L +
Sbjct: 123 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP---DLPPSLEFI 178
Query: 232 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSN 291
NN +P N+ L + N S L ++P+L ++ +I N
Sbjct: 179 AAGNNQL--EELP-ELQNLPFLTAIYADNNS-------LKKLPDLPL----SLESIVAGN 224
Query: 292 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI------------ 339
N L LP L ++ NN L ++P LN + ++
Sbjct: 225 NIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTF 281
Query: 340 LDFQNNNLTNISGSFNIPPNVTV 362
LD N + +S +PPN+
Sbjct: 282 LDVSENIFSGLS---ELPPNLYY 301
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 79/321 (24%), Positives = 122/321 (38%), Gaps = 51/321 (15%)
Query: 45 KSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGR 104
KS + Y+ S W R P + + + D EL+L NL LS +L
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH 92
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
L L N ++ +P+ ++KSL + N L+ LP L YL + N
Sbjct: 93 LESLVASC---NSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLEYL------GVSNN 141
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
+ LP N + + ++NNS+ ++P PSL + NN L PEL
Sbjct: 142 QLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE--LPELQN 193
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNI 284
LP L + DNN+ +P L + N L +P L L L
Sbjct: 194 LPFLTAIYADNNSL--KKLPDL---PLSLESIVAGNNIL-------EELPELQNLPFL-- 239
Query: 285 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI----- 339
TTI NN L T+P P L+ L + +N L+ +P L+ +E
Sbjct: 240 TTIYADNNLLK-TLPD---LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSE 294
Query: 340 -------LDFQNNNLTNISGS 353
L+ +N + ++
Sbjct: 295 LPPNLYYLNASSNEIRSLCDL 315
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-23
Identities = 51/273 (18%), Positives = 97/273 (35%), Gaps = 45/273 (16%)
Query: 88 QLLNLNLSGN-LS--PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
L ++ N L PE+ L +LT + N + ++P ++++L + N LT
Sbjct: 216 SLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVR---DNYLT- 270
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
LPE L LD + +N S L + NL + + ++N I + L L
Sbjct: 271 DLPELPQSLTFLD---VSENIFS-GLSELPPNL---YYLNASSNEIR-SLCDLPPSLEEL 322
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ NN L LP + P+L L N+ +P L +L + L+
Sbjct: 323 N---VSNNKLI-ELP---ALPPRLERLIASFNHL--AEVPEL---PQNLKQLHVEYNPLR 370
Query: 265 GPMPDLSRIPNLGYLLSL--------NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 316
+ +L L N+ + + N L P ++ L + +
Sbjct: 371 EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDI---PESVEDLRMNSE 426
Query: 317 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 349
+ + + L F++++ +
Sbjct: 427 RVVDPYEFAHETTDKLE-----DDVFEHHHHHH 454
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 50/270 (18%), Positives = 83/270 (30%), Gaps = 58/270 (21%)
Query: 123 PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL----- 177
P+ + N L+ L + + LT +P E + + + P
Sbjct: 5 PRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 178 --------NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 229
+ +NN +S +P L SLV N+LT LP L LL
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLL 117
Query: 230 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL-LSLN----- 283
+ + L L + N L+ +P+L L + + N
Sbjct: 118 VDNNNLKALS--------DLPPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKKL 168
Query: 284 ------ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 337
+ I NN+L +P LP L ++ NNSL +P ++ A
Sbjct: 169 PDLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAGNN 225
Query: 338 FI--------------LDFQNNNLTNISGS 353
+ + NN L +
Sbjct: 226 ILEELPELQNLPFLTTIYADNNLLKTLPDL 255
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 28/157 (17%), Positives = 54/157 (34%), Gaps = 30/157 (19%)
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253
I P L L ++NLT +P E + + +E P ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWER-NAPPGNGEQREM 60
Query: 254 LKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 313
LR+C L ++L+N L+ ++P P L+ L
Sbjct: 61 AVSRLRDC------------------LDRQAHELELNNLGLS-SLPEL---PPHLESLVA 98
Query: 314 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350
+ NSL+ +P ++L + + L+++
Sbjct: 99 SCNSLT-ELPELPQSLKSLL-----VDNNNLKALSDL 129
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+G +G VY ++A+K +AQ E + E++ S L H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 730
Y + L+ E+ GT+ +L SK E +A + Y H++
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYCHSKR--- 129
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
V HRDIK N+LL K+ADFG S A P+ T + GT YL PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRTDLCGTLDYLPPEMIE 180
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQP 816
+K D++SLGV+ E L G P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 674
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 675 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 728
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 729 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 785 DPEYF--------LTHKLTDKSDVYSLGVVFLELLTGMQP 816
P+ + K D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 54/263 (20%), Positives = 105/263 (39%), Gaps = 20/263 (7%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ L+L+N P + L L L F NK + + ++ SLE L L+ N L+
Sbjct: 306 WQHLELVNCKF--GQFPTLK-LKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLS 360
Query: 144 --GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE--LS 199
G + L + + N + ++ +F L + H ++++ Q+
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 418
Query: 200 RLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 258
L +L+++ + + + + L L +L++ N+F+ +P ++ + L L L
Sbjct: 419 SLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 259 RNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318
C L+ P L SL + +++N+L F L LQ++++ N
Sbjct: 478 SQCQLEQLSPTA-----FNSLSSL--QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
Query: 319 SGSIPSSIWQSRTLNATETFILD 341
S P + SR LN
Sbjct: 531 DCSCPRIDYLSRWLNKNSQKEQG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-28
Identities = 46/295 (15%), Positives = 105/295 (35%), Gaps = 26/295 (8%)
Query: 81 YLHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
L + E +L L+ + ++ L+ ++ + I + N + L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVN 313
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPE 197
+ +L L +L N + S +L ++ N +S G
Sbjct: 314 CKFGQFPTLKLKSLKRLT---FTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
SL ++ L N + + L +L L ++N + + + + ++ L+ L
Sbjct: 369 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 258 LRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANN 316
+ + + + L SL +K++ N + F+ L L L ++
Sbjct: 428 ISHTHTRVAFNGI-----FNGLSSL--EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 317 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPN-VTVRLRGNPF 369
L + + + + + +L+ +N L ++ G F+ + + L NP+
Sbjct: 481 QLE-QLSPTAFN----SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 41/257 (15%), Positives = 86/257 (33%), Gaps = 9/257 (3%)
Query: 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165
LD +N + + L++L L+ E+ L L + + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT-GYLPPELSE 224
I +F+ L+ + +++ + L +L + + +N + LP S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNI 284
L L L L +N +I +++ L ++ L N SL + ++ I G + +
Sbjct: 148 LTNLEHLDLSSNKI--QSIYC--TDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKEIRL 202
Query: 285 TTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 343
+ L NN + + GL L+ + + L L +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN--LTIE 260
Query: 344 NNNLTNISGSFNIPPNV 360
L + + ++
Sbjct: 261 EFRLAYLDYYLDDIIDL 277
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-23
Identities = 56/272 (20%), Positives = 98/272 (36%), Gaps = 18/272 (6%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
IP + S + L L+ N L P+L + + + I ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ N I S L SL ++ NL + L L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIP 299
+P +SN++ L L L + +Q DL + + L ++ LS N + P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN----LSLDLSLNPMNFIQP 194
Query: 300 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ----NNNLTNIS-GSF 354
F + RL +L + NN S ++ + Q L E L NL +
Sbjct: 195 GAFKEI-RLHKLTLRNNFDSLNVMKTCIQG--LAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 355 NIPPNVTV---RLRGNPFCLNTNAEQFCGSHS 383
N+T+ RL + L+ + F +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-20
Identities = 59/335 (17%), Positives = 113/335 (33%), Gaps = 50/335 (14%)
Query: 83 HLRELQLLNL---NLSGNLSPEIGRLSYLTI----LDFMWNKISGSIPKEIGNIKSLELL 135
+L L+ L+L + ++ L + + LD N ++ I L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205
Query: 136 LLNGNELTGSLPEE-LGYLPKLDRIQIDQN---------YISGSLPKSFANLNKTRHFHM 185
L N + ++ + + L L+ ++ S + NL
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245
+ I + L ++ L + + + S L+L N F P
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKF--GQFPT 321
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL-LSLN-----------------ITTI 287
+ L +L+ + +P+L +L LS N + +
Sbjct: 322 --LKLKSLKRLTFTSNKGGNA-FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 288 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 347
LS N + T+ SNF GL +L+ L +++L S++ + LD + +
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL----SLRNLIYLDISHTHT 433
Query: 348 TNI-SGSFNIPPNVTV-RLRGNPFCLNTNAEQFCG 380
+G FN ++ V ++ GN F N + F
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 64/284 (22%), Positives = 112/284 (39%), Gaps = 40/284 (14%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRL-HH 664
+F +G G G + + D VAVKR E + E+Q L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 665 RNLVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 722
N++ +C E+ Q + E + TL++ + K LG ++ ++ G+ +
Sbjct: 78 PNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 723 LHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
LH+ + HRD+K NIL+ A ++DFGL + G + V
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA----VGRHSFSRRSGV 186
Query: 778 KGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834
GT G++ PE T D++S G VF +++ GK++ R+ NI +
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANILLGAC 245
Query: 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + + + I+ K + RPS V++
Sbjct: 246 SLDCLHPEK---HEDVIARELIE---KMIAMDPQKRPSAKHVLK 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-28
Identities = 60/320 (18%), Positives = 111/320 (34%), Gaps = 30/320 (9%)
Query: 617 IGQG--GYGKVYKGI-LPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 671
IG+G V P G V V+R + S + E+ +H N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
+ E +V FM+ G+ +D + + + I G + + Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---Y 149
Query: 732 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
HR +KAS+IL+ ++ + + + +V V +L PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLSPEVLQ 208
Query: 791 THKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS-MMFSVIDGNM--- 844
+ KSD+YS+G+ EL G P ++ M+ ++G +
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKD-----------MPATQMLLEKLNGTVPCL 257
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 904
+ E+ + + + + R P T +P F +
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 905 KEETP---PSSSSMLKHPYV 921
+ P PS+S++L H +
Sbjct: 318 LQRNPDARPSASTLLNHSFF 337
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+G + VY+ + G VA+K + + E++ +L H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADP 729
Y ++ LV E NG + L + K E I G+LYLH+
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG-- 132
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
+ HRD+ SN+LL K+ADFGL+ +P + GTP Y+ PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-------EKHYTLCGTPNYISPE-I 183
Query: 790 LTHKLTD-KSDVYSLGVVFLELLTGMQP 816
T +SDV+SLG +F LL G P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 48/260 (18%), Positives = 95/260 (36%), Gaps = 31/260 (11%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS--GSLPKSFANLN 178
S+P I S L L N+L L +L ++ + N +S G +S
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNN 236
++ ++ N + + L L H+ ++NL + L L+ L + +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 237 NFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLLSLNITTIKLSNNK 293
+ ++ +S L L + S Q + + NL +L LS +
Sbjct: 137 HT--RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD--------LSQCQ 186
Query: 294 LTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 352
L + F+ L LQ L +++N+ S+ + ++ +LD+ N++
Sbjct: 187 LE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK----CLNSLQVLDYSLNHIMTSKK 240
Query: 353 S--FNIPPN-VTVRLRGNPF 369
+ P + + L N F
Sbjct: 241 QELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 44/246 (17%), Positives = 93/246 (37%), Gaps = 21/246 (8%)
Query: 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT--GSLPEELGYLPKLDRIQIDQNY 165
T L+ NK+ + L L L+ N L+ G + L + + N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 166 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPE-L 222
+ ++ +F L + H ++++ Q+ L +L+++ + + +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146
Query: 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSL 282
+ L L +L++ N+F+ +P ++ + L L L C L+ P +L L L
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN--SLSSLQVL 204
Query: 283 NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 341
N +S+N ++ + + L LQ L + N + + Q + L+
Sbjct: 205 N-----MSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAF---LN 254
Query: 342 FQNNNL 347
N+
Sbjct: 255 LTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 46/266 (17%), Positives = 89/266 (33%), Gaps = 29/266 (10%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKIS- 119
C T + L + L L N L + +L+ LT L N +S
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 120 -GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANL 177
G + SL+ L L+ N + ++ L +L+ + + + S F +L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 178 NKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDN 235
+ +++ + L SL + + N+ P+ +EL L L L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 236 NNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKL 294
+ +++++S L L++ + + L L L+ S N +
Sbjct: 185 CQL--EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP--YKCLNSLQVLD-----YSLNHI 235
Query: 295 TGTIPSNFSGLPR-LQRLFIANNSLS 319
+ P L L + N +
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 23/111 (20%), Positives = 43/111 (38%), Gaps = 13/111 (11%)
Query: 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
C+ +G L+ +P + + T ++L +NKL F L +L +L +++N LS
Sbjct: 13 RCNSKG----LTSVPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 320 -GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGNP 368
S T LD N + +S +F + + +
Sbjct: 66 FKGCCSQSDF----GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 112
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 674
IG+G +G+V+KGI VVA+K + E E + EI LS+ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
++ + ++ E++ G+ D L PL +I +G+ YLH+E HR
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHR 143
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
DIKA+N+LL K+ADFG++ + D + +T V GTP ++ PE
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQ----IKRNTFV-GTPFWMAPEVIKQSAY 196
Query: 795 TDKSDVYSLGVVFLELLTGMQPISH 819
K+D++SLG+ +EL G P S
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSE 221
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 58/310 (18%), Positives = 120/310 (38%), Gaps = 43/310 (13%)
Query: 82 LHLRELQLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELL 135
+ L + + + L + + +L+ +I I +++ L
Sbjct: 48 ITLNNQK--IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKL 104
Query: 136 LLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 194
+ N + LP + +P L + +++N +S F N K M+NN++ +I
Sbjct: 105 YMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RI 162
Query: 195 PPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253
+ SL ++ L +N LT ++ L +P L + N +T+ + +
Sbjct: 163 EDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLL--STLAIPIA----V 213
Query: 254 LKLSLRNCSLQ----GPMPDLS-------RIPNLGYLLSL-NITTIKLSNNKLTGTIPSN 301
+L + S+ +L+ + + +LL+ + + LS N+L I +
Sbjct: 214 EELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYH 272
Query: 302 -FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPN 359
F + RL+RL+I+NN L ++ TL +LD +N+L ++
Sbjct: 273 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-----VLDLSHNHLLHVERNQPQFDRL 326
Query: 360 VTVRLRGNPF 369
+ L N
Sbjct: 327 ENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 60/305 (19%), Positives = 115/305 (37%), Gaps = 46/305 (15%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
Q+ LNL+ + + L +N I +P + N+ L +L+L N+
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 142 LTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
L+ SLP + PKL + + N + +F ++ +++N ++ + S
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 190
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
+PSL H + N L+ L+ + L +N+ + +L L L++
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI--NVVRGP--VNVELTILKLQH 241
Query: 261 CSLQGPMPDLSRIPNLGYL-LSLN-ITTI--------------KLSNNKLTGTIPSNFSG 304
+L L P L + LS N + I +SNN+L +
Sbjct: 242 NNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
Query: 305 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRL 364
+P L+ L +++N L + + Q L L +N++ + S + L
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLE-----NLYLDHNSIVTLKLS-THHTLKNLTL 352
Query: 365 RGNPF 369
N +
Sbjct: 353 SHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 61/271 (22%), Positives = 96/271 (35%), Gaps = 40/271 (14%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
L L L N L I LT L N + I + SL+ L L+ N
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 182
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
LT + L +P L + N +S + A ++NSI+ + +
Sbjct: 183 LT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--N 231
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRN 260
L + L +NNLT L P L+ + L N I + M +L +L + N
Sbjct: 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL--EKIMYHPFVKMQRLERLYISN 287
Query: 261 CSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320
L IP L + LS+N L + N RL+ L++ +NS+
Sbjct: 288 NRLVALNLYGQPIPTL--------KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV- 337
Query: 321 SIPSSIWQSRTLNATETFILDFQNNNLTNIS 351
++ S + L +N+ S
Sbjct: 338 TLKLSTHHTLK-------NLTLSHNDWDCNS 361
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 55/280 (19%), Positives = 104/280 (37%), Gaps = 56/280 (20%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
++ + E L+ I+ F + + +P + + + +ELL LN
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LS 199
++ + +FA + + +M N+I +PP
Sbjct: 86 QIE-EIDTY-----------------------AFAYAHTIQKLYMGFNAIR-YLPPHVFQ 120
Query: 200 RLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLS 257
+P L ++L+ N+L+ LP + PKL L + NNN I + + L L
Sbjct: 121 NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL--ERIEDDTFQATTSLQNLQ 177
Query: 258 LRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 317
L + L+ + L + SL +S N L+ + ++ L ++NS
Sbjct: 178 LSSNR-------LTHVD-LSLIPSL--FHANVSYNLLS-----TLAIPIAVEELDASHNS 222
Query: 318 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 357
++ + + T IL Q+NNLT+ + N P
Sbjct: 223 IN-VVRGPVNVELT-------ILKLQHNNLTDTAWLLNYP 254
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 5e-15
Identities = 47/295 (15%), Positives = 104/295 (35%), Gaps = 50/295 (16%)
Query: 88 QLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEI--------------------G 127
L + N+S NL + + LD N I+ + +
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLL 251
Query: 128 NIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186
N L + L+ NEL + + +L+R+ I N + +L + + ++
Sbjct: 252 NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 246
+N + + + L ++ LD+N++ L L L L +N+++ ++ A
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRAL 365
Query: 247 YSNMSKL------------LKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKL 294
+ N+++ +L C + P L R+ L + +T++ +
Sbjct: 366 FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL-----LQYIALTSVVEKVQRA 420
Query: 295 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 349
G + + + ++ ++ + + L A E L + LTN
Sbjct: 421 QGRCSA----TDTINSVQSLSHYITQQGGVPLQGNEQLEA-EVNELRAEVQQLTN 470
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+G +G VY + ++A+K ++Q E + EI+ S L H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
Y + L+ EF G L +L + + L + Y H V
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD--ALHYCHERK---VI 136
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDPEYF 789
HRDIK N+L+ +K K+ADFG S AP S + GT YL PE
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAP------------SLRRRTMCGTLDYLPPEMI 184
Query: 790 LTHKLTDKSDVYSLGVVFLELLTGMQP 816
+K D++ GV+ E L GM P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+G G +GKVYK G + A K + S + ++++ EI+ L+ H +V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
+G+ ++ EF G + + + L + + +LH++ + HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKR---IIHRD 142
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTPGYLDPEY 788
+KA N+L+ + ++ADFG+S A + + GTP ++ PE
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS-------------AKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 789 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 819
+ + D K+D++SLG+ +E+ P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 29/300 (9%), Positives = 59/300 (19%), Gaps = 55/300 (18%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+ G V+ + A+K E S + +RL +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 673 YC--------------------------DEEGEQMLVYEFMSNGTLRDQLSA-----KSK 701
+L+ S L S +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 702 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761
G + R L ++ + H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQPISH 819
Y E+ T + + LG+ + P
Sbjct: 243 -------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 820 GKNIVRE-VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
++ + + + V+ I + + R E M
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
+ +IGQG G VY + + G VA+++ ++ + EI + + N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
+ E +V E+++ G+L D ++ + A ++ + + +LH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ-- 136
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDP 786
V HRDIK+ NILL + K+ DFG + S T+V GTP ++ P
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFC---------AQITPEQSKRSTMV-GTPYWMAP 185
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
E K D++SLG++ +E++ G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVS----- 669
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 670 LVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
+ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTP 781
V HRDIK N+LL K+ DFG+S A + T + GTP
Sbjct: 150 --VIHRDIKGQNVLLTENAEVKLVDFGVS-------------AQLDRTVGRRNTFI-GTP 193
Query: 782 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 819
++ PE + D KSD++SLG+ +E+ G P+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 53/250 (21%), Positives = 98/250 (39%), Gaps = 19/250 (7%)
Query: 89 LLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNEL 142
+ +L+LS N +S R L L N I+ +I ++ ++ SLE L L+ N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 143 TGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPE-L 198
+ +L L L + + N +L ++ F++L K + + N +I +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLS 257
+ L L + +D ++L Y P L + + L L + S + L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH--ILLLEIFVDVTSSVECLE 228
Query: 258 LRNCSLQG-PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 316
LR+ L +LS + +K+++ L + + + L L + N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287
Query: 317 SLSGSIPSSI 326
L S+P I
Sbjct: 288 QLK-SVPDGI 296
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 53/282 (18%), Positives = 101/282 (35%), Gaps = 46/282 (16%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
SIP + ++++ L L+ N +T +L L + + N I+ SF++L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 181 RHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNN 237
H ++ N +S + L SL + L N L S L KL IL++ N +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLLSLNITTIKLSNNKLTG 296
++ ++ L +L + LQ L I N+ +L L +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL--------ILHMKQHI- 211
Query: 297 TIPSN-FSGLPRLQRLFIANNSLSGSIPSSI-----------WQSRTLNATETFI----- 339
+ ++ L + + L S + + R + T+ +
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK 271
Query: 340 ----------LDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 369
L+F N L ++ G F+ ++ + L NP+
Sbjct: 272 LLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 43/240 (17%), Positives = 74/240 (30%), Gaps = 60/240 (25%)
Query: 88 QLLNLNLSGN----LSPEI--GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGN 140
L LNL GN L L+ L IL I ++ + LE L ++ +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-S 199
+L S PKS ++ H ++ +
Sbjct: 185 DLQ-SYE-----------------------PKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259
S+ + L + +L SEL L + +
Sbjct: 220 VTSSVECLELRDTDLDT---FHFSELSTGETNSL--------------IKKFTFRNVKIT 262
Query: 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 318
+ SL M L++I L ++ S N+L ++P F L LQ++++ N
Sbjct: 263 DESLFQVMKLLNQISGL--------LELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 23/143 (16%), Positives = 46/143 (32%), Gaps = 15/143 (10%)
Query: 84 LRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
L EL++ +L + P+ + ++ L + + + S+E L L +
Sbjct: 176 LEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD 233
Query: 142 LTG----SLPE----ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193
L L L ++I + + K ++ + N +
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS- 291
Query: 194 IPPE-LSRLPSLVHMLLDNNNLT 215
+P RL SL + L N
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 12/114 (10%)
Query: 259 RNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318
RN +G L+ IP+ L+ + ++ LSNN++T S+ LQ L + +N +
Sbjct: 32 RNGICKGSSGSLNSIPSG---LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88
Query: 319 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 369
+ +I + S +L LD N L+N+ S F ++T L GNP+
Sbjct: 89 N-TIEEDSFSSLGSLE-----HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 34/217 (15%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
+S +IG+G G V G VAVK Q + E+ + H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRG 719
+ E ++ EF+ G L D Q++ + L +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL-------------QA 153
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+ YLH + V HRDIK+ +ILL K++DFG A + ++V G
Sbjct: 154 LAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDV----PKRKSLV-G 203
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
TP ++ PE + D++SLG++ +E++ G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+G G + +V+ G + A+K ++ + EI L ++ H N+V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ LV + +S G L D++ + E + + + YLH +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----SAVKYLHENG---IV 128
Query: 733 HRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
HRD+K N+L + DFGLS++ +ST GTPGY+ PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM--------EQNGIMSTAC-GTPGYVAPEVL 179
Query: 790 LTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ D +S+GV+ LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 665
F+ ++G+G YG VYK I G +VA+K+ ++ + +E + EI + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
++V G + + +V E+ G++ D + ++K L +I + +G+ YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHF 143
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
HRDIKA NILL+ + AK+ADFG++ + D A +TV+ GTP ++
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTM----AKRNTVI-GTPFWMA 193
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819
PE +D++SLG+ +E+ G P +
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 584 RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ 642
H +S G + + M + + +G+G YG V K G +VA+K+
Sbjct: 4 HHHHHSSGVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 643 EGSLQGEKEF-----LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 697
E + + + EI+ L +L H NLV+L+ C ++ LV+EF+ + T+ D L
Sbjct: 60 ESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE 115
Query: 698 AKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755
P G ++ GI + H+ + HRDIK NIL+ K+ DFG
Sbjct: 116 LF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFG 169
Query: 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGM 814
+R P + V T Y PE + K+ DV+++G + E+ G
Sbjct: 170 FARTLAAP-----GEVYDDEVA--TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG- 221
Query: 815 QPISHGKN 822
+P+ G +
Sbjct: 222 EPLFPGDS 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 662
+ +IG+G YG V+K +VA+KR + L + E L EI L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL 58
Query: 663 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGI 720
H+N+V L + + LV+EF D + L + S +G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
+ H+ V HRD+K N+L++ K+A+FGL+R +P V + + VV T
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVV--T 164
Query: 781 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
Y P+ KL S D++S G +F EL +P+ G +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-26
Identities = 77/352 (21%), Positives = 130/352 (36%), Gaps = 55/352 (15%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNL 667
N S +G G G V G VAVKR + L EI+ L+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 668 VSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGI 720
+ YC E ++ + E N L+D + +K+ ++ +S+ + G+
Sbjct: 72 IRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 721 LYLHTEADPPVFHRDIKASNILLDHK-------------FTAKVADFGLSRLAPVPDIEG 767
+LH+ + HRD+K NIL+ ++DFGL + + +
Sbjct: 129 AHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--LDSGQS 183
Query: 768 IVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHG 820
+++ GT G+ PE +LT D++S+G VF +L+ +
Sbjct: 184 SFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR-E 879
K RE NI + + I + + RP+ +V+R
Sbjct: 243 KYS-RESNI-IRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLRHP 297
Query: 880 LESIWNMMPESDTKTPEFIN--SEHTSKEETPPSSSSMLKHPYVSSDVSGSN 929
L W +K EF+ S+ E P S+ ++K S V S
Sbjct: 298 L--FWP-----KSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 61/273 (22%), Positives = 103/273 (37%), Gaps = 35/273 (12%)
Query: 84 LRELQLLNLNLSGNLS-PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ L N + +S + ++ + L +S S+P + + +L + N L
Sbjct: 36 WEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL 92
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 202
SLPE L LD N +S +LP+ A+L +H ++NN ++ +P + L
Sbjct: 93 I-SLPELPASLEYLD---ACDNRLS-TLPELPASL---KHLDVDNNQLT-MLPELPALLE 143
Query: 203 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262
+ DNN LT LP + L +L + NN T +P L L +
Sbjct: 144 YI---NADNNQLT-MLPELPT---SLEVLSVRNNQL--TFLPEL---PESLEALDVSTNL 191
Query: 263 LQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322
L+ +P + + I + N++T IP N L + + +N LS I
Sbjct: 192 LES-LPAV--PVRNHHSEETEIF-FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246
Query: 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSFN 355
S+ Q T + G N
Sbjct: 247 RESLSQQ-----TAQPDYHGPRIYFSMSDGQQN 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 70/310 (22%), Positives = 113/310 (36%), Gaps = 43/310 (13%)
Query: 38 SALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYL-HLRELQLLNLNLSG 96
S +I + D +S W + N + + + + + ELQL LNLS
Sbjct: 17 SFYNTISGTYADYFSAWDKWEKQALPGENRNEAV---SLLKECLINQFSELQLNRLNLS- 72
Query: 97 NLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156
+L + +T+L+ N + S+P+ + LE L N L+ +LPE L L
Sbjct: 73 SLPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHL 125
Query: 157 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 216
D +D N ++ LP+ A L + + +NN ++ +P + L L + NN LT
Sbjct: 126 D---VDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSLEVL---SVRNNQLT- 173
Query: 217 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK----LSLRNCSLQGPMPDLSR 272
+LP L L + N ++PA + R ++
Sbjct: 174 FLPELPE---SLEALDVSTNLL--ESLPAVPVRNHHSEETEIFFRCREN-------RITH 221
Query: 273 IP-NLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 331
IP N+ L TI L +N L+ I + S S S R
Sbjct: 222 IPENILSLDPT--CTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279
Query: 332 LNATETFILD 341
L T
Sbjct: 280 LADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 37/248 (14%), Positives = 65/248 (26%), Gaps = 28/248 (11%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL----LN 138
L L + N L+ L L LD N + S+P E
Sbjct: 161 SLEVLSVRNNQLTF-LPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCR 215
Query: 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198
N +T +PE + L I ++ N +S + +S + +H S +
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ- 273
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF-----------EGTTIPASY 247
++S++ + N F
Sbjct: 274 -NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFR 332
Query: 248 SNMSKLLKL-----SLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNF 302
++ L+ LR S + L N+ L + G ++
Sbjct: 333 EQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDT 392
Query: 303 SGLPRLQR 310
L L R
Sbjct: 393 GALLSLGR 400
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLHHRNLVSL 670
++G G Y VYKG+ G VA+K + L E+ + EI + L H N+V L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 671 VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
E + LV+EFM N + + + L + +G+ + H
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HRD+K N+L++ + K+ DFGL+R +P V S VV T Y P+
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-----VNTFSSEVV--TLWYRAPD 178
Query: 788 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
+ + S D++S G + E++TG +P+ G N
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTN 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 63/250 (25%), Positives = 103/250 (41%), Gaps = 21/250 (8%)
Query: 573 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 631
H ++H+ R + ++ F + + + ++G G YG+V
Sbjct: 2 HHHHHHSSGRENLYFQGDLQA-TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 632 DGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689
A+K ++ S+ L E+ L L H N++ L + +++ LV E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--- 746
G L D++ + K A + + S G+ YLH + HRD+K N+LL+ K
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLS--GVTYLHKHN---IVHRDLKPENLLLESKEKD 175
Query: 747 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 806
K+ DFGLS + GT Y+ PE L K +K DV+S+GV+
Sbjct: 176 ALIKIVDFGLSAV--------FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 807 FLELLTGMQP 816
LL G P
Sbjct: 227 LFILLAGYPP 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+G G +G V++ + G V K + EI +++LHH L++L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPV 731
++ E +L+ EF+S G L D+++A+ + M + + R G+ ++H + +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 732 FHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
H DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIV 222
Query: 790 LTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ +D++++GV+ LL+G+ P
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 57/249 (22%), Positives = 89/249 (35%), Gaps = 54/249 (21%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 669
IGQG YG V I + A+K + ++ + + + TE++ + +LHH N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----------- 718
L ++E LV E G L D+L+ + G +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 719 ---------------------------GILYLHTEADPPVFHRDIKASNILLDHKFTA-- 749
+ YLH + + HRDIK N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE--YFLTHKLTDKSDVYSLGVVF 807
K+ DFGLS+ + ++T GTP ++ PE K D +S GV+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYG--MTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 808 LELLTGMQP 816
LL G P
Sbjct: 267 HLLLMGAVP 275
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 663
+ ++G+G YG VYK G +VA+KR + L E E + EI L LH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELH 77
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 721
H N+VSL+ E LV+EFM D ++ ++K L + RG+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
+ H + HRD+K N+L++ K+ADFGL+R +P V ++ VV T
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-----VRSYTHEVV--TL 183
Query: 782 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
Y P+ + K S D++S+G +F E++TG +P+ G
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVT 224
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
IG G +G VY + + VVA+K+ + + S + ++ + E++FL +L H N + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
E LV E+ G+ D L K PL ++ G+ +G+ YLH+ +
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHN---MI 176
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDPEYF 789
HRD+KA NILL K+ DFG + + ++ + V GTP ++ PE
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSA-------------SIMAPANSFV-GTPYWMAPEVI 222
Query: 790 LTHKLTD---KSDVYSLGVVFLELLTGMQPISH 819
L K DV+SLG+ +EL P+ +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 671
+G+G +G+V G AVK + Q ++ L E+Q L +L H N++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731
+ +++G LV E + G L D++ ++ + A R+ + S GI Y+H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS--GITYMHKNK---I 147
Query: 732 FHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
HRD+K N+LL+ K ++ DFGLS + GT Y+ PE
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTH--------FEASKKMKDKIGTAYYIAPE- 198
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQP 816
L +K DV+S GV+ LL+G P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 663
++ +IG+G YG VYK G A+K+ + L+ E E + EI L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 721
H N+V L + +LV+E + D +L + L S L GI
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
Y H V HRD+K N+L++ + K+ADFGL+R +P V + +V T
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-----VRKYTHEIV--TL 164
Query: 782 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
Y P+ + K + D++S+G +F E++ G P+ G +
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVS 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSRL 662
+ + +IGQG +G+V+K G VA+K+ ++ EKE F L EI+ L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 663 HHRNLVSLVGYCDEEGEQM--------LVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSI 712
H N+V+L+ C + LV++F + D L + + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIKRV 129
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772
G+ Y+H + HRD+KA+N+L+ K+ADFGL+R + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNRY 185
Query: 773 VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831
+ VV T Y PE L D++ G + E+ T PI G E +
Sbjct: 186 TNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNT---EQH--- 236
Query: 832 QSSMMFSVIDGNMGSYPSE 850
Q +++ + GS +
Sbjct: 237 QLALISQL----CGS-ITP 250
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLSRL 662
+ +IG+G YG V+K G +VA+K+ E + L EI+ L +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59
Query: 663 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGI 720
H NLV+L+ + LV+E+ + T+ +L G L SI + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY---QRGVPEHLVKSITWQTLQAV 115
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
+ H HRD+K NIL+ K+ DFG +RL P + V T
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-----SDYYDDEVA--T 165
Query: 781 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
Y PE + DV+++G VF ELL+G P+ GK+
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKS 207
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 49/266 (18%), Positives = 95/266 (35%), Gaps = 25/266 (9%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLNGN 140
+ +R L + L +LS L + + +K+ +P ++KSLE L L+ N
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN 344
Query: 141 ELTGSLPEE---LGYLPKLDRIQIDQNYIS--GSLPKSFANLNKTRHFHMNNNSISGQIP 195
+ + G P L + + QN++ + L ++ N+ +P
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403
Query: 196 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255
+ + L + + + + L +L + NNN + + +L +
Sbjct: 404 DSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL--DSFS---LFLPRLQE 455
Query: 256 LSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 315
L + L +P+ L +K+S N+L F L LQ++++
Sbjct: 456 LYISRNKL-------KTLPDASLFPVL--LVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 316 NSLSGSIPSSIWQSRTLNATETFILD 341
N S P + SR LN
Sbjct: 507 NPWDCSCPRIDYLSRWLNKNSQKEQG 532
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 47/310 (15%), Positives = 100/310 (32%), Gaps = 34/310 (10%)
Query: 83 HLRELQLLNLNLSGNLSPE-IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
+L+ L++ N+ + L+ L L+ + + + +I+ + L L+ +E
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 201
L L + +++ ++ + S + L
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 202 PSLVHMLLDNNNLT---------GYLPPE----LSELPKLLILQLDNNNFEGTTI----P 244
L+ +L+ + + G P +SEL K+ + + + +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 245 ASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-- 301
YS + K+ ++++ N + P + +L + LS N + N
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL--------EFLDLSENLMVEEYLKNSA 355
Query: 302 -FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNV 360
P LQ L ++ N L S+ + TL + LD N + S P +
Sbjct: 356 CKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTS--LDISRNTFHPMPDSCQWPEKM 412
Query: 361 TV-RLRGNPF 369
L
Sbjct: 413 RFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 49/293 (16%), Positives = 99/293 (33%), Gaps = 33/293 (11%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKE-IGNIKSLELLLLNGN 140
L LNL GN ++ L+ L L + I + + SL L +
Sbjct: 99 SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
L + L + + + + + + L L+ R+ + + +++ L
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
M + +EL KLL L+ + E +L N
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-------------FDDCTL-N 264
Query: 261 CSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320
+ + LG + ++ I + + L + + +S L +++R+ + N+ +
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF- 323
Query: 321 SIPSSIWQS-RTLNATETFILDFQNNNLTNI----SGSFNIPPNV-TVRLRGN 367
+P S Q ++L LD N + S P++ T+ L N
Sbjct: 324 LVPCSFSQHLKSLE-----FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-19
Identities = 53/322 (16%), Positives = 111/322 (34%), Gaps = 45/322 (13%)
Query: 83 HLRELQLLNLNLSGNLSPEIG------RLSYLTILDFMWNKISGSIPKEIGNIKSLELLL 136
+R++ L L+LS + + YL + D + S ++ L
Sbjct: 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
Query: 137 LNGNELT----GSLPEELGYLPKLDRIQIDQN------YISGSLPKSFANLNKT-----R 181
G+ LT L + L Y+ +L ++ D + S + L K R
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
H+ + + S L + + ++N+ + L L L L N
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 242 TI--PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSL-NITTIKLSNNKLTGTI 298
+ A L L L L+ + + + LL+L N+T++ +S N +
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLR----SMQKTGEI--LLTLKNLTSLDISRNTFH-PM 402
Query: 299 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFI------------LDFQNN 345
P + +++ L +++ + + + I Q+ L+ + + L N
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRN 461
Query: 346 NLTNISGSFNIPPNVTVRLRGN 367
L + + P + +++ N
Sbjct: 462 KLKTLPDASLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-18
Identities = 33/260 (12%), Positives = 86/260 (33%), Gaps = 19/260 (7%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + LD +NKI+ ++ +L++L+L + + + L L+ + + N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPE-L 222
++S F L+ ++ ++ N + L +L + + N +
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 223 SELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLS 281
+ L L L++ + + ++ + L+L + + + +
Sbjct: 145 AGLTSLNELEIKALSL--RNYQSQSLKSIRDIHHLTLHLSE-------SAFLLEIFADIL 195
Query: 282 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW------QSRTLNAT 335
++ ++L + L S + S + + L +
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS-VLTDESFNELLKLLRYILELS 254
Query: 336 ETFILDFQNNNLTNISGSFN 355
E D N L + + S +
Sbjct: 255 EVEFDDCTLNGLGDFNPSES 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 674
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 795 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 826
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRLHHRNLVSLV 671
+G+G YGKV + + AVK ++ L+ EIQ L RL H+N++ LV
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 672 GYCDEEGEQM--LVYEFMSNGT--LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
E +Q +V E+ G + D + K + P+ A L G+ YLH++
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLID--GLEYLHSQG 129
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ H+DIK N+LL T K++ G++ + S G+P + PE
Sbjct: 130 ---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQ---GSPAFQPPE 181
Query: 788 YFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVR 825
K D++S GV + TG+ P G NI +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYK 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 44/305 (14%), Positives = 93/305 (30%), Gaps = 46/305 (15%)
Query: 603 EMALATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEI 656
E L + +G+G + +VY+ + +K + + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 657 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-----PLGFAMRLS 711
+ L + + +LV E S GTL + ++ P G + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA-----------KVADFGLSRLA 760
+ + I +H + H DIK N +L + F + D G S
Sbjct: 179 MRM--LYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-- 231
Query: 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820
D++ + T T G+ E + D + + +L G
Sbjct: 232 ---DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM---- 284
Query: 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880
V+ + +F + +F + L + PS+ + ++L
Sbjct: 285 --KVKNEGGECKPEGLFR------RLPHLDMWNEFFHVMLN--IPDCHHLPSLDLLRQKL 334
Query: 881 ESIWN 885
+ ++
Sbjct: 335 KKVFQ 339
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 45/254 (17%), Positives = 85/254 (33%), Gaps = 46/254 (18%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
++P I + + + L+GN ++ L + + N ++ +F L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 181 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 238
+++N+ + P L L + LD L L P L L L L +N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 239 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGT 297
+P ++ ++ L L L N+++
Sbjct: 142 --QALPDDTFRDLGNLTHLF-------------------------------LHGNRISSV 168
Query: 298 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNI 356
F GL L RL + N ++ + ++ L T L NNL+ + +
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD--LGRLMT--LYLFANNLSALPTEALAP 223
Query: 357 PPNVT-VRLRGNPF 369
+ +RL NP+
Sbjct: 224 LRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 45/223 (20%), Positives = 88/223 (39%), Gaps = 27/223 (12%)
Query: 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165
+ + N+IS ++L +L L+ N L L L+++ + N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 166 ISGSLPKS-FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-L 222
S+ + F L + H++ + ++ P L +L ++ L +N L LP +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 223 SELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIP-----NL 276
+L L L L N +++P ++ + L +L L + + +L
Sbjct: 150 RDLGNLTHLFLHGNRI--SSVPERAFRGLHSLDRLLLHQNRVA-------HVHPHAFRDL 200
Query: 277 GYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 318
G L++L L N L+ +P+ + L LQ L + +N
Sbjct: 201 GRLMTLY-----LFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
+ + +G G +G+V+K G +A K + ++ ++E EI +++L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGIL 721
L + + + +LV E++ G L D++ +S + + F M+ GI
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-MKQICE-------GIR 201
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
++H + H D+K NIL ++ K+ DFGL+R P V G
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--------YKPREKLKVNFG 250
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
TP +L PE ++ +D++S+GV+ LL+G+ P
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 41/211 (19%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 671
+G+G +G V++ + K + + + EI L+ HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLH 67
Query: 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTEA 727
+ E ++++EF+S + ++++ F + + + +LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 728 DPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ H DI+ NI+ + ++ K+ +FG +R + P ++ P Y
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--------LKPGDNFRLLFTAPEYYA 171
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE ++ +D++SLG + LL+G+ P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 669
+G+G + VYK +VA+K+ + G K+ L EI+ L L H N++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
L+ + LV++FM D + + L + + L + +G+ YLH
Sbjct: 77 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HRD+K +N+LLD K+ADFGL++ P A+ VV T Y PE
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVV--TRWYRAPE 182
Query: 788 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
++ D++++G + ELL P G +
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDS 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK-------------RAQEGSLQGEKEFLTEIQFLSR 661
++G G YG+V + A+K + + +E EI L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 721
L H N++ L +++ LV EF G L +Q+ + K A + + S GI
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS--GIC 160
Query: 722 YLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
YLH + HRDIK NILL++K K+ DFGLS +
Sbjct: 161 YLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF--------FSKDYKLRDRL 209
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
GT Y+ PE L K +K DV+S GV+ LL G P
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 673
++G G +G V+ G +K + Q E EI+ L L H N++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 729
++ +V E G L +++ + L + + + Y H++
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN--ALAYFHSQH-- 144
Query: 730 PVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
V H+D+K NIL K+ DFGL+ L ST GT Y+ P
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--------FKSDEHSTNAAGTALYMAP 195
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
E +T K D++S GVV LLTG P
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+G G +G V++ G A K ++ EIQ +S L H LV+L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGILYLHTEAD 728
++ E +++YEFMS G L ++++ + E + + MR G+ ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQVCK-------GLCHMHENN- 275
Query: 729 PPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
H D+K NI+ K + K+ DFGL+ + P V GT + P
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAAP 325
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
E + +D++S+GV+ LL+G+ P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 18/205 (8%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
IG+G +G+V + A K+ + ++ F EI+ + L H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
++ + LV E + G L +++ K A R+ + S + Y H V HR
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS--AVAYCHKLN---VAHR 130
Query: 735 DIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 791
D+K N L K+ DFGL+ P + GTP Y+ P+ L
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAAR--------FKPGKMMRTKVGTPYYVSPQ-VLE 181
Query: 792 HKLTDKSDVYSLGVVFLELLTGMQP 816
+ D +S GV+ LL G P
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 32/240 (13%), Positives = 63/240 (26%), Gaps = 49/240 (20%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL---------- 662
+GQ + G V + K+ E+ L L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 663 ------------HHRNLVSLVGYCDEEGEQMLVYEF-------MSNGTLRDQLSAKSK-- 701
++ +E + ++ F + T + L + S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 702 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761
+ L RL + L R + LH + H ++ +I+LD + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----LTDKSDVYSLGVVFLELLTGMQP 816
+G P + +T D ++LG+ + P
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 58/220 (26%), Positives = 84/220 (38%), Gaps = 34/220 (15%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK---------RAQEGSLQGEKEFLTEIQFLSRL-HH 664
+G+G V + I P AVK + E + + L E+ L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILY 722
N++ L + LV++ M G L D L+ K E + ++ I
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL----EVICA 139
Query: 723 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 782
LH + HRD+K NILLD K+ DFG S + P V GTP
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVCGTPS 188
Query: 783 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
YL PE + D++S GV+ LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 674
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 795 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 826
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 672
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
++ +V E + G L D++ + + A R+ + S GI Y+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMHKHN---IV 143
Query: 733 HRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE-V 194
Query: 790 LTHKLTDKSDVYSLGVVFLELLTGMQP 816
L +K DV+S GV+ LL+G P
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVG 672
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 730
++ +V E + G L D++ + + E + + GI Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITYMHKHN--- 141
Query: 731 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE 193
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
L +K DV+S GV+ LL+G P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLV 668
++G G + V K G A K R S +G +E E+ L + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILY 722
+L + + + +L+ E +S G L D L+ K E F ++ L G+ Y
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVHY 123
Query: 723 LHTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
LH++ + H D+K NI+L K K+ DFG++ I + +
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--------IEAGNEFKNIF 172
Query: 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
GTP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 669
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 723
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 724 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 25/213 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 670
IG+G + V + I G AVK S E E L H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTE 726
+ +G +V+EFM L ++ ++ ++ ++ R IL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY--MRQILEALRYCHDN 149
Query: 727 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
+ HRD+K +LL K K+ FG++ + V GTP +
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV------AGGRV-GTPHF 199
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ PE DV+ GV+ LL+G P
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 38/282 (13%), Positives = 72/282 (25%), Gaps = 74/282 (26%)
Query: 583 RRHSSKTSIKIDGVRSFTY--GEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK 639
G R T G + +GQ + G V
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTV------------LGQEDPYAYLEATDQETGESFEVH 104
Query: 640 ------RAQEGSLQGEKE----------------------FLTEIQFLSRLHHRNLVSLV 671
R +++ KE F+ + + ++ +
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 672 GYCDEEGEQMLVYEFM----SNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHT 725
+ + + + T + L + S + L RL + L R + LH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ H ++ +I+LD + + F V V + G+
Sbjct: 225 YG---LVHTYLRPVDIVLDQRGGVFLTGFEHL-----------VRDGARVVSSVSRGFEP 270
Query: 786 PEYFLTHKL-----------TDKSDVYSLGVVFLELLTGMQP 816
PE T D ++LG+V + P
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 39/259 (15%), Positives = 92/259 (35%), Gaps = 27/259 (10%)
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
I + + ++ +P+ + + E LLL+ N + +L +L +++ Y +
Sbjct: 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 170 L-PKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE--LSEL 225
+ ++F NL R + ++ I + P+ L L + L L+ + + L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNIT 285
L L L N + S+ ++ L + + + L L ++
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH-----ELEPLQGKTLS 177
Query: 286 TIKLSNNKLTGTIPSNFSGLP------RLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 339
L+ N L + ++ L+ L ++ N + I + + + + + I
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI 237
Query: 340 -------LDFQNNNLTNIS 351
F +N+ +
Sbjct: 238 LAHHIMGAGFGFHNIKDPD 256
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-23
Identities = 62/310 (20%), Positives = 104/310 (33%), Gaps = 25/310 (8%)
Query: 80 GYLHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLN 138
L+ L+L + + E L L ILD +KI P + L L L
Sbjct: 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105
Query: 139 GNELTGSL--PEELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIP 195
L+ ++ L L R+ + +N I L SF LN + ++N I
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165
Query: 196 PELSRL--PSLVHMLLDNNNLTGYLPPELSELPKLL------ILQLDNNNFEGTTIPASY 247
EL L +L L N+L + + + IL + N +
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225
Query: 248 SNMSKLLKLSLRN----CSLQGPMPDLSRIPN--LGYLLSLNITTIKLSNNKLTGTIPSN 301
+ +SK SL ++ L ++ + LS+ +
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285
Query: 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNV 360
F L L+ L +A N ++ I + L+ + L+ N L + S +F P V
Sbjct: 286 FETLKDLKVLNLAYNKIN-KIADEAFYG--LDNLQV--LNLSYNLLGELYSSNFYGLPKV 340
Query: 361 TV-RLRGNPF 369
L+ N
Sbjct: 341 AYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-23
Identities = 46/292 (15%), Positives = 98/292 (33%), Gaps = 26/292 (8%)
Query: 88 QLLNLNLSGNLSPEIGR-------LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
++ + + + S + LD + + +K L++L L N
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
++ E L L + + N + +F L K + + N I+
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L L + L +N LT + +P + + L N +N+ L + L N
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLEN 415
Query: 261 CSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTG-TIPSNFSGLPRLQRLFIANNSLS 319
+ + + ++ + L+ N+ + + S P L++LF+ N L
Sbjct: 416 LDILYFLLRVP-----------HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 369
+ + + + +L +N L ++ G F+ + L N
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 49/285 (17%), Positives = 90/285 (31%), Gaps = 29/285 (10%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQ 163
L+ L +N I ++ L+LL L ++ +E LP L + +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTG-YLPP 220
+ I P +F L + +S + + L +L + L N + YL P
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 221 ELSELPKLLILQLDNNNFEGTTIPASY---SNMSKLLKLSLRNCSLQG-PMPDLSRIPNL 276
+L L + +N + L SL SL D + N
Sbjct: 143 SFGKLNSLKSIDFSSNQI--FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 277 GYLLSLNITTIKLSNNKLTGTIPSNFS------------GLPRLQRLFIANNSLSGSIPS 324
+ L + +S N T I NFS + +++
Sbjct: 201 FRNMVL--EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQ 257
Query: 325 SIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 367
+ + ++ LD + + ++ S F ++ V L N
Sbjct: 258 NTFAGLARSSVRH--LDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 6e-20
Identities = 48/227 (21%), Positives = 79/227 (34%), Gaps = 17/227 (7%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 190
+ LT +P+ L +R+ + NYI SF L + + + +
Sbjct: 5 DGRIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 191 SGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY- 247
I E LP+L + L ++ + +L P+ L L L+L + Y
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL-- 305
N+ L +L L ++ L P+ G L SL +I S+N++ L
Sbjct: 120 RNLKALTRLDLSKNQIR----SLYLHPSFGKLNSL--KSIDFSSNQIFLVCEHELEPLQG 173
Query: 306 PRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNIS 351
L +A NSL + + ILD N T
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 35/191 (18%), Positives = 66/191 (34%), Gaps = 21/191 (10%)
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
+++ Q+P L + +LL N + L +L +L+L + T
Sbjct: 11 YRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTI--PSNF 302
++ N+ L L L + + PD + L +L L L L+ + F
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQ--GLFHLFELR-----LYFCGLSDAVLKDGYF 119
Query: 303 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFN---IPP 358
L L RL ++ N + + LN+ ++ +DF +N + +
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGK--LNSLKS--IDFSSNQIFLVCEHELEPLQGKT 175
Query: 359 NVTVRLRGNPF 369
L N
Sbjct: 176 LSFFSLAANSL 186
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 672
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 730
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 125
Query: 731 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 177
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ D+++ GV+ LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLH 663
+ ++G+G Y VYKG +VA+K + L+ E+ + E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLK 58
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 721
H N+V+L E LV+E++ +D Q + RG+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
Y H V HRD+K N+L++ + K+ADFGL+R +P + + VV T
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYDNEVV--TL 164
Query: 782 GYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
Y P+ L + + + D++ +G +F E+ TG +P+ G
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGST 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 57/250 (22%), Positives = 98/250 (39%), Gaps = 36/250 (14%)
Query: 582 RRRHSSKTSIKIDGVRSFTYGEMALATNNFN-SSTQIGQGGYGKVYKGI-LPDGTVVAVK 639
HSS + + + + N + +S ++G+G + V + I G A K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENF---NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 640 --RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 696
+ + E L EI L +++L + E +L+ E+ + G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 697 SAKSKEPLG-----FAMR--LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749
+ E + ++ L G+ YLH + H D+K NILL +
Sbjct: 121 LPELAEMVSENDVIRLIKQILE-------GVYYLHQNN---IVHLDLKPQNILLSSIYPL 170
Query: 750 ---KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 806
K+ DFG+SR I A + GTP YL PE +T +D++++G++
Sbjct: 171 GDIKIVDFGMSRK--------IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 807 FLELLTGMQP 816
LLT P
Sbjct: 223 AYMLLTHTSP 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 65/233 (27%), Positives = 94/233 (40%), Gaps = 33/233 (14%)
Query: 607 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT--------EIQ 657
AT+ + +IG G YG VYK G VA+K + + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVA 63
Query: 658 FLSRLH---HRNLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 709
L RL H N+V L+ D E + LV+E + LR L L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 710 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769
+ RG+ +LH + HRD+K NIL+ T K+ADFGL+R+
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ------ 173
Query: 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
A VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 174 MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNS 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 33/224 (14%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 666
+G G G+V VA++ TEI+ L +L+H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 724
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 202 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 256
Query: 725 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 257 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 305
Query: 782 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
YL PE T D +SLGV+ L+G P S +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 65/233 (27%), Positives = 92/233 (39%), Gaps = 47/233 (20%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK----------------------RAQEGSLQGEKEFL 653
IG+G YG V D T A+K R G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 654 T----EIQFLSRLHHRNLVSL--VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGF 706
EI L +L H N+V L V E +V+E ++ G + + + K E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ-- 138
Query: 707 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766
A L GI YLH + + HRDIK SN+L+ K+ADFG+S D
Sbjct: 139 ARFYFQDLIK--GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-- 191
Query: 767 GIVPAHVSTVVKGTPGYLDPEYFL-THKLTD--KSDVYSLGVVFLELLTGMQP 816
A +S V GTP ++ PE T K+ DV+++GV + G P
Sbjct: 192 ----ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-23
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 669
+G G + V K G A K R + S +G ++ E+ L + H N+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 723
L + + + +L+ E ++ G L D L+ K +E F ++ L+ G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVYYL 130
Query: 724 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
H+ + H D+K NI+L + K+ DFGL+ I + + G
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFG 179
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 669
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 723
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 724 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 69/254 (27%), Positives = 109/254 (42%), Gaps = 34/254 (13%)
Query: 616 QIGQGGYGKVYKGI---LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
++G+G YG VYK D A+K+ + + EI L L H N++SL
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 673 YCDEEGEQ--MLVYEFMSN------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
++ L++++ + R + K L M S+ GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 725 TEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
V HRD+K +NIL+ + K+AD G +RL P + VV T
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL--KPLADLDPVVV--T 198
Query: 781 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAY---QSSMM 836
Y PE L + K+ D++++G +F ELLT +PI H + + + Y Q +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLDRI 257
Query: 837 FSVIDGNMGSYPSE 850
F+V MG P++
Sbjct: 258 FNV----MGF-PAD 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 35/220 (15%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH-HR 665
IG+G V + + G AVK + E + + E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYL 723
++++L+ + LV++ M G L D L+ K E ++ S+ + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL----EAVSFL 216
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVKGTPG 782
H + HRD+K NILLD +++DFG S + P + GTPG
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--------LEPGEKLRELC-GTPG 264
Query: 783 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
YL PE + D+++ GV+ LL G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 31/254 (12%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 674
+G+G + +V I L AVK ++ E++ L + HRN++ L+ +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+EE LV+E M G++ + + E A + + S + +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELE----ASVVVQDVAS--ALDFLH---NKG 131
Query: 731 VFHRDIKASNILLDHK---FTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRD+K NIL +H K+ DF L + D I + T G+ Y+ P
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAP 190
Query: 787 EYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP-----ISHGKNIVREVNIAYQSSMM 836
E D++SLGV+ LL+G P S E A Q+ +
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 837 FSVIDGNMGSYPSE 850
S+ +G +P +
Sbjct: 251 ESIQEGKY-EFPDK 263
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 29/226 (12%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 662
+ + T++G+G YG+VYK I VA+KR + L+ E+E + E+ L L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90
Query: 663 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 722
HRN++ L L++E+ N L+ + + + S G+ +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNF 147
Query: 723 LHTEADPPVFHRDIKASNILLDHKFTA-----KVADFGLSRLAPVPDIEGIVPAHVSTVV 777
H HRD+K N+LL + K+ DFGL+R +P + ++
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-----IRQFTHEII 199
Query: 778 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
T Y PE L + S D++S+ ++ E+L P+ G +
Sbjct: 200 --TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDS 242
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 67/269 (24%), Positives = 109/269 (40%), Gaps = 46/269 (17%)
Query: 581 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ----------IGQGGYGKVYKGIL 630
++ S+ S+K+ + + +AT IG G +G VY+ L
Sbjct: 16 PVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKL 75
Query: 631 -PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM------LV 683
G +VA+K+ LQ ++ E+Q + +L H N+V L + GE+ LV
Sbjct: 76 CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIK 737
+++ + + ++ L + R + Y+H+ + HRDIK
Sbjct: 132 LDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIK 183
Query: 738 ASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-T 795
N+LLD K+ DFG ++ V +VS + + Y PE T
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAK-QLVRG-----EPNVSYIC--SRYYRAPELIFGATDYT 235
Query: 796 DKSDVYSLGVVFLELLTGMQPISHGKNIV 824
DV+S G V ELL G QPI G + V
Sbjct: 236 SSIDVWSAGCVLAELLLG-QPIFPGDSGV 263
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 44/266 (16%)
Query: 582 RRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILPD 632
++ +K++ + LA++ + IG G +G V++ L +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 633 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL------VGYCDEEGEQMLVYEF 686
VA+K+ LQ ++ E+Q + + H N+V L G +E LV E+
Sbjct: 64 SDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASN 740
+ T+ +K + + L R + Y+H+ + HRDIK N
Sbjct: 120 VPE-TVYRASRHYAKLK----QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171
Query: 741 ILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKS 798
+LLD K+ DFG ++ + +VS + + Y PE T
Sbjct: 172 LLLDPPSGVLKLIDFGSAK-ILIAG-----EPNVSYIC--SRYYRAPELIFGATNYTTNI 223
Query: 799 DVYSLGVVFLELLTGMQPISHGKNIV 824
D++S G V EL+ G QP+ G++ +
Sbjct: 224 DIWSTGCVMAELMQG-QPLFPGESGI 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 609 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSR 661
+ +IG+G YGKV+K + G VA+KR + +Q +E + E+ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 662 LH---HRNLVSL-----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 713
L H N+V L V D E + LV+E + L L + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 714 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+ A
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALT 177
Query: 774 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
S VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 178 SVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSS 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH----HR 665
+G+GG+G V+ G L D VA+K L E+ L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRG 719
++ L+ + + + MLV E L D ++ K E F ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-------A 151
Query: 720 ILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
I + H+ V HRDIK NIL+D + AK+ DFG L +
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--------DEPYTDFD- 199
Query: 779 GTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 825
GT Y PE+ H+ + V+SLG++ +++ G P + I+
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE 247
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLHHR--NL 667
+G GG+G VY GI + D VA+K + G L E+ L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 668 VSLVGYCDEEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+ L+ + + +L+ E L D ++ + A + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--AVRHCHNC 168
Query: 727 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
V HRDIK NIL+D ++ K+ DFG L + GT Y
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--------DTVYTDFD-GTRVYSP 216
Query: 786 PEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 825
PE+ H+ + V+SLG++ +++ G P H + I+R
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 257
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ +V E++S G L D + + A RL + S + Y H V
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--AVDYCHRHM---VV 133
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 184
Query: 793 KLTD--KSDVYSLGVVFLELLTGMQP 816
+L + D++S GV+ LL G P
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 672
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 730
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 148
Query: 731 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 200
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
+ D+++ GV+ LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL--VG 672
+G+G Y +V++ I + + V VK + +K+ EI+ L L N+++L +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADPP 730
LV+E ++N + + + F M L + + Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------KALDYCHSMG--- 150
Query: 731 VFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
+ HRD+K N+++DH+ ++ D+GL+ P V + + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAE--------FYHPGQEYNVRVASRYFKGPELL 202
Query: 790 LTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 822
+ +++ D S D++SLG + ++ +P HG +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
IG+G + KV + G VA+K + Q +K F E++ + L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ E L+ E+ S G + D L A + A + S + Y H + +
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--AVQYCHQKR---IV 136
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+KA N+LLD K+ADFG S + G P Y PE F
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNE-FTVG------GKLDAFC-GAPPYAAPELFQ-G 187
Query: 793 KLTD--KSDVYSLGVVFLELLTGMQP 816
K D + DV+SLGV+ L++G P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 36/217 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLT---EIQFLSRLHHRNL 667
+G G +G V+ + V VK + E + + EI LSR+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRGIL 721
+ ++ + +G LV E +G L + + EPL F +S +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-------AVG 144
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
YL + + HRDIK NI++ FT K+ DFG + T GT
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERG------KLFYTFC-GTI 193
Query: 782 GYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQP 816
Y PE L + +++SLGV L+ P
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 8e-22
Identities = 45/242 (18%), Positives = 83/242 (34%), Gaps = 25/242 (10%)
Query: 645 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEP 703
S +I+ + +N V + + + + L+D ++ S E
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 704 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR----- 758
+ L I + + + +LH++ + HRD+K SNI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 759 --LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
V H V GT Y+ PE + + K D++SLG++ ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQV--GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
Query: 817 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV 876
I+ +V + ++ + + RP +++
Sbjct: 276 QMERVRIITDVR------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
Query: 877 MR 878
+
Sbjct: 324 IE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 666
+F +G+GG+G V++ D A+KR ++ + E++ L++L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 667 LVSLVGYCDEEGEQMLVYEFMSN 689
+V E + E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEI 88
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-22
Identities = 55/285 (19%), Positives = 100/285 (35%), Gaps = 43/285 (15%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ + +L+ LT LD + I+ + I + L L+ N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+L L L + D N ++ +L L K + + + N ++ ++ +S+ P
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L ++ N LT ++S +L L N + ++L L +
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK---ITKLDVTPQTQLTTLDCSFNKI 182
Query: 264 QGPMPDLSRIPNLGYL---------LSL----NITTIKLSNNKLTGTIPSNFSGLPRLQR 310
D+S+ L L L L +T + S+NKLT I + L +L
Sbjct: 183 TE--LDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTY 237
Query: 311 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 355
+ N L+ + S T L +L I + N
Sbjct: 238 FDCSVNPLT-ELDVSTLSKLT-------TLHCIQTDLLEIDLTHN 274
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 55/302 (18%), Positives = 103/302 (34%), Gaps = 44/302 (14%)
Query: 88 QLLNLNLSGNL--SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L LN + N ++ + LT LD NK + + L L + N++T
Sbjct: 128 LLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-E 184
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
L + L+R+ D N I+ L + ++N ++ +I ++ L L
Sbjct: 185 LD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ N LT L +S L KL L + I + + ++L+ C +
Sbjct: 237 YFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDL--LEIDLT--HNTQLIYFQAEGCR-KI 288
Query: 266 PMPDLSRIPNLGYL---------LSL----NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 312
D++ L L L L + + L+N +LT + S +L+ L
Sbjct: 289 KELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLS 345
Query: 313 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN 372
N + S + + LN + ++T+ + +
Sbjct: 346 CVNAHIQ-DFSS-VGKIPALN-----NNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
Query: 373 TN 374
N
Sbjct: 399 GN 400
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 51/285 (17%), Positives = 100/285 (35%), Gaps = 38/285 (13%)
Query: 88 QLLNLNLSGN---LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
QL L+ N ++ + LT LD +NKI+ + + K L L + N +T
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT- 204
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L +L + N ++ + L + +F + N ++ ++ +S L L
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKL 256
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ +L + L+ +L+ Q + ++ ++L L + +
Sbjct: 257 TTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK---IKELDVTHNTQLYLLDCQAAGIT 310
Query: 265 GPMPDLSRIPNLGYL---------LSL----NITTIKLSNNKLTGTIPSNFSGLPRLQRL 311
DLS+ P L YL L + + ++ N + S +P L
Sbjct: 311 --ELDLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNN 366
Query: 312 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 356
F A ++ + A +LD N + G +
Sbjct: 367 FEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGV 411
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 48/280 (17%), Positives = 97/280 (34%), Gaps = 39/280 (13%)
Query: 88 QLLNLNLSGNL--SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L L N + ++ L+ LT L+ NK++ + + L L N LT
Sbjct: 86 NLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-E 141
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
+ + + +L + N L + + N I+ ++ +S+ L
Sbjct: 142 ID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLN 194
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+ D NN+T +L++ +L L +N T I + +++L L
Sbjct: 195 RLNCDTNNITK---LDLNQNIQLTFLDCSSNKL--TEIDVT--PLTQLTYFDCSVNPLTE 247
Query: 266 -PMPDLSRIPNLGYLLSLNITTIKLSNNK---------LTGTIPSNFSGLPRLQRLFIAN 315
+ LS++ L + + ++ I L++N + + +L L
Sbjct: 248 LDVSTLSKLTTL-HCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQA 306
Query: 316 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 355
++ + S + L N LT + S N
Sbjct: 307 AGIT-ELDLS-------QNPKLVYLYLNNTELTELDVSHN 338
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 28/169 (16%), Positives = 55/169 (32%), Gaps = 18/169 (10%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
LH + LL ++L+ N L Y KI ++ + L LL
Sbjct: 258 TLHCIQTDLLEIDLTHNTQ-----LIYFQAEG--CRKIK---ELDVTHNTQLYLLDCQAA 307
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
+T L L PKL + ++ ++ L ++ K + N I + +
Sbjct: 308 GIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGK 359
Query: 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSN 249
+P+L + L+ + + D + G + +
Sbjct: 360 IPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGD 408
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 666
+G G G+V VA+K TEI+ L +L+H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 724
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 77 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 131
Query: 725 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 180
Query: 782 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
YL PE T D +SLGV+ L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 22/209 (10%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 672
++G+G + V + + + G A L ++ E + L H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 730
EEG L+++ ++ G L + + A+ E I +L+ H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----EAVLHCHQMG--- 130
Query: 731 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
V HR++K N+LL K K+ADFGL+ GTPGYL PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ------QAWFGFA-GTPGYLSPE 183
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
D+++ GV+ LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 36/214 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 673
+G G GKV + G A+K L + E+ + ++V ++ Y
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 674 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 725
+ + + E M G L ++ + + MR I I +LH+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-DIG----TAIQFLHS 146
Query: 726 EADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 782
+ HRD+K N+L K K+ DFG ++ + T TP
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--------TTQNALQTPC-YTPY 194
Query: 783 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
Y+ PE K D++SLGV+ LL G P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ +V E++S G L D + + + RL + S G+ Y H V
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHRHM---VV 138
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 189
Query: 793 KLTD--KSDVYSLGVVFLELLTGMQP 816
+L + D++S GV+ LL G P
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 34/213 (15%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL 670
+G+G + K + AVK + E + Q EI L H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKL 71
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTE 726
++ LV E ++ G L +++ K E A + L S + ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE----ASYIMRKLVS--AVSHMHDV 125
Query: 727 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
V HRD+K N+L + K+ DFG +RL P + + T T Y
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN------QPLKTPC-FTLHY 175
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE + + D++SLGV+ +L+G P
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAV----KRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
++G+G VY+ A+ K + ++ TEI L RL H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEIGVLLRLSHPNIIKL 113
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEAD 728
+ E LV E ++ G L D++ K E I + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENG- 168
Query: 729 PPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ HRD+K N+L K+ADFGLS++ + + V GTPGY
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--------VEHQVLMKTVCGTPGYCA 218
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
PE + D++S+G++ LL G +P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 673
IG G Y + I AVK + +E I+ L R H N+++L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKDV 84
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 729
D+ +V E M G L D++ + F A + + + YLH +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASAVLFTITK--TVEYLHAQG-- 136
Query: 730 PVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
V HRD+K SNIL + + ++ DFG ++ + + T T ++
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN------GLLMTPC-YTANFVA 188
Query: 786 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
PE L + D + D++SLGV+ +LTG P
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 40/237 (16%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRL 662
+ F GQG +G V G G VA+K+ + + F L +Q L+ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 663 HHRNLVSLVGYCDEEGEQ-------MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 715
HH N+V L Y GE+ +V E++ D L + + L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILI 131
Query: 716 SS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGI 768
R I LH + V HRDIK N+L++ T K+ DFG ++ P
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPS---- 185
Query: 769 VPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIV 824
+V+ + + Y PE ++ T D++S+G +F E++ G +PI G N
Sbjct: 186 -EPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSA 238
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 45/256 (17%), Positives = 82/256 (32%), Gaps = 28/256 (10%)
Query: 82 LHLRELQLLNLNLSGNLSPEIGRL---SYLTILDFMWNKISGSIPKEIGNI--KSLELLL 136
L L+ L + + + R+ S L L +++G+ P + L +L
Sbjct: 68 LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127
Query: 137 LNGNELTGSLPEELG----YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
L P L + I Q + + +++N G
Sbjct: 128 LRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 193 QIPPELS----RLPSLVHMLLDNNNLT---GYLPPELSELPKLLILQLDNNNFEGTTIPA 245
+ + + P+L + L N + G + +L L L +N+
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL 305
S S+L L+L L+ L ++ + LS N+L PS L
Sbjct: 248 SCDWPSQLNSLNLSFTGLKQVPKGLPA----------KLSVLDLSYNRLD-RNPS-PDEL 295
Query: 306 PRLQRLFIANNSLSGS 321
P++ L + N S
Sbjct: 296 PQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 53/278 (19%), Positives = 88/278 (31%), Gaps = 55/278 (19%)
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200
EL G L ++D + + + I +I R
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTD------IIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 201 L---PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 257
+ L + L+N +TG PP L E + L+ N T A + + + LK
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 258 LRNCSLQG------PMPDLSRIPNLGYL-LSLN-------------------ITTIKLSN 291
L+ S+ + P L L LS N + + L N
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 292 NKLT---GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLNATETFI----- 339
+ G + + +LQ L +++NSL + + +LN + T +
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK 270
Query: 340 --------LDFQNNNLTNISGSFNIPPNVTVRLRGNPF 369
LD N L +P + L+GNPF
Sbjct: 271 GLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 5e-20
Identities = 67/344 (19%), Positives = 113/344 (32%), Gaps = 95/344 (27%)
Query: 616 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNL 667
+G+G +G+V + VAVK +EG+ E + ++E++ L + HH N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 668 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR----------------- 709
V+L+G C G M++ EF G L L +K E + + +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 710 --------------LSIALGSSRGILYLHTEADPPVFHRDIKASNILL------------ 743
S + + + E P ++D L+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 744 ------------------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
K K+ DFGL+R DI V+ L
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIY-----KDPDYVRKGDARLP 258
Query: 786 -----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839
PE T +SDV+S GV+ E+ + G P + +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---------GVKIDEEFCRRL 309
Query: 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+G P + + L C E RP+ SE++ L ++
Sbjct: 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 43/285 (15%), Positives = 91/285 (31%), Gaps = 28/285 (9%)
Query: 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQN 164
+++ +D N I+ ++ L+ L + + L L +++D N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSI-SGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE- 221
+F L + ++ + L SL ++L +NN+ + P
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPAS 148
Query: 222 -LSELPKLLILQLDNNNFEGTTIPAS---YSNMSKLLKLSLRN---CSLQGPMPDLSRIP 274
+ + +L L N +I L L + + +
Sbjct: 149 FFLNMRRFHVLDLTFNKV--KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 275 NLGYLLSLNITTIKLSNNKLTGTIPSNFSGLP---RLQRLFIANNSLSGSIPSSI----- 326
N S+ TT+ LS N ++ F ++Q L ++N+ GS
Sbjct: 207 NPFKNTSI--TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264
Query: 327 --WQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 367
+ + L A+ D + + + F+ ++ L N
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN 309
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 56/337 (16%), Positives = 103/337 (30%), Gaps = 56/337 (16%)
Query: 83 HLRELQLLNL--NLSGNLSPEI-GRLSYLTILDFMWNKI-SGSIPKEI-GNIKSLELLLL 137
L L +L L N L L+ L +L + + + SLE+L+L
Sbjct: 77 GLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 138 NGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTR----------HFHMN 186
N + P + + + + N + + N MN
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196
Query: 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP---KLLILQLDNNNFEGTTI 243
+ + + S+ + L N + + K+ L L N+ G++
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 244 PASY-----------SNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYL-LSLN-ITTI-- 287
+ S + L + S +L L L+ N I I
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDD 316
Query: 288 ------------KLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 334
LS N L +I S F L +L+ L ++ N + ++ +
Sbjct: 317 NAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL----GL 370
Query: 335 TETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGNPF 369
L N L ++ G F+ ++ + L NP+
Sbjct: 371 PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-18
Identities = 37/238 (15%), Positives = 78/238 (32%), Gaps = 19/238 (7%)
Query: 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNN 212
++ + + N I+ SF+ L + + + I L SL+ + LD N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 213 NLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDL 270
L + L L +L L N +G + ++ ++ L L LR+ +++
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK------ 142
Query: 271 SRIPNLGYLLSL-NITTIKLSNNKLTGTIPSNFSGLP--RLQRLFIANN---SLSGSIPS 324
+I + L++ + L+ NK+ + L +++ ++
Sbjct: 143 -KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201
Query: 325 SIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVRLRGNPFCLNTNAEQFCGS 381
T LD N + F T +++ + N G
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT-KIQSLILSNSYNMGSSFGH 258
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 32/200 (16%), Positives = 65/200 (32%), Gaps = 32/200 (16%)
Query: 198 LSRLPSL----VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 253
L ++P L ++ L N++ S L L L+++ ++ +S L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 254 LKLSLRNCSLQG-PMPDLSRIPNLGYL-LSLN-----------------ITTIKLSNNKL 294
+ L L + + NL L L+ + + L +N +
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 295 TGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 353
P++ F + R L + N + SI + +L + L +++
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLN--FQGKHFTLLRLSSITLQDMN-- 196
Query: 354 FNIPPNVTVRLRGNPFCLNT 373
+ GNPF +
Sbjct: 197 ---EYWLGWEKCGNPFKNTS 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 21/97 (21%), Positives = 40/97 (41%), Gaps = 13/97 (13%)
Query: 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
C +G L ++P L ++ + LS N + ++FS L LQ L + +
Sbjct: 16 ICINRG----LHQVPEL----PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG 67
Query: 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFN 355
I ++ ++ + IL N + +G+FN
Sbjct: 68 LVIRNNTFR----GLSSLIILKLDYNQFLQLETGAFN 100
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 48/272 (17%), Positives = 100/272 (36%), Gaps = 31/272 (11%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + + + L +T L ++ +I + + +L L L N++T
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD 77
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L K+ +++ N + + A L + + + I+ P L+ L +L
Sbjct: 78 --LAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNL 131
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ LD N +T L+ L L L + N + + +N+SKL L +
Sbjct: 132 QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV--SDLTP-LANLSKLTTLKADDNK-- 184
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 324
+S I L L +L + L NN+++ S + L + + N +++ + P
Sbjct: 185 -----ISDISPLASLPNL--IEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT-NQPV 234
Query: 325 SIWQSRTLNATETFILDFQNNNLTNISGSFNI 356
+ + + + + S N
Sbjct: 235 FYNNNLVVPNV---VKGPSGAPIAPATISDNG 263
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 54/277 (19%), Positives = 111/277 (40%), Gaps = 29/277 (10%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ L+ G + L+ L L+ N+I+ + + N+ + L L+GN L
Sbjct: 42 GITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLKN 99
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
+ L + + + I+ P A L+ + +++ N I+ I P L+ L +L
Sbjct: 100 --VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNL 153
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
++ + N ++ L P L+ L KL L+ D+N + I +++ L+++ L+N +
Sbjct: 154 QYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKI--SDISP-LASLPNLIEVHLKNNQI- 207
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 324
S + L +L + L+N +T + L + S + P+
Sbjct: 208 ------SDVSPLANTSNL--FIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPA 257
Query: 325 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVT 361
+I S + + + N+S +FN
Sbjct: 258 TI--SDNGTYASPNLTWNLTSFINNVSYTFNQSVTFK 292
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 37/241 (15%), Positives = 82/241 (34%), Gaps = 29/241 (12%)
Query: 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187
+ + + + +T L + + ++ ++ LN + +
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 247
N I+ + P L L + + L N L ++ L + L L + T +
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQI--TDVTPL- 125
Query: 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPR 307
+ +S L L L + + I L L +L + + N +++ + + L +
Sbjct: 126 AGLSNLQVLYLDLNQI-------TNISPLAGLTNL--QYLSIGNAQVSDL--TPLANLSK 174
Query: 308 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 367
L L +N +S P + + + +NN ++++S N V L
Sbjct: 175 LTTLKADDNKISDISPLA-------SLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQ 227
Query: 368 P 368
Sbjct: 228 T 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 44/219 (20%), Positives = 86/219 (39%), Gaps = 27/219 (12%)
Query: 150 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 209
L +I ++ ++ + A+L+ ++ I + L +L+ + L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 210 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD 269
+N +T L L K+ L+L N + A + + + L L + + D
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPL--KNVSA-IAGLQSIKTLDLTSTQIT----D 121
Query: 270 LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 329
++ + L L L L N++T S +GL LQ L I N +S + + +
Sbjct: 122 VTPLAGLSNLQVLY-----LDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DL-TPLANL 172
Query: 330 RTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 368
L L +N +++IS ++P + V L+ N
Sbjct: 173 SKLT-----TLKADDNKISDISPLASLPNLIEVHLKNNQ 206
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 45/220 (20%), Positives = 85/220 (38%), Gaps = 30/220 (13%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ L+L+ + LS L +L N+I+ +I + + +L+ L + +++
Sbjct: 108 SIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS- 164
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
L L L KL ++ D N IS + A+L H+ NN IS + P L+ +L
Sbjct: 165 DL-TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNL 219
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L N +T + L++ + PA+ S+ + + +L
Sbjct: 220 FIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSGAPIAPATISD-----NGTYASPNLT 271
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSG 304
+ I N+ Y + ++T FSG
Sbjct: 272 WNLTSF--INNVSYTFNQSVT---------FKNTTVPFSG 300
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-20
Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 32/233 (13%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 664
+ + IG G G V VA+K+ + K E+ + ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 665 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 715
+N++ L V + E+ +V E M ++ +L + L + M
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML------ 137
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 775
GI +LH+ A + HRD+K SNI++ T K+ DFGL+R + + T
Sbjct: 138 --CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMT 184
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828
T Y PE L + D++S+G + E++ G + G + + + N
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWN 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 664
+ F +G+GG+G+V+ + G + A K+ + L+ K + + E + L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 665 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 717
R +VSL Y E + LV M+ G +R + ++ GF + I G
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
+ +LH + +RD+K N+LLD +++D GL+ E +
Sbjct: 302 --LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV-------ELKAGQTKTKGY 349
Query: 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
GTPG++ PE L + D ++LGV E++ P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 60/271 (22%), Positives = 91/271 (33%), Gaps = 45/271 (16%)
Query: 617 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHR 665
I G YG V G+ +G VA+KR G K L EI+ L+ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 666 NLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
N++ L + LV E M T Q+ + + G+
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 721 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST--VVK 778
LH A V HRD+ NILL + DF L+R T V
Sbjct: 148 HVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAR--------EDTADANKTHYVT- 195
Query: 779 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837
Y PE + K K D++S G V E+ + + G Q + +
Sbjct: 196 -HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYN------QLNKIV 247
Query: 838 SVI----DGNMGSYPSECVEKFIKLALKCCQ 864
V+ ++ + S +++ +L
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 20/205 (9%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
IG G +G +VAVK + G+ E EI L H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFKEVIL 86
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
++ E+ S G L +++ + A L S G+ Y H+ + HRD
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--GVSYCHSMQ---ICHRD 141
Query: 736 IKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
+K N LLD K+ DFG S+ V + + V GTP Y+ PE L +
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKS-SVLH------SQPKSTV-GTPAYIAPE-VLLRQ 192
Query: 794 LTD--KSDVYSLGVVFLELLTGMQP 816
D +DV+S GV +L G P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G+G +GKV VA+K R EI +L L H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ ++V E+ + G L D + K + R + I Y H +
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC--AIEYCHRHK---IV 130
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K N+LLD K+ADFGLS + + T G+P Y PE +
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNI-MTDG------NFLKTSC-GSPNYAAPE-VING 181
Query: 793 KLTD--KSDVYSLGVVFLELLTGMQP 816
KL + DV+S G+V +L G P
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 673
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 674 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 725
+ + + E + G L ++ + + M+ SI I YLH+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-SIG----EAIQYLHS 179
Query: 726 EADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 782
+ HRD+K N+L K K+ DFG ++ + ++T TP
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-------LTTPC-YTPY 228
Query: 783 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
Y+ PE K D++SLGV+ LL G P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 61/258 (23%), Positives = 105/258 (40%), Gaps = 45/258 (17%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--V 671
+G G YG V I G VA+K+ S K E+ L + H N++ L V
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 672 GYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
LV FM + + S + + L + M +G+ Y+H
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML--------KGLKYIH 143
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ A V HRD+K N+ ++ K+ DFGL+R A ++ G V T Y
Sbjct: 144 S-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYV---------VTRWYR 190
Query: 785 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI--- 840
PE L+ +++ D++S+G + E+LTG + + GK+ + Q + + V
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLD------QLTQILKVTGVP 243
Query: 841 -DGNMGSYPSECVEKFIK 857
+ + + +I+
Sbjct: 244 GTEFVQKLNDKAAKSYIQ 261
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 47/193 (24%), Positives = 72/193 (37%), Gaps = 21/193 (10%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239
T H++ N + L L + LD LT LP L L L +N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQL- 89
Query: 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLLSLNITTIKLSNNKLTGTI 298
++P + L L + L + L L L N+L T+
Sbjct: 90 -QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY--------LKGNELK-TL 139
Query: 299 PSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNI 356
P + P+L++L +ANN+L+ +P+ + L +T L Q N+L I G F
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLT-ELPAGLLNG--LENLDT--LLLQENSLYTIPKGFFGS 194
Query: 357 PPNVTVRLRGNPF 369
L GNP+
Sbjct: 195 HLLPFAFLHGNPW 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 52/188 (27%), Positives = 72/188 (38%), Gaps = 18/188 (9%)
Query: 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167
TIL N + + L L L+ ELT L + LP L + + N +
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGT-LPVLGTLDLSHNQLQ 90
Query: 168 GSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SEL 225
SLP L ++ N ++ +P L L + L N L LPP L +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 226 PKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNI 284
PKL L L NNN T +PA + + L L L+ SL IP G+ S +
Sbjct: 148 PKLEKLSLANNNL--TELPAGLLNGLENLDTLLLQENSLY-------TIPK-GFFGSHLL 197
Query: 285 TTIKLSNN 292
L N
Sbjct: 198 PFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 50/178 (28%), Positives = 75/178 (42%), Gaps = 16/178 (8%)
Query: 91 NLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
L+LS N S + LT L+ +++ + G + L L L+ N+L S
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-S 91
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPS 203
LP LP L + + N ++ SLP L + + ++ N + +PP L + P
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149
Query: 204 LVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L + L NNNLT LP L + L L L L N+ TIP + L L
Sbjct: 150 LEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSL--YTIPKGFFGSHLLPFAFLHG 204
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 32/264 (12%)
Query: 573 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 631
+ I++ + SK+ + + + IG G G V
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 632 DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LV 683
VA+K+ + K E+ + ++H+N++SL V + E+ LV
Sbjct: 86 LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 684 YEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 740
E M ++ +L + L + M GI +LH+ A + HRD+K SN
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQML--------CGIKHLHS-AG--IIHRDLKPSN 194
Query: 741 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 800
I++ T K+ DFGL+R A + + T T Y PE L + D+
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 801 YSLGVVFLELLTGMQPISHGKNIV 824
+S+G + E++ + + G++ +
Sbjct: 247 WSVGCIMGEMVRH-KILFPGRDYI 269
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 59/327 (18%), Positives = 108/327 (33%), Gaps = 42/327 (12%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNK 179
IP ++ ++ L +L L++I+I QN + + F+NL K
Sbjct: 23 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 180 TRHFHM-NNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNN 236
+ N++ I PE LP+L ++L+ N + +LP + ++L + +N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 237 NFEGTTIP--ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKL 294
TI + + + L L +Q L L + NN L
Sbjct: 139 I-NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD-------NNNL 190
Query: 295 TGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 353
+P++ F G L I+ + S+PS + N + NL +
Sbjct: 191 E-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLE----NLKKLRARS--TYNLKKLPTL 242
Query: 354 FNIPPNVTVRLRGNPFC--------LNTNAEQFCGSHSDDDNEIDRSTN------STLDC 399
+ + L C + C + S E+D T S +
Sbjct: 243 EKLVALMEASLTYPSHCCAFANWRRQISELHPIC-NKSILRQEVDYMTQARGQRSSLAED 301
Query: 400 RAQSCPTDYEYSPTSPIRCFCAAPLLV 426
S ++ + T C + V
Sbjct: 302 NESSYSRGFDMTYTEFDYDLCNEVVDV 328
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 42/244 (17%), Positives = 75/244 (30%), Gaps = 26/244 (10%)
Query: 83 HLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSL-ELLLLNG 139
+ EL+ + L + L ++ N + I ++ N+ L E+ +
Sbjct: 31 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE-L 198
N L PE LP L + I I + + + +N I
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 199 SRLPSLVHML-LDNNNLTGYLPPELSELPKLL-ILQLDNNNFEGTTIPA-SYSNMSKLLK 255
L +L L+ N + + +L + DNNN +P + S +
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNL--EELPNDVFHGASGPVI 206
Query: 256 LSLRNCSLQGPMPDLSRIPN--LGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 313
L + + +P+ L L L S L +P+ L L +
Sbjct: 207 LDISRTR-------IHSLPSYGLENLKKLRA----RSTYNLK-KLPT-LEKLVALMEASL 253
Query: 314 ANNS 317
S
Sbjct: 254 TYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 32/187 (17%), Positives = 68/187 (36%), Gaps = 21/187 (11%)
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIP 244
+ ++ +IP +L + + + L + S L +++ N+ I
Sbjct: 17 QESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL-EVIE 71
Query: 245 AS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSL-NITTIKLSNNKLTGTIPSN- 301
A +SN+ KL ++ + +L I +L N+ + +SN + +P
Sbjct: 72 ADVFSNLPKLHEIRIEKA------NNLLYINP-EAFQNLPNLQYLLISNTGIK-HLPDVH 123
Query: 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNV 360
+ L I +N +I + + + + IL N + I + +FN
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFE---SVILWLNKNGIQEIHNSAFNGTQLD 180
Query: 361 TVRLRGN 367
+ L N
Sbjct: 181 ELNLSDN 187
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 51/241 (21%), Positives = 86/241 (35%), Gaps = 53/241 (21%)
Query: 91 NLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTG 144
NL+LS N L L +LD +I +I ++ L L+L GN +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89
Query: 145 SLPEEL-GYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHMNNNSISGQIPPEL-SRL 201
SL L L ++ + ++ SL +L + ++ +N I PE S L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 202 PSLVHMLLDNNNLTGYLPPE----LSELPKL-LILQLDNNNFEGTTIPASYSNMSKLLKL 256
+L H+ L +N + + L ++P L L L L N I
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM--NFIQP----------- 194
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 315
G + + + L N+L ++P F L LQ++++
Sbjct: 195 --------------------GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHT 233
Query: 316 N 316
N
Sbjct: 234 N 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 39/225 (17%), Positives = 80/225 (35%), Gaps = 29/225 (12%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNL 214
+ + N + SF + + + ++ I I L L ++L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 215 TGYLPPEL-SELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSR 272
L S L L L N ++ ++ L +L++ + +Q
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNL--ASLENFPIGHLKTLKELNVAHNLIQ-------S 138
Query: 273 IPNLGYLLSL-NITTIKLSNNKLTGTIPSN-FSGLPRLQ----RLFIANNSLSGSIPSSI 326
Y +L N+ + LS+NK+ +I L ++ L ++ N ++ I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 327 WQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 369
++ L L N L ++ G F+ ++ + L NP+
Sbjct: 197 FKEIRLK-----ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 23/112 (20%), Positives = 41/112 (36%), Gaps = 16/112 (14%)
Query: 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 318
C +IP+ L + + LS N L + S F P LQ L ++ +
Sbjct: 13 QCMELN----FYKIPD-N--LPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI 64
Query: 319 SGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNP 368
+I +QS L+ T L N + ++ G+F+ ++
Sbjct: 65 Q-TIEDGAYQS--LSHLST--LILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 23/207 (11%), Positives = 51/207 (24%), Gaps = 49/207 (23%)
Query: 616 QIGQGGYGKVYKGILPD---GTVVAVK--RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVS 669
G + ++ + D VA+ Q + L+ LSR+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 670 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 729
++ ++V E++ G+L++ + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 730 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 789
V S + + +A + +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPAT--MPDA----------------------NPQ-- 182
Query: 790 LTHKLTDKSDVYSLGVVFLELLTGMQP 816
D+ +G LL P
Sbjct: 183 --------DDIRGIGASLYALLVNRWP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 61/268 (22%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 671
+G+G YG V P G +VA+K+ + L EI+ L H N++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 672 --GYCDEEGEQMLVYEFM--------SNGTLRD--------QLSAKSKEPLGFAMRLSIA 713
+ E ++ E M S L D Q
Sbjct: 79 RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT----------------- 121
Query: 714 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773
L R + LH ++ V HRD+K SN+L++ KV DFGL+R+ + P
Sbjct: 122 L---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 774 STVVKG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNI 829
+ + T Y PE LT ++ DV+S G + EL +PI G++
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRH---- 230
Query: 830 AYQSSMMFSVIDGNMGSYPSECVEKFIK 857
Q ++F +I G+ S+ + I+
Sbjct: 231 --QLLLIFGII----GTPHSDNDLRCIE 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 609 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 661
++F IG+G +GKV + A+K + E E+Q +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 662 LHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGS 716
L H LV+L Y ++ E M +V + + G LR L E F L +AL
Sbjct: 72 LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD- 129
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 776
YL + + HRD+K NILLD + DF ++ + + T
Sbjct: 130 -----YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM--------LPRETQITT 173
Query: 777 VKGTPGYLDPEYFLTHKLT--DKS-DVYSLGVVFLELLTGMQP 816
+ GT Y+ PE F + K + D +SLGV ELL G +P
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 664
N F +G+GG+G+V + G + A K+ ++ ++ K L E Q L +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 665 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 717
R +VSL Y E + + LV M+ G L+ + + GF + I G
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAEICCG-- 298
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
+ LH E + +RD+K NILLD +++D GL+ + V
Sbjct: 299 --LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV-------HVPEGQTIKGRV 346
Query: 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
GT GY+ PE + T D ++LG + E++ G P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 609 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 661
+F +G+G + V A+K ++ + E + E +SR
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 717
L H V L ++ + + NG L + E + + AL
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE-- 144
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
YLH + + HRD+K NILL+ ++ DFG +++ + A+ + V
Sbjct: 145 ----YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV--LSPESKQARAN--SFV 193
Query: 778 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
GT Y+ PE LT K KS D+++LG + +L+ G+ P
Sbjct: 194 -GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 68/257 (26%), Positives = 103/257 (40%), Gaps = 33/257 (12%)
Query: 573 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY----KG 628
R S S + S + + N F +G+G +GKV K
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171
Query: 629 ILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVY 684
G A+K ++ + + E LTE + L H L +L Y + +++ V
Sbjct: 172 ---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM 227
Query: 685 EFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 740
E+ + G L LS + E + + AL YLH+E + V +RD+K N
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALD------YLHSEKN--VVYRDLKLEN 279
Query: 741 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 799
++LD K+ DFGL + EGI GTP YL PE L ++ D
Sbjct: 280 LMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 331
Query: 800 VYSLGVVFLELLTGMQP 816
+ LGVV E++ G P
Sbjct: 332 WWGLGVVMYEMMCGRLP 348
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 671
IG G YG V + + VVA+K+ L K L EI L+RL+H ++V ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 672 ---GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE 726
++ E +V E + D ++ L ++ G+ Y+H+
Sbjct: 121 VIPKDVEKFDELYVVLEIA--DS--D-FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
A + HRD+K +N L++ + KV DFGL+R P+
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 787 EYFLTHKLTD--------------------KS-DVYSLGVVFLELLTGMQP 816
L +LT ++ DV+S+G +F ELL ++
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 40/196 (20%), Positives = 81/196 (41%), Gaps = 14/196 (7%)
Query: 73 FNTTMDDGYLHLRELQLLNLNLSGN---LSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F Y + + N +SG ++S LDF N ++ ++ + G++
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 130 KSLELLLLNGNELTGSLPEELGY---LPKLDRIQIDQNYISGSLPK-SFANLNKTRHFHM 185
LE L+L N+L L + + L ++ I QN +S K + +M
Sbjct: 348 TELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP- 244
++N ++ I L P + + L +N + +P ++ +L L L + +N ++P
Sbjct: 407 SSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQL--KSVPD 461
Query: 245 ASYSNMSKLLKLSLRN 260
+ ++ L K+ L
Sbjct: 462 GIFDRLTSLQKIWLHT 477
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 6e-17
Identities = 55/333 (16%), Positives = 100/333 (30%), Gaps = 67/333 (20%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE 141
L +L+LS N + E G +S L L + S I ++ ++LL+ G
Sbjct: 91 NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 142 LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN------------------------- 176
E+ L + + + + +
Sbjct: 151 YG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 177 ----------LNKTRHFHMNNNSISGQIPPELSRLP---SLVHMLLDNNNLTGYLPPELS 223
K + +NN + + +L ++ + + N L G L
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 224 E-----LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLG 277
+ L L I Q+ ++ F G Y S + + + M S+I
Sbjct: 269 DYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 278 YLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 337
+L SNN LT T+ N L L+ L + N L + T
Sbjct: 328 HL--------DFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA--EMTTQMKSL 376
Query: 338 FILDFQNNNLTNIS--GSFNIPPNVTV-RLRGN 367
LD N+++ G + ++ + N
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 29/243 (11%), Positives = 82/243 (33%), Gaps = 18/243 (7%)
Query: 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140
Y + ++L + L L+I + + ++ + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE--- 197
+ + N ++ ++ ++ +L + + N + ++
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEM 369
Query: 198 LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 256
+++ SL + + N+++ S LL L + +N T ++ L
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL--TDTIFR-CLPPRIKVL 426
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 315
L + ++ + ++ L L +++N+L ++P F L LQ++++
Sbjct: 427 DLHSNKIKSIPKQVVKLEALQELN--------VASNQLK-SVPDGIFDRLTSLQKIWLHT 477
Query: 316 NSL 318
N
Sbjct: 478 NPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 48/287 (16%), Positives = 93/287 (32%), Gaps = 20/287 (6%)
Query: 91 NLNLSGN----LSPE-IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS 145
LN+S N L I LS L IL N+I + LE L L+ N+L
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83
Query: 146 LPEELGYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPELSRLPS 203
+ L + + N +LP F N+++ + ++ + ++ L
Sbjct: 84 IS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 204 LVHMLLDNNNLTGYLPPEL---SELPKLLILQLDNNNFEGTTIPASYSNMS---KLLKLS 257
+L+ PE L I+ N F + + + +K
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 258 LRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 317
L + + L+++ L +L + I+ + N + I+N
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVWYFSISNVK 258
Query: 318 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVR 363
L G + + + I ++ S + I N+ ++
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 49/361 (13%), Positives = 109/361 (30%), Gaps = 41/361 (11%)
Query: 43 IKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEI 102
++KS V + L+ + D L + N L +
Sbjct: 127 LEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 103 GRLSYLTILDFMWNKISG------SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPK- 155
++ L + + SI ++ L L LN E T + + L
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 156 -------LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
+ +++ S +L + ++ ++
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPM 267
+ S++ L L NN T ++++L L L+ L+
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLL--TDTVFENCGHLTELETLILQMNQLK--- 361
Query: 268 PDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI 326
+LS+I + + ++ + +S N ++ S L L +++N L+ +I +
Sbjct: 362 -ELSKIAEMTTQMK-SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 327 WQSRTL----------------NATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNP 368
+ L+ +N L ++ G F+ ++ + L NP
Sbjct: 420 PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479
Query: 369 F 369
+
Sbjct: 480 W 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 38/282 (13%), Positives = 84/282 (29%), Gaps = 18/282 (6%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG 168
++D N + +PK++ + +L ++ N ++ ++ L KL + I N I
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 169 SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY-LPPELSELPK 227
F + + +++N + I +L H+ L N + E + +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 228 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTI 287
L L L + + K+ L G D + + SL+I +
Sbjct: 117 LKFLGLSTTHL--EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDF-NTESLHI--V 171
Query: 288 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF------ILD 341
+N + + + + L+ I + L ++
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231
Query: 342 FQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 383
N+ I + + F S +
Sbjct: 232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 42/236 (17%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 658
N+F+ IG+GG+G+VY D G + A+K + E E+ L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-- 246
Query: 659 LSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------ 711
S +V + Y +++ + + M+ G L LS F+
Sbjct: 247 -STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAE 300
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771
I LG + ++H V +RD+K +NILLD +++D GL+ V
Sbjct: 301 IILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVRE 826
GT GY+ PE D S D +SLG + +LL G P K +
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 68/255 (26%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-- 673
+G G +G V + + G A+K+ LQ + E+ + L H N++ LV Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 674 ------------------------------------CDEEGEQMLVYEFMSNGTLRDQLS 697
+ ++ E++ D L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----DTLH 125
Query: 698 AKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTAK 750
K + + + L S R + ++H+ + HRDIK N+L++ T K
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLK 182
Query: 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLE 809
+ DFG ++ +P V+ + + Y PE L + T D++S+G VF E
Sbjct: 183 LCDFGSAKKL-IPS-----EPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 810 LLTGMQPISHGKNIV 824
L+ G +P+ G+ +
Sbjct: 235 LILG-KPLFSGETSI 248
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 7e-17
Identities = 61/276 (22%), Positives = 109/276 (39%), Gaps = 29/276 (10%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + NL + L+ + + + I S+ + I + ++ L LNGN+LT
Sbjct: 22 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT- 78
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
+ + L L L + +D+N I L S +L K + + +N IS I L LP L
Sbjct: 79 DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQL 133
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L NN +T LS L KL L L++N + I + ++KL L L +
Sbjct: 134 ESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI--SDIV-PLAGLTKLQNLYLSKNHIS 188
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 324
DL + L N+ ++L + + ++ S L + + GS+ +
Sbjct: 189 ----DLRALAGLK-----NLDVLELFSQECLNKPINHQSNLVVPNTV----KNTDGSLVT 235
Query: 325 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNV 360
S + + + +S F P +
Sbjct: 236 PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 271
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 9e-17
Identities = 47/243 (19%), Positives = 89/243 (36%), Gaps = 29/243 (11%)
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
+ + + P + + + + ++ ++ LN NN+ I
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMS 251
+ + LP++ + L+ N LT P L+ L L L LD N + S ++
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI--KDLS-SLKDLK 109
Query: 252 KLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 311
KL LSL + + D++ + +L L SL L NNK+T + S L +L L
Sbjct: 110 KLKSLSLEHNGIS----DINGLVHLPQLESLY-----LGNNKIT--DITVLSRLTKLDTL 158
Query: 312 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 371
+ +N +S I L + L N+++++ + + L
Sbjct: 159 SLEDNQIS-----DIVPLAGLTKLQN--LYLSKNHISDLRALAGLKNLDVLELFSQECLN 211
Query: 372 NTN 374
Sbjct: 212 KPI 214
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 3e-15
Identities = 53/274 (19%), Positives = 102/274 (37%), Gaps = 24/274 (8%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ + + + + I L +T L NK++ I K + N+K+L L L+ N++
Sbjct: 44 SIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK 100
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
L L L KL + ++ N IS + +L + ++ NN I+ I LSRL
Sbjct: 101 -DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTK 154
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L++N ++ L+ L KL L L N+ + + A + + L L L +
Sbjct: 155 LDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI--SDLRAL-AGLKNLDVLELFSQEC 209
Query: 264 QGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 323
++ NL ++ + +T I S+ + + +
Sbjct: 210 L--NKPINHQSNLVVPNTVK----NTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSF 263
Query: 324 SSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 357
A F + S+++
Sbjct: 264 IFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVD 297
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 59/259 (22%), Positives = 102/259 (39%), Gaps = 46/259 (17%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--V 671
+G G YG V + G VA+K+ S K E++ L + H N++ L V
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 672 GYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYL 723
DE + LV FM ++ + L + L + M +G+ Y+
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML--------KGLRYI 144
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
H A + HRD+K N+ ++ K+ DFGL+R VV T Y
Sbjct: 145 HA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVV--TRWY 191
Query: 784 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI-- 840
PE L ++ D++S+G + E++TG + + G + + Q + V
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLD------QLKEIMKVTGT 244
Query: 841 --DGNMGSYPSECVEKFIK 857
+ S+ + ++K
Sbjct: 245 PPAEFVQRLQSDEAKNYMK 263
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 57/250 (22%), Positives = 82/250 (32%), Gaps = 64/250 (25%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 671
IG+G YG VY VA+K+ L K L EI L+RL ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 672 ---GYCDEEGEQMLVYEFM---------SNGTLRD--------QLSAKSKEPLGFAMRLS 711
+ E +V E + L + L
Sbjct: 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL--------------- 138
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771
L G ++H + + HRD+K +N LL+ + KV DFGL+R IV
Sbjct: 139 --L---LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 772 HVSTVVKGTPGYLD---------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 815
G PE L + KS D++S G +F ELL +Q
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 816 PISHGKNIVR 825
+
Sbjct: 251 SHINDPTNRF 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 53/302 (17%)
Query: 574 MKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPD 632
M ++H + + +++ + + + + +G G YG V
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTI-WE------VPERYQNLSPVGSGAYGSVCAAFDTKT 53
Query: 633 GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LVY 684
G VAVK+ S+ K E++ L + H N++ L V E+ LV
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 685 EFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 740
M N ++ Q L+ + L + + RG+ Y+H+ AD + HRD+K SN
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQFLIYQIL--------RGLKYIHS-AD--IIHRDLKPSN 162
Query: 741 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 799
+ ++ K+ DFGL+R ++ G V T Y PE L +++ D
Sbjct: 163 LAVNEDCELKILDFGLARHT-ADEMTGYV---------ATRWYRAPEIMLNWMHYNQTVD 212
Query: 800 VYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI----DGNMGSYPSECVEKF 855
++S+G + ELLTG + + G + + Q ++ ++ + SE +
Sbjct: 213 IWSVGCIMAELLTG-RTLFPGTDHID------QLKLILRLVGTPGAELLKKISSESARNY 265
Query: 856 IK 857
I+
Sbjct: 266 IQ 267
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL----- 670
+G GG G V+ + VA+K+ Q K L EI+ + RL H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 671 ---------VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 717
VG E +V E+M L L + + +
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL-------- 130
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSR-LAPVPDIEGIVPAHVST 775
RG+ Y+H+ A+ V HRD+K +N+ ++ + K+ DFGL+R + P +G + +
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV- 186
Query: 776 VVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 824
T Y P L+ + T D+++ G +F E+LTG + + G + +
Sbjct: 187 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHEL 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 66/258 (25%), Positives = 114/258 (44%), Gaps = 40/258 (15%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 671
IG+G YG V + VA+K+ + L EI+ L R H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 672 --GYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
++ + +V + M L+ Q LS + + L RG+ Y+H+
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI-----L---RGLKYIHS 146
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGYL 784
A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 147 -AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-----TRWYR 198
Query: 785 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI--- 840
PE L K KS D++S+G + E+L+ +PI GK+ + Q + + ++
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLD------QLNHILGILGSP 251
Query: 841 -DGNMGSYPSECVEKFIK 857
++ + ++
Sbjct: 252 SQEDLNCIINLKARNYLL 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 85/343 (24%), Positives = 138/343 (40%), Gaps = 61/343 (17%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVSL-- 670
+G+G YG V+K I G VVAVK+ + + + EI L+ L H N+V+L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 671 VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
V D + + LV+++M + +R L K+ + + + + + I YLH+
Sbjct: 77 VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL-----I---KVIKYLHS- 127
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD- 785
+ HRD+K SNILL+ + KVADFGLSR
Sbjct: 128 GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 786 -------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831
PE L K D++SLG + E+L G +PI G + +
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSSTMN------ 238
Query: 832 QSSMMFSVI----DGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNM 886
Q + VI + ++ S S + I+ L K +++ R ++ L I
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 887 MPESD------TKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923
++ K +F ++ S + LKHP+VS
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISAND-------ALKHPFVSI 334
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 27/172 (15%), Positives = 60/172 (34%), Gaps = 15/172 (8%)
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
+ SL + L +T L + Y + + I+ + + + L+
Sbjct: 39 TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
+ ++ P LS L SL + + ++ + +++ LPK+ + L N T
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG--AITDI 152
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTG 296
+ +L L+++ + D I + L L + + G
Sbjct: 153 MPLKTLPELKSLNIQFDGVH----DYRGIEDFPKLNQLY-----AFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 28/167 (16%), Positives = 67/167 (40%), Gaps = 16/167 (9%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212
+ Q+ + + A +N + + N +++ + + ++ + ++N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNI 76
Query: 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR 272
+ T Y P +S L L L++ + IP + S ++ L L + + + L++
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIP-NLSGLTSLTLLDISHSAHDDS--ILTK 131
Query: 273 IPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
I L + S++++ N +T LP L+ L I + +
Sbjct: 132 INTLPKVNSIDLS----YNGAITD--IMPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 33/178 (18%), Positives = 71/178 (39%), Gaps = 21/178 (11%)
Query: 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
+ + + +S + +++ SL ++ L N N+T L + + L ++
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTIN 74
Query: 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKL 294
N + T S +S L +L + + +IPNL L SL T + +S++
Sbjct: 75 NIHA--TNY-NPISGLSNLERLRIMGKDVTS-----DKIPNLSGLTSL--TLLDISHSAH 124
Query: 295 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 352
+I + + LP++ + ++ N I + L L+ Q + + + G
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELK-----SLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 21/110 (19%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+L L+++ +++ + P + L+ LT+LD + SI +I + + + L+ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
+ L LP+L + I + + + K + + +I G
Sbjct: 149 ITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 25/234 (10%)
Query: 88 QLLNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144
+ + NL + L+ + + + I S+ + I + ++ L LNGN+LT
Sbjct: 25 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT- 81
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
+ + L L L + +D+N + L S +L K + + +N IS I L LP L
Sbjct: 82 DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQL 136
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264
+ L NN +T + LS L KL L L++N + I + ++KL L L +
Sbjct: 137 ESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQI--SDIV-PLAGLTKLQNLYLSKNHIS 191
Query: 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318
DL + L N+ ++L + + ++ S L + + SL
Sbjct: 192 ----DLRALAGLK-----NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 47/230 (20%), Positives = 84/230 (36%), Gaps = 27/230 (11%)
Query: 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207
+ + + + ++ + LN NN+ I + + LP++ +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 267
L+ N LT P L+ L L L LD N + S ++ KL LSL + +
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKV--KDLS-SLKDLKKLKSLSLEHNGI---- 124
Query: 268 PDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 327
S I L +L L ++ L NNK+T + S L +L L + +N +S I
Sbjct: 125 ---SDINGLVHLPQL--ESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIV 172
Query: 328 QSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQ 377
L + L N+++++ + + L Q
Sbjct: 173 PLAGLTKLQN--LYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQ 220
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 45/291 (15%), Positives = 87/291 (29%), Gaps = 38/291 (13%)
Query: 73 FNTTMDDGYLHLRELQLLNLNLSG-------NLSPEIGRLSYLTILDFMWNKISGSIPKE 125
F+ ++ L LQL N+ L+ E+ R L + + + +
Sbjct: 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK 268
Query: 126 IGNI---KSLELLLLNGNELTGSLPEELG-----YLPKLDRIQIDQNYISGSLPKSFANL 177
+ + +E L + +T + E L L + S ++
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237
+ ++ + S + N T + S L +L L L N
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQ----GPMPDLSRIP-NLGYL------------- 279
+ L + SL ++ L
Sbjct: 389 L--KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
Query: 280 -LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 329
L + + L NN++ +IP + + L LQ L +A+N L S+P ++
Sbjct: 447 CLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 33/196 (16%), Positives = 77/196 (39%), Gaps = 14/196 (7%)
Query: 73 FNTTMDDGYLHLRELQLLNL---NLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129
F + + Y E+ + L + S T L+F N + S+ + +
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376
Query: 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI----SGSLPKSFANLNKTRHFHM 185
K L+ L+L N L + + + ++ + S + ++ A ++
Sbjct: 377 KRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP- 244
++N ++G + L P + + L NN + +P +++ L L L + +N ++P
Sbjct: 436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL--KSVPD 490
Query: 245 ASYSNMSKLLKLSLRN 260
+ ++ L + L +
Sbjct: 491 GVFDRLTSLQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 2e-13
Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 24/288 (8%)
Query: 91 NLNLSGN----LSP-EIGRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTG 144
L+LS N L +I LS L +L N+I S+ + + LE L ++ N L
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ- 113
Query: 145 SLPEELGYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPELSRLP 202
++ + L + + N LP F NL K ++ ++ L
Sbjct: 114 NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 203 SLVHML-LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
+L L + ++ G L +L L + ++ + S ++ L L L N
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMS-VNALGHLQLSN- 227
Query: 262 SLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL-----PRLQRLFIANN 316
++ + R+ L+ T + ++ + T + ++ L I N
Sbjct: 228 -IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286
Query: 317 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVR 363
+++ I + I +N +++ + ++
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 59/321 (18%), Positives = 108/321 (33%), Gaps = 45/321 (14%)
Query: 88 QLLNLNLSGN------LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLL-LNGN 140
L +L+LS N + E G L+ LT L K + ++ +LL L
Sbjct: 122 SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181
Query: 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ------- 193
+ G E L + + + S + ++N H ++N ++ +
Sbjct: 182 HIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPELSEL---PKLLILQLDNNNFEGTTIPASYSNM 250
EL+R P+L+++ L + T +L + + L + N ++
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300
Query: 251 SKLLK----LSLRNCSLQGPMPDL-SRIPNLGYL-LSLN---------------ITTIKL 289
LK ++N L S + LS++ T +
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNF 360
Query: 290 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 349
+ N T ++ S L RLQ L + N L + T N + LD N+L +
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVA--LMTKNMSSLETLDVSLNSLNS 417
Query: 350 I--SGSFNIPPNVTV-RLRGN 367
+ ++ V L N
Sbjct: 418 HAYDRTCAWAESILVLNLSSN 438
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 40/240 (16%), Positives = 78/240 (32%), Gaps = 16/240 (6%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNK 179
+PK++ + L L+ N ++ ++ +L +L +++ N I SL F
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNN 237
+ +++N + I + SL H+ L N+ LP E L KL L L
Sbjct: 102 LEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGT 297
F + L + L S + + L++ N+ +
Sbjct: 158 F--RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVF--HPNSLFSVQ 212
Query: 298 IPSNFSGLPRLQRLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 356
+ + + L LQ I N + + + + + L F
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 91 NLNLSGN----LSPEI--GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELT 143
L+LS N L E RL+ L L N ++ I E + +L L L+ N L
Sbjct: 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 144 GSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE----L 198
+L E L L+ + + N+I +F ++ + + +++ N IS + P E
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159
Query: 199 SRLPSLVHMLLDNNNLTGYLPPELSELPKL--LILQLDNNNF 238
++LP L+ + L +N L +L +LP L L NN
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 40/185 (21%), Positives = 69/185 (37%), Gaps = 29/185 (15%)
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNNFEGTTIPA-SYSNM 250
+P + L L +NNL+ L E + L L L L +N+ I + ++ +
Sbjct: 37 LPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL--NFISSEAFVPV 87
Query: 251 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRL 308
L L L + L S + L L L NN + + N F + +L
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVL--------LLYNNHIV-VVDRNAFEDMAQL 138
Query: 309 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPN---VTVRL 364
Q+L+++ N +S P + + + +LD +N L + P + L
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGN-KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196
Query: 365 RGNPF 369
NP
Sbjct: 197 HNNPL 201
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 35/214 (16%), Positives = 69/214 (32%), Gaps = 22/214 (10%)
Query: 108 LTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNY 165
L + + +IP N+ ++ + ++ + L L K+ I+I
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 166 ISGSLPKS-FANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPE- 221
+ L + + N + P + + + +N +P
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 222 LSELPKLLI-LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN--LGY 278
L + L+L NN F T++ N +KL + L L+ I G
Sbjct: 151 FQGLCNETLTLKLYNNGF--TSVQGYAFNGTKLDAVYLNKN------KYLTVIDKDAFGG 202
Query: 279 LLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRL 311
+ S + + +S +T +PS L L
Sbjct: 203 VYS-GPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 37/206 (17%), Positives = 74/206 (35%), Gaps = 19/206 (9%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDN 211
P +++ + ++ +F+NL +++ + Q+ L + H+ + N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 212 NNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY--SNMSKLLKLSLRNCSLQGPMP 268
Y+ P+ L ELP L L + N P + L + +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGL--KMFPDLTKVYSTDIFFILEITDNPY----- 142
Query: 269 DLSRIP-NLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI 326
++ IP N L T+KL NN T ++ F+G +L +++ N I
Sbjct: 143 -MTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGT-KLDAVYLNKNKYLTVIDKDA 199
Query: 327 WQSRTLNATETFILDFQNNNLTNISG 352
+ + LD ++T +
Sbjct: 200 FGGVYSGPSL---LDVSQTSVTALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 35/169 (20%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 210 DNNNLTGYLPPELSELPK-LLILQLDNNNFEGTTIPA-SYSNMSKLLKLSL-RNCSLQGP 266
++ + LP L+L + TIP+ ++SN+ + ++ + + +L
Sbjct: 19 TCKDIQ-----RIPSLPPSTQTLKLIETHL--RTIPSHAFSNLPNISRIYVSIDVTL--- 68
Query: 267 MPDLSRIPNLGYLLSL-NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPS 324
++ + +L +T I++ N + I + LP L+ L I N L P
Sbjct: 69 ----QQLES-HSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 325 SIWQSRTLNATETFILDFQNNN-LTNIS-GSFNIPPN--VTVRLRGNPF 369
++ + FIL+ +N +T+I +F N +T++L N F
Sbjct: 123 L---TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 48/241 (19%)
Query: 598 SFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQE 643
S G + F +G+GGYGKV+ K + G + A+K
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 644 GSLQGEKEFLTEIQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKS 700
+ E+ L E++ F+ L Y + G ++ L+ E++S G L QL +
Sbjct: 66 AHTKAERNILEEVKHPFIVDLI---------YAFQTGGKLYLILEYLSGGELFMQLEREG 116
Query: 701 K--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756
E + +S+ALG +LH + + +RD+K NI+L+H+ K+ DFGL
Sbjct: 117 IFMEDTACFYLAEISMALG------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167
Query: 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 815
+ E I V+ GT Y+ PE L +++ D +SLG + ++LTG
Sbjct: 168 CK-------ESIHDGTVTHTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAP 219
Query: 816 P 816
P
Sbjct: 220 P 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-15
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 609 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 655
N+F+ +G+G +GKV K G A+K + + E L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 656 IQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAM 708
+ FL+ L Y + +++ V E+ + G L LS + E +
Sbjct: 62 TRHPFLTALK---------YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 112
Query: 709 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768
+ AL YLH+ V +RDIK N++LD K+ DFGL + EGI
Sbjct: 113 EIVSALE------YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGI 156
Query: 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
GTP YL PE L ++ D + LGVV E++ G P
Sbjct: 157 SDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 51/230 (22%)
Query: 609 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 655
+F+ IG+G Y KV K + A+K +Q EK +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 656 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 707
FL LH C + ++ V E+++ G L + + K E ++
Sbjct: 66 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116
Query: 708 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 117 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 160
Query: 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 161 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 592 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQ 647
+I G + F +GQG +GKV+ K D + A+K ++ +L+
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 648 --GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--E 702
E L ++H +V L Y + ++ L+ +F+ G L +LS + E
Sbjct: 67 VRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125
Query: 703 PLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760
+ L++AL +LH+ + +RD+K NILLD + K+ DFGLS+
Sbjct: 126 EDVKFYLAELALALD------HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-- 174
Query: 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
E I + GT Y+ PE + + +S D +S GV+ E+LTG P
Sbjct: 175 -----ESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 609 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 655
+NF +G+G +GKV K G + AVK EK L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 656 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 707
+ FL++L C + +++ V EF++ G L + + E +A
Sbjct: 80 ARNHPFLTQLF---------CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 708 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767
+ AL +LH + + +RD+K N+LLDH+ K+ADFG+ + EG
Sbjct: 131 AEIISALM------FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-------EG 174
Query: 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
I + GTP Y+ PE L L + D +++GV+ E+L G P
Sbjct: 175 ICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-14
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 609 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 655
+FN +G+G +GKV KG + AVK EK L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 656 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLS--AKSKEPLG--FA 707
FL++LH C + +++ V E+++ G L + + KEP +A
Sbjct: 398 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 448
Query: 708 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 449 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 492
Query: 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 493 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 609 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 655
+FN +G+G +GKV KG + AVK EK L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 656 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 707
FL++LH C + +++ V E+++ G L + + EP +A
Sbjct: 77 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127
Query: 708 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 128 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 171
Query: 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 172 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 41/235 (17%)
Query: 603 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 655
E+ L ++F IG+G + +V K G V A+K + + E F E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 656 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 709
L R + L + ++ + LV E+ G L LS + + +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 710 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769
+ +A+ +H HRDIK NILLD ++ADFG +
Sbjct: 171 IVMAID------SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL-------KLRA 214
Query: 770 PAHVST-VVKGTPGYLDPEYFLTHKLTDKSDVY-------SLGVVFLELLTGMQP 816
V + V GTP YL PE + Y +LGV E+ G P
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 609 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 655
+F+ IG+G Y KV K + A++ +Q EK +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 656 IQ---FLSRLHHRNLVSLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FA 707
FL LH C + E V E+++ G L + + K E ++
Sbjct: 109 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 159
Query: 708 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 160 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 203
Query: 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 204 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 47/213 (22%), Positives = 75/213 (35%), Gaps = 54/213 (25%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 673
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 674 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTE 726
+ + + E + G L ++ + + F A + ++G I YLH+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGE--AIQYLHSI 136
Query: 727 ADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
+ HRD+K N+L K K+ DFG A Y
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE-------------TTGE--KY 175
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816
D D++SLGV+ LL G P
Sbjct: 176 -DKS----------CDMWSLGVIMYILLCGYPP 197
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 58/233 (24%), Positives = 89/233 (38%), Gaps = 39/233 (16%)
Query: 603 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 655
+M L +F IG+G +G+V K V A+K + + E F E
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREE 124
Query: 656 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 709
L + + +L Y ++ + LV ++ G L LS E + +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 710 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769
+ IA+ +H HRDIK NIL+D ++ADFG + +
Sbjct: 184 MVIAID------SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL-------KLME 227
Query: 770 PAHVSTVVK-GTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP 816
V + V GTP Y+ PE + D +SLGV E+L G P
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 51/230 (22%)
Query: 609 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 655
+F +G+G +GKV +K A+K EK L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 656 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 707
FL+ + + E + V E+++ G L + + K +A
Sbjct: 74 AWEHPFLTHMF---------CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 708 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767
+ + L +LH++ + +RD+K NILLD K+ADFG+ + E
Sbjct: 125 AEIILGLQ------FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-------EN 168
Query: 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
++ + GTP Y+ PE L + + S D +S GV+ E+L G P
Sbjct: 169 MLGDAKTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 51/230 (22%)
Query: 609 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 655
++F+ IG+G +GKV K + AVK + +E + E+ L +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 656 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 707
FL LH + + +++ V ++++ G L L + EP +A
Sbjct: 95 NVKHPFLVGLH---------FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 708 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767
++ ALG YLH+ + +RD+K NILLD + + DFGL + E
Sbjct: 146 AEIASALG------YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-------EN 189
Query: 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
I ++ GTP YL PE L + D++ D + LG V E+L G+ P
Sbjct: 190 IEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 609 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 661
+ F+ +G G +G+V K G A+K + + K+ L E + L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 717
++ LV L + +V E+++ G + L + EP +A ++ +
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE-- 155
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
YLH+ + +RD+K N+L+D + +V DFG ++ V T+
Sbjct: 156 ----YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLC 199
Query: 778 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
GTP L PE + K +K+ D ++LGV+ E+ G P
Sbjct: 200 -GTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 7e-13
Identities = 52/322 (16%), Positives = 92/322 (28%), Gaps = 50/322 (15%)
Query: 52 SKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTIL 111
L P + W N L L +
Sbjct: 272 GTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKEC 331
Query: 112 DFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP 171
+ ++ ++ + L L+ + T L EL +L ++ + +
Sbjct: 332 VLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL---- 385
Query: 172 KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 231
T M L L L + L P + L L
Sbjct: 386 -------LTIILLMRA----------LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428
Query: 232 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSN 291
L N + + L L + DL+ + +L LL + T + LS+
Sbjct: 429 FLLEN-------SVLKMEYADVRVLHLAHK-------DLTVLCHLEQLLLV--THLDLSH 472
Query: 292 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 351
N+L +P + L L+ L ++N+L ++ + L L NN L +
Sbjct: 473 NRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQ-----ELLLCNNRLQQSA 524
Query: 352 GSFNIPPN---VTVRLRGNPFC 370
+ V + L+GN C
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 52/300 (17%), Positives = 99/300 (33%), Gaps = 30/300 (10%)
Query: 9 LFLFLCLCWSSSKIVVAADDDSITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWT 68
+ L + + V D P V SL D + + S
Sbjct: 271 MGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKE 330
Query: 69 GVLCFNTTMDDGYLHLRELQLLNLNLSGNLS----PEIGRLSYLTIL--DFMWNKISG-S 121
VL + + QL LS S E+ L L + W ++
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIIL 390
Query: 122 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG------------- 168
+ + + + + L + L P YL L + +N +
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450
Query: 169 ---SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSEL 225
++ L H +++N + +PP L+ L L + +N L ++ L
Sbjct: 451 KDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANL 507
Query: 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN---CSLQGPMPDLSRI-PNLGYLLS 281
P+L L L NN + + + +L+ L+L+ C +G L+ + P++ +L+
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 66/284 (23%)
Query: 560 TISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQ 619
+ A+V L A KN + + T KI +R + ++ IG+
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLR--------MKAEDYEVVKVIGR 79
Query: 620 GGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTEIQ--FLSRLHH 664
G +G+V K V A+K R+ E++ + ++ +L +
Sbjct: 80 GAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 665 -----RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLG--FAMRLSIALGS 716
R L Y +V E+M G L + +S E + + +AL
Sbjct: 137 AFQDDRYL-----Y--------MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD- 182
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 776
+H+ HRD+K N+LLD K+ADFG + EG+V T
Sbjct: 183 -----AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCD--TA 229
Query: 777 VKGTPGYLDPEYFLTHKLT---DKS-DVYSLGVVFLELLTGMQP 816
V GTP Y+ PE + + D +S+GV E+L G P
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 3e-12
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 609 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 661
+F +G G +G+V+ + +G A+K ++ + K+ E LS
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 717
+ H ++ + G + + ++ +++ G L L + P+ +A + +AL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE-- 120
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
YLH++ + +RD+K NILLD K+ DFG ++ VP T+
Sbjct: 121 ----YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTYTLC 164
Query: 778 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 816
GTP Y+ PE ++ K +KS D +S G++ E+L G P
Sbjct: 165 -GTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 18/191 (9%)
Query: 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHMNNNS 189
+ L L N+L+ + L KL + ++ N + +LP F L + +N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 190 ISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFEGTTIPA-S 246
+ +P + +L +L + LD N L LPP + L KL L L N ++P
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL--QSLPKGV 152
Query: 247 YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSL-NITTIKLSNNKLTGTIPSNFSGL 305
+ ++ L +L L N L+ R+P G L + T+KL NN+L F L
Sbjct: 153 FDKLTSLKELRLYNNQLK-------RVPE-GAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 306 PRLQRLFIANN 316
+L+ L + N
Sbjct: 205 EKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 19/176 (10%)
Query: 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNL 214
++ + N +S K+F L K R ++N+N + +P + L +L + + +N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 215 TGYLPPEL-SELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSR 272
LP + +L L L+LD N ++P + +++KL LSL LQ
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQL--KSLPPRVFDSLTKLTYLSLGYNELQ-------S 147
Query: 273 IPNLGYLLSL-NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI 326
+P G L ++ ++L NN+L +P F L L+ L + NN L +P
Sbjct: 148 LPK-GVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 32/138 (23%), Positives = 58/138 (42%), Gaps = 13/138 (9%)
Query: 83 HLRELQLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLL 136
L+ L+ L ++ N L + +L L L N++ S+P + ++ L L
Sbjct: 83 ELKNLE--TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 137 LNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQI 194
L NEL SLP+ + L L +++ N + +P+ F L + + ++NN +
Sbjct: 140 LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 195 PPELSRLPSLVHMLLDNN 212
L L + L N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 24/89 (26%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 283 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 342
+ + L +NKL+ F L +L+ L++ +N L ++P+ I++ L ET L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKE--LKNLET--LWV 92
Query: 343 QNNNLTNI-SGSFNIPPNVTV-RLRGNPF 369
+N L + G F+ N+ RL N
Sbjct: 93 TDNKLQALPIGVFDQLVNLAELRLDRNQL 121
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 63/233 (27%), Positives = 95/233 (40%), Gaps = 50/233 (21%)
Query: 609 NNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQEGSLQGEKEFLT 654
NF +G G YGKV+ K D G + A+K + E++ L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 655 EIQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--F 706
I+ FL LH Y + ++ L+ ++++ G L LS + + E +
Sbjct: 114 HIRQSPFLVTLH---------YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 707 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766
+ +AL +LH + +RDIK NILLD + DFGLS+ E
Sbjct: 165 VGEIVLALE------HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-------E 208
Query: 767 GIVPAHVSTV-VKGTPGYLDPEYFLTHKL-TDKS-DVYSLGVVFLELLTGMQP 816
+ GT Y+ P+ DK+ D +SLGV+ ELLTG P
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 2e-11
Identities = 95/609 (15%), Positives = 178/609 (29%), Gaps = 172/609 (28%)
Query: 7 AVLFLFLCLCWSSSKIVVAADDDS-------ITDPIEVSALRSIKKSLV-DDYSKLSN-- 56
L LF L ++V ++ + PI+ + S++ Y + +
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT---EQRQPSMMTRMYIEQRDRL 119
Query: 57 WNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPE----IGR--LSYLTI 110
+N +N + YL LR+ LL L + N+ + G+ ++
Sbjct: 120 YNDNQVFAK-------YNVSRLQPYLKLRQA-LLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 111 LDFMWNKISGSIPKEI-----GNIKSLELLLLNGNEL--------------TGSLPEELG 151
L + K+ + +I N S E +L +L + ++ +
Sbjct: 172 LSY---KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 152 YL-PKLDRIQIDQNY-----I-----SGSLPKSFAN----LNKTRHFHMNNNSISGQIPP 196
+ +L R+ + Y + + +F L TR ++ +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR-----FKQVTDFLSA 283
Query: 197 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 256
+ SL H + P E+ LL+ LD + +P + L
Sbjct: 284 ATTTHISLDHHSM------TLTPDEVKS---LLLKYLDCRPQD---LPREVLTTNPRR-L 330
Query: 257 SLRNCSLQGPMPDLSRIPNLGYLLSLNI-TTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 315
S+ S++ L+ N ++ + T I+ S N L P+ + RL +
Sbjct: 331 SIIAESIR---DGLATWDNWKHVNCDKLTTIIESSLNVLE---PAEYR--KMFDRLSVFP 382
Query: 316 NSLSGSIPSS----IWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 371
S IP+ IW + + +L P T+ + L
Sbjct: 383 PSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-----PKESTISIPSIYLEL 435
Query: 372 NTNAEQFCGSHSDDDNEIDR-STNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRL 430
E H + +D + T D P +Y +G+ L
Sbjct: 436 KVKLENEYALH---RSIVDHYNIPKTFDSDDLIPPYLDQY-----FYSH------IGHHL 481
Query: 431 KSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRW-------------EKGP------ 471
K+ LF ++ LD FR+ G
Sbjct: 482 KNIEHP---ERMTLFRM---------VF-LD---FRFLEQKIRHDSTAWNASGSILNTLQ 525
Query: 472 RLKMYLKLF----PVYDNSSGN--SYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFT 525
+LK Y P Y+ ++ E I S +D+ +
Sbjct: 526 QLKFYKPYICDNDPKYERLVNAILDFLPKIEEN-LICS-------KYTDL------LRIA 571
Query: 526 LQGPYRDVF 534
L +F
Sbjct: 572 LMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 3e-11
Identities = 77/447 (17%), Positives = 137/447 (30%), Gaps = 113/447 (25%)
Query: 77 MDDGYLHLRELQLLNLN-LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKS---- 131
MD E Q + LS + + D + +S I K
Sbjct: 7 MD---FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 132 ----LELLLLNGNE-----LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182
LL E + L +L + I+ +Q S ++
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFL--MSPIKTEQRQPSMMTRMYIEQRDRL-- 119
Query: 183 FHMNNNSISGQIPP-ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF--- 238
N+N + +SR +L + L L+L
Sbjct: 120 --YNDNQV---FAKYNVSR------------------LQPYLKLRQAL-LELRPAKNVLI 155
Query: 239 EG------TTIPASYSNMSKLLK--------LSLRNCSLQGPMPDLSRIPNLGYLLSLNI 284
+G T + K+ L+L+NC P L + L Y + N
Sbjct: 156 DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC--NSPETVLEMLQKLLYQIDPNW 213
Query: 285 TTIKLSNNKLTGTIPSNFSGL-PRLQRLFIA---NNSLSGSIPSSIWQSRTLNATETFIL 340
T S + + I + L+RL + N L + ++ ++ NA F
Sbjct: 214 T----SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQNAKAWNA---F-- 262
Query: 341 DFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE-QFCGSHSDDDNEIDRSTN---ST 396
+ L +T R + L+ H D +
Sbjct: 263 NLSCKIL------------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 397 LDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLN 456
LDCR Q P E T+P R ++ ++ GL+ + +K++ + +T+ ++ +
Sbjct: 311 LDCRPQDLPR--EVLTTNPRRL-----SIIAESIR-DGLATWDNWKHVNCDKLTTIIESS 362
Query: 457 LYQLDIDSFRWEKGPRLKMYLKL--FP 481
L L+ +R KM+ +L FP
Sbjct: 363 LNVLEPAEYR-------KMFDRLSVFP 382
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 3e-09
Identities = 57/350 (16%), Positives = 104/350 (29%), Gaps = 97/350 (27%)
Query: 618 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 677
G G GK T VA+ +Q + +F +I +L+ + C+
Sbjct: 157 GVLGSGK---------TWVALDVCLSYKVQCKMDF--KIFWLN----------LKNCNSP 195
Query: 678 GE-----QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
Q L+Y+ N T R S+ K +R+ R +L
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLL----------K 239
Query: 733 HRDIKASNILLDHKFTAKVAD-FGL-------SRLAPVPD-IEGIVPAHVSTVVKGTPGY 783
+ + ++L + AK + F L +R V D + H+S + +
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS-LDHHSMTL 298
Query: 784 LDPEYFLTHKLTDKSDVYSLGVV--FLELLTGMQPISHGKNIVREVN------IAYQSSM 835
E ++ +L+ P V N IA
Sbjct: 299 TPDE--------------VKSLLLKYLDCRPQDLPRE-----VLTTNPRRLSIIAESIRD 339
Query: 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE--VMRE--------LESIWN 885
+ D N + + I+ +L + + R V L IW
Sbjct: 340 GLATWD-NWKHVNCDKLTTIIESSLNV-LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397
Query: 886 MMPESDTKTPEFINSEHTSK---EETPPSSSSMLKHPYVSSDVSGSNLVS 932
+ +SD + ++ E+ P S+ + Y+ V N +
Sbjct: 398 DVIKSD---VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 42/194 (21%), Positives = 73/194 (37%), Gaps = 26/194 (13%)
Query: 175 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234
L ++ S++ + L + + DN+N+ L + L L L
Sbjct: 16 PGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLS 71
Query: 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKL 294
+N + + +++KL +LS+ R+ NL + S ++ + L NN+L
Sbjct: 72 HNQI--SDLSP-LKDLTKLEELSVNRN----------RLKNLNGIPSACLSRLFLDNNEL 118
Query: 295 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 354
T + L L+ L I NN L SI + L +LD N +TN G
Sbjct: 119 RDT--DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLE-----VLDLHGNEITNTGGLT 169
Query: 355 NIPPNVTVRLRGNP 368
+ + L G
Sbjct: 170 RLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 47/274 (17%), Positives = 85/274 (31%), Gaps = 32/274 (11%)
Query: 89 LLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE 148
+ + P L+ + ++ + + ++ + + + SL
Sbjct: 3 IQRPTPINQVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-A 57
Query: 149 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 208
+ + L + + N IS L +L K +N N + + L +
Sbjct: 58 GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLF 112
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
LDNN L L L L IL + NN +I +SKL L L +
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKL--KSIV-MLGFLSKLEVLDLHGNEIT---- 163
Query: 269 DLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN--SLSGSIPSSI 326
+ + L + I L+ K + L+I N G S
Sbjct: 164 NTGGLTRLK-----KVNWIDLTGQKCV------NEPVKYQPELYITNTVKDPDGRWISPY 212
Query: 327 WQSRTLNATETFILDFQNNNLTNISGSFNIPPNV 360
+ S + + +L +S F+ NV
Sbjct: 213 YISNGGSYVDGCVLWELPVYTDEVSYKFSEYINV 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 41/231 (17%), Positives = 71/231 (30%), Gaps = 31/231 (13%)
Query: 88 QLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
+ N N + L+ + + L L N+IS + + ++ LE L +N N L
Sbjct: 42 GVQNFNGDNSNIQSLAG-MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK 98
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203
L R+ +D N + S +L + NN + I L L
Sbjct: 99 NLNGIP---SACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSK 151
Query: 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263
L + L N +T L+ L K+ + L L ++
Sbjct: 152 LEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK-----CVNEPVKYQPELYITNTVKDP 204
Query: 264 QGPMPDLSRIPNLGYLLSLNIT--------TIKLSNNKLT--GTIPSNFSG 304
G I N G + + + ++ G + F G
Sbjct: 205 DGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 34/146 (23%), Positives = 51/146 (34%), Gaps = 16/146 (10%)
Query: 84 LRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNG 139
+ L L L N + L L IL NK+ SI +G + LE+L L+G
Sbjct: 103 IPSACLSRLFLDNNELRDTDS-LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHG 159
Query: 140 NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199
NE+T + L L K++ I + K L T + P +S
Sbjct: 160 NEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYIS 215
Query: 200 RLPSLVHMLLDNNNLTGYLPPELSEL 225
S + + LP E+
Sbjct: 216 NGGS-----YVDGCVLWELPVYTDEV 236
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 32/134 (23%), Positives = 53/134 (39%), Gaps = 6/134 (4%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
T + N I P K L + L+ N+++ L + L L+ + + N I+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSEL 225
LPKS F L + +N N I+ + + L +L + L +N L S L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 226 PKLLILQLDNNNFE 239
+ + L N F
Sbjct: 152 RAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 19/156 (12%)
Query: 72 CFNTTMDDGYLHLREL------QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISG 120
C N +D L E+ + + L N + P L +D N+IS
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS- 69
Query: 121 SIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPK-SFANL 177
+ + ++SL L+L GN++T LP+ L L L + ++ N I+ L +F +L
Sbjct: 70 ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127
Query: 178 NKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNN 212
+ + +N + I S L ++ M L N
Sbjct: 128 HNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 35/141 (24%), Positives = 52/141 (36%), Gaps = 16/141 (11%)
Query: 180 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 237
+ N+I IPP S L + L NN ++ L P+ L L L L N
Sbjct: 34 ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 238 FEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSL-NITTIKLSNNKLT 295
T +P S + + L L L + + L N+ + L +NKL
Sbjct: 92 I--TELPKSLFEGLFSLQLLLLNANKIN-------CLRV-DAFQDLHNLNLLSLYDNKLQ 141
Query: 296 GTIPSNFSGLPRLQRLFIANN 316
FS L +Q + +A N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 36/180 (20%), Positives = 61/180 (33%), Gaps = 49/180 (27%)
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPA-SYSNMS 251
+P ++ + L+ N + +PP S KL + L NN + + ++ +
Sbjct: 30 LPETITEI------RLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQI--SELAPDAFQGLR 80
Query: 252 KLLKLSLRNCSLQG-PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQ 309
L L L + P + +L L L+ NK+ + + F L L
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLL--------LLNANKIN-CLRVDAFQDLHNLN 131
Query: 310 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 369
L + +N L +I TF + L I T+ L NPF
Sbjct: 132 LLSLYDNKLQ-TIAK-----------GTF------SPLRAIQ---------TMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 17/98 (17%)
Query: 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 318
+C +G L+ IP L IT I+L N + IP FS +L+R+ ++NN +
Sbjct: 17 DCRGKG----LTEIPTN---LPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI 68
Query: 319 SGSIPSSI-WQSRTLNATETFILDFQNNNLTNI-SGSF 354
S + R+LN L N +T + F
Sbjct: 69 S-ELAPDAFQGLRSLN-----SLVLYGNKITELPKSLF 100
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 49/264 (18%), Positives = 94/264 (35%), Gaps = 49/264 (18%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---------- 663
+G G + V+ + + T VA+K R + + EI+ L R++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 664 -HRNLVSLVG---YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGS 716
+++ L+ + G + +V+E + L + K E G + I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI--KKYEHRGIPLIYVKQISKQL 140
Query: 717 SRGILYLHTEADPPVFHRDIKASNILLDH------KFTAKVADFGLSRLAPVPDIEGIVP 770
G+ Y+H + H DIK N+L++ K+AD G +
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---------YD 189
Query: 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830
H + ++ T Y PE L +D++S + EL+TG +
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDD 247
Query: 831 YQSSMMFSVIDGNMGSYPSECVEK 854
+ + ++ G PS +
Sbjct: 248 DHIAQIIELL----GELPSYLLRN 267
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-10
Identities = 38/217 (17%), Positives = 61/217 (28%), Gaps = 56/217 (25%)
Query: 594 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVK--------RAQEGS 645
G F++ L T +IG+G +G+V++ I D T VA+K
Sbjct: 8 KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 646 LQGEKEFLTEIQFLSRLH---------HRNLVSLVGYCDEEGE----------------- 679
+ +E L EI L + L +G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 680 -------------QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+V EF G L + A SI + +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763
HRD+ N+LL K+ + + +P
Sbjct: 181 --LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 21/164 (12%)
Query: 62 PCTSNWTGVLCFN---TTMDDG------YLHLRELQLLNLNLSGNLSPEIGRLSYLTILD 112
C T V C N + + L L + L +G +L L ++
Sbjct: 8 KCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFK----KLPQLRKIN 63
Query: 113 FMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSL 170
F NKI+ I + + +LL N L ++ ++ L L + + N I+ +
Sbjct: 64 FSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CV 120
Query: 171 PK-SFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNN 212
SF L+ R + +N I+ + P L SL + L N
Sbjct: 121 GNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 36/181 (19%), Positives = 69/181 (38%), Gaps = 50/181 (27%)
Query: 194 IPPELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNNFEGTTIPA-SYSNM 250
IP + L L+NN T L +LP+L + NN T I ++
Sbjct: 30 IPQYTAEL------RLNNNEFTV-LEATGIFKKLPQLRKINFSNNKI--TDIEEGAFEGA 80
Query: 251 SKLLKLSLRNCSLQG-PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN-FSGLPRL 308
S + ++ L + L+ + +L T+ L +N++T + ++ F GL +
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESL--------KTLMLRSNRIT-CVGNDSFIGLSSV 131
Query: 309 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 368
+ L + +N ++ ++ F + L ++S T+ L NP
Sbjct: 132 RLLSLYDNQIT-TVAP-----------GAF------DTLHSLS---------TLNLLANP 164
Query: 369 F 369
F
Sbjct: 165 F 165
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 47/186 (25%), Positives = 74/186 (39%), Gaps = 27/186 (14%)
Query: 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-Y 247
S+ IP + +L L + L L KL L LD N T+ A +
Sbjct: 28 SVPSGIPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQL--QTLSAGVF 79
Query: 248 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSL-NITTIKLSNNKLTGTIPSN-FSGL 305
++++L L L N L +P G L + + L N+L ++PS F L
Sbjct: 80 DDLTELGTLGLANNQLA-------SLPL-GVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL 130
Query: 306 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVT-VR 363
+L+ L + N L SIP+ + T L N L ++ G+F+ + +
Sbjct: 131 TKLKELRLNTNQLQ-SIPAGAFDK----LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
Query: 364 LRGNPF 369
L GN F
Sbjct: 186 LFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 9/154 (5%)
Query: 90 LNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLP 147
L LS L+ LT L+ +N++ ++ + ++ L L L N+L SLP
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLP 99
Query: 148 EEL-GYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSL 204
+ +L +LD++ + N + SLP F L K + +N N + IP +L +L
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 205 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+ L N L L KL + L N F
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 36/163 (22%), Positives = 66/163 (40%), Gaps = 15/163 (9%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
LD ++ + L L L+ N+L +L + L +L + + N ++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SE 224
SLP F +L + ++ N + +P + RL L + L+ N L +P +
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDK 153
Query: 225 LPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRN----CS 262
L L L L N ++P ++ + KL ++L CS
Sbjct: 154 LTNLQTLSLSTNQL--QSVPHGAFDRLGKLQTITLFGNQFDCS 194
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 17/148 (11%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 238
T + + ++ L L + LD N L L + +L +L L L NN
Sbjct: 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL 95
Query: 239 EGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSL-NITTIKLSNNKLTG 296
++P + ++++L KL L L+ +P+ G L + ++L+ N+L
Sbjct: 96 --ASLPLGVFDHLTQLDKLYLGGNQLK-------SLPS-GVFDRLTKLKELRLNTNQLQ- 144
Query: 297 TIPSN-FSGLPRLQRLFIANNSLSGSIP 323
+IP+ F L LQ L ++ N L S+P
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQ-SVP 171
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 11/133 (8%)
Query: 88 QLLNLNLSGN----LSPEI-GRLSYLTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNE 141
+L LNL N LS + L+ L L N+++ S+P + ++ L+ L L GN+
Sbjct: 60 KLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQ 118
Query: 142 LTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMNNNSISGQIPPELS 199
L SLP + L KL ++++ N + S+P F L + ++ N +
Sbjct: 119 LK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD 176
Query: 200 RLPSLVHMLLDNN 212
RL L + L N
Sbjct: 177 RLGKLQTITLFGN 189
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 49/233 (21%), Positives = 89/233 (38%), Gaps = 46/233 (19%)
Query: 616 QIGQGGYGKVYKGI---------LPDGTVVAVKR-AQEGSLQGEKEFLT------EIQFL 659
+ G +Y+ P ++K A++G L E+ F ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 660 SRLHHRNLV---SLVGYCDEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 715
+L+ L+ + +G+ + + + LV + +L+ L K L L +A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLS-RLAP----VPDIEGI 768
+ +LH H ++ A NI +D + ++V A +G + R P V +EG
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 769 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 816
H G + +D HK + +SD+ SLG L+ L G P
Sbjct: 225 RSPHE-----GDLEFISMD-----LHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------N 666
IG+G +G+V K + VA+K + ++ Q E++ L ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+V L + LV+E +S L D L + + + A +L+L T
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 727 ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ + H D+K NILL + + K+ DFG S + + ++ + Y
Sbjct: 177 -ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---------QLGQRIYQYIQ-SRFYR 225
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822
PE L D++SLG + +E+ TG +P+ G N
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 262
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 34/160 (21%), Positives = 58/160 (36%), Gaps = 21/160 (13%)
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
E+G LEL +++ +EL LD + ++ + G +
Sbjct: 2 EMGRRIHLELRNRTPSDV-----KEL----VLDNSRSNEGKLEGLT----DEFEELEFLS 48
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
N ++ I L +L L + L +N ++G L + P L L L N + +
Sbjct: 49 TINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI 106
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYL 279
+ L L L NC + + D +P L YL
Sbjct: 107 EPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 11/142 (7%)
Query: 98 LSPEIGRLSYLTILDFMWNKISGSIPKEIGNI---KSLELLLLNGNELTGSLPEELGYLP 154
+ E+ + + + + + + K G + LE L LT S+ L L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNN 212
KL ++++ N +SG L H +++ N I I P L +L +L + L N
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123
Query: 213 ---NLTGYLPPELSELPKLLIL 231
NL Y LP+L L
Sbjct: 124 EVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 9/89 (10%)
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLS 290
L LDN+ + +L LS N L+ I NL L L ++LS
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINV-------GLTSIANLPKLNKL--KKLELS 72
Query: 291 NNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
+N+++G + P L L ++ N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 21/129 (16%), Positives = 47/129 (36%), Gaps = 16/129 (12%)
Query: 249 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRL 308
S + +L L N + ++ L + + N LT +I +N L +L
Sbjct: 15 TPSDVKELVLDNSRS-----NEGKLEGLTDEFE-ELEFLSTINVGLT-SI-ANLPKLNKL 66
Query: 309 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPN---VTVRLR 365
++L +++N +SG + + L L+ N + ++S + ++ L
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLT-----HLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121
Query: 366 GNPFCLNTN 374
+
Sbjct: 122 NCEVTNLND 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 41/166 (24%), Positives = 59/166 (35%), Gaps = 21/166 (12%)
Query: 119 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 178
SGS ++ LEL + EL LD + + I G L F NL
Sbjct: 3 SGSSGMDMKRRIHLELRNRTPAAVR-----EL----VLDNCKSNDGKIEG-LTAEFVNL- 51
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+ N + + L +LP L + L N + G L +LP L L L N
Sbjct: 52 --EFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYL 279
+ + + L L L NC + + D +P L YL
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 25/96 (26%), Positives = 35/96 (36%), Gaps = 9/96 (9%)
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN 283
+ L LDN I + L LSL N L + NL L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV-------GLISVSNLPKLPKL- 73
Query: 284 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
++LS N++ G + LP L L ++ N L
Sbjct: 74 -KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 28/150 (18%), Positives = 55/150 (36%), Gaps = 28/150 (18%)
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN 283
++ + + L+L N + + +L L NC + +I L N
Sbjct: 9 DMKRRIHLELRNRTP------------AAVRELVLDNCKS-----NDGKIEGLTAEFV-N 50
Query: 284 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 343
+ + L N L ++ SN LP+L++L ++ N + G + + L L+
Sbjct: 51 LEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT-----HLNLS 103
Query: 344 NNNLTNISGSFNIPPN---VTVRLRGNPFC 370
N L +IS + ++ L
Sbjct: 104 GNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 27/182 (14%), Positives = 46/182 (25%), Gaps = 31/182 (17%)
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN--LGYLLSLNITTIKLSNNKLTGTI 298
L +L + N L + L L L + + + L +
Sbjct: 21 LDSLHHLPGAENLTELYIEN------QQHLQHLELRDLRGLGEL--RNLTIVKSGLR-FV 71
Query: 299 PSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT--------- 348
+ F PRL RL ++ N+L S+ Q +L L N L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ-----ELVLSGNPLHCSCALRWLQ 125
Query: 349 ----NISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSC 404
G N + + +D + L C+ +
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGR 185
Query: 405 PT 406
Sbjct: 186 GL 187
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 17/96 (17%), Positives = 39/96 (40%), Gaps = 2/96 (2%)
Query: 121 SIPKEIGNIKSL-ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179
+ ++L EL + N L +L L +L + I ++ + P +F +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+++ N++ + + + SL ++L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 17/113 (15%), Positives = 40/113 (35%), Gaps = 14/113 (12%)
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTI 243
+ ++ L +L + ++N +L L L +L L + + +
Sbjct: 16 TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL--RFV 71
Query: 244 PA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT 295
++ +L +L+L +L+ + L++ + LS N L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKT--------VQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 3e-06
Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 11/113 (9%)
Query: 61 DPCTSNW-TGVLCFNTTMDD------GYLHLRELQLLNLNLSGNLSPE-IGRLSYLTILD 112
D C + +G+ C D G +L EL + N +L + L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 113 FMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + + + + L L L+ N L SL + L + + N
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 48/301 (15%), Positives = 92/301 (30%), Gaps = 65/301 (21%)
Query: 83 HLRELQLLNLNLS----GNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI-----KSLE 133
+ ++L + L+ ++S + L L+ N++ + ++
Sbjct: 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 88
Query: 134 LLLLNGNELT----GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 189
L L LT G L L LP L + + N + + +
Sbjct: 89 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ------- 141
Query: 190 ISGQIPPELSRLPSLVHMLLDNNNLT----GYLPPELSELPKLLILQLDNNNFEGTTI-- 243
RL L L+ +L+ L L P L + NN+ +
Sbjct: 142 ---------CRLEKLQ---LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRV 189
Query: 244 --PASYSNMSKLLKLSLRNCSL--QGPMPDLSRIPNLGYLLSLN--ITTIKLSNNKLTGT 297
+ +L L L +C + +L +++ + + L +NKL
Sbjct: 190 LCQGLKDSPCQLEALKLESCGVTSDN-------CRDLCGIVASKASLRELALGSNKLGDV 242
Query: 298 -----IPSNFSGLPRLQRLFIANNSLS----GSIPSSIWQSRTLNATETFILDFQNNNLT 348
P RL+ L+I ++ G + + +L E L N L
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL--KE---LSLAGNELG 297
Query: 349 N 349
+
Sbjct: 298 D 298
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-05
Identities = 49/301 (16%), Positives = 93/301 (30%), Gaps = 72/301 (23%)
Query: 89 LLNLNLSGN---------LSPEIGRLSYLTILDFMWNKISGSIPKEIG-----NIKSLEL 134
L L L L+ + L N I+ + + + + LE
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 135 LLLNGNELT----GSLPEELGYLPKLDRIQIDQNYISGS----LPKSFANLNKT-RHFHM 185
L L +T L + L + + N + L + + R +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263
Query: 186 NNNSISGQ----IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
I+ + + L SL + L N L E +LL L
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELG-------DEGARLLCETLLEPG---- 312
Query: 242 TIPASYSNMSKLLKLSLRNCSL--QGPMPDLSRIPNLGYLLSLN--ITTIKLSNNKLTGT 297
+L L +++CS + +L+ N + +++SNN+L
Sbjct: 313 ---------CQLESLWVKSCSFTAAC-------CSHFSSVLAQNRFLLELQISNNRLEDA 356
Query: 298 IPSNFS-----GLPRLQRLFIANNSLS----GSIPSSIWQSRTLNATETFILDFQNNNLT 348
L+ L++A+ +S S+ +++ + +L LD NN L
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR-----ELDLSNNCLG 411
Query: 349 N 349
+
Sbjct: 412 D 412
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 54/309 (17%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSL-QGEKEFLTEIQFLSRLHHR------N 666
IG+G +G+V K VA+K R ++ Q EI+ L L + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLH 724
++ ++ + +E +S L + + K + GF++ L A + + LH
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELI--KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 725 TEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 782
+ H D+K NILL + KV DFG S V T ++ +
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---------YEHQRVYTYIQ-SRF 264
Query: 783 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
Y PE L + D++SLG + ELLTG P+ G++ E + Q + M ++
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGED---EGD---QLACMIELL-- 315
Query: 843 NMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVM---RELESIWNMMPESDTK 893
G + ++ F+ S V+ R PES
Sbjct: 316 --GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREW 373
Query: 894 TPEFINSEH 902
+
Sbjct: 374 GNALKGCDD 382
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 31/137 (22%), Positives = 52/137 (37%), Gaps = 21/137 (15%)
Query: 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLT---GYLPPELSELPKLLILQLDNNNFEG 240
H I + LS L + H+ L NN+ LS + L IL L N
Sbjct: 31 HGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLI-- 82
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTG-TIP 299
I + L +L + ++ + + L++L + +SNNK+T
Sbjct: 83 KKIENLDAVADTLEELWISYNQ-------IASLSGIEKLVNL--RVLYMSNNKITNWGEI 133
Query: 300 SNFSGLPRLQRLFIANN 316
+ L +L+ L +A N
Sbjct: 134 DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 26/127 (20%), Positives = 53/127 (41%), Gaps = 7/127 (5%)
Query: 111 LDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL 170
L M I + + +K+ + L L+ N + + L + L + + +N I +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 171 PKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLL 229
A + ++ N I+ + + +L +L + + NN +T + + L+ L KL
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 230 ILQLDNN 236
L L N
Sbjct: 144 DLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 36/166 (21%), Positives = 59/166 (35%), Gaps = 22/166 (13%)
Query: 82 LHLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137
+ E + + L+ + + L L N I I + +++L +L L
Sbjct: 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSL 77
Query: 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIP 195
N + + L+ + I N I+ SL L R +M+NN I+ G+I
Sbjct: 78 GRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 196 PELSRLPSLVHMLLDNNNLTGYLPPE----------LSELPKLLIL 231
L+ L L +LL N L + LP L L
Sbjct: 135 K-LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 28/160 (17%), Positives = 58/160 (36%), Gaps = 20/160 (12%)
Query: 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLL 280
+ + ++L + A+ S + L+L ++ +I +L +
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTN-------NIEKISSLSGME 70
Query: 281 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 340
+L + L N + I + + L+ L+I+ N ++ S+ S I + L +L
Sbjct: 71 NL--RILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLR-----VL 120
Query: 341 DFQNNNLTNISGSFNIPPN---VTVRLRGNPFCLNTNAEQ 377
NN +TN + + L GNP +
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENN 160
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 50/271 (18%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQ---FLSRLHH 664
IGQGG+G +Y + V + G L E +F + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 665 RNLVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMR--L 710
+ +G + Y FM + + + + F+ + L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR------FSRKTVL 155
Query: 711 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGI 768
++L + Y+H H DIKASN+LL++K +V D+GL+ +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 769 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGM---QPISHG 820
A GT + +D H + + D+ LG ++ LTG +
Sbjct: 213 YAADPKRCHDGTIEFTSID-----AHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
Query: 821 KNIVREVNIAYQ-SSMMFSVIDGNMGSYPSE 850
VR+ I Y+ + + P E
Sbjct: 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGE 298
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IG G +G +Y G + G VA+K E + E + + + + +C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 675 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 729
EG+ ++V E + S L + S K F+++ L +A I Y+H++
Sbjct: 74 GAEGDYNVMVMELLGPSLEDLFNFCSRK------FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 730 PVFHRDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
HRD+K N L+ + DFGL++ +P + + GT Y
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 787 EYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 816
TH ++S D+ SLG V + G P
Sbjct: 185 N---THLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IG G +G++Y G + VA+K E + L E + L + V +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 675 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 729
EG+ +LV + + S L + S K +++ L +A + ++H+++
Sbjct: 72 GVEGDYNVLVMDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 730 PVFHRDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
HRDIK N L+ A + DFGL++ +P + + GT Y
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS- 181
Query: 787 EYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 816
TH ++S D+ SLG V + L G P
Sbjct: 182 --VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 58/335 (17%), Positives = 109/335 (32%), Gaps = 52/335 (15%)
Query: 617 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 665
+G+G +GKV + + + VA+K R EI L ++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENKF 82
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYL 723
V + + + G + +E + + L K + + +A + +L
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGK-NTFEFL--KENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHV 773
H + + H D+K NIL + + + S I H
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 774 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 833
+T+V T Y PE L DV+S+G + E G +
Sbjct: 197 TTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLFQTHE---NRE---HL 248
Query: 834 SMMFSVIDGNMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVMRELESIWNMM 887
MM ++ G PS + + F K L ++ +D R + E + L+S
Sbjct: 249 VMMEKIL----GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR-YVKENCKPLKSYMLQD 303
Query: 888 PESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922
+ + + + + L HP+ +
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 675 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 729
+EG +LV + + S L D K F+++ A + +H ++
Sbjct: 75 GQEGLHNVLVIDLLGPSLEDLLDLCGRK------FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 730 PVFHRDIKASNILLDHKFTAK-----VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ +RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 785 DPEYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 816
TH ++S D+ +LG VF+ L G P
Sbjct: 186 SIN---THLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 53/229 (23%), Positives = 80/229 (34%), Gaps = 41/229 (17%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVA-----VKRAQEGSLQGEKEFLTEIQ---FLSRLHHRN 666
+IG GG+G +Y A V+ + G L E +F + + + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 667 LVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMRLSIAL 714
+ +G + Y FM L+ ++L I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID---LQKISGQNGTFKKSTVLQLGIRM 160
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGIVPAH 772
+ Y+H H DIKA+N+LL +K +V AD+GLS +
Sbjct: 161 LDV--LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 773 VSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 816
GT + LD HK L+ +SDV LG L L G P
Sbjct: 216 PRKGHNGTIEFTSLD-----AHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 6e-06
Identities = 28/199 (14%), Positives = 62/199 (31%), Gaps = 31/199 (15%)
Query: 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL--SRL 201
L L +P L+ ++I K NL + + + + + ++ S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSDL 218
Query: 202 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261
P+L ++L +++ L S L L + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLF----------------SKDRFPNLKWLGIVDA 262
Query: 262 SLQGPMP-DLSRIPNLGYLLSLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANN 316
Q + L L +++ +S LT + + + L+ + + N
Sbjct: 263 EEQNVVVEMFLESDILPQLETMD-----ISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317
Query: 317 SLSGSIPSSIWQSRTLNAT 335
LS + + +S +
Sbjct: 318 YLSDEMKKELQKSLPMKID 336
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 54/305 (17%), Positives = 96/305 (31%), Gaps = 91/305 (29%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL-----HHRNLV 668
+G G + V+ + VA+K ++ E + + EI+ L + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 669 SLVGYCDE------EGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 721
+V D+ G + +V+E + + L + + + L I +G+
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 722 YLHTEADPPVFHRDIKASNILL-------------------------------------- 743
YLHT+ + H DIK NILL
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 744 -----------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
K K+AD G + E I Y E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----------YRSLEVLIGS 268
Query: 793 KLTDKSDVYSLGVVFLELLTG---MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
+D++S + EL TG +P S + E +IA ++ + +G P
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA----LIIEL----LGKVPR 320
Query: 850 ECVEK 854
+ +
Sbjct: 321 KLIVA 325
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 20/139 (14%), Positives = 44/139 (31%), Gaps = 13/139 (9%)
Query: 148 EELGYLPKLDRIQIDQNYIS--GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 205
+ + + + I +L + ++N I ++ L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQF---DAIDFSDNEIR-KLDG-FPLLRRLK 67
Query: 206 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
+L++NN + LP L L L NN+ +++ L L + +
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 127
Query: 266 PMPD-----LSRIPNLGYL 279
+ ++P + L
Sbjct: 128 -KKHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 17/113 (15%), Positives = 37/113 (32%), Gaps = 13/113 (11%)
Query: 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266
+ L + + + + L L I + + + + +
Sbjct: 2 VKLTAELIE--QAAQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDN----- 52
Query: 267 MPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319
++ ++ L L T+ ++NN++ LP L L + NNSL
Sbjct: 53 --EIRKLDGFPLLRRL--KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 30/163 (18%), Positives = 57/163 (34%), Gaps = 40/163 (24%)
Query: 79 DGYLHLRELQLLNLNLSGNLSPEI----GRLSYLTILDFMWNKISGSIPKEIGNI---KS 131
Y + + L+L G P I L +DF N+I +++ +
Sbjct: 13 AQYTNAVRDR--ELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRR 65
Query: 132 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191
L+ LL+N N + LP L + + N + +L+
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDP------------ 108
Query: 192 GQIPPELSRLPSLVHMLLDNN---NLTGYLPPELSELPKLLIL 231
L+ L SL ++ + N N Y + ++P++ +L
Sbjct: 109 ------LASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 63/333 (18%), Positives = 111/333 (33%), Gaps = 48/333 (14%)
Query: 617 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 665
+G+G +GKV + I G VAVK + + +EIQ L L+
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNSTF 77
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
V ++ + + G +V+E + + D + P +A + + +LH
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH- 135
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHVST 775
+ H D+K NIL + + + R I H ST
Sbjct: 136 --SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835
+V T Y PE L + DV+S+G + +E G + + +M
Sbjct: 194 LVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG-FTVFPTHD---SKE---HLAM 245
Query: 836 MFSVIDGNMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889
M ++ G P ++K F L + + R +S + L+
Sbjct: 246 MERIL----GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR-YVSRACKPLKEFMLSQDV 300
Query: 890 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922
+ + I + LKHP+
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 22/161 (13%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 667
NF +IG G +G++ G L VA+K E + E +F +L +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 668 VSLVGYCDEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILY 722
+ V Y G+ +V E + S L D F+++ L IA+ + Y
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT------FSLKTVLMIAIQLISRMEY 120
Query: 723 LHTEADPPVFHRDIKASNILLDHKFTAK-----VADFGLSR 758
+H++ + +RD+K N L+ + DF L++
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 34/130 (26%), Positives = 55/130 (42%), Gaps = 5/130 (3%)
Query: 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYIS 167
IL N+I+ P ++ +L+ L L N+L +LP + L +L + + N ++
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 168 GSLPKS-FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP 226
LP + F L + M N ++ +P + RL L H+ LD N L L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 227 KLLILQLDNN 236
L L N
Sbjct: 160 SLTHAYLFGN 169
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 10/104 (9%)
Query: 270 LSRIPNLGYLLSL-NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIW 327
L RI + G L ++ ++L N+LT I N F G +Q L + N + I + ++
Sbjct: 41 LGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMF 98
Query: 328 QSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 369
L+ +N ++ + GSF ++T + L NPF
Sbjct: 99 LGLH-QLKT---LNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 33/140 (23%), Positives = 57/140 (40%), Gaps = 25/140 (17%)
Query: 63 CTSNWTGVLCFN-----------TTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTIL 111
CT T V C N + + YL + L+ E+ +LT++
Sbjct: 8 CTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTLV--------PKELSNYKHLTLI 59
Query: 112 DFMWNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGS 169
D N+IS ++ + N+ L L+L+ N L +P L L + + N IS
Sbjct: 60 DLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-V 116
Query: 170 LPK-SFANLNKTRHFHMNNN 188
+P+ +F +L+ H + N
Sbjct: 117 VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK-SFANLNK 179
+PK I + + L L+GN+ T +P+EL L I + N IS +L SF+N+ +
Sbjct: 24 VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 180 TRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNL 214
++ N + IPP L SL + L N++
Sbjct: 80 LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 51/303 (16%), Positives = 97/303 (32%), Gaps = 48/303 (15%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRL-----HHRNL 667
+G G +G+V + + AVK R + + E L ++ ++ N+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNNI 98
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
V G L++E + +L + ++ + + + + YL
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--- 154
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA---------------- 771
+ H D+K NILLD + K +
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831
+ +++ T Y PE L SD++S G V EL TG + +
Sbjct: 215 YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLLFRTHE---HME--- 266
Query: 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI---WNMMP 888
+MM S+I P + + K ++ + + + E + SI +P
Sbjct: 267 HLAMMESII----QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 889 ESD 891
Sbjct: 323 LYK 325
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 37/218 (16%), Positives = 69/218 (31%), Gaps = 45/218 (20%)
Query: 88 QLLNLNLSGN---------LSPEIGRLSYLTILDFMWNKIS-------------GSIPKE 125
+L + LS N L + + + L L N + ++ K+
Sbjct: 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 154
Query: 126 IGNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYI-----SGSLPKSFAN 176
N L ++ N L + L +++ QN I L + A
Sbjct: 155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214
Query: 177 LNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLTG----YLPPELSEL--P 226
+ + + +N+ + + L P+L + L++ L+ + S+L
Sbjct: 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274
Query: 227 KLLILQLDNNNFEGTTIP----ASYSNMSKLLKLSLRN 260
L L+L N E + M LL L L
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 312
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 941 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.98 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.98 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.98 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.98 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.98 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.96 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.93 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.92 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.59 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.59 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.56 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.48 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.74 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.68 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.63 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.36 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.29 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.17 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.6 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.45 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.37 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.07 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.84 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.81 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.74 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.43 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.41 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.15 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 95.34 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 95.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.19 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 93.89 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.44 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 93.43 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 93.02 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 92.58 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 92.47 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 91.78 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 91.3 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 90.89 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 90.81 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 90.4 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 90.21 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 89.63 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 89.36 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 89.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.85 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 88.81 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 88.42 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 88.29 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.21 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 87.53 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.15 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 86.46 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 83.77 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=454.27 Aligned_cols=262 Identities=30% Similarity=0.488 Sum_probs=222.5
Q ss_pred cCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999863 478899999987766667889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-----------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 002289 683 VYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 751 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 751 (941)
|||||++|+|.++++... ...+++..++.|+.||++||+|||+++ ||||||||+|||+++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 356999999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~ 830 (941)
+|||+|+.....+. ........||+.|||||++.+..|+.++|||||||++|||+| |+.||...... +.
T Consensus 170 ~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-~~---- 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EV---- 239 (299)
T ss_dssp CCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HH----
T ss_pred CCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH----
Confidence 99999986533211 122334568999999999999999999999999999999999 89999765431 11
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
+..+..+.....|..+++++.+++.+||+.+|++||++.++.+.|+++.+..|
T Consensus 240 -----~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 240 -----IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -----HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -----HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 12233445556778888999999999999999999999999999998876544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=456.18 Aligned_cols=262 Identities=29% Similarity=0.488 Sum_probs=216.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++|.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478999999987766667889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 002289 683 VYEFMSNGTLRDQLSAKS-------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 749 (941)
|||||++|+|.++++... ..++++.+++.|+.||++||+|||+++ ||||||||+|||+++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997642 246899999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 828 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~ 828 (941)
||+|||+|+.....+. ........||+.|||||++.+..++.++|||||||++|||+| |+.||....... .
T Consensus 198 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-~-- 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-A-- 269 (329)
T ss_dssp EECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-H--
T ss_pred EEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-H--
Confidence 9999999986543221 122344579999999999999999999999999999999999 899997654321 1
Q ss_pred HHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
+..+..+.....|..+++++.+++.+||+.+|++||++.+++++|+.+.+..|
T Consensus 270 -------~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 270 -------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp -------HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred -------HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 11223344456677888999999999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=457.79 Aligned_cols=264 Identities=22% Similarity=0.375 Sum_probs=216.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
+.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999975 69999999997655555677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
+||+|.+++.+. .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 224 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 224 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC---
Confidence 999999999653 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||....... ..
T Consensus 225 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~-------------------- 279 (346)
T 4fih_A 225 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AM-------------------- 279 (346)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH--------------------
T ss_pred ----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HH--------------------
Confidence 22345689999999999999999999999999999999999999997543211 11
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCCC
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 927 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~~ 927 (941)
+.+.... +..-+.. ....+++.+||.+||+.||++|+||+|+|+||||+....-
T Consensus 280 ---------~~i~~~~---~~~~~~~--------------~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 280 ---------KMIRDNL---PPRLKNL--------------HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp ---------HHHHHSS---CCCCSCG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ---------HHHHcCC---CCCCCcc--------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 1111100 0000000 1122344578999999999999999999999999875544
Q ss_pred Ccccc
Q 002289 928 SNLVS 932 (941)
Q Consensus 928 ~~~~~ 932 (941)
+.+++
T Consensus 334 ~~l~p 338 (346)
T 4fih_A 334 ASIVP 338 (346)
T ss_dssp GGTGG
T ss_pred cccCc
Confidence 44443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=451.39 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=216.5
Q ss_pred CCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++++.++||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556789999999999999863 468899999975433 235689999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 002289 683 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 748 (941)
|||||++|+|.++|+.+. ...+++..++.|+.|||+||+|||+++ ||||||||+|||++++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996532 235899999999999999999999999 999999999999999999
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 827 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~ 827 (941)
+||+|||+|+.....+. ........||+.|||||++.++.|+.++|||||||++|||+| |+.||...... +.
T Consensus 184 ~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-~~- 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DV- 256 (308)
T ss_dssp EEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-HH-
T ss_pred EEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-HH-
Confidence 99999999986543221 122344579999999999999999999999999999999999 89999765431 11
Q ss_pred HHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
...+..+...+.|++++..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 257 --------~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 257 --------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp --------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --------HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1123344555678888999999999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=446.62 Aligned_cols=259 Identities=20% Similarity=0.324 Sum_probs=211.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999964 799999999875322 22457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|||+||+|.+++.+.+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997654 4899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+...
T Consensus 187 ~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~---------------- 244 (311)
T 4aw0_A 187 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFA---------------- 244 (311)
T ss_dssp T-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH----------------
T ss_pred C-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHH----------------
Confidence 1 1223456899999999999999999999999999999999999999975432 11100
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC------CCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM------LKH 918 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~------L~H 918 (941)
++ ..+ .+. -| ....+++.+||.+||+.||++|+|++|+ ++|
T Consensus 245 ------------~i-~~~---~~~-~p----------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~H 291 (311)
T 4aw0_A 245 ------------KI-IKL---EYD-FP----------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 291 (311)
T ss_dssp ------------HH-HHT---CCC-CC----------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred ------------HH-HcC---CCC-CC----------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCC
Confidence 01 100 000 00 1112334578999999999999999986 789
Q ss_pred CCCCCCCCC
Q 002289 919 PYVSSDVSG 927 (941)
Q Consensus 919 pwf~~~~~~ 927 (941)
|||++-.+.
T Consensus 292 p~F~~idw~ 300 (311)
T 4aw0_A 292 PFFESVTWE 300 (311)
T ss_dssp GGGTTCCCT
T ss_pred CCcCCCCHH
Confidence 999886554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=443.59 Aligned_cols=268 Identities=25% Similarity=0.447 Sum_probs=214.5
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
+...++|.+.++||+|+||+||+|++++ .||||+++... ....+.|.+|++++++++|||||+++|++.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3445678889999999999999999753 59999987533 2335689999999999999999999999865 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|||||++|+|.++++... ..+++..++.|+.|||+||+|||+++ ||||||||+|||+++++++||+|||+|+....
T Consensus 109 VmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999997543 45999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||....+........ .. ..
T Consensus 185 ~~~-----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~-~~----~~ 254 (307)
T 3omv_A 185 WSG-----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV-GR----GY 254 (307)
T ss_dssp --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HT----TC
T ss_pred CCc-----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH-hc----CC
Confidence 221 223345679999999999964 468999999999999999999999997654432221111 11 11
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
..+.....+.+++..+.+++.+||+.+|++||++.++++.|+.+...+|+
T Consensus 255 ~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 12223345667888999999999999999999999999999988776654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=459.03 Aligned_cols=265 Identities=22% Similarity=0.373 Sum_probs=217.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.+.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999975 6999999999876655667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
|+||+|.+++... .+++..+..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 9999999999653 3899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ..
T Consensus 302 -----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~------------------- 356 (423)
T 4fie_A 302 -----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AM------------------- 356 (423)
T ss_dssp -----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH-------------------
T ss_pred -----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HH-------------------
Confidence 22345689999999999999999999999999999999999999997543211 10
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
+.+......... ......+++.+||.+||+.||++|+||+|+|+||||+....
T Consensus 357 ----------~~i~~~~~~~~~-----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 357 ----------KMIRDNLPPRLK-----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp ----------HHHHHSCCCCCS-----------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ----------HHHHcCCCCCCc-----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 111110000000 01122334457999999999999999999999999987554
Q ss_pred CCcccc
Q 002289 927 GSNLVS 932 (941)
Q Consensus 927 ~~~~~~ 932 (941)
-+.+++
T Consensus 410 p~~l~p 415 (423)
T 4fie_A 410 PASIVP 415 (423)
T ss_dssp GGGTGG
T ss_pred Cccccc
Confidence 444444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=449.26 Aligned_cols=270 Identities=22% Similarity=0.303 Sum_probs=208.5
Q ss_pred cCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++|++.+.||+|+||+||+|+.. +++.||||+++..... ....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 4789999998754322 23468899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|||||+||+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997654 4899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.. .......||+.|||||++.+..|+.++||||+||++|||+||+.||...... +.... +...
T Consensus 179 ~~-------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~---------i~~~ 241 (304)
T 3ubd_A 179 HE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTM---------ILKA 241 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH---------HHHC
T ss_pred CC-------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHHH---------HHcC
Confidence 21 2234567999999999999999999999999999999999999999754321 11110 0000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC-----ccCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-----SSMLK 917 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa-----~e~L~ 917 (941)
...+|.. .++++.+||.+||+.||++|+|| +|+++
T Consensus 242 -~~~~p~~---------------------------------------~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 -KLGMPQF---------------------------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCCCTT---------------------------------------SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCCCc---------------------------------------CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0011111 12234467888888899999986 58999
Q ss_pred CCCCCCCCCCCccccccccccCC
Q 002289 918 HPYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 918 Hpwf~~~~~~~~~~~~~~~~~~~ 940 (941)
||||++..+..-.-..+.||+.|
T Consensus 282 Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 282 HSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp SGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CccccCCCHHHHHhCCCCcCcCC
Confidence 99998865433333445677765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=440.88 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=209.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.+.|++.++||+|+||+||+|++. +|+.||||+++... ...+|++++++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 346778889999999999999975 69999999997532 235799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeeccccccCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 765 (941)
|+||+|.+++++.+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999997654 4899999999999999999999999 99999999999999987 699999999987643321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC-
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM- 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 844 (941)
.. ........+||+.|||||++.+..|+.++||||+||++|||+||+.||....... .+..+.....
T Consensus 207 ~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------~~~~i~~~~~~ 274 (336)
T 4g3f_A 207 GK--SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----------LCLKIASEPPP 274 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----------CHHHHHHSCCG
T ss_pred cc--ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----------HHHHHHcCCCC
Confidence 11 0112234579999999999999999999999999999999999999997543211 1111111111
Q ss_pred -CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 845 -GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 845 -~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..++..++..+.+++.+||+.||.+||++.|+++++.....
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 23456677889999999999999999999999999887643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=446.28 Aligned_cols=251 Identities=23% Similarity=0.388 Sum_probs=209.0
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999965 699999999975432 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
||+||+|.+++..+....+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999998776667899999999999999999999999 999999999999999999999999999865321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+. +..+..+..+
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~---------~~~i~~~~~~ 243 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNL---------VLKIISGSFP 243 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHH---------HHHHHHTCCC
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHH---------HHHHHcCCCC
Confidence 1223456799999999999999999999999999999999999999976543 221 1223334444
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
..+..++.++.+++.+|++.||++||++.|++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 5566677788889999999999999999988753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=435.73 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=199.1
Q ss_pred CccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeecccc----CCcEEEEE
Q 002289 612 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 684 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~LV~ 684 (941)
+..++||+|+||+||+|.+. +++.||+|++.... ....+.|.+|++++++++|||||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999975 68999999987532 2234679999999999999999999999854 35689999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeeccccccCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGla~~~~~~ 763 (941)
|||++|+|.+++.+.. .+++..++.++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999997654 5899999999999999999999875 46999999999999985 78999999999985422
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......||+.|||||++.+ +|+.++|||||||++|||+||+.||....+........ ..+
T Consensus 185 --------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i---------~~~- 245 (290)
T 3fpq_A 185 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------TSG- 245 (290)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---------TTT-
T ss_pred --------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH---------HcC-
Confidence 22345679999999998865 69999999999999999999999997544322211110 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.+|.. ......+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 246 -------------------------~~~~~------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 -------------------------VKPAS------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------------------CCCGG------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------------------CCCCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 00100 00011223447888899999999999999999999986
Q ss_pred C
Q 002289 924 D 924 (941)
Q Consensus 924 ~ 924 (941)
+
T Consensus 289 ~ 289 (290)
T 3fpq_A 289 E 289 (290)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=435.32 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=195.4
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 799999999875432 22457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+ +|+|.+++.+++ .+++..++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 789999997654 5899999999999999999999999 999999999999999999999999999865322
Q ss_pred CCCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ...
T Consensus 166 -------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~----------------- 220 (275)
T 3hyh_A 166 -------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVL----------------- 220 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHH-----------------
T ss_pred -------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHH-----------------
Confidence 22344679999999999998876 5799999999999999999999965332 110
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.+.+....-.-| ...++++.+||.+||+.||++|+|++|+|+||||+.
T Consensus 221 ------------~~~i~~~~~~~p--------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 221 ------------FKNISNGVYTLP--------------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------HHHHHHTCCCCC--------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------HHHHHcCCCCCC--------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 111111100000 011233457899999999999999999999999986
Q ss_pred CC
Q 002289 924 DV 925 (941)
Q Consensus 924 ~~ 925 (941)
+.
T Consensus 269 ~~ 270 (275)
T 3hyh_A 269 DL 270 (275)
T ss_dssp TC
T ss_pred CC
Confidence 54
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=439.94 Aligned_cols=272 Identities=25% Similarity=0.416 Sum_probs=225.5
Q ss_pred cchHHHHHHhcCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCCchh-hHhHHHHHHHHHhcCC-Cceeee
Q 002289 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHH-RNLVSL 670 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h-~nIv~l 670 (941)
+..++|+...++|++.+.||+|+||+||+|.+.. ++.||||+++...... .+.|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445677888999999999999999999998632 4689999998654433 4679999999999965 899999
Q ss_pred eeccccC-CcEEEEEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 002289 671 VGYCDEE-GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735 (941)
Q Consensus 671 ~~~~~~~-~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 735 (941)
+|+|.+. +..++|||||++|+|.++|+... ...+++..++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9998664 56899999999999999997532 345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CC
Q 002289 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 814 (941)
Q Consensus 736 Lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~ 814 (941)
|||+|||+++++++||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 999999999999999999999986643221 122345678999999999999999999999999999999998 99
Q ss_pred CCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 815 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 815 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
.||........... .+..+.....|+.++.++.+++..||+.+|++||++.+++++|+++.+.-
T Consensus 286 ~Pf~~~~~~~~~~~---------~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 286 SPYPGVKIDEEFCR---------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CSSTTCCCSHHHHH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCCHHHHHHH---------HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 99976443221111 12234445667778889999999999999999999999999999887643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=438.93 Aligned_cols=304 Identities=18% Similarity=0.265 Sum_probs=213.3
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcE
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 680 (941)
...++|++.++||+|+||+||+|+.+ +++.||||++.... ...++.+|+++++.+ +||||+++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34688999999999999999999853 46889999987543 345688999999998 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeeccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRL 759 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFGla~~ 759 (941)
++||||+++|+|.+++. .+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999983 3889999999999999999999999 9999999999999877 7999999999986
Q ss_pred cCCCCCCCc---------------------cccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCC
Q 002289 760 APVPDIEGI---------------------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPI 817 (941)
Q Consensus 760 ~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf 817 (941)
......... .........+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543221100 001122345799999999999875 5899999999999999999999999
Q ss_pred CCCchhHHHHHHHHhhccc------hhhhc---CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 818 SHGKNIVREVNIAYQSSMM------FSVID---GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~------~~~~~---~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
..+.+..+........... ..... ......|......+.+.+...-...|. ...-..........+.
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~----~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPK----LTSDIQGHATNLEGWN 323 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------------CT
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccc----cccccccccccccccc
Confidence 8776654443322210000 00000 000011111111111111111111111 1111111111112233
Q ss_pred CCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 889 ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 889 ~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
..++++.|||.+||++||++|+||+|+|+||||++
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 44566789999999999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=440.43 Aligned_cols=287 Identities=22% Similarity=0.358 Sum_probs=215.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccc------cCCc
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCD------EEGE 679 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~------~~~~ 679 (941)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|+.++|||||++++++. +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 799999999975432 33467889999999999999999999864 3467
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.|||||||+ |+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 7899999654 45999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
+...... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...... +........
T Consensus 208 ~~~~~~~---~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~----- 278 (398)
T 4b99_A 208 LCTSPAE---HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMV----- 278 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHH-----
T ss_pred cccCccc---cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHh-----
Confidence 6432111 12234557899999999998875 5699999999999999999999999765432 222211110
Q ss_pred hhcCCCCCCChHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 839 VIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
. +..+......+ .......+...|...|.. +...++..++++.|||.+||++||++|+||+|+|+
T Consensus 279 -~----g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 279 -L----GTPSPAVIQAVGAERVRAYIQSLPPRQPVP---------WETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -H----CCCCGGGTC-----CHHHHHHSSCCCCCCC---------HHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -c----CCCChHHhhhhhhhhhhhhhhcCCCcCCCC---------HHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 01111100000 001112222333333321 11234555667789999999999999999999999
Q ss_pred CCCCCCC
Q 002289 918 HPYVSSD 924 (941)
Q Consensus 918 Hpwf~~~ 924 (941)
||||+.-
T Consensus 345 Hp~f~~~ 351 (398)
T 4b99_A 345 HPFLAKY 351 (398)
T ss_dssp SGGGTTT
T ss_pred CHhhCcC
Confidence 9999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=421.35 Aligned_cols=263 Identities=22% Similarity=0.356 Sum_probs=192.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCC--------
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-------- 678 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 678 (941)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999975 7999999998754433 3467899999999999999999999986543
Q ss_pred ----cEEEEEecCCCCCHHHHHhhcCC-CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 679 ----EQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 679 ----~~~LV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
..|+|||||++|+|.+++..+.. ...++..++.|+.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976543 23566778899999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCCCc-----cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002289 754 FGLSRLAPVPDIEGI-----VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828 (941)
Q Consensus 754 FGla~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~ 828 (941)
||+|+.......... ......+..+||+.|||||++.+..|+.++|||||||++|||++ ||....+......
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999987654322111 01112344679999999999999999999999999999999996 7753221111000
Q ss_pred HHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCC
Q 002289 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 908 (941)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~ 908 (941)
.+.. ..+|+. ..+. .+...+||.+||+.||++
T Consensus 239 ---------~~~~---~~~p~~----------------------~~~~--------------~~~~~~li~~~L~~dP~~ 270 (299)
T 4g31_A 239 ---------DVRN---LKFPPL----------------------FTQK--------------YPCEYVMVQDMLSPSPME 270 (299)
T ss_dssp ---------HHHT---TCCCHH----------------------HHHH--------------CHHHHHHHHHHTCSSGGG
T ss_pred ---------HHhc---CCCCCC----------------------Cccc--------------CHHHHHHHHHHcCCChhH
Confidence 0000 011111 0000 111236888999999999
Q ss_pred CCCCccCCCCCCCCCCC
Q 002289 909 PPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 909 R~sa~e~L~Hpwf~~~~ 925 (941)
||||.|+|+||||++-.
T Consensus 271 Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 271 RPEAINIIENAVFEDLD 287 (299)
T ss_dssp SCCHHHHHTSGGGCCC-
T ss_pred CcCHHHHhcCHhhCCCC
Confidence 99999999999998643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=418.27 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=199.7
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC----cEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~LV~ 684 (941)
.+|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3567788999999999999998 689999999975321 1223345666667889999999999997654 579999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-----ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
|||++|+|.++++.. .+++..+.+++.|+++||+|||++ ..++||||||||+|||++.++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999764 489999999999999999999987 133499999999999999999999999999987
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccC------CCCchhHhHHHHHHHHHHHhCCCCCCCCch-----------
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHGKN----------- 822 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlG~ll~elltG~~Pf~~~~~----------- 822 (941)
....... .........||+.|||||++.+. .++.++|||||||++|||+||+.||.....
T Consensus 158 ~~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 158 HDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EETTTTE---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccCCCCc---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 6432211 01122345799999999999764 367799999999999999999877642211
Q ss_pred --hHHHHHHHHhhccchhhhcCC-CCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 823 --IVREVNIAYQSSMMFSVIDGN-MGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 823 --~~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
........ +.... .+..| .+++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 235 ~~~~~~~~~~--------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 235 DPSVEEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHH--------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHH--------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111111 11111 12222 3567789999999999999999999999999998765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=438.80 Aligned_cols=272 Identities=21% Similarity=0.308 Sum_probs=209.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHH---HHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLT---EIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....+.+ ++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999975 6999999998643221 1223333 45677778999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
|+|||||+||+|.+++.+.+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999997654 4899999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
... .....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||........
T Consensus 343 ~~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-------------- 399 (689)
T 3v5w_A 343 SKK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------- 399 (689)
T ss_dssp SSC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--------------
T ss_pred CCC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--------------
Confidence 432 2234579999999999974 5799999999999999999999999964221000
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC-----Ccc
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSS 914 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s-----a~e 914 (941)
..+.+.+ +...+ .-| ...++++.+||.+||+.||++|++ |+|
T Consensus 400 -------------~~i~~~i---~~~~~-~~p----------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~e 446 (689)
T 3v5w_A 400 -------------HEIDRMT---LTMAV-ELP----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 446 (689)
T ss_dssp -------------HHHHHHH---HHCCC-CCC----------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHH
T ss_pred -------------HHHHHhh---cCCCC-CCC----------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHH
Confidence 0000111 11111 001 112234457888889999999988 689
Q ss_pred CCCCCCCCCCCCCCccccccccccCC
Q 002289 915 MLKHPYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 915 ~L~Hpwf~~~~~~~~~~~~~~~~~~~ 940 (941)
+++||||++-.+..-....+.||+.|
T Consensus 447 i~~HpfF~~idW~~l~~~~~~pP~~P 472 (689)
T 3v5w_A 447 VKESPFFRSLDWQMVFLQKYPPPLIP 472 (689)
T ss_dssp HTTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HhcCccccCCCHHHHHcCCCCcCccC
Confidence 99999999866643333334444444
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=436.27 Aligned_cols=260 Identities=22% Similarity=0.361 Sum_probs=215.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++........+.+.+|+++|+.++||||++++++|.+.+..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 6999999999876666667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC--CcEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DFGla~~~~~~~ 764 (941)
|+||+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999643 245999999999999999999999999 9999999999999854 89999999999876432
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||+.|||||++.+..|+.++||||+||++|||++|+.||........ ..
T Consensus 311 -------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~---------------- 366 (573)
T 3uto_A 311 -------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LR---------------- 366 (573)
T ss_dssp -------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HH----------------
T ss_pred -------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HH----------------
Confidence 223455799999999999999999999999999999999999999975443111 10
Q ss_pred CCCChHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c-~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.+..+ +...+. .++..++.+.+||.+||+.||++|+||+|+|+||||+.
T Consensus 367 -------------~i~~~~~~~~~~-----------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 367 -------------NVKSCDWNMDDS-----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp -------------HHHTTCCCCCSG-----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred -------------HHHhCCCCCCcc-----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 01111 000000 01122334568999999999999999999999999986
Q ss_pred CCC
Q 002289 924 DVS 926 (941)
Q Consensus 924 ~~~ 926 (941)
..+
T Consensus 417 ~~~ 419 (573)
T 3uto_A 417 GNA 419 (573)
T ss_dssp CCC
T ss_pred CCC
Confidence 544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=386.17 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=210.5
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999997 579999999987532 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999997654 4889999999999999999999999 999999999999999999999999999765322
Q ss_pred CCCccccccccccccCCCcccccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......||+.|+|||++.+..+. .++||||+||++|||++|+.||...... +..
T Consensus 168 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~---------------- 223 (328)
T 3fe3_A 168 -------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-ELR---------------- 223 (328)
T ss_dssp -------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH----------------
T ss_pred -------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-HHH----------------
Confidence 223456799999999999988875 7899999999999999999999654321 100
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
+.+....... |. ...+.+.+|+++||..||++|||++|+++||||+.
T Consensus 224 -------------~~i~~~~~~~----p~----------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 224 -------------ERVLRGKYRI----PF----------------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp -------------HHHHHCCCCC----CT----------------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred -------------HHHHhCCCCC----CC----------------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 0011000000 10 11223346888899999999999999999999987
Q ss_pred CCCCCcc
Q 002289 924 DVSGSNL 930 (941)
Q Consensus 924 ~~~~~~~ 930 (941)
......+
T Consensus 271 ~~~~~~~ 277 (328)
T 3fe3_A 271 GHEEDEL 277 (328)
T ss_dssp TCTTCCC
T ss_pred CCccccc
Confidence 5544443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=374.78 Aligned_cols=261 Identities=22% Similarity=0.354 Sum_probs=212.1
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999996 47899999998765555567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999999764 4889999999999999999999999 9999999999999999999999999998654322
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 171 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----------------- 228 (297)
T 3fxz_A 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----------------- 228 (297)
T ss_dssp -----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----------------
T ss_pred -----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------------
Confidence 1233456999999999999999999999999999999999999999754432211110
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
.... .+... .. ........+||.+||..||++|||++|+|+||||+....
T Consensus 229 ------------~~~~---~~~~~-~~--------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 229 ------------ATNG---TPELQ-NP--------------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp ------------HHHC---SCCCS-CG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ------------HhCC---CCCCC-Cc--------------cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 0000 00000 00 001112346888899999999999999999999987654
Q ss_pred CC
Q 002289 927 GS 928 (941)
Q Consensus 927 ~~ 928 (941)
-+
T Consensus 279 ~~ 280 (297)
T 3fxz_A 279 LS 280 (297)
T ss_dssp GG
T ss_pred cc
Confidence 33
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=381.59 Aligned_cols=284 Identities=43% Similarity=0.754 Sum_probs=233.1
Q ss_pred cCCccccchHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeee
Q 002289 593 IDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLV 671 (941)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~ 671 (941)
......+++.++....++|++.+.||+|+||+||+|...+|+.||||++...... ....+.+|+++++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3456778999999999999999999999999999999888999999998764433 234789999999999999999999
Q ss_pred eccccCCcEEEEEecCCCCCHHHHHhhcC--CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 002289 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749 (941)
Q Consensus 672 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 749 (941)
+++...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++..++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999997643 3459999999999999999999999922229999999999999999999
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC-------Cch
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-------GKN 822 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~-------~~~ 822 (941)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.. ...
T Consensus 174 kl~Dfg~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 174 VVGDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp EECCCSSCEECCSSS------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred EeccCccccccCccc------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 999999998664322 2223445699999999999999999999999999999999999999951 112
Q ss_pred hHHHHHHHHhhccchhhhcCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 823 IVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
..++..............+... ..++.+.+..+.+++..|++.+|.+||++.+++++|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 2233322222223333333322 34678889999999999999999999999999999985
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=380.87 Aligned_cols=281 Identities=30% Similarity=0.511 Sum_probs=257.1
Q ss_pred CCCHHHHHHHHHHHHhCcCCCCCCCCCCCCCCCC-CCCCceEecCCCCCCCcceeeEEEecCCCCCc--cCCccccCCCC
Q 002289 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT-SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSY 107 (941)
Q Consensus 31 ~~~~~d~~aL~~~k~~~~~~~~~~~~w~~~~~c~-~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~--~~~~~l~~l~~ 107 (941)
.|+++|.+||++||+++.++. .+.+|..+++|| |.|.||+|...+ ...+|++|+|++++++| .+|+.|+++++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~---~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSS---SCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCC---CCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 478899999999999998765 678998655543 459999997543 12479999999999999 89999999999
Q ss_pred CCEEEccc-CCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecc
Q 002289 108 LTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (941)
Q Consensus 108 L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (941)
|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..|..+++|++|+|+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 99999995 99999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCchhccCCC-ccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcC
Q 002289 187 NNSISGQIPPELSRLP-SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 187 ~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
+|++++.+|..++.++ +|++|+|++|++++.+|..+..++ |+.|+|++|++++ ..|..|..+++|+.|+|++|++++
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE-CCGGGCCTTSCCSEEECCSSEECC
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccC-cCCHHHhcCCCCCEEECCCCceee
Confidence 9999999999999998 999999999999999999999997 9999999999998 689999999999999999999998
Q ss_pred CCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcc
Q 002289 266 PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 325 (941)
Q Consensus 266 ~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 325 (941)
.++.+.. ..+|++|+|++|+|++.+|..|..+++|+.|+|++|+++|.+|..
T Consensus 236 ~~~~~~~--------l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 236 DLGKVGL--------SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp BGGGCCC--------CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ecCcccc--------cCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 7765433 356799999999999999999999999999999999999988876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=378.39 Aligned_cols=278 Identities=43% Similarity=0.722 Sum_probs=231.8
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
+.++...+++|++.+.||+|+||+||+|++++++.||||++........+.+.+|+++++.++||||+++++++...+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34445577899999999999999999999888999999998876666667899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC--CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999996543 235899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc-----hhHHHHHHHHhh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK-----NIVREVNIAYQS 833 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~-----~~~~~~~~~~~~ 833 (941)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+.......
T Consensus 188 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 188 KGTELDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp ECSSSSC-----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred ccccccc-----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 6432211 122334568999999999999999999999999999999999999996432 222332222233
Q ss_pred ccchhhhcCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 834 SMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 834 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
..+...++... ...+.+++..+.+++.+||+.+|++||++.++++.|+.+.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 33333444333 346788999999999999999999999999999999988764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=381.46 Aligned_cols=277 Identities=24% Similarity=0.346 Sum_probs=209.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
..++|++.+.||+|+||+||+|++.+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999999988999999998754322 2467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||++ |+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9996 58888886543 45899999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 174 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------------- 231 (311)
T 3niz_A 174 -------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK--------------- 231 (311)
T ss_dssp -------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---------------
T ss_pred -------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---------------
Confidence 22234568999999999876 5689999999999999999999999975443211111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH---------HhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE---------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~---------~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
+...+-...|...+...++....+ .+....+...+++.+||.+||.+||++|||++|
T Consensus 232 --------------i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 232 --------------IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp --------------HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred --------------HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 011111111111111111000000 001112333445568999999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 915 MLKHPYVSSD 924 (941)
Q Consensus 915 ~L~Hpwf~~~ 924 (941)
+|+||||++.
T Consensus 298 ll~hp~f~~~ 307 (311)
T 3niz_A 298 AMNHPYFKDL 307 (311)
T ss_dssp HHTSGGGTTS
T ss_pred HhcCcccccC
Confidence 9999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=393.94 Aligned_cols=280 Identities=20% Similarity=0.306 Sum_probs=212.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.++||+|+||+||+|+.+ +++.||+|+++.... ...+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467889999999999999999975 688999999875422 2234678899999887 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999997653 4899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 206 ~-------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~--------------- 263 (396)
T 4dc2_A 206 P-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------------- 263 (396)
T ss_dssp T-------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------------
T ss_pred C-------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc---------------
Confidence 1 223345679999999999999999999999999999999999999996322100000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC------ccCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS------SSML 916 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa------~e~L 916 (941)
... ...+.+.+... .+ . .....++.+.+||++||+.||++|+++ +|++
T Consensus 264 ---~~~---~~~~~~~i~~~---~~-~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~ 317 (396)
T 4dc2_A 264 ---QNT---EDYLFQVILEK---QI-R----------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 317 (396)
T ss_dssp ----CC---HHHHHHHHHHC---CC-C----------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHH
T ss_pred ---hhh---HHHHHHHHhcc---cc-C----------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHh
Confidence 000 00111111110 00 0 001122334578888899999999987 5899
Q ss_pred CCCCCCCCCCCCccccccccccCC
Q 002289 917 KHPYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 917 ~Hpwf~~~~~~~~~~~~~~~~~~~ 940 (941)
+||||++..+....-..+.|++.|
T Consensus 318 ~Hpff~~i~w~~l~~~~~~pp~~p 341 (396)
T 4dc2_A 318 GHPFFRNVDWDMMEQKQVVPPFKP 341 (396)
T ss_dssp HSTTTTTCCHHHHHTTCSCCSCCC
T ss_pred cCccccCCCHHHHHcCCCCCCCcC
Confidence 999998755433223334455554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=390.94 Aligned_cols=203 Identities=26% Similarity=0.416 Sum_probs=173.1
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 681 (941)
..++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999975 689999999875321 2235678899999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 101 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999997653 4899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 176 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 176 CN-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cC-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 21 122345679999999999999999999999999999999999999997543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=395.07 Aligned_cols=281 Identities=19% Similarity=0.262 Sum_probs=218.1
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeecccc
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 676 (941)
..++....++|++.+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566789999999999999999999975 689999999865221 123458899999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
.+..++||||+++|+|.++++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999653 4889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCC----CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
|+...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ..
T Consensus 215 a~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~---- 283 (410)
T 3v8s_A 215 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YS---- 283 (410)
T ss_dssp CEECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH----
T ss_pred eEeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HH----
Confidence 98654321 11233567999999999998765 78899999999999999999999975432111 11
Q ss_pred hccchhhhcCCCCCCChHHHHHHHHHHHHhcc-cCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCC--C
Q 002289 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQ-DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET--P 909 (941)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~-~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~--R 909 (941)
+++..-.. ..|. .....+.+.+||.+||+.+|++ |
T Consensus 284 ------------------------~i~~~~~~~~~p~------------------~~~~s~~~~~li~~lL~~~~~rlgR 321 (410)
T 3v8s_A 284 ------------------------KIMNHKNSLTFPD------------------DNDISKEAKNLICAFLTDREVRLGR 321 (410)
T ss_dssp ------------------------HHHTHHHHCCCCT------------------TCCCCHHHHHHHHHHSSCGGGCTTS
T ss_pred ------------------------HHHhccccccCCC------------------cccccHHHHHHHHHHccChhhhCCC
Confidence 00000000 0000 0012233446777788877777 8
Q ss_pred CCCccCCCCCCCCCCCCCCccccccccccCC
Q 002289 910 PSSSSMLKHPYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 910 ~sa~e~L~Hpwf~~~~~~~~~~~~~~~~~~~ 940 (941)
++++|+++||||++..+.......+.||+.|
T Consensus 322 ~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p 352 (410)
T 3v8s_A 322 NGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 352 (410)
T ss_dssp SCHHHHHTSGGGCCSSCCSTTGGGSCCSCCC
T ss_pred CCHHHHhcCccccCCCHHHHhhcccCCCCCC
Confidence 8888999999998876655555555666655
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=382.14 Aligned_cols=202 Identities=26% Similarity=0.343 Sum_probs=177.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367889999999999999999975 68999999987532 12245688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999997643 4889999999999999999999999 999999999999999999999999999753221
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 159 -------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp -------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 122345679999999999999999999999999999999999999997543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=396.80 Aligned_cols=272 Identities=24% Similarity=0.273 Sum_probs=215.5
Q ss_pred chHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccc
Q 002289 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCD 675 (941)
Q Consensus 600 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 675 (941)
.+.++....++|++.++||+|+||+||+|+.. +++.||+|+++..... ..+.+.+|..+++.++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45566677899999999999999999999976 5889999998753221 1234889999999999999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
+.+..++|||||++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999763 345899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~ 830 (941)
+|+...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..
T Consensus 221 la~~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~-- 291 (437)
T 4aw2_A 221 SCLKLMEDG------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YG-- 291 (437)
T ss_dssp TCEECCTTS------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH--
T ss_pred hhhhcccCC------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HH--
Confidence 997654321 12233457999999999997 46789999999999999999999999975432111 11
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCC-
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCC-QDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET- 908 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~-~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~- 908 (941)
+++.... -..|.. .+...+.+.+||++||..+|++
T Consensus 292 --------------------------~i~~~~~~~~~p~~-----------------~~~~s~~~~dLi~~lL~~~~~r~ 328 (437)
T 4aw2_A 292 --------------------------KIMNHKERFQFPTQ-----------------VTDVSENAKDLIRRLICSREHRL 328 (437)
T ss_dssp --------------------------HHHTHHHHCCCCSS-----------------CCCSCHHHHHHHHTTSSCGGGCT
T ss_pred --------------------------hhhhccccccCCcc-----------------cccCCHHHHHHHHHHhccccccc
Confidence 1110000 000110 0112334457888999888888
Q ss_pred -CCCCccCCCCCCCCCCCCC
Q 002289 909 -PPSSSSMLKHPYVSSDVSG 927 (941)
Q Consensus 909 -R~sa~e~L~Hpwf~~~~~~ 927 (941)
|++++|+++||||++..+.
T Consensus 329 ~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 329 GQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp TTTTTHHHHTSGGGTTCCTT
T ss_pred CCCCHHHHhCCCccCCCCHH
Confidence 9999999999999876554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=380.64 Aligned_cols=199 Identities=24% Similarity=0.417 Sum_probs=176.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999975 699999999875322 2235678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999997643 4889999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 159 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 ---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp ---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1234569999999999999999999999999999999999999997544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=381.88 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=210.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 567999999999999999999975 6899999998764332 235789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 756 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFGl 756 (941)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999654 35899999999999999999999999 99999999999998877 799999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..
T Consensus 166 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~-------- 228 (361)
T 2yab_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LA-------- 228 (361)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HH--------
T ss_pred ceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HH--------
Confidence 98654321 12345699999999999999999999999999999999999999975432111 10
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
.+.. ....++... ++.....+.+||.+||..||++|||++|+|
T Consensus 229 -~i~~-~~~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 229 -NITA-VSYDFDEEF-----------------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp -HHHT-TCCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred -HHHh-cCCCCCchh-----------------------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000 011111111 012223345799999999999999999999
Q ss_pred CCCCCCCC
Q 002289 917 KHPYVSSD 924 (941)
Q Consensus 917 ~Hpwf~~~ 924 (941)
+||||+..
T Consensus 272 ~hp~~~~~ 279 (361)
T 2yab_A 272 RHPWITPV 279 (361)
T ss_dssp TSTTTSCS
T ss_pred cCcCcCCC
Confidence 99999854
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=376.36 Aligned_cols=275 Identities=24% Similarity=0.401 Sum_probs=209.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|+||+||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 6899999998754322 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|++ |++.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 996 4676666543 245899999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCccccccccccccCCCcccccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||+.|+|||++.+.. ++.++||||+||++|||++|..||....+..+.......
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~------------ 217 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR------------ 217 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH------------
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH------------
Confidence 2233456899999999998765 899999999999999999999998765554333322211
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--------HHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--------LESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~--------L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
.+-...+...+.+.+.... ........+..++...+||.+||+.||++||||+|+|
T Consensus 218 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 218 ----------------LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp ----------------HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ----------------HhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 1111111111111100000 0000111222334446899999999999999999999
Q ss_pred CCCCCCC
Q 002289 917 KHPYVSS 923 (941)
Q Consensus 917 ~Hpwf~~ 923 (941)
+||||+.
T Consensus 282 ~hp~f~~ 288 (292)
T 3o0g_A 282 QHPYFSD 288 (292)
T ss_dssp TSGGGTT
T ss_pred cCccccc
Confidence 9999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=382.74 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=175.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357888999999999999999975 689999999975432 2345678999999988 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999997653 4899999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 163 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 P-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp T-------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 1 1223456799999999999999999999999999999999999999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=374.32 Aligned_cols=272 Identities=22% Similarity=0.322 Sum_probs=216.1
Q ss_pred cccchHHHHHHhcC----------CCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCC
Q 002289 597 RSFTYGEMALATNN----------FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR 665 (941)
Q Consensus 597 ~~~~~~~~~~~~~~----------y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 665 (941)
+.++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34667777766654 677789999999999999976 7999999999876555567889999999999999
Q ss_pred ceeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC
Q 002289 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH 745 (941)
Q Consensus 666 nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~ 745 (941)
||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 999999999999999999999999999999854 34899999999999999999999999 999999999999999
Q ss_pred CCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHH
Q 002289 746 KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 825 (941)
Q Consensus 746 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~ 825 (941)
++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV-------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCcEEEeeeeeeeecccCc-------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999998654321 112345699999999999999999999999999999999999999975432111
Q ss_pred HHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCC
Q 002289 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 905 (941)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~d 905 (941)
... +.... .|... .. ....+...+++.+||..|
T Consensus 250 -~~~---------~~~~~----------------------~~~~~-~~--------------~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 250 -MKR---------LRDSP----------------------PPKLK-NS--------------HKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp -HHH---------HHHSS----------------------CCCCT-TG--------------GGSCHHHHHHHHHHSCSS
T ss_pred -HHH---------HhcCC----------------------CCCcC-cc--------------ccCCHHHHHHHHHHccCC
Confidence 000 00000 00000 00 001122346788899999
Q ss_pred CCCCCCCccCCCCCCCCCCCCCC
Q 002289 906 EETPPSSSSMLKHPYVSSDVSGS 928 (941)
Q Consensus 906 P~~R~sa~e~L~Hpwf~~~~~~~ 928 (941)
|++|||++|+++||||......+
T Consensus 283 p~~Rps~~ell~hp~~~~~~~~~ 305 (321)
T 2c30_A 283 PQERATAQELLDHPFLLQTGLPE 305 (321)
T ss_dssp TTTSCCHHHHHTSGGGGGCCCGG
T ss_pred hhhCcCHHHHhcChhhccCCCcc
Confidence 99999999999999997654433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=382.06 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=207.5
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcE
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 680 (941)
...++|++.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+..|.++++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999975 689999999875321 2234678899999887 999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999997643 4889999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +...
T Consensus 169 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~------------ 228 (345)
T 1xjd_A 169 MLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFH------------ 228 (345)
T ss_dssp CCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH------------
T ss_pred ccCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HHHH------------
Confidence 3211 1234567999999999999999999999999999999999999999754321 1000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCc-cCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS-SMLKHP 919 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~-e~L~Hp 919 (941)
.+.. ..+. -| ...++.+.+||.+||..||++|+++. |+++||
T Consensus 229 -----------------~i~~---~~~~-~p----------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 229 -----------------SIRM---DNPF-YP----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp -----------------HHHH---CCCC-CC----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred -----------------HHHh---CCCC-CC----------------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 0000 0000 00 01122334788889999999999998 999999
Q ss_pred CCCCCCC
Q 002289 920 YVSSDVS 926 (941)
Q Consensus 920 wf~~~~~ 926 (941)
||++..+
T Consensus 272 ~f~~~~w 278 (345)
T 1xjd_A 272 LFREINW 278 (345)
T ss_dssp GGTTCCH
T ss_pred cccCCCH
Confidence 9987544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=387.13 Aligned_cols=301 Identities=19% Similarity=0.242 Sum_probs=226.3
Q ss_pred CccccchHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-----CCcee
Q 002289 595 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----HRNLV 668 (941)
Q Consensus 595 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv 668 (941)
....+++.+.....++|++.++||+|+||+||+|+.. +++.||||+++.. ....+.+..|+++++.++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 4556777788888899999999999999999999974 6899999999752 334456788999999986 99999
Q ss_pred eeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---
Q 002289 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--- 745 (941)
Q Consensus 669 ~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--- 745 (941)
++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9999999999999999999 999999998776667999999999999999999999999 999999999999975
Q ss_pred ----------------------CCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHH
Q 002289 746 ----------------------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSL 803 (941)
Q Consensus 746 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSl 803 (941)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 789999999999864321 234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHH-------HhcccCCCCCCCHHHH
Q 002289 804 GVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLAL-------KCCQDETDARPSMSEV 876 (941)
Q Consensus 804 G~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~-------~c~~~~p~~RPs~~~v 876 (941)
||++|||++|+.||............ .......+............ ......|.........
T Consensus 246 G~il~ell~g~~pf~~~~~~~~~~~~-----------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 314 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHMEHLAMM-----------ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHH-----------HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHH-----------HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhh
Confidence 99999999999999765432211111 01112233332221110000 0001112222222221
Q ss_pred HHHHHHhHh-hCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 877 MRELESIWN-MMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 877 ~~~L~~~~~-~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
. .+..... .....++.+.+||.+||+.||++||||+|+|+||||+
T Consensus 315 ~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 315 K-HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp H-HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred h-hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1 1111000 0011234456899999999999999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=388.29 Aligned_cols=308 Identities=19% Similarity=0.216 Sum_probs=213.4
Q ss_pred HhcCCCccceeecc--CcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 607 ATNNFNSSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 607 ~~~~y~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
..++|++.+.||+| +||+||+|+.. +|+.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35689999999999 99999999976 69999999987543 223467888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999998765567999999999999999999999999 9999999999999999999999999986543
Q ss_pred CCCCCCccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCcc
Confidence 221111111122233468999999999987 6799999999999999999999999975443222111000 000000
Q ss_pred hcCCCCCCChHHHH-H-HHHHH---HHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 840 IDGNMGSYPSECVE-K-FIKLA---LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 840 ~~~~~~~~~~~~~~-~-l~~l~---~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
.+... .+.+... . ..... ..........||...+.. ........++.+.+||.+||+.||++|||++|
T Consensus 258 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 258 LDTST--IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP-----SHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred ccccc--cccccccccccccccccccccccccCccccccCCCC-----CCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 00000 0000000 0 00000 000000001111111100 00111223445678999999999999999999
Q ss_pred CCCCCCCCCCCC
Q 002289 915 MLKHPYVSSDVS 926 (941)
Q Consensus 915 ~L~Hpwf~~~~~ 926 (941)
+|+||||+....
T Consensus 331 ll~hp~f~~~~~ 342 (389)
T 3gni_B 331 LLNHSFFKQIKR 342 (389)
T ss_dssp HTTSGGGGGC--
T ss_pred HhcCHHHHHHhh
Confidence 999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=373.80 Aligned_cols=274 Identities=23% Similarity=0.350 Sum_probs=206.0
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|+||+||+|+..+|+.||+|++....... .+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999889999999987543322 35788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ ++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp CS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 96 59999986543 45889999999999999999999999 9999999999999999999999999997653221
Q ss_pred CccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||............ .
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~-------------- 214 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI-F-------------- 214 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-H--------------
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H--------------
Confidence 12234468999999999976 45899999999999999999999999765432211111 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH--------HHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL--------ESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L--------~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
...-...+...|...+....- ..+.......++...+||.+||..||++|||++|+|+
T Consensus 215 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 215 --------------RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp --------------HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------------HHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000001111100000000 0001111223344468999999999999999999999
Q ss_pred CCCCCC
Q 002289 918 HPYVSS 923 (941)
Q Consensus 918 Hpwf~~ 923 (941)
||||++
T Consensus 281 hp~f~~ 286 (288)
T 1ob3_A 281 HAYFKE 286 (288)
T ss_dssp SGGGGC
T ss_pred Ccchhh
Confidence 999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=377.95 Aligned_cols=263 Identities=25% Similarity=0.472 Sum_probs=218.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC--------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeeeeeccccC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 677 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 677 (941)
.++|++.+.||+|+||+||+|.+. ++..||||+++..... ..+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 3567999999865333 346789999999999 899999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 743 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 743 (941)
+..++||||+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997643 235889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCch
Q 002289 744 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 822 (941)
Q Consensus 744 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~ 822 (941)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCT-----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccc-----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999986543221 112233457889999999999999999999999999999999 9999975432
Q ss_pred hHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
. +.. ..+..+.....+..++..+.+++..||+.+|.+||++.++++.|+.+.....
T Consensus 312 ~-~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 312 E-ELF---------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp G-GHH---------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H-HHH---------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 111 1122233344566778889999999999999999999999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=386.63 Aligned_cols=212 Identities=28% Similarity=0.315 Sum_probs=182.5
Q ss_pred chHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccc
Q 002289 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCD 675 (941)
Q Consensus 600 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 675 (941)
.+++.....++|++.+.||+|+||+||+|+.+ +|+.||||+++..... ..+.+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44566667789999999999999999999975 7999999998753221 2345889999999999999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
+.+..++||||+++|+|.+++.+.+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999997643 35899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccc-------cCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
+++...... ........||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 208 la~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 208 SCLKLRADG------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TCEECCTTS------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hheeccCCC------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 998654321 11223457999999999997 3568999999999999999999999997544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=370.60 Aligned_cols=264 Identities=28% Similarity=0.432 Sum_probs=216.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||+||+|.+. .+..||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999974 355699999986433 335679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999996543 45899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ . ..+..
T Consensus 204 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~---------~~~~~ 269 (325)
T 3kul_A 204 DPDA----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-I---------SSVEE 269 (325)
T ss_dssp ---C----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-H---------HHHHT
T ss_pred Cccc----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-H---------HHHHc
Confidence 2211 112233446788999999999999999999999999999999 9999976543211 1 11122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
+.....+..++..+.+++..||..+|++||++.++++.|+.+......
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 233345667778899999999999999999999999999998775543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=383.94 Aligned_cols=305 Identities=25% Similarity=0.343 Sum_probs=207.7
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcC-CCceeeeeeccccC--CcE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQ 680 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~ 680 (941)
..++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++++. ||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 6899999998643 2333567889999999997 99999999998644 378
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++|||||+ |+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999996 6999999753 4889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCC--------------ccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHH
Q 002289 761 PVPDIEG--------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 825 (941)
Q Consensus 761 ~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~ 825 (941)
....... ...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4311100 001122344679999999999987 6789999999999999999999999976554322
Q ss_pred HHHHHHhhcc--chhhhcCCCCCCChHHHHHHHHHHHHhcc-cCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccC
Q 002289 826 EVNIAYQSSM--MFSVIDGNMGSYPSECVEKFIKLALKCCQ-DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 902 (941)
Q Consensus 826 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~c~~-~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L 902 (941)
......... ..+.+......+. ..+.+-...... .....+..+......+... .......+.+.+||.+||
T Consensus 240 -~~~i~~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 240 -LERIIGVIDFPSNEDVESIQSPFA----KTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI-NPKADCNEEALDLLDKLL 313 (388)
T ss_dssp -HHHHHHHHCCCCHHHHHTSCCSSH----HHHHHHHHHHCC-----CCCCHHHHHHHHHHH-CTTCCCCHHHHHHHHHHC
T ss_pred -HHHHHHhcCCCCHHHHHhccCHHH----HHHHHhCcccccccCCCHHHhCcchhhhcccc-cccccCCHHHHHHHHHhh
Confidence 221111000 0000000000111 111111111111 1112223333333332222 122244566789999999
Q ss_pred CCCCCCCCCCccCCCCCCCCCC
Q 002289 903 TSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 903 ~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
++||++|+||+|+|+||||+.-
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTT
T ss_pred ccCcccCCCHHHHhCCHHHHHh
Confidence 9999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=377.92 Aligned_cols=199 Identities=23% Similarity=0.351 Sum_probs=176.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357889999999999999999975 689999999865322 2235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999997654 4889999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 195 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 195 ----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp ----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=374.93 Aligned_cols=259 Identities=19% Similarity=0.348 Sum_probs=208.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||+||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999975 68999999987543 3455788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--CCcEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFGla~~~~~~~ 764 (941)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999653 345899999999999999999999999 999999999999987 789999999999876432
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ... .+....
T Consensus 158 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~---------~i~~~~- 219 (321)
T 1tki_A 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIE---------NIMNAE- 219 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHH---------HHHHTC-
T ss_pred -------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHH---------HHHcCC-
Confidence 12334568999999999999889999999999999999999999997544311 111 001000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
..++... ++.....+.+|+.+||..||++|||++|+|+||||...
T Consensus 220 ~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 220 YTFDEEA-----------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCCHHH-----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCChhh-----------------------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 0111100 01222334578889999999999999999999999765
Q ss_pred C
Q 002289 925 V 925 (941)
Q Consensus 925 ~ 925 (941)
.
T Consensus 265 ~ 265 (321)
T 1tki_A 265 I 265 (321)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=378.14 Aligned_cols=202 Identities=26% Similarity=0.407 Sum_probs=168.7
Q ss_pred hcCCCccceeeccCcEEEEEEEe----CCCcEEEEEEeccCCc----hhhHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
.++|++.+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999996 4789999999976432 223567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997653 4888999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 171 SIHD-------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccC-------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 4221 112234568999999999999999999999999999999999999997543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=375.63 Aligned_cols=290 Identities=22% Similarity=0.394 Sum_probs=199.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||+||+|... +|+.||+|+++..... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999965 6899999998754332 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcC----CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 686 FMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
|++ |+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886532 245899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...... ..
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~------~~ 225 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFD------IM 225 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH------HH
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH------Hh
Confidence 221 12234468999999999986 4689999999999999999999999976543221 111110 00
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCC--CCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDAR--PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R--Ps~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
... +...+..+.++. -+..+...+ ....+. +.. ......+..+.+||.+||+.||++|||++|+|+|
T Consensus 226 ~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTP----NESLWPSVTKLP--KYNPNIQQRPPRDLRQV---LQP--HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSC----CTTTCGGGGGCT--TCCTTCCCCCCCCSHHH---HGG--GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCC----ChhHhhhhhhhh--hcccccccccchhHHHh---hcc--cccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 000000000000 000000011 111111 110 0111233456789999999999999999999999
Q ss_pred CCCCCCCC
Q 002289 919 PYVSSDVS 926 (941)
Q Consensus 919 pwf~~~~~ 926 (941)
|||+....
T Consensus 295 p~f~~~~~ 302 (317)
T 2pmi_A 295 PWFAEYYH 302 (317)
T ss_dssp GGGGGGCC
T ss_pred hhhhcccc
Confidence 99976443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.54 Aligned_cols=281 Identities=25% Similarity=0.351 Sum_probs=207.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc-----hhhHhHHHHHHHHHhcC---CCceeeeeeccccC
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL-----QGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEE 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~ 677 (941)
..++|++.+.||+|+||+||+|++ .+++.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999996 4789999999864221 11346778888777765 99999999998765
Q ss_pred C-----cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEe
Q 002289 678 G-----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 752 (941)
Q Consensus 678 ~-----~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 752 (941)
. ..++||||++ |+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 4 5799999996 69999998776666999999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 753 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 753 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...
T Consensus 163 Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-i~~ 233 (308)
T 3g33_A 163 DFGLARIYSYQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFD 233 (308)
T ss_dssp SCSCTTTSTTC--------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH-HHH
T ss_pred eCccccccCCC--------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHH
Confidence 99999865322 122445689999999999999999999999999999999999999976544222111 110
Q ss_pred hccchhhhcCCCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCC
Q 002289 833 SSMMFSVIDGNMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 909 (941)
Q Consensus 833 ~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 909 (941)
.... ....... ..+. . ...+....... ...+...+...+||.+||+.||++|
T Consensus 234 ~~~~--~~~~~~~~~~~~~~-----------~--~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R 288 (308)
T 3g33_A 234 LIGL--PPEDDWPRDVSLPR-----------G--AFPPRGPRPVQ----------SVVPEMEESGAQLLLEMLTFNPHKR 288 (308)
T ss_dssp HHCC--CCTTTSCSSCSSCG-----------G--GSCCCCCCCHH----------HHSCSCCHHHHHHHHHHTCSSTTTS
T ss_pred HhCC--CChhhccchhhccc-----------c--ccCCCCCCcHH----------HhCccccHHHHHHHHHHhcCCCccC
Confidence 0000 0000000 0000 0 00011111111 1223444556789999999999999
Q ss_pred CCCccCCCCCCCCCCC
Q 002289 910 PSSSSMLKHPYVSSDV 925 (941)
Q Consensus 910 ~sa~e~L~Hpwf~~~~ 925 (941)
|||+|+|+||||+...
T Consensus 289 ~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 289 ISAFRALQHSYLHKDE 304 (308)
T ss_dssp CCHHHHHTSTTC----
T ss_pred CCHHHHhcCccccCCC
Confidence 9999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=382.17 Aligned_cols=199 Identities=27% Similarity=0.391 Sum_probs=175.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367889999999999999999965 689999999864321 2235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999754 35899999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCCccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 --------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 169 --------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp --------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 22345679999999999974 4589999999999999999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=377.06 Aligned_cols=260 Identities=22% Similarity=0.400 Sum_probs=210.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||+||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999975 6899999999876555566889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--CCcEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFGla~~~~~~~ 764 (941)
+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999998653 345899999999999999999999999 999999999999974 5789999999998654321
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 206 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~---------------- 260 (387)
T 1kob_A 206 --------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQ---------------- 260 (387)
T ss_dssp --------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HH----------------
T ss_pred --------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HH----------------
Confidence 12334689999999999999999999999999999999999999975443111 00
Q ss_pred CCCChHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c-~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
. +..+ +...+.. .....+.+.+||.+||..||++|||++|+|+||||.+
T Consensus 261 ------------~-i~~~~~~~~~~~-----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 261 ------------N-VKRCDWEFDEDA-----------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp ------------H-HHHCCCCCCSST-----------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ------------H-HHhCCCCCCccc-----------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 0 1111 1111110 0112233457888999999999999999999999987
Q ss_pred CCC
Q 002289 924 DVS 926 (941)
Q Consensus 924 ~~~ 926 (941)
...
T Consensus 311 ~~~ 313 (387)
T 1kob_A 311 DHS 313 (387)
T ss_dssp CCT
T ss_pred Ccc
Confidence 543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=366.68 Aligned_cols=267 Identities=32% Similarity=0.501 Sum_probs=211.7
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
.++....++|++.+.||+|+||+||+|++ +|+.||||++...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34445567899999999999999999987 6889999998765432 34578999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
.++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ ++|+||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999975432 24889999999999999999999875 459999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 188 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-------- 252 (309)
T 3p86_A 188 LKASTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-------- 252 (309)
T ss_dssp ---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--------
T ss_pred cccccc-------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------
Confidence 543211 12234568999999999999999999999999999999999999997654322111110
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
........+..++..+.+++..||+.+|.+||++.++++.|+.+.+.
T Consensus 253 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 253 -FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11223345666778899999999999999999999999999988653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=371.51 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=208.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||.||+|... +|+.||+|+++..... ..+.+.+|++++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467899999999999999999975 6899999998754322 246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 756 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFGl 756 (941)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999654 45899999999999999999999999 99999999999999887 899999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 165 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~------ 229 (326)
T 2y0a_A 165 AHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANV------ 229 (326)
T ss_dssp CEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHH------
T ss_pred CeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHH------
Confidence 98654221 12345689999999999999999999999999999999999999975432111 0000
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
... ...++... .+.....+.+||.+||..||++|||++|+|
T Consensus 230 ---~~~-~~~~~~~~-----------------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 230 ---SAV-NYEFEDEY-----------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp ---HHT-CCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ---Hhc-CCCcCccc-----------------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 000 00111100 011223345788899999999999999999
Q ss_pred CCCCCCCCC
Q 002289 917 KHPYVSSDV 925 (941)
Q Consensus 917 ~Hpwf~~~~ 925 (941)
+||||....
T Consensus 271 ~hp~~~~~~ 279 (326)
T 2y0a_A 271 QHPWIKPKD 279 (326)
T ss_dssp HSTTTSCCS
T ss_pred cCCCccCCc
Confidence 999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=398.12 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=210.3
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
..++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999975 799999999865322 224568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||++||+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999998766666999999999999999999999999 99999999999999999999999999986542
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 339 ~--------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----------------- 393 (576)
T 2acx_A 339 G--------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----------------- 393 (576)
T ss_dssp T--------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-----------------
T ss_pred C--------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-----------------
Confidence 2 112345799999999999999999999999999999999999999975321000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC-----CCccCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLK 917 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~ 917 (941)
...+.+.+... +..-| ....+.+.+||.+||+.||++|+ +++|+++
T Consensus 394 ---------~~~i~~~i~~~----~~~~p----------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 394 ---------REEVERLVKEV----PEEYS----------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---------HHHHHHHHHHC----CCCCC----------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---------HHHHHHHhhcc----cccCC----------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00111111110 00000 11123345677888888888888 7789999
Q ss_pred CCCCCCCCC
Q 002289 918 HPYVSSDVS 926 (941)
Q Consensus 918 Hpwf~~~~~ 926 (941)
||||++..+
T Consensus 445 HpfF~~i~w 453 (576)
T 2acx_A 445 HPLFKKLNF 453 (576)
T ss_dssp SGGGTTCCH
T ss_pred ChhhccCCH
Confidence 999987544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=391.80 Aligned_cols=284 Identities=21% Similarity=0.315 Sum_probs=206.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccC------C
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 678 (941)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999965 6899999998753 223356788999999999999999999998554 4
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||+++ +|.+.+.. .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 57999999964 67777643 3889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........+.... .
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~-~------ 277 (464)
T 3ttj_A 213 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI-E------ 277 (464)
T ss_dssp ----C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H------
T ss_pred ecCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-H------
Confidence 65321 22344679999999999999999999999999999999999999997655433222211 1
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCC-------CCCCcccccccCCCCCCCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPES-------DTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~-------~~~~~dll~~~L~~dP~~R~ 910 (941)
. .+..+.+....+...........|.. +..+..... . ..++.. .+++.+||.+||++||++|+
T Consensus 278 ~----lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 348 (464)
T 3ttj_A 278 Q----LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP---D--SLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348 (464)
T ss_dssp H----HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSC---G--GGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred h----cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCc---c--cccccccccccccCHHHHHHHHHHcCCChhhCC
Confidence 0 11122222222222222222222221 111111100 0 000000 12356899999999999999
Q ss_pred CCccCCCCCCCCC
Q 002289 911 SSSSMLKHPYVSS 923 (941)
Q Consensus 911 sa~e~L~Hpwf~~ 923 (941)
||+|+|+||||+.
T Consensus 349 ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 349 SVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHTSTTTGG
T ss_pred CHHHHhcChhhhh
Confidence 9999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=374.30 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=203.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 789999999875433 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999998543 35899999999999999999999999 99999999999999999999999999986532211
Q ss_pred CCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||............... ...
T Consensus 161 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---------~~~ 226 (323)
T 3tki_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---------KKT 226 (323)
T ss_dssp -----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT---------TCT
T ss_pred -----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---------ccc
Confidence 122334679999999999988775 77899999999999999999999754332111111000 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
.. +.. ...+....+||.+||..||++|||++|+++||||...
T Consensus 227 -------------------~~-----~~~--------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 227 -------------------YL-----NPW--------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -------------------TS-----TTG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -------------------cC-----Ccc--------------ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 00 000 0111222467788888888999999999999998754
Q ss_pred C
Q 002289 925 V 925 (941)
Q Consensus 925 ~ 925 (941)
.
T Consensus 269 ~ 269 (323)
T 3tki_A 269 L 269 (323)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=375.54 Aligned_cols=203 Identities=22% Similarity=0.355 Sum_probs=176.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 681 (941)
..++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+..|.++++.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999976 488999999875322 2235678899999988 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999997654 4899999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 173 WD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CT-------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cC-------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 21 122345679999999999999999999999999999999999999997543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=355.14 Aligned_cols=280 Identities=35% Similarity=0.617 Sum_probs=231.2
Q ss_pred CccccchHHHHHHhcCCCcc------ceeeccCcEEEEEEEeCCCcEEEEEEeccCC----chhhHhHHHHHHHHHhcCC
Q 002289 595 GVRSFTYGEMALATNNFNSS------TQIGQGGYGKVYKGILPDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHH 664 (941)
Q Consensus 595 ~~~~~~~~~~~~~~~~y~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 664 (941)
....|++.++..++++|... +.||+|+||+||+|.. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678999999999999887 8999999999999997 67899999986532 2234678999999999999
Q ss_pred CceeeeeeccccCCcEEEEEecCCCCCHHHHHhhc-CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 002289 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 743 (941)
Q Consensus 665 ~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 743 (941)
|||+++++++...+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999999743 3346899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch-
Q 002289 744 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN- 822 (941)
Q Consensus 744 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~- 822 (941)
+.++.+||+|||+++....... ........||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSS-----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cCCCcEEEeecccccccccccc-----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999986543211 112234568999999998865 578999999999999999999999975432
Q ss_pred --hHHHHHHHH-hhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 823 --IVREVNIAY-QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 823 --~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
......... ....+...++......+..++..+.+++..||+.+|.+||++.++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111111 12223444555666678889999999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=356.90 Aligned_cols=258 Identities=29% Similarity=0.488 Sum_probs=216.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..++|++.+.||+|+||+||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3567889999999999999999998889999999986443 346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 160 (269)
T ss_dssp CTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc--
Confidence 99999999996543 45899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ... .+..+...
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~~---------~~~~~~~~ 226 (269)
T 4hcu_A 161 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVE---------DISTGFRL 226 (269)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH---------HHHTTCCC
T ss_pred ----cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HHH---------HHhcCccC
Confidence 112233456778999999999999999999999999999999 999997654321 111 11222223
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+...+..+.+++..|++.+|++||++.+++++|+++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 3455566789999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=365.27 Aligned_cols=269 Identities=23% Similarity=0.427 Sum_probs=215.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|.+.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467888999999999999999975 6899999998776666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999997643 45899999999999999999999999 999999999999999999999999999876433211
Q ss_pred Cc-------cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 767 GI-------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 767 ~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.. ..........||+.|+|||++.+..++.++|||||||++|||++|..|+.......... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----~~~~~~~ 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----GLNVRGF 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----SBCHHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----hhhhhcc
Confidence 00 00111124579999999999999999999999999999999999999986422100000 0000000
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
.. ...+..++..+.+++.+||+.+|++||++.++++.|+.+.....
T Consensus 240 ~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 240 LD---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HH---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cc---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 01234455678899999999999999999999999998876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=376.13 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=206.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 568999999999999999999975 689999999976433 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---CcEEEeeeccccccC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAP 761 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DFGla~~~~ 761 (941)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999654 35899999999999999999999999 9999999999999865 459999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 183 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~------------- 240 (362)
T 2bdw_A 183 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YA------------- 240 (362)
T ss_dssp TCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH-------------
T ss_pred CCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HH-------------
Confidence 221 12345699999999999999999999999999999999999999975432110 00
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
.+.......|. +.. ....+.+.+||.+||..||++|||++|+|+||||
T Consensus 241 ----------------~i~~~~~~~~~--~~~--------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 241 ----------------QIKAGAYDYPS--PEW--------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp ----------------HHHHTCCCCCT--TGG--------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred ----------------HHHhCCCCCCc--ccc--------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 00000000000 000 0112233478889999999999999999999999
Q ss_pred CC
Q 002289 922 SS 923 (941)
Q Consensus 922 ~~ 923 (941)
..
T Consensus 289 ~~ 290 (362)
T 2bdw_A 289 CN 290 (362)
T ss_dssp HT
T ss_pred CC
Confidence 65
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=383.01 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=207.0
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
..++|++.+.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999964 7899999998765433 345789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeecccccc
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLA 760 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFGla~~~ 760 (941)
|||+++|+|.+.+.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999997653 4899999999999999999999999 99999999999998 4678999999999765
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..
T Consensus 164 ~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~------------ 223 (444)
T 3soa_A 164 EGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQ------------ 223 (444)
T ss_dssp CTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HH------------
T ss_pred cCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HH------------
Confidence 4321 122345799999999999999999999999999999999999999965432111 00
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
.+........+... +...+.+.+||.+||..||++|||++|+|+|||
T Consensus 224 ----------------~i~~~~~~~~~~~~-----------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 224 ----------------QIKAGAYDFPSPEW-----------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp ----------------HHHHTCCCCCTTTT-----------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred ----------------HHHhCCCCCCcccc-----------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 00000000000000 112233457889999999999999999999999
Q ss_pred CCC
Q 002289 921 VSS 923 (941)
Q Consensus 921 f~~ 923 (941)
|+.
T Consensus 271 ~~~ 273 (444)
T 3soa_A 271 ISH 273 (444)
T ss_dssp THH
T ss_pred ccC
Confidence 964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=377.11 Aligned_cols=259 Identities=21% Similarity=0.315 Sum_probs=203.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-----chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999975 68999999986321 113467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeecc
Q 002289 682 LVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGL 756 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DFGl 756 (941)
+||||+++|+|.+.+... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999887643 3345899999999999999999999999 999999999999987654 99999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... +...
T Consensus 180 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~-------- 242 (351)
T 3c0i_A 180 AIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFE-------- 242 (351)
T ss_dssp CEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHH--------
T ss_pred eeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHH--------
Confidence 98664321 122345699999999999999999999999999999999999999975321 0000
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
.+..+.. ..+... .+.....+.+||.+||..||++|||+.|+|
T Consensus 243 -~i~~~~~-~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 285 (351)
T 3c0i_A 243 -GIIKGKY-KMNPRQ-----------------------------------WSHISESAKDLVRRMLMLDPAERITVYEAL 285 (351)
T ss_dssp -HHHHTCC-CCCHHH-----------------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred -HHHcCCC-CCCccc-----------------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0111110 011000 011122334678888888888888888888
Q ss_pred CCCCCCC
Q 002289 917 KHPYVSS 923 (941)
Q Consensus 917 ~Hpwf~~ 923 (941)
+||||+.
T Consensus 286 ~hp~~~~ 292 (351)
T 3c0i_A 286 NHPWLKE 292 (351)
T ss_dssp TSHHHHT
T ss_pred cChhhcC
Confidence 8888865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=358.11 Aligned_cols=258 Identities=27% Similarity=0.445 Sum_probs=216.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..++|++.+.||+|+||+||+|.++++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4578999999999999999999998888999999986443 346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-- 158 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh--
Confidence 99999999997643 35899999999999999999999999 9999999999999999999999999998654322
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.......... .+..+...
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----------~~~~~~~~ 224 (268)
T 3sxs_A 159 ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL----------KVSQGHRL 224 (268)
T ss_dssp ----EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----------HHHTTCCC
T ss_pred ----hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH----------HHHcCCCC
Confidence 112233456778999999999899999999999999999999 999997554322111 11122223
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+..++..+.+++..|++.+|.+||++.++++.|+.+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 3444556789999999999999999999999999987743
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=363.05 Aligned_cols=271 Identities=25% Similarity=0.420 Sum_probs=214.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-----CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc--CCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGE 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 679 (941)
..++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 357889999999999999999984 3689999999987666666789999999999999999999999854 456
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred eEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 899999999999999997643 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh-------
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ------- 832 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~------- 832 (941)
....... ........++..|+|||++.+..++.++||||||+++|||++|..|+....... ......
T Consensus 164 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 164 LPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MRMIGNDKQGQMI 237 (295)
T ss_dssp ----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--HHHHCTTCCTHHH
T ss_pred ccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH--HhhhcCccccchh
Confidence 6432210 112233457778999999999999999999999999999999999986432110 000000
Q ss_pred -hccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 833 -SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 833 -~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
......+........+..++..+.+++..||+.+|++||++.++++.|+++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0011122233344566778889999999999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=371.44 Aligned_cols=285 Identities=22% Similarity=0.386 Sum_probs=206.4
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh-hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|+||+||+|+.. +++.||||++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999975 78999999987543222 23566899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++ |+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 154 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence 96 69999987643 45899999999999999999999999 9999999999999999999999999997543221
Q ss_pred CccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ..... ........
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~------~~~~~~~~ 222 (324)
T 3mtl_A 155 -----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIF------RILGTPTE 222 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH------HHHCCCCT
T ss_pred -----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH------HHhCCCCh
Confidence 12234468999999999887 5689999999999999999999999976543221 11110 00000000
Q ss_pred -CCChHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 846 -SYPSECV-EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 846 -~~~~~~~-~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
..+.... ..+.. ...|..+.. ......+..++...+||.+||.+||++|||++|+|+||||.+
T Consensus 223 ~~~~~~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 223 ETWPGILSNEEFKT------YNYPKYRAE---------ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp TTSTTGGGCHHHHH------TCCCCCCCC---------CHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred Hhchhhhcchhhcc------cccccccch---------hhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 0000000 00000 001111110 011122344555678999999999999999999999999987
Q ss_pred CCCC
Q 002289 924 DVSG 927 (941)
Q Consensus 924 ~~~~ 927 (941)
....
T Consensus 288 ~~~~ 291 (324)
T 3mtl_A 288 LGER 291 (324)
T ss_dssp GCST
T ss_pred cccc
Confidence 6544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=390.45 Aligned_cols=257 Identities=22% Similarity=0.293 Sum_probs=198.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC---CchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|... +|+.||||+++.. .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999964 6899999998753 222335678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|||+++|+|.+++.... .+++..++.++.||++||+|||+ .+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997654 48999999999999999999998 88 99999999999999999999999999975432
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ...
T Consensus 302 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i---------~~~ 364 (446)
T 4ejn_A 302 D-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELI---------LME 364 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------HHC
T ss_pred C-------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHH---------HhC
Confidence 1 1223446799999999999999999999999999999999999999975432111 0000 000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC-----CCccCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLK 917 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa~e~L~ 917 (941)
...+|. ...+.+.+||.+||..||++|+ +++|+++
T Consensus 365 -~~~~p~---------------------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 -EIRFPR---------------------------------------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCCCT---------------------------------------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCc---------------------------------------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 001111 1122334677888888899998 9999999
Q ss_pred CCCCCCCCC
Q 002289 918 HPYVSSDVS 926 (941)
Q Consensus 918 Hpwf~~~~~ 926 (941)
||||++..+
T Consensus 405 hp~f~~~~~ 413 (446)
T 4ejn_A 405 HRFFAGIVW 413 (446)
T ss_dssp SGGGTTCCH
T ss_pred CccccCCCH
Confidence 999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=372.10 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=203.7
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|.+.+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|+++++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36789999999999999999996 57899999998643211 235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+ +|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 789999886654 4899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... .+...+..
T Consensus 162 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~i~~ 222 (336)
T 3h4j_B 162 --------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----------NLFKKVNS 222 (336)
T ss_dssp --------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----------TCBCCCCS
T ss_pred --------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHHc
Confidence 12234569999999999988776 68999999999999999999999643210 01111111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
.....|.. .++.+.+||++||..||++|||++|+++||||+
T Consensus 223 ~~~~~p~~---------------------------------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 223 CVYVMPDF---------------------------------------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp SCCCCCTT---------------------------------------SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred CCCCCccc---------------------------------------CCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 11111111 112234688888999999999999999999997
Q ss_pred CCC
Q 002289 923 SDV 925 (941)
Q Consensus 923 ~~~ 925 (941)
...
T Consensus 264 ~~~ 266 (336)
T 3h4j_B 264 VNL 266 (336)
T ss_dssp TTC
T ss_pred cCC
Confidence 643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=388.74 Aligned_cols=265 Identities=24% Similarity=0.436 Sum_probs=220.6
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.+++....++|++.+.||+|+||+||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345556678899999999999999999999888999999998644 34568999999999999999999999986 5678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|+|.++++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999997654445788999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... ........++..|+|||++.+..++.++|||||||++|||+| |+.||....... ... .+
T Consensus 335 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-~~~---------~i 398 (454)
T 1qcf_A 335 EDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIR---------AL 398 (454)
T ss_dssp CCHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH---------HH
T ss_pred CCCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HH
Confidence 3211 111223346788999999999999999999999999999999 999997654321 111 11
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
..+.....+..++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 399 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 22233345667788999999999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=390.98 Aligned_cols=297 Identities=22% Similarity=0.292 Sum_probs=196.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeecccc-----CCc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EGE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 679 (941)
.++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999965 68999999986532 2335678999999999999999999999843 357
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+ +|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 67999999654 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCcc--------------------ccccccccccCCCcccccccc-cCCCCchhHhHHHHHHHHHHHhC-----
Q 002289 760 APVPDIEGIV--------------------PAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTG----- 813 (941)
Q Consensus 760 ~~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlG~ll~elltG----- 813 (941)
.......... .........||+.|+|||++. +..++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6432211000 012234567899999999864 56799999999999999999994
Q ss_pred ------CCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH--------HHH
Q 002289 814 ------MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV--------MRE 879 (941)
Q Consensus 814 ------~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v--------~~~ 879 (941)
+.+|............ ................+..+...+ . .|+..++ ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~i~~~~-g-----~p~~~~~~~~~~~~~~~~ 350 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQ---------KAGNDFKFHTRGNRDQLNVIFNIL-G-----TPSEEDIEALEKEDAKRY 350 (458)
T ss_dssp SSGGGCCCSCC-----------------------------CHHHHHHHHHHHHHH-C-----CCCHHHHHTSSCHHHHHH
T ss_pred cccccccccCCCCccccccccc---------cccccccccccCCHHHHHHHHHHc-C-----CCCHHHHhhcCCHHHHHH
Confidence 4444322110000000 000000000111111221111111 0 1111111 000
Q ss_pred HH--------HhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 880 LE--------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 880 L~--------~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
+. .+...++...+.+.+||.+||++||++|+|++|+|+||||+..-
T Consensus 351 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 00 11223344556678899999999999999999999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=372.39 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=195.9
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
..++|++.+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3568999999999999999999976 58899999997543 34578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeeccccccCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAPV 762 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGla~~~~~ 762 (941)
|+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999654 35899999999999999999999999 999999999999975 88999999999986532
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 204 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------------- 262 (349)
T 2w4o_A 204 Q--------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR------------- 262 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-------------
T ss_pred c--------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-------------
Confidence 1 1223456899999999999999999999999999999999999999754432111110
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
+..+....+. | ..+.......+||.+||..||++|||++|+|+||||.
T Consensus 263 ----------------i~~~~~~~~~--~--------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 263 ----------------ILNCEYYFIS--P--------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp ----------------HHTTCCCCCT--T--------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred ----------------HHhCCCccCC--c--------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 1111000000 0 0011222345789999999999999999999999998
Q ss_pred CCCCC
Q 002289 923 SDVSG 927 (941)
Q Consensus 923 ~~~~~ 927 (941)
+....
T Consensus 311 ~~~~~ 315 (349)
T 2w4o_A 311 GKAAN 315 (349)
T ss_dssp STTCC
T ss_pred CCccc
Confidence 76543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=375.92 Aligned_cols=264 Identities=28% Similarity=0.452 Sum_probs=217.9
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
+....++|.+.+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3445678889999999999999999986 7899999998764332 3457899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 189 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999997543 34889999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+.
T Consensus 265 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~--------~~~ 329 (377)
T 3cbl_A 265 DGVY-----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--RE--------FVE 329 (377)
T ss_dssp TSEE-----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HH--------HHH
T ss_pred CCce-----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH--------HHH
Confidence 2110 111112235678999999999999999999999999999998 9999976543211 11 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.+.....|..++..+.+++..||+.+|++||++.++++.|+++.+.
T Consensus 330 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 2233445666778899999999999999999999999999988653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=377.92 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=201.3
Q ss_pred cceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 614 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999964 6899999999876666677899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE--cCCCcEEEeeeccccccCCCCCCCccc
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL--DHKFTAKVADFGLSRLAPVPDIEGIVP 770 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~ 770 (941)
.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------ 243 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------ 243 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC------
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc------
Confidence 99886532 35889999999999999999999999 9999999999999 567899999999998764321
Q ss_pred cccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChH
Q 002289 771 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 850 (941)
Q Consensus 771 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (941)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------------------- 296 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------------------------- 296 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------------------
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------------------
Confidence 12334689999999999999999999999999999999999999975443111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 851 CVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 851 ~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
+.++....+...+.. ++...+.+.+||.+||..||++|||++|+|+||||+..
T Consensus 297 ----~~~i~~~~~~~~~~~-----------------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 297 ----LNNILACRWDLEDEE-----------------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----HHHHHHTCCCSCSGG-----------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----HHHHHhccCCCChhh-----------------hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 111111111111110 11223344578999999999999999999999999764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=392.50 Aligned_cols=203 Identities=24% Similarity=0.420 Sum_probs=178.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|.+.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999975 6999999998753222 235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 684 YEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
|||++||+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 446999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 321 1123457999999999999999999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=362.89 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=197.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--------------------------hhHhHHHHHHHHH
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------------------GEKEFLTEIQFLS 660 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 660 (941)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999964 6899999998754321 1246889999999
Q ss_pred hcCCCceeeeeecccc--CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 002289 661 RLHHRNLVSLVGYCDE--EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 738 (941)
Q Consensus 661 ~l~h~nIv~l~~~~~~--~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 738 (941)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.|+++||+|||+++ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999876 568899999999999988653 235899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCC---CCchhHhHHHHHHHHHHHhCCC
Q 002289 739 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQ 815 (941)
Q Consensus 739 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlG~ll~elltG~~ 815 (941)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999998654321 1223456899999999998765 3778999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCc
Q 002289 816 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTP 895 (941)
Q Consensus 816 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~ 895 (941)
||....... .. ..+.......|. . +...+...
T Consensus 239 pf~~~~~~~-~~-----------------------------~~~~~~~~~~~~-~-----------------~~~~~~l~ 270 (298)
T 2zv2_A 239 PFMDERIMC-LH-----------------------------SKIKSQALEFPD-Q-----------------PDIAEDLK 270 (298)
T ss_dssp SSCCSSHHH-HH-----------------------------HHHHHCCCCCCS-S-----------------SCCCHHHH
T ss_pred CCCCccHHH-HH-----------------------------HHHhcccCCCCC-c-----------------cccCHHHH
Confidence 997543211 00 000000000000 0 11122234
Q ss_pred ccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 896 EFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 896 dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
++|.+||..||++|||++|+++||||+
T Consensus 271 ~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 271 DLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 688889999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=365.99 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=184.1
Q ss_pred cceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEEecCCCCC
Q 002289 614 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~~~gs 691 (941)
.+.||+|+||+||+|... +++.||||++... ....+.+|+++++.+. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 6899999998642 3457789999999997 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEeeeccccccCCCCCCCc
Q 002289 692 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 692 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 768 (941)
|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++......
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---- 163 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---- 163 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC----
Confidence 99999765 35899999999999999999999999 99999999999997765 89999999998653321
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (941)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||........ . ..
T Consensus 164 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~-------------~~ 220 (325)
T 3kn6_A 164 ---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-------C-------------TS 220 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------------C-------------CC
T ss_pred ---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-------c-------------cc
Confidence 122345689999999999999999999999999999999999999964321000 0 00
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 849 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
..+++.......+...+ .. .....+.+.+||.+||..||++|||++|+++||||+....
T Consensus 221 ------~~~~~~~i~~~~~~~~~--~~-----------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 221 ------AVEIMKKIKKGDFSFEG--EA-----------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ------HHHHHHHHTTTCCCCCS--HH-----------HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ------HHHHHHHHHcCCCCCCc--cc-----------ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 00011111111100000 00 0012233457899999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=372.45 Aligned_cols=270 Identities=25% Similarity=0.429 Sum_probs=220.7
Q ss_pred cchHHHHHHhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeee
Q 002289 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSL 670 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l 670 (941)
+...++....++|++.+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45567777889999999999999999999983 24689999999864433 346799999999999 79999999
Q ss_pred eeccccCC-cEEEEEecCCCCCHHHHHhhcCC------------------------------------------------
Q 002289 671 VGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK------------------------------------------------ 701 (941)
Q Consensus 671 ~~~~~~~~-~~~LV~e~~~~gsL~~~l~~~~~------------------------------------------------ 701 (941)
++++.+.+ ..++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99987755 48999999999999999976432
Q ss_pred ----------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 702 ----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 702 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12899999999999999999999999 99999999999999999999999999986533221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||............ +..+..
T Consensus 249 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---------~~~~~~ 314 (359)
T 3vhe_A 249 -----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---------LKEGTR 314 (359)
T ss_dssp -----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH---------HHHTCC
T ss_pred -----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH---------HHcCCC
Confidence 122344568899999999999999999999999999999998 99999764432211111 112223
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
...+..++..+.+++..|++.+|.+||++.+++++|+.+..
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 34455667789999999999999999999999999998765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=378.87 Aligned_cols=202 Identities=27% Similarity=0.381 Sum_probs=168.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHH-HHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||.||+|+.+ +++.||||+++..... ....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999975 5899999999754322 23456677776 577899999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999997643 4888999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 192 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 192 H-------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp C-------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred C-------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 1 122345679999999999999999999999999999999999999997544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=378.74 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=215.7
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC-cEEE
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQML 682 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~L 682 (941)
+....++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3345678889999999999999999985 7899999998643 4567999999999999999999999986654 7999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999998776666899999999999999999999999 99999999999999999999999999985422
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
. .....++..|+|||++.+..++.++|||||||++|||++ |+.||........ ...+..
T Consensus 342 ~----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------~~~i~~ 401 (450)
T 1k9a_A 342 T----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------VPRVEK 401 (450)
T ss_dssp ---------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH----------HHHHHT
T ss_pred c----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------HHHHHc
Confidence 1 112246789999999999999999999999999999998 9999975432111 111222
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+.....|..++..+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 402 ~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 402 GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 33345667788899999999999999999999999999998865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=372.32 Aligned_cols=261 Identities=27% Similarity=0.458 Sum_probs=204.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467899999999999999999864 577899999976432 335679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.++++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999754 345899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+..
T Consensus 200 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-~~~---------~i~~ 265 (373)
T 2qol_A 200 DPEA----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-VIK---------AVDE 265 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-HHH---------HHHT
T ss_pred CCcc----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHHc
Confidence 2110 111122345778999999999999999999999999999998 999997654321 111 1111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 122334556778899999999999999999999999999988653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=366.57 Aligned_cols=283 Identities=20% Similarity=0.305 Sum_probs=203.7
Q ss_pred hcCCCcc-ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++. +.||+|+||+||+|... +++.||||++........+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999964 7899999999876555567899999999985 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeeccccccC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAP 761 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DFGla~~~~ 761 (941)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++...
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999997653 4889999999999999999999999 999999999999998776 9999999997654
Q ss_pred CCCCCCccccccccccccCCCccccccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------~~ 235 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----------CG 235 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC----------SC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc----------cc
Confidence 322111111122234569999999999875 557889999999999999999999997543210 00
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
+ ............+.+.+..... ..|. . ..........+||.+||..||++|||++|+|
T Consensus 236 ~-----~~~~~~~~~~~~~~~~i~~~~~----~~~~-~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 236 W-----DRGEACPACQNMLFESIQEGKY----EFPD-K-----------DWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp C---------CCHHHHHHHHHHHHHCCC----CCCH-H-----------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred c-----cccccchhHHHHHHHHHhccCc----ccCc-h-----------hcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 0 0000111112222222221110 0110 0 0012233456899999999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 917 KHPYVSSDVS 926 (941)
Q Consensus 917 ~Hpwf~~~~~ 926 (941)
+||||++...
T Consensus 295 ~hp~~~~~~~ 304 (316)
T 2ac3_A 295 QHPWVQGCAP 304 (316)
T ss_dssp HSTTCC----
T ss_pred cChhhcCCCC
Confidence 9999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=358.68 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=216.0
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.+....++|++.+.||+|+||+||+|.+.++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 44455778999999999999999999998888999999986443 34679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999996532 35899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......... . .+..
T Consensus 173 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-~---------~~~~ 236 (283)
T 3gen_A 173 DE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-E---------HIAQ 236 (283)
T ss_dssp HH------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-H---------HHHT
T ss_pred cc------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-H---------HHhc
Confidence 21 112233446788999999999999999999999999999998 99999765432111 1 1112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+.....+..++..+.+++..||+.+|.+||++.++++.|+++.+
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 22233445556789999999999999999999999999998765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=384.24 Aligned_cols=264 Identities=30% Similarity=0.469 Sum_probs=215.8
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
+.+....++|++.+.||+|+||.||+|.++++..||||+++.... ..+.|.+|++++++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 445556788999999999999999999998888899999986443 34679999999999999999999999876 6789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999997644456899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... .......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+.
T Consensus 332 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~---------~i~ 395 (452)
T 1fmk_A 332 DNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLD---------QVE 395 (452)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHH---------HHH
T ss_pred CCce------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHH
Confidence 3211 11223446789999999999999999999999999999999 999997554321 111 112
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.+.....+..++..+.+++..||+.+|++||++.++++.|+.+...
T Consensus 396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 2233445667788999999999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=368.31 Aligned_cols=265 Identities=29% Similarity=0.484 Sum_probs=218.7
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeecccc
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 676 (941)
+....++|++.+.||+|+||.||+|++. +++.||||+++..... ..+.+.+|++++++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445688999999999999999999974 3489999999864333 35678999999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC----------------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 734 (941)
.+..++||||+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 999999999999999999997642 256899999999999999999999999 9999
Q ss_pred cCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-C
Q 002289 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-G 813 (941)
Q Consensus 735 DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G 813 (941)
||||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 9999999999999999999999976532211 112234457889999999999999999999999999999999 9
Q ss_pred CCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 814 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 814 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
+.||....... .. ..+..+.....+..++..+.+++..||+.+|.+||++.++++.|+++...
T Consensus 274 ~~p~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 274 LQPYYGMAHEE-VI---------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CCTTTTSCHHH-HH---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCcCCCCChHH-HH---------HHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 99997544311 11 12223334455667778899999999999999999999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=372.99 Aligned_cols=286 Identities=22% Similarity=0.354 Sum_probs=203.3
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
..++|++.+.||+|+||+||+|+.. +++.||||+++...... .+.+.+|++++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3568999999999999999999964 78999999997543322 35678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE-----cCCCcEEEeeecccc
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-----DHKFTAKVADFGLSR 758 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-----~~~~~~kl~DFGla~ 758 (941)
|||++ |+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99996 59999997654 4889999999999999999999999 9999999999999 455669999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||............ .....
T Consensus 186 ~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~-- 255 (329)
T 3gbz_A 186 AFGIPI-------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI-FEVLG-- 255 (329)
T ss_dssp HHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHHHC--
T ss_pred ccCCcc-------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH-HHHhC--
Confidence 654221 222345679999999999874 4899999999999999999999999765543222111 10000
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
.......+. ...+ .......|..+ ........ ...++.+.+||.+||+.||++|||++|+|
T Consensus 256 ---~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 256 ---LPDDTTWPG-----VTAL-PDWKQSFPKFRGKTLKRVLG---------ALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp ---CCCTTTSTT-----GGGS-TTCCTTCCCCCCCCHHHHHG---------GGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---CCchhhhhh-----hhhh-hhhhhhhhhhccccHhhhcc---------cccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 000000000 0000 00001111111 12221110 11234456899999999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 917 KHPYVSSDVS 926 (941)
Q Consensus 917 ~Hpwf~~~~~ 926 (941)
+||||++..+
T Consensus 318 ~hp~f~~~~~ 327 (329)
T 3gbz_A 318 EHPYFSHNDF 327 (329)
T ss_dssp TSGGGSSSCS
T ss_pred CCcccCCCCC
Confidence 9999998543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=357.64 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=208.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999965 689999999864322 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.... ++++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997654 5899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||............ +...
T Consensus 165 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~----------~~~~ 228 (294)
T 4eqm_A 165 S------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH----------IQDS 228 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH----------HSSC
T ss_pred c------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----------hhcc
Confidence 1 12223456899999999999999999999999999999999999999765543222111 1111
Q ss_pred CC----CCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHh
Q 002289 844 MG----SYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 885 (941)
Q Consensus 844 ~~----~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~ 885 (941)
.+ ..+..++..+.+++.+|++.+|.+|| ++.++.+.|+.+..
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11 12334567889999999999999998 88888888876643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=368.47 Aligned_cols=265 Identities=26% Similarity=0.458 Sum_probs=219.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC--------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeeeeecccc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 676 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 676 (941)
..++|.+.+.||+|+||+||+|++. ++..||||+++..... ..+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578899999999999999999852 2467999999765333 346789999999999 99999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 742 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 742 (941)
.+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999997654 245899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCc
Q 002289 743 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 821 (941)
Q Consensus 743 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~ 821 (941)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999986643321 112233457889999999999999999999999999999999 999997543
Q ss_pred hhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
. .+... .+..+.....+..++..+.+++..||+.+|++||++.++++.|+++......
T Consensus 299 ~-~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 299 V-EELFK---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp H-HHHHH---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred H-HHHHH---------HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2 11111 1122223345566778899999999999999999999999999998776543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=374.74 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=195.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
..++|++.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3568999999999999999999976 789999999976432 34578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--EEEeeeccccccCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRLAPVP 763 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DFGla~~~~~~ 763 (941)
|+++|+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 97 YASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999997644 4899999999999999999999999 999999999999987765 999999998743221
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCch-hHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.......||+.|+|||++.+..++.+ +||||+||++|||++|+.||..........
T Consensus 172 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--------------- 228 (361)
T 3uc3_A 172 --------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--------------- 228 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH---------------
T ss_pred --------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH---------------
Confidence 12234569999999999998887766 899999999999999999996432210000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
..+..+ ..... ..|. .....+.+.+||.+||..||++|||++|+++||||.
T Consensus 229 ----------~~~~~~----~~~~~-~~~~--------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 229 ----------KTIQRI----LSVKY-SIPD--------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp ----------HHHHHH----HTTCC-CCCT--------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred ----------HHHHHH----hcCCC-CCCC--------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 000000 00000 0000 001122334688889999999999999999999995
Q ss_pred CC
Q 002289 923 SD 924 (941)
Q Consensus 923 ~~ 924 (941)
..
T Consensus 280 ~~ 281 (361)
T 3uc3_A 280 KN 281 (361)
T ss_dssp TT
T ss_pred cC
Confidence 54
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=368.86 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=198.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.++||+|+||+||+|++. +|+.||||++..... .....+..|+..+.++ +|+||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999976 799999999865332 2334556666666555 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 789999887653 45999999999999999999999999 999999999999999999999999998765332
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......||+.|+|||++.+ .++.++|||||||++|||++|..|+....... .+..+
T Consensus 211 --------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------------~~~~~- 267 (311)
T 3p1a_A 211 --------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-------------QLRQG- 267 (311)
T ss_dssp ------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-------------HHTTT-
T ss_pred --------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------------HHhcc-
Confidence 12234568999999999876 78999999999999999999977765322110 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
..+.+.. ....+...+++.+||..||++|||++|+|+||||+.
T Consensus 268 --~~~~~~~-----------------------------------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 --YLPPEFT-----------------------------------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --CCCHHHH-----------------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --CCCcccc-----------------------------------cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0111100 112233457888899999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=380.05 Aligned_cols=286 Identities=19% Similarity=0.250 Sum_probs=211.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc------CCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL------HHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~ 680 (941)
..+|++.+.||+|+||+||+|... +++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999865 5899999999753 23345778898888887 567999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--EEEeeecccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSR 758 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DFGla~ 758 (941)
++||||+. ++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 79999998776667999999999999999999999999 999999999999999887 9999999997
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.... +
T Consensus 251 ~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-l~~i~------~ 313 (429)
T 3kvw_A 251 YEHQ----------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ-LACMI------E 313 (429)
T ss_dssp ETTC----------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH------H
T ss_pred ecCC----------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHH------H
Confidence 5432 12335689999999999999999999999999999999999999976543221 11111 0
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCC---------------------C------CCCHHHHHHHHHHhHhhCCCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETD---------------------A------RPSMSEVMRELESIWNMMPESD 891 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~---------------------~------RPs~~~v~~~L~~~~~~~~~~~ 891 (941)
. .+..+.+....... ....+..... . .|...+.... .....+
T Consensus 314 ~----~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------l~~~~~ 382 (429)
T 3kvw_A 314 L----LGMPSQKLLDASKR-AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA------LKGCDD 382 (429)
T ss_dssp H----HCCCCHHHHHTBTT-HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHH------TTTCCC
T ss_pred H----cCCCCHHHHHhhhh-hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhh------ccccch
Confidence 0 11112222111100 0111100000 0 0001111110 011223
Q ss_pred CCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 892 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 892 ~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
+.+.+||.+||++||++||||+|+|+||||+....
T Consensus 383 ~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred HHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence 45678999999999999999999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=357.72 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=208.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||+||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 567999999999999999999975 5789999998765555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeeccccccCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFGla~~~~~~ 763 (941)
+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999987643 4889999999999999999999999 9999999999999 78899999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
. ......||+.|+|||++.+. ++.++||||||+++|||++|+.||........... +..+
T Consensus 163 ~--------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----------~~~~- 222 (277)
T 3f3z_A 163 K--------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----------IREG- 222 (277)
T ss_dssp S--------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------HHHC-
T ss_pred c--------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----------HHhC-
Confidence 1 22344689999999998664 89999999999999999999999975443211100 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
...++.... ....+...+++.+||..||++|||+.|+|+||||+.
T Consensus 223 ~~~~~~~~~-----------------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 223 TFTFPEKDW-----------------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CCCCCHHHH-----------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CCCCCchhh-----------------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 011111100 111223346888899999999999999999999976
Q ss_pred CCC
Q 002289 924 DVS 926 (941)
Q Consensus 924 ~~~ 926 (941)
...
T Consensus 268 ~~~ 270 (277)
T 3f3z_A 268 QLS 270 (277)
T ss_dssp HHC
T ss_pred ccc
Confidence 433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=361.76 Aligned_cols=286 Identities=23% Similarity=0.331 Sum_probs=209.0
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999975 5899999988654332 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999988654 34889999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||..|+|||++.+ ..++.++||||+||++|||++|+.||.............. ..
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~---- 219 (311)
T 4agu_A 157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK-------TL---- 219 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------HH----
T ss_pred ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-------Hh----
Confidence 12234568999999999986 6789999999999999999999999976554322111110 00
Q ss_pred CCCChHHHHHHHH--HHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 845 GSYPSECVEKFIK--LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 845 ~~~~~~~~~~l~~--l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
+.........+.. ........+|....... ...+.......+|+.+||..||++|||++|+|+||||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLE----------LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHH----------HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccccccccccccccccCcCCCccccchhh----------hhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 0111111110000 00000011111111111 11233444566899999999999999999999999998
Q ss_pred CCCCC
Q 002289 923 SDVSG 927 (941)
Q Consensus 923 ~~~~~ 927 (941)
+-..-
T Consensus 290 ~~~~~ 294 (311)
T 4agu_A 290 NIREI 294 (311)
T ss_dssp TCC--
T ss_pred hccCH
Confidence 75443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=362.42 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=209.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||.||+|... +|+.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999975 6899999998754322 246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 756 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFGl 756 (941)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999654 45899999999999999999999999 99999999999999888 799999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 166 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~------- 229 (321)
T 2a2a_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN------- 229 (321)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH-------
T ss_pred ceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHH-------
Confidence 98654321 12344689999999999999999999999999999999999999975432111 000
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
+.. ....++... .........+||.+||..||++|||++|++
T Consensus 230 --i~~-~~~~~~~~~-----------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 271 (321)
T 2a2a_A 230 --ITS-VSYDFDEEF-----------------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEAL 271 (321)
T ss_dssp --HHT-TCCCCCHHH-----------------------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHH
T ss_pred --HHh-cccccChhh-----------------------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 000 000111110 011223345789999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 917 KHPYVSSDV 925 (941)
Q Consensus 917 ~Hpwf~~~~ 925 (941)
+||||+...
T Consensus 272 ~hp~~~~~~ 280 (321)
T 2a2a_A 272 RHPWITPVD 280 (321)
T ss_dssp HSTTTSCSS
T ss_pred cCccccCCC
Confidence 999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=362.26 Aligned_cols=268 Identities=24% Similarity=0.294 Sum_probs=208.2
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC----cEE
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQM 681 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~ 681 (941)
...++|++.+.||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34678999999999999999999875 7999999997533 23345667999999999999999999997644 469
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC----------CCCCeEeccCCCCcEEEcCCCcEEE
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------ADPPVFHRDIKASNILLDHKFTAKV 751 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~DLkp~NILl~~~~~~kl 751 (941)
+||||+++|+|.++++.. .+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||
T Consensus 99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 999999999999999764 389999999999999999999998 7 999999999999999999999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccC-----CCCchhHhHHHHHHHHHHHhCCCCCCCCchhH--
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-- 824 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~-- 824 (941)
+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....+..
T Consensus 173 ~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 173 ADFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCCTTCEEECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred ccCCcccccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 99999986643321 1122345689999999999873 45668899999999999999999996432100
Q ss_pred HHHHHHHh---hccchh-hhcCC-CCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 825 REVNIAYQ---SSMMFS-VIDGN-MGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 825 ~~~~~~~~---~~~~~~-~~~~~-~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.+...... ...+.. ..... .+.. ...++..+.+++.+||+.+|++||++.++++.|+.+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000000 000000 11111 1111 235677899999999999999999999999999988653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=381.26 Aligned_cols=301 Identities=23% Similarity=0.299 Sum_probs=207.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeeccccC-----Cc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 679 (941)
.++|++.+.||+|+||.||+|++. +++.||||+++.. .....+.+.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999975 6899999999753 223356789999999999999999999998765 57
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||++ |+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999995 6999999654 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCcc---------------ccccccccccCCCccccccc-ccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchh
Q 002289 760 APVPDIEGIV---------------PAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 823 (941)
Q Consensus 760 ~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~ 823 (941)
.......... .........||+.|+|||++ .+..++.++||||+||++|||++|..||.....-
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6433211000 00123566799999999986 4567999999999999999999865555321100
Q ss_pred HHHHHHHHhhccchhhhcCC----------CCCCC-hHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHHHH--------
Q 002289 824 VREVNIAYQSSMMFSVIDGN----------MGSYP-SECVEKFIKLALKCCQDETD--ARPSMSEVMRELES-------- 882 (941)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~----------~~~~~-~~~~~~l~~l~~~c~~~~p~--~RPs~~~v~~~L~~-------- 882 (941)
. .-.+.+. ..... ......+..++..+-....+ .+....++.+.+..
T Consensus 259 ~------------~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (432)
T 3n9x_A 259 R------------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326 (432)
T ss_dssp C------------CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred c------------cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCC
Confidence 0 0000000 00000 00111111111111000000 00001111111111
Q ss_pred hHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 883 IWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 883 ~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
+...++..++.+.+||.+||++||++||||+|+|+||||++...
T Consensus 327 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 11123445666788999999999999999999999999987544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.45 Aligned_cols=263 Identities=29% Similarity=0.465 Sum_probs=217.6
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccC
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 677 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 677 (941)
....++|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34567899999999999999999985 2458899999976433 3346789999999999999999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC----------------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSK----------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 735 (941)
+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999976432 34899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CC
Q 002289 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 814 (941)
Q Consensus 736 Lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~ 814 (941)
|||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cchheEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999986543221 112233457788999999999999999999999999999999 99
Q ss_pred CCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 815 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 815 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.||........ . ..+..+.....+..++..+.+++..|++.+|.+||++.++++.|+++..
T Consensus 251 ~p~~~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 251 NPYPGIPPERL-F---------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CSSTTCCGGGH-H---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHH-H---------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99975443111 1 1111222334556677889999999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=373.05 Aligned_cols=276 Identities=22% Similarity=0.358 Sum_probs=206.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccC------C
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 678 (941)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467899999999999999999974 69999999986532 22346788999999999999999999998665 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 88999999753 4889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ......
T Consensus 177 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~----- 240 (367)
T 1cm8_A 177 QADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMK----- 240 (367)
T ss_dssp ECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-----
T ss_pred cccc----------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-----
Confidence 6432 1234568999999999987 7899999999999999999999999976544322 111110
Q ss_pred hhhcCCCCCCChHHHHH-----HHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC
Q 002289 838 SVIDGNMGSYPSECVEK-----FIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 911 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~-----l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 911 (941)
. .+..+.+.... ....+.. .|.. +.. +...++...+.+.+||.+||+.||++|+|
T Consensus 241 -~----~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~~~ll~~mL~~dP~~R~t 301 (367)
T 1cm8_A 241 -V----TGTPPAEFVQRLQSDEAKNYMKG----LPELEKKD----------FASILTNASPLAVNLLEKMLVLDAEQRVT 301 (367)
T ss_dssp -H----HCCCCHHHHHTCSCHHHHHHHHH----SCCCCCCC----------GGGTCTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred -h----cCCCCHHHHHHhhhHHHHHHHHh----CCCCCCCC----------HHHHCCCCCHHHHHHHHHHccCChhHCCC
Confidence 0 11122222211 1111111 1111 111 11223444556778999999999999999
Q ss_pred CccCCCCCCCCCCC
Q 002289 912 SSSMLKHPYVSSDV 925 (941)
Q Consensus 912 a~e~L~Hpwf~~~~ 925 (941)
++|+|+||||+...
T Consensus 302 ~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 302 AGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHSGGGTTTC
T ss_pred HHHHhcChHHHhhc
Confidence 99999999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=363.94 Aligned_cols=278 Identities=22% Similarity=0.304 Sum_probs=215.5
Q ss_pred cccchHHHHHHhcCCCcc-ceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhc-CCCceeeee
Q 002289 597 RSFTYGEMALATNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLV 671 (941)
Q Consensus 597 ~~~~~~~~~~~~~~y~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~ 671 (941)
+...+.......++|.+. +.||+|+||+||+|... +++.||+|+++... ......+.+|+.+++.+ +||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344556667778888887 88999999999999975 68999999987532 22356789999999999 569999999
Q ss_pred eccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCc
Q 002289 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFT 748 (941)
Q Consensus 672 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~ 748 (941)
+++...+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999999997665667999999999999999999999999 999999999999987 789
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 828 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~ 828 (941)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 173 ~kL~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 244 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA--------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244 (327)
T ss_dssp EEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEeeCccccccCCc--------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 999999999865422 112345689999999999999999999999999999999999999975443211111
Q ss_pred HHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCC
Q 002289 829 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 908 (941)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~ 908 (941)
+........+... ........++|.+||..||++
T Consensus 245 -----------------------------i~~~~~~~~~~~~-----------------~~~~~~~~~li~~~L~~dP~~ 278 (327)
T 3lm5_A 245 -----------------------------ISQVNVDYSEETF-----------------SSVSQLATDFIQSLLVKNPEK 278 (327)
T ss_dssp -----------------------------HHHTCCCCCTTTT-----------------TTSCHHHHHHHHHHSCSSGGG
T ss_pred -----------------------------HHhcccccCchhh-----------------cccCHHHHHHHHHHcCCChhh
Confidence 0000000000000 111222346888899999999
Q ss_pred CCCCccCCCCCCCCCCCCCCccc
Q 002289 909 PPSSSSMLKHPYVSSDVSGSNLV 931 (941)
Q Consensus 909 R~sa~e~L~Hpwf~~~~~~~~~~ 931 (941)
|||++|+|+||||++..+.....
T Consensus 279 Rpt~~~ll~h~~~~~~~~~~~~~ 301 (327)
T 3lm5_A 279 RPTAEICLSHSWLQQWDFENLFH 301 (327)
T ss_dssp SCCHHHHTTCGGGCCCCTTCC--
T ss_pred CcCHHHHhCCHhhcccccccccC
Confidence 99999999999998766554433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.91 Aligned_cols=280 Identities=18% Similarity=0.321 Sum_probs=210.0
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeecccc--CCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~LV 683 (941)
.++|++.+.||+|+||+||+|+. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999986 478999999987532 457899999999997 9999999999977 6678999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeeccccccCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPV 762 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~~~ 762 (941)
|||+++++|.+++.. +++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999843 788899999999999999999999 99999999999999776 899999999986543
Q ss_pred CCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. ......||..|+|||++.+ ..++.++|||||||++|||++|+.||....+..+..........
T Consensus 184 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~------ 249 (330)
T 3nsz_A 184 GQ--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG------ 249 (330)
T ss_dssp TC--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC------
T ss_pred CC--------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC------
Confidence 21 1233468899999999987 67899999999999999999999999766554333322111100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH--HhHhhCC-----CCCCCCcccccccCCCCCCCCCCCcc
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE--SIWNMMP-----ESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~--~~~~~~~-----~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
...+.+.+.. ......|...+...... .+..... ...+.+.+||.+||..||++||||+|
T Consensus 250 ----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 316 (330)
T 3nsz_A 250 ----------TEDLYDYIDK---YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316 (330)
T ss_dssp ----------HHHHHHHHHH---TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ----------CchhhhHHHH---hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 0011111111 11111122211110000 0000000 12344567999999999999999999
Q ss_pred CCCCCCCCCCC
Q 002289 915 MLKHPYVSSDV 925 (941)
Q Consensus 915 ~L~Hpwf~~~~ 925 (941)
+|+||||++..
T Consensus 317 ~l~hp~f~~~~ 327 (330)
T 3nsz_A 317 AMEHPYFYTVV 327 (330)
T ss_dssp HHTSGGGTTCC
T ss_pred HhcCccHhhhc
Confidence 99999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=364.84 Aligned_cols=262 Identities=21% Similarity=0.347 Sum_probs=198.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCC-------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------- 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------- 678 (941)
.++|++.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999976 799999999875433 34567999999999999999999999875432
Q ss_pred --------------------------------------------------cEEEEEecCCCCCHHHHHhhcCC-CCccHH
Q 002289 679 --------------------------------------------------EQMLVYEFMSNGTLRDQLSAKSK-EPLGFA 707 (941)
Q Consensus 679 --------------------------------------------------~~~LV~e~~~~gsL~~~l~~~~~-~~l~~~ 707 (941)
..++||||+++|+|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999976533 345667
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc-----ccccccccccCCC
Q 002289 708 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV-----PAHVSTVVKGTPG 782 (941)
Q Consensus 708 ~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~-----~~~~~~~~~gt~~ 782 (941)
.++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........... .........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999999 999999999999999999999999999876543211100 0112234569999
Q ss_pred cccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHh
Q 002289 783 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKC 862 (941)
Q Consensus 783 y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 862 (941)
|+|||++.+..++.++|||||||++|||++|..|+..... .. ...... ..+...
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---~~---------~~~~~~---~~~~~~----------- 295 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---II---------TDVRNL---KFPLLF----------- 295 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---HH---------HHHHTT---CCCHHH-----------
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---HH---------HHhhcc---CCCccc-----------
Confidence 9999999999999999999999999999998665421100 00 000000 111100
Q ss_pred cccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 863 CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 863 ~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
... .+...+++.+||..||++|||++|+|+||||++
T Consensus 296 -----------~~~--------------~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 296 -----------TQK--------------YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp -----------HHH--------------CHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred -----------ccC--------------ChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 000 011136788889999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=386.59 Aligned_cols=262 Identities=30% Similarity=0.470 Sum_probs=220.1
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCC-CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
+++...++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.|.+|++++++++||||++++++|...+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 344456778899999999999999999764 88999999986433 3567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999998766677999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+.
T Consensus 370 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-~~~---------~~~ 433 (495)
T 1opk_A 370 GDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE---------LLE 433 (495)
T ss_dssp TCC------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHH---------HHH
T ss_pred CCc------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHH
Confidence 321 111223446788999999999999999999999999999999 999997544211 111 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
.+.....+..++..+.+++..||+.+|.+||++.++++.|+.+.
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 12233456677888999999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.67 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=204.1
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCC----CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
...++|++.+.||+|+||.||+|.+.. +..||+|+.+.... ...+.+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 346789999999999999999999642 56799999876433 33567899999999999999999999985 4678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999999754 345899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ...+
T Consensus 167 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~----------~~~i 230 (281)
T 1mp8_A 167 EDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----------IGRI 230 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------HHHH
T ss_pred Cccc------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH----------HHHH
Confidence 4322 111223446789999999999999999999999999999997 9999975443211 1112
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+.....+..++..+.+++..|++.+|++||++.++++.|+++..
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2233344566677889999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=356.21 Aligned_cols=264 Identities=30% Similarity=0.461 Sum_probs=222.3
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
+++....++|++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 445556788999999999999999999976 48899999997643 3456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999998877777999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||........ .. .+
T Consensus 162 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-~~---------~~ 225 (288)
T 3kfa_A 162 TGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YE---------LL 225 (288)
T ss_dssp CSSS------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HH---------HH
T ss_pred cCCc------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH---------HH
Confidence 4322 122334457889999999999999999999999999999999 9999975432111 11 11
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
........+..++..+.+++..|+..+|.+||++.++++.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1122233455667889999999999999999999999999988765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.97 Aligned_cols=265 Identities=28% Similarity=0.452 Sum_probs=218.1
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++....++|++.+.||+|+||.||+|...+++.||||+++... ...+.+.+|++++++++||||+++++++.. +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3444567899999999999999999998888899999997643 235678999999999999999999999864 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999996543335899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .+..
T Consensus 162 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~---------~~~~ 225 (279)
T 1qpc_A 162 NE------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQ---------NLER 225 (279)
T ss_dssp SC------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHH---------HHHT
T ss_pred cc------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-HHH---------HHhc
Confidence 22 111233456789999999998899999999999999999999 999997544321 111 1111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
+.....+..++..+.+++..|++.+|++||++.++++.|+.+.....
T Consensus 226 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 22233455667889999999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.90 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=207.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999975 689999999875332 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeeccccccC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAP 761 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DFGla~~~~ 761 (941)
||+++++|.+.+.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999887653 4889999999999999999999999 999999999999986655 9999999997654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...........
T Consensus 160 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~------------- 218 (284)
T 3kk8_A 160 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ------------- 218 (284)
T ss_dssp SSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------------
T ss_pred cCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH-------------
Confidence 321 12345689999999999999999999999999999999999999975443111000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
+............ ....+...+|+.+||..||++|||++|+|+||||
T Consensus 219 ----------------~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 219 ----------------IKAGAYDYPSPEW-----------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp ----------------HHHTCCCCCTTTT-----------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred ----------------HHhccccCCchhh-----------------cccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 0000000000000 0111223468888999999999999999999999
Q ss_pred CCCCC
Q 002289 922 SSDVS 926 (941)
Q Consensus 922 ~~~~~ 926 (941)
+....
T Consensus 266 ~~~~~ 270 (284)
T 3kk8_A 266 CNRER 270 (284)
T ss_dssp HSCCC
T ss_pred cCChh
Confidence 77544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.56 Aligned_cols=296 Identities=23% Similarity=0.310 Sum_probs=213.7
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeecccc--------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 676 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 676 (941)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999997 47899999998654322 24578899999999999999999999866
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
.+..++||||++ |+|.+.+.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 456899999996 58888775443 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
|+........ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 171 a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---- 243 (351)
T 3mi9_A 171 ARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ---- 243 (351)
T ss_dssp CEECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----
T ss_pred cccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH----
Confidence 9876432211 1222344568999999999986 4589999999999999999999999976543222111110
Q ss_pred chhhhcCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 836 MFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 836 ~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
........ .+...... .. .-+......++...+.+.... .++.+.+||.+||+.||++|||++|
T Consensus 244 ---~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 244 ---LCGSITPEVWPNVDNYE---LY-EKLELVKGQKRKVKDRLKAYV--------RDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp ---HHCCCCTTTSTTGGGCG---GG-TSSCCCSSCCCCHHHHHHHHH--------CCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ---HhCCCChhhccccccch---hh-cccccccccccCHHHHhhhcc--------CChHHHHHHHHHhcCChhhCCCHHH
Confidence 00000000 00000000 00 001111122223322221111 1344568999999999999999999
Q ss_pred CCCCCCCCCCCCCCcc
Q 002289 915 MLKHPYVSSDVSGSNL 930 (941)
Q Consensus 915 ~L~Hpwf~~~~~~~~~ 930 (941)
+|+||||.++...+.+
T Consensus 309 ~l~hp~f~~~~~~~~~ 324 (351)
T 3mi9_A 309 ALNHDFFWSDPMPSDL 324 (351)
T ss_dssp HHTSGGGGSSSCCCCS
T ss_pred HhCCCCcCCCCCcccc
Confidence 9999999886665443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=369.97 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=214.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||+||+|++. +++.||||+++... ......+.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467889999999999999999953 46789999997543 33456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC-----CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEe
Q 002289 681 MLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVA 752 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~ 752 (941)
++||||+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 245899999999999999999999999 99999999999999554 59999
Q ss_pred eeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHH
Q 002289 753 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 831 (941)
Q Consensus 753 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~ 831 (941)
|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 227 DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-~~~~--- 297 (367)
T 3l9p_A 227 DFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLE--- 297 (367)
T ss_dssp CCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH---
T ss_pred CCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH---
Confidence 9999975422111 112234457899999999999999999999999999999998 99999765432 1111
Q ss_pred hhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+..+.....+..++..+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 298 ------~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 298 ------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 122233344556677889999999999999999999999999988765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=352.58 Aligned_cols=262 Identities=27% Similarity=0.452 Sum_probs=207.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.++|++.+.||+|+||+||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 357888999999999999999984 788999998753 335678999999999999999999999874 479999999
Q ss_pred CCCCHHHHHhhcCC-CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-EEEeeeccccccCCCCC
Q 002289 688 SNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-AKVADFGLSRLAPVPDI 765 (941)
Q Consensus 688 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-~kl~DFGla~~~~~~~~ 765 (941)
++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976543 24788999999999999999999932223999999999999998886 799999999754321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....+...
T Consensus 160 --------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~ 223 (307)
T 2eva_A 160 --------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--------WAVHNGTRP 223 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH--------HHHHTTCCC
T ss_pred --------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH--------HHHhcCCCC
Confidence 1234589999999999999999999999999999999999999975432211111 111222333
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 892 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~ 892 (941)
..+..++..+.+++.+|++.+|++||++.++++.|+.+...++..+.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 44555667899999999999999999999999999999887765543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=358.34 Aligned_cols=269 Identities=17% Similarity=0.244 Sum_probs=215.0
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... .+.+.+|+++++++ +|+||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46789999999999999999996 4789999999875432 34688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-----EEEeeecccccc
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 760 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DFGla~~~ 760 (941)
|+ +++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999764 346999999999999999999999999 999999999999998887 999999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHhhccchh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK--NIVREVNIAYQSSMMFS 838 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~ 838 (941)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.......... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-AT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-HS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-cC
Confidence 5433222222223355679999999999999999999999999999999999999997532 22221111110000 00
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
.. ......++ ++.+++..||+.+|.+||++.++.+.|+++......
T Consensus 240 ~~----~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 240 PI----EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp CH----HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CH----HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00 00011133 899999999999999999999999999988776543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=351.59 Aligned_cols=270 Identities=19% Similarity=0.252 Sum_probs=216.6
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 578999999987533 335688999999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-----EEEeeecccccc
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 760 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DFGla~~~ 760 (941)
|+ +++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997643 35899999999999999999999999 999999999999987776 999999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHHhhccchh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 838 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~ 838 (941)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~--- 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-K--- 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-H---
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh-c---
Confidence 54432222222234556799999999999999999999999999999999999999976332 11111111000 0
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
...........++..+.+++..||+.+|++||++.++++.|+++.+....
T Consensus 238 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 238 -QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp -HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 00000011223457889999999999999999999999999998876544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.17 Aligned_cols=258 Identities=29% Similarity=0.479 Sum_probs=216.0
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
..++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3567889999999999999999998889999999986443 346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 158 (267)
T ss_dssp CTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc--
Confidence 99999999997643 45889999999999999999999999 9999999999999999999999999998653211
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
........++..|+|||++.+..++.++||||+|+++|||++ |+.||....... ... .+..+...
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~---------~i~~~~~~ 224 (267)
T 3t9t_A 159 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVE---------DISTGFRL 224 (267)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH---------HHHTTCCC
T ss_pred ----ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-HHH---------HHhcCCcC
Confidence 112233456788999999999999999999999999999999 899997644321 111 11122223
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+..++..+.+++..|++.+|.+||++.++++.|+++.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3445566789999999999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=347.54 Aligned_cols=254 Identities=20% Similarity=0.354 Sum_probs=211.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccC--CcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~LV 683 (941)
.++|++.+.||+|+||+||+|+++ ++.||||+++... ....+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457888999999999999999984 8899999987643 23346799999999999999999999999776 788999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++.......+++..++.++.|+++||+|||+++ ++|+||||||+||+++.++.++|+|||.+....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 99999999999998766667999999999999999999999865 459999999999999999999999998875422
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCc---hhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.....||+.|+|||++.+..++. ++|||||||++|||++|+.||............ ..
T Consensus 165 ----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---------~~ 225 (271)
T 3kmu_A 165 ----------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV---------AL 225 (271)
T ss_dssp ----------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH---------HH
T ss_pred ----------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH---------Hh
Confidence 12345789999999998765544 799999999999999999999765442221111 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
.......+..++..+.+++..||+.+|++||++.++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 22233456667788999999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=348.09 Aligned_cols=253 Identities=32% Similarity=0.510 Sum_probs=201.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch----hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|.+. ++.||||+++..... ..+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467889999999999999999974 889999998753322 235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--------CCcEEEeeec
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--------KFTAKVADFG 755 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--------~~~~kl~DFG 755 (941)
|||+++++|.+++.. ..+++..++.++.|+++||+|||+++..+|+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999853 35899999999999999999999988666899999999999986 7789999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............
T Consensus 162 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------ 226 (271)
T 3dtc_A 162 LAREWHRT---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV------ 226 (271)
T ss_dssp C----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------
T ss_pred cccccccc---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh------
Confidence 99765322 122346899999999999999999999999999999999999999765542221111
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
.........+..++..+.+++..|++.+|.+||++.+++++|++
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 227 ---AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11112233556677889999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=361.25 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=202.6
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCC-C---cEEEEEEeccC--CchhhHhHHHHHHHHHhcCCCceeeeeecccc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPD-G---TVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 676 (941)
++....++|++.+.||+|+||+||+|.+.. + ..||||+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344456789999999999999999999653 3 37999998764 23345679999999999999999999999977
Q ss_pred CCcE------EEEEecCCCCCHHHHHhhcC----CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC
Q 002289 677 EGEQ------MLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 746 (941)
Q Consensus 677 ~~~~------~LV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 746 (941)
.+.. ++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 6655 99999999999999986432 235899999999999999999999999 9999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHH
Q 002289 747 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 825 (941)
Q Consensus 747 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~ 825 (941)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp SCEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CCEEEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999986543221 112233456789999999999999999999999999999999 8999976543221
Q ss_pred HHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
. ..+..+.....+..++..+.+++.+|++.+|++||++.++++.++++..
T Consensus 249 ~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 249 Y----------NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp H----------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----------HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 1222333344566677889999999999999999999999999998755
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=373.01 Aligned_cols=296 Identities=20% Similarity=0.322 Sum_probs=212.9
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467899999999999999999975 689999999886532 335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|+++++|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999997654 488999999999999999999985 8 99999999999999999999999999865421
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ...+..
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~-----~~~~~~ 250 (360)
T 3eqc_A 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGC-----QVEGDA 250 (360)
T ss_dssp -------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH--HHHC------------
T ss_pred -------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhcc-----cccccC
Confidence 1223456899999999999999999999999999999999999999765432111 11000 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh-CC--CCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM-MP--ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~-~~--~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
...+.... ...... .-+..+........++.+.+...... .+ ..+....+||.+||+.||++|||++|+|+||||
T Consensus 251 ~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 251 AETPPRPR-TPGRPL-NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp -------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCCCcc-cCCCcc-cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 00000000 000000 00111111222333333333221110 00 012235689999999999999999999999999
Q ss_pred CCCCC
Q 002289 922 SSDVS 926 (941)
Q Consensus 922 ~~~~~ 926 (941)
+....
T Consensus 329 ~~~~~ 333 (360)
T 3eqc_A 329 KRSDA 333 (360)
T ss_dssp HHHHH
T ss_pred hcchH
Confidence 76443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=369.31 Aligned_cols=284 Identities=22% Similarity=0.352 Sum_probs=203.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh-----hHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
..++|++.+.||+|+||.||+|++. +|+.||||++....... .+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999975 68999999987532211 24688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++ +|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999975 899988654 345888899999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..||........ ....+....
T Consensus 163 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~---- 230 (346)
T 1ua2_A 163 GSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLG---- 230 (346)
T ss_dssp TSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC----
T ss_pred cCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcC----
Confidence 4321 122345689999999999764 589999999999999999999988876543222 111111000
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
.......+..+ .+. -......+|... +............+||.+||..||++|||++|+|+||
T Consensus 231 -~~~~~~~~~~~-----~~~---~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 231 -TPTEEQWPDMC-----SLP---DYVTFKSFPGIP--------LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp -CCCTTTSSSTT-----SST---TCCCCCCCCCCC--------HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred -CCChhhhhhhc-----cCc---ccccccccCCCC--------hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000000000 000 000000111100 0111233344566899999999999999999999999
Q ss_pred CCCCC
Q 002289 920 YVSSD 924 (941)
Q Consensus 920 wf~~~ 924 (941)
||+..
T Consensus 294 ~f~~~ 298 (346)
T 1ua2_A 294 YFSNR 298 (346)
T ss_dssp GGTSS
T ss_pred hhhcC
Confidence 99764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=367.99 Aligned_cols=258 Identities=21% Similarity=0.347 Sum_probs=201.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
..++|++.+.||+|+||+||+|..+ +|+.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999975 689999999975432 356788888888 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC----CcEEEeeecccccc
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRLA 760 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~~kl~DFGla~~~ 760 (941)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999996543 5899999999999999999999999 9999999999998543 35999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 171 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------------- 227 (342)
T 2qr7_A 171 RAEN-------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---------------- 227 (342)
T ss_dssp BCTT-------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----------------
T ss_pred cCCC-------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----------------
Confidence 4321 12234568999999999998889999999999999999999999996432100
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
..++.+.+...-...+.. ..+...+.+.+||.+||..||++|||++|+++|||
T Consensus 228 -----------~~~~~~~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 228 -----------PEEILARIGSGKFSLSGG----------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp -----------HHHHHHHHHHCCCCCCST----------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred -----------HHHHHHHHccCCcccCcc----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 000111111100000000 00112233457888999999999999999999999
Q ss_pred CCC
Q 002289 921 VSS 923 (941)
Q Consensus 921 f~~ 923 (941)
|..
T Consensus 281 ~~~ 283 (342)
T 2qr7_A 281 IVH 283 (342)
T ss_dssp HHT
T ss_pred ecC
Confidence 954
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.91 Aligned_cols=267 Identities=24% Similarity=0.393 Sum_probs=218.9
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeeccc
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 675 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 675 (941)
+....++|++.+.||+|+||+||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 334567899999999999999999984 3568999999986443 3356789999999999 9999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCC----------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKSK----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 739 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~ 739 (941)
..+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999976542 25899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCC
Q 002289 740 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 818 (941)
Q Consensus 740 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~ 818 (941)
||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999986643321 112233457789999999999999999999999999999999 999997
Q ss_pred CCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 819 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
............ . .......+..++..+.+++.+|++.+|.+||++.++++.|+++....
T Consensus 250 ~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 250 GMPVDSKFYKMI-K--------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp TCCSSHHHHHHH-H--------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cccchhHHHHHh-c--------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 644322211111 1 11112234556678999999999999999999999999999887653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=394.68 Aligned_cols=272 Identities=19% Similarity=0.293 Sum_probs=212.0
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 681 (941)
..++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+..|.+++..+ +|++|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999975 689999999875321 2235678899999987 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.++++... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999997654 4899999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +... .+..
T Consensus 494 ~~-------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~~---------~i~~ 556 (674)
T 3pfq_A 494 WD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQ---------SIME 556 (674)
T ss_dssp CT-------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH---------HHHS
T ss_pred cC-------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-HHHH---------HHHh
Confidence 22 12234567999999999999999999999999999999999999999754321 1111 0111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC-----ccCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-----SSML 916 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa-----~e~L 916 (941)
....+|... .+++.+||.+||+.||++|+++ +|++
T Consensus 557 -~~~~~p~~~---------------------------------------s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 557 -HNVAYPKSM---------------------------------------SKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp -SCCCCCTTS---------------------------------------CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred -CCCCCCccC---------------------------------------CHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 111122211 2233467777788888888877 7888
Q ss_pred CCCCCCCCCCCCccccccccccCC
Q 002289 917 KHPYVSSDVSGSNLVSGVIPTITP 940 (941)
Q Consensus 917 ~Hpwf~~~~~~~~~~~~~~~~~~~ 940 (941)
+||||+...+..-.-..+.|++.|
T Consensus 597 ~h~ff~~i~w~~l~~~~~~pp~~p 620 (674)
T 3pfq_A 597 EHAFFRYIDWEKLERKEIQPPYKP 620 (674)
T ss_dssp SSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred cCccccCCCHHHHHhCCCCCCCCC
Confidence 888887755433333334455554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=349.96 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=207.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467889999999999999999976 58899999986532 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999986643 5889999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........... +...
T Consensus 169 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----------~~~~- 230 (294)
T 2rku_A 169 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR----------IKKN- 230 (294)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----------HHTT-
T ss_pred c-------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------Hhhc-
Confidence 1 122345689999999999999999999999999999999999999975432111100 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
....+. ..++...+++.+||..||++|||++|+++||||.+
T Consensus 231 ~~~~~~---------------------------------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 231 EYSIPK---------------------------------------HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp CCCCCT---------------------------------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred cCCCcc---------------------------------------ccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 000110 01112235778889999999999999999999976
Q ss_pred CCC
Q 002289 924 DVS 926 (941)
Q Consensus 924 ~~~ 926 (941)
...
T Consensus 272 ~~~ 274 (294)
T 2rku_A 272 GYI 274 (294)
T ss_dssp SCC
T ss_pred CCc
Confidence 544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.96 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=200.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|.+.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467899999999999999999975 689999999875432 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeecccccc
Q 002289 686 FMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLA 760 (941)
Q Consensus 686 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFGla~~~ 760 (941)
|+++|+|.+++... ....+++..++.++.|+++||+|||+++ |+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988643 2356899999999999999999999999 9999999999999 45678999999999765
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... .......||+.|+|||++. ..++.++|||||||++|||++|+.||..............
T Consensus 178 ~~~--------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~--------- 239 (285)
T 3is5_A 178 KSD--------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--------- 239 (285)
T ss_dssp -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred CCc--------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc---------
Confidence 432 1223456899999999875 5689999999999999999999999975432111000000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
.........++ ..+...+|+.+||..||++|||++|+|+|||
T Consensus 240 --------------------~~~~~~~~~~~------------------~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 240 --------------------KEPNYAVECRP------------------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp --------------------CCCCCCC--CC------------------CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred --------------------CCcccccccCc------------------CCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 00000000111 1122346888899999999999999999999
Q ss_pred CCC
Q 002289 921 VSS 923 (941)
Q Consensus 921 f~~ 923 (941)
|++
T Consensus 282 f~~ 284 (285)
T 3is5_A 282 FKQ 284 (285)
T ss_dssp GGC
T ss_pred hhc
Confidence 975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=360.27 Aligned_cols=268 Identities=25% Similarity=0.388 Sum_probs=215.8
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeecc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYC 674 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 674 (941)
++....++|++.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4555678999999999999999999995 2467899999975432 2346789999999999 899999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcCC---------------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 002289 675 DEEGEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733 (941)
Q Consensus 675 ~~~~~~~LV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 733 (941)
...+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999999999999999999999976432 24789999999999999999999999 999
Q ss_pred ccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-
Q 002289 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT- 812 (941)
Q Consensus 734 ~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt- 812 (941)
|||||+||+++.++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 99999999999999999999999986543221 112334557889999999999999999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 813 GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 813 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
|+.||............ . ..+.....+..++..+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 271 g~~p~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKL-I--------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SCCSSTTCCCSHHHHHH-H--------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCCcccCCcHHHHHHH-H--------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 99999765432211111 1 111223345556788999999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=368.75 Aligned_cols=271 Identities=24% Similarity=0.314 Sum_probs=205.4
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccC-----CchhhHhHHHHHHHHHhcCCCceeeeeecccc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 676 (941)
++....++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45567889999999999999999999974 6889999998643 22334678999999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhc--------------------------------------CCCCccHHHHHHHHHHHHH
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAK--------------------------------------SKEPLGFAMRLSIALGSSR 718 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 718 (941)
.+..++||||+++|+|.+++... ....+++..++.++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 0223467888999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCcEEEcCCC--cEEEeeeccccccCCCCCCCccccccccccccCCCccccccccc--CCC
Q 002289 719 GILYLHTEADPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKL 794 (941)
Q Consensus 719 gL~yLH~~~~~~ivH~DLkp~NILl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 794 (941)
||+|||+++ |+||||||+||+++.++ .+||+|||+++........ .........||+.|+|||++.+ ..+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchhhccCCCCC
Confidence 999999999 99999999999998776 8999999999865332111 0112344568999999999975 678
Q ss_pred CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 002289 795 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 874 (941)
Q Consensus 795 ~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~ 874 (941)
+.++|||||||++|||++|+.||........... +...... ...|..
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----------~~~~~~~----------------------~~~~~~- 300 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ----------VLNKKLC----------------------FENPNY- 300 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------HHHCCCC----------------------TTSGGG-
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHH----------HHhcccc----------------------cCCccc-
Confidence 9999999999999999999999975443211110 0000000 000100
Q ss_pred HHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 875 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 875 ~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
....+...++|.+||..||++|||+.|+|+||||++-.
T Consensus 301 -------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 301 -------------NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp -------------GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred -------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 00122234678888999999999999999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=371.55 Aligned_cols=277 Identities=21% Similarity=0.355 Sum_probs=195.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccC------C
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 678 (941)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999964 68999999987532 23356788999999999999999999998643 5
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++|+||+ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899998854 35899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
.... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||........ ......
T Consensus 181 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~----- 244 (367)
T 2fst_X 181 HTAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILR----- 244 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH-----
T ss_pred cccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-----
Confidence 6432 1234568999999999987 6789999999999999999999999976544222 211111
Q ss_pred hhhcCCCCCCChHHHH-----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC
Q 002289 838 SVIDGNMGSYPSECVE-----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 912 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~-----~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa 912 (941)
.+ +..+.+... .....+.. +...| +..+. ..++..++.+.+||.+||++||++|+|+
T Consensus 245 -~~----g~p~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~----------~~~~~~~~~~~dLl~~mL~~dP~~R~t~ 306 (367)
T 2fst_X 245 -LV----GTPGAELLKKISSESARNYIQS-LTQMP--KMNFA----------NVFIGANPLAVDLLEKMLVLDSDKRITA 306 (367)
T ss_dssp -HH----CSCCHHHHTTCCCHHHHHHHHT-SCCCC--CCCHH----------HHTTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred -Hh----CCCCHHHHHHhhhHHHHHHHhc-cCCCC--CCCHH----------HHCCCCCHHHHHHHHHhCCCCcccCcCH
Confidence 00 111111111 11111111 11111 12222 1234455667899999999999999999
Q ss_pred ccCCCCCCCCCCC
Q 002289 913 SSMLKHPYVSSDV 925 (941)
Q Consensus 913 ~e~L~Hpwf~~~~ 925 (941)
+|+|+||||+...
T Consensus 307 ~e~L~hp~~~~~~ 319 (367)
T 2fst_X 307 AQALAHAYFAQYH 319 (367)
T ss_dssp HHHHTSGGGTTTC
T ss_pred HHHhcChhhhhcc
Confidence 9999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=376.61 Aligned_cols=295 Identities=24% Similarity=0.324 Sum_probs=194.3
Q ss_pred cCCCc-cceeeccCcEEEEEEEeC---CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecc--ccCCcEEE
Q 002289 609 NNFNS-STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC--DEEGEQML 682 (941)
Q Consensus 609 ~~y~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~~L 682 (941)
+.|++ .++||+|+||+||+|+.. +++.||||++..... ...+.+|++++++++||||+++++++ ......++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 458999999999999965 578999999975432 34688999999999999999999999 45678999
Q ss_pred EEecCCCCCHHHHHhhc-------CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEE
Q 002289 683 VYEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKV 751 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl 751 (941)
||||++ |+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999995 6888887532 2235899999999999999999999999 9999999999999 77889999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhH------
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV------ 824 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~------ 824 (941)
+|||+|+....... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 174 ~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 174 ADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 99999986643211 11223446789999999999874 58999999999999999999999996543210
Q ss_pred --HHHHHHHhhccchhhhcCCCCC-CCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccc
Q 002289 825 --REVNIAYQSSMMFSVIDGNMGS-YPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINS 900 (941)
Q Consensus 825 --~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~ 900 (941)
+.+...+ ..+...... .+. ........+.. .+...........+. ........++.+.+||.+
T Consensus 250 ~~~~l~~i~------~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~Ll~~ 316 (405)
T 3rgf_A 250 HHDQLDRIF------NVMGFPADKDWEDIKKMPEHSTLMK-DFRRNTYTNCSLIKY------MEKHKVKPDSKAFHLLQK 316 (405)
T ss_dssp CHHHHHHHH------HHHCCCCTTTCGGGGGSTTHHHHHH-HCCGGGGTTCCHHHH------HHTTTCCTTSHHHHHHHH
T ss_pred hHHHHHHHH------HhhCCCChhhcchhhcCcchhhhhh-hccccCCCcchhhhh------HhhcCCCCCHHHHHHHHH
Confidence 1111000 000000000 000 00000000000 011111111111111 111223345667889999
Q ss_pred cCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 901 EHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 901 ~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
||++||++||||+|+|+||||.....
T Consensus 317 ~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 317 LLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred HccCCcccCCCHHHHhcChhhccCCC
Confidence 99999999999999999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=356.58 Aligned_cols=277 Identities=27% Similarity=0.430 Sum_probs=214.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC-----CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.++|++.+.||+|+||+||+|.+.. +..||||+++.... .....+.+|++++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4567778999999999999998642 24699999976433 33457899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999999754 345899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
..... ........+|..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+.
T Consensus 199 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~---------~~~~ 264 (333)
T 1mqb_A 199 DDPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VM---------KAIN 264 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HH---------HHHH
T ss_pred ccccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-HH---------HHHH
Confidence 32110 111223346788999999999999999999999999999999 999997544311 11 1122
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 910 (941)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.... +.+..+..++|..|+
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~--------~~~~~~~~~~p~~~~ 326 (333)
T 1mqb_A 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP--------DSLKTLADFDPRVSI 326 (333)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG--------GGGGSBCCC------
T ss_pred CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc--------hhhhhhcCCCccchh
Confidence 22233445567788999999999999999999999999999887532 445566777776655
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=361.35 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=206.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|.+.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888999999999999999975 58899999986532 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987643 5889999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
. .......||..|+|||++.+..++.++||||||+++|||++|+.||............ ...
T Consensus 195 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----------~~~- 256 (335)
T 2owb_A 195 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----------KKN- 256 (335)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------HHT-
T ss_pred c-------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----------hcC-
Confidence 1 1223456899999999999999999999999999999999999999754321111000 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
....+. ..++...++|.+||..||++|||++|+++||||++
T Consensus 257 ~~~~~~---------------------------------------~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 257 EYSIPK---------------------------------------HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CCCCCT---------------------------------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCCCCc---------------------------------------cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 000110 01112235777888999999999999999999977
Q ss_pred CCC
Q 002289 924 DVS 926 (941)
Q Consensus 924 ~~~ 926 (941)
...
T Consensus 298 ~~~ 300 (335)
T 2owb_A 298 GYI 300 (335)
T ss_dssp SCC
T ss_pred CCc
Confidence 544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=381.58 Aligned_cols=201 Identities=28% Similarity=0.433 Sum_probs=176.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|.+.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357889999999999999999975 7999999998753221 235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999654 35899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
. ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 170 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 170 E--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp C--------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c--------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 1 2234569999999999998765 689999999999999999999997543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=388.23 Aligned_cols=264 Identities=30% Similarity=0.466 Sum_probs=219.5
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++++...++|++.++||+|+||.||+|.+.++..||||+++.... ..+.|.+|+++|++++|+||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 3445556788999999999999999999998888899999986443 34679999999999999999999999876 678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999997644455899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+
T Consensus 414 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-~~~---------~i 477 (535)
T 2h8h_A 414 EDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLD---------QV 477 (535)
T ss_dssp CCHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-HHH---------HH
T ss_pred CCCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HH
Confidence 3211 111223446788999999999999999999999999999999 999997554321 111 11
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+.....+..++..+.+++..||+.+|++||++.++++.|+.+..
T Consensus 478 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 2222334566777889999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=363.93 Aligned_cols=278 Identities=18% Similarity=0.199 Sum_probs=211.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCCchhh-----------HhHHHHHHHHHhcCCCceee
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHRNLVS 669 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~ 669 (941)
..++|++.+.||+|+||+||+|.+.+ ++.||||++........ ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999754 47899999876442111 12345666777888999999
Q ss_pred eeeccccC----CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-
Q 002289 670 LVGYCDEE----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD- 744 (941)
Q Consensus 670 l~~~~~~~----~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~- 744 (941)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99998654 4589999999 99999999764 346999999999999999999999999 99999999999999
Q ss_pred -CCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchh
Q 002289 745 -HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 823 (941)
Q Consensus 745 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~ 823 (941)
.++.+||+|||+|+....................||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876433221111112224456999999999999999999999999999999999999999743221
Q ss_pred HHH---HHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCC
Q 002289 824 VRE---VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 892 (941)
Q Consensus 824 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~ 892 (941)
... ....+. .....+++..+. +..++..+.+++..||+.+|.+||++.++++.|+.+.........
T Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 268 PKYVRDSKIRYR-ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp HHHHHHHHHHHH-HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHHhh-hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 111 111111 112222222111 123356788999999999999999999999999998876654443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=369.90 Aligned_cols=281 Identities=21% Similarity=0.331 Sum_probs=202.9
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc-------
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------- 676 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------- 676 (941)
....++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999996 479999999986532 234579999999999999999999833
Q ss_pred -------------------------------CCcEEEEEecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHh
Q 002289 677 -------------------------------EGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 723 (941)
Q Consensus 677 -------------------------------~~~~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 723 (941)
....++||||++ |+|.+.+.. .....+++..++.++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999997 688887764 3345699999999999999999999
Q ss_pred hcCCCCCeEeccCCCCcEEEc-CCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhH
Q 002289 724 HTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVY 801 (941)
Q Consensus 724 H~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVw 801 (941)
|+++ |+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++|||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999 99999999999998 68999999999998653321 22345689999999998875 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 802 SLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 802 SlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
|+||++|||++|+.||.............. . .+..+.+..... .-......-|.... .
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~-------~----~g~p~~~~~~~~------~~~~~~~~~~~~~~-----~ 284 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQ-------I----MGTPTKEQMIRM------NPHYTEVRFPTLKA-----K 284 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------H----HCCCCHHHHHHH------CTTC--CCCCCCCC-----C
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHH-------H----hCCCCHHHHHHh------CcccccccCCccCc-----c
Confidence 999999999999999976554322221110 0 011111111100 00000000000000 0
Q ss_pred HhHhhCC-CCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 882 SIWNMMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 882 ~~~~~~~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.+...++ ...+.+.+||.+||++||++|+|+.|+|+||||+.
T Consensus 285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred cHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 0111112 23344678999999999999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=372.86 Aligned_cols=196 Identities=24% Similarity=0.361 Sum_probs=162.6
Q ss_pred cCCCcc-ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHh-cCCCceeeeeecccc----CCcEE
Q 002289 609 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE----EGEQM 681 (941)
Q Consensus 609 ~~y~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~ 681 (941)
++|.+. +.||+|+||+||+|... +|+.||||+++. ...+.+|++++.+ .+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999975 689999999864 2357788888744 589999999998864 56789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecccc
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 758 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGla~ 758 (941)
+||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998766667999999999999999999999999 999999999999997 7899999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 213 ETTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccCCC--------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 65321 1223456899999999999999999999999999999999999999754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=360.12 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=207.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcE----EEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 457888999999999999999964 4443 7888875433 223456789999999999999999999986 46789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999999654 345888999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... ........||..|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+.
T Consensus 167 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~---------~~~ 231 (325)
T 3kex_A 167 PDDK-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-PD---------LLE 231 (325)
T ss_dssp CCTT-----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-HH---------HHH
T ss_pred cccc-----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-HH---------HHH
Confidence 4321 122334567889999999999999999999999999999999 9999975432111 11 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.......+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 122233445566678899999999999999999999999988743
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=369.74 Aligned_cols=201 Identities=27% Similarity=0.353 Sum_probs=172.4
Q ss_pred hcCCCccceeeccCcEEEEEEEe----CCCcEEEEEEeccCCc----hhhHhHHHHHHHHHhc-CCCceeeeeeccccCC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 678 (941)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46789999999999999999997 3689999999875321 2345678899999999 6999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||+++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997654 4889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 208 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 208 EFVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp ECCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred ecccCC------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 653211 122334579999999999986 3478999999999999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.43 Aligned_cols=286 Identities=24% Similarity=0.364 Sum_probs=210.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467889999999999999999975 5899999998654332 2456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999988875433 4899999999999999999999999 9999999999999999999999999997653321
Q ss_pred CCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......||..|+|||++.+. .++.++||||+||++|||++|+.||................
T Consensus 179 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 241 (331)
T 4aaa_A 179 -------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL---------- 241 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH----------
T ss_pred -------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh----------
Confidence 122345689999999999875 78999999999999999999999997665433222111100
Q ss_pred CCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALK--CCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~--c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
+..++.....+..-... ........+.... ...+...+...+|+.+||..||++|||++|+|+||||
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 242 -GNLIPRHQELFNKNPVFAGVRLPEIKEREPLE----------RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp -CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHH----------HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -CCCChhhhhHhhhccccccccCccccccchhh----------hcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 01111111111000000 0000001111111 1223344556689999999999999999999999999
Q ss_pred CCCCC
Q 002289 922 SSDVS 926 (941)
Q Consensus 922 ~~~~~ 926 (941)
+.+..
T Consensus 311 ~~~~~ 315 (331)
T 4aaa_A 311 QMDGF 315 (331)
T ss_dssp HGGGH
T ss_pred ccCCh
Confidence 87644
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.66 Aligned_cols=291 Identities=22% Similarity=0.280 Sum_probs=211.4
Q ss_pred chHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch-----------hhHhHHHHHHHHHhcCCCcee
Q 002289 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-----------GEKEFLTEIQFLSRLHHRNLV 668 (941)
Q Consensus 600 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv 668 (941)
...++....++|++.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356778889999999999999999999999888999999988642221 126789999999999999999
Q ss_pred eeeeccc-----cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 002289 669 SLVGYCD-----EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 743 (941)
Q Consensus 669 ~l~~~~~-----~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 743 (941)
++++++. .....++||||++ |+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9999983 3346899999996 7998888643 346899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeeccccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCch
Q 002289 744 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822 (941)
Q Consensus 744 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~ 822 (941)
+.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCCEEEEecCcccccccc--------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999754321 12234568899999999987 6789999999999999999999999976543
Q ss_pred hHHHHHHHHhhccchhhhcCCCCCCChHHH-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccc
Q 002289 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECV-----EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 897 (941)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dl 897 (941)
... ...... .. +..+.+.. ....+.........|..+ +....+..++...+|
T Consensus 240 ~~~-~~~i~~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l 296 (362)
T 3pg1_A 240 YNQ-LNKIVE------VV----GTPKIEDVVMFSSPSARDYLRNSLSNVPARA------------WTAVVPTADPVALDL 296 (362)
T ss_dssp HHH-HHHHHH------HH----CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC------------HHHHSTTSCHHHHHH
T ss_pred HHH-HHHHHH------Hc----CCCChHHhhhccchhhhHHHHhhcccCChhh------------HHhhCCCCCHHHHHH
Confidence 221 111110 00 00111100 011111111111111111 111233445556789
Q ss_pred ccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 898 INSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 898 l~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
|.+||..||++|||++|+|+||||++...
T Consensus 297 i~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 297 IAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 99999999999999999999999987544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=357.79 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=205.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCc----EEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.++|++.+.||+|+||+||+|++. +++ .||+|.+.... ....+.+.+|++++++++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 467888999999999999999964 444 36888876433 23456899999999999999999999999875 478
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997643 45899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... ........+|..|+|||++.+..++.++|||||||++|||++ |+.||.......- . ..+.
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~---------~~~~ 233 (327)
T 3poz_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-S---------SILE 233 (327)
T ss_dssp TTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-H---------HHHH
T ss_pred CCcc-----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-H---------HHHH
Confidence 3321 112233456889999999999999999999999999999999 9999975433111 0 0111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222334556677889999999999999999999999999988754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.88 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=184.1
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5788999999999999999997 47899999998643221 1357889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999754 346899999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 167 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~~--- 226 (278)
T 3cok_A 167 -------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------LNKVVL--- 226 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCS---
T ss_pred -------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------HHHHhh---
Confidence 112335689999999999998999999999999999999999999965332100 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
.+. ..|. .......+++.+||..||++|||++|+++||||...
T Consensus 227 --------------------~~~-~~~~----------------~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 --------------------ADY-EMPS----------------FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp --------------------SCC-CCCT----------------TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred --------------------ccc-CCcc----------------ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 000 0010 011222468888999999999999999999999875
Q ss_pred CC
Q 002289 925 VS 926 (941)
Q Consensus 925 ~~ 926 (941)
..
T Consensus 270 ~~ 271 (278)
T 3cok_A 270 SS 271 (278)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=366.70 Aligned_cols=285 Identities=21% Similarity=0.321 Sum_probs=204.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCC------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 678 (941)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999965 68999999987532 233467889999999999999999999986654
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||++ |+|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999996 588888852 3889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........+...
T Consensus 176 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------- 238 (371)
T 2xrw_A 176 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV--------- 238 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------
T ss_pred ccccc--------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------
Confidence 65321 1223456899999999999999999999999999999999999999766543322211
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCC-------CCCCcccccccCCCCCCCCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPES-------DTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~-------~~~~~dll~~~L~~dP~~R~ 910 (941)
+ ...+....+....+...+.......|.. +.++.+.... . .++.. ...+.+||.+||..||++||
T Consensus 239 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 311 (371)
T 2xrw_A 239 -I-EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD---V--LFPADSEHNKLKASQARDLLSKMLVIDASKRI 311 (371)
T ss_dssp -H-C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCG---G--GSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC
T ss_pred -H-HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccc---c--cCcccccccccccHHHHHHHHHHCcCChhhCC
Confidence 1 1122223333322222222222222221 1122211100 0 00000 12346899999999999999
Q ss_pred CCccCCCCCCCCCC
Q 002289 911 SSSSMLKHPYVSSD 924 (941)
Q Consensus 911 sa~e~L~Hpwf~~~ 924 (941)
|++|+|+||||+..
T Consensus 312 t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 312 SVDEALQHPYINVW 325 (371)
T ss_dssp CHHHHHHSHHHHTT
T ss_pred CHHHHhCCcchhhh
Confidence 99999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=352.61 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=202.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHh--cCCCceeeeeecccc----CCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDE----EGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~~~ 681 (941)
.++|++.+.||+|+||+||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6899999998642 34456677777766 799999999998643 35689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhh--------cCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
+||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999954 35899999999999999999999 777 99999999999999999999999
Q ss_pred eccccccCCCCCCCccccccccccccCCCcccccccccC------CCCchhHhHHHHHHHHHHHhC----------CCCC
Q 002289 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTG----------MQPI 817 (941)
Q Consensus 754 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlG~ll~elltG----------~~Pf 817 (941)
||+|+........ .........||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 157 fg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999765432211 01112334699999999999876 455789999999999999999 8888
Q ss_pred CCCch---hHHHHHHHHhhccchhhhcCCCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 818 SHGKN---IVREVNIAYQSSMMFSVIDGNMGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 818 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
..... .......... ........ +..++..+.+++..||+.+|++||++.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVC-------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHHT-------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHh-------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54221 1111111111 11112222 346788999999999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.24 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=199.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||+||+|... +++.||||+++... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 567999999999999999999976 79999999987532 33456788999999999 999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC----------------
Q 002289 684 YEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---------------- 745 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---------------- 745 (941)
|||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997542 245899999999999999999999999 999999999999984
Q ss_pred ---CCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 746 ---KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 746 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
...+||+|||.+...... ....||+.|+|||++.+. .++.++|||||||++|||++|..++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred cCCceEEEEcccccccccCCc-----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 448999999999865432 123489999999999876 56689999999999999999987764332
Q ss_pred hhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccc
Q 002289 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSE 901 (941)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~ 901 (941)
... .+..+.....+.. ..+...+++.+|
T Consensus 236 ~~~-------------~~~~~~~~~~~~~---------------------------------------~~~~~~~li~~~ 263 (289)
T 1x8b_A 236 QWH-------------EIRQGRLPRIPQV---------------------------------------LSQEFTELLKVM 263 (289)
T ss_dssp HHH-------------HHHTTCCCCCSSC---------------------------------------CCHHHHHHHHHH
T ss_pred HHH-------------HHHcCCCCCCCcc---------------------------------------cCHHHHHHHHHH
Confidence 110 0111111111111 112234677788
Q ss_pred CCCCCCCCCCCccCCCCCCCCCCC
Q 002289 902 HTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 902 L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
|..||++|||++|+++||||.+..
T Consensus 264 l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 264 IHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp TCSSGGGSCCHHHHHTCTTC----
T ss_pred hCCCcccCCCHHHHhhChHhhhhc
Confidence 999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.13 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=210.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCC--cEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~LV 683 (941)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467899999999999999999976 589999999875332 23467889999999999999999999986654 78999
Q ss_pred EecCCCCCHHHHHhhcC-CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEeeecccc
Q 002289 684 YEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 758 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DFGla~ 758 (941)
|||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997643 234899999999999999999999999 9999999999999 888899999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccc--------cCCCCchhHhHHHHHHHHHHHhCCCCCCCCch---hHHHH
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--------THKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREV 827 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~---~~~~~ 827 (941)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... ..+..
T Consensus 165 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 165 ELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred ecCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 764322 123456899999999986 57789999999999999999999999964322 11111
Q ss_pred HHHHhhcc---chhh---h------c---CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 828 NIAYQSSM---MFSV---I------D---GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 828 ~~~~~~~~---~~~~---~------~---~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
........ ...+ . . ......+......+..++..|++.||++||++.|++++..+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111100 0000 0 0 011135578888899999999999999999999999888764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=356.39 Aligned_cols=266 Identities=24% Similarity=0.477 Sum_probs=217.3
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC--------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeeccc
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 675 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 675 (941)
...++|++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34678999999999999999999863 467899999976433 3346789999999999 8999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCC--------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 741 (941)
..+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999999976432 34889999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCC
Q 002289 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 820 (941)
Q Consensus 742 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~ 820 (941)
+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEcCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999986543221 112233456789999999999999999999999999999999 99999754
Q ss_pred chhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
... +... .+..+.....+..++..+.+++..||+.+|.+||++.++++.|+++......
T Consensus 264 ~~~-~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 264 PVE-ELFK---------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp CHH-HHHH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CHH-HHHH---------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 321 1111 1112223344556678899999999999999999999999999998775443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.54 Aligned_cols=201 Identities=24% Similarity=0.428 Sum_probs=174.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
..++|.+.+.||+|+||+||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467899999999999999999975 789999999986554455678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeeccccccCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFGla~~~~~ 762 (941)
|+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999986643 4889999999999999999999999 9999999999999 7889999999999875421
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 162 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 162 ---------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp ---------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 11233468999999999999999999999999999999999999996543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=373.55 Aligned_cols=198 Identities=22% Similarity=0.272 Sum_probs=171.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC--------CCceeeeeeccc---
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH--------HRNLVSLVGYCD--- 675 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~--- 675 (941)
.++|++.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999964 6899999999753 334567889999999986 788999999986
Q ss_pred -cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCC------
Q 002289 676 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKF------ 747 (941)
Q Consensus 676 -~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~------ 747 (941)
.....++||||+ +++|.+.+.......+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 566899999999 67887777666556799999999999999999999998 8 99999999999999775
Q ss_pred -------------------------------------------cEEEeeeccccccCCCCCCCccccccccccccCCCcc
Q 002289 748 -------------------------------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784 (941)
Q Consensus 748 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ 784 (941)
.+||+|||+|+..... .....||+.|+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~~y~ 260 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCGGGC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCCccc
Confidence 7999999999865321 23346899999
Q ss_pred cccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 785 aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
|||++.+..++.++|||||||++|||++|+.||...
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=364.16 Aligned_cols=285 Identities=24% Similarity=0.349 Sum_probs=211.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccC-----CcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 680 (941)
.++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999965 6889999999754332 346789999999999999999999998654 468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 6999998653 4889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
..... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||............. ..
T Consensus 179 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~~ 247 (364)
T 3qyz_A 179 DPDHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL-------GI 247 (364)
T ss_dssp CGGGC----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH-------HH
T ss_pred CCCCC----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH-------HH
Confidence 42211 0111234579999999998765 558999999999999999999999997654322211110 00
Q ss_pred hcCCCCCCChHHHHHHHHHH-HHhcccCCC-CCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLA-LKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~-~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
.+..+.+....+.... .......|. .+.... ...+..++.+.+||.+||.+||++|||++|+|+
T Consensus 248 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 ----LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN----------RLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp ----HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH----------HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHH----------HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0111111111100000 000011111 111111 122344555678999999999999999999999
Q ss_pred CCCCCCC
Q 002289 918 HPYVSSD 924 (941)
Q Consensus 918 Hpwf~~~ 924 (941)
||||+..
T Consensus 314 hp~~~~~ 320 (364)
T 3qyz_A 314 HPYLEQY 320 (364)
T ss_dssp SGGGTTT
T ss_pred Ccchhhc
Confidence 9999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=353.76 Aligned_cols=271 Identities=25% Similarity=0.427 Sum_probs=220.0
Q ss_pred cchHHHHHHhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeee
Q 002289 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSL 670 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l 670 (941)
+...++....++|++.+.||+|+||+||+|.+ .+++.||||+++..... ..+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34456666788999999999999999999984 35689999999865433 345789999999999 79999999
Q ss_pred eeccccCC-cEEEEEecCCCCCHHHHHhhcCC--------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 002289 671 VGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735 (941)
Q Consensus 671 ~~~~~~~~-~~~LV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 735 (941)
++++...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987654 58999999999999999976542 23899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CC
Q 002289 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 814 (941)
Q Consensus 736 Lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~ 814 (941)
|||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceEEECCCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999986543221 122234557889999999999999999999999999999998 99
Q ss_pred CCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 815 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 815 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.||............ +..+.....+..++..+.+++..||+.+|.+||++.+++++|+.+...
T Consensus 249 ~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 249 SPYPGVKIDEEFCRR---------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CSSTTCCCSHHHHHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccchhHHHHHH---------hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 999754432221111 111222334455667899999999999999999999999999988654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=361.84 Aligned_cols=200 Identities=24% Similarity=0.374 Sum_probs=175.1
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--------hhHhHHHHHHHHHhcCCCceeeeeeccccC
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 677 (941)
..++|++.+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3578999999999999999999964 6899999998764321 234678899999999999999999999999
Q ss_pred CcEEEEEecCCCC-CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 678 GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 678 ~~~~LV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
+..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9999996543 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 177 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 177 AAYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CEECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ceECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 98654321 1234568999999999998876 7899999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=356.84 Aligned_cols=266 Identities=24% Similarity=0.384 Sum_probs=216.1
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCCc-hhhHhHHHHHHHHHhc-CCCceeeeeecc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYC 674 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 674 (941)
++....++|++.+.||+|+||+||+|.... ++.||+|+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455667899999999999999999999642 24899999976443 3356789999999999 899999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcC------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 002289 675 DEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 742 (941)
Q Consensus 675 ~~~~~~~LV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 742 (941)
...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999997532 345799999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCc
Q 002289 743 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 821 (941)
Q Consensus 743 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~ 821 (941)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECCCCeEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999986533211 112233457789999999999999999999999999999999 999997543
Q ss_pred hhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
........ . ........+..++..+.+++..||+.+|.+||++.++++.|+++..
T Consensus 272 ~~~~~~~~-~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 272 VNSKFYKL-V--------KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SSHHHHHH-H--------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHH-H--------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 32211111 1 0111222344456788999999999999999999999999988754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=364.46 Aligned_cols=202 Identities=24% Similarity=0.301 Sum_probs=173.7
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CC-----ceeeeeeccccCC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCDEEG 678 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~ 678 (941)
...++|++.+.||+|+||+||+|... +++.||||+++.. .....++..|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34678999999999999999999965 6889999999753 233456788999988885 55 4999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc--CCCCCeEeccCCCCcEEEc--CCCcEEEeee
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT--EADPPVFHRDIKASNILLD--HKFTAKVADF 754 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~--~~~~~ivH~DLkp~NILl~--~~~~~kl~DF 754 (941)
..++||||++ |+|.+++.......+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 699999987765679999999999999999999995 45 99999999999995 4788999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~ 822 (941)
|+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 206 G~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 206 GSSCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999865321 2345689999999999999999999999999999999999999986544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=372.97 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=195.9
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--------hhhHhHHHHHHHHHhcCCCceeeeeecccc
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 676 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 676 (941)
...++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34679999999999999999999965 689999999875321 112358899999999999999999999854
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cEEEee
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVAD 753 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~D 753 (941)
+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 4589999999999999988654 45899999999999999999999999 99999999999997544 599999
Q ss_pred eccccccCCCCCCCccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002289 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830 (941)
Q Consensus 754 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~ 830 (941)
||+|+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 286 FG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~---- 353 (419)
T 3i6u_A 286 FGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---- 353 (419)
T ss_dssp SSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH----
T ss_pred cccceecCCC--------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH----
Confidence 9999865422 22334569999999999864 66888999999999999999999999653321100
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 910 (941)
...+......+..+. .....+.+.+||.+||..||++||
T Consensus 354 ------~~~i~~~~~~~~~~~-----------------------------------~~~~~~~~~~li~~~L~~dP~~Rp 392 (419)
T 3i6u_A 354 ------KDQITSGKYNFIPEV-----------------------------------WAEVSEKALDLVKKLLVVDPKARF 392 (419)
T ss_dssp ------HHHHHTTCCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred ------HHHHhcCCCCCCchh-----------------------------------hcccCHHHHHHHHHHccCChhHCc
Confidence 000111111111100 011223345788899999999999
Q ss_pred CCccCCCCCCCCCC
Q 002289 911 SSSSMLKHPYVSSD 924 (941)
Q Consensus 911 sa~e~L~Hpwf~~~ 924 (941)
|++|+|+||||+..
T Consensus 393 s~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 393 TTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHSGGGCCH
T ss_pred CHHHHhCCcccCCh
Confidence 99999999999763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.19 Aligned_cols=272 Identities=27% Similarity=0.415 Sum_probs=214.8
Q ss_pred cCC-CccceeeccCcEEEEEEEeC-----CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeecccc--CCc
Q 002289 609 NNF-NSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGE 679 (941)
Q Consensus 609 ~~y-~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 679 (941)
++| ++.+.||+|+||+||++.+. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 88999999999999998642 588999999986533 335678999999999999999999999976 457
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+++|+|.+++.... +++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 899999999999999996543 889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHH----HHHhhcc
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN----IAYQSSM 835 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~----~~~~~~~ 835 (941)
...... .........+|..|+|||++.+..++.++|||||||++|||++|+.||........... .......
T Consensus 184 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 184 VPEGHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp CCTTCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred cccccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 643221 11223345578889999999999999999999999999999999999864322100000 0000001
Q ss_pred chhh-hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002289 836 MFSV-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 890 (941)
Q Consensus 836 ~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~ 890 (941)
+... ........+..++..+.+++..||+.+|.+||++.++++.|+.+.+.+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1111 223334456677889999999999999999999999999999987765543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.17 Aligned_cols=265 Identities=31% Similarity=0.472 Sum_probs=210.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC----CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeecc-ccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~ 681 (941)
..+|++.+.||+|+||+||+|.+.+ +..||+|.+..... ...+.+.+|++++++++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998642 23689999876433 3356789999999999999999999985 5566889
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999999653 345889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCC-CCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ-PISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~-Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
..... .........+|+.|+|||.+.+..++.++||||+|+++|||++|.. ||..... .+... .+.
T Consensus 180 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~---------~~~ 246 (298)
T 3f66_A 180 DKEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV---------YLL 246 (298)
T ss_dssp CGGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHH---------HHH
T ss_pred ccchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHH---------HHh
Confidence 32211 1122344567889999999999999999999999999999999544 5543322 11111 112
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
.+.....+..++..+.+++..|++.+|.+||++.++++.|+++...+..
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 2223334555667899999999999999999999999999999876544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=352.71 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=198.1
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCc----
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE---- 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 679 (941)
.++|++.+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 57899999999764322 23578899999999999999999999866543
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+++|+|.++++... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999997654 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||............ ........
T Consensus 166 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~- 239 (311)
T 3ork_A 166 IADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDPIPP- 239 (311)
T ss_dssp --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHCCCCCH-
T ss_pred ccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCCCc-
Confidence 5432210 12223456899999999999999999999999999999999999999765432221111 11100000
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHh
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM-RELESI 883 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~-~~L~~~ 883 (941)
......++..+.+++.+|++.+|++||+..+++ ..+...
T Consensus 240 -----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 -----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 001123457788999999999999999776655 444443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=357.01 Aligned_cols=273 Identities=27% Similarity=0.389 Sum_probs=216.6
Q ss_pred hcCCCccceeeccCcEEEEEEEe-----CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccc--cCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~ 680 (941)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++|+||+++++++. ..+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46888999999999999999984 368899999998766666678999999999999999999999875 45678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999997643 25899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHH-HHH----hhcc
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN-IAY----QSSM 835 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~-~~~----~~~~ 835 (941)
...... ........||..|+|||++.+..++.++|||||||++|||++|+.||........... ... ....
T Consensus 178 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ccCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 432211 1122344578889999999999999999999999999999999999864322110000 000 0001
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
...+..+.....+..++..+.+++..|++.+|.+||++.++++.|+.+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11122233344566778889999999999999999999999999998866443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.21 Aligned_cols=254 Identities=31% Similarity=0.533 Sum_probs=206.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhh-------HhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGE-------KEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
.++|++.+.||+|+||+||+|++. +++.||+|++........ +.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468889999999999999999974 789999999865432221 57899999999999999999999997654
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc-----EEEeee
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADF 754 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DF 754 (941)
++||||+++|+|.+.+.... ..+++..++.++.|++.||+|||+++ ++|+||||||+||+++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 69999999999999886543 46899999999999999999999875 45999999999999988776 999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccc--cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
|+++.... ......||+.|+|||++. ...++.++||||+||++|||++|+.||...............
T Consensus 174 g~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 243 (287)
T 4f0f_A 174 GLSQQSVH----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243 (287)
T ss_dssp TTCBCCSS----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred Cccccccc----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence 99974321 223456899999999984 456789999999999999999999999754332111111110
Q ss_pred hccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
........+..++..+.+++..||+.+|.+||++.++++.|++
T Consensus 244 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 -------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1122234566777889999999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=351.04 Aligned_cols=269 Identities=25% Similarity=0.402 Sum_probs=211.3
Q ss_pred hcCCCccceeeccCcEEEEEEEe-----CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccC--Cc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 679 (941)
..+|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45688899999999999999983 3689999999875432 2346789999999999999999999999776 67
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999996543 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH-----hhc
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY-----QSS 834 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~-----~~~ 834 (941)
...... .........||..|+|||++.+..++.++||||+|+++|||++|+.|+.............. ...
T Consensus 176 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 176 IETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CCTTCC----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccCCCc----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 643321 01223345678889999999999999999999999999999999998643211100000000 000
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
....+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11112223334456677788999999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=357.44 Aligned_cols=267 Identities=27% Similarity=0.450 Sum_probs=219.3
Q ss_pred cchHHHHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeee
Q 002289 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLV 671 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~ 671 (941)
+..+++....++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|+++++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344566677889999999999999999999864 368899999976433 3345789999999999999999999
Q ss_pred eccccCCcEEEEEecCCCCCHHHHHhhcC--------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE
Q 002289 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 743 (941)
Q Consensus 672 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 743 (941)
+++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999986532 245789999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCch
Q 002289 744 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 822 (941)
Q Consensus 744 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~ 822 (941)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred cCCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 9999999999999975432110 112233456889999999999999999999999999999999 8889875433
Q ss_pred hHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
. +... .+..+.....+..++..+.+++..|++.+|.+||++.++++.|++.
T Consensus 247 ~-~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 247 E-QVLR---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp H-HHHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H-HHHH---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 1 1111 1222333445566778899999999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=350.38 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=207.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CC-------cEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DG-------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
.++|.+.+.||+|+||+||+|... ++ ..||+|++........+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467888999999999999999864 23 5799999976555566789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc--------EEE
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKV 751 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--------~kl 751 (941)
.++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997643 34889999999999999999999999 999999999999998887 999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~ 830 (941)
+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....+........
T Consensus 163 ~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp CCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 99999875421 123457889999999987 778999999999999999999666555443322222111
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
. .....+...+..+.+++..||+.+|.+||++.++++.|+++..
T Consensus 232 ~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 E-----------DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp H-----------TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred h-----------ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 1112233335668899999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.41 Aligned_cols=261 Identities=27% Similarity=0.436 Sum_probs=214.3
Q ss_pred hcCCCccc-eeeccCcEEEEEEEeC---CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|.+.+ .||+|+||.||+|.+. ++..||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 8999999999999853 578899999986433 3456789999999999999999999999 4567999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999643 345899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ... .+..
T Consensus 163 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~---------~i~~ 228 (287)
T 1u59_A 163 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMA---------FIEQ 228 (287)
T ss_dssp CSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHH---------HHHT
T ss_pred Ccce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HHH---------HHhc
Confidence 2210 111233456889999999998899999999999999999999 999997654321 111 1122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
+.....+..++..+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 2334456677789999999999999999999999999999886643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=360.73 Aligned_cols=271 Identities=15% Similarity=0.169 Sum_probs=209.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeCC---------CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceee---------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS--------- 669 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~--------- 669 (941)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999753 789999998753 46889999999999999998
Q ss_pred ------eeecccc-CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 002289 670 ------LVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 742 (941)
Q Consensus 670 ------l~~~~~~-~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 742 (941)
+++++.. .+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 4555544 67889999999 999999998764456999999999999999999999999 999999999999
Q ss_pred EcCCC--cEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 743 LDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 743 l~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
++.++ .+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999866432211111112223457999999999999999999999999999999999999999754
Q ss_pred chhHHHHHHHHh--hccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 821 KNIVREVNIAYQ--SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 821 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
............ ........... .....++..+.+++..|++.+|.+||++.++++.|+.+......
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPC--GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTT--SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CcCHHHHHHHHHhccCChhhhhhhc--cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 311111111110 00000000000 00113357789999999999999999999999999998876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=361.18 Aligned_cols=262 Identities=24% Similarity=0.416 Sum_probs=207.7
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--------hhhHhHHHHHHHHHhc-CCCceeeee
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRL-HHRNLVSLV 671 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l~ 671 (941)
.......++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344455678999999999999999999975 799999999875431 1134678999999999 799999999
Q ss_pred eccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEE
Q 002289 672 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 751 (941)
Q Consensus 672 ~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 751 (941)
+++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999997543 4899999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCccccccccc------CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 825 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~ 825 (941)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 242 ~DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp CCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999998654321 2234568999999999864 3578899999999999999999999975432111
Q ss_pred HHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCC
Q 002289 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 905 (941)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~d 905 (941)
... +..+.. .++ ... .........++|.+||..|
T Consensus 314 -~~~---------i~~~~~-~~~------------------------~~~-----------~~~~~~~~~~li~~~L~~d 347 (365)
T 2y7j_A 314 -LRM---------IMEGQY-QFS------------------------SPE-----------WDDRSSTVKDLISRLLQVD 347 (365)
T ss_dssp -HHH---------HHHTCC-CCC------------------------HHH-----------HSSSCHHHHHHHHHHSCSS
T ss_pred -HHH---------HHhCCC-CCC------------------------Ccc-----------cccCCHHHHHHHHHHcCCC
Confidence 000 000000 000 000 0111223447888999999
Q ss_pred CCCCCCCccCCCCCCCC
Q 002289 906 EETPPSSSSMLKHPYVS 922 (941)
Q Consensus 906 P~~R~sa~e~L~Hpwf~ 922 (941)
|++|||++|+|+||||+
T Consensus 348 P~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 348 PEARLTAEQALQHPFFE 364 (365)
T ss_dssp TTTSCCHHHHHHSGGGC
T ss_pred hhHCcCHHHHhcCcccC
Confidence 99999999999999996
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.18 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=209.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCC----CcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
..++|.+.+.||+|+||+||+|.+.+ +..||+|++.... ....+.+.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45788899999999999999998542 3469999987653 3345679999999999999999999999865 4568
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 35889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......... . .+.
T Consensus 165 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-~---------~~~ 228 (281)
T 3cc6_A 165 DED------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-G---------VLE 228 (281)
T ss_dssp --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-H---------HHH
T ss_pred ccc------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-H---------HHh
Confidence 322 111233456789999999999999999999999999999998 99999754332111 1 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.+.....+..++..+.+++.+|++.+|.+||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1222334555677899999999999999999999999999987653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=371.97 Aligned_cols=279 Identities=22% Similarity=0.306 Sum_probs=200.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccC------CcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~ 680 (941)
..+|++.+.||+|+||.||+|++. +|+.||||++.... ....+|++++++++||||++++++|... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346888999999999999999975 68999999986532 2345799999999999999999988432 236
Q ss_pred EEEEecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-CcEEEeeeccc
Q 002289 681 MLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 757 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFGla 757 (941)
++||||+++ ++.+.+.. .....+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999964 77776643 33456899999999999999999999999 9999999999999965 67899999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............. .
T Consensus 205 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~-~---- 271 (420)
T 1j1b_A 205 KQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII-K---- 271 (420)
T ss_dssp EECCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H----
T ss_pred hhcccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-H----
Confidence 8653321 12345689999999999765 79999999999999999999999997654422211111 0
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC-CCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM-PESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~-~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
.+ +....+.... . .-......-|.... ..+...+ +...+.+.+||.+||.+||++|+|+.|+
T Consensus 272 --~l----g~p~~~~~~~---~---~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~ 334 (420)
T 1j1b_A 272 --VL----GTPTREQIRE---M---NPNYTEFKFPQIKA-----HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334 (420)
T ss_dssp --HH----CSCCHHHHHH---H---CSCCCCCCCCCCCC-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred --Hh----CCCCHHHHHh---h---ChhhhhhccCccCC-----CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence 00 0111111110 0 00000000010000 0000011 2234456789999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 916 LKHPYVSSD 924 (941)
Q Consensus 916 L~Hpwf~~~ 924 (941)
|+||||+.-
T Consensus 335 l~hp~f~~~ 343 (420)
T 1j1b_A 335 CAHSFFDEL 343 (420)
T ss_dssp HTSGGGGGG
T ss_pred hCCHhhccc
Confidence 999999653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=356.03 Aligned_cols=288 Identities=21% Similarity=0.316 Sum_probs=210.0
Q ss_pred hcCCCccceeeccCcEEEEEEEe-C-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCc------eeeeeeccccCCc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-P-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN------LVSLVGYCDEEGE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 679 (941)
.++|++.+.||+|+||+||+|.+ . +++.||||+++.. ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 3 6899999999753 233567889999999987654 9999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--------------
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------- 745 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-------------- 745 (941)
.++||||+ +++|.+++......++++..++.++.|+++||+|||+++ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 899999998776667999999999999999999999999 999999999999987
Q ss_pred -----CCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 746 -----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 746 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999764321 23346899999999999999999999999999999999999999765
Q ss_pred chhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh----hC---CCCCCC
Q 002289 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN----MM---PESDTK 893 (941)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~----~~---~~~~~~ 893 (941)
.......... .. .+..|......... ......+....+.............. .. ....+.
T Consensus 238 ~~~~~~~~~~-------~~----~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 238 DSKEHLAMME-------RI----LGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304 (339)
T ss_dssp CHHHHHHHHH-------HH----HCSCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred ChHHHHHHHH-------HH----hCCCCHHHHhhccc--hhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence 4322111100 00 01122221111000 00000000000111111111111100 00 000122
Q ss_pred CcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 894 TPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 894 ~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
..+||.+||..||++|||++|+|+||||+.
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred HHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 357999999999999999999999999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.57 Aligned_cols=265 Identities=31% Similarity=0.506 Sum_probs=203.0
Q ss_pred cCCCccceeeccCcEEEEEEEeC--CC--cEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccc-cCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~L 682 (941)
..|++.+.||+|+||+||+|.+. ++ ..||||.++... ....+.+.+|+.++++++||||+++++++. .++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34667789999999999999863 22 468999987533 234568999999999999999999999864 4567899
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 169 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999996543 45889999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||........ . ..+..
T Consensus 245 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-~---------~~~~~ 311 (373)
T 3c1x_A 245 KEFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-T---------VYLLQ 311 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-H---------HHHHT
T ss_pred cccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-H---------HHHHc
Confidence 2211 1112234457889999999999999999999999999999999 6667754332111 1 11122
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 890 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~ 890 (941)
+.....+..++..+.+++.+||+.+|++||++.++++.|+.+...+...
T Consensus 312 ~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 2333445667788999999999999999999999999999998766543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=352.76 Aligned_cols=270 Identities=26% Similarity=0.437 Sum_probs=209.1
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccc
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 675 (941)
+++....++|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 444556788999999999999999999853 34589999987543 233467899999999999999999999987
Q ss_pred cCC-----cEEEEEecCCCCCHHHHHhh----cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC
Q 002289 676 EEG-----EQMLVYEFMSNGTLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 746 (941)
Q Consensus 676 ~~~-----~~~LV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 746 (941)
..+ ..++||||+++|+|.+++.. .....+++..++.++.|+++||.|||+++ |+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 654 35999999999999999853 23456999999999999999999999999 9999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHH
Q 002289 747 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 825 (941)
Q Consensus 747 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~ 825 (941)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp SCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 9999999999986543221 112233457889999999999999999999999999999999 8889875443211
Q ss_pred HHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
. ..+..+.....+..++..+.+++..|+..+|.+||++.++++.|+++....++
T Consensus 259 ~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 259 Y----------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp H----------HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred H----------HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1 11222333445566778899999999999999999999999999999876653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=381.51 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=209.6
Q ss_pred CCCccc-eeeccCcEEEEEEEeC---CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 610 NFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 610 ~y~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++.+.+ .||+|+||.||+|.+. ++..||||+++.... ...+.+.+|++++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999864 467899999986433 345789999999999999999999999976 5699999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999654 346899999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.. ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+..+.
T Consensus 491 ~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~---------~~i~~~~ 556 (613)
T 2ozo_A 491 SY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VM---------AFIEQGK 556 (613)
T ss_dssp ---------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HH---------HHHHTTC
T ss_pred ce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HH---------HHHHcCC
Confidence 10 111223345689999999999999999999999999999998 999997654321 11 1122233
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
....+..++..+.+++..||+.+|++||++.++++.|+.+.....
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 445667788899999999999999999999999999998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.71 Aligned_cols=262 Identities=27% Similarity=0.477 Sum_probs=201.6
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
...++|++.++||+|+||+||+|++.. .||||+++.... ...+.+.+|++++++++|+||+++++++ ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 346789999999999999999998643 599999875432 3346789999999999999999999965 45578999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999999654 345899999999999999999999999 999999999999999999999999999765322
Q ss_pred CCCCccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.. ........||+.|+|||++. +..++.++||||||+++|||++|+.||.............. .. ..
T Consensus 174 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~----~~ 243 (289)
T 3og7_A 174 SG-----SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG-RG----SL 243 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH-HT----SC
T ss_pred cc-----cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc-cc----cc
Confidence 11 12233456899999999987 56788899999999999999999999976554332222211 11 11
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
..........++..+.+++..|++.+|.+||++.++++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11222334566788999999999999999999999999998864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.05 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=207.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999975 68999999987433 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998543 45899999999999999999999999 99999999999999999999999999976532211
Q ss_pred CCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
........||..|+|||++.+..+ +.++||||||+++|||++|+.||..............
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 222 (276)
T 2yex_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------- 222 (276)
T ss_dssp -----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-------------
T ss_pred -----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-------------
Confidence 112234568999999999988765 7789999999999999999999975432111111000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
. .....+.. ...++...++|.+||..||++|||++|+++||||+..
T Consensus 223 ---------------~-----~~~~~~~~--------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 223 ---------------E-----KKTYLNPW--------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ---------------T-----TCTTSTTG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---------------h-----cccccCch--------------hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0 00000000 0112223468888999999999999999999999876
Q ss_pred CCC
Q 002289 925 VSG 927 (941)
Q Consensus 925 ~~~ 927 (941)
...
T Consensus 269 ~~~ 271 (276)
T 2yex_A 269 LKK 271 (276)
T ss_dssp CC-
T ss_pred hhc
Confidence 543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=363.75 Aligned_cols=278 Identities=23% Similarity=0.371 Sum_probs=206.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE----
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ---- 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~---- 680 (941)
.++|.+.+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999965 689999999976432 2346788999999999999999999999776654
Q ss_pred --EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 681 --MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 681 --~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
++||||++ ++|.+++.. .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 689888732 3899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ..
T Consensus 193 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-~~----- 256 (371)
T 4exu_A 193 HADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI-LK----- 256 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HH-----
T ss_pred cccc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HH-----
Confidence 5432 1234568999999999987 78899999999999999999999999765432221111 10
Q ss_pred hhhcCCCCCCChHHHHHHHH-HHHHhcc-cCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 838 SVIDGNMGSYPSECVEKFIK-LALKCCQ-DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~-l~~~c~~-~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
.. +..+.+....+.. ....... .....+....+ ..+...+.+.+||.+||+.||++|||++|+
T Consensus 257 -~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 321 (371)
T 4exu_A 257 -VT----GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ----------LFPRASPQAADLLEKMLELDVDKRLTAAQA 321 (371)
T ss_dssp -HH----CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHH----------HSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred -Hh----CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHH----------hccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence 00 0111111110000 0000001 11111222221 223445566789999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 916 LKHPYVSSD 924 (941)
Q Consensus 916 L~Hpwf~~~ 924 (941)
|+||||+.-
T Consensus 322 l~hp~f~~~ 330 (371)
T 4exu_A 322 LTHPFFEPF 330 (371)
T ss_dssp HTSGGGTTT
T ss_pred hcCcccccC
Confidence 999999764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=364.95 Aligned_cols=281 Identities=23% Similarity=0.337 Sum_probs=202.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC------cEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------EQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 681 (941)
..+|++.+.||+|+||+||+|+..++..||+|++.... ....+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 45788999999999999999998777779999876432 22347999999999999999999985433 378
Q ss_pred EEEecCCCCCHHHHHh--hcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEeeecccc
Q 002289 682 LVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSR 758 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFGla~ 758 (941)
+||||+++ ++.+.+. ......+++..++.++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999976 4444433 123456899999999999999999999999 99999999999999 79999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..............
T Consensus 191 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~------ 256 (394)
T 4e7w_A 191 ILIAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK------ 256 (394)
T ss_dssp ECCTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred cccCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH------
Confidence 653321 22345689999999999765 589999999999999999999999976554322211110
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS-MSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs-~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
. .+..+.+....... ...-..-|..++. .... ..+...+.+.+||.+||+.||++|||+.|+|
T Consensus 257 -~----~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 257 -V----LGTPSREQIKTMNP--NYMEHKFPQIRPHPFSKV---------FRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp -H----HCCCCHHHHHHHCG--GGSSSCCCCCCCCCHHHH---------SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred -H----hCCCCHHHHHhhCh--hhhhhccccccCCcHHHh---------ccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 0 01111111110000 0000111121221 1110 1122445567899999999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 917 KHPYVSSDVS 926 (941)
Q Consensus 917 ~Hpwf~~~~~ 926 (941)
+||||+.-..
T Consensus 321 ~hp~f~~~~~ 330 (394)
T 4e7w_A 321 CHPFFDELRT 330 (394)
T ss_dssp TSGGGSTTTS
T ss_pred cChhhhhhcc
Confidence 9999986544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.92 Aligned_cols=263 Identities=26% Similarity=0.380 Sum_probs=212.2
Q ss_pred HHHhcCCCccc-eeeccCcEEEEEEEe---CCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 605 ALATNNFNSST-QIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 605 ~~~~~~y~~~~-~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
....++|.+.+ .||+|+||+||+|.+ .+++.||||+++.... ...+.+.+|+++++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 33456788887 999999999999964 2478999999875432 2246789999999999999999999999 567
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 8899999999999999997643 4889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
........ ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ..
T Consensus 166 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~--------- 231 (291)
T 1xbb_A 166 ALRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA--------- 231 (291)
T ss_dssp ECCTTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HH---------
T ss_pred eeccCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HH---------
Confidence 76432211 111223346788999999999889999999999999999999 9999976543211 11
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
.+..+.....+..++..+.+++..||+.+|.+||++.++++.|+++....
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11222334456677788999999999999999999999999999887643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.77 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=199.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeecccc----CCcEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQM 681 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~ 681 (941)
..|.+.+.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777889999999999999975 68899999987532 2334678999999999999999999998754 35689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEeeecccccc
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLA 760 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFGla~~~ 760 (941)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||||+||+++ .++.+||+|||++...
T Consensus 106 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999997643 4889999999999999999999875 4599999999999998 7899999999999754
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
... ......||+.|+|||++. +.++.++||||+||++|||++|+.||....+..........
T Consensus 183 ~~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------- 244 (290)
T 1t4h_A 183 RAS---------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-------- 244 (290)
T ss_dssp CTT---------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--------
T ss_pred ccc---------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc--------
Confidence 321 223456899999999886 45899999999999999999999999764443222211100
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
+.. +.. ......+...++|.+||..||++|||++|+|+|||
T Consensus 245 -~~~---~~~-----------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 245 -GVK---PAS-----------------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp -TCC---CGG-----------------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -cCC---ccc-----------------------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 000 000 00001112346788899999999999999999999
Q ss_pred CCCC
Q 002289 921 VSSD 924 (941)
Q Consensus 921 f~~~ 924 (941)
|+++
T Consensus 286 f~~~ 289 (290)
T 1t4h_A 286 FQEE 289 (290)
T ss_dssp GC--
T ss_pred cccC
Confidence 9875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.17 Aligned_cols=254 Identities=30% Similarity=0.451 Sum_probs=205.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc-CCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~LV~e 685 (941)
..++|++.+.||+|+||+||+|.. +|+.||||+++... ..+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 356889999999999999999987 48899999987543 34678999999999999999999998754 457899999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++|+|.+++.......+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997654444788999999999999999999999 999999999999999999999999998754321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ..+..+..
T Consensus 171 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~---------~~~~~~~~ 232 (278)
T 1byg_A 171 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VV---------PRVEKGYK 232 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HH---------HHHTTTCC
T ss_pred --------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HH---------HHHhcCCC
Confidence 122356889999999999999999999999999999998 999997543211 11 11112223
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
...+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 345566778899999999999999999999999999988653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.35 Aligned_cols=287 Identities=24% Similarity=0.333 Sum_probs=211.7
Q ss_pred HhcCCCccceeeccCcEEEEEEEe--CCCcEEEEEEeccCCch--hhHhHHHHHHHHHhc---CCCceeeeeeccc----
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL--PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCD---- 675 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~---- 675 (941)
..++|++.+.||+|+||.||+|.. .+|+.||+|+++..... ....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 36889999998643221 234577888887776 8999999999986
Q ss_pred -cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 002289 676 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 754 (941)
Q Consensus 676 -~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 754 (941)
.....++||||++ |+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999996 69999998776667999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhc
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
|+++.... ........||..|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 165 g~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 165 GLARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CSCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccC--------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 99976432 1223445689999999999999999999999999999999999999976544221111100000
Q ss_pred cc-hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCc
Q 002289 835 MM-FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 913 (941)
Q Consensus 835 ~~-~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 913 (941)
.. ...... ....+. ..+. ....+. +....+..+....+||.+||..||++|||++
T Consensus 237 ~~~~~~~~~-~~~~~~-----------~~~~--~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 292 (326)
T 1blx_A 237 LPGEEDWPR-DVALPR-----------QAFH--SKSAQP----------IEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292 (326)
T ss_dssp CCCGGGSCT-TCSSCG-----------GGSC--CCCCCC----------GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCcccCcc-ccccch-----------hhhc--ccCcch----------hhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence 00 000000 000000 0000 000000 1111223334456899999999999999999
Q ss_pred cCCCCCCCCCCCCCCc
Q 002289 914 SMLKHPYVSSDVSGSN 929 (941)
Q Consensus 914 e~L~Hpwf~~~~~~~~ 929 (941)
|+|+||||+.......
T Consensus 293 e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 293 SALSHPYFQDLERCKE 308 (326)
T ss_dssp HHHTSGGGTTCCCCCC
T ss_pred HHhcCccccccchhhh
Confidence 9999999987655433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=376.04 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=199.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++.+.||+|+||+||+|+.. ++..||+|++..... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999975 689999999875432 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeeccccccC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAP 761 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGla~~~~ 761 (941)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999886653 4889999999999999999999999 999999999999976 4559999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. .......||+.|+|||++. ..++.++||||+||++|||++|+.||....... ....
T Consensus 191 ~~--------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~------------ 248 (494)
T 3lij_A 191 NQ--------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRK------------ 248 (494)
T ss_dssp TT--------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH------------
T ss_pred CC--------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH------------
Confidence 32 1233456999999999886 568999999999999999999999997543211 1000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
+........+ |. +....+.+.+||.+||+.||++|||++|+|+||||
T Consensus 249 ----------------i~~~~~~~~~---~~--------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 249 ----------------VEKGKYTFDS---PE--------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp ----------------HHHTCCCCCS---GG--------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ----------------HHhCCCCCCc---hh--------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 0000000000 00 01112234478888999999999999999999999
Q ss_pred CC
Q 002289 922 SS 923 (941)
Q Consensus 922 ~~ 923 (941)
+.
T Consensus 296 ~~ 297 (494)
T 3lij_A 296 KE 297 (494)
T ss_dssp HH
T ss_pred cc
Confidence 65
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=356.61 Aligned_cols=293 Identities=22% Similarity=0.289 Sum_probs=209.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccC-----CcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 680 (941)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 689999999975432 2345788999999999999999999987653 678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6999998653 4899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcc---ccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 761 PVPDIEGIV---PAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 761 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
......... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 432211100 0111234568999999998765 778999999999999999999999997654322111110000000
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
. .+.......... ..+.+. ..|.. +.... ...+...+...+||.+||..||++|||++|+
T Consensus 243 ~--~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (353)
T 2b9h_A 243 H--SDNDLRCIESPR---AREYIK----SLPMYPAAPLE----------KMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303 (353)
T ss_dssp C--STTTTTTCCCHH---HHHHHH----TSCCCCCCCHH----------HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred c--hhccccccccch---hhHHhh----cccCCCCcchh----------hhcccCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 0 000000000111 111111 01110 11111 1223444556789999999999999999999
Q ss_pred CCCCCCCCCCC
Q 002289 916 LKHPYVSSDVS 926 (941)
Q Consensus 916 L~Hpwf~~~~~ 926 (941)
|+||||+....
T Consensus 304 l~hp~~~~~~~ 314 (353)
T 2b9h_A 304 LEHPYLQTYHD 314 (353)
T ss_dssp HTSGGGTTTCC
T ss_pred hcCccccccCC
Confidence 99999977544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=342.53 Aligned_cols=264 Identities=26% Similarity=0.383 Sum_probs=212.2
Q ss_pred CCCccceeeccCcEEEEEEEeC-C---CcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE-EEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ-MLV 683 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~LV 683 (941)
.|...+.||+|+||+||+|.+. + +..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556789999999999999853 2 33799999876433 3356789999999999999999999999766655 999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+.+|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999653 346899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.. ..........+|+.|+|||.+.+..++.++|||||||++|||++|..|+....+....... +....
T Consensus 178 ~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~---------~~~~~ 245 (298)
T 3pls_A 178 EY---YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---------LAQGR 245 (298)
T ss_dssp GG---GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH---------HHTTC
T ss_pred cc---cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH---------hhcCC
Confidence 11 1112233456788999999999999999999999999999999976666544332221111 11222
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
....+..++..+.+++..|++.+|.+||++.++++.|+++...+..
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2334556677899999999999999999999999999998876654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=376.45 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=204.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-------------hhhHhHHHHHHHHHhcCCCceeeeee
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------------QGEKEFLTEIQFLSRLHHRNLVSLVG 672 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~ 672 (941)
..++|.+.++||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999975 689999999875332 22457889999999999999999999
Q ss_pred ccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC---cE
Q 002289 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TA 749 (941)
Q Consensus 673 ~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~ 749 (941)
++.+.+..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999987653 4899999999999999999999999 99999999999998776 69
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 829 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~ 829 (941)
||+|||+++..... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... +....
T Consensus 189 kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD--------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKK 258 (504)
T ss_dssp EECCCTTCEECCTT--------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred EEEECCCCEEcCCC--------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 99999999865432 1223456999999999986 46899999999999999999999999754321 11100
Q ss_pred HHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCC
Q 002289 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 909 (941)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 909 (941)
+..+. ..++... +....+.+.+||.+||+.||++|
T Consensus 259 ---------i~~~~-~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dp~~R 293 (504)
T 3q5i_A 259 ---------VEKGK-YYFDFND-----------------------------------WKNISDEAKELIKLMLTYDYNKR 293 (504)
T ss_dssp ---------HHHCC-CCCCHHH-----------------------------------HTTSCHHHHHHHHHHTCSSTTTS
T ss_pred ---------HHcCC-CCCCccc-----------------------------------cCCCCHHHHHHHHHHcCCChhHC
Confidence 00000 0011000 01223344578999999999999
Q ss_pred CCCccCCCCCCCCCCC
Q 002289 910 PSSSSMLKHPYVSSDV 925 (941)
Q Consensus 910 ~sa~e~L~Hpwf~~~~ 925 (941)
||++|+|+||||+...
T Consensus 294 ~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 294 CTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCHHHHHTSHHHHHTC
T ss_pred CCHHHHhcCHhhhhch
Confidence 9999999999997643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.94 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=208.3
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc---------
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------- 676 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------- 676 (941)
..++|++.+.||+|+||.||+|.+. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3567899999999999999999976 79999999987543 367899999999999999999998743
Q ss_pred -------CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 002289 677 -------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749 (941)
Q Consensus 677 -------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 749 (941)
....++||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 445799999999999999998765567999999999999999999999999 9999999999999999999
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 829 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~ 829 (941)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+........
T Consensus 162 kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT---- 229 (284)
T ss_dssp EECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH----
T ss_pred EECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH----
Confidence 999999998654321 12334589999999999999999999999999999999999988742211110
Q ss_pred HHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
.+... ..+..++..+.+++..|++.+|.+||++.++++.++.+.+..
T Consensus 230 --------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 --------DLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp --------HHHTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred --------Hhhcc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11111 123344567889999999999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=357.99 Aligned_cols=295 Identities=22% Similarity=0.274 Sum_probs=199.3
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCc-
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE- 679 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~- 679 (941)
.+.....++|++.+.||+|+||+||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999975 68999999886532 223456788888999999999999999855433
Q ss_pred ------EEEEEecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhh--cCCCCCeEeccCCCCcEEEcC-CCc
Q 002289 680 ------QMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLH--TEADPPVFHRDIKASNILLDH-KFT 748 (941)
Q Consensus 680 ------~~LV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~DLkp~NILl~~-~~~ 748 (941)
.++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| +++ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999965 66555442 23456889999999999999999999 888 999999999999997 899
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 827 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~ 827 (941)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..........
T Consensus 171 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp EEECCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEeeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 9999999998654321 223456899999999997654 8999999999999999999999997654422211
Q ss_pred HHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCC
Q 002289 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 907 (941)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~ 907 (941)
... . . .+..+.+....+..-. .........+.....+. ........+.+.+||.+||+.||+
T Consensus 243 ~~~-~------~----~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~ 304 (360)
T 3e3p_A 243 EIV-R------V----LGCPSREVLRKLNPSH-TDVDLYNSKGIPWSNVF------SDHSLKDAKEAYDLLSALLQYLPE 304 (360)
T ss_dssp HHH-H------H----HCCCCHHHHHHHCTTC-CCGGGGCCCCCCHHHHT------TTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred HHH-H------H----cCCCCHHHHHhcccch-hhccccccccCCccccc------chhhccccHHHHHHHHHHhccCcc
Confidence 110 0 0 0111111111110000 00000000111111110 001111223456899999999999
Q ss_pred CCCCCccCCCCCCCCCCCCC
Q 002289 908 TPPSSSSMLKHPYVSSDVSG 927 (941)
Q Consensus 908 ~R~sa~e~L~Hpwf~~~~~~ 927 (941)
+|||++|+|+||||++....
T Consensus 305 ~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 305 ERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp GSCCHHHHTTSGGGGGGGCT
T ss_pred ccCCHHHHhcCccccccCCc
Confidence 99999999999999875543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.77 Aligned_cols=200 Identities=30% Similarity=0.465 Sum_probs=173.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||+||+|... +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999965 5789999998643221 245688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999997653 4889999999999999999999999 999999999999999999999999998654321
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
......||+.|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 163 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 1234568999999999999999999999999999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=353.66 Aligned_cols=285 Identities=22% Similarity=0.366 Sum_probs=205.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccc-----------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----------- 675 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----------- 675 (941)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 58999999998766666678999999999999999999998873
Q ss_pred ---cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEE
Q 002289 676 ---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKV 751 (941)
Q Consensus 676 ---~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl 751 (941)
..+..++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+++ |+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999996 699999954 35889999999999999999999999 99999999999997 5679999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~ 830 (941)
+|||+++....... .........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 163 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~ 237 (320)
T 2i6l_A 163 GDFGLARIMDPHYS----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLI 237 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH
T ss_pred ccCccccccCCCcc----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 99999986542211 0112234457899999999876 6789999999999999999999999976554221 1111
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccC-CCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCC
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDE-TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 909 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~-p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R 909 (941)
.. ..+....+...++...+......+ ...+.... ...+.......+||.+||..||++|
T Consensus 238 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 238 LE----------SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT----------QLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HH----------HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHH----------HHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HH----------hcCCCchhhhhhhhhcCcccccccccCCCCChh----------HhcchhhHHHHHHHHHHcCCCcccc
Confidence 10 111122222222211110000000 00111111 1123344556789999999999999
Q ss_pred CCCccCCCCCCCCCC
Q 002289 910 PSSSSMLKHPYVSSD 924 (941)
Q Consensus 910 ~sa~e~L~Hpwf~~~ 924 (941)
||++|+|+||||+..
T Consensus 298 pt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 298 LTAEEALSHPYMSIY 312 (320)
T ss_dssp CCHHHHHTSHHHHTT
T ss_pred CCHHHHhCCcccccc
Confidence 999999999999763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=378.52 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=207.4
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
..++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999975 78999999986543 2235678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeeccccc
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRL 759 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFGla~~ 759 (941)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 104 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999986543 5899999999999999999999999 9999999999999 5678999999999986
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .... +
T Consensus 179 ~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~---------i 239 (484)
T 3nyv_A 179 FEAS--------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKK---------V 239 (484)
T ss_dssp BCCC--------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH---------H
T ss_pred cccc--------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHH---------H
Confidence 5432 12234569999999999876 68999999999999999999999997543311 1100 0
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
..+... + ..|.. ....+.+.+||.+||+.||++|||++|+|+||
T Consensus 240 ~~~~~~-~---------------------~~~~~--------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 240 EKGKYT-F---------------------ELPQW--------------KKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHCCCC-C---------------------CSGGG--------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HcCCCC-C---------------------CCccc--------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 000000 0 00000 11122345789999999999999999999999
Q ss_pred CCCCCC
Q 002289 920 YVSSDV 925 (941)
Q Consensus 920 wf~~~~ 925 (941)
||+...
T Consensus 284 ~~~~~~ 289 (484)
T 3nyv_A 284 WIQTYT 289 (484)
T ss_dssp HHHHHT
T ss_pred hhcccc
Confidence 997643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=350.87 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=202.3
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3578999999999999999999976 589999999886655556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999986533 35899999999999999999999999 999999999999999999999999987532110
Q ss_pred CCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
........||..|+|||++. +..++.++||||||+++|||++|+.||...........
T Consensus 171 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------ 233 (302)
T 2j7t_A 171 -----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK------------ 233 (302)
T ss_dssp -----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------------
T ss_pred -----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH------------
Confidence 11123346899999999984 66789999999999999999999999965432111000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 920 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpw 920 (941)
+.. ..+...+... .......+++.+||..||++|||++|+++|||
T Consensus 234 -----------------~~~----~~~~~~~~~~--------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 234 -----------------IAK----SDPPTLLTPS--------------KWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp -----------------HHH----SCCCCCSSGG--------------GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred -----------------Hhc----cCCcccCCcc--------------ccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 000 0000000000 01112336788889999999999999999999
Q ss_pred CCCCCC
Q 002289 921 VSSDVS 926 (941)
Q Consensus 921 f~~~~~ 926 (941)
|++...
T Consensus 279 ~~~~~~ 284 (302)
T 2j7t_A 279 VSSITS 284 (302)
T ss_dssp TTTCCC
T ss_pred Hhhhcc
Confidence 987554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=375.48 Aligned_cols=247 Identities=14% Similarity=0.144 Sum_probs=189.5
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccC---CchhhHhHHHHH---HHHHhcCCCceeeee-------ec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEI---QFLSRLHHRNLVSLV-------GY 673 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~ 673 (941)
.++|++.+.||+|+||+||+|++ .+|+.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 56788999999999999999996 46999999998743 233456789999 455566899999998 44
Q ss_pred cccCC-----------------cEEEEEecCCCCCHHHHHhhcC-----CCCccHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 002289 674 CDEEG-----------------EQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPV 731 (941)
Q Consensus 674 ~~~~~-----------------~~~LV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 731 (941)
+...+ ..++||||+ +|+|.+++.... ...+++..++.|+.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 44332 378999999 689999997532 123556888999999999999999999 9
Q ss_pred EeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccC-----------CCCchhHh
Q 002289 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----------KLTDKSDV 800 (941)
Q Consensus 732 vH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDV 800 (941)
+||||||+|||++.++.+||+|||+|+... .......| +.|+|||++.+. .++.++||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999998532 12234457 999999999887 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002289 801 YSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 880 (941)
Q Consensus 801 wSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L 880 (941)
|||||++|||++|+.||...... .....+. ...
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~----------~~~~~~~-~~~------------------------------------ 329 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAAL----------GGSEWIF-RSC------------------------------------ 329 (377)
T ss_dssp HHHHHHHHHHHHSSCCC----------------CCSGGGG-SSC------------------------------------
T ss_pred HHHHHHHHHHHHCCCCCcccccc----------cchhhhh-hhc------------------------------------
Confidence 99999999999999999643210 0000110 000
Q ss_pred HHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 881 ESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 881 ~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
+...+...++|.+||..||++|||+.|+++||||++
T Consensus 330 -------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 330 -------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp -------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred -------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 111222345777788888999999999999999865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=377.55 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=204.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999975 78999999986422 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeeccccccC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAP 761 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFGla~~~~ 761 (941)
||+++|+|.+.+.... .+++..++.++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999886653 4899999999999999999999999 99999999999995 45689999999998654
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.. .......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .... +..
T Consensus 176 ~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~---------i~~ 236 (486)
T 3mwu_A 176 QN--------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKR---------VET 236 (486)
T ss_dssp CC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH---------HHH
T ss_pred CC--------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH---------HHh
Confidence 32 12234569999999999876 58999999999999999999999997543211 1100 000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
+... ...|.. ....+.+.+||.+||+.||++|||+.|+|+||||
T Consensus 237 ~~~~----------------------~~~~~~--------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 237 GKYA----------------------FDLPQW--------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp TCCC----------------------SCSGGG--------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred CCCC----------------------CCCccc--------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 0000 000100 1112234578899999999999999999999999
Q ss_pred CCCCC
Q 002289 922 SSDVS 926 (941)
Q Consensus 922 ~~~~~ 926 (941)
+....
T Consensus 281 ~~~~~ 285 (486)
T 3mwu_A 281 QKYSS 285 (486)
T ss_dssp HHTCC
T ss_pred ccCcc
Confidence 76544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=345.01 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=205.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---------hhhHhHHHHHHHHHhcC-CCceeeeeecccc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---------QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE 676 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 676 (941)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999975 689999999875431 12356789999999995 9999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999764 35889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccc------cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 830 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~ 830 (941)
+....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ..
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~-- 239 (298)
T 1phk_A 171 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LR-- 239 (298)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH--
T ss_pred hhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-HH--
Confidence 98654321 123456899999999985 45688999999999999999999999965432111 00
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 910 (941)
.+........ .|.. ........+++.+||..||++||
T Consensus 240 --------------------------~~~~~~~~~~---~~~~--------------~~~~~~l~~li~~~l~~dp~~Rp 276 (298)
T 1phk_A 240 --------------------------MIMSGNYQFG---SPEW--------------DDYSDTVKDLVSRFLVVQPQKRY 276 (298)
T ss_dssp --------------------------HHHHTCCCCC---TTTG--------------GGSCHHHHHHHHHHCCSSGGGSC
T ss_pred --------------------------HHhcCCcccC---cccc--------------cccCHHHHHHHHHHccCCcccCC
Confidence 0000000000 0000 00112234688889999999999
Q ss_pred CCccCCCCCCCCCCC
Q 002289 911 SSSSMLKHPYVSSDV 925 (941)
Q Consensus 911 sa~e~L~Hpwf~~~~ 925 (941)
|++|+|+||||+...
T Consensus 277 s~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 277 TAEEALAHPFFQQYV 291 (298)
T ss_dssp CHHHHTTSGGGCTTC
T ss_pred CHHHHHhChHhhhcc
Confidence 999999999998644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=350.08 Aligned_cols=269 Identities=26% Similarity=0.433 Sum_probs=215.0
Q ss_pred hcCCCccceeeccCcEEEEEEEe-----CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC--cE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~ 680 (941)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46788899999999999999984 368999999998766666678999999999999999999999986544 78
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997653 45899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh-------h
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ-------S 833 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~-------~ 833 (941)
...... ........++..|+|||.+.+..++.++||||||+++|||++|..||....... ...... .
T Consensus 196 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~--~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 196 PQDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MRMIGNDKQGQMIV 269 (326)
T ss_dssp CSSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH--HHHHCTTCCTHHHH
T ss_pred cccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH--HHhhccccchhhhH
Confidence 432210 111223456778999999999889999999999999999999999885321110 000000 0
Q ss_pred ccchhh-hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 834 SMMFSV-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 834 ~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
..+.+. ........+..++..+.+++..||+.+|.+||++.++++.|+.+.+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 001111 12223345667778899999999999999999999999999988654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=350.16 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=204.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCc----EEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+.... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467899999999999999999964 444 35777775432 334568999999999999999999999998654 88
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997643 35899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......- .. .+.
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~---------~~~ 233 (327)
T 3lzb_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SS---------ILE 233 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HH---------HHH
T ss_pred Cccc-----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HH---------HHH
Confidence 3221 112233456789999999999999999999999999999999 9999975443211 00 111
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.......+..++..+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222334556677889999999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=352.19 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=198.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCC--CceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++++++| +||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 467899999999999999999998899999999875432 234678999999999976 9999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||+ .+|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 5889999997653 5889999999999999999999999 99999999999997 678999999999865432
Q ss_pred CCCCccccccccccccCCCccccccccc-----------CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+.......
T Consensus 161 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--- 232 (343)
T 3dbq_A 161 TT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA--- 232 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH---
T ss_pred cc-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH---
Confidence 11 112334579999999999865 67899999999999999999999999765443222221
Q ss_pred hccchhhhcC-CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 833 SSMMFSVIDG-NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 833 ~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
.++. ....++......+.+++..|++.+|.+||++.+++++
T Consensus 233 ------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 1223444445677888889999999999999888765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=357.86 Aligned_cols=268 Identities=18% Similarity=0.180 Sum_probs=201.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCchh-----------hHhHHHHHHHHHhcCCCceeeeee
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQG-----------EKEFLTEIQFLSRLHHRNLVSLVG 672 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~l~~ 672 (941)
.++|++.+.||+|+||+||+|.+. ++..||||+........ ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467899999999999999999975 57889999987643221 124667888999999999999999
Q ss_pred cccc----CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-
Q 002289 673 YCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF- 747 (941)
Q Consensus 673 ~~~~----~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~- 747 (941)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9876 67899999999 999999997654 6899999999999999999999999 99999999999999887
Q ss_pred -cEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch-h--
Q 002289 748 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-I-- 823 (941)
Q Consensus 748 -~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~-~-- 823 (941)
.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643221111112223456799999999999999999999999999999999999999954211 1
Q ss_pred HHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 824 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
........... ....+.... ....++..+.+++..||+.+|++||++.++++.|+...
T Consensus 270 ~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDE-LPQSVLKWA--PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHT-TTHHHHHHS--CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhccc-ccHHHHhhc--cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111100 000000000 01134568999999999999999999999999988653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.80 Aligned_cols=262 Identities=26% Similarity=0.372 Sum_probs=204.4
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc--CCCceeeeeeccccC----C
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE----G 678 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~----~ 678 (941)
....++|++.+.||+|+||.||+|++. ++.||||++... ....+.+|.+++... +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 345678999999999999999999985 899999998642 233455666666554 899999999998766 6
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC--------CCCCeEeccCCCCcEEEcCCCcEE
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDHKFTAK 750 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------~~~~ivH~DLkp~NILl~~~~~~k 750 (941)
..++||||+++|+|.++++.. .+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEE
T ss_pred ceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEE
Confidence 889999999999999999654 489999999999999999999988 7 99999999999999999999
Q ss_pred EeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCch------hHhHHHHHHHHHHHhC----------C
Q 002289 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK------SDVYSLGVVFLELLTG----------M 814 (941)
Q Consensus 751 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDVwSlG~ll~elltG----------~ 814 (941)
|+|||+++......... ........||+.|+|||++.+.....+ +|||||||++|||++| +
T Consensus 183 l~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEV---DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp ECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEeCCCceeeccccccc---cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999997654322110 111224569999999999988766654 9999999999999999 6
Q ss_pred CCCCCCch---hHHHHHHHHhhccchhhhcCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 815 QPISHGKN---IVREVNIAYQSSMMFSVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 815 ~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.||..... .......... .......++ .+++..+.+++..||+.+|.+||++.++++.|+.+.+.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVC-------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHT-------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccHhhhcCCCCchhhhHHHHh-------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 66643211 1111111110 111122233 37889999999999999999999999999999998764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.53 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=189.0
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchh-hH-hHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG-EK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
..++|++.+.||+|+||+||+|.. .+|+.||||+++...... .. .+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999997 478999999997643222 22 344455568888999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 684 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
|||++ |+|.+++.. .....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 699888754 2345699999999999999999999997 8 999999999999999999999999999765
Q ss_pred CCCCCCCccccccccccccCCCccccccc----ccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
.... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||..............
T Consensus 161 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 227 (290)
T 3fme_A 161 VDDV--------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV----- 227 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH-----
T ss_pred cccc--------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh-----
Confidence 4321 12334689999999996 556789999999999999999999999975333222111110
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
....... +.. ...+...+++.+||..||++|||++|++
T Consensus 228 ----~~~~~~~-------------------~~~-------------------~~~~~~~~li~~~l~~~p~~Rpt~~e~l 265 (290)
T 3fme_A 228 ----EEPSPQL-------------------PAD-------------------KFSAEFVDFTSQCLKKNSKERPTYPELM 265 (290)
T ss_dssp ----HSCCCCC-------------------CTT-------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ----ccCCCCc-------------------ccc-------------------cCCHHHHHHHHHHhhcChhhCcCHHHHH
Confidence 0000000 000 0112234677788899999999999999
Q ss_pred CCCCCCCC
Q 002289 917 KHPYVSSD 924 (941)
Q Consensus 917 ~Hpwf~~~ 924 (941)
+||||+..
T Consensus 266 ~hp~f~~~ 273 (290)
T 3fme_A 266 QHPFFTLH 273 (290)
T ss_dssp TSHHHHHH
T ss_pred hCcccccC
Confidence 99999654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.77 Aligned_cols=275 Identities=20% Similarity=0.295 Sum_probs=210.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh-----------------hHhHHHHHHHHHhcCCCceeee
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-----------------EKEFLTEIQFLSRLHHRNLVSL 670 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~l 670 (941)
.++|++.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999987432111 1678999999999999999999
Q ss_pred eeccccCCcEEEEEecCCCCCHHHH------HhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEE
Q 002289 671 VGYCDEEGEQMLVYEFMSNGTLRDQ------LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILL 743 (941)
Q Consensus 671 ~~~~~~~~~~~LV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl 743 (941)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||+|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 655445679999999999999999999998 88 9999999999999
Q ss_pred cCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccC-CCCc-hhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 744 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTD-KSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 744 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
+.++.+||+|||.+...... ......||..|+|||++.+. .++. ++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999865321 23345689999999999887 6666 9999999999999999999997654
Q ss_pred hhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccccc
Q 002289 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSE 901 (941)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~ 901 (941)
...+...... .+ ...++..... .. .+...... ............+|+.+|
T Consensus 257 ~~~~~~~~i~---------~~-~~~~~~~~~~--------~~--~~~~~~~~----------~~~~~~~~~~l~~li~~~ 306 (348)
T 2pml_X 257 SLVELFNNIR---------TK-NIEYPLDRNH--------FL--YPLTNKKS----------TCSNNFLSNEDIDFLKLF 306 (348)
T ss_dssp CSHHHHHHHT---------SC-CCCCCCSSSS--------ST--TTTCC------------------CCCHHHHHHHHHH
T ss_pred cHHHHHHHHh---------cc-CcCCccchhh--------hh--cccccccc----------ccchhhcCHHHHHHHHHH
Confidence 4222221111 00 0011100000 00 00000000 000122233446799999
Q ss_pred CCCCCCCCCCCccCCCCCCCCCCC
Q 002289 902 HTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 902 L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
|..||++|||++|+++||||+...
T Consensus 307 L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 307 LRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccCChhhCCCHHHHhcCccccCCC
Confidence 999999999999999999998743
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=348.40 Aligned_cols=274 Identities=24% Similarity=0.395 Sum_probs=201.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHH--HHhcCCCceeeeeecc-----ccCCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF--LSRLHHRNLVSLVGYC-----DEEGE 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~-----~~~~~ 679 (941)
..++|++.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ ++.++|+||+++++++ .....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 356889999999999999999987 68999999987432 2344444444 4558999999999744 33346
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC---------CCCCeEeccCCCCcEEEcCCCcEE
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE---------ADPPVFHRDIKASNILLDHKFTAK 750 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivH~DLkp~NILl~~~~~~k 750 (941)
.++||||+++|+|.+++.... .++..++.++.|+++||+|||+. + |+||||||+|||++.++.+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 789999999999999996543 58889999999999999999998 7 99999999999999999999
Q ss_pred EeeeccccccCCCCCCCc-cccccccccccCCCccccccccc-------CCCCchhHhHHHHHHHHHHHhCCCCCCCCch
Q 002289 751 VADFGLSRLAPVPDIEGI-VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822 (941)
Q Consensus 751 l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~ 822 (941)
|+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643321110 11122334569999999999987 4566789999999999999999888754322
Q ss_pred hHH---HHHHHHhh----ccchhhh--cCCCCCC------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 823 IVR---EVNIAYQS----SMMFSVI--DGNMGSY------PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 823 ~~~---~~~~~~~~----~~~~~~~--~~~~~~~------~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
... ........ ..+.... ....+.+ ...++..+.+++.+||+.+|++||++.++++.|+++...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 100 00000000 0000000 1111122 2357778999999999999999999999999999998766
Q ss_pred CCC
Q 002289 888 PES 890 (941)
Q Consensus 888 ~~~ 890 (941)
...
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.74 Aligned_cols=290 Identities=19% Similarity=0.290 Sum_probs=209.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CC-cEEEEEEeccCCchhhHhHHHHHHHHHhcCCCc------eeeeeeccccCCc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN------LVSLVGYCDEEGE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 679 (941)
.++|++.+.||+|+||+||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999974 34 78999999753 334567889999999997665 8999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----------------
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---------------- 743 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---------------- 743 (941)
.++||||+ ++++.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 778888887766567999999999999999999999999 9999999999999
Q ss_pred ---cCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 744 ---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 744 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999764321 23456899999999999999999999999999999999999999765
Q ss_pred chhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh----hCCC---CCCC
Q 002289 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN----MMPE---SDTK 893 (941)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~----~~~~---~~~~ 893 (941)
.......... .. .+..|.........- ..+.......+........+..... .... ....
T Consensus 243 ~~~~~~~~~~-------~~----~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 243 ENREHLVMME-------KI----LGPIPSHMIHRTRKQ--KYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp SHHHHHHHHH-------HH----HCCCCHHHHHHCSCG--GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred CHHHHHHHHH-------HH----cCCCcHHHhhhccch--hhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 4422111110 00 112222221110000 0000000000000000001110000 0000 0113
Q ss_pred CcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 894 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 894 ~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
+.+||.+||..||++|||++|+|+||||++..
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 45799999999999999999999999998743
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=343.36 Aligned_cols=270 Identities=19% Similarity=0.286 Sum_probs=207.6
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecc-ccCCcEEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVY 684 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~LV~ 684 (941)
..++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+++++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 578999999876532 234688999999999988877666665 6667889999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeeccccccC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFGla~~~~ 761 (941)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999997533 35899999999999999999999999 9999999999999 788999999999998765
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHHhhccchhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQSSMMFSV 839 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~ 839 (941)
........+........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~---- 234 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-K---- 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-H----
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc-c----
Confidence 44322222222334567999999999999999999999999999999999999999753221 0111000000 0
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
...........++..+.+++..||+.+|++||++.++++.|+++.....
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0000000112235688999999999999999999999999999877543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.91 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=203.5
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35788999999999999999996 478999999987532 23346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 684 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
|||+++|+|.+++.. .....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 23456899999999999999999999999 9999999999999999999999999997653
Q ss_pred CCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.||.............. ..
T Consensus 188 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~ 252 (310)
T 2wqm_A 188 SKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--------EQ 252 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH--------HT
T ss_pred CCC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh--------hc
Confidence 221 112334689999999999999999999999999999999999999975432211111111 11
Q ss_pred CCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 842 GNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 842 ~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
..... .+..++..+.+++..||+.+|.+||++.++++.++++.....
T Consensus 253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11122 224556789999999999999999999999999998876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.33 Aligned_cols=270 Identities=19% Similarity=0.278 Sum_probs=210.9
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecc-ccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999996 5799999999875432 34688999999999988877666655 56677899999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeeccccccCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFGla~~~~~ 762 (941)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999997433 45899999999999999999999999 9999999999999 4889999999999987654
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHHhhccchhhh
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~ 840 (941)
.......+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+....... .. .
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~----~ 235 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-KK----M 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH-HH----H
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc-cc----c
Confidence 432221112223456799999999999999999999999999999999999999975321 0000100000 00 0
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
.......+..++..+.+++..||+.+|.+||++.++++.|+.+......
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0000001133457789999999999999999999999999998775543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=348.40 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=209.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcE--EEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTV--VAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|++.+.||+|+||.||+|+.. ++.. ||+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367889999999999999999964 5664 4999887532 23346789999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc
Q 002289 683 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 748 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 748 (941)
||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997543 246899999999999999999999999 999999999999999999
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 827 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~ 827 (941)
+||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 181 ~kL~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LY 251 (327)
T ss_dssp EEECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HH
T ss_pred EEEcccCcCccccc--------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-HH
Confidence 99999999874321 111233456789999999999889999999999999999998 999997654311 11
Q ss_pred HHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
. .+..+.....+..++..+.+++.+|+..+|.+||++.++++.|+.+...
T Consensus 252 ~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 E---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp H---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H---------HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1 1122223334556678899999999999999999999999999988764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=359.88 Aligned_cols=295 Identities=17% Similarity=0.265 Sum_probs=208.1
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-----------CCceeeeeeccc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCD 675 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~ 675 (941)
.++|++.+.||+|+||+||+|+. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 47899999999753 234567889999999886 899999999987
Q ss_pred cCC----cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEc------
Q 002289 676 EEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLD------ 744 (941)
Q Consensus 676 ~~~----~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~------ 744 (941)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 544 789999999 89999999876666799999999999999999999998 8 99999999999994
Q ss_pred CCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhH
Q 002289 745 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 824 (941)
Q Consensus 745 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~ 824 (941)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999865321 233468999999999999999999999999999999999999997533110
Q ss_pred HHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCC-------CCCCCHHHHHHHHHHhHhhCCCCCCCCccc
Q 002289 825 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDET-------DARPSMSEVMRELESIWNMMPESDTKTPEF 897 (941)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p-------~~RPs~~~v~~~L~~~~~~~~~~~~~~~dl 897 (941)
.... ......+... .+..|......-. .....+.... .......++.. ..............+|
T Consensus 243 ~~~~-~~~~~~~~~~----~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l 313 (373)
T 1q8y_A 243 YTKD-DDHIAQIIEL----LGELPSYLLRNGK-YTRTFFNSRGLLRNISKLKFWPLEDVLT---EKYKFSKDEAKEISDF 313 (373)
T ss_dssp --CH-HHHHHHHHHH----HCSCCHHHHHHCT-THHHHBCC--CBSSCCCCCBCCHHHHHH---HTTCCCHHHHHHHHHH
T ss_pred cCCh-HHHHHHHHHh----cCCCCHHHHhccc-hhhhhcCCcchhcccccccccchhhhhh---hcccCCcchHHHHHHH
Confidence 0000 0000000011 1222322211100 0001111000 01111222211 1111111112334589
Q ss_pred ccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 898 INSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 898 l~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
|.+||..||++|||++|+|+||||+....
T Consensus 314 i~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred HHHHhccCccccCCHHHHhhChhhhcccC
Confidence 99999999999999999999999987544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=347.49 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=209.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccc----cCCcEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----EEGEQM 681 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~ 681 (941)
..++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999997 578999999987666566678999999999999999999999986 345789
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 682 LVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
+||||+++|+|.+++... ....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999998752 3456899999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCCCc--cccccccccccCCCcccccccccCC---CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhc
Q 002289 760 APVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 834 (941)
Q Consensus 760 ~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~ 834 (941)
......... ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-----
Confidence 432110000 0001112345799999999987654 688999999999999999999999421100000000
Q ss_pred cchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 835 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
..........+..++..+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 259 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 259 ---AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp ---HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ---HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 01111112223455678999999999999999999999999999875433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=348.87 Aligned_cols=261 Identities=27% Similarity=0.444 Sum_probs=210.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCc
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 679 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 679 (941)
..++|++.+.||+|+||.||+|++ .+++.||||++.... .....++.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999984 247789999997543 3345678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-----CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEE
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKV 751 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl 751 (941)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976532 45899999999999999999999999 999999999999984 456999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 830 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~ 830 (941)
+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 185 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~-- 256 (327)
T 2yfx_A 185 GDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLE-- 256 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH--
T ss_pred Cccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HHHH--
Confidence 99999975432211 112234457889999999999999999999999999999998 99999755432 1111
Q ss_pred HhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 831 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.+..+.....+..++..+.+++..||+.+|.+||++.++++.++.+..
T Consensus 257 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 -------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 112222334455667889999999999999999999999999987754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=350.69 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=197.1
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--------hhhHhHHHHHHHHHhcCCCceeeeeeccccC
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 677 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 677 (941)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3568999999999999999999975 689999999875321 1224688999999999999999999998765
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeee
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADF 754 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DF 754 (941)
+ .++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 89999999999999998643 45899999999999999999999999 999999999999987664 999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~ 831 (941)
|+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||............
T Consensus 162 g~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-- 231 (322)
T 2ycf_A 162 GHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ-- 231 (322)
T ss_dssp TTCEECCCC--------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH--
T ss_pred ccceecccc--------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH--
Confidence 999865321 1223456899999999974 467889999999999999999999999643321100000
Q ss_pred hhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC
Q 002289 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 911 (941)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 911 (941)
+..+.. .+..+. .........+|+.+||..||++|||
T Consensus 232 -------~~~~~~-~~~~~~-----------------------------------~~~~~~~~~~li~~~l~~dP~~Rps 268 (322)
T 2ycf_A 232 -------ITSGKY-NFIPEV-----------------------------------WAEVSEKALDLVKKLLVVDPKARFT 268 (322)
T ss_dssp -------HHHTCC-CCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred -------HHhCcc-ccCchh-----------------------------------hhhcCHHHHHHHHHHcccCHhhCCC
Confidence 000000 000000 0111223346788888888999999
Q ss_pred CccCCCCCCCCCC
Q 002289 912 SSSMLKHPYVSSD 924 (941)
Q Consensus 912 a~e~L~Hpwf~~~ 924 (941)
++|+|+||||+..
T Consensus 269 ~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 269 TEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHTSGGGCCH
T ss_pred HHHHhhCcCcCCH
Confidence 9999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=353.21 Aligned_cols=269 Identities=16% Similarity=0.197 Sum_probs=213.5
Q ss_pred HHhcCCCccceeeccCcEEEEEEE------eCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC---CCceeeeeecccc
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDE 676 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 676 (941)
...++|.+.+.||+|+||+||+|. ..+++.||||+++... ..++.+|+++++.++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 3468899999997643 346778888888886 9999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhc---CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--------
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------- 745 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-------- 745 (941)
.+..++||||+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999742 3456999999999999999999999999 999999999999998
Q ss_pred ---CCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch
Q 002289 746 ---KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822 (941)
Q Consensus 746 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~ 822 (941)
++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP-----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC-----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccCCEEEeeCchhhhhhccC-----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997543211 12233456799999999999999999999999999999999999999964322
Q ss_pred hHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhCCCCCCCCccccccc
Q 002289 823 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSE 901 (941)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~~~~~~~~~~dll~~~ 901 (941)
. . ..+......++ ..+.+.+++..|++.+|.+| |++.++.+.++++..... ....+++.++
T Consensus 291 ~------------~-~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~---~~~~~~l~~~ 352 (365)
T 3e7e_A 291 G------------E-CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY---TNKIRALRNR 352 (365)
T ss_dssp T------------E-EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT---TTTHHHHHHH
T ss_pred C------------c-eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh---hhchHHHHHH
Confidence 0 0 00111122222 24567788999999999988 678888888888776432 3334555555
Q ss_pred CC
Q 002289 902 HT 903 (941)
Q Consensus 902 L~ 903 (941)
|.
T Consensus 353 l~ 354 (365)
T 3e7e_A 353 LI 354 (365)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=357.54 Aligned_cols=267 Identities=22% Similarity=0.281 Sum_probs=212.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCC--cEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~LV 683 (941)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467899999999999999999976 589999999975332 23467789999999999999999999987654 78999
Q ss_pred EecCCCCCHHHHHhhcC-CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE----cCCCcEEEeeecccc
Q 002289 684 YEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 758 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DFGla~ 758 (941)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997543 234899999999999999999999999 9999999999999 788889999999998
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc--------CCCCchhHhHHHHHHHHHHHhCCCCCCCCch---hHHHH
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREV 827 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~---~~~~~ 827 (941)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+..
T Consensus 165 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 165 ELEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCCG--------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EccCC--------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 65432 12234569999999999875 5677899999999999999999999964221 11211
Q ss_pred HHHHhhcc---chhh---h------c---CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 828 NIAYQSSM---MFSV---I------D---GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 828 ~~~~~~~~---~~~~---~------~---~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
........ ...+ . . ......+......+.+++..|++.||++||++.++++.++++..
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11111100 0000 0 0 01123457888899999999999999999999999999988765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.06 Aligned_cols=276 Identities=24% Similarity=0.355 Sum_probs=189.2
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999964 68999999887543 2234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhh------cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 683 VYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
||||+++++|.+++.. .....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999864 12346899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
+......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 168 ~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------- 238 (303)
T 2vwi_A 168 SAFLATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML------- 238 (303)
T ss_dssp HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-------
T ss_pred hheeccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-------
Confidence 9765432110 01122234568999999999876 5689999999999999999999999975443211110
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
............. .++ ...........+++.+||..||++|||++|+
T Consensus 239 ---~~~~~~~~~~~~~-------------~~~-----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 285 (303)
T 2vwi_A 239 ---TLQNDPPSLETGV-------------QDK-----------------EMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285 (303)
T ss_dssp ---HHTSSCCCTTC-----------------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ---HhccCCCcccccc-------------ccc-----------------hhhhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000000000000 000 0111122233468888999999999999999
Q ss_pred CCCCCCCCCC
Q 002289 916 LKHPYVSSDV 925 (941)
Q Consensus 916 L~Hpwf~~~~ 925 (941)
++||||....
T Consensus 286 l~h~~~~~~~ 295 (303)
T 2vwi_A 286 LRHKFFQKAK 295 (303)
T ss_dssp HTSTTC----
T ss_pred hhChhhhcCC
Confidence 9999997643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=376.85 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=204.5
Q ss_pred ceeeccCcEEEEEEEeC---CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
+.||+|+||+||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 468899999976432 234689999999999999999999999964 568999999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+........
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---
Confidence 99999997543 5889999999999999999999999 999999999999999999999999999876433211
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (941)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ . ..+..+.....+
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-~---------~~i~~~~~~~~p 594 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-T---------AMLEKGERMGCP 594 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-H---------HHHHTTCCCCCC
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-H---------HHHHcCCCCCCC
Confidence 112233456789999999999999999999999999999998 9999976543211 1 112223344566
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 849 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..++..+.+++..||+.+|++||++.++++.|+++..
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 7788899999999999999999999999999998764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=387.21 Aligned_cols=317 Identities=21% Similarity=0.298 Sum_probs=273.4
Q ss_pred CCCCHHHHHHHHHHHHhCcCCCCCCCCCCCC------CCCCCCC------------CceEecCCCCCCCcceeeEEEecC
Q 002289 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRG------DPCTSNW------------TGVLCFNTTMDDGYLHLRELQLLN 91 (941)
Q Consensus 30 ~~~~~~d~~aL~~~k~~~~~~~~~~~~w~~~------~~c~~~w------------~gv~C~~~~~~~~~~~l~~L~L~~ 91 (941)
+.+...|+.||++||+++.++ +|+.. ++|+|+| .||+|+.. .+|+.|+|++
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~------~~V~~L~Ls~ 332 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN------GRVTGLSLAG 332 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT------SCEEEEECTT
T ss_pred cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCC------CCEEEEECcc
Confidence 344567999999999999765 67543 5666899 99999752 3799999999
Q ss_pred CCCCccCCccccCCCCCCEEEc-ccCCCCCC-------------------------------------------------
Q 002289 92 LNLSGNLSPEIGRLSYLTILDF-MWNKISGS------------------------------------------------- 121 (941)
Q Consensus 92 ~~l~~~~~~~l~~l~~L~~L~L-s~N~l~~~------------------------------------------------- 121 (941)
+++.|.+|+.|++|++|+.|+| ++|.+.|.
T Consensus 333 ~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~ 412 (876)
T 4ecn_A 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP 412 (876)
T ss_dssp TCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCT
T ss_pred CCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCc
Confidence 9999999999999999999999 77755443
Q ss_pred ---------------------------CCCccCCccccceecccCccccC-----------------CCCcccC--CcCc
Q 002289 122 ---------------------------IPKEIGNIKSLELLLLNGNELTG-----------------SLPEELG--YLPK 155 (941)
Q Consensus 122 ---------------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~ 155 (941)
+|..|+++++|++|+|++|+|++ .+|..++ ++++
T Consensus 413 ~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~ 492 (876)
T 4ecn_A 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD 492 (876)
T ss_dssp TSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred cccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCC
Confidence 78889999999999999999998 3899988 9999
Q ss_pred cceeecccccccccCCcccccccccceEeccccc-ccc-cCchhccCCC-------ccceeeccCCcCCCCCCc--cCCC
Q 002289 156 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-ISG-QIPPELSRLP-------SLVHMLLDNNNLTGYLPP--ELSE 224 (941)
Q Consensus 156 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~~~~ 224 (941)
|++|+|++|.+.+.+|..|.++++|+.|+|++|+ ++| .+|..++.++ +|++|+|++|+++ .+|. .|++
T Consensus 493 L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~ 571 (876)
T 4ecn_A 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQK 571 (876)
T ss_dssp CCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTT
T ss_pred CCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhc
Confidence 9999999999999999999999999999999998 998 8888776555 9999999999999 8888 8999
Q ss_pred CCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCC-cCEEEccCCcCCCCcchhhc
Q 002289 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN-ITTIKLSNNKLTGTIPSNFS 303 (941)
Q Consensus 225 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~-L~~L~Ls~N~l~~~~p~~~~ 303 (941)
+++|+.|+|++|+|+ .+| .|..+++|+.|+|++|+|+..+..+.. ..+ |+.|+|++|+|+ .+|..+.
T Consensus 572 L~~L~~L~Ls~N~l~--~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~--------l~~~L~~L~Ls~N~L~-~lp~~~~ 639 (876)
T 4ecn_A 572 MVKLGLLDCVHNKVR--HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCA--------FTDQVEGLGFSHNKLK-YIPNIFN 639 (876)
T ss_dssp CTTCCEEECTTSCCC--BCC-CCCTTSEESEEECCSSCCSCCCTTSCE--------ECTTCCEEECCSSCCC-SCCSCCC
T ss_pred CCCCCEEECCCCCcc--cch-hhcCCCcceEEECcCCccccchHHHhh--------ccccCCEEECcCCCCC-cCchhhh
Confidence 999999999999998 577 899999999999999999943333322 244 799999999999 7888888
Q ss_pred CCcc--cceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCc
Q 002289 304 GLPR--LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFC 370 (941)
Q Consensus 304 ~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~ 370 (941)
.++. |+.|+|++|+++|.+|.....+..+...+|+.|+|++|+|+.++..+ .++.++.|+|++|.+.
T Consensus 640 ~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~ 710 (876)
T 4ecn_A 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710 (876)
T ss_dssp TTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS
T ss_pred ccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC
Confidence 7764 99999999999988876655666666678999999999999888665 5788999999999876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.01 Aligned_cols=199 Identities=31% Similarity=0.503 Sum_probs=172.8
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|+..+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588899999999999999996 57899999998754322 235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||++ |+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99996 78988886433 45899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCCccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCCCch
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~ 822 (941)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 207 ----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 207 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp ----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 12346899999999985 56789999999999999999999999975543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=353.97 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=199.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCC--chhhHhHHHHHHHHHhcC--CCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~LV 683 (941)
..+|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35689999999999999999998889999999987543 233467899999999996 59999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|| +.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 45899999997654 5888899999999999999999999 99999999999995 589999999999865432
Q ss_pred CCCCccccccccccccCCCccccccccc-----------CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+......
T Consensus 208 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---- 278 (390)
T 2zmd_A 208 TT-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---- 278 (390)
T ss_dssp -----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----
T ss_pred Cc-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH----
Confidence 11 112234569999999999875 4688999999999999999999999976543322222
Q ss_pred hccchhhhcCC-CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 833 SSMMFSVIDGN-MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 833 ~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
.+++.. ...++...+..+.+++..||..+|.+||++.+++++
T Consensus 279 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 -----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 122211 122334445678889999999999999999998865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=343.88 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=202.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
-++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 6899999998754322 236788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997653 4889999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
. ........|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......... ..
T Consensus 188 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~------~~ 253 (309)
T 2h34_A 188 K------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI------PR 253 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC------CC
T ss_pred c------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC------CC
Confidence 1 11223456899999999999999999999999999999999999999765432 1111111000 00
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHh
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 885 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~~ 885 (941)
....+..++..+.+++.+||+.+|++|| ++.++++.|+....
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 1113345566788999999999999999 99999999887644
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.44 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=203.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367889999999999999999975 688999999864322 1235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999997654 4889999999999999999999999 999999999999999999999999998754321
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
......|++.|+|||++.+..++.++||||||+++|||++|+.||......... .. +...
T Consensus 168 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~---------~~~~- 227 (284)
T 2vgo_A 168 ---------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-RR---------IVNV- 227 (284)
T ss_dssp ---------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH---------HHTT-
T ss_pred ---------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-HH---------Hhcc-
Confidence 123456899999999999999999999999999999999999999754432111 00 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
...++.. ......++|.+||..||++|||++|+++||||+.
T Consensus 228 ~~~~~~~---------------------------------------~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 228 DLKFPPF---------------------------------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp CCCCCTT---------------------------------------SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCCCc---------------------------------------CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 0011111 1122236777788888888888888999999875
Q ss_pred C
Q 002289 924 D 924 (941)
Q Consensus 924 ~ 924 (941)
.
T Consensus 269 ~ 269 (284)
T 2vgo_A 269 N 269 (284)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.35 Aligned_cols=207 Identities=27% Similarity=0.445 Sum_probs=173.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeecc--ccCCcEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYC--DEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~~L 682 (941)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++ ...+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999975 689999999875432 3346789999999999999999999987 44678999
Q ss_pred EEecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 683 VYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 3445899999999999999999999876 2349999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
...... .......||..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDT-------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---C-------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 653211 11234568999999999999999999999999999999999999997543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.79 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=199.0
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
+|.....||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555669999999999999964 689999999987655556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcC-CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeeccccccCCCCCC
Q 002289 689 NGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 689 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||.++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999997653 345778999999999999999999999 999999999999987 8999999999998654221
Q ss_pred CccccccccccccCCCcccccccccCC--CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||+.|+|||++.+.. ++.++||||||+++|||++|+.||............. ......
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~ 244 (295)
T 2clq_A 178 -----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--------GMFKVH 244 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--------HHHCCC
T ss_pred -----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--------cccccc
Confidence 1123456899999999997653 8899999999999999999999996432211100000 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
...+.. ..+...+++.+||..||++|||++|+|+||||+..
T Consensus 245 ~~~~~~---------------------------------------~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 245 PEIPES---------------------------------------MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp CCCCTT---------------------------------------SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred cccccc---------------------------------------CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 111111 11222357777888888999999999999999765
Q ss_pred CC
Q 002289 925 VS 926 (941)
Q Consensus 925 ~~ 926 (941)
..
T Consensus 286 ~~ 287 (295)
T 2clq_A 286 SK 287 (295)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=354.38 Aligned_cols=276 Identities=22% Similarity=0.372 Sum_probs=203.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCc-----
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 679 (941)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467889999999999999999975 689999999875332 224678899999999999999999999876653
Q ss_pred -EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 680 -QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 680 -~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
.++||||++ ++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999996 688887732 3899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .......
T Consensus 175 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~---- 239 (353)
T 3coi_A 175 HADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKV---- 239 (353)
T ss_dssp C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHH----
T ss_pred CCCC----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH----
Confidence 5422 1233468999999999887 6789999999999999999999999976543221 1111100
Q ss_pred hhhcCCCCCCChHHHHHH----HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCc
Q 002289 838 SVIDGNMGSYPSECVEKF----IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 913 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l----~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 913 (941)
. +..+.+....+ .......+...+ |+.+. ...+...+.+.+||.+||..||++|||++
T Consensus 240 --~----~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 301 (353)
T 3coi_A 240 --T----GVPGTEFVQKLNDKAAKSYIQSLPQTP--RKDFT----------QLFPRASPQAADLLEKMLELDVDKRLTAA 301 (353)
T ss_dssp --H----CBCCHHHHTTCSCHHHHHHHHTSCBCS--SCCTT----------TTCTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred --h----CCCCHHHHHHHhhHHHHHHHHhCcCCC--CccHH----------HhcCCcCHHHHHHHHHHcCCCcccCCCHH
Confidence 0 00111111100 000000111111 11111 11223344556899999999999999999
Q ss_pred cCCCCCCCCCC
Q 002289 914 SMLKHPYVSSD 924 (941)
Q Consensus 914 e~L~Hpwf~~~ 924 (941)
|+|+||||+..
T Consensus 302 e~l~hp~f~~~ 312 (353)
T 3coi_A 302 QALTHPFFEPF 312 (353)
T ss_dssp HHHTSGGGTTT
T ss_pred HHhcCcchhhc
Confidence 99999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=331.85 Aligned_cols=201 Identities=26% Similarity=0.410 Sum_probs=174.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||+||+|... +++.||+|+++..... ..+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457899999999999999999976 6899999998754322 246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 756 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFGl 756 (941)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999997543 4899999999999999999999999 99999999999998877 899999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 159 AHKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp CEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 98653221 1233458999999999999999999999999999999999999997654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.37 Aligned_cols=200 Identities=28% Similarity=0.414 Sum_probs=167.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468899999999999999999976 789999999865322 2235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997653 4889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 165 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 165 E--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1233468899999999988765 68999999999999999999999654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=358.51 Aligned_cols=260 Identities=10% Similarity=-0.002 Sum_probs=181.4
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhc--CCCceeeeee-------cc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL--HHRNLVSLVG-------YC 674 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~l~~-------~~ 674 (941)
..+|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+++++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999965 789999999987543 2245677885555444 6999887553 33
Q ss_pred ccC-----------------CcEEEEEecCCCCCHHHHHhhcCCCCccHHHH------HHHHHHHHHHHHHhhcCCCCCe
Q 002289 675 DEE-----------------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR------LSIALGSSRGILYLHTEADPPV 731 (941)
Q Consensus 675 ~~~-----------------~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 731 (941)
... ...++||||++ |+|.+++..... .+.+..+ +.++.||++||+|||+++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 222 33799999998 899999976422 2344455 778899999999999999 9
Q ss_pred EeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHH
Q 002289 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLE 809 (941)
Q Consensus 732 vH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~e 809 (941)
+||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC----------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC----------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 9999999999999999999999999986431 1113456799999999987 779999999999999999
Q ss_pred HHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 810 LLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 810 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
|++|+.||........ ............ ..++.+ ...+.
T Consensus 286 lltg~~Pf~~~~~~~~--------~~~~~~~~~~~~----------------------~~~~~~-----------~~~~~ 324 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIK--------GSWKRPSLRVPG----------------------TDSLAF-----------GSCTP 324 (371)
T ss_dssp HHHSSCSTTBCCTTCT--------TCCCBCCTTSCC----------------------CCSCCC-----------TTSSC
T ss_pred HHhCCCCCCCcCcccc--------cchhhhhhhhcc----------------------ccccch-----------hhccC
Confidence 9999999975422100 000000000000 000000 00011
Q ss_pred CCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 890 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 890 ~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
..+...+||.+||..||++|||++|+|+||||+.
T Consensus 325 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 2233446888899999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=338.84 Aligned_cols=201 Identities=29% Similarity=0.443 Sum_probs=177.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467889999999999999999964 689999999875432 335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999954 35899999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 11234568999999999999999999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=338.15 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=199.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC----chhhHhHHHHHHHHHhcCCCceeeeeecc--ccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHHRNLVSLVGYC--DEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~ 680 (941)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999974 68999999987532 22346789999999999999999999998 445688
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||++++ |.+++.......+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999765 888887766667999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCC--CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
..... ........||..|+|||++.+.. ++.++||||||+++|||++|+.||...... +....
T Consensus 160 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~--------- 224 (305)
T 2wtk_C 160 HPFAA-----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KLFEN--------- 224 (305)
T ss_dssp CTTCS-----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHH---------
T ss_pred Ccccc-----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHH---------
Confidence 43221 12223456899999999998654 377999999999999999999999764421 11111
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
+.......+..++..+.+++.+|++.+|.+||++.+++++
T Consensus 225 -i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 -IGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111123344556677788888888888888888888754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.45 Aligned_cols=267 Identities=24% Similarity=0.380 Sum_probs=194.9
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeecc--------c
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYC--------D 675 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~--------~ 675 (941)
....+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++ .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34568999999999999999999965 78999999987666666678899999999996 99999999988 3
Q ss_pred cCCcEEEEEecCCCCCHHHHHhh-cCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 754 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 754 (941)
.....++||||++ |+|.+++.. .....+++..++.++.|++.||+|||+++ ++|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3445899999995 799998865 23446999999999999999999999875 45999999999999999999999999
Q ss_pred ccccccCCCCCCCccc-----cccccccccCCCccccccc---ccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002289 755 GLSRLAPVPDIEGIVP-----AHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 826 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~ 826 (941)
|+++............ ........||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998764332111000 0111244589999999998 56778999999999999999999999996433211
Q ss_pred HHHHHhhccchhhhcCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 827 VNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
+..... ...+...+..+.+++..|++.+|.+||++.++++.|+.+.....
T Consensus 261 ------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 ------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 011111 11223334567889999999999999999999999998876543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=357.53 Aligned_cols=269 Identities=21% Similarity=0.292 Sum_probs=211.1
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC-CceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.++||+|+||.||+|++ .+++.||||++..... ..++.+|+++++.++| ++|..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 4789999998875432 3468899999999987 556666666677788899999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEE---cCCCcEEEeeeccccccCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFGla~~~~~ 762 (941)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999997533 35899999999999999999999999 9999999999999 6889999999999987654
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHHhhccchhhh
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~ 840 (941)
.......+........||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+..... ......+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~-~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-KKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH-HHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh-ccccccH
Confidence 332221122233456799999999999999999999999999999999999999975332 1111111110 0000000
Q ss_pred cCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 841 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
......++.++.+++..||+.+|++||++.++++.|+.+.....
T Consensus 238 ----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 238 ----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp ----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 00112335678999999999999999999999999998876443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=378.61 Aligned_cols=320 Identities=20% Similarity=0.295 Sum_probs=271.0
Q ss_pred CCCHHHHHHHHHHHHhCcCCCC--------CCCCCCCCCCCCCCC---CceEecCCCCCCCcceeeEEEecCCCCCccCC
Q 002289 31 ITDPIEVSALRSIKKSLVDDYS--------KLSNWNRGDPCTSNW---TGVLCFNTTMDDGYLHLRELQLLNLNLSGNLS 99 (941)
Q Consensus 31 ~~~~~d~~aL~~~k~~~~~~~~--------~~~~w~~~~~c~~~w---~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~ 99 (941)
.....|+.||.++++++.++.. ...+|+...+| |.| .||+|+.. .+|+.|+|++++++|.+|
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~-c~w~~~~GV~C~~~------~~V~~L~L~~~~l~g~lp 98 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKEL-DMWGAQPGVSLNSN------GRVTGLSLEGFGASGRVP 98 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCG-GGTTCCTTEEECTT------CCEEEEECTTSCCEEEEC
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCc-ccccCCCCeEEcCC------CCEEEEEecCcccCCcCC
Confidence 3445799999999999975532 23479876555 479 99999653 389999999999999999
Q ss_pred ccccCCCCCCEEEcccCC--------------------------------------------------------------
Q 002289 100 PEIGRLSYLTILDFMWNK-------------------------------------------------------------- 117 (941)
Q Consensus 100 ~~l~~l~~L~~L~Ls~N~-------------------------------------------------------------- 117 (941)
++|++|++|++|+|++|.
T Consensus 99 ~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~ 178 (636)
T 4eco_A 99 DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178 (636)
T ss_dssp GGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCC
T ss_pred hHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccc
Confidence 999999999999999884
Q ss_pred ----------------CCCCCCCccCCccccceecccCccccCC-----------------CCcccC--CcCccceeecc
Q 002289 118 ----------------ISGSIPKEIGNIKSLELLLLNGNELTGS-----------------LPEELG--YLPKLDRIQID 162 (941)
Q Consensus 118 ----------------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls 162 (941)
++| +|..|+++++|++|+|++|++++. +|..++ ++++|++|+|+
T Consensus 179 ~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~ 257 (636)
T 4eco_A 179 SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257 (636)
T ss_dssp CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEec
Confidence 344 788899999999999999999986 999999 99999999999
Q ss_pred cccccccCCcccccccccceEeccccc-ccc-cCchhccCC------CccceeeccCCcCCCCCCc--cCCCCCCCCEEe
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNS-ISG-QIPPELSRL------PSLVHMLLDNNNLTGYLPP--ELSELPKLLILQ 232 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~ 232 (941)
+|.+.+.+|..|.++++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .++++++|++|+
T Consensus 258 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~ 336 (636)
T 4eco_A 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLE 336 (636)
T ss_dssp CCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEE
T ss_pred CCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEe
Confidence 999999999999999999999999998 998 899888876 99999999999999 8888 899999999999
Q ss_pred ccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCC-cCEEEccCCcCCCCcchhhcCCc--ccc
Q 002289 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN-ITTIKLSNNKLTGTIPSNFSGLP--RLQ 309 (941)
Q Consensus 233 Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~ 309 (941)
|++|+++| .+| .|..+++|++|+|++|+++..+..+.. ..+ |++|+|++|+|+ .+|..+..++ +|+
T Consensus 337 L~~N~l~g-~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~--------l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~ 405 (636)
T 4eco_A 337 CLYNQLEG-KLP-AFGSEIKLASLNLAYNQITEIPANFCG--------FTEQVENLSFAHNKLK-YIPNIFDAKSVSVMS 405 (636)
T ss_dssp CCSCCCEE-ECC-CCEEEEEESEEECCSSEEEECCTTSEE--------ECTTCCEEECCSSCCS-SCCSCCCTTCSSCEE
T ss_pred CcCCcCcc-chh-hhCCCCCCCEEECCCCccccccHhhhh--------hcccCcEEEccCCcCc-ccchhhhhcccCccC
Confidence 99999997 677 899999999999999999844433322 344 689999999998 7888887755 899
Q ss_pred eeecccccCccCCCccccc--ccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCc
Q 002289 310 RLFIANNSLSGSIPSSIWQ--SRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFC 370 (941)
Q Consensus 310 ~L~Ls~N~l~~~~p~~~~~--l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~ 370 (941)
.|++++|++++.+|..+.. ...+...+|+.|+|++|+|+.++..+ .++.++.|+|++|.+.
T Consensus 406 ~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp EEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS
T ss_pred EEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC
Confidence 9999999999888888762 22234457889999999999887765 4788899999998875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=341.97 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=210.1
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHh--cCCCceeeeeeccccCC--
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEEG-- 678 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~-- 678 (941)
......++|++.+.||+|+||+||+|++ +|+.||||++... ..+.+.+|.++++. ++||||+++++++...+
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3445568899999999999999999998 5899999998642 34567889998887 78999999999997765
Q ss_pred --cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhh--------cCCCCCeEeccCCCCcEEEcCCCc
Q 002289 679 --EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDHKFT 748 (941)
Q Consensus 679 --~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~DLkp~NILl~~~~~ 748 (941)
..++||||+++|+|.+++.+. .+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 789999999999999999753 4899999999999999999999 777 999999999999999999
Q ss_pred EEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCC------CCchhHhHHHHHHHHHHHhC---------
Q 002289 749 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTG--------- 813 (941)
Q Consensus 749 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlG~ll~elltG--------- 813 (941)
+||+|||+++........ .........||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 186 ~kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp EEECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred EEEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999765432210 011223456899999999998753 33689999999999999999
Q ss_pred -CCCCCCCch---hHHHHHHHHhhccchhhhcCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 814 -MQPISHGKN---IVREVNIAYQSSMMFSVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 814 -~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
+.||..... ........... .......+ .+++..+.+++..||+.+|++||++.+++++|+.+.
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVVCE-------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTT-------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCccccCcCcccHHHHHHHHHH-------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 778864321 11111111111 01112222 467889999999999999999999999999999986
Q ss_pred hh
Q 002289 885 NM 886 (941)
Q Consensus 885 ~~ 886 (941)
+.
T Consensus 336 ~~ 337 (342)
T 1b6c_B 336 QQ 337 (342)
T ss_dssp HT
T ss_pred HH
Confidence 64
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.73 Aligned_cols=212 Identities=29% Similarity=0.448 Sum_probs=173.9
Q ss_pred cchHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeecccc
Q 002289 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 676 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 676 (941)
+.+.++....++|++.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344445556789999999999999999999974 78999999987543 3346789999999999 89999999999865
Q ss_pred ------CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEE
Q 002289 677 ------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 750 (941)
Q Consensus 677 ------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 750 (941)
.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999998765556899999999999999999999999 99999999999999999999
Q ss_pred EeeeccccccCCCCCCCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 751 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 751 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 170 l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp ECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999987653211 1123446899999999987 5678999999999999999999999996544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=381.19 Aligned_cols=310 Identities=24% Similarity=0.344 Sum_probs=226.6
Q ss_pred CHHHHHHHHHHHHhCcCCCCCCCCCCCCCCCCCCCCceEecCCCCCCCcceeeEEEecCCCCCcc---CC----------
Q 002289 33 DPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGN---LS---------- 99 (941)
Q Consensus 33 ~~~d~~aL~~~k~~~~~~~~~~~~w~~~~~c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~---~~---------- 99 (941)
.++|++||++||+++.|+. .+++|..+++|| .|.||+|+. .+|+.|+|+++++.|. ++
T Consensus 10 ~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C-~w~gv~C~~-------~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 10 LYREIHQLISFKDVLPDKN-LLPDWSSNKNPC-TFDGVTCRD-------DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp HHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGG-GSTTEEEET-------TEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred CHHHHHHHHHHHhhCCCcc-cccCCCCCCCCc-CCcceEECC-------CcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 5679999999999999877 889998666664 799999972 3899999999999886 44
Q ss_pred -------------ccccCCCCCCEEEcccCCCCCCCCC--ccCCccccceecccCccccCCCCccc-CCcCccceeeccc
Q 002289 100 -------------PEIGRLSYLTILDFMWNKISGSIPK--EIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQ 163 (941)
Q Consensus 100 -------------~~l~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~ 163 (941)
+.|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 4667777788888888888777776 77788888888888888877777665 7778888888888
Q ss_pred ccccccCCcc---cccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 164 NYISGSLPKS---FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 164 N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|.+++..|.. +.++++|++|+|++|++++.++. ..+++|++|+|++|++++.+|. ++++++|++|+|++|++++
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~ 237 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG 237 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence 8887777766 67788888888888888776653 6788999999999999987776 8999999999999999988
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCC-cccceeecccccCc
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL-PRLQRLFIANNSLS 319 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~ 319 (941)
.+|..+.++++|++|+|++|++++.+|.. .+ .+|++|+|++|++++.+|..+..+ ++|+.|+|++|+++
T Consensus 238 -~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l--------~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~ 307 (768)
T 3rgz_A 238 -DFSRAISTCTELKLLNISSNQFVGPIPPL-PL--------KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307 (768)
T ss_dssp -CHHHHTTTCSSCCEEECCSSCCEESCCCC-CC--------TTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEE
T ss_pred -cccHHHhcCCCCCEEECCCCcccCccCcc-cc--------CCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCC
Confidence 68889999999999999999998877753 22 334555555555555555555443 55555555555555
Q ss_pred cCCCcccccccccCccccceEEccCCCCC-CCCCC-C-CCCCCcEEEecCCCC
Q 002289 320 GSIPSSIWQSRTLNATETFILDFQNNNLT-NISGS-F-NIPPNVTVRLRGNPF 369 (941)
Q Consensus 320 ~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~-~~~~~-~-~~~~~~~l~l~~Np~ 369 (941)
+.+|..+..+. +|+.|+|++|+++ .++.. + .++.++.|++++|.+
T Consensus 308 ~~~p~~~~~l~-----~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l 355 (768)
T 3rgz_A 308 GAVPPFFGSCS-----LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355 (768)
T ss_dssp ECCCGGGGGCT-----TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEE
T ss_pred CccchHHhcCC-----CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCcc
Confidence 55555554432 2335555555554 33322 1 344455555555543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=351.34 Aligned_cols=260 Identities=19% Similarity=0.309 Sum_probs=177.0
Q ss_pred HhcCCCccc-eeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHH-HHHHhcCCCceeeeeecccc----CCc
Q 002289 607 ATNNFNSST-QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEI-QFLSRLHHRNLVSLVGYCDE----EGE 679 (941)
Q Consensus 607 ~~~~y~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~----~~~ 679 (941)
..++|.+.+ .||+|+||+||+|... +|+.||||++.... ...+|+ ..++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 457888855 6999999999999976 68999999986521 223333 34666799999999999865 455
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeecc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGL 756 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGl 756 (941)
.++||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998776667999999999999999999999999 999999999999976 45699999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 178 ~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------- 238 (336)
T 3fhr_A 178 AKETTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---------- 238 (336)
T ss_dssp CEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred ceecccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh----------
Confidence 9764321 123446799999999998888999999999999999999999999643221000
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
......+.......|. | ......+.+.+||.+||..||++|||++|+|
T Consensus 239 ----------------~~~~~~~~~~~~~~~~--~--------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 286 (336)
T 3fhr_A 239 ----------------PGMKRRIRLGQYGFPN--P--------------EWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286 (336)
T ss_dssp ----------------------------CCCT--T--------------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ----------------hhHHHhhhccccccCc--h--------------hhccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000000000000000 0 0011222334688888999999999999999
Q ss_pred CCCCCCCCC
Q 002289 917 KHPYVSSDV 925 (941)
Q Consensus 917 ~Hpwf~~~~ 925 (941)
+||||+...
T Consensus 287 ~hp~~~~~~ 295 (336)
T 3fhr_A 287 NHPWINQSM 295 (336)
T ss_dssp HSHHHHTGG
T ss_pred cCccccccc
Confidence 999997643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=336.38 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=200.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC--CCc--EEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||+||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467889999999999999999853 333 68999887542 233567899999999999999999999998754 8
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999997542 35889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
...... ........+|..|+|||++.+..++.++||||||+++|||++ |+.||....... .......
T Consensus 172 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~------- 239 (291)
T 1u46_A 172 PQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDK------- 239 (291)
T ss_dssp CC-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHT-------
T ss_pred cccccc----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-HHHHHHc-------
Confidence 432210 112233457788999999999889999999999999999999 999997654321 1111110
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.......+..++..+.+++..|++.+|++||++.++++.|+++..
T Consensus 240 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 -EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111223445667889999999999999999999999999987643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=370.90 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=213.0
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC----CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccC
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 677 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 677 (941)
+.....++|++.+.||+|+||+||+|.+. .+..||||+++..... ..+.+.+|+.++++++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 44445678999999999999999999864 2567999998764332 3467899999999999999999999985 4
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 5789999999999999999754 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccc
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
+...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 539 ~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~--------- 602 (656)
T 2j0j_A 539 RYMEDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VI--------- 602 (656)
T ss_dssp CSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HH---------
T ss_pred eecCCCc------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-HH---------
Confidence 8654322 111223456789999999999999999999999999999997 999997654321 11
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 603 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1122233344566777889999999999999999999999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.49 Aligned_cols=202 Identities=29% Similarity=0.454 Sum_probs=172.2
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999975 58999999987543 34578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+.......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999643 345899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.......||..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 180 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 180 ------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp ------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=345.84 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=201.3
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch------hhHhHHHHHHHHHhcC--CCceeeeeeccc
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYCD 675 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~ 675 (941)
....++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 334678999999999999999999964 7899999998753321 2356788999999996 599999999999
Q ss_pred cCCcEEEEEecCCC-CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEee
Q 002289 676 EEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVAD 753 (941)
Q Consensus 676 ~~~~~~LV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~D 753 (941)
..+..++||||+.+ ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999976 89999997643 5889999999999999999999999 99999999999999 789999999
Q ss_pred eccccccCCCCCCCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHh
Q 002289 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832 (941)
Q Consensus 754 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~ 832 (941)
||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 194 fg~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------- 255 (320)
T 3a99_A 194 FGSGALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------- 255 (320)
T ss_dssp CTTCEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------
T ss_pred Cccccccccc---------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---------
Confidence 9999865422 1233458999999999987765 67899999999999999999999642210
Q ss_pred hccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCC
Q 002289 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 912 (941)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa 912 (941)
.... ..++.. ..+...+++.+||..||++|||+
T Consensus 256 -------~~~~-~~~~~~---------------------------------------~~~~~~~li~~~l~~dp~~Rps~ 288 (320)
T 3a99_A 256 -------IRGQ-VFFRQR---------------------------------------VSSECQHLIRWCLALRPSDRPTF 288 (320)
T ss_dssp -------HHCC-CCCSSC---------------------------------------CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -------hccc-cccccc---------------------------------------CCHHHHHHHHHHccCChhhCcCH
Confidence 0000 000100 11122357777888889999999
Q ss_pred ccCCCCCCCCCCCC
Q 002289 913 SSMLKHPYVSSDVS 926 (941)
Q Consensus 913 ~e~L~Hpwf~~~~~ 926 (941)
+|+++||||+....
T Consensus 289 ~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 289 EEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHTSGGGSSCCC
T ss_pred HHHhcCHhhcCccC
Confidence 99999999987654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=354.17 Aligned_cols=202 Identities=26% Similarity=0.322 Sum_probs=157.5
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEecC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345556889999999998776668999999998652 234678999999886 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCC-----ccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC-------------CcE
Q 002289 688 SNGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------------FTA 749 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-------------~~~ 749 (941)
+ |+|.+++....... ..+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 79999997653221 123345789999999999999999 9999999999999754 489
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCccccccccc-------CCCCchhHhHHHHHHHHHHHh-CCCCCCCC
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHG 820 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~ 820 (941)
||+|||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSS---FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCcc---ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999876432210 0111234579999999999976 678999999999999999999 99999654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=364.16 Aligned_cols=205 Identities=27% Similarity=0.407 Sum_probs=174.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeecccc------CCc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 679 (941)
.++|++.+.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999974 68999999987643 3335678999999999999999999998755 677
Q ss_pred EEEEEecCCCCCHHHHHhhcC-CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCc---EEEeeec
Q 002289 680 QMLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFG 755 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DFG 755 (941)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997643 235888999999999999999999999 999999999999997664 9999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchh
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 823 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~ 823 (941)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 170 ~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 170 YAKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp CCCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred ccccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence 998654322 223456899999999999999999999999999999999999999765443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.97 Aligned_cols=211 Identities=24% Similarity=0.343 Sum_probs=172.1
Q ss_pred cchHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcC--CCceeeeeecc
Q 002289 599 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLH--HRNLVSLVGYC 674 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~nIv~l~~~~ 674 (941)
+.++.+....++|++.+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++++++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 344445556788999999999999999999988899999999875432 33467899999999997 59999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeee
Q 002289 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 754 (941)
Q Consensus 675 ~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 754 (941)
...+..++||| +.+++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||++++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 45889999997653 5889999999999999999999999 999999999999964 89999999
Q ss_pred ccccccCCCCCCCccccccccccccCCCccccccccc-----------CCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 755 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 755 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 171 g~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 171 GIANQMQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp SSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCccc-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 99986543211 111234468999999999875 468889999999999999999999997543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=354.12 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=188.4
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
...+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 4456888999999999997655556889999999875332 3467899999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-----CCcEEEeeecccccc
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 760 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DFGla~~~ 760 (941)
|++ |+|.+++..... ...+..++.++.||++||+|||+++ |+||||||+|||++. ...+||+|||+|+..
T Consensus 99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 995 699999976542 3444456789999999999999999 999999999999953 346889999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccc---cCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccc
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
..... .........||+.|+|||++. ...++.++|||||||++|||++ |..||....... ....
T Consensus 174 ~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~~~~------ 241 (432)
T 3p23_A 174 AVGRH----SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANIL------ 241 (432)
T ss_dssp ----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--HHHH------
T ss_pred cCCCc----ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--HHHH------
Confidence 43211 012234467999999999997 4567889999999999999999 888985432211 1100
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
..... ......+.... ..+.+||.+||..||++|||++|++
T Consensus 242 ---~~~~~--------------------~~~~~~~~~~~----------------~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 242 ---LGACS--------------------LDCLHPEKHED----------------VIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp ---TTCCC--------------------CTTSCTTCHHH----------------HHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ---hccCC--------------------ccccCcccccc----------------HHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 00000 00000000000 0123678889999999999999999
Q ss_pred CCCCCCC
Q 002289 917 KHPYVSS 923 (941)
Q Consensus 917 ~Hpwf~~ 923 (941)
+||||.+
T Consensus 283 ~hp~f~~ 289 (432)
T 3p23_A 283 KHPFFWS 289 (432)
T ss_dssp TSTTTCC
T ss_pred hCccccC
Confidence 9999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=329.65 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=193.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc----------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE---------- 676 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------- 676 (941)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999964 7899999998642 2334678999999999999999999998744
Q ss_pred ---CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 677 ---EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 677 ---~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
.+..++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 457899999999999999997543 45788999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCCCc-------cccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHH
Q 002289 754 FGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 825 (941)
Q Consensus 754 FGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~ 825 (941)
||+++.......... ..........||..|+|||++.+. .++.++|||||||++|||++ ||....+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999986543210000 001223345689999999999864 78999999999999999998 5543222111
Q ss_pred HHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCC
Q 002289 826 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 905 (941)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~d 905 (941)
.... +.......|..-+ ........+++.+||..|
T Consensus 237 ~~~~-----------------------------~~~~~~~~~~~~~----------------~~~~~~~~~li~~~l~~d 271 (303)
T 1zy4_A 237 ILKK-----------------------------LRSVSIEFPPDFD----------------DNKMKVEKKIIRLLIDHD 271 (303)
T ss_dssp HHHH-----------------------------HHSTTCCCCTTCC----------------TTTSHHHHHHHHHHTCSS
T ss_pred HHHh-----------------------------ccccccccCcccc----------------ccchHHHHHHHHHHHhcC
Confidence 1110 0000000010000 011112235777889999
Q ss_pred CCCCCCCccCCCCCCCCCC
Q 002289 906 EETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 906 P~~R~sa~e~L~Hpwf~~~ 924 (941)
|++|||++|+++||||+..
T Consensus 272 p~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 272 PNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp GGGSCCHHHHHHSSCSCCC
T ss_pred cccCcCHHHHhCCCCcCCC
Confidence 9999999999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=340.66 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=205.6
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
..++....++|++.+.||+|+||.||+|.+.+ .||+|+++.... ...+.+.+|+.++++++|+||+++++++...+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34555567889999999999999999999754 499999875332 22356888999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++ ++.+||+|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999999654 345889999999999999999999999 99999999999998 6799999999987
Q ss_pred ccCCCCCCCccccccccccccCCCccccccccc---------CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 829 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~ 829 (941)
........ ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 178 ~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~- 254 (319)
T 2y4i_B 178 ISGVLQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ- 254 (319)
T ss_dssp ------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-
T ss_pred cccccccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 65322111 11122334568999999999874 4578899999999999999999999976543211111
Q ss_pred HHhhccchhhhcCCCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 830 AYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 830 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+..+.... .+..++..+.+++..||..+|.+||++.++++.|+.+..
T Consensus 255 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 255 ---------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp ---------HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ---------hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 122345678899999999999999999999999987654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.25 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=165.0
Q ss_pred HHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch------hhHhHHHHHHHHHhc----CCCceeeeeec
Q 002289 605 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRL----HHRNLVSLVGY 673 (941)
Q Consensus 605 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv~l~~~ 673 (941)
....++|++.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+++++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345678999999999999999999864 6899999999754321 234567899999998 89999999999
Q ss_pred cccCCcEEEEEec-CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEE
Q 002289 674 CDEEGEQMLVYEF-MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKV 751 (941)
Q Consensus 674 ~~~~~~~~LV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl 751 (941)
+...+..++|||| +++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 78999999997644 4899999999999999999999999 99999999999999 8899999
Q ss_pred eeeccccccCCCCCCCccccccccccccCCCcccccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCC
Q 002289 752 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
+|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||..
T Consensus 182 ~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 182 IDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9999998654321 2344589999999999877664 589999999999999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=332.91 Aligned_cols=203 Identities=28% Similarity=0.400 Sum_probs=153.4
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHH-HHHhcCCCceeeeeeccccCCcEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
..++|++.+.||+|+||.||+|... +|+.||||+++..... ...++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478889999999999999999975 7899999999764332 3345666666 77778999999999999999999999
Q ss_pred EecCCCCCHHHHHhh---cCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 684 YEFMSNGTLRDQLSA---KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
|||++ |+|.+++.. .....+++..+..++.|+++||.|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99996 588887753 2345689999999999999999999998 8 99999999999999999999999999976
Q ss_pred cCCCCCCCccccccccccccCCCccccccc----ccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 176 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 176 LVDSI--------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp --------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccccc--------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 53221 12234689999999998 45678999999999999999999999997543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=343.72 Aligned_cols=303 Identities=17% Similarity=0.227 Sum_probs=247.3
Q ss_pred CCCCCCCCceEecCCCC---CCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCC-CCccCCccccceec
Q 002289 61 DPCTSNWTGVLCFNTTM---DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLL 136 (941)
Q Consensus 61 ~~c~~~w~gv~C~~~~~---~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ 136 (941)
..|.|.+..|.|....+ +....++++|+|++|.+++..+..|+++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 34544455589976543 334468999999999999988999999999999999999998655 57899999999999
Q ss_pred ccCccccCCCCcccCCcCccceeecccccccccCCcc--cccccccceEecccccccccCchh-ccCCCccceeeccCCc
Q 002289 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNN 213 (941)
Q Consensus 137 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~ 213 (941)
|++|++++..|..|+++++|++|+|++|.+++..+.. |..+++|++|+|++|++++..|.. |.++++|++|+|++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999866554 999999999999999999887876 7899999999999999
Q ss_pred CCCCCCccCCCC----------------------------------CCCCEEeccCCcCCCC------------------
Q 002289 214 LTGYLPPELSEL----------------------------------PKLLILQLDNNNFEGT------------------ 241 (941)
Q Consensus 214 l~~~~p~~~~~l----------------------------------~~L~~L~Ls~N~l~~~------------------ 241 (941)
+++..+..+..+ ++|+.|+|++|++++.
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~ 245 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEe
Confidence 998877665433 4555555555554320
Q ss_pred --------------------------------------------CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCccc
Q 002289 242 --------------------------------------------TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG 277 (941)
Q Consensus 242 --------------------------------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~ 277 (941)
..|..|..+++|++|+|++|++++.++. .
T Consensus 246 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-------~ 318 (455)
T 3v47_A 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN-------A 318 (455)
T ss_dssp CTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-------T
T ss_pred eccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChh-------H
Confidence 2455666777777777777777765443 1
Q ss_pred ccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--C
Q 002289 278 YLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--N 355 (941)
Q Consensus 278 ~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~ 355 (941)
+....+|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..+..+ ++|+.|+|++|+|+.++... .
T Consensus 319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~ 393 (455)
T 3v47_A 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL-----PNLKELALDTNQLKSVPDGIFDR 393 (455)
T ss_dssp TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTC-----TTCCEEECCSSCCSCCCTTTTTT
T ss_pred hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccc-----ccccEEECCCCccccCCHhHhcc
Confidence 1223567999999999998889999999999999999999998888888664 46679999999999998755 6
Q ss_pred CCCCcEEEecCCCCccCCCc
Q 002289 356 IPPNVTVRLRGNPFCLNTNA 375 (941)
Q Consensus 356 ~~~~~~l~l~~Np~~c~c~~ 375 (941)
++.++.|+|++|||.|+|+.
T Consensus 394 l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 394 LTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CTTCCEEECCSSCBCCCTTT
T ss_pred CCcccEEEccCCCcccCCCc
Confidence 88999999999999999983
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=347.30 Aligned_cols=313 Identities=22% Similarity=0.227 Sum_probs=265.9
Q ss_pred CCCC--CCCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcccccee
Q 002289 62 PCTS--NWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELL 135 (941)
Q Consensus 62 ~c~~--~w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 135 (941)
.|.| .|..|.|....+. ....+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|
T Consensus 6 ~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 85 (477)
T 2id5_A 6 RCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTL 85 (477)
T ss_dssp TCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEE
Confidence 4555 4678999765432 234579999999999999888899999999999999999998889999999999999
Q ss_pred cccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCC
Q 002289 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 136 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 215 (941)
+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 86 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 86 GLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp ECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred ECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 99999999777778999999999999999999999999999999999999999999888999999999999999999999
Q ss_pred CCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCC-C----------------CCCCcccc
Q 002289 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-L----------------SRIPNLGY 278 (941)
Q Consensus 216 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~----------------~~l~~l~~ 278 (941)
+..+..|.++++|+.|+|++|.+.+ ..+..|..+++|++|++++|++.+.++. . ..++...+
T Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 244 (477)
T 2id5_A 166 SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAV 244 (477)
T ss_dssp SCCHHHHTTCTTCCEEEEESCCCCE-ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHH
T ss_pred ccChhHhcccCCCcEEeCCCCcCcE-eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHh
Confidence 7777789999999999999999987 5667888899899888888876554332 1 11111123
Q ss_pred cccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CC
Q 002289 279 LLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NI 356 (941)
Q Consensus 279 l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~ 356 (941)
....+|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..+..+ ++|+.|+|++|+|+.++... .+
T Consensus 245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l 319 (477)
T 2id5_A 245 RHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL-----NYLRVLNVSGNQLTTLEESVFHSV 319 (477)
T ss_dssp TTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTC-----TTCCEEECCSSCCSCCCGGGBSCG
T ss_pred cCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCc-----ccCCEEECCCCcCceeCHhHcCCC
Confidence 344678899999999988888888899999999999999988778877654 45679999999999997654 57
Q ss_pred CCCcEEEecCCCCccCCCcccccC
Q 002289 357 PPNVTVRLRGNPFCLNTNAEQFCG 380 (941)
Q Consensus 357 ~~~~~l~l~~Np~~c~c~~~~~~~ 380 (941)
+.+++|+|++|||.|+|.+.++-.
T Consensus 320 ~~L~~L~l~~N~l~c~c~~~~~~~ 343 (477)
T 2id5_A 320 GNLETLILDSNPLACDCRLLWVFR 343 (477)
T ss_dssp GGCCEEECCSSCEECSGGGHHHHT
T ss_pred cccCEEEccCCCccCccchHhHHh
Confidence 789999999999999999877644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=319.70 Aligned_cols=201 Identities=28% Similarity=0.431 Sum_probs=173.4
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3578999999999999999999975 689999999865322 2356789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC---CcEEEeeecccccc
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLA 760 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DFGla~~~ 760 (941)
|||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999886543 4889999999999999999999999 9999999999999754 47999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
.... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 175 QQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp CCCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 4321 1223457889999999876 48999999999999999999999997544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=331.56 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=153.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh-hH-hHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.++|++.+.||+|+||.||+|.+. +|+.||||++....... .. .+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 78999999997644322 22 3444555788889999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||+ ++.+..+.... ...+++..++.++.|+++||+|||++ + |+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 55666655432 34589999999999999999999985 8 999999999999999999999999999765322
Q ss_pred CCCCccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCCch
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 822 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~ 822 (941)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 179 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (318)
T 2dyl_A 179 K--------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred c--------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Confidence 1 123346899999999994 56788999999999999999999999976443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=335.28 Aligned_cols=192 Identities=23% Similarity=0.266 Sum_probs=159.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc--------hhhHhHHHHHHHHHhcC---------------
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLH--------------- 663 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~--------------- 663 (941)
..++|++.+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|++++++++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356788999999999999999998 789999999875432 12367889999999886
Q ss_pred -----------CCceeeeeecccc-------------CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHH
Q 002289 664 -----------HRNLVSLVGYCDE-------------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 719 (941)
Q Consensus 664 -----------h~nIv~l~~~~~~-------------~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g 719 (941)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 5555555555554 6789999999999977666633 358999999999999999
Q ss_pred HHHhh-cCCCCCeEeccCCCCcEEEcCCC--------------------cEEEeeeccccccCCCCCCCccccccccccc
Q 002289 720 ILYLH-TEADPPVFHRDIKASNILLDHKF--------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778 (941)
Q Consensus 720 L~yLH-~~~~~~ivH~DLkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 778 (941)
|+||| +++ |+||||||+|||++.++ .+||+|||+|+.... ....
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~~ 238 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIVV 238 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEEE
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcEE
Confidence 99999 899 99999999999999887 999999999986532 1346
Q ss_pred cCCCcccccccccCCCCchhHhHHHHHH-HHHHHhCCCCCC
Q 002289 779 GTPGYLDPEYFLTHKLTDKSDVYSLGVV-FLELLTGMQPIS 818 (941)
Q Consensus 779 gt~~y~aPE~~~~~~~~~~sDVwSlG~l-l~elltG~~Pf~ 818 (941)
||+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999999999998776 889999998777 778888988873
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=359.15 Aligned_cols=284 Identities=30% Similarity=0.460 Sum_probs=246.6
Q ss_pred eeeEEEecCCCCCccCCccccC--CCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 83 HLRELQLLNLNLSGNLSPEIGR--LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
+++.|++++|.++|.+++.+.. +++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..|+++++|++|+
T Consensus 369 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 448 (768)
T 3rgz_A 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448 (768)
T ss_dssp TCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEE
Confidence 7899999999999988888877 88999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|++|.+++.+|..+..+++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..++++++|++|+|++|+++|
T Consensus 449 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 528 (768)
T 3rgz_A 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred CCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCC-CCCCCcc-------------------------------------------
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNL------------------------------------------- 276 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l------------------------------------------- 276 (941)
.+|..+.++++|+.|+|++|+++|.+|. +.....+
T Consensus 529 -~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (768)
T 3rgz_A 529 -NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607 (768)
T ss_dssp -ECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGG
T ss_pred -cCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcc
Confidence 6899999999999999999999987774 1110000
Q ss_pred -------------------cccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCcccc
Q 002289 277 -------------------GYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 337 (941)
Q Consensus 277 -------------------~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L 337 (941)
.+....+|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..++.++. |
T Consensus 608 ~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~-----L 682 (768)
T 3rgz_A 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG-----L 682 (768)
T ss_dssp GGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT-----C
T ss_pred ccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCC-----C
Confidence 0112356889999999999999999999999999999999999999999887644 5
Q ss_pred ceEEccCCCCCC-CCCCC-CCCCCcEEEecCCCCccC
Q 002289 338 FILDFQNNNLTN-ISGSF-NIPPNVTVRLRGNPFCLN 372 (941)
Q Consensus 338 ~~L~Ls~N~l~~-~~~~~-~~~~~~~l~l~~Np~~c~ 372 (941)
+.|||++|+|++ +|..+ .+..++.|+|++|++...
T Consensus 683 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ 719 (768)
T 3rgz_A 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719 (768)
T ss_dssp CEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEE
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECcCCccccc
Confidence 689999999985 46555 678899999999987653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.05 Aligned_cols=240 Identities=20% Similarity=0.320 Sum_probs=183.0
Q ss_pred hcCCCcc-ceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHH-HhcCCCceeeeeecccc----CCcE
Q 002289 608 TNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFL-SRLHHRNLVSLVGYCDE----EGEQ 680 (941)
Q Consensus 608 ~~~y~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~ 680 (941)
.++|.+. +.||+|+||.||+|... +++.||+|+++. ...+.+|++++ +..+||||+++++++.. .+..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567676 77999999999999974 789999999864 24577889887 55699999999999866 6778
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeeccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLS 757 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGla 757 (941)
++||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998876667999999999999999999999999 999999999999998 789999999998
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
.... +..++.++|||||||++|||++|+.||........ ...+.
T Consensus 168 ~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------~~~~~ 211 (299)
T 3m2w_A 168 KETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------SPGMK 211 (299)
T ss_dssp EECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSC
T ss_pred cccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------hHHHH
Confidence 6432 13457799999999999999999999965432110 00000
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
..+.......+.... ....+...+++.+||..||++|||++|+|+
T Consensus 212 ~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEW-----------------------------------SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTTCCSSCHHHH-----------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhccccCCchhc-----------------------------------ccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111111111111100 112223346778888888899999999999
Q ss_pred CCCCCCCCC
Q 002289 918 HPYVSSDVS 926 (941)
Q Consensus 918 Hpwf~~~~~ 926 (941)
||||.....
T Consensus 257 hp~~~~~~~ 265 (299)
T 3m2w_A 257 HPWIMQSTK 265 (299)
T ss_dssp SHHHHTGGG
T ss_pred Chhhccccc
Confidence 999876543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.97 Aligned_cols=229 Identities=12% Similarity=0.069 Sum_probs=185.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999975 5899999999864332 236789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++... .....+.+++.|++.||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999542 244567889999999999999999 9999999999999999999998543
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
|++ .++.++|||||||++|||+||+.||........ .......+.+.
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~~~ 221 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------LAPAERDTAGQ 221 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-------SEECCBCTTSC
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-------hHHHHHHhccC
Confidence 333 268899999999999999999999975432100 00000111111
Q ss_pred CC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 844 MG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 844 ~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.. .....++..+.+++.+||+.||++| ++.++++.|+.+..
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 11 1123456779999999999999999 99999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=346.92 Aligned_cols=240 Identities=20% Similarity=0.322 Sum_probs=193.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC--CCcEEEEEEeccCC-chhhHhHHHHHHHHHhcCCCceeeeeeccccCCc-----
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 679 (941)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 68999999986533 2345678999999999999999999999977665
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+++++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988743 5899999999999999999999999 9999999999999986 999999999986
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... ....||+.|+|||++.+.. +.++|||||||++|||++|..||..... ..
T Consensus 231 ~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------------~~ 283 (681)
T 2pzi_A 231 INSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------------DG 283 (681)
T ss_dssp TTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------------SS
T ss_pred cccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------------cc
Confidence 5321 3356899999999987764 8899999999999999999888753110 00
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhH
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPS-MSEVMRELESIW 884 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs-~~~v~~~L~~~~ 884 (941)
+. ........+..+.+++.+|++.+|.+||+ ++++.+.+..+.
T Consensus 284 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 LP--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CC--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cc--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 00011234467889999999999999995 555666665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=320.85 Aligned_cols=241 Identities=15% Similarity=0.112 Sum_probs=182.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh---hHhHHHHHHHHHhcCC-Cceeeee-----------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHH-RNLVSLV----------- 671 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h-~nIv~l~----------- 671 (941)
..+|...+.||+|+||+||+|++. +|+.||||+++...... .+.+.+|+.+++.++| +|.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345667889999999999999954 79999999988433222 4678999999999987 3221111
Q ss_pred ----------ecccc-----CCcEEEEEecCCCCCHHHHHh-----hcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 002289 672 ----------GYCDE-----EGEQMLVYEFMSNGTLRDQLS-----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 731 (941)
Q Consensus 672 ----------~~~~~-----~~~~~LV~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 731 (941)
.++.. ....+++|+++ +++|.++++ ......+++..++.++.|+++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 22467888876 789999985 233446889999999999999999999999 9
Q ss_pred EeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCccccccc----------ccCCCCchhHhH
Q 002289 732 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF----------LTHKLTDKSDVY 801 (941)
Q Consensus 732 vH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDVw 801 (941)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC----------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 9999999999999999999999999875421 1334457 999999999 555688899999
Q ss_pred HHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002289 802 SLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878 (941)
Q Consensus 802 SlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~ 878 (941)
||||++|||++|+.||...... .....++. ....+ ++.+.+++..||+.+|++||++.++++
T Consensus 302 SlGvil~elltg~~Pf~~~~~~----------~~~~~~~~-~~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAAL----------GGSEWIFR-SCKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGG----------SCSGGGGS-SCCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCCcchh----------hhHHHHHh-hcccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999999754321 11111221 12223 367889999999999999999877753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=330.92 Aligned_cols=149 Identities=20% Similarity=0.233 Sum_probs=96.5
Q ss_pred CceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCcccc
Q 002289 68 TGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143 (941)
Q Consensus 68 ~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 143 (941)
..|.|....+. +...++++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~ 93 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc
Confidence 34777653321 23356777777777777666667777777777777777777666666777777777777777777
Q ss_pred CCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccc-cCchhccCCCccceeeccCCcCCC
Q 002289 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTG 216 (941)
Q Consensus 144 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~ 216 (941)
+..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++
T Consensus 94 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp CCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred ccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 6666677777777777777776665555566666666666666666654 345556666666666655555443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=313.11 Aligned_cols=308 Identities=18% Similarity=0.166 Sum_probs=218.4
Q ss_pred CCCCCCCCCCCCCCCceEecCCCC--------------CCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCC
Q 002289 54 LSNWNRGDPCTSNWTGVLCFNTTM--------------DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKIS 119 (941)
Q Consensus 54 ~~~w~~~~~c~~~w~gv~C~~~~~--------------~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 119 (941)
+++|.....|++.|.+..|..... .-...+++.|++.++.++...+..|..+++|++|+|++|.++
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~ 82 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82 (390)
T ss_dssp ----CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC
T ss_pred cCCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc
Confidence 568998888988766665532110 012367888888888887654455788888999999888888
Q ss_pred CCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhcc
Q 002289 120 GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 199 (941)
Q Consensus 120 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 199 (941)
+..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|.++...+..|.++++|++|+|++|++++..+..|.
T Consensus 83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162 (390)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence 77777888888899999998888887788888888899999988888865556678888888899988888877777888
Q ss_pred CCCccceeeccCCcCCCCCCccCCCC-------------------------------------CCCCEEeccCCcCCCCC
Q 002289 200 RLPSLVHMLLDNNNLTGYLPPELSEL-------------------------------------PKLLILQLDNNNFEGTT 242 (941)
Q Consensus 200 ~l~~L~~L~L~~N~l~~~~p~~~~~l-------------------------------------~~L~~L~Ls~N~l~~~~ 242 (941)
.+++|++|++++|++++.....+.++ ++|+.|+|++|.+++
T Consensus 163 ~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~-- 240 (390)
T 3o6n_A 163 ATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD-- 240 (390)
T ss_dssp SCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCC--
T ss_pred CCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcc--
Confidence 88888888888888885432222222 245555555555543
Q ss_pred cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCC
Q 002289 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 322 (941)
...+..+++|++|+|++|.+++.+|. .+....+|++|+|++|+|++ +|..+..+++|+.|+|++|+++ .+
T Consensus 241 -~~~l~~l~~L~~L~Ls~n~l~~~~~~-------~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~ 310 (390)
T 3o6n_A 241 -TAWLLNYPGLVEVDLSYNELEKIMYH-------PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HV 310 (390)
T ss_dssp -CGGGGGCTTCSEEECCSSCCCEEESG-------GGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CC
T ss_pred -cHHHcCCCCccEEECCCCcCCCcChh-------HccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ec
Confidence 14566677777777777777655432 12223456788888888874 4556677788888888888887 56
Q ss_pred CcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCccCCCccccc
Q 002289 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFC 379 (941)
Q Consensus 323 p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~~~~~ 379 (941)
|..+..+ ++|+.|+|++|+|+.++ ...++.++.|++++|||.|+|....+.
T Consensus 311 ~~~~~~l-----~~L~~L~L~~N~i~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~ 361 (390)
T 3o6n_A 311 ERNQPQF-----DRLENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFR 361 (390)
T ss_dssp GGGHHHH-----TTCSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTT
T ss_pred Ccccccc-----CcCCEEECCCCccceeC-chhhccCCEEEcCCCCccchhHHHHHH
Confidence 6666543 45679999999999886 236788999999999999998654443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-32 Score=326.34 Aligned_cols=309 Identities=18% Similarity=0.225 Sum_probs=240.1
Q ss_pred CceEecCCCC---CC-CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCcccc
Q 002289 68 TGVLCFNTTM---DD-GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143 (941)
Q Consensus 68 ~gv~C~~~~~---~~-~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 143 (941)
..|.|....+ +. -..++++|+|++|+|++..+..|.++++|++|||++|+|+++.|.+|.++++|++|+|++|+|+
T Consensus 34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 3467875432 22 3357999999999999877789999999999999999999888889999999999999999999
Q ss_pred CCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccc-cCchhccCCCccceeeccCCcCCCCCCccC
Q 002289 144 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPEL 222 (941)
Q Consensus 144 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 222 (941)
+..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|+|++..+..|
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 8777889999999999999999998888889999999999999999976 457888899999999999998765433211
Q ss_pred C-------------------------------------------------------------------------------
Q 002289 223 S------------------------------------------------------------------------------- 223 (941)
Q Consensus 223 ~------------------------------------------------------------------------------- 223 (941)
.
T Consensus 194 ~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~ 273 (635)
T 4g8a_A 194 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 273 (635)
T ss_dssp HHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTT
T ss_pred cchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 002289 224 -------------------------------------------------------------------------------- 223 (941)
Q Consensus 224 -------------------------------------------------------------------------------- 223 (941)
T Consensus 274 ~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~ 353 (635)
T 4g8a_A 274 ALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 353 (635)
T ss_dssp TTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCE
T ss_pred ccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhh
Confidence
Q ss_pred ---------------CCCCCCEEeccCCcCCCC-----------------------------------------------
Q 002289 224 ---------------ELPKLLILQLDNNNFEGT----------------------------------------------- 241 (941)
Q Consensus 224 ---------------~l~~L~~L~Ls~N~l~~~----------------------------------------------- 241 (941)
.+++|+.|++++|.+...
T Consensus 354 l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~ 433 (635)
T 4g8a_A 354 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK 433 (635)
T ss_dssp EEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEE
T ss_pred cccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccc
Confidence 123444455555544210
Q ss_pred --CcchhccCCCCCcEEEccCCCCcCCCCCC-CCCCcc-----------------cccccCCcCEEEccCCcCCCCcchh
Q 002289 242 --TIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNL-----------------GYLLSLNITTIKLSNNKLTGTIPSN 301 (941)
Q Consensus 242 --~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~l~~l-----------------~~l~~~~L~~L~Ls~N~l~~~~p~~ 301 (941)
..+..|.++++|+.++++.|.+++..+.. ..++.+ .+....+|++|+|++|+|++..|..
T Consensus 434 ~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~ 513 (635)
T 4g8a_A 434 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 513 (635)
T ss_dssp STTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHH
Confidence 01123444555666666666666554431 111111 1223457999999999999999999
Q ss_pred hcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CC-CCCcEEEecCCCCccCCCcccc
Q 002289 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NI-PPNVTVRLRGNPFCLNTNAEQF 378 (941)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~-~~~~~l~l~~Np~~c~c~~~~~ 378 (941)
|.++++|+.|+|++|+|++..|..+..+ ++|++|||++|+|++++... .+ ..++.|+|++|||.|||++.+|
T Consensus 514 f~~l~~L~~L~Ls~N~l~~l~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~ 588 (635)
T 4g8a_A 514 FNSLSSLQVLNMSHNNFFSLDTFPYKCL-----NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 588 (635)
T ss_dssp TTTCTTCCEEECTTSCCCBCCCGGGTTC-----TTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHH
T ss_pred HcCCCCCCEEECCCCcCCCCChhHHhCC-----CCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHH
Confidence 9999999999999999998777777654 45679999999999996554 45 4689999999999999998877
Q ss_pred cCC
Q 002289 379 CGS 381 (941)
Q Consensus 379 ~~~ 381 (941)
-..
T Consensus 589 ~~w 591 (635)
T 4g8a_A 589 LQW 591 (635)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=328.88 Aligned_cols=308 Identities=18% Similarity=0.174 Sum_probs=221.2
Q ss_pred CCCCCCCCCCCCCC---CCceEecCC----C------C-CCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCC
Q 002289 53 KLSNWNRGDPCTSN---WTGVLCFNT----T------M-DDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI 118 (941)
Q Consensus 53 ~~~~w~~~~~c~~~---w~gv~C~~~----~------~-~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l 118 (941)
.+.+|..+..|++. |.++.|... . . .-...+++.|++.++.+....+..|..+++|+.|+|++|.|
T Consensus 8 ~l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l 87 (597)
T 3oja_B 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87 (597)
T ss_dssp ---CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred cccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCC
Confidence 56789888888754 555554321 0 0 01235677888888887765555677888888888888888
Q ss_pred CCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhc
Q 002289 119 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL 198 (941)
Q Consensus 119 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 198 (941)
++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|.++++|++|+|++|++++..|..|
T Consensus 88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 167 (597)
T 3oja_B 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167 (597)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence 87777788888888888888888887777778888888888888888886666667888888888888888887777788
Q ss_pred cCCCccceeeccCCcCCCCCCccCCCC-------------------------------------CCCCEEeccCCcCCCC
Q 002289 199 SRLPSLVHMLLDNNNLTGYLPPELSEL-------------------------------------PKLLILQLDNNNFEGT 241 (941)
Q Consensus 199 ~~l~~L~~L~L~~N~l~~~~p~~~~~l-------------------------------------~~L~~L~Ls~N~l~~~ 241 (941)
+.+++|++|+|++|.+++.....+.++ ++|+.|+|++|.+++
T Consensus 168 ~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~- 246 (597)
T 3oja_B 168 QATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD- 246 (597)
T ss_dssp TTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC-
T ss_pred hcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC-
Confidence 888888888888888876533322221 235555555555553
Q ss_pred CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccC
Q 002289 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321 (941)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 321 (941)
+..+..+++|+.|+|++|.|++.+|. .+..+.+|+.|+|++|.|++ +|..+..+++|+.|+|++|+|+ .
T Consensus 247 --~~~l~~l~~L~~L~Ls~N~l~~~~~~-------~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~ 315 (597)
T 3oja_B 247 --TAWLLNYPGLVEVDLSYNELEKIMYH-------PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-H 315 (597)
T ss_dssp --CGGGGGCTTCSEEECCSSCCCEEESG-------GGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-C
T ss_pred --ChhhccCCCCCEEECCCCccCCCCHH-------HhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-c
Confidence 25567777777777777777765443 12223456888888888875 5666677888888888888887 6
Q ss_pred CCcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCccCCCcccc
Q 002289 322 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF 378 (941)
Q Consensus 322 ~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~~~~ 378 (941)
+|..+..+ ++|+.|+|++|.|+.++. ..++.+..|+|++|||.|+|....+
T Consensus 316 i~~~~~~l-----~~L~~L~L~~N~l~~~~~-~~~~~L~~L~l~~N~~~~~~~~~~~ 366 (597)
T 3oja_B 316 VERNQPQF-----DRLENLYLDHNSIVTLKL-STHHTLKNLTLSHNDWDCNSLRALF 366 (597)
T ss_dssp CGGGHHHH-----TTCSEEECCSSCCCCCCC-CTTCCCSEEECCSSCEEHHHHHHHT
T ss_pred cCcccccC-----CCCCEEECCCCCCCCcCh-hhcCCCCEEEeeCCCCCChhHHHHH
Confidence 77766554 456789999999988862 2578899999999999999865443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=304.25 Aligned_cols=274 Identities=21% Similarity=0.268 Sum_probs=186.9
Q ss_pred CCHHHHHHHHHHHHhCc-CCCCCCCCCC---CCCCCCCCCCceEecCCCC---CCCcceeeEEEecCCCCCccCCccccC
Q 002289 32 TDPIEVSALRSIKKSLV-DDYSKLSNWN---RGDPCTSNWTGVLCFNTTM---DDGYLHLRELQLLNLNLSGNLSPEIGR 104 (941)
Q Consensus 32 ~~~~d~~aL~~~k~~~~-~~~~~~~~w~---~~~~c~~~w~gv~C~~~~~---~~~~~~l~~L~L~~~~l~~~~~~~l~~ 104 (941)
...+|..||++||.++. ++.....+|. .....+|.|.|+.|..... .....+|+.|+|++|+++ .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 34568999999999995 4444567884 2333345799999953100 011246899999999998 77888888
Q ss_pred CCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCccccc--------
Q 002289 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN-------- 176 (941)
Q Consensus 105 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------- 176 (941)
+++|++|+|++|.|+ .+|..|+++++|++|+|++|+++ .+|..|+++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 999999999999998 88888999999999999999998 78888999999999999998888888887654
Q ss_pred -ccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcE
Q 002289 177 -LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255 (941)
Q Consensus 177 -l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 255 (941)
+++|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..+..+++|++|+|++|.+.+ .+|..|.++++|++
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~-~~p~~~~~l~~L~~ 257 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKR 257 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCC-BCCCCTTCCCCCCE
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchh-hhHHHhcCCCCCCE
Confidence 666677777766666 566666666666666666666663 44556666666666666666665 45666666666666
Q ss_pred EEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccC
Q 002289 256 LSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318 (941)
Q Consensus 256 L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 318 (941)
|+|++|++.+.+|.. +..+.+|++|+|++|++.+.+|..++++++|+.+++..|.+
T Consensus 258 L~L~~n~~~~~~p~~-------~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 258 LILKDCSNLLTLPLD-------IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp EECTTCTTCCBCCTT-------GGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred EECCCCCchhhcchh-------hhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 666555555444420 11122334445555444444454444444444444444433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-32 Score=326.23 Aligned_cols=291 Identities=19% Similarity=0.246 Sum_probs=181.7
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
+++.|++++|.+++..+..|..+++|++|+|++|+++ .+|..+.++++|++|+|++|++++..|..+.++++|++|+|+
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 4566666666666555555666666666666666665 455556666666666666666655555555555555555555
Q ss_pred cccccccCCc-ccccccccceEecccccccccC--chhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCC
Q 002289 163 QNYISGSLPK-SFANLNKTRHFHMNNNSISGQI--PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 163 ~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 239 (941)
+|.+.+.+|. .+..+++|++|++++|++++.. +..+..+++|++|++++|++++..|..|..+++|+.|+|++|+++
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 5555544332 2555555555555555554433 344445555555555555555444445555555555555555554
Q ss_pred CCCcchhccCCCCCcEEEccCCCCcCCCCC-CCCCCcc-------------------cccccCCcCEEEccCCcCCCCcc
Q 002289 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNL-------------------GYLLSLNITTIKLSNNKLTGTIP 299 (941)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l-------------------~~l~~~~L~~L~Ls~N~l~~~~p 299 (941)
+...+..+.++++|+.|++++|.+++.++. +..++++ .+....+|++|+|++|++++..|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 493 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence 422222344445555555555544443332 1122111 12234578999999999999999
Q ss_pred hhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCccCCCccc
Q 002289 300 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQ 377 (941)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~c~c~~~~ 377 (941)
..|.++++|+.|+|++|++++..|..+..+ +.| .|+|++|+|+.++... .++.++.|++++|||.|+|+..+
T Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-----~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~ 567 (606)
T 3t6q_A 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHL-----KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567 (606)
T ss_dssp TTTTTCTTCCEEECCSSCCCGGGGGGGTTC-----CSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHH
T ss_pred hhhccccCCCEEECCCCccCcCChhHhCcc-----ccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHH
Confidence 999999999999999999998888888654 456 7999999999987654 67889999999999999999766
Q ss_pred ccC
Q 002289 378 FCG 380 (941)
Q Consensus 378 ~~~ 380 (941)
|..
T Consensus 568 ~~~ 570 (606)
T 3t6q_A 568 FLE 570 (606)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-31 Score=318.95 Aligned_cols=280 Identities=23% Similarity=0.256 Sum_probs=177.5
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+++.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 46777777777777666667777777777777777777666777777777777777777776 44544 5666666666
Q ss_pred cccccccc-CCcccccccccceEeccccccc-------------------------------------------------
Q 002289 162 DQNYISGS-LPKSFANLNKTRHFHMNNNSIS------------------------------------------------- 191 (941)
Q Consensus 162 s~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~------------------------------------------------- 191 (941)
++|++++. +|..|.++++|++|+|++|+++
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~ 208 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSL 208 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccc
Confidence 66666652 3456666666666666655543
Q ss_pred --------------------------------------------------------------------------------
Q 002289 192 -------------------------------------------------------------------------------- 191 (941)
Q Consensus 192 -------------------------------------------------------------------------------- 191 (941)
T Consensus 209 ~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l 288 (562)
T 3a79_B 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288 (562)
T ss_dssp CCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEE
T ss_pred hhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEe
Confidence
Q ss_pred -ccCchhc-----------------------------------------------------cCCCccceeeccCCcCCCC
Q 002289 192 -GQIPPEL-----------------------------------------------------SRLPSLVHMLLDNNNLTGY 217 (941)
Q Consensus 192 -~~~p~~~-----------------------------------------------------~~l~~L~~L~L~~N~l~~~ 217 (941)
|.+|..+ ..+++|++|++++|++++.
T Consensus 289 ~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~ 368 (562)
T 3a79_B 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368 (562)
T ss_dssp CSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTT
T ss_pred eccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccc
Confidence 2222221 2334444444444444444
Q ss_pred CCccCCCCCCCCEEeccCCcCCCC-CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCC
Q 002289 218 LPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTG 296 (941)
Q Consensus 218 ~p~~~~~l~~L~~L~Ls~N~l~~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~ 296 (941)
+|..+.++++|++|+|++|++++. .+|..|.++++|++|+|++|++++.+|. ..+....+|++|+|++|+|++
T Consensus 369 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~------~~~~~l~~L~~L~l~~n~l~~ 442 (562)
T 3a79_B 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD------RTCAWAESILVLNLSSNMLTG 442 (562)
T ss_dssp TTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSS------CCCCCCTTCCEEECCSSCCCG
T ss_pred hhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccCh------hhhcCcccCCEEECCCCCCCc
Confidence 444444444555555555544431 1123344455555555555555442221 112223456777777777776
Q ss_pred CcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCC-C-CCCCCcEEEecCCCCccCCC
Q 002289 297 TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN 374 (941)
Q Consensus 297 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~-~-~~~~~~~l~l~~Np~~c~c~ 374 (941)
.+|..+. ++|+.|+|++|+|+ .+|..++. .++|+.|+|++|+|+.++.. + .++.++.|+|++|||.|+|+
T Consensus 443 ~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~-----l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 443 SVFRCLP--PKVKVLDLHNNRIM-SIPKDVTH-----LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp GGGSSCC--TTCSEEECCSSCCC-CCCTTTTS-----SCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred chhhhhc--CcCCEEECCCCcCc-ccChhhcC-----CCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 6655443 57888888888887 67776654 45677999999999999886 4 68889999999999999999
Q ss_pred cccc
Q 002289 375 AEQF 378 (941)
Q Consensus 375 ~~~~ 378 (941)
+.++
T Consensus 515 ~~~~ 518 (562)
T 3a79_B 515 GIRY 518 (562)
T ss_dssp HHHH
T ss_pred hHHH
Confidence 8766
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=314.22 Aligned_cols=281 Identities=21% Similarity=0.262 Sum_probs=195.2
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccC-CCCcccCCcCcccee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG-SLPEELGYLPKLDRI 159 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L 159 (941)
+.+++.|+|++|.+++..|..|+++++|++|+|++|+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 120 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEE
Confidence 345677777777777666667777777777777777776 45544 66777777777777765 356667777777666
Q ss_pred ecccccccc-------------------------cCCccccccc------------------------------------
Q 002289 160 QIDQNYISG-------------------------SLPKSFANLN------------------------------------ 178 (941)
Q Consensus 160 ~Ls~N~l~~-------------------------~~p~~~~~l~------------------------------------ 178 (941)
+|++|.+++ ..|..+..+.
T Consensus 121 ~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 200 (520)
T 2z7x_B 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200 (520)
T ss_dssp EEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEEC
T ss_pred EecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccc
Confidence 666666542 2233332211
Q ss_pred -----------------------------------------------ccceEecccccccccCchhc-------------
Q 002289 179 -----------------------------------------------KTRHFHMNNNSISGQIPPEL------------- 198 (941)
Q Consensus 179 -----------------------------------------------~L~~L~L~~N~l~~~~p~~~------------- 198 (941)
+|++|++++|+++|.+|..+
T Consensus 201 ~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~ 280 (520)
T 2z7x_B 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSI 280 (520)
T ss_dssp CSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEE
T ss_pred ccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEe
Confidence 45555666666665555443
Q ss_pred ----------------------------------------cCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcC
Q 002289 199 ----------------------------------------SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238 (941)
Q Consensus 199 ----------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 238 (941)
..+++|++|++++|++++.+|..+.++++|++|+|++|++
T Consensus 281 l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 360 (520)
T 2z7x_B 281 HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360 (520)
T ss_dssp EEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCC
T ss_pred ccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCcc
Confidence 4556677777777777766777777777777777777777
Q ss_pred CCC-CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeeccccc
Q 002289 239 EGT-TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 317 (941)
Q Consensus 239 ~~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 317 (941)
++. .+|..+..+++|++|+|++|++++.+|. ..+....+|++|+|++|++++.+|..+. ++|+.|+|++|+
T Consensus 361 ~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~------~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~ 432 (520)
T 2z7x_B 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKK------GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNK 432 (520)
T ss_dssp CBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG------CSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSC
T ss_pred CccccchHHHhhCCCCCEEECCCCcCCccccc------chhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCc
Confidence 641 2345677777777777777777753331 1122235678889999988887777664 689999999999
Q ss_pred CccCCCcccccccccCccccceEEccCCCCCCCCCC-C-CCCCCcEEEecCCCCccCCCcccc
Q 002289 318 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQF 378 (941)
Q Consensus 318 l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~-~-~~~~~~~l~l~~Np~~c~c~~~~~ 378 (941)
|+ .+|..++. .++|+.|+|++|+|+.++.. + .++.++.|++++|||.|+|++.++
T Consensus 433 l~-~ip~~~~~-----l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 489 (520)
T 2z7x_B 433 IK-SIPKQVVK-----LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 489 (520)
T ss_dssp CC-CCCGGGGG-----CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHH
T ss_pred cc-ccchhhhc-----CCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCchHH
Confidence 98 78887764 45677999999999999876 4 688899999999999999998776
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=317.45 Aligned_cols=162 Identities=19% Similarity=0.211 Sum_probs=137.0
Q ss_pred CCCCCceEecCCC-----CC-CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecc
Q 002289 64 TSNWTGVLCFNTT-----MD-DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137 (941)
Q Consensus 64 ~~~w~gv~C~~~~-----~~-~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 137 (941)
.|.|.|+ |+... ++ ....+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 3579888 86431 11 23458999999999999888889999999999999999999888899999999999999
Q ss_pred cCccccCCCCcccCCcCccceeeccccccccc-CCcccccccccceEecccccccccCc-hhccCCCccceeeccCCcCC
Q 002289 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 138 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 215 (941)
++|++++..|..|+++++|++|+|++|.+++. .|..|.++++|++|+|++|++.+.+| ..|.++++|++|++++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 99999988888899999999999999999874 57789999999999999998544554 67888999999999999998
Q ss_pred CCCCccCCCCC
Q 002289 216 GYLPPELSELP 226 (941)
Q Consensus 216 ~~~p~~~~~l~ 226 (941)
+..|..+..++
T Consensus 162 ~~~~~~l~~l~ 172 (549)
T 2z81_A 162 NYQSQSLKSIR 172 (549)
T ss_dssp EECTTTTTTCS
T ss_pred ccChhhhhccc
Confidence 87777776543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=330.09 Aligned_cols=283 Identities=23% Similarity=0.249 Sum_probs=219.1
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+++.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 57999999999999988889999999999999999999888999999999999999999999888999999999999999
Q ss_pred ccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCcc--------------------
Q 002289 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-------------------- 221 (941)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------------- 221 (941)
++|.+++..+..|.++++|++|+|++|++++. + .+++|+.|++++|+++ .+|..
T Consensus 346 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~-~l~~~~~~l~~L~ls~N~l~~l~~~ 419 (844)
T 3j0a_A 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENLDIL 419 (844)
T ss_dssp CSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCC-CCCCCCTTCCEEECCSCCCCSSTTH
T ss_pred CCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcc-cccccccccceeecccCccccCchh
Confidence 99999988888999999999999999999842 2 3677888888888777 34432
Q ss_pred --CCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcc
Q 002289 222 --LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIP 299 (941)
Q Consensus 222 --~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p 299 (941)
+.++++|+.|+|++|++++......+..+++|+.|+|++|.+++..+. ....-.+..+.+|+.|+|++|+|++..|
T Consensus 420 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 497 (844)
T 3j0a_A 420 YFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET--ELCWDVFEGLSHLQVLYLNHNYLNSLPP 497 (844)
T ss_dssp HHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCS--CCCSSCSSCBCCEECCCCCHHHHTTCCT
T ss_pred hhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccccc--ccchhhhcCcccccEEECCCCcccccCh
Confidence 223444555555555544322222334444555555555554432221 0001112334678999999999999999
Q ss_pred hhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCccCCCccccc
Q 002289 300 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFC 379 (941)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~~~~~ 379 (941)
..|.++++|+.|+|++|+|++..|..+. ++|+.|||++|+|++++... +..+..|++++|||.|+|++..|.
T Consensus 498 ~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-------~~L~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~c~~~~f~ 569 (844)
T 3j0a_A 498 GVFSHLTALRGLSLNSNRLTVLSHNDLP-------ANLEILDISRNQLLAPNPDV-FVSLSVLDITHNKFICECELSTFI 569 (844)
T ss_dssp TSSSSCCSCSEEEEESCCCSSCCCCCCC-------SCCCEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCCSSSCCSHH
T ss_pred hHccchhhhheeECCCCCCCccChhhhh-------ccccEEECCCCcCCCCChhH-hCCcCEEEecCCCcccccccHHHH
Confidence 9999999999999999999965555542 57889999999999986654 457889999999999999987664
Q ss_pred C
Q 002289 380 G 380 (941)
Q Consensus 380 ~ 380 (941)
.
T Consensus 570 ~ 570 (844)
T 3j0a_A 570 N 570 (844)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=317.96 Aligned_cols=295 Identities=19% Similarity=0.196 Sum_probs=224.0
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCC--CCCccCCc--cccceecccCccccCCCCcccCCcCccc
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGS--IPKEIGNI--KSLELLLLNGNELTGSLPEELGYLPKLD 157 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 157 (941)
.+++.|++++|.+++..+..|..+++|++|+|++|.+.+. .+..|..+ ++|+.|+|++|++++..|..|.++++|+
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 408 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCC
Confidence 4556666666666665555566666666666666654321 12223322 4667777777777777788888888899
Q ss_pred eeecccccccccCC-cccccccccceEecccccccccCchhccCCCccceeeccCCcCC--CCCCccCCCCCCCCEEecc
Q 002289 158 RIQIDQNYISGSLP-KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLD 234 (941)
Q Consensus 158 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls 234 (941)
+|+|++|.+++.+| ..|.++++|++|+|++|++.+..+..|..+++|+.|++++|.++ +.+|..|.++++|+.|+|+
T Consensus 409 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls 488 (680)
T 1ziw_A 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488 (680)
T ss_dssp EEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECC
T ss_pred EEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECC
Confidence 99999998887665 67888888999999999888888888888889999999998886 5678889999999999999
Q ss_pred CCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCC-CCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeec
Q 002289 235 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 313 (941)
Q Consensus 235 ~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 313 (941)
+|+|++ ..+..|.++++|++|+|++|++++..+.. ...+...+....+|++|+|++|+|+...+..|.++++|+.|+|
T Consensus 489 ~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 567 (680)
T 1ziw_A 489 NNNIAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567 (680)
T ss_dssp SSCCCC-CCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCCc-CChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeEC
Confidence 999987 56778899999999999999998653321 0111112334467899999999999666678999999999999
Q ss_pred ccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC---CCCCCcEEEecCCCCccCCCc-ccccCCC
Q 002289 314 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLNTNA-EQFCGSH 382 (941)
Q Consensus 314 s~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~---~~~~~~~l~l~~Np~~c~c~~-~~~~~~~ 382 (941)
++|+|++..+..+.. .++|+.|+|++|+|+.++... .++.+..|++++|||.|+|+. .+|-...
T Consensus 568 s~N~l~~l~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~ 635 (680)
T 1ziw_A 568 GLNNLNTLPASVFNN-----QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635 (680)
T ss_dssp CSSCCCCCCTTTTTT-----CTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCS
T ss_pred CCCCCCcCCHhHhCC-----CCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHHH
Confidence 999999544444444 356779999999999997654 468899999999999999996 7776544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-30 Score=284.37 Aligned_cols=272 Identities=22% Similarity=0.298 Sum_probs=149.9
Q ss_pred CCCCCCCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecc
Q 002289 62 PCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137 (941)
Q Consensus 62 ~c~~~w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 137 (941)
.|.|.|+.+.|...... ....+++.|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 28 ~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 28 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp TCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 45566777777543221 12235566666666666555455666666666666666666555666666666666666
Q ss_pred cCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccc--cCchhccCCCccceeeccCCcCC
Q 002289 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG--QIPPELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 138 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~ 215 (941)
++|+++ .+|..+. ++|++|++++|.+++..+..|.++++|++|+|++|++.. ..+..|..+++|++|++++|+++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 666665 3444333 556666666666665555556666666666666666642 44555566666666666666665
Q ss_pred CCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCC
Q 002289 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT 295 (941)
Q Consensus 216 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~ 295 (941)
. +|..+. ++|++|+|++|++++ ..|..|..+++|++|+|++|++++..+. .+....+|++|+|++|+|+
T Consensus 185 ~-l~~~~~--~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-------~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 185 T-IPQGLP--PSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNG-------SLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp S-CCSSCC--TTCSEEECTTSCCCE-ECTGGGTTCTTCCEEECCSSCCCEECTT-------TGGGSTTCCEEECCSSCCS
T ss_pred c-CCcccc--ccCCEEECCCCcCCc-cCHHHhcCCCCCCEEECCCCcCceeChh-------hccCCCCCCEEECCCCcCc
Confidence 3 343332 566666666666655 3455566666666666666666544332 0111234466666666665
Q ss_pred CCcchhhcCCcccceeecccccCccCCCcccccccc-cCccccceEEccCCCCC
Q 002289 296 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLT 348 (941)
Q Consensus 296 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-l~~~~L~~L~Ls~N~l~ 348 (941)
.+|..+..+++|+.|+|++|+|++..+..|..... .....++.|++++|.++
T Consensus 254 -~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp -SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred -cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence 55555566666666666666665433333332211 11234455555555554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=299.92 Aligned_cols=277 Identities=18% Similarity=0.177 Sum_probs=180.3
Q ss_pred CCCCCCCceEecCC--C---CC-CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcccccee
Q 002289 62 PCTSNWTGVLCFNT--T---MD-DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELL 135 (941)
Q Consensus 62 ~c~~~w~gv~C~~~--~---~~-~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 135 (941)
.|.|.|.|+ |+.. . ++ ....++++|++++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 455679887 6432 1 11 223467777777777776555577777777777777777776666777777777777
Q ss_pred cccCccccCCCCcccCCcCccceeecccccccccCC-cccccccccceEecccc-cccccCchhccCCCccceeeccCCc
Q 002289 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHMNNN-SISGQIPPELSRLPSLVHMLLDNNN 213 (941)
Q Consensus 136 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~ 213 (941)
+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++| .+++..+..|.++++|++|++++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 777777775444457777777777777777774443 46777777777777777 3665556667777777777777777
Q ss_pred CCCCCCccCCCCCCCCEEeccCCcCCCCCcch-hccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCC
Q 002289 214 LTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNN 292 (941)
Q Consensus 214 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N 292 (941)
+++..|..+.++++|++|+|++|+++. +|. .+..+++|+.|+|++|++++..+. .+... .....++.++|++|
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~~--~~~~~~~~~~~L~~L~L~~n~l~~~~~~--~l~~~--~~~~~l~~l~L~~~ 259 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHIL--LLEIFVDVTSSVECLELRDTDLDTFHFS--ELSTG--ETNSLIKKFTFRNV 259 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCSTT--HHHHHHHHTTTEEEEEEESCBCTTCCCC----------CCCCCCEEEEESC
T ss_pred cCccCHHHHhccccCCeecCCCCcccc--chhhhhhhcccccEEECCCCcccccccc--ccccc--cccchhhccccccc
Confidence 777777777777777777777777753 333 344577777777777777754332 11110 01123455555555
Q ss_pred cCCC----CcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecC
Q 002289 293 KLTG----TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRG 366 (941)
Q Consensus 293 ~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~ 366 (941)
.+++ .+|..+..+++|+.|+|++|+|+ .++... .++.+++|+|++
T Consensus 260 ~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-----------------------------~i~~~~~~~l~~L~~L~L~~ 310 (353)
T 2z80_A 260 KITDESLFQVMKLLNQISGLLELEFSRNQLK-----------------------------SVPDGIFDRLTSLQKIWLHT 310 (353)
T ss_dssp BCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-----------------------------CCCTTTTTTCTTCCEEECCS
T ss_pred cccCcchhhhHHHHhcccCCCEEECCCCCCC-----------------------------ccCHHHHhcCCCCCEEEeeC
Confidence 5554 24555555555555555555554 444332 456778899999
Q ss_pred CCCccCCC
Q 002289 367 NPFCLNTN 374 (941)
Q Consensus 367 Np~~c~c~ 374 (941)
|||.|+|+
T Consensus 311 N~~~~~~~ 318 (353)
T 2z80_A 311 NPWDCSCP 318 (353)
T ss_dssp SCBCCCHH
T ss_pred CCccCcCC
Confidence 99999996
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=288.49 Aligned_cols=264 Identities=17% Similarity=0.242 Sum_probs=198.2
Q ss_pred CCCCCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCc
Q 002289 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (941)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (941)
+.|.|.|++|.|.... ++ .+|..+ .++|++|+|++|+++...+..|.++++|++|+|++|
T Consensus 3 ~~C~C~~~~l~c~~~~-----------------l~-~ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n 62 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKG-----------------LT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62 (306)
T ss_dssp TTCEEETTEEECCSSC-----------------CS-SCCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCeeCCCEEEcCCCC-----------------cc-cCCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCC
Confidence 5688889999996542 33 234333 267888888888888555556788888888888888
Q ss_pred cccCC--CCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCc-hhccCCCccceeeccCCcCCCC
Q 002289 141 ELTGS--LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGY 217 (941)
Q Consensus 141 ~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ 217 (941)
+++.. .+..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|++++.
T Consensus 63 ~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 141 (306)
T 2z66_A 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 141 (306)
T ss_dssp CCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEEC
T ss_pred ccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCcc
Confidence 88732 3566777888888888888888 466678888888888888888886554 5778888888888888888888
Q ss_pred CCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCC-CCCCCcccccccCCcCEEEccCCcCCC
Q 002289 218 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTG 296 (941)
Q Consensus 218 ~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~ 296 (941)
.+..+.++++|++|+|++|.+++...|..+..+++|++|+|++|++++..+. +.. ..+|++|+|++|+|++
T Consensus 142 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~--------l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS--------LSSLQVLNMSHNNFFS 213 (306)
T ss_dssp STTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT--------CTTCCEEECTTSCCSB
T ss_pred chhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcC--------CCCCCEEECCCCccCc
Confidence 8888888888888888888887544677888888888888888888765443 222 2345777777777777
Q ss_pred CcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCccCCCcc
Q 002289 297 TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE 376 (941)
Q Consensus 297 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~~ 376 (941)
..+..|..+++|+.|+|++|++++..|..+..+. +.+..|+|++|||.|+|.+.
T Consensus 214 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~--------------------------~~L~~L~L~~N~~~~~c~~~ 267 (306)
T 2z66_A 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP--------------------------SSLAFLNLTQNDFACTCEHQ 267 (306)
T ss_dssp CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCC--------------------------TTCCEEECTTCCEECSGGGH
T ss_pred cChhhccCcccCCEeECCCCCCcccCHHHHHhhh--------------------------ccCCEEEccCCCeecccChH
Confidence 7777777777788888887777766666553321 25678899999999999876
Q ss_pred ccc
Q 002289 377 QFC 379 (941)
Q Consensus 377 ~~~ 379 (941)
.|-
T Consensus 268 ~~~ 270 (306)
T 2z66_A 268 SFL 270 (306)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=285.80 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=113.2
Q ss_pred CCCCCCCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecc
Q 002289 62 PCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137 (941)
Q Consensus 62 ~c~~~w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 137 (941)
.|.|.|+.+.|....+. ....+++.|++++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 30 ~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 30 GCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp SCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred CCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 34455666666433211 11234455555555555444444555555555555555555444445555555555555
Q ss_pred cCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEeccccccc--ccCchhccCCCccceeeccCCcCC
Q 002289 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 138 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~ 215 (941)
++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|+.|++++|+++ +..+..|..+ +|++|++++|+++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 555554 3333332 44555555555555444444555555555555555553 2334444444 5555555555554
Q ss_pred CCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCC
Q 002289 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT 295 (941)
Q Consensus 216 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~ 295 (941)
+ +|..+. ++|+.|+|++|++++ ..+..|..+++|+.|+|++|++++..+. .+....+|+.|+|++|+|+
T Consensus 186 ~-l~~~~~--~~L~~L~l~~n~i~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 186 G-IPKDLP--ETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENG-------SLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp S-CCSSSC--SSCSCCBCCSSCCCC-CCTTSSTTCTTCSCCBCCSSCCCCCCTT-------GGGGCTTCCEEECCSSCCC
T ss_pred c-cCcccc--CCCCEEECCCCcCCc-cCHHHhcCCCCCCEEECCCCcCCcCChh-------HhhCCCCCCEEECCCCcCe
Confidence 3 333322 345555555555544 2334445555555555555554443321 0111223344555555544
Q ss_pred CCcchhhcCCcccceeecccccCcc
Q 002289 296 GTIPSNFSGLPRLQRLFIANNSLSG 320 (941)
Q Consensus 296 ~~~p~~~~~l~~L~~L~Ls~N~l~~ 320 (941)
.+|..+..+++|+.|++++|+|++
T Consensus 255 -~lp~~l~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 255 -RVPAGLPDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp -BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred -ecChhhhcCccCCEEECCCCCCCc
Confidence 444444445555555555555543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=318.31 Aligned_cols=286 Identities=20% Similarity=0.284 Sum_probs=248.8
Q ss_pred CcceeeEEEecCCCCCcc-----------------CCcccc--CCCCCCEEEcccCCCCCCCCCccCCccccceecccCc
Q 002289 80 GYLHLRELQLLNLNLSGN-----------------LSPEIG--RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (941)
Q Consensus 80 ~~~~l~~L~L~~~~l~~~-----------------~~~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (941)
...+++.|+|++|.++|. +|+.++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|
T Consensus 204 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 283 (636)
T 4eco_A 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283 (636)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred cccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence 356899999999999996 999999 9999999999999999999999999999999999999
Q ss_pred c-ccC-CCCcccCCc------CccceeecccccccccCCc--ccccccccceEecccccccccCchhccCCCccceeecc
Q 002289 141 E-LTG-SLPEELGYL------PKLDRIQIDQNYISGSLPK--SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (941)
Q Consensus 141 ~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 210 (941)
+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .|.++++|++|+|++|+++|.+| .|+.+++|++|+|+
T Consensus 284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~ 361 (636)
T 4eco_A 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361 (636)
T ss_dssp TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECC
T ss_pred CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECC
Confidence 9 998 899988887 99999999999999 8888 99999999999999999999999 89999999999999
Q ss_pred CCcCCCCCCccCCCCCC-CCEEeccCCcCCCCCcchhccCCC--CCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEE
Q 002289 211 NNNLTGYLPPELSELPK-LLILQLDNNNFEGTTIPASYSNMS--KLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTI 287 (941)
Q Consensus 211 ~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L 287 (941)
+|+++ .+|..+.++++ |++|+|++|+++ .+|..+..++ +|++|+|++|++++.+|....-.........+|++|
T Consensus 362 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~--~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L 438 (636)
T 4eco_A 362 YNQIT-EIPANFCGFTEQVENLSFAHNKLK--YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438 (636)
T ss_dssp SSEEE-ECCTTSEEECTTCCEEECCSSCCS--SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEE
T ss_pred CCccc-cccHhhhhhcccCcEEEccCCcCc--ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEE
Confidence 99999 88999999999 999999999998 4788887765 999999999999998775211112222344578999
Q ss_pred EccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccc---cCccccceEEccCCCCCCCCCCC---CCCCCcE
Q 002289 288 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT---LNATETFILDFQNNNLTNISGSF---NIPPNVT 361 (941)
Q Consensus 288 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---l~~~~L~~L~Ls~N~l~~~~~~~---~~~~~~~ 361 (941)
+|++|+|+...+..+..+++|+.|+|++|+|+ .+|..++.... -+.++|+.|+|++|+|+.++..+ .++.++.
T Consensus 439 ~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~ 517 (636)
T 4eco_A 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVG 517 (636)
T ss_dssp ECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCCBCCGGGSTTTCTTCCE
T ss_pred ECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCCccChhhhhccCCCcCE
Confidence 99999999666666778999999999999999 78877654321 01237889999999999998766 6788999
Q ss_pred EEecCCCCcc
Q 002289 362 VRLRGNPFCL 371 (941)
Q Consensus 362 l~l~~Np~~c 371 (941)
|+|++|.+..
T Consensus 518 L~Ls~N~l~~ 527 (636)
T 4eco_A 518 IDLSYNSFSK 527 (636)
T ss_dssp EECCSSCCSS
T ss_pred EECCCCCCCC
Confidence 9999998764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=298.38 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=175.1
Q ss_pred eeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
...++..+.+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 346777777777 3555443 6788888888888877777888888888888888888877777777788888888888
Q ss_pred ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccC-CcCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN-NNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|+|++
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-- 210 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-- 210 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS--
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc--
Confidence 877766666677777777777777777755555666677777777766 33333333345566666666666666553
Q ss_pred cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCC
Q 002289 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 322 (941)
+| .+..++ +|+.|+|++|+|++..|..|.++++|+.|+|++|++++..
T Consensus 211 ~~-~~~~l~-------------------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 258 (452)
T 3zyi_A 211 MP-NLTPLV-------------------------------GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258 (452)
T ss_dssp CC-CCTTCT-------------------------------TCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEEC
T ss_pred cc-cccccc-------------------------------cccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceEC
Confidence 12 233333 3466666666666666777777777777777777777666
Q ss_pred CcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCccCCCccccc
Q 002289 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFC 379 (941)
Q Consensus 323 p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~c~c~~~~~~ 379 (941)
|..+..+ ++|+.|+|++|+|+.++... .++.++.|+|++|||.|||++.++-
T Consensus 259 ~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~l~ 312 (452)
T 3zyi_A 259 RNAFDGL-----ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLA 312 (452)
T ss_dssp TTTTTTC-----TTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHHHH
T ss_pred HHHhcCC-----CCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchHHH
Confidence 6665443 34557777777777776544 5678899999999999999987653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=296.90 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=170.2
Q ss_pred eeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
...++..+.+++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 346778887777 4565553 6778888888888777777778888888888888887766667777777777777777
Q ss_pred ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCC-cCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN-NLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++| .+....+..|.++++|++|+|++|+|+.
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-- 199 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-- 199 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS--
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc--
Confidence 7777666666777777777777777777655556666677777777663 3333333356666666666666666653
Q ss_pred cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCC
Q 002289 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 322 (941)
+| .+..+++| +.|+|++|+|++..|..|.++++|+.|+|++|+|++..
T Consensus 200 ~~-~~~~l~~L-------------------------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 247 (440)
T 3zyj_A 200 IP-NLTPLIKL-------------------------------DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE 247 (440)
T ss_dssp CC-CCTTCSSC-------------------------------CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred cc-ccCCCccc-------------------------------CEEECCCCccCccChhhhccCccCCEEECCCCceeEEC
Confidence 22 23444444 55555555555555666666666666666666666555
Q ss_pred CcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCccCCCccccc
Q 002289 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFC 379 (941)
Q Consensus 323 p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~c~c~~~~~~ 379 (941)
|..|..+ ++|+.|+|++|+|+.++... .++.++.|+|++|||.|||.+.++-
T Consensus 248 ~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~ 301 (440)
T 3zyj_A 248 RNAFDNL-----QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLS 301 (440)
T ss_dssp TTSSTTC-----TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHH
T ss_pred hhhhcCC-----CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHH
Confidence 5555433 34456666666666665443 5677889999999999999987764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=308.47 Aligned_cols=91 Identities=16% Similarity=0.320 Sum_probs=64.0
Q ss_pred CcCEEEccCCcCC-CCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCC
Q 002289 283 NITTIKLSNNKLT-GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPN 359 (941)
Q Consensus 283 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~ 359 (941)
+|++|+|++|.+. +.+|..|..+++|+.|+|++|++++..|..+.. .++|+.|+|++|+|+.++... .++.+
T Consensus 446 ~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L~l~~n~l~~~~~~~~~~l~~L 520 (570)
T 2z63_A 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS-----LSSLQVLNMASNQLKSVPDGIFDRLTSL 520 (570)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT-----CTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred cCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhc-----ccCCCEEeCCCCcCCCCCHHHhhcccCC
Confidence 4555555555554 345555666666666666666666555555544 346779999999999987653 67889
Q ss_pred cEEEecCCCCccCCCcccc
Q 002289 360 VTVRLRGNPFCLNTNAEQF 378 (941)
Q Consensus 360 ~~l~l~~Np~~c~c~~~~~ 378 (941)
+.|++++|||.|+|+...+
T Consensus 521 ~~L~l~~N~~~~~~~~~~~ 539 (570)
T 2z63_A 521 QKIWLHTNPWDCSCPRIDY 539 (570)
T ss_dssp CEEECCSSCBCCCTTTTHH
T ss_pred cEEEecCCcccCCCcchHH
Confidence 9999999999999986543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=318.74 Aligned_cols=283 Identities=18% Similarity=0.257 Sum_probs=245.5
Q ss_pred CcceeeEEEecCCCCCc-----------------cCCcccc--CCCCCCEEEcccCCCCCCCCCccCCccccceecccCc
Q 002289 80 GYLHLRELQLLNLNLSG-----------------NLSPEIG--RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (941)
Q Consensus 80 ~~~~l~~L~L~~~~l~~-----------------~~~~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (941)
.+.+++.|+|++|.++| .+|+.++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|
T Consensus 446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 35689999999999999 4899988 9999999999999999999999999999999999999
Q ss_pred c-ccC-CCCcccCCcC-------ccceeecccccccccCCc--ccccccccceEecccccccccCchhccCCCccceeec
Q 002289 141 E-LTG-SLPEELGYLP-------KLDRIQIDQNYISGSLPK--SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 209 (941)
Q Consensus 141 ~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 209 (941)
+ +++ .+|..++.++ +|++|+|++|+++ .+|. .|.++++|+.|+|++|+++ .+| .|+.+++|+.|+|
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~L 602 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKL 602 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEEC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEEC
Confidence 8 998 8888776665 9999999999999 8888 9999999999999999999 888 8999999999999
Q ss_pred cCCcCCCCCCccCCCCCC-CCEEeccCCcCCCCCcchhccCCCC--CcEEEccCCCCcCCCCCCCCCCcccccccCCcCE
Q 002289 210 DNNNLTGYLPPELSELPK-LLILQLDNNNFEGTTIPASYSNMSK--LLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITT 286 (941)
Q Consensus 210 ~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~ 286 (941)
++|+++ .+|..+.++++ |+.|+|++|+|+ .+|..+..++. |+.|+|++|+|++.+|.+. ..+..+...+|+.
T Consensus 603 s~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~--~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~--~~l~~~~~~~L~~ 677 (876)
T 4ecn_A 603 DYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK--YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS--CSMDDYKGINAST 677 (876)
T ss_dssp CSSCCS-CCCTTSCEECTTCCEEECCSSCCC--SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCS--SCTTTCCCCCEEE
T ss_pred cCCccc-cchHHHhhccccCCEEECcCCCCC--cCchhhhccccCCCCEEECcCCcCCCccccch--hhhccccCCCcCE
Confidence 999999 88999999999 999999999998 47888887765 9999999999999877543 2333344557899
Q ss_pred EEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccc---cCccccceEEccCCCCCCCCCCC---CCCCCc
Q 002289 287 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT---LNATETFILDFQNNNLTNISGSF---NIPPNV 360 (941)
Q Consensus 287 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---l~~~~L~~L~Ls~N~l~~~~~~~---~~~~~~ 360 (941)
|+|++|+|+...+..+..+++|+.|+|++|+|+ .+|..++.... -+.++|+.|+|++|+|+.+|..+ .++.++
T Consensus 678 L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~ 756 (876)
T 4ecn_A 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLS 756 (876)
T ss_dssp EECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCC
T ss_pred EEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcC
Confidence 999999999544444568999999999999999 88887765331 12237889999999999998766 578899
Q ss_pred EEEecCCCCcc
Q 002289 361 TVRLRGNPFCL 371 (941)
Q Consensus 361 ~l~l~~Np~~c 371 (941)
.|+|++|.+..
T Consensus 757 ~L~Ls~N~L~~ 767 (876)
T 4ecn_A 757 NMDVSYNCFSS 767 (876)
T ss_dssp EEECCSSCCSS
T ss_pred EEEeCCCCCCc
Confidence 99999998764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-30 Score=307.40 Aligned_cols=181 Identities=20% Similarity=0.137 Sum_probs=155.9
Q ss_pred CCCCCCC--CCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccc
Q 002289 60 GDPCTSN--WTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLE 133 (941)
Q Consensus 60 ~~~c~~~--w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 133 (941)
...|.|. +..|.|...... +...+++.|+|++|.+++..|..|+++++|++|+|++|++.+..|..|+++++|+
T Consensus 5 ~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 84 (606)
T 3t6q_A 5 DQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84 (606)
T ss_dssp -CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCC
T ss_pred cCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccC
Confidence 3446553 566888764432 2345799999999999998888999999999999999999988899999999999
Q ss_pred eecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCc
Q 002289 134 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 213 (941)
Q Consensus 134 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 213 (941)
+|+|++|++++..|..|+++++|++|+|++|.+++..+..|.++++|++|+|++|++++.....+..+++|++|++++|+
T Consensus 85 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 164 (606)
T 3t6q_A 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164 (606)
T ss_dssp EEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred eeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence 99999999998899999999999999999999998878889999999999999999997554555569999999999999
Q ss_pred CCCCCCccCCCCCCCC--EEeccCCcCCC
Q 002289 214 LTGYLPPELSELPKLL--ILQLDNNNFEG 240 (941)
Q Consensus 214 l~~~~p~~~~~l~~L~--~L~Ls~N~l~~ 240 (941)
+++..+..|+.+++|+ .|++++|.+++
T Consensus 165 l~~~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp CCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred ccccChhhhhhhcccceeEEecCCCccCc
Confidence 9988788888888888 78888888775
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=311.02 Aligned_cols=302 Identities=22% Similarity=0.260 Sum_probs=242.0
Q ss_pred CCCCCCCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecc
Q 002289 62 PCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLL 137 (941)
Q Consensus 62 ~c~~~w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 137 (941)
+|.|.++.|.|....+. +...+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 1 ~C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 80 (680)
T 1ziw_A 1 KCTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNL 80 (680)
T ss_dssp ---CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEEC
T ss_pred CceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEEC
Confidence 37677778888764332 23468999999999999877778999999999999999999999999999999999999
Q ss_pred cCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCC
Q 002289 138 NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY 217 (941)
Q Consensus 138 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 217 (941)
++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..++++++|++|++++|++++.
T Consensus 81 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 99999966666899999999999999999988889999999999999999999999899999999999999999999987
Q ss_pred CCccCC--CCCCCCEEeccCCcCCCCCcchhccCC---------------------------CCCcEEEccCCCCcCCCC
Q 002289 218 LPPELS--ELPKLLILQLDNNNFEGTTIPASYSNM---------------------------SKLLKLSLRNCSLQGPMP 268 (941)
Q Consensus 218 ~p~~~~--~l~~L~~L~Ls~N~l~~~~~p~~~~~l---------------------------~~L~~L~Ls~N~l~~~~~ 268 (941)
.+..+. .+++|+.|+|++|++++ ..|..|..+ ++|+.|++++|.+++..+
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~ 239 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCC-BCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECT
T ss_pred CHHHhhccccccccEEECCCCcccc-cChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccCh
Confidence 776654 56899999999999987 566666654 456677777777776554
Q ss_pred CCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccC---------------
Q 002289 269 DLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN--------------- 333 (941)
Q Consensus 269 ~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~--------------- 333 (941)
.. +..+...+|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+..|.
T Consensus 240 ~~-----~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~ 314 (680)
T 1ziw_A 240 TT-----FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314 (680)
T ss_dssp TT-----TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC----
T ss_pred hH-----hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccc
Confidence 31 1112224589999999999988888999999999999999999988887765543321
Q ss_pred -------------ccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCC
Q 002289 334 -------------ATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPF 369 (941)
Q Consensus 334 -------------~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~ 369 (941)
.++|+.|+|++|+++.++... .++.+++|++++|.+
T Consensus 315 ~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~ 365 (680)
T 1ziw_A 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365 (680)
T ss_dssp --CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBS
T ss_pred ccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCch
Confidence 245666777777776664432 456667777776653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=274.22 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=231.4
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
+++.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 6889999999988 4666553 689999999999998888899999999999999999998889999999999999999
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCC--CCCccCCCCCCCCEEeccCCcCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG--YLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
+|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|+++. ..+..+.++++|++|++++|.++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 99999 5565554 799999999999998888889999999999999999964 778889999999999999999985
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCcc
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 320 (941)
+|..+. ++|++|+|++|++++..+. .+....+|+.|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus 186 --l~~~~~--~~L~~L~l~~n~l~~~~~~-------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~- 253 (330)
T 1xku_A 186 --IPQGLP--PSLTELHLDGNKITKVDAA-------SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253 (330)
T ss_dssp --CCSSCC--TTCSEEECTTSCCCEECTG-------GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-
T ss_pred --CCcccc--ccCCEEECCCCcCCccCHH-------HhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-
Confidence 565554 8999999999999976553 1223356799999999999988889999999999999999999
Q ss_pred CCCcccccccccCccccceEEccCCCCCCCCCCCC--------CCCCcEEEecCCCCccC
Q 002289 321 SIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN--------IPPNVTVRLRGNPFCLN 372 (941)
Q Consensus 321 ~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~--------~~~~~~l~l~~Np~~c~ 372 (941)
.+|..+..+ ++|+.|+|++|+|+.++.... .+.+..+++.+||+.+.
T Consensus 254 ~lp~~l~~l-----~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~ 308 (330)
T 1xku_A 254 KVPGGLADH-----KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308 (330)
T ss_dssp SCCTTTTTC-----SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred cCChhhccC-----CCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccc
Confidence 888887654 567799999999999975442 35577999999998764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=291.64 Aligned_cols=287 Identities=19% Similarity=0.194 Sum_probs=247.4
Q ss_pred CceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCC
Q 002289 68 TGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147 (941)
Q Consensus 68 ~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 147 (941)
.+-.|... .+.++..+++++ .+|..+ .++|+.|+|++|+|++..|..|.++++|++|+|++|.+++..|
T Consensus 5 ~~C~C~~~--------~~~v~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 73 (477)
T 2id5_A 5 PRCECSAQ--------DRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEP 73 (477)
T ss_dssp TTCEEETT--------TTEEECCSCCCS-SCCSCC--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECT
T ss_pred CCCeECCC--------CCEEEeCCCCcC-cCCCCC--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeCh
Confidence 46667532 246888888888 466655 3689999999999998889999999999999999999998889
Q ss_pred cccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCC
Q 002289 148 EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPK 227 (941)
Q Consensus 148 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 227 (941)
..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++
T Consensus 74 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 153 (477)
T 2id5_A 74 GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153 (477)
T ss_dssp TTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTT
T ss_pred hhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCC
Confidence 99999999999999999999877788999999999999999999999999999999999999999999998999999999
Q ss_pred CCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCC-CCCCCccccccc----------------CCcCEEEcc
Q 002289 228 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLS----------------LNITTIKLS 290 (941)
Q Consensus 228 L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~l~~----------------~~L~~L~Ls 290 (941)
|+.|+|++|++++ ..+..|.++++|+.|+|++|++++..+. +..++++..+.. .+|++|+|+
T Consensus 154 L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~ 232 (477)
T 2id5_A 154 LEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232 (477)
T ss_dssp CCEEEEESCCCSS-CCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEE
T ss_pred CCEEECCCCcCcc-cChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECc
Confidence 9999999999997 5667899999999999999999986653 445444443322 278999999
Q ss_pred CCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCC-CC-CCCCCcEEEecCCC
Q 002289 291 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG-SF-NIPPNVTVRLRGNP 368 (941)
Q Consensus 291 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~-~~-~~~~~~~l~l~~Np 368 (941)
+|+|++..+..|..+++|+.|+|++|+|++..+..+..+ ++|+.|+|++|+|+.+.. .+ .++.++.|+|++|.
T Consensus 233 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 307 (477)
T 2id5_A 233 HCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL-----LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307 (477)
T ss_dssp SSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTC-----TTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSC
T ss_pred CCcccccCHHHhcCccccCeeECCCCcCCccChhhcccc-----ccCCEEECCCCccceECHHHhcCcccCCEEECCCCc
Confidence 999997767889999999999999999997777666554 456799999999999854 33 67889999999998
Q ss_pred Ccc
Q 002289 369 FCL 371 (941)
Q Consensus 369 ~~c 371 (941)
+..
T Consensus 308 l~~ 310 (477)
T 2id5_A 308 LTT 310 (477)
T ss_dssp CSC
T ss_pred Cce
Confidence 753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=312.09 Aligned_cols=286 Identities=19% Similarity=0.211 Sum_probs=213.7
Q ss_pred CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCC-CCccCCccccceecccCccccCCCCcccCCcCccce
Q 002289 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158 (941)
Q Consensus 80 ~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 158 (941)
...+++.|+|++|.+++..+..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..|.++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 4568999999999999888889999999999999999766666 788999999999999999999888999999999999
Q ss_pred eecccccccccCCcc--cccccccceEecccccccccCc-hhccCCCccceeeccCCcCCCCCCccCCCC--CCCCEEec
Q 002289 159 IQIDQNYISGSLPKS--FANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSEL--PKLLILQL 233 (941)
Q Consensus 159 L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L 233 (941)
|+|++|.+++.+|.. |.++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..+..+..+ ++|+.|+|
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 999999999866655 8999999999999999987655 578999999999999999998888777766 67777777
Q ss_pred cCCcCCCCCcchhccCCCC------CcEEEccCCCCcCCCCC-CCC----------------------------------
Q 002289 234 DNNNFEGTTIPASYSNMSK------LLKLSLRNCSLQGPMPD-LSR---------------------------------- 272 (941)
Q Consensus 234 s~N~l~~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~~~-~~~---------------------------------- 272 (941)
++|.+.+ ..|..+..+.+ |+.|+|++|.+++..+. +..
T Consensus 182 ~~n~l~~-~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f 260 (844)
T 3j0a_A 182 AANSLYS-RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260 (844)
T ss_dssp CCSBSCC-CCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTT
T ss_pred CCCcccc-ccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhh
Confidence 7777766 45555554444 67777776665543332 000
Q ss_pred -------CC-------------cccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCccccccccc
Q 002289 273 -------IP-------------NLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 332 (941)
Q Consensus 273 -------l~-------------~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 332 (941)
+. ...+....+|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..+..+
T Consensus 261 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--- 337 (844)
T 3j0a_A 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL--- 337 (844)
T ss_dssp TTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSC---
T ss_pred hccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCC---
Confidence 00 0011123456666777777766666667777777777777777765556665543
Q ss_pred CccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCcc
Q 002289 333 NATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCL 371 (941)
Q Consensus 333 ~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~c 371 (941)
++|+.|+|++|+|+.++... .++.++.|+|++|.+..
T Consensus 338 --~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 338 --PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp --TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred --CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 34567777777777775443 46777777777777653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=282.44 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=232.3
Q ss_pred CCCCEEEcccCCCCC--CCCCccCCccccceecccC-ccccCCCCcccCCcCccceeecccccccccCCcccccccccce
Q 002289 106 SYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (941)
.+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999999 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCC-CCCEEeccCCcCCCCCcchhccCCCCCcEEEccCC
Q 002289 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP-KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (941)
Q Consensus 183 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (941)
|+|++|++++.+|..|..+++|++|+|++|++++.+|..+..++ +|++|+|++|++++ .+|..+..++ |++|+|++|
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~-~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-KIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE-ECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeec-cCChHHhCCc-ccEEECcCC
Confidence 99999999999999999999999999999999999999999998 99999999999998 6899999997 999999999
Q ss_pred CCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEE
Q 002289 262 SLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 341 (941)
Q Consensus 262 ~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~ 341 (941)
++++.++.. +....+|+.|+|++|++++.+|. +..+++|++|+|++|+|++.+|..+..+ ++|+.|+
T Consensus 208 ~l~~~~~~~-------~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-----~~L~~L~ 274 (313)
T 1ogq_A 208 MLEGDASVL-------FGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQL-----KFLHSLN 274 (313)
T ss_dssp EEEECCGGG-------CCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGC-----TTCCEEE
T ss_pred cccCcCCHH-------HhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcC-----cCCCEEE
Confidence 999876641 22335679999999999987776 8899999999999999999999998765 4567999
Q ss_pred ccCCCCCC-CCCCCCCCCCcEEEecCCCCccCCCc
Q 002289 342 FQNNNLTN-ISGSFNIPPNVTVRLRGNPFCLNTNA 375 (941)
Q Consensus 342 Ls~N~l~~-~~~~~~~~~~~~l~l~~Np~~c~c~~ 375 (941)
|++|+|++ +|....++.+..+++.+||+.|+.++
T Consensus 275 Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 275 VSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp CCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred CcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence 99999994 56555778889999999999887544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=273.43 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=230.5
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
+++.+++++++++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 6889999999998 5676663 799999999999998888899999999999999999998889999999999999999
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCC--CCCCccCCCCCCCCEEeccCCcCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
+|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++ +..+..+..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 99999 5565554 89999999999999777778999999999999999996 4778888888 99999999999986
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCC-CCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCc
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
+|..+. ++|++|+|++|++++..+. +.. ..+|++|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus 187 --l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~--------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 187 --IPKDLP--ETLNELHLDHNKIQAIELEDLLR--------YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp --CCSSSC--SSCSCCBCCSSCCCCCCTTSSTT--------CTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred --cCcccc--CCCCEEECCCCcCCccCHHHhcC--------CCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 565554 7999999999999977653 333 345699999999999999999999999999999999999
Q ss_pred cCCCcccccccccCccccceEEccCCCCCCCCCCCC--------CCCCcEEEecCCCCccC
Q 002289 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN--------IPPNVTVRLRGNPFCLN 372 (941)
Q Consensus 320 ~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~--------~~~~~~l~l~~Np~~c~ 372 (941)
.+|..+..+ ++|+.|+|++|+|+.++.... .+.+..|++.+||+.+.
T Consensus 255 -~lp~~l~~l-----~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 255 -RVPAGLPDL-----KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp -BCCTTGGGC-----TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred -ecChhhhcC-----ccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 889887654 456799999999999975441 35578999999999753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=297.06 Aligned_cols=127 Identities=19% Similarity=0.187 Sum_probs=108.3
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+++.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|+++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 57999999999999888789999999999999999999888999999999999999999999 67766 8999999999
Q ss_pred ccccccc-cCCcccccccccceEecccccccccCchhccCCCcc--ceeeccCCcC
Q 002289 162 DQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL--VHMLLDNNNL 214 (941)
Q Consensus 162 s~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l 214 (941)
++|.+++ .+|..|+++++|++|+|++|++++ ..+..+++| ++|++++|++
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccc
Confidence 9999997 478999999999999999998864 223333344 4444444444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=292.84 Aligned_cols=256 Identities=17% Similarity=0.199 Sum_probs=172.1
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCc--cCCccccceecccCccccCCCCcc-cCCcCccce
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKE--IGNIKSLELLLLNGNELTGSLPEE-LGYLPKLDR 158 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~ 158 (941)
.++++|+|++|.+++..|..|+++++|++|+|++|++++.+|.. |.++++|++|+|++|++++..|.. |.++++|++
T Consensus 79 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~ 158 (455)
T 3v47_A 79 SSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158 (455)
T ss_dssp TTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCE
T ss_pred ccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccE
Confidence 34555555555555444445555555555555555555433322 455555555555555555444443 455555555
Q ss_pred eecccccccccCCcccccc----------------------------------cccceEecccccccccCchhccC----
Q 002289 159 IQIDQNYISGSLPKSFANL----------------------------------NKTRHFHMNNNSISGQIPPELSR---- 200 (941)
Q Consensus 159 L~Ls~N~l~~~~p~~~~~l----------------------------------~~L~~L~L~~N~l~~~~p~~~~~---- 200 (941)
|+|++|.+++..+..+..+ ++|++|+|++|++++.+|..+..
T Consensus 159 L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 238 (455)
T 3v47_A 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238 (455)
T ss_dssp EECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTT
T ss_pred EeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccc
Confidence 5555555554444443332 34555555555444433332211
Q ss_pred -----------------------------------CCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcch
Q 002289 201 -----------------------------------LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 245 (941)
Q Consensus 201 -----------------------------------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~ 245 (941)
.++|++|++++|++++..|..|..+++|++|+|++|++++ ..|.
T Consensus 239 ~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~ 317 (455)
T 3v47_A 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK-IDDN 317 (455)
T ss_dssp CCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE-ECTT
T ss_pred cceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccc-cChh
Confidence 1467777777778887788899999999999999999997 6788
Q ss_pred hccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcc
Q 002289 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 325 (941)
Q Consensus 246 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 325 (941)
.|.++++|++|+|++|+|++.++. .+....+|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..
T Consensus 318 ~~~~l~~L~~L~Ls~N~l~~~~~~-------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 390 (455)
T 3v47_A 318 AFWGLTHLLKLNLSQNFLGSIDSR-------MFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGI 390 (455)
T ss_dssp TTTTCTTCCEEECCSSCCCEECGG-------GGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred HhcCcccCCEEECCCCccCCcChh-------HhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhH
Confidence 999999999999999999876553 1223456799999999999999999999999999999999999655555
Q ss_pred cccccccCccccceEEccCCCCCCC
Q 002289 326 IWQSRTLNATETFILDFQNNNLTNI 350 (941)
Q Consensus 326 ~~~l~~l~~~~L~~L~Ls~N~l~~~ 350 (941)
+..+ ++|+.|+|++|.++.-
T Consensus 391 ~~~l-----~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 391 FDRL-----TSLQKIWLHTNPWDCS 410 (455)
T ss_dssp TTTC-----TTCCEEECCSSCBCCC
T ss_pred hccC-----CcccEEEccCCCcccC
Confidence 5443 5677999999999864
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-28 Score=282.07 Aligned_cols=248 Identities=23% Similarity=0.269 Sum_probs=216.1
Q ss_pred CCCCC--CCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcccccee
Q 002289 62 PCTSN--WTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELL 135 (941)
Q Consensus 62 ~c~~~--w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 135 (941)
.|.|. |..|.|....+. ....+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|
T Consensus 38 ~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L 117 (440)
T 3zyj_A 38 VCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTL 117 (440)
T ss_dssp SSEECTTSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEE
T ss_pred CCEeCCCCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEE
Confidence 46554 678999775432 234679999999999999888999999999999999999998888999999999999
Q ss_pred cccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccc-cccccCchhccCCCccceeeccCCcC
Q 002289 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN-SISGQIPPELSRLPSLVHMLLDNNNL 214 (941)
Q Consensus 136 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l 214 (941)
+|++|++++..+..|..+++|++|+|++|.|++..+..|.++++|++|+|++| .+....+..|.++++|++|+|++|++
T Consensus 118 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 197 (440)
T 3zyj_A 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197 (440)
T ss_dssp ECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred ECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence 99999999777778999999999999999999888889999999999999995 45544455799999999999999999
Q ss_pred CCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcC
Q 002289 215 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKL 294 (941)
Q Consensus 215 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l 294 (941)
+ .+| .+..+++|+.|+|++|+|++ ..|..|.++++|+.|+|++|+|++..+. .+....+|+.|+|++|+|
T Consensus 198 ~-~~~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~-------~~~~l~~L~~L~L~~N~l 267 (440)
T 3zyj_A 198 R-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERN-------AFDNLQSLVEINLAHNNL 267 (440)
T ss_dssp S-SCC-CCTTCSSCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTT-------SSTTCTTCCEEECTTSCC
T ss_pred c-ccc-ccCCCcccCEEECCCCccCc-cChhhhccCccCCEEECCCCceeEEChh-------hhcCCCCCCEEECCCCCC
Confidence 9 455 58999999999999999997 6788999999999999999999876654 122335679999999999
Q ss_pred CCCcchhhcCCcccceeecccccCc
Q 002289 295 TGTIPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 295 ~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
++..+..|..+++|+.|+|++|.+.
T Consensus 268 ~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 268 TLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CccChhHhccccCCCEEEcCCCCcc
Confidence 9888888999999999999999886
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=282.97 Aligned_cols=249 Identities=21% Similarity=0.244 Sum_probs=216.4
Q ss_pred CCCCCC--CCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccce
Q 002289 61 DPCTSN--WTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134 (941)
Q Consensus 61 ~~c~~~--w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 134 (941)
..|.|. |..|.|....+. +...+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++
T Consensus 48 ~~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 127 (452)
T 3zyi_A 48 SVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNT 127 (452)
T ss_dssp TTSEECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCEECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCE
Confidence 456554 578999775432 23457999999999999988999999999999999999999888899999999999
Q ss_pred ecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEeccc-ccccccCchhccCCCccceeeccCCc
Q 002289 135 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN-NSISGQIPPELSRLPSLVHMLLDNNN 213 (941)
Q Consensus 135 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~ 213 (941)
|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|+.|+|++ |.+....+..|.++++|++|+|++|+
T Consensus 128 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 207 (452)
T 3zyi_A 128 LELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207 (452)
T ss_dssp EECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence 99999999987788899999999999999999988888999999999999999 45554445579999999999999999
Q ss_pred CCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCc
Q 002289 214 LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNK 293 (941)
Q Consensus 214 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~ 293 (941)
+++. | .+..+++|+.|+|++|+|++ ..|..|.++++|+.|+|++|+|++..+.. +....+|+.|+|++|+
T Consensus 208 l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~l~~L~~L~L~~N~ 277 (452)
T 3zyi_A 208 IKDM-P-NLTPLVGLEELEMSGNHFPE-IRPGSFHGLSSLKKLWVMNSQVSLIERNA-------FDGLASLVELNLAHNN 277 (452)
T ss_dssp CSSC-C-CCTTCTTCCEEECTTSCCSE-ECGGGGTTCTTCCEEECTTSCCCEECTTT-------TTTCTTCCEEECCSSC
T ss_pred cccc-c-cccccccccEEECcCCcCcc-cCcccccCccCCCEEEeCCCcCceECHHH-------hcCCCCCCEEECCCCc
Confidence 9954 4 58899999999999999998 67899999999999999999998766541 2223566999999999
Q ss_pred CCCCcchhhcCCcccceeecccccCc
Q 002289 294 LTGTIPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 294 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
|++..+..|..+++|+.|+|++|.+.
T Consensus 278 l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 278 LSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCccChHHhccccCCCEEEccCCCcC
Confidence 99888888889999999999999876
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=278.45 Aligned_cols=275 Identities=18% Similarity=0.200 Sum_probs=219.8
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
+.+++.|+|++|.+++..+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|.++++|++|+
T Consensus 68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 46799999999999987777899999999999999999988888899999999999999999955555678999999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCC-------------------------------------Cc
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL-------------------------------------PS 203 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-------------------------------------~~ 203 (941)
|++|.+++..+..|..+++|++|+|++|++++.....+..+ ++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 227 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 227 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSS
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeecccccccc
Confidence 99999998888889999999999999999886533333222 35
Q ss_pred cceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCC
Q 002289 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN 283 (941)
Q Consensus 204 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~ 283 (941)
|+.|++++|++++. ..+..+++|++|+|++|.+++ ..|..|..+++|++|+|++|++++....+.. ..+
T Consensus 228 L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--------l~~ 296 (390)
T 3o6n_A 228 LTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLVALNLYGQP--------IPT 296 (390)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCE-EESGGGTTCSSCCEEECCSSCCCEEECSSSC--------CTT
T ss_pred ccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCC-cChhHccccccCCEEECCCCcCcccCcccCC--------CCC
Confidence 66777777777643 578899999999999999998 6789999999999999999999875443322 346
Q ss_pred cCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEE
Q 002289 284 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 363 (941)
Q Consensus 284 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~ 363 (941)
|++|+|++|+++ .+|..+..+++|+.|+|++|+|+. +| +. ..++|+.|+|++|.++.-.....+.......
T Consensus 297 L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~-----~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~ 367 (390)
T 3o6n_A 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LS-----THHTLKNLTLSHNDWDCNSLRALFRNVARPA 367 (390)
T ss_dssp CCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CC-----TTCCCSEEECCSSCEEHHHHHHHTTTCCTTT
T ss_pred CCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eC--ch-----hhccCCEEEcCCCCccchhHHHHHHHHHhhc
Confidence 799999999999 567778999999999999999984 43 22 2457889999999997642111122223334
Q ss_pred ecCCCCccCCCc
Q 002289 364 LRGNPFCLNTNA 375 (941)
Q Consensus 364 l~~Np~~c~c~~ 375 (941)
+.+|+..|.+..
T Consensus 368 ~~~~~~~c~~~~ 379 (390)
T 3o6n_A 368 VDDADQHCKIDY 379 (390)
T ss_dssp BCCCCSCCCTTC
T ss_pred ccccCceecccc
Confidence 567888887643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-28 Score=267.21 Aligned_cols=229 Identities=19% Similarity=0.316 Sum_probs=207.9
Q ss_pred CCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceE
Q 002289 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (941)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (941)
...+++.|+|++|+++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..|.++++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 4688999999999999 88889999999999999999999 89999999999999999999999 789999999999999
Q ss_pred ecccccccccCchhccC---------CCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCc
Q 002289 184 HMNNNSISGQIPPELSR---------LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254 (941)
Q Consensus 184 ~L~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 254 (941)
+|++|++.+.+|..+.. +++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..+..+++|+
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~--l~~~l~~l~~L~ 232 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA--LGPAIHHLPKLE 232 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC--CCGGGGGCTTCC
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc--CchhhccCCCCC
Confidence 99999999999987764 999999999999999 889999999999999999999995 677899999999
Q ss_pred EEEccCCCCcCCCCC-CCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccC
Q 002289 255 KLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 333 (941)
Q Consensus 255 ~L~Ls~N~l~~~~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~ 333 (941)
+|+|++|++.+.+|. +.. ..+|++|+|++|.+.+.+|..+.++++|+.|+|++|++.+.+|..+..++.
T Consensus 233 ~L~Ls~n~~~~~~p~~~~~--------l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~-- 302 (328)
T 4fcg_A 233 ELDLRGCTALRNYPPIFGG--------RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA-- 302 (328)
T ss_dssp EEECTTCTTCCBCCCCTTC--------CCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCT--
T ss_pred EEECcCCcchhhhHHHhcC--------CCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccC--
Confidence 999999999988775 322 356799999999999999999999999999999999999999999987655
Q ss_pred ccccceEEccCCCCCCCC
Q 002289 334 ATETFILDFQNNNLTNIS 351 (941)
Q Consensus 334 ~~~L~~L~Ls~N~l~~~~ 351 (941)
|+.+++..|.+..++
T Consensus 303 ---L~~l~l~~~~~~~l~ 317 (328)
T 4fcg_A 303 ---NCIILVPPHLQAQLD 317 (328)
T ss_dssp ---TCEEECCGGGSCC--
T ss_pred ---ceEEeCCHHHHHHHh
Confidence 568899888877653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=282.76 Aligned_cols=127 Identities=17% Similarity=0.211 Sum_probs=114.8
Q ss_pred eeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
.+.++++++++++ +|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3789999999996 777664 8999999999999988889999999999999999999988899999999999999999
Q ss_pred ccccccCCcccccccccceEecccccccc-cCchhccCCCccceeeccCCcCCC
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTG 216 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~ 216 (941)
|+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 9999 56665 89999999999999997 356899999999999999998764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=290.90 Aligned_cols=249 Identities=20% Similarity=0.245 Sum_probs=213.4
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
+.+|+.|+|++|.+++..+..|+.+++|+.|+|++|.|++..|..|+++++|++|+|++|.+++..+..|+++++|++|+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 46899999999999988888999999999999999999998888999999999999999999976667789999999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCC-------------------------------------Cc
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL-------------------------------------PS 203 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-------------------------------------~~ 203 (941)
|++|.+++..|..|.++++|++|+|++|++++.....+..+ ++
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~ 233 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 233 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCC
Confidence 99999999999999999999999999999986544333322 24
Q ss_pred cceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCC
Q 002289 204 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN 283 (941)
Q Consensus 204 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~ 283 (941)
|+.|+|++|.+++ +..+..+++|+.|+|++|.|++ ..|..|..+++|+.|+|++|+|++.+..+.. +.+
T Consensus 234 L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--------l~~ 302 (597)
T 3oja_B 234 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLVALNLYGQP--------IPT 302 (597)
T ss_dssp CCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCE-EESGGGTTCSSCCEEECTTSCCCEEECSSSC--------CTT
T ss_pred CCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCC-CCHHHhcCccCCCEEECCCCCCCCCCccccc--------CCC
Confidence 6666777777765 3678999999999999999998 6889999999999999999999986544322 346
Q ss_pred cCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCC
Q 002289 284 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 349 (941)
Q Consensus 284 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~ 349 (941)
|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++. | +. ..+.|+.|+|++|.++.
T Consensus 303 L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~-----~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LS-----THHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CC-----TTCCCSEEECCSSCEEH
T ss_pred CcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hh-----hcCCCCEEEeeCCCCCC
Confidence 799999999999 6788899999999999999999854 3 22 23577899999999875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=259.78 Aligned_cols=232 Identities=19% Similarity=0.266 Sum_probs=151.7
Q ss_pred eEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccc
Q 002289 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (941)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (941)
+.++.++++++. +|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 567788877774 44433 467888888888887666677777788888888888777666777777777777777777
Q ss_pred c-ccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCc
Q 002289 165 Y-ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (941)
Q Consensus 165 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 243 (941)
. ++...|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++ ..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-EC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc-cC
Confidence 6 665556667777777777777777766656666666666666666666665555556666666666666666654 22
Q ss_pred chhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCC
Q 002289 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 323 (941)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 323 (941)
+..|..+++|+ +|+|++|++++..|..|..+++|+.|+|++|++++..+
T Consensus 170 ~~~~~~l~~L~-------------------------------~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 218 (285)
T 1ozn_A 170 ERAFRGLHSLD-------------------------------RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (285)
T ss_dssp TTTTTTCTTCC-------------------------------EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred HHHhcCccccC-------------------------------EEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCH
Confidence 33344444444 44444444444555666666666666666666664333
Q ss_pred cccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCccCCCcccc
Q 002289 324 SSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF 378 (941)
Q Consensus 324 ~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~~~~ 378 (941)
..+. .++.++.|+|++|||.|+|...++
T Consensus 219 ~~~~---------------------------~l~~L~~L~l~~N~~~c~~~~~~~ 246 (285)
T 1ozn_A 219 EALA---------------------------PLRALQYLRLNDNPWVCDCRARPL 246 (285)
T ss_dssp HHHT---------------------------TCTTCCEEECCSSCEECSGGGHHH
T ss_pred HHcc---------------------------cCcccCEEeccCCCccCCCCcHHH
Confidence 3332 234456777788888899887544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=261.96 Aligned_cols=259 Identities=17% Similarity=0.192 Sum_probs=217.7
Q ss_pred CCCCCCCC---ceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccc
Q 002289 61 DPCTSNWT---GVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLE 133 (941)
Q Consensus 61 ~~c~~~w~---gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 133 (941)
+.|.|... .|.|....+. ....++++|++++|++++..+..|..+++|++|+|++|.+++..|..|.++++|+
T Consensus 4 ~~C~C~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 83 (285)
T 1ozn_A 4 GACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83 (285)
T ss_dssp TTCEEECSSSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CCceECCCCCeEEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCC
Confidence 35666443 3778664432 2456899999999999988778899999999999999999988899999999999
Q ss_pred eecccCcc-ccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCC
Q 002289 134 LLLLNGNE-LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212 (941)
Q Consensus 134 ~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 212 (941)
+|+|++|. ++...|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 163 (285)
T 1ozn_A 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (285)
T ss_dssp EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence 99999998 88777899999999999999999999988999999999999999999999877778999999999999999
Q ss_pred cCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCC
Q 002289 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNN 292 (941)
Q Consensus 213 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N 292 (941)
++++..+..|.++++|+.|+|++|++++ ..|..|..+++|+.|+|++|+|++.++. .+....+|+.|+|++|
T Consensus 164 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~-------~~~~l~~L~~L~l~~N 235 (285)
T 1ozn_A 164 RISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTE-------ALAPLRALQYLRLNDN 235 (285)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCSCCCHH-------HHTTCTTCCEEECCSS
T ss_pred cccccCHHHhcCccccCEEECCCCcccc-cCHhHccCcccccEeeCCCCcCCcCCHH-------HcccCcccCEEeccCC
Confidence 9998777789999999999999999997 5788999999999999999999865543 1223355689999999
Q ss_pred cCCCCcchhhcCCcccceeecccccCccCCCccccc
Q 002289 293 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 328 (941)
Q Consensus 293 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 328 (941)
++....+.. .-+..|+.+..+.|.+....|..+..
T Consensus 236 ~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 236 PWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp CEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred CccCCCCcH-HHHHHHHhcccccCccccCCchHhCC
Confidence 987654432 12244666778888888888877643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=271.72 Aligned_cols=241 Identities=18% Similarity=0.221 Sum_probs=196.3
Q ss_pred CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCC-cccCCcCccc
Q 002289 79 DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP-EELGYLPKLD 157 (941)
Q Consensus 79 ~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~ 157 (941)
....+++.|++++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|+
T Consensus 73 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 73 QRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ 152 (353)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred ccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCc
Confidence 345689999999999998888889999999999999999996655669999999999999999995444 4799999999
Q ss_pred eeecccc-cccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCC
Q 002289 158 RIQIDQN-YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 236 (941)
Q Consensus 158 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 236 (941)
+|+|++| .+++..+..|.++++|++|++++|++++..|..|..+++|++|++++|+++...+..+..+++|+.|+|++|
T Consensus 153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n 232 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232 (353)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESC
T ss_pred EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCC
Confidence 9999999 577777889999999999999999999998999999999999999999997544444566899999999999
Q ss_pred cCCCCCcchh---ccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeec
Q 002289 237 NFEGTTIPAS---YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 313 (941)
Q Consensus 237 ~l~~~~~p~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 313 (941)
++++. .+.. ......++.++|++|.+++.. +..++. .+....+|+.|+|++|+|+...+..|..+++|+.|+|
T Consensus 233 ~l~~~-~~~~l~~~~~~~~l~~l~L~~~~l~~~~--l~~l~~-~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L 308 (353)
T 2z80_A 233 DLDTF-HFSELSTGETNSLIKKFTFRNVKITDES--LFQVMK-LLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWL 308 (353)
T ss_dssp BCTTC-CCC------CCCCCCEEEEESCBCCHHH--HHHHHH-HHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccccc-cccccccccccchhhccccccccccCcc--hhhhHH-HHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEe
Confidence 99873 3332 234677999999999887520 000000 1223456799999999999554455799999999999
Q ss_pred ccccCccCCC
Q 002289 314 ANNSLSGSIP 323 (941)
Q Consensus 314 s~N~l~~~~p 323 (941)
++|++++..|
T Consensus 309 ~~N~~~~~~~ 318 (353)
T 2z80_A 309 HTNPWDCSCP 318 (353)
T ss_dssp CSSCBCCCHH
T ss_pred eCCCccCcCC
Confidence 9999986554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=274.86 Aligned_cols=252 Identities=19% Similarity=0.257 Sum_probs=158.3
Q ss_pred ccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccc-cCCCCcccC-------CcCccceeecccccccccCCcc
Q 002289 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL-TGSLPEELG-------YLPKLDRIQIDQNYISGSLPKS 173 (941)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~ 173 (941)
++..++|+.|++++|.+ .+|..+... |+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34455666667777776 555555443 67777777776 334555444 5667777777777777666665
Q ss_pred c--ccccccceEecccccccccCchhccCC-----CccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCC-Ccch
Q 002289 174 F--ANLNKTRHFHMNNNSISGQIPPELSRL-----PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPA 245 (941)
Q Consensus 174 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~p~ 245 (941)
+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..+..|+++++|++|+|++|++.+. ..+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 6677777777777777655 5555555 6777777777777766666777777777777777776541 0233
Q ss_pred hc--cCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcc-hhhcCCcccceeecccccCccCC
Q 002289 246 SY--SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIP-SNFSGLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 246 ~~--~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 322 (941)
.+ ..+++|++|+|++|+|++... +....+....+|++|+|++|+|++.+| ..+..+++|+.|+|++|+|+ .+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~i 268 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSG----VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHH----HHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SC
T ss_pred HHHhccCCCCCEEECCCCcCcchHH----HHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hh
Confidence 33 666777777777776652110 000011122456777777777776664 44556677777777777777 66
Q ss_pred CcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCc
Q 002289 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 370 (941)
Q Consensus 323 p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~ 370 (941)
|..+. ++|+.|||++|+|+.+|.-..++.+++|+|++|+|.
T Consensus 269 p~~~~-------~~L~~L~Ls~N~l~~~p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 269 PKGLP-------AKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CSSCC-------SEEEEEECCSSCCCSCCCTTTSCEEEEEECTTCTTT
T ss_pred hhhcc-------CCceEEECCCCCCCCChhHhhCCCCCEEeccCCCCC
Confidence 66553 456677777777777755336667777777777764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=275.40 Aligned_cols=248 Identities=20% Similarity=0.213 Sum_probs=208.4
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCC-CCCCCCccC-------CccccceecccCccccCCCCccc--C
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKI-SGSIPKEIG-------NIKSLELLLLNGNELTGSLPEEL--G 151 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~--~ 151 (941)
.+++.|++++|.+ .+|..+... |+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..+ .
T Consensus 43 ~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 118 (312)
T 1wwl_A 43 RSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118 (312)
T ss_dssp EECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSC
T ss_pred CCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHh
Confidence 3688899999999 778777655 99999999999 456776665 79999999999999999999886 8
Q ss_pred CcCccceeecccccccccCCcccccc-----cccceEecccccccccCchhccCCCccceeeccCCcCCCC--CCccC--
Q 002289 152 YLPKLDRIQIDQNYISGSLPKSFANL-----NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY--LPPEL-- 222 (941)
Q Consensus 152 ~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~-- 222 (941)
.+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. .+..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 999999999999999987 8888888 9999999999999988889999999999999999998875 33444
Q ss_pred CCCCCCCEEeccCCcCCCC--CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcch
Q 002289 223 SELPKLLILQLDNNNFEGT--TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPS 300 (941)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~ 300 (941)
.++++|++|+|++|+|++. .....+.++++|++|+|++|+|++.+|.- .+....+|++|+|++|+|+ .+|.
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------~~~~l~~L~~L~Ls~N~l~-~ip~ 270 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP------SCDWPSQLNSLNLSFTGLK-QVPK 270 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCS------CCCCCTTCCEEECTTSCCS-SCCS
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchh------hhhhcCCCCEEECCCCccC-hhhh
Confidence 8999999999999999841 12245678899999999999999866421 1112356799999999999 7787
Q ss_pred hhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCC
Q 002289 301 NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350 (941)
Q Consensus 301 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~ 350 (941)
.+. ++|+.|+|++|+|++. |. +.. .++|+.|+|++|.|+..
T Consensus 271 ~~~--~~L~~L~Ls~N~l~~~-p~-~~~-----l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 271 GLP--AKLSVLDLSYNRLDRN-PS-PDE-----LPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp SCC--SEEEEEECCSSCCCSC-CC-TTT-----SCEEEEEECTTCTTTCC
T ss_pred hcc--CCceEEECCCCCCCCC-hh-Hhh-----CCCCCEEeccCCCCCCC
Confidence 776 8999999999999965 65 544 45678999999999864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=248.86 Aligned_cols=165 Identities=21% Similarity=0.264 Sum_probs=95.3
Q ss_pred CCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccC
Q 002289 65 SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144 (941)
Q Consensus 65 ~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 144 (941)
|.|.|+.|.... +++.+++++++++. +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++.
T Consensus 5 C~~~~~~C~c~~------~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 75 (270)
T 2o6q_A 5 CKKDGGVCSCNN------NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT 75 (270)
T ss_dssp BGGGTCSBEEET------TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC
T ss_pred CCCCCCCCEeCC------CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe
Confidence 479999985432 35678888887774 555443 567777777777776555667777777777777777765
Q ss_pred CCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCC
Q 002289 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224 (941)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 224 (941)
..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..
T Consensus 76 i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 155 (270)
T 2o6q_A 76 LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155 (270)
T ss_dssp CCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred eChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccC
Confidence 44455566666666666666666544445555555555555555555444444444444444444444444333333333
Q ss_pred CCCCCEEeccCCcC
Q 002289 225 LPKLLILQLDNNNF 238 (941)
Q Consensus 225 l~~L~~L~Ls~N~l 238 (941)
+++|+.|+|++|++
T Consensus 156 l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 156 LTSLKELRLYNNQL 169 (270)
T ss_dssp CTTCCEEECCSSCC
T ss_pred CcccceeEecCCcC
Confidence 33433333333333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=257.58 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=188.7
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
..++++|++++|.+++. ++ +..+++|++|+|++|.++. +| .|.++++|++|+|++|.+++. +. +..+++|++|+
T Consensus 65 ~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~ 138 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISDI-SP-LANLTKMYSLN 138 (347)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCCEEE
T ss_pred cCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccCc-hh-hccCCceeEEE
Confidence 45789999999988864 33 8899999999999999885 44 688899999999999998854 43 88888999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
+++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+.+
T Consensus 139 l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 213 (347)
T 4fmz_A 139 LGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213 (347)
T ss_dssp CTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCC
Confidence 99886654444 38888888888888888875433 7788888888888888875432 7778888888888888875
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCcc
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 320 (941)
. . . +..+++|++|++++|++++..+ +. ...+|++|+|++|.+++. ..+..+++|+.|++++|++++
T Consensus 214 ~-~-~-~~~~~~L~~L~l~~n~l~~~~~-~~--------~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~ 279 (347)
T 4fmz_A 214 I-T-P-VANMTRLNSLKIGNNKITDLSP-LA--------NLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD 279 (347)
T ss_dssp C-G-G-GGGCTTCCEEECCSSCCCCCGG-GT--------TCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred C-c-h-hhcCCcCCEEEccCCccCCCcc-hh--------cCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC
Confidence 2 2 2 7778888888888888775433 22 224557777777777653 456777777777777777764
Q ss_pred CCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCccCCC
Q 002289 321 SIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN 374 (941)
Q Consensus 321 ~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~c~c~ 374 (941)
. | .+.. .++|+.|+|++|.++.++... .++.++.|++++|++....+
T Consensus 280 ~-~-~~~~-----l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 280 I-S-VLNN-----LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp C-G-GGGG-----CTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred C-h-hhcC-----CCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 2 2 2222 345667777777776654332 56667777777777665544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=257.99 Aligned_cols=232 Identities=18% Similarity=0.206 Sum_probs=206.7
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCC--CCCCccCCccccceecccCccccCCCCcccCCcCccce
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISG--SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 158 (941)
..++++|+|++|+++...+..|.++++|++|+|++|+++. ..|..+..+++|++|+|++|.++ .+|..+..+++|++
T Consensus 27 ~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~ 105 (306)
T 2z66_A 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105 (306)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCE
Confidence 3579999999999996544568999999999999999983 33667788999999999999999 67888999999999
Q ss_pred eecccccccccCC-cccccccccceEecccccccccCchhccCCCccceeeccCCcCCC-CCCccCCCCCCCCEEeccCC
Q 002289 159 IQIDQNYISGSLP-KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG-YLPPELSELPKLLILQLDNN 236 (941)
Q Consensus 159 L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N 236 (941)
|+|++|.+++..+ ..+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++ .+|..+..+++|++|+|++|
T Consensus 106 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n 185 (306)
T 2z66_A 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185 (306)
T ss_dssp EECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCC
Confidence 9999999997765 689999999999999999999999999999999999999999987 57889999999999999999
Q ss_pred cCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCc-ccceeeccc
Q 002289 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLP-RLQRLFIAN 315 (941)
Q Consensus 237 ~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~ 315 (941)
++++ ..|..|..+++|++|+|++|++++..+. .+....+|+.|+|++|+|++..|..+..++ +|+.|+|++
T Consensus 186 ~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~ 257 (306)
T 2z66_A 186 QLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTF-------PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257 (306)
T ss_dssp CCCE-ECTTTTTTCTTCCEEECTTSCCSBCCSG-------GGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTT
T ss_pred CcCC-cCHHHhcCCCCCCEEECCCCccCccChh-------hccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccC
Confidence 9997 5688999999999999999999875542 223346679999999999999999999995 999999999
Q ss_pred ccCccC
Q 002289 316 NSLSGS 321 (941)
Q Consensus 316 N~l~~~ 321 (941)
|++++.
T Consensus 258 N~~~~~ 263 (306)
T 2z66_A 258 NDFACT 263 (306)
T ss_dssp CCEECS
T ss_pred CCeecc
Confidence 999854
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=276.82 Aligned_cols=176 Identities=15% Similarity=0.206 Sum_probs=155.6
Q ss_pred EEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccc
Q 002289 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI 166 (941)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 166 (941)
.++++++++ .+|+.+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 688888888 5676654 8999999999999988899999999999999999999988889999999999999999999
Q ss_pred cccCCcccccccccceEecccccccc-cCchhccCCCccceeeccCCcCCCCCC-ccCCCCCCCCEEeccCCcCCCCCcc
Q 002289 167 SGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIP 244 (941)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~p 244 (941)
++..|..|+++++|++|+|++|++++ ..|..|+++++|++|++++|++.+.+| ..|.++++|++|+|++|++++ ..|
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~ 165 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQS 165 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE-ECT
T ss_pred CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc-cCh
Confidence 98888889999999999999999996 357789999999999999999554554 689999999999999999987 456
Q ss_pred hhcc------------------------CCCCCcEEEccCCCCcCC
Q 002289 245 ASYS------------------------NMSKLLKLSLRNCSLQGP 266 (941)
Q Consensus 245 ~~~~------------------------~l~~L~~L~Ls~N~l~~~ 266 (941)
..+. .+++|++|++++|++++.
T Consensus 166 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 211 (549)
T 2z81_A 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211 (549)
T ss_dssp TTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTC
T ss_pred hhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccc
Confidence 5554 367888888888888874
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-26 Score=261.96 Aligned_cols=265 Identities=17% Similarity=0.168 Sum_probs=166.0
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+++.|+|++|++++. + ++.+++|++|+|++|+|++. | ++++++|++|+|++|++++ +| ++.+++|++|+|
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 4567777777777663 2 66677777777777777653 2 6666777777777777664 33 666666666666
Q ss_pred ccccccccCC--------------------cccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCcc
Q 002289 162 DQNYISGSLP--------------------KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 221 (941)
Q Consensus 162 s~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 221 (941)
++|++++. + -.+..+++|++|+|++|++++ +| ++.+++|+.|++++|++++. .
T Consensus 135 ~~N~l~~l-~l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~ 207 (457)
T 3bz5_A 135 ARNTLTEI-DVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---D 207 (457)
T ss_dssp TTSCCSCC-CCTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---C
T ss_pred CCCcccee-ccccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---c
Confidence 66666653 2 023444555555555555553 23 44555555555555555543 2
Q ss_pred CCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCccccc--ccCCcCEEEccCCcCCCCcc
Q 002289 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL--LSLNITTIKLSNNKLTGTIP 299 (941)
Q Consensus 222 ~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l--~~~~L~~L~Ls~N~l~~~~p 299 (941)
++.+++|+.|+|++|+|++ +| +..+++|++|++++|+|++.++ ..++++..+ ...+|+.|++++|.+.+.+|
T Consensus 208 l~~l~~L~~L~Ls~N~l~~--ip--~~~l~~L~~L~l~~N~l~~~~~--~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 208 LNQNIQLTFLDCSSNKLTE--ID--VTPLTQLTYFDCSVNPLTELDV--STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp CTTCTTCSEEECCSSCCSC--CC--CTTCTTCSEEECCSSCCSCCCC--TTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred cccCCCCCEEECcCCcccc--cC--ccccCCCCEEEeeCCcCCCcCH--HHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 5556666666666666664 33 5566666666666666665432 222332221 12346666777777666666
Q ss_pred hhhcCCcccceeecccccCccCCCcccccccccC---ccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCcc
Q 002289 300 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN---ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 371 (941)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~---~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c 371 (941)
++.+++|+.|++++|++.+.+|.....+..+. .++|+.|+|++|+|+.++ -..++.++.|++++|.+.-
T Consensus 282 --~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l~-l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 282 --AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELD-VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp --CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCCC-CTTCTTCSEEECCSSCCCB
T ss_pred --ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccccc-cccCCcCcEEECCCCCCCC
Confidence 45678888888888888777776555454443 357899999999999984 2367889999999998763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-28 Score=287.66 Aligned_cols=185 Identities=18% Similarity=0.107 Sum_probs=129.5
Q ss_pred eeeccCcEEEEEEE-eCCCcEEEEEEeccCCc----------hhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEE
Q 002289 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL----------QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 616 ~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 683 (941)
..+.|++|.+..++ ...|+.||||++..... ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666666554 23588999999875321 1235689999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||++|++|.+++.+.+ +++.. +|+.||+.||+|+|++| ||||||||+|||+++++++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997654 35543 48899999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~P 816 (941)
. .......||++|||||++.+. +..++|+||+|++++++.++..+
T Consensus 393 ~-------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 C-------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C-------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 1 223456799999999999764 56789999999998887665443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-28 Score=280.94 Aligned_cols=242 Identities=22% Similarity=0.213 Sum_probs=171.9
Q ss_pred CCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEec
Q 002289 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (941)
++|+.|+|++|.|++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|++|+|
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 378888888888887777788888888888888888886655 8888888888888888875432 378888888
Q ss_pred ccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhcc-CCCCCcEEEccCCCCc
Q 002289 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS-NMSKLLKLSLRNCSLQ 264 (941)
Q Consensus 186 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~-~l~~L~~L~Ls~N~l~ 264 (941)
++|+|++..+. .+++|+.|+|++|.+++..|..++.+++|+.|+|++|.|++ ..|..+. .+++|+.|+|++|.|+
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCE-EEGGGGGGGTTTCCEEECTTSCCC
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCC-cChHHHhhhCCcccEEecCCCccc
Confidence 88888865543 35778888888888888777788888888888888888887 4566664 7888888888888887
Q ss_pred CCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccC
Q 002289 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 344 (941)
Q Consensus 265 ~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~ 344 (941)
+.++.. .+.+|+.|+|++|.|++..| .|..+++|+.|+|++|+|++ +|..+..+ ++|+.|+|++
T Consensus 183 ~~~~~~---------~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l-----~~L~~L~l~~ 246 (487)
T 3oja_A 183 DVKGQV---------VFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFS-----QNLEHFDLRG 246 (487)
T ss_dssp EEECCC---------CCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCC-----TTCCEEECTT
T ss_pred cccccc---------cCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccC-----CCCCEEEcCC
Confidence 653211 23456888888888886444 47778888888888888874 56655433 3445666666
Q ss_pred CCCC--CCCCCC-CCCCCcEEEec-------CCCCccCCC
Q 002289 345 NNLT--NISGSF-NIPPNVTVRLR-------GNPFCLNTN 374 (941)
Q Consensus 345 N~l~--~~~~~~-~~~~~~~l~l~-------~Np~~c~c~ 374 (941)
|.++ .++..+ .++.+..+++. +|++.|.|.
T Consensus 247 N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~ 286 (487)
T 3oja_A 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286 (487)
T ss_dssp CCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred CCCcCcchHHHHHhCCCCcEEeccccccccCCCcccccCC
Confidence 6665 222211 23334444444 666666653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-26 Score=244.42 Aligned_cols=207 Identities=18% Similarity=0.211 Sum_probs=111.4
Q ss_pred ccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeecc
Q 002289 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 210 (941)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 210 (941)
+|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 34444444444443333344444444444444444444444444445555555555555554444555555566666666
Q ss_pred CCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEcc
Q 002289 211 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLS 290 (941)
Q Consensus 211 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls 290 (941)
+|++++..+..+.++++|++|+|++|++++..+|..|.++++|++|+|++|++++..
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~----------------------- 165 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY----------------------- 165 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC-----------------------
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCC-----------------------
Confidence 666655544456666666666666666665335666666666666666655555322
Q ss_pred CCcCCCCcchhhcCCcccc----eeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEe
Q 002289 291 NNKLTGTIPSNFSGLPRLQ----RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRL 364 (941)
Q Consensus 291 ~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l 364 (941)
+..|..+++|+ .|++++|++++..+..+. ..+|+.|+|++|+|+.++... .++.++.|+|
T Consensus 166 --------~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~------~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 231 (276)
T 2z62_A 166 --------CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK------EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231 (276)
T ss_dssp --------GGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC------SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEEC
T ss_pred --------HHHhhhhhhccccceeeecCCCcccccCccccC------CCcccEEECCCCceeecCHhHhcccccccEEEc
Confidence 22222222222 444555555432222221 113556666666666665443 4677889999
Q ss_pred cCCCCccCCC
Q 002289 365 RGNPFCLNTN 374 (941)
Q Consensus 365 ~~Np~~c~c~ 374 (941)
++|||.|+|+
T Consensus 232 ~~N~~~c~c~ 241 (276)
T 2z62_A 232 HTNPWDCSCP 241 (276)
T ss_dssp CSSCBCCCTT
T ss_pred cCCcccccCC
Confidence 9999999996
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-25 Score=261.44 Aligned_cols=260 Identities=25% Similarity=0.358 Sum_probs=176.3
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
..+++.|+|++|.+++..+ +.++++|++|+|++|.+.+..+ +.++++|++|+|++|++++. +. +.++++|++|+
T Consensus 67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~ 140 (466)
T 1o6v_A 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLE 140 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEE
Confidence 4578889999888886543 8888888888888888886554 88888888888888888854 33 78888888888
Q ss_pred cccccccccCC-------------------cccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCcc
Q 002289 161 IDQNYISGSLP-------------------KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 221 (941)
Q Consensus 161 Ls~N~l~~~~p-------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 221 (941)
|++|.+++... ..+.++++|+.|++++|++++. ..+..+++|++|++++|++++..|
T Consensus 141 l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-- 216 (466)
T 1o6v_A 141 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-- 216 (466)
T ss_dssp EEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred CCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--
Confidence 88888775321 1256677888888888888743 347778888888888888886544
Q ss_pred CCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchh
Q 002289 222 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN 301 (941)
Q Consensus 222 ~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~ 301 (941)
++.+++|+.|+|++|++++ + ..+..+++|+.|++++|++++..+ +.. ..+|+.|+|++|.+++..+
T Consensus 217 ~~~l~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~--------l~~L~~L~l~~n~l~~~~~-- 282 (466)
T 1o6v_A 217 LGILTNLDELSLNGNQLKD--I-GTLASLTNLTDLDLANNQISNLAP-LSG--------LTKLTELKLGANQISNISP-- 282 (466)
T ss_dssp GGGCTTCCEEECCSSCCCC--C-GGGGGCTTCSEEECCSSCCCCCGG-GTT--------CTTCSEEECCSSCCCCCGG--
T ss_pred ccccCCCCEEECCCCCccc--c-hhhhcCCCCCEEECCCCccccchh-hhc--------CCCCCEEECCCCccCcccc--
Confidence 6677888888888888775 2 357777888888888887775543 222 2344666666666664433
Q ss_pred hcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCcc
Q 002289 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 371 (941)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c 371 (941)
+..+++|+.|++++|++++..| +.. .++|+.|+|++|+++.++....++.++.|++++|++..
T Consensus 283 ~~~l~~L~~L~L~~n~l~~~~~--~~~-----l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 283 LAGLTALTNLELNENQLEDISP--ISN-----LKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp GTTCTTCSEEECCSSCCSCCGG--GGG-----CTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC
T ss_pred ccCCCccCeEEcCCCcccCchh--hcC-----CCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCC
Confidence 5566666666666666654322 221 23455566666666555443345555556666555544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-25 Score=250.62 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=126.8
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
+++.|++.++.+... + .+..+++|++|+|++|++++..+ +..+++|++|+|++|.++. ++ .|.++++|++|+|+
T Consensus 45 ~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 45 SITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLN 118 (347)
T ss_dssp TCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECT
T ss_pred cccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECc
Confidence 455555555555432 2 35555555555555555553222 5555555555555555553 22 35555555555555
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
+|.+++..+ +..+++|+.|++++|.....++. +..+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+
T Consensus 119 ~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-- 191 (347)
T 4fmz_A 119 EDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-- 191 (347)
T ss_dssp TSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC--
T ss_pred CCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc--
Confidence 555553322 55555555555555544433322 5555555555555555553322 4555555555555555553
Q ss_pred cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCC
Q 002289 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 322 (941)
++. +..+++|+.|++++|.+++..+ +....+|++|+|++|++++..+ +..+++|+.|++++|++++ +
T Consensus 192 ~~~-~~~l~~L~~L~l~~n~l~~~~~---------~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~ 258 (347)
T 4fmz_A 192 ISP-LASLTSLHYFTAYVNQITDITP---------VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I 258 (347)
T ss_dssp CGG-GGGCTTCCEEECCSSCCCCCGG---------GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C
T ss_pred ccc-ccCCCccceeecccCCCCCCch---------hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C
Confidence 222 5555555555555555543222 1122344555555555554333 5555555555555555553 1
Q ss_pred CcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCC
Q 002289 323 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 369 (941)
Q Consensus 323 p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~ 369 (941)
..+. ..++|+.|++++|+++.++.-..++.++.|++++|++
T Consensus 259 -~~~~-----~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 259 -NAVK-----DLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp -GGGT-----TCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCC
T ss_pred -hhHh-----cCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcC
Confidence 1121 1234455555555555553323445555555555554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=276.16 Aligned_cols=282 Identities=20% Similarity=0.219 Sum_probs=249.3
Q ss_pred CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCcccee
Q 002289 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (941)
Q Consensus 80 ~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (941)
...+++.|+++++.+.. ++ .+..+++|++|++++|.+ +.+| .+ .+++|++|+|++|+..+.+ .+..+++|++|
T Consensus 283 ~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L 355 (606)
T 3vq2_A 283 CLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYL 355 (606)
T ss_dssp GGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEE
T ss_pred cCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEE
Confidence 34679999999999964 55 899999999999999999 5888 56 9999999999999766444 67899999999
Q ss_pred eccccccccc--CCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCC-ccCCCCCCCCEEeccCC
Q 002289 160 QIDQNYISGS--LPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNN 236 (941)
Q Consensus 160 ~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N 236 (941)
+|++|.+++. +|..+..+++|++|+|++|.+++ +|..|..+++|++|++++|++.+..+ ..+.++++|++|+|++|
T Consensus 356 ~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n 434 (606)
T 3vq2_A 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434 (606)
T ss_dssp ECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTS
T ss_pred ECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCC
Confidence 9999999977 48899999999999999999995 66889999999999999999998887 68999999999999999
Q ss_pred cCCCCCcchhccCCCCCcEEEccCCCCcCC-CCC-CCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecc
Q 002289 237 NFEGTTIPASYSNMSKLLKLSLRNCSLQGP-MPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 314 (941)
Q Consensus 237 ~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 314 (941)
++.+ ..|..+.++++|++|++++|++++. +|. +.. ..+|++|+|++|++++..|..|.++++|+.|+|+
T Consensus 435 ~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--------l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 505 (606)
T 3vq2_A 435 NTKI-DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN--------TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505 (606)
T ss_dssp CCEE-CCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT--------CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCc-cchhhhcCCCCCCEEECCCCcCCCcchHHhhcc--------CCCCCEEECCCCcCCccChhhhcccccCCEEECC
Confidence 9998 6889999999999999999999873 443 333 3566999999999999999999999999999999
Q ss_pred cccCccCCCcccccccccCccccceEEccCCCCCCCCCCC-CCC-CCcEEEecCCCCccCCCcccccCCCC
Q 002289 315 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIP-PNVTVRLRGNPFCLNTNAEQFCGSHS 383 (941)
Q Consensus 315 ~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~-~~~-~~~~l~l~~Np~~c~c~~~~~~~~~~ 383 (941)
+|++++.+|..+..+ ++|+.|||++|+|+.+|..+ .++ .++.|++++|||.|+|++.+|.....
T Consensus 506 ~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l~ 571 (606)
T 3vq2_A 506 HNNLLFLDSSHYNQL-----YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVK 571 (606)
T ss_dssp SSCCSCEEGGGTTTC-----TTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTTT
T ss_pred CCcCCCcCHHHccCC-----CcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHHH
Confidence 999998888888765 45679999999999998876 566 49999999999999999988776553
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=259.98 Aligned_cols=256 Identities=20% Similarity=0.175 Sum_probs=206.5
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
..+++.|++++|++++. | .++.+++|++|+|++|+|++. | ++.+++|++|+|++|++++. + ++++++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 34699999999999975 4 799999999999999999974 4 89999999999999999974 4 89999999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|++|++++. | +..+++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..+++|+.|+|++|++++
T Consensus 113 L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 113 CDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp CCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence 999999974 4 89999999999999999974 3 889999999999999766666 58899999999999999997
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCcc
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 320 (941)
+| +..+++|+.|++++|++++. .+. ...+|+.|+|++|+|++ +| ++.+++|+.|++++|++++
T Consensus 185 --l~--l~~l~~L~~L~l~~N~l~~~--~l~--------~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 185 --LD--VSQNKLLNRLNCDTNNITKL--DLN--------QNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp --CC--CTTCTTCCEEECCSSCCSCC--CCT--------TCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred --ec--cccCCCCCEEECcCCcCCee--ccc--------cCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence 44 88999999999999999865 122 33567999999999998 56 8899999999999999997
Q ss_pred CCCcccccccccC--ccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCC
Q 002289 321 SIPSSIWQSRTLN--ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 369 (941)
Q Consensus 321 ~~p~~~~~l~~l~--~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~ 369 (941)
..+..+..+..|. ..+|+.|++++|.+..--+...++.++.|++++|+.
T Consensus 248 ~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~ 298 (457)
T 3bz5_A 248 LDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298 (457)
T ss_dssp CCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTT
T ss_pred cCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcc
Confidence 6554444333221 123444444444432211112456777888888863
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=245.87 Aligned_cols=215 Identities=17% Similarity=0.227 Sum_probs=179.4
Q ss_pred CCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccc
Q 002289 98 LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL 177 (941)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 177 (941)
+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++
T Consensus 22 ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 99 (276)
T 2z62_A 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99 (276)
T ss_dssp CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC
T ss_pred cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC
Confidence 444443 578899999999987777788889999999999999987777788899999999999999988888889999
Q ss_pred cccceEecccccccccCchhccCCCccceeeccCCcCCCC-CCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCc--
Q 002289 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL-- 254 (941)
Q Consensus 178 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~-- 254 (941)
++|++|++++|++++..+..+..+++|++|++++|++++. +|..|.++++|++|+|++|++++ ..+..|..+.+|+
T Consensus 100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLL 178 (276)
T ss_dssp TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE-ECGGGGHHHHTCTTC
T ss_pred ccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc-CCHHHhhhhhhcccc
Confidence 9999999999999877776788899999999999999864 58889999999999999999987 4566777666666
Q ss_pred --EEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCC
Q 002289 255 --KLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 323 (941)
Q Consensus 255 --~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 323 (941)
.|++++|++++..+..... .+|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 179 ~l~L~ls~n~l~~~~~~~~~~--------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQPGAFKE--------IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEEEECCSSCCCEECTTSSCS--------CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ceeeecCCCcccccCccccCC--------CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 8999999998766643222 257999999999998888888999999999999999986554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-26 Score=245.40 Aligned_cols=212 Identities=21% Similarity=0.280 Sum_probs=117.9
Q ss_pred ccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccc
Q 002289 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (941)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (941)
+.++++|++|++++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 455666666666666666 4444432 4566666666666655555566666666666666665533221 4444555
Q ss_pred eEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCC
Q 002289 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (941)
Q Consensus 182 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (941)
+|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++ ..+..|..++
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~---------- 148 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTP---------- 148 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC-CCTTTTTTCT----------
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc-cChhhccccc----------
Confidence 5555555554 334444444444444444444444333444444444444444444443 2222233333
Q ss_pred CCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEE
Q 002289 262 SLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 341 (941)
Q Consensus 262 ~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~ 341 (941)
+|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..++.
T Consensus 149 ---------------------~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~------------- 193 (290)
T 1p9a_G 149 ---------------------KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG------------- 193 (290)
T ss_dssp ---------------------TCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT-------------
T ss_pred ---------------------CCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcc-------------
Confidence 3355555555555445555666777777777777776 55555433
Q ss_pred ccCCCCCCCCCCCCCCCCcEEEecCCCCccCCCccccc
Q 002289 342 FQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFC 379 (941)
Q Consensus 342 Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~~~~~ 379 (941)
.+.+..++|.+|||.|+|.+.++-
T Consensus 194 --------------~~~L~~l~L~~Np~~C~c~~~~l~ 217 (290)
T 1p9a_G 194 --------------SHLLPFAFLHGNPWLCNCEILYFR 217 (290)
T ss_dssp --------------TCCCSEEECCSCCBCCSGGGHHHH
T ss_pred --------------cccCCeEEeCCCCccCcCccHHHH
Confidence 335668899999999999886654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=260.71 Aligned_cols=260 Identities=27% Similarity=0.345 Sum_probs=180.2
Q ss_pred CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCC------------
Q 002289 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP------------ 147 (941)
Q Consensus 80 ~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------ 147 (941)
...++++|++++|.+++..+ ++++++|++|+|++|.+++..+ +.++++|++|+|++|.+++...
T Consensus 88 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l 163 (466)
T 1o6v_A 88 NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSF 163 (466)
T ss_dssp TCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEE
T ss_pred ccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeec
Confidence 45678999999999987544 8899999999999999986533 8888999999999988875311
Q ss_pred -------cccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCc
Q 002289 148 -------EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220 (941)
Q Consensus 148 -------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 220 (941)
..+.++++|++|+|++|.+++. ..+..+++|++|++++|++++..| ++.+++|++|++++|++++. .
T Consensus 164 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 237 (466)
T 1o6v_A 164 GNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--G 237 (466)
T ss_dssp EESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--G
T ss_pred CCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--h
Confidence 1266778888999999998854 347888899999999998886655 66788888888888888753 4
Q ss_pred cCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcch
Q 002289 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPS 300 (941)
Q Consensus 221 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~ 300 (941)
.+..+++|+.|+|++|.+++ ..+ +..+++|++|++++|++++..+ +.. ..+|+.|+|++|++++..+
T Consensus 238 ~l~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~--------l~~L~~L~L~~n~l~~~~~- 304 (466)
T 1o6v_A 238 TLASLTNLTDLDLANNQISN-LAP--LSGLTKLTELKLGANQISNISP-LAG--------LTALTNLELNENQLEDISP- 304 (466)
T ss_dssp GGGGCTTCSEEECCSSCCCC-CGG--GTTCTTCSEEECCSSCCCCCGG-GTT--------CTTCSEEECCSSCCSCCGG-
T ss_pred hhhcCCCCCEEECCCCcccc-chh--hhcCCCCCEEECCCCccCcccc-ccC--------CCccCeEEcCCCcccCchh-
Confidence 57778888888888888876 222 7778888888888888876443 222 2344666666666665443
Q ss_pred hhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCc
Q 002289 301 NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 370 (941)
Q Consensus 301 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~ 370 (941)
+..+++|+.|+|++|++++..| +.. .++|+.|++++|.++.++.-..++.++.|++++|++.
T Consensus 305 -~~~l~~L~~L~L~~n~l~~~~~--~~~-----l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 305 -ISNLKNLTYLTLYFNNISDISP--VSS-----LTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp -GGGCTTCSEEECCSSCCSCCGG--GGG-----CTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred -hcCCCCCCEEECcCCcCCCchh--hcc-----CccCCEeECCCCccCCchhhccCCCCCEEeCCCCccC
Confidence 5566666666666666664433 221 2344455555555555543334555555555555543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=259.58 Aligned_cols=222 Identities=22% Similarity=0.216 Sum_probs=165.9
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
++..++++++++...+...+..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..+ |..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 35556666666665555556677889999999999988777888899999999999999886554 8888999999999
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
+|.+++.. .+++|++|++++|++++..+. .+++|++|++++|++++..+..+..+++|++|+|++|.+++ .
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~ 159 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-V 159 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE-E
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc-c
Confidence 99888443 347888999999988865543 35788889999999887777788888889999999988887 3
Q ss_pred cchhc-cCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccC
Q 002289 243 IPASY-SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321 (941)
Q Consensus 243 ~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 321 (941)
.+..+ ..+++|++|+|++|+|++..+. . ...+|++|+|++|+|++. |..|..+++|+.|+|++|+|+ .
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~--------~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~ 228 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDVKGQ-V--------VFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-L 228 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEECC-C--------CCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-E
T ss_pred cHHHHhhccCcCCEEECCCCcCcccccc-c--------ccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-c
Confidence 44544 4788888888888888754221 1 134567777777777743 344777777777777777776 4
Q ss_pred CCccc
Q 002289 322 IPSSI 326 (941)
Q Consensus 322 ~p~~~ 326 (941)
+|..+
T Consensus 229 l~~~~ 233 (317)
T 3o53_A 229 IEKAL 233 (317)
T ss_dssp ECTTC
T ss_pred hhhHh
Confidence 55544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=270.66 Aligned_cols=276 Identities=26% Similarity=0.322 Sum_probs=171.1
Q ss_pred CCCCCCCCCCCCCCCceEecCCCCCC-CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcccc
Q 002289 54 LSNWNRGDPCTSNWTGVLCFNTTMDD-GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSL 132 (941)
Q Consensus 54 ~~~w~~~~~c~~~w~gv~C~~~~~~~-~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 132 (941)
+..|....+|| .|+|..|....... ...+++.|++++++|+ .+|..+. ++|+.|+|++|+|+ .+|. .+++|
T Consensus 12 w~~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L 83 (622)
T 3g06_A 12 WSAWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPEL 83 (622)
T ss_dssp HHHHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTC
T ss_pred HHHHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCC
Confidence 35576555553 67654321100000 0113677777777777 5565554 67777777777777 4554 45677
Q ss_pred ceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCC
Q 002289 133 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212 (941)
Q Consensus 133 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 212 (941)
++|+|++|+|+ .+|. .+++|++|+|++|.|++. |. .+++|+.|+|++|+|++ +|.. +++|++|+|++|
T Consensus 84 ~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 84 RTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred CEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCC
Confidence 77777777777 4454 567777777777777743 33 45667777777777763 4432 366777777777
Q ss_pred cCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCccccc---------ccCC
Q 002289 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL---------LSLN 283 (941)
Q Consensus 213 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l---------~~~~ 283 (941)
++++ +|. .+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++.++.+..+..+... ...+
T Consensus 152 ~l~~-l~~---~~~~L~~L~L~~N~l~~--l~---~~~~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~ 222 (622)
T 3g06_A 152 QLAS-LPA---LPSELCKLWAYNNQLTS--LP---MLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSG 222 (622)
T ss_dssp CCSC-CCC---CCTTCCEEECCSSCCSC--CC---CCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCCTT
T ss_pred cCCC-cCC---ccCCCCEEECCCCCCCC--Cc---ccCCCCcEEECCCCCCCCCCCccchhhEEECcCCcccccCCCCCC
Confidence 7764 332 23455666666666653 33 33455666666666665433222111111000 1256
Q ss_pred cCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC-CCCCCcEE
Q 002289 284 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTV 362 (941)
Q Consensus 284 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~-~~~~~~~l 362 (941)
|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. ..++|+.|+|++|+|+.+|..+ .++.+..|
T Consensus 223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~--------~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L 289 (622)
T 3g06_A 223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM--------LPSGLLSLSVYRNQLTRLPESLIHLSSETTV 289 (622)
T ss_dssp CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC--------CCTTCCEEECCSSCCCSCCGGGGGSCTTCEE
T ss_pred CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc--------ccccCcEEeCCCCCCCcCCHHHhhccccCEE
Confidence 7888888888885 45 45678888899999888 5665 2356788999999999887666 67888899
Q ss_pred EecCCCCcc
Q 002289 363 RLRGNPFCL 371 (941)
Q Consensus 363 ~l~~Np~~c 371 (941)
+|++|++..
T Consensus 290 ~L~~N~l~~ 298 (622)
T 3g06_A 290 NLEGNPLSE 298 (622)
T ss_dssp ECCSCCCCH
T ss_pred EecCCCCCC
Confidence 999998864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-25 Score=268.17 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=201.2
Q ss_pred CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCcccee
Q 002289 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (941)
Q Consensus 80 ~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (941)
.+.+++.|+|++|+|++..+..|.+|++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|
T Consensus 74 ~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L 153 (635)
T 4g8a_A 74 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 153 (635)
T ss_dssp TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEE
T ss_pred CCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCee
Confidence 45689999999999998777789999999999999999997777889999999999999999997777789999999999
Q ss_pred eccccccccc-CCcccccccccceEecccccccccCchhcc---------------------------------------
Q 002289 160 QIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQIPPELS--------------------------------------- 199 (941)
Q Consensus 160 ~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--------------------------------------- 199 (941)
+|++|.+++. .|..+..+++|++|+|++|+|++..+..|.
T Consensus 154 ~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~ 233 (635)
T 4g8a_A 154 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 233 (635)
T ss_dssp ECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEES
T ss_pred ccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhc
Confidence 9999999864 578888899999999988877543221110
Q ss_pred --------------------------------------------------------------------------------
Q 002289 200 -------------------------------------------------------------------------------- 199 (941)
Q Consensus 200 -------------------------------------------------------------------------------- 199 (941)
T Consensus 234 n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~ 313 (635)
T 4g8a_A 234 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSL 313 (635)
T ss_dssp CCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEE
T ss_pred ccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccc
Confidence
Q ss_pred -------------------------------------------------------CCCccceeeccCCcCC---------
Q 002289 200 -------------------------------------------------------RLPSLVHMLLDNNNLT--------- 215 (941)
Q Consensus 200 -------------------------------------------------------~l~~L~~L~L~~N~l~--------- 215 (941)
.+++|+.|++++|.+.
T Consensus 314 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 393 (635)
T 4g8a_A 314 VSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 393 (635)
T ss_dssp ESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHH
T ss_pred cccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccch
Confidence 1223444444444332
Q ss_pred -----------------------------------------------------------------CCCCccCCCCCCCCE
Q 002289 216 -----------------------------------------------------------------GYLPPELSELPKLLI 230 (941)
Q Consensus 216 -----------------------------------------------------------------~~~p~~~~~l~~L~~ 230 (941)
+..+..+..+++|+.
T Consensus 394 ~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~ 473 (635)
T 4g8a_A 394 FGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 473 (635)
T ss_dssp HSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred hhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 222333444556666
Q ss_pred EeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccce
Q 002289 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 310 (941)
Q Consensus 231 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 310 (941)
|+|++|++.....|..|..+++|++|+|++|+|++.+|.. +..+.+|++|+|++|+|++..|..|.++++|+.
T Consensus 474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~-------f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 546 (635)
T 4g8a_A 474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA-------FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 546 (635)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT-------TTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHH-------HcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence 7777766443356778888899999999999998876651 222346799999999999999999999999999
Q ss_pred eecccccCccCCCcccccccccCccccceEEccCCCCCC
Q 002289 311 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 349 (941)
Q Consensus 311 L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~ 349 (941)
|+|++|+|++..|..+..+ .++|+.|+|++|.++-
T Consensus 547 L~Ls~N~l~~~~~~~l~~l----~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 547 LDYSLNHIMTSKKQELQHF----PSSLAFLNLTQNDFAC 581 (635)
T ss_dssp EECTTSCCCBCCSSCTTCC----CTTCCEEECTTCCBCC
T ss_pred EECCCCcCCCCCHHHHHhh----hCcCCEEEeeCCCCcc
Confidence 9999999999889888654 2467899999999863
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-24 Score=247.93 Aligned_cols=161 Identities=29% Similarity=0.313 Sum_probs=76.1
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+++.|++++|.+++ +|+. +++|++|++++|++++ +|.. .++|++|+|++|++++ +| .|+++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 456666666666665 4432 2455555555555542 2211 1355555555555553 44 3555555555555
Q ss_pred ccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCC
Q 002289 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (941)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 241 (941)
++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++|++++ +|... ++|++|++++|+++.
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~~- 229 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILEE- 229 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSS-
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCCc-
Confidence 5555553 33322 245555555555553 33 34455555555555555543 22211 244444444444442
Q ss_pred CcchhccCCCCCcEEEccCCCCcC
Q 002289 242 TIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
+| .+..+++|++|++++|++++
T Consensus 230 -lp-~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 230 -LP-ELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp -CC-CCTTCTTCCEEECCSSCCSS
T ss_pred -cc-ccCCCCCCCEEECCCCcCCc
Confidence 33 24444444444444444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-26 Score=268.40 Aligned_cols=237 Identities=20% Similarity=0.183 Sum_probs=204.0
Q ss_pred CcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCcccee
Q 002289 80 GYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRI 159 (941)
Q Consensus 80 ~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 159 (941)
...+|+.|+|++|++++..|..|+.+++|++|+|++|.|++..| |+.+++|++|+|++|.|++..+ .++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34589999999999999888899999999999999999997666 9999999999999999995432 3899999
Q ss_pred ecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCC-CCCCCCEEeccCCcC
Q 002289 160 QIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS-ELPKLLILQLDNNNF 238 (941)
Q Consensus 160 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l 238 (941)
+|++|.|++..+.. +++|+.|+|++|+|++..|..|+.+++|++|+|++|.+++..|..+. .+++|+.|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 99999999876654 57899999999999998898999999999999999999998888886 799999999999999
Q ss_pred CCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccC
Q 002289 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318 (941)
Q Consensus 239 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 318 (941)
++. | .+..+++|+.|+|++|+|++.++.+. .+.+|+.|+|++|.|++ +|..+..+++|+.|++++|.+
T Consensus 182 ~~~--~-~~~~l~~L~~L~Ls~N~l~~~~~~~~--------~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 182 YDV--K-GQVVFAKLKTLDLSSNKLAFMGPEFQ--------SAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp CEE--E-CCCCCTTCCEEECCSSCCCEECGGGG--------GGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred ccc--c-ccccCCCCCEEECCCCCCCCCCHhHc--------CCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 863 3 34469999999999999998776533 33567999999999995 788899999999999999999
Q ss_pred c-cCCCcccccccccCccccceEEcc
Q 002289 319 S-GSIPSSIWQSRTLNATETFILDFQ 343 (941)
Q Consensus 319 ~-~~~p~~~~~l~~l~~~~L~~L~Ls 343 (941)
. +.+|..+..+.. |+.|+++
T Consensus 250 ~c~~~~~~~~~l~~-----L~~l~~~ 270 (487)
T 3oja_A 250 HCGTLRDFFSKNQR-----VQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHTTCHH-----HHHHHHH
T ss_pred cCcchHHHHHhCCC-----CcEEecc
Confidence 8 666666655443 3455554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=257.60 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=137.4
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcccc-------------ceecccCccccCCCCc
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSL-------------ELLLLNGNELTGSLPE 148 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p~ 148 (941)
.++++|++++|++ |.+|++|+++++|++|++++|++.|.+|..++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 3578888888888 7888888888888888888888888888888877764 777777777774 333
Q ss_pred ccCCcCccceeecccccccccCCcccc----------------cc-cccceEecccccccccCchhccCCCccceeeccC
Q 002289 149 ELGYLPKLDRIQIDQNYISGSLPKSFA----------------NL-NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 211 (941)
Q Consensus 149 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~----------------~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 211 (941)
. .++|++|+|++|.+++ +|..+. .+ ++|++|+|++|++++ +| .|+++++|++|++++
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~ 162 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDN 162 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred C---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCC
Confidence 2 2556666666666665 443220 01 345555555555553 34 345555555555555
Q ss_pred CcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccC
Q 002289 212 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSN 291 (941)
Q Consensus 212 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~ 291 (941)
|++++ +|..+ .+|++|+|++|++++ +| .+.++++|++|++++|++++.+.. ..+|++|++++
T Consensus 163 N~l~~-lp~~~---~~L~~L~L~~n~l~~--l~-~~~~l~~L~~L~l~~N~l~~l~~~-----------~~~L~~L~l~~ 224 (454)
T 1jl5_A 163 NSLKK-LPDLP---PSLEFIAAGNNQLEE--LP-ELQNLPFLTAIYADNNSLKKLPDL-----------PLSLESIVAGN 224 (454)
T ss_dssp SCCSC-CCCCC---TTCCEEECCSSCCSS--CC-CCTTCTTCCEEECCSSCCSSCCCC-----------CTTCCEEECCS
T ss_pred CcCcc-cCCCc---ccccEEECcCCcCCc--Cc-cccCCCCCCEEECCCCcCCcCCCC-----------cCcccEEECcC
Confidence 55553 33222 355555555555553 23 355555555555555555542110 12578888888
Q ss_pred CcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCcc
Q 002289 292 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 371 (941)
Q Consensus 292 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c 371 (941)
|+++ .+| .|+.+++|+.|++++|++++ +|..+ .+|+.|++++|+++.++.. .+.++.|++++|.+..
T Consensus 225 n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~~--------~~L~~L~l~~N~l~~l~~~--~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 225 NILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLP--------PSLEALNVRDNYLTDLPEL--PQSLTFLDVSENIFSG 291 (454)
T ss_dssp SCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSCC--------TTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSE
T ss_pred CcCC-ccc-ccCCCCCCCEEECCCCcCCc-ccccc--------cccCEEECCCCcccccCcc--cCcCCEEECcCCccCc
Confidence 8887 566 37788888888888888874 55432 4567777888877776643 3567777777776654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-25 Score=261.98 Aligned_cols=292 Identities=17% Similarity=0.209 Sum_probs=237.0
Q ss_pred ceEecCCCC---C-CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccC
Q 002289 69 GVLCFNTTM---D-DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG 144 (941)
Q Consensus 69 gv~C~~~~~---~-~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 144 (941)
-+.|..... + ....+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus 11 ~~~c~~~~l~~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~ 90 (570)
T 2z63_A 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (570)
T ss_dssp EEECCSSCCSSCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEEeCCCCccccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc
Confidence 467765322 2 234579999999999998888899999999999999999998888999999999999999999998
Q ss_pred CCCcccCCcCccceeecccccccccCCcccccccccceEecccccccc-cCchhccCCCccceeeccCCcCCCCCCccCC
Q 002289 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223 (941)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 223 (941)
..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++++..+..++
T Consensus 91 ~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 170 (570)
T 2z63_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170 (570)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGH
T ss_pred cCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHcc
Confidence 888999999999999999999998777789999999999999999987 4799999999999999999999988888898
Q ss_pred CCCCC----CEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCC------------------------CCCCCCC-
Q 002289 224 ELPKL----LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM------------------------PDLSRIP- 274 (941)
Q Consensus 224 ~l~~L----~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~------------------------~~~~~l~- 274 (941)
.+++| +.|++++|.+++ ..|..|..+ +|+.|++++|...... ..+..++
T Consensus 171 ~l~~L~~~~~~L~l~~n~l~~-~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~ 248 (570)
T 2z63_A 171 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248 (570)
T ss_dssp HHHTCTTCCCEEECTTCCCCE-ECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCT
T ss_pred chhccchhhhhcccCCCCcee-cCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcch
Confidence 88888 899999999997 566777766 8999999998432100 0000000
Q ss_pred -cccccccCCcCEEEccCC-cCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCC
Q 002289 275 -NLGYLLSLNITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 352 (941)
Q Consensus 275 -~l~~l~~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~ 352 (941)
.+..+....++.+++++| .+.+.+|..|..+++|+.|++++|+++ .+|..+..+ +|+.|++++|.++.++.
T Consensus 249 ~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~------~L~~L~l~~n~~~~l~~ 321 (570)
T 2z63_A 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF------GWQHLELVNCKFGQFPT 321 (570)
T ss_dssp TTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC------CCSEEEEESCBCSSCCB
T ss_pred hhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC------CccEEeeccCcccccCc
Confidence 011111224677788887 677888888888889999999999888 677776543 56788888888887766
Q ss_pred CCCCCCCcEEEecCCCCc
Q 002289 353 SFNIPPNVTVRLRGNPFC 370 (941)
Q Consensus 353 ~~~~~~~~~l~l~~Np~~ 370 (941)
..++.++.|++.+|...
T Consensus 322 -~~l~~L~~L~l~~n~~~ 338 (570)
T 2z63_A 322 -LKLKSLKRLTFTSNKGG 338 (570)
T ss_dssp -CBCSSCCEEEEESCBSC
T ss_pred -ccccccCEEeCcCCccc
Confidence 36777888888888753
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-26 Score=251.02 Aligned_cols=236 Identities=20% Similarity=0.194 Sum_probs=201.3
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
..++++|+|++|++++..+..|..+++|++|+|++|++++..+ |..+++|++|+|++|++++.. ..++|++|+
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~ 105 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLH 105 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEE
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEE
Confidence 3479999999999998877899999999999999999997655 999999999999999999433 348999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccC-CCCCCCCEEeccCCcCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFE 239 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~ 239 (941)
+++|++++..+.. +++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+ ..+++|++|+|++|+|+
T Consensus 106 l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 182 (317)
T 3o53_A 106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (317)
T ss_dssp CCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence 9999999776654 5789999999999998888889999999999999999998877776 47899999999999998
Q ss_pred CCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCc
Q 002289 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 240 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
+ ++ ....+++|++|+|++|+|++.++.+. ...+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++
T Consensus 183 ~--~~-~~~~l~~L~~L~Ls~N~l~~l~~~~~--------~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~ 250 (317)
T 3o53_A 183 D--VK-GQVVFAKLKTLDLSSNKLAFMGPEFQ--------SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250 (317)
T ss_dssp E--EE-CCCCCTTCCEEECCSSCCCEECGGGG--------GGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCB
T ss_pred c--cc-cccccccCCEEECCCCcCCcchhhhc--------ccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCcc
Confidence 6 33 33459999999999999997665432 3456799999999999 57888999999999999999998
Q ss_pred -cCCCcccccccccCccccceEEcc
Q 002289 320 -GSIPSSIWQSRTLNATETFILDFQ 343 (941)
Q Consensus 320 -~~~p~~~~~l~~l~~~~L~~L~Ls 343 (941)
+.+|..+..+. .|+.|+++
T Consensus 251 ~~~~~~~~~~~~-----~L~~l~l~ 270 (317)
T 3o53_A 251 CGTLRDFFSKNQ-----RVQTVAKQ 270 (317)
T ss_dssp HHHHHHHHHTCH-----HHHHHHHH
T ss_pred CcCHHHHHhccc-----cceEEECC
Confidence 66777766544 34466666
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=234.60 Aligned_cols=227 Identities=19% Similarity=0.212 Sum_probs=181.3
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
.+..+++.++++... ..+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ + ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECC
Confidence 344555666666544 24567888899999998887 344 57888899999999999885 3 478888899999999
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
+|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++ .
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~ 172 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-L 172 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-C
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc-c
Confidence 999988878888888999999999999987777778888999999999999987777778888999999999999887 5
Q ss_pred cchhccCCCCCcEEEccCCCCcCCCCC-CCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccC
Q 002289 243 IPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 321 (941)
.+..|..+++|++|+|++|++++.++. +.. ..+|+.|+|++|.+.+. +++|+.|+++.|+++|.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ 237 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDR--------LTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGV 237 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTT--------CTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGG
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhC--------CcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCc
Confidence 666788889999999999998876664 222 34568899999988754 45788999999999999
Q ss_pred CCcccccccc
Q 002289 322 IPSSIWQSRT 331 (941)
Q Consensus 322 ~p~~~~~l~~ 331 (941)
+|.+++.+..
T Consensus 238 ip~~~~~~~~ 247 (272)
T 3rfs_A 238 VRNSAGSVAP 247 (272)
T ss_dssp BBCTTSCBCG
T ss_pred ccCcccccCC
Confidence 9998876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=264.52 Aligned_cols=190 Identities=14% Similarity=0.187 Sum_probs=145.3
Q ss_pred CccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch--------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 612 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
...+.||+|+||+||+|.. .++.+++|+....... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 5788899876542211 124589999999999999999766666677788999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. ++||+|||+|+.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999964 5579999999999999999 999999999999999 9999999999876432
Q ss_pred CCCCccccccccccccCCCccccccccc--CCCCchhHhHHHHHHHHHHHhCCCCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPI 817 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlG~ll~elltG~~Pf 817 (941)
...............||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1000000001235679999999999987 66788899999999988888877666
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=231.43 Aligned_cols=209 Identities=17% Similarity=0.230 Sum_probs=188.9
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
+.+++.|++.++.++.. +.+..+++|++|+|++|.+++ + ..+..+++|++|+|++|.+++..+..|.++++|++|+
T Consensus 40 l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 115 (272)
T 3rfs_A 40 LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV 115 (272)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEE
Confidence 34689999999998843 468999999999999999996 3 3799999999999999999988888899999999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++
T Consensus 116 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 99999998888889999999999999999998888888999999999999999998888889999999999999999998
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCccc
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRL 308 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 308 (941)
..+..|..+++|++|+|++|.+.+..| +|+.|+++.|.++|.+|..++.++..
T Consensus 196 -~~~~~~~~l~~L~~L~l~~N~~~~~~~--------------~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 196 -VPDGVFDRLTSLQYIWLHDNPWDCTCP--------------GIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp -CCTTTTTTCTTCCEEECCSSCBCCCTT--------------TTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred -cCHHHHhCCcCCCEEEccCCCccccCc--------------HHHHHHHHHHhCCCcccCcccccCCC
Confidence 577789999999999999999986554 34777899999999999999877653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-23 Score=225.36 Aligned_cols=208 Identities=24% Similarity=0.302 Sum_probs=182.2
Q ss_pred CCCCCCCCCC--CCCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCc
Q 002289 56 NWNRGDPCTS--NWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNI 129 (941)
Q Consensus 56 ~w~~~~~c~~--~w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 129 (941)
.|. +..|.| .|..|.|....+. ....+++.|+|++|++++..+..|.++++|++|+|++|+|+...+..|.++
T Consensus 6 ~~~-~~~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l 84 (270)
T 2o6q_A 6 KKD-GGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL 84 (270)
T ss_dssp GGG-TCSBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSC
T ss_pred CCC-CCCCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCC
Confidence 464 345544 5788999765433 233569999999999998777799999999999999999997777778999
Q ss_pred cccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeec
Q 002289 130 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 209 (941)
Q Consensus 130 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 209 (941)
++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 164 (270)
T 2o6q_A 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRL 164 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEe
Confidence 99999999999999877788999999999999999999988899999999999999999999777777999999999999
Q ss_pred cCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcC
Q 002289 210 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 210 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
++|++++..+..|.++++|++|+|++|+|++ ..+..|..+++|+.|+|++|.+..
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCCcCcEeChhHhccCCCcCEEECCCCcCCc-CCHHHhccccCCCEEEecCCCeeC
Confidence 9999998877789999999999999999997 456678889999999999888763
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.7e-24 Score=225.50 Aligned_cols=191 Identities=18% Similarity=0.258 Sum_probs=164.4
Q ss_pred CCCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccc
Q 002289 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142 (941)
Q Consensus 63 c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 142 (941)
|+ .|.|.+|.. ..+++++++++++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|++
T Consensus 4 Cp-~~~gC~C~~--------~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 71 (251)
T 3m19_A 4 CE-TVTGCTCNE--------GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL 71 (251)
T ss_dssp CH-HHHSSEEEG--------GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CC-CCCceEcCC--------CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcC
Confidence 43 699999953 3568999999998 4666554 6899999999999988888999999999999999999
Q ss_pred cCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccC
Q 002289 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL 222 (941)
Q Consensus 143 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 222 (941)
++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|
T Consensus 72 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 151 (251)
T 3m19_A 72 QTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHc
Confidence 98888889999999999999999998888889999999999999999997777778889999999999999997777788
Q ss_pred CCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCC
Q 002289 223 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266 (941)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (941)
..+++|++|+|++|+|++ ..+..|..+++|+.|+|++|++++.
T Consensus 152 ~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 152 DKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCcCCCEEECCCCcCCc-cCHHHHhCCCCCCEEEeeCCceeCC
Confidence 899999999999999987 5666788888888888888887643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-24 Score=238.54 Aligned_cols=227 Identities=16% Similarity=0.145 Sum_probs=172.0
Q ss_pred CCCCEEEcccCCCCCCCCC---ccCCccccceecccCccccCCCCccc--CCcCccceeecccccccccCC----ccccc
Q 002289 106 SYLTILDFMWNKISGSIPK---EIGNIKSLELLLLNGNELTGSLPEEL--GYLPKLDRIQIDQNYISGSLP----KSFAN 176 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 176 (941)
..++.|.+.++.++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3478888888777521100 12235679999999999998888887 889999999999999987655 34567
Q ss_pred ccccceEecccccccccCchhccCCCccceeeccCCcCCCC--C--CccCCCCCCCCEEeccCCcCCCCCcch----hcc
Q 002289 177 LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY--L--PPELSELPKLLILQLDNNNFEGTTIPA----SYS 248 (941)
Q Consensus 177 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~~p~----~~~ 248 (941)
+++|++|+|++|++++..+..|..+++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+.
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--l~~~~~~l~~ 221 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET--PTGVCAALAA 221 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC--HHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc--hHHHHHHHHh
Confidence 88999999999999888888888999999999999998752 2 2334788899999999999873 343 357
Q ss_pred CCCCCcEEEccCCCCcCCCCC-CCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccc
Q 002289 249 NMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 327 (941)
Q Consensus 249 ~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (941)
++++|++|+|++|+|++..|. +..+. ...+|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +.
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~-----~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~ 291 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCM-----WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PD 291 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCC-----CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TT
T ss_pred cCCCCCEEECCCCCCCccchhhHHhcc-----CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hh
Confidence 889999999999999887443 32221 1256799999999999 6677664 7899999999999853 33 22
Q ss_pred cccccCccccceEEccCCCCCC
Q 002289 328 QSRTLNATETFILDFQNNNLTN 349 (941)
Q Consensus 328 ~l~~l~~~~L~~L~Ls~N~l~~ 349 (941)
. .++|+.|+|++|.|+.
T Consensus 292 ~-----l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 292 E-----LPEVDNLTLDGNPFLV 308 (310)
T ss_dssp S-----CCCCSCEECSSTTTSC
T ss_pred h-----CCCccEEECcCCCCCC
Confidence 2 3567799999999875
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=220.34 Aligned_cols=195 Identities=17% Similarity=0.207 Sum_probs=137.6
Q ss_pred CCCEEEcccCCCCCCCCCccCCccccceecccCcc-ccCCCCcccCCcCccceeeccc-ccccccCCcccccccccceEe
Q 002289 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE-LTGSLPEELGYLPKLDRIQIDQ-NYISGSLPKSFANLNKTRHFH 184 (941)
Q Consensus 107 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 184 (941)
+|++|+|++|+|++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777776666677777777777777776 7655556777777777777777 777766667777777788888
Q ss_pred cccccccccCchhccCCCccc---eeeccCC-cCCCCCCccCCCCCCCC-EEeccCCcCCCCCcch-hccCCCCCcEEEc
Q 002289 185 MNNNSISGQIPPELSRLPSLV---HMLLDNN-NLTGYLPPELSELPKLL-ILQLDNNNFEGTTIPA-SYSNMSKLLKLSL 258 (941)
Q Consensus 185 L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~~p~-~~~~l~~L~~L~L 258 (941)
|++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ .|+|++|+++. +|. .|.. ++|++|+|
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~--i~~~~~~~-~~L~~L~L 186 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS--VQGYAFNG-TKLDAVYL 186 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCE--ECTTTTTT-CEEEEEEC
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcc--cCHhhcCC-CCCCEEEc
Confidence 88877775 555 67777776 7888887 77766666677778888 88888887773 333 3444 77888888
Q ss_pred cCCC-CcCCCCCCCCCCccccccc-CCcCEEEccCCcCCCCcchhhcCCcccceeecccc
Q 002289 259 RNCS-LQGPMPDLSRIPNLGYLLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 316 (941)
Q Consensus 259 s~N~-l~~~~~~~~~l~~l~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 316 (941)
++|+ +++..+. .+... .+|+.|+|++|+|++..+. .+++|+.|+++++
T Consensus 187 ~~n~~l~~i~~~-------~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 187 NKNKYLTVIDKD-------AFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TTCTTCCEECTT-------TTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCCcccCCHH-------HhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 8884 7754443 11222 4567888888888754443 5667788888776
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-23 Score=223.13 Aligned_cols=199 Identities=24% Similarity=0.206 Sum_probs=167.1
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.++++|++.+++++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|.+++..+ . +.+++|++|+|
T Consensus 10 ~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~L 84 (290)
T 1p9a_G 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDL 84 (290)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEEC
T ss_pred CCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEEC
Confidence 36899999999998 4666554 789999999999998888999999999999999999995433 3 78999999999
Q ss_pred ccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCC
Q 002289 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (941)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 241 (941)
++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++
T Consensus 85 s~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~- 162 (290)
T 1p9a_G 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE- 162 (290)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-
T ss_pred CCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc-
Confidence 999998 778899999999999999999998888899999999999999999998888889999999999999999996
Q ss_pred CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCC
Q 002289 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT 295 (941)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~ 295 (941)
..+..|..+++|++|+|++|+|+..++.+... .+|+.|+|++|++.
T Consensus 163 l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~--------~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 163 LPAGLLNGLENLDTLLLQENSLYTIPKGFFGS--------HLLPFAFLHGNPWL 208 (290)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT--------CCCSEEECCSCCBC
T ss_pred cCHHHhcCcCCCCEEECCCCcCCccChhhccc--------ccCCeEEeCCCCcc
Confidence 45566788889988888888887444332211 23455555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-25 Score=261.73 Aligned_cols=287 Identities=16% Similarity=0.128 Sum_probs=213.4
Q ss_pred eeeEEEecCCCCCc----cCCccccCCCCCCEEEcccCCCCCCCCCccC-----CccccceecccCccccCCC----Ccc
Q 002289 83 HLRELQLLNLNLSG----NLSPEIGRLSYLTILDFMWNKISGSIPKEIG-----NIKSLELLLLNGNELTGSL----PEE 149 (941)
Q Consensus 83 ~l~~L~L~~~~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~----p~~ 149 (941)
++++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|++++.. +..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 58899999998884 4677888899999999999988754333332 2567999999999888643 556
Q ss_pred cCCcCccceeecccccccccCCccccc-----ccccceEeccccccccc----CchhccCCCccceeeccCCcCCCCC--
Q 002289 150 LGYLPKLDRIQIDQNYISGSLPKSFAN-----LNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLTGYL-- 218 (941)
Q Consensus 150 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-- 218 (941)
+..+++|++|+|++|.++...+..+.. +++|++|+|++|++++. ++..+..+++|++|+|++|+++...
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 677789999999999987655554443 56899999999998864 5677778899999999999887532
Q ss_pred ---CccCCCCCCCCEEeccCCcCCCCC---cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCC
Q 002289 219 ---PPELSELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNN 292 (941)
Q Consensus 219 ---p~~~~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N 292 (941)
+..+..+++|++|+|++|.++... ++..+..+++|++|+|++|.+++..+. .+...-.....+|++|+|++|
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~--~l~~~l~~~~~~L~~L~L~~n 323 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR--LLCETLLEPGCQLESLWVKSC 323 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH--HHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH--HHHHHhccCCccceeeEcCCC
Confidence 233446889999999999987521 567788899999999999988642211 011110111247899999999
Q ss_pred cCCCC----cchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCC-----CCCCCC-CCCCCcEE
Q 002289 293 KLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-----NISGSF-NIPPNVTV 362 (941)
Q Consensus 293 ~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~-----~~~~~~-~~~~~~~l 362 (941)
.+++. ++..+..+++|+.|+|++|++++..+..+...-.-..++|+.|+|++|.++ .++..+ ..+.++.|
T Consensus 324 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L 403 (461)
T 1z7x_W 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403 (461)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred CCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEE
Confidence 99976 577788889999999999999876666555432222468899999999998 344444 57889999
Q ss_pred EecCCCCcc
Q 002289 363 RLRGNPFCL 371 (941)
Q Consensus 363 ~l~~Np~~c 371 (941)
+|++|++..
T Consensus 404 ~l~~N~i~~ 412 (461)
T 1z7x_W 404 DLSNNCLGD 412 (461)
T ss_dssp ECCSSSCCH
T ss_pred ECCCCCCCH
Confidence 999998754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-23 Score=244.99 Aligned_cols=212 Identities=29% Similarity=0.362 Sum_probs=137.0
Q ss_pred CCCCCC---CCCce-EecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCcccccee
Q 002289 60 GDPCTS---NWTGV-LCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELL 135 (941)
Q Consensus 60 ~~~c~~---~w~gv-~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 135 (941)
.++|.. .|.|+ .|... +++.|+|++|+|++ +|..+ +++|+.|+|++|+|+ .+| ..+++|++|
T Consensus 40 ~~~~~~~~~~~~~l~~C~~~-------~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L 105 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECLIN-------QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYL 105 (571)
T ss_dssp CCTTCCHHHHHHHHHHHHHT-------TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEE
T ss_pred CCccccccchhhhccccccC-------CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEE
Confidence 445533 58898 78542 57888888888886 66655 377888888888888 566 446778888
Q ss_pred cccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCC
Q 002289 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 136 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 215 (941)
+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|+
T Consensus 106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~ 173 (571)
T 3cvr_A 106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLT 173 (571)
T ss_dssp ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCC
Confidence 888888875 665 554 77777777777775 444 45666666666666664 443 3456666666666665
Q ss_pred CCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCC
Q 002289 216 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT 295 (941)
Q Consensus 216 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~ 295 (941)
+ +|. |. ++|+.|+|++|+|+. +|. |.. +| +.....|+.|+|++|+|+
T Consensus 174 ~-lp~-l~--~~L~~L~Ls~N~L~~--lp~-~~~--~L------------------------~~~~~~L~~L~Ls~N~l~ 220 (571)
T 3cvr_A 174 F-LPE-LP--ESLEALDVSTNLLES--LPA-VPV--RN------------------------HHSEETEIFFRCRENRIT 220 (571)
T ss_dssp C-CCC-CC--TTCCEEECCSSCCSS--CCC-CC----------------------------------CCEEEECCSSCCC
T ss_pred C-cch-hh--CCCCEEECcCCCCCc--hhh-HHH--hh------------------------hcccccceEEecCCCcce
Confidence 4 444 43 555555555555552 333 221 22 001122377778888777
Q ss_pred CCcchhhcCCcccceeecccccCccCCCcccccccc
Q 002289 296 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 331 (941)
Q Consensus 296 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (941)
.+|..+..+++|+.|+|++|+|++.+|..+..+..
T Consensus 221 -~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp -CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred -ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 56777777888888888888888888887776654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=8.5e-23 Score=224.29 Aligned_cols=200 Identities=23% Similarity=0.363 Sum_probs=139.2
Q ss_pred ccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccc
Q 002289 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (941)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (941)
+..+++|++|++++|.++. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 3456667777777777663 44 46667777777777777774333 67777777777777777643 2567777777
Q ss_pred eEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCC
Q 002289 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC 261 (941)
Q Consensus 182 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 261 (941)
+|+|++|++++ ++. +..+++|++|++++|++++..+ +..+++|+.|+|++|++++ ++. +..+++|+.|+|++|
T Consensus 111 ~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n 183 (308)
T 1h6u_A 111 TLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--LTP-LANLSKLTTLKADDN 183 (308)
T ss_dssp EEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGG-GTTCTTCCEEECCSS
T ss_pred EEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC--Chh-hcCCCCCCEEECCCC
Confidence 77777777774 332 6777777777777777775433 7777788888888887775 333 777788888888888
Q ss_pred CCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCccc
Q 002289 262 SLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 326 (941)
Q Consensus 262 ~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 326 (941)
++++..+ +....+|++|+|++|+|++..+ +..+++|+.|+|++|+++ ..|..+
T Consensus 184 ~l~~~~~---------l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~-~~~~~~ 236 (308)
T 1h6u_A 184 KISDISP---------LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT-NQPVFY 236 (308)
T ss_dssp CCCCCGG---------GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE-CCCEEC
T ss_pred ccCcChh---------hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee-cCCeee
Confidence 7775433 2233556888888888886653 888999999999999998 444443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-22 Score=213.95 Aligned_cols=180 Identities=22% Similarity=0.285 Sum_probs=112.8
Q ss_pred CCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecc
Q 002289 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (941)
Q Consensus 107 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (941)
..++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3556777777776 4555443 467777777777776666666777777777777777766666666666666666666
Q ss_pred cccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCC
Q 002289 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP 266 (941)
Q Consensus 187 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 266 (941)
+|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++ ..+..|..+++|+
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~------------ 158 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQ------------ 158 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCC------------
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc-cCHHHcCcCcCCC------------
Confidence 666665555556666666666666666665555555666666666666666654 2333455555554
Q ss_pred CCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccC
Q 002289 267 MPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321 (941)
Q Consensus 267 ~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 321 (941)
+|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 159 -------------------~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 159 -------------------TLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp -------------------EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred -------------------EEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 445555555545555666677777777777777644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=213.06 Aligned_cols=178 Identities=22% Similarity=0.279 Sum_probs=91.2
Q ss_pred ccceecccCccccCCCCcccCCcCccceeeccccc-ccccCCcccccccccceEeccc-ccccccCchhccCCCccceee
Q 002289 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY-ISGSLPKSFANLNKTRHFHMNN-NSISGQIPPELSRLPSLVHML 208 (941)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 208 (941)
+|++|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444455555555555555554 5544444555555555555555 555544444555555555555
Q ss_pred ccCCcCCCCCCccCCCCCCCC---EEeccCC-cCCCCCcchhccCCCCCc-EEEccCCCCcCCCCCCCCCCcccccccCC
Q 002289 209 LDNNNLTGYLPPELSELPKLL---ILQLDNN-NFEGTTIPASYSNMSKLL-KLSLRNCSLQGPMPDLSRIPNLGYLLSLN 283 (941)
Q Consensus 209 L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~ 283 (941)
+++|++++ +|. |..+++|+ +|+|++| ++++ ..+..|.++++|+ +|++++|+++..++.. +.. .+
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~-i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~-------~~~-~~ 180 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTS-IPVNAFQGLCNETLTLKLYNNGFTSVQGYA-------FNG-TK 180 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCE-ECTTTTTTTBSSEEEEECCSCCCCEECTTT-------TTT-CE
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhh-cCcccccchhcceeEEEcCCCCCcccCHhh-------cCC-CC
Confidence 55555553 333 55555555 5555555 5543 2333455555555 5555555554222211 111 23
Q ss_pred cCEEEccCCc-CCCCcchhhcCC-cccceeecccccCc
Q 002289 284 ITTIKLSNNK-LTGTIPSNFSGL-PRLQRLFIANNSLS 319 (941)
Q Consensus 284 L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~ 319 (941)
|+.|+|++|+ |++..+..|.++ ++|+.|++++|+|+
T Consensus 181 L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp EEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 4555555553 554445555555 55555555555555
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-24 Score=240.34 Aligned_cols=261 Identities=16% Similarity=0.154 Sum_probs=186.0
Q ss_pred EEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCC----CccCCcc-ccceecccCccccCCCCcccCCc-----Cc
Q 002289 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIP----KEIGNIK-SLELLLLNGNELTGSLPEELGYL-----PK 155 (941)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 155 (941)
.++++.++++|.+|..+...++|++|+|++|.|++..+ ..|.+++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35788889998888777777889999999999987666 6777888 89999999999998877777775 89
Q ss_pred cceeecccccccccCCcccccc-----cccceEecccccccccCchhcc----C-CCccceeeccCCcCCCCCC----cc
Q 002289 156 LDRIQIDQNYISGSLPKSFANL-----NKTRHFHMNNNSISGQIPPELS----R-LPSLVHMLLDNNNLTGYLP----PE 221 (941)
Q Consensus 156 L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~L~~N~l~~~~p----~~ 221 (941)
|++|+|++|.+++..+..+... ++|++|+|++|+|++..+..+. . .++|++|+|++|+++.... ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999988777755544 8999999999999877665543 3 3589999999999985433 33
Q ss_pred CCCCC-CCCEEeccCCcCCCCCcch----hccCC-CCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCC
Q 002289 222 LSELP-KLLILQLDNNNFEGTTIPA----SYSNM-SKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT 295 (941)
Q Consensus 222 ~~~l~-~L~~L~Ls~N~l~~~~~p~----~~~~l-~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~ 295 (941)
+..++ +|++|+|++|+|++ ..+. .+..+ ++|++|+|++|+|++.... .++..-.....+|++|+|++|+|+
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~--~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLAS-KNCAELAKFLASIPASVTSLDLSANLLGLKSYA--ELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGG-SCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH--HHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HhcCCccccEeeecCCCCch-hhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH--HHHHHHhcCCCCceEEECcCCCCC
Confidence 44555 89999999999886 3443 34445 5899999999988742110 011110011246788888888888
Q ss_pred CCcc----hhhcCCcccceeecccccCccCCCcccccccc--cCccccceEEccCCCCCC
Q 002289 296 GTIP----SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT--LNATETFILDFQNNNLTN 349 (941)
Q Consensus 296 ~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--l~~~~L~~L~Ls~N~l~~ 349 (941)
+..+ ..+..+++|+.|+|++|++.+..+..+..+.. -...+|+.|||++|+|..
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 7655 33456788888888888866443332322211 123456677777777654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=222.91 Aligned_cols=224 Identities=19% Similarity=0.191 Sum_probs=185.7
Q ss_pred eeeEEEecCCCCCccCCc---cccCCCCCCEEEcccCCCCCCCCCcc--CCccccceecccCccccCCCC----cccCCc
Q 002289 83 HLRELQLLNLNLSGNLSP---EIGRLSYLTILDFMWNKISGSIPKEI--GNIKSLELLLLNGNELTGSLP----EELGYL 153 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~---~l~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l 153 (941)
+++.+.+.++.++...-. .+..+++|++|+|++|++.+..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 478889998888643111 22345779999999999999999888 999999999999999998666 445689
Q ss_pred CccceeecccccccccCCcccccccccceEeccccccccc--Cc--hhccCCCccceeeccCCcCCCCCCc----cCCCC
Q 002289 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ--IP--PELSRLPSLVHMLLDNNNLTGYLPP----ELSEL 225 (941)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p--~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l 225 (941)
++|++|+|++|.+++..+..|..+++|++|+|++|++.+. ++ ..+..+++|++|+|++|+++. ++. .++.+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 9999999999999999999999999999999999998753 22 234689999999999999973 333 35788
Q ss_pred CCCCEEeccCCcCCCCCcchhccCC---CCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhh
Q 002289 226 PKLLILQLDNNNFEGTTIPASYSNM---SKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNF 302 (941)
Q Consensus 226 ~~L~~L~Ls~N~l~~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~ 302 (941)
++|++|+|++|+|++ ..|..+..+ ++|++|+|++|+|+..+..+ ..+|++|+|++|+|++. |. +
T Consensus 224 ~~L~~L~Ls~N~l~~-~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~----------~~~L~~L~Ls~N~l~~~-~~-~ 290 (310)
T 4glp_A 224 VQPHSLDLSHNSLRA-TVNPSAPRCMWSSALNSLNLSFAGLEQVPKGL----------PAKLRVLDLSSNRLNRA-PQ-P 290 (310)
T ss_dssp CCCSSEECTTSCCCC-CCCSCCSSCCCCTTCCCEECCSSCCCSCCSCC----------CSCCSCEECCSCCCCSC-CC-T
T ss_pred CCCCEEECCCCCCCc-cchhhHHhccCcCcCCEEECCCCCCCchhhhh----------cCCCCEEECCCCcCCCC-ch-h
Confidence 999999999999997 567777776 69999999999999543322 15789999999999975 33 6
Q ss_pred cCCcccceeecccccCcc
Q 002289 303 SGLPRLQRLFIANNSLSG 320 (941)
Q Consensus 303 ~~l~~L~~L~Ls~N~l~~ 320 (941)
..+++|+.|+|++|+|+.
T Consensus 291 ~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 291 DELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TSCCCCSCEECSSTTTSC
T ss_pred hhCCCccEEECcCCCCCC
Confidence 889999999999999974
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=208.50 Aligned_cols=181 Identities=19% Similarity=0.250 Sum_probs=130.3
Q ss_pred CCCCCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCc
Q 002289 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (941)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (941)
+.|.|.|.+|.|.... ++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 3 ~~C~C~~~~v~c~~~~-----------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 62 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQG-----------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN 62 (208)
T ss_dssp TTCEEETTEEECCSSC-----------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCEECCCEEEecCCC-----------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCC
Confidence 5688899999996543 22 223222 346777777777777666666777777777777777
Q ss_pred cccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCc
Q 002289 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 220 (941)
Q Consensus 141 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 220 (941)
++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+.
T Consensus 63 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 142 (208)
T 2o6s_A 63 KLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence 77766566677777777777777777766666677777777777777777766666677777788888888877766666
Q ss_pred cCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCC
Q 002289 221 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD 269 (941)
Q Consensus 221 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 269 (941)
.|..+++|+.|+|++|.+.+ .+++|++|+++.|+++|.+|.
T Consensus 143 ~~~~l~~L~~L~l~~N~~~~--------~~~~l~~L~~~~n~~~g~ip~ 183 (208)
T 2o6s_A 143 VFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSEWINKHSGVVRN 183 (208)
T ss_dssp TTTTCTTCCEEECCSCCBCC--------CTTTTHHHHHHHHHCTTTBBC
T ss_pred HhccCCCccEEEecCCCeec--------CCCCHHHHHHHHHhCCceeec
Confidence 67777788888888877664 245777777888888777664
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.5e-22 Score=223.59 Aligned_cols=246 Identities=19% Similarity=0.176 Sum_probs=158.9
Q ss_pred eEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCC-cccCCcCccce-eecc
Q 002289 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP-EELGYLPKLDR-IQID 162 (941)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~Ls 162 (941)
+.++.++++|+ .+|..+ .++|++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 35778888888 566655 3678888888888885555678888888888888888765555 46777877664 5566
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccC-CcCCCCCCccCCCCC-CCCEEeccCCcCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN-NNLTGYLPPELSELP-KLLILQLDNNNFEG 240 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 240 (941)
.|+|++..|+.|.++++|++|++++|+|++..+..+....++..|++.+ |++....+..|..+. .|+.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 7778777777777788888888888877765555566666666777654 455544444555543 45566666666653
Q ss_pred CCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccC-CcCCCCcchhhcCCcccceeecccccCc
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
+|.......+| +.|++++ |.++.+.+..|.++++|+.|+|++|+|+
T Consensus 169 --i~~~~f~~~~L-------------------------------~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 169 --IHNSAFNGTQL-------------------------------DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp --ECTTSSTTEEE-------------------------------EEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred --CChhhccccch-------------------------------hHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 33332233334 5555543 4455444456677777777777777777
Q ss_pred cCCCcccccccccCccccceEEc-cCCCCCCCCCCCCCCCCcEEEecCCCCccCCCc
Q 002289 320 GSIPSSIWQSRTLNATETFILDF-QNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNA 375 (941)
Q Consensus 320 ~~~p~~~~~l~~l~~~~L~~L~L-s~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~ 375 (941)
.+|... ..+|+.|.+ +.++++.+|.--.++.+..+++. |||.|.|-.
T Consensus 216 -~lp~~~-------~~~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~-~~~~c~~~~ 263 (350)
T 4ay9_X 216 -SLPSYG-------LENLKKLRARSTYNLKKLPTLEKLVALMEASLT-YPSHCCAFA 263 (350)
T ss_dssp -CCCSSS-------CTTCCEEECTTCTTCCCCCCTTTCCSCCEEECS-CHHHHHHHH
T ss_pred -ccChhh-------hccchHhhhccCCCcCcCCCchhCcChhhCcCC-CCccccchh
Confidence 444432 122333433 34566777754467788888885 788886643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.7e-24 Score=236.68 Aligned_cols=260 Identities=14% Similarity=0.177 Sum_probs=208.2
Q ss_pred CCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCC--CCCCEEEcccCCCCCCCCCccCCccccceecccCcccc
Q 002289 66 NWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRL--SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143 (941)
Q Consensus 66 ~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 143 (941)
.|.++.|... .++.|+++++++. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.++
T Consensus 38 ~W~~~~~~~~-------~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~ 106 (336)
T 2ast_B 38 RWYRLASDES-------LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE 106 (336)
T ss_dssp HHHHHHTCST-------TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC
T ss_pred HHHHHhcCch-------hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC
Confidence 6999887532 3789999998887 4567777 8999999999999987765 668999999999999998
Q ss_pred CC-CCcccCCcCccceeecccccccccCCcccccccccceEecccc-ccccc-CchhccCCCccceeeccCC-cCCCC-C
Q 002289 144 GS-LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN-SISGQ-IPPELSRLPSLVHMLLDNN-NLTGY-L 218 (941)
Q Consensus 144 ~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~ 218 (941)
+. ++..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+..+++|++|++++| .+++. +
T Consensus 107 ~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~ 186 (336)
T 2ast_B 107 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186 (336)
T ss_dssp HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHH
T ss_pred HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHH
Confidence 66 8888999999999999999999888999999999999999999 68763 6777889999999999999 99864 5
Q ss_pred CccCCCCC-CCCEEeccCC--cCCCCCcchhccCCCCCcEEEccCCC-CcCCCCCCCCCCcccccccCCcCEEEccCCc-
Q 002289 219 PPELSELP-KLLILQLDNN--NFEGTTIPASYSNMSKLLKLSLRNCS-LQGPMPDLSRIPNLGYLLSLNITTIKLSNNK- 293 (941)
Q Consensus 219 p~~~~~l~-~L~~L~Ls~N--~l~~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~- 293 (941)
+..+..++ +|++|+|++| .++...++..+..+++|++|+|++|. +++..+. . +....+|++|+|++|.
T Consensus 187 ~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~-----~--l~~l~~L~~L~l~~~~~ 259 (336)
T 2ast_B 187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ-----E--FFQLNYLQHLSLSRCYD 259 (336)
T ss_dssp HHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG-----G--GGGCTTCCEEECTTCTT
T ss_pred HHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH-----H--HhCCCCCCEeeCCCCCC
Confidence 67788899 9999999999 55533577888899999999999999 6543221 1 1223677999999995
Q ss_pred CCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCC
Q 002289 294 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 351 (941)
Q Consensus 294 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~ 351 (941)
+.......+.++++|+.|++++| ++. ..+..+. ..++.|++++|+++++.
T Consensus 260 ~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~----~~l~~L~l~~n~l~~~~ 309 (336)
T 2ast_B 260 IIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLK----EALPHLQINCSHFTTIA 309 (336)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHH----HHSTTSEESCCCSCCTT
T ss_pred CCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHH----hhCcceEEecccCcccc
Confidence 33333336888999999999999 432 2233221 23567789999998864
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.1e-21 Score=228.50 Aligned_cols=222 Identities=24% Similarity=0.297 Sum_probs=146.6
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEEC
Confidence 467888888887773 444 5677888888888877 4554 56777777777777774 443 4566777777
Q ss_pred ccccccccCCcccccccccceEecccccccccCchhc-----------------cCCCccceeeccCCcCCCCCCccCCC
Q 002289 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-----------------SRLPSLVHMLLDNNNLTGYLPPELSE 224 (941)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----------------~~l~~L~~L~L~~N~l~~~~p~~~~~ 224 (941)
++|+|++ +|.. +++|++|+|++|++++ +|..+ ..+++|+.|+|++|+|++ +|..
T Consensus 129 ~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~--- 199 (622)
T 3g06_A 129 FGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTL--- 199 (622)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCC---
T ss_pred CCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCc---
Confidence 7777764 3432 3666777777776663 33221 122455555555555553 2221
Q ss_pred CCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcC
Q 002289 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSG 304 (941)
Q Consensus 225 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~ 304 (941)
+++|+.|++++|.|+. +|. .+++|+.|+|++|+|++.+. ...+|+.|+|++|+|+. +|. .
T Consensus 200 ~~~L~~L~L~~N~l~~--l~~---~~~~L~~L~Ls~N~L~~lp~-----------~l~~L~~L~Ls~N~L~~-lp~---~ 259 (622)
T 3g06_A 200 PSELYKLWAYNNRLTS--LPA---LPSGLKELIVSGNRLTSLPV-----------LPSELKELMVSGNRLTS-LPM---L 259 (622)
T ss_dssp CTTCCEEECCSSCCSS--CCC---CCTTCCEEECCSSCCSCCCC-----------CCTTCCEEECCSSCCSC-CCC---C
T ss_pred cchhhEEECcCCcccc--cCC---CCCCCCEEEccCCccCcCCC-----------CCCcCcEEECCCCCCCc-CCc---c
Confidence 2455555555555553 332 23667777777777765321 22568999999999994 555 6
Q ss_pred CcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCC
Q 002289 305 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350 (941)
Q Consensus 305 l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~ 350 (941)
+++|+.|+|++|+|+ .+|..+..+ ++|+.|+|++|.|+..
T Consensus 260 ~~~L~~L~Ls~N~L~-~lp~~l~~l-----~~L~~L~L~~N~l~~~ 299 (622)
T 3g06_A 260 PSGLLSLSVYRNQLT-RLPESLIHL-----SSETTVNLEGNPLSER 299 (622)
T ss_dssp CTTCCEEECCSSCCC-SCCGGGGGS-----CTTCEEECCSCCCCHH
T ss_pred cccCcEEeCCCCCCC-cCCHHHhhc-----cccCEEEecCCCCCCc
Confidence 789999999999999 889888764 4567999999999875
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=218.99 Aligned_cols=244 Identities=16% Similarity=0.133 Sum_probs=194.5
Q ss_pred CCCCCCCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCC-CccCCccccce-e
Q 002289 62 PCTSNWTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIP-KEIGNIKSLEL-L 135 (941)
Q Consensus 62 ~c~~~w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L 135 (941)
.|.|.|..|.|.+..+. +...++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|++ +
T Consensus 6 ~C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 6 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp SSEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred ccEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 48789999999864432 234679999999999996555689999999999999999977665 57899998775 6
Q ss_pred cccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEeccc-ccccccCchhccCCC-ccceeeccCCc
Q 002289 136 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN-NSISGQIPPELSRLP-SLVHMLLDNNN 213 (941)
Q Consensus 136 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~L~~N~ 213 (941)
++++|+++...|..|.++++|++|++++|+|++..+..+....++..|++.+ |++....+..|..+. .|+.|+|++|+
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred cccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence 7788999988899999999999999999999988888888888999999966 677766666777765 68999999999
Q ss_pred CCCCCCccCCCCCCCCEEeccC-CcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCC
Q 002289 214 LTGYLPPELSELPKLLILQLDN-NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNN 292 (941)
Q Consensus 214 l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N 292 (941)
|+. ++.......+|+.|++++ |.++. ..+..|.++++|++|+|++|+|+..++.. ..+|+.|.+.++
T Consensus 166 i~~-i~~~~f~~~~L~~l~l~~~n~l~~-i~~~~f~~l~~L~~LdLs~N~l~~lp~~~----------~~~L~~L~~l~~ 233 (350)
T 4ay9_X 166 IQE-IHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIHSLPSYG----------LENLKKLRARST 233 (350)
T ss_dssp CCE-ECTTSSTTEEEEEEECTTCTTCCC-CCTTTTTTEECCSEEECTTSCCCCCCSSS----------CTTCCEEECTTC
T ss_pred ccC-CChhhccccchhHHhhccCCcccC-CCHHHhccCcccchhhcCCCCcCccChhh----------hccchHhhhccC
Confidence 995 455555567899999985 66764 34467899999999999999999665431 234567766555
Q ss_pred cCCCCcchhhcCCcccceeecccccC
Q 002289 293 KLTGTIPSNFSGLPRLQRLFIANNSL 318 (941)
Q Consensus 293 ~l~~~~p~~~~~l~~L~~L~Ls~N~l 318 (941)
.--..+| .+.++++|+.++++++.-
T Consensus 234 ~~l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 234 YNLKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp TTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred CCcCcCC-CchhCcChhhCcCCCCcc
Confidence 4333666 478889999999987653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-24 Score=252.15 Aligned_cols=286 Identities=15% Similarity=0.140 Sum_probs=185.7
Q ss_pred ceeeEEEecCCCCCc----cCCccccCCCCCCEEEcccCCCCCCCCCcc-CCcc----ccceecccCccccC----CCCc
Q 002289 82 LHLRELQLLNLNLSG----NLSPEIGRLSYLTILDFMWNKISGSIPKEI-GNIK----SLELLLLNGNELTG----SLPE 148 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~----~L~~L~Ls~N~l~~----~~p~ 148 (941)
.+++.|+|++|++++ .++..+..+++|++|+|++|.++...+..+ ..+. +|++|+|++|+++. .++.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 357777787777764 245567777788888888877764333222 2233 58888888887773 4567
Q ss_pred ccCCcCccceeecccccccccCCccccc-----ccccceEecccccccccC----chhccCCCccceeeccCCcCCCCCC
Q 002289 149 ELGYLPKLDRIQIDQNYISGSLPKSFAN-----LNKTRHFHMNNNSISGQI----PPELSRLPSLVHMLLDNNNLTGYLP 219 (941)
Q Consensus 149 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p 219 (941)
.+..+++|++|+|++|.+++..+..+.. .++|++|+|++|++++.. +..+..+++|++|+|++|.++...+
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 187 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHH
Confidence 7777788888888888776544443332 456888888888777533 4555667788888888887765433
Q ss_pred ccCC-----CCCCCCEEeccCCcCCCCC---cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccC
Q 002289 220 PELS-----ELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSN 291 (941)
Q Consensus 220 ~~~~-----~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~ 291 (941)
..+. ..++|++|+|++|.+++.. ++..+..+++|++|+|++|++++.... .+....+....+|++|+|++
T Consensus 188 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~--~l~~~~~~~~~~L~~L~L~~ 265 (461)
T 1z7x_W 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA--ELCPGLLHPSSRLRTLWIWE 265 (461)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH--HHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH--HHHHHHhcCCCCceEEECcC
Confidence 3332 2557888888888877521 466677778888888888877632100 00000011235678888888
Q ss_pred CcCCCC----cchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCC-----CCC-CCCCCcE
Q 002289 292 NKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-----GSF-NIPPNVT 361 (941)
Q Consensus 292 N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~-----~~~-~~~~~~~ 361 (941)
|.|+.. ++..+..+++|+.|+|++|++++..+..+...-.-..++|+.|+|++|.++... ..+ ..+.+++
T Consensus 266 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 345 (461)
T 1z7x_W 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCE
T ss_pred CCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccE
Confidence 888764 577777788888888888888755555554433223357788888888887642 111 3567788
Q ss_pred EEecCCCC
Q 002289 362 VRLRGNPF 369 (941)
Q Consensus 362 l~l~~Np~ 369 (941)
|+|++|.+
T Consensus 346 L~Ls~n~i 353 (461)
T 1z7x_W 346 LQISNNRL 353 (461)
T ss_dssp EECCSSBC
T ss_pred EEccCCcc
Confidence 88888864
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=217.55 Aligned_cols=153 Identities=12% Similarity=0.056 Sum_probs=122.7
Q ss_pred hHHHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc------------------hhhHhHHHHHHHHHhc
Q 002289 601 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRL 662 (941)
Q Consensus 601 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 662 (941)
...+......|.+.+.||+|+||.||+|.+.+|+.||||+++.... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555666778899999999999999997799999999864321 1245688999999999
Q ss_pred CCCceeeeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEE
Q 002289 663 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 742 (941)
Q Consensus 663 ~h~nIv~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 742 (941)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|+++||+|||+.+ |+||||||+|||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 9 5 666665543 56699999999999998 421 123469999999999999999 999999999999
Q ss_pred EcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccc
Q 002289 743 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790 (941)
Q Consensus 743 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 790 (941)
++ ++.+||+|||+|+.. ..|+|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~~--------------------~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV--------------------GEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEET--------------------TSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeEC--------------------CCCCHHHHHH
Confidence 99 999999999998732 3578899874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-23 Score=237.93 Aligned_cols=237 Identities=20% Similarity=0.287 Sum_probs=126.0
Q ss_pred eeeEEEecCCCCCcc----CCccccCCCCCCEEEcccC---CCCCCCCCcc-------CCccccceecccCccccC----
Q 002289 83 HLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWN---KISGSIPKEI-------GNIKSLELLLLNGNELTG---- 144 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls~N~l~~---- 144 (941)
+++.|+|++|++++. ++..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|.+++
T Consensus 33 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 112 (386)
T 2ca6_A 33 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 112 (386)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHH
Confidence 456666666666554 2233556666666666664 3333444333 455666666666666664
Q ss_pred CCCcccCCcCccceeecccccccccCCcccc----cc---------cccceEeccccccc-ccCc---hhccCCCcccee
Q 002289 145 SLPEELGYLPKLDRIQIDQNYISGSLPKSFA----NL---------NKTRHFHMNNNSIS-GQIP---PELSRLPSLVHM 207 (941)
Q Consensus 145 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L 207 (941)
.+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++ +.++ ..+..+++|++|
T Consensus 113 ~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L 192 (386)
T 2ca6_A 113 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 192 (386)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEE
Confidence 2455556666666666666666543333322 22 56666666666665 2333 344555666666
Q ss_pred eccCCcCC--C---CCCccCCCCCCCCEEeccCCcCC----CCCcchhccCCCCCcEEEccCCCCcCCCCCCCCC-Cccc
Q 002289 208 LLDNNNLT--G---YLPPELSELPKLLILQLDNNNFE----GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRI-PNLG 277 (941)
Q Consensus 208 ~L~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l-~~l~ 277 (941)
+|++|+++ | ..+..+..+++|+.|+|++|.|+ + .+|..+..+++|++|+|++|+|++.... .+ ..+.
T Consensus 193 ~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~--~l~~~l~ 269 (386)
T 2ca6_A 193 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS-ALAIALKSWPNLRELGLNDCLLSARGAA--AVVDAFS 269 (386)
T ss_dssp ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH-HHHHHGGGCTTCCEEECTTCCCCHHHHH--HHHHHHH
T ss_pred ECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHH-HHHHHHccCCCcCEEECCCCCCchhhHH--HHHHHHh
Confidence 66666665 2 22335556666666666666663 2 3455566666666666666665532000 00 0000
Q ss_pred ccccCCcCEEEccCCcCCC----Ccchhh-cCCcccceeecccccCccCC
Q 002289 278 YLLSLNITTIKLSNNKLTG----TIPSNF-SGLPRLQRLFIANNSLSGSI 322 (941)
Q Consensus 278 ~l~~~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~ 322 (941)
.....+|++|+|++|.|++ .+|..+ .++++|+.|+|++|++++..
T Consensus 270 ~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp TCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred hccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 0113345666666666665 355554 44566666666666665444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=199.93 Aligned_cols=181 Identities=17% Similarity=0.218 Sum_probs=143.9
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccc
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (941)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 56788888887 556544 458999999999999777777889999999999999999777777888999999999999
Q ss_pred cccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCC
Q 002289 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (941)
Q Consensus 189 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (941)
++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++ ..+..|..+++|++|+|++|.+.+..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccce-eCHHHhccCCCccEEEecCCCeecCCC
Confidence 9997767778889999999999999987777778889999999999999886 455567888888888888887764433
Q ss_pred CCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcc
Q 002289 269 DLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPR 307 (941)
Q Consensus 269 ~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 307 (941)
+|+.|+++.|+++|.+|..++.++.
T Consensus 166 --------------~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 166 --------------GIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp --------------TTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred --------------CHHHHHHHHHhCCceeeccCccccC
Confidence 2355566666666666666665544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.8e-23 Score=233.69 Aligned_cols=259 Identities=15% Similarity=0.169 Sum_probs=201.5
Q ss_pred EEEcccCCCCCCCCCccCCccccceecccCccccCCCC----cccCCcC-ccceeecccccccccCCcccccc-----cc
Q 002289 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP----EELGYLP-KLDRIQIDQNYISGSLPKSFANL-----NK 179 (941)
Q Consensus 110 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 179 (941)
.++|++|++++.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|.|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888878889999999999997777 7788898 99999999999998888888876 99
Q ss_pred cceEecccccccccCchhcc----CC-CccceeeccCCcCCCCCCccC----CC-CCCCCEEeccCCcCCCC---Ccchh
Q 002289 180 TRHFHMNNNSISGQIPPELS----RL-PSLVHMLLDNNNLTGYLPPEL----SE-LPKLLILQLDNNNFEGT---TIPAS 246 (941)
Q Consensus 180 L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~~----~~-l~~L~~L~Ls~N~l~~~---~~p~~ 246 (941)
|++|+|++|++++..+..+. .+ ++|++|+|++|++++..+..+ .. .++|++|+|++|+|++. .++..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 99999999999988777544 44 899999999999997766543 44 36999999999999852 13344
Q ss_pred ccCCC-CCcEEEccCCCCcCCCCCCCCCCccccccc-CCcCEEEccCCcCCCC----cchhhcCC-cccceeecccccCc
Q 002289 247 YSNMS-KLLKLSLRNCSLQGPMPDLSRIPNLGYLLS-LNITTIKLSNNKLTGT----IPSNFSGL-PRLQRLFIANNSLS 319 (941)
Q Consensus 247 ~~~l~-~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~-~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l~ 319 (941)
+..++ +|++|+|++|+|++..+. .+... +... .+|++|+|++|.|++. ++..+..+ ++|+.|+|++|+|+
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~--~l~~~-l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCA--ELAKF-LASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHH--HHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HhcCCccccEeeecCCCCchhhHH--HHHHH-HHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 56666 999999999999865432 00000 0111 4789999999999973 56666664 59999999999999
Q ss_pred cCCCcccccccccCccccceEEccCCCCCCCCC--------CC-CCCCCcEEEecCCCCccC
Q 002289 320 GSIPSSIWQSRTLNATETFILDFQNNNLTNISG--------SF-NIPPNVTVRLRGNPFCLN 372 (941)
Q Consensus 320 ~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~--------~~-~~~~~~~l~l~~Np~~c~ 372 (941)
+..+..+..+. -..++|+.|+|++|.+..+.. .+ .++.++.|++++|++...
T Consensus 239 ~~~~~~l~~~~-~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 239 GPSLENLKLLK-DSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp CCCHHHHHHTT-TTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred cHHHHHHHHHH-hcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 76665544321 124578999999999666542 22 456688899999997554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=212.52 Aligned_cols=210 Identities=24% Similarity=0.407 Sum_probs=152.4
Q ss_pred EcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEeccccccc
Q 002289 112 DFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 191 (941)
Q Consensus 112 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 191 (941)
.+..+.+...+ .+..+++|++|++++|.++. +| .+..+++|++|+|++|.+++..+ +..+++|++|+|++|+++
T Consensus 25 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~ 98 (308)
T 1h6u_A 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (308)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC
Confidence 44555555332 34568888899999888884 45 57888888888888888886544 888888888888888888
Q ss_pred ccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCC
Q 002289 192 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLS 271 (941)
Q Consensus 192 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 271 (941)
+ ++ .+..+++|++|+|++|++++. + .+..+++|++|+|++|++++ ++. +..+++|++|+|++|++++..+ +.
T Consensus 99 ~-~~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~-l~ 170 (308)
T 1h6u_A 99 N-VS-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITN--ISP-LAGLTNLQYLSIGNAQVSDLTP-LA 170 (308)
T ss_dssp C-CG-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCC--CGG-GGGCTTCCEEECCSSCCCCCGG-GT
T ss_pred C-ch-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCc--Ccc-ccCCCCccEEEccCCcCCCChh-hc
Confidence 5 33 578888888888888888853 3 38888888888888888876 233 7788888888888888875433 22
Q ss_pred CCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCC
Q 002289 272 RIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 351 (941)
Q Consensus 272 ~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~ 351 (941)
.+.+|+.|+|++|++++..+ +..+++|+.|+|++|++++..| +. ..++|+.|+|++|.++..+
T Consensus 171 --------~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~-----~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 171 --------NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LA-----NTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp --------TCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GT-----TCTTCCEEEEEEEEEECCC
T ss_pred --------CCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--cc-----CCCCCCEEEccCCeeecCC
Confidence 23456888888888876544 7778888888888888874332 32 2345667777777776654
Q ss_pred C
Q 002289 352 G 352 (941)
Q Consensus 352 ~ 352 (941)
.
T Consensus 234 ~ 234 (308)
T 1h6u_A 234 V 234 (308)
T ss_dssp E
T ss_pred e
Confidence 3
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-23 Score=236.33 Aligned_cols=241 Identities=17% Similarity=0.250 Sum_probs=154.6
Q ss_pred CCccccCCCCCCEEEcccCCCCCCC----CCccCCccccceecccCc---cccCCCCccc-------CCcCccceeeccc
Q 002289 98 LSPEIGRLSYLTILDFMWNKISGSI----PKEIGNIKSLELLLLNGN---ELTGSLPEEL-------GYLPKLDRIQIDQ 163 (941)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls~ 163 (941)
++..+..+++|++|+|++|+|+... +..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 5667788889999999999888653 344778889999999885 4455566554 6788888888888
Q ss_pred ccccc----cCCcccccccccceEecccccccccCchhccC----C---------CccceeeccCCcCC-CCCC---ccC
Q 002289 164 NYISG----SLPKSFANLNKTRHFHMNNNSISGQIPPELSR----L---------PSLVHMLLDNNNLT-GYLP---PEL 222 (941)
Q Consensus 164 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~l~-~~~p---~~~ 222 (941)
|.+++ .+|..+..+++|++|+|++|+++...+..+.. + ++|++|+|++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 88886 46777888888888888888887544433333 3 77777777777776 3333 345
Q ss_pred CCCCCCCEEeccCCcCCCC----CcchhccCCCCCcEEEccCCCCc----CCCCCCCCCCcccccccCCcCEEEccCCcC
Q 002289 223 SELPKLLILQLDNNNFEGT----TIPASYSNMSKLLKLSLRNCSLQ----GPMPDLSRIPNLGYLLSLNITTIKLSNNKL 294 (941)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~~----~~p~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l 294 (941)
..+++|+.|+|++|+|+.. ..+..+..+++|+.|+|++|.|+ +.++. .+....+|++|+|++|.|
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~-------~l~~~~~L~~L~L~~n~i 256 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI-------ALKSWPNLRELGLNDCLL 256 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH-------HGGGCTTCCEEECTTCCC
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH-------HHccCCCcCEEECCCCCC
Confidence 5667777777777777521 12335666777777777777764 11111 011223456666666666
Q ss_pred CCC----cchhhcC--CcccceeecccccCcc----CCCcccccccccCccccceEEccCCCCCC
Q 002289 295 TGT----IPSNFSG--LPRLQRLFIANNSLSG----SIPSSIWQSRTLNATETFILDFQNNNLTN 349 (941)
Q Consensus 295 ~~~----~p~~~~~--l~~L~~L~Ls~N~l~~----~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~ 349 (941)
++. ++..+.. +++|+.|+|++|+|++ .+|..+.. ..++|+.|+|++|.++.
T Consensus 257 ~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~----~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 257 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE----KMPDLLFLELNGNRFSE 317 (386)
T ss_dssp CHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHH----HCTTCCEEECTTSBSCT
T ss_pred chhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHh----cCCCceEEEccCCcCCc
Confidence 654 4455532 6666666666666664 24444311 12344455555555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-22 Score=222.62 Aligned_cols=235 Identities=14% Similarity=0.172 Sum_probs=194.4
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCC-CCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGS-IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
.+++.|++.+|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..+..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4689999999999987655 66899999999999999865 888899999999999999999988899999999999999
Q ss_pred cccc-ccccc-CCcccccccccceEecccc-ccccc-CchhccCCC-ccceeeccCC--cCC-CCCCccCCCCCCCCEEe
Q 002289 161 IDQN-YISGS-LPKSFANLNKTRHFHMNNN-SISGQ-IPPELSRLP-SLVHMLLDNN--NLT-GYLPPELSELPKLLILQ 232 (941)
Q Consensus 161 Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~L~~N--~l~-~~~p~~~~~l~~L~~L~ 232 (941)
|++| .+++. ++..+.++++|++|+|++| ++++. ++..+..++ +|++|+|++| .++ +.++..+.++++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 9999 78863 6777899999999999999 99865 577788999 9999999999 555 45677788899999999
Q ss_pred ccCCc-CCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCc-ccce
Q 002289 233 LDNNN-FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLP-RLQR 310 (941)
Q Consensus 233 Ls~N~-l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~ 310 (941)
|++|. +++ ..+..+..+++|++|++++|. +..+. .+. .+....+|+.|+|++| +.. ..+..+. +|..
T Consensus 229 l~~~~~l~~-~~~~~l~~l~~L~~L~l~~~~--~~~~~--~~~--~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~ 297 (336)
T 2ast_B 229 LSDSVMLKN-DCFQEFFQLNYLQHLSLSRCY--DIIPE--TLL--ELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPH 297 (336)
T ss_dssp CTTCTTCCG-GGGGGGGGCTTCCEEECTTCT--TCCGG--GGG--GGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTT
T ss_pred CCCCCcCCH-HHHHHHhCCCCCCEeeCCCCC--CCCHH--HHH--HHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcc
Confidence 99999 665 567789999999999999996 11121 111 1223567899999999 442 2344443 4778
Q ss_pred eecccccCccCCCccccc
Q 002289 311 LFIANNSLSGSIPSSIWQ 328 (941)
Q Consensus 311 L~Ls~N~l~~~~p~~~~~ 328 (941)
|++++|++++..|..+..
T Consensus 298 L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 298 LQINCSHFTTIARPTIGN 315 (336)
T ss_dssp SEESCCCSCCTTCSSCSS
T ss_pred eEEecccCccccCCcccc
Confidence 889999999999988754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.1e-21 Score=215.05 Aligned_cols=129 Identities=20% Similarity=0.235 Sum_probs=85.1
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccC-CcCccceeecccccccccCCcccccccccceEeccc
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELG-YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (941)
+.+++++|+|+ .+|..+. ..|+.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46788888887 4665543 3577777877777766666666 777777777777777766666666666666666666
Q ss_pred ccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 188 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 150 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe
Confidence 66665555556666666666666666665555555555555555555555553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.7e-20 Score=192.58 Aligned_cols=157 Identities=22% Similarity=0.301 Sum_probs=116.7
Q ss_pred CCCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccc
Q 002289 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142 (941)
Q Consensus 63 c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 142 (941)
|.|+|++|.|... +++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 17 ~~Cs~~~v~c~~~-----------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l 76 (229)
T 3e6j_A 17 CSCSGTTVDCRSK-----------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL 76 (229)
T ss_dssp CEEETTEEECTTS-----------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CEEeCCEeEccCC-----------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence 4457999999543 233 3444333 7888888888888888888888888888888888888
Q ss_pred cCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccC
Q 002289 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL 222 (941)
Q Consensus 143 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 222 (941)
+...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|
T Consensus 77 ~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~ 155 (229)
T 3e6j_A 77 GALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155 (229)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTT
T ss_pred CCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHH
Confidence 8666667788888888888888888766667777777777777777777 666667777777777777777776555566
Q ss_pred CCCCCCCEEeccCCcCCC
Q 002289 223 SELPKLLILQLDNNNFEG 240 (941)
Q Consensus 223 ~~l~~L~~L~Ls~N~l~~ 240 (941)
..+++|+.|+|++|.+.+
T Consensus 156 ~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 156 DRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTCTTCCEEECTTSCBCT
T ss_pred hCCCCCCEEEeeCCCccC
Confidence 666677777777666654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.2e-20 Score=193.24 Aligned_cols=146 Identities=20% Similarity=0.226 Sum_probs=100.6
Q ss_pred CCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccC
Q 002289 91 NLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL 170 (941)
Q Consensus 91 ~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 170 (941)
+++++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..
T Consensus 20 ~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~ 96 (220)
T 2v9t_B 20 GKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELP 96 (220)
T ss_dssp TSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccC
Confidence 34454 3454443 57788888888887666667777888888888888887777777777777777777777777555
Q ss_pred CcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCC
Q 002289 171 PKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 171 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 239 (941)
+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 97 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 97 KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred HhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 555666777777777777776666666666666666666666666555555666666666666666654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.3e-20 Score=190.49 Aligned_cols=152 Identities=18% Similarity=0.201 Sum_probs=98.6
Q ss_pred EEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCC-CccCCccccceecccCccccCCCCcccCCcCccceeecccc
Q 002289 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIP-KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (941)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (941)
.+++++++++. +|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 45556666663 555442 345777777777776544 34677777777777777777666666777777777777777
Q ss_pred cccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 7766666666666666666666666666556666666666666666666665555666666666666666666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.4e-21 Score=234.50 Aligned_cols=220 Identities=19% Similarity=0.205 Sum_probs=129.1
Q ss_pred HHHHHHHHHHHhCcCC-CCCCCCCCC-CCCCCCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCC----
Q 002289 35 IEVSALRSIKKSLVDD-YSKLSNWNR-GDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYL---- 108 (941)
Q Consensus 35 ~d~~aL~~~k~~~~~~-~~~~~~w~~-~~~c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L---- 108 (941)
.+.++|.++..+.... ...-..|.. ..++ +.|.++.+... +++.|+|.++++... +..+.....|
T Consensus 132 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~-------~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~ 202 (727)
T 4b8c_D 132 CTKQALMEMADTLTDSKTAKKQQPTGDSTPS-GTATNSAVSTP-------LTPKIELFANGKDEA-NQALLQHKKLSQYS 202 (727)
T ss_dssp CCCHHHHHHHHHHHHHHTTC------------------------------------------------------------
T ss_pred cchhhhhhhhhhcccccCcccCCCcCCCCcc-ccCCCceecCC-------ccceEEeeCCCCCcc-hhhHhhcCccCccc
Confidence 4578888888777533 223345643 3333 36888877543 588999999888863 3333222222
Q ss_pred -CEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEeccc
Q 002289 109 -TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (941)
Q Consensus 109 -~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (941)
..++++.|.+. ..|..|..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|.+|++|++|+|++
T Consensus 203 i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~ 279 (727)
T 4b8c_D 203 IDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSH 279 (727)
T ss_dssp --------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTT
T ss_pred ccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcC
Confidence 23334445554 56788899999999999999998 77777779999999999999998 8888899999999999999
Q ss_pred ccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCC-CcEEEccCCCCcCC
Q 002289 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK-LLKLSLRNCSLQGP 266 (941)
Q Consensus 188 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~-L~~L~Ls~N~l~~~ 266 (941)
|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|+.|+|++|.|++ .+|..+..+.. +..|+|++|.++|.
T Consensus 280 N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~~~~~~~l~l~~N~l~~~ 356 (727)
T 4b8c_D 280 NRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK-QFLKILTEKSVTGLIFYLRDNRPEIP 356 (727)
T ss_dssp SCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS-HHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred CcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC-CChHHHhhcchhhhHHhhccCcccCc
Confidence 9999 77888999999999999999997 778889999999999999999988 67777655432 23467888888877
Q ss_pred CCC
Q 002289 267 MPD 269 (941)
Q Consensus 267 ~~~ 269 (941)
+|.
T Consensus 357 ~p~ 359 (727)
T 4b8c_D 357 LPH 359 (727)
T ss_dssp CCC
T ss_pred Ccc
Confidence 664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.5e-19 Score=209.08 Aligned_cols=159 Identities=29% Similarity=0.397 Sum_probs=88.8
Q ss_pred CccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEec
Q 002289 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 233 (941)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 233 (941)
++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 33444444444444 233 223444455555555543 333 332 55555555555554 333 3455666666
Q ss_pred cCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCccc-----
Q 002289 234 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRL----- 308 (941)
Q Consensus 234 s~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L----- 308 (941)
++|+|++ +|. .+++|++|+|++|+|++ +|.+. .+|+.|+|++|+|+ .+|. |.. +|
T Consensus 148 s~N~l~~--lp~---~l~~L~~L~Ls~N~L~~-lp~l~----------~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~ 207 (571)
T 3cvr_A 148 DNNQLTM--LPE---LPTSLEVLSVRNNQLTF-LPELP----------ESLEALDVSTNLLE-SLPA-VPV--RNHHSEE 207 (571)
T ss_dssp CSSCCSC--CCC---CCTTCCEEECCSSCCSC-CCCCC----------TTCCEEECCSSCCS-SCCC-CC----------
T ss_pred CCCccCc--CCC---cCCCcCEEECCCCCCCC-cchhh----------CCCCEEECcCCCCC-chhh-HHH--hhhcccc
Confidence 6666554 333 34566666666666654 22111 34567777777776 4454 443 55
Q ss_pred --ceeecccccCccCCCcccccccccCccccceEEccCCCCCCC
Q 002289 309 --QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350 (941)
Q Consensus 309 --~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~ 350 (941)
+.|+|++|+|+ .+|..++.+ ++|+.|+|++|.|++.
T Consensus 208 ~L~~L~Ls~N~l~-~lp~~l~~l-----~~L~~L~L~~N~l~~~ 245 (571)
T 3cvr_A 208 TEIFFRCRENRIT-HIPENILSL-----DPTCTIILEDNPLSSR 245 (571)
T ss_dssp CCEEEECCSSCCC-CCCGGGGGS-----CTTEEEECCSSSCCHH
T ss_pred cceEEecCCCcce-ecCHHHhcC-----CCCCEEEeeCCcCCCc
Confidence 99999999998 688877654 4567889999988764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=203.61 Aligned_cols=176 Identities=21% Similarity=0.273 Sum_probs=147.2
Q ss_pred eEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccC-CccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIG-NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
+.+++++++|+. +|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 356677777774 565553 4689999999999988888887 999999999999999988888999999999999999
Q ss_pred ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccC---CCCCCCCEEeccCCcCCC
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL---SELPKLLILQLDNNNFEG 240 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 240 (941)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998888899999999999999999998889999999999999999999996555555 568999999999999986
Q ss_pred CCcchhccCCCCC--cEEEccCCCCc
Q 002289 241 TTIPASYSNMSKL--LKLSLRNCSLQ 264 (941)
Q Consensus 241 ~~~p~~~~~l~~L--~~L~Ls~N~l~ 264 (941)
..+..+..++++ +.|+|++|.+.
T Consensus 178 -l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 -LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp -CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred -cCHHHhhhccHhhcceEEecCCCcc
Confidence 344567766653 56666666654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-19 Score=185.67 Aligned_cols=152 Identities=21% Similarity=0.314 Sum_probs=131.8
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccc
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (941)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46888999998 6776654 68999999999999877788999999999999999999888999999999999999999
Q ss_pred cccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCc
Q 002289 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (941)
Q Consensus 189 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (941)
+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++ ..+..|..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCE-ECHHHHhCCCCCCEEEeCCCCcC
Confidence 9996666678889999999999999998888889999999999999999987 45667888888888888888775
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.3e-19 Score=185.52 Aligned_cols=153 Identities=22% Similarity=0.289 Sum_probs=134.4
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCCC-cccCCcCccceeecccccccccCCcccccccccceEeccc
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLP-EELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (941)
+.+++++|.++ .+|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 58999999998 5776654 357899999999997755 4588999999999999999988888999999999999999
Q ss_pred ccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcC
Q 002289 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 188 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++ ..|..|..+++|+.|+|++|.++.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT-VAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCC-BCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCE-ECHHHhcCCCCCCEEEecCcCCcC
Confidence 99998888889999999999999999998888999999999999999999987 568888888888888888888764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.2e-19 Score=193.06 Aligned_cols=172 Identities=28% Similarity=0.419 Sum_probs=88.5
Q ss_pred cCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccce
Q 002289 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRH 182 (941)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 182 (941)
..+++|+.|++++|.+.. ++ .+..+++|++|+|++|++++..+ +.++++|++|+|++|.+++. + .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCE
Confidence 345556666666666553 23 35555666666666666654332 55555555555555555531 2 2455555555
Q ss_pred EecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCC
Q 002289 183 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS 262 (941)
Q Consensus 183 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 262 (941)
|+|++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|+|++|++++ ..+ +..+++|
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~-~~~--l~~l~~L--------- 180 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP--LAGLTKL--------- 180 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG--GTTCTTC---------
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc-chh--hcCCCcc---------
Confidence 55555555432 2344445555555555555432 334444444455554444443 111 3444444
Q ss_pred CcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCcc
Q 002289 263 LQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 320 (941)
Q Consensus 263 l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 320 (941)
+.|+|++|+|++. + .+..+++|+.|++++|+++.
T Consensus 181 ----------------------~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 181 ----------------------QNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ----------------------CEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred ----------------------CEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 4444444444432 2 36667777777777777763
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=191.91 Aligned_cols=170 Identities=26% Similarity=0.353 Sum_probs=150.9
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
+.+++.|++++|++... +.+..+++|++|+|++|++++..+ +.++++|++|+|++|++++ +| .+..+++|++|+
T Consensus 45 l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~ 118 (291)
T 1h6t_A 45 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (291)
T ss_dssp HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred cCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEE
Confidence 45699999999999865 458999999999999999996555 9999999999999999995 34 499999999999
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|++|+|++|++++..+ +..+++|+.|+|++|.|++
T Consensus 119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 999999965 5789999999999999999965 678999999999999999997654 9999999999999999986
Q ss_pred CCcchhccCCCCCcEEEccCCCCcC
Q 002289 241 TTIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 241 ~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
++ .+..+++|+.|++++|+++.
T Consensus 193 --l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 193 --LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp --CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred --Ch-hhccCCCCCEEECcCCcccC
Confidence 44 48899999999999998874
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5e-19 Score=211.01 Aligned_cols=33 Identities=21% Similarity=0.308 Sum_probs=14.7
Q ss_pred CEEEccCCcCCCCcchhhcCCcccceeecccccCc
Q 002289 285 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 285 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
+.|+|++|+|++. ..+..+++|+.|+|++|+++
T Consensus 178 ~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 178 QNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred CEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 4444444444432 23444455555555555544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=181.40 Aligned_cols=151 Identities=22% Similarity=0.307 Sum_probs=117.5
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccc
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (941)
+.+++++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 46788888887 6665544 78888888888888888888888888888888888887666677788888888888888
Q ss_pred cccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCc
Q 002289 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ 264 (941)
Q Consensus 189 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 264 (941)
+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ ..+..|..+++|+.|+|++|.+.
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECTTSCBC
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCc-cCHHHHhCCCCCCEEEeeCCCcc
Confidence 888666666777888888888888887 667777778888888888888875 34456777777777777777665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.8e-21 Score=227.95 Aligned_cols=207 Identities=18% Similarity=0.172 Sum_probs=140.9
Q ss_pred cCCCCCCEEEcccCCCCCCCCCccCCccccceecccCcc-------------ccCCCCcccCCcCccceee-cccccccc
Q 002289 103 GRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNE-------------LTGSLPEELGYLPKLDRIQ-IDQNYISG 168 (941)
Q Consensus 103 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~ 168 (941)
...++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 45666666777777666 566666667777777766554 3444455555555555555 444433
Q ss_pred cCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhcc
Q 002289 169 SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS 248 (941)
Q Consensus 169 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 248 (941)
..|..+.+++|.++.. +. ..|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+
T Consensus 423 ---------~~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~--~lp~~~~ 483 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR--ALPPALA 483 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC--CCCGGGG
T ss_pred ---------chhhhhhhhccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc--ccchhhh
Confidence 2334444555555532 21 258889999999986 565 888999999999999998 5788899
Q ss_pred CCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCc-chhhcCCcccceeecccccCccCCCcccc
Q 002289 249 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTI-PSNFSGLPRLQRLFIANNSLSGSIPSSIW 327 (941)
Q Consensus 249 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (941)
++++|+.|+|++|+|++. |.+.. +.+|+.|+|++|+|++.. |..|+.+++|+.|+|++|+|++..| .+.
T Consensus 484 ~l~~L~~L~Ls~N~l~~l-p~l~~--------l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~ 553 (567)
T 1dce_A 484 ALRCLEVLQASDNALENV-DGVAN--------LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG-IQE 553 (567)
T ss_dssp GCTTCCEEECCSSCCCCC-GGGTT--------CSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS-CTT
T ss_pred cCCCCCEEECCCCCCCCC-cccCC--------CCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc-HHH
Confidence 999999999999998863 33332 345688999999998887 8899999999999999999986544 332
Q ss_pred cccccCccccceEEc
Q 002289 328 QSRTLNATETFILDF 342 (941)
Q Consensus 328 ~l~~l~~~~L~~L~L 342 (941)
.+.. ..++|++||+
T Consensus 554 ~l~~-~lp~L~~L~l 567 (567)
T 1dce_A 554 RLAE-MLPSVSSILT 567 (567)
T ss_dssp HHHH-HCTTCSEEEC
T ss_pred HHHH-HCcccCccCC
Confidence 2211 1345556653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=9e-19 Score=208.80 Aligned_cols=199 Identities=26% Similarity=0.342 Sum_probs=133.4
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
.+..+.+..+.+...+ .+..|++|+.|+|++|.|.. +| .|..+++|+.|+|++|+|++..| +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCccccc--chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 3444555555555443 24567777777888777773 44 47777778888888887775444 7777778888888
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
+|.|++. | .+..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++ .
T Consensus 96 ~N~l~~l-~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-~ 168 (605)
T 1m9s_A 96 ENKIKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-I 168 (605)
T ss_dssp SSCCCCC-T-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC-C
T ss_pred CCCCCCC-h-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC-c
Confidence 8777742 2 57777777777777777774 2 3467777777777777777754 567777777777777777775 3
Q ss_pred cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCC
Q 002289 243 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL 305 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l 305 (941)
.| +..+++|+.|+|++|+|++. +.+. .+.+|+.|+|++|++.+.....+..+
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l-~~l~--------~l~~L~~L~L~~N~l~~~p~~~~~~l 220 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL-RALA--------GLKNLDVLELFSQECLNKPINHQSNL 220 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC-GGGT--------TCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred hh--hccCCCCCEEECcCCCCCCC-hHHc--------cCCCCCEEEccCCcCcCCcccccccE
Confidence 33 77777777777777777653 2222 22455777777777775444333333
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=175.25 Aligned_cols=154 Identities=16% Similarity=0.236 Sum_probs=116.4
Q ss_pred ccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccc
Q 002289 102 IGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181 (941)
Q Consensus 102 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 181 (941)
.+.+++|+.|++++|.++ .+| .+..+++|++|+|++|.++ .+..+..+++|++|+|++|.+++..+..|..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356677888888888887 555 5778888888888888665 234677788888888888888877777888888888
Q ss_pred eEecccccccccCchhccCCCccceeeccCCc-CCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccC
Q 002289 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNN-LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260 (941)
Q Consensus 182 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~ 260 (941)
+|+|++|++++..+..+..+++|++|+|++|+ ++ .++ .+..+++|+.|+|++|++++ ++ .+..+++|++|++++
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~--~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD--YR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC--CT-TGGGCSSCCEEEECB
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC--hH-HhccCCCCCEEEeeC
Confidence 88888888887777778888888888888887 54 444 57778888888888888875 33 677778888888888
Q ss_pred CCCc
Q 002289 261 CSLQ 264 (941)
Q Consensus 261 N~l~ 264 (941)
|+|.
T Consensus 191 N~i~ 194 (197)
T 4ezg_A 191 QTIG 194 (197)
T ss_dssp C---
T ss_pred cccC
Confidence 7765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.5e-18 Score=183.46 Aligned_cols=136 Identities=19% Similarity=0.108 Sum_probs=106.8
Q ss_pred CCccceeeccCcEEEEEEEe-CCCcE--EEEEEeccCCch------------------------hhHhHHHHHHHHHhcC
Q 002289 611 FNSSTQIGQGGYGKVYKGIL-PDGTV--VAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 663 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 663 (941)
|++.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999997 68888 999987543111 1136789999999998
Q ss_pred CCce--eeeeeccccCCcEEEEEecCCC-C----CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhh-cCCCCCeEecc
Q 002289 664 HRNL--VSLVGYCDEEGEQMLVYEFMSN-G----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRD 735 (941)
Q Consensus 664 h~nI--v~l~~~~~~~~~~~LV~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~D 735 (941)
|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8764 334432 357899999942 3 77776532 234456789999999999999 888 99999
Q ss_pred CCCCcEEEcCCCcEEEeeecccccc
Q 002289 736 IKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 736 Lkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.9e-18 Score=183.47 Aligned_cols=168 Identities=20% Similarity=0.224 Sum_probs=104.1
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+++.+++.++++++.. .+..+++|+.|++++|+|+ .+| .+..+++|++|+|++|++++..+ +.++++|++|+|
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 34555666666666432 4666777777777777776 344 56677777777777777774433 667777777777
Q ss_pred ccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCC
Q 002289 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (941)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 241 (941)
++|++++. |... . ++|+.|+|++|++++. + .+..+++|+.|+|++|++++. + .+..+++|+.|+|++|++++.
T Consensus 93 ~~N~l~~l-~~~~-~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 93 NRNRLKNL-NGIP-S-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSCC-TTCC-C-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCCc-Cccc-c-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 77777643 2222 2 6666666666666642 2 466666666666666666643 2 466666666666666666642
Q ss_pred CcchhccCCCCCcEEEccCCCCcC
Q 002289 242 TIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 242 ~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
..+..+++|+.|++++|++++
T Consensus 166 ---~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 166 ---GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp ---TTSTTCCCCCEEEEEEEEEEC
T ss_pred ---HHhccCCCCCEEeCCCCcccC
Confidence 455666666666666666553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.5e-20 Score=216.38 Aligned_cols=202 Identities=18% Similarity=0.233 Sum_probs=160.5
Q ss_pred CCccccceecccCccccCCCCcccCCcCccceeeccccc-------------ccccCCcccccccccceEe-cccccccc
Q 002289 127 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY-------------ISGSLPKSFANLNKTRHFH-MNNNSISG 192 (941)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~ 192 (941)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56788899999999998 788889999999999987775 5566677777788888777 6666543
Q ss_pred cCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCC
Q 002289 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR 272 (941)
Q Consensus 193 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 272 (941)
+|..+.+++|.++...+ ..|+.|+|++|+|++ +|. |..+++|+.|+|++|+|+..+..+.
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~--lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~- 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV--LCH-LEQLLLVTHLDLSHNRLRALPPALA- 483 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS--CCC-GGGGTTCCEEECCSSCCCCCCGGGG-
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC--CcC-ccccccCcEeecCcccccccchhhh-
Confidence 56667777888774322 258999999999996 566 9999999999999999994433232
Q ss_pred CCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCC-CcccccccccCccccceEEccCCCCCCCC
Q 002289 273 IPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI-PSSIWQSRTLNATETFILDFQNNNLTNIS 351 (941)
Q Consensus 273 l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~ 351 (941)
.+.+|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.. |..+..++ +|+.|+|++|.|++++
T Consensus 484 -------~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~-----~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 484 -------ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP-----RLVLLNLQGNSLCQEE 549 (567)
T ss_dssp -------GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCT-----TCCEEECTTSGGGGSS
T ss_pred -------cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCC-----CCCEEEecCCcCCCCc
Confidence 34567999999999997 67 8999999999999999999876 99887654 5669999999999987
Q ss_pred CCC-----CCCCCcEEEe
Q 002289 352 GSF-----NIPPNVTVRL 364 (941)
Q Consensus 352 ~~~-----~~~~~~~l~l 364 (941)
... .+|.+..|++
T Consensus 550 ~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 550 GIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCTTHHHHHCTTCSEEEC
T ss_pred cHHHHHHHHCcccCccCC
Confidence 654 2677777653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-17 Score=170.68 Aligned_cols=152 Identities=21% Similarity=0.281 Sum_probs=134.1
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
+.+++.|++++|+++ .++ .+..+++|++|++++|.++ . +..+..+++|++|+|++|++++..+..|+.+++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 346899999999998 455 7999999999999999776 3 34799999999999999999988899999999999999
Q ss_pred cccccccccCCcccccccccceEeccccc-ccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNS-ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 239 (941)
|++|++++..+..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|++.
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 99999998889999999999999999998 55 566 68999999999999999996 44 7899999999999999986
Q ss_pred C
Q 002289 240 G 240 (941)
Q Consensus 240 ~ 240 (941)
+
T Consensus 195 ~ 195 (197)
T 4ezg_A 195 G 195 (197)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.4e-18 Score=208.96 Aligned_cols=188 Identities=15% Similarity=0.170 Sum_probs=76.7
Q ss_pred CCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEec
Q 002289 106 SYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 185 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 185 (941)
+.++.|+|++|.+.. ++.. .|+.++|+.|.|.+ ++++.|.+. ..++.|..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQA-----LLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chhh-----HhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 557888888888874 3333 34455555555442 233334433 34445555555555555
Q ss_pred ccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcC
Q 002289 186 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 186 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
++|++. .+|..+..+++|++|+|++|+|+ .+|..|+++++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+.
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT--SLPAELGSCFQLKYFYFFDNMVTT 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS--SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC--ccChhhcCCCCCCEEECCCCCCCc
Confidence 555555 44444445555555555555555 45555555555555555555555 345555555555555555555553
Q ss_pred CCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcc-cceeecccccCccCCCccc
Q 002289 266 PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPR-LQRLFIANNSLSGSIPSSI 326 (941)
Q Consensus 266 ~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~ 326 (941)
.+..+..+ .+|++|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|..+
T Consensus 308 lp~~~~~l--------~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l 361 (727)
T 4b8c_D 308 LPWEFGNL--------CNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER 361 (727)
T ss_dssp CCSSTTSC--------TTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred cChhhhcC--------CCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc
Confidence 32222222 23466666666666666666655432 2346777777777776654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=8.5e-18 Score=179.86 Aligned_cols=171 Identities=20% Similarity=0.266 Sum_probs=112.3
Q ss_pred CccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCcccee
Q 002289 128 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207 (941)
Q Consensus 128 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 207 (941)
.+.++..++|++|.+++. + .+..+++|++|++++|.++. ++ .+..+++|++|+|++|+|++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 455666667777766633 2 45666677777777777663 33 56667777777777777764333 6677777777
Q ss_pred eccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEE
Q 002289 208 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTI 287 (941)
Q Consensus 208 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L 287 (941)
+|++|++++ +|. +.. ++|+.|+|++|+|++ + ..+..+++|+.|+|++|+|++. +. +..+.+|+.|
T Consensus 91 ~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~--~-~~l~~l~~L~~L~Ls~N~i~~~-~~--------l~~l~~L~~L 155 (263)
T 1xeu_A 91 SVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD--T-DSLIHLKNLEILSIRNNKLKSI-VM--------LGFLSKLEVL 155 (263)
T ss_dssp ECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB--S-GGGTTCTTCCEEECTTSCCCBC-GG--------GGGCTTCCEE
T ss_pred ECCCCccCC-cCc-ccc-CcccEEEccCCccCC--C-hhhcCcccccEEECCCCcCCCC-hH--------HccCCCCCEE
Confidence 777777764 332 222 677777777777765 2 3477777777777777777643 11 1223456777
Q ss_pred EccCCcCCCCcchhhcCCcccceeecccccCccC
Q 002289 288 KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 321 (941)
Q Consensus 288 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 321 (941)
+|++|+|++. ..+..+++|+.|++++|++++.
T Consensus 156 ~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 156 DLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp ECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 7777777765 6677888888888888888743
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-19 Score=214.43 Aligned_cols=86 Identities=9% Similarity=0.064 Sum_probs=58.5
Q ss_pred cCCcCEEEccCC--cCCCCcchhhcC-CcccceeecccccCccCC-CcccccccccCccccceEEccCCCCCCC--CCCC
Q 002289 281 SLNITTIKLSNN--KLTGTIPSNFSG-LPRLQRLFIANNSLSGSI-PSSIWQSRTLNATETFILDFQNNNLTNI--SGSF 354 (941)
Q Consensus 281 ~~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~-p~~~~~l~~l~~~~L~~L~Ls~N~l~~~--~~~~ 354 (941)
..+|+.|+|+++ .+++..+..+.. +++|+.|+|++|++++.. +..+.. .++|+.|+|++|.|+.. +...
T Consensus 435 ~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~-----~~~L~~L~l~~n~l~~~~~~~~~ 509 (592)
T 3ogk_B 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG-----CPNLQKLEMRGCCFSERAIAAAV 509 (592)
T ss_dssp CTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTC-----CTTCCEEEEESCCCBHHHHHHHH
T ss_pred CCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhc-----CcccCeeeccCCCCcHHHHHHHH
Confidence 456788888753 366666666554 788999999999887532 222222 35678999999997542 2111
Q ss_pred -CCCCCcEEEecCCCCcc
Q 002289 355 -NIPPNVTVRLRGNPFCL 371 (941)
Q Consensus 355 -~~~~~~~l~l~~Np~~c 371 (941)
.++.++.|+|++|++.-
T Consensus 510 ~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 510 TKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHCSSCCEEEEESCBCCT
T ss_pred HhcCccCeeECcCCcCCH
Confidence 57888999999998543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=7.7e-17 Score=163.80 Aligned_cols=129 Identities=26% Similarity=0.394 Sum_probs=76.9
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCCCc-ccCCcCccceeecccccccccCCcccccccccceEeccc
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPE-ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (941)
+.|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56777777775 55654433 666777777776655443 366666666666666666665566666666666666666
Q ss_pred ccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 188 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 66665555555555555555555555555555555555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=8.8e-17 Score=163.33 Aligned_cols=131 Identities=22% Similarity=0.268 Sum_probs=95.2
Q ss_pred eEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCC-ccCCccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK-EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
+.|++++++++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 46777777774 45555533 777777777777755553 377777777777777777777777777777777777777
Q ss_pred ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCC
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYL 218 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 218 (941)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 7777777777777777777777777777777777777777777777777777543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=9.3e-17 Score=160.85 Aligned_cols=135 Identities=20% Similarity=0.267 Sum_probs=77.3
Q ss_pred CCCCCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCc
Q 002289 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (941)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (941)
+.|.|.|.+|.|... +++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 3 ~~C~C~~~~l~~~~~-----------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 62 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK-----------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQN 62 (177)
T ss_dssp TTCEEETTEEECCSS-----------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCEeCCCEEEecCC-----------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCC
Confidence 567778888888543 333 233222 256777777777777655556667777777777777
Q ss_pred cccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCC
Q 002289 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 141 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 215 (941)
++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.++
T Consensus 63 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 63 QIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 776555555666666666666666666544444555555555555555554333333344444444444444444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=158.35 Aligned_cols=133 Identities=23% Similarity=0.241 Sum_probs=80.1
Q ss_pred CCCCCEEEcccCCCC-CCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceE
Q 002289 105 LSYLTILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (941)
Q Consensus 105 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (941)
.++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 356677777777766 56666666677777777777776644 556666666666666666665556555556666666
Q ss_pred ecccccccccC-chhccCCCccceeeccCCcCCCCCC---ccCCCCCCCCEEeccCCcCC
Q 002289 184 HMNNNSISGQI-PPELSRLPSLVHMLLDNNNLTGYLP---PELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 184 ~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 239 (941)
+|++|+|++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 66666665321 1455555555555555555554333 24555555555555555544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.65 E-value=4.6e-18 Score=204.11 Aligned_cols=278 Identities=12% Similarity=0.079 Sum_probs=167.7
Q ss_pred ceeeEEEecCCCCCccCCccccCC--CCCCEEEcccCC-CCC-CCCCccCCccccceecccCccccCC----CCcccCCc
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRL--SYLTILDFMWNK-ISG-SIPKEIGNIKSLELLLLNGNELTGS----LPEELGYL 153 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l--~~L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l 153 (941)
.++++|+|+++.+++..+..+..+ .+|++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.++
T Consensus 112 ~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~ 191 (592)
T 3ogk_B 112 RQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHN 191 (592)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHC
T ss_pred CCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcC
Confidence 357777777777666555555543 347777777765 210 1122223567788888888877655 33345567
Q ss_pred Cccceeeccccccc----ccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCC---CCCCccCCCCC
Q 002289 154 PKLDRIQIDQNYIS----GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT---GYLPPELSELP 226 (941)
Q Consensus 154 ~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~ 226 (941)
++|++|+|++|.++ +.++..+.++++|+.|+|++|.+.+ ++..+..+++|++|+++.+... +..+..+..++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~ 270 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccc
Confidence 77888888888876 2344455677888888888888774 5667777778888877753322 23334566677
Q ss_pred CCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCC-C-CCCCCccccc----------------ccCCcCEEE
Q 002289 227 KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-D-LSRIPNLGYL----------------LSLNITTIK 288 (941)
Q Consensus 227 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~-~~~l~~l~~l----------------~~~~L~~L~ 288 (941)
+|+.|+++++... .+|..+..+++|++|+|++|.+++... . +..++++..+ ...+|++|+
T Consensus 271 ~L~~L~l~~~~~~--~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 271 KLCRLGLSYMGPN--EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp TCCEEEETTCCTT--TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEE
T ss_pred cccccCccccchh--HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEE
Confidence 7777777775433 467777778888888888887653211 0 1222332222 124577777
Q ss_pred cc-----------CCcCCCCc-chhhcCCcccceeecccccCccCCCcccccccccCccccceEEcc----CCCCCCCCC
Q 002289 289 LS-----------NNKLTGTI-PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ----NNNLTNISG 352 (941)
Q Consensus 289 Ls-----------~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls----~N~l~~~~~ 352 (941)
|+ .|.+++.. +..+..+++|++|+++.|++++..+..+.. ..++|+.|+|+ .|.++..+.
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~----~~~~L~~L~l~~~~~~n~l~~~p~ 424 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT----YLKNLCDFRLVLLDREERITDLPL 424 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHH----HCCSCCEEEEEECSCCSCCSSCCC
T ss_pred eecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHh----hCCCCcEEEEeecCCCccccCchH
Confidence 77 35565432 223445677777777777776554444432 12355677774 666665432
Q ss_pred C------C-CCCCCcEEEecC
Q 002289 353 S------F-NIPPNVTVRLRG 366 (941)
Q Consensus 353 ~------~-~~~~~~~l~l~~ 366 (941)
+ + .++.++.|+|+.
T Consensus 425 ~~~~~~~~~~~~~L~~L~L~~ 445 (592)
T 3ogk_B 425 DNGVRSLLIGCKKLRRFAFYL 445 (592)
T ss_dssp HHHHHHHHHHCTTCCEEEEEC
T ss_pred HHHHHHHHHhCCCCCEEEEec
Confidence 2 1 356666676654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-16 Score=156.43 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=117.7
Q ss_pred ccccceecccCcccc-CCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCcccee
Q 002289 129 IKSLELLLLNGNELT-GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 207 (941)
Q Consensus 129 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 207 (941)
.++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 478999999999998 78888899999999999999999876 788999999999999999998788888889999999
Q ss_pred eccCCcCCCCCC-ccCCCCCCCCEEeccCCcCCCCCcc---hhccCCCCCcEEEccCCCCcCCC
Q 002289 208 LLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIP---ASYSNMSKLLKLSLRNCSLQGPM 267 (941)
Q Consensus 208 ~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~ 267 (941)
+|++|++++... ..+..+++|+.|+|++|.+++ ..+ ..+..+++|++|++++|.++..+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 999999986432 788999999999999999986 333 47889999999999999887443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.4e-16 Score=159.05 Aligned_cols=126 Identities=22% Similarity=0.264 Sum_probs=67.5
Q ss_pred EEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccc
Q 002289 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI 166 (941)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 166 (941)
+++++++++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 444455555 3443332 45666666666665 4555555555555555555555554445555555555555555555
Q ss_pred cccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 167 SGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
++..|. .|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 91 ~~i~~~------------------------~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 91 RCIPPR------------------------TFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CBCCTT------------------------TTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CEeCHH------------------------HhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 544444 44455555555555555554444445556666666666666553
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.2e-16 Score=156.67 Aligned_cols=127 Identities=21% Similarity=0.352 Sum_probs=98.6
Q ss_pred eecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCc
Q 002289 134 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 213 (941)
Q Consensus 134 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 213 (941)
.+++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4455555554 3443332 35666666666665 555667777777777777777777777778889999999999999
Q ss_pred CCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcC
Q 002289 214 LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 214 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
|++..+..|.++++|++|+|++|+|++ ..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCe-eChhhhhcCccccEEEeCCCCeec
Confidence 998888899999999999999999996 456679999999999999999873
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.6e-16 Score=154.26 Aligned_cols=84 Identities=23% Similarity=0.278 Sum_probs=37.0
Q ss_pred CCCCEEEcccCCCC-CCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEe
Q 002289 106 SYLTILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (941)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34444444444444 34444444444444444444444432 3344444444444444444433343333344444444
Q ss_pred ccccccc
Q 002289 185 MNNNSIS 191 (941)
Q Consensus 185 L~~N~l~ 191 (941)
|++|+++
T Consensus 95 ls~N~i~ 101 (149)
T 2je0_A 95 LSGNKIK 101 (149)
T ss_dssp CTTSCCC
T ss_pred CCCCcCC
Confidence 4444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.5e-16 Score=151.86 Aligned_cols=130 Identities=18% Similarity=0.253 Sum_probs=111.4
Q ss_pred CccccceecccCcccc-CCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccce
Q 002289 128 NIKSLELLLLNGNELT-GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206 (941)
Q Consensus 128 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 206 (941)
..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999998 78888899999999999999999876 77889999999999999999878888888999999
Q ss_pred eeccCCcCCCC-CCccCCCCCCCCEEeccCCcCCCCCcc---hhccCCCCCcEEEccC
Q 002289 207 MLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIP---ASYSNMSKLLKLSLRN 260 (941)
Q Consensus 207 L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~p---~~~~~l~~L~~L~Ls~ 260 (941)
|++++|++++. .+..+..+++|++|+|++|++++ ..+ ..+..+++|++|++++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG-STTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc-hHHHHHHHHHHCCCcccccCCC
Confidence 99999999864 34778889999999999999986 333 4788888888888763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.5e-15 Score=150.37 Aligned_cols=130 Identities=22% Similarity=0.244 Sum_probs=78.1
Q ss_pred CCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEeccc
Q 002289 108 LTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (941)
Q Consensus 108 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (941)
.+.+++++|+++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 356677777776 444333 25677777777777655555566666677766666666655555566666666666666
Q ss_pred ccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 188 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+.+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 66665544455555666666666666654444444555555555555555554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.6e-16 Score=173.26 Aligned_cols=137 Identities=17% Similarity=0.227 Sum_probs=98.5
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCc-----hh---------hHhH--------HHHHHHHHhcCCCc
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-----QG---------EKEF--------LTEIQFLSRLHHRN 666 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~---------~~~~--------~~E~~~l~~l~h~n 666 (941)
.-|++.++||+|+||.||+|...+|+.||||+++.... .. .... .+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999998999999998763211 00 0112 23455555554333
Q ss_pred ee--eeeeccccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc
Q 002289 667 LV--SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD 744 (941)
Q Consensus 667 Iv--~l~~~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 744 (941)
+. ..++ ....+|||||++|++|.++... .....++.|++.+|.|||+.+ ||||||||.|||++
T Consensus 175 v~vp~p~~----~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIA----QSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEE----EETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCeeee----ccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 21 1111 1234799999999888765421 123467899999999999999 99999999999998
Q ss_pred CCC----------cEEEeeecccccc
Q 002289 745 HKF----------TAKVADFGLSRLA 760 (941)
Q Consensus 745 ~~~----------~~kl~DFGla~~~ 760 (941)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 4899999987643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.4e-17 Score=199.83 Aligned_cols=128 Identities=15% Similarity=0.165 Sum_probs=86.0
Q ss_pred ceeeEEEecCCCCCccCCcccc-CCCCCCEEEcccC-CCCCC-CCCccCCccccceecccCccccCCCCcccC----CcC
Q 002289 82 LHLRELQLLNLNLSGNLSPEIG-RLSYLTILDFMWN-KISGS-IPKEIGNIKSLELLLLNGNELTGSLPEELG----YLP 154 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~ 154 (941)
.++++|+|+++.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4688999999888876666665 6889999999988 55432 344445788999999999988765544443 567
Q ss_pred ccceeeccccc--ccc-cCCcccccccccceEecccc-cccccCchhccCCCccceeecc
Q 002289 155 KLDRIQIDQNY--ISG-SLPKSFANLNKTRHFHMNNN-SISGQIPPELSRLPSLVHMLLD 210 (941)
Q Consensus 155 ~L~~L~Ls~N~--l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~ 210 (941)
+|++|+|++|. ++. .++..+..+++|+.|+|++| .+.+ ++..+..+++|++|+++
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~ 243 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTG 243 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECS
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccc
Confidence 88899988886 221 11222345688888888887 3332 45555555555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.59 E-value=8.2e-16 Score=170.26 Aligned_cols=234 Identities=13% Similarity=0.171 Sum_probs=134.1
Q ss_pred cceeeEEEecCCCCCccCCccccC-CCCCCEEEcccCCCC--CCCCCccCCccccceecccCccccCCCCcccCC-----
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGR-LSYLTILDFMWNKIS--GSIPKEIGNIKSLELLLLNGNELTGSLPEELGY----- 152 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----- 152 (941)
..++++|.++++ +.+.--..+.. +++|+.|||++|+|. ...+. .++.++.+.+..|.+. +..|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I~---~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFVP---AYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEEC---TTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccccC---HHHhccccccc
Confidence 456788887753 22111112333 788999999999887 21111 1222333444444222 233444
Q ss_pred ---cCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcC----CCCCCccC---
Q 002289 153 ---LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL----TGYLPPEL--- 222 (941)
Q Consensus 153 ---l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~~--- 222 (941)
+++|+.|+|.+ .++.+.+.+|.++++|+.|+|.+|.+....+.+|.++.++..+.+..+.. .......|
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 55555555555 55544455555555555555555555544444555544444444433111 00000000
Q ss_pred -----------------------------------------------CCCCCCCEEeccCCcCCCCCcchhccCCCCCcE
Q 002289 223 -----------------------------------------------SELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 255 (941)
Q Consensus 223 -----------------------------------------------~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 255 (941)
..+++|+.|+|++|+++. ..+.+|.++++|+.
T Consensus 176 ~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~-I~~~aF~~~~~L~~ 254 (329)
T 3sb4_A 176 EPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATT-IPDFTFAQKKYLLK 254 (329)
T ss_dssp CCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCE-ECTTTTTTCTTCCE
T ss_pred cccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcce-ecHhhhhCCCCCCE
Confidence 026788888888888875 45567888888888
Q ss_pred EEccCCCCcCCCCCCCCCCcccccccCCcC-EEEccCCcCCCCcchhhcCCcccceeecccccCccCCCccccccccc
Q 002289 256 LSLRNCSLQGPMPDLSRIPNLGYLLSLNIT-TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 332 (941)
Q Consensus 256 L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 332 (941)
|+|++| ++ .++.-.|....+|+ .|+|.+ .++.+.+.+|.++++|+.|++++|+++...+..|..+..|
T Consensus 255 l~l~~n-i~-------~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 255 IKLPHN-LK-------TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp EECCTT-CC-------EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCC
T ss_pred EECCcc-cc-------eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcch
Confidence 888877 54 33344455556677 888887 7776777888888888888888888885555566554433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.56 E-value=8.2e-17 Score=193.25 Aligned_cols=283 Identities=12% Similarity=0.109 Sum_probs=139.5
Q ss_pred cceeeEEEecCC-CCCcc-CCccccCCCCCCEEEcccCCCCCCCCCccC----CccccceecccCcc--ccC-CCCcccC
Q 002289 81 YLHLRELQLLNL-NLSGN-LSPEIGRLSYLTILDFMWNKISGSIPKEIG----NIKSLELLLLNGNE--LTG-SLPEELG 151 (941)
Q Consensus 81 ~~~l~~L~L~~~-~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~Ls~N~--l~~-~~p~~~~ 151 (941)
..++++|+|.+| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++|+|++|. ++. .++..+.
T Consensus 129 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 129 FKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVT 208 (594)
T ss_dssp CTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHH
T ss_pred CCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHH
Confidence 356788888777 44432 333344677888888887776654433332 45577777777775 110 0111122
Q ss_pred CcCccceeeccccc--------------------------------------------------ccc----cCCcccccc
Q 002289 152 YLPKLDRIQIDQNY--------------------------------------------------ISG----SLPKSFANL 177 (941)
Q Consensus 152 ~l~~L~~L~Ls~N~--------------------------------------------------l~~----~~p~~~~~l 177 (941)
++++|++|+|++|. +.. .++..+..+
T Consensus 209 ~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~ 288 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288 (594)
T ss_dssp HCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHH
T ss_pred hCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhh
Confidence 34666666666551 111 122223356
Q ss_pred cccceEecccccccccCc-hhccCCCccceeeccCCcCCCC-CCccCCCCCCCCEEec---------cCCcCCCCCcchh
Q 002289 178 NKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGY-LPPELSELPKLLILQL---------DNNNFEGTTIPAS 246 (941)
Q Consensus 178 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L---------s~N~l~~~~~p~~ 246 (941)
++|+.|+|++|.+++... ..+..+++|++|++++| ++.. ++.....+++|+.|+| +.|.+++..+...
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l 367 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence 788888888888764332 23456777888877776 3311 1111223556666655 2233332111111
Q ss_pred ccCCCCCcEEEccCCCCcCCCCC-CC-CCCcc----------------c-----------ccccCCcCEEEccCCcCCCC
Q 002289 247 YSNMSKLLKLSLRNCSLQGPMPD-LS-RIPNL----------------G-----------YLLSLNITTIKLSNNKLTGT 297 (941)
Q Consensus 247 ~~~l~~L~~L~Ls~N~l~~~~~~-~~-~l~~l----------------~-----------~l~~~~L~~L~Ls~N~l~~~ 297 (941)
..++++|+.|+++.|++++.... +. .++++ . .....+|+.|+|++ .+++.
T Consensus 368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~ 446 (594)
T 2p1m_B 368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDK 446 (594)
T ss_dssp HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHH
T ss_pred HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHH
Confidence 22345555555555544321100 00 00000 0 11123456666655 45544
Q ss_pred cchhhcC-CcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCC--CC-CCCCCcEEEecCCCC
Q 002289 298 IPSNFSG-LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG--SF-NIPPNVTVRLRGNPF 369 (941)
Q Consensus 298 ~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~--~~-~~~~~~~l~l~~Np~ 369 (941)
.+..+.. +++|+.|+|++|.+++..+..+.. ..++|+.|+|++|.++.... .. .++.++.|++++|+.
T Consensus 447 ~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~----~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLS----GCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHHHCTTCCEEEEESCCSSHHHHHHHHH----HCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHhchhccEeeccCCCCcHHHHHHHHh----cCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 4444444 566666666666665433322211 13455666666666643211 11 345566666666654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.1e-15 Score=167.00 Aligned_cols=237 Identities=15% Similarity=0.181 Sum_probs=158.4
Q ss_pred CCCCCCEEEcccCCCCCCCCCccCC-ccccceecccCcccc--CCCCcccCCcCccceeecccccccccCCccccc----
Q 002289 104 RLSYLTILDFMWNKISGSIPKEIGN-IKSLELLLLNGNELT--GSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN---- 176 (941)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---- 176 (941)
.+.+|+.|.++++ +...--..+.. +++|++|||++|++. ...+. .++.++.+.+..|. +.+..|.+
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~---I~~~aF~~~~~~ 95 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANF---VPAYAFSNVVNG 95 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTE---ECTTTTEEEETT
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccc---cCHHHhcccccc
Confidence 3778999999875 22111122333 788999999999998 22222 33335666666664 33456777
Q ss_pred ----ccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcC----CCCCcchhcc
Q 002289 177 ----LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF----EGTTIPASYS 248 (941)
Q Consensus 177 ----l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l----~~~~~p~~~~ 248 (941)
+++|+.|+|.+ +++...+.+|.++++|+.|++++|.+....+.+|.++.++..+.+..+.. .. .....|.
T Consensus 96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~-i~~~~f~ 173 (329)
T 3sb4_A 96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNR-WEHFAFI 173 (329)
T ss_dssp EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTT-TTTSCEE
T ss_pred cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccc-ccccccc
Confidence 99999999999 88877778899999999999999999978888999998888887766321 11 0111121
Q ss_pred --------------------------------------------------CCCCCcEEEccCCCCcCCCCCCCCCCcccc
Q 002289 249 --------------------------------------------------NMSKLLKLSLRNCSLQGPMPDLSRIPNLGY 278 (941)
Q Consensus 249 --------------------------------------------------~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~ 278 (941)
.+++|+.|+|++|+++. ++...|
T Consensus 174 ~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~-------I~~~aF 246 (329)
T 3sb4_A 174 EGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATT-------IPDFTF 246 (329)
T ss_dssp ESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCE-------ECTTTT
T ss_pred cccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcce-------ecHhhh
Confidence 25677777777777763 333344
Q ss_pred cccCCcCEEEccCCcCCCCcchhhcCCcccc-eeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--C
Q 002289 279 LLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ-RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--N 355 (941)
Q Consensus 279 l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~ 355 (941)
....+|+.|+|.+| ++.+.+.+|.++++|+ .|++.+ +++...+..|..+ .+|+.|+|++|+++.|+... .
T Consensus 247 ~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c-----~~L~~l~l~~n~i~~I~~~aF~~ 319 (329)
T 3sb4_A 247 AQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGC-----DNLRYVLATGDKITTLGDELFGN 319 (329)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTC-----TTEEEEEECSSCCCEECTTTTCT
T ss_pred hCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCC-----ccCCEEEeCCCccCccchhhhcC
Confidence 45556677777777 6666677777777777 777777 5653444555443 34557777777777775443 4
Q ss_pred CCCCcEEE
Q 002289 356 IPPNVTVR 363 (941)
Q Consensus 356 ~~~~~~l~ 363 (941)
.+.+++++
T Consensus 320 ~~~L~~ly 327 (329)
T 3sb4_A 320 GVPSKLIY 327 (329)
T ss_dssp TCCCCEEE
T ss_pred Ccchhhhc
Confidence 45555554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=3.4e-15 Score=149.28 Aligned_cols=133 Identities=18% Similarity=0.226 Sum_probs=83.0
Q ss_pred cccCCCCCCEEEcccCCCCCCCCCccCCcc-ccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccc
Q 002289 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIK-SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179 (941)
Q Consensus 101 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 179 (941)
.+.++.+|++|+|++|+++ .+|. +..+. +|++|+|++|.+++. ..|..+++|++|+|++|.|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4556677777777777777 3443 44444 777777777777754 56667777777777777777554455566667
Q ss_pred cceEecccccccccCch--hccCCCccceeeccCCcCCCCCCcc----CCCCCCCCEEeccCCcCC
Q 002289 180 TRHFHMNNNSISGQIPP--ELSRLPSLVHMLLDNNNLTGYLPPE----LSELPKLLILQLDNNNFE 239 (941)
Q Consensus 180 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 239 (941)
|++|+|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 777777777665 3444 5556666666666666665 33332 555556666666555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=4.4e-17 Score=166.49 Aligned_cols=130 Identities=20% Similarity=0.296 Sum_probs=63.8
Q ss_pred CCCCEEEcccCCCCCCCCC------ccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccc
Q 002289 106 SYLTILDFMWNKISGSIPK------EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 179 (941)
..++.++++.|.+.|.+|. .|..+++|++|+|++|++++ +| .+.++++|++|+|++|.++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3444444444444444443 44555555555555555553 33 4455555555555555555 34444444555
Q ss_pred cceEecccccccccCchhccCCCccceeeccCCcCCCCCC-ccCCCCCCCCEEeccCCcCCC
Q 002289 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 180 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
|++|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|+|++|.+++
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 5555555555553 22 34445555555555555553211 244555555555555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=5.4e-17 Score=165.79 Aligned_cols=149 Identities=23% Similarity=0.302 Sum_probs=124.7
Q ss_pred eeEEEecCCCCCccCCc------cccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccc
Q 002289 84 LRELQLLNLNLSGNLSP------EIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLD 157 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~------~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 157 (941)
++.+++.++++.|.+|. .+..+++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 45555666666666665 89999999999999999996 77 8999999999999999999 7888888899999
Q ss_pred eeecccccccccCCcccccccccceEecccccccccCc-hhccCCCccceeeccCCcCCCCCCcc----------CCCCC
Q 002289 158 RIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPE----------LSELP 226 (941)
Q Consensus 158 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~ 226 (941)
+|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+|.. +..++
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~ 174 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCS
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCC
Confidence 99999999996 45 68999999999999999995433 47899999999999999998776543 56677
Q ss_pred CCCEEeccCCcCC
Q 002289 227 KLLILQLDNNNFE 239 (941)
Q Consensus 227 ~L~~L~Ls~N~l~ 239 (941)
+|+.|| +|.++
T Consensus 175 ~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 175 NLKKLD--GMPVD 185 (198)
T ss_dssp SCSEEC--CGGGT
T ss_pred CcEEEC--CcccC
Confidence 777765 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=4.6e-15 Score=148.30 Aligned_cols=133 Identities=23% Similarity=0.271 Sum_probs=104.4
Q ss_pred ccCCccccceecccCccccCCCCcccCCc-CccceeecccccccccCCcccccccccceEecccccccccCchhccCCCc
Q 002289 125 EIGNIKSLELLLLNGNELTGSLPEELGYL-PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPS 203 (941)
Q Consensus 125 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 203 (941)
.+.++.+|++|+|++|+++ .+|. +..+ ++|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4667888999999999998 4555 4444 4899999999998865 67888888888899888888665566688888
Q ss_pred cceeeccCCcCCCCCCc--cCCCCCCCCEEeccCCcCCCCCcchh----ccCCCCCcEEEccCCCCc
Q 002289 204 LVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNNFEGTTIPAS----YSNMSKLLKLSLRNCSLQ 264 (941)
Q Consensus 204 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~p~~----~~~l~~L~~L~Ls~N~l~ 264 (941)
|++|+|++|+|+ .+|. .+..+++|+.|+|++|.++. +|.. +..+++|+.|++++|.++
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~--~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN--KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG--STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC--cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888888886 4554 67888888888888888874 4553 778888888888887764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.48 E-value=3.5e-13 Score=152.72 Aligned_cols=264 Identities=9% Similarity=0.088 Sum_probs=199.3
Q ss_pred eeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
++++.+.+ +++..-..+|.+ .+|+.++|.+| ++.+-..+|.+. +|+.+.|.+ .++..-+..|.++++|+.++|++
T Consensus 115 l~~i~ip~-~i~~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILPN-SVKSIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECCT-TCCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEECC-ccCEehHhhccc-CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 44555544 455444456776 47999999877 765667788884 799999986 67767778899999999999999
Q ss_pred ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCc
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 243 (941)
|.++.+....|. ..+|+.+.|.+| ++.....+|.++++|+.+++.+| ++.....+|.+ .+|+.+.|. |.++. ..
T Consensus 190 n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~-I~ 263 (401)
T 4fdw_A 190 TKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN-IA 263 (401)
T ss_dssp SCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE-EC
T ss_pred CcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE-EC
Confidence 999976667777 589999999855 77667788999999999999875 66566677887 789999994 55654 45
Q ss_pred chhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCC
Q 002289 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 323 (941)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 323 (941)
..+|.++++|+.+++.+|.+... ....++.-.|....+|+.++|. |.++.+-..+|.++++|+.|.|.+| ++..-+
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~--~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~ 339 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDD--PEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF 339 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCC--TTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred hhHhhCCCCCCEEEeCCccccCC--cccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence 67899999999999999887511 1223455566677788999999 4588788899999999999999665 663334
Q ss_pred cccccccccCccccceEEccCCCCCCCCCCC--CCC-CCcEEEecCCC
Q 002289 324 SSIWQSRTLNATETFILDFQNNNLTNISGSF--NIP-PNVTVRLRGNP 368 (941)
Q Consensus 324 ~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~-~~~~l~l~~Np 368 (941)
..|.. . +|+.|++++|.+..++... .++ .+.+|++..|.
T Consensus 340 ~aF~~-----~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 340 SAFNN-----T-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp TSSSS-----S-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred HhCCC-----C-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 45533 2 5779999999999886554 343 46788887765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-12 Score=147.33 Aligned_cols=240 Identities=13% Similarity=0.117 Sum_probs=181.1
Q ss_pred CCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceE
Q 002289 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (941)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (941)
....++.+.+.+ .++.+-..+|.+. +|+.+.|.+| ++..-..+|.+. +|+.+.|.+ .++.+.+.+|.++++|+.+
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCee
Confidence 357788888875 4554566788875 7999999877 665666778874 799999986 7776778889999999999
Q ss_pred ecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCC
Q 002289 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (941)
Q Consensus 184 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (941)
+|.+|+++.....+|. ..+|+.+.|.+| ++.....+|.++++|+.++|..| ++. ....+|.+ .+|+.+.|. |.+
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~-I~~~aF~~-~~L~~i~lp-~~i 259 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VST-IGQEAFRE-SGITTVKLP-NGV 259 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCE-ECTTTTTT-CCCSEEEEE-TTC
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccC-cccccccc-CCccEEEeC-CCc
Confidence 9999999865556666 689999999854 77677788999999999999876 443 45567777 789999994 444
Q ss_pred cCCCCCCCCCCcccccccCCcCEEEccCCcCC-----CCcchhhcCCcccceeecccccCccCCCcccccccccCccccc
Q 002289 264 QGPMPDLSRIPNLGYLLSLNITTIKLSNNKLT-----GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 338 (941)
Q Consensus 264 ~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~ 338 (941)
+ .++...|....+|+.++|.+|.+. .+.+.+|.++++|+.++|. |.++..-...|..+ .+|+
T Consensus 260 ~-------~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c-----~~L~ 326 (401)
T 4fdw_A 260 T-------NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGN-----RKVT 326 (401)
T ss_dssp C-------EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTC-----CSCC
T ss_pred c-------EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCC-----CCcc
Confidence 4 444556667778899999988876 5668889999999999998 44763334444433 4566
Q ss_pred eEEccCCCCCCCCCCC--CCCCCcEEEecCCCC
Q 002289 339 ILDFQNNNLTNISGSF--NIPPNVTVRLRGNPF 369 (941)
Q Consensus 339 ~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~ 369 (941)
.++|..| ++.|.... .. .+..|.+.+|..
T Consensus 327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp EEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 8999554 88885444 45 788999988854
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=135.50 Aligned_cols=104 Identities=20% Similarity=0.249 Sum_probs=51.1
Q ss_pred eEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccc
Q 002289 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (941)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (941)
+.|++++++|+. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 455666665553 34333 245555555555555444555555555555555555555444444444555555555555
Q ss_pred cccccCCcccccccccceEeccccccc
Q 002289 165 YISGSLPKSFANLNKTRHFHMNNNSIS 191 (941)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 191 (941)
+|++..+..|..+++|++|+|++|.+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 444443444444444444444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=2.6e-13 Score=134.67 Aligned_cols=86 Identities=20% Similarity=0.295 Sum_probs=38.3
Q ss_pred CccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEec
Q 002289 154 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 233 (941)
Q Consensus 154 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 233 (941)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 33444444444444333444444444444444444444333333444444444444444444433334444444444444
Q ss_pred cCCcCC
Q 002289 234 DNNNFE 239 (941)
Q Consensus 234 s~N~l~ 239 (941)
++|.++
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 444444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.6e-13 Score=134.18 Aligned_cols=104 Identities=21% Similarity=0.269 Sum_probs=56.4
Q ss_pred eEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccc
Q 002289 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (941)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (941)
+.+++++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666664 3444443 55666666666666555555555666666666666655444444455555555555555
Q ss_pred cccccCCcccccccccceEeccccccc
Q 002289 165 YISGSLPKSFANLNKTRHFHMNNNSIS 191 (941)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 191 (941)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555443434444555555555554444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=5.4e-13 Score=132.92 Aligned_cols=85 Identities=21% Similarity=0.332 Sum_probs=36.0
Q ss_pred ccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEecc
Q 002289 155 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 234 (941)
Q Consensus 155 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 234 (941)
+|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~ 113 (174)
T 2r9u_A 34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY 113 (174)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeC
Confidence 33333444443333333333334444444444444443333333444444444444444443333334444444445444
Q ss_pred CCcCC
Q 002289 235 NNNFE 239 (941)
Q Consensus 235 ~N~l~ 239 (941)
+|.+.
T Consensus 114 ~N~~~ 118 (174)
T 2r9u_A 114 NNPWD 118 (174)
T ss_dssp SSCBC
T ss_pred CCCcc
Confidence 44444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=7.7e-13 Score=147.36 Aligned_cols=113 Identities=18% Similarity=0.270 Sum_probs=94.5
Q ss_pred CCC-CCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEccc-CCCCCCCCCccCCccccceeccc
Q 002289 61 DPC-TSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMW-NKISGSIPKEIGNIKSLELLLLN 138 (941)
Q Consensus 61 ~~c-~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls 138 (941)
+.| .|.|.+|.|.+. |+|++ +|. |..+++|++|+|++ |+|++..+..|++|++|++|+|+
T Consensus 3 ~~c~~C~~~~v~~~~~----------------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~ 64 (347)
T 2ifg_A 3 DACCPHGSSGLRCTRD----------------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64 (347)
T ss_dssp SSSCCSSSSCEECCSS----------------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECC
T ss_pred CcCccccCCEEEcCCC----------------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECC
Confidence 346 677877777431 15664 777 99999999999996 99998888889999999999999
Q ss_pred CccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccc
Q 002289 139 GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192 (941)
Q Consensus 139 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 192 (941)
+|+|++..|..|.+|++|++|+|++|+|++..+..|..++ |+.|+|++|+|..
T Consensus 65 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999988888999999999999999999977777777766 9999999998873
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.8e-14 Score=160.15 Aligned_cols=46 Identities=17% Similarity=0.204 Sum_probs=24.0
Q ss_pred CcCEEEccCCcCCCC----cchhhcCCcccceeecccccCccCCCccccc
Q 002289 283 NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 328 (941)
Q Consensus 283 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 328 (941)
+|++|+|++|.|+.. +...+...++|+.|+|++|.|++.....+..
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 345555555555432 3334445566777777777666444344433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-13 Score=154.00 Aligned_cols=110 Identities=15% Similarity=0.183 Sum_probs=48.3
Q ss_pred CCCCEEEcccCCCCCCCCCccCCc-----cccceecccCccccCCCCccc-CCcCccceeecccccccccCCcccc----
Q 002289 106 SYLTILDFMWNKISGSIPKEIGNI-----KSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSFA---- 175 (941)
Q Consensus 106 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~---- 175 (941)
++|+.|+|++|.|+......+... ++|++|+|++|.++......+ ..+++|++|+|++|.|+......+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456666666666653222222221 456666666665543211111 2234555555555555433222221
Q ss_pred -cccccceEeccccccccc----CchhccCCCccceeeccCCcCC
Q 002289 176 -NLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 176 -~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 215 (941)
..++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 234455555555544321 1222233444444444444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=136.59 Aligned_cols=79 Identities=15% Similarity=0.212 Sum_probs=36.2
Q ss_pred EEcccC-CCCCCCCCccCCccccceecccC-ccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccc
Q 002289 111 LDFMWN-KISGSIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (941)
Q Consensus 111 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (941)
++++++ +|+ .+|. |..+++|++|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 344444 444 2444 44444455555543 4444444444444444444444444444444444444444444444444
Q ss_pred ccc
Q 002289 189 SIS 191 (941)
Q Consensus 189 ~l~ 191 (941)
+|+
T Consensus 91 ~l~ 93 (347)
T 2ifg_A 91 ALE 93 (347)
T ss_dssp CCS
T ss_pred ccc
Confidence 444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3.2e-11 Score=128.58 Aligned_cols=144 Identities=14% Similarity=0.086 Sum_probs=112.5
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e 685 (941)
..+.|++...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456877888888889999999864 6889999987532223346889999999984 6778899999988889999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-------------------------------------- 727 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 727 (941)
|++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 91 ~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999876411 1123467889999999999811
Q ss_pred ------------------CCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 728 ------------------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 728 ------------------~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876666799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=3.2e-10 Score=120.31 Aligned_cols=128 Identities=21% Similarity=0.149 Sum_probs=97.6
Q ss_pred eccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCc--eeeeeeccccCCcEEEEEecCCCCCHHHH
Q 002289 618 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 695 (941)
Q Consensus 618 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~LV~e~~~~gsL~~~ 695 (941)
+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998777888999997653 2346789999999986544 456888888778899999999998884
Q ss_pred HhhcCCCCccHHHHHHHHHHHHHHHHHhhcCC------------------------------------------------
Q 002289 696 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEA------------------------------------------------ 727 (941)
Q Consensus 696 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 727 (941)
... .+ ...++.++++.|..||+..
T Consensus 104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 11 2256777888888888643
Q ss_pred -------CCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 728 -------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 728 -------~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
...++|+|++|.||+++++..+.|+|||.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999875
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.96 E-value=1e-08 Score=115.96 Aligned_cols=269 Identities=12% Similarity=0.034 Sum_probs=149.2
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCC---------------
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL--------------- 146 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--------------- 146 (941)
.+|+++.+.+ +++..-..+|.++++|+.++|.++ ++.+-..+|.++.+|+.+.+..+- ...-
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l-~~i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLML-KSIGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTC-CEECTTTTTTCCCSEEECC
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCce-eeecceeeecccccccccC
Confidence 3577777764 455444457888888888888754 543445677777777777665441 1111
Q ss_pred -------CcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCC
Q 002289 147 -------PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLP 219 (941)
Q Consensus 147 -------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 219 (941)
...|.++++|+.+.|.++. ..+....|.++.+|+.+.+..| ++.....+|.++..|+.+.+.++... +.
T Consensus 148 ~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~ 223 (394)
T 4fs7_A 148 EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LG 223 (394)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--EC
T ss_pred ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--ee
Confidence 2335555555555555433 2244445555555665555544 33233344555555555555443322 11
Q ss_pred ccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCC-------------CCCcccccccCCcCE
Q 002289 220 PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLS-------------RIPNLGYLLSLNITT 286 (941)
Q Consensus 220 ~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------------~l~~l~~l~~~~L~~ 286 (941)
..+....+|+.+.+..+. +. .....|.++.+|+.+.+..+..+-....+. .++...|....+|+.
T Consensus 224 ~~~~~~~~l~~i~ip~~~-~~-i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~ 301 (394)
T 4fs7_A 224 DFALSKTGVKNIIIPDSF-TE-LGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTE 301 (394)
T ss_dssp TTTTTTCCCCEEEECTTC-CE-ECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCE
T ss_pred hhhcccCCCceEEECCCc-ee-cccccccccccceeEEcCCCcceeeccccccccccceeccCceeeccccccccccccc
Confidence 222223344444443221 11 223456666777777776554321111111 122334555667888
Q ss_pred EEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEe
Q 002289 287 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRL 364 (941)
Q Consensus 287 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l 364 (941)
+.+.++ ++.+-..+|.++.+|+.++|.++ ++..-...|..+ .+|+.++|..| ++.|.... ....++.+.|
T Consensus 302 i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c-----~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 302 VKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGC-----TSLSNINFPLS-LRKIGANAFQGCINLKKVEL 373 (394)
T ss_dssp EEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC-----TTCCEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred cccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCC-----CCCCEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence 888765 66666788889999999988654 653334444433 45667888766 88775444 4567777877
Q ss_pred cCC
Q 002289 365 RGN 367 (941)
Q Consensus 365 ~~N 367 (941)
..|
T Consensus 374 p~~ 376 (394)
T 4fs7_A 374 PKR 376 (394)
T ss_dssp EGG
T ss_pred CCC
Confidence 654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=3e-09 Score=118.85 Aligned_cols=141 Identities=22% Similarity=0.316 Sum_probs=105.5
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEec--cCC-chhhHhHHHHHHHHHhcC--CCceeeeeeccccC---CcEEEEEe
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQ--EGS-LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEE---GEQMLVYE 685 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~LV~e 685 (941)
.+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998754 578888775 322 123457889999999997 45578888888766 45899999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-------------------------------------- 727 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 727 (941)
|++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99987775421 123677888889999999999999731
Q ss_pred -----------------CCCeEeccCCCCcEEEcCCCc--EEEeeeccccc
Q 002289 728 -----------------DPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 759 (941)
Q Consensus 728 -----------------~~~ivH~DLkp~NILl~~~~~--~kl~DFGla~~ 759 (941)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.82 E-value=5.8e-10 Score=123.98 Aligned_cols=87 Identities=10% Similarity=0.175 Sum_probs=43.6
Q ss_pred CCCCCCEEeccCCcCCCCCcchhcc---CCCCCcEEEccCCCCcCCCCCCCCC-CcccccccCCcCEEEccCCcCCCCcc
Q 002289 224 ELPKLLILQLDNNNFEGTTIPASYS---NMSKLLKLSLRNCSLQGPMPDLSRI-PNLGYLLSLNITTIKLSNNKLTGTIP 299 (941)
Q Consensus 224 ~l~~L~~L~Ls~N~l~~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~~~~~~l-~~l~~l~~~~L~~L~Ls~N~l~~~~p 299 (941)
.+++|++|+|++|.+.. ..+..+. .+++|+.|+|+.|.|++.-.. .+ ..+ -.+.+|+.|+|++|.|+...-
T Consensus 250 ~~p~Lr~L~L~~~~i~~-~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~--~L~~~L--~~l~~L~~L~L~~n~i~d~~~ 324 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQN-VVVEMFLESDILPQLETMDISAGVLTDEGAR--LLLDHV--DKIKHLKFINMKYNYLSDEMK 324 (362)
T ss_dssp TCTTCCEEEEESCTTHH-HHHHHHHHCSSGGGCSEEECCSSCCBHHHHH--HHHTTH--HHHTTCSEEECCSBBCCHHHH
T ss_pred CCCCcCEEeCCCCCCch-HHHHHHHhCccCCCCCEEECCCCCCChHHHH--HHHhhc--ccCCcceEEECCCCcCCHHHH
Confidence 35667777777666653 1222222 456777777777776532100 00 000 122456778888887764443
Q ss_pred hhhcC-Ccccceeeccccc
Q 002289 300 SNFSG-LPRLQRLFIANNS 317 (941)
Q Consensus 300 ~~~~~-l~~L~~L~Ls~N~ 317 (941)
..+.. + ...+++++|+
T Consensus 325 ~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 325 KELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHC--CSEEECCSBC
T ss_pred HHHHHHc--CCEEEecCCc
Confidence 33332 2 2334555544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=6.1e-09 Score=113.39 Aligned_cols=192 Identities=16% Similarity=0.156 Sum_probs=121.1
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCc--eeeeeeccccCC---cEEEEEecC
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRN--LVSLVGYCDEEG---EQMLVYEFM 687 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~LV~e~~ 687 (941)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 45888886532 33467889999998883 332 345555543333 348899999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------------------------------------- 726 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 726 (941)
+|.++.+.... .++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888653321 256667777888888888888851
Q ss_pred --------------CCCCeEeccCCCCcEEEcC--CCcEEEeeeccccccCCCC-CCCcc------ccccccccccCCCc
Q 002289 727 --------------ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD-IEGIV------PAHVSTVVKGTPGY 783 (941)
Q Consensus 727 --------------~~~~ivH~DLkp~NILl~~--~~~~kl~DFGla~~~~~~~-~~~~~------~~~~~~~~~gt~~y 783 (941)
..+.++|+|+++.||++++ ...+.|+||+.+..-.... ..... ............++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1234899999999999998 4568899999986532110 00000 00000000000111
Q ss_pred cc-ccccccCCCCchhHhHHHHHHHHHHHhCCCCC
Q 002289 784 LD-PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 817 (941)
Q Consensus 784 ~a-PE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf 817 (941)
.. |+..... ....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 12368999999999999997766
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.9e-09 Score=119.74 Aligned_cols=87 Identities=16% Similarity=0.200 Sum_probs=56.5
Q ss_pred CCCCCcEEEccCCCCcCCCCC-CCCCCcccccccCCcCEEEccCCcCCCCc----chhhcCCcccceeecccccCccCCC
Q 002289 249 NMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTI----PSNFSGLPRLQRLFIANNSLSGSIP 323 (941)
Q Consensus 249 ~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p 323 (941)
.+++|++|+|++|.+....+. +... ..+++|++|+|+.|.|.+.. +..+..+++|+.|+|++|.|+...-
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a-----~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~ 324 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLES-----DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK 324 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHC-----SSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhC-----ccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH
Confidence 478999999999988642211 0000 12356899999999998753 3334567899999999998874332
Q ss_pred cccccccccCccccceEEccCCC
Q 002289 324 SSIWQSRTLNATETFILDFQNNN 346 (941)
Q Consensus 324 ~~~~~l~~l~~~~L~~L~Ls~N~ 346 (941)
..+... + ...+++++|+
T Consensus 325 ~~l~~a--l----g~~~~~~~~~ 341 (362)
T 2ra8_A 325 KELQKS--L----PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHH--C----CSEEECCSBC
T ss_pred HHHHHH--c----CCEEEecCCc
Confidence 222220 1 2468999887
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.74 E-value=7.8e-11 Score=124.40 Aligned_cols=67 Identities=10% Similarity=0.141 Sum_probs=32.5
Q ss_pred cCCccccce--ecccCcccc---CCCCcccCCcCccceeecccccccc--cCCcccccccccceEecccccccc
Q 002289 126 IGNIKSLEL--LLLNGNELT---GSLPEELGYLPKLDRIQIDQNYISG--SLPKSFANLNKTRHFHMNNNSISG 192 (941)
Q Consensus 126 ~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~ 192 (941)
|...+.|+. ++++.|+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~ 210 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 210 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC
Confidence 444555555 555666332 1111122345556666666666554 233444455555555555555553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.68 E-value=6.1e-07 Score=101.34 Aligned_cols=264 Identities=13% Similarity=0.132 Sum_probs=162.0
Q ss_pred eeEEEecCCCCCccCCccccCCCCCCEEEcccCC---CCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNK---ISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
|+++.+.+ +++..-..+|.+.++|+.+.+..|. ++.+-..+|.++.+|+.+.+..+ ++..-...|.++.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 66666654 3554444577888888888887764 55444567778888888877655 4435556778888888888
Q ss_pred cccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 240 (941)
+..+ +..+....|..+.+|+.+.+.++ ++..-..+|.. .+|+.+.+..+-.. ....+|.++.+|+......+....
T Consensus 144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~ 219 (394)
T 4gt6_A 144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA 219 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB
T ss_pred ccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceeccccccccc
Confidence 8644 34355667778888888887655 33233344433 46777776554332 444556666666655443332210
Q ss_pred ---------------------------C--------CcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcC
Q 002289 241 ---------------------------T--------TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNIT 285 (941)
Q Consensus 241 ---------------------------~--------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~ 285 (941)
. ....+|.++.+|+.+.+.++.. .+....|....+|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~--------~I~~~aF~~c~~L~ 291 (394)
T 4gt6_A 220 IDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVV--------SIGTGAFMNCPALQ 291 (394)
T ss_dssp SSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCC--------EECTTTTTTCTTCC
T ss_pred ccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccc--------eecCcccccccccc
Confidence 0 1123566667777776654432 23334445556678
Q ss_pred EEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEE
Q 002289 286 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVR 363 (941)
Q Consensus 286 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~ 363 (941)
.+.+. +.++.+...+|.++.+|+.++|.++ ++..-...|..+ .+|+.+.|.. +++.|.... ....++.+.
T Consensus 292 ~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C-----~~L~~i~ip~-sv~~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 292 DIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGC-----EQLERIAIPS-SVTKIPESAFSNCTALNNIE 363 (394)
T ss_dssp EEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC-----TTCCEEEECT-TCCBCCGGGGTTCTTCCEEE
T ss_pred cccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCC-----CCCCEEEECc-ccCEEhHhHhhCCCCCCEEE
Confidence 88875 4566566778888888888888754 542233344333 4556788854 477775443 567788888
Q ss_pred ecCCCC
Q 002289 364 LRGNPF 369 (941)
Q Consensus 364 l~~Np~ 369 (941)
+.+|.-
T Consensus 364 ~~~~~~ 369 (394)
T 4gt6_A 364 YSGSRS 369 (394)
T ss_dssp ESSCHH
T ss_pred ECCcee
Confidence 887753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.63 E-value=4e-07 Score=102.82 Aligned_cols=225 Identities=10% Similarity=0.038 Sum_probs=143.2
Q ss_pred ccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccc
Q 002289 100 PEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 179 (941)
Q Consensus 100 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 179 (941)
.+|.++++|+.+.+.++... +-...|.++.+|+.+++..| ++......|.++..|+.+.+..+... +.+.+....+
T Consensus 156 ~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~ 231 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTG 231 (394)
T ss_dssp TTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCC
T ss_pred hhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCC
Confidence 35667777777777655322 44566777777777777666 44345566777777777777665432 2233344456
Q ss_pred cceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEcc
Q 002289 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (941)
Q Consensus 180 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (941)
|+.+.+.++ ++......|..+..|+.+.+..+... .....|..+..|+.+.+..+.+. ...|..+.+|+.+.+.
T Consensus 232 l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~----~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 232 VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP----EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC----TTTTTTCTTCCEEEEC
T ss_pred CceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec----cccccccccccccccc
Confidence 666666543 23233456677778888887766544 55567777778877777665542 3467778888888876
Q ss_pred CCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccce
Q 002289 260 NCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 339 (941)
Q Consensus 260 ~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~ 339 (941)
.+ ++ .+....|....+|+.++|.++ ++.+-..+|.++.+|+.++|..| ++..-...|..+ .+|+.
T Consensus 306 ~~-i~-------~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C-----~~L~~ 370 (394)
T 4fs7_A 306 DS-VK-------FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGC-----INLKK 370 (394)
T ss_dssp TT-CC-------EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTC-----TTCCE
T ss_pred cc-cc-------eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCC-----CCCCE
Confidence 54 33 344445566667788888654 77666788888889999888776 653334445443 44567
Q ss_pred EEccCCCCCCC
Q 002289 340 LDFQNNNLTNI 350 (941)
Q Consensus 340 L~Ls~N~l~~~ 350 (941)
++|..| ++.+
T Consensus 371 i~lp~~-~~~~ 380 (394)
T 4fs7_A 371 VELPKR-LEQY 380 (394)
T ss_dssp EEEEGG-GGGG
T ss_pred EEECCC-CEEh
Confidence 777643 4443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.6e-06 Score=97.84 Aligned_cols=243 Identities=11% Similarity=0.178 Sum_probs=137.3
Q ss_pred ceeeEEEecCCC---CCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccce
Q 002289 82 LHLRELQLLNLN---LSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158 (941)
Q Consensus 82 ~~l~~L~L~~~~---l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 158 (941)
.+|+++.+.++. ++..-..+|....+|+.+.+..+ ++.+-...|.++.+|+.+.|..+. .......|.++.+|+.
T Consensus 87 ~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~ 164 (394)
T 4gt6_A 87 TSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHT 164 (394)
T ss_dssp TTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCE
T ss_pred ccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccccccee-eeecccceeccccccc
Confidence 457888887653 44333456777777887777654 443445677778888888876543 3255566777777777
Q ss_pred eecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccC---------------------------
Q 002289 159 IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN--------------------------- 211 (941)
Q Consensus 159 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~--------------------------- 211 (941)
+.+..+ ++.+...+|.+ .+|+.+.+..+-.. ....+|..+.+|+......
T Consensus 165 i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (394)
T 4gt6_A 165 VTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQ 241 (394)
T ss_dssp EECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTT
T ss_pred ccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccccccccc
Confidence 777654 33333444433 45555555433222 2223333333333332211
Q ss_pred ---------CcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccC
Q 002289 212 ---------NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSL 282 (941)
Q Consensus 212 ---------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~ 282 (941)
+.++.....+|.++.+|+.+.+..+..+ ....+|.++++|+.+.+.. .++ .++...|....
T Consensus 242 ~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~--I~~~aF~~c~~L~~i~l~~-~i~-------~I~~~aF~~c~ 311 (394)
T 4gt6_A 242 REDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS--IGTGAFMNCPALQDIEFSS-RIT-------ELPESVFAGCI 311 (394)
T ss_dssp CCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE--ECTTTTTTCTTCCEEECCT-TCC-------EECTTTTTTCT
T ss_pred cccceEEcCCcceEcccceeeecccccEEecccccce--ecCcccccccccccccCCC-ccc-------ccCceeecCCC
Confidence 1122223345677777777777665443 3455677777777777752 232 34444555556
Q ss_pred CcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCC
Q 002289 283 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 346 (941)
Q Consensus 283 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~ 346 (941)
+|+.++|..+ ++.+-..+|.++.+|+.+.|..+ ++..-...|.. ..+|+.+++.+|.
T Consensus 312 ~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~-----C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 312 SLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSN-----CTALNNIEYSGSR 368 (394)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTT-----CTTCCEEEESSCH
T ss_pred CcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhC-----CCCCCEEEECCce
Confidence 6777777654 55555677777777777777544 54222233333 3445567777664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.36 E-value=3.8e-08 Score=103.79 Aligned_cols=121 Identities=25% Similarity=0.266 Sum_probs=70.0
Q ss_pred eecccCccccCCCCc-ccCCcCccce--eeccccccc---ccCCcccccccccceEecccccccc--cCchhccCCCccc
Q 002289 134 LLLLNGNELTGSLPE-ELGYLPKLDR--IQIDQNYIS---GSLPKSFANLNKTRHFHMNNNSISG--QIPPELSRLPSLV 205 (941)
Q Consensus 134 ~L~Ls~N~l~~~~p~-~~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~ 205 (941)
.|...+|..++.++- .|...+.|+. ++++.|... +.++....++++|+.|+|++|+|++ .+|..+..+++|+
T Consensus 120 ~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~ 199 (267)
T 3rw6_A 120 IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 199 (267)
T ss_dssp HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCC
T ss_pred HHHhccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCC
Confidence 344445544443332 2555566666 677777543 2222223456777888888888776 3445566677777
Q ss_pred eeeccCCcCCCCCCccCCCCC--CCCEEeccCCcCCCCCcc-------hhccCCCCCcEEE
Q 002289 206 HMLLDNNNLTGYLPPELSELP--KLLILQLDNNNFEGTTIP-------ASYSNMSKLLKLS 257 (941)
Q Consensus 206 ~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~p-------~~~~~l~~L~~L~ 257 (941)
.|+|++|+|++. ..+..+. +|+.|+|++|.+.+ .+| ..+..+++|+.||
T Consensus 200 ~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~-~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 200 ILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD-TFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp EEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG-GCSSHHHHHHHHHHHCTTCCEES
T ss_pred EEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc-ccCcchhHHHHHHHHCcccCeEC
Confidence 777777777754 2233333 67777777777664 232 2355566666554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=4.2e-08 Score=98.29 Aligned_cols=69 Identities=14% Similarity=0.139 Sum_probs=34.8
Q ss_pred CccccCCCCCCEEEcccC-CCCCC----CCCccCCccccceecccCccccCC----CCcccCCcCccceeeccccccc
Q 002289 99 SPEIGRLSYLTILDFMWN-KISGS----IPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYIS 167 (941)
Q Consensus 99 ~~~l~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 167 (941)
...+...+.|++|+|++| .|... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|+
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 344556667777777776 66521 223344445566666666665421 1222233344555555555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.29 E-value=8.1e-08 Score=96.23 Aligned_cols=38 Identities=18% Similarity=0.318 Sum_probs=16.9
Q ss_pred CccceeeccCCcCCCC----CCccCCCCCCCCEEec--cCCcCC
Q 002289 202 PSLVHMLLDNNNLTGY----LPPELSELPKLLILQL--DNNNFE 239 (941)
Q Consensus 202 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~ 239 (941)
++|++|+|++|.|+.. +...+...++|++|+| ++|.|.
T Consensus 93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 4444444444444421 2233344445555555 445543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=7e-07 Score=83.56 Aligned_cols=65 Identities=22% Similarity=0.302 Sum_probs=46.2
Q ss_pred eeecccccCc-cCCCcccccccccCccccceEEccCCCCCCCCCCC--CCCCCcEEEecCCCCccCCCcccccCC
Q 002289 310 RLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGS 381 (941)
Q Consensus 310 ~L~Ls~N~l~-~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--~~~~~~~l~l~~Np~~c~c~~~~~~~~ 381 (941)
.++.+++.|+ ..+|..+ ..+|+.|+|++|+|+.++... .++.++.|+|.+|||.|||.+.+|-..
T Consensus 12 ~v~Cs~~~L~~~~vP~~l-------p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~w 79 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF-------PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAW 79 (130)
T ss_dssp EEECCSSCCCTTTSCSCC-------CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHH
T ss_pred EEEeCCCCCccccCCCCC-------CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHH
Confidence 4555555554 3455443 235667788888888876555 577889999999999999999777653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=3.3e-06 Score=89.79 Aligned_cols=134 Identities=16% Similarity=0.152 Sum_probs=97.3
Q ss_pred eeeccCcE-EEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 616 QIGQGGYG-KVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 616 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
.+..|..| .||+.... ++..+++|+.... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556655 68988764 5678999986532 3456888999998884 33467888888888899999999999888
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCC---------------------------------------------
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--------------------------------------------- 727 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 727 (941)
.+...... .....+..++++.|.-||+..
T Consensus 108 ~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 77653321 122345666667777777511
Q ss_pred ----------CCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 728 ----------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 728 ----------~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
.+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137899999999999988777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.8e-06 Score=89.79 Aligned_cols=136 Identities=20% Similarity=0.199 Sum_probs=92.4
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCC---ceeeeeeccc-cCCcEEEEEecCCC
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR---NLVSLVGYCD-EEGEQMLVYEFMSN 689 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~LV~e~~~~ 689 (941)
.+.++.|....||+. |..+++|+... ......+.+|.++|+.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888998999987 56688888532 23346789999999999653 3556666663 45667899999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE------------------------------------------- 726 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 726 (941)
.++.+..-. .++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888663211 123334444444444444444432
Q ss_pred --------------CCCCeEeccCCCCcEEEcC---CCc-EEEeeeccccc
Q 002289 727 --------------ADPPVFHRDIKASNILLDH---KFT-AKVADFGLSRL 759 (941)
Q Consensus 727 --------------~~~~ivH~DLkp~NILl~~---~~~-~kl~DFGla~~ 759 (941)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 58999998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.17 E-value=3.5e-05 Score=86.24 Aligned_cols=77 Identities=6% Similarity=-0.004 Sum_probs=43.0
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
+++++.+.. +++..-..+|.++.+|+.++|..+ ++.+-..+|.++ +|+.+.+..+ ++..-...|.+ .+|+.+.+.
T Consensus 47 ~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp 121 (379)
T 4h09_A 47 RISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFP 121 (379)
T ss_dssp GCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECC
T ss_pred CCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCC
Confidence 466666653 444333446777777887777644 554445666665 5666666543 33233344444 356666665
Q ss_pred cc
Q 002289 163 QN 164 (941)
Q Consensus 163 ~N 164 (941)
.+
T Consensus 122 ~~ 123 (379)
T 4h09_A 122 GA 123 (379)
T ss_dssp TT
T ss_pred Cc
Confidence 44
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.12 E-value=7.1e-05 Score=83.69 Aligned_cols=244 Identities=11% Similarity=0.066 Sum_probs=128.7
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.+|++++|.+ +++..-..+|.+. +|+.+.+..+ ++.+-..+|.. .+|+.+.|.++-.. .-...|.+. +|+.+.+
T Consensus 69 ~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~ 142 (379)
T 4h09_A 69 YNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGATTE-IGNYIFYNS-SVKRIVI 142 (379)
T ss_dssp TTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTCCE-ECTTTTTTC-CCCEEEE
T ss_pred CCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcccc-ccccccccc-eeeeeec
Confidence 4688888865 3553333456665 6777776543 44233445544 36777777654222 222333332 3333333
Q ss_pred ccccccccCCcccccccccceEeccccc-----------------------------------ccccCchhccCCCccce
Q 002289 162 DQNYISGSLPKSFANLNKTRHFHMNNNS-----------------------------------ISGQIPPELSRLPSLVH 206 (941)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~-----------------------------------l~~~~p~~~~~l~~L~~ 206 (941)
..+ ++.+....|..+.+|+.+.+..+. ........+....+|+.
T Consensus 143 ~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~ 221 (379)
T 4h09_A 143 PKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKK 221 (379)
T ss_dssp CTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSE
T ss_pred cce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccccccccce
Confidence 322 222233334444444333332211 11122334555667777
Q ss_pred eeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCE
Q 002289 207 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITT 286 (941)
Q Consensus 207 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~ 286 (941)
+.+..+ +......+|.++.+|+.+.+..+ ++. ....+|.++.+|+.+.+..+ ++ .++...|....+|+.
T Consensus 222 i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~-I~~~aF~~~~~l~~i~l~~~-i~-------~i~~~aF~~c~~L~~ 290 (379)
T 4h09_A 222 ITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTS-IGSFLLQNCTALKTLNFYAK-VK-------TVPYLLCSGCSNLTK 290 (379)
T ss_dssp EECCTT-CCEECTTTTTTCSSCCEEEECTT-CCE-ECTTTTTTCTTCCEEEECCC-CS-------EECTTTTTTCTTCCE
T ss_pred eeeccc-eeEEccccccCCccceEEEcCCC-ccE-eCccccceeehhcccccccc-ce-------ecccccccccccccc
Confidence 777544 33344556777777777777665 433 34456777777777777543 22 333444555566777
Q ss_pred EEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCC
Q 002289 287 IKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350 (941)
Q Consensus 287 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~ 350 (941)
+.+.++.++.+-..+|.++.+|+.+.|.++ ++..-...|..+. +|+.+.+..+ ++.|
T Consensus 291 i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~-----~L~~i~ip~~-v~~I 347 (379)
T 4h09_A 291 VVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCK-----ALSTISYPKS-ITLI 347 (379)
T ss_dssp EEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT-----TCCCCCCCTT-CCEE
T ss_pred ccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCC-----CCCEEEECCc-cCEE
Confidence 777777777666777777777777777644 4422233443333 3344555432 5555
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=4.5e-06 Score=92.70 Aligned_cols=80 Identities=4% Similarity=-0.013 Sum_probs=56.1
Q ss_pred ccee-eccCcEEEEEEEeC-------CCcEEEEEEeccCC---chhhHhHHHHHHHHHhcC-C--CceeeeeeccccC--
Q 002289 614 STQI-GQGGYGKVYKGILP-------DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEE-- 677 (941)
Q Consensus 614 ~~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~-- 677 (941)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999988754 26788999865422 111246788999888884 3 3567788877654
Q ss_pred -CcEEEEEecCCCCCHH
Q 002289 678 -GEQMLVYEFMSNGTLR 693 (941)
Q Consensus 678 -~~~~LV~e~~~~gsL~ 693 (941)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 4578999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=5.6e-05 Score=85.19 Aligned_cols=75 Identities=16% Similarity=0.061 Sum_probs=49.6
Q ss_pred cceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-------hhhHhHHHHHHHHHhcCC--C-ceeeeeeccccCCcEEE
Q 002289 614 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------QGEKEFLTEIQFLSRLHH--R-NLVSLVGYCDEEGEQML 682 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~L 682 (941)
.+.||.|.++.||++... +++.|+||....... ....++..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999864 468899997653211 123456789998888742 3 34455544 3345689
Q ss_pred EEecCCCC
Q 002289 683 VYEFMSNG 690 (941)
Q Consensus 683 V~e~~~~g 690 (941)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00012 Score=80.35 Aligned_cols=139 Identities=18% Similarity=0.169 Sum_probs=79.4
Q ss_pred ceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC--Cceeeeeec------cccCCcEEEEEec
Q 002289 615 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGY------CDEEGEQMLVYEF 686 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~------~~~~~~~~LV~e~ 686 (941)
+.|+.|..+.||+....+| .+++|+.... ...+..|.++++.+.. -.+.+++.. ....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987655 4889988752 2234455666655531 133444431 1245678999999
Q ss_pred CCCCCHH--------------HHHhhc--C---CC-------CccHHHH-------------------------------
Q 002289 687 MSNGTLR--------------DQLSAK--S---KE-------PLGFAMR------------------------------- 709 (941)
Q Consensus 687 ~~~gsL~--------------~~l~~~--~---~~-------~l~~~~~------------------------------- 709 (941)
++|.++. ..+|.. . .. ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 112211 0 00 0112110
Q ss_pred HHHHHHHHHHHHHhhc----------CCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 710 LSIALGSSRGILYLHT----------EADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 710 ~~i~~~ia~gL~yLH~----------~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..+...+.+++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223345666653 023449999999999999888899999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.0001 Score=79.08 Aligned_cols=78 Identities=19% Similarity=0.234 Sum_probs=57.8
Q ss_pred CCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC---CceeeeeeccccCCcEEEEEecC
Q 002289 611 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH---RNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 611 y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
....+.+|.|..+.||+.+..||+.|++|+...........|..|.+.|+.+.- -.+.+++++. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 334678999999999999999999999998765444444568899999988842 2344555542 347899999
Q ss_pred CCCCH
Q 002289 688 SNGTL 692 (941)
Q Consensus 688 ~~gsL 692 (941)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00021 Score=77.38 Aligned_cols=137 Identities=16% Similarity=0.151 Sum_probs=91.4
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC---CCceeeeeeccccCCcEEEEEecCCCC
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVYEFMSNG 690 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~LV~e~~~~g 690 (941)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+.+++++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999886 4678889987642 2456889999888884 356788888887778899999999987
Q ss_pred CHH--------H---HHhhcCC-C-------------------CccHHHHH---HHH----------------HHHHH-H
Q 002289 691 TLR--------D---QLSAKSK-E-------------------PLGFAMRL---SIA----------------LGSSR-G 719 (941)
Q Consensus 691 sL~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~ia~-g 719 (941)
.+. + .||.... . .-+|.... ++. ..+.. .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 652 1 2233211 0 01343221 011 11111 1
Q ss_pred HHHhhc-CCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 720 ILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 720 L~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 234432 2345699999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.45 E-value=3.7e-05 Score=75.15 Aligned_cols=34 Identities=12% Similarity=-0.008 Sum_probs=14.0
Q ss_pred CCCEEEcccCCCCCCCCCccCCccccceecccCc
Q 002289 107 YLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (941)
Q Consensus 107 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (941)
+|+.|||+++.|+..--..+.++++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 3455555554444222222333444444444443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.37 E-value=4.4e-05 Score=74.65 Aligned_cols=34 Identities=6% Similarity=0.070 Sum_probs=15.6
Q ss_pred ccceecccCccccCCCCcccCCcCccceeecccc
Q 002289 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164 (941)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 164 (941)
+|++|||+++.++..--..+.++++|++|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555544332233344444444444444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00057 Score=77.48 Aligned_cols=73 Identities=11% Similarity=0.132 Sum_probs=44.8
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccC------C-c--hhhHhHHHHHHHHH-hcCCCceeeeeeccccCCcEEEE
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG------S-L--QGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.+.||.|..+.||++.. +++.++||..... . . .....+..|+..+. ......+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999965 5678999943210 1 0 02223344443322 22234566676665 4667999
Q ss_pred EecC-CC
Q 002289 684 YEFM-SN 689 (941)
Q Consensus 684 ~e~~-~~ 689 (941)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0014 Score=71.74 Aligned_cols=140 Identities=14% Similarity=0.130 Sum_probs=73.9
Q ss_pred ceeeccCcEE-EEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC--CceeeeeeccccCCcEEEEEecCCCCC
Q 002289 615 TQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 615 ~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~LV~e~~~~gs 691 (941)
+.|+.|+... +|+....+|+.+++|...... ...+..|+++++.+.. -.+.+++.+....+ ++|||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565555444 667765446777787654321 1345667777777642 23456666644333 78999997766
Q ss_pred HHHHHhhc---------------------C---CCCccHHHHH--------HH------------HHHHHHHHHHhh---
Q 002289 692 LRDQLSAK---------------------S---KEPLGFAMRL--------SI------------ALGSSRGILYLH--- 724 (941)
Q Consensus 692 L~~~l~~~---------------------~---~~~l~~~~~~--------~i------------~~~ia~gL~yLH--- 724 (941)
+.+++... . ...++..... .+ ...+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443211 0 0111111100 00 001111222221
Q ss_pred cCCCCCeEeccCCCCcEEEcCC----CcEEEeeeccccc
Q 002289 725 TEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRL 759 (941)
Q Consensus 725 ~~~~~~ivH~DLkp~NILl~~~----~~~kl~DFGla~~ 759 (941)
......++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123349999999999999875 6899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0025 Score=69.14 Aligned_cols=157 Identities=12% Similarity=0.117 Sum_probs=87.1
Q ss_pred cchHHHHHHhcCCCc-----cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCc--eeeee
Q 002289 599 FTYGEMALATNNFNS-----STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLV 671 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~ 671 (941)
++.+++.....+|.+ .+.|+.|....+|+....+| .+++|+.... .....+..|+++++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344455555555654 24566788889999987666 5788987652 12235667888887774222 33444
Q ss_pred ecc------ccCCcEEEEEecCCCCCHHH--------------HHhhc----CCC-----C-ccHHHHHH----------
Q 002289 672 GYC------DEEGEQMLVYEFMSNGTLRD--------------QLSAK----SKE-----P-LGFAMRLS---------- 711 (941)
Q Consensus 672 ~~~------~~~~~~~LV~e~~~~gsL~~--------------~l~~~----~~~-----~-l~~~~~~~---------- 711 (941)
... ...+..++||+|++|..+.. .+|.. ... . ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 321 12356789999998865311 12211 000 0 11222110
Q ss_pred --HHHHHHHHHHHhhcC----CCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 712 --IALGSSRGILYLHTE----ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 712 --i~~~ia~gL~yLH~~----~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
+...+.+.++++++. ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133445555421 12348999999999999987666899999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.008 Score=65.29 Aligned_cols=141 Identities=17% Similarity=0.167 Sum_probs=81.1
Q ss_pred ceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCC--ceeeeeec-----cccCCcEEEEEecC
Q 002289 615 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR--NLVSLVGY-----CDEEGEQMLVYEFM 687 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~-----~~~~~~~~LV~e~~ 687 (941)
..++ |....||+....+|+.+++|+...... ....+..|..+++.+... .+.+++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 777899998877787899999864321 234677788888877422 24445443 11245668899999
Q ss_pred CCCCHH-----H------H---Hhhc----C---CCCccHHHH----------------------HHHHHHHHHHHHHhh
Q 002289 688 SNGTLR-----D------Q---LSAK----S---KEPLGFAMR----------------------LSIALGSSRGILYLH 724 (941)
Q Consensus 688 ~~gsL~-----~------~---l~~~----~---~~~l~~~~~----------------------~~i~~~ia~gL~yLH 724 (941)
+|.++. . . +|.. . ....++... ...+..++..++-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 1 1 1210 0 111222110 011111122222221
Q ss_pred c-CCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 725 T-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 725 ~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
. .....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1223488999999999999 4 899999988753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00041 Score=69.08 Aligned_cols=40 Identities=15% Similarity=0.195 Sum_probs=18.4
Q ss_pred CccccceecccCc-cccCC----CCcccCCcCccceeeccccccc
Q 002289 128 NIKSLELLLLNGN-ELTGS----LPEELGYLPKLDRIQIDQNYIS 167 (941)
Q Consensus 128 ~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 167 (941)
+-+.|++|+|++| +|... +-..+..-+.|+.|+|++|+|.
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence 3445666666653 44321 1222333444555555555544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00015 Score=72.31 Aligned_cols=87 Identities=20% Similarity=0.220 Sum_probs=49.5
Q ss_pred cccCCCCCCEEEcccC-CCCC----CCCCccCCccccceecccCccccCC----CCcccCCcCccceeecccccccccC-
Q 002289 101 EIGRLSYLTILDFMWN-KISG----SIPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYISGSL- 170 (941)
Q Consensus 101 ~l~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~- 170 (941)
.+.+-+.|++|+|++| +|.. .+-+.+..-+.|+.|+|++|+|+.. +...+..-+.|++|+|++|.|....
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3455667888888775 6652 1234455567788888888888732 2223334466777777777766332
Q ss_pred ---CcccccccccceEeccc
Q 002289 171 ---PKSFANLNKTRHFHMNN 187 (941)
Q Consensus 171 ---p~~~~~l~~L~~L~L~~ 187 (941)
-+.+..-+.|++|+|++
T Consensus 116 ~ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCC
T ss_pred HHHHHHHhhCCceeEEECCC
Confidence 12233334455555543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0027 Score=68.30 Aligned_cols=71 Identities=8% Similarity=0.072 Sum_probs=45.2
Q ss_pred cceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCce-eeeeeccccCCcEEEEEecC-CCCC
Q 002289 614 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFM-SNGT 691 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~LV~e~~-~~gs 691 (941)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+....+ .++++++. +.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 578999999999998 45888887643211 1233568887777742222 45665543 3346899999 6654
Q ss_pred H
Q 002289 692 L 692 (941)
Q Consensus 692 L 692 (941)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0017 Score=73.65 Aligned_cols=73 Identities=18% Similarity=0.214 Sum_probs=50.4
Q ss_pred cceeeccCcEEEEEEEeCC--------CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCce-eeeeeccccCCcEEEEE
Q 002289 614 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~LV~ 684 (941)
.+.|+.|....+|+....+ ++.+++|+..... ....+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998653 5789999884321 11355689998888853333 567776643 3899
Q ss_pred ecCCCCCH
Q 002289 685 EFMSNGTL 692 (941)
Q Consensus 685 e~~~~gsL 692 (941)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0042 Score=68.96 Aligned_cols=139 Identities=18% Similarity=0.177 Sum_probs=81.4
Q ss_pred ceeeccCcEEEEEEEeC--------CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEEe
Q 002289 615 TQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~e 685 (941)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777777889998864 3578999986432 223345678999988884 3223567777654 29999
Q ss_pred cCCCCCHHH--------------H---HhhcC---CCCc--cHHHHHHHHHHHHH-------------------HHHHh-
Q 002289 686 FMSNGTLRD--------------Q---LSAKS---KEPL--GFAMRLSIALGSSR-------------------GILYL- 723 (941)
Q Consensus 686 ~~~~gsL~~--------------~---l~~~~---~~~l--~~~~~~~i~~~ia~-------------------gL~yL- 723 (941)
|++|.+|.. . +|... .... -+.++.++..++.. .++.|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998765521 1 11111 1111 23444444433321 22333
Q ss_pred ---hcC-CCCCeEeccCCCCcEEEcCC----CcEEEeeecccc
Q 002289 724 ---HTE-ADPPVFHRDIKASNILLDHK----FTAKVADFGLSR 758 (941)
Q Consensus 724 ---H~~-~~~~ivH~DLkp~NILl~~~----~~~kl~DFGla~ 758 (941)
... ....++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 22348899999999999876 789999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0068 Score=69.11 Aligned_cols=74 Identities=14% Similarity=0.007 Sum_probs=48.5
Q ss_pred cceeeccCcEEEEEEEeCC-CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCce-eeeeeccccCCcEEEEEecCCCCC
Q 002289 614 STQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~LV~e~~~~gs 691 (941)
.+.|+.|-...+|+....+ +..+++|+..... ...-...+|..+++.+...++ .++++++.. .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4578888889999998765 5788899875422 111122578999998865444 567777632 35999998754
Q ss_pred H
Q 002289 692 L 692 (941)
Q Consensus 692 L 692 (941)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0033 Score=58.38 Aligned_cols=54 Identities=28% Similarity=0.388 Sum_probs=23.1
Q ss_pred EEEcccCCCC-CCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccccc
Q 002289 110 ILDFMWNKIS-GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY 165 (941)
Q Consensus 110 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 165 (941)
.++.++++++ ..+|..+. ++|++|+|++|+|+...+..|..+++|+.|+|++|.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 4555555554 23342221 234444444444443333334444444444444443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0079 Score=66.65 Aligned_cols=73 Identities=14% Similarity=0.116 Sum_probs=44.1
Q ss_pred ceeeccCcEEEEEEEeCC---------CcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCc-eeeeeeccccCCcEEEEE
Q 002289 615 TQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~LV~ 684 (941)
..|+.|....+|+....+ ++.+++|+..... ........|.++++.+...+ +.++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 467778888999988654 2688899875432 11113467888888874333 346665442 26899
Q ss_pred ecCCCCCH
Q 002289 685 EFMSNGTL 692 (941)
Q Consensus 685 e~~~~gsL 692 (941)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.042 Score=60.02 Aligned_cols=67 Identities=9% Similarity=0.053 Sum_probs=43.3
Q ss_pred ccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC---CCceeeeeecc------ccCCcEEEEEecCCC
Q 002289 619 QGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYC------DEEGEQMLVYEFMSN 689 (941)
Q Consensus 619 ~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~------~~~~~~~LV~e~~~~ 689 (941)
.|....||+....+| .+++|+...... ..|+.+++.+. -+.+.+.+... ...+..++||+|++|
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 333678999987777 899998765432 34556565552 22245554331 234678999999998
Q ss_pred CCH
Q 002289 690 GTL 692 (941)
Q Consensus 690 gsL 692 (941)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=95.34 E-value=0.002 Score=70.58 Aligned_cols=61 Identities=11% Similarity=0.116 Sum_probs=40.6
Q ss_pred ccCCCCCCCHHHHHHHHHHhH--hhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 864 QDETDARPSMSEVMRELESIW--NMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 864 ~~~p~~RPs~~~v~~~L~~~~--~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
-..|-...+..+++..+..-. .......+++.+||.+||+.||++|||++|+|+||||+..
T Consensus 221 G~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 221 LKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 444555556665554433211 0111223445789999999999999999999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=95.06 E-value=0.003 Score=66.81 Aligned_cols=63 Identities=13% Similarity=0.268 Sum_probs=43.9
Q ss_pred ccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 864 QDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 864 ~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
...|-...+..+..+.+......++. ......+||.+||..||++|||++|+++||||+....
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 203 GKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp SSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 34455555666666655544333332 2334567999999999999999999999999976544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.80 E-value=0.16 Score=50.78 Aligned_cols=103 Identities=15% Similarity=0.136 Sum_probs=66.5
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
-||.+.|...+ .++++.++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 47999997654 5799999999999999988776221111 1223446899999999998764 2111
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 816 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~P 816 (941)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122567888763 3456788999999999998864333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.19 E-value=0.16 Score=57.03 Aligned_cols=74 Identities=11% Similarity=0.051 Sum_probs=48.0
Q ss_pred cceeeccCcEEEEEEEeCC--------CcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEE
Q 002289 614 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~ 684 (941)
.+.+..|-...+|+....+ ++.+++|+..... ...-...+|.++++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3467777788899988653 5789999865432 11123457888888874 322345665443 27899
Q ss_pred ecCCCCCH
Q 002289 685 EFMSNGTL 692 (941)
Q Consensus 685 e~~~~gsL 692 (941)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=93.89 E-value=0.0044 Score=65.34 Aligned_cols=62 Identities=6% Similarity=0.106 Sum_probs=41.7
Q ss_pred ccCCCCCCCHHHHHHHHHHhHhhCCC-CCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 864 QDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 864 ~~~p~~RPs~~~v~~~L~~~~~~~~~-~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
...|-...+..++.+.+..-....+. .+....+++.+||..||++|||++|+++||||+...
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 207 GTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred CCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 34454445555555544432222222 234456799999999999999999999999998753
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.44 E-value=0.032 Score=38.87 Aligned_cols=30 Identities=20% Similarity=0.491 Sum_probs=20.9
Q ss_pred CCCCCccceeeehhHHHHHHHHHHHHHHHH
Q 002289 539 NSGISKAALAGIILGAIAGAVTISAIVSLL 568 (941)
Q Consensus 539 ~~~~~~~~~~~ii~g~~~~~~~~~~~~~~~ 568 (941)
+++.+..+++||++|++++++.+.+++.++
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~ 34 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFR 34 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHH
Confidence 345677788999999888777666554433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=93.43 E-value=0.012 Score=62.22 Aligned_cols=13 Identities=23% Similarity=0.102 Sum_probs=5.5
Q ss_pred cCCCCCCCHHHHH
Q 002289 865 DETDARPSMSEVM 877 (941)
Q Consensus 865 ~~p~~RPs~~~v~ 877 (941)
..|-..++..+..
T Consensus 209 ~~pf~~~~~~~~~ 221 (284)
T 2vgo_A 209 MPPFDSPSHTETH 221 (284)
T ss_dssp SCTTCCSSHHHHH
T ss_pred CCCCCCCCHhHHH
Confidence 3444444444443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.02 E-value=0.012 Score=62.81 Aligned_cols=63 Identities=5% Similarity=0.044 Sum_probs=42.0
Q ss_pred ccCCCCCCCHHHHHHHHHHhHhhCC-CCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 864 QDETDARPSMSEVMRELESIWNMMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 864 ~~~p~~RPs~~~v~~~L~~~~~~~~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
...|-...+..++.+.+.......+ ...+...++|.+||..||++|||++|+++||||.....
T Consensus 209 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 209 GLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 3445444455555554443221111 22334568999999999999999999999999976544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=92.58 E-value=0.0061 Score=65.27 Aligned_cols=32 Identities=25% Similarity=0.226 Sum_probs=29.8
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
...++..+.+++.+|++.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 38899999999999999999999999999865
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=92.47 E-value=0.019 Score=60.59 Aligned_cols=33 Identities=12% Similarity=0.252 Sum_probs=29.5
Q ss_pred CCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 891 DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 891 ~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.....+++.+||..||++|||++|+++||||+.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 344578999999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=91.78 E-value=0.01 Score=62.90 Aligned_cols=33 Identities=15% Similarity=0.282 Sum_probs=29.3
Q ss_pred CCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 892 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 892 ~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
....++|.+||..||++|||++|+|+||||+..
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 345679999999999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.30 E-value=0.056 Score=57.92 Aligned_cols=34 Identities=21% Similarity=0.446 Sum_probs=30.3
Q ss_pred CCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 893 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 893 ~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
...+++.+||..||++|||++|+++||||.+...
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 4467999999999999999999999999987554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.89 E-value=0.03 Score=59.32 Aligned_cols=25 Identities=20% Similarity=0.477 Sum_probs=22.7
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002289 855 FIKLALKCCQDETDARPSMSEVMRE 879 (941)
Q Consensus 855 l~~l~~~c~~~~p~~RPs~~~v~~~ 879 (941)
+.+++.+||+.+|++||++.+++++
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 6799999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.81 E-value=0.015 Score=62.40 Aligned_cols=36 Identities=17% Similarity=0.286 Sum_probs=29.7
Q ss_pred CCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 891 DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 891 ~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
.....++|.+||..||++|||++|+++||||+....
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 344567999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.40 E-value=0.022 Score=62.21 Aligned_cols=32 Identities=19% Similarity=0.311 Sum_probs=28.8
Q ss_pred CCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 893 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 893 ~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
...+|+.+||..||++|||++|+|+||||+..
T Consensus 249 ~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 249 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 35679999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=90.21 E-value=0.062 Score=56.39 Aligned_cols=63 Identities=16% Similarity=0.119 Sum_probs=41.8
Q ss_pred ccCCCCCCCHHHHHHHHHHhHh-hCC-CCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 864 QDETDARPSMSEVMRELESIWN-MMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 864 ~~~p~~RPs~~~v~~~L~~~~~-~~~-~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
...|-...+..++.+.+..-.. ..+ .......+++.+||..||++|||++|+++|+|+.....
T Consensus 212 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 212 LMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred CCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 3445444455555554443211 111 22344567999999999999999999999999987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=89.63 E-value=0.026 Score=60.56 Aligned_cols=31 Identities=19% Similarity=0.329 Sum_probs=23.5
Q ss_pred ccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 896 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 896 dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
+++.+||..||++|||++|+|+||||+....
T Consensus 271 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 271 DVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred HHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 5666778888888888888899999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=89.36 E-value=0.054 Score=57.74 Aligned_cols=35 Identities=17% Similarity=0.380 Sum_probs=30.3
Q ss_pred CCcccccccCCCCCCCCCCCccCCCCCCCCCCCCC
Q 002289 893 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 927 (941)
Q Consensus 893 ~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~~ 927 (941)
...+++.+||..||++|||++|+++||||......
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence 34679999999999999999999999999765543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.85 E-value=1.3 Score=49.09 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=24.7
Q ss_pred eEeccCCCCcEEE------cCCCcEEEeeeccccc
Q 002289 731 VFHRDIKASNILL------DHKFTAKVADFGLSRL 759 (941)
Q Consensus 731 ivH~DLkp~NILl------~~~~~~kl~DFGla~~ 759 (941)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4567899999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=88.81 E-value=0.035 Score=61.91 Aligned_cols=33 Identities=18% Similarity=0.302 Sum_probs=29.2
Q ss_pred CCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 893 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 893 ~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
.+.+||.+||..||++|||++|+|+||||+...
T Consensus 296 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 296 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 356799999999999999999999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.42 E-value=0.028 Score=60.68 Aligned_cols=30 Identities=23% Similarity=0.563 Sum_probs=24.6
Q ss_pred ccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 896 EFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 896 dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
+||.+||..||++|||++|+++||||....
T Consensus 265 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 567778888888889999999999997643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.29 E-value=0.04 Score=59.14 Aligned_cols=29 Identities=17% Similarity=0.448 Sum_probs=23.7
Q ss_pred cccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 895 PEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 895 ~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.+++.+||..||++|||++|+++||||+.
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 35677778888888889999999999864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.21 E-value=0.45 Score=34.23 Aligned_cols=7 Identities=29% Similarity=0.544 Sum_probs=2.8
Q ss_pred ehhHHHH
Q 002289 550 IILGAIA 556 (941)
Q Consensus 550 ii~g~~~ 556 (941)
|+.|++.
T Consensus 13 IA~gVVg 19 (44)
T 2ks1_B 13 IATGMVG 19 (44)
T ss_dssp STHHHHH
T ss_pred EEeehhH
Confidence 3344443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=87.53 E-value=0.028 Score=60.77 Aligned_cols=29 Identities=31% Similarity=0.526 Sum_probs=23.9
Q ss_pred cccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 895 PEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 895 ~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.+++.+||..||++|||++|+++||||..
T Consensus 263 ~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 263 INFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 35777788888888999999999999854
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.15 E-value=0.37 Score=34.57 Aligned_cols=7 Identities=43% Similarity=0.629 Sum_probs=2.9
Q ss_pred ehhHHHH
Q 002289 550 IILGAIA 556 (941)
Q Consensus 550 ii~g~~~ 556 (941)
|+.|++.
T Consensus 12 IA~gVVg 18 (44)
T 2l2t_A 12 IAAGVIG 18 (44)
T ss_dssp HHHHHHH
T ss_pred EEEeehH
Confidence 3344443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=86.46 E-value=0.083 Score=57.80 Aligned_cols=34 Identities=24% Similarity=0.359 Sum_probs=29.7
Q ss_pred CCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 893 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 893 ~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
...+||.+||..||++|||++|+++||||.....
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 3467999999999999999999999999976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=83.77 E-value=0.053 Score=60.96 Aligned_cols=34 Identities=6% Similarity=-0.009 Sum_probs=29.8
Q ss_pred CCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 890 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 890 ~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
..+...++|.+||..||++|||+.|+++||||+.
T Consensus 336 ~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 336 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 3445677999999999999999999999999965
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 941 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-32 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-07 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-10 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 6e-73
Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 18/277 (6%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
+IG G +G VYKG V + + Q + F E+ L + H N++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 735
+ +V ++ +L L + + IA +++G+ YLH + HRD
Sbjct: 75 -APQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 736 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-- 793
+K++NI L T K+ DFGL+ + +H + G+ ++ PE
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWS-----GSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 794 -LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
+ +SDVY+ G+V EL+TG P S+ N + + + + + ++ S C
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-----GYLSPDLSKVRSNCP 239
Query: 853 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889
+ +L +C + + D RP +++ +E + +P+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 4e-68
Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 20/275 (7%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
++G G +G+V+ G T VAVK ++GS FL E + +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
L + ++ E+M NG+L D L S L L +A + G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
HRD++A+NIL+ + K+ADFGL+RL + K + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------YTAREGAKFPIKWTAPEA 181
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
T KSDV+S G++ E++T + G ++ ++ G P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQNLERGYRMVRP 232
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
C E+ +L C ++ + RP+ + LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 4e-67
Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 20/275 (7%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
+ +IG G +G V+ G + VA+K +EG+ E++F+ E + + +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
L G C E+ LV+EFM +G L D + L + L G + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
V HRD+ A N L+ KV+DFG++R ST K + PE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEV 173
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
F + + KSDV+S GV+ E+ + + ++ S ++ + G P
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEVVEDISTGFRLYKP 224
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
++ C ++ + RP+ S ++R+L I
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 3e-65
Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 23/293 (7%)
Query: 603 EMALATNNFN-SSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGE-KEFLTEIQ 657
++ L +N + ++G G +G V +G+ VA+K ++G+ + + +E + E Q
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 658 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 717
+ +L + +V L+G C + MLV E G L L K +E + + + S
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVS 119
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
G+ YL + HRD+ A N+LL ++ AK++DFGLS+ D +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAG 172
Query: 778 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837
K + PE K + +SDV+S GV E L+ Q +M
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------GPEVMA 223
Query: 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 890
+ G P EC + L C + + RP V + + + + +
Sbjct: 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (556), Expect = 5e-65
Identities = 82/296 (27%), Positives = 128/296 (43%), Gaps = 20/296 (6%)
Query: 597 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTE 655
S Y + + + ++G G YG+VY+G+ VAVK +E +++ E EFL E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 656 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 715
+ + H NLV L+G C E ++ EFM+ G L D L +++ + + L +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 716 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 775
S + YL HRD+ A N L+ KVADFGLSRL
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHA 174
Query: 776 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835
K + PE +K + KSDV++ GV+ E+ T G ++ + +
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------ 228
Query: 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 891
+ P C EK +L C Q RPS +E+ + E+++ SD
Sbjct: 229 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 9e-65
Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 20/282 (7%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
+ ++GQG +G+V+ G T VA+K + G+ + FL E Q + +L H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
L E +V E+MS G+L D L ++ + L + +A + G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
HRD++A+NIL+ KVADFGL+RL + K + PE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEA 185
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
L + T KSDV+S G++ EL T + G ++ V G P
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCP 236
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 890
EC E L +C + E + RP+ + LE +
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (554), Expect = 1e-64
Identities = 76/310 (24%), Positives = 123/310 (39%), Gaps = 46/310 (14%)
Query: 603 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKR-AQEGSLQGEKEFLTE 655
+ NN IG+G +G+V++ P T+VAVK +E S + +F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 656 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------------- 696
++ + N+V L+G C L++E+M+ G L + L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 697 ---SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753
S+ PL A +L IA + G+ YL + HRD+ N L+ K+AD
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 754 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 813
FGLSR D ++ PE ++ T +SDV++ GVV E+ +
Sbjct: 184 FGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 814 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSM 873
+G +++ V DGN+ + P C + L C RPS
Sbjct: 239 GLQPYYGMA---------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 289
Query: 874 SEVMRELESI 883
+ R L+ +
Sbjct: 290 CSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (554), Expect = 1e-64
Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 29/302 (9%)
Query: 596 VRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILP----DGTVVAVKRAQ 642
+ FT+ + A F IG G +G+V G L VA+K +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 643 EG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 701
G + + ++FL+E + + H N++ L G + M++ EFM NG+L D ++
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQND 122
Query: 702 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761
+ + G + G+ YL D HRD+ A NIL++ KV+DFGLSR
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-- 177
Query: 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821
+ D + K + PE K T SDV+S G+V E+++ +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 822 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
++ ++ P +C +L L C Q + + RP +++ L+
Sbjct: 238 T---------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 882 SI 883
+
Sbjct: 289 KM 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-64
Identities = 72/276 (26%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
IG+G +G V G G VAVK + + + FL E +++L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 669 SLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
L+G +E+G +V E+M+ G+L D L ++ + LG L +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
HRD+ A N+L+ AKV+DFGL++ A K + PE
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVKWTAPE 170
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847
K + KSDV+S G++ E+ + + + ++ V G
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPRVEKGYKMDA 221
Query: 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P C ++ C + RPS ++ +LE I
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-64
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 20/275 (7%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
+ ++G G +G V G VA+K +EGS E EF+ E + + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
L G C ++ ++ E+M+NG L + L + L + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
HRD+ A N L++ + KV+DFGLSR + S K + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEV 172
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
+ K + KSD+++ GV+ E+ + + S + G P
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---------NSETAEHIAQGLRLYRP 223
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
EK + C ++ D RP+ ++ + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-64
Identities = 85/313 (27%), Positives = 139/313 (44%), Gaps = 22/313 (7%)
Query: 585 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKR 640
H +++ + V++ + + ++ + + IG+G +G VY G L D AVK
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 641 AQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSA 698
+ GE +FLTE + H N++SL+G C EG ++V +M +G LR+
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIR 121
Query: 699 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758
+ L ++G + A HRD+ A N +LD KFT KVADFGL+R
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 818
+ + + H T K ++ E T K T KSDV+S GV+ EL+T P
Sbjct: 179 DMYDKEFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 819 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
N + ++ G P C + ++ LKC + + RPS SE++
Sbjct: 236 PDVNTF---------DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 879 ELESIWNMMPESD 891
+ +I++
Sbjct: 287 RISAIFSTFIGEH 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-62
Identities = 73/298 (24%), Positives = 130/298 (43%), Gaps = 24/298 (8%)
Query: 606 LATNNFNSSTQIGQGGYGKVYKGILPDGT-----VVAVKRAQEGSLQGEK-EFLTEIQFL 659
+ + IG G +G+VYKG+L + VA+K + G + ++ +FL E +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 660 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 719
+ H N++ L G + M++ E+M NG L + + + G + G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAG 122
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+ YL + HRD+ A NIL++ KV+DFGLSR+ + + ++ K
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEATYTTSGGKI 175
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839
+ PE K T SDV+S G+V E++T + + +M ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMKAI 226
Query: 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 897
DG P +C +L ++C Q E RP ++++ L+ + P+S +F
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-APDSLKTLADF 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-61
Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 25/280 (8%)
Query: 616 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 670
++G G +G V KG VAVK + + E L E + +L + +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G C+ E MLV E G L L + + + + S G+ YL +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
HRD+ A N+LL + AK++DFGLS+ T K + PE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYAPECIN 183
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 850
+K + KSDV+S GV+ E + Q G S + + G P+
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------GSEVTAMLEKGERMGCPAG 234
Query: 851 CVEKFIKLALKCCQDETDARPSMSEVMRELESIW-NMMPE 889
C + L C + + RP + V L + + +++ E
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-60
Identities = 71/326 (21%), Positives = 127/326 (38%), Gaps = 33/326 (10%)
Query: 604 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSR 661
M L ++F +++G G G V+K P G V+A K + + E+Q L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 721
+ +V G +GE + E M G+L L K + + +++ +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 118
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
YL + + HRD+K SNIL++ + K+ DFG+S + ++ GT
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG---------QLIDSMANSFVGTR 167
Query: 782 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841
Y+ PE + +SD++S+G+ +E+ G PI + M ++
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-------DAKELELMFGCQVE 220
Query: 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP---ESDTKTPE-- 896
G+ P D+RP M+ + L+ I N P S + E
Sbjct: 221 GDAAETPPRP----RTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 897 -FINSEHTSKEETPPSSSSMLKHPYV 921
F+N ++ H ++
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-59
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 34/294 (11%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675
IG+G +G+V++G G VAVK + EI L H N++ + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 676 EEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 727
++ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 728 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
P + HRD+K+ NIL+ T +AD GL+ D GT Y+ P
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH---DSATDTIDIAPNHRVGTKRYMAP 181
Query: 787 EYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQSSM 835
E + ++D+Y++G+VF E+ ++ + M
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 836 MFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
V + + E + K+ +C AR + + + L +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 6e-59
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 26/278 (9%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRN 666
++ IG G YG+ K DG ++ K GS+ ++ ++E+ L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 667 LVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILY 722
+V + L V E+ G L ++ K ++ L L + + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 723 LH--TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
H ++ V HRD+K +N+ LD K K+ DFGL+R+ + GT
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------SFAKAFVGT 177
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
P Y+ PE +KSD++SLG + EL M P + Q + +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----------QKELAGKIR 227
Query: 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+G P ++ ++ + + RPS+ E++
Sbjct: 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 7e-59
Identities = 76/338 (22%), Positives = 130/338 (38%), Gaps = 58/338 (17%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPDG---TVVAVKR-AQEGSLQGEKEFLTEIQFLSRL-H 663
N+ IG+G +G+V K + A+KR + S ++F E++ L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMR 709
H N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 710 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769
L A +RG+ YL HRD+ A NIL+ + AK+ADFGLSR
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 178
Query: 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 829
T+ + ++ E T SDV+S GV+ E+++ G
Sbjct: 179 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---- 234
Query: 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889
+ + G P C ++ L +C +++ RPS ++++ L +
Sbjct: 235 -----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM------ 283
Query: 890 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 927
+ +T +++ K Y D S
Sbjct: 284 -------------LEERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-58
Identities = 67/273 (24%), Positives = 106/273 (38%), Gaps = 25/273 (9%)
Query: 616 QIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 670
IG+G +G V++GI VA+K + + +E FL E + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+G E ++ E + G LR K L A + A S + YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
HRDI A N+L+ K+ DFGLSR + ++ K ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN 182
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 850
+ T SDV+ GV E+L G + ++ + +G P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------NNDVIGRIENGERLPMPPN 233
Query: 851 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
C L KC + RP +E+ +L +I
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-57
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 31/272 (11%)
Query: 616 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 672
+IG+G + VYKG+ + VA Q+ L + F E + L L H N+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 673 YCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
+ + +LV E M++GTL+ L K + + + S +G+ +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH-TRT 132
Query: 729 PPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
PP+ HRD+K NI + + K+ D GL+ L A + V GTP ++ PE
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIGTPEFMAPE 183
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN-MGS 846
K + DVY+ G+ LE+ T P S +N + + V G S
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKPAS 233
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + + ++ C + D R S+ +++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-57
Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 45/303 (14%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEKE-FLTEIQFLSR 661
N +G G +GKV VAVK +E + E+E ++E++ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 662 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------------------- 701
L H N+V+L+G C G L++E+ G L + L +K +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 702 --EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759
L F L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR- 212
Query: 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819
DI V + ++ PE T KSDV+S G++ E+ +
Sbjct: 213 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 820 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879
G + + +G P E+ + C ++ RPS +
Sbjct: 269 GIPVDAN--------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 880 LES 882
L
Sbjct: 321 LGC 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 4e-57
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 32/275 (11%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 666
F+ +IG G +G VY + + VVA+K+ Q ++ + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+ G E LV E+ K+PL ++ G+ +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH-- 132
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRD+KA NILL K+ DFG + + + GTP ++ P
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----------MAPANSFVGTPYWMAP 180
Query: 787 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
E L + K DV+SLG+ +EL P+ + + +IA S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----- 235
Query: 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
E F C Q RP+ +++
Sbjct: 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-56
Identities = 74/328 (22%), Positives = 132/328 (40%), Gaps = 33/328 (10%)
Query: 611 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHH 664
F +G G +G VYKG+ +P+G V + A + S + KE L E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
++ L+G C L+ + M G L D + K+ +G L+ + ++G+ YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
D + HRD+ A N+L+ K+ DFGL++L + E + + K ++
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----YHAEGGKVPIKWM 180
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
E L T +SDV+S GV EL+T G S + + G
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------ASEISSILEKGER 231
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 904
P C + +KC + D+RP E++ E + + P+
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--------ARDPQRYLVIQGD 283
Query: 905 KEETPPSSSSMLKHPYVSSDVSGSNLVS 932
+ PS + + + + ++V
Sbjct: 284 ERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-56
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 42/293 (14%)
Query: 616 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRL-HHRNL 667
+G G +GKV + VAVK + + E+E ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRLS 711
V+L+G C G +++ E+ G L + L K + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 712 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 771
+ ++G+ +L HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 201
Query: 772 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831
V + ++ PE T +SDV+S G+ EL + G
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--------- 252
Query: 832 QSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
S + +I P + + C + RP+ ++++ +E
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-56
Identities = 67/274 (24%), Positives = 104/274 (37%), Gaps = 29/274 (10%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 664
+F +G+G +G VY ++A+K +AQ E + E++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
N++ L GY + L+ E+ GT+ +L + + + + Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
V HRDIK N+LL K+ADFG S P+ T + GT YL
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH---------APSSRRTTLCGTLDYL 171
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE +K D++SLGV+ E L G P + I
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----------ETYKRISRVE 220
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
++P E L + + RP + EV+
Sbjct: 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 7e-56
Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 25/269 (9%)
Query: 616 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
++G G +GKVYK + + A K S + ++++ EI L+ H N+V L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E ++ EF + G + + + + PL + + + + YLH D + HR
Sbjct: 79 YYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
D+KA NIL K+ADFG+S GTP ++ PE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTI-------QRRDSFIGTPYWMAPEVVMCETS 187
Query: 795 TD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 849
D K+DV+SLG+ +E+ P + + IA + PS
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--------AQPS 239
Query: 850 ECVEKFIKLALKCCQDETDARPSMSEVMR 878
F KC + DAR + S++++
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 9e-56
Identities = 62/276 (22%), Positives = 102/276 (36%), Gaps = 26/276 (9%)
Query: 616 QIGQGGYGKVYKGILP----DGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
++G G +G V +G VAVK + +F+ E+ + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
L G +V E G+L D K + A+ + G+ YL
Sbjct: 75 RLYGVV-LTPPMKMVTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 729 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
HRD+ A N+LL + K+ DFGL R P + + K + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKVPFAWCAPES 185
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI-DGNMGSY 847
T + SD + GV E+ T Q G N + ++ + +G
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEGERLPR 236
Query: 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
P +C + + ++C + + RP+ + L
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 5e-55
Identities = 71/308 (23%), Positives = 122/308 (39%), Gaps = 36/308 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSR 661
S ++GQG +G VY+G+ T VA+K + S++ EFL E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRLSIA 713
+ ++V L+G + +++ E M+ G L+ L + P + + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 714 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 773
+ G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RK 191
Query: 774 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 833
++ PE T SDV+S GVV E+ T + G +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------NE 242
Query: 834 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 893
++ V++G + P C + +L C Q RPS E++ ++ E +
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM----EPGFR 298
Query: 894 TPEFINSE 901
F SE
Sbjct: 299 EVSFYYSE 306
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-54
Identities = 62/294 (21%), Positives = 119/294 (40%), Gaps = 28/294 (9%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
E +V E+++ G+L D ++ + ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 735 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 794
DIK+ NILL + K+ DFG + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 795 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 854
K D++SLG++ +E++ G P + + IA + P +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------QNPEKLSAI 245
Query: 855 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 908
F +C + + R S E+ L+ + + + + I + +KE T
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKEL---LQHQFLKIAKPLSSLTPLIAA---AKEAT 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 21/273 (7%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 666
+++ +G+G YG+V + VAVK + ++ + EI L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+V G+ E Q L E+ S G L D++ + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRDIK N+LLD + K++DFGL+ + + E + + GT Y+ P
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAP 174
Query: 787 EYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
E + + DV+S G+V +L G P + +E +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--------KEKKTYL 226
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + + L K + AR ++ ++ +
Sbjct: 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 1e-53
Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 39/291 (13%)
Query: 616 QIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSR-LHHRNL 667
+G+G +G+V + VAVK +EG+ E + ++E++ L HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 668 VSLVGYCDEEGEQ-MLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 712
V+L+G C + G M++ EF G L L +K K+ L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 713 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 772
+ ++G+ +L + HRD+ A NILL K K+ DFGL+R
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYV 191
Query: 773 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832
+ ++ PE T +SDV+S GV+ E+ + G I E
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----- 246
Query: 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ +G P + + L C E RP+ SE++ L ++
Sbjct: 247 ---CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKR-AQEGSLQGEKEFLTEIQFL 659
+ +G+G +G+V T VAVK + + + + ++E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 660 SRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPL 704
+ H+N+++L+G C ++G ++ E+ S G LR+ L S +E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 705 GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764
+S A +RG+ YL HRD+ A N+L+ K+ADFGL+R D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----D 184
Query: 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 824
I I +T + ++ PE T +SDV+S GV+ E+ T G +
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243
Query: 825 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884
+ + +G+ PS C + + C RP+ +++ +L+ I
Sbjct: 244 --------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 885 NM 886
+
Sbjct: 296 AL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 5e-50
Identities = 65/318 (20%), Positives = 125/318 (39%), Gaps = 30/318 (9%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 667
++++ ++G G +G V++ G A K ++ EIQ +S L H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 668 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
V+L +++ E +++YEFMS G L ++++ + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGLCHMH--- 141
Query: 728 DPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ H D+K NI+ K K+ DFGL+ + P V GT +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAA 193
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
PE + +D++S+GV+ LL+G+ P G+N +
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMD------D 246
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR-------ELESIWNMMPESD-TKTPEF 897
S S E K + + R ++ + + + +P S TK +
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
Query: 898 INSEHTSKEETPPSSSSM 915
I +++ + E P +
Sbjct: 307 IKTKYDAWPEPLPPLGRI 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 8e-50
Identities = 50/276 (18%), Positives = 91/276 (32%), Gaps = 25/276 (9%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHR 665
+F +G+G + V L A+K ++ + E E +SRL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
V L ++ + + NG L + + + + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI-----VSALEY 123
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ HRD+K NILL+ ++ DFG +++ + GT Y+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-----KQARANSFVGTAQYVS 178
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
PE SD+++LG + +L+ G+ P G + + +I
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------IFQKIIKLEY- 227
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881
+P + K L K + R E+
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (447), Expect = 2e-49
Identities = 59/313 (18%), Positives = 125/313 (39%), Gaps = 28/313 (8%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
++G G +G V++ + G V K + EI +++LHH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
+++ E +L+ EF+S G L D+++A+ + A ++ + G+ ++H + + H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 735 DIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
+ +D++++GV+ LL+G+ P + ++ N+ S
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-------DAFSSVS 256
Query: 853 EKFIKLALKCCQDETDARPSMSEVMR------ELESIWNMMPESDTKTPEFINSEHTSKE 906
+ Q E R ++ + + + ++ + +P S E +
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316
Query: 907 ETPPSSSSMLKHP 919
P + + +
Sbjct: 317 PAPQPAIGRIANF 329
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (417), Expect = 3e-46
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 25/287 (8%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLH 663
++ + +G GG +V+ L VAVK + + F E Q + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 664 HRNLVSLVGYCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 719
H +V++ + E +V E++ TLRD + ++ P+ + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQA 123
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+ + H + HRD+K +NI++ KV DFG++R + + V G
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIG 176
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839
T YL PE + +SDVYSLG V E+LTG P + + + + S
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 235
Query: 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 885
+ + LK + R + +E+ +L + N
Sbjct: 236 ------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 6e-46
Identities = 54/273 (19%), Positives = 102/273 (37%), Gaps = 19/273 (6%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHR 665
+ ++ +G G + +V +VA+K + +L+G E EI L ++ H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
N+V+L + G L+ + +S G L D++ K + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ LD ++DFGLS++ P V + GTPGY+
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------EDPGSVLSTACGTPGYVA 177
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845
PE + D +S+GV+ LL G P + +N + ++ F
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDS------ 230
Query: 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
Y + + + + + R + + ++
Sbjct: 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-45
Identities = 52/266 (19%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+G+G +G V++ + K + + EI L+ HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 675 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 734
+ E ++++EF+S + ++++ S L +S + +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 735 DIKASNILLDHK--FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
DI+ NI+ + T K+ +FG +R D ++ P Y PE
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHD 178
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 852
++ +D++SLG + LL+G+ P N NI E
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------EAFKEIS 231
Query: 853 EKFIKLALKCCQDETDARPSMSEVMR 878
+ + + E +R + SE ++
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 2e-45
Identities = 51/274 (18%), Positives = 90/274 (32%), Gaps = 15/274 (5%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IG G +G +Y G + G VA+K + + E + + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 675 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
EG+ ++V E + L +A I Y+H H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 734 RDIKASNIL---LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
RD+K N L + DFGL++ +P + + GT Y L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 791 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 850
+ + + D+ SLG V + G P K + S S +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL---CKG 243
Query: 851 CVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884
+F C D +P S + + +++
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (411), Expect = 2e-45
Identities = 67/286 (23%), Positives = 99/286 (34%), Gaps = 37/286 (12%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR---------AQEGSLQGEKEFLTEIQFL 659
N+ +G+G V + I P AVK + E + + L E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 660 SRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR 718
++ H N++ L + LV++ M G L D L K L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 719 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 778
I LH + HRD+K NILLD K+ DFG S + P V
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVC 170
Query: 779 GTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 832
GTP YL PE + D++S GV+ LL G P H K ++ I
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 833 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ S + + L + + R + E +
Sbjct: 231 NYQFGS-------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 4e-44
Identities = 60/332 (18%), Positives = 116/332 (34%), Gaps = 46/332 (13%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 664
+F +G G +G+V+ +G A+K + L+ + E LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
++ + G + + ++ +++ G L L + P A + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ +RD+K NILLD K+ DFG ++ P V+ + GTP Y+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----------DVTYTLCGTPDYI 168
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE T D +S G++ E+L G P +++ +
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----------TMKTYEKILNAEL 218
Query: 845 GSYPSECVEKFIKLALKCCQDE-----TDARPSMSEVMRE--LESI-WNMMPESDTKTP- 895
+P E L + + + + +V + + W + + +TP
Sbjct: 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPY 277
Query: 896 -------EFINSEHTSKEETPPSSSSMLKHPY 920
+ S+ E + + PY
Sbjct: 278 EPPIQQGQGDTSQFDKYPEEDINYGVQGEDPY 309
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (396), Expect = 3e-43
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 17/275 (6%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 674
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 675 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+EG +LV + + G + L A + +H + + +
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 734 RDIKASNILLD-----HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 788
RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 789 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848
L + + + D+ +LG VF+ L G P K + S +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---PLRELC 241
Query: 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883
+ E+F K DA P + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (400), Expect = 6e-43
Identities = 60/275 (21%), Positives = 100/275 (36%), Gaps = 30/275 (10%)
Query: 609 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTE---IQFLSR 661
N+F+ IG+GG+G+VY D G + A+K + + QGE L E + +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 662 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 721
+V + + + + M+ G L LS + + G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLE 121
Query: 722 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 781
++H + V +RD+K +NILLD +++D GL+ GT
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD---------FSKKKPHASVGTH 169
Query: 782 GYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840
GY+ PE D +D +SLG + +LL G P K + +M
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226
Query: 841 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 875
P + L Q + + R
Sbjct: 227 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 60/274 (21%), Positives = 100/274 (36%), Gaps = 41/274 (14%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH--HRN 666
+G GG+G VY GI + D VA+K + G L E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
++ L+ + + +L+ E + L + S + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 727 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ V HRDIK NIL+D ++ K+ DFG L + V T GT Y
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---------LKDTVYTDFDGTRVYSP 177
Query: 786 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE+ H+ +S V+SLG++ +++ G P H + I+R
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--------------- 222
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
+ + L C RP+ E+
Sbjct: 223 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 70/338 (20%), Positives = 127/338 (37%), Gaps = 48/338 (14%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSR-LH 663
+F +G+G +GKV+ A+K ++ + + + + E + LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 664 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 723
H L + + V E+++ G L + + K L A + + IL L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI-----ILGL 116
Query: 724 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
+ +RD+K NILLD K+ADFG+ + E ++ + GTP Y
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDY 169
Query: 784 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843
+ PE L K D +S GV+ E+L G P HG++ +F I +
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEE----------LFHSIRMD 218
Query: 844 MGSYPSECVEKFIKLALKCCQDETDARPSM-SEVM---------------RELESIWNMM 887
YP ++ L +K E + R + ++ +E++ +
Sbjct: 219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPK 278
Query: 888 PESDTKT----PEFINSEHTSKEETPPSSSSMLKHPYV 921
+S EF+N + +SM ++ +
Sbjct: 279 VKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFR 316
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-42
Identities = 71/300 (23%), Positives = 109/300 (36%), Gaps = 40/300 (13%)
Query: 607 ATNNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL 662
A + +IG+G YGKV+K + G VA+K R Q G + E+ L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 663 ---HHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 714
H N+V L C D E + LV+E + L + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123
Query: 715 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 774
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------FQMAL 172
Query: 775 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP------ISHGKNIVREV- 827
T V T Y PE L D++S+G +F E+ + I+ +
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 828 ---------NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
++A S + + ++ E L LKC R S +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 54/296 (18%), Positives = 108/296 (36%), Gaps = 34/296 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE------KEFLTEIQFLSRLHHRNLV 668
++G G + V K G A K ++ + ++ E+ L + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 669 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 728
+L + + + +L+ E ++ G L D L+ K A + + ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHS 131
Query: 729 PPVFHRDIKASNILLDH----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ H D+K NI+L K K+ DFGL+ I + + GTP ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFGTPEFV 183
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE L ++D++S+GV+ LL+G P N++ +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------ 237
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESI-WNMMPESDTKTPEF 897
Y S + + R ++ + ++ ++ S P+F
Sbjct: 238 -EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 67/290 (23%), Positives = 107/290 (36%), Gaps = 31/290 (10%)
Query: 610 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRN 666
NF +IG+G YG VYK G VVA+K R + + EI L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 667 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+V L+ E + LV+EF+ L+ + A + + + S +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
V HRD+K N+L++ + K+ADFGL+R VP + V
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPE 172
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846
+ D++SLG +F E++T I + I V+ + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 847 YP------------------SECVEKFIKLALKCCQDETDARPSMSEVMR 878
P E L + + + R S +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 56/286 (19%), Positives = 97/286 (33%), Gaps = 36/286 (12%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 670
+G+G + VYK +VA+K+ E + L EI+ L L H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 671 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+ + LV++FM + + L
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-----LQGLEYLHQHW 120
Query: 731 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 790
+ HRD+K +N+LLD K+ADFGL++ P+ T T Y PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-------RAYTHQVVTRWYRAPELLF 173
Query: 791 THKLTD-KSDVYSLGVVFLELLTGMQP------------ISHGKNIVREVNIAYQSSMMF 837
++ D++++G + ELL + I E S+
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 838 SVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMR 878
V + P S + + L AR + ++ ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-39
Identities = 64/315 (20%), Positives = 109/315 (34%), Gaps = 35/315 (11%)
Query: 617 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 674
+G G GKV + A+K LQ + E++ R ++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 675 D----EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 730
+ ++V E + G L ++ + + I I YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 731 VFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HRD+K N+L K K+ DFG ++ + T TP Y+ PE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--------TTSHNSLTTPCYTPYYVAPE 183
Query: 788 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847
K D++SLGV+ LL G P + + + M S
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW----NMMPESDTKTPEFINSEHT 903
SE V+ I+ + E R +++E + W +P++ T + +
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 904 SKEETPPSSSSMLKH 918
E+ +S L
Sbjct: 298 RWEDVKEEMTSALAT 312
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (365), Expect = 4e-39
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 31/283 (10%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 673
+IG+G YG VYK G A+K R ++ + EI L L H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 733
+ +LV+E + + + L S L GI Y H D V H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 734 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 793
RD+K N+L++ + K+ADFGL+R +P + + + K
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPV------RKYTHEIVTLWYRAPDVLMGSKK 177
Query: 794 LTDKSDVYSLGVVFLELLTGMQPIS------------------HGKNIVREVNIAYQSSM 835
+ D++S+G +F E++ G + KN +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
S+ E I L K + + + R + + +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-39
Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 27/269 (10%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 664
N+F+ +G+G +GKV G A+K ++ + + E +TE + L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
L +L V E+ + G L LS + A + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI-----VSALE 119
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
V +RDIK N++LD K+ DFGL + GTP YL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-------ATMKTFCGTPEYL 172
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE + D + LGVV E++ G P + ++ R +F +I
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHER----------LFELILMEE 221
Query: 845 GSYPSECVEKFIKLALKCCQDETDARPSM 873
+P + L + + R
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-38
Identities = 59/295 (20%), Positives = 103/295 (34%), Gaps = 31/295 (10%)
Query: 608 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 665
+ + + IG+G YG V + VA+K+ Q + L EI+ L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTL-RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
N++ + + + ++ + D + L RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
V HRD+K SN+LL+ K+ DFGL+R+A T T Y
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD----PDHDHTGFLTEYVATRWYR 179
Query: 785 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI-----VREVNIAYQSSMMFS 838
PE L K KS D++S+G + E+L+ + + + + +
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 839 VIDGNMGSYPSECVEK---------------FIKLALKCCQDETDARPSMSEVMR 878
+I+ +Y K + L K R + + +
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-38
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 33/285 (11%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+IG+G YG V+K +VA+K R + L EI L L H+N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 673 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732
+ + LV+EF + S L + L V
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL-----LKGLGFCHSRNVL 123
Query: 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 792
HRD+K N+L++ K+A+FGL+R +P S V F
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV------RCYSAEVVTLWYRPPDVLFGAK 177
Query: 793 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID----------- 841
+ D++S G +F EL +P+ G ++ ++ ++ +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 842 --------GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 878
++ + + L + R S E ++
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 66/328 (20%), Positives = 119/328 (36%), Gaps = 38/328 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHR 665
+ + +IGQG +G+V+K G VA+K+ + + L EI+ L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 666 NLVSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 717
N+V+L+ C +G LV++F + + K L R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 718 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 777
+ L+ + HRD+KA+N+L+ K+ADFGL+R + + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS---QPNRYTNR 181
Query: 778 KGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836
T Y PE L + D++ G + E+ T + + I+ +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 896
+ N+ +Y + +K + +D A + ++ + + P
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR----- 296
Query: 897 FINSEHTSKEETPPSSSSMLKHPYVSSD 924
S L H + SD
Sbjct: 297 -------------IDSDDALNHDFFWSD 311
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-37
Identities = 70/339 (20%), Positives = 122/339 (35%), Gaps = 47/339 (13%)
Query: 610 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 668
++ + IG G +G VY+ L D G +VA+K+ LQ ++ E+Q + +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 669 SLVGYCDEEGEQM------LVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIALGSSRGIL 721
L + GE+ LV +++ R +++K+ L R +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 722 YLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 780
Y+H + HRDIK N+LLD K+ DFG ++ + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-------PNVSYICSR 186
Query: 781 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP------ISHGKNIVREVNIAYQSS 834
F T DV+S G V ELL G + I++ + +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 835 MMFSVIDGNMGSYPS------------ECVEKFIKLALKCCQDETDARPSMSEVM----- 877
+ + +P + I L + + AR + E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 878 RELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916
EL +P + TP N PP ++ ++
Sbjct: 307 DELRDPNVKLP-NGRDTPALFNFTTQELSSNPPLATILI 344
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-36
Identities = 52/279 (18%), Positives = 99/279 (35%), Gaps = 35/279 (12%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 664
+ F+ +G G +G+V G A+K + + K+ L E + L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 665 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
LV L + +V E+++ G + L + A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 725 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 784
+ +RD+K N+L+D + +V DFG ++ + + GTP L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTWTLCGTPEAL 205
Query: 785 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844
PE L+ D ++LGV+ E+ G P ++ ++ I
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQ----------IYEKIVSGK 254
Query: 845 GSYPSECVEKFIKLALKCCQDE-----TDARPSMSEVMR 878
+PS L Q + + + ++++
Sbjct: 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-33
Identities = 63/324 (19%), Positives = 113/324 (34%), Gaps = 49/324 (15%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G G YG V + G VA+K S K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 673 YCDEEG------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+ + LV FM GT +L E LG + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKL--MKHEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRD+K N+ ++ K+ DFGL+R + ++ V
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------QADSEMTGYVVTRWYRAPE 188
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI-------------AYQS 833
+ T D++S+G + E++TG ++ + I QS
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 834 SMMFSVIDG-------NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIW 884
+ + G + S + + L K + + R + E + ES+
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 885 NMMPESDTKT--PEFINSEHTSKE 906
+ E + F + + T E
Sbjct: 309 DTEDEPQVQKYDDSFDDVDRTLDE 332
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 125 bits (314), Expect = 4e-32
Identities = 79/322 (24%), Positives = 123/322 (38%), Gaps = 25/322 (7%)
Query: 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRG-DPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
+ +P + AL IKK L + + LS+W D C W GVLC T + L L
Sbjct: 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDL 57
Query: 90 LNLNLSGN--LSPEIGRLSYLTILDFMWN-KISGSIPKEIGNIKSLELLLLNGNELTGSL 146
LNL + + L YL L + G IP I + L L + ++G++
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 147 PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206
P+ L + L + N +SG+LP S ++L + N ISG IP L
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 207 -MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265
M + N LTG +PP + L + N ++
Sbjct: 178 SMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN----------TQKIH 227
Query: 266 PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 325
+ LS N+ + L NN++ GT+P + L L L ++ N+L G IP
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-Q 286
Query: 326 IWQSRTLNATETFILDFQNNNL 347
+ + + + NN
Sbjct: 287 GGNLQRFD-----VSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 1/92 (1%)
Query: 56 NWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMW 115
++ L F+ +L L L N + G L + +L +L L+ +
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 116 NKISGSIPKEIGNIKSLELLLLNGNELTGSLP 147
N + G IP + GN++ ++ N+ P
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.9 bits (120), Expect = 4e-07
Identities = 17/63 (26%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 160 QIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN-LTGY- 217
+ N I G+LP+ L +++ N++ G+IP + L NN L G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 218 LPP 220
LP
Sbjct: 309 LPA 311
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 2e-31
Identities = 54/318 (16%), Positives = 119/318 (37%), Gaps = 37/318 (11%)
Query: 609 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRN 666
+++ ++G+G Y +V++ I + + V VK + +K+ EI+ L L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 667 LVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 724
+++L + + LV+E ++N + + L + + Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146
Query: 725 TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 783
+ HRD+K N+++DH+ ++ D+GL+ P V + +
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--------YHPGQEYNVRVASRYF 195
Query: 784 LDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842
PE + +++ D D++SLG + ++ +P HG + Q + V+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD------QLVRIAKVLGT 249
Query: 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 902
+ K ++ D S E + +F++
Sbjct: 250 ED------LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 903 TSKEETPPSSSSMLKHPY 920
++ ++ ++HPY
Sbjct: 304 RYDHQSRLTAREAMEHPY 321
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 62/282 (21%), Positives = 100/282 (35%), Gaps = 29/282 (10%)
Query: 609 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLS 660
NF +G G YGKV+ G + A+K ++ ++ + + TE Q L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 661 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 719
+ LV+L E + L+ ++++ G L LS + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 720 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
+L L + +RDIK NILLD + DFGLS+ + E G
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------G 192
Query: 780 TPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837
T Y+ P+ D +SLGV+ ELLTG P + + +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-------GEKNSQAEIS 245
Query: 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 879
I + YP E L + + R +
Sbjct: 246 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 7e-30
Identities = 59/319 (18%), Positives = 111/319 (34%), Gaps = 39/319 (12%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
IG G G V VA+K + K E+ + ++H+N++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 673 YC------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 726
+E + LV E M + E + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLH-- 136
Query: 727 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 786
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAP 187
Query: 787 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846
E L + D++S+G + E++ + + G++ + ++ + +G+
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYID----------QWNKVIEQLGT 236
Query: 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE---FINSEHT 903
E ++K ++ + + K + ++
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 904 SKEETPPSSSSMLKHPYVS 922
S L+HPY++
Sbjct: 297 IDPAKRISVDDALQHPYIN 315
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-28
Identities = 58/292 (19%), Positives = 96/292 (32%), Gaps = 45/292 (15%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 672
+G G YG V G VAVK S+ K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 673 YCDE-----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 727
E + + + D + + L + RG+ Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 728 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 787
+ HRD+K SN+ ++ K+ DFGL+R T T Y PE
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTDDEMTGYVATRWYRAPE 188
Query: 788 YFLTHKLTD-KSDVYSLGVVFLELLTGMQP------------ISHGKNIVREVNIAYQSS 834
L + D++S+G + ELLTG I + SS
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 835 MMFSVIDGNMGSYPSECVEK--------FIKLALKCCQDETDARPSMSEVMR 878
++ P + L K ++D R + ++ +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 6e-24
Identities = 44/331 (13%), Positives = 101/331 (30%), Gaps = 26/331 (7%)
Query: 616 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG-- 672
++G G + V+ + + T VA+K G + EI+ L R++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 673 ------------YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 720
+ G +++ + L + + I+ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 721 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 779
Y+H + H DIK N+L++ + ++ L T
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHYTNSIQ 191
Query: 780 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839
T Y PE L +D++S + EL+TG + + + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFIN 899
+ G + SY + ++ + L + + + +F++
Sbjct: 251 L-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 900 SEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 930
+ ++ HP++ + +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 340
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 3e-20
Identities = 31/204 (15%), Positives = 59/204 (28%), Gaps = 29/204 (14%)
Query: 616 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------QGEKEFLTEIQFLSRLHHR 665
+G+G V+ VK + G G+ F +R R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 666 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 725
L L G + VY + N L + + AK + + + +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 726 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 785
+ H D+ N+L+ + + DF S I+ V ++
Sbjct: 121 --HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT------- 170
Query: 786 PEYFLTHKLTDKSDVYSLGVVFLE 809
+ + + D+ S L+
Sbjct: 171 ---YFSRTYRTEKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 8e-18
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 46/315 (14%)
Query: 62 PCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGS 121
C + V C + L+ + +L + +LD NKI+
Sbjct: 7 RCQCHLRVVQCSD----------LGLEKVPKDLPPDT----------ALLDLQNNKITEI 46
Query: 122 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTR 181
+ N+K+L L+L N+++ P L KL+R+ + +N + LP+ +
Sbjct: 47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQEL 105
Query: 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
H N + + +V + + +G + KL +++ + N T
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI--T 163
Query: 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSN 301
TIP L +L L + + L L L + S N ++ +
Sbjct: 164 TIPQ--GLPPSLTELHLDGNKITKVDAAS--LKGLNNLAKLGL-----SFNSISAVDNGS 214
Query: 302 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNV- 360
+ P L+ L + NN L +P + + + ++ NNN++ I + PP
Sbjct: 215 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-----VVYLHNNNISAIGSNDFCPPGYN 268
Query: 361 -------TVRLRGNP 368
V L NP
Sbjct: 269 TKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 1e-10
Identities = 45/214 (21%), Positives = 83/214 (38%), Gaps = 11/214 (5%)
Query: 52 SKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTIL 111
K+ + N + + + + EL L SG + + L+ +
Sbjct: 96 EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 155
Query: 112 DFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP 171
I+ +IP+ G SL L L+GN++T L L L ++ + N IS
Sbjct: 156 RIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 212
Query: 172 KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG------YLPPELSEL 225
S AN R H+NNN + ++P L+ + + L NNN++ P ++
Sbjct: 213 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 271
Query: 226 PKLLILQLDNNNFEGTTI-PASYSNMSKLLKLSL 258
+ L +N + I P+++ + + L
Sbjct: 272 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.0 bits (196), Expect = 2e-16
Identities = 49/207 (23%), Positives = 75/207 (36%), Gaps = 29/207 (14%)
Query: 174 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 233
A L NN IS P + +L + L+ N L L+ L L L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 234 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN---------- 283
NN A S ++KL +L L + P L+ N
Sbjct: 249 ANNQISN---LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 284 ---ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 340
+T + L N ++ P S L +LQRLF ANN +S SS+ +N L
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN-----WL 356
Query: 341 DFQNNNLTNISGSFNIPPNVTVRLRGN 367
+N +++++ N+ + L
Sbjct: 357 SAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.3 bits (176), Expect = 7e-14
Identities = 42/189 (22%), Positives = 73/189 (38%), Gaps = 22/189 (11%)
Query: 135 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 194
L+ N+++ P + LD + ++ N + + A+L + NN IS
Sbjct: 202 LIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 195 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 254
P LS L L + L N ++ +S L L L N + SN+ L
Sbjct: 258 P--LSGLTKLTELKLGANQISN-----ISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 255 KLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 314
L+L ++ P +S + L L +NNK++ S+ + L + L
Sbjct: 311 YLTLYFNNISDISP-VSSLTKLQRL--------FFANNKVSD--VSSLANLTNINWLSAG 359
Query: 315 NNSLSGSIP 323
+N +S P
Sbjct: 360 HNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 2e-08
Identities = 58/315 (18%), Positives = 109/315 (34%), Gaps = 46/315 (14%)
Query: 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
+ LQ L + ++ + L+ LT ++F N+++ P + N+ L +L+N N++
Sbjct: 45 QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 143 TGSLPEELGYLPKLDRIQIDQNYISGSLPK------------SFANLNKTRHFHMNNNSI 190
P + +Q L + ++++
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 191 SGQIPPELSRLPSL-VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSN 249
G +L L +L LD ++ L++L L L NN T
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDIT---PLGI 217
Query: 250 MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 309
++ L +LSL L+ L+ + NL L L+NN+++ P SGL +L
Sbjct: 218 LTNLDELSLNGNQLKDI-GTLASLTNLTDL--------DLANNQISNLAP--LSGLTKLT 266
Query: 310 RLFIANNSLSGSIPSSIWQSRTLNATETF---------------ILDFQNNNLTNISGSF 354
L + N +S P + + T L NN+++IS
Sbjct: 267 ELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS 326
Query: 355 NIPPNVTVRLRGNPF 369
++ + N
Sbjct: 327 SLTKLQRLFFANNKV 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.6 bits (130), Expect = 3e-08
Identities = 27/138 (19%), Positives = 54/138 (39%), Gaps = 9/138 (6%)
Query: 30 SITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCTSNWTGVLCFNTTMDDGYLHLRELQL 89
I++ +S L + L +++SN + T+ L N D + + L
Sbjct: 252 QISNLAPLSGLTKLT-ELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK-NL 309
Query: 90 LNLNLSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL 146
L L N + L+ L L F NK+S + N+ ++ L N+++
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 147 PEELGYLPKLDRIQIDQN 164
P L L ++ ++ ++
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 0.001
Identities = 32/217 (14%), Positives = 72/217 (33%), Gaps = 6/217 (2%)
Query: 153 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 212
L + + + + ++ ++ ++ +L++ + I + L +L + NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 213 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR 272
LT L L KL+ + ++NN T A+ +N++ L + + + +
Sbjct: 77 QLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 273 IPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 332
+++ + L N + L S S
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 333 NATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 369
T L NN +++I+ + + L GN
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLDELSLNGNQL 231
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 50/316 (15%), Positives = 97/316 (30%), Gaps = 47/316 (14%)
Query: 14 CLCWSSSKIVVAADDDSITD-PIEVSAL--------RSIKKSLVDDYSKLSNWNRGDPCT 64
C+C++ K+ + + P+ + A I + N +
Sbjct: 6 CVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 65 SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPK 124
+ + T L N L L L L + P
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSD--NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123
Query: 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184
+ +L+ L L N L + L L + + N IS ++F L+
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 185 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244
++ N ++ P L L+ + L NNL+ L+ L L L+L++N +
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC---- 239
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSG 304
+C + L + + S++++ ++P +G
Sbjct: 240 ---------------DCRARP--------------LWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 305 LPRLQRLFIANNSLSG 320
+ +A N L G
Sbjct: 271 RDLKR---LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 51/255 (20%), Positives = 81/255 (31%), Gaps = 15/255 (5%)
Query: 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239
++ ++ N IS +L + L +N L + L L L L +N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 240 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIP 299
+ PA++ + +L L L C LQ P L R + + L +N L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA-------ALQYLYLQDNALQALPD 146
Query: 300 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPN 359
F L L LF+ N +S + +L +L QN +F
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL----DRLLLHQNRVAHVHPHAFRDLGR 202
Query: 360 VTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNS-TLDCRAQSCPTDYEYSPTSPIRC 418
+ E + + + N DCRA+ + S
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRA--LQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEV 260
Query: 419 FCAAPL-LVGYRLKS 432
C+ P L G LK
Sbjct: 261 PCSLPQRLAGRDLKR 275
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (147), Expect = 1e-10
Identities = 47/286 (16%), Positives = 85/286 (29%), Gaps = 29/286 (10%)
Query: 67 WTGV-LCFNTTMDDGYLHLRELQLLNLNLSGNL----SPEIGRLSYLTILDFMWNKISG- 120
W + L D L ++ + E + +D + I
Sbjct: 2 WQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
++ + L+ L L G L+ + L L R+ + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPK--------LLILQ 232
R +N + + + V + NL+GY L+ L
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP--MPDLSRIPNLGYLLSLNITTIKLS 290
L ++ + ++ L LSL C P + +L IP L T+++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL--------KTLQVF 233
Query: 291 NNKLTGTIPSNFSGLPRLQ---RLF--IANNSLSGSIPSSIWQSRT 331
GT+ LP LQ F IA ++ IW +
Sbjct: 234 GIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKC 279
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 1e-07
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 9/132 (6%)
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
Q+ +S+ LD L P+L ++L ++ T+ N+ +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMA--ATLRIIEENIPE 66
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 312
LL L+L N L S + L LN LS N+L + +L+ L+
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILN-----LSGNELKSERELDKIKGLKLEELW 121
Query: 313 IANNSLSGSIPS 324
+ NSLS +
Sbjct: 122 LDGNSLSDTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 4e-06
Identities = 25/139 (17%), Positives = 48/139 (34%), Gaps = 13/139 (9%)
Query: 87 LQLLNLNLSGN-LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTG- 144
L+L G P++ + +L+ + ++ ++ NI L L L+ N L
Sbjct: 22 GSQQALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLYRL 80
Query: 145 -SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE------ 197
+ + P L + + N + K ++ NS+S +
Sbjct: 81 DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140
Query: 198 -LSRLPSLVHMLLDNNNLT 215
R P L+ LD + L
Sbjct: 141 IRERFPKLLR--LDGHELP 157
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 5e-06
Identities = 21/127 (16%), Positives = 40/127 (31%), Gaps = 5/127 (3%)
Query: 246 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL 305
+ +L + + DL + + L++ NI + + + T+ +
Sbjct: 5 KPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENI 64
Query: 306 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG--SFNIPPNVTVR 363
P L L ++NN L S + N L+ N L + +
Sbjct: 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKI---LNLSGNELKSERELDKIKGLKLEELW 121
Query: 364 LRGNPFC 370
L GN
Sbjct: 122 LDGNSLS 128
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 8e-04
Identities = 20/138 (14%), Positives = 46/138 (33%), Gaps = 6/138 (4%)
Query: 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180
+ + L+ L +L + + + +L N+ +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 181 RHFHMNNNSISGQ--IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238
+++NN + + + + P+L + L N L + + KL L LD N+
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 239 EGTTIPASYSNMSKLLKL 256
T + +S + +
Sbjct: 128 S-DTFRDQSTYISAIRER 144
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 42/200 (21%), Positives = 66/200 (33%), Gaps = 30/200 (15%)
Query: 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELT 143
E+ NL+ L P++ + TIL N + + L L L+ ELT
Sbjct: 12 HLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 144 GSLPEELGYLPKLDRIQIDQN-----------------------YISGSLPKSFANLNKT 180
+ LP L + + N ++ + L +
Sbjct: 69 KLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+ ++ N + P L+ P L + L NNNLT L+ L L L L N+
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL-- 184
Query: 241 TTIPASYSNMSKLLKLSLRN 260
TIP + L L
Sbjct: 185 YTIPKGFFGSHLLPFAFLHG 204
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 39/211 (18%), Positives = 71/211 (33%), Gaps = 22/211 (10%)
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232
+ + + + +++ +PP+L + L N L + L +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-------------DLSRIPNLGYL 279
LD + + + L + SL L+ +P
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 280 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 339
+ + L N+L P + P+L++L +ANN+L+ + L+
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD-----T 176
Query: 340 LDFQNNNLTNI-SGSFNIPPNVTVRLRGNPF 369
L Q N+L I G F L GNP+
Sbjct: 177 LLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 23/121 (19%), Positives = 43/121 (35%), Gaps = 7/121 (5%)
Query: 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS 169
+L ++ + + + + L L+ N L P L L L+ + + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVL--QASDNALE 56
Query: 170 LPKSFANLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 228
ANL + + + NN + L P LV + L N+L L ++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 229 L 229
L
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 9e-07
Identities = 22/113 (19%), Positives = 34/113 (30%), Gaps = 14/113 (12%)
Query: 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268
L + +LT L +L + L L +N ++ L L + S
Sbjct: 5 LAHKDLTV--LCHLEQLLLVTHLDLSHNRLRAL-----PPALAALRCLEVLQASDNALEN 57
Query: 269 DLSRIPNLGYLLSLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSG 320
+ L NN+L + PRL L + NSL
Sbjct: 58 VDGVANLPRL------QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 2e-05
Identities = 24/127 (18%), Positives = 46/127 (36%), Gaps = 29/127 (22%)
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL------------ 228
R H+ + ++ + L +L + H+ L +N L PP L+ L L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 229 ----------LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG----PMPDLSRIP 274
L L NN + + + +L+ L+L+ SL +P
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 275 NLGYLLS 281
++ +L+
Sbjct: 118 SVSSILT 124
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 5e-06
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 9/92 (9%)
Query: 113 FMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK 172
+ N S I SLE L ++ N+L LP L +L N+++ +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204
NL + H+ N + + P + L
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 20/95 (21%), Positives = 33/95 (34%), Gaps = 9/95 (9%)
Query: 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
N+ S +I PSL + + NN L LP + P+L L N+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL--A 317
Query: 242 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 276
+P L +L + L+ + +L
Sbjct: 318 EVPEL---PQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 17/85 (20%)
Query: 283 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 342
++ + +SNNKL +P+ PRL+RL + N L+ +P + L
Sbjct: 285 SLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPELPQNLKQ--------LHV 331
Query: 343 QNNNLTNISGSFNIPPNVTVRLRGN 367
+ N L +IP +V LR N
Sbjct: 332 EYNPLREFP---DIPESVE-DLRMN 352
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 21/74 (28%), Positives = 32/74 (43%), Gaps = 4/74 (5%)
Query: 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 221
S ANL+K ++N IS P L+ LP+L+ + L NN ++
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSP 212
Query: 222 LSELPKLLILQLDN 235
L+ L I+ L N
Sbjct: 213 LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 35/219 (15%), Positives = 68/219 (31%), Gaps = 24/219 (10%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
L+ + + ++ ++ + ++ + L G +T E + YL L +++ N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
I+ P N I S + + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNI 284
L L + + G T S + + L+ + L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIG----------NAQVSDLTPLANLSKL-------- 175
Query: 285 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 323
TT+K +NK++ P + LP L + + NN +S P
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 17/79 (21%), Positives = 33/79 (41%), Gaps = 5/79 (6%)
Query: 182 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241
+++ + L+ L L + D+N ++ L+ LP L+ + L NN
Sbjct: 153 LQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDV 210
Query: 242 TIPASYSNMSKLLKLSLRN 260
+ +N S L ++L N
Sbjct: 211 S---PLANTSNLFIVTLTN 226
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 2e-05
Identities = 33/211 (15%), Positives = 78/211 (36%), Gaps = 24/211 (11%)
Query: 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN 164
+ + ++ ++ + + S++ ++ N +++ + YLP + ++ ++ N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 224
++ K ANL ++ N + + L + +L +++
Sbjct: 79 KLTD--IKPLANLKNLGWLFLDENKVKDLSSLK-------DLKKLKSLSLEHNGISDING 129
Query: 225 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNI 284
L L L+ T S ++KL LSL + + + L+ + L L
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNL----- 183
Query: 285 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 315
LS N ++ +GL L L + +
Sbjct: 184 ---YLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 34/201 (16%), Positives = 72/201 (35%), Gaps = 24/201 (11%)
Query: 139 GNELTGSLPEELGY------LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
G+E ++P + + + + + ++ ++ ++ LN NN+ I
Sbjct: 4 GSETI-TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ LP++ + L+ N LT L+ L L L LD N + + +
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116
Query: 253 LLKLSLRNCSLQG---------PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFS 303
L + G ++I ++ L L + I +
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLA 175
Query: 304 GLPRLQRLFIANNSLSGSIPS 324
GL +LQ L+++ N +S + +
Sbjct: 176 GLTKLQNLYLSKNHIS-DLRA 195
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 29/193 (15%), Positives = 57/193 (29%), Gaps = 22/193 (11%)
Query: 84 LRELQLLNLNL-SGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNEL 142
E NL S + L+ + + + I I + ++ L LNGN+L
Sbjct: 23 FAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL 80
Query: 143 TG---------------SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187
T + D ++ + + L
Sbjct: 81 TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140
Query: 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 247
+ + + + L +N + P L+ L KL L L N+ + + +
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI--SDLR-AL 196
Query: 248 SNMSKLLKLSLRN 260
+ + L L L +
Sbjct: 197 AGLKNLDVLELFS 209
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 3e-05
Identities = 25/145 (17%), Positives = 50/145 (34%), Gaps = 10/145 (6%)
Query: 94 LSGNL---SPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL 150
L+ L + + LD KI I + + + + NE+ +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGF 59
Query: 151 GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLL 209
L +L + ++ N I L + NNS+ L+ L SL ++ +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
Query: 210 DNNN---LTGYLPPELSELPKLLIL 231
N Y + ++P++ +L
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 5e-05
Identities = 26/138 (18%), Positives = 47/138 (34%), Gaps = 12/138 (8%)
Query: 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSG 304
A Y+N + +L LR + I NLG L I S+N++ F
Sbjct: 12 AQYTNAVRDRELDLRGYK-------IPVIENLGATLD-QFDAIDFSDNEI--RKLDGFPL 61
Query: 305 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRL 364
L RL+ L + NN + + TE + + L ++ ++ + +
Sbjct: 62 LRRLKTLLVNNNRICRIGEGLDQALP--DLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
Query: 365 RGNPFCLNTNAEQFCGSH 382
NP + +
Sbjct: 120 LRNPVTNKKHYRLYVIYK 137
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.001
Identities = 25/140 (17%), Positives = 43/140 (30%), Gaps = 9/140 (6%)
Query: 173 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 232
+ N + R + I I + L + +N + L +L L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 233 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIK-LSN 291
++NN + L +L L N SL +L + L L SL I
Sbjct: 70 VNNNRICR-IGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCILRNPV 124
Query: 292 NKLTGTIPSNFSGLPRLQRL 311
+P+++ L
Sbjct: 125 TNKKHYRLYVIYKVPQVRVL 144
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 12/72 (16%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 281 SLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 339
SL+I ++ + +L+ L + Q + + + L+ + I + +N
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE- 59
Query: 340 LDFQNNNLTNIS 351
L+ ++N L ++
Sbjct: 60 LNLRSNELGDVG 71
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 19/102 (18%), Positives = 34/102 (33%), Gaps = 9/102 (8%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKI 118
GV + LR L L + ++S + L+ + L LD N +
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 119 SGSIPKEIG-----NIKSLELLLLNGNELTGSLPEELGYLPK 155
+ ++ LE L+L + + + L L K
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 181 RHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTG----YLPPELSELPKLLILQLDN 235
+ + +S EL L + LD+ LT + L P L L L +
Sbjct: 5 QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64
Query: 236 NNFEGTTIP----ASYSNMSKLLKLSLRNC 261
N + + K+ KLSL+NC
Sbjct: 65 NELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 108 LTILDFMWNKISGSIPKEI-GNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQID 162
+ LD ++S + E+ ++ +++ L+ LT + L P L + +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQ 193
N + +T + S+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 8/73 (10%), Positives = 25/73 (34%), Gaps = 4/73 (5%)
Query: 283 NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 338
+ + L++ ++ + + + L+ L ++NN L + + +S
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 339 ILDFQNNNLTNIS 351
L + +
Sbjct: 430 QLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 13/97 (13%), Positives = 26/97 (26%), Gaps = 15/97 (15%)
Query: 128 NIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYISGSLPKSFA-----NLN 178
L +L L +++ SL L L + + N + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 179 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 215
+ + S ++ L L D +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL------EKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 15/112 (13%), Positives = 32/112 (28%), Gaps = 5/112 (4%)
Query: 82 LHLRELQLLNLNLSGNLSPEI-GRLSYLTILDFMWNKISGSIPKEIG----NIKSLELLL 136
L ++ L + LS E+ L ++ ++ + K+I +L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 137 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188
L NEL + + +I + + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT 113
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 10/90 (11%), Positives = 32/90 (35%), Gaps = 5/90 (5%)
Query: 156 LDRIQIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLD 210
+ + I +S + + L + + +++ ++ I L P+L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 211 NNNLTGYLPPELSELPKLLILQLDNNNFEG 240
+N L + + + ++ + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 13/104 (12%), Positives = 29/104 (27%), Gaps = 7/104 (6%)
Query: 228 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN--IT 285
+ L + + + + L +C L +R ++ L +N +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTE-----ARCKDISSALRVNPALA 58
Query: 286 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 329
+ L +N+L + I SL +
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 16/126 (12%), Positives = 32/126 (25%), Gaps = 21/126 (16%)
Query: 178 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG----YLPPELSELPKLLILQL 233
+ + + + + L + L + +++ L L L L L
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404
Query: 234 DNNNFEGTTIP----ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKL 289
NN I + L +L L + M D + ++
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR-------------LQALEK 451
Query: 290 SNNKLT 295
L
Sbjct: 452 DKPSLR 457
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 37/310 (11%), Positives = 86/310 (27%), Gaps = 22/310 (7%)
Query: 82 LHLRELQLLNLNLSG--NLSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELL 135
+ + L+L + ++ + + + N I + + I + K LE+
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 136 LLNGN---ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 192
+ + +PE L L + + + S + ++ ++
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 193 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 252
+ + L + + + P L + N E ++
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 253 LLKLSLRNCSLQGPMPDLSRIPNLGYL-----LSLNITTIKLSNNKLTGTIPSNFSGLPR 307
L G P+ L L L + + + + P
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 308 LQRLFIANNSLSGSIPSSIWQSRTLNATETF-ILDFQNNNLTN------ISGSFNIPPNV 360
L+ L + + LS +++ + + L Q N + + P++
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 361 TV-RLRGNPF 369
L GN F
Sbjct: 305 LFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 14/90 (15%), Positives = 27/90 (30%), Gaps = 13/90 (14%)
Query: 182 HFHMNNNSISGQIPPELSR------LPSLVHMLLDNNNLTGYLPPELSE-----LPKLLI 230
+N+ +S + + L + L N + L +P LL
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 231 LQLDNNNFEGTTIPASYSNMSKLLKLSLRN 260
L+L+ N F + ++ R
Sbjct: 307 LELNGNRFSE--EDDVVDEIREVFSTRGRG 334
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 27/208 (12%), Positives = 62/208 (29%), Gaps = 26/208 (12%)
Query: 105 LSYLTILDFMWNKISGSIP-KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163
L+ ++ ++ ++ + +L+ L + G + YL L +I
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 71
Query: 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS 223
N ++ P + N + + + + + L+
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 224 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLN 283
L D + G T + S ++ + L L +L
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSS----------------NQVTDLKPLANLTTL- 174
Query: 284 ITTIKLSNNKLTGTIPSNFSGLPRLQRL 311
+ +S+NK++ S + L L+ L
Sbjct: 175 -ERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 32/266 (12%), Positives = 76/266 (28%), Gaps = 35/266 (13%)
Query: 63 CTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI 122
C + LC ++ + +L N L F+ K+
Sbjct: 6 CHCSNRVFLCQE----------SKVTEIPSDLPRNA----------IELRFVLTKLRVIQ 45
Query: 123 PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL--PKSFANLNKT 180
LE + ++ N++ + ++ + + P++F NL
Sbjct: 46 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 105
Query: 181 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 240
++ ++N I V + + +N + + L N
Sbjct: 106 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165
Query: 241 TTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLLSLNITTIKLSNNKLTGTI 298
I N ++L +L+L + + +P+ + +S ++
Sbjct: 166 QEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGP--------VILDISRTRIHSLP 217
Query: 299 PSNFSGLPRLQRLFIANNSLSGSIPS 324
L +L+ N +P+
Sbjct: 218 SYGLENLKKLRARSTYNLK---KLPT 240
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 941 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.4 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.54 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.52 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.4 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.25 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.64 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.48 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.77 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 89.82 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=432.71 Aligned_cols=265 Identities=22% Similarity=0.364 Sum_probs=214.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999964 7999999998765545567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|+|.+++.+. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 99 ~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred cCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 9999999988653 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 171 -----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~----------------- 227 (293)
T d1yhwa1 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYL----------------- 227 (293)
T ss_dssp -----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH-----------------
T ss_pred -----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHH-----------------
Confidence 223455799999999999999999999999999999999999999975443211 110
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCCC
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 926 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~~ 926 (941)
+... ..|.- +.. +..++.+.+||.+||..||++||||+|+|+||||+....
T Consensus 228 -----------~~~~---~~~~~-~~~--------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~ 278 (293)
T d1yhwa1 228 -----------IATN---GTPEL-QNP--------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (293)
T ss_dssp -----------HHHH---CSCCC-SSG--------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -----------HHhC---CCCCC-CCc--------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence 0000 00000 000 011223447888999999999999999999999986554
Q ss_pred CCcccc
Q 002289 927 GSNLVS 932 (941)
Q Consensus 927 ~~~~~~ 932 (941)
-+.+.|
T Consensus 279 ~~~l~p 284 (293)
T d1yhwa1 279 LSSLTP 284 (293)
T ss_dssp GGGGHH
T ss_pred CCcCCC
Confidence 444433
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-51 Score=434.24 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=208.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999975 699999999875433 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~- 158 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 158 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc-
Confidence 9999999999543 46899999999999999999999999 99999999999999999999999999987543221
Q ss_pred CccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
........||+.|||||++.+..+ +.++||||+||++|||++|+.||....+..........
T Consensus 159 ----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~------------- 221 (271)
T d1nvra_ 159 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------- 221 (271)
T ss_dssp ----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-------------
T ss_pred ----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Confidence 222345679999999999988876 57899999999999999999999754432211111000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
.+...+.. +..++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 222 --------------------~~~~~~~~--------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 222 --------------------KKTYLNPW--------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp --------------------TCTTSTTG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --------------------CCCCCCcc--------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 00000000 01122335788999999999999999999999998755
Q ss_pred C
Q 002289 926 S 926 (941)
Q Consensus 926 ~ 926 (941)
.
T Consensus 268 ~ 268 (271)
T d1nvra_ 268 K 268 (271)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=453.17 Aligned_cols=292 Identities=22% Similarity=0.363 Sum_probs=214.1
Q ss_pred HhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
..++|++.++||+|+||+||+|+.. +|+.||+|+++.... ...+.+.+|++++++++|||||+++++|.++++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999999975 789999999875432 33567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||+++|+|.+++.+.. .+++..++.++.|+++||+|||++ + |+||||||+|||+++++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999997654 489999999999999999999974 7 99999999999999999999999999986531
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. .+.+.
T Consensus 158 --------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~-------~~~~~ 222 (322)
T d1s9ja_ 158 --------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC-------QVEGD 222 (322)
T ss_dssp --------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred --------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-------HhcCC
Confidence 223346799999999999999999999999999999999999999976543222111000 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC------CCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE------SDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~------~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
+...+.................+|... ..+.+..+....+. .+.++.|||.+||+.||++||||+|+|+
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 223 ----AAETPPRPRTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------------------CCCC-HHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----cccCCcccccccccccccccccccchh-HHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001111111111222222333333322 11222222222221 1234568999999999999999999999
Q ss_pred CCCCCCC
Q 002289 918 HPYVSSD 924 (941)
Q Consensus 918 Hpwf~~~ 924 (941)
||||++.
T Consensus 298 Hpf~~~~ 304 (322)
T d1s9ja_ 298 HAFIKRS 304 (322)
T ss_dssp SHHHHHH
T ss_pred CHhhCcC
Confidence 9999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=429.72 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=208.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|+.+ +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56889999999999999999975 689999999864322 22467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999765322
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... +.. ..
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~---------i~~-~~ 220 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYKR---------ISR-VE 220 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHH---------HHT-TC
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-HHHHHH---------HHc-CC
Confidence 22345699999999999999999999999999999999999999965432 111110 000 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
..+|+ ..++++.+||.+||..||++|||++|+|+||||+++
T Consensus 221 ~~~p~---------------------------------------~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 221 FTFPD---------------------------------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CCCCT---------------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCCCc---------------------------------------cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 01111 112234478889999999999999999999999865
Q ss_pred C
Q 002289 925 V 925 (941)
Q Consensus 925 ~ 925 (941)
.
T Consensus 262 s 262 (263)
T d2j4za1 262 S 262 (263)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-50 Score=427.84 Aligned_cols=264 Identities=27% Similarity=0.437 Sum_probs=221.4
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
+++...++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3444567899999999999999999999888999999997643 335679999999999999999999998865 56799
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++.......+++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence 999999999999887655556899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.. ........||+.|+|||++.++.++.++|||||||++|||+||..|+....+..+... .+..+
T Consensus 162 ~~------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---------~i~~~ 226 (272)
T d1qpca_ 162 NE------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---------NLERG 226 (272)
T ss_dssp SC------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---------HHHTT
T ss_pred Cc------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH---------HHHhc
Confidence 22 1223445689999999999999999999999999999999997676655444332222 22233
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
.....|..+++++.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 34455677788899999999999999999999999999987653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=425.05 Aligned_cols=268 Identities=25% Similarity=0.458 Sum_probs=213.1
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEE
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
|+...++|++.+.||+|+||+||+|++++ .||||+++... ....+.|.+|++++++++||||+++++++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 34456789999999999999999998743 59999987532 3345689999999999999999999998764 5689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.++++... ..+++..++.|+.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 80 lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999997543 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
.... ........||+.|||||++.+ ..++.++|||||||++|||+||+.||............. ...
T Consensus 156 ~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~-~~~---- 225 (276)
T d1uwha_ 156 RWSG-----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-GRG---- 225 (276)
T ss_dssp ---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HHT----
T ss_pred ccCC-----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH-hcC----
Confidence 3221 123345679999999999874 358999999999999999999999997654432221111 111
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 888 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 888 (941)
...+.....+..+++.+.+++.+||+.+|++|||+.++++.|+.+.+.+|
T Consensus 226 ~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11111223455677889999999999999999999999999999887665
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=429.02 Aligned_cols=266 Identities=29% Similarity=0.460 Sum_probs=226.4
Q ss_pred chHHHHHHhcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCC
Q 002289 600 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 678 (941)
Q Consensus 600 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 678 (941)
.|++|+...++|++.+.||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++|||||+++++|.+.+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 44556667788999999999999999999975 58999999987643 33567999999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
..++||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++++||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 9999999999999999998777778999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
...... ........||+.|+|||++.+..++.++|||||||++|||++|..||....+..+....
T Consensus 164 ~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~--------- 228 (287)
T d1opja_ 164 LMTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--------- 228 (287)
T ss_dssp TCCSSS------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---------
T ss_pred ecCCCC------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH---------
Confidence 754322 12233456889999999999999999999999999999999988887665543332221
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
+..+.....+..++.++.+++..||+.+|++|||+.++++.|+.+.
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122334566777889999999999999999999999999888764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=419.96 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=208.3
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 688 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~ 688 (941)
++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||++++|+|..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999888999999997643 345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCc
Q 002289 689 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 768 (941)
Q Consensus 689 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 768 (941)
+|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~---- 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 155 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC----
Confidence 99999998654 345889999999999999999999999 9999999999999999999999999998664322
Q ss_pred cccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC
Q 002289 769 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848 (941)
Q Consensus 769 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (941)
........||+.|+|||++.+..++.++|||||||++|||+|+..|+....+..+.... +..+.....|
T Consensus 156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~---------i~~~~~~~~p 224 (263)
T d1sm2a_ 156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---------ISTGFRLYKP 224 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---------HHHTCCCCCC
T ss_pred --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---------HHhcCCCCCc
Confidence 12223456899999999999999999999999999999999965555444433322221 2223334456
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 849 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+++++.+++.+||+.+|++||++++++++|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 6777889999999999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-49 Score=422.97 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=209.8
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
+.|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56889999999999999999975 68999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++|+|.+++.+.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 9999999986543 35899999999999999999999999 999999999999999999999999999754211
Q ss_pred ccccccccccccCCCcccccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
........||+.|+|||++. +..|+.++||||+||++|||+||+.||.......... .+...
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~----------~i~~~ 230 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL----------KIAKS 230 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH----------HHHHS
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH----------HHHcC
Confidence 12234567999999999984 4568899999999999999999999997543211100 01111
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
..... ..| +..++++.+||.+||+.||++|||++|+|+||||+
T Consensus 231 ~~~~~---------------------~~~----------------~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 231 EPPTL---------------------AQP----------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp CCCCC---------------------SSG----------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred CCCCC---------------------Ccc----------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 00000 000 01122345788899999999999999999999998
Q ss_pred CCC
Q 002289 923 SDV 925 (941)
Q Consensus 923 ~~~ 925 (941)
.+.
T Consensus 274 ~~~ 276 (288)
T d2jfla1 274 VDS 276 (288)
T ss_dssp CCC
T ss_pred CCC
Confidence 643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=421.46 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=192.9
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeecccc--CCcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~LV 683 (941)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999965 6899999998764432 24568999999999999999999999854 4568999
Q ss_pred EecCCCCCHHHHHhhc--CCCCccHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 684 YEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
|||+++|+|.+++.+. ....+++..++.++.|++.||+|||+++ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 3456999999999999999999999864 23499999999999999999999999999987
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +... .+
T Consensus 164 ~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~~~~---------~i 226 (269)
T d2java1 164 LNHDT-------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAG---------KI 226 (269)
T ss_dssp C------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH---------HH
T ss_pred cccCC-------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-HHHH---------HH
Confidence 64321 2234567999999999999999999999999999999999999999754321 1100 11
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
..+.....+..++ +++.+||.+||+.||++|||++|+|+||
T Consensus 227 ~~~~~~~~~~~~s---------------------------------------~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 227 REGKFRRIPYRYS---------------------------------------DELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp HHTCCCCCCTTSC---------------------------------------HHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HcCCCCCCCcccC---------------------------------------HHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 1111111121111 2233677778888888888999999999
Q ss_pred CC
Q 002289 920 YV 921 (941)
Q Consensus 920 wf 921 (941)
|+
T Consensus 268 ~i 269 (269)
T d2java1 268 LI 269 (269)
T ss_dssp TC
T ss_pred cC
Confidence 95
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-48 Score=421.15 Aligned_cols=261 Identities=27% Similarity=0.453 Sum_probs=204.8
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CC---cEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
++|++.+.||+|+||+||+|+++ ++ ..||||.+..... ...++|.+|+++|++++|||||+++|+|...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45666789999999999999975 23 3689998875433 3356799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||||++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999886543 35899999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
.... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.. ..+..+
T Consensus 182 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~---------~~i~~~ 249 (299)
T d1jpaa_ 182 TSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVI---------NAIEQD 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHH---------HHHHTT
T ss_pred CCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-HHH---------HHHHcC
Confidence 2111 1112233468899999999999999999999999999999998 89999765432 111 122233
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
...+.+.+++..+.+++..||+.+|++||++.++++.|+++.+
T Consensus 250 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 4455677788899999999999999999999999999998765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-48 Score=426.67 Aligned_cols=258 Identities=21% Similarity=0.371 Sum_probs=210.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56899999999999999999974 699999999874322 22457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 9999999999987654 4778888999999999999999999 99999999999999999999999999987532
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +... .+..+ .
T Consensus 157 --------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~---------~i~~~-~ 217 (316)
T d1fota_ 157 --------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYE---------KILNA-E 217 (316)
T ss_dssp --------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHH---------HHHHC-C
T ss_pred --------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHH---------HHHcC-C
Confidence 123467999999999999999999999999999999999999999764432 1111 11111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
..+|...+.++.+++.+|+..+|.+|+ +..|+|++|+|+||||++.
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~----------------------------------~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRL----------------------------------GNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCT----------------------------------TSSTTTTHHHHTSGGGSSC
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhcc----------------------------------ccchhhHHHHHcCcccccC
Confidence 223444455566666677766666664 3356799999999999875
Q ss_pred CC
Q 002289 925 VS 926 (941)
Q Consensus 925 ~~ 926 (941)
.+
T Consensus 264 ~~ 265 (316)
T d1fota_ 264 VW 265 (316)
T ss_dssp CH
T ss_pred CH
Confidence 44
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=408.64 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=217.5
Q ss_pred hcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
.++|+..++||+|+||+||+|++++++.||||+++.... .+++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368899999999999999999998899999999986443 3568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++|+|.+++.... ..+++..+++++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--- 154 (258)
T d1k2pa_ 82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--- 154 (258)
T ss_dssp TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS---
T ss_pred CCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC---
Confidence 9999999976543 35889999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 846 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (941)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... + +. ..+..+....
T Consensus 155 ---~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~-~~--------~~i~~~~~~~ 221 (258)
T d1k2pa_ 155 ---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-E-TA--------EHIAQGLRLY 221 (258)
T ss_dssp ---CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-H-HH--------HHHHTTCCCC
T ss_pred ---ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-H-HH--------HHHHhCCCCC
Confidence 122334568999999999999999999999999999999998 89999755432 1 11 1223334455
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002289 847 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 882 (941)
Q Consensus 847 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~ 882 (941)
.|..+++++.+++.+||+.+|++|||+.+++++|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 667777899999999999999999999999998864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-49 Score=428.47 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=195.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 567999999999999999999975 6899999998754432 34568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeeccccccCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFGla~~~~~ 762 (941)
||+||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999654 35999999999999999999999999 99999999999994 578999999999986532
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. .......||+.|||||++.+..++.++||||+||++|||++|+.||......... . .+...
T Consensus 163 ~--------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~---------~i~~~ 224 (307)
T d1a06a_ 163 G--------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-E---------QILKA 224 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-H---------HHHTT
T ss_pred C--------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-H---------HHhcc
Confidence 2 2233457999999999999999999999999999999999999999754431111 0 00000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
.. ... .| ..+..++.+.+||.+||..||++|||++|+|+||||+
T Consensus 225 ~~-------------------~~~---~~--------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 225 EY-------------------EFD---SP--------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp CC-------------------CCC---TT--------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred CC-------------------CCC---Cc--------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 00 000 00 0011223345788999999999999999999999998
Q ss_pred CCCC
Q 002289 923 SDVS 926 (941)
Q Consensus 923 ~~~~ 926 (941)
++..
T Consensus 269 ~~~~ 272 (307)
T d1a06a_ 269 GDTA 272 (307)
T ss_dssp SSCC
T ss_pred CCCc
Confidence 7554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=421.83 Aligned_cols=258 Identities=19% Similarity=0.321 Sum_probs=206.4
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999974 799999999874322 22357899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987654 4899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... .+....
T Consensus 163 ~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~---------~i~~~~- 226 (288)
T d1uu3a_ 163 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQ---------KIIKLE- 226 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH---------HHHTTC-
T ss_pred c-----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-HHHH---------HHHcCC-
Confidence 1 12234457999999999999999999999999999999999999999754321 1100 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC------CCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM------LKH 918 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~------L~H 918 (941)
..+|. ...+.+.+||.+||..||++|+|++|+ ++|
T Consensus 227 ~~~p~---------------------------------------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~H 267 (288)
T d1uu3a_ 227 YDFPE---------------------------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267 (288)
T ss_dssp CCCCT---------------------------------------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred CCCCc---------------------------------------cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcC
Confidence 01111 112234578889999999999999985 789
Q ss_pred CCCCCCCC
Q 002289 919 PYVSSDVS 926 (941)
Q Consensus 919 pwf~~~~~ 926 (941)
|||++-.+
T Consensus 268 pff~~i~w 275 (288)
T d1uu3a_ 268 PFFESVTW 275 (288)
T ss_dssp GGGTTCCC
T ss_pred CccCCCCH
Confidence 99987544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.1e-48 Score=427.96 Aligned_cols=259 Identities=21% Similarity=0.380 Sum_probs=212.6
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 687 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~ 687 (941)
++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 79999999998766566678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc--CCCcEEEeeeccccccCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DFGla~~~~~~~~ 765 (941)
++|+|.+++... ..++++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999999987543 345999999999999999999999999 99999999999998 6789999999999876432
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||........ ..
T Consensus 183 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~----------------- 238 (352)
T d1koba_ 183 ------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQ----------------- 238 (352)
T ss_dssp ------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HH-----------------
T ss_pred ------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HH-----------------
Confidence 223456789999999999999999999999999999999999999975443111 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
-+..+--..|.. ..+...+++.+||.+||+.||++|||++|+|+||||++..
T Consensus 239 ------------~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 239 ------------NVKRCDWEFDED----------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp ------------HHHHCCCCCCSS----------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ------------HHHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 011110000000 0111223445789999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=427.37 Aligned_cols=202 Identities=26% Similarity=0.350 Sum_probs=179.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999974 799999999875322 2245788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
||||++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999997654 4888999999999999999999999 999999999999999999999999999865332
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCc
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 821 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~ 821 (941)
. .......||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 159 ~-------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 159 G-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp T-------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 1 22345679999999999999999999999999999999999999997544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=413.04 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=197.5
Q ss_pred CccceeeccCcEEEEEEEeC-CCcEEEEEEeccCC--chhhHhHHHHHHHHHhcCCCceeeeeecccc----CCcEEEEE
Q 002289 612 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 684 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~LV~ 684 (941)
+..++||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999975 68899999987533 2234678999999999999999999999854 34679999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc-CCCcEEEeeeccccccCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFGla~~~~~~ 763 (941)
||+++|+|.+++.+.. .+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 9999999999997653 4889999999999999999999875 5599999999999996 578999999999985432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
.......||+.|||||++.+ .++.++|||||||++|||++|+.||....+........ ..+.
T Consensus 168 --------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i---------~~~~ 229 (270)
T d1t4ha_ 168 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------TSGV 229 (270)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---------TTTC
T ss_pred --------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH---------HcCC
Confidence 12335679999999998865 59999999999999999999999997544322211110 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 922 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~ 922 (941)
. + +.. .....+++.+||.+||..||++|||++|+|+||||+
T Consensus 230 ~---~----------------------~~~-------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 230 K---P----------------------ASF-------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp C---C----------------------GGG-------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred C---C----------------------ccc-------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0 0 000 001122344688889999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.6e-48 Score=429.54 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=210.3
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999974 7999999999876666667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC--CCcEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFGla~~~~~~~ 764 (941)
|++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.....
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 99999999995433 35999999999999999999999999 999999999999964 578999999999876432
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......||+.|||||++.+..++.++||||+||++|||++|+.||..... .+....
T Consensus 180 -------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~--------------- 236 (350)
T d1koaa2 180 -------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRN--------------- 236 (350)
T ss_dssp -------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH---------------
T ss_pred -------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHH---------------
Confidence 223456799999999999999999999999999999999999999975432 111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
+..+-...+.. ..+...+.+.+||.+||..||++|||++|+|+||||+..
T Consensus 237 --------------i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 237 --------------VKSCDWNMDDS----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp --------------HHHTCCCSCCG----------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred --------------HHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11110000000 000112233478888999999999999999999999754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-48 Score=428.99 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=206.4
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 799999999864322 22356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
||+.+|+|.+++.+.. .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999875321
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...... ..... +.. ..
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~---------i~~-~~ 254 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEK---------IVS-GK 254 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH---------HHH-CC
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHHH---------Hhc-CC
Confidence 23457999999999999999999999999999999999999999754321 11111 111 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
..++..++.++.+++.+|+..||.+|+ +..|+|++|+++||||++.
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~----------------------------------~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRF----------------------------------GNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCT----------------------------------TSSTTTTHHHHTSGGGTTC
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhcc----------------------------------ccccccHHHHHcCccccCC
Confidence 122333344445555555555555443 2234689999999999875
Q ss_pred CC
Q 002289 925 VS 926 (941)
Q Consensus 925 ~~ 926 (941)
.+
T Consensus 301 ~~ 302 (350)
T d1rdqe_ 301 DW 302 (350)
T ss_dssp CH
T ss_pred CH
Confidence 44
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=415.69 Aligned_cols=262 Identities=29% Similarity=0.445 Sum_probs=215.6
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEE
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
++...++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 334457899999999999999999999888899999997543 345689999999999999999999999854 568999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999999987665556999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
. ........||+.|+|||++.++.++.++|||||||++|||++|..|+.......+.... +..+.
T Consensus 167 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---------i~~~~ 231 (285)
T d1fmka3 167 E------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------VERGY 231 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTC
T ss_pred C------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---------HHhcC
Confidence 2 12233456899999999999999999999999999999999987777665543332222 22233
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+.+..+++++.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 345667788899999999999999999999999999887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=416.77 Aligned_cols=262 Identities=21% Similarity=0.346 Sum_probs=209.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch------hhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999974 7999999998653322 246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC----cEEEeeecc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 756 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFGl 756 (941)
++|||||++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997654 5899999999999999999999999 99999999999998776 599999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 836 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 836 (941)
|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 164 a~~~~~~--------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~------- 227 (293)
T d1jksa_ 164 AHKIDFG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN------- 227 (293)
T ss_dssp CEECTTS--------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-------
T ss_pred hhhcCCC--------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHH-------
Confidence 9876432 223345689999999999999999999999999999999999999975432111 110
Q ss_pred hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCC
Q 002289 837 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 916 (941)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L 916 (941)
+... ...++.. ..+..++.+.+||.+||..||++|||++|+|
T Consensus 228 --i~~~-~~~~~~~-----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 228 --VSAV-NYEFEDE-----------------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp --HHTT-CCCCCHH-----------------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred --HHhc-CCCCCch-----------------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0000 0011110 0012233345799999999999999999999
Q ss_pred CCCCCCCCCCCC
Q 002289 917 KHPYVSSDVSGS 928 (941)
Q Consensus 917 ~Hpwf~~~~~~~ 928 (941)
+||||+......
T Consensus 270 ~hp~~~~~~~~~ 281 (293)
T d1jksa_ 270 QHPWIKPKDTQQ 281 (293)
T ss_dssp HSTTTCC-----
T ss_pred cCcccCCCChhH
Confidence 999998654443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=411.56 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=214.6
Q ss_pred hcCCCccc-eeeccCcEEEEEEEeC---CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 608 TNNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 608 ~~~y~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
.++|.+.+ +||+|+||+||+|.++ ++..||||+++.... ...++|.+|+++|++++|||||+++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 34566666 4999999999999864 356899999976443 335789999999999999999999999865 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+++|+|.+++... +..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999998543 346899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.. ..+..
T Consensus 162 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~---------~~i~~ 227 (285)
T d1u59a_ 162 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVM---------AFIEQ 227 (285)
T ss_dssp CSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHH---------HHHHT
T ss_pred cccc----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHH---------HHHHc
Confidence 3211 122334568999999999999999999999999999999998 89999765432 111 12233
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+.....|..++.++.+++..||+.+|++||++.++.+.|+....
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 44556777888999999999999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=408.30 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=210.0
Q ss_pred cCCCccceeeccCcEEEEEEEeCCC-----cEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDG-----TVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
+.|++.+.||+|+||+||+|.+++. ..||||+++..... ...+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997532 47999998754333 34578999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
||||+.+|++.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999886543 45899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
... .........||+.|+|||++.+..++.++|||||||++|||++|..|+....+..+... .+.++
T Consensus 163 ~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---------~i~~~ 229 (283)
T d1mqba_ 163 DPE----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---------AINDG 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---------HHHTT
T ss_pred CCc----cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH---------HHhcc
Confidence 221 11223345689999999999999999999999999999999997777665544332221 22334
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
...+.+.+++..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 4556677788899999999999999999999999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-48 Score=419.34 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=203.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~ 684 (941)
+.|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45889999999999999999964 7899999998764432 2356899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~ 764 (941)
|||++|+|..++..+ .++++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999998766543 35899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccccccccCCCccccccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||......... . .+..
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~-~---------~i~~ 228 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-Y---------HIAQ 228 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-H---------HHHH
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-H---------HHHh
Confidence 223569999999999864 46899999999999999999999999754332111 0 0111
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCC
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 921 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf 921 (941)
... |...+ ...++.+.+||.+||..||++||||+|+|+||||
T Consensus 229 ~~~----------------------~~~~~----------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 229 NES----------------------PALQS----------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp SCC----------------------CCCSC----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CCC----------------------CCCCC----------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 111 10000 0111233467888899999999999999999999
Q ss_pred CCCCC
Q 002289 922 SSDVS 926 (941)
Q Consensus 922 ~~~~~ 926 (941)
.....
T Consensus 271 ~~~~~ 275 (309)
T d1u5ra_ 271 LRERP 275 (309)
T ss_dssp HSCCC
T ss_pred cCCCC
Confidence 76443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=407.43 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=205.6
Q ss_pred ceeeccCcEEEEEEEeC---CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEecCCC
Q 002289 615 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 689 (941)
Q Consensus 615 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~~~~ 689 (941)
++||+|+||+||+|.++ .++.||||+++.... ...++|.+|++++++++||||++++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 357899999875332 234679999999999999999999999865 467899999999
Q ss_pred CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCcc
Q 002289 690 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 769 (941)
Q Consensus 690 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 769 (941)
|+|.++++... .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~---- 162 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---- 162 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS----
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc----
Confidence 99999997643 4899999999999999999999999 99999999999999999999999999987643221
Q ss_pred ccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCCC
Q 002289 770 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 848 (941)
Q Consensus 770 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (941)
.........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... + +. ..+..+.....|
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~-~~--------~~i~~~~~~~~p 232 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E-VT--------AMLEKGERMGCP 232 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-H-HH--------HHHHTTCCCCCC
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-H-HH--------HHHHcCCCCCCC
Confidence 1122334568999999999999999999999999999999998 89999764431 1 11 112234455667
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 849 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 849 ~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..++.++.+++.+||+.+|++||++.++.+.|+.++.
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 7788899999999999999999999999999887643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.2e-47 Score=422.15 Aligned_cols=198 Identities=27% Similarity=0.398 Sum_probs=170.8
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch---hhHhHHHH---HHHHHhcCCCceeeeeeccccCCcEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTE---IQFLSRLHHRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~~ 681 (941)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ....+.+| +++++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999975 6999999998643221 12334444 66777788999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997654 4789999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCC
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 820 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~ 820 (941)
.. ......||+.|+|||++.. ..++.++||||+||++|||+||+.||...
T Consensus 159 ~~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 159 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp SS---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CC---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 32 1234569999999999975 56899999999999999999999999653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=414.72 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=204.7
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc---hhhHhHHHHHHHHH-hcCCCceeeeeeccccCCcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~LV 683 (941)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 699999999974321 12345667777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCC
Q 002289 684 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~ 763 (941)
|||+++|+|.++++... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997654 4788999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 843 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (941)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +..
T Consensus 157 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~---------------- 212 (320)
T d1xjda_ 157 D-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELF---------------- 212 (320)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH----------------
T ss_pred c-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHH----------------
Confidence 1 2234467999999999999999999999999999999999999999754321 100
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCc-cCCCCCCCC
Q 002289 844 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS-SMLKHPYVS 922 (941)
Q Consensus 844 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~-e~L~Hpwf~ 922 (941)
+.+.. ..|. -| ...++.+.+||++||+.||++|||++ |+++||||+
T Consensus 213 -------------~~i~~---~~~~-~p----------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 213 -------------HSIRM---DNPF-YP----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp -------------HHHHH---CCCC-CC----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred -------------HHHHc---CCCC-CC----------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 00111 0110 01 01223345788889999999999995 899999997
Q ss_pred CC
Q 002289 923 SD 924 (941)
Q Consensus 923 ~~ 924 (941)
+-
T Consensus 260 ~~ 261 (320)
T d1xjda_ 260 EI 261 (320)
T ss_dssp TC
T ss_pred cC
Confidence 64
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=412.71 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=211.0
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCC------CcEEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeeccccC
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 677 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 677 (941)
...++|++.++||+|+||+||+|++.. ...||||++.... ......+.+|+.+++++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 445789999999999999999998642 2369999986533 23346789999999998 899999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC---------------------CCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 736 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL 736 (941)
+..++|||||++|+|.++++.+.. ..+++..++.++.||++||+|||+++ ||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999975432 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCC
Q 002289 737 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 815 (941)
Q Consensus 737 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~ 815 (941)
||+|||++.++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||+| |+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred chhccccccCCeEEEeeccccccccCCCc-----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 99999999999999999999986543221 122334568999999999999999999999999999999998 899
Q ss_pred CCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002289 816 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 881 (941)
Q Consensus 816 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~ 881 (941)
||........... . +..+.....|..+++++.+++.+||+.+|++|||+++++++|.
T Consensus 266 Pf~~~~~~~~~~~-~--------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDANFYK-L--------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SSTTCCCSHHHHH-H--------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHH-H--------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9975433211111 1 1112234566777889999999999999999999999999885
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-46 Score=408.36 Aligned_cols=265 Identities=28% Similarity=0.457 Sum_probs=219.2
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeecc
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYC 674 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~ 674 (941)
.+++...++|++.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556788999999999999999999863 3578999999764433 356799999999999999999999999
Q ss_pred ccCCcEEEEEecCCCCCHHHHHhhcC----------------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 002289 675 DEEGEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVF 732 (941)
Q Consensus 675 ~~~~~~~LV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 732 (941)
...+..++||||+++|+|.++++... ...+++..++.|+.|++.||+|||+++ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999996422 234889999999999999999999999 99
Q ss_pred eccCCCCcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh
Q 002289 733 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 812 (941)
Q Consensus 733 H~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt 812 (941)
||||||+|||++.++++||+|||+|+....... ........||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCcc-----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 999999999999999999999999986533211 122344568899999999999999999999999999999999
Q ss_pred CCC-CCCCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 002289 813 GMQ-PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 884 (941)
Q Consensus 813 G~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 884 (941)
|.. ||..... .+.. ..+.++.....|..++.++.+++..||+.+|++|||+.+|+++|+++.
T Consensus 238 ~~~~p~~~~~~-~e~~---------~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 238 YGLQPYYGMAH-EEVI---------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTCCTTTTSCH-HHHH---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCCCCCH-HHHH---------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 965 5554332 2221 223344555667778889999999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=413.23 Aligned_cols=277 Identities=22% Similarity=0.342 Sum_probs=202.3
Q ss_pred ccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchh-----hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 613 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 613 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
.+++||+|+||+||+|++. +|+.||||+++...... .+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 69999999987533221 34688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
++++++..+... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-- 154 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-- 154 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--
Confidence 988777666533 345888899999999999999999999 9999999999999999999999999998654322
Q ss_pred CccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC-CC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG-NM 844 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 844 (941)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||....+.. ....... .... ..
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~------~~~~~~~ 222 (299)
T d1ua2a_ 155 -----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFE------TLGTPTE 222 (299)
T ss_dssp -----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH------HHCCCCT
T ss_pred -----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHH------hcCCCCh
Confidence 122345689999999998754 57999999999999999999999997554322 1111110 0000 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
...+... ... ....-...|... .....+..++++.|||.+||+.||++||||+|+|+||||++.
T Consensus 223 ~~~~~~~-----~~~---~~~~~~~~~~~~--------~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 223 EQWPDMC-----SLP---DYVTFKSFPGIP--------LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTSSSTT-----SST---TCCCCCCCCCCC--------HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccchh-----ccc---hhhhhccCCCCC--------hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000000 000 000000111100 111233445567789999999999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=400.02 Aligned_cols=253 Identities=29% Similarity=0.456 Sum_probs=206.8
Q ss_pred HhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc-CCcEEEEEe
Q 002289 607 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 685 (941)
Q Consensus 607 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~LV~e 685 (941)
..++|++.+.||+|+||.||+|++ .|+.||||+++... ..+.+.+|++++++++||||++++|+|.+ .+..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 345688889999999999999998 47889999997543 34679999999999999999999999854 467899999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+++|+|.+++..+....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 999999999997665556899999999999999999999998 999999999999999999999999999864321
Q ss_pred CCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.....+|..|+|||++.+..++.++|||||||++|||+| |+.||..... .+. ...+..+..
T Consensus 157 --------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~~~---------~~~i~~~~~ 218 (262)
T d1byga_ 157 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDV---------VPRVEKGYK 218 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGH---------HHHHTTTCC
T ss_pred --------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-HHH---------HHHHHcCCC
Confidence 223457889999999999999999999999999999998 6777754332 111 112233445
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
...+..++.++.+++.+||+.||.+||++.+++++|+.+..
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 56777788899999999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=401.03 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=205.9
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCC----CcEEEEEEeccCCch-hhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
...++|++.+.||+|+||+||+|++.. +..||||+++..... ..+.+.+|++++++++||||++++|++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999998642 457899998754333 3467999999999999999999999996 4678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999999987654 346899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+
T Consensus 159 ~~~~------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----------~~~~i 222 (273)
T d1mp8a_ 159 EDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------VIGRI 222 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------HHHHH
T ss_pred cCCc------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----------HHHHH
Confidence 4322 122344568999999999999999999999999999999998 888887544321 11122
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+...+.+..+++.+.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3344456677788899999999999999999999999999988754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.4e-46 Score=397.71 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=205.7
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCch---------hhHhHHHHHHHHHhcC-CCceeeeeeccccC
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE 677 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 677 (941)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999996 47999999998753321 1246889999999997 99999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 678 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 678 ~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
+..|+|||||++|+|.+++..+. ++++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997654 5899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCccccccccc------CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 831 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~ 831 (941)
+..... .......||..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...
T Consensus 158 ~~~~~~--------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-~~~-- 226 (277)
T d1phka_ 158 CQLDPG--------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRM-- 226 (277)
T ss_dssp EECCTT--------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH--
T ss_pred eEccCC--------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-HHH--
Confidence 876432 12244579999999999863 3468899999999999999999999975443111 100
Q ss_pred hhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCC
Q 002289 832 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 911 (941)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~s 911 (941)
+..+. ... + .|. .+..++++.+|+.+||..||++|||
T Consensus 227 -------i~~~~-------------------~~~-~--~~~--------------~~~~s~~~~~li~~~L~~~p~~R~s 263 (277)
T d1phka_ 227 -------IMSGN-------------------YQF-G--SPE--------------WDDYSDTVKDLVSRFLVVQPQKRYT 263 (277)
T ss_dssp -------HHHTC-------------------CCC-C--TTT--------------GGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred -------HHhCC-------------------CCC-C--Ccc--------------cccCCHHHHHHHHHHccCChhHCcC
Confidence 00000 000 0 000 0112233457888899999999999
Q ss_pred CccCCCCCCCCC
Q 002289 912 SSSMLKHPYVSS 923 (941)
Q Consensus 912 a~e~L~Hpwf~~ 923 (941)
++|+|+||||+.
T Consensus 264 ~~eil~h~~~~~ 275 (277)
T d1phka_ 264 AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHTTSGGGCT
T ss_pred HHHHHcCHHHHH
Confidence 999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=408.55 Aligned_cols=282 Identities=26% Similarity=0.381 Sum_probs=209.8
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCch--hhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.+.||+|+||+||+|++ .+|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999997 47999999999754322 24678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
|+. |++.+++.......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--
Confidence 995 56666665555567999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCccccccccccccCCCcccccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
........||+.|+|||.+.... ++.++||||+||++|||++|+.||...................
T Consensus 156 -----~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 222 (298)
T d1gz8a_ 156 -----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP-------- 222 (298)
T ss_dssp -----SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC--------
T ss_pred -----cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC--------
Confidence 12334457999999999987765 5789999999999999999999997654432211111000000
Q ss_pred CCCChHHHHHHHHHHHHhccc-CCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQD-ETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~-~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.+......... ...... ....+.... ...+..++++.|||.+||+.||++||||+|+|+||||++
T Consensus 223 ---~~~~~~~~~~~-~~~~~~~~~~~~~~~~----------~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 223 ---DEVVWPGVTSM-PDYKPSFPKWARQDFS----------KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp ---CTTTSTTGGGS-TTCCTTSCCCCCCCHH----------HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ---chhhccccccc-cccccccccccccchh----------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 00000000000 000000 001111111 122344455678999999999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=410.29 Aligned_cols=258 Identities=19% Similarity=0.351 Sum_probs=208.0
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
-++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+|+++|++++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 368999999999999999999975 68999999998644 3345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCC--CcEEEeeeccccccCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPD 764 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DFGla~~~~~~~ 764 (941)
|+||+|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 99999999996543 35899999999999999999999999 9999999999999854 58999999999865322
Q ss_pred CCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 765 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 765 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......+|+.|+|||...+..++.++||||+||++|||++|+.||........ .. .+....
T Consensus 158 -------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~---------~i~~~~- 219 (321)
T d1tkia_ 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IE---------NIMNAE- 219 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH---------HHHHTC-
T ss_pred -------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-HH---------HHHhCC-
Confidence 223445689999999999999999999999999999999999999975443111 00 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 924 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~~ 924 (941)
..++... ++...+++.+||.+||+.||++|||++|+|+||||+..
T Consensus 220 ~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 220 YTFDEEA-----------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCCHHH-----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCChhh-----------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0111100 01122334578889999999999999999999999654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-46 Score=404.31 Aligned_cols=282 Identities=22% Similarity=0.307 Sum_probs=206.9
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchh--hHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e~ 686 (941)
++|++.++||+|+||+||+|++++|+.||||+++...... .+.+.+|+.+|++++||||+++++++..++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999997643322 46789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 766 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 766 (941)
+.++.+..+.... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 9776666665433 45999999999999999999999999 9999999999999999999999999998754322
Q ss_pred CccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCC
Q 002289 767 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 845 (941)
Q Consensus 767 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (941)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........ ....... .......
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~-----~~~~~~~ 223 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRI-----LGTPNSK 223 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH-----HCCCCTT
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHh-----hCCCChh
Confidence 223344688999999999764 568999999999999999999999976543222 1111100 0000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 846 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 846 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
..+ ................+.. .....+..++.+.||+++||+.||++||||+|+|+||||+.
T Consensus 224 ~~~-----~~~~~~~~~~~~~~~~~~~----------~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 224 NWP-----NVTELPKYDPNFTVYEPLP----------WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TST-----TGGGSTTCCTTCCCCCCCC----------GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcc-----chhhhhhcccccccccCcc----------hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 000 0000000000000000000 11122333445568999999999999999999999999973
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=395.50 Aligned_cols=260 Identities=31% Similarity=0.499 Sum_probs=213.1
Q ss_pred cceeeccCcEEEEEEEeCC----CcEEEEEEeccC-CchhhHhHHHHHHHHHhcCCCceeeeeecccc-CCcEEEEEecC
Q 002289 614 STQIGQGGYGKVYKGILPD----GTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEFM 687 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~LV~e~~ 687 (941)
.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|++++++++||||++++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999743 236899998753 33345789999999999999999999999865 56889999999
Q ss_pred CCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCCCC
Q 002289 688 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 767 (941)
Q Consensus 688 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 767 (941)
++|+|.++++... ...++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 9999999986543 45788899999999999999999999 999999999999999999999999999876543221
Q ss_pred ccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCCCCC
Q 002289 768 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 847 (941)
Q Consensus 768 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (941)
.........||+.|+|||++.+..++.++||||||+++|||+||..||....+..+. ...+..+.....
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~---------~~~i~~g~~~~~ 255 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---------TVYLLQGRRLLQ 255 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C---------HHHHHTTCCCCC
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH---------HHHHHcCCCCCC
Confidence 122234457899999999999999999999999999999999988888765433221 222334445556
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002289 848 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 889 (941)
Q Consensus 848 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~ 889 (941)
|..+++++.+++.+||+.+|++||++.||+++|+++.+.+..
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 677788999999999999999999999999999999876544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=399.12 Aligned_cols=267 Identities=26% Similarity=0.416 Sum_probs=207.1
Q ss_pred HHHHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeeeeec
Q 002289 602 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVGY 673 (941)
Q Consensus 602 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~ 673 (941)
..++...++|++.++||+|+||+||+|++. +++.||||+++..... ..+.+.+|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 445555678999999999999999999853 3578999998754433 346788888888777 68999999998
Q ss_pred ccc-CCcEEEEEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 002289 674 CDE-EGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 738 (941)
Q Consensus 674 ~~~-~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 738 (941)
+.. .+..++|||||++|+|.++++... ...+++..++.++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 765 456899999999999999997532 235899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCC-CCC
Q 002289 739 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM-QPI 817 (941)
Q Consensus 739 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~-~Pf 817 (941)
+|||+++++++||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+||. .||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceeECCCCcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 999999999999999999986543221 12234567999999999999999999999999999999999975 466
Q ss_pred CCCchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 818 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
....... .+... +..+.....|+.++.++.+++.+||+.+|++|||+.+++++|+++.+
T Consensus 238 ~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 238 PGVKIDE-EFCRR--------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TTCCCSH-HHHHH--------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHH-HHHHH--------HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 5433222 11111 12233445667778889999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=398.90 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=207.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCc----EEEEEEeccC-CchhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~L 682 (941)
++|++.++||+|+||+||+|.+. +|+ .||+|+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999964 444 6899988653 333467899999999999999999999999764 5778
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCC
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 762 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~ 762 (941)
|+||+.+|+|.+++... ...+++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999988664 346899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhhhc
Q 002289 763 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 841 (941)
Q Consensus 763 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 841 (941)
... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||...... +.. ..+..
T Consensus 164 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~---------~~i~~ 228 (317)
T d1xkka_ 164 EEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EIS---------SILEK 228 (317)
T ss_dssp TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHH---------HHHHH
T ss_pred ccc-----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HHH---------HHHHc
Confidence 321 122234468999999999999999999999999999999999 78888654321 111 11222
Q ss_pred CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 842 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 842 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
+.....|..++..+.+++.+||+.+|.+||++.+++++++.+..
T Consensus 229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 34455677788899999999999999999999999999887654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=408.46 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=200.8
Q ss_pred hcCCCccc-eeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhc-CCCceeeeeecccc----CCcE
Q 002289 608 TNNFNSST-QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQ 680 (941)
Q Consensus 608 ~~~y~~~~-~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~ 680 (941)
.++|.+.. .||+|+||+||+|++ .+++.||||+++. .+.+.+|++++.++ +||||++++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788875 599999999999996 4789999999864 24677899987655 89999999999854 4678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC---CCcEEEeeeccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLS 757 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFGla 757 (941)
|+|||||+||+|.+++..++...+++..++.|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999998766667999999999999999999999999 999999999999985 567999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
+...... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.......... .+.
T Consensus 162 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-------~~~ 226 (335)
T d2ozaa1 162 KETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMK 226 (335)
T ss_dssp EECCCCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------
T ss_pred eeccCCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-------HHH
Confidence 8654322 2234579999999999999999999999999999999999999996433211000 000
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 917 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~ 917 (941)
..+......+|.... . ..++.+.+||++||+.||++|||++|+|+
T Consensus 227 ~~i~~~~~~~~~~~~---------------------~--------------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEW---------------------S--------------EVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -CCCSCSSSCCTTHH---------------------H--------------HSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCCCCCccc---------------------c--------------cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001000111111000 0 01223457888889999999999999999
Q ss_pred CCCCCCCC
Q 002289 918 HPYVSSDV 925 (941)
Q Consensus 918 Hpwf~~~~ 925 (941)
||||....
T Consensus 272 hp~~~~~~ 279 (335)
T d2ozaa1 272 HPWIMQST 279 (335)
T ss_dssp SHHHHTTT
T ss_pred CHHhhCCC
Confidence 99986543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=396.46 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=211.3
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCc--EEEEEEeccCC-chhhHhHHHHHHHHHhc-CCCceeeeeeccccCCcEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 683 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~LV 683 (941)
++|++.++||+|+||+||+|+++ +|. .||||+++... ....+.|.+|+++++++ +||||++++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999975 444 57888876433 23456799999999998 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhc--------------CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcE
Q 002289 684 YEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 749 (941)
Q Consensus 684 ~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 749 (941)
|||+++|+|.++++.. ....+++..+++++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 2356899999999999999999999999 9999999999999999999
Q ss_pred EEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002289 750 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 829 (941)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~ 829 (941)
||+|||+|+..... .......||..|+|||.+.+..++.++|||||||++|||++|..|+....+..+..
T Consensus 167 kl~DfG~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~-- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-- 236 (309)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--
T ss_pred EEcccccccccccc--------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence 99999999754321 11234458999999999999999999999999999999999776544343322221
Q ss_pred HHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 830 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
..+..+.....+..+++++.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 237 -------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 12233445566777888999999999999999999999999999988753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=401.25 Aligned_cols=279 Identities=24% Similarity=0.356 Sum_probs=204.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-C-CcEEEEEEeccCCch--hhHhHHHHHHHHHhc---CCCceeeeeeccc-----
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCD----- 675 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~----- 675 (941)
.++|++.++||+|+||+||+|++. + ++.||||+++..... ....+.+|+++++.+ +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999963 4 678999998643222 234577888887766 7999999999984
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeec
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 755 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFG 755 (941)
.....++||||++++++.... ......+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 335789999999876665444 344556899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhh-c
Q 002289 756 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS-S 834 (941)
Q Consensus 756 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~-~ 834 (941)
+++.... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||........ ....... .
T Consensus 162 ~~~~~~~--------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~ 232 (305)
T d1blxa_ 162 LARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIG 232 (305)
T ss_dssp SCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred hhhhhcc--------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhC
Confidence 9875432 2334556799999999999999999999999999999999999999976543221 1111100 0
Q ss_pred cc-hhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCc
Q 002289 835 MM-FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 913 (941)
Q Consensus 835 ~~-~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 913 (941)
.. ....... ...+. ... ......| ........++.+.|||.+||+.||++||||+
T Consensus 233 ~~~~~~~~~~-~~~~~-----------~~~-~~~~~~~-----------~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~ 288 (305)
T d1blxa_ 233 LPGEEDWPRD-VALPR-----------QAF-HSKSAQP-----------IEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288 (305)
T ss_dssp CCCGGGSCTT-CSSCG-----------GGS-CCCCCCC-----------GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCchhccccc-ccchh-----------hhh-ccccccc-----------hhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 00 0000000 00000 000 0000000 1112233344567899999999999999999
Q ss_pred cCCCCCCCCC
Q 002289 914 SMLKHPYVSS 923 (941)
Q Consensus 914 e~L~Hpwf~~ 923 (941)
|+|+||||+.
T Consensus 289 e~L~Hpff~~ 298 (305)
T d1blxa_ 289 SALSHPYFQD 298 (305)
T ss_dssp HHHTSGGGTT
T ss_pred HHhcChhhcC
Confidence 9999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=393.04 Aligned_cols=247 Identities=24% Similarity=0.410 Sum_probs=200.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCch------hhHhHHHHHHHHHhcC--CCceeeeeeccccCC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEG 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~ 678 (941)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... ..+++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999964 7999999998743221 1245789999999996 899999999999999
Q ss_pred cEEEEEecCCC-CCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-CCcEEEeeecc
Q 002289 679 EQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGL 756 (941)
Q Consensus 679 ~~~LV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFGl 756 (941)
..++||||+.+ +++.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 99999999975 68888886543 4899999999999999999999999 999999999999985 47999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......
T Consensus 158 a~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------ 216 (273)
T d1xwsa_ 158 GALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------ 216 (273)
T ss_dssp CEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------
T ss_pred ceecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------------
Confidence 9865321 2334579999999999988765 56799999999999999999999642210
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
.... ..++ + ..++++.+||.+||..||++|||++|+
T Consensus 217 ----~~~~-~~~~----------------------~-----------------~~s~~~~~li~~~L~~dp~~R~s~~ei 252 (273)
T d1xwsa_ 217 ----IRGQ-VFFR----------------------Q-----------------RVSSECQHLIRWCLALRPSDRPTFEEI 252 (273)
T ss_dssp ----HHCC-CCCS----------------------S-----------------CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----hhcc-cCCC----------------------C-----------------CCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 0000 0000 1 112233478889999999999999999
Q ss_pred CCCCCCCCC
Q 002289 916 LKHPYVSSD 924 (941)
Q Consensus 916 L~Hpwf~~~ 924 (941)
|+||||+..
T Consensus 253 l~hp~~~~~ 261 (273)
T d1xwsa_ 253 QNHPWMQDV 261 (273)
T ss_dssp HTSGGGSSC
T ss_pred hcCHhhCCC
Confidence 999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.7e-44 Score=383.02 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=204.0
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc---hhhHhHHHHHHHHHhcCCCceeeeeeccccCC----c
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----E 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~ 679 (941)
.++|++.+.||+|+||+||+|++ .+|+.||||+++.... ...+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46899999999999999999996 4799999999975433 22457899999999999999999999986544 3
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.|+||||++||+|.+++...+ .+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999987654 4899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
...... .........||+.|+|||++.+..++.++||||+||++|||+||+.||....... ............
T Consensus 161 ~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~~~-- 233 (277)
T d1o6ya_ 161 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDPIP-- 233 (277)
T ss_dssp CC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCCCC--
T ss_pred hccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCCCC--
Confidence 533221 1223345679999999999999999999999999999999999999997654322 111111111000
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhH
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIW 884 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~v~~~L~~~~ 884 (941)
........++++.+++.+|++.||.+|| +++++.+.|.++.
T Consensus 234 ----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0012234567888999999999999999 8999988887764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=394.25 Aligned_cols=264 Identities=26% Similarity=0.436 Sum_probs=218.5
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeC------CCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccc
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCD 675 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 675 (941)
+|+...++|++.++||+|+||+||+|.++ +++.||||+++.... .....|.+|++++++++||||++++++|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45556688999999999999999999863 357899999975433 33457899999999999999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhc--------CCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAK--------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 747 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 747 (941)
.++..++||||+++|+|.+++... ....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 999999999999999999988642 2235789999999999999999999998 99999999999999999
Q ss_pred cEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHH
Q 002289 748 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 827 (941)
Q Consensus 748 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~ 827 (941)
++||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++|||+||..|+....+..+..
T Consensus 171 ~~Kl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred eEEEeecccceeccCCc-----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999998654321 1222344568999999999999999999999999999999999864433333333322
Q ss_pred HHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 828 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
. .+.++.....|..++..+.+++.+||+.+|++||++.+++++|++.
T Consensus 246 ~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 246 R---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp H---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H---------HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2 2334455566777888999999999999999999999999988765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=391.27 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=218.0
Q ss_pred HHHHhcCCCccceeeccCcEEEEEEEe------CCCcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeeeeeccc
Q 002289 604 MALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVGYCD 675 (941)
Q Consensus 604 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 675 (941)
++...++|++.++||+|+||.||+|++ .+++.||||+++..... ....+.+|+.+++++ +|||||+++++|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 444567899999999999999999985 24678999999864433 345789999999999 6999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC----------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKS----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 739 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~ 739 (941)
+.+..++|||||++|+|.++++... ...+++..+..++.||++||+|||+++ ||||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999997542 235889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 002289 740 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 819 (941)
Q Consensus 740 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~ 819 (941)
||+++.++.+|++|||.++....... ........||+.|+|||++.+..++.++|||||||++|||+|+..|+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999987643221 2233456789999999999999999999999999999999995555544
Q ss_pred CchhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 820 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
..+....+.... ..+.....+..++..+.+++.+||+.+|++||++.+++++|+++..
T Consensus 250 ~~~~~~~~~~~i--------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 250 GMPVDSKFYKMI--------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp TCCSSHHHHHHH--------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHH--------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 333222222111 1122334556677889999999999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=386.61 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=200.7
Q ss_pred hcCCCccceeeccCcEEEEEEEeC--CC--cEEEEEEeccCC---chhhHhHHHHHHHHHhcCCCceeeeeeccccCCcE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 680 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 680 (941)
.++|++.+.||+|+||+||+|++. ++ ..||||+++... ....++|.+|++++++++||||++++|+|.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356889999999999999999853 23 478999887532 2334679999999999999999999999975 467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccccc
Q 002289 681 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 760 (941)
Q Consensus 681 ~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~ 760 (941)
++||||+++|++.+++..+. ..+++..++.++.||++||+|||+++ |+||||||+||+++.++++||+|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred heeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 89999999999999886543 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
...... ........|+..|+|||++.+..++.++|||||||++|||+| |+.||...... +.......
T Consensus 162 ~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~~~~i~~------- 229 (273)
T d1u46a_ 162 PQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------- 229 (273)
T ss_dssp CC-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT-------
T ss_pred ccCCCc----ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-HHHHHHHh-------
Confidence 433211 122334567889999999999999999999999999999998 89999754332 21111111
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 883 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 883 (941)
.+...+.+..++..+.+++..||+.+|++|||+.++.+.|++.
T Consensus 230 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 -EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1223345566778899999999999999999999999888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=389.72 Aligned_cols=262 Identities=26% Similarity=0.463 Sum_probs=213.0
Q ss_pred HHhcCCCccceeeccCcEEEEEEEeCC--------CcEEEEEEeccCCch-hhHhHHHHHHHHHhc-CCCceeeeeeccc
Q 002289 606 LATNNFNSSTQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVGYCD 675 (941)
Q Consensus 606 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 675 (941)
...++|++.+.||+|+||.||+|+... +..||||+++..... ...++.+|...+.++ +||||++++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345788899999999999999998532 357999999765443 346788999999888 8999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC--------------CCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcE
Q 002289 676 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 741 (941)
Q Consensus 676 ~~~~~~LV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 741 (941)
+++..++||||+++|+|.+++.... ...+++.++++++.||++||+|||+++ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 9999999999999999999997543 245899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCC
Q 002289 742 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 820 (941)
Q Consensus 742 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~ellt-G~~Pf~~~ 820 (941)
|++.++.+||+|||+++....... ........||+.|+|||.+.++.|+.++|||||||++|||++ |+.||...
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCT-----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eecCCCCeEeccchhhcccccccc-----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999986643221 223345668999999999999999999999999999999998 67777644
Q ss_pred chhHHHHHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 821 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
.. .+ +.. .+..+.....|..++..+.+++.+||+.+|.+|||+.|+++.|+++..
T Consensus 242 ~~-~~-~~~--------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 PV-EE-LFK--------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CH-HH-HHH--------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CH-HH-HHH--------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 32 11 111 122334455666777889999999999999999999999999998864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=393.61 Aligned_cols=291 Identities=21% Similarity=0.275 Sum_probs=207.1
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeecccc--------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 676 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 676 (941)
.++|++.++||+|+||+||+|++. +|+.||||++..... ...+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 799999999864322 234678899999999999999999998744
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecc
Q 002289 677 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 756 (941)
Q Consensus 677 ~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGl 756 (941)
.+..++||||++++.+..... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 356899999998766654443 3345888999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhcc
Q 002289 757 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 835 (941)
Q Consensus 757 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~ 835 (941)
++......... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....+.............
T Consensus 164 ~~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeecccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 98765432211 1222345699999999999865 6899999999999999999999999765432221111100000
Q ss_pred chhhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 836 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
.. .......... . ...........++...+.+... ..++.+.|||.+||++||++|+||+|+
T Consensus 241 ~~---~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 241 IT---PEVWPNVDNY---E----LYEKLELVKGQKRKVKDRLKAY--------VRDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp CC---TTTSTTCCCC--------------CCSSCCBCHHHHHHHH--------HCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CC---hhhccccchh---h----hhhhhcccccccccchhhhccc--------cCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 00 0000000000 0 0011122233344444433221 123455689999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 916 LKHPYVSSD 924 (941)
Q Consensus 916 L~Hpwf~~~ 924 (941)
|+||||+.+
T Consensus 303 L~Hpff~~~ 311 (318)
T d3blha1 303 LNHDFFWSD 311 (318)
T ss_dssp HHSGGGSSS
T ss_pred HcChhhccC
Confidence 999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=390.79 Aligned_cols=283 Identities=24% Similarity=0.358 Sum_probs=213.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCCcEEEEEe
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~LV~e 685 (941)
++|++.++||+|+||+||+|++. +|+.||||+++.... ...+++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999974 789999999865432 235688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccCCCCC
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 765 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~~~~~ 765 (941)
++.++++..++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999988887544 35788999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCccccccccccccCCCcccccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcCCC
Q 002289 766 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 844 (941)
Q Consensus 766 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (941)
.......++..|+|||.+.+.. ++.++||||+||++|||++|+.||....+..+......... ....
T Consensus 156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------~~~~ 223 (292)
T d1unla_ 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL------GTPT 223 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH------CCCC
T ss_pred ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc------CCCC
Confidence 2223345778999999988765 68999999999999999999999887766554443321110 0000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCCCCCC
Q 002289 845 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 923 (941)
Q Consensus 845 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hpwf~~ 923 (941)
.. ......+... ...-..++.. .......+..++.+.|||++||+.||++||||+|+|+||||+.
T Consensus 224 ~~----~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 224 EE----QWPSMTKLPD---YKPYPMYPAT-------TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TT----TCTTGGGSTT---CCCCCCCCTT-------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred hh----hhhhhhhccc---cccccccccc-------chhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00 0000000000 0000000000 0011122233445568999999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=398.91 Aligned_cols=279 Identities=22% Similarity=0.358 Sum_probs=204.2
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeeccccCC------
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 678 (941)
.++|++.++||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999974 699999999975332 23467899999999999999999999986554
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
+.++||||+ +.+|.++++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 579999999 67888877543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
.... ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...............
T Consensus 170 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~----- 234 (346)
T d1cm8a_ 170 QADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV----- 234 (346)
T ss_dssp ECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-----
T ss_pred ccCC----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc-----
Confidence 6532 22445799999999999864 5689999999999999999999999766543221111100
Q ss_pred hhhcCCCCCCChHHHHHHHHH-HHHhcccCCC-CCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccC
Q 002289 838 SVIDGNMGSYPSECVEKFIKL-ALKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 915 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l-~~~c~~~~p~-~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~ 915 (941)
.+..+.+........ ........+. .+... ....+..++.+.|||.+||++||++||||+|+
T Consensus 235 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei 298 (346)
T d1cm8a_ 235 ------TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF----------ASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298 (346)
T ss_dssp ------HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG----------GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ------cCCCcHHHHhhhcchhhhhhhccCCcccccch----------HHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 111222221110000 0000001111 11111 11223344556789999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 916 LKHPYVSSD 924 (941)
Q Consensus 916 L~Hpwf~~~ 924 (941)
|+||||++.
T Consensus 299 L~Hp~f~~~ 307 (346)
T d1cm8a_ 299 LAHPYFESL 307 (346)
T ss_dssp HHSGGGTTT
T ss_pred hcChhhCcC
Confidence 999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=394.49 Aligned_cols=279 Identities=22% Similarity=0.307 Sum_probs=200.9
Q ss_pred CCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceeeeeecccc------CCcEEE
Q 002289 610 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQML 682 (941)
Q Consensus 610 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~L 682 (941)
+|+..++||+|+||+||+|++. +|+.||||++.... ....+|+++|++++||||++++++|.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999975 69999999987543 234579999999999999999999843 235789
Q ss_pred EEecCCCCCHHHHHh-hcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeecccccc
Q 002289 683 VYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLA 760 (941)
Q Consensus 683 V~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~ 760 (941)
|||||+++.+..+.+ ......+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999997654444332 234556999999999999999999999999 99999999999999775 8999999999865
Q ss_pred CCCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 839 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 839 (941)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||............ . ..
T Consensus 174 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i-~------~~ 238 (350)
T d1q5ka_ 174 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI-I------KV 238 (350)
T ss_dssp CTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH-H------HH
T ss_pred cCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH-H------HH
Confidence 4322 2234568999999999875 56899999999999999999999999765442221111 0 00
Q ss_pred hcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCCC
Q 002289 840 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 919 (941)
Q Consensus 840 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~Hp 919 (941)
.+..+.+.......-............| .. ....+..++++.+||.+||++||++||||+|+|+||
T Consensus 239 ----~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---------~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 239 ----LGTPTREQIREMNPNYTEFKFPQIKAHP-WT---------KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp ----HCCCCHHHHHHHCC---CCCCCCCCCCC-GG---------GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ----hCCChHHhhhhhccchhhccccccccCc-hh---------hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 1111222111110000000000000000 00 001123344567899999999999999999999999
Q ss_pred CCCCC
Q 002289 920 YVSSD 924 (941)
Q Consensus 920 wf~~~ 924 (941)
||+..
T Consensus 305 ~f~~~ 309 (350)
T d1q5ka_ 305 FFDEL 309 (350)
T ss_dssp GGGGG
T ss_pred hhccc
Confidence 99764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=392.71 Aligned_cols=288 Identities=22% Similarity=0.309 Sum_probs=209.0
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc-hhhHhHHHHHHHHHhcCCCceeeeeeccccCC----cEE
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQM 681 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~ 681 (941)
+++|++.++||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999996 4799999999975433 33567899999999999999999999986543 234
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccccC
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 761 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~~~ 761 (941)
++++|+.+|+|.+++..+ .+++..++.++.|+++||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 445556699999999654 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCccccccccccccCCCccccccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhh
Q 002289 762 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 840 (941)
Q Consensus 762 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 840 (941)
..... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||............... .
T Consensus 161 ~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~-------~ 229 (345)
T d1pmea_ 161 PDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-------L 229 (345)
T ss_dssp GGGCB----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-------H
T ss_pred CCCcc----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh-------c
Confidence 32111 122345679999999999854 56789999999999999999999999765432221111100 0
Q ss_pred cCCCCCCChHHHH-HHHHHHHHhcccCCCC-CCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCccCCCC
Q 002289 841 DGNMGSYPSECVE-KFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 918 (941)
Q Consensus 841 ~~~~~~~~~~~~~-~l~~l~~~c~~~~p~~-RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e~L~H 918 (941)
......... ....-...+....+.. ++.... ..+..++.+.+|+.+||+.||++||||+|+|+|
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 ----GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR----------LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp ----CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH----------HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cCCChhhhhhhhhhhhhcccccCCccCCCCHHH----------hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111000 0000111222223322 233332 233445567789999999999999999999999
Q ss_pred CCCCCCCC
Q 002289 919 PYVSSDVS 926 (941)
Q Consensus 919 pwf~~~~~ 926 (941)
|||+....
T Consensus 296 pf~~~~~~ 303 (345)
T d1pmea_ 296 PYLEQYYD 303 (345)
T ss_dssp GGGTTTCC
T ss_pred HhhccCCC
Confidence 99985443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=392.00 Aligned_cols=276 Identities=22% Similarity=0.272 Sum_probs=211.6
Q ss_pred cCCCccceeeccCcEEEEEEEe----CCCcEEEEEEeccCCc----hhhHhHHHHHHHHHhcCC-CceeeeeeccccCCc
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGE 679 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~ 679 (941)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999985 2489999999864321 224578899999999976 899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++||||+.+|+|.+++..... +.+..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999976654 667888899999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccch
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 837 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 837 (941)
..... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||........
T Consensus 179 ~~~~~------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~------------ 240 (322)
T d1vzoa_ 179 FVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS------------ 240 (322)
T ss_dssp CCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC------------
T ss_pred hcccc------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------------
Confidence 54321 2233456799999999999764 468899999999999999999999965432100
Q ss_pred hhhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCC-----CC
Q 002289 838 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SS 912 (941)
Q Consensus 838 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~-----sa 912 (941)
..++....+...+. .....++.+.+||.+||..||++|+ ||
T Consensus 241 -----------------~~~i~~~~~~~~~~-----------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~ 286 (322)
T d1vzoa_ 241 -----------------QAEISRRILKSEPP-----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286 (322)
T ss_dssp -----------------HHHHHHHHHHCCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred -----------------HHHHHHhcccCCCC-----------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccH
Confidence 00011111111110 0112233445678888888888888 47
Q ss_pred ccCCCCCCCCCCCCCCccccccccccCCC
Q 002289 913 SSMLKHPYVSSDVSGSNLVSGVIPTITPR 941 (941)
Q Consensus 913 ~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~ 941 (941)
+|+|+||||+...+.......+-+|+.||
T Consensus 287 ~eil~Hpff~~i~~~~l~~~~~~~p~~p~ 315 (322)
T d1vzoa_ 287 DEIKEHLFFQKINWDDLAAKKVPAPFKPV 315 (322)
T ss_dssp HHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence 89999999987655444444555666664
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=381.34 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=198.5
Q ss_pred cCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHH--HHHHHHHhcCCCceeeeeeccccCC----cEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGYCDEEG----EQML 682 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~nIv~l~~~~~~~~----~~~L 682 (941)
.+|.+.++||+|+||+||+|++ +|+.||||+++... .+.+. .|+..+++++||||+++++++.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4566788999999999999997 68899999986432 23344 4555556789999999999996553 5799
Q ss_pred EEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCC-----CCCeEeccCCCCcEEEcCCCcEEEeeeccc
Q 002289 683 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-----DPPVFHRDIKASNILLDHKFTAKVADFGLS 757 (941)
Q Consensus 683 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~DFGla 757 (941)
|||||++|+|.+++++. .+++..+++++.|++.||+|+|+.. .++||||||||+|||++.++++||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999764 4899999999999999999999741 233999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccccccCCCcccccccccCC------CCchhHhHHHHHHHHHHHhCCCCCCCCch---------
Q 002289 758 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTGMQPISHGKN--------- 822 (941)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlG~ll~elltG~~Pf~~~~~--------- 822 (941)
+....... ..........||+.|+|||++.+.. ++.++|||||||++|||+||..||.....
T Consensus 156 ~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 156 VRHDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp EEEETTTT---EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred ccccCCCc---ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 87643221 1112234567999999999987643 56789999999999999999887742111
Q ss_pred ----hHHHHHHHHhhccchhhhcCC-CCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 002289 823 ----IVREVNIAYQSSMMFSVIDGN-MGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 886 (941)
Q Consensus 823 ----~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 886 (941)
........ ...+. .+.. +.+....+.+++.+||+.+|++||++.|+++.|+++.+.
T Consensus 233 ~~~~~~~~~~~~--------~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHH--------HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHH--------HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 01111111 11111 1222 235667899999999999999999999999999988653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-43 Score=392.38 Aligned_cols=277 Identities=18% Similarity=0.313 Sum_probs=204.9
Q ss_pred cCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeecccc--CCcEEEEE
Q 002289 609 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLVY 684 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~LV~ 684 (941)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5899999999999999999997 479999999987532 457889999999995 9999999999863 45789999
Q ss_pred ecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCC-cEEEeeeccccccCCC
Q 002289 685 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVP 763 (941)
Q Consensus 685 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFGla~~~~~~ 763 (941)
||+++++|.++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997764 34899999999999999999999999 99999999999998655 6999999999875432
Q ss_pred CCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (941)
. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....+.......... .+.
T Consensus 184 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~------~~g- 248 (328)
T d3bqca1 184 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK------VLG- 248 (328)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH------HHC-
T ss_pred C--------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH------HHC-
Confidence 1 23445689999999998875 4799999999999999999999999876553332221110 000
Q ss_pred CCCCCChHHHHHHHHHHHHhc-c--------cCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCc
Q 002289 843 NMGSYPSECVEKFIKLALKCC-Q--------DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 913 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~-~--------~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~ 913 (941)
...... .....- . .....+........ .......++++.|||++||++||++|+||+
T Consensus 249 ------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 249 ------TEDLYD---YIDKYNIELDPRFNDILGRHSRKRWERFVH-----SENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp ------HHHHHH---HHHHTTCCCCGGGGGTCCCCCCCCGGGGCC-----TTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ------Cchhhh---hhhhcccccCcccchhcccccccchhhccc-----ccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 000000 000000 0 00001111100000 000011234457899999999999999999
Q ss_pred cCCCCCCCCCCC
Q 002289 914 SMLKHPYVSSDV 925 (941)
Q Consensus 914 e~L~Hpwf~~~~ 925 (941)
|+|+||||++..
T Consensus 315 e~L~Hp~F~~v~ 326 (328)
T d3bqca1 315 EAMEHPYFYTVV 326 (328)
T ss_dssp HHHTSGGGTTSC
T ss_pred HHhcCcccCCCC
Confidence 999999998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=389.63 Aligned_cols=277 Identities=21% Similarity=0.327 Sum_probs=204.6
Q ss_pred hcCCCccceeeccCcEEEEEEEe-CCCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeecccc-----CCc
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EGE 679 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 679 (941)
.++|++.++||+|+||+||+|++ .+|+.||||+++.... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999996 4799999999975432 334678899999999999999999998853 234
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeeccccc
Q 002289 680 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 759 (941)
Q Consensus 680 ~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~~ 759 (941)
.++|++|+.+|+|.+++..+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||.|..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 46667778899999999543 4899999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCCCccccccccccccCCCcccccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 760 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
.. .......||+.|+|||...+. .++.++||||+||++|||++|+.||................
T Consensus 171 ~~----------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~----- 235 (348)
T d2gfsa1 171 TD----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV----- 235 (348)
T ss_dssp CT----------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-----
T ss_pred cC----------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-----
Confidence 42 223445688999999997775 46889999999999999999999997655432221111000
Q ss_pred hhcCCCCCCChHHHHH----HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCcccccccCCCCCCCCCCCcc
Q 002289 839 VIDGNMGSYPSECVEK----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 914 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~----l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~~~L~~dP~~R~sa~e 914 (941)
...+.+.... ...-........ .+..... .....++.+.|||.+||+.||++|+||+|
T Consensus 236 ------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 236 ------GTPGAELLKKISSESARNYIQSLTQM--PKMNFAN----------VFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp ------CCCCHHHHTTCCCHHHHHHHTTSCCC--CCCCHHH----------HSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ------CCCChHHhhhccchhhhhhhhhcccC--CCcchhh----------hcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 0111111100 000000011111 1122221 22344556778999999999999999999
Q ss_pred CCCCCCCCC
Q 002289 915 MLKHPYVSS 923 (941)
Q Consensus 915 ~L~Hpwf~~ 923 (941)
+|+||||+.
T Consensus 298 lL~Hp~f~~ 306 (348)
T d2gfsa1 298 ALAHAYFAQ 306 (348)
T ss_dssp HHTSGGGTT
T ss_pred HhcCHhhCC
Confidence 999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=392.28 Aligned_cols=285 Identities=21% Similarity=0.276 Sum_probs=197.6
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCc--hhhHhHHHHHHHHHhcCCCceeeeeecccc------CC
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EG 678 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~ 678 (941)
.++|++.++||+|+||+||+|++. +|+.||||++..... ...+++.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999975 699999999975432 234578899999999999999999999853 46
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 679 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 679 ~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
+.|+||||+.+ ++.+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 88999999965 5555553 24889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHhhccchh
Q 002289 759 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 838 (941)
Q Consensus 759 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 838 (941)
.... ........||+.|+|||++.+..++.++||||+||+++||++|+.||...............
T Consensus 168 ~~~~--------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~------ 233 (355)
T d2b1pa1 168 TAGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ------ 233 (355)
T ss_dssp ---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH------
T ss_pred cccc--------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh------
Confidence 5532 22334557899999999999999999999999999999999999999765543222111100
Q ss_pred hhcCCCCCCChHHHH----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC----CCCCCCCcccccccCCCCCCCCC
Q 002289 839 VIDGNMGSYPSECVE----KFIKLALKCCQDETDARPSMSEVMRELESIWNMM----PESDTKTPEFINSEHTSKEETPP 910 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~----~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~----~~~~~~~~dll~~~L~~dP~~R~ 910 (941)
. .....+... .+...... ..+....+...+.. +...... ....+++.|||++||.+||++||
T Consensus 234 -~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 303 (355)
T d2b1pa1 234 -L----GTPCPEFMKKLQPTVRNYVEN---RPKYAGLTFPKLFP--DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_dssp -H----CCCCHHHHTTSCHHHHHHHHT---SCCCCCCCHHHHSC--GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred -c----cCCCHHHHHHhhhhHHHHhhc---Cccccccccccccc--cccccccccccccCCHHHHHHHHHHCcCChhHCc
Confidence 0 001111111 11111111 11111111111100 0000000 00012346899999999999999
Q ss_pred CCccCCCCCCCCCC
Q 002289 911 SSSSMLKHPYVSSD 924 (941)
Q Consensus 911 sa~e~L~Hpwf~~~ 924 (941)
||+|+|+||||+..
T Consensus 304 ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 304 SVDDALQHPYINVW 317 (355)
T ss_dssp CHHHHHTSTTTGGG
T ss_pred CHHHHhcCcccCCC
Confidence 99999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-41 Score=365.11 Aligned_cols=268 Identities=19% Similarity=0.251 Sum_probs=212.8
Q ss_pred hcCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC-CceeeeeeccccCCcEEEEEe
Q 002289 608 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 685 (941)
Q Consensus 608 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~LV~e 685 (941)
.++|++.++||+|+||+||+|++. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999965 68999999886532 23467889999999965 899999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcC-----CCcEEEeeecccccc
Q 002289 686 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 760 (941)
Q Consensus 686 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DFGla~~~ 760 (941)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 789999986543 45899999999999999999999999 999999999999974 578999999999987
Q ss_pred CCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHHhhccchh
Q 002289 761 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 838 (941)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~ 838 (941)
.........+........||+.|||||++.+..++.++|||||||++|||+||+.||..... ........... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-~~~- 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQS- 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HHH-
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-cCC-
Confidence 65433332333344567899999999999999999999999999999999999999974332 11111111000 000
Q ss_pred hhcCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhC
Q 002289 839 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 887 (941)
Q Consensus 839 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 887 (941)
.........+++++.+++..|+..+|++||+++.+.+.++++.+..
T Consensus 235 ---~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 235 ---TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp ---SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0000011234467889999999999999999999999888876544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-41 Score=366.83 Aligned_cols=266 Identities=19% Similarity=0.267 Sum_probs=204.1
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCceee-eeeccccCCcEEEEEec
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS-LVGYCDEEGEQMLVYEF 686 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~LV~e~ 686 (941)
++|++.+.||+|+||+||+|++. +|+.||||++.... ..+++..|+++++.++|+|++. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999964 68999999987543 2346889999999998776554 45555777888999999
Q ss_pred CCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEc---CCCcEEEeeeccccccCCC
Q 002289 687 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVP 763 (941)
Q Consensus 687 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFGla~~~~~~ 763 (941)
+ ++++.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 67777776543 345899999999999999999999999 99999999999986 3557999999999987654
Q ss_pred CCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHHHHH-HHhhccchhhhcC
Q 002289 764 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI-AYQSSMMFSVIDG 842 (941)
Q Consensus 764 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 842 (941)
...............||+.|+|||++.+..++.++|||||||++|||+||+.||............ ...... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~----~~~ 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----MST 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH----HHS
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc----CCC
Confidence 433222233445667999999999999999999999999999999999999999754332111110 000000 000
Q ss_pred CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 002289 843 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 885 (941)
Q Consensus 843 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 885 (941)
........++.++.+++..||+.+|++||++.++.+.|+.+..
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0001123345778999999999999999999999998887654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.6e-40 Score=364.50 Aligned_cols=296 Identities=28% Similarity=0.478 Sum_probs=261.7
Q ss_pred CCCHHHHHHHHHHHHhCcCCCCCCCCCCCCCCCC-CCCCceEecCCCCCCCcceeeEEEecCCCCCc--cCCccccCCCC
Q 002289 31 ITDPIEVSALRSIKKSLVDDYSKLSNWNRGDPCT-SNWTGVLCFNTTMDDGYLHLRELQLLNLNLSG--NLSPEIGRLSY 107 (941)
Q Consensus 31 ~~~~~d~~aL~~~k~~~~~~~~~~~~w~~~~~c~-~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~--~~~~~l~~l~~ 107 (941)
-|+|+|++||++||+++.++. .+++|..+++|| +.|.||+|+..+ ...||++|+|++++++| .+|++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~---~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSS---SCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCCcCCCeEEeCCC---CcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 478999999999999998764 688997655554 579999997543 34589999999999998 48899999999
Q ss_pred CCEEEccc-CCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecc
Q 002289 108 LTILDFMW-NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 186 (941)
Q Consensus 108 L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 186 (941)
|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+.++++|+.++++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 99999996 89999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCchhccCCCcc-ceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcC
Q 002289 187 NNSISGQIPPELSRLPSL-VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 187 ~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
+|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.+.+ .+|..+..+++|+.|++++|.+++
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~-~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEE-CCGGGCCTTSCCSEEECCSSEECC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc-ccccccccccc-cccccccccccccccccccccccc
Confidence 999999999999988876 899999999999999999888655 79999999998 789999999999999999999998
Q ss_pred CCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCC
Q 002289 266 PMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 345 (941)
Q Consensus 266 ~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N 345 (941)
.++.+... .+|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|. +..+. +|+.+++++|
T Consensus 236 ~~~~~~~~--------~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~-----~L~~l~l~~N 301 (313)
T d1ogqa_ 236 DLGKVGLS--------KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQ-----RFDVSAYANN 301 (313)
T ss_dssp BGGGCCCC--------TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGG-----GSCGGGTCSS
T ss_pred cccccccc--------cccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCC-----CCCHHHhCCC
Confidence 87755443 4569999999999999999999999999999999999999995 33333 3445555555
Q ss_pred C
Q 002289 346 N 346 (941)
Q Consensus 346 ~ 346 (941)
+
T Consensus 302 ~ 302 (313)
T d1ogqa_ 302 K 302 (313)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-38 Score=353.05 Aligned_cols=294 Identities=17% Similarity=0.227 Sum_probs=199.2
Q ss_pred cCCCccceeeccCcEEEEEEEeC-CCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-----------CCceeeeeecccc
Q 002289 609 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCDE 676 (941)
Q Consensus 609 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~ 676 (941)
++|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999974 79999999998643 23457788999888875 5789999988754
Q ss_pred --CCcEEEEEecCCCC-CHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCcEEEcCCC-----
Q 002289 677 --EGEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKF----- 747 (941)
Q Consensus 677 --~~~~~LV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~----- 747 (941)
....++|++++..+ +............+++..++.++.||++||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34556666665444 34444444555678999999999999999999997 77 99999999999998665
Q ss_pred -cEEEeeeccccccCCCCCCCccccccccccccCCCcccccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002289 748 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 826 (941)
Q Consensus 748 -~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG~ll~elltG~~Pf~~~~~~~~~ 826 (941)
.++++|||.|..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||.........
T Consensus 169 ~~~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp EEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceeeEeeccccccccc----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 499999999875432 123456999999999999999999999999999999999999999643221000
Q ss_pred HHHHHhhccchhhhcCCCCCCChHHHHHHHHHHHHhc-------ccCCCCCCCHHHHHHHHHHhHhhCCCCCCCCccccc
Q 002289 827 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCC-------QDETDARPSMSEVMRELESIWNMMPESDTKTPEFIN 899 (941)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~-------~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~dll~ 899 (941)
...... ...... ++..+.+...... -....+ ......+....++... .........+.+.|||.
T Consensus 239 ~~~~~~-~~~~~~----lg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 239 KDDDHI-AQIIEL----LGELPSYLLRNGK-YTRTFFNSRGLLRNISKLKFWPLEDVLTE---KYKFSKDEAKEISDFLS 309 (362)
T ss_dssp CHHHHH-HHHHHH----HCSCCHHHHHHCT-THHHHBCC--CBSSCCCCCBCCHHHHHHH---TTCCCHHHHHHHHHHHG
T ss_pred chhHHH-HHHHHH----hCCCCHHHhhccc-ccccccccchhhhccccccCCchhhhccc---ccccCcccCHHHHHHHH
Confidence 000000 000000 1122222211100 001111 1111122333333221 11111122345678999
Q ss_pred ccCCCCCCCCCCCccCCCCCCCCCCC
Q 002289 900 SEHTSKEETPPSSSSMLKHPYVSSDV 925 (941)
Q Consensus 900 ~~L~~dP~~R~sa~e~L~Hpwf~~~~ 925 (941)
+||++||++||||+|+|+||||+...
T Consensus 310 ~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHCCCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999998543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=4.4e-27 Score=256.65 Aligned_cols=230 Identities=30% Similarity=0.426 Sum_probs=209.8
Q ss_pred CcceeeEEEecC-CCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccce
Q 002289 80 GYLHLRELQLLN-LNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR 158 (941)
Q Consensus 80 ~~~~l~~L~L~~-~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 158 (941)
.+.++++|+|++ |+++|.+|+.|++|++|++|+|++|+|.+..+..+..+.+|++|++++|.+.+.+|..+.++++|+.
T Consensus 74 ~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence 456899999997 8999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCccccccccc-ceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCc
Q 002289 159 IQIDQNYISGSLPKSFANLNKT-RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 237 (941)
Q Consensus 159 L~Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 237 (941)
+++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..+..+++|+.|++++|.
T Consensus 154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 232 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred eeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence 9999999999999999998886 899999999999999998887555 79999999999999999999999999999999
Q ss_pred CCCCCcchhccCCCCCcEEEccCCCCcCCCCC-CCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccc
Q 002289 238 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 316 (941)
Q Consensus 238 l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 316 (941)
+.+ .+..+..+++|+.|+|++|+|+|.+|. +.. +.+|++|+|++|+|+|.+|. ++++++|+.+++++|
T Consensus 233 l~~--~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~--------L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N 301 (313)
T d1ogqa_ 233 LAF--DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ--------LKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301 (313)
T ss_dssp ECC--BGGGCCCCTTCCEEECCSSCCEECCCGGGGG--------CTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSS
T ss_pred ccc--cccccccccccccccCccCeecccCChHHhC--------CCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCC
Confidence 987 345789999999999999999988775 332 34679999999999999985 688999999999999
Q ss_pred c-CccC
Q 002289 317 S-LSGS 321 (941)
Q Consensus 317 ~-l~~~ 321 (941)
+ ++|.
T Consensus 302 ~~l~g~ 307 (313)
T d1ogqa_ 302 KCLCGS 307 (313)
T ss_dssp SEEEST
T ss_pred ccccCC
Confidence 7 6654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=4.9e-25 Score=239.28 Aligned_cols=271 Identities=21% Similarity=0.317 Sum_probs=181.9
Q ss_pred CCCCCCCCceEecCCCCCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCc
Q 002289 61 DPCTSNWTGVLCFNTTMDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGN 140 (941)
Q Consensus 61 ~~c~~~w~gv~C~~~~~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 140 (941)
-.|.|.|++|.|.+. +++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|
T Consensus 6 ~~c~c~~~~~~C~~~-----------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n 65 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDL-----------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65 (305)
T ss_dssp TTCEEETTEEECTTS-----------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCEecCCEEEecCC-----------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccc
Confidence 357778888888653 343 3444442 56777777777777544456777777777777777
Q ss_pred cccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCC--CCC
Q 002289 141 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYL 218 (941)
Q Consensus 141 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~ 218 (941)
.+....|..|.++++|++|++++|+|+. +|..+ ...|+.|++.+|.+.+..+..+.....+..++...|... ...
T Consensus 66 ~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~ 142 (305)
T d1xkua_ 66 KISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142 (305)
T ss_dssp CCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC
T ss_pred cccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCC
Confidence 7776666777777777777777777773 34332 246677777777777666666666667777777666543 233
Q ss_pred CccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCc
Q 002289 219 PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTI 298 (941)
Q Consensus 219 p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~ 298 (941)
+..+..+++|+.+++++|.++. +|..+ +++|+.|++++|.+++..+. .+.....++.|++++|.+.+..
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~--l~~~~--~~~L~~L~l~~n~~~~~~~~-------~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITT--IPQGL--PPSLTELHLDGNKITKVDAA-------SLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCS--CCSSC--CTTCSEEECTTSCCCEECTG-------GGTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccccCccccccCCccc--cCccc--CCccCEEECCCCcCCCCChh-------Hhhccccccccccccccccccc
Confidence 4556677777777777777763 34332 46777777777777654442 1222344577778888887777
Q ss_pred chhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC--------CCCCCcEEEecCCCCc
Q 002289 299 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--------NIPPNVTVRLRGNPFC 370 (941)
Q Consensus 299 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~--------~~~~~~~l~l~~Np~~ 370 (941)
+..|.++++|++|+|++|+|+ .+|..+..+ ++|++|+|++|+|+.++... ..+.+..|+|.||||.
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l-----~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADH-----KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTC-----SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccccccceeeeccccccc-ccccccccc-----cCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 777888888888888888887 667766543 35568888888888775432 2456788999999986
Q ss_pred c
Q 002289 371 L 371 (941)
Q Consensus 371 c 371 (941)
+
T Consensus 286 ~ 286 (305)
T d1xkua_ 286 Y 286 (305)
T ss_dssp G
T ss_pred c
Confidence 5
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.4e-25 Score=241.02 Aligned_cols=231 Identities=19% Similarity=0.264 Sum_probs=155.5
Q ss_pred EEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc-cc
Q 002289 86 ELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID-QN 164 (941)
Q Consensus 86 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N 164 (941)
.++.++.+++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++....+..+.+++.++.++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3455666666 4565443 567888888888886666678888888888888888887777777777887777654 55
Q ss_pred cccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcc
Q 002289 165 YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 244 (941)
Q Consensus 165 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p 244 (941)
.++...+..|.++++|++|++++|.+....+..+....+|+.+++++|+|++..+..|..+++|+.|+|++|+|++ ..+
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~ 170 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPE 170 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc-cch
Confidence 6666667777777777777777777765556666667777777777777776555666666667777777776665 344
Q ss_pred hhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCc
Q 002289 245 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 324 (941)
Q Consensus 245 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 324 (941)
..|.++++|++|++++| ++++..|..|.++++|+.|++++|++++..|.
T Consensus 171 ~~f~~l~~L~~l~l~~N-------------------------------~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~ 219 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQN-------------------------------RVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219 (284)
T ss_dssp TTTTTCTTCCEEECCSS-------------------------------CCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred hhhccccccchhhhhhc-------------------------------cccccChhHhhhhhhccccccccccccccccc
Confidence 55555555555544444 44445555666666666666666666644444
Q ss_pred ccccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCccCCCcccc
Q 002289 325 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF 378 (941)
Q Consensus 325 ~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~~~~ 378 (941)
.|.. .+.+..|+|++|||.|+|++.++
T Consensus 220 ~~~~---------------------------~~~L~~L~l~~N~l~C~C~~~~l 246 (284)
T d1ozna_ 220 ALAP---------------------------LRALQYLRLNDNPWVCDCRARPL 246 (284)
T ss_dssp HHTT---------------------------CTTCCEEECCSSCEECSGGGHHH
T ss_pred cccc---------------------------ccccCEEEecCCCCCCCccchHH
Confidence 4432 23455777888999999987654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.6e-25 Score=238.06 Aligned_cols=211 Identities=23% Similarity=0.304 Sum_probs=114.9
Q ss_pred CCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceE
Q 002289 104 RLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHF 183 (941)
Q Consensus 104 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 183 (941)
+...+.++|.++++|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~--------------- 69 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--------------- 69 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE---------------
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc---------------
Confidence 3444455555555555 3454332 345555555555554333445555555555555555442
Q ss_pred ecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCC
Q 002289 184 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (941)
Q Consensus 184 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (941)
++ .++.+++|++|+|++|++++ .+..+.++++|+.|++++|.+.+ ..+..+..+.+|+.|++++|.+
T Consensus 70 ----------l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~-~~~~~~~~l~~l~~L~l~~n~l 136 (266)
T d1p9ag_ 70 ----------LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNEL 136 (266)
T ss_dssp ----------EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCC-CCSSTTTTCTTCCEEECTTSCC
T ss_pred ----------cc-cccccccccccccccccccc-cccccccccccccccccccccce-eecccccccccccccccccccc
Confidence 22 12344555555555555542 34445555555555555555554 3344445555555555555555
Q ss_pred cCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEcc
Q 002289 264 QGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 343 (941)
Q Consensus 264 ~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls 343 (941)
++..+.. +....+|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..++.
T Consensus 137 ~~l~~~~-------~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~--------------- 193 (266)
T d1p9ag_ 137 KTLPPGL-------LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG--------------- 193 (266)
T ss_dssp CCCCTTT-------TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT---------------
T ss_pred ceecccc-------ccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCC---------------
Confidence 4333221 111233455666666666566666667777777777777766 56665543
Q ss_pred CCCCCCCCCCCCCCCCcEEEecCCCCccCCCcccccC
Q 002289 344 NNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCG 380 (941)
Q Consensus 344 ~N~l~~~~~~~~~~~~~~l~l~~Np~~c~c~~~~~~~ 380 (941)
.+.++.|+|+||||.|||.+.+|-.
T Consensus 194 ------------~~~L~~L~L~~Np~~CdC~~~~l~~ 218 (266)
T d1p9ag_ 194 ------------SHLLPFAFLHGNPWLCNCEILYFRR 218 (266)
T ss_dssp ------------TCCCSEEECCSCCBCCSGGGHHHHH
T ss_pred ------------CCCCCEEEecCCCCCCCcchHHHHH
Confidence 3456688999999999999876543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.5e-24 Score=229.98 Aligned_cols=257 Identities=17% Similarity=0.187 Sum_probs=210.6
Q ss_pred CCCCC---CCceEecCCCCC----CCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccce
Q 002289 62 PCTSN---WTGVLCFNTTMD----DGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLEL 134 (941)
Q Consensus 62 ~c~~~---w~gv~C~~~~~~----~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 134 (941)
.|.|. |.-|.|.+..+. ..+..+++|+|++|+|+...+..|.++++|++|++++|+|..+.+..+.++..++.
T Consensus 5 ~C~C~~~~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~ 84 (284)
T d1ozna_ 5 ACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQ 84 (284)
T ss_dssp TCEEECSSSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCEEcCCCCeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccc
Confidence 46552 334888764332 23446899999999999766678999999999999999999888889999999999
Q ss_pred eccc-CccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCc
Q 002289 135 LLLN-GNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 213 (941)
Q Consensus 135 L~Ls-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 213 (941)
|+.. .|.++...+..|.++++|++|+|++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|++++|+
T Consensus 85 l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp EECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence 8764 667887778899999999999999999998888899999999999999999997778889999999999999999
Q ss_pred CCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCc
Q 002289 214 LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNK 293 (941)
Q Consensus 214 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~ 293 (941)
|++..+..|.++++|++|++++|++++ ..|..|.++++|++|++++|++++.++. .+....+|++|+|++|+
T Consensus 165 l~~l~~~~f~~l~~L~~l~l~~N~l~~-i~~~~f~~l~~L~~L~l~~N~i~~~~~~-------~~~~~~~L~~L~l~~N~ 236 (284)
T d1ozna_ 165 ISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTE-------ALAPLRALQYLRLNDNP 236 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCSCCCHH-------HHTTCTTCCEEECCSSC
T ss_pred ccccchhhhccccccchhhhhhccccc-cChhHhhhhhhccccccccccccccccc-------ccccccccCEEEecCCC
Confidence 998888999999999999999999998 6789999999999999999999865553 12233456888888888
Q ss_pred CCCCcchhhcCCcccceeecccccCccCCCcccc
Q 002289 294 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 327 (941)
Q Consensus 294 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (941)
+...-+. ..-...++.+....+++....|..+.
T Consensus 237 l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 237 WVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp EECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred CCCCccc-hHHHHHHHhCcCCCCceEeCCchHHc
Confidence 8754331 11123466667777777766777654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=4.1e-23 Score=231.06 Aligned_cols=262 Identities=26% Similarity=0.342 Sum_probs=173.4
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
++++|++++++|+.. +.+..|++|++|+|++|+|++. | .|+++++|++|+|++|++++.. .++++++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc--cccccccccccccc
Confidence 467777777777642 3466677777777777777743 3 2777777777777777776432 26677777777777
Q ss_pred cccccccC---------------------------------------------------------------Ccccccccc
Q 002289 163 QNYISGSL---------------------------------------------------------------PKSFANLNK 179 (941)
Q Consensus 163 ~N~l~~~~---------------------------------------------------------------p~~~~~l~~ 179 (941)
+|.+++.. ...+..+++
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 198 (384)
T d2omza2 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccc
Confidence 66654321 123445567
Q ss_pred cceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEcc
Q 002289 180 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLR 259 (941)
Q Consensus 180 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 259 (941)
++.+++++|.+++..| +..+++|++|++++|+++. + ..+..+++|+.|++++|++++. + .+..+++|+.|+++
T Consensus 199 ~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~--~-~~~~~~~L~~L~l~ 271 (384)
T d2omza2 199 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNL--A-PLSGLTKLTELKLG 271 (384)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--G-GGTTCTTCSEEECC
T ss_pred cceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCC--C-cccccccCCEeecc
Confidence 7777777777775443 3456777777887777774 2 3567777778888888777752 2 36677777888887
Q ss_pred CCCCcCCCCCCCCCCcc--------------cccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcc
Q 002289 260 NCSLQGPMPDLSRIPNL--------------GYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 325 (941)
Q Consensus 260 ~N~l~~~~~~~~~l~~l--------------~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 325 (941)
+|++++..+ +..+..+ .+....+++.|+|++|+|++..+ +..+++|++|++++|+|++ ++ .
T Consensus 272 ~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~ 346 (384)
T d2omza2 272 ANQISNISP-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-S 346 (384)
T ss_dssp SSCCCCCGG-GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-G
T ss_pred CcccCCCCc-cccccccccccccccccccccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-h
Confidence 777765432 1111111 12223567888888888886543 7788888888888888873 33 3
Q ss_pred cccccccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCC
Q 002289 326 IWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGN 367 (941)
Q Consensus 326 ~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~N 367 (941)
+.. .++|++|+|++|+|+++++-..++.++.|+|++|
T Consensus 347 l~~-----l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 347 LAN-----LTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp GGG-----CTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred HcC-----CCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 433 3567788888888888765446778888888877
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.89 E-value=2.7e-22 Score=217.44 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=206.9
Q ss_pred cceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceee
Q 002289 81 YLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQ 160 (941)
Q Consensus 81 ~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 160 (941)
..+++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+|++|+++ .+|..+ ...|+.|+
T Consensus 30 ~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~ 106 (305)
T d1xkua_ 30 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELR 106 (305)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEE
T ss_pred CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhh
Confidence 357899999999998665568999999999999999999888889999999999999999999 556543 35789999
Q ss_pred cccccccccCCcccccccccceEeccccccc--ccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcC
Q 002289 161 IDQNYISGSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238 (941)
Q Consensus 161 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 238 (941)
+++|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|+++ .+|..+ +++|+.|++++|.+
T Consensus 107 ~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~ 183 (305)
T d1xkua_ 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 183 (305)
T ss_dssp CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCC
T ss_pred ccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcC
Confidence 9999999887778888888999999888653 344567888999999999999998 455443 67999999999999
Q ss_pred CCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccC
Q 002289 239 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 318 (941)
Q Consensus 239 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 318 (941)
.+ ..+..|.+++.++.|++++|.+++..+. .+....+|++|+|++|+|+ .+|.+|..+++|++|+|++|+|
T Consensus 184 ~~-~~~~~~~~~~~l~~L~~s~n~l~~~~~~-------~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 184 TK-VDAASLKGLNNLAKLGLSFNSISAVDNG-------SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp CE-ECTGGGTTCTTCCEEECCSSCCCEECTT-------TGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred CC-CChhHhhccccccccccccccccccccc-------cccccccceeeeccccccc-ccccccccccCCCEEECCCCcc
Confidence 87 5788899999999999999999876553 2223456799999999998 5688999999999999999999
Q ss_pred ccCCCc-ccccccc-cCccccceEEccCCCCCCC
Q 002289 319 SGSIPS-SIWQSRT-LNATETFILDFQNNNLTNI 350 (941)
Q Consensus 319 ~~~~p~-~~~~l~~-l~~~~L~~L~Ls~N~l~~~ 350 (941)
+ .++. .|..... ....+|+.|+|++|.++..
T Consensus 255 ~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 255 S-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp C-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred C-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 9 5544 3332222 2346788999999998753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3.9e-22 Score=211.64 Aligned_cols=175 Identities=27% Similarity=0.265 Sum_probs=146.8
Q ss_pred eeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
..+++.++++|+. +|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++
T Consensus 12 ~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCS
T ss_pred CeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccc
Confidence 5678999999994 777664 68999999999999777788999999999999999998 444 467899999999999
Q ss_pred ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCc
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 243 (941)
|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+|++|++++|.++...+..+..+++|+.|++++|+|++ ..
T Consensus 87 N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~-~~ 164 (266)
T d1p9ag_ 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LP 164 (266)
T ss_dssp SCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CC
T ss_pred cccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc-cC
Confidence 9998 457788889999999999999887777778888889999999998887777778888888888888888886 45
Q ss_pred chhccCCCCCcEEEccCCCCcC
Q 002289 244 PASYSNMSKLLKLSLRNCSLQG 265 (941)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~ 265 (941)
+..|..+++|++|+|++|+|+.
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~~ 186 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLYT 186 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCCC
T ss_pred ccccccccccceeecccCCCcc
Confidence 6677777777777777777763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.7e-22 Score=200.61 Aligned_cols=133 Identities=14% Similarity=0.132 Sum_probs=105.1
Q ss_pred CccceeeccCcEEEEEEEeCCCcEEEEEEeccCCch------------------hhHhHHHHHHHHHhcCCCceeeeeec
Q 002289 612 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ------------------GEKEFLTEIQFLSRLHHRNLVSLVGY 673 (941)
Q Consensus 612 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~l~~~ 673 (941)
.+.++||+|+||+||+|+..+|+.||||+++..... .......|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999889999999987532110 01234568889999999999988765
Q ss_pred cccCCcEEEEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcEEEcCCCcEEEee
Q 002289 674 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 753 (941)
Q Consensus 674 ~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 753 (941)
.. .++||||++++.+.+ ++......++.|+++|++|||+++ |+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 42 379999998765533 223345678999999999999999 9999999999999865 589999
Q ss_pred eccccccC
Q 002289 754 FGLSRLAP 761 (941)
Q Consensus 754 FGla~~~~ 761 (941)
||.|....
T Consensus 146 FG~a~~~~ 153 (191)
T d1zara2 146 FPQSVEVG 153 (191)
T ss_dssp CTTCEETT
T ss_pred CCCcccCC
Confidence 99997653
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=2.1e-20 Score=208.77 Aligned_cols=261 Identities=26% Similarity=0.311 Sum_probs=189.8
Q ss_pred EEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccc
Q 002289 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI 166 (941)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 166 (941)
..+...++++.++ ...+.+|++|++++|+|+. + +.++.+++|++|+|++|+|++. | .++++++|++|+|++|.+
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccc
Confidence 3455556666554 3567889999999999984 4 4688999999999999999954 4 399999999999999999
Q ss_pred cccCCcccccccccceEecccccccccC----------------------------------------------------
Q 002289 167 SGSLPKSFANLNKTRHFHMNNNSISGQI---------------------------------------------------- 194 (941)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~---------------------------------------------------- 194 (941)
++..+ ++++++|+.|++++|.+++..
T Consensus 101 ~~i~~--l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (384)
T d2omza2 101 ADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178 (384)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCC
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence 86543 889999999999998876321
Q ss_pred -----------chhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCC
Q 002289 195 -----------PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 263 (941)
Q Consensus 195 -----------p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l 263 (941)
...+..+++++.+++++|.+++..| +..+++|+.|++++|+++. + ..+..+++|+.|++++|.+
T Consensus 179 ~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L~l~~n~l 253 (384)
T d2omza2 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I-GTLASLTNLTDLDLANNQI 253 (384)
T ss_dssp EEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--C-GGGGGCTTCSEEECCSSCC
T ss_pred cccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--c-chhhcccccchhccccCcc
Confidence 1234556788899999999986544 5667899999999999975 2 4688899999999999999
Q ss_pred cCCCCCCCCCCccccc--------------ccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccc
Q 002289 264 QGPMPDLSRIPNLGYL--------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 329 (941)
Q Consensus 264 ~~~~~~~~~l~~l~~l--------------~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (941)
++..+ +..++++..+ ....++.+++++|.+.+ ...+..+++++.|++++|++++..| +..
T Consensus 254 ~~~~~-~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~- 327 (384)
T d2omza2 254 SNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSS- 327 (384)
T ss_dssp CCCGG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGG-
T ss_pred CCCCc-ccccccCCEeeccCcccCCCCcccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--ccc-
Confidence 86543 2222222111 11223444444444443 2346667778888888888875322 332
Q ss_pred cccCccccceEEccCCCCCCCCCCCCCCCCcEEEecCCCCc
Q 002289 330 RTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 370 (941)
Q Consensus 330 ~~l~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~l~~Np~~ 370 (941)
.++|+.|+|++|+|+.++.-..++.+++|++++|.+.
T Consensus 328 ----l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 328 ----LTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp ----CTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred ----CCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCC
Confidence 3467788888888888774346788888888888765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=9.7e-19 Score=182.23 Aligned_cols=210 Identities=18% Similarity=0.227 Sum_probs=129.2
Q ss_pred CCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCC-CcccCCcCccceeecc-ccccccc
Q 002289 92 LNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL-PEELGYLPKLDRIQID-QNYISGS 169 (941)
Q Consensus 92 ~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls-~N~l~~~ 169 (941)
.+++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++. .|++...
T Consensus 18 ~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~ 94 (242)
T d1xwdc1 18 SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI 94 (242)
T ss_dssp CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEE
T ss_pred CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccc
Confidence 4455 4555442 57888888888888555567888888888888888887544 4467888888888775 4677777
Q ss_pred CCcccccccccceEecccccccccCch-hccCCCccceeeccCCcCCCCCCccCCCCC-CCCEEeccCCcCCCCCcchhc
Q 002289 170 LPKSFANLNKTRHFHMNNNSISGQIPP-ELSRLPSLVHMLLDNNNLTGYLPPELSELP-KLLILQLDNNNFEGTTIPASY 247 (941)
Q Consensus 170 ~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~p~~~ 247 (941)
.+..|.++++|+.|++++|++....+. .+..+..|..+..+++++....+..|.+++ .++.|++++|+++. ++...
T Consensus 95 ~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~--i~~~~ 172 (242)
T d1xwdc1 95 NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE--IHNCA 172 (242)
T ss_dssp CTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE--ECTTT
T ss_pred ccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc--ccccc
Confidence 777888888888888888888743332 233455666666677777755556666654 67777777777764 33333
Q ss_pred cCCCCCcEE-EccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeec
Q 002289 248 SNMSKLLKL-SLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 313 (941)
Q Consensus 248 ~~l~~L~~L-~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 313 (941)
....+++.+ ++++|+|+..++. .|....+|++|+|++|+|+...+..|.++++|+.|++
T Consensus 173 ~~~~~l~~~~~l~~n~l~~l~~~-------~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 173 FNGTQLDELNLSDNNNLEELPND-------VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTTCCEEEEECTTCTTCCCCCTT-------TTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccchhhhccccccccccccccHH-------HhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 333443333 3444555432221 1122233455555555555433444455555544444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.1e-18 Score=180.09 Aligned_cols=205 Identities=20% Similarity=0.309 Sum_probs=136.0
Q ss_pred eeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccc
Q 002289 84 LRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 84 l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 163 (941)
+..+++..+++++.+ .+..|.+|+.|++.+|+|+. ++ .+.++++|++|+|++|++++..| +.++++|++|++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 344555566666543 44567788888888888874 43 57888888888888888875433 77788888888888
Q ss_pred ccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCc
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTI 243 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 243 (941)
|.++.. ..+.++++|+.+++++|...+. ..+...+.+..+.++++.+... ..+.++++|+.|++++|.+.. .
T Consensus 95 n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~--~ 166 (227)
T d1h6ua2 95 NPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD--L 166 (227)
T ss_dssp CCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC--C
T ss_pred cccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccccccc--c
Confidence 877632 2467778888888887777643 2355667777777777777643 235667777788887777764 1
Q ss_pred chhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecc
Q 002289 244 PASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 314 (941)
Q Consensus 244 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 314 (941)
..+.++++|++|+|++|++++. +.+. .+.+|++|+|++|+|++..| ++++++|+.|+|+
T Consensus 167 -~~l~~l~~L~~L~Ls~n~l~~l-~~l~--------~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 167 -TPLANLSKLTTLKADDNKISDI-SPLA--------SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp -GGGTTCTTCCEEECCSSCCCCC-GGGG--------GCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred -hhhcccccceecccCCCccCCC-hhhc--------CCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 2367777777777777777642 2121 22345666777776664432 6666666666665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=2.5e-18 Score=172.34 Aligned_cols=127 Identities=26% Similarity=0.393 Sum_probs=64.9
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCC-CcccCCcCccceeecccccccccCCcccccccccceEeccc
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSL-PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 187 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 187 (941)
++++.++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|.+.+..++.|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 35666666666 4554432 45566666666665422 33445555555555555555555555555555555555555
Q ss_pred ccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcC
Q 002289 188 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 238 (941)
Q Consensus 188 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 238 (941)
|+|++..+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence 555544444444445555555555554444444444444444444444444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=8.6e-19 Score=175.80 Aligned_cols=167 Identities=20% Similarity=0.205 Sum_probs=98.3
Q ss_pred cCCCCCccCCccccCCCCCCEEEcccCCCCCCC-CCccCCccccceecccCccccCCCCcccCCcCccceeecccccccc
Q 002289 90 LNLNLSGNLSPEIGRLSYLTILDFMWNKISGSI-PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG 168 (941)
Q Consensus 90 ~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 168 (941)
++++|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|++.+..+..|..+++|++|+|++|+|++
T Consensus 16 s~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~ 92 (192)
T d1w8aa_ 16 TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92 (192)
T ss_dssp TTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE
T ss_pred eCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccc
Confidence 344454 3444442 46666666666665433 4555666666666666666666666666666666666666666666
Q ss_pred cCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhcc
Q 002289 169 SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS 248 (941)
Q Consensus 169 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 248 (941)
..|++|.++++|++|+|++|+|++..+.+|..+++|++|+|++|.+.......+ -...|+.+.+..|.+.. ..|..
T Consensus 93 l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c-~~p~~-- 168 (192)
T d1w8aa_ 93 ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARC-GAPSK-- 168 (192)
T ss_dssp ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBB-CSSTT--
T ss_pred cCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEe-CCChh--
Confidence 666666666666677777776666666666666666777776666653322111 01234445555565554 23332
Q ss_pred CCCCCcEEEccCCCCc
Q 002289 249 NMSKLLKLSLRNCSLQ 264 (941)
Q Consensus 249 ~l~~L~~L~Ls~N~l~ 264 (941)
+..++.++|+.|.++
T Consensus 169 -l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 169 -VRDVQIKDLPHSEFK 183 (192)
T ss_dssp -TTTSBGGGSCTTTCC
T ss_pred -hcCCEeeecCHhhCc
Confidence 344555566666664
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.74 E-value=2.1e-16 Score=173.27 Aligned_cols=255 Identities=27% Similarity=0.314 Sum_probs=148.3
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
++++|+|++++|+. +|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 36778888888873 5642 467888888888888 667543 46778888888877 33321 1358888888
Q ss_pred cccccccCCcccccccccceEecccccccccCc------------------hhccCCCccceeeccCCcCCCCC------
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIP------------------PELSRLPSLVHMLLDNNNLTGYL------ 218 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------------~~~~~l~~L~~L~L~~N~l~~~~------ 218 (941)
+|.++ .+|. ++.+++|+.|++++|.+..... ..+..++.++.|++++|.+....
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred ccccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 88887 4453 5677888888888887763321 22334455566666655554211
Q ss_pred ------------CccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccc-----cc-
Q 002289 219 ------------PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGY-----LL- 280 (941)
Q Consensus 219 ------------p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~-----l~- 280 (941)
...+..++.|+.+++++|.... ++ ....++..+.+.+|.+.........+..... ..
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~--~~---~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l 259 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKT--LP---DLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS--CC---SCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEE
T ss_pred cccccccccccccccccccccccccccccccccc--cc---ccccccccccccccccccccccccccccccccccccccc
Confidence 0112334444455554444432 11 1223344444444444332211111100000 00
Q ss_pred ---cCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCCCCC
Q 002289 281 ---SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 357 (941)
Q Consensus 281 ---~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~~~~ 357 (941)
.......++..|.+.+. ...+++|++|+|++|+|+ .+|..+ ++|+.|+|++|+|+.++.. ..
T Consensus 260 ~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~~--------~~L~~L~L~~N~L~~l~~~--~~ 324 (353)
T d1jl5a_ 260 SELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPALP--------PRLERLIASFNHLAEVPEL--PQ 324 (353)
T ss_dssp SCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCCC--------TTCCEEECCSSCCSCCCCC--CT
T ss_pred ccccchhcccccccCccccc----cccCCCCCEEECCCCccC-cccccc--------CCCCEEECCCCcCCccccc--cC
Confidence 01223444444444422 234578999999999998 677543 4677899999999988753 34
Q ss_pred CCcEEEecCCCCcc
Q 002289 358 PNVTVRLRGNPFCL 371 (941)
Q Consensus 358 ~~~~l~l~~Np~~c 371 (941)
.+++|+|++|++..
T Consensus 325 ~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 325 NLKQLHVEYNPLRE 338 (353)
T ss_dssp TCCEEECCSSCCSS
T ss_pred CCCEEECcCCcCCC
Confidence 68899999998764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2e-17 Score=172.14 Aligned_cols=208 Identities=21% Similarity=0.218 Sum_probs=161.5
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccC-CcccccccccceEecc-
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMN- 186 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~- 186 (941)
+.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 57888888988 7776653 58999999999999666678999999999999999988655 5678999999999876
Q ss_pred cccccccCchhccCCCccceeeccCCcCCCCCCc-cCCCCCCCCEEeccCCcCCCCCcchhccCCC-CCcEEEccCCCCc
Q 002289 187 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP-ELSELPKLLILQLDNNNFEGTTIPASYSNMS-KLLKLSLRNCSLQ 264 (941)
Q Consensus 187 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~-~L~~L~Ls~N~l~ 264 (941)
.|++....+..|.++++|++|++++|++....+. .+..+..|..+..+++.+.. ..+..|.+++ .++.|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~-i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT-IERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE-ECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccccccccccccccc-ccccccccccccceeeeccccccc
Confidence 4788878888899999999999999999854332 34456677777778888875 3455666664 7899999999998
Q ss_pred CCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCc-cccc
Q 002289 265 GPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS-SIWQ 328 (941)
Q Consensus 265 ~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~ 328 (941)
...+.......+ ++.+++++|+|+...+..|.++++|++|+|++|+|+ .+|. .+..
T Consensus 167 ~i~~~~~~~~~l-------~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~ 223 (242)
T d1xwdc1 167 EIHNCAFNGTQL-------DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLEN 223 (242)
T ss_dssp EECTTTTTTCCE-------EEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTT
T ss_pred ccccccccchhh-------hccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcC
Confidence 655543222221 234467888999766778999999999999999998 5554 3433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=5.9e-17 Score=166.86 Aligned_cols=187 Identities=22% Similarity=0.376 Sum_probs=107.9
Q ss_pred CEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccc
Q 002289 109 TILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 188 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 188 (941)
..++++.+++++.+ .+..+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..| +..+++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 34455566666433 34556677777777777663 33 46667777777777777664433 666667777777776
Q ss_pred cccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCC
Q 002289 189 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 268 (941)
Q Consensus 189 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 268 (941)
.++ .++ .+.++++|+.+++++|...+. ..+...+.+..+.++.+.+.. ...+.++++|++|++++|.+++..+
T Consensus 96 ~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~L~~L~l~~n~~~~~~~ 168 (227)
T d1h6ua2 96 PLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN---ISPLAGLTNLQYLSIGNAQVSDLTP 168 (227)
T ss_dssp CCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC---CGGGGGCTTCCEEECCSSCCCCCGG
T ss_pred ccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhch---hhhhccccccccccccccccccchh
Confidence 665 232 355666666666666666532 235555666666666666643 1235556666666666666553211
Q ss_pred CCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCc
Q 002289 269 DLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 319 (941)
Q Consensus 269 ~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (941)
+. .+.+|+.|+|++|++++. + .|+++++|++|+|++|+|+
T Consensus 169 -l~--------~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 169 -LA--------NLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp -GT--------TCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCC
T ss_pred -hc--------ccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCC
Confidence 11 123446666666666542 2 2555666666666666665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=9.5e-17 Score=163.07 Aligned_cols=162 Identities=26% Similarity=0.343 Sum_probs=86.5
Q ss_pred eeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecc
Q 002289 83 HLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQID 162 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 162 (941)
.+++|++.++.++... .+..+++|++|+|++|+|++. + .++.+++|++|++++|++++ +| .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccccc
Confidence 3555666666555321 255566666666666666532 2 24556666666666666652 33 35555666666666
Q ss_pred cccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCC
Q 002289 163 QNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 242 (941)
Q Consensus 163 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 242 (941)
+|.+... ..+.++++|+.+++++|.+++ +..+..+++|+.+++++|++++. + .+.++++|+.|+|++|+|+.
T Consensus 121 ~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-- 192 (210)
T d1h6ta2 121 HNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-- 192 (210)
T ss_dssp TSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB--
T ss_pred ccccccc--ccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC--
Confidence 6655421 235555556666666665553 12344555566666666655532 2 25555556666666555553
Q ss_pred cchhccCCCCCcEEEcc
Q 002289 243 IPASYSNMSKLLKLSLR 259 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls 259 (941)
++ .+.++++|++|+|+
T Consensus 193 l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CG-GGTTCTTCSEEEEE
T ss_pred Ch-hhcCCCCCCEEEcc
Confidence 22 35555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=7.2e-17 Score=163.99 Aligned_cols=80 Identities=26% Similarity=0.397 Sum_probs=36.0
Q ss_pred CCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEe
Q 002289 105 LSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 184 (941)
Q Consensus 105 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 184 (941)
|.+|++|++++|.++. ++ .+..+++|++|+|++|+|++. + .++.+++|++|++++|+|++ +| .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence 4445555555555542 22 244455555555555555432 2 13444455555555554442 12 244444444444
Q ss_pred cccccc
Q 002289 185 MNNNSI 190 (941)
Q Consensus 185 L~~N~l 190 (941)
+++|.+
T Consensus 119 l~~~~~ 124 (210)
T d1h6ta2 119 LEHNGI 124 (210)
T ss_dssp CTTSCC
T ss_pred cccccc
Confidence 444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.68 E-value=2.6e-15 Score=164.46 Aligned_cols=253 Identities=27% Similarity=0.299 Sum_probs=177.9
Q ss_pred CCCCcceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCcc
Q 002289 77 MDDGYLHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL 156 (941)
Q Consensus 77 ~~~~~~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 156 (941)
+++...++++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.. .++|++|+|++|.++ .+|. ++.+++|
T Consensus 53 lp~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L 122 (353)
T d1jl5a_ 53 LPELPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFL 122 (353)
T ss_dssp CCSCCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTC
T ss_pred CCCCCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccc
Confidence 3445568999999999998 56654 468999999999998 44421 246999999999998 5664 6889999
Q ss_pred ceeecccccccccCC------------------cccccccccceEecccccccccC------------------chhccC
Q 002289 157 DRIQIDQNYISGSLP------------------KSFANLNKTRHFHMNNNSISGQI------------------PPELSR 200 (941)
Q Consensus 157 ~~L~Ls~N~l~~~~p------------------~~~~~l~~L~~L~L~~N~l~~~~------------------p~~~~~ 200 (941)
+.|++++|.+..... ..+..++.++.|++++|.+.... ...+..
T Consensus 123 ~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 202 (353)
T d1jl5a_ 123 KIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202 (353)
T ss_dssp CEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTT
T ss_pred eeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccccccccccccc
Confidence 999999998764322 23556778889999888766321 123456
Q ss_pred CCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCC---C-------
Q 002289 201 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD---L------- 270 (941)
Q Consensus 201 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---~------- 270 (941)
++.|+.+++++|.... ++. ...++..+.+.+|.+.. .+. ...++..+++..|.+.+...- .
T Consensus 203 l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~--~~~---~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~ 273 (353)
T d1jl5a_ 203 LPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD--LPE---LPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273 (353)
T ss_dssp CTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSEESCCCTTCCEEECCS
T ss_pred cccccccccccccccc-ccc---ccccccccccccccccc--ccc---ccccccccccccccccccccccchhccccccc
Confidence 7899999999998873 443 34678889999998864 222 234566666666655432111 0
Q ss_pred CCCCcccccccCCcCEEEccCCcCCCCcchhhcCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCC
Q 002289 271 SRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 350 (941)
Q Consensus 271 ~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~ 350 (941)
..+..+. -...+|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ..+|+.|+|++|+|+.+
T Consensus 274 ~~~~~~~-~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~--------~~~L~~L~L~~N~L~~l 339 (353)
T d1jl5a_ 274 NEIRSLC-DLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL--------PQNLKQLHVEYNPLREF 339 (353)
T ss_dssp SCCSEEC-CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC--------CTTCCEEECCSSCCSSC
T ss_pred Ccccccc-ccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc--------cCCCCEEECcCCcCCCC
Confidence 0011110 11357999999999999 5664 4678999999999998 67754 24688999999999998
Q ss_pred CCCCCCCCCcEEEe
Q 002289 351 SGSFNIPPNVTVRL 364 (941)
Q Consensus 351 ~~~~~~~~~~~l~l 364 (941)
|... ..+.+|.+
T Consensus 340 p~~~--~~L~~L~~ 351 (353)
T d1jl5a_ 340 PDIP--ESVEDLRM 351 (353)
T ss_dssp CCCC--TTCCEEEC
T ss_pred Cccc--cccCeeEC
Confidence 7532 23556654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.6e-16 Score=159.94 Aligned_cols=141 Identities=26% Similarity=0.325 Sum_probs=68.4
Q ss_pred EEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccc
Q 002289 87 LQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI 166 (941)
Q Consensus 87 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 166 (941)
+.+..+++++.++ ...+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..| ++++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 3444455554332 2345566666666666652 22 35555666666666666653322 55555555555555555
Q ss_pred cccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCC
Q 002289 167 SGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 167 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 239 (941)
... + .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|+++
T Consensus 97 ~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 97 ADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp CCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred ccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccccccccccccccc
Confidence 422 1 244555555555555544421 123444445555554444442 1 23444444444444444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.7e-16 Score=159.71 Aligned_cols=160 Identities=25% Similarity=0.397 Sum_probs=137.1
Q ss_pred ceeeEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeec
Q 002289 82 LHLRELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 161 (941)
Q Consensus 82 ~~l~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 161 (941)
.++++|++++++++. + +.+..+++|++|+|++|+|++..| ++++++|++|++++|.+. .++ .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 468999999999985 3 358899999999999999996543 899999999999999998 444 4899999999999
Q ss_pred ccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCcCCCCCCccCCCCCCCCEEeccCCcCCCC
Q 002289 162 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 241 (941)
Q Consensus 162 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 241 (941)
++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|++|++++|++++. ..++++++|++|+|++|+++.
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~- 186 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSD- 186 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCC-
Confidence 99998754 358889999999999999983 43 588999999999999999964 358999999999999999985
Q ss_pred CcchhccCCCCCcEE
Q 002289 242 TIPASYSNMSKLLKL 256 (941)
Q Consensus 242 ~~p~~~~~l~~L~~L 256 (941)
++ .++++++|+.|
T Consensus 187 -i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 -IS-VLAKLTNLESL 199 (199)
T ss_dssp -CG-GGGGCTTCSEE
T ss_pred -Cc-cccCCCCCCcC
Confidence 33 57888888876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=4.2e-17 Score=185.56 Aligned_cols=286 Identities=16% Similarity=0.151 Sum_probs=150.1
Q ss_pred eeeEEEecCCCCCcc-CCccccCCCCCCEEEcccCCCCC----CCCCccCCccccceecccCccccCC----CCcccC-C
Q 002289 83 HLRELQLLNLNLSGN-LSPEIGRLSYLTILDFMWNKISG----SIPKEIGNIKSLELLLLNGNELTGS----LPEELG-Y 152 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 152 (941)
+|++||++++++++. +..-+..+++|++|+|++|+|+. .+...+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 577777777777653 23345556777777777777652 2234455667777777777776521 112222 2
Q ss_pred cCccceeeccccccccc----CCcccccccccceEecccccccccCc---------------------------------
Q 002289 153 LPKLDRIQIDQNYISGS----LPKSFANLNKTRHFHMNNNSISGQIP--------------------------------- 195 (941)
Q Consensus 153 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p--------------------------------- 195 (941)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 24677777777777643 34455666777777777776542100
Q ss_pred hhccCCCccceeec---------------------------------------------------------cCCcCCC--
Q 002289 196 PELSRLPSLVHMLL---------------------------------------------------------DNNNLTG-- 216 (941)
Q Consensus 196 ~~~~~l~~L~~L~L---------------------------------------------------------~~N~l~~-- 216 (941)
..+.....++.+++ ++|++..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 00011122233333 2222210
Q ss_pred ---CCCccCCCCCCCCEEeccCCcCCCCC---cchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEcc
Q 002289 217 ---YLPPELSELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLS 290 (941)
Q Consensus 217 ---~~p~~~~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls 290 (941)
...........|+.|++++|.+.... ....+...+.++.+++++|.++.... ..+..........|+.++++
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~--~~l~~~l~~~~~~L~~l~l~ 320 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA--RLLCETLLEPGCQLESLWVK 320 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH--HHHHHHHTSTTCCCCEEECT
T ss_pred cchhhccccccccccccccccccccccccccccccccccccccccccccccccccccc--chhhcccccccccccccccc
Confidence 01111222334555555555443210 11223344555555555555531100 00000001122457889999
Q ss_pred CCcCCCCcchhh----cCCcccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCC-----CCC-CCCCCc
Q 002289 291 NNKLTGTIPSNF----SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-----GSF-NIPPNV 360 (941)
Q Consensus 291 ~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~-----~~~-~~~~~~ 360 (941)
+|.++......+ ...++|++|+|++|+|++.....+...-.-....|++|+|++|+|+... ..+ ..+.++
T Consensus 321 ~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~ 400 (460)
T d1z7xw1 321 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400 (460)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred ccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCC
Confidence 998876544433 4556899999999988743222232211112356889999999987631 112 457788
Q ss_pred EEEecCCCCc
Q 002289 361 TVRLRGNPFC 370 (941)
Q Consensus 361 ~l~l~~Np~~ 370 (941)
+|+|++|++.
T Consensus 401 ~L~Ls~N~i~ 410 (460)
T d1z7xw1 401 ELDLSNNCLG 410 (460)
T ss_dssp EEECCSSSCC
T ss_pred EEECCCCcCC
Confidence 9999999864
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=6.2e-15 Score=142.53 Aligned_cols=112 Identities=20% Similarity=0.166 Sum_probs=58.2
Q ss_pred cccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCccccccccc
Q 002289 101 EIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 180 (941)
Q Consensus 101 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 180 (941)
.+.+..+|++|||++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 3445555666666666665 33444455666666666666665 232 35555566666666666554444444455555
Q ss_pred ceEecccccccccCc-hhccCCCccceeeccCCcCC
Q 002289 181 RHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 181 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 215 (941)
+.|+|++|+|+.... ..+..+++|++|++++|.++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc
Confidence 555555555542111 23344444444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=5.9e-15 Score=142.72 Aligned_cols=131 Identities=21% Similarity=0.206 Sum_probs=95.7
Q ss_pred ccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCcc
Q 002289 125 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 204 (941)
Q Consensus 125 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 204 (941)
.|.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+.. +.|..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 4667778888888888888 5577777788888888888888844 347788888888888888886655566678888
Q ss_pred ceeeccCCcCCCCCC-ccCCCCCCCCEEeccCCcCCCCCc--chhccCCCCCcEEEc
Q 002289 205 VHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTI--PASYSNMSKLLKLSL 258 (941)
Q Consensus 205 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~--p~~~~~l~~L~~L~L 258 (941)
++|++++|+|+.... ..+..+++|++|++++|.++.... +..+..+++|++||-
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 888888888874322 356777888888888887764211 124666777777653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=3.3e-14 Score=130.68 Aligned_cols=55 Identities=22% Similarity=0.338 Sum_probs=25.6
Q ss_pred EEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeeccccccc
Q 002289 110 ILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS 167 (941)
Q Consensus 110 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 167 (941)
+|||++|+|+ .++ .+.++++|++|+|++|+|+ .+|..|+.+++|+.|++++|+|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 56 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc
Confidence 4455555554 233 2444455555555555554 33444444444444444444444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=3.1e-14 Score=130.87 Aligned_cols=101 Identities=27% Similarity=0.433 Sum_probs=51.3
Q ss_pred eecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccCCCccceeeccCCc
Q 002289 134 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 213 (941)
Q Consensus 134 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 213 (941)
+|+|++|+++ .++ .+..+++|++|+|++|+|+ .+|..|..+++|+.|++++|+|++ +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4555555555 333 2455555555555555555 334445555555555555555552 22 24555555555555555
Q ss_pred CCCCCC-ccCCCCCCCCEEeccCCcCC
Q 002289 214 LTGYLP-PELSELPKLLILQLDNNNFE 239 (941)
Q Consensus 214 l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 239 (941)
|+.... ..+..+++|+.|+|++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 553221 34455555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=2.7e-15 Score=164.56 Aligned_cols=94 Identities=16% Similarity=0.164 Sum_probs=53.2
Q ss_pred CCccccCCCCCCEEEcccCCCCCC----CCCccCCccccceecccCccccCCC----------CcccCCcCccceeeccc
Q 002289 98 LSPEIGRLSYLTILDFMWNKISGS----IPKEIGNIKSLELLLLNGNELTGSL----------PEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----------p~~~~~l~~L~~L~Ls~ 163 (941)
+...+.....|+.|+|++|.|... +-..+...++|+.|+++++.+.... ...+..+++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 334556667777777777766421 2234556677777777766544211 12234456677777777
Q ss_pred cccccc----CCcccccccccceEeccccccc
Q 002289 164 NYISGS----LPKSFANLNKTRHFHMNNNSIS 191 (941)
Q Consensus 164 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 191 (941)
|.++.. +...+...++|+.|++++|.+.
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred cccccccccchhhhhcccccchheeccccccc
Confidence 766543 2233445566666666666654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=3.3e-15 Score=163.81 Aligned_cols=235 Identities=17% Similarity=0.201 Sum_probs=155.0
Q ss_pred eeeEEEecCCCCCcc----CCccccCCCCCCEEEcccCCCCCCC----------CCccCCccccceecccCccccCC---
Q 002289 83 HLRELQLLNLNLSGN----LSPEIGRLSYLTILDFMWNKISGSI----------PKEIGNIKSLELLLLNGNELTGS--- 145 (941)
Q Consensus 83 ~l~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~----------p~~~~~l~~L~~L~Ls~N~l~~~--- 145 (941)
.+++|+|++|.+... +...+...++|+.|+++++.+.... ...+...++|++|+|++|.++..
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 111 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccccc
Confidence 588999999988643 4456778899999999988654221 22345678999999999999864
Q ss_pred -CCcccCCcCccceeecccccccccCCcc-------------cccccccceEecccccccccC----chhccCCCcccee
Q 002289 146 -LPEELGYLPKLDRIQIDQNYISGSLPKS-------------FANLNKTRHFHMNNNSISGQI----PPELSRLPSLVHM 207 (941)
Q Consensus 146 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L 207 (941)
+...+..+++|++|+|++|.+....... ....+.|+.|++++|+++... ...+...++|++|
T Consensus 112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L 191 (344)
T d2ca6a1 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred chhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccc
Confidence 2334556789999999999876321111 134567888999988876332 2334567788899
Q ss_pred eccCCcCCCC-----CCccCCCCCCCCEEeccCCcCCCC---CcchhccCCCCCcEEEccCCCCcCCCCC-CCCCCcccc
Q 002289 208 LLDNNNLTGY-----LPPELSELPKLLILQLDNNNFEGT---TIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGY 278 (941)
Q Consensus 208 ~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~l~~ 278 (941)
+|++|+++.. +...+..+++|+.|+|++|.++.. .+...+..+++|++|+|++|.|++.... +. ..+..
T Consensus 192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~--~~l~~ 269 (344)
T d2ca6a1 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV--DAFSK 269 (344)
T ss_dssp ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH--HHHHT
T ss_pred ccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH--HHhhh
Confidence 9998888632 234566778888888888887531 1345567788888888888887632110 00 01111
Q ss_pred cccCCcCEEEccCCcCCCCc----chhhc-CCcccceeecccccCc
Q 002289 279 LLSLNITTIKLSNNKLTGTI----PSNFS-GLPRLQRLFIANNSLS 319 (941)
Q Consensus 279 l~~~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~Ls~N~l~ 319 (941)
.....|++|+|++|+|+..- ...+. ++++|+.|+|++|++.
T Consensus 270 ~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 270 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred ccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 12245677777777776432 22232 4566777777777765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.2e-14 Score=154.49 Aligned_cols=223 Identities=14% Similarity=0.150 Sum_probs=136.2
Q ss_pred eEEEecCCCCCccCCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCC-CCcccCCcCccceeeccc
Q 002289 85 RELQLLNLNLSGNLSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGS-LPEELGYLPKLDRIQIDQ 163 (941)
Q Consensus 85 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~ 163 (941)
+.|||+++++.......+.. ..+..+.++...+..... ......+|++|||++|.++.. +...+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 46777777665332222211 235566666665553322 334556788888888877643 344567788888888888
Q ss_pred ccccccCCcccccccccceEecccc-ccccc-CchhccCCCccceeeccCC-cCCCC-CCccCC-CCCCCCEEeccCC--
Q 002289 164 NYISGSLPKSFANLNKTRHFHMNNN-SISGQ-IPPELSRLPSLVHMLLDNN-NLTGY-LPPELS-ELPKLLILQLDNN-- 236 (941)
Q Consensus 164 N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~-~l~~L~~L~Ls~N-- 236 (941)
|.++...+..++.+++|++|+|+++ .++.. +...+.++++|++|+++++ .++.. +...+. ..++|+.|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 8877777777777888888888874 45422 1222345778888888875 34321 111222 2467888888764
Q ss_pred cCCCCCcchhccCCCCCcEEEccCCC-CcCCCCCCCCCCcccccccCCcCEEEccC-CcCCCCcchhhcCCcccceeecc
Q 002289 237 NFEGTTIPASYSNMSKLLKLSLRNCS-LQGPMPDLSRIPNLGYLLSLNITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIA 314 (941)
Q Consensus 237 ~l~~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls 314 (941)
.++...+...+.++++|++|++++|. +++... ..+ ...++|++|+|++ +.|+......++++++|+.|+++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~-----~~l--~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~ 233 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF-----QEF--FQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGG-----GGG--GGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred ccccccccccccccccccccccccccCCCchhh-----hhh--cccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeee
Confidence 34432344445667888888888764 443211 111 1234668888887 45776666777788888888887
Q ss_pred cc
Q 002289 315 NN 316 (941)
Q Consensus 315 ~N 316 (941)
++
T Consensus 234 ~~ 235 (284)
T d2astb2 234 GI 235 (284)
T ss_dssp TS
T ss_pred CC
Confidence 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=4.8e-15 Score=168.24 Aligned_cols=192 Identities=17% Similarity=0.129 Sum_probs=120.8
Q ss_pred ccccceEecccccccc-----cCchhccCCCccceeeccCCcCCCCC----CccCCCCCCCCEEeccCCcCCCCCc---c
Q 002289 177 LNKTRHFHMNNNSISG-----QIPPELSRLPSLVHMLLDNNNLTGYL----PPELSELPKLLILQLDNNNFEGTTI---P 244 (941)
Q Consensus 177 l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~~---p 244 (941)
.+.++.+++.+|++.. .....+.....|+.|++++|.+.... ...+...+.++.+++++|.+..... .
T Consensus 225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~ 304 (460)
T d1z7xw1 225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 304 (460)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence 3455566666665432 12233345678999999999987432 2334567899999999999864111 1
Q ss_pred hh-ccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCC----cchhhc-CCcccceeecccccC
Q 002289 245 AS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGT----IPSNFS-GLPRLQRLFIANNSL 318 (941)
Q Consensus 245 ~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l 318 (941)
.. ......|+.+++++|.++..... .+..+ .....+|++|+|++|+|+.. ++..+. ..+.|++|+|++|+|
T Consensus 305 ~~l~~~~~~L~~l~l~~~~l~~~~~~--~l~~~-~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i 381 (460)
T d1z7xw1 305 ETLLEPGCQLESLWVKSCSFTAACCS--HFSSV-LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381 (460)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHH--HHHHH-HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred ccccccccccccccccccchhhhhhh--hcccc-cccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence 11 23456899999999988632110 11111 11235689999999999754 344443 467799999999999
Q ss_pred ccCCCcccccccccCccccceEEccCCCCCCC-----CCCC--CCCCCcEEEecCCCCccC
Q 002289 319 SGSIPSSIWQSRTLNATETFILDFQNNNLTNI-----SGSF--NIPPNVTVRLRGNPFCLN 372 (941)
Q Consensus 319 ~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~-----~~~~--~~~~~~~l~l~~Np~~c~ 372 (941)
+..-...+...-. ..++|++|||++|+|+.- ...+ +...+..|++.+|.|..+
T Consensus 382 ~~~~~~~l~~~l~-~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 382 SDSSCSSLAATLL-ANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CHHHHHHHHHHHH-HCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred ChHHHHHHHHHHh-cCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 7432222221100 135788999999999752 1111 334578999999998653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.5e-12 Score=124.61 Aligned_cols=118 Identities=17% Similarity=0.112 Sum_probs=69.4
Q ss_pred CCCCEEeccCCcCCCCCcchhccCCCCCcEEEccCCCCcCCCCCCCCCCcccccccCCcCEEEccCCcCCCCcchhhcCC
Q 002289 226 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLLSLNITTIKLSNNKLTGTIPSNFSGL 305 (941)
Q Consensus 226 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l 305 (941)
...+.++.+++.+.. .|..+..+++|++|++++|+ .|+.+.+.+|.++
T Consensus 8 ~~~~~l~c~~~~~~~--~p~~l~~l~~l~~L~l~~n~------------------------------~l~~i~~~~f~~l 55 (156)
T d2ifga3 8 HGSSGLRCTRDGALD--SLHHLPGAENLTELYIENQQ------------------------------HLQHLELRDLRGL 55 (156)
T ss_dssp SSSSCEECCSSCCCT--TTTTSCSCSCCSEEECCSCS------------------------------SCCEECGGGSCSC
T ss_pred CCCCeEEecCCCCcc--CcccccCccccCeeecCCCc------------------------------cccccCchhhccc
Confidence 344556666666652 44555555555555554332 2444444555556
Q ss_pred cccceeecccccCccCCCcccccccccCccccceEEccCCCCCCCCCCC-CCCCCcEEEecCCCCccCCCcccccC
Q 002289 306 PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNAEQFCG 380 (941)
Q Consensus 306 ~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~~L~~L~Ls~N~l~~~~~~~-~~~~~~~l~l~~Np~~c~c~~~~~~~ 380 (941)
++|+.|+|++|+|+...|..|..+ ++|++|+|++|+|+.++... ....+.+|+|++|||.|+|.+.++-.
T Consensus 56 ~~L~~L~Ls~N~l~~i~~~~f~~l-----~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~ 126 (156)
T d2ifga3 56 GELRNLTIVKSGLRFVAPDAFHFT-----PRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126 (156)
T ss_dssp CCCSEEECCSSCCCEECTTGGGSC-----SCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHH
T ss_pred cccCcceeeccccCCccccccccc-----ccccceeccCCCCcccChhhhccccccccccCCCcccCCchHHHHHH
Confidence 666666666666654434444332 34446666666666665444 34467899999999999999876644
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=1.5e-14 Score=144.77 Aligned_cols=113 Identities=23% Similarity=0.289 Sum_probs=69.4
Q ss_pred CCccccCCCCCCEEEcccCCCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccc
Q 002289 98 LSPEIGRLSYLTILDFMWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL 177 (941)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 177 (941)
++..+..|++|++|+|++|+|+ .++ .|.++++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.. ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence 3455667777777777777776 333 4666777777777777776 4555455555677777777766632 235566
Q ss_pred cccceEecccccccccCc-hhccCCCccceeeccCCcCC
Q 002289 178 NKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 178 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 215 (941)
++|+.|+|++|+|+.... ..+..+++|++|+|++|.+.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 666666666666653211 34555666666666666554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=1.5e-14 Score=144.73 Aligned_cols=131 Identities=20% Similarity=0.300 Sum_probs=108.0
Q ss_pred CCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccCchhccC
Q 002289 121 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 200 (941)
Q Consensus 121 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 200 (941)
.+|..+..+++|++|+|++|+|+ .++ .+.++++|+.|+|++|.|+ .+|..+..+++|++|++++|+++. + +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 45677889999999999999999 454 5889999999999999998 566667777899999999999984 3 35788
Q ss_pred CCccceeeccCCcCCCCCC-ccCCCCCCCCEEeccCCcCCCCCcch----------hccCCCCCcEEE
Q 002289 201 LPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPA----------SYSNMSKLLKLS 257 (941)
Q Consensus 201 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~p~----------~~~~l~~L~~L~ 257 (941)
+++|+.|++++|+|+.... ..+..+++|+.|+|++|++.. ..+. .+..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN-DYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH-HHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCcccc-CcccccchhhHHHHHHHHCCCcCEeC
Confidence 9999999999999985422 468999999999999999864 1211 267789999987
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=2.8e-13 Score=143.85 Aligned_cols=222 Identities=17% Similarity=0.198 Sum_probs=153.5
Q ss_pred CEEEcccCCCCCCCCCccCCcc--ccceecccCccccCCCCcccCCcCccceeeccccccccc-CCcccccccccceEec
Q 002289 109 TILDFMWNKISGSIPKEIGNIK--SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKSFANLNKTRHFHM 185 (941)
Q Consensus 109 ~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L 185 (941)
+.|||+++.+. |+.++.+. .+..+.++.+.+...+. ......+|++|||++|.++.. ++..+..+++|++|+|
T Consensus 3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCC---chHHHHHHhccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 57999998876 44444332 35666777777663333 344567899999999998754 4556888999999999
Q ss_pred ccccccccCchhccCCCccceeeccCC-cCCCC-CCccCCCCCCCCEEeccCC-cCCCCCcchhccC-CCCCcEEEccCC
Q 002289 186 NNNSISGQIPPELSRLPSLVHMLLDNN-NLTGY-LPPELSELPKLLILQLDNN-NFEGTTIPASYSN-MSKLLKLSLRNC 261 (941)
Q Consensus 186 ~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~~p~~~~~-l~~L~~L~Ls~N 261 (941)
++|++++..+..++.+++|++|+++++ .++.. +...+.++++|++|+|+++ .++...+...+.. .++|+.|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~ 158 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccc
Confidence 999998888888999999999999985 56522 1122456899999999985 4543223333433 478999999875
Q ss_pred C--CcCCCCCCCCCCcccccccCCcCEEEccCC-cCCCCcchhhcCCcccceeecccc-cCccCCCcccccccccCcccc
Q 002289 262 S--LQGPMPDLSRIPNLGYLLSLNITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANN-SLSGSIPSSIWQSRTLNATET 337 (941)
Q Consensus 262 ~--l~~~~~~~~~l~~l~~l~~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~l~~~~L 337 (941)
. ++.. .+..+ ....++|++|+|++| .+++.....+.++++|++|+|++| .+++.....+.+ .++|
T Consensus 159 ~~~i~~~-----~l~~l-~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~-----~~~L 227 (284)
T d2astb2 159 RKNLQKS-----DLSTL-VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE-----IPTL 227 (284)
T ss_dssp GGGSCHH-----HHHHH-HHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG-----CTTC
T ss_pred ccccccc-----ccccc-ccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhc-----CCCC
Confidence 3 3210 01111 112357899999986 488788888899999999999995 566544444433 3467
Q ss_pred ceEEccCC
Q 002289 338 FILDFQNN 345 (941)
Q Consensus 338 ~~L~Ls~N 345 (941)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 78888776
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=2.5e-12 Score=123.05 Aligned_cols=93 Identities=15% Similarity=0.194 Sum_probs=74.6
Q ss_pred CCccccCCCCCCEEEcccC-CCCCCCCCccCCccccceecccCccccCCCCcccCCcCccceeecccccccccCCccccc
Q 002289 98 LSPEIGRLSYLTILDFMWN-KISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFAN 176 (941)
Q Consensus 98 ~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 176 (941)
.|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+...+..|.++++|++|+|++|+|+...++.|..
T Consensus 23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 102 (156)
T d2ifga3 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG 102 (156)
T ss_dssp TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc
Confidence 4566778889999999766 488666678888999999999999998777888888999999999999988555555554
Q ss_pred ccccceEeccccccc
Q 002289 177 LNKTRHFHMNNNSIS 191 (941)
Q Consensus 177 l~~L~~L~L~~N~l~ 191 (941)
+ +|+.|+|++|.+.
T Consensus 103 ~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 103 L-SLQELVLSGNPLH 116 (156)
T ss_dssp C-CCCEEECCSSCCC
T ss_pred c-cccccccCCCccc
Confidence 4 6888888888875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=3.4e-09 Score=101.48 Aligned_cols=86 Identities=13% Similarity=0.106 Sum_probs=37.0
Q ss_pred ccccceecccCccccCCCCcccCCcCccceeecccccccccC--CcccccccccceEecccccccccCchhccCCCccce
Q 002289 129 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL--PKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 206 (941)
Q Consensus 129 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 206 (941)
+..+..|++.+|... .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+...+-.+....+|+.
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~ 119 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence 333344444333332 23333344455555555555555321 233444555555555555554222212222334555
Q ss_pred eeccCCcCC
Q 002289 207 MLLDNNNLT 215 (941)
Q Consensus 207 L~L~~N~l~ 215 (941)
|++++|.+.
T Consensus 120 L~L~~Npl~ 128 (162)
T d1koha1 120 LWLDGNSLS 128 (162)
T ss_dssp CCCTTSTTS
T ss_pred eecCCCCcC
Confidence 555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1.8e-08 Score=96.27 Aligned_cols=121 Identities=21% Similarity=0.159 Sum_probs=68.5
Q ss_pred ccceecccCccccCCCCcccCCcCccceeecccccccccCCcccccccccceEecccccccccC--chhccCCCccceee
Q 002289 131 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI--PPELSRLPSLVHML 208 (941)
Q Consensus 131 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ 208 (941)
..+.|+++++... ..+..+..+..+++.+|... .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3556666655432 22444455555555555443 44455566777777777777777432 33455677777777
Q ss_pred ccCCcCCCCCCccCCCCCCCCEEeccCCcCCCCCcc-------hhccCCCCCcEEE
Q 002289 209 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP-------ASYSNMSKLLKLS 257 (941)
Q Consensus 209 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~p-------~~~~~l~~L~~L~ 257 (941)
|++|+|+...+-.+....+|+.|+|++|.+... .. ..+..+++|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~-~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDT-FRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS-SSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcC-cccchhHHHHHHHHCCCCCEEC
Confidence 777777743332333344567777777776542 21 1244556666553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=4.9e-07 Score=93.22 Aligned_cols=148 Identities=14% Similarity=0.112 Sum_probs=100.7
Q ss_pred HHHHHhcCCCccceeeccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEE
Q 002289 603 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQM 681 (941)
Q Consensus 603 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 681 (941)
++...-+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555556776655544445568998875 45567788876543333446788998888774 333567788888888899
Q ss_pred EEEecCCCCCHHHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhcCC----------------------------------
Q 002289 682 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---------------------------------- 727 (941)
Q Consensus 682 LV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------- 727 (941)
+||++++|.++.+...... ....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~~-------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ-------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS-------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEecccccccccccccc-------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999988866542111 12234555666666666411
Q ss_pred ----------------------CCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 728 ----------------------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 728 ----------------------~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127899999999999987767799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=1.1e-05 Score=82.33 Aligned_cols=130 Identities=22% Similarity=0.167 Sum_probs=85.6
Q ss_pred eeeccCc-EEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCC--CceeeeeeccccCCcEEEEEecCCCCCH
Q 002289 616 QIGQGGY-GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTL 692 (941)
Q Consensus 616 ~lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~LV~e~~~~gsL 692 (941)
.+..|.. +.||+...+++..+++|...... ...+..|.+.++.+.. -.+.+++++..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 57999998888889999876533 2357788888887743 3356778888888889999999988665
Q ss_pred HHHHhhcCCCCccHHHHHHHHHHHHHHHHHhhc-----------------------------------------------
Q 002289 693 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT----------------------------------------------- 725 (941)
Q Consensus 693 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~----------------------------------------------- 725 (941)
.+.. ... ...+.++++.|+-||+
T Consensus 94 ~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 3210 000 0111222223333332
Q ss_pred ----C----CCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 726 ----E----ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 726 ----~----~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
. ..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11237999999999999987777899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.52 E-value=1.9e-05 Score=75.05 Aligned_cols=38 Identities=24% Similarity=0.188 Sum_probs=17.2
Q ss_pred CCccceeeccCCcCCCC----CCccCCCCCCCCEEeccCCcC
Q 002289 201 LPSLVHMLLDNNNLTGY----LPPELSELPKLLILQLDNNNF 238 (941)
Q Consensus 201 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 238 (941)
.+.|++|+|++|.++.. +-..+...++|++|+|++|.+
T Consensus 71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence 34455555555544421 112334444555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.40 E-value=1.4e-05 Score=75.91 Aligned_cols=64 Identities=16% Similarity=0.199 Sum_probs=33.4
Q ss_pred CcCccceeeccccccccc----CCcccccccccceEecccccccccC----chhccCCCccceeeccCCcCC
Q 002289 152 YLPKLDRIQIDQNYISGS----LPKSFANLNKTRHFHMNNNSISGQI----PPELSRLPSLVHMLLDNNNLT 215 (941)
Q Consensus 152 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~ 215 (941)
..++|++|+|++|.+... +...+...+.|+.|+|++|.|+... -.++...++|++|+|++|.+.
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 334455555555544421 1223334456666666666665321 223455567777777777655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.25 E-value=0.00055 Score=74.08 Aligned_cols=77 Identities=18% Similarity=0.091 Sum_probs=49.1
Q ss_pred cceeeccCcEEEEEEEeCC-CcEEEEEEeccC------C-chhhHhHHHHHHHHHhcC-C--CceeeeeeccccCCcEEE
Q 002289 614 STQIGQGGYGKVYKGILPD-GTVVAVKRAQEG------S-LQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEEGEQML 682 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~L 682 (941)
.+.||.|....||+....+ ++.|+||..... . .....+...|.+.|+.+. + ..+.+++.+. ++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 3568999999999998654 678999965321 1 111234567888887763 2 3455666553 445679
Q ss_pred EEecCCCCCH
Q 002289 683 VYEFMSNGTL 692 (941)
Q Consensus 683 V~e~~~~gsL 692 (941)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.64 E-value=0.0036 Score=65.53 Aligned_cols=68 Identities=19% Similarity=0.193 Sum_probs=46.3
Q ss_pred EEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCce--eeeee-----ccccCCcEEEEEecCCCCC
Q 002289 623 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL--VSLVG-----YCDEEGEQMLVYEFMSNGT 691 (941)
Q Consensus 623 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~-----~~~~~~~~~LV~e~~~~gs 691 (941)
-.||++..++|+.|++|+..... ...+++..|.+.+..+....+ +..+. .+...+..+.|+++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 48999999999999999987542 234678889988888753222 22221 1234566789999997643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.48 E-value=0.00012 Score=69.23 Aligned_cols=16 Identities=19% Similarity=0.169 Sum_probs=8.2
Q ss_pred CCCCCCCCEEeccCCc
Q 002289 222 LSELPKLLILQLDNNN 237 (941)
Q Consensus 222 ~~~l~~L~~L~Ls~N~ 237 (941)
+...++|+.|+++.|.
T Consensus 128 L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 128 LEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHCSSCCEEECCCSS
T ss_pred HHhCCCcCEEeCcCCC
Confidence 3344555555555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.48 E-value=0.00019 Score=67.68 Aligned_cols=86 Identities=15% Similarity=0.221 Sum_probs=37.4
Q ss_pred cccccceEecccccccccC----chhccCCCccceeeccCCcCCCC----CCccCCCCCCCCEEec--cCCcCCCC---C
Q 002289 176 NLNKTRHFHMNNNSISGQI----PPELSRLPSLVHMLLDNNNLTGY----LPPELSELPKLLILQL--DNNNFEGT---T 242 (941)
Q Consensus 176 ~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~---~ 242 (941)
..++|++|+|++|.++... -..+...++|+.|++++|.++.. +...+...++|+.++| ++|.+... .
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 3444555555555443221 12233345555555555555422 1233444555554333 34444310 1
Q ss_pred cchhccCCCCCcEEEccCC
Q 002289 243 IPASYSNMSKLLKLSLRNC 261 (941)
Q Consensus 243 ~p~~~~~l~~L~~L~Ls~N 261 (941)
+...+...++|+.|+++.+
T Consensus 124 La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHhCCCcCEEeCcCC
Confidence 2233444555555555443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.93 E-value=0.0071 Score=62.77 Aligned_cols=157 Identities=10% Similarity=0.047 Sum_probs=83.5
Q ss_pred cchHHHHHHhcCCCcccee-----eccCcEEEEEEEeCCCcEEEEEEeccCCchhhHhHHHHHHHHHhcCCCce--eeee
Q 002289 599 FTYGEMALATNNFNSSTQI-----GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL--VSLV 671 (941)
Q Consensus 599 ~~~~~~~~~~~~y~~~~~l-----G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~ 671 (941)
.+.++++....+|.+.+.. ..|---+.|+....+|+ +++|+.... ...+++..|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 3456777777788775443 35555688998876665 889987643 223456667777777743222 1111
Q ss_pred ec------cccCCcEEEEEecCCCCCHHH--------------HHhhc----C-----CCCcc----------------H
Q 002289 672 GY------CDEEGEQMLVYEFMSNGTLRD--------------QLSAK----S-----KEPLG----------------F 706 (941)
Q Consensus 672 ~~------~~~~~~~~LV~e~~~~gsL~~--------------~l~~~----~-----~~~l~----------------~ 706 (941)
.. ....+....++.+..+..... .++.. . ..... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 122345667777776543310 01100 0 00000 0
Q ss_pred HHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCcEEEcCCCcEEEeeecccc
Q 002289 707 AMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 758 (941)
Q Consensus 707 ~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFGla~ 758 (941)
......+..+...+.-.+.. -...+||+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00111222222223332221 12339999999999999988877899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.77 E-value=0.0081 Score=64.60 Aligned_cols=73 Identities=15% Similarity=0.146 Sum_probs=49.6
Q ss_pred cceeeccCcEEEEEEEeCC--------CcEEEEEEeccCCchhhHhHHHHHHHHHhcC-CCceeeeeeccccCCcEEEEE
Q 002289 614 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 684 (941)
Q Consensus 614 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~LV~ 684 (941)
++.|+.|-.-.+|+....+ .+.|++++.... .......+|.++++.+. +.-..++++++.. .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568888888999988643 356777776532 22334567888888884 4334577887754 5899
Q ss_pred ecCCCCCH
Q 002289 685 EFMSNGTL 692 (941)
Q Consensus 685 e~~~~gsL 692 (941)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.82 E-value=0.043 Score=55.82 Aligned_cols=16 Identities=0% Similarity=-0.228 Sum_probs=7.2
Q ss_pred ccCCCCCCCHHHHHHH
Q 002289 864 QDETDARPSMSEVMRE 879 (941)
Q Consensus 864 ~~~p~~RPs~~~v~~~ 879 (941)
...|-...+..++.+.
T Consensus 206 g~~Pf~~~~~~~~~~~ 221 (288)
T d1uu3a_ 206 GLPPFRAGNEYLIFQK 221 (288)
T ss_dssp SSCSSCCSSHHHHHHH
T ss_pred CCCCCCCcCHHHHHHH
Confidence 3444444455554443
|